Citrus Sinensis ID: 040472

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------63
Protein Sequence
MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDKKKEKNDRPRSFDGVIFRRSSPRESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccEEEEEEEcccccEEEEEEEEEcccccccHHHHHHHHHHHHHHHcccccccEEEEcEEEEccEEEEEEEEcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEcccccccccccccccccccccccccccEEEcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccEEEEEccccccEEEEEEcccccEEccccccccccccHHccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEccccccEEEEEEEcccccEEEEEEEEEcHHHcccHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccHHHcEEccccccEccccccHHHccHHHHcccccccccEEHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHHcccHcccccHHHHHcccHHccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccHcccccccccccccccccHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mpawwgkkssknkdeshspqgnhfnfikfsgdkkkekndrprsfdgvifrrsspreskdygiagagssgfsgfdsdsgekkghplprpldsimqsdhgnglgsgsgsvssvsssgssedhvigsdqgqfggsrsygdprvngdikfnlmpkspcagsrgptsptsplharlsgmsvdsptgkiedgksqchklplppgsptspsalpcsrtsgvtenslskwkkgkllgrgtfghvylgfnsesgqmcaikevrvvcddqtSKECLKQLNQEINLLSqlshpnivryhgselsdERLSVYLEYVSGGSIHKLLqeygpfnepvIQTYTRQILLGLAYLHARNTvhrdikganilvdphgeikladfgmakHMTSCAsmlsfkgspywmapevvmntngySLTVDIWSLGCTvlematskppwsqyeGVAAIFKignskdipeipehlsdDAKSFIKQClqrdpsarppasklldhpfvrDQAVARAgnvnlakdsspysldgsrtppkldllptrksitlcegdylanplvptsralnnprenartitslpvspcssplrqygpshkscflspphpsyavmgqssgynlgdysgyptrsnpryindpwletsllkaqtpgtsprsrpi
Flexible Loop (DISEMBL)
mpawwgkkssknkdeshspqgnhfnfikfsgdkkkekndrprsfdgvifrrsspreskdygiaGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSGSSEDHvigsdqgqfggsrSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTsgvtenslskwkkgkllgrGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARagnvnlakdsspysldgsrtppkldllpTRKSITLCEGDYlanplvptsralnnprenartitslpvspcsSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLEtsllkaqtpgtsprsrpi
Low Complexity Region (SEG)
MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDKKKEKNDRPRSFDGVIFRRSSPRESKDYGIagagssgfsgfdsdsgEKKGHPLPRPLDSIMQSDHGNGLgsgsgsvssvsssgssEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKlplppgsptspsalpCSRTSGVTENslskwkkgkllgRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI
Disordered region (IsUnstruct)
****************************************************************************************************************************************************************************************************************************KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK****************************************************************************RKSITLCEGDYLANPLV*******************************************************YNLGDYSGY******RYINDPWLE******************
Disordered Region (DISOPRED)
MPAW*************************************************************************************************************************************************************************************************************************WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVR*****************EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD****************************************************************************************************************************************************
Disordered Region (DISEMBL)
*******************QGNHFNFIKFSGD*********RSFDGVIFRRSSPRESKDYGIAGAGSSGFSG**********HPLPRPLDSIMQSDHG***********************IGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSP*************LHARLSGMSVDSPTGKIEDGKSQCHKLPLPP**********************SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLK*************
Disordered Region (DISPRO)
********************************************************************************KGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSR*YGD*RV*****************************************************************************SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSL*******KLDLLPTRKSITLCEGDYLANPLVPTSR*********************************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDKKKEKNDRPRSFDGVIFRRSSPRESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	628	2.2.26 [Sep-21-2011]
O22040	666	Mitogen-activated protein	no	no	0.407	0.384	0.549	2e-81
Q9FZ36	651	Mitogen-activated protein	no	no	0.409	0.394	0.528	2e-80
O22042	651	Mitogen-activated protein	no	no	0.409	0.394	0.516	2e-76
Q54R82	942	Mitogen-activated protein	no	no	0.412	0.274	0.484	5e-72
Q39008	608	Mitogen-activated protein	no	no	0.409	0.422	0.505	7e-70
Q10407	1116	MAP kinase kinase kinase	yes	no	0.426	0.240	0.430	1e-67
Q01389	1478	Serine/threonine-protein	yes	no	0.433	0.184	0.427	8e-64
P28829	659	Protein kinase byr2 OS=Sc	no	no	0.445	0.424	0.441	1e-63
Q99759	626	Mitogen-activated protein	yes	no	0.406	0.407	0.460	2e-63
Q61084	626	Mitogen-activated protein	yes	no	0.406	0.407	0.456	1e-62

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  304 bits (778), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 145/264 (54%), Positives = 193/264 (73%), Gaps = 8/264 (3%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD---DQTSKECLKQLNQEINLLSQ 278
           W+KG+L+GRG FG VY+G N +SG++ A+K+V +  +    + ++  +++L +E+ LL  
Sbjct: 69  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           LSHPNIVRY G+   D+ L++ LE+V GGSI  LL+++GPF E V++TYTRQ+LLGL YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMN 395
           H    +HRDIKGANILVD  G IKLADFG +K +   A+M    S KG+PYWMAPEV++ 
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQ 248

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWS-QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
           T G+S + DIWS+GCTV+EM T K PWS QY+ VAAIF IG +K  P IP+ LS DAK F
Sbjct: 249 T-GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDF 307

Query: 455 IKQCLQRDPSARPPASKLLDHPFV 478
           + +CLQ  P+ RP AS+LL HPFV
Sbjct: 308 LLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  300 bits (768), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 140/265 (52%), Positives = 194/265 (73%), Gaps = 8/265 (3%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD---DQTSKECLKQLNQEINLLS 277
           +W+KG+L+GRG FG VY+G N +SG++ A+K+V +  +    + ++  +++L +E+ LL 
Sbjct: 67  RWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLK 126

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            LSHPNIVRY G+   DE L++ LE+V GGSI  LL+++G F E V++TYT Q+LLGL Y
Sbjct: 127 NLSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEY 186

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSFKGSPYWMAPEVVM 394
           LH    +HRDIKGANILVD  G IKLADFG +K +   A++    S KG+PYWMAPEV++
Sbjct: 187 LHNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVIL 246

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWS-QYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
            T G+S + DIWS+GCTV+EM T K PWS QY+ +AAIF IG +K  P IP+++S DA  
Sbjct: 247 QT-GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDAND 305

Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
           F+ +CLQ++P+ RP AS+LL HPFV
Sbjct: 306 FLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  287 bits (734), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 137/265 (51%), Positives = 189/265 (71%), Gaps = 8/265 (3%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV---CDDQTSKECLKQLNQEINLLS 277
           +W+KG+L+G G FG VY+G N +SG++ AIK+V +       + ++  +++L +E+ LL 
Sbjct: 67  RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            LSHPNIVRY G+    + L++ +E+V GGSI  LL+++G F EPVI  YT+Q+LLGL Y
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSFKGSPYWMAPEVVM 394
           LH    +HRDIKGANILVD  G I+LADFG +K +   A++    S KG+PYWMAPEV++
Sbjct: 187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVIL 246

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWS-QYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
            T G+S + DIWS+GCTV+EMAT KPPWS QY+  AA+  IG +K  P IPE LS +AK 
Sbjct: 247 QT-GHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKD 305

Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
           F+ +CL ++PS R  A++LL HPFV
Sbjct: 306 FLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  272 bits (696), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 128/264 (48%), Positives = 183/264 (69%), Gaps = 5/264 (1%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV--CDDQTSKECLKQLNQEINLLSQ 278
           KW+KG++LGRG +G VYLG N ++G++ A+K++ +V    D   K  +   ++EI ++  
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           L H NIVRY G+ L    LSV+LEY+ GGSI  LL ++G F+E VI+ YT+QIL GL++L
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFL 288

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTN 397
           HA + +HRDIKGANIL+D  G +KL+DFG +K  +   S   S +G+PYWMAPEV+  T 
Sbjct: 289 HANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIKQT- 347

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI-FKIGNSKDIPEIPEHLSDDAKSFIK 456
           G+  + DIWSLGC ++EMAT++PPWS    +AA+ + I +S  IP IP H+S +A  F+ 
Sbjct: 348 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLN 407

Query: 457 QCLQRDPSARPPASKLLDHPFVRD 480
            C +RDP  RP A++LL HPF+ +
Sbjct: 408 LCFKRDPKERPDANQLLKHPFIMN 431

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  265 bits (678), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 133/263 (50%), Positives = 182/263 (69%), Gaps = 6/263 (2%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           ++ W+KG+LLGRG+FG VY G + + G   A+KEV ++     ++EC++QL  EI LLSQ
Sbjct: 330 ITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQ 388

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           L H NIVRY G+      L ++LE V+ GS+ KL Q Y    + V+  YTRQIL GL YL
Sbjct: 389 LQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRY-QLRDSVVSLYTRQILDGLKYL 447

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNT 396
           H +  +HRDIK ANILVD +G +KLADFG+AK ++    + S KG+P+WMAPEV+   ++
Sbjct: 448 HDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAPEVINRKDS 506

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           +GY    DIWSLGCTVLEM T + P+S  E V A+F+IG    +PE+P+ LS DA+ FI 
Sbjct: 507 DGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGT-LPEVPDTLSLDARLFIL 565

Query: 457 QCLQRDPSARPPASKLLDHPFVR 479
           +CL+ +P  RP A++LL+HPFVR
Sbjct: 566 KCLKVNPEERPTAAELLNHPFVR 588

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1

 Score =  258 bits (658), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 121/281 (43%), Positives = 183/281 (65%), Gaps = 13/281 (4%)

Query: 212  SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD-----DQTSKECL 266
            S V++N+  KW KG+L+G GT+G V+L  N  +G++ A+K+V +        DQ  K+ +
Sbjct: 815  SVVSQNATFKWMKGELIGNGTYGKVFLAMNINTGELIAVKQVEIPQTINGRHDQLRKDIV 874

Query: 267  KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
              +N EI++++ L H NIV+Y G E ++  +S++LEYVSGGSI + L+ YGPF E +++ 
Sbjct: 875  DSINAEISMIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYGPFEEQLVRF 934

Query: 327  YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---SMLSFKG 383
             +RQ+L GL+YLH++  +HRD+K  N+L+D  G  K++DFG++KH  +     + LS +G
Sbjct: 935  VSRQVLYGLSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDNDANLSMQG 994

Query: 384  SPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE 442
            S +WMAPEV+ N + GYS  VD+WSLGC VLEM   + PWS  E + A+FK+G  K  P 
Sbjct: 995  SIFWMAPEVIHNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAMFKLGTEKKAPP 1054

Query: 443  IPEHL----SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
            IP  L    S +A  F+  C   +   RP A +LL+HPF++
Sbjct: 1055 IPSELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095

May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q01389|BCK1_YEAST Serine/threonine-protein kinase BCK1/SLK1/SSP31 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=BCK1 PE=1 SV=1

 Score =  245 bits (625), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 120/281 (42%), Positives = 174/281 (61%), Gaps = 9/281 (3%)

Query: 222  WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV---VCDDQTSKECLKQLNQEINLLSQ 278
            W KG+++G+G+FG VYL  N  +G+M A+K+V V      ++     ++ L  E++ L  
Sbjct: 1175 WMKGEMIGKGSFGAVYLCLNVTTGEMMAVKQVEVPKYSSQNEAILSTVEALRSEVSTLKD 1234

Query: 279  LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
            L H NIV+Y G E  +   S++LEYV+GGS+  L++ YG F+EP+I+  T Q+L GLAYL
Sbjct: 1235 LDHLNIVQYLGFENKNNIYSLFLEYVAGGSVGSLIRMYGRFDEPLIKHLTTQVLKGLAYL 1294

Query: 339  HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM--LSFKGSPYWMAPEVVMNT 396
            H++  +HRD+K  N+L+D  G  K++DFG+++      S   ++ +G+ +WMAPE+V   
Sbjct: 1295 HSKGILHRDMKADNLLLDQDGICKISDFGISRKSKDIYSNSDMTMRGTVFWMAPEMVDTK 1354

Query: 397  NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH----LSDDAK 452
             GYS  VDIWSLGC VLEM   K PWS  E VAA+FKIG SK  P IPE     +S   +
Sbjct: 1355 QGYSAKVDIWSLGCIVLEMFAGKRPWSNLEVVAAMFKIGKSKSAPPIPEDTLPLISQIGR 1414

Query: 453  SFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAK 493
            +F+  C + +P  RP A++LL HPF          +  LAK
Sbjct: 1415 NFLDACFEINPEKRPTANELLSHPFSEVNETFNFKSTRLAK 1455

Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involve the kinase PKC1 that may act on this kinase. BCK1 probably phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  244 bits (623), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 129/292 (44%), Positives = 187/292 (64%), Gaps = 12/292 (4%)

Query: 197 PGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV 256
           P SPTS ++   +     T++   KW +G L+G G+FG VYLG N+ SG++ A+K+V + 
Sbjct: 369 PISPTSTTSEDTNTLEEDTDDQSIKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILD 428

Query: 257 CDDQTS---KECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL 313
              ++     + L  L  EI LL +LSH +IV+Y GS L+ + L+++LEYV GGS+  LL
Sbjct: 429 SVSESKDRHAKLLDALAGEIALLQELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLL 488

Query: 314 QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT 373
             YG F E +++ + +Q L GL YLH+R  VHRDIKGANILVD  G+IK++DFG++K + 
Sbjct: 489 TMYGSFEETLVKNFIKQTLKGLEYLHSRGIVHRDIKGANILVDNKGKIKISDFGISKKLE 548

Query: 374 SCASML-------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE 426
             ++         SF+GS +WMAPEVV  T  ++   DIWSLGC V+EM TSK P+   +
Sbjct: 549 LNSTSTKTGGARPSFQGSSFWMAPEVVKQT-MHTEKTDIWSLGCLVIEMLTSKHPYPNCD 607

Query: 427 GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
            + AIF+IG +  +PE P ++S  A  F+++    D + RP AS+LL HPFV
Sbjct: 608 QMQAIFRIGENI-LPEFPSNISSSAIDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  244 bits (622), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 122/265 (46%), Positives = 174/265 (65%), Gaps = 10/265 (3%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLS 280
           W++GKLLG+G FG VYL ++ ++G+  A K+V+   D  +TSKE +  L  EI LL  L 
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKE-VSALECEIQLLKNLQ 420

Query: 281 HPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           H  IV+Y+G   + +++ L++++EY+ GGS+   L+ YG   E V + YTRQIL G++YL
Sbjct: 421 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 480

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVM 394
           H+   VHRDIKGANIL D  G +KL DFG +K + T C S   M S  G+PYWM+PEV+ 
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVI- 539

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
           +  GY    D+WSLGCTV+EM T KPPW++YE +AAIFKI      P++P H+S+  + F
Sbjct: 540 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDF 599

Query: 455 IKQCLQRDPSARPPASKLLDHPFVR 479
           +++    +   RP A +LL H F +
Sbjct: 600 LRRIFV-EARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  241 bits (616), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 121/265 (45%), Positives = 174/265 (65%), Gaps = 10/265 (3%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLS 280
           W++GKLLG+G FG VYL ++ ++G+  A K+V+   D  +TSKE +  L  EI LL  L 
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKE-VSALECEIQLLKNLQ 420

Query: 281 HPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           H  IV+Y+G   + +++ L++++EY+ GGS+   L+ YG   E V + YTRQIL G++YL
Sbjct: 421 HERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 480

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVM 394
           H+   VHRDIKGANIL D  G +KL DFG +K + T C S   + S  G+PYWM+PEV+ 
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI- 539

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
           +  GY    D+WSLGCTV+EM T KPPW++YE +AAIFKI      P++P H+S+  + F
Sbjct: 540 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDF 599

Query: 455 IKQCLQRDPSARPPASKLLDHPFVR 479
           +++    +   RP A +LL H F +
Sbjct: 600 LRRIFV-EARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	628
297748058	661	mitogen-activated protein kinase kinase	0.996	0.947	0.683	0.0
225431467	623	PREDICTED: serine/threonine-protein kina	0.974	0.982	0.655	0.0
357464659	647	Mitogen-activated protein kinase kinase	0.984	0.955	0.627	0.0
296088548	600	unnamed protein product [Vitis vinifera]	0.942	0.986	0.649	0.0
224093390	610	predicted protein [Populus trichocarpa]	0.964	0.993	0.634	0.0
449461855	623	PREDICTED: serine/threonine-protein kina	0.966	0.974	0.641	0.0
449528853	623	PREDICTED: protein kinase wis1-like [Cuc	0.966	0.974	0.639	0.0
356516360	616	PREDICTED: mitogen-activated protein kin	0.936	0.954	0.631	0.0
224080951	594	predicted protein [Populus trichocarpa]	0.934	0.988	0.626	0.0
45476486	627	mitogen-activated kinase kinase kinase a	0.949	0.950	0.622	0.0

>gi|297748058|gb|ADI52619.1| mitogen-activated protein kinase kinase kinase [Gossypium hirsutum]

 Score =  848 bits (2191), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 453/663 (68%), Positives = 516/663 (77%), Gaps = 37/663 (5%)

Query: 1   MPAWWGKKSSKNKDES---HSPQGNHFNFIKFS-------------------GDKKKEKN 38
           MP WWGKKSSKNK++S    +P+G    F+KFS                        + N
Sbjct: 1   MPGWWGKKSSKNKEDSPRNQTPRGTSVGFLKFSPAKTDAATAAAAGKKKAPAATPDDKNN 60

Query: 39  DRPRSFD---GVIF-RRSSPRESKDYGIAGAGSSGFSGFDSDSG------EKKGHPLPRP 88
           + P+  D   G++F  RSSPR S+D+G+ G      SG    SG      EK+G PLP P
Sbjct: 61  NYPKGCDDGGGLVFSTRSSPRVSRDFGVGGGAVVPGSGSSGFSGFDSDSGEKRGIPLPTP 120

Query: 89  LDSIMQSDHGNGLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNL 148
             S +QSDH  GLGSGS SV S SSSGSSED+ I +D  QF   RSY D R  G  + N+
Sbjct: 121 SVSSLQSDHVVGLGSGSPSVCSFSSSGSSEDNQIPNDPVQFIAYRSYNDMRGQGGNRSNV 180

Query: 149 MPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPC 208
             +SP   SRGPTSPTSPLH RLSG+S++SPTGK EDGKS CHKLPLPPGSPTSPSALP 
Sbjct: 181 RSRSPGPRSRGPTSPTSPLHHRLSGVSLESPTGKKEDGKSVCHKLPLPPGSPTSPSALPN 240

Query: 209 SRTSGVTENS---LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC 265
           +RTSGV+EN+   LSKW+KG+LLGRGTFGHVYLGFNSESGQMCAIKEVR V DDQTSKEC
Sbjct: 241 TRTSGVSENTPCTLSKWRKGRLLGRGTFGHVYLGFNSESGQMCAIKEVRFVSDDQTSKEC 300

Query: 266 LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ 325
           LKQLNQEINLL+QLSHPNIVRY+GSEL +E LSVYLEYVSGGSIHKLLQEYG F EPVIQ
Sbjct: 301 LKQLNQEINLLNQLSHPNIVRYYGSELGEETLSVYLEYVSGGSIHKLLQEYGAFKEPVIQ 360

Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP 385
            YTRQIL GLAYLH RNTVHRDIKGANILVDP GEIKLADFGMAKH+++C  MLSFKGSP
Sbjct: 361 NYTRQILSGLAYLHGRNTVHRDIKGANILVDPTGEIKLADFGMAKHISACGKMLSFKGSP 420

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
           YWMAPEVVMNTNGY+L VDIWSLGCT+LEMATSKPPWSQYEGVAAIFKIGNSKD+PEIP+
Sbjct: 421 YWMAPEVVMNTNGYNLAVDIWSLGCTILEMATSKPPWSQYEGVAAIFKIGNSKDVPEIPD 480

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRT 505
            LS++AKSFI+ CLQRDPSARP A +LLDHPF+RDQA  R  N+++ KD+ PY+ DGSRT
Sbjct: 481 RLSNEAKSFIRLCLQRDPSARPTAFQLLDHPFIRDQATTRVANISITKDAFPYTFDGSRT 540

Query: 506 PPKLDLLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPS 565
           PP L++   R +I   +GDY    +  TSRAL  PR+NARTITSLPVSPCSSPLR YGP+
Sbjct: 541 PPILEMQSNRNNILSFDGDYGTKGMATTSRALRTPRDNARTITSLPVSPCSSPLR-YGPA 599

Query: 566 HKSCFLSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRS 625
           H+SCFLSPPHP+Y  +GQ SG+NLGD+SG  +R NPRY +DPWLET  LK QTPGTSPR+
Sbjct: 600 HRSCFLSPPHPAYHFVGQ-SGHNLGDFSGNTSRPNPRYTHDPWLETPQLKVQTPGTSPRT 658

Query: 626 RPI 628
           RPI
Sbjct: 659 RPI 661

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431467|ref|XP_002280682.1| PREDICTED: serine/threonine-protein kinase cst-1-like isoform 1 [Vitis vinifera]

 Score =  750 bits (1936), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/639 (65%), Positives = 485/639 (75%), Gaps = 27/639 (4%)

Query: 1   MPAWWGKKSSKNKDE--SHSPQGNHFNFIKFS-GDKKKEKNDRPRSFDGVIFRRSSPRES 57
           MPAWWG+KSSK K+E    +P+   +N  K S  + KK   D+P+SFD  +F R+SPR S
Sbjct: 1   MPAWWGRKSSKCKEEVQQQNPESTLYNISKISIRNDKKNGKDKPKSFDEGLFSRNSPRSS 60

Query: 58  KDYGIAGAGSSGFSGFDSDS----GEK-KGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVS 112
           KDYG       G S   S      G+K +GHPLP P   I         GSGSGSVSSVS
Sbjct: 61  KDYGALTVSGGGGSSGFSGFDSDCGDKIRGHPLPLPSAGIEHGV-----GSGSGSVSSVS 115

Query: 113 SSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLS 172
           SSGSS+DH    D   FG  R        G+ K N   +SP  GSR   S TSPLH R S
Sbjct: 116 SSGSSDDHPSPHDHAPFGVYRG------QGETKSNTRSRSPGPGSR---SATSPLHPRFS 166

Query: 173 GMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENS---LSKWKKGKLLG 229
             ++DS TGK E+G+S CH+LPLPPGSPTSPS L  +RT  VTE++   +SKWKKG+LLG
Sbjct: 167 TSNIDSLTGKQEEGRS-CHRLPLPPGSPTSPSTLSSTRTCVVTESTTCNMSKWKKGRLLG 225

Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RGTFGHVY+GFNSE+GQMCAIKEV+VV DD TSKECLKQLNQEINLLSQLSHPNIV+Y+G
Sbjct: 226 RGTFGHVYVGFNSENGQMCAIKEVKVVSDDHTSKECLKQLNQEINLLSQLSHPNIVQYYG 285

Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           SE+ +E LSVYLEYVSGGSIHKLLQEYGPF EPVIQ Y RQI+ GLAYLH R+TVHRDIK
Sbjct: 286 SEMGEETLSVYLEYVSGGSIHKLLQEYGPFKEPVIQNYARQIISGLAYLHGRSTVHRDIK 345

Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
           GANILV P+GEIKLADFGMAKH+ S +SMLSFKGSPYWMAPEVVMNTNGYSL VDIWSLG
Sbjct: 346 GANILVGPNGEIKLADFGMAKHINSSSSMLSFKGSPYWMAPEVVMNTNGYSLAVDIWSLG 405

Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
           CT+LEMATSKPPWSQYEGVAAIFKIGNS+D+PEIP+HLS+DAKSF++ CLQRDPSARP A
Sbjct: 406 CTILEMATSKPPWSQYEGVAAIFKIGNSRDVPEIPDHLSNDAKSFVRLCLQRDPSARPTA 465

Query: 470 SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANP 529
            +LLDH FVRDQA  R  N+ + KD+ P + DGSRTP  L+L   R S+TL +GDY+  P
Sbjct: 466 LQLLDHSFVRDQATTRIANIAITKDAFPSTFDGSRTPTALELHSNRTSLTLFDGDYVTKP 525

Query: 530 LVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNL 589
           +   SRA  N R++ RTITSLPVSPCSSPLR YGP+HKSCFLSPPHPSY ++GQSS YN 
Sbjct: 526 VGTVSRAAKNSRDSVRTITSLPVSPCSSPLRNYGPAHKSCFLSPPHPSYPIVGQSS-YNS 584

Query: 590 GDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
            DYS YPTR+  +Y +DPW +    ++ TP  SPR+RPI
Sbjct: 585 NDYSLYPTRAITKYTHDPWSDNPPFRSLTPNGSPRTRPI 623

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357464659|ref|XP_003602611.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355491659|gb|AES72862.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  740 bits (1911), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/657 (62%), Positives = 479/657 (72%), Gaps = 39/657 (5%)

Query: 1   MPAWWGKKSSKNKDESHSPQGN---------------HFNFIKFSGDKKKEKN----DRP 41
           MP WWGKKSSK K E   P+G                HFNF   S  +   KN    + P
Sbjct: 1   MPTWWGKKSSKPK-EHEEPRGGSSTSNGSSGGGGGVLHFNFSNKSPIRNSNKNGYKPENP 59

Query: 42  RSFDGVIFR-RSSPRESKDYG--IAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQS--- 95
           RSFD      R++PR S+D+   I  AG    S +DSD+G K G PLP P  S  QS   
Sbjct: 60  RSFDDASSNFRNTPRSSRDFSPSINSAGGGSSSCWDSDAGYKTGFPLPHPSVSSTQSLSN 119

Query: 96  DHGNGLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCA 155
           D G   G GS SVS  S S +       +   Q   +R         + KFN+ PKSP  
Sbjct: 120 DQGITFGFGSASVSGSSVSSNGSYDDPSTSNSQINTARG------QCETKFNVRPKSPGP 173

Query: 156 GSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPC-SRTSGV 214
           GSRGPTSPTSPLH RL+ +S+DSPT + EDG+S+CH LPLPPGSPTS S+LP  +R +G+
Sbjct: 174 GSRGPTSPTSPLHPRLNVLSLDSPTSRQEDGRSECHPLPLPPGSPTSSSSLPNNTRPNGL 233

Query: 215 TENSLSK---WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
            E+S +    WK+GKLLGRGTFGHVYLGFNSESGQ+CAIKEVR VCDDQTSKECLKQLNQ
Sbjct: 234 IESSTTNRGSWKRGKLLGRGTFGHVYLGFNSESGQLCAIKEVRAVCDDQTSKECLKQLNQ 293

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
           EI LLS+LSHPNIV+Y+GS+L +E LSVYLEYVSGGSIHKLLQEYG F EPVIQ YTRQI
Sbjct: 294 EIILLSKLSHPNIVQYYGSDLGEETLSVYLEYVSGGSIHKLLQEYGAFKEPVIQNYTRQI 353

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
           + GL+YLHARNTVHRDIKGANILVDP+GEIKLADFGMAKH+ S +SMLSFKGSP+WMAPE
Sbjct: 354 VSGLSYLHARNTVHRDIKGANILVDPNGEIKLADFGMAKHINSSSSMLSFKGSPHWMAPE 413

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
           VVMNTNGYSL VDIWSLGCT+LEMATSKPPWSQYEGVAAIFKIGNSKD+PEIP+HLS+DA
Sbjct: 414 VVMNTNGYSLPVDIWSLGCTILEMATSKPPWSQYEGVAAIFKIGNSKDMPEIPDHLSNDA 473

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDL 511
           K+FIK CL RDPS RP A  LL+HPF+RDQ+  +A  V + +D+ PY  DGSRTPP  DL
Sbjct: 474 KNFIKLCLHRDPSTRPTAQMLLNHPFIRDQSATKAAIVRITRDAFPYMCDGSRTPPASDL 533

Query: 512 LPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFL 571
              R  I   + DY    ++  SRA+ +PR+N R ITSLPVSPCSSPLRQ GP+HKSCFL
Sbjct: 534 HSNRTCIASQDADYATKSVLAASRAVRSPRDNTRMITSLPVSPCSSPLRQSGPAHKSCFL 593

Query: 572 SPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
           SPPHP+YA+MGQ++   L  Y  YP RSN ++  DPW ET + K +TPG SPR+R I
Sbjct: 594 SPPHPTYAMMGQNT---LTSYESYPMRSNTKFTLDPWHETHMYKVRTPGASPRTRLI 647

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088548|emb|CBI37539.3| unnamed protein product [Vitis vinifera]

 Score =  736 bits (1899), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/636 (64%), Positives = 476/636 (74%), Gaps = 44/636 (6%)

Query: 1   MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDKKKEKNDRPRSFDGVIFRRSSPRESKDY 60
           MPAWWG+KSSK K+E+                      D+P+SFD  +F R+SPR SKDY
Sbjct: 1   MPAWWGRKSSKCKEEN--------------------GKDKPKSFDEGLFSRNSPRSSKDY 40

Query: 61  GIAGAGSSGFSGFDSDS----GEK-KGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSG 115
           G       G S   S      G+K +GHPLP P   I         GSGSGSVSSVSSSG
Sbjct: 41  GALTVSGGGGSSGFSGFDSDCGDKIRGHPLPLPSAGIEHGV-----GSGSGSVSSVSSSG 95

Query: 116 SSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMS 175
           SS+DH    D   FG  R        G+ K N   +SP  GSR   S TSPLH R S  +
Sbjct: 96  SSDDHPSPHDHAPFGVYRG------QGETKSNTRSRSPGPGSR---SATSPLHPRFSTSN 146

Query: 176 VDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENS---LSKWKKGKLLGRGT 232
           +DS TGK E+G+S CH+LPLPPGSPTSPS L  +RT  VTE++   +SKWKKG+LLGRGT
Sbjct: 147 IDSLTGKQEEGRS-CHRLPLPPGSPTSPSTLSSTRTCVVTESTTCNMSKWKKGRLLGRGT 205

Query: 233 FGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL 292
           FGHVY+GFNSE+GQMCAIKEV+VV DD TSKECLKQLNQEINLLSQLSHPNIV+Y+GSE+
Sbjct: 206 FGHVYVGFNSENGQMCAIKEVKVVSDDHTSKECLKQLNQEINLLSQLSHPNIVQYYGSEM 265

Query: 293 SDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGAN 352
            +E LSVYLEYVSGGSIHKLLQEYGPF EPVIQ Y RQI+ GLAYLH R+TVHRDIKGAN
Sbjct: 266 GEETLSVYLEYVSGGSIHKLLQEYGPFKEPVIQNYARQIISGLAYLHGRSTVHRDIKGAN 325

Query: 353 ILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTV 412
           ILV P+GEIKLADFGMAKH+ S +SMLSFKGSPYWMAPEVVMNTNGYSL VDIWSLGCT+
Sbjct: 326 ILVGPNGEIKLADFGMAKHINSSSSMLSFKGSPYWMAPEVVMNTNGYSLAVDIWSLGCTI 385

Query: 413 LEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
           LEMATSKPPWSQYEGVAAIFKIGNS+D+PEIP+HLS+DAKSF++ CLQRDPSARP A +L
Sbjct: 386 LEMATSKPPWSQYEGVAAIFKIGNSRDVPEIPDHLSNDAKSFVRLCLQRDPSARPTALQL 445

Query: 473 LDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVP 532
           LDH FVRDQA  R  N+ + KD+ P + DGSRTP  L+L   R S+TL +GDY+  P+  
Sbjct: 446 LDHSFVRDQATTRIANIAITKDAFPSTFDGSRTPTALELHSNRTSLTLFDGDYVTKPVGT 505

Query: 533 TSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDY 592
            SRA  N R++ RTITSLPVSPCSSPLR YGP+HKSCFLSPPHPSY ++GQSS YN  DY
Sbjct: 506 VSRAAKNSRDSVRTITSLPVSPCSSPLRNYGPAHKSCFLSPPHPSYPIVGQSS-YNSNDY 564

Query: 593 SGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
           S YPTR+  +Y +DPW +    ++ TP  SPR+RPI
Sbjct: 565 SLYPTRAITKYTHDPWSDNPPFRSLTPNGSPRTRPI 600

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093390|ref|XP_002309908.1| predicted protein [Populus trichocarpa] gi|222852811|gb|EEE90358.1| predicted protein [Populus trichocarpa]

 Score =  727 bits (1876), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/632 (63%), Positives = 472/632 (74%), Gaps = 26/632 (4%)

Query: 1   MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDKKK---EKNDRPRSFDGVIFRRSSPRES 57
           MPAWW K+SSK+K+ S+    +  N      DKK     +N R  S D    R++SPR S
Sbjct: 1   MPAWWSKRSSKSKEGSNQENSHGKN------DKKICSITENKRKSSLDEAALRKNSPRGS 54

Query: 58  KDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSGSS 117
           K++  +G  S      +SD+ EK+G PLP P  S + +  G G  +G       S S SS
Sbjct: 55  KEFAGSGGSSGFSGF-ESDAAEKRGLPLPEPCVSDLGAGGGIGGAAGGVGFGPGSGSVSS 113

Query: 118 EDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMSVD 177
                 S  G    S   G              +SP  GSR  + PTSPLH  L GMS+D
Sbjct: 114 VSSSGSSGHGGGSRSPVPGS-------------RSPVPGSRTTSRPTSPLHPLLGGMSLD 160

Query: 178 SPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENS-LSKWKKGKLLGRGTFGHV 236
           S TG++ED KSQ H LPLPPGSPTSP +LP +RT+G T+NS LSKWKKGKLLGRGTFGHV
Sbjct: 161 SLTGRLEDAKSQWHPLPLPPGSPTSPPSLPGTRTTGATDNSTLSKWKKGKLLGRGTFGHV 220

Query: 237 YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER 296
           YLGFNS SGQMCAIKEV+V+ DD TSKECLKQL QEI+LLSQLSH NIVRY+GSELS+E 
Sbjct: 221 YLGFNSRSGQMCAIKEVKVISDDSTSKECLKQLKQEIDLLSQLSHANIVRYYGSELSEET 280

Query: 297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD 356
           LSVYLEYVSGGSIHKLLQEYG F EPVIQ YTRQIL GLAYLH RNTVHRDIKGANILVD
Sbjct: 281 LSVYLEYVSGGSIHKLLQEYGAFTEPVIQNYTRQILSGLAYLHGRNTVHRDIKGANILVD 340

Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
           P+GEIKL DFGMAKH+ +C+SMLSFKGSPYWMAPEVVMNTNGYSL VD+WSLGCT+LEMA
Sbjct: 341 PNGEIKLVDFGMAKHIMTCSSMLSFKGSPYWMAPEVVMNTNGYSLAVDVWSLGCTILEMA 400

Query: 417 TSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
           TSKPPWSQYEGVAAIFKIGNSKD+P+IP+++S+DAKSFIK CLQRDP ARP AS+LLDHP
Sbjct: 401 TSKPPWSQYEGVAAIFKIGNSKDMPDIPDYISNDAKSFIKLCLQRDPLARPTASQLLDHP 460

Query: 477 FVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPTSRA 536
           F+RDQ+  R  N+N+ +D+ P + DGSRTPP L+L   R +   C+GD+   P+V   RA
Sbjct: 461 FIRDQSTTRVANINITRDAFPRTFDGSRTPPALELHSNRTNANSCDGDFAMKPVVNNIRA 520

Query: 537 LNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYSGYP 596
           L NPR++ R ITS+PVSPCSSPLRQ+GP+H+S +LSPPHP++A+MGQSS YNL D+S YP
Sbjct: 521 LKNPRDDGRMITSMPVSPCSSPLRQHGPAHRSSYLSPPHPAFAMMGQSS-YNLSDFSLYP 579

Query: 597 TRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
            R  P Y +D + +T  LK QTPGTSPR+RPI
Sbjct: 580 IRQGP-YTHDLFFDTPPLKFQTPGTSPRTRPI 610

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461855|ref|XP_004148657.1| PREDICTED: serine/threonine-protein kinase KIC1-like [Cucumis sativus]

 Score =  723 bits (1867), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/644 (64%), Positives = 478/644 (74%), Gaps = 37/644 (5%)

Query: 1   MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDK------KKEKND----RPRSFDGV--- 47
           MP  W KK S+NKD  +       N  K S         K + N+    +P+SFD V   
Sbjct: 1   MPLGWVKKLSRNKDHHNQNHPTSLNLFKSSSSSSSSSSPKTQPNNTITHKPKSFDEVSAL 60

Query: 48  IFRRSSPRESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGS 107
           IF R+SPR S+D G +G  SSGFSGFDSDSG K   PLPRP  S +  DHG G GSGS S
Sbjct: 61  IFSRNSPRSSRDLGSSGTASSGFSGFDSDSGHKS-LPLPRPATSGLGIDHGAGNGSGSSS 119

Query: 108 VSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPL 167
           VSS  SSGSS+D     +Q QFG  R + D R+          +SP  GS+GPTSPTSPL
Sbjct: 120 VSSDISSGSSDDQPSAQEQLQFGAYRGFADNRIE------TRARSPGPGSKGPTSPTSPL 173

Query: 168 HARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSL---SKWKK 224
           + R  GMS++SP           HKLPLPP +PTSPS+L   R   + +N+    SKWKK
Sbjct: 174 NPRFCGMSLESPP---------THKLPLPPSAPTSPSSLTSMRAINIGDNNAAVQSKWKK 224

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           G+LLGRGTFGHVYLGFNS SGQMCAIKEVRV+ DD TSKECLKQLNQEI +LSQLSHPNI
Sbjct: 225 GRLLGRGTFGHVYLGFNSVSGQMCAIKEVRVISDDSTSKECLKQLNQEITVLSQLSHPNI 284

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           VRY+GSE+ +E LSVYLEY+SGGSIHKLLQEYG F EPVI+ YTR+IL GLAYLH RNTV
Sbjct: 285 VRYYGSEMGEESLSVYLEYISGGSIHKLLQEYGAFKEPVIRNYTRKILSGLAYLHGRNTV 344

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           HRDIKGANILVDP GE+KL DFGMAKH+T+C SMLSFKGSPYWMAPEVVMNTNGYSL VD
Sbjct: 345 HRDIKGANILVDPKGEVKLVDFGMAKHITNCTSMLSFKGSPYWMAPEVVMNTNGYSLAVD 404

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           IWSLGCTVLEMATSKPPW++YEGVAAIFKIGNSKDIPEIP+ LS DA+SF++ CLQRDPS
Sbjct: 405 IWSLGCTVLEMATSKPPWNRYEGVAAIFKIGNSKDIPEIPDSLSSDARSFVQLCLQRDPS 464

Query: 465 ARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGD 524
           ARP A++LLDHPFV+D    RA +VNL+ D+ P+S DG +T P LD  P RKSI++C+GD
Sbjct: 465 ARPSAAELLDHPFVQDAVTPRASDVNLSVDAFPFSFDGIQTSPLLDRHPNRKSISICDGD 524

Query: 525 YLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQS 584
           Y+ NP   +SRA  +PR N R ITSLPVSPCSSPLR YGP+H+SC+LSPPH SY  +GQ 
Sbjct: 525 YVTNPTF-SSRA-PSPRGNGRLITSLPVSPCSSPLRSYGPTHQSCYLSPPHTSYMGVGQ- 581

Query: 585 SGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
           SGYNL +Y+ Y TR N  +  DP  E+SLLK QT   SPR RP+
Sbjct: 582 SGYNLNEYA-YNTRPNTLFTLDPSRESSLLKVQTHLGSPR-RPL 623

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449528853|ref|XP_004171417.1| PREDICTED: protein kinase wis1-like [Cucumis sativus]

 Score =  722 bits (1863), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/644 (63%), Positives = 478/644 (74%), Gaps = 37/644 (5%)

Query: 1   MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDK------KKEKND----RPRSFDGV--- 47
           MP  W KK S+NKD  +       N  K S         K + N+    +P+SFD V   
Sbjct: 1   MPLGWVKKLSRNKDHHNQNHPTSLNLFKSSSSSSSSSSPKTQPNNTITHKPKSFDEVSAL 60

Query: 48  IFRRSSPRESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGS 107
           IF R+SPR S+D G +G  SSGFSGFDSDSG K   PLPRP  S +  DHG G GSGS S
Sbjct: 61  IFSRNSPRSSRDLGSSGTASSGFSGFDSDSGHKS-LPLPRPATSGLGIDHGAGNGSGSSS 119

Query: 108 VSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPL 167
           VSS  SSGSS+D     +Q QFG  R + D R+          +SP  GS+GPTSPTSPL
Sbjct: 120 VSSDISSGSSDDQPSAQEQLQFGAYRGFADNRIE------TRARSPGPGSKGPTSPTSPL 173

Query: 168 HARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSL---SKWKK 224
           + R  GMS++SP           HKLPLPP +PTSPS+L   R   + +N+    SKWKK
Sbjct: 174 NPRFCGMSLESPP---------THKLPLPPSAPTSPSSLTSMRAINIGDNNAAVQSKWKK 224

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           G+LLGRGTFGHVYLGFNS SGQMCAIKEVRV+ DD TSKECLKQLNQEI +LSQLSHPNI
Sbjct: 225 GRLLGRGTFGHVYLGFNSVSGQMCAIKEVRVISDDSTSKECLKQLNQEITVLSQLSHPNI 284

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           VRY+GSE+ +E LSVYLE++SGGSIHKLLQEYG F EPVI+ YTR+IL GLAYLH RNTV
Sbjct: 285 VRYYGSEMGEESLSVYLEFISGGSIHKLLQEYGAFKEPVIRNYTRKILSGLAYLHGRNTV 344

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           HRDIKGANILVDP GE+KL DFGMAKH+T+C SMLSFKGSPYWMAPEVVMNTNGYSL VD
Sbjct: 345 HRDIKGANILVDPKGEVKLVDFGMAKHITNCTSMLSFKGSPYWMAPEVVMNTNGYSLAVD 404

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           IWSLGCTVLEMATSKPPW++YEGVAAIFKIGNSKDIPEIP+ LS DA+SF++ CLQRDPS
Sbjct: 405 IWSLGCTVLEMATSKPPWNRYEGVAAIFKIGNSKDIPEIPDSLSSDARSFVQLCLQRDPS 464

Query: 465 ARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGD 524
           ARP A++LLDHPFV+D    RA +VNL+ D+ P+S DG +T P LD  P RKSI++C+GD
Sbjct: 465 ARPSAAELLDHPFVQDAVTPRASDVNLSVDAFPFSFDGIQTSPLLDRHPNRKSISICDGD 524

Query: 525 YLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQS 584
           Y+ NP   +SRA  +PR N R ITSLPVSPCSSPLR YGP+H+SC+LSPPH SY  +GQ 
Sbjct: 525 YVTNPTF-SSRA-PSPRGNGRLITSLPVSPCSSPLRSYGPTHQSCYLSPPHTSYMGVGQ- 581

Query: 585 SGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
           SGYNL +Y+ Y TR N  +  DP  E+SLLK QT   SPR RP+
Sbjct: 582 SGYNLNEYA-YNTRPNTLFTLDPSRESSLLKVQTHLGSPR-RPL 623

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356516360|ref|XP_003526863.1| PREDICTED: mitogen-activated protein kinase kinase kinase kinase 3-like [Glycine max]

 Score =  719 bits (1857), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/649 (63%), Positives = 481/649 (74%), Gaps = 61/649 (9%)

Query: 1   MPAWWGKKSSKNKDESHSPQGN-----------------HFNFIKFSGDKKKEKNDRP-R 42
           MP WWGKKSSK+KD+   PQ +                 +FNF K +    K + DRP +
Sbjct: 1   MPTWWGKKSSKSKDQQ--PQEDHHHPPHGGGGGAATSVLNFNFNKLN----KPRPDRPSK 54

Query: 43  SFDGVIFRRSSPRESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQS---DHGN 99
           SFD V+  R+SPR S+D+  + A +             +G PLPRP  S  QS   + G 
Sbjct: 55  SFDDVV--RNSPRCSRDFSSSAAAAV-----------DQGLPLPRPSVSSTQSFGIEQGL 101

Query: 100 GLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRG 159
             GSGS S SSVSSSGS +DH   +   Q   SR        GD KF    KSP  GSRG
Sbjct: 102 VFGSGSVSGSSVSSSGSYDDH--PTCHSQINASRG------QGDTKFYARSKSPGPGSRG 153

Query: 160 PTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCS-RTSGVTENS 218
           PTSPTSPLH +L  +S+DSPTG+ E    +CH LPLPPGSPTSPS+   S R +G+TE++
Sbjct: 154 PTSPTSPLHPKLHVLSLDSPTGRQE---GECHPLPLPPGSPTSPSSSLPSTRANGMTEHT 210

Query: 219 ---LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
              LSKWKKGKLLGRGTFGHVYLGFNS+SGQ+CAIKEVRVVCDDQ+SKECLKQLNQEI+L
Sbjct: 211 TGNLSKWKKGKLLGRGTFGHVYLGFNSDSGQLCAIKEVRVVCDDQSSKECLKQLNQEIHL 270

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           LSQLSHPNIV+Y+GS+L +E LSVYLEYVSGGSIHKLLQEYG F EPVIQ YTRQI+ GL
Sbjct: 271 LSQLSHPNIVQYYGSDLGEETLSVYLEYVSGGSIHKLLQEYGAFKEPVIQNYTRQIVSGL 330

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           +YLH RNTVHRDIKGANILVDP+GEIKLADFGMAKH+ S +SMLSFKGSPYWMAPEVVMN
Sbjct: 331 SYLHGRNTVHRDIKGANILVDPNGEIKLADFGMAKHINSSSSMLSFKGSPYWMAPEVVMN 390

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
           TNGYSL VDIWSLGCT+LEMATSKPPW+QYEGVAAIFKIGNS+D+PEIP+HLS +AK+FI
Sbjct: 391 TNGYSLPVDIWSLGCTILEMATSKPPWNQYEGVAAIFKIGNSRDMPEIPDHLSSEAKNFI 450

Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTR 515
           + CLQRDPSARP A KL++HPF+RDQ+  +A NV + +D+ PY  DGSRTPP +     R
Sbjct: 451 QLCLQRDPSARPTAQKLIEHPFIRDQSATKATNVRITRDAFPYMFDGSRTPPPVLDHSNR 510

Query: 516 KSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPH 575
            S+T  +GDY   P+  TSR + +PR+N R ITSLPVSPCSSPLRQYGP+HKSCFLSPPH
Sbjct: 511 TSLTSFDGDYATKPIPVTSRTVRSPRDNTRMITSLPVSPCSSPLRQYGPAHKSCFLSPPH 570

Query: 576 PSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPR 624
           P+Y +MGQ++         YP RSN  +  DP+ ET+  KA TPG SPR
Sbjct: 571 PTYTLMGQNT------LPSYPVRSNATFTLDPFHETAFYKAHTPGGSPR 613

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224080951|ref|XP_002306242.1| predicted protein [Populus trichocarpa] gi|222855691|gb|EEE93238.1| predicted protein [Populus trichocarpa]

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/635 (62%), Positives = 466/635 (73%), Gaps = 48/635 (7%)

Query: 1   MPAWWGKKSSK-----NKDESHSPQGNHFNFIKFSGDKKKEKNDRPRSFDGVIFRRSSPR 55
           MPAWWGKKSSK     N++  H         IK        +N R  S D    R++SPR
Sbjct: 1   MPAWWGKKSSKSKEGSNQENPHGKNDKKLFKIK--------ENKRRSSLDEAALRKNSPR 52

Query: 56  ESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQSDHGNGLGSGSGSVSSVSSSG 115
            ++++  +G G S FSGFDSD+GEK+G PLP+P  S +          G G   S   S 
Sbjct: 53  ANREFSGSG-GLSAFSGFDSDAGEKRGLPLPKPFTSDLGG-------GGGGVGVSSYGSS 104

Query: 116 SSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMS 175
             EDH    +     GSRS                  P  GSR  + PTSPLH  L  +S
Sbjct: 105 GGEDH---DNNQSSNGSRS------------------PAPGSRAASRPTSPLHQLLGALS 143

Query: 176 VDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENS-LSKWKKGKLLGRGTFG 234
           +DS TG++EDGK++CH LPLPPGSPTSP +LP  RT+G TE S LS+WKKGKLLGRGTFG
Sbjct: 144 IDSSTGRLEDGKNECHPLPLPPGSPTSPPSLPGPRTAGATEMSTLSRWKKGKLLGRGTFG 203

Query: 235 HVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD 294
           HVYLGFNS SGQMCAIKEV V+ DD TSKECLKQLNQEINLLSQLSH NIVRY+GSELS+
Sbjct: 204 HVYLGFNSGSGQMCAIKEVTVISDDSTSKECLKQLNQEINLLSQLSHANIVRYYGSELSE 263

Query: 295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANIL 354
           ERLSVYLEYVSGGS+HKLLQEYG F EPVIQ YTRQIL GLAYLH RNTVHRDIKGANIL
Sbjct: 264 ERLSVYLEYVSGGSVHKLLQEYGAFKEPVIQNYTRQILSGLAYLHGRNTVHRDIKGANIL 323

Query: 355 VDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE 414
           VDP+GEIKL DFGMAKH+T+C+SMLSFKGSPYWMAPEVVMNTNGYSL VDIWSLGCT+LE
Sbjct: 324 VDPNGEIKLVDFGMAKHITACSSMLSFKGSPYWMAPEVVMNTNGYSLAVDIWSLGCTLLE 383

Query: 415 MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           MATSKPPWS YEGVAAIFKIGNSKD+P+IP++LS+DAKSFIK CLQRDPSARP A +LLD
Sbjct: 384 MATSKPPWSHYEGVAAIFKIGNSKDMPDIPDYLSNDAKSFIKLCLQRDPSARPTAFQLLD 443

Query: 475 HPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPT- 533
           HPF+RDQA  R  N+N+ +D+ P + DGSRTPP LDL   R S    +GD+   P V + 
Sbjct: 444 HPFIRDQATTRVANINITRDAFPRTFDGSRTPPVLDLHSNRTSANSWDGDFAMKPGVNSN 503

Query: 534 SRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAVMGQSSGYNLGDYS 593
           +RAL NPR++   ITS+PVSPCSSPLRQ+G ++++ F   PH  YA++GQSS Y++ D S
Sbjct: 504 TRALKNPRDDGGMITSMPVSPCSSPLRQHGSAYRNYF--SPHSPYAMVGQSS-YHVSDPS 560

Query: 594 GYPTRSNPRYINDPWLETSLLKAQTPGTSPRSRPI 628
            +P R    Y +D + +T+LLK QTPGTSPR+RPI
Sbjct: 561 LHPIRQT-TYTHDLFFDTTLLKVQTPGTSPRTRPI 594

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|45476486|dbj|BAD12492.1| mitogen-activated kinase kinase kinase alpha [Lotus japonicus]

 Score =  714 bits (1844), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/659 (62%), Positives = 467/659 (70%), Gaps = 63/659 (9%)

Query: 1   MPAWWGKKSSKNKDESHSPQ---------------GNHFNFIKFSGDKKKEKNDRPR--- 42
           MPAWW +K  KNK E    +               G  FNF+K      +  + + +   
Sbjct: 1   MPAWWNRKPWKNKQEHDDDEDGEYEAEEVEEAPRSGLQFNFMKSPISSARSSDKKKKKKI 60

Query: 43  -------SFDGVIFRRSSPRESKDYGIAGAGSSGFSGFDSDSGEKKGHPLPRPLDSIMQS 95
                  SFD V++R +SPR SKD     A             EKKG PLPRP     Q+
Sbjct: 61  KDKKKPKSFDEVLYR-NSPRTSKDCDGGAAAM-----------EKKGLPLPRPTTPCDQA 108

Query: 96  DHGNGLGSGSGSVSSVSSSGSSEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLMPKSPCA 155
                  S SGS  S S+S S +DH I         S  +   R   ++KFN+ PKSPC 
Sbjct: 109 -------SISGSSLSSSASASFDDHSI---------SPHFNANRGQEEVKFNVRPKSPC- 151

Query: 156 GSRGPTSPTSPLHARLSGMSVDSPTG-KIEDGKSQCHKLPLPPGSPTSPSALPC-SRTSG 213
            SRGPTSPTSPLH RL  +S+DSPTG K ++G SQCH LPLPPGSPTSPSA PC +R +G
Sbjct: 152 -SRGPTSPTSPLHQRLHALSLDSPTGGKQDEGTSQCHPLPLPPGSPTSPSA-PCNTRANG 209

Query: 214 VTENS---LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN 270
           V EN+   LSKWKKGKLLGRGTFGHVYLGFNSE+GQMCAIKEV+V  DD+TSKECLKQLN
Sbjct: 210 VLENNTCNLSKWKKGKLLGRGTFGHVYLGFNSENGQMCAIKEVKVFSDDKTSKECLKQLN 269

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           QEINLL+Q SHPNIV+Y+GSEL +E LSVYLEYVSGGSIHKLLQEYG F EPVIQ YTRQ
Sbjct: 270 QEINLLNQFSHPNIVQYYGSELGEESLSVYLEYVSGGSIHKLLQEYGAFKEPVIQNYTRQ 329

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           I+ GLAYLH+RNTVHRDIKGANILVDP+GEIKLADFGM+KH+ S ASMLSFKGSPYWMAP
Sbjct: 330 IVSGLAYLHSRNTVHRDIKGANILVDPNGEIKLADFGMSKHINSAASMLSFKGSPYWMAP 389

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD 450
           EVVMNTNGY L VDI SLGCT+LEMATSKPPWSQ+EGVAAIFKIGNSKD+PEIPEHLSDD
Sbjct: 390 EVVMNTNGYGLPVDISSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDMPEIPEHLSDD 449

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLD 510
           AK+FIKQCLQRDP ARP A  LL+HPF+RDQ+  +  N ++ +D+ PY  DGSRTPP L+
Sbjct: 450 AKNFIKQCLQRDPLARPTAQSLLNHPFIRDQSATKVANASITRDAFPYMSDGSRTPPVLE 509

Query: 511 LLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYGPSHKSCF 570
               R SIT  + DY   P +   R L NPR++ RTITSLPVSP SSPLRQ+ P+H S F
Sbjct: 510 PHSNRSSITTLDVDYATKPALAAVRTLRNPRDSTRTITSLPVSPSSSPLRQHRPTHNSPF 569

Query: 571 LSPPHPSYAVMGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQT-PGTSPRSRPI 628
            SPPHPSYA+MGQSS Y   +    P RSN     DPWLETS  KA T PG SPR R I
Sbjct: 570 FSPPHPSYAMMGQSS-YTSNNMHKNPARSNATLTLDPWLETSRYKAHTPPGGSPRMRFI 627

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	628
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.934	0.963	0.541	2.4e-163
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.683	0.485	0.486	9.4e-105
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.466	0.409	0.5	1.4e-78
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.441	0.415	0.503	1.4e-71
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.461	0.420	0.476	2.6e-70
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.488	0.471	0.452	2.1e-68
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.394	0.195	0.482	6.9e-63
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.391	0.404	0.503	9e-61
UNIPROTKB|J3KRN4	622	MAP3K3 "Mitogen-activated prot	0.393	0.397	0.451	5.4e-59
UNIPROTKB|Q99759	626	MAP3K3 "Mitogen-activated prot	0.393	0.394	0.451	5.4e-59

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1590 (564.8 bits), Expect = 2.4e-163, P = 2.4e-163
 Identities = 350/646 (54%), Positives = 412/646 (63%)

Query:     1 MPAWWGKKSSKNKDESHSPQGNHFNFIKFSGDKKKEKN--DRPRSFDGVIFRRSSPRESK 58
             MP WWG+KS KNKD+      NH   I    D K      D P +      R  +PR S+
Sbjct:     1 MPTWWGRKSCKNKDD------NHRGIISTDRDIKSSAVVVDPPLTPT----RGGTPRCSR 50

Query:    59 DYGIXXXXXXXXXXXXXXXXEKKGHPLPRPL---DSIMQSDHGNGLXXXXXXXXXXXXXX 115
             ++                  EKKGHPLPRPL    SI   DH +G               
Sbjct:    51 EFA---GASSAFSGFDSDSTEKKGHPLPRPLLSPVSIHHQDHVSGSTSGSTSVSSVSSSG 107

Query:   116 XXEDHVIGSDQGQFGGSRSYGDPRVNGDIKFNLM--PKSPCAGSRGP----TSPTSPLHA 169
               +D      Q Q   SR        GD+KFN+   P+SP   S       T PTSP H 
Sbjct:   108 SADD------QSQLVASRG------RGDVKFNVAAAPRSPERVSPKAATITTRPTSPRHQ 155

Query:   170 RLSGM-SVDSPTGKIEDGKS--QCHKXXXXXXXXXXXXXXXCSRTSGVTENXXXXXXX-- 224
             RLSG+ S++S TG+ +DG+S  +CH                 SR  G  E          
Sbjct:   156 RLSGVVSLESSTGRNDDGRSSSECHPLPRPPTSPTSPSAVHGSRIGGGYETSPSGFSTWK 215

Query:   225 -XXXXXRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
                    GTFG VYLGFNSE G+MCAIKEV+V+ DDQTSKECLKQLNQEINLL+QL HPN
Sbjct:   216 KGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCHPN 275

Query:   284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             IV+Y+GSELS+E LSVYLEYVSGGSIHKLL++YG F EPVIQ YTRQIL GLAYLH RNT
Sbjct:   276 IVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGRNT 335

Query:   344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
             VHRDIKGANILVDP+GEIKLADFGMAKH+T+ ++MLSFKGSPYWMAPEVVM+ NGY+  V
Sbjct:   336 VHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEVVMSQNGYTHAV 395

Query:   404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
             DIWSLGCT+LEMATSKPPWSQ+EGVAAIFKIGNSKD PEIP+HLS+DAK+FI+ CLQR+P
Sbjct:   396 DIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCLQRNP 455

Query:   464 SARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSIT--LC 521
             + RP AS+LL+HPF+R+    R  + +L KD  P S DG+       L PTR+     L 
Sbjct:   456 TVRPTASQLLEHPFLRN--TTRVASTSLPKDFPPRSYDGN-----FSLQPTREPYPGRLS 508

Query:   522 EGDYLANPLVPTSRALNNP-RENARTITSLPVSPCSSPLRQYGPSHKSCFLSPPHPSYAV 580
               +Y   PL   SR + +P REN R ITSLPVSPCSSPLRQ GP++KSCFLSPPHPSYA 
Sbjct:   509 HDNYAKQPL---SRTIKSPSRENVRAITSLPVSPCSSPLRQLGPAYKSCFLSPPHPSYAF 565

Query:   581 MGQSSGYNLGDYSGYPTRSNPRYINDPWLETSLLKAQTPGTSPRSR 626
              GQ SGYNL +++  P R       D  +E S  + QTP +  RSR
Sbjct:   566 PGQDSGYNLAEFAASPFRMK----KDAMMEPSSFRTQTPNSPLRSR 607

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1014 (362.0 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
 Identities = 220/452 (48%), Positives = 288/452 (63%)

Query:   152 SPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKX----XXXXXXXXXXXXXX 207
             SP   SR  +   +PLH R  G +  SPT +++D + Q H+                   
Sbjct:   317 SPGPSSRIQSGAVTPLHPRAGGSTTGSPTRRLDDNRQQSHRLPLPPLLISNTCPFSPTYS 376

Query:   208 CSRTSGVTENXXXXXXXXXXXXR---------GTFGHVYLGFNSESGQMCAIKEVRVVCD 258
              + +  V  +            R         G+FGHVYLGFNSESG+MCA+KEV +  D
Sbjct:   377 AATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSD 436

Query:   259 DQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP 318
             D  S+E  +QL QEI++LS+L H NIV+Y+GSE  D++L +YLEYVSGGSI+KLLQEYG 
Sbjct:   437 DPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQ 496

Query:   319 FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM 378
             F E  I+ YT+QIL GLAYLHA+NTVHRDIKGANILVDPHG +K+ADFGMAKH+T+ +  
Sbjct:   497 FGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGP 556

Query:   379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK 438
             LSFKGSPYWMAPEV+ N+NG +L VDIWSLGCTVLEMAT+KPPWSQYEGV A+FKIGNSK
Sbjct:   557 LSFKGSPYWMAPEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSK 616

Query:   439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPY 498
             ++P+IP+HLS++ K F+++CLQR+P+ RP A++LLDH FVR+        V+  + +   
Sbjct:   617 ELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMPMERPIVS-GEPAEAM 675

Query:   499 SLDGSRTPPKLDLLPTRKSITLCEGD---YLANPLVPTSRALNNPRENARTITSLPVSPC 555
             ++  S T   LD+   R    L   D   Y    L   S    +  ++ R + S P+SP 
Sbjct:   676 NV-ASSTMRSLDIGHARSLPCLDSEDATNYQQKGLKHGSGF--SISQSPRNM-SCPISPV 731

Query:   556 SSPLRQYGPSHKSCFLSP-PHPS-YAVMGQSS 585
              SP+      H S   SP P  S +A+ G S+
Sbjct:   732 GSPIFHSHSPHISGRRSPSPISSPHALSGSST 763

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 764 (274.0 bits), Expect = 1.4e-78, Sum P(2) = 1.4e-78
 Identities = 154/308 (50%), Positives = 210/308 (68%)

Query:   230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
             RGTFG VY+  NSE+G +CA+KEV +  DD  S EC+KQL QEI LLS L HPNIV+Y G
Sbjct:   354 RGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQHPNIVQYFG 413

Query:   290 SELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
             SE  ++R  +YLEYV  GSI+K ++++ G   E V++ +TR IL GLAYLH + TVHRDI
Sbjct:   414 SETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRNFTRHILSGLAYLHNKKTVHRDI 473

Query:   349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV---VMNTNG---YSLT 402
             KGAN+LVD  G +KLADFGMAKH+T   + LS KGSPYWMAPE+   VM  +     +  
Sbjct:   474 KGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQKDSNPDLAFA 533

Query:   403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
             VDIWSLGCT++EM T KPPWS++EG AA+FK+   +D P IPE +S + K F++ C QR+
Sbjct:   534 VDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKV--MRDSPPIPESMSPEGKDFLRLCFQRN 591

Query:   463 PSARPPASKLLDHPFVRDQAVARA-GNVNLAKDSSPYSL---DGSRTPP--KLDLLPTRK 516
             P+ RP AS LL+H F+++     +  N ++++  +  ++      R  P  KLD +P  +
Sbjct:   592 PAERPTASMLLEHRFLKNSLQPTSPSNSDVSQLFNGMNITEPSSRREKPNFKLDQVPRAR 651

Query:   517 SITLCEGD 524
             ++T  E +
Sbjct:   652 NMTSSESE 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 724 (259.9 bits), Expect = 1.4e-71, P = 1.4e-71
 Identities = 146/290 (50%), Positives = 199/290 (68%)

Query:   230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC---LKQLNQEINLLSQLSHPNIVR 286
             RG FG VY+G N +SG++ A+K+V +  +  + ++    +++L +E+ LL  LSHPNIVR
Sbjct:    77 RGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHPNIVR 136

Query:   287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             Y G+   D+ L++ LE+V GGSI  LL+++GPF E V++TYTRQ+LLGL YLH    +HR
Sbjct:   137 YLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYLHNHAIMHR 196

Query:   347 DIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTV 403
             DIKGANILVD  G IKLADFG +K +   A+M    S KG+PYWMAPEV++ T G+S + 
Sbjct:   197 DIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQT-GHSFSA 255

Query:   404 DIWSLGCTVLEMATSKPPWSQ-YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
             DIWS+GCTV+EM T K PWSQ Y+ VAAIF IG +K  P IP+ LS DAK F+ +CLQ  
Sbjct:   256 DIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDFLLKCLQEV 315

Query:   463 PSARPPASKLLDHPFV----RDQAVARAGNV-NLAKDSSPYSLDGSRTPP 507
             P+ RP AS+LL HPFV    ++ A    G+V N      P  ++ +++ P
Sbjct:   316 PNLRPTASELLKHPFVMGKHKESASTDLGSVLNNLSTPLPLQINNTKSTP 365

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 712 (255.7 bits), Expect = 2.6e-70, P = 2.6e-70
 Identities = 143/300 (47%), Positives = 197/300 (65%)

Query:   231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC---LKQLNQEINLLSQLSHPNIVRY 287
             G FG VY+G N +SG++ AIKEV +  +  + +     +++L +E+NLL  LSHPNIVRY
Sbjct:    89 GAFGRVYMGMNVDSGELLAIKEVSIAMNGASRERAQAHVRELEEEVNLLKNLSHPNIVRY 148

Query:   288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
              G+      L++ LE+V GGSI  LL ++G F E VI+ YT+Q+LLGL YLH    +HRD
Sbjct:   149 LGTAREAGSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 208

Query:   348 IKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTVD 404
             IKGANILVD  G IKLADFG +K +   A+M    S KG+PYWMAPEV++ T G+S + D
Sbjct:   209 IKGANILVDNKGCIKLADFGASKKVVELATMTGAKSMKGTPYWMAPEVILQT-GHSFSAD 267

Query:   405 IWSLGCTVLEMATSKPPWSQ-YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
             IWS+GCT++EMAT KPPWSQ Y+ VAA+F IG +K  P IPEHLS ++K F+ +CLQ++P
Sbjct:   268 IWSVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKDFLLKCLQKEP 327

Query:   464 SARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEG 523
               R  AS LL HPFV  +       +  +   +P ++   R   +  ++P  ++   C G
Sbjct:   328 HLRHSASNLLQHPFVTAEHQEARPFLRSSFMGNPENMAAQRMDVRTSIIPDMRAS--CNG 385

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 694 (249.4 bits), Expect = 2.1e-68, P = 2.1e-68
 Identities = 146/323 (45%), Positives = 208/323 (64%)

Query:   231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC----LKQLNQEINLLSQLSHPNIVR 286
             G FG VY+G N +SG++ AIK+V ++     SKE     +++L +E+ LL  LSHPNIVR
Sbjct:    77 GAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLKNLSHPNIVR 135

Query:   287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             Y G+    + L++ +E+V GGSI  LL+++G F EPVI  YT+Q+LLGL YLH    +HR
Sbjct:   136 YLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEYLHNNGIMHR 195

Query:   347 DIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSFKGSPYWMAPEVVMNTNGYSLTV 403
             DIKGANILVD  G I+LADFG +K +   A++    S KG+PYWMAPEV++ T G+S + 
Sbjct:   196 DIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVILQT-GHSFSA 254

Query:   404 DIWSLGCTVLEMATSKPPWS-QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
             DIWS+GCTV+EMAT KPPWS QY+  AA+  IG +K  P IPE LS +AK F+ +CL ++
Sbjct:   255 DIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKDFLMKCLHKE 314

Query:   463 PSARPPASKLLDHPFV--RDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSIT- 519
             PS R  A++LL HPFV  + Q    A   +L +  +P +  G      ++ L  R + + 
Sbjct:   315 PSLRLSATELLQHPFVTGKRQEPYPAYRNSLTECGNPITTQGMNVRSSINSLIRRSTCSG 374

Query:   520 ---LCEGDYLANPLVPTSRALNN 539
                +CE   L + ++   ++ N+
Sbjct:   375 LKDVCELGSLRSSIIYPQKSNNS 397

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 652 (234.6 bits), Expect = 6.9e-63, P = 6.9e-63
 Identities = 122/253 (48%), Positives = 173/253 (68%)

Query:   230 RGTFGHVYLGFNSESGQMCAIKEVRVVC--DDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
             RG +G VYLG N ++G++ A+K++ +V    D   K  +   ++EI ++  L H NIVRY
Sbjct:   503 RGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRY 562

Query:   288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
              G+ L    LSV+LEY+ GGSI  LL ++G F+E VI+ YT+QIL GL++LHA + +HRD
Sbjct:   563 LGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLHANSIIHRD 622

Query:   348 IKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDIW 406
             IKGANIL+D  G +KL+DFG +K  +   S   S +G+PYWMAPEV+  T G+  + DIW
Sbjct:   623 IKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIKQT-GHGRSSDIW 681

Query:   407 SLGCTVLEMATSKPPWSQYEGVAAI-FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
             SLGC ++EMAT++PPWS    +AA+ + I +S  IP IP H+S +A  F+  C +RDP  
Sbjct:   682 SLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNLCFKRDPKE 741

Query:   466 RPPASKLLDHPFV 478
             RP A++LL HPF+
Sbjct:   742 RPDANQLLKHPFI 754

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 622 (224.0 bits), Expect = 9.0e-61, P = 9.0e-61
 Identities = 127/252 (50%), Positives = 172/252 (68%)

Query:   230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
             RG+FG VY G + + G   A+KEV ++     ++EC++QL  EI LLSQL H NIVRY G
Sbjct:   341 RGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRG 399

Query:   290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +      L ++LE V+ GS+ KL Q Y    + V+  YTRQIL GL YLH +  +HRDIK
Sbjct:   400 TAKDGSNLYIFLELVTQGSLLKLYQRY-QLRDSVVSLYTRQILDGLKYLHDKGFIHRDIK 458

Query:   350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDIWS 407
              ANILVD +G +KLADFG+AK ++    + S KG+P+WMAPEV+   +++GY    DIWS
Sbjct:   459 CANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWS 517

Query:   408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
             LGCTVLEM T + P+S  E V A+F+IG    +PE+P+ LS DA+ FI +CL+ +P  RP
Sbjct:   518 LGCTVLEMCTGQIPYSDLEPVQALFRIGRGT-LPEVPDTLSLDARLFILKCLKVNPEERP 576

Query:   468 PASKLLDHPFVR 479
              A++LL+HPFVR
Sbjct:   577 TAAELLNHPFVR 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

UNIPROTKB|J3KRN4 MAP3K3 "Mitogen-activated protein kinase kinase kinase 3" [Homo sapiens (taxid:9606)]

 Score = 574 (207.1 bits), Expect = 5.4e-59, Sum P(2) = 5.4e-59
 Identities = 116/257 (45%), Positives = 165/257 (64%)

Query:   230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLSHPNIVRYH 288
             +G FG VYL ++ ++G+  A K+V+   D  +TSKE +  L  EI LL  L H  IV+Y+
Sbjct:   366 QGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKE-VSALECEIQLLKNLQHERIVQYY 424

Query:   289 GS--ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             G   + +++ L++++EY+ GGS+   L+ YG   E V + YTRQIL G++YLH+   VHR
Sbjct:   425 GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHR 484

Query:   347 DIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVMNTNGYSLT 402
             DIKGANIL D  G +KL DFG +K + T C S   M S  G+PYWM+PEV+    GY   
Sbjct:   485 DIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVISG-EGYGRK 543

Query:   403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
              D+WSLGCTV+EM T KPPW++YE +AAIFKI      P++P H+S+  + F+++    +
Sbjct:   544 ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDFLRRIFV-E 602

Query:   463 PSARPPASKLLDHPFVR 479
                RP A +LL H F +
Sbjct:   603 ARQRPSAEELLTHHFAQ 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q99759 MAP3K3 "Mitogen-activated protein kinase kinase kinase 3" [Homo sapiens (taxid:9606)]

 Score = 574 (207.1 bits), Expect = 5.4e-59, Sum P(2) = 5.4e-59
 Identities = 116/257 (45%), Positives = 165/257 (64%)

Query:   230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLSHPNIVRYH 288
             +G FG VYL ++ ++G+  A K+V+   D  +TSKE +  L  EI LL  L H  IV+Y+
Sbjct:   370 QGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKE-VSALECEIQLLKNLQHERIVQYY 428

Query:   289 GS--ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             G   + +++ L++++EY+ GGS+   L+ YG   E V + YTRQIL G++YLH+   VHR
Sbjct:   429 GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHR 488

Query:   347 DIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVMNTNGYSLT 402
             DIKGANIL D  G +KL DFG +K + T C S   M S  G+PYWM+PEV+    GY   
Sbjct:   489 DIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVISG-EGYGRK 547

Query:   403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
              D+WSLGCTV+EM T KPPW++YE +AAIFKI      P++P H+S+  + F+++    +
Sbjct:   548 ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDFLRRIFV-E 606

Query:   463 PSARPPASKLLDHPFVR 479
                RP A +LL H F +
Sbjct:   607 ARQRPSAEELLTHHFAQ 623

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEP

GO:0004672 "protein kinase activity" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0000186 "activation of MAPKK activity" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_VII000360 hypothetical protein (610 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	628
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-166
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-134
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-104
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-99
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-97
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-93
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-93
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-91
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-90
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-89
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-87
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-86
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-77
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-77
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-76
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-75
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-75
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-75
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-72
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-71
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-70
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-69
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-69
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-68
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-66
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-65
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-61
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-60
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-58
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-58
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-58
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-57
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-56
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-56
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-55
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-53
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-52
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-52
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-52
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-52
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-51
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-51
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-51
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-51
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-50
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-48
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-48
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-47
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-47
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-47
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-47
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-47
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-47
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-46
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-46
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-45
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-45
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-45
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-45
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-45
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-44
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-43
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-43
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-43
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-43
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-43
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-42
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-42
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-42
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-42
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-42
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-41
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-41
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-41
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-41
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-41
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-40
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-40
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-39
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-38
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-38
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-38
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-38
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-38
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-38
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-37
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-37
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-36
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-36
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-36
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-36
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-36
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-36
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-36
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-36
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-36
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-35
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-35
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-35
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-35
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-35
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-35
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-35
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-35
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-35
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-34
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-34
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-34
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-33
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-33
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-33
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-33
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-32
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-32
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-32
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-32
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-32
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-32
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-32
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-32
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-32
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-31
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-31
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-31
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-31
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-31
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-31
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-30
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-30
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-30
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-30
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-30
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-29
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-29
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-29
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-29
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-29
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-29
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-29
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-29
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-29
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-29
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-29
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-29
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-29
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-28
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-28
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-28
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-28
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-28
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-28
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-28
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-28
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-28
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-28
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-27
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-27
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-27
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-27
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-27
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-27
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-27
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-26
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-26
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-26
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-26
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-25
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-25
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-25
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-25
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-25
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-25
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-24
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-23
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-22
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-22
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-22
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-22
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-21
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-21
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-20
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-20
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-20
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-19
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-19
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-18
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-17
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-17
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-16
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-15
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-13
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-11
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	8e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-04

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  473 bits (1220), Expect = e-166
 Identities = 169/258 (65%), Positives = 203/258 (78%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +W+KG+LLG G+FG VY G N + G   A+KEV +  D QT +E +KQL QEI LLS+L 
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HPNIV+Y G+E  ++ L ++LE V GGS+ KLL++YG F EPVI+ YTRQILLGL YLH 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
           RNTVHRDIKGANILVD +G +KLADFGMAK +   +   SFKGSPYWMAPEV+    GY 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
           L  DIWSLGCTVLEMAT KPPWSQ EGVAA+FKIG SK++P IP+HLSD+AK FI +CLQ
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 461 RDPSARPPASKLLDHPFV 478
           RDPS RP A++LL+HPFV
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  393 bits (1013), Expect = e-134
 Identities = 146/264 (55%), Positives = 194/264 (73%), Gaps = 10/264 (3%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +W +G+LLGRG+FG VYL  + ++G++ A+K V +  D   S+E L+ L +EI +LS L 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD---SEEELEALEREIRILSSLQ 57

Query: 281 HPNIVRYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           HPNIVRY+GSE  +E+  L+++LEYVSGGS+  LL+++G   EPVI+ YTRQIL GLAYL
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMN 395
           H+   VHRDIKGANILVD  G +KLADFG AK +    +     S +G+PYWMAPEV+  
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEIPEHLSDDAKSF 454
              Y    DIWSLGCTV+EMAT KPPWS+    +AA++KIG+S + PEIPEHLS++AK F
Sbjct: 178 E-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236

Query: 455 IKQCLQRDPSARPPASKLLDHPFV 478
           +++CL+RDP  RP A +LL HPF+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  316 bits (811), Expect = e-104
 Identities = 97/259 (37%), Positives = 153/259 (59%), Gaps = 7/259 (2%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           ++  + LG G+FG VYL  + ++G++ AIK ++     +  K+  +++ +EI +L +L H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKH 56

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           PNIVR +     +++L + +EY  GG +  LL++ G  +E   + Y RQIL  L YLH++
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
             VHRD+K  NIL+D  G +KLADFG+A+ +     + +F G+P +MAPEV++   GY  
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCL 459
            VDIWSLG  + E+ T KPP+   + +  +FK       P  P    +S +AK  I++ L
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235

Query: 460 QRDPSARPPASKLLDHPFV 478
            +DP  R  A + L HPF 
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  302 bits (776), Expect = 4e-99
 Identities = 116/259 (44%), Positives = 164/259 (63%), Gaps = 6/259 (2%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            ++ G L+GRG FG VY G N E+G   AIK++ +       +E LK + QEI+LL  L 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLK 57

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HPNIV+Y GS  + + L + LEY   GS+ ++++++GPF E ++  Y  Q+L GLAYLH 
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNGY 399
           +  +HRDIK ANIL    G +KLADFG+A  +   +    S  G+PYWMAPEV+   +G 
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMSGA 176

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           S   DIWSLGCTV+E+ T  PP+     +AA+F+I      P +PE +S + K F+ QC 
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISPELKDFLMQCF 235

Query: 460 QRDPSARPPASKLLDHPFV 478
           Q+DP+ RP A +LL HP++
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  299 bits (767), Expect = 1e-97
 Identities = 123/261 (47%), Positives = 172/261 (65%), Gaps = 5/261 (1%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W++GKLLG+G FG VYL ++ ++G+  A+K+V    D   +K+ +  L  EI LL  L H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
             IV+Y+G    DE LS+++EY+ GGS+   L+ YG   E V + YTRQIL G+ YLH+ 
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVMNTN 397
             VHRDIKGANIL D  G +KL DFG +K + T C+S   M S  G+PYWM+PEV+ +  
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI-SGE 182

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           GY    D+WS+GCTV+EM T KPPW+++E +AAIFKI      P++P H+S DA++F+++
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Query: 458 CLQRDPSARPPASKLLDHPFV 478
               +   RP A +LL H FV
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  287 bits (737), Expect = 4e-93
 Identities = 117/268 (43%), Positives = 171/268 (63%), Gaps = 14/268 (5%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +W++G  +G GTFG VY   N ++G++ A+KE+R+  +D  +   +K++  E+ +L  L 
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HPN+V+Y+G E+  E++ +++EY SGG++ +LL+     +E VI+ YT Q+L GLAYLH+
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAK----HMTSCASML-SFKGSPYWMAPEVVMN 395
              VHRDIK ANI +D +G IKL DFG A     + T+    + S  G+P +MAPEV+  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 396 TN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI-FKIGNSKDIPEIPEH--LSDD 450
               G+    DIWSLGC VLEMAT K PWS+ +    I F +G +   P IP+   LS +
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPE 236

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHPFV 478
            K F+ +CL+ DP  RP AS+LL HPFV
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  287 bits (735), Expect = 7e-93
 Identities = 123/270 (45%), Positives = 170/270 (62%), Gaps = 13/270 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVC-----DDQTSKECLKQLNQEINL 275
           KW KG+L+G+GT+G VYL  N  +G+M A+K+V +        D   K+ +K L  EI  
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           L  L H NIV+Y G E ++E LS++LEYV GGSI   L+ YG F E +++ +T Q+L GL
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH---MTSCASMLSFKGSPYWMAPEV 392
           AYLH++  +HRD+K  N+LVD  G  K++DFG++K    +      +S +GS +WMAPEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 393 VMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE----HL 447
           + + + GYS  VDIWSLGC VLEM   + PWS  E +AA+FK+GN +  P IP     +L
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241

Query: 448 SDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           S  A  F+  C   +P  RP A +LL HPF
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  282 bits (725), Expect = 3e-91
 Identities = 101/262 (38%), Positives = 151/262 (57%), Gaps = 9/262 (3%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             +   + +G+G+FG VY   +  + Q+ AIK +    D + +++ ++ + QEI  LSQ 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI----DLEEAEDEIEDIQQEIQFLSQC 56

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
             P I +Y+GS L   +L + +EY  GGS   LL + G  +E  I    R++LLGL YLH
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMNTNG 398
               +HRDIK ANIL+   G++KLADFG++  +TS  S   +F G+P+WMAPEV+  + G
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS-G 174

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL-SDDAKSFIKQ 457
           Y    DIWSLG T +E+A  +PP S    +  +F I  +   P +  +  S   K F+  
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLEGNKFSKPFKDFVSL 233

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
           CL +DP  RP A +LL H F++
Sbjct: 234 CLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  279 bits (715), Expect = 5e-90
 Identities = 104/260 (40%), Positives = 156/260 (60%), Gaps = 10/260 (3%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            ++  + +G+G FG VY   +  +G+  AIK +++      SKE  +++  EI +L +  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE-----SKEKKEKIINEIQILKKCK 55

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
           HPNIV+Y+GS L  + L + +E+ SGGS+  LL+       E  I    +++L GL YLH
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           +   +HRDIK ANIL+   GE+KL DFG++  ++   +  +  G+PYWMAPEV+     Y
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK-PY 174

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQ 457
               DIWSLG T +E+A  KPP+S+   + A+FKI      P +  PE  SD+ K F+K+
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK 233

Query: 458 CLQRDPSARPPASKLLDHPF 477
           CLQ++P  RP A +LL HPF
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  277 bits (709), Expect = 6e-89
 Identities = 126/269 (46%), Positives = 173/269 (64%), Gaps = 13/269 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE----CLKQLNQEINLL 276
           KW KG L+G G+FG VYLG N+ SG++ A+K+V +     +SK+     L  L +EI LL
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
            +L H NIV+Y GS L  + L+++LEYV GGS+  LL  YG F E +++ + RQIL GL 
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH-------MTSCASMLSFKGSPYWMA 389
           YLH R  +HRDIKGANILVD  G IK++DFG++K          +  +  S +GS +WMA
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD 449
           PEVV  T+ Y+   DIWSLGC V+EM T K P+     + AIFKIG     PEIP ++S 
Sbjct: 181 PEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS 238

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           +A  F+++  + D + RP A++LL HPF+
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  272 bits (698), Expect = 2e-87
 Identities = 119/266 (44%), Positives = 170/266 (63%), Gaps = 11/266 (4%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQLS 280
           W KG++LG+G +G VY G  ++ GQ+ A+K+V +   +   +++  ++L +E++LL  L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           H NIV+Y G+ L D  +S+++E+V GGSI  +L  +GP  EPV   YT+QIL G+AYLH 
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAK-------HMTSCASMLSFKGSPYWMAPEVV 393
              VHRDIKG N+++ P+G IKL DFG A+       H T    + S  G+PYWMAPEV+
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAK 452
            N +GY    DIWS+GCTV EMAT KPP +  + +AA+F IG  +  +P +P+  S  A 
Sbjct: 181 -NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239

Query: 453 SFIKQCLQRDPSARPPASKLLDHPFV 478
            F+  CL RD   RP A +LL H F+
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  269 bits (691), Expect = 2e-86
 Identities = 98/263 (37%), Positives = 154/263 (58%), Gaps = 9/263 (3%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           ++  + LG G+FG VY   +  +G++ A+K ++         +  +   +EI +L +LSH
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSH 57

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           PNIVR   +    + L + +EY  GG +   L   GP +E   +    QIL GL YLH+ 
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             +HRD+K  NIL+D +G +K+ADFG+AK  + S +S+ +F G+P++MAPEV++  NGY 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 401 LTVDIWSLGCTVLEMATSKPPWS---QYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFI 455
             VD+WSLG  + E+ T KPP+S     + +  I +I       + P+    S++AK  I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 456 KQCLQRDPSARPPASKLLDHPFV 478
           K+CL +DPS RP A ++L HP+ 
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  246 bits (631), Expect = 1e-77
 Identities = 104/258 (40%), Positives = 147/258 (56%), Gaps = 17/258 (6%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
            LG G++G VY   + E+GQ+ AIK V V       +E L+++ +EI++L Q   P IV+
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIVK 62

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVH 345
           Y+GS   +  L + +EY   GS+  +++       E  I     Q L GL YLH+   +H
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RDIK  NIL++  G+ KLADFG++  +T   A   +  G+P+WMAPEV+    GY+   D
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKAD 181

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP----EIPEHLSDDAKSFIKQCLQ 460
           IWSLG T +EMA  KPP+S    + AIF I N    P      PE  S +   F+K+CL 
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPTLSDPEKWSPEFNDFVKKCLV 238

Query: 461 RDPSARPPASKLLDHPFV 478
           +DP  RP A +LL HPF+
Sbjct: 239 KDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 3e-77
 Identities = 109/257 (42%), Positives = 150/257 (58%), Gaps = 12/257 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G GT+G VY   +  +G++ AIK +++   D       + + QEI++L +  HPNIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----FEIIQQEISMLKECRHPNIVAY 65

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            GS L  ++L + +EY  GGS+  + Q   GP +E  I    R+ L GLAYLH    +HR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEV--VMNTNGYSLTV 403
           DIKGANIL+   G++KLADFG++  +T + A   SF G+PYWMAPEV  V    GY    
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP---EIPEHLSDDAKSFIKQCLQ 460
           DIW+LG T +E+A  +PP      + A+F I  S   P   +  E  S     FIK+CL 
Sbjct: 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLT 245

Query: 461 RDPSARPPASKLLDHPF 477
           +DP  RP A+KLL HPF
Sbjct: 246 KDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  243 bits (621), Expect = 4e-76
 Identities = 123/263 (46%), Positives = 170/263 (64%), Gaps = 8/263 (3%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W+ GKLLGRG FG VYL +++++G+  A+K+V    D Q + + +  L  EI LL  L H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 282 PNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
             IV+Y+G   +  +++LS+++EY+ GGSI   L+ YG   E V + YTRQIL G++YLH
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVMN 395
           +   VHRDIKGANIL D  G +KL DFG +K + T C S   + S  G+PYWM+PEV+ +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI-S 182

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
             GY    D+WS+ CTV+EM T KPPW++YE +AAIFKI      P +P+ +SD  + F+
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242

Query: 456 KQCLQRDPSARPPASKLLDHPFV 478
           KQ    +   RP A  LL HPFV
Sbjct: 243 KQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  241 bits (617), Expect = 2e-75
 Identities = 104/268 (38%), Positives = 165/268 (61%), Gaps = 11/268 (4%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE-CLKQLNQEINLLSQLS 280
           W KG+ LG G F   Y   + ++G + A+K+V  V +  + +E  ++ L +EI L+++L+
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HP+I+R  G+   D   ++++E+++GGS+  LL +YG F E VI  YT Q+L GL+YLH 
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 341 RNTVHRDIKGANILVDPHGE-IKLADFGMAKHMTSCASML-----SFKGSPYWMAPEVVM 394
              +HRD+KGAN+L+D  G+ +++ADFG A  + +  +          G+  +MAPEV+ 
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE---GVAAIFKIGNSKDIPEIPEHLSDDA 451
               Y  + D+WS+GC ++EMAT+KPPW+  +    +A IFKI ++   P IPEHLS   
Sbjct: 182 GEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVR 479
           +    +CL+  P  RPP+ +LL HP  R
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  241 bits (616), Expect = 3e-75
 Identities = 123/265 (46%), Positives = 176/265 (66%), Gaps = 10/265 (3%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLS 280
           W++GKLLG+G FG VYL ++ ++G+  A K+V+   +  +TSKE +  L  EI LL  L 
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE-VSALECEIQLLKNLQ 62

Query: 281 HPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           H  IV+Y+G   + +++ L++++EY+ GGS+   L+ YG   E V + YTRQIL G++YL
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEVVM 394
           H+   VHRDIKGANIL D  G +KL DFG +K + T C S   + S  G+PYWM+PEV+ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI- 181

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
           +  GY    D+WSLGCTV+EM T KPPW++YE +AAIFKI      P++P H+S+ A+ F
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241

Query: 455 IKQCLQRDPSARPPASKLLDHPFVR 479
           +  C+  +   RP A +LL HPF +
Sbjct: 242 LG-CIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  241 bits (615), Expect = 3e-75
 Identities = 124/266 (46%), Positives = 173/266 (65%), Gaps = 10/266 (3%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQ 278
           + W+ GKLLG+G FG VYL +++++G+  A+K+V+   +  +TSKE +  L  EI LL  
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKN 60

Query: 279 LSHPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           L H  IV+Y+G   +  +  LS+++E++ GGSI   L+ YG   E V + YTRQIL G++
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCAS---MLSFKGSPYWMAPEV 392
           YLH+   VHRDIKGANIL D  G +KL DFG +K + T C S   M S  G+PYWM+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           + +  GY    DIWS+GCTV+EM T KPPW+++E +AAIFKI      P +P H+SD  +
Sbjct: 181 I-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239

Query: 453 SFIKQCLQRDPSARPPASKLLDHPFV 478
            F+K+    +   RP A +LL H FV
Sbjct: 240 DFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  233 bits (598), Expect = 1e-72
 Identities = 90/266 (33%), Positives = 144/266 (54%), Gaps = 16/266 (6%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K++  K +G+G+FG VYL      G++  +KE+ +    +  +E       E+ +L +L+
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLN 57

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGS----IHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           HPNI++Y+ S     +L + +EY  GG     I K  +E  PF E  I  +  Q+ L L 
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMN 395
           YLH+R  +HRDIK  NI +  +G +KL DFG++K ++S   +  +  G+PY+++PE+  N
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPP---WSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
              Y+   DIWSLGC + E+ T K P    +  E      KI      P IP   S + +
Sbjct: 178 -KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI-LKGQYPPIPSQYSSELR 232

Query: 453 SFIKQCLQRDPSARPPASKLLDHPFV 478
           + +   LQ+DP  RP  +++L  PF+
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  227 bits (582), Expect = 7e-71
 Identities = 92/252 (36%), Positives = 138/252 (54%), Gaps = 40/252 (15%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G FG VYL  + ++G+  AIK ++     + S   L++L +EI +L +L+HPNIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +G    +  L + +EY  GGS+  LL+E  G  +E  I     QIL GL YLH+   +HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 347 DIKGANILVD-PHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVD 404
           D+K  NIL+D  +G++KLADFG++K +TS  S+L +  G+P +MAPEV++    YS   D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           IWSLG  + E+                                  + K  I++ LQ+DP 
Sbjct: 177 IWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE 203

Query: 465 ARPPASKLLDHP 476
            RP A ++L+H 
Sbjct: 204 KRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  229 bits (585), Expect = 1e-70
 Identities = 95/262 (36%), Positives = 152/262 (58%), Gaps = 10/262 (3%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           ++ K+LG+G+ G VY   +  +G++ A+K++ V  D++      KQL +E+  L     P
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF----RKQLLRELKTLRSCESP 59

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-R 341
            +V+ +G+   +  +S+ LEY+ GGS+  LL++ G   EPV+    RQIL GL YLH  R
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM-LSFKGSPYWMAPEVVMNTNGYS 400
           + +HRDIK +N+L++  GE+K+ADFG++K + +      +F G+  +M+PE +     YS
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGESYS 178

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYE--GVAAIFKIGNSKDIPEIPEHL-SDDAKSFIKQ 457
              DIWSLG T+LE A  K P+          + +       P +P    S + + FI  
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
           CLQ+DP  RP A++LL HPF++
Sbjct: 239 CLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  225 bits (577), Expect = 4e-69
 Identities = 103/254 (40%), Positives = 147/254 (57%), Gaps = 12/254 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G  G VY   +  +G+  AIK++R+   +       + +  EI ++    HPNIV Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQN------KELIINEILIMKDCKHPNIVDY 80

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           + S L  + L V +EY+ GGS+  ++ +     NEP I    R++L GL YLH++N +HR
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  NIL+   G +KLADFG A  +T   S   S  G+PYWMAPEV+   + Y   VDI
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDI 199

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDP 463
           WSLG   +EMA  +PP+ +   + A+F I  +K IP +  PE  S + K F+ +CL +DP
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLI-TTKGIPPLKNPEKWSPEFKDFLNKCLVKDP 258

Query: 464 SARPPASKLLDHPF 477
             RP A +LL HPF
Sbjct: 259 EKRPSAEELLQHPF 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  225 bits (574), Expect = 5e-69
 Identities = 114/259 (44%), Positives = 158/259 (61%), Gaps = 12/259 (4%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +LG+GT+G VY   +  +    AIKE+    D +  +     L++EI L S L H NIV+
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQP----LHEEIALHSYLKHRNIVQ 69

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPF--NEPVIQTYTRQILLGLAYLHARNT 343
           Y GS+  +    +++E V GGS+  LL+ ++GP   NE  I  YT+QIL GL YLH    
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 344 VHRDIKGANILVDPH-GEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVV-MNTNGYS 400
           VHRDIKG N+LV+ + G +K++DFG +K +        +F G+  +MAPEV+     GY 
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQY-EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
              DIWSLGCT++EMAT KPP+ +  E  AA+FK+G  K  PEIPE LS +AK+FI +C 
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249

Query: 460 QRDPSARPPASKLLDHPFV 478
           + DP  R  A  LL  PF+
Sbjct: 250 EPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  222 bits (567), Expect = 5e-68
 Identities = 101/268 (37%), Positives = 150/268 (55%), Gaps = 11/268 (4%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           S +++ +L+GRG +G VY G +  +G++ A+K + +   D    +    + +E+ LLSQL
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD----IQREVALLSQL 56

Query: 280 SH---PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
                PNI +Y+GS L   RL + +EY  GGS+  L+ + GP  E  I    R++L+ L 
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALK 115

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMN 395
           Y+H    +HRDIK ANILV   G +KL DFG+A  +   +S  S F G+PYWMAPEV+  
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE-HLSDDAKSF 454
              Y    DIWSLG T+ EMAT  PP+S  +   A+  I  SK  P + +   S   + F
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-PRLEDNGYSKLLREF 234

Query: 455 IKQCLQRDPSARPPASKLLDHPFVRDQA 482
           +  CL  +P  R  A +LL   +++  +
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIKAHS 262

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  219 bits (559), Expect = 1e-66
 Identities = 101/274 (36%), Positives = 151/274 (55%), Gaps = 14/274 (5%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
            N    W+    LG G FG VY   + E+G   A K    +   ++ +E L+    EI++
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAK----IIQIESEEE-LEDFMVEIDI 55

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLG 334
           LS+  HPNIV  + +   + +L + +E+  GG++  ++ E      EP I+   RQ+L  
Sbjct: 56  LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVV 393
           L +LH+   +HRD+K  NIL+   G++KLADFG+ AK+ ++     +F G+PYWMAPEVV
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175

Query: 394 M----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHL 447
                  N Y    DIWSLG T++E+A  +PP  +   +  + KI  S + P +  P   
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-EPPTLDQPSKW 234

Query: 448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
           S     F+K CL +DP  RP A++LL HPFV DQ
Sbjct: 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  213 bits (544), Expect = 9e-65
 Identities = 95/261 (36%), Positives = 148/261 (56%), Gaps = 23/261 (8%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQLSH 281
           LG+G+FG V L    ++G++ A+K ++        K+ + +  +      E N+LS+++H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P IV+ H +  ++E+L + LEY  GG +   L + G F+E   + Y  +I+L L YLH+ 
Sbjct: 53  PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  NIL+D  G IKL DFG+AK ++S  +   +F G+P ++APEV++   GY 
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYG 171

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCL 459
             VD WSLG  + EM T KPP+   E    I+ KI         PE LS +A+  I   L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLL 228

Query: 460 QRDPSAR---PPASKLLDHPF 477
           Q+DP+ R     A ++  HPF
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  204 bits (520), Expect = 3e-61
 Identities = 88/263 (33%), Positives = 139/263 (52%), Gaps = 18/263 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G    VY      + +  AIK +    D +  +  + +L +E+  +SQ +HPN+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ---EYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           + S +  + L + + Y+SGGS+  +++     G  +E +I T  +++L GL YLH+   +
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 345 HRDIKGANILVDPHGEIKLADFG----MAKHMTSCASML-SFKGSPYWMAPEVVMNTNGY 399
           HRDIK  NIL+   G +K+ADFG    +A        +  +F G+P WMAPEV+   +GY
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA-----KSF 454
               DIWS G T +E+AT   P+S+Y  +  +     + D P +             +  
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKM 243

Query: 455 IKQCLQRDPSARPPASKLLDHPF 477
           I  CLQ+DPS RP A +LL H F
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  202 bits (515), Expect = 3e-60
 Identities = 95/276 (34%), Positives = 151/276 (54%), Gaps = 25/276 (9%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            ++  +++G GT+G VY   + ++GQ+ AIK + ++ D++      +++ +E N+L + S
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE------EEIKEEYNILRKYS 60

Query: 281 -HPNIVRYHG------SELSDERLSVYLEYVSGGSI----HKLLQEYGPFNEPVIQTYTR 329
            HPNI  ++G         +D++L + +E   GGS+      L ++     E  I    R
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWM 388
           + L GLAYLH    +HRDIKG NIL+  + E+KL DFG++  + S      +F G+PYWM
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180

Query: 389 APEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI- 443
           APEV+         Y    D+WSLG T +E+A  KPP      + A+FKI  +   P + 
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP-PTLK 239

Query: 444 -PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
            PE+ S     FI +CL ++   RP   +LL+HPF+
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  197 bits (502), Expect = 2e-58
 Identities = 103/256 (40%), Positives = 158/256 (61%), Gaps = 8/256 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+G+FG V+ G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           +GS L D +L + +EY+ GGS   LL E GP +E  I T  R+IL GL YLH+   +HRD
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK AN+L+  HGE+KLADFG+A  +T      + F G+P+WMAPEV+  +  Y    DIW
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIW 185

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           SLG T +E+A  +PP S+   +  +F I  + + P +  + S   K F++ CL ++PS R
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPSFR 244

Query: 467 PPASKLLDHPFVRDQA 482
           P A +LL H F+   A
Sbjct: 245 PTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  195 bits (497), Expect = 7e-58
 Identities = 101/252 (40%), Positives = 150/252 (59%), Gaps = 8/252 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+G+FG VY G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P I RY
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           +GS L   +L + +EY+ GGS   LL+  GP  E  I T  R+IL GL YLH+   +HRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRD 126

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK AN+L+   G++KLADFG+A  +T       +F G+P+WMAPEV+  +  Y    DIW
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIW 185

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           SLG T +E+A  +PP S    +  +F I  +   P +    S   K F++ CL +DP  R
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR 244

Query: 467 PPASKLLDHPFV 478
           P A +LL H F+
Sbjct: 245 PTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  195 bits (497), Expect = 7e-58
 Identities = 101/252 (40%), Positives = 153/252 (60%), Gaps = 8/252 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+G+FG V+ G ++ + Q+ AIK +    D + +++ ++ + QEI +LSQ   P + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKII----DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           +GS L   +L + +EY+ GGS   LL+  GPF+E  I T  ++IL GL YLH+   +HRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK AN+L+   G++KLADFG+A  +T       +F G+P+WMAPEV+  +  Y    DIW
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIW 185

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           SLG T +E+A  +PP S    +  +F I  + + P +    S   K FI  CL +DPS R
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPKN-NPPTLTGEFSKPFKEFIDACLNKDPSFR 244

Query: 467 PPASKLLDHPFV 478
           P A +LL H F+
Sbjct: 245 PTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  193 bits (493), Expect = 3e-57
 Identities = 91/265 (34%), Positives = 136/265 (51%), Gaps = 17/265 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           + +G+G+FG V        G++   KE+     + T KE  +QL  E+N+L +L HPNIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDY--GNMTEKEK-QQLVSEVNILRELKHPNIV 62

Query: 286 RYHGSEL--SDERLSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLH 339
           RY+   +  S++ L + +EY  GG + +L+Q+         E  I     Q+LL L   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 340 ----ARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVV 393
                 NTV HRD+K ANI +D +  +KL DFG+AK +   +S   ++ G+PY+M+PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
            +   Y    DIWSLGC + E+    PP++    +    KI   K    IP   S +   
Sbjct: 183 NH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-FRRIPYRYSSELNE 240

Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            IK  L  DP  RP   +LL  P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  192 bits (490), Expect = 1e-56
 Identities = 87/292 (29%), Positives = 144/292 (49%), Gaps = 49/292 (16%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEINLLSQLSH 281
           +K + LG GT+G VY   + ++G++ A+K++R+   ++      L+    EI+LL +L H
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKH 57

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLGLAYLHA 340
           PNIV+      ++ +L +  EY     + K L +  GP +  +I++   Q+L GLAY H+
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-------WM-APEV 392
              +HRD+K  NIL++  G +KLADFG+A+               Y       W  APE+
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVVTLWYRAPEI 169

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI-G--NSKDIPEIPEH 446
           ++ +  YS  VDIWS+GC   EM T KP +   S+ + +  IF+I G    +  P + + 
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 447 ---------------------LSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                                L  +    + + LQ +P+ R  A + L HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  191 bits (486), Expect = 2e-56
 Identities = 102/256 (39%), Positives = 150/256 (58%), Gaps = 11/256 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G GT+G VY   N  +G++ A+K +++   D  S      + QEI ++ +  H NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVKECKHCNIVAY 71

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            GS LS E+L + +EY  GGS+  +    GP +E  I    R+ L GLAYLH++  +HRD
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEV--VMNTNGYSLTVD 404
           IKGANIL+  +G++KLADFG+A  +T+  A   SF G+PYWMAPEV  V    GY+   D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHL--SDDAKSFIKQCLQR 461
           IW++G T +E+A  +PP      + A+F +  S    P++ +    S    +F+K  L +
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTK 251

Query: 462 DPSARPPASKLLDHPF 477
           +P  RP A +LL H F
Sbjct: 252 NPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  189 bits (482), Expect = 3e-55
 Identities = 94/255 (36%), Positives = 136/255 (53%), Gaps = 9/255 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+FG VY   +  + ++ AIK++      + S E  + + +E+  L QL HPN + Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            G  L +    + +EY  G +   L     P  E  I       L GLAYLH+   +HRD
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDI 405
           IK  NIL+   G +KLADFG A   +  +   SF G+PYWMAPEV+  M+   Y   VD+
Sbjct: 141 IKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI-PEHLSDDAKSFIKQCLQRDPS 464
           WSLG T +E+A  KPP      ++A++ I  + D P +     SD  ++F+  CLQ+ P 
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSNDWSDYFRNFVDSCLQKIPQ 256

Query: 465 ARPPASKLLDHPFVR 479
            RP + +LL H FV 
Sbjct: 257 DRPSSEELLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  188 bits (479), Expect = 5e-55
 Identities = 103/273 (37%), Positives = 150/273 (54%), Gaps = 14/273 (5%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W+    LG G FG VY   N E+G + A K +     +  S+E L+    EI +L+  +H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYMVEIEILATCNH 68

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHA 340
           P IV+  G+   D +L + +E+  GG++  ++ E      EP IQ   RQ+L  L YLH+
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVV----MN 395
              +HRD+K  N+L+   G+IKLADFG+ AK++ +     SF G+PYWMAPEVV    M 
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKS 453
              Y    DIWSLG T++EMA  +PP  +   +  + KI  S + P +  P   S + + 
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLSQPSKWSMEFRD 247

Query: 454 FIKQCLQRDPSARPPASKLLDHPFVRDQAVARA 486
           F+K  L + P  RP A++LL+HPFV      R 
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  183 bits (466), Expect = 2e-53
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 15/261 (5%)

Query: 223 KKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
             GK LG G FG VY G             A+K ++    +Q  +E L    +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL----REARIMRK 57

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ--TYTRQILLGLA 336
           L HPNIV+  G    +E L + +EY+ GG +   L++  P    +    ++  QI  G+ 
Sbjct: 58  LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG-SPY-WMAPEVVM 394
           YL ++N +HRD+   N LV  +  +K++DFG+++ +          G  P  WMAPE  +
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE-SL 176

Query: 395 NTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
               ++   D+WS G  + E+ T  + P+        +  +         P +   +   
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELYK 235

Query: 454 FIKQCLQRDPSARPPASKLLD 474
            + QC   DP  RP  S+L++
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  183 bits (465), Expect = 3e-53
 Identities = 99/256 (38%), Positives = 148/256 (57%), Gaps = 11/256 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G GT+G VY   N  +G++ AIK +++        E    + QEI ++    H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            GS L  ++L + +E+  GGS+  +    GP +E  I   +R+ L GL YLH++  +HRD
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEV--VMNTNGYSLTVD 404
           IKGANIL+  +G +KLADFG++  +T+  A   SF G+PYWMAPEV  V    GY+   D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHL--SDDAKSFIKQCLQR 461
           IW++G T +E+A  +PP      + A+F +  S    P++ + +  S+    F+K  L +
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK 251

Query: 462 DPSARPPASKLLDHPF 477
           +P  RP A KLL HPF
Sbjct: 252 NPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  180 bits (460), Expect = 1e-52
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 22/264 (8%)

Query: 223 KKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
             GK LG G FG VY G       +     A+K ++    +Q  +E L    +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL----REARIMRK 57

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT-----YTRQILL 333
           L HPN+V+  G    +E L + +EY+ GG +   L++    N P +       +  QI  
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK----NRPKLSLSDLLSFALQIAR 113

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG-SPY-WMAPE 391
           G+ YL ++N +HRD+   N LV  +  +K++DFG+++ +          G  P  WMAPE
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD 450
             +    ++   D+WS G  + E+ T  + P+        +  + N       P +   +
Sbjct: 174 -SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNCPPE 231

Query: 451 AKSFIKQCLQRDPSARPPASKLLD 474
               + QC   DP  RP  S+L++
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  180 bits (460), Expect = 2e-52
 Identities = 88/259 (33%), Positives = 148/259 (57%), Gaps = 15/259 (5%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G  G V    +  +G++ A+K +R+   +       KQ+ +E+++L + + P IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL---EINEAI-QKQILRELDILHKCNSPYIVGF 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH-ARNTVH 345
           +G+  ++  +S+ +EY+ GGS+ K+L+E  G   E ++      +L GL YLH     +H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +NILV+  G+IKL DFG++  + +  +  +F G+  +MAPE +   N YS+  DI
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERI-QGNDYSVKSDI 182

Query: 406 WSLGCTVLEMATSKPPWSQY-EGVAAIF----KIGNSKDIPEIPEH-LSDDAKSFIKQCL 459
           WSLG +++E+AT + P+    +    IF     I N +  P +P    S D + F+  CL
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCL 241

Query: 460 QRDPSARPPASKLLDHPFV 478
            +DP  RP   +LL+HPF+
Sbjct: 242 IKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  180 bits (460), Expect = 3e-52
 Identities = 86/285 (30%), Positives = 141/285 (49%), Gaps = 43/285 (15%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ--TSKECLKQLNQEINLLSQLS-H 281
           GK++G G+F  V L    E+ +  AIK    + D +    ++ +K +  E  +L++L+ H
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIK----ILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P I++ + +   +E L   LEY   G + + +++YG  +E   + Y  +ILL L YLH++
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHM-------------TSCASML--------S 380
             +HRD+K  NIL+D    IK+ DFG AK +             T+  S +        S
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 381 FKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGN 436
           F G+  +++PE++     G S   D+W+LGC + +M T KPP+   ++Y     I K+  
Sbjct: 182 FVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE- 238

Query: 437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARP----PASKLLDHPF 477
                  P +   DAK  I++ L  DP  R        +L  HPF
Sbjct: 239 ----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  178 bits (455), Expect = 7e-52
 Identities = 85/249 (34%), Positives = 136/249 (54%), Gaps = 21/249 (8%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           LG G FG V L       +  A+K V+   +V   +T ++  + +  E  +L + +HP I
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV---ETGQQ--EHIFSEKEILEECNHPFI 55

Query: 285 VRYHGSELSDERLSVY--LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
           V+ + +   D++  +Y  +EY  GG +  +L++ G F+E   + Y   ++L   YLH R 
Sbjct: 56  VKLYRT-FKDKK-YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
            ++RD+K  N+L+D +G +KL DFG AK + S     +F G+P ++APE+++N  GY  +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFS 172

Query: 403 VDIWSLGCTVLEMATSKPPWS-----QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           VD WSLG  + E+ T +PP+        E    I K GN K   E P ++   AK  IKQ
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-GNGK--LEFPNYIDKAAKDLIKQ 229

Query: 458 CLQRDPSAR 466
            L+R+P  R
Sbjct: 230 LLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  179 bits (456), Expect = 8e-52
 Identities = 101/265 (38%), Positives = 147/265 (55%), Gaps = 14/265 (5%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W+    LG G FG VY   N E+G + A K +     D  S+E L+    EI++L+   H
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI-----DTKSEEELEDYMVEIDILASCDH 61

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHA 340
           PNIV+   +   +  L + +E+ +GG++  ++ E   P  EP I+   +Q L  L YLH 
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVVM----N 395
              +HRD+K  NIL    G+IKLADFG+ AK+  +     SF G+PYWMAPEVVM     
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKS 453
              Y    D+WSLG T++EMA  +PP  +   +  + KI  S + P +  P   S + K 
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEFKD 240

Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
           F+K+CL+++  AR   ++LL HPFV
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (453), Expect = 1e-51
 Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 15/260 (5%)

Query: 223 KKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           + GK LG G FG VY G        +    A+K       +  S+E  ++  +E +++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK----TLKEGASEEEREEFLEEASIMKK 57

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAY 337
           LSHPNIVR  G     E L +  EY+ GG +   L+++G       +     QI  G+ Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVM 394
           L ++N VHRD+   N LV  +  +K++DFG+++ +          G      WMAPE + 
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 395 NTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +   ++   D+WS G  + E+ T  + P+        +  + +       PE+  D+   
Sbjct: 178 D-GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY-RLPRPENCPDELYE 235

Query: 454 FIKQCLQRDPSARPPASKLL 473
            + QC   DP  RP  S+L+
Sbjct: 236 LMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  179 bits (456), Expect = 1e-51
 Identities = 92/267 (34%), Positives = 135/267 (50%), Gaps = 26/267 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE---CLKQL---NQEINLLSQL 279
           K LG G+FG V L  +  SG+  A+K          SK     LKQ+     E  +L  +
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALK--------ILSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            HP +V  +GS   D  L + +EYV GG +   L++ G F EPV + Y  Q++L L YLH
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           + + V+RD+K  N+L+D  G IK+ DFG AK +      L   G+P ++APE++++  GY
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEIILSK-GY 175

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQC 458
              VD W+LG  + EM    PP+   +    I+ KI   K     P   S DAK  I+  
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGK--VRFPSFFSPDAKDLIRNL 232

Query: 459 LQRDPSAR-----PPASKLLDHPFVRD 480
           LQ D + R        + + +HP+   
Sbjct: 233 LQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  179 bits (455), Expect = 3e-51
 Identities = 98/260 (37%), Positives = 142/260 (54%), Gaps = 7/260 (2%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+FG VY   NS + ++ A+K++      + + E  + + +E+  L QL HPN + Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            G  L +    + +EY  G +   L     P  E  I   T   L GLAYLH+ N +HRD
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDI 405
           IK  NIL+   G++KLADFG A   +S A+  SF G+PYWMAPEV+  M+   Y   VD+
Sbjct: 147 IKAGNILLTEPGQVKLADFGSAS-KSSPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           WSLG T +E+A  KPP      ++A++ I  +          +D  + F+  CLQ+ P  
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQE 263

Query: 466 RPPASKLLDHPFVRDQAVAR 485
           RP +++LL H FVR    AR
Sbjct: 264 RPASAELLRHDFVRRDRPAR 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  176 bits (449), Expect = 6e-51
 Identities = 91/267 (34%), Positives = 142/267 (53%), Gaps = 19/267 (7%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           + +G +G V+L     +G + AIK ++    D   K  + Q+  E ++LSQ   P +V+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           + S    + L + +EY+ GG +  LL+  G  +E V + Y  +I+L L YLH+   +HRD
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 348 IKGANILVDPHGEIKLADFGMAKH-MTSCASMLS--------FKGSPYWMAPEVVMNTNG 398
           +K  NIL+D +G +KL DFG++K  +      L+          G+P ++APEV++   G
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QG 177

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSK-DIPEIPEHLSDDAKSFIK 456
           +S TVD WSLGC + E     PP+   E    IF  I N K + PE  E +SD+A   I 
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDVE-VSDEAIDLIS 235

Query: 457 QCLQRDPSARPPA---SKLLDHPFVRD 480
           + L  DP  R  A    ++ +HPF + 
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  174 bits (443), Expect = 3e-50
 Identities = 89/257 (34%), Positives = 131/257 (50%), Gaps = 10/257 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K LG+G++G VY        Q  A+KEV +     + KE    +N EI +L+ ++HPNI+
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDL--GSMSQKEREDAVN-EIRILASVNHPNII 62

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTRQILLGLAYLHAR 341
            Y  + L   +L + +EY   G + K + +         E  I     Q+L GL  LH +
Sbjct: 63  SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
             +HRD+K ANIL+  +  +K+ D G++K +    +     G+P++MAPEV      YS 
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGR-PYSY 180

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             DIWSLGC + EMAT  PP+         +K+   K  P IP   S D ++FI+  LQ 
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSMLQV 239

Query: 462 DPSARPPASKLLDHPFV 478
            P  RP   K+L  P V
Sbjct: 240 KPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  177 bits (449), Expect = 8e-50
 Identities = 101/366 (27%), Positives = 168/366 (45%), Gaps = 30/366 (8%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            ++  + LG G+FG VYL  +    ++ A+K +      ++  + +++  +EI +L+ L+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLA--KKLESKSKEVERFLREIQILASLN 55

Query: 281 HP-NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLA 336
           HP NIV+ +     +  L + +EYV GGS+  LL++ G   P +E        QIL  L 
Sbjct: 56  HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 337 YLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSCASML-------SFKGSPYWM 388
           YLH++  +HRDIK  NIL+D  G  +KL DFG+AK +    S         +  G+P +M
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 389 APEVV--MNTNGYSLTVDIWSLGCTVLEMATSKPPW------SQYEGVAAIFKIGNSKDI 440
           APEV+  ++    S + DIWSLG T+ E+ T  PP+      S       I     +  +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 441 P-----EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDS 495
                   PE +S  A   +K+ L +DP  R  +S  L H  +    +  +   +L K  
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 496 SPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLVPTSRALNNPRENARTITSLPVSPC 555
               L  S  P    L+ +  S+ +   D   +    +     N   ++   +S  +   
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLST 355

Query: 556 SSPLRQ 561
           +S  R 
Sbjct: 356 ASSKRS 361

Length = 384

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  170 bits (432), Expect = 3e-48
 Identities = 98/262 (37%), Positives = 144/262 (54%), Gaps = 11/262 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+ + + +G+G  G VY   +  +GQ  AIK++ +    Q  KE +  +N EI ++ +  
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL--QQQPKKELI--IN-EILVMRENK 74

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HPNIV Y  S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS 133

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGY 399
              +HRDIK  NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 192

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQ 457
              VDIWSLG   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNR 251

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
           CL+ D   R  A +LL HPF++
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  168 bits (428), Expect = 4e-48
 Identities = 86/261 (32%), Positives = 143/261 (54%), Gaps = 8/261 (3%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K++K +++GRG FG V+L       ++  IK++ V  +  T  E L   N E  +L  LS
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPV--EQMTKDERLAAQN-ECQVLKLLS 57

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYL 338
           HPNI+ Y+ + L D+ L + +EY  GG++ + +Q+      +E  I  +  QILL L ++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 339 HARNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
           H +  +HRD+K  NIL+D H  + K+ DFG++K ++S +   +  G+P +++PE+     
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC-EGK 176

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            Y+   DIW+LGC + E+A+ K  +      A + KI +    P I +  S D +  I  
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRYSPDLRQLILS 235

Query: 458 CLQRDPSARPPASKLLDHPFV 478
            L  DPS RP  S+++  P  
Sbjct: 236 MLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  169 bits (429), Expect = 1e-47
 Identities = 94/253 (37%), Positives = 139/253 (54%), Gaps = 7/253 (2%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+FG VY   +  + ++ AIK++      + S E  + + +E+  L ++ HPN + Y
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            G  L +    + +EY  G +   L     P  E  I   T   L GLAYLH+ N +HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDI 405
           IK  NIL+   G++KLADFG A  + S A+  SF G+PYWMAPEV+  M+   Y   VD+
Sbjct: 151 IKAGNILLTEPGQVKLADFGSAS-IASPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDV 207

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           WSLG T +E+A  KPP      ++A++ I  ++         SD  ++F+  CLQ+ P  
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQD 267

Query: 466 RPPASKLLDHPFV 478
           RP + +LL H FV
Sbjct: 268 RPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  168 bits (427), Expect = 2e-47
 Identities = 91/253 (35%), Positives = 134/253 (52%), Gaps = 7/253 (2%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+FG VY   +  + ++ AIK++      + S E  + + +E+  L +L HPN ++Y
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            G  L +    + +EY  G +   L     P  E  I   T   L GLAYLH+ N +HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDI 405
           +K  NIL+   G +KL DFG A  M        F G+PYWMAPEV+  M+   Y   VD+
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           WSLG T +E+A  KPP      ++A++ I  ++       H S+  ++F+  CLQ+ P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 466 RPPASKLLDHPFV 478
           RP +  LL H FV
Sbjct: 258 RPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  167 bits (426), Expect = 2e-47
 Identities = 89/270 (32%), Positives = 147/270 (54%), Gaps = 22/270 (8%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G  G V       +G + A+K +        + +  KQ+ +E+ +      P IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITT----DPNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 288 HGSELSDERLSVY--LEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHAR 341
           +G+ L +   S+   +EY  GGS+  + ++     G   E V+      +L GL+YLH+R
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
             +HRDIK +NIL+   G++KL DFG++  + +  +  +F G+ ++MAPE +     YS+
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKP-YSI 182

Query: 402 TVDIWSLGCTVLEMATSK--------PPWSQYEGVAAIFKIGNS--KDIPEIPEHLSDDA 451
           T D+WSLG T+LE+A ++        PP    E ++ I  + N   KD P      S++ 
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
           K FIKQCL++DP+ RP    +L+HP+++ Q
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  167 bits (425), Expect = 4e-47
 Identities = 87/297 (29%), Positives = 135/297 (45%), Gaps = 64/297 (21%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEINLLSQLSHPN 283
           +G GT+G VY   N ++G++ A+K++R+  + +    T+         EI LL +L HPN
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-------EIKLLQKLRHPN 59

Query: 284 IVRYHGSELSDERLSVYL--EYVSGGSIHKL----LQEYGPFNEPVIQTYTRQILLGLAY 337
           IVR      S  + S+Y+  EY+     H L          F E  I+ Y +Q+L GL Y
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-------WM-A 389
           LH+   +HRDIKG+NIL++  G +KLADFG+A+  T   S      + Y       W   
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS------ADYTNRVITLWYRP 169

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIP-- 444
           PE+++    Y   VD+WS+GC + E+   KP +   ++ E +  IF++  S      P  
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229

Query: 445 ------------------------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                                     +   A   + + L  DP  R  A + L H +
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  166 bits (423), Expect = 5e-47
 Identities = 84/255 (32%), Positives = 141/255 (55%), Gaps = 11/255 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+ G V +  +  +G+  A+K++     D   ++  + L  E+ ++    HPNIV  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEM 81

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           + S L  + L V +E++ GG++  ++      NE  I T    +L  L++LHA+  +HRD
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK  +IL+   G +KL+DFG    ++       S  G+PYWMAPEV+ +   Y   VDIW
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGTEVDIW 199

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPS 464
           SLG  V+EM   +PP+     + A+ +I ++   P++     +S   +SF+ + L RDP+
Sbjct: 200 SLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPA 258

Query: 465 ARPPASKLLDHPFVR 479
            R  A++LL+HPF+ 
Sbjct: 259 QRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  165 bits (420), Expect = 7e-47
 Identities = 82/258 (31%), Positives = 143/258 (55%), Gaps = 14/258 (5%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRV--VCDDQTSKECLKQLNQEINLLSQLSHPN 283
           K +G+G F  VY       G++ A+K+V++  + D +  ++CLK    EI+LL QL HPN
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLLKQLDHPN 63

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTRQILLGLAYLH 339
           +++Y  S + +  L++ LE    G + ++++ +        E  I  Y  Q+   L ++H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNG 398
           ++  +HRDIK AN+ +   G +KL D G+ +  +S   +  S  G+PY+M+PE + + NG
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-HENG 182

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPEIP-EHLSDDAKSFIK 456
           Y+   DIWSLGC + EMA  + P+   +  + ++ K     D P +P +H S++ +  + 
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242

Query: 457 QCLQRDPSARPPASKLLD 474
           +C+  DP  RP  S +L 
Sbjct: 243 RCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  163 bits (415), Expect = 3e-46
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 10/253 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSK-ECLKQLNQEINLLSQLSHPNIVR 286
           +G+G+FG V+        ++ A+K++ +   ++  + E +     E  +L++L    I+R
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIR 63

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTV 344
           Y+ S L   +L++ +EY   G +HKLL+     P  E  +  +  QILLGLA+LH++  +
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTV 403
           HRDIK  N+ +D +  +K+ D G+AK ++   +   +  G+PY+++PE+  +   Y+   
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED-KPYNEKS 182

Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           D+W+LG  + E  T K P+      A I KI      P + +  S      I QCL +D 
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMYSQQLAQLIDQCLTKDY 241

Query: 464 SARPPASKLLDHP 476
             RP   +LL +P
Sbjct: 242 RQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 7e-46
 Identities = 95/295 (32%), Positives = 146/295 (49%), Gaps = 60/295 (20%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSK---ECLKQLNQEINLLSQL-SH 281
           K LG GTFG VYL  N E+G++ AIK+++     +      EC+  L  E+  L +L  H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECM-NLR-EVKSLRKLNEH 57

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLH 339
           PNIV+       ++ L    EY+ G ++++L+  ++  PF+E VI++   QIL GLA++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-------WM-APE 391
                HRD+K  N+LV     +K+ADFG+A+ + S          PY       W  APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--------PPYTDYVSTRWYRAPE 168

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKP------------------------PWSQ-YE 426
           +++ +  YS  VDIW+LGC + E+ T +P                         W + Y+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228

Query: 427 GVAAI-FKIGNSKDIPE---IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
             + + F+            IP + S +A   IK  L+ DP  RP AS+ L HP+
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  162 bits (411), Expect = 1e-45
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 20/267 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNI 284
           +L+G GT+G VY G + ++GQ+ AIK + V  D++      +++ QEIN+L + SH  NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNI 65

Query: 285 VRYHGSELS------DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLA 336
             Y+G+ +       D++L + +E+   GS+  L++        E  I    R+IL GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVM- 394
           +LH    +HRDIKG N+L+  + E+KL DFG++  +  +     +F G+PYWMAPEV+  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 395 --NTNG-YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
             N +  Y    D+WSLG T +EMA   PP      + A+F I  +       +  S   
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 245

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFV 478
           +SFI+ CL ++ S RP   +L+ HPF+
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  161 bits (410), Expect = 1e-45
 Identities = 89/257 (34%), Positives = 140/257 (54%), Gaps = 12/257 (4%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           ++LG+G FG   L   +E   +   KEV +     + KE    LN EI +LS L HPNI+
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLT--RLSEKERRDALN-EIVILSLLQHPNII 62

Query: 286 RYHGSELSDERLSVYLEYVSGGSIH-KLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNT 343
            Y+   + D  L + +EY +GG+++ K++++ G  F E ++  Y  QI+  ++Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLT 402
           +HRDIK  NI +   G IKL DFG++K + S  SM  +  G+PY+M+PE+      Y+  
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFK 181

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI--GNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            DIW+LGC + E+ T K  +     +  + KI  GN   +  +    S +  S +   LQ
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV---YSSELISLVHSLLQ 238

Query: 461 RDPSARPPASKLLDHPF 477
           +DP  RP A ++LD P 
Sbjct: 239 QDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  161 bits (410), Expect = 2e-45
 Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 16/257 (6%)

Query: 229 GRGTFGHVYLGFNSESGQMCAIKE-VRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G+G FG V +    ++ +M A+K   +  C     K  ++ +  E  +L +L+HP +V  
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV---EKGSVRNVLNERRILQELNHPFLVNL 65

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +E + + ++ + GG +   L +   F+E  ++ +  +I+L L YLH++  +HRD
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           IK  NIL+D  G + + DF +A  +T      S  G+P +MAPEV+    GYS+ VD WS
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC-RQGYSVAVDWWS 184

Query: 408 LGCTVLEMATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           LG T  E    K P+     +  + + A  +          P   S +A   I + L+RD
Sbjct: 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----TADVLYPATWSTEAIDAINKLLERD 240

Query: 463 PSAR--PPASKLLDHPF 477
           P  R       L +HP+
Sbjct: 241 PQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (409), Expect = 3e-45
 Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 34/272 (12%)

Query: 226 KLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K LG G FG VY G            A+K ++    +  S+E  K   +E  ++ +L HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK----EDASEEERKDFLKEARVMKKLGHP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILL-------- 333
           N+VR  G    +E L + LEY+ GG +   L++    F  P   T + + LL        
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP---YWMAP 390
           G+ YL ++  VHRD+   N LV     +K++DFG+++ +          G      WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKI---GNSKDIPEI 443
           E  +    ++   D+WS G  + E+ T  + P    Y G++   + +    G        
Sbjct: 177 E-SLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGY---RLPK 228

Query: 444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           PE+  D+    +  C Q DP  RP  S+L++ 
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  160 bits (407), Expect = 6e-45
 Identities = 94/267 (35%), Positives = 147/267 (55%), Gaps = 20/267 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNI 284
           +++G GT+G VY G + ++GQ+ AIK + V  D++      +++  EIN+L + SH  NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE------EEIKLEINMLKKYSHHRNI 75

Query: 285 VRYHGSELS------DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLA 336
             Y+G+ +       D++L + +E+   GS+  L++        E  I    R+IL GLA
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVM- 394
           +LHA   +HRDIKG N+L+  + E+KL DFG++  +  +     +F G+PYWMAPEV+  
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 395 --NTNG-YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
             N +  Y    DIWSLG T +EMA   PP      + A+F I  +       +  S   
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKF 255

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFV 478
             FI+ CL ++  +RP   +LL HPF+
Sbjct: 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 6e-45
 Identities = 82/288 (28%), Positives = 143/288 (49%), Gaps = 38/288 (13%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           ++K   +G GT+G VY   +  +G++ AIK++++  + +      K   +EI LL +L+H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP---KTALREIKLLKELNH 57

Query: 282 PNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYL 338
           PNI++    ++   +  +YL  E++    ++KL+++      E +I++Y  Q+L GLA+ 
Sbjct: 58  PNIIKLL--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTN 397
           H+   +HRD+K  N+L++  G +KLADFG+A+   S     +      W  APE+++   
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI------GNSKDIPEI-------- 443
           GYS  VDIWS+GC   E+ + +P +     +  +FKI       + +  P+         
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 444 ----------PEHL----SDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                        L    S  A   + Q L  DP  R  A + L HP+
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  158 bits (400), Expect = 6e-44
 Identities = 92/273 (33%), Positives = 146/273 (53%), Gaps = 22/273 (8%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS- 280
           W+  + +G+GT+G V+   N ++G   A+K +  + D        +++  E N+L  LS 
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID------EEIEAEYNILKALSD 73

Query: 281 HPNIVRYHG-----SELSDERLSVYLEYVSGGSIHKL----LQEYGPFNEPVIQTYTRQI 331
           HPN+V+++G        + ++L + LE  +GGS+  L    L+      EP+I     + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAP 390
           L+GL +LH   T+HRD+KG NIL+   G +KL DFG++  +TS     +   G+P+WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 391 EVVMNT----NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG-NSKDIPEIPE 445
           EV+       + Y    D+WSLG T +E+    PP +    + A+FKI  N       PE
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
             S++   FI++CL +D   RP  S LL H F+
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  158 bits (400), Expect = 1e-43
 Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 22/274 (8%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS- 280
           W+  + +G+GT+G VY   N + G + A+K +  + D        +++  E N+L  L  
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD------EEIEAEYNILQSLPN 77

Query: 281 HPNIVRYHG-----SELSDERLSVYLEYVSGGSIHKL----LQEYGPFNEPVIQTYTRQI 331
           HPN+V+++G      +L   +L + LE  +GGS+ +L    L      +E +I       
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAP 390
           LLGL +LH    +HRD+KG NIL+   G +KL DFG++  +TS     +   G+P+WMAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 391 EVVMNTNGYSLT----VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG-NSKDIPEIPE 445
           EV+     Y  +     D+WSLG T +E+    PP      V  +FKI  N       PE
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
                   FI QCL +D  ARP  + LL+HPF++
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  156 bits (396), Expect = 1e-43
 Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 26/270 (9%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+ K K +G G+FG   L  + E G+   IKE+ +    + S +  ++  +E+ +LS + 
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINI---SKMSPKEREESRKEVAVLSNMK 57

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYL 338
           HPNIV+Y  S   +  L + ++Y  GG ++K +  Q    F E  I  +  QI L L ++
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTN 397
           H R  +HRDIK  NI +   G IKL DFG+A+ + S   +  +  G+PY+++PE+  N  
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-R 176

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI---------PEIPEHLS 448
            Y+   DIW+LGC + EM T K            F+ GN K++         P +  H S
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK----------HAFEAGNMKNLVLKIIRGSYPPVSSHYS 226

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
            D ++ + Q  +R+P  RP  + +L+  F+
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  157 bits (397), Expect = 2e-43
 Identities = 95/262 (36%), Positives = 143/262 (54%), Gaps = 11/262 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+ + + +G+G  G V+   +  +GQ  AIK++ +    Q  KE +     EI ++ +L 
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL--QKQPKKELIIN---EILVMKELK 74

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           +PNIV +  S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LHA
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHA 133

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGY 399
              +HRDIK  N+L+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 192

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQ 457
              VDIWSLG   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSPIFRDFLNR 251

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
           CL+ D   R  A +LL HPF++
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  157 bits (399), Expect = 7e-43
 Identities = 106/314 (33%), Positives = 166/314 (52%), Gaps = 30/314 (9%)

Query: 193 LPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKE 252
           LP P  S +S S+   S ++     SLS+ ++   +G G  G VY   +  +G++ A+K 
Sbjct: 47  LPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 253 VRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL 312
           +    +D       +Q+ +EI +L  ++HPN+V+ H     +  + V LE++ GGS    
Sbjct: 107 IYGNHEDTV----RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS---- 158

Query: 313 LQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG----M 368
           L+     +E  +    RQIL G+AYLH R+ VHRDIK +N+L++    +K+ADFG    +
Sbjct: 159 LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218

Query: 369 AKHMTSCASMLSFKGSPYWMAPEVVMNT-------NGYSLTVDIWSLGCTVLEMATSKPP 421
           A+ M  C S +   G+  +M+PE + NT       +GY+   DIWSLG ++LE    + P
Sbjct: 219 AQTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGYA--GDIWSLGVSILEFYLGRFP 272

Query: 422 WS---QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           +    Q +  + +  I  S   PE P   S + + FI  CLQR+P+ R  A +LL HPF+
Sbjct: 273 FGVGRQGDWASLMCAICMS-QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Query: 479 -RDQAVARAGNVNL 491
            R Q     G  NL
Sbjct: 332 LRAQPGQGQGGPNL 345

Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  155 bits (393), Expect = 9e-43
 Identities = 96/262 (36%), Positives = 142/262 (54%), Gaps = 11/262 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+ + + +G+G  G VY   +  +GQ  AIK++ +    Q  KE +     EI ++ +  
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL--QQQPKKELIIN---EILVMRENK 74

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           +PNIV Y  S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHS 133

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGY 399
              +HRDIK  NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 192

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQ 457
              VDIWSLG   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPERLSAVFRDFLNR 251

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
           CL+ D   R  A +LL HPF++
Sbjct: 252 CLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  153 bits (388), Expect = 2e-42
 Identities = 87/259 (33%), Positives = 138/259 (53%), Gaps = 14/259 (5%)

Query: 228 LGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           LG+G+FG VYL  +       ++  +KE+ V   +    E + Q NQE  LLS+L HP I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV--GELNPNETV-QANQEAQLLSKLDHPAI 64

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP----FNEPVIQTYTRQILLGLAYLHA 340
           V++H S L  +   +  EY  G  +   L+E        +E  +  +  Q+LLG+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           R  +HRD+K  NI +  +  +K+ DFG+++  M SC    +F G+PY+M+PE  +   GY
Sbjct: 125 RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGY 182

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
               DIWSLGC + EM      +     ++ + +I      P +PE  S    S ++  L
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLPETYSRQLNSIMQSML 241

Query: 460 QRDPSARPPASKLLDHPFV 478
            +DPS RP A+++L +PF+
Sbjct: 242 NKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  154 bits (390), Expect = 3e-42
 Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 37/290 (12%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K++   ++G G +G V    N  +G++ AIK+ +   DD+  K   K   +E+ +L QL 
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK---KTALREVKVLRQLR 58

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
           H NIV    +     RL +  EYV   ++ +LL+   G      +++Y  Q+L  +AY H
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--MLSFKGSPYWMAPEVVMNTN 397
           + N +HRDIK  NILV   G +KL DFG A+ + +  +  +  +  + ++ APE+++   
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN-------------SKD----- 439
            Y   VD+W++GC + E+   +P +     +  ++ I               S +     
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 440 --IPEIPE----------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
              PE  +           +S  A  F+K CL+ DP  R    +LL HP+
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  152 bits (386), Expect = 4e-42
 Identities = 83/265 (31%), Positives = 144/265 (54%), Gaps = 14/265 (5%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV--VCDDQTSKECLKQLNQEINLL 276
           L+ ++  K +GRG F  VY       G   A+K+V++  + D +   +C+K    EI+LL
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLL 56

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP----FNEPVIQTYTRQIL 332
            QL+HPN+++Y+ S + D  L++ LE    G + ++++ +        E  +  Y  Q+ 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPE 391
             L ++H+R  +HRDIK AN+ +   G +KL D G+ +  +S   +  S  G+PY+M+PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIFKIGNSKDIPEIP-EHLSD 449
            + + NGY+   DIWSLGC + EMA  + P +     + ++ K     D P +P +H S+
Sbjct: 177 RI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235

Query: 450 DAKSFIKQCLQRDPSARPPASKLLD 474
           + +  +  C+  DP  RP  + + D
Sbjct: 236 ELRQLVNMCINPDPEKRPDITYVYD 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  152 bits (384), Expect = 5e-42
 Identities = 88/257 (34%), Positives = 136/257 (52%), Gaps = 9/257 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K +G G+FG +YL       + C IKE+ +       KE  K+   E+ LL+++ HPNIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ-EYGP-FNEPVIQTYTRQILLGLAYLHARNT 343
            +  S   + RL + +EY  GG + K +  + G  F+E  I ++  QI LGL ++H R  
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 344 VHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSL 401
           +HRDIK  NI +  +G + KL DFG+A+ +     +  +  G+PY+++PE+  N   Y+ 
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNN 181

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             DIWSLGC + E+ T K P+        + KI      P  P + S D +S I Q  + 
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-NFSRDLRSLISQLFKV 240

Query: 462 DPSARPPASKLLDHPFV 478
            P  RP  + +L  PF+
Sbjct: 241 SPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  152 bits (387), Expect = 8e-42
 Identities = 86/306 (28%), Positives = 136/306 (44%), Gaps = 71/306 (23%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ----EINLL 276
           +++KGK LG GT+  VY   + E+G++ AIK++++       KE    +N     EI LL
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLL 56

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSG--------GSIHKLLQEYGPFNEPVIQTYT 328
            +L HPNI+           +++  E++           SI              I++Y 
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--------VLTPADIKSYM 108

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP--- 385
              L GL YLH+   +HRD+K  N+L+   G +KLADFG+A+         SF GSP   
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR---------SF-GSPNRK 158

Query: 386 --------YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI 434
                   ++ APE++     Y + VD+WS+GC   E+    P     S  + +  IF+ 
Sbjct: 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA 218

Query: 435 ----------GNS--------KDIPEIP-----EHLSDDAKSFIKQCLQRDPSARPPASK 471
                     G +        K  P  P        SDDA   +++ L  +P+ R  A +
Sbjct: 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278

Query: 472 LLDHPF 477
            L+HP+
Sbjct: 279 ALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  150 bits (380), Expect = 3e-41
 Identities = 82/260 (31%), Positives = 140/260 (53%), Gaps = 18/260 (6%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV--VCDDQTSKECLKQLNQEINLL 276
           L+ ++  K +GRG F  VY        +  A+K+V++  + D +  ++C+K    EI+LL
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLL 56

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP----FNEPVIQTYTRQIL 332
            QL+HPN+++Y  S + D  L++ LE    G + ++++ +        E  +  Y  Q+ 
Sbjct: 57  KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPE 391
             + ++H+R  +HRDIK AN+ +   G +KL D G+ +  +S   +  S  G+PY+M+PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK---DIPEIP-EHL 447
            + + NGY+   DIWSLGC + EMA  + P+  Y     +F +       D P +P EH 
Sbjct: 177 RI-HENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTEHY 233

Query: 448 SDDAKSFIKQCLQRDPSARP 467
           S+  +  +  C+  DP  RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 4e-41
 Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 18/264 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQE-INLLSQLSHPNI 284
           K + +G FG VYL     +G   AIK ++    D  +K  +  +  E   ++ Q   P +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKK--SDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
            + + S  S + L + +EY++GG    L++  G   E   + Y  +++LG+  LH R  +
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNTNGYSLT 402
           HRDIK  N+L+D  G +KL DFG+++       + +  F G+P ++APE ++   G    
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILG-VGDDKM 173

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCL 459
            D WSLGC + E     PP+   E   A+F    S+ I    E+ E  S +A   I + L
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 460 QRDPSARPPAS---KLLDHPFVRD 480
             DP+ R  A+   ++  HPF + 
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  151 bits (384), Expect = 4e-41
 Identities = 85/265 (32%), Positives = 139/265 (52%), Gaps = 20/265 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K+LG+G+FG V L     + ++ A+K ++   ++ DD    EC   + ++  L     HP
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV--ECT--MTEKRVLALAGKHP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            + + H    + +RL   +EYV+GG +   +Q  G F+EP  + Y  +I+LGL +LH R 
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+L+D  G IK+ADFGM K  +    +  +F G+P ++APE++     Y  
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGP 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
            VD W+LG  + EM   + P   +EG     +F+     ++   P  LS +AKS +K  L
Sbjct: 176 AVDWWALGVLLYEMLAGQSP---FEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFL 231

Query: 460 QRDPSARPPASK-----LLDHPFVR 479
            ++P  R          +  HPF R
Sbjct: 232 TKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  150 bits (380), Expect = 4e-41
 Identities = 82/262 (31%), Positives = 144/262 (54%), Gaps = 16/262 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG+G +G VY   +  +G   A+KE+R+  D+        Q+  E+++L +   P IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK----FNQIIMELDILHKAVSPYIVDF 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLL---QEYGPFNEPVIQTYTRQILLGLAYLHAR-NT 343
           +G+   +  + + +EY+  GS+ KL           E V++  T  ++ GL +L    N 
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV----MNTNG- 398
           +HRD+K  N+LV+ +G++KL DFG++ ++ +  +  +  G   +MAPE +     N N  
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPT 183

Query: 399 YSLTVDIWSLGCTVLEMATSKPPW--SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           Y++  D+WSLG ++LEMA  + P+    Y  + A        D P +P   SDDA+ F+ 
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243

Query: 457 QCLQRDPSARPPASKLLDHPFV 478
           +CL + P+ RP  ++LL+HP++
Sbjct: 244 KCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  151 bits (381), Expect = 5e-41
 Identities = 94/262 (35%), Positives = 140/262 (53%), Gaps = 11/262 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+ + + +G+G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENK 75

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           +PNIV Y  S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS 134

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGY 399
              +HRDIK  NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQ 457
              VDIWSLG   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNR 252

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
           CL  D   R  A +LL H F++
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  149 bits (377), Expect = 1e-40
 Identities = 86/290 (29%), Positives = 147/290 (50%), Gaps = 42/290 (14%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           ++K + +G GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY------GPFNEPVIQTYTRQILLGL 335
           PNIV+      ++ +L +  E+     +H+ L+++           P+I++Y  Q+L GL
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVM 394
           A+ H+   +HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPE 445
               YS  VDIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P+
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233

Query: 446 H------------------LSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           +                  L +D +  + Q L  DP+ R  A   L HPF
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  147 bits (371), Expect = 3e-40
 Identities = 87/251 (34%), Positives = 140/251 (55%), Gaps = 9/251 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +++G G+FG   L  +  S Q  A+KE+R+      S   ++   +E  LL+++ HPNIV
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 286 RYHGSELSDERLSVYLEYVSGGSI-HKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNT 343
            +  S  +D  L + +EY  GG +  K+  + G  F E  I  +  Q+ LG+ ++H +  
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           +HRDIK  NI +  +G++KL DFG A+ +TS  A   ++ G+PY++ PE+  N   Y+  
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNK 180

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
            DIWSLGC + E+ T K P+        I K+      P +P H S + +S IKQ  +R+
Sbjct: 181 SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRN 239

Query: 463 PSARPPASKLL 473
           P +RP A+ +L
Sbjct: 240 PRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  145 bits (366), Expect = 6e-39
 Identities = 87/257 (33%), Positives = 136/257 (52%), Gaps = 17/257 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+ G V +     SG+  A+K +     D   ++  + L  E+ ++    H N+V  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           + S L  E L V +E++ GG++  ++ +    NE  I T    +L  L YLH++  +HRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK  +IL+   G +KL+DFG    ++       S  G+PYWMAPEV+  T  Y   VDIW
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIW 201

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-----KDIPEIPEHLSDDAKSFIKQCLQR 461
           SLG  V+EM   +PP+     V A+ ++ +S     K+  +I   L D    F+++ L R
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRD----FLERMLTR 257

Query: 462 DPSARPPASKLLDHPFV 478
           +P  R  A +LLDHPF+
Sbjct: 258 EPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  143 bits (363), Expect = 1e-38
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 33/287 (11%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K++K   +G G++G V+   N E+GQ+ AIK+     DD   K   K   +EI +L QL 
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK---KIALREIRMLKQLK 58

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HPN+V          +L +  EY     +++L +      E +I+    Q L  + + H 
Sbjct: 59  HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGY 399
            N +HRD+K  NIL+   G+IKL DFG A+ +T      + +  + ++ APE+++    Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--KDIP---------------E 442
              VD+W++GC   E+ T +P W     V  ++ I  +    IP                
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 443 IPE------------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           IPE            ++S  A SF+K CLQ DP+ R    +LL+HP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 1e-38
 Identities = 82/297 (27%), Positives = 132/297 (44%), Gaps = 62/297 (20%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-----TSKEC--LKQLNQEINLLSQL 279
            +G G +G VY   +  +G+  A+K+VRV   ++     T +E   LKQL          
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-------F 58

Query: 280 SHPNIVR----YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP--FNEPVIQTYTRQI 331
            HPNIVR     HG     E L + L  E+V    +   L +          I+   RQ+
Sbjct: 59  EHPNIVRLLDVCHGPRTDRE-LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK----HM--TSCASMLSFKGSP 385
           L G+ +LH+   VHRD+K  NILV   G++K+ADFG+A+     M  TS    L      
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL------ 170

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI-------- 434
           ++ APEV++ ++ Y+  VD+WS+GC   E+   +P +   S+ + +  IF +        
Sbjct: 171 WYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229

Query: 435 --------------GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                            +        + ++    +K+ L  +P  R  A + L HP+
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 1e-38
 Identities = 84/298 (28%), Positives = 145/298 (48%), Gaps = 70/298 (23%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEINLLSQLSHPN 283
           +G GT+G VY   +  +G++ A+K++R+  +D+    T+        +EI+LL +L+HPN
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKELNHPN 59

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY------GPFNEPVIQTYTRQILLGLAY 337
           IVR      S+ +L +  E++        L++Y         + P+I++Y  Q+L G+AY
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----------Y 386
            H+   +HRD+K  N+L+D  G +KLADFG+A+         +F G P           +
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLAR---------AF-GVPVRTYTHEVVTLW 164

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI----GN------ 436
           + APE+++ +  YS  VDIWS+GC   EM   +P +     +  +F+I    G       
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 437 -----------------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                             +D+ ++  +L +D    + + L  DP+ R  A   L HP+
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  142 bits (361), Expect = 2e-38
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 35/281 (12%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G GT+G VY G N ++GQ+ A+K++R+  +++       +   EI+LL +L HPNIV  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIVCL 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHARNTV 344
               + + RL +  E++S   + K L         +  ++++Y  QIL G+ + H+R  +
Sbjct: 65  QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L+D  G IKLADFG+A+       + + +    W  APEV++ +  YS  V
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183

Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS------KDIPEIPEH-------- 446
           DIWS+G    EMAT KP +   S+ + +  IF+I  +        +  +P++        
Sbjct: 184 DIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK 243

Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                     L +D    +++ L  DP+ R  A K L+HP+
Sbjct: 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  142 bits (359), Expect = 3e-38
 Identities = 77/259 (29%), Positives = 136/259 (52%), Gaps = 17/259 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G  G VY  ++  + ++ A+K   V+  D T  E  KQ+  E+ +L +   P I+ +
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVK---VIPLDITV-ELQKQIMSELEILYKCDSPYIIGF 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           +G+   + R+S+  E++ GGS    L  Y    E V+      ++ GL YL +   +HRD
Sbjct: 65  YGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K +N+LV+  G++KL DFG++  + +  +  ++ G+  +MAPE +     Y +  D+WS
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISGEQ-YGIHSDVWS 178

Query: 408 LGCTVLEMATSKPPWSQYEGVAA------IFKIGNSKDIPEIPEHL-SDDAKSFIKQCLQ 460
           LG + +E+A  + P+ Q +          + +    +D P +P    S+    FI QC++
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238

Query: 461 RDPSARPPASKLLDHPFVR 479
           + P  RP    L+DHPF+ 
Sbjct: 239 KQPKERPAPENLMDHPFIV 257

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  143 bits (362), Expect = 3e-38
 Identities = 86/312 (27%), Positives = 128/312 (41%), Gaps = 59/312 (18%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ-EINLL 276
            L  ++    LG GTFG VY     ++G++ A+K++ +       K+        EI +L
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKIL 61

Query: 277 SQLSHPNIVRY------HGSELSDERLSVYLEYVSGGSIHKL--LQEYGP---FNEPVIQ 325
            +L HPN+V           +   +R SVY+  V+    H L  L E  P     E  I+
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLLE-NPSVKLTESQIK 118

Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP 385
            Y  Q+L G+ YLH  + +HRDIK ANIL+D  G +K+ADFG+A+            G  
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 386 ------------YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------------- 420
                       ++  PE+++    Y+  VDIW +GC   EM T +P             
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238

Query: 421 -------P-------WSQYEGVAAIFKIGNSKDI-PEIPEHLSDDAKSFIKQCLQRDPSA 465
                  P       W    G   +    N      E    L  +    + + L  DP  
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298

Query: 466 RPPASKLLDHPF 477
           R  AS  L+HP+
Sbjct: 299 RLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  141 bits (356), Expect = 1e-37
 Identities = 85/249 (34%), Positives = 124/249 (49%), Gaps = 23/249 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K +G GTFG V+L  +  S    A+K +    V+   Q      + ++ E  +L ++SHP
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-----QHVHNEKRVLKEVSHP 61

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            I+R   +E     L + +EYV GG +   L+  G F+      Y  +I+  L YLH++ 
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTN 397
            V+RD+K  NIL+D  G IKL DFG AK +     T C       G+P ++APEV+ +  
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-------GTPEYLAPEVIQSK- 173

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           G++  VD W+LG  + EM    PP+          KI   K   E P HL   AK  IK+
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLIKK 231

Query: 458 CLQRDPSAR 466
            L  D + R
Sbjct: 232 LLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  140 bits (354), Expect = 5e-37
 Identities = 83/264 (31%), Positives = 134/264 (50%), Gaps = 19/264 (7%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVR----VVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           LGRG FG V L    ++G++ AIK ++    +  D+  S  C K++ +  N      HP 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPF 63

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           +V       +++ +   +EY +GG +   +     F+EP    Y   ++LGL YLH    
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKI 122

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           V+RD+K  N+L+D  G +K+ADFG+ K  M       +F G+P ++APEV+  T+ Y+  
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRA 181

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           VD W LG  + EM   + P+   +    +F  I N  D    P  LS +A S +++ L+R
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVN--DEVRYPRFLSREAISIMRRLLRR 238

Query: 462 DPSARPPASK-----LLDHPFVRD 480
           +P  R  + +     +   PF RD
Sbjct: 239 NPERRLGSGEKDAEDVKKQPFFRD 262

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  137 bits (348), Expect = 1e-36
 Identities = 84/292 (28%), Positives = 142/292 (48%), Gaps = 44/292 (15%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQL 279
           K++K + +G GT+G V+   N E+ ++ A+K VR+  DD+      L+    EI LL +L
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKEL 56

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLG 334
            H NIVR +    SD++L++  EY       + L++Y     G  +  +++++  Q+L G
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVV 393
           LA+ H+ N +HRD+K  N+L++ +GE+KLADFG+A+         S +    W   P+V+
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA----AIFKI--------------- 434
                YS ++D+WS GC   E+A +  P      V      IF++               
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231

Query: 435 GNSKDIPEIPE---------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
            + K  P  P           L+   +  ++  L  +P  R  A + L HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  137 bits (348), Expect = 2e-36
 Identities = 87/281 (30%), Positives = 137/281 (48%), Gaps = 33/281 (11%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           L+G G++G V    + E+GQ+ AIK+     + +  K   K   +EI +L QL H N+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                   +RL +  E+V    +  L +     +E  ++ Y  QIL G+ + H+ N +HR
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHR 124

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  NILV   G +KL DFG A+ + +   + + +  + ++ APE+++    Y   VDI
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKI----GN---------SKD-------IPEIPE 445
           W++GC V EM T +P +     +  ++ I    GN          K+       +PE+ E
Sbjct: 185 WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244

Query: 446 ---------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                     LS       KQCL+ DP  RP +S+LL H F
Sbjct: 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  138 bits (351), Expect = 2e-36
 Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 52/295 (17%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLSQLSHPNI 284
           K +G G +G V    +  +G+  AIK++  V DD    K  L+    EI LL  L H NI
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 285 VRYH---GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
           +           ++   VY+  E +    +HK+++   P  +  IQ +  QIL GL YLH
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----WM-APEVVM 394
           + N +HRD+K +NILV+ + ++K+ DFG+A+ +        F  + Y    W  APE+++
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TEYVVTRWYRAPELLL 179

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKP--PWSQY-EGVAAIFK-IG--NSKDIPEIPEHLS 448
           +++ Y+  +DIWS+GC   E+ T KP  P   Y + +  I + +G  + +D+  I    S
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT---S 236

Query: 449 DDAKSFIK--------------------------QCLQRDPSARPPASKLLDHPF 477
           + A++++K                          + L  DP  R  A + L HP+
Sbjct: 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  138 bits (350), Expect = 2e-36
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 13/263 (4%)

Query: 226 KLLGRGTFGHVYL---GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K+LG+G +G V+       +++G++ A+K ++     +  K+       E N+L  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDT-AHTKAERNILEAVKHP 60

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            IV    +  +  +L + LEY+SGG +   L+  G F E     Y  +I L L +LH + 
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  NIL+D  G +KL DFG+ K      ++  +F G+  +MAPE++M + G+  
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGK 179

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
            VD WSLG  + +M T  PP++       I KI   K    +P +L+ +A+  +K+ L+R
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN--LPPYLTPEARDLLKKLLKR 237

Query: 462 DPSAR-----PPASKLLDHPFVR 479
           +PS+R       A+++  HPF R
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  137 bits (346), Expect = 3e-36
 Identities = 81/281 (28%), Positives = 141/281 (50%), Gaps = 36/281 (12%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG GT+  VY G N  +G++ A+KE+ +  ++ T    ++    EI+L+ +L H NIVR 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVRL 63

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTV 344
           H    ++ +L +  EY+    + K +  +G     +   ++++T Q+L G+A+ H    +
Sbjct: 64  HDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  GE+KLADFG+A+      +  S +    W  AP+V++ +  YS ++
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182

Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI------GNSKDIPEIPE--------- 445
           DIWS+GC + EM T +P +   +  + +  IF+I           I ++PE         
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYP 242

Query: 446 ---------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                    H        + + LQ +P  R  A   L HP+
Sbjct: 243 PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  137 bits (347), Expect = 4e-36
 Identities = 82/259 (31%), Positives = 133/259 (51%), Gaps = 12/259 (4%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K+LG+G+FG V L     + +  AIK ++   V+ DD    EC     + + L  +  HP
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDV--ECTMVERRVLALAWE--HP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +     +  + E L   +EY++GG +   +Q  G F+E   + Y  +I+ GL +LH + 
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+L+D  G IK+ADFGM K +M       +F G+P ++APE++     Y+ 
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNE 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           +VD WS G  + EM   + P+   +       I N  D P  P  +S +AK  + +  +R
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFER 233

Query: 462 DPSAR-PPASKLLDHPFVR 479
           DP+ R      +  HPF R
Sbjct: 234 DPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  135 bits (342), Expect = 5e-36
 Identities = 83/257 (32%), Positives = 137/257 (53%), Gaps = 9/257 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +++G+G++G V L  +   G+   IK++ +      S+   K   QE  LLSQL HPNIV
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 286 RYHGS-ELSDERLSVYLEYVSGGSI-HKLLQEYGPF-NEPVIQTYTRQILLGLAYLHARN 342
            Y  S E  D  L + + +  GG + HKL ++ G    E  +  +  QI + L YLH ++
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSL 401
            +HRD+K  N+ +     IK+ D G+A+ + +   M S   G+PY+M+PE+  N   Y+ 
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNY 181

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             D+W+LGC V EMAT K  ++  +  + +++I   K +P +P+  S +    I   L +
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATMLSK 240

Query: 462 DPSARPPASKLLDHPFV 478
            P  RP    +L  P++
Sbjct: 241 RPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  136 bits (345), Expect = 7e-36
 Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 60/302 (19%)

Query: 227 LLGRGTFGH--VYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           L+G+       V+L  +  +  + A+K++ +   D  SKE LK L QEI    QL HPNI
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARN 342
           + Y  S + D  L V    ++ GS   LL+ + P    E  I    + +L  L Y+H++ 
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-------FKGSP-------YWM 388
            +HR +K ++IL+   G++ L+            SM+            P        W+
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGL------RYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 389 APEVV-MNTNGYSLTVDIWSLGCTVLEMATSKPPWS------------------------ 423
           +PEV+  N  GY+   DI+S+G T  E+A    P+                         
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST 235

Query: 424 --QYEGVAA----IFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              YE   +      +  N++D  + P     S+    F++ CLQRDP +RP AS+LL+H
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295

Query: 476 PF 477
            F
Sbjct: 296 SF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  137 bits (346), Expect = 8e-36
 Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 22/263 (8%)

Query: 214 VTENSLSKWK-----KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK- 267
            T+   S WK      G+ LG G+FG V +  +  +G+  AIK ++        +E LK 
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-------KREILKM 59

Query: 268 ----QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV 323
                + QE ++L +LSHP IV    S   + R+   LE+V GG +   L++ G F   V
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG 383
            + Y  +++L   YLH+++ ++RD+K  N+L+D  G +K+ DFG AK +      L   G
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--G 177

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI 443
           +P ++APEV+  + G+   VD W++G  + E     PP+          KI   +   + 
Sbjct: 178 TPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKF 234

Query: 444 PEHLSDDAKSFIKQCLQRDPSAR 466
           P      A+  +K  LQ D + R
Sbjct: 235 PNWFDGRARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  135 bits (341), Expect = 1e-35
 Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 36/274 (13%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-------LNQEINLLSQLS 280
           LG+G FG V       +G+M A K++         K+ LK+       LN++  +L ++S
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKK-ILEKVS 51

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYL 338
              IV    +  + + L + +  ++GG +   +   G   F E     Y  QI+ GL +L
Sbjct: 52  SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNG 398
           H R  V+RD+K  N+L+D HG ++++D G+A  +     +    G+P +MAPEV+     
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV- 170

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-------DIPEIPEHLSDDA 451
           Y  +VD ++LGCT+ EM   + P+ Q +      K+   +          E P+  S +A
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKE-----KVEKEELKRRTLEMAVEYPDKFSPEA 225

Query: 452 KSFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
           K   +  LQ+DP  R       A ++ +HP  +D
Sbjct: 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 2e-35
 Identities = 86/290 (29%), Positives = 131/290 (45%), Gaps = 43/290 (14%)

Query: 224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLS 280
             K++GRG FG V+L  + ++GQ+ A+K +R   ++  +Q +      +  E ++L+   
Sbjct: 5   VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-----HVRAERDILADAD 59

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
            P IV+ + S   +E L + +EY+ GG +  LL     F E   + Y  +++L L  +H 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK------------------ 382
              +HRDIK  NIL+D  G IKLADFG+ K M        +                   
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 383 ------------GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA 430
                       G+P ++APEV+  T  Y L  D WSLG  + EM    PP+        
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238

Query: 431 IFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPSAR-PPASKLLDHPF 477
             KI N K+    P    +S +A   I + L  DP  R     ++  HPF
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  134 bits (339), Expect = 3e-35
 Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 37/282 (13%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL-KQLNQEINLLSQLSHPNIVR 286
           +G G  G V+   + E+G+  A+K+V +       +  +  Q  +EI  L    HP +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALR----RLEGGIPNQALREIKALQACQHPYVVK 63

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVH 345
                       + +EY+    + ++L++   P  E  +++Y R +L G+AY+HA   +H
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK--GSPYWMAPEVVMNTNGYSLTV 403
           RD+K AN+L+   G +K+ADFG+A+  +     L      + ++ APE++     Y   V
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182

Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI-G--NSKDIPEI-----------PEH 446
           D+W++GC   E+    P +   +  E +A +F+  G  N +  P +           PE 
Sbjct: 183 DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPES 242

Query: 447 -----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                       S +A   +K  L  DPS R  A++ L HP+
Sbjct: 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  134 bits (338), Expect = 4e-35
 Identities = 77/265 (29%), Positives = 139/265 (52%), Gaps = 23/265 (8%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           LGRG +G V    +  +G + A+K +R   + Q  K  L  L+  I++ S     P  V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRS--VDCPYTVT 64

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLL-QEYGP---FNEPVIQTYTRQILLGLAYLHAR- 341
           ++G+   +  + + +E V   S+ K   + Y       E ++      I+  L YLH++ 
Sbjct: 65  FYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVV---MNTN 397
           + +HRD+K +N+L++ +G++KL DFG++ ++  S A  +     PY MAPE +   +N  
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPY-MAPERINPELNQK 182

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQ----YEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           GY +  D+WSLG T++E+AT + P+      ++ +  + +   S  +P   E  S + + 
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPA--EKFSPEFQD 239

Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
           F+ +CL+++   RP   +LL HPF 
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  134 bits (337), Expect = 4e-35
 Identities = 82/255 (32%), Positives = 135/255 (52%), Gaps = 11/255 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+ G V +     +G+  A+K++     D   ++  + L  E+ ++    H N+V  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-----DLRKQQRRELLFNEVVIMRDYHHENVVDM 84

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           + S L  + L V +E++ GG++  ++  +   NE  I T    +L  L+YLH +  +HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 348 IKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK  +IL+   G IKL+DFG    ++       S  G+PYWMAPEV+     Y   VDIW
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIW 202

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRDPS 464
           SLG  V+EM   +PP+     + A+ +I ++   P + +   +S   + F+   L R+PS
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRGFLDLMLVREPS 261

Query: 465 ARPPASKLLDHPFVR 479
            R  A +LL HPF++
Sbjct: 262 QRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  133 bits (337), Expect = 6e-35
 Identities = 88/302 (29%), Positives = 142/302 (47%), Gaps = 65/302 (21%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVR 286
           +G GT+G VY   + ++G++ A+K+VR+       KE       +EI +L QL+H NIV 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRL----DNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 287 YH--------GSELSDERLSVYL--EYVSGGSIHKL--LQEYG--PFNEPVIQTYTRQIL 332
                       +   ++ + YL  EY+     H L  L E G   F+E  I+++ +Q+L
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY------ 386
            GL Y H +N +HRDIK +NIL++  G+IKLADFG+A+   S  S       PY      
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES------RPYTNKVIT 180

Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA---IFKIGNS---- 437
             +  PE+++    Y   +D+WS GC + E+ T KP +   + +A    I ++  S    
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240

Query: 438 --KDIPEIP-------------------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
              D+ ++P                     +   A   +   L  DPS R  A + L+ P
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300

Query: 477 FV 478
           ++
Sbjct: 301 WL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  134 bits (338), Expect = 8e-35
 Identities = 82/264 (31%), Positives = 137/264 (51%), Gaps = 19/264 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KLLG+GTFG V L     +G+  A+K ++   ++  D+ +         E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-----TESRVLQNTRHP 55

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +     S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            V+RD+K  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APE V+  N Y  
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGR 174

Query: 402 TVDIWSLGCTVLEMATSKPP-WSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            VD W LG  + EM   + P ++Q      +F++   ++I   P  LS +AKS +   L+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLSPEAKSLLAGLLK 231

Query: 461 RDPSAR-----PPASKLLDHPFVR 479
           +DP  R       A ++++H F  
Sbjct: 232 KDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  133 bits (337), Expect = 8e-35
 Identities = 87/305 (28%), Positives = 148/305 (48%), Gaps = 50/305 (16%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G  G V    +  SG + A K + +    +       Q+ +E+ +L + + P IV +
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL----EIKPAIRNQIIRELKVLHECNSPYIVGF 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH-ARNTVHR 346
           +G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   +  +L GL YL      +HR
Sbjct: 65  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K +NILV+  GEIKL DFG++  +    SM  SF G+  +M+PE +  T+ Y++  DI
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH-YTVQSDI 181

Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIF----KIGNSKDIPEIPE------------- 445
           WSLG +++EMA  +   PP    E + A+F      G +K+                   
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240

Query: 446 -----------------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
                              SD+ + F+ +CL+++P  R    +L  HPF++    A    
Sbjct: 241 ELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR---AELEE 297

Query: 489 VNLAK 493
           V+ A 
Sbjct: 298 VDFAG 302

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  134 bits (338), Expect = 9e-35
 Identities = 80/267 (29%), Positives = 137/267 (51%), Gaps = 24/267 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
            +LG+G+FG V L     + ++ AIK ++   ++ DD    EC      E  +L+    P
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDV--ECTMV---EKRVLALPGKP 60

Query: 283 N-IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
             + + H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +LH++
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  N+++D  G IK+ADFGM K ++    +  +F G+P ++APE++     Y 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYG 179

Query: 401 LTVDIWSLGCTVLEMATSKPPWS---QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            +VD W+ G  + EM   +PP+    + E   +I      +     P+ LS +A S  K 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI-----MEHNVSYPKSLSKEAVSICKG 234

Query: 458 CLQRDPSAR----PPASK-LLDHPFVR 479
            L + P+ R    P   + + +H F R
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 2e-34
 Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 25/265 (9%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQLSH 281
           +G+G +G V+L    ++G++ A+K +         K  L +LN+      E ++L+    
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRM--------KKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
             +V+   +   DE L + +EYV GG    LL   G  +E   + Y  ++   +  LH  
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
             +HRD+K  N L+D  G IKL DFG++K + + A+  S  GSP +MAPEV+    GY  
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN--SVVGSPDYMAPEVL-RGKGYDF 177

Query: 402 TVDIWSLGCTVLEMATSKPPWS------QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
           TVD WSLGC + E     PP+S       +E +    +        +   +LSD+A   I
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237

Query: 456 KQCLQRDPSARPPASK-LLDHPFVR 479
            + +  DPS R  + + + +HPF +
Sbjct: 238 TKLIN-DPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  130 bits (329), Expect = 4e-34
 Identities = 75/254 (29%), Positives = 126/254 (49%), Gaps = 15/254 (5%)

Query: 227 LLGRGTFGHVY-LGFNSESGQMCAIKEVRVV-----CDDQTSKECLKQLNQEINLL-SQL 279
            LG G FG VY +   +    + A+KE+ V       D +   + +  +  E+ ++  QL
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTRQILLGL 335
            HPNIVRY+ + L ++RL + ++ + G  + +      ++   F E  I     Q++L L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 336 AYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM 394
            YLH  +  VHRD+   NI++    ++ + DFG+AK     + + S  G+  +  PE+V 
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK 186

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL-SDDAKS 453
           N   Y    D+W+ GC + +M T +PP+     ++   KI  +   P +PE + S+D   
Sbjct: 187 NEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGMYSEDVTD 244

Query: 454 FIKQCLQRDPSARP 467
            I  CL  D  ARP
Sbjct: 245 VITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  130 bits (328), Expect = 8e-34
 Identities = 77/283 (27%), Positives = 139/283 (49%), Gaps = 22/283 (7%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           +    LG G  G V    +  +G + A K V +       K+ L+    E+ ++ +   P
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR----ELQIMHECRSP 63

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH-AR 341
            IV ++G+ L++  + + +E++  GS+ ++ ++ GP    ++      ++ GL YL+   
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             +HRDIK +NILV+  G+IKL DFG++  +  S A   +F G+  +M+PE +     Y+
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERI-QGGKYT 180

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGV-------AAIFKIGN---SKDIPEIP-EHLSD 449
           +  D+WSLG +++E+A  K P++              I  +      +  P +P     +
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLA 492
           D + F+  CL +DP+ RP   +L   P        RA NV+L 
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPF--IQALRASNVDLQ 281

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 3e-33
 Identities = 87/319 (27%), Positives = 135/319 (42%), Gaps = 82/319 (25%)

Query: 229 GRGTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQ----EINLLSQLSHP 282
           GRGT+G VY     N + G+  AIK+ +        KE    ++Q    EI LL +L H 
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFK------GDKEQYTGISQSACREIALLRELKHE 62

Query: 283 NIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQ--------EYGPFNEPVIQTYTRQIL 332
           N+V      L     SVYL  +Y      H L Q        +       ++++   QIL
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 333 LGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSP--- 385
            G+ YLH+   +HRD+K ANILV       G +K+ D G+A+   +          P   
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-PLKPLADLDPVVV 177

Query: 386 -YWM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS------------QYEGVAAI 431
             W  APE+++    Y+  +DIW++GC   E+ T +P +             Q + +  I
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 432 FKI-GN--SKDIPEI---PEHLSDDAKSF---------------------------IKQC 458
           F++ G    KD P+I   PE+     K F                           +++ 
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEY-DTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 459 LQRDPSARPPASKLLDHPF 477
           L+ DP+ R  A + L+HP+
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  129 bits (325), Expect = 3e-33
 Identities = 83/260 (31%), Positives = 135/260 (51%), Gaps = 12/260 (4%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K+LG+G+FG V+L     + Q  AIK ++   V+ DD    EC     + ++L     HP
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSL--AWEHP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +   + +  + E L   +EY++GG +   +Q    F+ P    Y  +I+ GL +LH++ 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            V+RD+K  NIL+D  G IK+ADFGM K +M   A   +F G+P ++APE+++    Y+ 
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNT 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           +VD WS G  + EM   + P+  ++       I    D P  P  L+ +AK  + +   R
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTREAKDILVKLFVR 233

Query: 462 DPSARPPA-SKLLDHPFVRD 480
           +P  R      +  HPF R+
Sbjct: 234 EPERRLGVKGDIRQHPFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  128 bits (323), Expect = 3e-33
 Identities = 82/255 (32%), Positives = 136/255 (53%), Gaps = 13/255 (5%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEM 82

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           + S L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 348 IKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           IK  +IL+   G +KL+DFG    ++       S  G+PYWMAPE++     Y   VDIW
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIW 200

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDP 463
           SLG  V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPKLKNLHKVSPSLKGFLDRLLVRDP 258

Query: 464 SARPPASKLLDHPFV 478
           + R  A++LL HPF+
Sbjct: 259 AQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  127 bits (322), Expect = 7e-33
 Identities = 86/270 (31%), Positives = 138/270 (51%), Gaps = 19/270 (7%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
            +G GT G VY     ++G + A+K++R   + + +K  L  L  ++ L S    P IV+
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKSHDC-PYIVK 78

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTV- 344
            +G  ++D  + + +E +S   + KLL+   GP  E ++   T  I+  L YL  ++ V 
Sbjct: 79  CYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI 137

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNG---YSL 401
           HRD+K +NIL+D  G +KL DFG++  +    +     G   +MAPE +   +    Y +
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDI 197

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIF----KIGNSKDIPEIP--EHLSDDAKSFI 455
             D+WSLG +++E+AT + P   Y+     F    KI    + P +P  E  S D  SF+
Sbjct: 198 RADVWSLGISLVELATGQFP---YKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDFCSFV 253

Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVAR 485
             CL +D   RP   +LL HPF+R    A 
Sbjct: 254 DLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 1e-32
 Identities = 87/272 (31%), Positives = 139/272 (51%), Gaps = 33/272 (12%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQLSH 281
           +G+GTFG VY     ++ ++ A+K +        SK+ +    +      E N+L +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL--------SKKEIVAKKEVAHTIGERNILVRTLL 52

Query: 282 ---PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
              P IV    S  +D  L +  +Y+SGG +   LQ+ G F+E   + Y  +++L L +L
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTN 397
           H  + V+RD+K  NIL+D  G I L DFG++K ++T   +  +F G+  ++APEV+++  
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           GY+  VD WSLG  V EM     P+      Q     A  K+   K++      LSD+ +
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV------LSDEGR 226

Query: 453 SFIKQCLQRDPSAR----PPASKLLDHPFVRD 480
            F+K  L R+P  R      A +L +HPF  D
Sbjct: 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  126 bits (319), Expect = 1e-32
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 32/278 (11%)

Query: 223 KKGKLLGRGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           K  K LG G FG V L         +G+  A+K +    ++Q   +      +EI +L  
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRT 62

Query: 279 LSHPNIVRYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGL 335
           L H NIV+Y G         L + +EY+  GS+   LQ +    N   +  ++ QI  G+
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG---SP-YWMAPE 391
            YL ++  +HRD+   NILV+    +K++DFG+AK +         K    SP +W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGN---- 436
            +  T+ +S   D+WS G T+ E+ T    S+ P +++       +G   + ++      
Sbjct: 183 CLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241

Query: 437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            + +P  P    D+    +K C + +P  RP  + L+ 
Sbjct: 242 GERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  127 bits (321), Expect = 1e-32
 Identities = 86/261 (32%), Positives = 136/261 (52%), Gaps = 17/261 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KLLG+GTFG V L     SG+  A+K ++   ++  D+ +         E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-----TESRVLKNTRHP 55

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +     S  + +RL   +EYV+GG +   L     F+E   + Y  +I+  L YLH+  
Sbjct: 56  FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            V+RD+K  N+++D  G IK+ DFG+ K  +T  A+M +F G+P ++APE V+  N Y  
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGR 174

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
            VD W LG  + EM   + P+   +    +F++   +DI + P  LS DAKS +   L +
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEDI-KFPRTLSADAKSLLSGLLIK 232

Query: 462 DPSAR-----PPASKLLDHPF 477
           DP+ R       A +++ H F
Sbjct: 233 DPNKRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  127 bits (321), Expect = 2e-32
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 34/274 (12%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K+LG+G+FG V L     + ++ AIK ++   ++ DD    +C     + I  L+   HP
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDV--DC-TMTEKRILALAA-KHP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +   H    + +RL   +EYV+GG +   +Q    F+EP  + Y  ++ L L +LH   
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  NIL+D  G  KLADFGM K  + +  +  +F G+P ++APE++     Y  
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGP 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKS 453
           +VD W+LG  + EM   +PP          F+  N  D+ E         P  LS +A S
Sbjct: 176 SVDWWALGVLMYEMMAGQPP----------FEADNEDDLFESILHDDVLYPVWLSKEAVS 225

Query: 454 FIKQCLQRDPSAR-------PPASKLLDHPFVRD 480
            +K  + ++P+ R            +  HPF ++
Sbjct: 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  127 bits (320), Expect = 2e-32
 Identities = 80/254 (31%), Positives = 140/254 (55%), Gaps = 28/254 (11%)

Query: 226 KLLGRGTFGHVYLG---FNSESGQMCAIKEVRV----VCDDQTSKECLKQLNQEINLLSQ 278
           K+LG+G+FG V+L       ++GQ+ A+K ++     V D   +K        E ++L++
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-------MERDILAE 54

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           ++HP IV+ H +  ++ +L + L+++ GG +   L +   F E  ++ Y  ++ L L +L
Sbjct: 55  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTN 397
           H+   ++RD+K  NIL+D  G IKL DFG++K  +       SF G+  +MAPEVV N  
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRR 173

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIF--KIGNSKDIPEIPEHLSDDAK 452
           G++ + D WS G  + EM T   P+    + E +  I   K+G       +P+ LS +A+
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-------MPQFLSPEAQ 226

Query: 453 SFIKQCLQRDPSAR 466
           S ++   +R+P+ R
Sbjct: 227 SLLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  127 bits (321), Expect = 2e-32
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 48/292 (16%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV-- 285
           +G G +G V    ++ SG+  AIK++    D  T     K+  +E+ +L    H NI+  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNIIAI 69

Query: 286 ----RYHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
               R  G++  D    VY+   +    +H ++    P  E  I+ +  Q+L GL Y+H+
Sbjct: 70  RDILRPPGADFKD----VYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-----CASMLSFKGSPYWMAPEVVMN 395
            N +HRD+K +N+LV+   E+++ DFGMA+ ++S        M  +  + ++ APE++++
Sbjct: 126 ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKP--PWSQYEG-------------VAAIFKIGNSK-- 438
              Y+  +D+WS+GC   EM   +   P   Y                  + +IG+ +  
Sbjct: 186 LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVR 245

Query: 439 -------DIPEIPEH-----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                      +P        S +A   + Q LQ DP  R    + L HPF+
Sbjct: 246 KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  126 bits (318), Expect = 3e-32
 Identities = 83/261 (31%), Positives = 136/261 (52%), Gaps = 17/261 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KLLG+GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHP 55

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +     +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+
Sbjct: 56  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            V+RDIK  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APE V+  N Y  
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGR 174

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
            VD W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 232

Query: 462 DPSAR-----PPASKLLDHPF 477
           DP  R       A ++++H F
Sbjct: 233 DPKQRLGGGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  125 bits (316), Expect = 4e-32
 Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 45/297 (15%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQL 279
            ++K + +G GT+G VY   +  +G++ A+K+ R+  D++      L+    EI+LL  L
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQML 57

Query: 280 SH-PNIVRYHGSELSDE---RLSVYL--EYVSGGSIHKLLQEYG-----PFNEPVIQTYT 328
           S    IVR    E  +E   + S+YL  EY+    + K +   G     P     I+++ 
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGE-IKLADFGMAKHMTSCASMLSFKGSPYW 387
            Q+L G+A+ H    +HRD+K  N+LVD     +K+AD G+ +  +      + +    W
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 388 M-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFK---------- 433
             APEV++ +  YS  VDIWS+GC   EM+  +P +   S+ + +  IFK          
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236

Query: 434 --IGNSKDIPEIP-----------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
             +   +D  E P             LS +    +++ L+ DP+ R  A   L HP+
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 7e-32
 Identities = 83/260 (31%), Positives = 136/260 (52%), Gaps = 15/260 (5%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+G+FG V      ++ ++ A+K +R       S+  +     E  +L+Q++ P IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKA--HIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S  S E+L + L +++GG +   LQ  G F+    + YT ++L  L  LH  N ++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 348 IKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           +K  NIL+D  G I L DFG+ K +M       +F G+P ++APE+++  +GY+  VD W
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWW 177

Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---IPEHLSDDAKSFIKQCLQRDP 463
           +LG  + EM T  PP+   E V  +++    K + E    P+    DAK  +   L RDP
Sbjct: 178 TLGVLLYEMLTGLPPFYD-ENVNEMYR----KILQEPLRFPDGFDRDAKDLLIGLLSRDP 232

Query: 464 SAR---PPASKLLDHPFVRD 480
           + R     A ++ +HPF   
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  125 bits (315), Expect = 8e-32
 Identities = 84/263 (31%), Positives = 137/263 (52%), Gaps = 18/263 (6%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           +LG+G+FG V L     + ++ AIK ++   V+ DD    EC      E  +L+    P 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMV---EKRVLALQDKPP 61

Query: 284 -IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            + + H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +LH R 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+++D  G IK+ADFGM K HM    +  +F G+P ++APE++     Y  
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGK 180

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           +VD W+ G  + EM   +PP+   E    +F+     ++   P+ LS +A S  K  + +
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLMTK 238

Query: 462 DPSAR----PPASK-LLDHPFVR 479
            PS R    P   + + +H F R
Sbjct: 239 HPSKRLGCGPEGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  124 bits (313), Expect = 1e-31
 Identities = 86/297 (28%), Positives = 143/297 (48%), Gaps = 35/297 (11%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           + +++K + +G GT+G VY   +  + +  A+K++R+   +Q  +       +EI+LL +
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL---EQEDEGVPSTAIREISLLKE 57

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQTYTRQILLGLA 336
           + H NIVR      S++RL +  EY+    + K +     F  N  +I+TY  QIL G+A
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 337 YLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVM 394
           Y H+   +HRD+K  N+L+D     +KLADFG+A+         + +    W  APE+++
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI----------------- 434
            +  YS  VDIWS+GC   EM   KP +   S+ + +  IF+I                 
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 435 -------GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
                     KD+  +   L       + + L+ DPS R  A   L+H + +D   A
Sbjct: 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  124 bits (312), Expect = 1e-31
 Identities = 83/282 (29%), Positives = 140/282 (49%), Gaps = 29/282 (10%)

Query: 226 KLLGRGTFGHVYL---GFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS 280
           ++LG G +G V+L       ++G++ A+K ++   +     + E  +   Q +  + +  
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR-- 63

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
            P +V  H +  +D +L + L+YV+GG +   L +   F E  ++ Y  +I+L L +LH 
Sbjct: 64  CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMT--SCASMLSFKGSPYWMAPEVVMN-TN 397
              ++RDIK  NIL+D  G + L DFG++K           SF G+  +MAPEV+   + 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPW-------SQYEGVAAIFKIGNSKDIPEIPEHLSDD 450
           G+   VD WSLG    E+ T   P+       SQ E    I      K  P  P+ +S +
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-----KSKPPFPKTMSAE 238

Query: 451 AKSFIKQCLQRDPSAR---PPASKLLDHPFVR----DQAVAR 485
           A+ FI++ L++DP  R     A ++ +HPF +    D   A+
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  124 bits (312), Expect = 1e-31
 Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 32/274 (11%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIV 285
            +GRG FG V    +  SG + A+K +R   D+   KE  K+L  +++++ + S  P IV
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KE-QKRLLMDLDVVMRSSDCPYIV 66

Query: 286 RYHGS-----------ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLG 334
           +++G+           EL D  L  + +YV     +++L+      E ++       +  
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYV-----YEVLKSV--IPEEILGKIAVATVKA 119

Query: 335 LAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEV 392
           L YL      +HRD+K +NIL+D +G IKL DFG++  +  S A        PY MAPE 
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPER 178

Query: 393 VM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQ----YEGVAAIFKIGNSKDIPEIPEH 446
           +     +GY +  D+WSLG T+ E+AT K P+ +    ++ +  + K             
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
            S    +FI  CL +D S RP   +LL+HPF++D
Sbjct: 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  124 bits (314), Expect = 2e-31
 Identities = 82/262 (31%), Positives = 123/262 (46%), Gaps = 15/262 (5%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQLSHPNIV 285
           L+GRG FG V +     +G + A+K   V+      ++E +    +E ++LS  + P I 
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMK---VMKKSVLLAQETVSFFEEERDILSISNSPWIP 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTV 344
           +   +    + L + +EY  GG +  LL  Y   F+E + Q Y  +++L +  +H    V
Sbjct: 65  QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK--GSPYWMAPEVVMNTNG---- 398
           HRDIK  N+L+D  G IKLADFG A  +T+   + S    G+P ++APEV+   NG    
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 399 -YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL--SDDAKSFI 455
            Y +  D WSLG    EM   + P+ +         I N +   + PE    S D    I
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI 244

Query: 456 KQCLQRDPSARPPASKLLDHPF 477
            Q L      R     L  HPF
Sbjct: 245 -QSLLCGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  123 bits (311), Expect = 2e-31
 Identities = 87/294 (29%), Positives = 138/294 (46%), Gaps = 64/294 (21%)

Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH-- 288
           GT+G VY   + ++G++ A+K++++  + +     +  L +EIN+L +L HPNIV     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSL-REINILLKLQHPNIVTVKEV 72

Query: 289 --GSELSDERLSVYL--EYVSGGSIHKL--LQEY--GPFNEPVIQTYTRQILLGLAYLHA 340
             GS L      +Y+  EYV     H L  L E    PF +  ++    Q+L G+A+LH 
Sbjct: 73  VVGSNLDK----IYMVMEYVE----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMA-------KHMTSCASMLSFKGSPYWMAPEVV 393
              +HRD+K +N+L++  G +K+ DFG+A       K  T     L      ++ APE++
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL------WYRAPELL 178

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI-G--NSKDIPEIPEHL 447
           +    YS  +D+WS+GC   E+ T KP +   S+ + +  IFK+ G    K  P   E  
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238

Query: 448 SDDAKSFIKQ--------------------CLQR----DPSARPPASKLLDHPF 477
               K+F K                      L R    DP+ R  A   L HP+
Sbjct: 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (312), Expect = 7e-31
 Identities = 83/297 (27%), Positives = 138/297 (46%), Gaps = 46/297 (15%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K++GRG FG V L    ++G + A+K++R    +   KE +  +  E ++L++  +P +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRK--SEMLEKEQVAHVRAERDILAEADNPWVV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           + + S   +  L + +EY+ GG +  LL +   F E   + Y  + +L +  +H    +H
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124

Query: 346 RDIKGANILVDPHGEIKLADFGM----------------------------AKHMTSCAS 377
           RDIK  N+L+D  G IKL+DFG+                            +K M+S   
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 378 MLSFK-----------GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE 426
             ++K           G+P ++APEV + T GY+   D WSLG  + EM    PP+    
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCSDN 243

Query: 427 GVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQ--CLQRDPSARPPASKLLDHPFVR 479
                 KI N K+  + P+   LS +AK  IK+  C           +++  HPF +
Sbjct: 244 PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  120 bits (304), Expect = 2e-30
 Identities = 70/213 (32%), Positives = 116/213 (54%), Gaps = 20/213 (9%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           S+++++K   +G GT+G VY   ++ SG++ A+K+VR+  D++     +  L +EI LL 
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLL 61

Query: 278 QLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLG 334
            L HPNIV      +     S++L  EY     +  LL     PF+E  ++    Q+L G
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA-------KHMTSCASMLSFKGSPYW 387
           L YLH    +HRD+K +N+L+   G +K+ADFG+A       K MT     L      ++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL------WY 174

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP 420
            APE+++    Y+  +D+W++GC + E+   KP
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  119 bits (299), Expect = 6e-30
 Identities = 83/267 (31%), Positives = 143/267 (53%), Gaps = 20/267 (7%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEI--NLLSQL 279
           ++GRG FG VY    +++G+M A+K     C D+   + +KQ     LN+ I  +L+S  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIK-MKQGETLALNERIMLSLVSTG 54

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
             P IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL ++H
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
            R  V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+     Y
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAY 173

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI-FKIGNSKDIPEIPEHLSDDAKSFIKQC 458
             + D +SLGC + ++     P+ Q++                E+P+  S + +S ++  
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 233

Query: 459 LQRDPSAR-----PPASKLLDHPFVRD 480
           LQRD + R       A ++ +HPF R 
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  120 bits (301), Expect = 7e-30
 Identities = 83/262 (31%), Positives = 135/262 (51%), Gaps = 18/262 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KLLG+GTFG V L     +G+  A+K ++   +V  D+ +         E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-----TENRVLQNSRHP 55

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-R 341
            +     S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
           N V+RD+K  N+++D  G IK+ DFG+ K  +   A+M +F G+P ++APE V+  N Y 
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYG 174

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             VD W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L+
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLSPEAKSLLSGLLK 232

Query: 461 RDPSAR-----PPASKLLDHPF 477
           +DP  R       A +++ H F
Sbjct: 233 KDPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  120 bits (302), Expect = 8e-30
 Identities = 76/314 (24%), Positives = 138/314 (43%), Gaps = 55/314 (17%)

Query: 215 TENSLSK--WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN-- 270
              S+S+   +KG  LG GT+G V   +++ +G++ AIK+V++  +        +QL   
Sbjct: 2   MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGM 60

Query: 271 --------QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEP 322
                   +E+ +++++ H NI+      +  + +++ ++ ++   + K++       E 
Sbjct: 61  CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTES 119

Query: 323 VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA------------- 369
            ++    QIL GL  LH    +HRD+  ANI ++  G  K+ADFG+A             
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 370 --KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------- 420
             + M     M S   + ++ APE++M    Y   VD+WS+GC   E+ T KP       
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239

Query: 421 -------------------PWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
                              P ++   +   F     KD+  I  + SDDA   ++  L+ 
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299

Query: 462 DPSARPPASKLLDH 475
           +P  R  A + L H
Sbjct: 300 NPLERISAKEALKH 313

Length = 335

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 8e-30
 Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 20/268 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           ++LG+G FG V       +G+M A K++      +   E +  LN E  +L +++   +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LN-EKQILEKVNSRFVV 63

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNT 343
               +  + + L + L  ++GG +   +   G   F+E     Y  +I  GL  LH    
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           V+RD+K  NIL+D +G I+++D G+A  +    ++    G+  +MAPEVV N   Y+ + 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER-YTFSP 182

Query: 404 DIWSLGCTVLEMATSKPPWSQY------EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           D W LGC + EM   K P+ Q       E V    K    +D  E  E  S+ A+S  +Q
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----EDQEEYSEKFSEAARSICRQ 238

Query: 458 CLQRDPSAR-----PPASKLLDHPFVRD 480
            L +DP  R       A ++  HPF R 
Sbjct: 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  118 bits (297), Expect = 1e-29
 Identities = 85/284 (29%), Positives = 150/284 (52%), Gaps = 26/284 (9%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEI--NLLSQL 279
           ++GRG FG VY    +++G+M A+K     C D+   + +KQ     LN+ I  +L+S  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIK-MKQGETLALNERIMLSLVSTG 54

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
             P IV    +  + ++L   L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL ++H
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
            R  V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+     Y
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAY 173

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
             + D +SLGC + ++     P+ Q+  +    I ++  + ++ E+P+  S + KS ++ 
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV-ELPDSFSPELKSLLEG 232

Query: 458 CLQRDPSAR-----PPASKLLDHPFVR----DQAVARAGNVNLA 492
            LQRD S R       A ++ +H F +     Q   +     L 
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLI 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  119 bits (299), Expect = 1e-29
 Identities = 75/262 (28%), Positives = 135/262 (51%), Gaps = 18/262 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K+LG+G+FG V L      G+  A+K ++   V+ DD    EC     + + L  +  +P
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEKRVLALAWE--NP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +   + +  + E L   +E+++GG +   +Q+ G F+      Y  +I+ GL +LH++ 
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+++D  G IK+ADFGM K      +  S F G+P ++APE++     Y+ 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTF 175

Query: 402 TVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           +VD WS G  + EM   + P+    + E   +I       D P  P  ++ ++K  +++ 
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-----RVDTPHYPRWITKESKDILEKL 230

Query: 459 LQRDPSAR-PPASKLLDHPFVR 479
            +RDP+ R      +  HPF +
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  119 bits (299), Expect = 1e-29
 Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 25/267 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-------LLSQ 278
           K++G+G+FG V L  +   G+  A+K +         K+ + +  ++ +       LL  
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVL--------QKKAILKKKEQKHIMAERNVLLKN 52

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           + HP +V  H S  + ++L   L+YV+GG +   LQ    F EP  + Y  +I   L YL
Sbjct: 53  VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYL 112

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTN 397
           H+ N ++RD+K  NIL+D  G + L DFG+ K  +    +  +F G+P ++APEV+    
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP-EIPEHLSDDAKSFIK 456
            Y  TVD W LG  + EM    PP+   +       I N    P  +  ++S  A+  ++
Sbjct: 173 -YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---PLRLKPNISVSARHLLE 228

Query: 457 QCLQRDPSARPPASK----LLDHPFVR 479
             LQ+D + R  A      + +H F  
Sbjct: 229 GLLQKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  119 bits (299), Expect = 1e-29
 Identities = 83/273 (30%), Positives = 139/273 (50%), Gaps = 24/273 (8%)

Query: 226 KLLGRGTFGHVYL---GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH- 281
           K+LG G +G V+L       ++G++ A+K ++     Q +K  ++    E N+L  +   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKT-VEHTRTERNVLEHVRQS 64

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P +V  H +  ++ +L + L+YVSGG +   L +   F+E  ++ Y+ +I+L L +LH  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--MLSFKGSPYWMAPEVVMNTNGY 399
             V+RDIK  NIL+D  G + L DFG++K   S       SF G+  +MAPE++    G+
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 400 SLTVDIWSLGCTVLEMATSKPPW-------SQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
              VD WSLG  + E+ T   P+       +Q E    I K       P  P  +  +A+
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-----PPFPSFIGPEAQ 239

Query: 453 SFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
             + + L++DP  R       AS++ +HPF + 
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  118 bits (298), Expect = 1e-29
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 37/282 (13%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           KL+  G +G VYL  + E+ Q  A+K++        +K+ L   NQ      E ++L+  
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKI--------NKQNLILRNQIQQVFVERDILTFA 58

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            +P +V    S  +   L + +EYV GG    LL+  G     + + Y  + +L L YLH
Sbjct: 59  ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAK-------------HMTSCASMLSFK---G 383
               VHRD+K  N+L+   G IKL DFG++K             H+         K   G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI--P 441
           +P ++APEV++   GY   VD W++G  + E      P+   +    +F    S DI  P
Sbjct: 179 TPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWP 236

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSAR---PPASKLLDHPFVRD 480
           E  E L  DA+  I + L+++P  R     A ++  H F   
Sbjct: 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  118 bits (298), Expect = 1e-29
 Identities = 78/266 (29%), Positives = 141/266 (53%), Gaps = 19/266 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           ++LG+G+FG V L    ESG++ A+K ++   ++ DD    EC     + ++L     HP
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDV--ECTMTEKRILSLARN--HP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            + + +    + +RL   +E+V+GG +   +Q+   F+E   + Y  +I   L +LH + 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+L+D  G  KLADFGM K  + +  +  +F G+P ++APE++     Y  
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGP 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
           +VD W++G  + EM     P+ + E    +F+ I N + +   P  LS DA   +K  + 
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVV--YPTWLSQDAVDILKAFMT 232

Query: 461 RDPSARPPA------SKLLDHPFVRD 480
           ++P+ R  +        +L HPF ++
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  119 bits (299), Expect = 2e-29
 Identities = 77/284 (27%), Positives = 143/284 (50%), Gaps = 33/284 (11%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQ 278
           +K+   K +GRG +G V    NSE+ +  AIK++    D++  +K  L+    EI LL  
Sbjct: 5   TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRH 60

Query: 279 LSHPNIVRY-------HGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           L H N++         H    +D    VY+ Y +    +H++++     ++   Q +  Q
Sbjct: 61  LDHENVIAIKDIMPPPHREAFND----VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ 116

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYW 387
           +L GL Y+H+ N +HRD+K +N+L++ + ++K+ DFG+A+  T+      M  +  + ++
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP--PWSQY-EGVAAIFKIGNSKDIPEIP 444
            APE+++N + Y+  +D+WS+GC   E+   KP  P   Y   +  I ++  S    ++ 
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234

Query: 445 EHLSDDAKSFIKQC--------LQRDPSARPPASKLLDHPFVRD 480
              ++ A+ +I+           +  P A P A  LL+   V D
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFD 278

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  118 bits (297), Expect = 2e-29
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 7/200 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           K++G+G+FG V L      G+  A+K  + ++V + +  K  + + N    LL  + HP 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV---LLKNVKHPF 57

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           +V  H S  + E+L   L++V+GG +   LQ    F EP  + Y  +I   L YLH+ N 
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNGYSLT 402
           V+RD+K  NIL+D  G + L DFG+ K   + + +  +F G+P ++APEV+     Y  T
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI-RKQPYDNT 176

Query: 403 VDIWSLGCTVLEMATSKPPW 422
           VD W LG  + EM    PP+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  116 bits (294), Expect = 3e-29
 Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 55/290 (18%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVR 286
           +G GTF  V    + ++G+  AIK ++       S E +  L  EI  L +LS HPNI+R
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---SLEQVNNLR-EIQALRRLSPHPNILR 62

Query: 287 YHGSELSDE---RLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARN 342
                L D    RL++  E +   ++++L++    P  E  +++Y  Q+L  L ++H   
Sbjct: 63  LI-EVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-------WM-APEVVM 394
             HRDIK  NIL+     +KLADFG      SC  + S K  PY       W  APE ++
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFG------SCRGIYS-KP-PYTEYISTRWYRAPECLL 171

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKP--PWS-QYEGVAAI--------------FKIGNS 437
               Y   +DIW++GC   E+ +  P  P + + + +A I              F+    
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 438 KD----------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
            +          + ++  + S +    +K+ L  DP  R  A + L HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  117 bits (295), Expect = 4e-29
 Identities = 88/282 (31%), Positives = 135/282 (47%), Gaps = 42/282 (14%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS-HP 282
           +++GRG++  V L    ++ ++ A+K V+  +V DD    E +  +  E ++  Q S HP
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 56

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +V  H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R 
Sbjct: 57  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+L+D  G IKL D+GM K         S F G+P ++APE++   + Y  
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGF 175

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE-----------------IP 444
           +VD W+LG  + EM   + P          F I  S D P+                 IP
Sbjct: 176 SVDWWALGVLMFEMMAGRSP----------FDIVGSSDNPDQNTEDYLFQVILEKQIRIP 225

Query: 445 EHLSDDAKSFIKQCLQRDPSAR---PPASKLLD---HPFVRD 480
             LS  A S +K  L +DP  R    P +   D   HPF R+
Sbjct: 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 6e-29
 Identities = 82/296 (27%), Positives = 139/296 (46%), Gaps = 46/296 (15%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L  +KK   LG G++  VY G +  +GQ+ A+KE+R+  ++      ++    E +LL  
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKD 59

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILL 333
           L H NIV  H    + + L++  EY+        L++Y     G  +   ++ +  Q+L 
Sbjct: 60  LKHANIVTLHDIIHTKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEV 392
           GLAY H R  +HRD+K  N+L+   GE+KLADFG+A+  +  +   S +    W   P+V
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKP--PWSQ--YEGVAAIFKI----------GNSK 438
           ++ +  YS ++D+W +GC   EMAT +P  P S    + +  IF++          G S 
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234

Query: 439 DIPEIPEHLSD-----------------DAKSFIKQCLQRDPSARPPASKLLDHPF 477
           +    P                        +    + LQ +P  R  A++ + HP+
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  117 bits (294), Expect = 6e-29
 Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 70/316 (22%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN-QEINL 275
           + +SK++K   +G+GTFG V+   + ++ Q+ A+K+V +    +  KE       +EI +
Sbjct: 9   DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM----ENEKEGFPITALREIKI 64

Query: 276 LSQLSHPNIV------RYHGSELSDERLSVYL-----EYVSGGSIHKLLQE-YGPFNEPV 323
           L  L H N+V      R   +  +  + S YL     E+   G    LL      F    
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG----LLSNKNVKFTLSE 120

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG 383
           I+   + +L GL Y+H    +HRD+K ANIL+   G +KLADFG+A+     A  LS   
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-----AFSLSKNS 175

Query: 384 SP----------YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------------- 420
            P          ++  PE+++    Y   +D+W  GC + EM T  P             
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235

Query: 421 ---------PWSQYEGVAAIFKIGNSKDIPE-----IPEHL-----SDDAKSFIKQCLQR 461
                    P   + GV    ++    ++P+     + E L        A   I + L  
Sbjct: 236 ISQLCGSITP-EVWPGVDK-LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293

Query: 462 DPSARPPASKLLDHPF 477
           DP+ R  A   L+H F
Sbjct: 294 DPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  117 bits (294), Expect = 6e-29
 Identities = 74/244 (30%), Positives = 121/244 (49%), Gaps = 9/244 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           K++G+G+FG V L      G   A+K  + + +   +     + + N    LL  L HP 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV---LLKNLKHPF 57

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           +V  H S  + E+L   L+YV+GG +   LQ    F EP  + Y  ++   + YLH+ N 
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNI 117

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           ++RD+K  NIL+D  G + L DFG+ K  +    +  +F G+P ++APE V+    Y  T
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRT 176

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           VD W LG  + EM    PP+   + V+ ++     K + ++P   +  A   +   L +D
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPL-QLPGGKTVAACDLLVGLLHKD 234

Query: 463 PSAR 466
              R
Sbjct: 235 QRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  117 bits (294), Expect = 8e-29
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 57/290 (19%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G FG V    +  +GQ  AIK++       ++    K+  +E+ LL  L H NI+  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKI---MKPFSTPVLAKRTYRELKLLKHLRHENII-- 72

Query: 288 HGSELSDERLS----VYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
               LSD  +S    +Y    + G  +H+LL    P  +  IQ +  QIL GL Y+H+  
Sbjct: 73  ---SLSDIFISPLEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG 128

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNG 398
            VHRD+K +NIL++ + ++K+ DFG+A+     MT   S      + Y+ APE+++    
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRYYRAPEIMLTWQK 182

Query: 399 YSLTVDIWSLGCTVLEMATSKP------PWSQYEGVAAIFKIGNSKD------------- 439
           Y + VDIWS GC   EM   KP        +Q+  +  +  +G   D             
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL--LGTPPDDVINTICSENTLR 240

Query: 440 ------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                         E  ++    A   +++ L  DP  R  A++ L HP+
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  115 bits (289), Expect = 1e-28
 Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 32/276 (11%)

Query: 223 KKGKLLGRGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           KK ++LG G FG V    Y   N  +G+M A+K ++  C  Q +        +EIN+L  
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTS----GWKKEINILKT 62

Query: 279 LSHPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           L H NIV+Y G  SE   + L + +EYV  GS+   L ++   N   +  + +QI  G+A
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMA 121

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEV 392
           YLH+++ +HRD+   N+L+D    +K+ DFG+AK +         +    SP +W A E 
Sbjct: 122 YLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE- 180

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEI----- 443
            +  N +S   D+WS G T+ E+ T     + P  ++E +    K G    +  I     
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-KQGQMTVVRLIELLER 239

Query: 444 ------PEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
                 P++   +    +K C + +   RP    L+
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  116 bits (291), Expect = 1e-28
 Identities = 75/244 (30%), Positives = 126/244 (51%), Gaps = 9/244 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           K++G+G+FG V L  +    +  A+K  + + +   +  K  + + N    LL  + HP 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV---LLKNVKHPF 57

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           +V  H S  + ++L   L+Y++GG +   LQ    F EP  + Y  +I   L YLH+ N 
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           V+RD+K  NIL+D  G I L DFG+ K ++    +  +F G+P ++APE V++   Y  T
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRT 176

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           VD W LG  + EM    PP+           I N     ++  ++++ A+  ++  LQ+D
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKD 234

Query: 463 PSAR 466
            + R
Sbjct: 235 RTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  116 bits (292), Expect = 2e-28
 Identities = 84/325 (25%), Positives = 146/325 (44%), Gaps = 83/325 (25%)

Query: 214 VTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV----RVVCDDQ-TSKE--CL 266
           + ++ L K++  + LG+G +G V+   +  + ++ A+K++    R   D Q T +E   L
Sbjct: 1   IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFL 60

Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGG-----------SIHKLL 313
           ++L           HPNIV+      ++    +YL  EY+               +HK  
Sbjct: 61  QELGD---------HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK-- 109

Query: 314 QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT 373
                      +    Q+L  L Y+H+ N +HRD+K +NIL++    +KLADFG+A+   
Sbjct: 110 -----------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR--- 155

Query: 374 SCASMLSFKGSP----Y----WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP--PW 422
           S + +     +P    Y    W  APE+++ +  Y+  VD+WS+GC + EM   KP  P 
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215

Query: 423 S----QYEGVAAIFKIGNSKDI-----------------------PEIPEHLSDDAKSFI 455
           +    Q E +  +    +++DI                        E+    SDDA   +
Sbjct: 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL 275

Query: 456 KQCLQRDPSARPPASKLLDHPFVRD 480
           K+ L  +P+ R  A + L+HP+V  
Sbjct: 276 KKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  115 bits (290), Expect = 3e-28
 Identities = 83/283 (29%), Positives = 135/283 (47%), Gaps = 37/283 (13%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           ++   K +G G +G V    +  +G+  AIK++        S+   K+  +E+ LL  + 
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSEIFAKRAYRELTLLKHMQ 72

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHK--LLQEY----------GPFNEPVIQTYT 328
           H N++           L V+   VSG       L+  Y           P +E  +Q   
Sbjct: 73  HENVIGL---------LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM 388
            Q+L GL Y+H+   +HRD+K  N+ V+   E+K+ DFG+A+H    A M  +  + ++ 
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYR 181

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEH 446
           APEV++N   Y+ TVDIWS+GC + EM T K  +   + +  + +I     +P  E  + 
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241

Query: 447 LSD-DAKSFIK---QCLQRD-----PSARPPASKLLDHPFVRD 480
           L D  AKS+IK   +  ++D     P A P A  LL+     D
Sbjct: 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD 284

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  114 bits (286), Expect = 3e-28
 Identities = 84/271 (30%), Positives = 137/271 (50%), Gaps = 25/271 (9%)

Query: 226 KLLGRGTFGHVYLG---FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH- 281
           K+LG G +G V+L       +SG++ A+K ++     Q +K   +    E  +L  +   
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIRQS 64

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P +V  H +  +D +L + L+Y++GG +   L +   F E  +Q Y+ +I+L L +LH  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK--HMTSCASMLSFKGSPYWMAPEVVMNTN-G 398
             ++RDIK  NIL+D +G + L DFG++K  H        SF G+  +MAP++V   + G
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 399 YSLTVDIWSLGCTVLEMATSKPPW-------SQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
           +   VD WS+G  + E+ T   P+       SQ E    I K     + P  P+ +S  A
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SE-PPYPQEMSALA 239

Query: 452 KSFIKQCLQRDPSAR-----PPASKLLDHPF 477
           K  I++ L +DP  R       A ++  HPF
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  117 bits (294), Expect = 3e-28
 Identities = 84/309 (27%), Positives = 150/309 (48%), Gaps = 50/309 (16%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
           + +  +    +K G ++G G+FG VY     ++ +  AIK  +V+ D Q         N+
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYK-------NR 108

Query: 272 EINLLSQLSHPNIV-----RYHGSELSDER---LSVYLEYVSGGSIHKLLQEYGPFNEPV 323
           E+ ++  L+H NI+      Y      +E+   L+V +E++   ++HK ++ Y   N  +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 324 ----IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE-IKLADFGMAKHMTSCASM 378
               ++ Y+ Q+   LAY+H++   HRD+K  N+L+DP+   +KL DFG AK++ +    
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227

Query: 379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI---- 434
           +S+  S ++ APE+++    Y+  +D+WSLGC + EM    P +S    V  + +I    
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287

Query: 435 ----------------------GNSKDIPEI-PEHLSDDAKSFIKQCLQRDPSARPPASK 471
                                    KD+ ++ P+   DDA +FI Q L+ +P  R    +
Sbjct: 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347

Query: 472 LLDHPFVRD 480
            L  PF  D
Sbjct: 348 ALADPFFDD 356

Length = 440

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 3e-28
 Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 31/261 (11%)

Query: 228 LGRGTFGHVYLG-FNSESGQM--CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           LG G FG V  G +  +SG+    A+K ++        KE L+    E ++++QL HP I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR----EASVMAQLDHPCI 58

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           VR  G    +  + V +E    G + K L++        ++    Q+ +G+AYL +++ V
Sbjct: 59  VRLIGVCKGEPLMLV-MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY------------WMAPEV 392
           HRD+   N+L+    + K++DFGM++ + +        GS Y            W APE 
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGA--------GSDYYRATTAGRWPLKWYAPEC 169

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
           + N   +S   D+WS G T+ E  +    P+ + +G   I  + + + +P  PE    + 
Sbjct: 170 I-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR-PEECPQEI 227

Query: 452 KSFIKQCLQRDPSARPPASKL 472
            S +  C +  P  RP  S+L
Sbjct: 228 YSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  113 bits (284), Expect = 6e-28
 Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 42/278 (15%)

Query: 226 KLLGRGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           + LG+G FG V    Y      +G++ A+K+++      ++ E L+   +EI +L  L H
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHLRDFEREIEILKSLQH 64

Query: 282 PNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYL 338
            NIV+Y G   S  R ++ L  EY+  GS+   LQ++    +   +  Y  QI  G+ YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVM 394
            ++  VHRD+   NILV+    +K+ DFG+ K +         +    SP +W APE  +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE-SL 183

Query: 395 NTNGYSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD 450
             + +S+  D+WS G  + E+ T    S  P +++     +  +GN K    I  HL + 
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-----MRMMGNDKQGQMIVYHLIEL 238

Query: 451 AKS----------------FIKQCLQRDPSARPPASKL 472
            K+                 +K+C   DPS RP  S+L
Sbjct: 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  114 bits (286), Expect = 7e-28
 Identities = 78/263 (29%), Positives = 138/263 (52%), Gaps = 16/263 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
            +LG+G+FG V L     + ++ AIK ++   V+ DD    EC   + + +  LS    P
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--EC-TMVEKRVLALSG-KPP 61

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            + + H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +LH++ 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            ++RD+K  N+++D  G IK+ADFGM K +M    +  +F G+P ++APE++     Y  
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA-YQPYGK 180

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           +VD W+ G  + EM   + P+ + E    +F+     ++   P+ +S +A +  K  + +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTK 238

Query: 462 DPSAR----PPASK-LLDHPFVR 479
            P  R    P   + + +H F R
Sbjct: 239 HPGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  114 bits (287), Expect = 8e-28
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 24/278 (8%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV-RVVCDDQTSKECLKQLNQEINLLSQ 278
            +++  K +G G +G V    +  +G   AIK++ R    +  +K   +    E+ LL  
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70

Query: 279 LSHPNIVRYHGSELSDERLSVYLEY-----VSGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
           + H N++        D  L  + ++       G  + KL++ +   +E  IQ    Q+L 
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLK 129

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV 393
           GL Y+HA   +HRD+K  N+ V+   E+K+ DFG+A+   S   M  +  + ++ APEV+
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVI 187

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHL-SDD 450
           +N   Y+ TVDIWS+GC + EM T KP +  ++ +  + +I      P  E  + L S+D
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Query: 451 AKSFIK---QCLQRD-----PSARPPASKLLDHPFVRD 480
           AK+++K   +  ++D     P+A P A  +L+   V D
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD 285

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 9e-28
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 59/303 (19%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KK KLLG+G  G V+L     +G++ A+K +      + +K  +K++  E  +L+ L HP
Sbjct: 4   KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK--VKRVLTEQEILATLDHP 61

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHA 340
            +   + S  ++  L + ++Y  GG + +LLQ       +E V + Y  ++LL L YLH 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML--------------------- 379
              V+RD+K  NIL+   G I L+DF ++K        +                     
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 380 ---------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA 430
                    SF G+  ++APEV+ + +G+   VD W+LG  + EM     P         
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTP--------- 231

Query: 431 IFKIGNSKDI--------PEIPEH--LSDDAKSFIKQCLQRDPSAR----PPASKLLDHP 476
            FK  N  +            P    +S  A+  I++ L +DPS R      A+++  HP
Sbjct: 232 -FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290

Query: 477 FVR 479
           F R
Sbjct: 291 FFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  113 bits (284), Expect = 2e-27
 Identities = 84/286 (29%), Positives = 131/286 (45%), Gaps = 52/286 (18%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR--VVCDD------QTSKECLKQLNQEINLLS 277
           +++GRG++  V L    ++ ++ A+K ++  +V DD      QT K   +  +       
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS------- 53

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
             +HP +V  H    ++ RL   +E+VSGG +   +Q      E   + Y+ +I L L +
Sbjct: 54  --NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNT 396
           LH R  ++RD+K  N+L+D  G IKL D+GM K         S F G+P ++APE++   
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE-------------- 442
           + Y  +VD W+LG  + EM   + P          F I    D P+              
Sbjct: 172 D-YGFSVDWWALGVLMFEMMAGRSP----------FDIVGMSDNPDQNTEDYLFQVILEK 220

Query: 443 ---IPEHLSDDAKSFIKQCLQRDPSAR---PPASKLLD---HPFVR 479
              IP  LS  A S +K  L +DP  R    P +   D   HPF R
Sbjct: 221 QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  112 bits (281), Expect = 2e-27
 Identities = 94/291 (32%), Positives = 135/291 (46%), Gaps = 52/291 (17%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLS---HPN 283
           +G G +G VY   +  SG   A+K VRV    QT+++ L     +E+ LL +L    HPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 284 IVRYH---GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLA 336
           IVR      +  +D    V L  E+V    +   L +  P   P   I+   RQ L GL 
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMN 395
           +LHA   VHRD+K  NILV   G++KLADFG+A+ + SC   L+      W  APEV++ 
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI-----------------G 435
           +  Y+  VD+WS+GC   EM   KP +   S+ + +  IF +                 G
Sbjct: 182 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240

Query: 436 N---------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                        +PEI E  +      + + L  +P  R  A + L HPF
Sbjct: 241 AFSPRGPRPVQSVVPEIEESGAQ----LLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  112 bits (281), Expect = 2e-27
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 8/209 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           + LG G++  VY G +  +GQ+ A+K + +  ++      ++    E +LL  L H NIV
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIV 66

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
             H    + E L+   EY+       ++Q  G  +   ++ +  Q+L GLAY+H ++ +H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVD 404
           RD+K  N+L+   GE+KLADFG+A+  +  +   S +    W   P+V++    YS  +D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFK 433
           IW  GC  +EM   +P    + GV+ +F+
Sbjct: 187 IWGAGCIFIEMLQGQP---AFPGVSDVFE 212

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  115 bits (290), Expect = 2e-27
 Identities = 75/218 (34%), Positives = 117/218 (53%), Gaps = 15/218 (6%)

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL----LQEYGPFNEPVIQTY 327
           E++ L+   H  IV++     SD++L + +EY SGG ++K     L+E+ PF E  +   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSFKGS 384
             QI+L L  +H+R  +HRD+K ANI + P G IKL DFG +K  +   S+    SF G+
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           PY++APE +     YS   D+WSLG  + E+ T   P+   SQ E +  +   G     P
Sbjct: 235 PYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL-YGKYDPFP 292

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             P  +S   K+ +   L ++P+ RP   +LL   F++
Sbjct: 293 -CP--VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  112 bits (280), Expect = 2e-27
 Identities = 60/194 (30%), Positives = 104/194 (53%), Gaps = 5/194 (2%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG GT+  V+ G +  +  + A+KE+R+  ++      ++    E++LL  L H NIV  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           H    ++  L++  EY+       L       +   ++ +  Q+L GL+Y H R  +HRD
Sbjct: 69  HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIW 406
           +K  N+L++  GE+KLADFG+A+  +      S +    W   P+V++ +  YS  +D+W
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMW 188

Query: 407 SLGCTVLEMATSKP 420
            +GC + EMAT +P
Sbjct: 189 GVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (278), Expect = 3e-27
 Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 10/256 (3%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K LG G+FG V  G  S SG       V+ +  D+ S + +    +E  ++  L H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLI 59

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           R +G  L+   + V  E    GS+   L     G F    +  Y  QI  G+ YL ++  
Sbjct: 60  RLYGVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGY 399
           +HRD+   NIL+    ++K+ DFG+ + +        M      P+ W APE  + T  +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRTRTF 177

Query: 400 SLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           S   D+W  G T+ EM T  + PW+   G   + KI    +  E PE    D  + + QC
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237

Query: 459 LQRDPSARPPASKLLD 474
              +P+ RP  + L +
Sbjct: 238 WAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  112 bits (280), Expect = 3e-27
 Identities = 64/199 (32%), Positives = 109/199 (54%), Gaps = 15/199 (7%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG GT+  V+ G +  +  + A+KE+R+  ++      ++    E++LL  L H NIV  
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLGLAYLHARN 342
           H    +D+ L++  EY+      K L++Y        +   ++ +  QIL GLAY H R 
Sbjct: 70  HDIVHTDKSLTLVFEYLD-----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSL 401
            +HRD+K  N+L++  GE+KLADFG+A+  +      S +    W   P+V++ ++ YS 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 402 TVDIWSLGCTVLEMATSKP 420
            +D+W +GC   EMA+ +P
Sbjct: 185 QIDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  112 bits (281), Expect = 6e-27
 Identities = 77/292 (26%), Positives = 143/292 (48%), Gaps = 46/292 (15%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR- 286
           +G G +G V   F++++G+  AIK++        S    K+  +E+ LL  + H N++  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS---RPFQSAIHAKRTYRELRLLKHMDHENVIGL 79

Query: 287 ---YHGSELSDERLSVYLEYVS---GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
              +  +   ++   VYL  V+   G  ++ +++     ++  IQ    QIL GL Y+H+
Sbjct: 80  LDVFTPASSLEDFQDVYL--VTHLMGADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHS 136

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
              +HRD+K +NI V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYN 194

Query: 401 LTVDIWSLGCTVLEMATSKP--PWSQY-EGVAAIFKIGNSKDIPEIPEHL-SDDAKSFIK 456
            TVDIWS+GC + E+ T K   P S + + +  I  +  + D  E+ + + S+ A+++I+
Sbjct: 195 QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD-EELLQKISSESARNYIQ 253

Query: 457 Q--------------------------CLQRDPSARPPASKLLDHPFVRDQA 482
                                       L  DP  R  A++ L HP++ +  
Sbjct: 254 SLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  111 bits (278), Expect = 6e-27
 Identities = 70/225 (31%), Positives = 118/225 (52%), Gaps = 18/225 (8%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L  + K   LG GT+  VY G +  +  + A+KE+R+  ++      ++    E++LL  
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKD 60

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILL 333
           L H NIV  H    +++ L++  EY+      K L++Y        N   ++ +  Q+L 
Sbjct: 61  LKHANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNSINMHNVKLFLFQLLR 115

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEV 392
           GL Y H R  +HRD+K  N+L++  GE+KLADFG+A+  +      S +    W   P++
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKP--PWSQY-EGVAAIFKI 434
           ++ +  YS  +D+W +GC   EM+T +P  P S   E +  IF+I
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  110 bits (277), Expect = 1e-26
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 19/261 (7%)

Query: 226 KLLGRGTFGHVYLG-FNSESGQMCAIK---EVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           + LG G+FG V L  + +E     AIK   + +++   Q     +  +  E  +L+ ++H
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-----VDHVFSERKILNYINH 90

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P  V  +GS   +  L + LE+V GG     L+    F   V   Y  QI+L   YL + 
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
           N V+RD+K  N+L+D  G IK+ DFG AK + +    L   G+P ++APE+++N  G+  
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--GTPEYIAPEILLNV-GHGK 207

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             D W+LG  + E+    PP+   E +    KI   + I   P+ L ++ K  +K+ L  
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKI--LEGIIYFPKFLDNNCKHLMKKLLSH 265

Query: 462 DPSAR-----PPASKLLDHPF 477
           D + R       A  + +HP+
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  110 bits (275), Expect = 2e-26
 Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 26/256 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR--VVCDD------QTSKECLKQLNQEINLLS 277
           +++GRG++  V L    ++ Q+ A+K V+  +V DD      QT K   +Q +       
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS------- 53

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
             S+P +V  H    +  RL + +EYV+GG +   +Q      E   + Y  +I + L +
Sbjct: 54  --SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNF 111

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNT 396
           LH R  ++RD+K  N+L+D  G IKL D+GM K         S F G+P ++APE++   
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWS------QYEGVAAIFKIGNSKDIPEIPEHLSDD 450
             Y  +VD W+LG  + EM   + P+              +F++   K I  IP  LS  
Sbjct: 172 E-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-RIPRFLSVK 229

Query: 451 AKSFIKQCLQRDPSAR 466
           A   +K  L +DP  R
Sbjct: 230 ASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 31/263 (11%)

Query: 228 LGRGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG G FG V+LG  ++ E      +  V+ +  +  S +  K   +E  LL+   H NIV
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP------FNEPVIQTYTR--------QI 331
           +++G     +   +  EY+  G ++K L+ +GP        +  +   T         QI
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGS 384
             G+ YL +++ VHRD+   N LV     +K+ DFGM++ + +         +ML  +  
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR-- 189

Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEI 443
             WM PE +M    ++   D+WS G  + E+ T  K PW        I  I     + + 
Sbjct: 190 --WMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-TQGRLLQR 245

Query: 444 PEHLSDDAKSFIKQCLQRDPSAR 466
           P     +    +  C +RDP  R
Sbjct: 246 PRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  107 bits (268), Expect = 7e-26
 Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 40/274 (14%)

Query: 223 KKGKLLGRGTFGHVYL-GFNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           K+ + LG G FG V L  ++ E   +G+  A+K ++     ++    +  L +EI +L  
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRN 62

Query: 279 LSHPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ-----TYTRQI 331
           L H NIV+Y G  +E     + + +E++  GS    L+EY P N+  I       Y  QI
Sbjct: 63  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQI 118

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YW 387
             G+ YL +R  VHRD+   N+LV+   ++K+ DFG+ K + +     + K    SP +W
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGN 436
            APE ++ +  Y +  D+WS G T+ E+ T       P + +        G   + ++  
Sbjct: 179 YAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237

Query: 437 ----SKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
                K +P  P +  ++    +++C +  PS R
Sbjct: 238 VLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  107 bits (268), Expect = 7e-26
 Identities = 78/271 (28%), Positives = 131/271 (48%), Gaps = 20/271 (7%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           +++ ++LG+G FG V       +G+M A K++      +   E +  LN++  +L +++ 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEK-QILEKVNS 59

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLH 339
             +V    +  + + L + L  ++GG +   +   G   F E     Y  +I  GL  LH
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               V+RD+K  NIL+D HG I+++D G+A H+    ++    G+  +MAPEVV N   Y
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-Y 178

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQ------YEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           + + D W+LGC + EM   + P+ Q       E V  + K        E  E  S DA+S
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----EYSEKFSPDARS 234

Query: 454 FIKQCLQRDPSAR-----PPASKLLDHPFVR 479
             K  L +DP  R       A ++ +HP  +
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  107 bits (270), Expect = 1e-25
 Identities = 82/313 (26%), Positives = 148/313 (47%), Gaps = 66/313 (21%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR- 286
           LG G+ G V+   +S+  +  A+K++ +     T  + +K   +EI ++ +L H NIV+ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVL-----TDPQSVKHALREIKIIRRLDHDNIVKV 67

Query: 287 YH-----GSELSD------ERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
           Y      GS+L++      E  SVY+  EY+    +  +L E GP +E   + +  Q+L 
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLR 125

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKG-------SP 385
           GL Y+H+ N +HRD+K AN+ ++    + K+ DFG+A+ +       S KG       + 
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD---PHYSHKGYLSEGLVTK 182

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQ----------YEGVAAI---- 431
           ++ +P ++++ N Y+  +D+W+ GC   EM T KP ++            E V  +    
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 432 ---------FKIGNSKDIPEIP-----EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                      + N    P  P       ++ +A  F++Q L  +P  R  A + L HP+
Sbjct: 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302

Query: 478 V------RDQAVA 484
           +       D+ V+
Sbjct: 303 MSCYSCPFDEPVS 315

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  107 bits (267), Expect = 2e-25
 Identities = 77/291 (26%), Positives = 136/291 (46%), Gaps = 36/291 (12%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           ++K + LG G++  VY G +  +G++ A+K +R+  ++ T    ++    E +LL  L H
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLKGLKH 62

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
            NIV  H    + E L++  EYV       + +  G  +   ++ +  Q+L GL+Y+H R
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYS 400
             +HRD+K  N+L+   GE+KLADFG+A+  +  +   S +    W   P+V++ +  YS
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 401 LTVDIWSLGCTVLEM----------------------ATSKPPWSQYEGVAAI------- 431
             +D+W +GC  +EM                          P    + GV ++       
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242

Query: 432 FKIGNSKDIPEIPEHLS--DDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           F + + K++ +    LS  + A+    + LQ  P  R  A   L H +  D
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  107 bits (268), Expect = 2e-25
 Identities = 73/298 (24%), Positives = 138/298 (46%), Gaps = 45/298 (15%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSES--GQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLSQ 278
           ++  K LG+G +G V    N+E+   +  AIK++  V   +   K  L+    E+ LL  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRH 57

Query: 279 L-SHPNIVRYHGSEL--SDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLG 334
              H NI   +  ++        +YL E +    +H++++   P  +   Q++  QIL G
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK-----HMTSCASMLSFKGSPYWMA 389
           L Y+H+ N +HRD+K  N+LV+   E+K+ DFG+A+        +   M  +  + ++ A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF---------------KI 434
           PE++++   Y+  +D+WS+GC + E+   KP +   + V  +                +I
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237

Query: 435 GNSK--------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           G+ K                  I  + +  A   +++ L  DP+ R    + L+HP++
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 2e-25
 Identities = 73/290 (25%), Positives = 137/290 (47%), Gaps = 44/290 (15%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
            +G G +G V    +  +G   AIK++    + QT   C + L +EI +L +  H NI+ 
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTF--CQRTL-REIKILRRFKHENIIG 67

Query: 287 YHGSELSDERLS---VYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
                      S   VY+  E +    ++KL++     +   IQ +  QIL GL Y+H+ 
Sbjct: 68  ILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSA 125

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS----MLSFKGSPYWMAPEVVMNTN 397
           N +HRD+K +N+L++ + ++K+ DFG+A+           +  +  + ++ APE+++N+ 
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK 185

Query: 398 GYSLTVDIWSLGCTVLEMATSKP--PWSQY-EGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
           GY+  +DIWS+GC + EM +++P  P   Y   +  I  +  +    ++   +S  A+++
Sbjct: 186 GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY 245

Query: 455 IK--------------------------QCLQRDPSARPPASKLLDHPFV 478
           IK                          + L  +P  R    + L HP++
Sbjct: 246 IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  105 bits (263), Expect = 3e-25
 Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 43/274 (15%)

Query: 221 KWKKGKLLGRGTFGHVYLG----FNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINL 275
           KW+    LG G FG V+L        E  +M  A+K ++     + S+   +   +E  L
Sbjct: 10  KWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAEL 60

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP---------------FN 320
           L+ L H +IVR++G       L +  EY+  G +++ L+ +GP                 
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 321 EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----- 375
              +     QI  G+ YL + + VHRD+   N LV     +K+ DFGM++ + S      
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 376 --ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIF 432
              +ML  +    WM PE ++    ++   DIWS G  + E+ T  K PW Q     AI 
Sbjct: 181 GGRTMLPIR----WMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Query: 433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
            I   +++ E P     +  + ++ C QR+P  R
Sbjct: 236 CITQGREL-ERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  107 bits (268), Expect = 4e-25
 Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 25/272 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSK-ECLKQLN-----QEINLLSQL 279
           K++GRG FG V L  +  S Q+ A+K          SK E +K+ +     +E ++++  
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMK--------LLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
           +   IV+ H +   D+ L + +EY+ GG +  L+  Y    E   + YT +++L L  +H
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK--GSPYWMAPEVVMNTN 397
           +   +HRD+K  N+L+D  G +KLADFG    M +   +      G+P +++PEV+ +  
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 398 G---YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAK 452
           G   Y    D WS+G  + EM     P+     V    KI + K+    P+   +S  AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279

Query: 453 SFIKQCLQRDPS--ARPPASKLLDHP-FVRDQ 481
             I   L        R    ++  HP F  DQ
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  107 bits (268), Expect = 4e-25
 Identities = 78/311 (25%), Positives = 126/311 (40%), Gaps = 57/311 (18%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           S + K K +G G FG V L    ++  + A+K +R    D   +     +  E ++L++ 
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--DVLMRNQAAHVKAERDILAEA 58

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            +  +V+ + S    + L   ++Y+ GG +  LL   G F E + + Y  ++   +  +H
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH 118

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFG-------------------------------- 367
               +HRDIK  NIL+D  G IKL DFG                                
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 368 --------------MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVL 413
                           +H    A   S  G+P ++APEV++ T GY+   D WS+G  + 
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAH--SLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 235

Query: 414 EMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPSAR---PP 468
           EM   +PP+          K+ N +    IP    LS +A   I + L      R     
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNG 294

Query: 469 ASKLLDHPFVR 479
           A ++  HPF +
Sbjct: 295 ADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  104 bits (261), Expect = 6e-25
 Identities = 70/250 (28%), Positives = 119/250 (47%), Gaps = 14/250 (5%)

Query: 225 GKLLGRGTFGHVYLG-FNSESGQM--CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           G+ +G G FG VY G + S   +    A+K  +  C   + +E   +  QE  ++ Q  H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN-CTSPSVRE---KFLQEAYIMRQFDH 66

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT-YTRQILLGLAYLHA 340
           P+IV+  G  +++  + + +E    G +   LQ      +      Y+ Q+   LAYL +
Sbjct: 67  PHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS-PY-WMAPEVVMNTNG 398
           +  VHRDI   N+LV     +KL DFG+++++   +   + KG  P  WMAPE + N   
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI-NFRR 184

Query: 399 YSLTVDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+W  G  + E +     P+   +    I +I N + +P +P +      S + +
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 243

Query: 458 CLQRDPSARP 467
           C   DPS RP
Sbjct: 244 CWAYDPSKRP 253

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  105 bits (262), Expect = 1e-24
 Identities = 73/263 (27%), Positives = 136/263 (51%), Gaps = 49/263 (18%)

Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L+E     E ++   
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108

Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  +L GLAYL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 167

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS---------------------------- 418
           +M+PE +  T+ YS+  DIWS+G +++E+A                              
Sbjct: 168 YMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226

Query: 419 -------KPPWSQYEG-------VAAIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQ 460
                  +PP     G         AIF++ +   ++  P++P  + + D + F+ +CL 
Sbjct: 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286

Query: 461 RDPSARPPASKLLDHPFVRDQAV 483
           ++P+ R     L++H F++   V
Sbjct: 287 KNPAERADLKMLMNHTFIKRSEV 309

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 76/261 (29%), Positives = 120/261 (45%), Gaps = 29/261 (11%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K G  +G+G FG V LG     GQ  A+K ++   DD T+ +       E ++++ L HP
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKCLK---DDSTAAQ---AFLAEASVMTTLRHP 60

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT-----YTRQILLGLAY 337
           N+V+  G  L    L +  EY++ GS+   L+  G     VI       +   +  G+ Y
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEY 117

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
           L  +N VHRD+   N+LV      K++DFG+AK   +     S K    W APE +    
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTAPEALRE-K 174

Query: 398 GYSLTVDIWSLGCTVLEM-ATSKPPW---SQYEGVAAIFKIGNSKDIPE-IPEHLSDDAK 452
            +S   D+WS G  + E+ +  + P+      + V  + K G   + PE  P  +     
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYK--- 230

Query: 453 SFIKQCLQRDPSARPPASKLL 473
             +K C + DP+ RP   +L 
Sbjct: 231 -VMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  103 bits (258), Expect = 2e-24
 Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 41/286 (14%)

Query: 228 LGRGTFGHVYLGFN-SESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLS---HP 282
           +G G +G V+   +    G+  A+K VRV    QT +E +     +E+ +L  L    HP
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 283 NIVRYHG----SELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNEP-VIQTYTRQILLGLA 336
           N+VR       S    E +L++  E+V       L +   P      I+    Q+L GL 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT 396
           +LH+   VHRD+K  NILV   G+IKLADFG+A+  +   ++ S   + ++ APEV++ +
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH- 446
           + Y+  VD+WS+GC   EM   KP +     V  + KI +   +P          +P   
Sbjct: 185 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243

Query: 447 ---------------LSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                          + +  K  + +CL  +P+ R  A   L HP+
Sbjct: 244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 50/278 (17%)

Query: 223 KKGKLLGRGTFGHVYLGF---NSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           +K K+LG G FG VY G      E  ++  AIK +R    ++TS +  K++  E  +++ 
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDEAYVMAS 65

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAY 337
           + HP++VR  G  LS  ++ +  + +  G +   ++ +        +  +  QI  G++Y
Sbjct: 66  VDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----------W 387
           L  +  VHRD+   N+LV     +K+ DFG+AK       +L      Y          W
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK-------LLDVDEKEYHAEGGKVPIKW 177

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI-- 443
           MA E +++   Y+   D+WS G TV E+ T  +KP    YEG+        + +IP++  
Sbjct: 178 MALESILHRI-YTHKSDVWSYGVTVWELMTFGAKP----YEGI-------PAVEIPDLLE 225

Query: 444 -------PEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                  P   + D    + +C   D  +RP   +L++
Sbjct: 226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 39/266 (14%)

Query: 228 LGRGTFGHVYLG----FNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           LG+G+FG VY G          +   AIK V    ++ + +E ++ LN E +++ + +  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLN-EASVMKEFNCH 69

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE--PVIQTYTRQILL------- 333
           ++VR  G   + +   V +E ++ G +   L+   P  E  P +   T Q  +       
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 334 -GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK-------HMTSCASMLSFKGSP 385
            G+AYL A+  VHRD+   N +V     +K+ DFGM +       +      +L  +   
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVA--AIFKIGNSKDIP 441
            WMAPE + +   ++   D+WS G  + EMAT   +P    Y+G++   + K        
Sbjct: 187 -WMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQP----YQGLSNEEVLKFVIDGGHL 240

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARP 467
           ++PE+  D     ++ C Q +P  RP
Sbjct: 241 DLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  101 bits (253), Expect = 4e-24
 Identities = 67/248 (27%), Positives = 121/248 (48%), Gaps = 16/248 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K LG G FG V++G+ + S ++ A+K ++           ++   +E NL+  L H  +V
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKV-AVKTLK------PGTMSVQAFLEEANLMKTLQHDKLV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           R +     +E + +  EY++ GS+   L   E G    P +  ++ QI  G+AY+  +N 
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYS 400
           +HRD++ AN+LV      K+ADFG+A+ +       + +G+ +   W APE + N   ++
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAI-NFGSFT 182

Query: 401 LTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +  D+WS G  + E+ T  K P+        +  +     +P   E+  D+    +K C 
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-MENCPDELYDIMKTCW 241

Query: 460 QRDPSARP 467
           +     RP
Sbjct: 242 KEKAEERP 249

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (255), Expect = 5e-24
 Identities = 74/286 (25%), Positives = 124/286 (43%), Gaps = 51/286 (17%)

Query: 225 GKLLGRGTFGHVYL-------GFNSESGQ---------MCAIKEVRVVCDDQTSKECLKQ 268
            + LG G FG V+L        F+ ++           + A+K +R    D   ++ LK 
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK- 68

Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV---IQ 325
              E+ +LS+LS PNI R  G    D  L + +EY+  G +++ LQ++      +    +
Sbjct: 69  ---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 326 TYTRQILL--------GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-- 375
           + +   LL        G+ YL + N VHRD+   N LV  +  IK+ADFGM++++ S   
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 376 -----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGV 428
                 + L  +    WMA E V+    ++   D+W+ G T+ E+ T   + P+      
Sbjct: 186 YRVQGRAPLPIR----WMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240

Query: 429 AAIFKIGNSKDIPEIPEHLS------DDAKSFIKQCLQRDPSARPP 468
             I   G+         +L        D    + +C +RD   RP 
Sbjct: 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  101 bits (253), Expect = 7e-24
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 33/263 (12%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKE---VRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           LG G FG V+L   +E   +C  ++   V V      S    K  ++E  LL+ L H +I
Sbjct: 13  LGEGAFGKVFL---AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-------FNEPVIQTYT------RQI 331
           V+++G  +  + L +  EY+  G ++K L+ +GP        N P   T +      +QI
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGS 384
             G+ YL +++ VHRD+   N LV  +  +K+ DFGM++ + S         +ML  +  
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-- 187

Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEI 443
             WM PE +M    ++   D+WSLG  + E+ T  K PW Q      I  I   + + + 
Sbjct: 188 --WMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQR 243

Query: 444 PEHLSDDAKSFIKQCLQRDPSAR 466
           P     +    +  C QR+P  R
Sbjct: 244 PRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 9e-24
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 22/259 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           + +G+G FG VY G    + ++ A+K  R        ++ L    QE  +L Q  HPNIV
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIV 55

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL---LGLAYLHARN 342
           +  G  +  + + + +E V GGS+   L+     N   ++   +  L    G+ YL ++N
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPY-WMAPEVVMNTNGY 399
            +HRD+   N LV  +  +K++DFGM++        +S   K  P  W APE  +N   Y
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRY 172

Query: 400 SLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
           +   D+WS G  + E      T  P  S  +      +I +   +P  P+   ++    +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIESGYRMPA-PQLCPEEIYRLM 228

Query: 456 KQCLQRDPSARPPASKLLD 474
            QC   DP  RP  S++ +
Sbjct: 229 LQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  102 bits (255), Expect = 9e-24
 Identities = 64/195 (32%), Positives = 115/195 (58%), Gaps = 7/195 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G  G V+   +  SG + A K + +    +       Q+ +E+ +L + + P IV +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVGF 68

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV-HR 346
           +G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   +  ++ GL YL  ++ + HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           D+K +NILV+  GEIKL DFG++  +    +  SF G+  +M+PE +  T+ YS+  DIW
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH-YSVQSDIW 186

Query: 407 SLGCTVLEMATSKPP 421
           S+G +++EMA  + P
Sbjct: 187 SMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  100 bits (251), Expect = 2e-23
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 31/266 (11%)

Query: 228 LGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           LG G FG VY G         S    AIK ++    +    +  ++  QE  L+S L HP
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLK----ENAEPKVQQEFRQEAELMSDLQHP 68

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR------------- 329
           NIV   G    ++   +  EY++ G +H+ L    P ++   ++                
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 330 ---QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--SMLSFKGS 384
              QI  G+ YL + + VHRD+   N LV     +K++DFG+++ + S     + S    
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 385 PY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYEGVAAIFKIGNSKDIPE 442
           P  WM PE ++    ++   DIWS G  + E+ +    P+  +     I  I  S+ +  
Sbjct: 189 PVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-RSRQLLP 246

Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPP 468
            PE       + + +C    P+ RP 
Sbjct: 247 CPEDCPARVYALMIECWNEIPARRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  100 bits (250), Expect = 2e-23
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 16/275 (5%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           +++ ++LG+G FG V       +G+M A K +      +   E +  LN++  +L +++ 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEK-QILEKVNS 59

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLH 339
             +V    +  + + L + L  ++GG +   +   G   F E     Y  +IL GL  LH
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
             NTV+RD+K  NIL+D +G I+++D G+A  +    S+    G+  +MAPEV+ N   Y
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR-Y 178

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE----HLSDDAKSFI 455
           +L+ D W LGC + EM   + P+   +      ++   + + E  E      S++AKS  
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRVLETEEVYSAKFSEEAKSIC 236

Query: 456 KQCLQRDPSAR-----PPASKLLDHPFVRDQAVAR 485
           K  L +DP  R       A ++  HPF R+    R
Sbjct: 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  100 bits (249), Expect = 3e-23
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 33/273 (12%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEINLLSQLSHPN 283
           GK LG G FG V                V V +  +  S   L+ L  E NLL Q++HP+
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE--------------------YGPFNEPV 323
           +++ +G+   D  L + +EY   GS+   L+E                      P    +
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 324 ----IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML 379
               + ++  QI  G+ YL     VHRD+   N+LV    ++K++DFG+++ +    S +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 380 --SFKGSPY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA--IFKI 434
             S    P  WMA E + + + Y+   D+WS G  + E+ T     + Y G+A   +F +
Sbjct: 185 KRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIAPERLFNL 241

Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
             +    E PE+ S++  + +  C +++P  RP
Sbjct: 242 LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 98.2 bits (244), Expect = 5e-23
 Identities = 71/248 (28%), Positives = 104/248 (41%), Gaps = 17/248 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +GRG FG V+ G         A+K     C +    +   +  QE  +L Q SHPNIVR 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKS----CRETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + + +E V GG     L+  GP      +         G+ YL +++ +HR
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTS--CASMLSFKGSPY-WMAPEVVMNTNGYSLTV 403
           D+   N LV     +K++DFGM++       AS    K  P  W APE  +N   YS   
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSSES 177

Query: 404 DIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           D+WS G  + E     A      S  +   AI +          PE   D     +++C 
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL----PCPELCPDAVYRLMERCW 233

Query: 460 QRDPSARP 467
           + DP  RP
Sbjct: 234 EYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.4 bits (245), Expect = 6e-23
 Identities = 69/248 (27%), Positives = 122/248 (49%), Gaps = 17/248 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K LG G FG V++G+ +   ++ AIK ++     Q S      L  E NL+ QL HP +V
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKV-AIKSLK-----QGSMSPEAFL-AEANLMKQLQHPRLV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           R + + ++ E + +  EY+  GS+   L+  E        +     QI  G+A++  +N 
Sbjct: 65  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYS 400
           +HRD++ ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   ++
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFT 181

Query: 401 LTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +  D+WS G  + E+ T  + P+        I  +     +P  P++  ++    ++ C 
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-PDNCPEELYELMRLCW 240

Query: 460 QRDPSARP 467
           +  P  RP
Sbjct: 241 KEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 45/270 (16%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K++GRG FG V L    ++G + A+K +R    D   KE +  +  E ++L +     +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKA--DMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   S      L + +E++ GG +  LL +     E   Q Y  + +L +  +H    +H
Sbjct: 65  KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124

Query: 346 RDIKGANILVDPHGEIKLADFGMAK-----HMT--------SCASMLSFK---------- 382
           RDIK  N+L+D  G +KL+DFG+       H T        S  S  +F+          
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 383 -------------GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA 429
                        G+P ++APEV M   GY+   D WSLG  + EM    PP+       
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 430 AIFKIGNSKDI----PEIPEHLSDDAKSFI 455
              K+ N K+     PE+P  +S+ AK  I
Sbjct: 244 TYKKVMNWKETLIFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 26/264 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMC---AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K++G G FG V  G     G+     AIK ++    D+   + L     E +++ Q  HP
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT----EASIMGQFDHP 65

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHAR 341
           NI+R  G       + +  EY+  GS+ K L+E  G F    +    R I  G+ YL   
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG--SPY-WMAPEVVMNTNG 398
           N VHRD+   NILV+ +   K++DFG+++ +    +  + KG   P  W APE +     
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI-AYRK 184

Query: 399 YSLTVDIWSLGCTVLE-MATSKPP---WSQYEGVAAI---FKIGNSKDIPEIPEHLSDDA 451
           ++   D+WS G  + E M+  + P    S  + + A+   +++    D P     L    
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL---- 240

Query: 452 KSFIKQCLQRDPSARPPASKLLDH 475
              +  C Q+D + RP  S+++  
Sbjct: 241 ---MLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 45/270 (16%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K++GRG FG V L    ++G + A+K +R    D   KE +  +  E ++L +     +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--DMLEKEQVAHIRAERDILVEADGAWVV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   S      L + +E++ GG +  LL +    +E   Q Y  + +L +  +H    +H
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124

Query: 346 RDIKGANILVDPHGEIKLADFGMAK-----HMT--------SCASMLSFK---------- 382
           RDIK  N+L+D  G +KL+DFG+       H T        +  S  SF+          
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 383 -------------GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA 429
                        G+P ++APEV M T GY+   D WSLG  + EM    PP+       
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 430 AIFKIGNSKDI----PEIPEHLSDDAKSFI 455
              K+ N K+     PE+P  +S+ AK  I
Sbjct: 244 TYRKVMNWKETLVFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 77/266 (28%), Positives = 127/266 (47%), Gaps = 33/266 (12%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           +L K   G+++G G FG V  G    +GQ  A+K ++    D T++  L    +E  +++
Sbjct: 4   NLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKC---DVTAQAFL----EETAVMT 54

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ--TYTRQILLGL 335
           +L H N+VR  G  L +  L + +E +S G++   L+  G     VIQ   ++  +  G+
Sbjct: 55  KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK--HMTSCASMLSFKGSPYWMAPEVV 393
            YL ++  VHRD+   NILV   G  K++DFG+A+   M    S L  K    W APE +
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEAL 169

Query: 394 MNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQY------EGVAAIFKIGNSKDIPEIPEH 446
            +   +S   D+WS G  + E+ +  + P+ +       E V   +++       E PE 
Sbjct: 170 KH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-------EPPEG 221

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKL 472
              D    +  C + +P  RP   KL
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 31/273 (11%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQLSH 281
           LG+G FG V       +G++ A K++        +K+ LK+         E  +L+++  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKL--------NKKRLKKRKGYEGAMVEKRILAKVHS 52

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGS----IHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
             IV    +  +   L + +  ++GG     I+ + +E   F EP    YT QI+ GL +
Sbjct: 53  RFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNT 396
           LH R  ++RD+K  N+L+D  G ++++D G+A  +    S    + G+P +MAPE++   
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
             Y  +VD ++LG T+ EM  ++ P+     + E      +I N  D    P+  S  +K
Sbjct: 173 E-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSVTYPDKFSPASK 229

Query: 453 SFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
           SF +  L +DP  R          L  HP  RD
Sbjct: 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K LG G FG V+LG    +    AIK +    +   S+E      +E  ++ +LSHP +V
Sbjct: 10  KELGSGQFGVVHLG-KWRAQIKVAIKAIN---EGAMSEE---DFIEEAKVMMKLSHPKLV 62

Query: 286 RYHGSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           + +G     + L +  E++  G + + L Q  G  ++ ++ +  + +  G+ YL   + +
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSPYWMAPEVVMNTNG 398
           HRD+   N LV   G +K++DFGM +++      +S  +    K    W  PE V N + 
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPE-VFNFSK 177

Query: 399 YSLTVDIWSLGCTVLEMATS-KPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
           YS   D+WS G  + E+ T  K P+   S YE V  I + G     P++           
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMT---VYEV 233

Query: 455 IKQCLQRDPSARPPASKLL 473
           +  C    P  RP  ++LL
Sbjct: 234 MYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 98.8 bits (246), Expect = 3e-22
 Identities = 80/308 (25%), Positives = 139/308 (45%), Gaps = 59/308 (19%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K++G+G FG V L    ++G++ A+K +     +   K+ L  +  E ++L++   P +V
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLK--SEMFKKDQLAHVKAERDVLAESDSPWVV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
             + S    + L + +E++ GG +  +L +Y  F+E V + Y  + +L +  +H    +H
Sbjct: 65  SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH 124

Query: 346 RDIKGANILVDPHGEIKLADFGMA-----KH----------------------------- 371
           RDIK  NIL+D  G IKL+DFG++     +H                             
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 372 ---MTSCASMLSFK-----------GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
              M+S   + ++K           G+P ++APE+ +   GY    D WSLG  + E   
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLI 243

Query: 418 SKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCL----QRDPSARPPASK 471
             PP+          KI N ++    P+  HLS +A+  I++ +     R    R  A +
Sbjct: 244 GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENR--LGRGGAHE 301

Query: 472 LLDHPFVR 479
           +  HPF R
Sbjct: 302 IKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 98.2 bits (244), Expect = 5e-22
 Identities = 87/332 (26%), Positives = 142/332 (42%), Gaps = 61/332 (18%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           S + K K LG G FG V L    ++  + A+K +R    D   +  +  +  E ++L++ 
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRK--KDVLLRNQVAHVKAERDILAEA 58

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            +  +VR + S    + L   ++Y+ GG +  LL   G F E + + Y  ++   +  +H
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGM---------AKHMTS---------------- 374
               +HRDIK  NIL+D  G IKL DFG+         +K+  S                
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 375 ------CASML-----------------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCT 411
                 C   L                 S  G+P ++APEV++ T GY+   D WS+G  
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVI 237

Query: 412 VLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPS---AR 466
           + EM   +PP+     +    K+ N +    IP    LS +A   I + L R P     +
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGK 296

Query: 467 PPASKLLDHPFVRDQAVARAGNVNLAKDSSPY 498
             A ++  HPF +    +     +L + S+PY
Sbjct: 297 NGADEIKAHPFFKTIDFSS----DLRQQSAPY 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 70/264 (26%), Positives = 126/264 (47%), Gaps = 12/264 (4%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           ++LG+G FG V       +G+M A K++      +   E +  LN E  +L +++   +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LN-EKRILEKVNSRFVV 63

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNT 343
               +  + + L + L  ++GG +   +   G   F+E     Y  ++  GL  L     
Sbjct: 64  SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           V+RD+K  NIL+D  G I+++D G+A  +    ++    G+  +MAPEV+ N   Y+ + 
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSP 182

Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--SKDIPEIPEHLSDDAKSFIKQCLQR 461
           D W LGC + EM   + P+ + +      ++     +D  E  E  S+DAKS  +  L +
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTK 242

Query: 462 DPSAR-----PPASKLLDHPFVRD 480
           +P  R       A+ +  HP  ++
Sbjct: 243 NPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 97.8 bits (243), Expect = 5e-22
 Identities = 77/269 (28%), Positives = 133/269 (49%), Gaps = 22/269 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN-----QEINLLSQLS 280
           K++GRG FG V L  +  S ++ A+K +       +  E +K+ +     +E ++++  +
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
            P +V+   +   D+ L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTNG 398
              +HRD+K  N+L+D HG +KLADFG    M  T      +  G+P +++PEV+ +  G
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 399 ---YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKS 453
              Y    D WS+G  + EM     P+     V    KI + K+    PE   +S  AK+
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280

Query: 454 FIKQCL-QRDPS-ARPPASKLLDHPFVRD 480
            I   L  R+    R    ++  HPF ++
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKQHPFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 97.4 bits (242), Expect = 8e-22
 Identities = 81/331 (24%), Positives = 136/331 (41%), Gaps = 59/331 (17%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           S + K K LG G FG V L    ++  + A+K +R    D  ++  +  +  E ++L++ 
Sbjct: 1   SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRK--KDVLNRNQVAHVKAERDILAEA 58

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            +  +V+ + S    + L   ++Y+ GG +  LL     F E + + Y  ++ L +  +H
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGM---------------AKHMTS---------- 374
               +HRDIK  NIL+D  G IKL DFG+                 H+            
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 375 ------CASML-----------------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCT 411
                 C   L                 S  G+P ++APEV++   GY+   D WS+G  
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237

Query: 412 VLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQ--CLQRDPSARP 467
           + EM   +PP+          K+ N ++   IP    LS +A   I +  C   +   R 
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297

Query: 468 PASKLLDHPFVRDQAVARAGNVNLAKDSSPY 498
            A  +  HPF  +   +     ++    +PY
Sbjct: 298 GADDIKAHPFFSEVDFSS----DIRTQPAPY 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 96.3 bits (239), Expect = 1e-21
 Identities = 71/270 (26%), Positives = 135/270 (50%), Gaps = 24/270 (8%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR- 286
           +G G +G V   F++++G   A+K++             K+  +E+ LL  + H N++  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGL 81

Query: 287 ---YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
              +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ +
Sbjct: 82  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
            +HRD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ T
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQT 198

Query: 403 VDIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           VDIWS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSL 257

Query: 460 QRDPS---------ARPPASKLLDHPFVRD 480
            + P          A P A  LL+   V D
Sbjct: 258 TQMPKMNFANVFIGANPLAVDLLEKMLVLD 287

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 97.6 bits (243), Expect = 2e-21
 Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 20/266 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           ++LG G  G V        G+  A+K V +   +  S+    +   E+  L      +IV
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDM---EGMSEADKNRAQAEVCCLLNCDFFSIV 94

Query: 286 RYHGS-ELSDER-------LSVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTRQILL 333
           + H      D R       +++ L+Y + G + + ++        F E        Q+LL
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAP 390
            + ++H+++ +HRDIK ANIL+  +G +KL DFG +K   +  S     +F G+PY++AP
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD 450
           E +     YS   D++SLG  + E+ T K P+   E +  +     +     +P  +S +
Sbjct: 215 E-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDPLPPSISPE 272

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHP 476
            +  +   L  DP  RP +SKLL+ P
Sbjct: 273 MQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 42/278 (15%)

Query: 225 GKLLGRGTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           G++LG+G FG V    L     S Q  A+K ++    D  S   +++  +E   + +  H
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA---DIFSSSDIEEFLREAACMKEFDH 60

Query: 282 PNIVRYHGSEL---SDERLS---VYLEYVSGGSIHK--LLQEYG--PFNEPVIQTYTR-- 329
           PN+++  G  L   +  RL    V L ++  G +H   L+   G  PF  P+ QT  R  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL-QTLVRFM 119

Query: 330 -QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-------CASMLSF 381
             I  G+ YL ++N +HRD+   N +++ +  + +ADFG++K + S       CAS L  
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKI---GNS 437
           K    W+A E + + N Y+   D+W+ G T+ E+ T  + P++  E  + I+     GN 
Sbjct: 180 K----WLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNR 233

Query: 438 -KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            K  P+  E + +     + QC   +P  RP    L D
Sbjct: 234 LKQPPDCLEDVYE----LMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 17/247 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQL 67

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFN-EPVIQTY-TRQILLGLAYLHARNTVH 345
            G    +    +  E+++ G++   L+E        V+  Y   QI   + YL  +N +H
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+ 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIK 185

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            D+W+ G  + E+AT     S Y G+  + ++++       E PE         ++ C Q
Sbjct: 186 SDVWAFGVLLWEIATYG--MSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQ 243

Query: 461 RDPSARP 467
            +PS RP
Sbjct: 244 WNPSDRP 250

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 42/290 (14%)

Query: 216 ENSLSKWKKGKLLGRGTFGHV----YLGFNSESGQM-CAIKEVRVVCDDQTSKECLKQLN 270
           E    +   GK LG G FG V     +G ++ +     A+K ++   DD T K+ L  L 
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATEKD-LSDLV 63

Query: 271 QEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------- 321
            E+ ++  +  H NI+   G    +  L V +EY + G++   L+   P  E        
Sbjct: 64  SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 322 PVIQTYTR--------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT 373
           P  +T T+        Q+  G+ +L ++  +HRD+   N+LV     +K+ADFG+A+ + 
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183

Query: 374 SC-------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE 426
                       L  K    WMAPE  +    Y+   D+WS G  + E+ T     S Y 
Sbjct: 184 HIDYYRKTTNGRLPVK----WMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGG--SPYP 236

Query: 427 GVAA--IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           G+    +FK+       E P++ + +    ++ C    PS RP   +L++
Sbjct: 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 34/265 (12%)

Query: 228 LGRGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG G FG V+L   +N    +   +  V+ + D   +    K   +E  LL+ L H +IV
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR---------------- 329
           +++G     + L +  EY+  G ++K L+ +GP    ++    R                
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFK 382
           QI  G+ YL +++ VHRD+   N LV  +  +K+ DFGM++ + S         +ML  +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIP 441
               WM PE +M    ++   D+WS G  + E+ T  K PW Q      I  I   + + 
Sbjct: 191 ----WMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VL 244

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSAR 466
           E P     +    +  C QR+P  R
Sbjct: 245 ERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 92.6 bits (230), Expect = 7e-21
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 36/276 (13%)

Query: 225 GKLLGRGTFGHVYLG-FNSESG--QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           GK+LG G FG V  G  + + G     A+K +++  D  T  E +++   E   +    H
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSE-IEEFLSEAACMKDFDH 60

Query: 282 PNIVRYHGSELSDERLS------VYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTR-- 329
           PN+++  G       L       V L ++  G +H  L        P   P+ QT  +  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL-QTLLKFM 119

Query: 330 -QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-------CASMLSF 381
             I LG+ YL  RN +HRD+   N ++     + +ADFG++K + S         + +  
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKD 439
           K    W+A E + +   Y+   D+W+ G T+ E+AT     + Y GV    I+      +
Sbjct: 180 K----WIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQ--TPYPGVENHEIYDYLRHGN 232

Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
             + PE   D+    +  C + DP  RP  +KL + 
Sbjct: 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 93.2 bits (231), Expect = 8e-21
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 42/291 (14%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVY----LGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
           E S  K   GK LG G FG V     LG + +  +      V+++ DD T K+ L  L  
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVS 69

Query: 272 EINLLSQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP------------ 318
           E+ ++  +  H NI+   G+   D  L V +EY S G++ + L+   P            
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 319 ------FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK-- 370
                 F + V  TY  Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+  
Sbjct: 130 PDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 371 -----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY 425
                +  +    L  K    WMAPE + +   Y+   D+WS G  + E+ T     S Y
Sbjct: 188 NNIDYYKKTTNGRLPVK----WMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPY 240

Query: 426 EG--VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            G  V  +FK+       + P + +++    ++ C    PS RP   +L++
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 96.0 bits (238), Expect = 2e-20
 Identities = 80/297 (26%), Positives = 142/297 (47%), Gaps = 37/297 (12%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E+ L++++  K +G G FG V+L  +  + +    K +      +  K    QL  E+N+
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNV 65

Query: 276 LSQLSHPNIVRYHGSEL--SDERLSVYLEYVSGG----SIHKLLQEYGPFNEPVIQTYTR 329
           + +L H NIVRY    L  ++++L + +E+   G    +I K  + +G   E  I   TR
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 330 QILLGLAYLH-------ARNTVHRDIKGANILVDPH----GEI-------------KLAD 365
           Q+L  LAY H           +HRD+K  NI +       G+I             K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMN-TNGYSLTVDIWSLGCTVLEMATSKPPWSQ 424
           FG++K++   +   S  G+PY+ +PE++++ T  Y    D+W+LGC + E+ + K P+ +
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 425 YEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
               + +  I   K  P++P +  S +    IK  L      RP A + L +  +++
Sbjct: 246 ANNFSQL--ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 69/255 (27%), Positives = 126/255 (49%), Gaps = 10/255 (3%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG+G FG V       +G+M A K++      + S E +  L +EI  L +++ P IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFN---EPVIQTYTRQILLGLAYLHARNTV 344
             +  S   L + +  ++GG +   +   G      E VI  Y+ QI  G+ +LH+ + V
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH-YSAQITCGILHLHSMDIV 117

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           +RD+K  N+L+D  G  +L+D G+A  +    ++    G+  +MAPE++     YS  VD
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVD 176

Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EH--LSDDAKSFIKQCLQR 461
            +++GC++ EM   + P+  ++   A  ++       E+  EH   ++++K   +  L +
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236

Query: 462 DPSARPPASKLLDHP 476
            P  R  + +  D P
Sbjct: 237 KPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 72/249 (28%), Positives = 127/249 (51%), Gaps = 23/249 (9%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG+G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQL 66

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVH 345
           + + +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VH
Sbjct: 67  Y-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++ 
Sbjct: 126 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIK 183

Query: 403 VDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIP---EIPEHLSDDAKSFIKQC 458
            D+WS G  + E+ T  + P+        + ++     +P   E PE L D     + QC
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQC 239

Query: 459 LQRDPSARP 467
            +++P  RP
Sbjct: 240 WRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 69/247 (27%), Positives = 112/247 (45%), Gaps = 13/247 (5%)

Query: 228 LGRGTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG G FG V  G     +S +  A+K ++   +D   K+   +L +E N++ QL +P IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKD---ELLREANVMQQLDNPYIV 59

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           R  G     E   + +E    G ++K LQ+     E  I     Q+ +G+ YL   N VH
Sbjct: 60  RMIGI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS---PY-WMAPEVVMNTNGYSL 401
           RD+   N+L+      K++DFG++K + +  +    K     P  W APE  MN   +S 
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-CMNYYKFSS 177

Query: 402 TVDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             D+WS G  + E  +  + P+   +G      I + + + E P+    +    +K C  
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-ECPQRCPPEMYDLMKLCWT 236

Query: 461 RDPSARP 467
                RP
Sbjct: 237 YGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 84/295 (28%), Positives = 129/295 (43%), Gaps = 54/295 (18%)

Query: 228 LGRGTFGHVYL------------GFNSESGQ--MCAIKEVRVVCDDQTSKECLKQLNQEI 273
           LG G FG V+L            G     GQ  + A+K +R         + LK    EI
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK----EI 68

Query: 274 NLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE---YGPF----NEPVIQT 326
            ++S+L +PNI+R  G  +SD+ L +  EY+  G +++ L +      F    N P +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 327 -----YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF 381
                   QI  G+ YL + N VHRD+   N LV  H  IK+ADFGM++++ S       
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS-GDYYRI 187

Query: 382 KGSPY----WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIG 435
           +G       WMA E ++    ++   D+W+ G T+ EM T   + P+S       I   G
Sbjct: 188 QGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246

Query: 436 -----NSKDI-----PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                  + I     P  P  +       + +C  RD   RP  +K+  H F+R+
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVFK----LMMRCWSRDIKDRPTFNKI--HHFLRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 53/296 (17%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR- 286
           +G G FG V+   +   G+  A+K++  V  +  S    K++ +E+ +L    H N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64

Query: 287 ---YHGSELSD-ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
                   +   E + V  E +    +HK++    P +   ++ +  QIL GL YLH+  
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMA--------KHMTSCASMLSFKGSPYWMAPEVVM 394
            +HRDIK  N+LV+ +  +K+ DFG+A        KHMT          + Y+ APE++M
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV------TQYYRAPEILM 177

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSK---------------------PPWSQ--YEGVAAI 431
            +  Y+  VDIWS+GC   E+   +                     P           A 
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237

Query: 432 FKIGNSKDIPE-------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             I      P        +    + +A   + + L  DP  R  A+  L HP++ +
Sbjct: 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 23/259 (8%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
            K LG G FG V+LG       + AIK +R   +   S++      +E  ++ +LSHPN+
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDV-AIKMIR---EGAMSED---DFIEEAKVMMKLSHPNL 61

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNT 343
           V+ +G       + +  EY++ G +   L+E  G      +      +   + YL +   
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYS 400
           +HRD+   N LV     +K++DFG+A+++       S  G+ +   W  PEV   +  +S
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSR-FS 179

Query: 401 LTVDIWSLGCTVLEMAT-SKPP---WSQYEGVAAIFKIGNSKDIPEI-PEHLSDDAKSFI 455
              D+WS G  + E+ +  K P   +S  E V ++   G     P++ P  +       +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYT----IM 234

Query: 456 KQCLQRDPSARPPASKLLD 474
             C    P  RP   KLL 
Sbjct: 235 YSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 3e-20
 Identities = 79/301 (26%), Positives = 135/301 (44%), Gaps = 32/301 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLS 280
           K++GRG FG V +     +GQ+ A+K +          E LK+       +E ++L    
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKIL-------NKWEMLKRAETACFREERDVLVNGD 59

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLH 339
              I   H +   +  L + ++Y  GG +  LL ++     E + + Y  +++L +  +H
Sbjct: 60  RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF--KGSPYWMAPEVVMNTN 397
               VHRDIK  N+L+D +G I+LADFG    + +  ++ S    G+P +++PE++    
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179

Query: 398 G----YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH---LSDD 450
                Y    D WSLG  + EM   + P+     V    KI N K+  + P     +S++
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239

Query: 451 AKSFIKQ--CLQRDPSARPPASKLLDHPF--------VRDQAVARAGNVNLAKDSSPYSL 500
           AK  I++  C       R       DHPF        +R+        V+   D+S + +
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDV 299

Query: 501 D 501
           D
Sbjct: 300 D 300

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 92.4 bits (229), Expect = 4e-20
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 26/245 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN-----QEINLLSQLS 280
           K++GRG FG V L  +  + ++ A+K +       +  E +K+ +     +E ++++  +
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
            P +V+   +   D  L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFG----MAKH-MTSCASMLSFKGSPYWMAPEVVMN 395
              +HRD+K  N+L+D  G +KLADFG    M K  M  C + +   G+P +++PEV+ +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISPEVLKS 217

Query: 396 TNG---YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDD 450
             G   Y    D WS+G  + EM     P+     V    KI N K+    P+   +S +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277

Query: 451 AKSFI 455
           AK+ I
Sbjct: 278 AKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 44/263 (16%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE---CLKQLNQEINLLSQLSH 281
            + LG G FG V++G  + + ++ A+K         T K      +   QE  ++ +L H
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKV-AVK---------TLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLH 339
             +V+ +     +E + +  EY+S GS+   L+  E      P +     QI  G+AYL 
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAK------HMTSCASMLSFKGSPYWMAPEVV 393
           +RN +HRD+   NILV  +   K+ADFG+A+      +     +    K    W APE  
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEAA 176

Query: 394 MNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEI--------P 444
            N   +++  D+WS G  + E+ T  + P   Y G+       N + + ++        P
Sbjct: 177 -NYGRFTIKSDVWSFGILLTEIVTYGRVP---YPGMT------NREVLEQVERGYRMPRP 226

Query: 445 EHLSDDAKSFIKQCLQRDPSARP 467
            +  ++    + QC  +DP  RP
Sbjct: 227 PNCPEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.6 bits (222), Expect = 7e-20
 Identities = 75/263 (28%), Positives = 121/263 (46%), Gaps = 35/263 (13%)

Query: 224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ---EINLLSQLS 280
           K K++G G FG V+ G     G+    KEV V           KQ      E +++ Q S
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
           H NI+R  G     +   +  EY+  G++ K L+++ G F+   +    R I  G+ YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMAPE 391
             N VHRD+   NILV+ + E K++DFG+++ +        T+    +  +    W APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR----WTAPE 180

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIP 444
            +     ++   D+WS G  + E+ +   +P W  S +E + AI   F++    D P   
Sbjct: 181 AI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239

Query: 445 EHLSDDAKSFIKQCLQRDPSARP 467
             L       + QC Q+D + RP
Sbjct: 240 YQL-------MLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 90.5 bits (224), Expect = 7e-20
 Identities = 75/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)

Query: 225 GKLLGRGTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL- 279
           GK LG G FG V +    G + E         V+++  D T K+ L  L  E+ ++  + 
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIG 81

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE---------YGPFNEPVIQTYTR- 329
            H NI+   G+   D  L V +EY S G++ + L+          Y P   P  Q   + 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 330 ------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLS 380
                 Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       +
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA--IFKIGNSK 438
            +    WMAPE + +   Y+   D+WS G  + E+ T     S Y GV    +FK+    
Sbjct: 202 GRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEG 258

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
              + P + +++    ++ C    PS RP   +L++
Sbjct: 259 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 47/300 (15%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD---DQTSKECLKQLNQEINLLS 277
           ++K  +++G+G++G V    ++ +G+  AIK++  V +   D T      ++ +EI LL 
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT------RILREIKLLR 54

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYV----SGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
            L HP+IV      L   R      YV        +H++++          Q +  Q+L 
Sbjct: 55  LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF----KGSPYWMA 389
            L Y+H  N  HRD+K  NIL +   ++K+ DFG+A+   +      F      + ++ A
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 390 PEVVMNTNG-YSLTVDIWSLGCTVLEMATSKPPWSQYEGV---------------AAIFK 433
           PE+  +    Y+  +DIWS+GC   E+ T KP +     V                 I +
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 434 IGNSKDI-------PEIPEHLSD---DAKSFIKQCLQR----DPSARPPASKLLDHPFVR 479
           + N K          + P   S    +A     + L+R    DP  RP A + L  P+ +
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 49/280 (17%)

Query: 228 LGRGTFGHVY----LGFNS-ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           +G+G FG V+     G    E   M A+K ++         +      +E  L+++  HP
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD----FQREAALMAEFDHP 68

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLL----------------------QEYGPFN 320
           NIV+  G     + + +  EY++ G +++ L                          P +
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 321 EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS 380
                   +Q+  G+AYL  R  VHRD+   N LV  +  +K+ADFG+++++ S      
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---Y 185

Query: 381 FKGSP------YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS--KPPWS-QYEGVAAI 431
           +K S        WM PE +   N Y+   D+W+ G  + E+ +   +P +   +E V   
Sbjct: 186 YKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244

Query: 432 FKIGNSKDIPE-IPEHLSDDAKSFIKQCLQRDPSARPPAS 470
            + GN    P+  P  L +     ++ C  + PS RP  +
Sbjct: 245 VRDGNVLSCPDNCPLELYN----LMRLCWSKLPSDRPSFA 280

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 92.2 bits (229), Expect = 2e-19
 Identities = 52/145 (35%), Positives = 79/145 (54%), Gaps = 2/145 (1%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K + RG FG VYLG    + ++ A+K V+    D  +K  + Q+  E + L+    P IV
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMINKNMVHQVQAERDALALSKSPFIV 67

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
             + S  S   + + +EY+ GG +  LL  YG F+E +   Y  ++ L L YLH    +H
Sbjct: 68  HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIH 127

Query: 346 RDIKGANILVDPHGEIKLADFGMAK 370
           RD+K  N+L+   G IKL DFG++K
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 65/253 (25%), Positives = 121/253 (47%), Gaps = 15/253 (5%)

Query: 226 KLLGRGTFGHVYLGFNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           K LG G FG V  G     GQ   AIK ++   +   S++   +  +E  ++ +LSH  +
Sbjct: 10  KELGTGQFGVVKYG--KWRGQYDVAIKMIK---EGSMSED---EFIEEAKVMMKLSHEKL 61

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARNT 343
           V+ +G       + +  EY+S G +   L+E+G   +P  +    + +  G+AYL ++  
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
           +HRD+   N LVD  G +K++DFG+++++      S +  K    W  PEV++ +  +S 
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSS 180

Query: 402 TVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             D+W+ G  + E+ +  K P+ ++     + K+     +   P   S+   + +  C  
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-PHLASEKVYAIMYSCWH 239

Query: 461 RDPSARPPASKLL 473
                RP   +LL
Sbjct: 240 EKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 18/247 (7%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG G FG V+ G      ++ AIK ++            +   +E+  L +L H +++  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRV-AIKILK-----SDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVH 345
                  E + +  E +  GS+   L+       PV  +     Q+  G+AYL  +N++H
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVD 404
           RD+   NILV      K+ADFG+A+ +     + S K  PY W APE   +   +S   D
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA-SHGTFSTKSD 186

Query: 405 IWSLGCTVLEMAT-SKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + EM T  + P   Y G+       +I     +P  P     +    + +C  
Sbjct: 187 VWSFGILLYEMFTYGQVP---YPGMNNHEVYDQITAGYRMPC-PAKCPQEIYKIMLECWA 242

Query: 461 RDPSARP 467
            +P  RP
Sbjct: 243 AEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 65/254 (25%), Positives = 123/254 (48%), Gaps = 23/254 (9%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K  K LG G FG V++   ++  ++ A+K ++           ++    E N++  L H 
Sbjct: 9   KLEKKLGAGQFGEVWMATYNKHTKV-AVKTMK------PGSMSVEAFLAEANVMKTLQHD 61

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHA 340
            +V+ H + ++ E + +  E+++ GS+   L+  E      P +  ++ QI  G+A++  
Sbjct: 62  KLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTN 397
           RN +HRD++ ANILV      K+ADFG+A+ +       + +G+ +   W APE + N  
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI-NFG 178

Query: 398 GYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEI---PEHLSDDAKS 453
            +++  D+WS G  ++E+ T  + P+        I  +     +P     PE L +    
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN---- 234

Query: 454 FIKQCLQRDPSARP 467
            + +C +  P  RP
Sbjct: 235 IMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 88.6 bits (219), Expect = 4e-19
 Identities = 82/320 (25%), Positives = 144/320 (45%), Gaps = 74/320 (23%)

Query: 224 KGKLLGRGTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           +G  +GRGT+GHVY     + +  +  A+K++       ++  C     +EI LL +L H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--C-----REIALLRELKH 57

Query: 282 PNIVRYHGSELS--DERLSVYLEYVSGGSIH--KLLQEYGPFNEPV------IQTYTRQI 331
           PN++      LS  D ++ +  +Y      H  K  +      +PV      +++   QI
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 332 LLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFGMAKHMTS----CASMLSFKG 383
           L G+ YLHA   +HRD+K ANILV       G +K+AD G A+   S     A +     
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP-------------PWSQYEGVAA 430
           + ++ APE+++    Y+  +DIW++GC   E+ TS+P             P+  ++ +  
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY-HHDQLDR 236

Query: 431 IFKI------GNSKDIPEIPEH-------------------------LSDDAKSF--IKQ 457
           IF +       + +DI ++PEH                         +  D+K+F  +++
Sbjct: 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 296

Query: 458 CLQRDPSARPPASKLLDHPF 477
            L  DP  R  + + +  P+
Sbjct: 297 LLTMDPIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 88.5 bits (219), Expect = 4e-19
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 42/291 (14%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
           E S ++   GK LG G FG V +    G + +         V+++ DD T K+ L  L  
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVS 66

Query: 272 EINLLSQL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP------------ 318
           E+ ++  +  H NI+   G+   D  L V +EY S G++ + L+   P            
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 319 ------FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK-- 370
                 F + V   Y  Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+  
Sbjct: 127 PEEQLTFKDLVSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 371 -----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY 425
                +  +    L  K    WMAPE + +   Y+   D+WS G  + E+ T     S Y
Sbjct: 185 HNIDYYKKTTNGRLPVK----WMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGG--SPY 237

Query: 426 EG--VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            G  V  +FK+       + P + + +    +++C    PS RP   +L++
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 23/257 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +LLG+G FG V+ G   +   + A+K     C +   +E   +   E  +L Q  HPNIV
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVK----TCKEDLPQELKIKFLSEARILKQYDHPNIV 55

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL-------LGLAYL 338
           +  G     + + + +E V GG     L++         +  T+Q++        G+AYL
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD------ELKTKQLVKFALDAAAGMAYL 109

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPY-WMAPEVVMNT 396
            ++N +HRD+   N LV  +  +K++DFGM++       S    K  P  W APE  +N 
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNY 168

Query: 397 NGYSLTVDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
             YS   D+WS G  + E  +    P+       A  ++     +   P+   DD    +
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-SCPQKCPDDVYKVM 227

Query: 456 KQCLQRDPSARPPASKL 472
           ++C    P  RP  S+L
Sbjct: 228 QRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.7 bits (217), Expect = 6e-19
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 48/279 (17%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINL 275
           +++KK K+LG G FG VY G     G+      AIKE+R    + TS +  K++  E  +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYV 62

Query: 276 LSQLSHPNIVRYHGSELSD-----ERLSVY---LEYVSG-----GSIHKLLQEYGPFNEP 322
           ++ + +P++ R  G  L+       +L  +   L+YV       GS + L          
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL---------- 112

Query: 323 VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK 382
               +  QI  G+ YL  R  VHRD+   N+LV     +K+ DFG+AK + +       +
Sbjct: 113 ---NWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 383 GSPY---WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKI- 434
           G      WMA E +++   Y+   D+WS G TV E+ T  SKP    Y+G+ A  I  I 
Sbjct: 170 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSIL 224

Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
              + +P+ P   + D    + +C   D  +RP   +L+
Sbjct: 225 EKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 52/276 (18%)

Query: 226 KLLGRGTFGHVYLG------FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             LG G FG VY G               A+K +R    DQ  KE LK    E +L+S  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK----EAHLMSNF 56

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILL---- 333
           +HPNIV+  G  L +E   + +E + GG +   L++     F  P++ T    + +    
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLL-TLKELLDICLDV 115

Query: 334 --GLAYLHARNTVHRDIKGANILVDPHGE-----IKLADFGMAKHMTSCASMLSFKGSPY 386
             G  YL   + +HRD+   N LV   G      +K+ DFG+A+ +        +K   Y
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI--------YKSDYY 167

Query: 387 -----------WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAI 431
                      WMAPE +++   ++   D+WS G  + E+ T      P  +  E +  +
Sbjct: 168 RKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226

Query: 432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
              G      + PE+  D     +  C  +DPS RP
Sbjct: 227 TAGGRL----QKPENCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 43/225 (19%)

Query: 224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE-CLKQLN---------QEI 273
           +G  +GRGT+GHVY                    D +  KE  LKQ+          +EI
Sbjct: 5   EGCKVGRGTYGHVYKAKRK---------------DGKDEKEYALKQIEGTGISMSACREI 49

Query: 274 NLLSQLSHPNIVRYHGSELS--DERLSVYLEYVSGGSIHKLL------QEYGPFNEP--V 323
            LL +L HPN++      LS  D ++ +  +Y      H +           P   P  +
Sbjct: 50  ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFGMAKHMTS----C 375
           +++   QIL G+ YLHA   +HRD+K ANILV       G +K+AD G A+   S     
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP 420
           A +     + ++ APE+++    Y+  +DIW++GC   E+ TS+P
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 35/261 (13%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G G FG V+LG+  E  ++ AIK +R   +   S+E   +   E  ++ +LSHP +V+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIKTIR---EGAMSEEDFIE---EAQVMMKLSHPKLVQL 64

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +G       + +  E++  G +   L+ + G F++  +      +  G+AYL + N +HR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 347 DIKGANILVDPHGEIKLADFGMAK------HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
           D+   N LV  +  +K++DFGM +      + +S  +    K    W +PEV   +  YS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSK-YS 179

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--------PEHLSDDAK 452
              D+WS G  + E+ +        EG        NS+ +  I        P   S    
Sbjct: 180 SKSDVWSFGVLMWEVFS--------EGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231

Query: 453 SFIKQCLQRDPSARPPASKLL 473
             ++ C +  P  RP  S LL
Sbjct: 232 ELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 32/301 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLS 280
           K++GRG FG V +     + ++ A+K +          E LK+       +E N+L    
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKIL-------NKWEMLKRAETACFREERNVLVNGD 59

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
              I   H +   +  L + ++Y  GG +  LL ++     E + + Y  +++L +  +H
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVM--- 394
             + VHRDIK  N+L+D +G I+LADFG    M    ++ S    G+P +++PE++    
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 395 -NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD---D 450
                Y    D WSLG  + EM   + P+     V    KI N ++  + P H++D   +
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 451 AKSFIKQ--CLQRDPSARPPASKLLDHPF--------VRDQAVARAGNVNLAKDSSPYSL 500
           AK  I++  C +     +        H F        +R+       +V+   D+S + +
Sbjct: 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDV 299

Query: 501 D 501
           D
Sbjct: 300 D 300

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 79/310 (25%)

Query: 228 LGRGTFGHVYL--------------GFNSESGQ--MCAIKEVRVVCDDQTSKECLKQLNQ 271
           LG G FG V+L               FN   G+  + A+K +R   +     + LK    
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK---- 68

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG------SIHKLLQEYGPFNEPVIQ 325
           E+ +LS+L  PNI+R  G  + ++ L +  EY+  G      S H L  +    N+ V  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 326 TY-------------TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM 372
            +               QI  G+ YL + N VHRD+   N LV  +  IK+ADFGM++++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 373 TSCASMLSFKGSPY-----------WMAPEVVMNTNGYSLTVDIWSLGCTVLE--MATSK 419
                   + G  Y           WMA E ++    ++   D+W+ G T+ E  M   +
Sbjct: 189 --------YAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKE 239

Query: 420 PPWSQY------EGVAAIFKIGNSKDI-----PEIPEHLSDDAKSFIKQCLQRDPSARPP 468
            P+ +       E     F+    + +     P  P+ L +     + QC  RD   RP 
Sbjct: 240 QPYGELTDEQVIENAGEFFR-DQGRQVYLFRPPPCPQGLYE----LMLQCWSRDCRERPS 294

Query: 469 ASKLLDHPFV 478
            S +  H F+
Sbjct: 295 FSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 57/212 (26%), Positives = 113/212 (53%), Gaps = 10/212 (4%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           ++G G +G V    + E+ ++ AIK+ +   D + ++E  +   +E+ +L  L   NIV 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFK---DSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEP--VIQTYTRQILLGLAYLHARNTV 344
              +     +L +  EYV    + +LL+E  P   P   +++Y  Q++  + + H  + V
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNML-ELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMT--SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           HRDIK  N+L+  +  +KL DFG A++++  S A+   +  + ++ +PE+++    Y   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKA 181

Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           VD+WS+GC + E++  +P +     +  +F I
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 84.3 bits (208), Expect = 5e-18
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 39/269 (14%)

Query: 228 LGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           LG   FG +Y G       +  Q+ AIK ++    D  + +   +  QE +L+++L HPN
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK----DINNPQQWGEFQQEASLMAELHHPN 68

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT----------------- 326
           IV   G    ++ + +  EY++ G +H+ L    P ++    +                 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASML 379
              QI  G+ YL +   VH+D+   NIL+     +K++D G+++ + S         S+L
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSK 438
             +    WM PE +M    +S   DIWS G  + E+ +    P+  +     I  +   +
Sbjct: 189 PIR----WMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
            +P   E       S + +C Q  PS RP
Sbjct: 244 LLP-CSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 59/286 (20%)

Query: 228 LGRGTFGHVYL------------GFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQ 271
           LG G FG V+L             F+ +         A+K +R   +     + LK    
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK---- 68

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ-----T 326
           EI ++S+L  PNI+R     ++ + L +  EY+  G +++ L  + P            +
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 327 YTR------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS 380
           Y+       QI  G+ YL + N VHRD+   N LV  +  IK+ADFGM++++        
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-------- 180

Query: 381 FKGSPY-----------WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQY-- 425
           + G  Y           WM+ E ++    ++   D+W+ G T+ E+ T   + P+SQ   
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239

Query: 426 ----EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               E     F+    +     P    D     +  C +R+   RP
Sbjct: 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 78/279 (27%), Positives = 112/279 (40%), Gaps = 43/279 (15%)

Query: 225 GKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            + LG G FG VY G              A+K +   C +Q   + L     E  ++S+ 
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM----EALIMSKF 66

Query: 280 SHPNIVRYHGSELSDERLSVY--LEYVSGGSIHKLLQEYGP-FNEPVIQTYT------RQ 330
           +H NIVR  G  +S ERL  +  LE ++GG +   L+E  P    P   T        R 
Sbjct: 67  NHQNIVRLIG--VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSCA-------SMLS 380
           +  G  YL   + +HRDI   N L+   G     K+ADFGMA+ +   +       +ML 
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE---MATSKPPWSQYEGVAAIFKIGNS 437
            K    WM PE  ++    S T D+WS G  + E   +     P    + V      G  
Sbjct: 185 IK----WMPPEAFLDGIFTSKT-DVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239

Query: 438 KDIP-EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            D P   P          +  C Q  P  RP  + +L+ 
Sbjct: 240 LDPPKGCP----GPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 84.2 bits (208), Expect = 9e-18
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 32/277 (11%)

Query: 225 GKLLGRGTFGHVY----LGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           GK LG G FG V      G +           V+++ D+ T K+ L  L  E+ L+  + 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLISEMELMKLIG 75

Query: 281 -HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ-------EY---------GPFNEPV 323
            H NI+   G    +  L V +EY + G++ + L+       +Y            +   
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK--HMTSCASMLSF 381
           + +   Q+  G+ YL +R  +HRD+   N+LV     +K+ADFG+A+  H        S 
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 382 KGSPY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNS 437
              P  WMAPE + +   Y+   D+WS G  + E+ T   S  P    E +  + + G+ 
Sbjct: 196 GRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254

Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            D P    H   +    +++C    P+ RP   +L++
Sbjct: 255 MDKPSNCTH---ELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 64/246 (26%), Positives = 120/246 (48%), Gaps = 17/246 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           LG+G FG V++G  + + ++ AIK ++         E   Q   E  ++ +L H  +V  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLK---PGTMMPEAFLQ---EAQIMKKLRHDKLVPL 66

Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVH 345
           + + +S+E + +  E++  GS+   L+E        P +     QI  G+AY+   N +H
Sbjct: 67  Y-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++ 
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIK 183

Query: 403 VDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
            D+WS G  + E+ T  + P+        + ++     +P  P+   +     +K C ++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-CPQGCPESLHELMKLCWKK 242

Query: 462 DPSARP 467
           DP  RP
Sbjct: 243 DPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 72/261 (27%), Positives = 118/261 (45%), Gaps = 33/261 (12%)

Query: 226 KLLGRGTFGHVYLGFNSESG---QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           +++G G FG V  G     G      AIK ++    ++  ++ L     E +++ Q  HP
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL----SEASIMGQFDHP 65

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQT--YTRQILLGLAYLH 339
           NI+   G       + +  E++  G++   L Q  G F   VIQ     R I  G+ YL 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLS 123

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS-----PY-WMAPEVV 393
             N VHRD+   NILV+ +   K++DFG+++ +    S  ++  S     P  W APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 394 MNTNGYSLTVDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEH 446
                ++   D+WS G  + E+ +   +P W  S  + + AI   +++    D P     
Sbjct: 184 AYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242

Query: 447 LSDDAKSFIKQCLQRDPSARP 467
           L  D       C Q+D +ARP
Sbjct: 243 LMLD-------CWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 31/212 (14%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L +++  K +G G  G V   +++ +GQ  AIK++     + T     K+  +E+ L+  
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHA---KRAYRELVLMKL 71

Query: 279 LSHPNIVRYHGSELSDERLS----VYL--EYVSGGSIHKLLQEYGPFNEPVIQT---YTR 329
           ++H NI+         + L     VYL  E +       L Q        VIQ    + R
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQ--------VIQMDLDHER 119

Query: 330 ------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG 383
                 Q+L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 179

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM 415
           + Y+ APEV++   GY   VDIWS+GC + EM
Sbjct: 180 TRYYRAPEVILGM-GYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 71/233 (30%), Positives = 112/233 (48%), Gaps = 21/233 (9%)

Query: 228 LGRGTFGHVYLG-FNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG G FG V  G +     Q+  AIK    V  ++  K    ++ +E  ++ QL +P IV
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK----VLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-PV--IQTYTRQILLGLAYLHARN 342
           R  G     E L + +E  SGG ++K L   G  +E  V  +     Q+ +G+ YL  +N
Sbjct: 59  RMIGV-CEAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPY-WMAPEVVMNTNG 398
            VHRD+   N+L+      K++DFG++K + +  S     S    P  W APE + N   
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI-NFRK 174

Query: 399 YSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSKDIP-EIPEHL 447
           +S   D+WS G T+ E  +  + P+ + +G  V +  + G   D P E P  +
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 32/256 (12%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           + LG G FG V+ G  + +  + A+K ++        K+ L     E  ++ +L HP ++
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPV-AVKTLKP--GTMDPKDFL----AEAQIMKKLRHPKLI 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           + +     +E + +  E +  GS+ + LQ         P +     Q+  G+AYL A+N 
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-----------WMAPEV 392
           +HRD+   N+LV  +   K+ADFG+A+           K   Y           W APE 
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLAR---------VIKEDIYEAREGAKFPIKWTAPEA 175

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
               N +S+  D+WS G  + E+ T  + P+        + ++     +P  P     + 
Sbjct: 176 A-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKEL 233

Query: 452 KSFIKQCLQRDPSARP 467
              +  C + DP  RP
Sbjct: 234 YDIMLDCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 68/260 (26%), Positives = 117/260 (45%), Gaps = 21/260 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQM---CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           +++G+G FG VY G   +S      CA+K +  + D +  ++ LK    E  ++   SHP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLK----EGIIMKDFSHP 56

Query: 283 NIVRYHGSELSDERLS-VYLEYVSGGSIHKLLQEYGPFNEPVIQ---TYTRQILLGLAYL 338
           N++   G  L  E    V L Y+  G +   ++     + P ++    +  Q+  G+ YL
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYL 114

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMA-----KHMTSCASMLSFKGSPYWMAPEVV 393
            ++  VHRD+   N ++D    +K+ADFG+A     K   S  +    K    WMA E  
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE-S 173

Query: 394 MNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           + T  ++   D+WS G  + E+ T   PP+   +       +   + + + PE+  D   
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-PEYCPDPLY 232

Query: 453 SFIKQCLQRDPSARPPASKL 472
             +  C    P  RP  S+L
Sbjct: 233 EVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 26/269 (9%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           ++ KK K+LG G FG VY G     G+   I     V  + TS +  K++  E  +++ +
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
             P + R  G  L+     V      G  +  + +         +  +  QI  G++YL 
Sbjct: 67  GSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNT 396
               VHRD+   N+LV     +K+ DFG+A+ +    +     G      WMA E +++ 
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 397 NGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI---------PE 445
             ++   D+WS G TV E+ T  +KP    Y+G+ A       ++IP++         P 
Sbjct: 187 R-FTHQSDVWSYGVTVWELMTFGAKP----YDGIPA-------REIPDLLEKGERLPQPP 234

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
             + D    + +C   D   RP   +L+D
Sbjct: 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 66/268 (24%), Positives = 120/268 (44%), Gaps = 28/268 (10%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           ++ K+ K+LG G FG VY G     G+   I     + ++ T  +   +   E  +++ +
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYL 338
            HP++VR  G  LS   + +  + +  G +   + E+       ++  +  QI  G+ YL
Sbjct: 67  DHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMN 395
             R  VHRD+   N+LV     +K+ DFG+A+ +       +  G      WMA E + +
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI-H 184

Query: 396 TNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI---------P 444
              ++   D+WS G T+ E+ T   KP    Y+G+        +++IP++         P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP----YDGIP-------TREIPDLLEKGERLPQP 233

Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKL 472
              + D    + +C   D  +RP   +L
Sbjct: 234 PICTIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 27/274 (9%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQL-SHP 282
           GK LG G FG V         +  A+ +V V     T+    ++ L  E+ ++S L +H 
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSI----HKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           NIV   G+      + V  EY   G +     +  + +    +  + +++ Q+  G+A+L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED--LLSFSYQVAKGMAFL 157

Query: 339 HARNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPY----WMAPEVV 393
            ++N +HRD+   N+L+  HG+I K+ DFG+A+ + + ++ +  KG+      WMAPE +
Sbjct: 158 ASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVV-KGNARLPVKWMAPESI 215

Query: 394 MNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGV---AAIFKIGNSKDIPEIPEHLS 448
            N   Y+   D+WS G  + E+ +  S P    Y G+   +  +K+         PEH  
Sbjct: 216 FN-CVYTFESDVWSYGILLWEIFSLGSNP----YPGMPVDSKFYKLIKEGYRMAQPEHAP 270

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
            +    +K C   DP  RP   +++    +  Q 
Sbjct: 271 AEIYDIMKTCWDADPLKRPTFKQIVQ--LIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 39/281 (13%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLG--FNSESG---QMCAIKEVRVVCDDQTSKECLKQLN 270
           E +LS  +  + LG   FG VY G  F +  G   Q  AIK ++    D+      ++  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPLREEFK 56

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE--------- 321
            E  + S+L HPNIV   G    ++ LS+   Y S   +H+ L    P ++         
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 322 -------PVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS 374
                          QI  G+ +L + + VH+D+   N+LV     +K++D G+ + + +
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 375 C-------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYE 426
                    S+L  +    WM+PE +M    +S+  DIWS G  + E+ +    P+  Y 
Sbjct: 177 ADYYKLMGNSLLPIR----WMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231

Query: 427 GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               I  I N + +P  P+       + + +C    PS RP
Sbjct: 232 NQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 83.2 bits (205), Expect = 3e-17
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR- 286
           +G G +G V   +++   Q  A+K++             ++  +E+ LL  + H N++  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKHENVIGL 79

Query: 287 ---YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
              +  +   +    VYL     G+    + +    ++  +Q    Q+L GL Y+H+   
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGI 139

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           +HRD+K +N+ V+   E+++ DFG+A+       M  +  + ++ APE+++N   Y+ TV
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTV 197

Query: 404 DIWSLGCTVLEMATSK 419
           DIWS+GC + E+   K
Sbjct: 198 DIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 70/250 (28%), Positives = 119/250 (47%), Gaps = 29/250 (11%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+G FG V LG     G   A+K ++   +D T++  L     E ++++QL H N+V+ 
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIK---NDATAQAFLA----EASVMTQLRHSNLVQL 64

Query: 288 HGSELSDERLSVYL--EYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNT 343
            G  + +E+  +Y+  EY++ GS+   L+  G        +  ++  +   + YL A N 
Sbjct: 65  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSC--ASMLSFKGSPYWMAPEVVMNTNGYSL 401
           VHRD+   N+LV      K++DFG+ K  +S      L  K    W APE  +    +S 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPE-ALREKKFST 178

Query: 402 TVDIWSLGCTVLEMAT-SKPPWSQ--YEGVAAIFKIGNSKDIPE-IPEHLSDDAKSFIKQ 457
             D+WS G  + E+ +  + P+ +   + V    + G   D P+  P  + D     +KQ
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD----VMKQ 234

Query: 458 CLQRDPSARP 467
           C   D + RP
Sbjct: 235 CWHLDAATRP 244

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 81.9 bits (202), Expect = 6e-17
 Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 60/292 (20%)

Query: 244 SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY 303
           +G+   ++ + +   +  + E +  L  E+++    +HPNIV Y  + ++D  L V   +
Sbjct: 24  TGEYVTVRRINL---EACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80

Query: 304 VSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
           ++ GS   L+  +     +E  I    + +L  L Y+H    VHR +K ++IL+   G++
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 140

Query: 362 KL----ADFGMAKH-----MTSCASMLSFKGSPYWMAPEVV-MNTNGYSLTVDIWSLGCT 411
            L    ++  M  H     +       S K  P W++PEV+  N  GY    DI+S+G T
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGIT 199

Query: 412 VLEMATSKPPWSQY-------EGVA-------------------------AIFKIGNSKD 439
             E+A    P+          E +                          A   +G S  
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTT 259

Query: 440 I-------PEIPEH-----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           +        E   H      S     F++QCLQR+P ARP AS LL+H F +
Sbjct: 260 VSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.9 bits (210), Expect = 6e-17
 Identities = 81/344 (23%), Positives = 134/344 (38%), Gaps = 35/344 (10%)

Query: 243 ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS-ELSDERLSVYL 301
            +G   AIK +R   D    +    +  +E  L ++L HPNIV    S E     L    
Sbjct: 1   MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58

Query: 302 EYVSGGSIHKLLQEYGPFNEPVIQT--YTRQILLGLAYLHARNTVHRDIKGANILV---- 355
           EYV G ++ ++L   G    P  +T     Q+L  LA  H +  VHRD+K  NI+V    
Sbjct: 59  EYVPGRTLREVLAADGAL--PAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 356 -DPHGEIKLADFGM-----------AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
             PH   K+ DFG+              +T    +L   G+P + APE +      +   
Sbjct: 117 VRPHA--KVLDFGIGTLLPGVRDADVATLTRTTEVL---GTPTYCAPEQLRG-EPVTPNS 170

Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL-SDDAKSFIKQCLQRD 462
           D+++ G   LE  T +    Q   VA I     S     +P  +        +++ L +D
Sbjct: 171 DLYAWGLIFLECLTGQRV-VQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKD 229

Query: 463 PSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDG---SRTPPKLDLLPTRKSIT 519
           P  R  ++  L   F   +  A  G + + + +   ++     +      +    R+   
Sbjct: 230 PRQRAASAPALAERFRALELCALVGILRMGEGAGREAIAAPLVASGTLDGETGERRQLTA 289

Query: 520 LCEGDYLANPLVPTSRALNNPRENARTITSLPVSPCSSPLRQYG 563
           LC    L+ P  P      +  E    + S  ++ C+    +YG
Sbjct: 290 LCCHVGLSTPPEPAEGVEEDDEELDLLLRSW-LTRCADIAVRYG 332

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 81.6 bits (201), Expect = 9e-17
 Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 32/301 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLS 280
           K++GRG FG V +     + ++ A+K +          E LK+       +E ++L    
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKIL-------NKWEMLKRAETACFREERDVLVNGD 59

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
           +  I   H +   +  L + ++Y  GG +  LL ++     E + + Y  ++++ +  +H
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNTN 397
             + VHRDIK  NIL+D +G I+LADFG    +    ++ S    G+P +++PE++    
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 398 G----YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD---D 450
                Y    D WSLG  + EM   + P+     V    KI N K+  + P  ++D   D
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239

Query: 451 AKSFIKQ--CLQRDPSARPPASKLLDHPF--------VRDQAVARAGNVNLAKDSSPYSL 500
           AK  I++  C +     +        HPF        +R+        V+   D+S + +
Sbjct: 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDV 299

Query: 501 D 501
           D
Sbjct: 300 D 300

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 13/203 (6%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L ++++ K +G G  G V   F++  G   A+K++     +QT     K+  +E+ LL  
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKC 76

Query: 279 LSHPNIVR----YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           ++H NI+     +   +  +E   VYL  E +       +  E    +   +     Q+L
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQML 133

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 393 VMNTNGYSLTVDIWSLGCTVLEM 415
           ++   GY   VDIWS+GC + E+
Sbjct: 194 ILGM-GYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 65/248 (26%), Positives = 121/248 (48%), Gaps = 17/248 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           K LG G FG V++G  + + ++ A+K ++       S E   +   E  ++ +L H  +V
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKV-AVKTLK---PGTMSPESFLE---EAQIMKKLRHDKLV 64

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           + + + +S+E + +  EY+S GS+   L+  E      P +     Q+  G+AY+   N 
Sbjct: 65  QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYS 400
           +HRD++ ANILV      K+ADFG+A+ +       + +G+ +   W APE  +    ++
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFT 181

Query: 401 LTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +  D+WS G  + E+ T  + P+        + ++     +P  P+         + QC 
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-CPQDCPISLHELMLQCW 240

Query: 460 QRDPSARP 467
           ++DP  RP
Sbjct: 241 KKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 73/257 (28%), Positives = 114/257 (44%), Gaps = 25/257 (9%)

Query: 228 LGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQE-INLLSQLSHPN 283
           LG+GTF ++Y G     S+   +   +EV VV     S         E  +L+SQLSH +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARN 342
           +V+ +G  + DE + V  EYV  G +   L  E    +        +Q+   L YL  + 
Sbjct: 63  LVKLYGVCVRDENIMV-EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 343 TVHRDIKGANILVDPHGE-------IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
            VH ++ G NILV  +G        IKL+D G+   + S    +     P W+APE + N
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--RIP-WIAPECIRN 178

Query: 396 T-NGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAI--FKIGNSKDIPEIPEHLSDDA 451
                ++  D WS G T+LE+ +  + P S          ++  +   +P+  E      
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE-----L 233

Query: 452 KSFIKQCLQRDPSARPP 468
            + I QC   DP+ RP 
Sbjct: 234 ANLINQCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 6/202 (2%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           ++ +K KLLG G FG V+ G     G    I        D++ ++  +++   +  +  L
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGS-IHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
            H  IVR  G       L +  +    GS +  + Q     +   +  +  QI  G+ YL
Sbjct: 67  DHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF---KGSPYWMAPEVVMN 395
                VHR++   NIL+     +++ADFG+A  +        +   K    WMA E ++ 
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL- 184

Query: 396 TNGYSLTVDIWSLGCTVLEMAT 417
              Y+   D+WS G TV EM +
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 80/318 (25%), Positives = 133/318 (41%), Gaps = 68/318 (21%)

Query: 228 LGRG--TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +GRG      VYL  ++ +G +     VR+   +  ++E LK L  E+ L     HPNI+
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVT---VRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNT 343
                  +   L V   +++ GS + LL+ Y P   +E +I       L GL YLH    
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122

Query: 344 VHRDIKGANILVDPHGEIKLAD----FGMAKHMTSCASMLSFKGSPY----WMAPEVV-M 394
           +HR+IK ++IL+   G + L+     + + ++      +  F         W++PE++  
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSK------------------PPWSQYEGVAAIFKIGN 436
           +  GY++  DI+S+G T  E+AT +                  PP+S  +     F    
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD--ITTFPCEE 240

Query: 437 SK----------DIPE-------------------IPEHLSDDAKSFIKQCLQRDPSARP 467
           S+           I E                     +  S   ++ ++ CLQ+DP  RP
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300

Query: 468 PASKLLDHPF---VRDQA 482
            AS LL H F   V++Q 
Sbjct: 301 SASSLLSHAFFKQVKEQT 318

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 79.7 bits (196), Expect = 5e-16
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 13/207 (6%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L +++  K +G G  G V   +++   +  AIK++     +QT     K+  +E+ L+  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKC 72

Query: 279 LSHPNIVR----YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           ++H NI+     +   +  +E   VYL  E +       +  E    +   +     Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQML 129

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSK 419
           ++   GY   VDIWS+GC + EM   K
Sbjct: 190 ILGM-GYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 61/256 (23%), Positives = 115/256 (44%), Gaps = 26/256 (10%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCD--DQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG+GTF  ++ G   E G    + +  V+    D++ +   +   +  +++SQLSH ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT-----YTRQILLGLAYLHA 340
             +G  +  +   +  EYV  GS+   L++    N+ +I         +Q+   L +L  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLED 118

Query: 341 RNTVHRDIKGANILVDPHGE--------IKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
           +   H ++   N+L+    +        IKL+D G++  +T     +  +  P W+ PE 
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPEC 175

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
           + N    SL  D WS G T+ E+ +    P S  +      K+   +D  ++P     + 
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPAPKWTEL 232

Query: 452 KSFIKQCLQRDPSARP 467
            + I QC+  +P  RP
Sbjct: 233 ANLINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           PN+V  H   +S++ + + L++  GG +   + ++    E  ++ +  ++++ L  LH  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYS 400
             V RD+   NIL+D  G I+L  F     +  SC           + APEV   +   +
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV---ENMYCAPEVGGISE-ET 160

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
              D WSLG  + E+ T K     +   + I    N+     IPE +S++A+S ++Q LQ
Sbjct: 161 EACDWWSLGAILFELLTGKTLVECHP--SGI----NTHTTLNIPEWVSEEARSLLQQLLQ 214

Query: 461 RDPSARPPA-----SKLLDHPF 477
            +P+ R  A       +  HPF
Sbjct: 215 FNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 68/272 (25%), Positives = 111/272 (40%), Gaps = 36/272 (13%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKE--CLKQLNQEINLLSQLSHP 282
             LGRG FG V+L      G      E  V V   Q +K+     +  +E+++  +LSH 
Sbjct: 11  TTLGRGEFGEVFLA--KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTRQILL 333
           N+VR  G     E   + LEY   G + + L+         +  P +         QI L
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY------- 386
           G+ +L     VHRD+   N LV    E+K++   ++K + +         S Y       
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN---------SEYYKLRNAL 179

Query: 387 ----WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIP 441
               W+APE V   + +S   D+WS G  + E+ T  + P+        + ++   K   
Sbjct: 180 IPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
            +PE         + +C   +P  RP  S+L+
Sbjct: 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 76.2 bits (187), Expect = 8e-15
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 17/209 (8%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L +++  K +G G  G V   +++   +  AIK++     +QT     K+  +E+ L+  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKC 79

Query: 279 LSHPNIV--------RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           ++H NI+        +    E  D  + + +E +       +  E    +   +     Q
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQD--VYIVMELMDANLCQVIQME---LDHERMSYLLYQ 134

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM    
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 78/271 (28%), Positives = 119/271 (43%), Gaps = 37/271 (13%)

Query: 227 LLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI- 284
           LL  GTFG ++ G    E         V+ V  D  S+  +  L QE  LL  LSH NI 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 285 -VRYHGSELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTR--------QILL 333
            + +   E  +    V   Y++ G++   LQ+   G  N P  Q  +         QI  
Sbjct: 72  PILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNP--QALSTQQLVHMAIQIAC 128

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLAD-------FGMAKHMTSCASMLSFKGSPY 386
           G++YLH R  +H+DI   N ++D   ++K+ D       F M  H          K    
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ---YEGVAAIFKIGNSKDIPE 442
           WMA E ++N   YS   D+WS G  + E+ T  + P+ +   +E +AA  K G    + +
Sbjct: 185 WMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDG--YRLAQ 240

Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
            P +  D+  + +  C   DP  RP  S+L+
Sbjct: 241 -PINCPDELFAVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 43/251 (17%)

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
           E  LL  ++HP+++R   + +S     + L + S      L +   P          +QI
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
           L GL YLHA+  +HRD+K  NI ++   ++ + D G A+      + L   G+    APE
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE 226

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMAT------SKPPWSQYEGVAA--------IFKIG-N 436
           V+   + Y+   DIWS G  + EM          PP +  E V +        I  +  +
Sbjct: 227 VLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285

Query: 437 SKDIPEIPE---------------------------HLSDDAKSFIKQCLQRDPSARPPA 469
            ++ P  P                            +L  D +  + + L  D + RP A
Sbjct: 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345

Query: 470 SKLLDHPFVRD 480
            ++L++P    
Sbjct: 346 EEILNYPMFAQ 356

Length = 357

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 70/259 (27%), Positives = 118/259 (45%), Gaps = 31/259 (11%)

Query: 226 KLLGRGTFGHVYLGFNSESGQM---CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K++G G FG V  G     G+     AIK ++    ++  ++ L     E +++ Q  HP
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS----EASIMGQFDHP 65

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQT--YTRQILLGLAYLH 339
           NI+   G     + + +  EY+  GS+   L+++ G F   VIQ     R I  G+ YL 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT--VIQLVGMLRGIASGMKYLS 123

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMN 395
               VHRD+   NILV+ +   K++DFG+++ +     +  +    K    W APE +  
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 396 TNGYSLTVDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLS 448
              ++   D+WS G  + E+ +   +P W  S  + + AI   +++    D P     L 
Sbjct: 184 RK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242

Query: 449 DDAKSFIKQCLQRDPSARP 467
            D       C Q+D + RP
Sbjct: 243 LD-------CWQKDRNERP 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 38/272 (13%)

Query: 227 LLGRGTFGHVYLGFNSESG--QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPN 283
           ++G G FG V      + G     AIK ++    +  S+   +    E+ +L +L  HPN
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLK----EFASENDHRDFAGELEVLCKLGHHPN 64

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQ-----EYGPF---NEPVIQTYTRQILL-- 333
           I+   G+  +   L + +EY   G++   L+     E  P          T T Q LL  
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 334 ------GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYW 387
                 G+ YL  +  +HRD+   N+LV  +   K+ADFG+++           +    W
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPW------SQYEGVAAIFKIGNSKDI 440
           MA E  +N + Y+   D+WS G  + E+ +    P+        YE +   +++      
Sbjct: 185 MAIE-SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM------ 237

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
            E P +  D+    ++QC +  P  RPP +++
Sbjct: 238 -EKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 66/265 (24%), Positives = 121/265 (45%), Gaps = 37/265 (13%)

Query: 228 LGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           LG+G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCH 69

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QIL 332
           ++VR  G     +   V +E ++ G +   L+   P  E       P ++   +   +I 
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSP 385
            G+AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +   
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPE 442
            WM+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + +
Sbjct: 187 -WMSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGMSNEQVLRFVMEGGLLD 241

Query: 443 IPEHLSDDAKSFIKQCLQRDPSARP 467
            P++  D     ++ C Q +P  RP
Sbjct: 242 KPDNCPDMLFELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 73.7 bits (181), Expect = 2e-13
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 41/236 (17%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL-KQLNQEINLLSQLSHPNI 284
           +L+G+G  G VYL ++    +  A+K++R   +D +    L K+  +E  + + L HP I
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIR---EDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 285 VRYHGSELSDERLSVY--LEYVSGGSIHKLL-----QEYGPFNEPVIQTYTR-------Q 330
           V  +   +  +   VY  + Y+ G ++  LL     +E     E   +T          +
Sbjct: 65  VPVY--SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIFHK 121

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---------------HMTSC 375
           I   + Y+H++  +HRD+K  NIL+   GE+ + D+G A                    C
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 376 ASMLSFK----GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
            S ++      G+P +MAPE ++     S + DI++LG  + +M T   P+ + +G
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKG 236

Length = 932

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 33/270 (12%)

Query: 228 LGRGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG+G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 72

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGL 335
           R  G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWM 388
           AYL+A+  VHRD+   N +V     +K+ DFGM + +            +L  +    WM
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WM 188

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWS--QYEGVAAIFKIGNSKDIPE-IP 444
           APE  +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  P
Sbjct: 189 APE-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247

Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           E ++D     ++ C Q +P  RP   ++++
Sbjct: 248 ERVTD----LMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 38/273 (13%)

Query: 227 LLGRGTFGHVYLGFNSESG-QM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPN 283
           ++G G FG V      + G +M  AIK ++    +  SK+  +    E+ +L +L  HPN
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQ-----EYGP---FNEPVIQTYTRQILL-- 333
           I+   G+      L + +EY   G++   L+     E  P          T + Q LL  
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 334 ------GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYW 387
                 G+ YL  +  +HRD+   NILV  +   K+ADFG+++           +    W
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 189

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPW------SQYEGVAAIFKIGNSKDI 440
           MA E  +N + Y+   D+WS G  + E+ +    P+        YE +   +++      
Sbjct: 190 MAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL------ 242

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
            E P +  D+    ++QC +  P  RP  +++L
Sbjct: 243 -EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 38/272 (13%)

Query: 227 LLGRGTFGHVYLGFNSESG--QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PN 283
           ++G G FG V      + G     AIK ++    +  SK+  +    E+ +L +L H PN
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE---------YGPFNEPVIQTYTRQILL- 333
           I+   G+      L + +EY   G++   L++         +   N       ++Q+L  
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 334 ------GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYW 387
                 G+ YL  +  +HRD+   NILV  +   K+ADFG+++           +    W
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPW------SQYEGVAAIFKIGNSKDI 440
           MA E  +N + Y+   D+WS G  + E+ +    P+        YE +   +++      
Sbjct: 178 MAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL------ 230

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
            E P +  D+    ++QC +  P  RP  +++
Sbjct: 231 -EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 41/275 (14%)

Query: 225 GKLLGRGTFGHVYLGF--NSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEINLLSQLSH 281
           GK LG G FG V  G     +S    A+K +++ +C    ++  ++    E   + +  H
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC----TRSEMEDFLSEAVCMKEFDH 59

Query: 282 PNIVRYHGSELSD-ERLS-----VYLEYVSGGSIHKLLQEYGPFNEPV------IQTYTR 329
           PN++R  G  L   E        V L ++  G +H  L      + P       +  +  
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY--- 386
            I  G+ YL +++ +HRD+   N +++ +  + +ADFG++K +        + G  Y   
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI--------YNGDYYRQG 171

Query: 387 --------WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNS 437
                   W+A E + +   Y+   D+WS G T+ E+AT  + P+   E       +   
Sbjct: 172 RIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230

Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
             + + P+ L D   S +  C   +P  RP    L
Sbjct: 231 NRLKQPPDCL-DGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 13/256 (5%)

Query: 226 KLLGRGTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           ++LG G FG +    L   S+     AI  +R  C D+  +  L     E   L Q  H 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA----EALTLGQFDHS 66

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHAR 341
           NIVR  G       + +  EY+S G++   L+++ G      +      +  G+ YL   
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKH--MTSCASMLSFKGSPYWMAPEVVMNTNGY 399
             VH+ +    +LV+     K++ F   +     +  + +S K    W APE +   + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI-QYHHF 185

Query: 400 SLTVDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           S   D+WS G  + E M+  + P+    G   I  + +   +P  P +  +     +  C
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCPNLLHQLMLDC 244

Query: 459 LQRDPSARPPASKLLD 474
            Q++   RP  S++  
Sbjct: 245 WQKERGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 13/155 (8%)

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           ++ Q+  G+ +L ++N VHRD+   N+L+     +K+ DFG+A+ +   ++ +S KGS +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302

Query: 387 ----WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSK 438
               WMAPE + N N Y+   D+WS G  + E+     T  P     E      K G   
Sbjct: 303 LPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
                P H SD+    +++C +     RP  S+L+
Sbjct: 362 ---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 69/272 (25%), Positives = 114/272 (41%), Gaps = 29/272 (10%)

Query: 228 LGRGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G G FG V LG      S     +KE+R      T  E L  L QE+    +L+HPN++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELR---ASATPDEQLLFL-QEVQPYRELNHPNVL 58

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ-----EYGPFNEPVIQTYTRQILLGLAYLHA 340
           +  G  +      + LE+   G +   L+           + V+Q    ++  GL +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMA--KHMTSCASMLSFKGSPY-WMAPEVVMNTN 397
            + +H D+   N  +     +K+ D+G+A  ++             P  W+APE+V    
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 398 GYSLTVD------IWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDI----PEIPEH 446
              L  D      IWSLG T+ E+ T +  P+        + ++   +DI    P++   
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238

Query: 447 LSDDAKSFIKQCLQRDPSARPPAS---KLLDH 475
            SD     ++ C   DP  RP A    +LL +
Sbjct: 239 YSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 38/189 (20%)

Query: 307 GSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD 365
            S+  +L+  G P NE  I     Q L  L  LH +      +   + L+   G      
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDG------ 54

Query: 366 FGMAKHMTSCASM--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS 423
                   S A       +  PY+MAPEV+   + Y+   DI+SLG T+ E    + P++
Sbjct: 55  --------SVAFKTPEQSRPDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYN 105

Query: 424 QYEGVAAIFKIGNSKDIP--EIPEHLSDDAK------------SFIKQCLQRDPSARPPA 469
           +        ++    +I    +P     D               F++ C  R P  R  A
Sbjct: 106 E------ERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAA 159

Query: 470 SKLLDHPFV 478
           +  L H   
Sbjct: 160 NHYLAHCRA 168

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 282 PNIVRYHGSELSDERLSVY-----LEYVSGGSIHKLLQEYGPFNEPVIQ--TYTRQILLG 334
           P +     S+ SD + S Y      +  +   +  LL + G      +   ++T Q+  G
Sbjct: 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARG 249

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----WMAP 390
           + +L ++N VHRD+   N+L+     +K+ DFG+A+ +   ++ +S KGS +    WMAP
Sbjct: 250 MEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGSTFLPVKWMAP 308

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIF--KIGNSKDIPEIPEH 446
           E + + N Y+   D+WS G  + E+ +     + Y G  V + F  KI +   + + P+H
Sbjct: 309 ESIFD-NLYTTLSDVWSYGILLWEIFSLGG--TPYPGMIVDSTFYNKIKSGYRMAK-PDH 364

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLD 474
            + +    + +C   +P  RP    L D
Sbjct: 365 ATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 33/198 (16%)

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           +PN ++ + S  + +   + ++Y+  G +  LL++ G  +E  ++   RQ++  L  LH 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 341 RNTVHRDIKGANILVDPH-GEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTN 397
            N +H DIK  N+L D     I L D+G+ K +   SC     + G+  + +PE +   N
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC-----YDGTLDYFSPEKIKGHN 182

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN-------------SKDIPEIP 444
            Y ++ D W++G    E+ T K P          FK                 K +P   
Sbjct: 183 -YDVSFDWWAVGVLTYELLTGKHP----------FKEDEDEELDLESLLKRQQKKLP-FI 230

Query: 445 EHLSDDAKSFIKQCLQRD 462
           +++S +A  F++  L+ +
Sbjct: 231 KNVSKNANDFVQSMLKYN 248

Length = 267

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 59/255 (23%), Positives = 111/255 (43%), Gaps = 20/255 (7%)

Query: 228 LGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCD--DQTSKECLKQLNQEINLLSQLS 280
           LGRGT   +Y G      + E       KE++V+    D + ++      +  +++ Q+S
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLGLAYLH 339
           H +IV  +G  + D    +  E+V  G +   + ++      P      +Q+   L+YL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 340 ARNTVHRDIKGANILVDPHGE-------IKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            ++ VH ++   NIL+   G        IKL+D G+   +T  +     +  P W+APE 
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-WIAPEC 179

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           V ++   S+  D WS G T+ E+  +     + + +A   +    + +   P     +  
Sbjct: 180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS--CKELA 237

Query: 453 SFIKQCLQRDPSARP 467
             +  C+  DP+ RP
Sbjct: 238 DLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 17/159 (10%)

Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGS 384
           +++ Q+  G+++L ++N +HRD+   NIL+  HG I K+ DFG+A+ + +  S    KG+
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRN-DSNYVVKGN 275

Query: 385 PY----WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGV---AAIFKIG 435
                 WMAPE + N   Y+   D+WS G  + E+ +  S P    Y G+   +  +K+ 
Sbjct: 276 ARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSP----YPGMPVDSKFYKMI 330

Query: 436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                   PE    +    +K C   DP  RP   +++ 
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 52/277 (18%)

Query: 228 LGRGTFGHVYLGF-------NSESGQMCAI----------KEVRVVCD--DQTSKECLKQ 268
           LG+GT  ++Y G          E  +M             +E+RVV    D + ++    
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTY 327
             +  +L+SQ+SH ++   HG  +      +  E+V  G +   L +E G        T 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122

Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGE-------IKLADFGMAKHMTSCASMLS 380
            +Q+   L+YL  +N VH ++   NIL+   G        IKL+D G++   T+ +    
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREER 180

Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI 440
            +  P W+APE V   N  S   D WS G T+LE+         ++G   +      +  
Sbjct: 181 VERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEIC--------FDGEVPL----KERTP 227

Query: 441 PE----------IPEHLSDDAKSFIKQCLQRDPSARP 467
            E          +PE    +  + I QCL  +P+ RP
Sbjct: 228 SEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           Y+ Q+  G+ +L +R  +HRD+   NIL+  +  +K+ DFG+A+ +      +  KG   
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDAR 242

Query: 387 ----WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSK 438
               WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G   
Sbjct: 243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
                P++ + +    +  C   +PS RP  S+L++H
Sbjct: 302 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 13/156 (8%)

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           Y+ Q+  G+ +L +R  +HRD+   NIL+  +  +K+ DFG+A+ +      +  KGS  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGSAR 237

Query: 387 ----WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSK 438
               WMAPE + +   Y+   D+WS G  + E+    A+  P     E      K G   
Sbjct: 238 LPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                PE+ + +    +  C Q DP  RP  S L++
Sbjct: 297 ---RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 19/161 (11%)

Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK-------HMTSCASM 378
           +Y+ Q+  G+ +L +R  +HRD+   NIL+  +  +K+ DFG+A+       ++    + 
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKI 434
           L  K    WMAPE + +   Y+   D+WS G  + E+    A+  P     E      K 
Sbjct: 237 LPLK----WMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291

Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           G        PE+ + +  S +  C   +P  RP  S+L++ 
Sbjct: 292 GTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 49/187 (26%), Positives = 73/187 (39%), Gaps = 31/187 (16%)

Query: 256 VC---DDQTSKECL-------KQLNQEINLLSQLSHPNIVR----YHGSELSDERLSVY- 300
           VC    D+  K+ +       K   +EI++L  +SH  I+     Y         +  Y 
Sbjct: 110 VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169

Query: 301 ---LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP 357
                YV            GP       T  R++L  LAYLH R  +HRD+K  NI +D 
Sbjct: 170 CDLFTYVDR---------SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE 220

Query: 358 HGEIKLADFGMAKHMTSCASM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE 414
                L DFG A  + +         + G+    +PE ++  + Y    DIWS G  + E
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFE 279

Query: 415 MATSKPP 421
           M+     
Sbjct: 280 MSVKNVT 286

Length = 392

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 29/226 (12%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMC---AIKEVRVVCDDQTSKECLKQLN----QEI 273
           +WK  KL+G G FG VY      S       A+ ++  + ++    E L   N     +I
Sbjct: 13  EWKIDKLIGCGGFGCVY-ETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKI 71

Query: 274 NL---LSQLSHPNIVRYHGSELSDERLSVYLEYVSGG----SIHKLLQEYGPFNEPVIQT 326
            L   +  + H  I +Y+G   S +R  +Y  ++       +  ++ +     N+ +I+ 
Sbjct: 72  ALWKNIHNIDHLGIPKYYGCG-SFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF----- 381
             + +L  L Y+H     H DIK  NI+VD +    + D+G+A H       + +     
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190

Query: 382 ---KGSPYWMAPEVVMNTNGYSLTV--DIWSLGCTVLEMATSKPPW 422
              +G+ Y+   +     NG  +T   D+ SLG  +L+ A  K PW
Sbjct: 191 DLHRGTLYYAGLD---AHNGACVTRRGDLESLGYCMLKWAGIKLPW 233

Length = 294

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 48/154 (31%), Positives = 67/154 (43%), Gaps = 14/154 (9%)

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQ 325
            E  LL +LSHP ++      L D R+   L  +        L  Y      P     + 
Sbjct: 209 HEARLLRRLSHPAVL-----ALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVT 263

Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSFK 382
              RQ+L  + Y+H    +HRDIK  N+LV+   +I L DFG A       S        
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
           G+    APEV+   + Y+ +VDIWS G  + E A
Sbjct: 324 GTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 36/214 (16%)

Query: 226 KLLGRGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           K +G G FG V LG   +  +     +KE+RV    Q   + L    +E      L H N
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFL----EEAQPYRSLQHSN 56

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQ-----EYGPFNEPVIQTYTRQILLGLAYL 338
           +++  G         + +E+   G +   L+     E    +   +Q    +I LGL +L
Sbjct: 57  LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-----------W 387
           H  N +H D+   N L+     +K+ D+G+        S   +K   Y           W
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGL--------SHNKYKEDYYVTPDQLWVPLRW 168

Query: 388 MAPEVVMNTNGYSLTVD------IWSLGCTVLEM 415
           +APE+V   +G  L VD      +WSLG T+ E+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 23/159 (14%)

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           ++ Q+  G+ +L ++N +HRD+   N+L+      K+ DFG+A+ + +  S    KG+  
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN-DSNYVVKGNAR 275

Query: 387 ----WMAPEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYEGVAAIFKIGNSKDIP 441
               WMAPE + +   Y++  D+WS G  + E+ +  K P   Y G+       NSK   
Sbjct: 276 LPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP---YPGILV-----NSKFYK 326

Query: 442 EI--------PEHLSDDAKSFIKQCLQRDPSARPPASKL 472
            +        P+    +  S +K C   +P+ RP  S++
Sbjct: 327 MVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--MLSFKGSPY 386
           R +L  + YLH    +HRDIK  NI ++  G++ L DFG A       +     + G+  
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
             APE++   + Y   VDIWS G  + EMAT
Sbjct: 249 TNAPELLAR-DPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 51/236 (21%), Positives = 102/236 (43%), Gaps = 32/236 (13%)

Query: 257 CDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG--SELSDE--RLSVYLEYVSGGSIHKL 312
              +  K  +     EI  L ++   NI++ +G   ++ D+  RLS+ LEY + G + ++
Sbjct: 53  KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV 112

Query: 313 LQEYGPFNEPVIQTYTR-QILL----GLAYLHAR-NTVHRDIKGANILVDPHGEIKLADF 366
           L       E  +   T+  + +    GL  L+   N  ++++   + LV  + ++K+   
Sbjct: 113 LD-----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH 167

Query: 367 GMAKHMTSCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW 422
           G+ K ++S        + +    Y M  ++      Y++  DI+SLG  + E+ T K P+
Sbjct: 168 GLEKILSSPPFKNVNFMVYF--SYKMLNDIFSE---YTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 423 SQ--YEGV-AAIFKIGNSKDIP-EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                + +   I    NS  +P + P  +    K  ++ C   D   RP   ++L 
Sbjct: 223 ENLTTKEIYDLIINKNNSLKLPLDCPLEI----KCIVEACTSHDSIKRPNIKEILY 274

Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 4/97 (4%)

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-- 440
           G+P ++APE+++    +   VD W+LG  + E  T  PP++  E    +F+   ++DI  
Sbjct: 542 GTPDYLAPELLL-GKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIPW 599

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           PE  E LS +A++ I+  L  DP+ R    +L  HP 
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 82/321 (25%), Positives = 136/321 (42%), Gaps = 61/321 (19%)

Query: 150 PKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIED-GKSQCH----------------- 191
           PK+  + S G T+  S   AR SG   D  T    D G+++ H                 
Sbjct: 32  PKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNV 91

Query: 192 KLPLPPGSPTSPSALPC-SRTSG-----VTEN---SLSKWKKGKLLGRGTFGHVYLGFNS 242
           ++  PP       ALP  SR  G     + E+   S  ++K   LLG GTFG V   ++ 
Sbjct: 92  EVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDR 151

Query: 243 ESGQMCAIKEVRVVC----DDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS 298
           +  + CA+K VR V     D +   + ++++ Q  +   +     I RY  +E +     
Sbjct: 152 KRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA-DPADRFPLMKIQRYFQNE-TGHMCI 209

Query: 299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANIL--- 354
           V  +Y  G  +   + ++GPF+   +     Q  + L Y H   + +H D+K  NIL   
Sbjct: 210 VMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMET 267

Query: 355 ----VDPHG---------EIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNG 398
               VDP            +++ D G     +H     S  +   + ++ +PEVV+   G
Sbjct: 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGL-G 321

Query: 399 YSLTVDIWSLGCTVLEMATSK 419
           +  + D+WS+GC + E+ T K
Sbjct: 322 WMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 49/236 (20%), Positives = 94/236 (39%), Gaps = 20/236 (8%)

Query: 228 LGRGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G G FG V L   +         +KE++     +   E L+Q +        L HPNI+
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDP----YRILQHPNIL 58

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHAR 341
           +  G  +      +  EY   G +   L +           ++Q    +I  G+ ++H  
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGM--AKHMTSCASMLSFKGSPY-WMAPEVVMNTNG 398
           N +H D+   N  +     +K+ D+G+  +++          K  P  W+APE+V   +G
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178

Query: 399 YSLTVD------IWSLGCTVLEM-ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL 447
             +T +      +W+LG T+ E+   +  P+S       +  +   + +      L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 29/71 (40%), Positives = 38/71 (53%), Gaps = 2/71 (2%)

Query: 323 VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK 382
           VI+   RQ+L GL  LH    VHRDIK  N+LV   G++K+ DFG A  M +  +     
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLY 369

Query: 383 G--SPYWMAPE 391
           G   P +  PE
Sbjct: 370 GMLDPRYSPPE 380

Length = 507

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 37/118 (31%), Positives = 50/118 (42%), Gaps = 24/118 (20%)

Query: 323 VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCASML-- 379
           +IQT  RQIL  L  LH+   VHRD+K  NI+     G  K+ D G A  +    + +  
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315

Query: 380 SFKGSPYWMAPE-VVMNTNGYSLTV--------------------DIWSLGCTVLEMA 416
            F   P + APE  +M+T   S                       DI+S G   L+MA
Sbjct: 316 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS--CASMLSFKGSPY 386
           +Q+L  + Y+H +  +HRDIK  NI ++  G+I L DFG A        A    + G+  
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVA 333

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
             +PE++   +GY    DIWS G  +L+M +
Sbjct: 334 TNSPEILAG-DGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.1 bits (99), Expect = 9e-04
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 44/281 (15%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
            + LS  K+  ++ RG  G  Y G + ++G    +KE+  V    +S         EI  
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---------EIAD 736

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           + +L HPNIV+  G   S++   +  EY+ G ++ ++L+              R+I +G+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGI 789

Query: 336 A----YLHAR---NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM 388
           A    +LH R     V  ++    I++D   E  L    ++     C     F  S Y +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISSAY-V 845

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN------SKDI- 440
           APE    T   +   DI+  G  ++E+ T K P     GV  +I +           D+ 
Sbjct: 846 APET-RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW 904

Query: 441 --PEIPEHLSDDAKSFIK------QCLQRDPSARPPASKLL 473
             P I   +S +    ++       C   DP+ARP A+ +L
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	628
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.21
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.91
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
COG4248	637	Uncharacterized protein with protein kinase and he	98.77
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.74
PRK09902	216	hypothetical protein; Provisional	98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
PF01636	239	APH: Phosphotransferase enzyme family This family	98.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.38
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.36
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.27
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.18
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.09
PLN02876	822	acyl-CoA dehydrogenase	98.07
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.91
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.83
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.72
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.7
PRK10593	297	hypothetical protein; Provisional	97.69
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.46
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.42
KOG2270	520	consensus Serine/threonine protein kinase involved	97.31
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.3
PRK05231	319	homoserine kinase; Provisional	97.22
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.09
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.93
PLN02236	344	choline kinase	96.86
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.81
PRK12396	409	5-methylribose kinase; Reviewed	96.77
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.4
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.37
PLN02756	418	S-methyl-5-thioribose kinase	95.95
PTZ00384	383	choline kinase; Provisional	95.89
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.88
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.75
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.57
PRK06148	1013	hypothetical protein; Provisional	95.36
PRK11768	325	serine/threonine protein kinase; Provisional	95.04
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.89
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.55
PTZ00296	442	choline kinase; Provisional	94.17
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.51
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.79

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7e-61  Score=494.56  Aligned_cols=294  Identities=32%  Similarity=0.538  Sum_probs=263.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+++.+.|++.||+|++++..-  .....+++...|..||.+++||+||.|+..|++.+.+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i--v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI--VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh--hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            46799999999999999999999999999999999976432  2234568899999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc-cCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~-~~~~  376 (628)
                      |||+||+.||+|+.+|++.+.|+|..++.|+++|+.||.|||++|||||||||||||||.+|+|+|+||||++.. ....
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999954 4445


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ...++|||+.|||||++.+. +|+.++|||||||++||||+|.+||...+....+.+|.... .+..+..++.++++||+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             ccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence            66679999999999999877 49999999999999999999999999988777777776554 45667779999999999


Q ss_pred             HHhhcCCCCCC----CHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          457 QCLQRDPSARP----PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       457 ~~L~~dP~~Rp----ta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      ++|++||++|.    ++.+|.+||||++++|.......             ..||+.+.+....++++|+.+|+..
T Consensus       259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~-------------l~PpF~P~~~~~~~~~~Fd~eft~~  321 (357)
T KOG0598|consen  259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK-------------LSPPFKPNVTGLEDTSNFDNEFTSY  321 (357)
T ss_pred             HHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC-------------CCCCeecCCCCccccccccHHHHhc
Confidence            99999999996    68999999999999999886544             4567788888888899998877664

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-58  Score=478.72  Aligned_cols=265  Identities=32%  Similarity=0.483  Sum_probs=231.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch--HHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS--KECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ..+.|.+.+.||.|+||.|-+|+.+.||+.||||++.+.......  ......+++|++||++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            346788999999999999999999999999999999754322211  222345789999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccCCcccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHM  372 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFGla~~~  372 (628)
                      ..||||||+.||+|++.+-.++.+.|...+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999766   57999999999999


Q ss_pred             cCccccccccCCCCcCChhhhhccC--CCCccccccccccceeeeccCCCCCCCCchhH-HHhhhcCC--CCCCCCCCcC
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-AIFKIGNS--KDIPEIPEHL  447 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~-~~~~i~~~--~~~~~~p~~~  447 (628)
                      .....+.++||||.|.|||++.+.+  .+..++|||||||+||-||+|.+||....... ...+|...  ...+..|..+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            8888889999999999999996533  35568999999999999999999997654443 33334333  2345677889


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ++++.+||++||..||++||+++|+|+||||++..
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999999999999999998665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-57  Score=454.45  Aligned_cols=269  Identities=31%  Similarity=0.539  Sum_probs=245.2

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||.|+||+|.+++++.+|..||+|++++..  ......+++..+|..||+.+.||+|++|++.|.+...
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~--vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK--VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH--HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            36889999999999999999999999999999999997532  2234456788999999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||||+.||.|+.+|++.++|+|..+++|++||+.||+|||+++|+||||||||||||.+|++||+|||+|+..... 
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987654 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                       ..+.||||.|+|||++... +|+.++|||||||++|||+.|.+||...+......+|.....  .+|..++.++++||+
T Consensus       198 -T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLK  273 (355)
T ss_pred             -EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHH
Confidence             6789999999999999765 499999999999999999999999999888777777766543  688899999999999


Q ss_pred             HHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCcC
Q 040472          457 QCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNLA  492 (628)
Q Consensus       457 ~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~~  492 (628)
                      ++|+.|-.+|.     ...+|.+||||++..|.......+.
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie  314 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIE  314 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcccc
Confidence            99999999994     6789999999999999887765544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-57  Score=494.41  Aligned_cols=298  Identities=27%  Similarity=0.459  Sum_probs=267.2

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE  295 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~  295 (628)
                      ..+++|+++++||+|.||+|++|..+.+++.||||++++.  .....+.++.++.|.+|+.... ||++++|+.+|++.+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~--~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKG--DILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecc--ceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3678999999999999999999999999999999999863  3344556788889999998886 999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-C
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-S  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~  374 (628)
                      ++|+||||+.||+ ..++++.+.|+|..++.|+++|+.||+|||++||||||||.+|||||.+|++||+||||++..- .
T Consensus       443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999999999 4455566899999999999999999999999999999999999999999999999999998754 5


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      .....++||||.|||||++.+.. |+.++|||||||+|||||.|..||.+.++.+....|...  .+.+|..++.++.++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAI  598 (694)
T ss_pred             CCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHH
Confidence            55778899999999999998765 999999999999999999999999998887777777653  357888999999999


Q ss_pred             HHHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCC
Q 040472          455 IKQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANP  529 (628)
Q Consensus       455 I~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~  529 (628)
                      |+++|++||++|+.     +++|..||||+.++|....+..             .+||+.+.+....++++|+.+|+.+.
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~-------------i~PPf~P~i~~~~D~snFd~eFt~e~  665 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR-------------IKPPFVPTIKGPEDVSNFDEEFTSEK  665 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc-------------CCCCCCcccCChhhhcccchhhhcCC
Confidence            99999999999986     5789999999999999887654             46888899999999999999999986


Q ss_pred             CCcc
Q 040472          530 LVPT  533 (628)
Q Consensus       530 ~~~~  533 (628)
                      ...+
T Consensus       666 p~Lt  669 (694)
T KOG0694|consen  666 PALT  669 (694)
T ss_pred             CccC
Confidence            5544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-56  Score=481.98  Aligned_cols=255  Identities=33%  Similarity=0.610  Sum_probs=232.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+|+.+++||+|||++||++++..+|+.||+|++.+..-.  .....+.+.+||+|.++|+|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~--k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK--KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc--CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            6899999999999999999999999999999999653211  12334678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~  378 (628)
                      |+|+|..++|..++++.+.++|.+++.|++||+.||.|||+++|||||||..||||+.+.+|||+|||||..+... ...
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999988754 677


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      .++||||.|+|||++... +++..+||||+|||||-||+|++||...+-.+...+|.....  .+|..++.++++||.+|
T Consensus       176 ~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             ceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence            899999999999999754 599999999999999999999999998766666666665443  56779999999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccc
Q 040472          459 LQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      |+.||.+||++++||.|+||+
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhhh
Confidence            999999999999999999994

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-56  Score=475.82  Aligned_cols=294  Identities=28%  Similarity=0.482  Sum_probs=256.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||+|+||.||+|+.+.||+.||+|++++..  -.....+++++.|-.||....+++||+||..|++.++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~--M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE--MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH--HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            36789999999999999999999999999999999998632  2345567889999999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC--
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS--  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~--  374 (628)
                      +||||||++||++..+|.+.+.|+|..+++|+.+++.||+.||+.|||||||||+|+|||..|++||+||||+.-+..  
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999842100  


Q ss_pred             ---------------------c-c------------------------ccccccCCCCcCChhhhhccCCCCcccccccc
Q 040472          375 ---------------------C-A------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL  408 (628)
Q Consensus       375 ---------------------~-~------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSL  408 (628)
                                           . .                        ...+.+|||.||||||+++.+ |+..+|||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSL  374 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSL  374 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHH
Confidence                                 0 0                        011457999999999998765 9999999999


Q ss_pred             ccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCHHHHHHHHHHhhcCCCCCCC---HHHHhcCccccchHH
Q 040472          409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQRDPSARPP---ASKLLDHPFVRDQAV  483 (628)
Q Consensus       409 GvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rpt---a~eiL~Hpwf~~~~~  483 (628)
                      ||||||||.|.+||...+..+...+|......-.+|  ..++.++.|||.+||. ||++|..   ++||.+||||++++|
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence            999999999999999988888888887776444444  3478999999999999 9999985   999999999999999


Q ss_pred             HhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCCC
Q 040472          484 ARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPL  530 (628)
Q Consensus       484 ~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~~  530 (628)
                      ....               ...+|+++.+....++.+|+ +|..+..
T Consensus       454 ~~l~---------------~~~apfvP~v~~~~DT~yFd-dF~e~~~  484 (550)
T KOG0605|consen  454 DHLR---------------EMPAPFVPQVNSELDTQYFD-DFPEEDS  484 (550)
T ss_pred             chhh---------------cCCCCCCCCCCCcccccccc-cCccccc
Confidence            7653               23467788888899999998 5655433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-55  Score=452.39  Aligned_cols=257  Identities=35%  Similarity=0.660  Sum_probs=231.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER-  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~-  296 (628)
                      .+++.+.++.||+|..|+||+++|+.|++.+|+|+|..    ..+.+..+++.+|++||+.++|||||.+|++|.++.. 
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            45688889999999999999999999999999999954    2345667899999999999999999999999999995 


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ++|+||||+||+|.+++.+.++++|..+..++.++++||.|||+ ++||||||||+||||+..|+|||||||.++.+...
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999999999999999999999999999999999996 89999999999999999999999999999877554


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC-----chhHHHhhhcCCCCCCCCCCc-CCH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY-----EGVAAIFKIGNSKDIPEIPEH-LSD  449 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~-----~~~~~~~~i~~~~~~~~~p~~-~s~  449 (628)
                       ...+++||..|||||.+.+.. |+.++||||||++++||++|+.||...     ...+.+..|. ....|.+|.. +|+
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCCH
Confidence             557889999999999998765 999999999999999999999999763     3344444454 3456788886 999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ++++||.+||++||.+|+++.|+++|||++..
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            99999999999999999999999999999754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=464.01  Aligned_cols=265  Identities=33%  Similarity=0.574  Sum_probs=236.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDE  295 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~  295 (628)
                      ....+|..++.||+|+|++||+|+++.+++.||||++.+..  ...+.-++.+..|..+|.+| .||.||+||..|+++.
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~--Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY--IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH--HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            35679999999999999999999999999999999986421  12233356688899999999 6999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|+|+||+++|+|.++|++.|.|+|..++.|++||+.||+|||++|||||||||||||||.||++||+|||-|+.+.+.
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999876432


Q ss_pred             c------------c--cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC
Q 040472          376 A------------S--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP  441 (628)
Q Consensus       376 ~------------~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~  441 (628)
                      .            .  ..+++||..|.+||+|... ..+..+|||+||||||.||.|.+||.+.++-..+.+|....  .
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~--y  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD--Y  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc--c
Confidence            1            1  1458999999999999654 48999999999999999999999999888777777776533  3


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      .+++.+++.+++||+++|..||.+|+|++||.+||||.+++|...
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            678889999999999999999999999999999999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-53  Score=441.13  Aligned_cols=262  Identities=31%  Similarity=0.570  Sum_probs=236.0

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+.+|.+.+.||+|+||+||+|+++.++..||||.|.+..   ...+..+.+..||.||+.++|||||+|++++.+++.
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            35679999999999999999999999999999999986532   235566778899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC------CCEEEeccCCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH------GEIKLADFGMAK  370 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~------g~vKL~DFGla~  370 (628)
                      +|||||||+||+|.++|++.+.++|..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999764      358999999999


Q ss_pred             cccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCCCCCCcCCH
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSD  449 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~s~  449 (628)
                      .+.......+.||++.|||||+++.. +|+.|+|+||+|+|||+|++|++||......+.+..+... ..++.++..++.
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence            99988888899999999999999755 5999999999999999999999999987766666555444 345667778889


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ...+|+..+|++++.+|.+..+-+.|+++....
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            999999999999999999999999999986443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-52  Score=432.68  Aligned_cols=258  Identities=52%  Similarity=0.965  Sum_probs=228.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--c
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--R  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--~  296 (628)
                      ..+|..++.||+|+||.||++.+..+|..+|||.+....    ... .+.+.+|+++|.+|+|||||+++|.....+  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            457999999999999999999999999999999886531    111 677899999999999999999999865555  6


Q ss_pred             ceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~~~~  374 (628)
                      ++++|||+.||+|.+++.+.+ .|+|..++.+++||++||+|||++|||||||||+||||+. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999999887 7999999999999999999999999999999999999999 79999999999987663


Q ss_pred             ----ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCC-CchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 ----CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQ-YEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                          ......+.||+.|||||++........++|||||||++.||+||.+||.. ......+..+......|.+|..++.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence                22344578999999999997522233499999999999999999999998 6777778888877778899999999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ++++||.+||++||++||||.++|+|||.+..
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            99999999999999999999999999998654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.4e-53  Score=422.98  Aligned_cols=259  Identities=29%  Similarity=0.530  Sum_probs=225.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|+.+.++|+|+||+||+++++.||+.||||.+.-..   ......+-..+||++|++|+|+|+|.|+.+|.....++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese---dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE---DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC---ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            57889999999999999999999999999999885322   223444557899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Ccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~  378 (628)
                      |+|||+.--|.++-+....+++..++.|++|++.|+.|||+++|||||||||||||+.+|.+||||||+|+.+. +...+
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            99999886666655555779999999999999999999999999999999999999999999999999999887 56667


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--------------------
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--------------------  438 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--------------------  438 (628)
                      +.++.|.||+|||.+.+...|+..+||||+||++.||++|.+.|.+....++++.|....                    
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            789999999999999998889999999999999999999999999988888776663211                    


Q ss_pred             CCCCCC---------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 DIPEIP---------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ~~~~~p---------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .+|+..         +.++.-+.||+++||+.||.+|++.+|+|.|+||.+.
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            111111         2467789999999999999999999999999999543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-52  Score=446.28  Aligned_cols=260  Identities=32%  Similarity=0.547  Sum_probs=233.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-cchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~  295 (628)
                      ...+|++++.||+|+||+||+|++..++..||||++...... .. ....+++.+|+.+|++++ ||||++++.++....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            467999999999999999999999999999999977653211 11 234567789999999999 999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCcccc-c
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHM-T  373 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~~~-~  373 (628)
                      .+|+|||||.||+|+++|.+.+++.|..++.+++||+.||+|||++||+||||||||||++.+ +++||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 99999999999988 4


Q ss_pred             CccccccccCCCCcCChhhhhccC-CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcC-CHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL-SDDA  451 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~-s~~l  451 (628)
                      ......+.|||+.|+|||++.+.. +...++||||+||+||.|++|+.||...+......+|....  ..+|..+ +.++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~--~~~p~~~~S~~~  251 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE--FKIPSYLLSPEA  251 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC--ccCCCCcCCHHH
Confidence            666778899999999999998766 44689999999999999999999999877666666654433  3567778 9999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ++||++||..||.+|+++.+|++||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-52  Score=451.80  Aligned_cols=262  Identities=33%  Similarity=0.553  Sum_probs=240.6

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ...+.-|++++.||.|+-|.|.+|+|..||+.+|||+|.+..  .........+.+||-||+.+.||||++||+++.+..
T Consensus         8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen    8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cccccceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            346778999999999999999999999999999999996542  222334567889999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ++|||+||++||.|+++|.+.|+|+|.+++.+++||+.|+.|||..+|+||||||||+|||..+++||+|||||....++
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987777


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ....+.||+|.|.|||++++..+.+.++||||.|||||.||+|+.||++.+....+.++....  .++|..++.++++||
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f~MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--FEMPSNISSEAQDLL  243 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--ccCCCcCCHHHHHHH
Confidence            788889999999999999999888999999999999999999999999877767777776544  478899999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccccch
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ++||..||++|+|.+||++|||+...
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcC
Confidence            99999999999999999999998754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-52  Score=437.86  Aligned_cols=260  Identities=32%  Similarity=0.576  Sum_probs=230.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE-  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~-  295 (628)
                      ..++|.+.++||.|+||.||+|+.+.++..||||.++....  ...++.  -.+|++.|++|+ |||||+|++++.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            35799999999999999999999999999999998875322  222322  247999999999 999999999999987 


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+|+|||||+ .+|+++++.+ ..|+|..++.|+.||++||+|+|++|+.|||||||||||.....|||+|||+|+.+..
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            9999999996 4999999865 5799999999999999999999999999999999999999888999999999999998


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC-------------
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP-------------  441 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~-------------  441 (628)
                      ...++.++-|.||+|||+|+....|+.++||||+|||++|+.+-++.|.+..+.+++++|...-..|             
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            8888999999999999999999999999999999999999999999999999999988874322111             


Q ss_pred             ---------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          442 ---------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       442 ---------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                                     .+-...+.++.+||.+||++||.+||||.|+|+||||+...
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                           11234789999999999999999999999999999997554

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=423.47  Aligned_cols=296  Identities=28%  Similarity=0.473  Sum_probs=262.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|..+++||+|.||+|-+++.+.+++.||||++++..  ...++.+.+-..|-++|+..+||++..|...|+..+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            5789999999999999999999999999999999997532  23355567788899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc-ccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~-~~~~~  376 (628)
                      ++||||+.||+|+.+|.+...|+|..++.|..+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++. +....
T Consensus       244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999985 44556


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ...++||||.|+|||++.. ..|+.++|||.+||+||||++|+.||...+....+.-|. ..+ -.+|..++++++.||.
T Consensus       324 t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-~ed-~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-MED-LKFPRTLSPEAKTLLS  400 (516)
T ss_pred             eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-hhh-ccCCccCCHHHHHHHH
Confidence            7788999999999999965 459999999999999999999999999866654443333 233 2678899999999999


Q ss_pred             HHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCCCC
Q 040472          457 QCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPLV  531 (628)
Q Consensus       457 ~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~~~  531 (628)
                      .+|.+||.+|+.     +.||.+|+||..++|......             ...||+.+.+..+.+...|+.+|+..++.
T Consensus       401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K-------------ki~PPfKPqVtSetDTryFD~EFT~q~v~  467 (516)
T KOG0690|consen  401 GLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK-------------KIEPPFKPQVTSETDTRYFDEEFTSQPVT  467 (516)
T ss_pred             HHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh-------------ccCCCCCCCcccccchhhhhhhhhcceeE
Confidence            999999999974     889999999999999876543             45678888888999999999999987654

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-51  Score=427.61  Aligned_cols=264  Identities=32%  Similarity=0.473  Sum_probs=233.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|.-|+||+|+.+.++..+|+|++.+..  ......+.+++.|.+||+.++||++++||..|+.++..
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~--l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES--LASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH--HhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            4679999999999999999999999999999999997532  22345577899999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc--
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT--  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~--  373 (628)
                      |||||||.||+|+.+++++  +.|++..+++|+++++.||+|||..|||+||||||||||-++|+|.|.||.|+....  
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999999999875  579999999999999999999999999999999999999999999999999863210  


Q ss_pred             --------------------------------C-c----------------------cccccccCCCCcCChhhhhccCC
Q 040472          374 --------------------------------S-C----------------------ASMLSFKGSPYWMAPEVVMNTNG  398 (628)
Q Consensus       374 --------------------------------~-~----------------------~~~~~~~GT~~Y~APEvl~~~~~  398 (628)
                                                      . .                      ....+++||-.|+|||++.+.+ 
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-
Confidence                                            0 0                      1123478999999999998765 


Q ss_pred             CCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHHHHhhcCCCCCCC----HHHHh
Q 040472          399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDPSARPP----ASKLL  473 (628)
Q Consensus       399 ~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt----a~eiL  473 (628)
                      ++.++|||+|||+|||||+|..||.+.++.+.+..|.... ..++.+ .++..++|||+++|.+||.+|..    +.||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999988876544 233333 68899999999999999999998    99999


Q ss_pred             cCccccchHHHh
Q 040472          474 DHPFVRDQAVAR  485 (628)
Q Consensus       474 ~Hpwf~~~~~~~  485 (628)
                      +||||++.+|+.
T Consensus       391 ~HpFF~gVnWaL  402 (459)
T KOG0610|consen  391 RHPFFEGVNWAL  402 (459)
T ss_pred             cCccccCCChhh
Confidence            999999999983

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-51  Score=402.60  Aligned_cols=257  Identities=32%  Similarity=0.531  Sum_probs=233.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ++++|++++.||+|.||.||+|+.+.++..||||++.+..  .......+++.+|++|...|+||||+++|++|.++.++
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            6789999999999999999999999999999999997532  22234457899999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ||++||..+|+|+..|+  ...+|+|..+..|++|++.||.|||.++||||||||+|+|++.+|.+||+|||++.+.. .
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence            99999999999999999  56789999999999999999999999999999999999999999999999999998654 6


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ....+.|||..|++||++.+. .++..+|+|++|++.||+|.|.+||......+...+|.....  .+|..++.+++|||
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--KFPSTISGGAADLI  253 (281)
T ss_pred             CCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--cCCcccChhHHHHH
Confidence            677889999999999999765 499999999999999999999999998776666666655432  56789999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .+||.++|.+|....|+++|||+..
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999853

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-50  Score=429.92  Aligned_cols=258  Identities=32%  Similarity=0.564  Sum_probs=224.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--E  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~  295 (628)
                      ..+.|+.+++||+|+||.||+|++..||+.||||.++....   ..+......+||.||++|.|||||+|.+...+.  .
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~---~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE---KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC---CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            45689999999999999999999999999999999886432   234456678999999999999999999988776  6


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+|||+|||+. +|.-++... -.|++.+++.||.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+++..
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            89999999976 888888763 4799999999999999999999999999999999999999999999999999997765


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------CC--CCC
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------IP--EIP  444 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------~~--~~p  444 (628)
                      ..  .++..+-|.||+|||+|++...|+.++|+||+||||.||++|++.|.+..+++++.+|.....      ++  .+|
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            44  466778899999999999999999999999999999999999999998887777665522111      11  111


Q ss_pred             -------------------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          445 -------------------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       445 -------------------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                                         ..++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                               24778899999999999999999999999999994

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.8e-49  Score=415.64  Aligned_cols=258  Identities=31%  Similarity=0.486  Sum_probs=223.3

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      ++||+|+||.||+|+++.+++.||||+++....  .......++.+|+.+|++++||||+++++++..++.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            469999999999999999999999999874221  123345677889999999999999999999999999999999999


Q ss_pred             cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccCC
Q 040472          306 GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGS  384 (628)
Q Consensus       306 GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT  384 (628)
                      |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            999999999888999999999999999999999999999999999999999999999999999975422 2233457799


Q ss_pred             CCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCC
Q 040472          385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS  464 (628)
Q Consensus       385 ~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  464 (628)
                      +.|+|||++.+. .++.++|||||||++|||++|..||...+.......+...  ...++..++.++.+||++||+.||+
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999998654 4899999999999999999999999876554444444332  2356778999999999999999999


Q ss_pred             CCC-----CHHHHhcCccccchHHHhhcC
Q 040472          465 ARP-----PASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       465 ~Rp-----ta~eiL~Hpwf~~~~~~~~~~  488 (628)
                      +|+     ++.+|++|+||+...|.....
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~~~~~~~~  264 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASINWQDVVQ  264 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            999     899999999999887766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-51  Score=408.76  Aligned_cols=255  Identities=33%  Similarity=0.606  Sum_probs=220.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeec-ceeccc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG-SELSDE-  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~-~~~~~~-  295 (628)
                      ++.+|+++++||+|.||.||++++..+|+.||+|.++..   .......+++..|+.+|++|+|||||++++ .|..+. 
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~---~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG---MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh---hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            578999999999999999999999999999999988632   233444567889999999999999999998 455544 


Q ss_pred             cceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccccCCCceEeCCCCCEEEeccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHA--RN--TVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~--~g--IvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      -++||||||.+|+|.++|++    ...++|..++.++.|++.||..||.  .+  |+||||||.||+|+.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            49999999999999999974    3569999999999999999999998  45  9999999999999999999999999


Q ss_pred             CcccccCcc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC-C
Q 040472          368 MAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-E  445 (628)
Q Consensus       368 la~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p-~  445 (628)
                      |++.+.... ...+++|||+||+||++.+.+ |+.++|||||||++|||+.-++||.+.+-.....+|.+. +.+.+| .
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDE  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHH
Confidence            999886644 346789999999999998765 999999999999999999999999998666666666654 566667 7


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ..|.++..||..|+..|++.||+.     +|++.++.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence            899999999999999999999986     45554443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.9e-50  Score=396.30  Aligned_cols=257  Identities=28%  Similarity=0.507  Sum_probs=221.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+|...++||+|.||.||+|++..||+.||||+|+.....   ...-....+||++|+.++|+||+.|+++|-+.+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k---dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK---DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc---cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            4788899999999999999999999999999999864221   1123456789999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |+||++ -+|+.+|+.. ..|+..+++.|+.+++.||+|||.+.|+||||||+|+||+.+|.+||+|||+|+.+......
T Consensus        79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            999996 4999999864 57899999999999999999999999999999999999999999999999999988654433


Q ss_pred             -ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC------CCCC---------
Q 040472          379 -LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK------DIPE---------  442 (628)
Q Consensus       379 -~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~------~~~~---------  442 (628)
                       ...+-|.||+|||.+++...|+..+||||+|||+.||+.|.+-|.+..+.+++..|....      .+|+         
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence             334789999999999999999999999999999999999999998877777665542221      1111         


Q ss_pred             -----------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          443 -----------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       443 -----------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                 +-...+.++.||+.+||..||.+|+++.|+|+|+||+.
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                       11235778999999999999999999999999999974

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.5e-49  Score=414.69  Aligned_cols=263  Identities=29%  Similarity=0.522  Sum_probs=229.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++.+.||+|+||.||+|+++.+++.||||+++...  .......+.+.+|+.+|++++||||+++++++.+++.+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            4679999999999999999999999999999999986421  11223456788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....  
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999866432  


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+....  ..++..++.++++||++
T Consensus       172 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGRARDLVKG  248 (329)
T ss_pred             cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCCCCHHHHHHHHH
Confidence            2346799999999998765 48999999999999999999999998766555555554322  35667789999999999


Q ss_pred             HhhcCCCCCCC-----HHHHhcCccccchHHHhhc
Q 040472          458 CLQRDPSARPP-----ASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       458 ~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~  487 (628)
                      ||+.||.+|++     +++|++||||++..|....
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~  283 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY  283 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence            99999999996     7999999999987766543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.2e-50  Score=426.61  Aligned_cols=258  Identities=33%  Similarity=0.563  Sum_probs=232.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|.+.+.||+|.||+||+|+.+.|.+.||||.+.+..+.   ...++.+.+|++|++.|+|||||.++++|++..+++
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~---~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~   77 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN---EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW   77 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc---hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence            36899999999999999999999999999999999764332   345788999999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      +|.||+.| +|+.+|...+.++|+.++.++.|++.||.|||+++|+|||+||.|||++..|.+||||||+|+.+......
T Consensus        78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            99999977 99999999999999999999999999999999999999999999999999999999999999988765443


Q ss_pred             -ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          379 -LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       379 -~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                       ..+.|||.|||||++.+. .|+..+|+||||||+|||++|++||........+..|...  ...+|..++..+..||+.
T Consensus       157 ltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             eeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCcccccHHHHHHHHH
Confidence             457899999999999755 5999999999999999999999999876666666666543  345667899999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccchHH
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      +|.+||.+|.+..+++.|||++....
T Consensus       234 LL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             HhhcChhhcccHHHHhcChHHhhhhh
Confidence            99999999999999999999976543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-49  Score=408.04  Aligned_cols=262  Identities=32%  Similarity=0.486  Sum_probs=227.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....  .......+.+.+|+.+|++++||||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            47999999999999999999999999999999986421  1122345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      ||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~  156 (291)
T cd05612          79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TW  156 (291)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cc
Confidence            9999999999999998889999999999999999999999999999999999999999999999999999866432  23


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ..+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....  ..++..++..+++||++||
T Consensus       157 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         157 TLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCCHHHHHHHHHHc
Confidence            46799999999998654 48999999999999999999999998766555444444322  3566678999999999999


Q ss_pred             hcCCCCCCC-----HHHHhcCccccchHHHhhcC
Q 040472          460 QRDPSARPP-----ASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       460 ~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~  488 (628)
                      +.||.+|++     ++++++|+||+...+.....
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  267 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ  267 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCCHHHHhc
Confidence            999999995     99999999998877765543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=426.59  Aligned_cols=255  Identities=37%  Similarity=0.636  Sum_probs=228.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ....|....+||+|+.|.||.|+...+++.||||.+.+.+..     ..+-+.+|+.+|+.++|+|||++++.|...+.+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-----chhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            345788889999999999999999999999999999764332     235578999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||++||+|.+++... .++|.+++.|+++++.||+|||.+||||||||.+|||++.+|.|||+|||++..+.... 
T Consensus       346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999999999998764 49999999999999999999999999999999999999999999999999999887655 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-CCCCCcCCHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-PEIPEHLSDDAKSFI  455 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~s~~l~dLI  455 (628)
                      ...+.+|||+|||||++... .|+.++||||||+|++||+-|.+||-..+...+++.|...... -..++.+|.++++||
T Consensus       425 KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL  503 (550)
T ss_pred             ccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence            66788999999999999654 5999999999999999999999999887777777777554322 245678999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCcccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      .+||+.|+++|+++.|+|+||||+
T Consensus       504 ~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHHhhcchhcCCCHHHHhcChhhh
Confidence            999999999999999999999994

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-51  Score=398.17  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=230.0

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|.|+.||++.+..||+.+|+|++....-.   ....+.+.+|++|-+.|+|||||+|++.+..+...||
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            5789999999999999999999999999999998653322   2256778999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccCCcccccCcc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFGla~~~~~~~  376 (628)
                      |+|+|.|++|..-|-.+..++|..+-.+++||++||.|||.+||||||+||+|+|+...   --|||+|||+|..+....
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            99999999999888777889999999999999999999999999999999999999543   359999999999988766


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCC-CCCCcCCHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIP-EIPEHLSDDAKSF  454 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~-~~p~~~s~~l~dL  454 (628)
                      ....++|||.|||||++... .|+..+|||+.|||||-||.|++||.+.+......+|... .+.+ ..+.++++++++|
T Consensus       168 ~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             ccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            67788999999999999765 4999999999999999999999999987776666666544 2333 3677899999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      |++||..||.+|+|+.|+|+|||+++..
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcchH
Confidence            9999999999999999999999998654

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-48  Score=414.51  Aligned_cols=263  Identities=30%  Similarity=0.510  Sum_probs=224.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.++||+|+||+||+|++..+++.||||+++...  .........+.+|+.+|+.++|+||+++++++.+++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE--MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            47999999999999999999999999999999997421  1123445678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---  376 (628)
                      ||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....   
T Consensus        79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999987542211   


Q ss_pred             ------------------------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCC
Q 040472          377 ------------------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP  420 (628)
Q Consensus       377 ------------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~  420 (628)
                                                          .....+||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCC
Confidence                                                11235799999999998654 58999999999999999999999


Q ss_pred             CCCCCchhHHHhhhcCCCCCCCCC--CcCCHHHHHHHHHHhhcCCCCCCC---HHHHhcCccccchHHHhh
Q 040472          421 PWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQRDPSARPP---ASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       421 PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rpt---a~eiL~Hpwf~~~~~~~~  486 (628)
                      ||........+..+........++  ..+++++.+||++||. +|.+|++   +.++++||||++..|...
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~  307 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHI  307 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            998776665555554332222222  2478999999999997 9999998   999999999998877643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=413.77  Aligned_cols=263  Identities=29%  Similarity=0.501  Sum_probs=221.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||.||+|+++.+++.||||++.+..  ....+.++++.+|+++|++++|+|||++++++.++..+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE--MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            47999999999999999999999999999999986421  1223456778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---  376 (628)
                      ||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999986321100   


Q ss_pred             ---------------------------------------------ccccccCCCCcCChhhhhccCCCCccccccccccc
Q 040472          377 ---------------------------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCT  411 (628)
Q Consensus       377 ---------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvl  411 (628)
                                                                   .....+||+.|+|||++.+. .++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchh
Confidence                                                         00125799999999998655 48999999999999


Q ss_pred             eeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC--cCCHHHHHHHHHHhhcCCCCC---CCHHHHhcCccccchHHHhh
Q 040472          412 VLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRDPSAR---PPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       412 LyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~R---pta~eiL~Hpwf~~~~~~~~  486 (628)
                      ||||++|.+||........+..+........++.  .++.++++||++||. +|.+|   +++.|+++||||++..|...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~  316 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTI  316 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999999999987665555555543322223333  578999999999998 77765   59999999999998776554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-48  Score=416.19  Aligned_cols=265  Identities=28%  Similarity=0.454  Sum_probs=223.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++...  ....+....+.+|+.+|.+++|+||+++++.+.+...+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            47999999999999999999999999999999986421  1223445678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---  376 (628)
                      ||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.+....   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999999999999988999999999999999999999999999999999999999999999999999987542210   


Q ss_pred             ---------------------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCC
Q 040472          377 ---------------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS  423 (628)
Q Consensus       377 ---------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~  423 (628)
                                                       .....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             11246799999999998765 49999999999999999999999998


Q ss_pred             CCchhHHHhhhcCCCCCCCCCC--cCCHHHHHHHHHHhhcCCC---CCCCHHHHhcCccccchHHHhhcC
Q 040472          424 QYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRDPS---ARPPASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       424 ~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~---~Rpta~eiL~Hpwf~~~~~~~~~~  488 (628)
                      .........++........++.  .++.++++||.+|+. ++.   .||+++||++||||++..|.....
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~  306 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRE  306 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence            7666655555544322222332  478999999999775 444   458999999999999988876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-47  Score=415.10  Aligned_cols=263  Identities=28%  Similarity=0.475  Sum_probs=221.0

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +.|++++.||+|+||+||+|+++.+++.||||++....  ....+....+.+|+++|+.++|+|||++++++.+.+.+|+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l   78 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence            36899999999999999999999999999999986421  1223446778999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc----
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~----  375 (628)
                      ||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.....    
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999999999999998889999999999999999999999999999999999999999999999999997532100    


Q ss_pred             --------------------------------------------cccccccCCCCcCChhhhhccCCCCccccccccccc
Q 040472          376 --------------------------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCT  411 (628)
Q Consensus       376 --------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvl  411 (628)
                                                                  ......+||+.|+|||++.+. .++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~i  237 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhH
Confidence                                                        001245799999999998764 48999999999999


Q ss_pred             eeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCHHHHHHHHHHh--hcCCCCCCCHHHHhcCccccchHHHh
Q 040472          412 VLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCL--QRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       412 LyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L--~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      +|||++|..||..........++........++  ..++.++.+||.+||  ..++..|+++.+|++||||++..|..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence            999999999998766555555544322222233  358899999999965  44555699999999999998877654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-49  Score=414.28  Aligned_cols=265  Identities=28%  Similarity=0.457  Sum_probs=222.4

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc---------hHHHHHHHHHHHHHHHhCCCCCeeee
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT---------SKECLKQLNQEINLLSQLSHPNIVRY  287 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~---------~~~~~~~~~~Ei~iL~~l~HpnIV~l  287 (628)
                      ..+++|++++.||+|.||+|.+|++..+++.||||++.+......         ...-++++++||.||++|+|+|||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            367899999999999999999999999999999999964321110         01124578999999999999999999


Q ss_pred             ecceec--cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          288 HGSELS--DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       288 ~~~~~~--~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                      +.+..+  .+.+|||+|||..|.+...=....-+++.+++.|+++++.||+|||.+|||||||||.|+||+.+|+|||+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            999877  568999999999998765433323399999999999999999999999999999999999999999999999


Q ss_pred             cCCccccc------CccccccccCCCCcCChhhhhcc---CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC
Q 040472          366 FGMAKHMT------SCASMLSFKGSPYWMAPEVVMNT---NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN  436 (628)
Q Consensus       366 FGla~~~~------~~~~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~  436 (628)
                      ||.+....      ........+|||.|||||.+.+.   ...+.+.|||||||+||+||.|+.||-+....+...+|.+
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            99987552      12223346799999999998762   2357789999999999999999999998888888888877


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ....-...+.+.++++|||++||.+||++|+++.+|..|||+...
T Consensus       334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            654322223588999999999999999999999999999998543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.1e-48  Score=399.91  Aligned_cols=266  Identities=26%  Similarity=0.420  Sum_probs=224.6

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |++.+.||+|+||.||+|.+..+++.||||++......  .......+.+|+.+|++++|+||+.+++++.+++.+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            78899999999999999999999999999988643211  1223345778999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          302 EYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      ||+.+|+|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..........
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            999999999888643  368999999999999999999999999999999999999999999999999998765444445


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---HHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ..+||..|+|||++.+. .++.++|||||||++|||++|+.||......   ..+..... .....++..++.++.+||+
T Consensus       160 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         160 GRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             CCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-cccccCCccCCHHHHHHHH
Confidence            56799999999999765 4899999999999999999999999764432   12222111 2223466678999999999


Q ss_pred             HHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCc
Q 040472          457 QCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       457 ~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      +||+.||++|++     ++++++||||.+..+........
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~  277 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANML  277 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcC
Confidence            999999999997     89999999999988887765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-47  Score=410.88  Aligned_cols=263  Identities=28%  Similarity=0.457  Sum_probs=221.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||.||+|++..+++.||||++....  .........+.+|+.+|++++|+||+++++.+.+++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH--HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            47999999999999999999999999999999986421  1122335678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc----
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~----  375 (628)
                      ||||+.||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...    
T Consensus        79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999999999999998889999999999999999999999999999999999999999999999999997532100    


Q ss_pred             ----------------------------------------cccccccCCCCcCChhhhhccCCCCccccccccccceeee
Q 040472          376 ----------------------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM  415 (628)
Q Consensus       376 ----------------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyel  415 (628)
                                                              ......+||+.|||||++.+. .++.++|||||||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeeh
Confidence                                                    001235799999999998654 489999999999999999


Q ss_pred             ccCCCCCCCCchhHHHhhhcCCCCCCCC--CCcCCHHHHHHHHHHhhcCCCCCC---CHHHHhcCccccchHHHhh
Q 040472          416 ATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDPSARP---PASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       416 LtG~~PF~~~~~~~~~~~i~~~~~~~~~--p~~~s~~l~dLI~~~L~~dP~~Rp---ta~eiL~Hpwf~~~~~~~~  486 (628)
                      ++|+.||...........+........+  ...++.++.+||.+|+ .+|.+|+   ++.++++||||+...+...
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence            9999999876655544444332221122  2358899999999987 5999999   9999999999998776554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.9e-48  Score=415.14  Aligned_cols=261  Identities=30%  Similarity=0.491  Sum_probs=221.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|+++++||+|+||+||+|++..+++.||||++....  .........+.+|+.+|++++|+|||++++++.+++.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            6899999999999999999999999999999986421  12234466788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-----
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-----  375 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-----  375 (628)
                      |||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999997532100     


Q ss_pred             -------------------------------------------cccccccCCCCcCChhhhhccCCCCccccccccccce
Q 040472          376 -------------------------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTV  412 (628)
Q Consensus       376 -------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlL  412 (628)
                                                                 ......+||+.|+|||++.+. .++.++|||||||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHH
Confidence                                                       001235799999999998765 499999999999999


Q ss_pred             eeeccCCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCHHHHHHHHHHhhcCCCCCCC---HHHHhcCccccchHHHh
Q 040472          413 LEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQRDPSARPP---ASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       413 yelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rpt---a~eiL~Hpwf~~~~~~~  485 (628)
                      |||++|++||...+......++........++  ..+++++.+||.+|+ .+|++|++   +++|++||||+...+..
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~  315 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSS  315 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence            99999999998766655555554332222222  458999999999987 59999997   99999999999876654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=408.20  Aligned_cols=257  Identities=28%  Similarity=0.489  Sum_probs=235.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ...+|++.+.||+|.||+|-+|+....|+.||||.|++..  ....+.+-++++||+||..|+||||+++|.+|++.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            3468999999999999999999998999999999987532  34466678899999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      .|||||..+|+|++||.+.+.|+|.+++.+++||+.|+.|||+++++|||||.+|||+|.++++||+||||+..+.....
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ..++||+|-|.+||++.+..+-++.+|.|||||+||.|++|.+||++.+....+.+|......   .+.-+.++.-||+.
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRw  285 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---EPETPSDASGLIRW  285 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---CCCCCchHHHHHHH
Confidence            999999999999999988886788999999999999999999999999888888877665432   12345689999999


Q ss_pred             HhhcCCCCCCCHHHHhcCcccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ||..||++|.|+++|..|=|+.
T Consensus       286 mLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  286 MLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHhcCcccchhHHHHhhhheee
Confidence            9999999999999999998864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-47  Score=409.29  Aligned_cols=267  Identities=28%  Similarity=0.441  Sum_probs=230.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCC-cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|++.+.||+|+||.||+|.++.++ ..||||++....  .......+.+.+|+.+|+.++|||||++++++.+++.
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK--IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            5679999999999999999999876654 689999886421  1123345678899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|+||||+.||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+++..... 
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999865432 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                       ....+||+.|||||++.+. .++.++|||||||++|||++|..||...+.......+....  ..++..++.++.+||+
T Consensus       185 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLMK  260 (340)
T ss_pred             -cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence             3456799999999999764 48999999999999999999999998766655555554322  3567788999999999


Q ss_pred             HHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCc
Q 040472          457 QCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       457 ~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      +||+.||++|+     +++++++||||++..|.......+
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~  300 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV  300 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence            99999999995     899999999999888776554433

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-47  Score=401.73  Aligned_cols=257  Identities=31%  Similarity=0.488  Sum_probs=220.3

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      +.||+|+||+||+|++..+++.||||+++....  .......++.+|+++++.++|+||+++++++.+++.+||||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            469999999999999999999999999874321  123345667789999999999999999999999999999999999


Q ss_pred             cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          306 GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       306 GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      ||+|..++.+...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            99999999888899999999999999999999997 7999999999999999999999999999875432 223345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||+||||++|..||...+.......+...  ...++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         159 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             CcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999998654 4899999999999999999999999876554444443322  234667789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccchHHHhhc
Q 040472          464 SARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       464 ~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      ++|+     ++.++++|+||.+..|....
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~~~~~~~  264 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVY  264 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            9997     89999999999987766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-47  Score=405.32  Aligned_cols=258  Identities=32%  Similarity=0.492  Sum_probs=222.5

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      +.||+|+||.||+|++..+++.||||+++....  .......++.+|+++|+.++||||+++++++.+++.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            469999999999999999999999999874321  123345678889999999999999999999999999999999999


Q ss_pred             cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccCC
Q 040472          306 GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGS  384 (628)
Q Consensus       306 GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT  384 (628)
                      +|+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            999999998888899999999999999999999999999999999999999999999999999875432 2233456799


Q ss_pred             CCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCC
Q 040472          385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS  464 (628)
Q Consensus       385 ~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  464 (628)
                      +.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...  ...++..++.++.+||++||+.||+
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcCCCHH
Confidence            999999998654 4899999999999999999999999876554444443322  2356778999999999999999999


Q ss_pred             CCC-----CHHHHhcCccccchHHHhhcC
Q 040472          465 ARP-----PASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       465 ~Rp-----ta~eiL~Hpwf~~~~~~~~~~  488 (628)
                      +|+     ++.+|++|+||.+..|.....
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~~~~~~~~  264 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYD  264 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            997     899999999999887765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-47  Score=408.85  Aligned_cols=265  Identities=29%  Similarity=0.475  Sum_probs=225.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++...  ....+....+.+|+.+|..++|+||+++++.+.+++.+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            47899999999999999999999999999999986421  1223446778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---  376 (628)
                      ||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999987542110   


Q ss_pred             ---------------------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCC
Q 040472          377 ---------------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS  423 (628)
Q Consensus       377 ---------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~  423 (628)
                                                       .....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCC
Confidence                                             11245799999999998765 49999999999999999999999998


Q ss_pred             CCchhHHHhhhcCCCCCCCCCC--cCCHHHHHHHHHHhhcCCCCCC---CHHHHhcCccccchHHHhhcC
Q 040472          424 QYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRDPSARP---PASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       424 ~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rp---ta~eiL~Hpwf~~~~~~~~~~  488 (628)
                      .........++........++.  .++.++++||.+|+. ||.+|+   ++++|++||||++..|.....
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~  306 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRE  306 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence            7666555555544322222232  378999999999875 999998   589999999999988876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-47  Score=406.40  Aligned_cols=263  Identities=33%  Similarity=0.502  Sum_probs=226.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....  ........+.+|+++|..++|+||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            479999999999999999999999999999999874211  112345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---  376 (628)
                      ||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......   
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999997654332   


Q ss_pred             ---------------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH
Q 040472          377 ---------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA  429 (628)
Q Consensus       377 ---------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~  429 (628)
                                                 ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       22345799999999999765 59999999999999999999999998877655


Q ss_pred             HHhhhcCCCCCCCCCC--cCCHHHHHHHHHHhhcCCCCCCC-HHHHhcCccccchHHHhh
Q 040472          430 AIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRDPSARPP-ASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rpt-a~eiL~Hpwf~~~~~~~~  486 (628)
                      ...++........++.  .++.++.+||++||. ||.+|++ +++|++||||++..|...
T Consensus       238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~  296 (350)
T cd05573         238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENL  296 (350)
T ss_pred             HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHH
Confidence            5555544222222222  369999999999997 9999999 999999999998777543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-47  Score=405.06  Aligned_cols=257  Identities=32%  Similarity=0.501  Sum_probs=221.8

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      +.||+|+||.||+|+++.+++.||+|+++....  .......++.+|+++|+.++||||++++++|..++.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            469999999999999999999999999874321  123345677889999999999999999999999999999999999


Q ss_pred             cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccCC
Q 040472          306 GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGS  384 (628)
Q Consensus       306 GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT  384 (628)
                      +|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            999999999888999999999999999999999999999999999999999999999999999875322 2233456799


Q ss_pred             CCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCC
Q 040472          385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS  464 (628)
Q Consensus       385 ~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  464 (628)
                      +.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||+.||+
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999998654 48999999999999999999999998766554444443222  246678999999999999999999


Q ss_pred             CCC-----CHHHHhcCccccchHHHhhc
Q 040472          465 ARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       465 ~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      +|+     ++.++++|+||....|....
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~  263 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSINWQDVV  263 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            998     89999999999987776554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.5e-47  Score=400.24  Aligned_cols=264  Identities=29%  Similarity=0.457  Sum_probs=225.0

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|+++.+++.||||+++...  ....+..+.+.+|+.+++.++|+||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            47999999999999999999999999999999987432  1123455678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.||+|.+++.+. +.+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..... 
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999999876 7899999999999999999999999999999999999999999999999999986644322 


Q ss_pred             -cccccCCCCcCChhhhhc-----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCH
Q 040472          378 -MLSFKGSPYWMAPEVVMN-----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSD  449 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~-----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~  449 (628)
                       ....+||+.|+|||++..     ...++.++|||||||++|||++|..||........+.++........++  ..++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS  238 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence             223579999999999863     3457899999999999999999999998766555555554333222222  25789


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ++.+||++||+ +|.+|++++++++||||+...|...
T Consensus       239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence            99999999998 9999999999999999998776544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-49  Score=408.09  Aligned_cols=295  Identities=27%  Similarity=0.469  Sum_probs=257.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      ...+|..+.+||+|+||+|.+|..+.+.+.||||++++..-.+  ...++--..|.++|.... -|++++|+.+|++-++
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4568999999999999999999999999999999997532211  122333456778887665 7899999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc-ccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~-~~~~  375 (628)
                      +|+||||+.||+|..+|++.|.|.|+.+..|+++|+.||-|||++|||+||||.+|||+|.+|+|||+|||+++. +...
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999985 3455


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      .+..++||||.|+|||++.-. .|+.++||||+||+|||||.|++||++.+..+.+..|....-  .+|..+|.++.++.
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ic  581 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAIC  581 (683)
T ss_pred             cceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHH
Confidence            667789999999999998755 599999999999999999999999999888887777765443  68889999999999


Q ss_pred             HHHhhcCCCCCCCH-----HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCCC
Q 040472          456 KQCLQRDPSARPPA-----SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANPL  530 (628)
Q Consensus       456 ~~~L~~dP~~Rpta-----~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~~  530 (628)
                      +.+|.+.|.+|+.+     .+|..||||+.++|....+.+++             ||+.+.+..+++..+|+..|+.++.
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiq-------------PPfkPk~k~~r~~eNFD~~Ft~~~~  648 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQ-------------PPFKPKIKCGRDAENFDKFFTREPT  648 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCC-------------CCCCCccccCCchhhhhHHHhcCCC
Confidence            99999999999853     68999999999999998876654             6667777788899999988887654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-47  Score=405.53  Aligned_cols=262  Identities=28%  Similarity=0.477  Sum_probs=224.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|++..+++.||||+++....  ......+.+.+|+.+|..++|+||+++++++.+.+.+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            379999999999999999999999999999999874321  112345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      ||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....  ...
T Consensus        79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccC
Confidence            999999999999999888999999999999999999999999999999999999999999999999999976543  334


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC---CCCCC---CcCCHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD---IPEIP---EHLSDDAKS  453 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~---~~~~p---~~~s~~l~d  453 (628)
                      ..+||+.|+|||++.+. .++.++|||||||+||||++|..||...........+.....   .+...   ..++.++.+
T Consensus       157 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         157 SVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            56799999999998765 599999999999999999999999987655444433332211   11111   256899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ||.+||+.+|.+|+++.+|++||||++..+...
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~  268 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVDWNEL  268 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCCHHHH
Confidence            999999999999999999999999998766544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.1e-49  Score=398.68  Aligned_cols=260  Identities=28%  Similarity=0.486  Sum_probs=222.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--cc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~  295 (628)
                      ++++|+.++.|++|+||.||+|+++.|++.||+|.++.......   .--...+||.+|.+++|||||.+..+...  -+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G---FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG---FPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC---CcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            57889999999999999999999999999999999976432211   11234679999999999999999887654  46


Q ss_pred             cceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+|||||||+. +|..+|.... +|.+.+++.++.|++.||+|||.+.|+|||||+.|+|++..|.+||+|||+|+.+..
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            79999999976 9999998765 899999999999999999999999999999999999999999999999999998866


Q ss_pred             c-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------CCC-----
Q 040472          375 C-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------IPE-----  442 (628)
Q Consensus       375 ~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------~~~-----  442 (628)
                      . ..++..+-|.||+|||++.+...|+.++||||+|||+.|||++++.|.+....+++.+|.....      +|.     
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            4 4456678999999999999999999999999999999999999999988777666655532211      110     


Q ss_pred             ------------------CCC-cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          443 ------------------IPE-HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       443 ------------------~p~-~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                        ++. .+++...+|++.+|..||.+|.||.|.|+|.||++.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                              111 156899999999999999999999999999999863

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-47  Score=400.50  Aligned_cols=254  Identities=31%  Similarity=0.504  Sum_probs=219.6

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||+|+||.||+|++..+++.||||+++...  .........+.+|+.+|++++||||+++++++.+++.+|+||||+.||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            799999999999999999999999986421  112334567888999999999999999999999999999999999999


Q ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccCCCC
Q 040472          308 SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPY  386 (628)
Q Consensus       308 sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~  386 (628)
                      +|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence            9999999888999999999999999999999999999999999999999999999999999985432 223345679999


Q ss_pred             cCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCC
Q 040472          387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR  466 (628)
Q Consensus       387 Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  466 (628)
                      |+|||++.+. .++.++|||||||++|||++|+.||...........+...  ...++..++.++.+||.+||+.||++|
T Consensus       159 y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         159 YLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             cCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999998764 4899999999999999999999999876555544444332  235667899999999999999999999


Q ss_pred             C---CHHHHhcCccccchHHHhh
Q 040472          467 P---PASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       467 p---ta~eiL~Hpwf~~~~~~~~  486 (628)
                      +   ++.++|+||||++..+...
T Consensus       236 ~~~~~~~e~l~hp~~~~~~~~~~  258 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQLSWKKL  258 (312)
T ss_pred             CCCCCHHHHHcCCCcCCCCHHHH
Confidence            7   5899999999988766544

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-47  Score=402.95  Aligned_cols=284  Identities=27%  Similarity=0.471  Sum_probs=232.2

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||.||+|+++.+++.||||+++....  ......+.+..|+.++..+ +|+||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            469999999999999999999999999874211  1123345677888888876 6999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-CccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~~~~~G  383 (628)
                      .||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            999999999988899999999999999999999999999999999999999999999999999987542 2223345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         159 TPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             CccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999998654 48999999999999999999999998766655555554322  34566789999999999999999


Q ss_pred             CCCCCH------HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccC
Q 040472          464 SARPPA------SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLA  527 (628)
Q Consensus       464 ~~Rpta------~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~  527 (628)
                      ++|+++      +++++||||++..|.......             ..|+..+.+....++.+++..+..
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~  292 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQ-------------IEPPFRPRIKSREDVSNFDPDFIK  292 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCC-------------CCCCcCCCCCCcchhhhcCccccc
Confidence            999998      999999999987776543322             233344444455555665544433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.3e-47  Score=399.20  Aligned_cols=265  Identities=29%  Similarity=0.502  Sum_probs=221.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      +|++++.||+|+||+||+|++.   .+++.||||+++..... ......+++.+|+++|+.++ |+||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            5899999999999999999864   57899999998642211 12233567888999999995 9999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      +|+||||+.||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... 
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999999865332 


Q ss_pred             -cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc---hhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          376 -ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE---GVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       376 -~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                       ......+||+.|||||++.+...++.++|||||||+||||++|..||....   ....+..... ...+.++..++..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGPEA  238 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHH
Confidence             223356799999999999765558899999999999999999999996432   1222222111 12245667789999


Q ss_pred             HHHHHHHhhcCCCCCC-----CHHHHhcCccccchHHHhhc
Q 040472          452 KSFIKQCLQRDPSARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      .+||++||+.||++|+     +++++++||||++..|....
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  279 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA  279 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            9999999999999999     88999999999987766543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-47  Score=398.61  Aligned_cols=256  Identities=33%  Similarity=0.519  Sum_probs=214.6

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeecceeccccceEEEEec
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ||+|+||+||+|+++.+++.||||++....  ........++..|..++..+   .||||+.+++++.+...+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE--IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHH--HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            799999999999999999999999986421  11122344555677777665   6999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            9999999999888999999999999999999999999999999999999999999999999999875422 233445789


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC-CcCCHHHHHHHHHHhhcC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQRD  462 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p-~~~s~~l~dLI~~~L~~d  462 (628)
                      |+.|+|||++.+...++.++|||||||++|+|++|..||...+....+..+.... . .++ ..++.++.+||++||+.|
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~-~~~~~~~~~~~~~li~~~L~~~  236 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-V-RFPKNVLSDEGRQFVKGLLNRN  236 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-C-CCCCccCCHHHHHHHHHHcCCC
Confidence            9999999998766568999999999999999999999998765554444443222 1 222 347899999999999999


Q ss_pred             CCCCC----CHHHHhcCccccchHHHhhc
Q 040472          463 PSARP----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       463 P~~Rp----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      |++|+    ++.++++||||++..|....
T Consensus       237 P~~R~~~~~~~~~ll~h~~~~~~~~~~~~  265 (330)
T cd05586         237 PQHRLGAHRDAVELKEHPFFADIDWDLLS  265 (330)
T ss_pred             HHHCCCCCCCHHHHhcCccccCCCHHHHH
Confidence            99998    79999999999987765543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=443.64  Aligned_cols=285  Identities=27%  Similarity=0.414  Sum_probs=249.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|.++++||+|+||.|.+++++.|++.||+|++.+..-  ........|..|-.||..-+.+.||+|+..|++++++|+
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM--lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM--LKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH--hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            699999999999999999999999999999999865110  111223468889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc--
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~--  377 (628)
                      ||||+.||+|..+|.+.++++|..+++|++.|+.||+-||+.|+|||||||+|||||..|+|||+|||.+-.+..++.  
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            999999999999999999999999999999999999999999999999999999999999999999999877765443  


Q ss_pred             cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCHHH
Q 040472          378 MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDA  451 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  451 (628)
                      ....+|||.|++||+|..    .+.|+..+|||||||++||||+|..||+...-++...+|......-.+|  ..+|.++
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea  312 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA  312 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence            345689999999999853    2458999999999999999999999999988888888888776555555  4599999


Q ss_pred             HHHHHHHhhcCCCCCCC---HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 040472          452 KSFIKQCLQRDPSARPP---ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCE  522 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpt---a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~  522 (628)
                      ++||+++|. +++.|.+   +++|..||||.++.|....               ...||++|.+....++++|+
T Consensus       313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR---------------~~~pP~vPevssd~DTsnFd  370 (1317)
T KOG0612|consen  313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR---------------ESVPPVVPEVSSDDDTSNFD  370 (1317)
T ss_pred             HHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh---------------hcCCCCCCcCCCCCcccccc
Confidence            999999997 7899998   9999999999999995432               34578888899999999994

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.2e-47  Score=401.39  Aligned_cols=258  Identities=29%  Similarity=0.502  Sum_probs=218.0

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||.||+|+++.+++.||||+++...  ....+..+.+.+|+.++..+ +||||+++++++.+++.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            46999999999999999999999999997532  12234456788999999998 6999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc-cCccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~-~~~~~~~~~~G  383 (628)
                      .||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.. .........+|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999999988889999999999999999999999999999999999999999999999999999753 22333445789


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc--------hhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE--------GVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~--------~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|+.||....        ....+.+..... ...++..++.++.+||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li  236 (329)
T cd05588         159 TPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKASSVL  236 (329)
T ss_pred             CccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCCCCCCCCHHHHHHH
Confidence            9999999998764 48999999999999999999999996321        111222222212 2356678899999999


Q ss_pred             HHHhhcCCCCCCC------HHHHhcCccccchHHHhhc
Q 040472          456 KQCLQRDPSARPP------ASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       456 ~~~L~~dP~~Rpt------a~eiL~Hpwf~~~~~~~~~  487 (628)
                      ++||+.||.+|++      ++++++||||+...|....
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~  274 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLE  274 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence            9999999999987      7899999999887776554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=410.24  Aligned_cols=261  Identities=31%  Similarity=0.517  Sum_probs=231.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE  295 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~  295 (628)
                      .....|++++.||+|.||+||+++++.||+.||+|++.+.....  ......+.+|++||+++. |||||+++++|++..
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            34568999999999999999999999999999999997643322  224567889999999999 999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC----CCEEEeccCCccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH----GEIKLADFGMAKH  371 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~----g~vKL~DFGla~~  371 (628)
                      .+++|||+|.||+|++.|.+. .++|..+..+++||+.|++|||+.||+||||||||||+...    +.+|++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999876 49999999999999999999999999999999999999543    4799999999998


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--CCCCCCCcCCH
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--DIPEIPEHLSD  449 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~s~  449 (628)
                      ..........|||++|+|||++... .|+..+||||+||++|.||+|.+||..........++....  .....+..++.
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            8876677889999999999999644 59999999999999999999999999887776666665543  23456677999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .+++||++||..||.+|+++.++|+|||++..
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999998753

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-48  Score=387.71  Aligned_cols=268  Identities=30%  Similarity=0.460  Sum_probs=236.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc---hHHHHHHHHHHHHHHHhCC-CCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT---SKECLKQLNQEINLLSQLS-HPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~  293 (628)
                      ...+|...+.||+|..++|.++.++.+++.+|+|+|........   ..+..+...+|+.||+++. ||+|++|.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34678888999999999999999999999999999976543322   3344556778999999996 9999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +..+++|+|.|+.|.|+++|...-.++|...+.||+||++|++|||.++||||||||+|||++++.++||+|||++.++.
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCcCChhhhh-----ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCc
Q 040472          374 SCASMLSFKGSPYWMAPEVVM-----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEH  446 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~-----~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~  446 (628)
                      .+......||||+|+|||.+.     +..+|+..+|+|++|||||.||.|.+||.....+..+..|.....  ...-|..
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            998889999999999999973     445799999999999999999999999987766666655554432  2234567


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      ++.++++||.+||+.||.+|.|++|+|.||||.......
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence            999999999999999999999999999999997665443

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.3e-47  Score=399.42  Aligned_cols=263  Identities=28%  Similarity=0.483  Sum_probs=225.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC-CCeeeeecceeccccceE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYHGSELSDERLSV  299 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV~l~~~~~~~~~~~l  299 (628)
                      +|++.+.||+|+||.||+|+++.+++.||||+++....  ......+.+..|++++..+.| ++|+.+++++.+.+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            58999999999999999999999999999999874221  122345667889999999976 468899999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Ccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~  378 (628)
                      ||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++... .....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            99999999999999988899999999999999999999999999999999999999999999999999987532 22233


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+...  ...++..++.++.+||++|
T Consensus       159 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             eeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHH
Confidence            456799999999998765 4899999999999999999999999876665555555432  2356678999999999999


Q ss_pred             hhcCCCCCCCH-----HHHhcCccccchHHHhhcC
Q 040472          459 LQRDPSARPPA-----SKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       459 L~~dP~~Rpta-----~eiL~Hpwf~~~~~~~~~~  488 (628)
                      |..||.+|++.     +++++||||+...|.....
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~  270 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER  270 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999976     8999999999887766543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-48  Score=397.26  Aligned_cols=257  Identities=27%  Similarity=0.457  Sum_probs=222.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-----c
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-----D  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-----~  294 (628)
                      ..|...+.||+|+||.|+.|.++.||+.||||++...   ....-..++..+|+++|+.++|+||+.+++.+..     -
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~---F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP---FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh---hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            4566679999999999999999999999999987522   2234456788999999999999999999998876     3


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +.+|+|+|+| +-+|.++|+....|++..+..+++||+.||+|+|+.+|+||||||.|||++.+..+||||||+|+....
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence            5799999999 679999999888899999999999999999999999999999999999999999999999999998753


Q ss_pred             ---ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-----------
Q 040472          375 ---CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-----------  440 (628)
Q Consensus       375 ---~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-----------  440 (628)
                         ...++.++-|.||+|||++.....|+.++||||+||||.|||+|++.|.+.+...++..|...-..           
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence               445677889999999999998889999999999999999999999999887665555444221111           


Q ss_pred             ----------C--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          441 ----------P--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       441 ----------~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                +        .+-++.++.+.+||.+||..||.+|+|++|+|+||||..
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence                      1        122468899999999999999999999999999999964

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.7e-47  Score=397.82  Aligned_cols=257  Identities=30%  Similarity=0.485  Sum_probs=221.2

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||.||+|+++.+++.||||+++....  ......+.+..|+++|..+ +|+||+++++++.+++.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            469999999999999999999999999874211  1223345677889998866 7999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .|++|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            9999999999888999999999999999999999999999999999999999999999999999875432 223345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+....  ..++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         159 TPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             CccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCH
Confidence            9999999998654 48999999999999999999999998876666655554432  24556789999999999999999


Q ss_pred             CCCC-------CHHHHhcCccccchHHHhhc
Q 040472          464 SARP-------PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       464 ~~Rp-------ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      ++|+       ++.++++||||....|....
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~  266 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEIDWVLLE  266 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence            9999       89999999999988777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-49  Score=411.30  Aligned_cols=255  Identities=39%  Similarity=0.723  Sum_probs=230.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|...++||+|.||.||+|++..+++.||||++....    ....+..+++|+.+|.+++++||.++|+.|..+..+++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            35777799999999999999999999999999997532    24457789999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      +||||.||++.++|+..+.+.|..+..++++++.||.|||.++.+|||||+.||||..+|.|||+|||++.++.... ..
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999998876543 33


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      .+++|||+||||||+. ..+|+.|+||||||++.|||++|.+||.....+..++.|.. ...|.+...++..+++||..|
T Consensus       169 ~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccccccCHHHHHHHHHH
Confidence            7899999999999998 44699999999999999999999999998877666665544 345677778999999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccc
Q 040472          459 LQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |.+||+.||+|.++|+|.|++.
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHh
Confidence            9999999999999999999975

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-46  Score=401.63  Aligned_cols=255  Identities=33%  Similarity=0.530  Sum_probs=211.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+.+|+++++||+|+||.||+|++..+++.||||++....    .....+.+.+|+++|+.++|+||+++++++.+++.+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            4678999999999999999999999999999999986421    234456788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.+++|...    ..+.+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... 
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999999999998653    345688889999999999999999999999999999999999999999999998654322 


Q ss_pred             ccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCch--hHHHhhhcCCCCCCCCCCcCCHH
Q 040472          377 SMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ......||..|+|||++..    ...++.++|||||||+||||++|+.||.....  ...+.........+..+..++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2234679999999998742    12245689999999999999999999973221  11111111122334556678999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +++||++||+.||++||++.|||+||||..
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            999999999999999999999999999965

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-46  Score=397.27  Aligned_cols=260  Identities=30%  Similarity=0.513  Sum_probs=219.9

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHH---HhCCCCCeeeeecceeccccce
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL---SQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL---~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      |++.+.||+|+||.||+|++..+++.||||+++....  ......+.+.+|++++   +.++||||+++++++.+.+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            6889999999999999999999999999999874321  1122345566676665   5667999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~  377 (628)
                      +||||+.|++|..++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ...
T Consensus        79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence            99999999999988865 5799999999999999999999999999999999999999999999999999875432 223


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|||||++.+. .++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||++
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  234 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRR  234 (324)
T ss_pred             ccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence            3457899999999998764 48999999999999999999999998766555555444322  34566789999999999


Q ss_pred             HhhcCCCCCC-----CHHHHhcCccccchHHHhhc
Q 040472          458 CLQRDPSARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       458 ~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      ||+.||.+||     ++.++++|+||++..+....
T Consensus       235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~  269 (324)
T cd05589         235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLL  269 (324)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHH
Confidence            9999999999     79999999999987766543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-46  Score=397.53  Aligned_cols=265  Identities=26%  Similarity=0.460  Sum_probs=226.8

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~l  299 (628)
                      +|++.+.||+|+||.||+|++..+++.||||+++....  ......+.+..|+.++..+. |++|+++++++.+.+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            58899999999999999999999999999999875321  12233456677888888774 8999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-cccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~  378 (628)
                      ||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            999999999999999888999999999999999999999999999999999999999999999999999975432 2233


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++|
T Consensus       159 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHHHHHH
Confidence            456799999999998754 49999999999999999999999998776655555554332  346677999999999999


Q ss_pred             hhcCCCCCCC-----HHHHhcCccccchHHHhhcCCC
Q 040472          459 LQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVN  490 (628)
Q Consensus       459 L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~  490 (628)
                      |+.||++|++     ..++++|+||+...|.......
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~  272 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE  272 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence            9999999997     4899999999988887665443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-46  Score=395.51  Aligned_cols=257  Identities=32%  Similarity=0.500  Sum_probs=216.1

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHH-HHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-LLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||+||+|+++.+++.||||++.....  ......+++.+|+. +++.++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            469999999999999999999999999864211  11222344445544 568899999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            9999999999888999999999999999999999999999999999999999999999999999875422 223345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+....  ..++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         159 TPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999998754 48999999999999999999999998766555444443322  24556789999999999999999


Q ss_pred             CCCCCH----HHHhcCccccchHHHhhc
Q 040472          464 SARPPA----SKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       464 ~~Rpta----~eiL~Hpwf~~~~~~~~~  487 (628)
                      .+|+++    .++++||||+...|....
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~~~~~~~  263 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSINWDDLV  263 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHHHHh
Confidence            999987    699999999887766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2e-46  Score=397.13  Aligned_cols=260  Identities=30%  Similarity=0.504  Sum_probs=218.3

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||+||+|+++.+++.||+|++++...  ...+....+.+|+.++.++ +||||+++++++.+++.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            479999999999999999999999999975321  1234456788899998877 7999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-CccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~~~~~G  383 (628)
                      .+|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            999999999888899999999999999999999999999999999999999999999999999997532 2223345789


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc--------hhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE--------GVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~--------~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||....        ....+.+.... ....+|..++.++.+||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHH
Confidence            9999999998754 48999999999999999999999995311        11122222211 22356778999999999


Q ss_pred             HHHhhcCCCCCCC------HHHHhcCccccchHHHhhcCC
Q 040472          456 KQCLQRDPSARPP------ASKLLDHPFVRDQAVARAGNV  489 (628)
Q Consensus       456 ~~~L~~dP~~Rpt------a~eiL~Hpwf~~~~~~~~~~~  489 (628)
                      ++||+.||++|++      +.++++||||++..|......
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~  276 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQK  276 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcC
Confidence            9999999999998      589999999998887765443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=394.76  Aligned_cols=261  Identities=34%  Similarity=0.631  Sum_probs=224.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++..+||.|.-++||+|+...+++.||||++....    ....+..+++|++.|+.++||||++++..|..+..+
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk----c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK----CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh----hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            4579999999999999999999999999999999997532    223378899999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      |+||.||.+|++.++|+..  ..|.|..++.|+++++.||.|||++|.||||||+.||||+.+|.|||+|||....+...
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999999864  35999999999999999999999999999999999999999999999999987644322


Q ss_pred             c----cc-ccccCCCCcCChhhh-hccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CC-------
Q 040472          376 A----SM-LSFKGSPYWMAPEVV-MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IP-------  441 (628)
Q Consensus       376 ~----~~-~~~~GT~~Y~APEvl-~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~-------  441 (628)
                      .    .. .+++||+.|||||++ ....+|+.|+||||||++..||.+|..||..+..+..+....+... .+       
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            1    11 567899999999994 4556799999999999999999999999999887765544333221 11       


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      +....++..++.+|..||++||.+|||+.++|+|+||+...
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            11234677899999999999999999999999999997543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-46  Score=394.82  Aligned_cols=258  Identities=32%  Similarity=0.521  Sum_probs=220.6

Q ss_pred             eeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      ++||+|+||.||+|++.   .+++.||||+++.... .........+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            67999999999999863   5789999999874211 1112334567889999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccc
Q 040472          303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSF  381 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~  381 (628)
                      |+.|++|.+++.+.+.+.+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999999888999999999999999999999999999999999999999999999999999875432 2223446


Q ss_pred             cCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhc
Q 040472          382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       382 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      +||+.|+|||++.+. .++.++|||||||+||||++|+.||...+....+..+....  ..++..++.++.+||++||+.
T Consensus       161 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             CCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccc
Confidence            799999999998654 48899999999999999999999998776655555554332  356677899999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccchHHHhhc
Q 040472          462 DPSARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       462 dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      ||++|+     +++++++||||+...|....
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~  268 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL  268 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            999999     89999999999887766553

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-46  Score=392.97  Aligned_cols=256  Identities=30%  Similarity=0.508  Sum_probs=220.1

Q ss_pred             eeeccCCcEEEEEEEE---CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      +.||+|+||.||++++   ..+++.||||+++....   ......++.+|+++|++++|+||+++++++.+++.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999976   46789999999874321   12233457789999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cccccc
Q 040472          303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSF  381 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~~~~  381 (628)
                      |+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ......
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999999988888999999999999999999999999999999999999999999999999999765433 233456


Q ss_pred             cCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhc
Q 040472          382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       382 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      +||+.|+|||++.+. .++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||++||+.
T Consensus       159 ~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         159 CGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhc
Confidence            799999999998654 48999999999999999999999998766655555554322  346677899999999999999


Q ss_pred             CCCCCCC-----HHHHhcCccccchHHHhhc
Q 040472          462 DPSARPP-----ASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       462 dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~  487 (628)
                      ||++||+     +.++++|+||+...|....
T Consensus       236 ~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLY  266 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence            9999999     7889999999987776544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-46  Score=404.61  Aligned_cols=265  Identities=27%  Similarity=0.418  Sum_probs=224.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.++||+|+||.||+|+++.+++.||||++....  .......+.+.+|+.+|+.++|+||+++++++.+++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE--MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4578999999999999999999999999999999986421  11122345577899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999999875 468999999999999999999999999999999999999999999999999998654322 


Q ss_pred             -ccccccCCCCcCChhhhhcc---CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC--cCCHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNT---NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDD  450 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~s~~  450 (628)
                       .....+||+.|+|||++.+.   ..++.++|||||||+||||++|..||........+.++........++.  .++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence             22356799999999998653   2378999999999999999999999988766555555544332223333  57999


Q ss_pred             HHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHHh
Q 040472          451 AKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       451 l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      +.+||++||+.+|.+  |+++++|++||||++..|..
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~  314 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTF  314 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhh
Confidence            999999999999988  99999999999998866653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.5e-47  Score=388.89  Aligned_cols=255  Identities=24%  Similarity=0.448  Sum_probs=213.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|+++.+++.||||+++....   .....+.+.+|+.+++.++|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc---cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            379999999999999999999999999999999874322   12334667889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--c
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--S  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--~  377 (628)
                      ||||+.++.|..+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            99999998777666666789999999999999999999999999999999999999999999999999998754322  2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--------------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--------------------  437 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--------------------  437 (628)
                      .....||+.|+|||++.+.. ++.++|||||||++|||++|++||...........+...                    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             ccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            23467999999999987654 899999999999999999999999765443332221110                    


Q ss_pred             CCCC----------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          438 KDIP----------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       438 ~~~~----------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ...+          .....++.++.+||++||+.||++||+++|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0000          0112378889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-46  Score=390.68  Aligned_cols=256  Identities=27%  Similarity=0.492  Sum_probs=212.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++.++||+|+||.||+|+++.+++.||||+++.....    .....+.+|+++|++++|+||+++++++.+++..
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            367899999999999999999999999999999998643221    1224567899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      ++||||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            999999975 8999887654 5789999999999999999999999999999999999999999999999999764322 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-----------------
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-----------------  438 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-----------------  438 (628)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|++||......+.+..+....                 
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            223345689999999998766668999999999999999999999997655433332221000                 


Q ss_pred             ---CCC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 ---DIP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ---~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                         ..+        .....++.++++||++||+.||.+|+|++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence               000        1123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.9e-46  Score=391.65  Aligned_cols=256  Identities=32%  Similarity=0.486  Sum_probs=215.0

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHH-HHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-LLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||+||+|+++.+++.||||++.....  ........+..|.. +++.++||||+++++++..++.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            469999999999999999999999999864321  11222344555554 578899999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .||+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            9999999999888999999999999999999999999999999999999999999999999999875322 233445679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+....  ..++..++.++.++|++||+.+|
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         159 TPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCH
Confidence            9999999998654 48999999999999999999999998766555544444322  23445688999999999999999


Q ss_pred             CCCCCH----HHHhcCccccchHHHhh
Q 040472          464 SARPPA----SKLLDHPFVRDQAVARA  486 (628)
Q Consensus       464 ~~Rpta----~eiL~Hpwf~~~~~~~~  486 (628)
                      .+||++    .++++||||+...|...
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~~~~~~  262 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESLSWTDL  262 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            999976    59999999987766544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.4e-46  Score=394.87  Aligned_cols=260  Identities=29%  Similarity=0.484  Sum_probs=219.4

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||+||+|++..+++.||||+++...  ....+..+.+.+|+.++.++ +|+||+.+++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            47999999999999999999999999997422  12234456788999999888 5999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-CccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~~~~~G  383 (628)
                      .||+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            999999999888899999999999999999999999999999999999999999999999999997532 2233445789


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC------chhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY------EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~------~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      |+.|+|||++.+. .++.++|||||||+||||++|..||...      .....+.+..... ...++..++..+.++|++
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~  236 (327)
T cd05617         159 TPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Confidence            9999999998754 4899999999999999999999999532      1222233322222 234677789999999999


Q ss_pred             HhhcCCCCCCC------HHHHhcCccccchHHHhhcCC
Q 040472          458 CLQRDPSARPP------ASKLLDHPFVRDQAVARAGNV  489 (628)
Q Consensus       458 ~L~~dP~~Rpt------a~eiL~Hpwf~~~~~~~~~~~  489 (628)
                      ||+.||++|++      +++|++|+||+...|......
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~  274 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK  274 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence            99999999997      579999999999888765433

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.6e-46  Score=394.04  Aligned_cols=257  Identities=31%  Similarity=0.537  Sum_probs=220.2

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||+||+|++..+++.||||+++....  ........+.+|+.++..+ +|+||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999874321  1123345677899999888 6999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .|++|..++.+.+.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            9999999999888999999999999999999999999999999999999999999999999999875322 223344679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....  ..++..++.++.+||++||+.||
T Consensus       159 ~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         159 TPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             CccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHccCCH
Confidence            9999999998765 48999999999999999999999998766555444443322  34566789999999999999999


Q ss_pred             CCCCCH-----HHHhcCccccchHHHhhc
Q 040472          464 SARPPA-----SKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       464 ~~Rpta-----~eiL~Hpwf~~~~~~~~~  487 (628)
                      .+||++     .++++||||+...|....
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~~~~~~~  264 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREIDWDKLE  264 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            999999     999999999987776543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.3e-46  Score=400.99  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=220.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.++||+|+||.||+|+++.+++.||+|++.+...  ......+.+.+|+.+++.++||||+++++++.+++.+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34689999999999999999999999999999999864211  1122345678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.||+|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999999976 468999999999999999999999999999999999999999999999999998764322 


Q ss_pred             -ccccccCCCCcCChhhhhccC---CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC--cCCHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTN---GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDD  450 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~---~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~s~~  450 (628)
                       .....+||+.|||||++.+..   .++.++|||||||+||||++|+.||........+.++........++.  .++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence             224567999999999986532   378899999999999999999999987766655555554332233333  47899


Q ss_pred             HHHHHHHHhhcCCCC--CCCHHHHhcCccccchHH
Q 040472          451 AKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       451 l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~  483 (628)
                      +++||.+||+.++.+  |+++.|+++||||+...|
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            999999999855543  889999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-46  Score=393.49  Aligned_cols=258  Identities=30%  Similarity=0.519  Sum_probs=218.5

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||.||+|++..+++.||||+++....  ......+.+..|..++..+ +||||+++++++..++.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            469999999999999999999999999975321  1122334455677777654 7999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .||+|.+++...+.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            9999999999888999999999999999999999999999999999999999999999999999975432 233345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+....+..+..  ..+.++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         159 TPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             CccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999998755 489999999999999999999999987665555544433  2345677799999999999999999


Q ss_pred             CCCCCH-HHHhcCccccchHHHhhcC
Q 040472          464 SARPPA-SKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       464 ~~Rpta-~eiL~Hpwf~~~~~~~~~~  488 (628)
                      ++|+++ .++++|+||+...|.....
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~~~~~~~  261 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGIDWERLEK  261 (316)
T ss_pred             HHcCCChHHHHcCcccCCCCHHHHHh
Confidence            999986 5899999999887766543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-46  Score=394.27  Aligned_cols=256  Identities=27%  Similarity=0.484  Sum_probs=216.9

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||.||+|+++.+++.||||+++.....  .......+..|+.++..+ +|+||+++++++.+++.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4799999999999999999999999998742211  112344566788888754 8999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .||+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            9999999999888999999999999999999999999999999999999999999999999999875322 223345779


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+..  ..+.++..++.++++||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         159 TPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             CcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999998755 489999999999999999999999987655444444332  2345667789999999999999999


Q ss_pred             CCCCCH-HHHhcCccccchHHHhh
Q 040472          464 SARPPA-SKLLDHPFVRDQAVARA  486 (628)
Q Consensus       464 ~~Rpta-~eiL~Hpwf~~~~~~~~  486 (628)
                      ++|+++ +++++||||+...+...
T Consensus       236 ~~R~~~~~~~~~h~~f~~~~~~~~  259 (316)
T cd05620         236 TRRLGVVGNIRGHPFFKTINWTAL  259 (316)
T ss_pred             HHcCCChHHHHcCCCcCCCCHHHH
Confidence            999997 58999999998776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=401.69  Aligned_cols=252  Identities=33%  Similarity=0.525  Sum_probs=222.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcE-EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE-  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~-vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~-  295 (628)
                      ...+..+.+.||+|+||+||+|.+.  |+. ||||++.......  .. .+.|.+|+.+|.+++|||||+++|++.... 
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~--~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDD--ES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcCh--HH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456667777999999999999887  455 9999987533222  22 788999999999999999999999999887 


Q ss_pred             cceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccCCCceEeCCCC-CEEEeccCCccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARN-TVHRDIKGANILVDPHG-EIKLADFGMAKH  371 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g-IvHRDIKpeNILld~~g-~vKL~DFGla~~  371 (628)
                      .+.|||||+.+|+|.++|..  ...++...+..++.||+.||+|||+++ |||||||++||||+.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999987  688999999999999999999999999 99999999999999997 999999999987


Q ss_pred             ccCc-cccccccCCCCcCChhhhhc-cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          372 MTSC-ASMLSFKGSPYWMAPEVVMN-TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       372 ~~~~-~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      .... .......||+.|||||++.+ ...|+.|+||||||++||||+||+.||...........+......+.++..+++
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            6554 34444789999999999974 345999999999999999999999999998887777777777777888888999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+..||.+||..||.+||++.+|+.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999999864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-47  Score=391.39  Aligned_cols=259  Identities=32%  Similarity=0.575  Sum_probs=222.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC-eeeeecceeccc--
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN-IVRYHGSELSDE--  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IV~l~~~~~~~~--  295 (628)
                      +..|+.+++||+|+||+||+|+++.+|+.||||+++...+...   .-....+|+.+|+.|+|+| ||.|++++.+++  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            4568888899999999999999999999999999986544211   2234568999999999999 999999999887  


Q ss_pred             ----cceEEEEecccccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          296 ----RLSVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       296 ----~~~lVmEy~~GgsL~~~L~~~~----~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                          .++|||||++ .+|.+++....    .++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                8999999995 59999998755    57788999999999999999999999999999999999999999999999


Q ss_pred             Cccccc-CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC-----
Q 040472          368 MAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP-----  441 (628)
Q Consensus       368 la~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~-----  441 (628)
                      +|+.+. +.......++|.+|+|||++++...|+..+||||+|||++||+++++.|.+....+++.+|......|     
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999776 34446677899999999999999889999999999999999999999998877777666653222111     


Q ss_pred             -C-------------C---------CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          442 -E-------------I---------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       442 -~-------------~---------p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                       .             .         .+..+.++.+++.+||+.+|.+|.++..+|.||||.+.
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence             0             0         01234589999999999999999999999999999765

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-46  Score=391.46  Aligned_cols=259  Identities=27%  Similarity=0.495  Sum_probs=211.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|+++.+++.||||+++.....    .....+.+|+.+|+.++|+||+++++++.++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            46899999999999999999999999999999998643221    11235678999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          299 VYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      +||||+. ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            9999995 577777765 467899999999999999999999999999999999999999999999999999754322 2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH-H---hhhcCCCC---C------CC-
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA-I---FKIGNSKD---I------PE-  442 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~-~---~~i~~~~~---~------~~-  442 (628)
                      .....+||+.|+|||++.+...++.++|||||||++|||++|..||........ +   ..+.....   +      +. 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            234467899999999987666689999999999999999999999976533211 1   11110000   0      00 


Q ss_pred             --------CC---------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          443 --------IP---------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       443 --------~p---------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                              .+         ..++.++.+||++||+.||++|+|+.|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                    00         02457899999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-45  Score=389.32  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=215.6

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHH-HHHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEI-NLLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      ++||+|+||+||+|++..+++.||||++.....  .......++.+|+ .+++.++|+||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            469999999999999999999999999864221  1122234455555 4688999999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-CccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~~~~~G  383 (628)
                      .|++|..++.+...+.+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            999999999888889999999999999999999999999999999999999999999999999987532 2233345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+...  ...++...+.++.++|.+||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         159 TPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             CcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999998654 4899999999999999999999999876654444444332  235566788999999999999999


Q ss_pred             CCCCCH----HHHhcCccccchHHHhhc
Q 040472          464 SARPPA----SKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       464 ~~Rpta----~eiL~Hpwf~~~~~~~~~  487 (628)
                      .+|+++    .++++|+||....|....
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSPINWDDLY  263 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence            999865    599999999887766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=402.58  Aligned_cols=272  Identities=28%  Similarity=0.446  Sum_probs=237.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ...|+.-++||+|+||.||-++.+.||+.||+|.+.+..  ...........+|.+||++++.++||.|-..|++.+.++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR--iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR--IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH--HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            357888899999999999999999999999999875422  222333456778999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |||..|+||+|..+|.+.+  .|+|..+++|+++|+.||++||+.+||+|||||+|||+|+.|+|.|.|+|||..+....
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999999999877  79999999999999999999999999999999999999999999999999999998888


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH---HHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~---~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      .....+||.+|||||++.+.. |+..+|||+|||+||||+.|+.||.+.....   ++.+... ....+++..+|+++++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSDKFSEEAKS  419 (591)
T ss_pred             ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcccccCHHHHH
Confidence            888889999999999998776 9999999999999999999999997654322   2222221 2334678899999999


Q ss_pred             HHHHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCC
Q 040472          454 FIKQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKD  494 (628)
Q Consensus       454 LI~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~  494 (628)
                      |.+.+|++||++|+.     ++++.+||||++.+|.+....-+.++
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PP  465 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPP  465 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCC
Confidence            999999999999984     67999999999999998766554433

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=386.82  Aligned_cols=299  Identities=28%  Similarity=0.475  Sum_probs=260.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .+++|.++++||+|+|++|.+++++.|.+.||+|++++..-  ++.+.+.-++.|..+..+.+ ||++|-|+.+|+++.+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            57899999999999999999999999999999999976432  23445666778888887775 9999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc-ccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~-~~~~  375 (628)
                      +++|.||++||+|.-++++...++|+.++.|..+|+.||.|||++|||+||||.+|||||.+|++||+|||+++. +.+.
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999986 4556


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCC-------CchhHHHhhhcCCCCCCCCCCcCC
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQ-------YEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~-------~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ....++||||.|+|||++.+. .|...+|||+|||+|+||+.|+.||+-       .+..+.++++.....+ .+|..+|
T Consensus       406 d~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-riprsls  483 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RIPRSLS  483 (593)
T ss_pred             cccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cccceee
Confidence            677889999999999999765 599999999999999999999999942       2334445555444433 6788899


Q ss_pred             HHHHHHHHHHhhcCCCCCC------CHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 040472          449 DDAKSFIKQCLQRDPSARP------PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCE  522 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rp------ta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~  522 (628)
                      -.+..+++..|.+||.+|.      .+.++..|+||+.++|......++             .||+.+.+.....+.+|+
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v-------------~ppf~p~i~~d~~l~~fd  550 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQV-------------LPPFQPQITDDYGLDNFD  550 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhccc-------------CCCCCCccccccCccccc
Confidence            9999999999999999996      478999999999999988766544             467778888899999999


Q ss_pred             ccccCCCCCcc
Q 040472          523 GDYLANPLVPT  533 (628)
Q Consensus       523 ~~~~~~~~~~~  533 (628)
                      ..|+.+++..+
T Consensus       551 ~qft~e~~qlt  561 (593)
T KOG0695|consen  551 TQFTSEPVQLT  561 (593)
T ss_pred             cccccCCcccC
Confidence            99999876543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=402.02  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=234.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .-|.+.+.||+|.|++|.+|++.-||+.||||+|.+...+   .-...++.+|++.|+.++|||||+||.+..+...+||
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD---~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc---hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            4578889999999999999999999999999999764332   3345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe-CCCCCEEEeccCCcccccCccc
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV-DPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl-d~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+|+-+||+|+++|-++ ..+.|..+++|++||+.|+.|||+..|||||||||||.+ ..-|-|||+|||++..+.+...
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999998654 579999999999999999999999999999999999876 5578999999999999999999


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ..+.||+..|-|||++++..+..+++||||||||||-|++|++||...+..+.+-.|...+.  .+|.+++.++++||..
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDLIQS  252 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHHHHH
Confidence            99999999999999999988667899999999999999999999998888887777765443  6788999999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccchHH
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ||..||.+|.+.++|..|+|++..+.
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999999986553

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.6e-46  Score=390.55  Aligned_cols=258  Identities=31%  Similarity=0.483  Sum_probs=216.2

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHH-HHHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEI-NLLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      +.||+|+||+||+|++..+++.||||++.....  ........+..|. .+++.++|+||+++++++.+++.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI--LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            469999999999999999999999999864211  1112223344444 4578899999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .|++|.+++...+.+.+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            9999999999888899999999999999999999999999999999999999999999999999975432 233445779


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+....+..+....  ..++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         159 TPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             CccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999998754 48999999999999999999999998766555544443322  24456789999999999999999


Q ss_pred             CCCCCHH----HHhcCccccchHHHhhcC
Q 040472          464 SARPPAS----KLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       464 ~~Rpta~----eiL~Hpwf~~~~~~~~~~  488 (628)
                      .+|+++.    ++++|+||....|.....
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~~~~~~~~~  264 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSPINWDDLIN  264 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCCCCHHHHHh
Confidence            9999865    899999998887766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.8e-46  Score=391.50  Aligned_cols=258  Identities=30%  Similarity=0.501  Sum_probs=217.7

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHh-CCCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ-LSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      +.||+|+||+||+|++..+++.||||+++.....  .......+..|+.++.. ++||||+++++++.+++.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4699999999999999999999999998753211  11223455667888876 48999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-ccccccccC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKG  383 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~~~~~~~G  383 (628)
                      .||+|.+++.....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            9999999999888899999999999999999999999999999999999999999999999999875322 223345679


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      |+.|+|||++.+. .++.++|||||||++|||++|..||...+....+..+...  .+.++..++.++++||.+||+.||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         159 TPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             CccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCH
Confidence            9999999998755 4899999999999999999999999876655444444322  234566789999999999999999


Q ss_pred             CCCCCHH-HHhcCccccchHHHhhcC
Q 040472          464 SARPPAS-KLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       464 ~~Rpta~-eiL~Hpwf~~~~~~~~~~  488 (628)
                      ++|+++. ++++||||++..|.....
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~~~~~~~  261 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREIDWSALEE  261 (316)
T ss_pred             hhcCCChHHHHcCcccCCCCHHHHHh
Confidence            9999996 899999999988765543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-46  Score=383.23  Aligned_cols=264  Identities=28%  Similarity=0.443  Sum_probs=223.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|++.++||+|+||+||++.+..+++.||||++.....  ........+.+|+.+|+.++|+||+++++++.+++.+++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            48899999999999999999999999999999864221  1122345677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |||+.||+|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            9999999999988653  46899999999999999999999999999999999999999999999999999876544444


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH---HhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA---IFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~---~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ...+|++.|+|||++.+. .++.++|||||||++|||++|+.||........   +..... .....++..++..+.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-EDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-hcccccCcccCHHHHHHH
Confidence            456799999999998654 489999999999999999999999986543222   211111 222345667899999999


Q ss_pred             HHHhhcCCCCCC-----CHHHHhcCccccchHHHhhcC
Q 040472          456 KQCLQRDPSARP-----PASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       456 ~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~  488 (628)
                      .+||+.||++||     +++++++|+||....|....+
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence            999999999999     899999999999887776654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.2e-46  Score=390.91  Aligned_cols=265  Identities=29%  Similarity=0.483  Sum_probs=225.4

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~l  299 (628)
                      +|+..++||+|+||+||+|+++.+++.||||+++...  .......+.+..|+.++..+. |++|+++++++.+++.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            4788899999999999999999999999999987421  112233566778899998886 5778899999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~  378 (628)
                      ||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            9999999999999998889999999999999999999999999999999999999999999999999998754322 223


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+....  ..++..++.++.+||.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHH
Confidence            456799999999998654 48999999999999999999999998766655555544322  246677899999999999


Q ss_pred             hhcCCCCCCC-----HHHHhcCccccchHHHhhcCCC
Q 040472          459 LQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVN  490 (628)
Q Consensus       459 L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~  490 (628)
                      |+.+|.+|++     .+++++|+||+...|.......
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~  272 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENRE  272 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCC
Confidence            9999999997     5799999999988877665433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.6e-45  Score=386.88  Aligned_cols=265  Identities=25%  Similarity=0.375  Sum_probs=221.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+++++.+++.||||++....  .........+.+|+.++..++|+||+++++++.+++.+|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            47999999999999999999999999999999986421  1122334567889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..... 
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999999987 46899999999999999999999999999999999999999999999999999976544322 


Q ss_pred             -cccccCCCCcCChhhhhcc----CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC---CCCCCCcCCH
Q 040472          378 -MLSFKGSPYWMAPEVVMNT----NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD---IPEIPEHLSD  449 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~---~~~~p~~~s~  449 (628)
                       ....+||+.|+|||++.+.    ..++.++|||||||+||||++|+.||...+....+.++.....   .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence             1235799999999998642    3478899999999999999999999987665555555543322   2222345789


Q ss_pred             HHHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHHhh
Q 040472          450 DAKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ++++||.+||..++.+  |++++++++|+||++..|...
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999999999866544  468999999999998877655

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=374.01  Aligned_cols=258  Identities=47%  Similarity=0.884  Sum_probs=226.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|+++++||+|+||.||+|.+..+++.||||++.............+.+.+|++++++++|+||+++++++.+++.+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46899999999999999999999999999999987543333334445678999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc--
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~--  377 (628)
                      ||||+.|++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||+++.......  
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            999999999999999888899999999999999999999999999999999999999999999999999976533211  


Q ss_pred             --cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          378 --MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       378 --~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                        .....|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+........++..++.++.+||
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence              13356889999999987654 899999999999999999999999877766666666555555667778999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ++||..+|++||++.++++|+||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-46  Score=391.25  Aligned_cols=257  Identities=26%  Similarity=0.470  Sum_probs=209.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-----c
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-----E  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-----~  295 (628)
                      +|++.++||+|+||.||+|+++.+++.||||+++....   ......++.+|+++|+.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            58999999999999999999999999999998864221   122345678999999999999999999987643     3


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|+||||+ +++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            589999999 4689999988888999999999999999999999999999999999999999999999999999754321


Q ss_pred             c----ccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhHHHhhh----------------
Q 040472          376 A----SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI----------------  434 (628)
Q Consensus       376 ~----~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i----------------  434 (628)
                      .    .....+||+.|+|||++.+. ..++.++|||||||++|||++|++||...+....+..+                
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    12346799999999998642 45899999999999999999999999765432211110                


Q ss_pred             -----------cCCCC--CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          435 -----------GNSKD--IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       435 -----------~~~~~--~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                 .....  .......++.++.+||.+||+.||++||+++|||+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                       00000  001112467889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=389.90  Aligned_cols=265  Identities=26%  Similarity=0.404  Sum_probs=220.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||+||++++..+++.||||++.+..  .......+.+.+|+.++..++|+||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            47999999999999999999999999999999986421  1122335668889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.||+|.+++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++........ 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999986 45799999999999999999999999999999999999999999999999999876543322 


Q ss_pred             -cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC---CCCCCCCcCCH
Q 040472          378 -MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK---DIPEIPEHLSD  449 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~---~~~~~p~~~s~  449 (628)
                       ....+||+.|||||++..    ...++.++|||||||++|||++|+.||...........+....   ..+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence             123569999999999863    2347889999999999999999999998765555444443322   22233345899


Q ss_pred             HHHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHHhh
Q 040472          450 DAKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ++++||++||..++++  |+++.++++||||.+..|...
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence            9999999999754443  789999999999988776554

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.1e-45  Score=395.03  Aligned_cols=264  Identities=26%  Similarity=0.408  Sum_probs=220.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++....  .......+.+.+|+.+++.++||||+++++++.++..+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            3579999999999999999999999999999999986421  11122345678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++...... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999999999999876 458999999999999999999999999999999999999999999999999998664322 


Q ss_pred             -ccccccCCCCcCChhhhhccC---CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTN---GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDD  450 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~---~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~  450 (628)
                       .....+||+.|||||++.+..   .++.++|||||||+||||++|..||...+......++........++  ..++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence             223567999999999986532   37899999999999999999999998766655555554433222222  368999


Q ss_pred             HHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHH
Q 040472          451 AKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       451 l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~  484 (628)
                      +++||.+||..++.+  |+++++|++|+||++..+.
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~  313 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  313 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence            999999999844433  7899999999999876553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-45  Score=389.88  Aligned_cols=257  Identities=30%  Similarity=0.519  Sum_probs=216.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|++..++..||+|++....    .....+++.+|+++|++++|+||+++++++.+++.++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            468999999999999999999999999999999987422    2344567899999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||+.|++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++...... .
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            9999999999999999888899999999999999999999986 6999999999999999999999999999765432 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---------------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---------------------  436 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---------------------  436 (628)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+..                     
T Consensus       159 ~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            3446799999999998765 489999999999999999999999965433221111100                     


Q ss_pred             ------------------------CCCCCCC-CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 ------------------------SKDIPEI-PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 ------------------------~~~~~~~-p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                              ....+.. ...++.++++||++||++||++||++.+||+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                    0001111 12467899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.9e-45  Score=388.27  Aligned_cols=265  Identities=25%  Similarity=0.389  Sum_probs=222.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.++||+|+||.||+++++.+++.||||++.+..  .........+.+|+.++..++|+||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            47999999999999999999999999999999986421  1122234557889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.||+|.+++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++........ 
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999987 46799999999999999999999999999999999999999999999999999976533222 


Q ss_pred             -cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC---CCCCCCcCCH
Q 040472          378 -MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD---IPEIPEHLSD  449 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~---~~~~p~~~s~  449 (628)
                       ....+||+.|+|||++..    ...++.++|||||||+||||++|+.||...+....+.++.....   .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence             233579999999999862    34588999999999999999999999988766666655544322   2333346799


Q ss_pred             HHHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHHhh
Q 040472          450 DAKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ++++||++||..++.+  |++++++++||||++..|...
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence            9999999999765444  689999999999998777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-46  Score=386.94  Aligned_cols=251  Identities=33%  Similarity=0.557  Sum_probs=216.0

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--c---
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--E---  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~---  295 (628)
                      .|...+++|.|+||.||+|....+++.||||.+-...         +.-.+|++||+.+.|||||+|+.+|...  .   
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            5788899999999999999999999999999764321         1234799999999999999999887652  2   


Q ss_pred             cceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCcc
Q 040472          296 RLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAK  370 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~  370 (628)
                      .+.||||||+ .+|.++++.    +..++.-.++-|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+
T Consensus        96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            4668999996 599999985    4678889999999999999999999999999999999999987 899999999999


Q ss_pred             cccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC----------
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI----------  440 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~----------  440 (628)
                      .+.......++..|.+|+|||.+.+...|+.+.||||.|||+.||+.|++-|.+.....++..|......          
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            9988888888999999999999999999999999999999999999999999887666555444221111          


Q ss_pred             --------C--------C-CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          441 --------P--------E-IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       441 --------~--------~-~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                              +        + +...+++++.+|+.++|+.+|.+|.++.|+|.||||.+.
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence                    1        1 234578999999999999999999999999999999643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=404.77  Aligned_cols=290  Identities=25%  Similarity=0.402  Sum_probs=263.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++++++..||-|+||+|=++........+|+|++++..-.  .....+++..|.+||..++.++||+||-.|.+++++
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV--dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV--DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc--chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            567888999999999999999988766667999999764322  234457889999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |++||-|.||+|..+|+..+.|.+..+++|+..+++|++|||.+|||+|||||||+|++.+|-+||.|||+|+.+.....
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ..++||||.|.|||++.+.+ ++.++|+||||+++||||+|.+||.+.+.+.....|...-+.-.+|..++..+.+||++
T Consensus       576 TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            99999999999999998865 99999999999999999999999999999888888877777778899999999999999


Q ss_pred             HhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCc
Q 040472          458 CLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEG  523 (628)
Q Consensus       458 ~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~  523 (628)
                      +...+|.+|+.     +.+|..|.||.+.+|......             ...||+.+.+....++++|+.
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~-------------~L~pPi~~~va~ptD~s~Fd~  712 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSR-------------TLPPPIIPSVANPTDVSNFDN  712 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhc-------------cCCCCccccCCCcccchhccC
Confidence            99999999986     889999999999999876543             456777788888888888874

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-45  Score=379.76  Aligned_cols=254  Identities=30%  Similarity=0.513  Sum_probs=205.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECC-CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeeccee---
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSE-SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSEL---  292 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~---  292 (628)
                      ++|++.+.||+|+||+||+|++.. +++.||||+++.......   ....+.+|+.+++.+   .||||+++++++.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            479999999999999999999854 478899999875432221   123344567666655   6999999999875   


Q ss_pred             --ccccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          293 --SDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       293 --~~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                        ....+++||||+. ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence              3456899999996 5899988753  4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------C--
Q 040472          369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------I--  440 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------~--  440 (628)
                      ++............||+.|+|||++.+. .++.++|||||||++|||++|.+||........+.++.....      +  
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9876544444556799999999998654 489999999999999999999999987665544444321110      0  


Q ss_pred             -----------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          441 -----------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       441 -----------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                       ..+...++..+++||.+||+.||++||++.|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             01123477889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=390.58  Aligned_cols=256  Identities=30%  Similarity=0.464  Sum_probs=224.4

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      --.++||.|.||+||-|+++.+|+.||||+|.+..-.   .....++++|+.||+++.||.||.|...|++.+++++|||
T Consensus       567 f~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp---~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  567 FADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP---TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             hhHhhccCCcceeeecceecccCceeeeeeeecccCC---CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            3358999999999999999999999999999764322   1223778999999999999999999999999999999999


Q ss_pred             ecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccCCcccccCcccc
Q 040472          303 YVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       303 y~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFGla~~~~~~~~~  378 (628)
                      -+.|.-|+-+|. +.++|+|...++++.||+.||.|||.+||+|+||||||||+...   -++||||||+|+.+.+....
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            997755555554 57899999999999999999999999999999999999999654   37999999999999888888


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      .+.+|||.|+|||++.+.+ |+...||||+|||+|.-|.|..||...+......+.......+..|.+++.++.|||..+
T Consensus       724 rsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            8899999999999998765 999999999999999999999999876655444444444455677889999999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccchH
Q 040472          459 LQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      |+..-.+|.+++..|.|||+++..
T Consensus       803 LqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHhcchHhhccchhhhcch
Confidence            999999999999999999998643

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-45  Score=378.02  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=212.5

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||+|+||+||++.++.+++.||||++....  .......+.+..|+++|+.++|+||+++++++..+..+|+||||+.||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHH--HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            799999999999999999999999886421  112234466788999999999999999999999999999999999999


Q ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cccccc
Q 040472          308 SIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SMLSFK  382 (628)
Q Consensus       308 sL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~  382 (628)
                      +|..++..    ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+.... ......
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99988743    3568999999999999999999999999999999999999999999999999997654332 233467


Q ss_pred             CCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---HHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       383 GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ||+.|+|||++.+. .++.++|||||||++|||++|+.||......   ..+..... .....++..++.++.+||.+||
T Consensus       159 g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         159 GTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             CCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHh
Confidence            99999999999765 4899999999999999999999999754321   11111111 1223456678999999999999


Q ss_pred             hcCCCCCC-----CHHHHhcCccccchHHHhh
Q 040472          460 QRDPSARP-----PASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       460 ~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~  486 (628)
                      +.||++|+     +++++++||||++..|...
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence            99999999     8899999999988766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-45  Score=405.72  Aligned_cols=253  Identities=30%  Similarity=0.545  Sum_probs=208.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      ..+|+++++||+|+||+||+|++..+++.||||++....         ....+|+.+|+.++|+|||++++++...    
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            468999999999999999999999999999999875311         2234699999999999999998876432    


Q ss_pred             ----ccceEEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEec
Q 040472          295 ----ERLSVYLEYVSGGSIHKLLQ----EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLAD  365 (628)
Q Consensus       295 ----~~~~lVmEy~~GgsL~~~L~----~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~D  365 (628)
                          ..+++||||+.+ +|.+++.    ....+++..++.|+.||+.||+|||+++||||||||+||||+.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence                246789999975 6766664    346799999999999999999999999999999999999998765 699999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-------
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-------  438 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-------  438 (628)
                      ||+|+.+.........+||+.|+|||++.+...|+.++|||||||+||||++|.+||.+......+.++....       
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            9999877655555567899999999998776669999999999999999999999998765444333322100       


Q ss_pred             -----------CCC---------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 -----------DIP---------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 -----------~~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                 ..+         .++...+.++.+||.+||++||.+|+++.|+|+||||.+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                       001         1344578899999999999999999999999999999764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=395.42  Aligned_cols=259  Identities=33%  Similarity=0.582  Sum_probs=234.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc-c
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER-L  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~-~  297 (628)
                      +++|.+++.||+|+||.+++++++.+++.|++|.|.......   ...+...+|+.+++++.|||||.+++.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~---~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE---PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc---hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            578999999999999999999999999999999997644332   222367889999999999999999999999888 9


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +|||+||+||+|.+.|.+.  ..|+|+.+..|+.||+.||.|||+++|+|||||+.|||++.++.|||.|||+|+.+...
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999999999764  46899999999999999999999999999999999999999999999999999998776


Q ss_pred             c-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          376 A-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       376 ~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      . ...+++||++||.||++.+.. |+.|+|||||||++|||++-+++|...+-...+.+|.... ...++...+.+++.|
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSL  237 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHH
Confidence            5 667789999999999998765 9999999999999999999999999988888888887655 457888899999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      |+.||+.+|+.||++.++|.+|.+....
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999876544

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-44  Score=399.18  Aligned_cols=253  Identities=23%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC------CCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH------PNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIV~l~~~~  291 (628)
                      ...+|+++++||+|+||+||+|++..+++.||||+++...      ...+.+..|+++++.+.|      .+|+.++++|
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            3478999999999999999999999999999999986321      123345567777776654      4588999888


Q ss_pred             ecc-ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCC----------
Q 040472          292 LSD-ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHG----------  359 (628)
Q Consensus       292 ~~~-~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g----------  359 (628)
                      ..+ .++|||||++ |++|.+++.+.+.+++..++.|+.||+.||+|||. .|||||||||+||||+.++          
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            764 5788999988 78999999888899999999999999999999998 5999999999999998765          


Q ss_pred             ------CEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhh
Q 040472          360 ------EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK  433 (628)
Q Consensus       360 ------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~  433 (628)
                            .+||+|||++....  ......+||+.|||||++.+. .|+.++|||||||+||||++|++||...+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  49999999886432  233457899999999999765 499999999999999999999999987554333222


Q ss_pred             hcCCCC-------------------------CCCC-C--------------CcCCHHHHHHHHHHhhcCCCCCCCHHHHh
Q 040472          434 IGNSKD-------------------------IPEI-P--------------EHLSDDAKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       434 i~~~~~-------------------------~~~~-p--------------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      +.....                         .+.. +              ......+.+||++||++||++||+++|||
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            110000                         0000 0              01135678999999999999999999999


Q ss_pred             cCccccc
Q 040472          474 DHPFVRD  480 (628)
Q Consensus       474 ~Hpwf~~  480 (628)
                      +||||+.
T Consensus       437 ~Hp~~~~  443 (467)
T PTZ00284        437 THPYVLK  443 (467)
T ss_pred             cCccccc
Confidence            9999964

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.9e-45  Score=375.61  Aligned_cols=263  Identities=28%  Similarity=0.451  Sum_probs=220.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|++.++||+|+||.||+|.+..+++.||||.+......  ..+....+.+|+.+|++++|+||+.+++.+.+++.+++|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            378889999999999999999999999999988643211  223345677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |||+.|++|.+++...  ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+|||++.........
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            9999999999998654  35899999999999999999999999999999999999999999999999999766544444


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---HHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ...+||..|+|||++.+. .++.++|||||||++|+|++|+.||......   .....+.. .....++..++.++.+||
T Consensus       159 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHH
Confidence            456799999999998654 4899999999999999999999999764321   11222111 111234567889999999


Q ss_pred             HHHhhcCCCCCCC-----HHHHhcCccccchHHHhhc
Q 040472          456 KQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       456 ~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~  487 (628)
                      ++||+.||++|++     ++|+++||||+...+.+..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLE  273 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHh
Confidence            9999999999999     9999999999887776654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-44  Score=394.83  Aligned_cols=253  Identities=29%  Similarity=0.549  Sum_probs=216.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CC-----Ceeeeecceec
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HP-----NIVRYHGSELS  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIV~l~~~~~~  293 (628)
                      .+|.+.++||+|+||+|.+|++..|++.||||+++.      ......+...|+.||..|+ |.     |||+++++|..
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            378999999999999999999999999999999973      3566788889999999998 53     79999999999


Q ss_pred             cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC--CCEEEeccCCc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH--GEIKLADFGMA  369 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~--g~vKL~DFGla  369 (628)
                      .+++|||+|++ ..+|+++|+.+  ..|+...++.++.||+.||.+||+.+|||+|||||||||..-  ..|||+|||.+
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999999 56999999865  468999999999999999999999999999999999999653  37999999999


Q ss_pred             ccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--------
Q 040472          370 KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--------  441 (628)
Q Consensus       370 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--------  441 (628)
                      .+...  ...+++-+..|+|||+|.+.. |+.+.||||||||++||++|.+.|.+.+..+++..|......|        
T Consensus       339 c~~~q--~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQ--RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCC--cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            86543  333788999999999999876 9999999999999999999999998877766665542211100        


Q ss_pred             ------------------------------------------CCC-----------CcCCHHHHHHHHHHhhcCCCCCCC
Q 040472          442 ------------------------------------------EIP-----------EHLSDDAKSFIKQCLQRDPSARPP  468 (628)
Q Consensus       442 ------------------------------------------~~p-----------~~~s~~l~dLI~~~L~~dP~~Rpt  468 (628)
                                                                ..|           ..-...+.|||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                                                      011           012246789999999999999999


Q ss_pred             HHHHhcCccccchH
Q 040472          469 ASKLLDHPFVRDQA  482 (628)
Q Consensus       469 a~eiL~Hpwf~~~~  482 (628)
                      +.|+|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999997544

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-44  Score=373.49  Aligned_cols=253  Identities=30%  Similarity=0.527  Sum_probs=204.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeecceec----
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSELS----  293 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~~----  293 (628)
                      +|++.+.||+|+||+||+|+++.+++.||||+++.......   ....+.+|+.+++.+   +|+||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC---CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            58999999999999999999999999999999875322211   112344566666555   79999999998764    


Q ss_pred             -cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          294 -DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       294 -~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                       ...+++||||+.+ +|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             3458999999975 898888764  348999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC------C-----
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK------D-----  439 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~------~-----  439 (628)
                      ............||..|+|||++.+. .++.++|||||||++|+|++|.+||........+.++....      .     
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444456789999999998754 48999999999999999999999997655443332221100      0     


Q ss_pred             --------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          440 --------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       440 --------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                    ...+...++.++.+||.+||+.||++||++.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          001223577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.1e-45  Score=391.74  Aligned_cols=258  Identities=25%  Similarity=0.439  Sum_probs=215.4

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc-----
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE-----  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~-----  295 (628)
                      +|++++.||+|+||.||+|++..+++.||||++.....   .....+++.+|+.+|+.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            47889999999999999999999999999998853221   2234567889999999999999999999998776     


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            7899999996 589888888788999999999999999999999999999999999999999999999999999865332


Q ss_pred             c--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC----------------
Q 040472          376 A--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS----------------  437 (628)
Q Consensus       376 ~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~----------------  437 (628)
                      .  ......+|+.|+|||++.+...++.++|||||||++|||++|+.||........+..+...                
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            2  2334568999999999987666899999999999999999999999765544333222110                


Q ss_pred             --------CCC------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          438 --------KDI------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       438 --------~~~------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                              ...      ..+....+.++.+||.+||+.||++||++.|+|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                    000      022345688999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-44  Score=373.71  Aligned_cols=258  Identities=24%  Similarity=0.402  Sum_probs=211.9

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||+|+||.||+++++.+++.||+|++......  .....+.+..|+++|++++||||+++++++.++..+|+||||+.|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK--KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh--cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999999999999999988642111  1122344567999999999999999999999999999999999999


Q ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCC
Q 040472          308 SIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP  385 (628)
Q Consensus       308 sL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~  385 (628)
                      +|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............||.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            9999886543  58899999999999999999999999999999999999999999999999998765444444567999


Q ss_pred             CcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---HHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcC
Q 040472          386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD  462 (628)
Q Consensus       386 ~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~d  462 (628)
                      .|+|||++.+.. ++.++|||||||++|||++|..||......   ..+...............++.++++||++||+.|
T Consensus       159 ~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  237 (277)
T cd05607         159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK  237 (277)
T ss_pred             CccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence            999999987655 999999999999999999999999754321   1222211111222222468899999999999999


Q ss_pred             CCCCCCH----HHHhcCccccchHHHhhcC
Q 040472          463 PSARPPA----SKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       463 P~~Rpta----~eiL~Hpwf~~~~~~~~~~  488 (628)
                      |++||++    ++++.|+||+..++.+...
T Consensus       238 P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~  267 (277)
T cd05607         238 PEDRLGSREKNDDPRKHEFFKTINFPRLEA  267 (277)
T ss_pred             HhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence            9999999    6788999999877766544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-44  Score=386.61  Aligned_cols=256  Identities=24%  Similarity=0.435  Sum_probs=208.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      .+++|++.+.||+|+||.||+|++..+++.||||++....   ........+.+|+.+++.++|+||+++++++....  
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            4679999999999999999999999999999999986432   12334566788999999999999999999886543  


Q ss_pred             ----cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          296 ----RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       296 ----~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                          .+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence                57999999965 5666664  3588999999999999999999999999999999999999999999999999986


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---------------  436 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---------------  436 (628)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....+..+..               
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            5544444556799999999998765 489999999999999999999999976543322211100               


Q ss_pred             --------CCCCC-----------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          437 --------SKDIP-----------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       437 --------~~~~~-----------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                              ....+                 ......+.++++||.+||+.||++|||+.|+|+||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                    00000                 011234678999999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=393.39  Aligned_cols=250  Identities=44%  Similarity=0.791  Sum_probs=223.6

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEeccc
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSG  306 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~G  306 (628)
                      +||+|.||+||.|++..|....|||.|...     ..+..+-+.+||.+.++|+|.|||+++|.+..++.+-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc-----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            699999999999999999999999988532     223456788999999999999999999999999999999999999


Q ss_pred             ccHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccCCcccccCcc-ccccc
Q 040472          307 GSIHKLLQE-YGPF--NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCA-SMLSF  381 (628)
Q Consensus       307 gsL~~~L~~-~~~l--~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~~~~~~-~~~~~  381 (628)
                      |+|.++|+. .|++  .|..+.+|.+||++||.|||++.|||||||.+||||+. .|.+||.|||-++.+..-. -..++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            999999985 5888  89999999999999999999999999999999999975 6899999999998765433 34568


Q ss_pred             cCCCCcCChhhhh-ccCCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          382 KGSPYWMAPEVVM-NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       382 ~GT~~Y~APEvl~-~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      .||..|||||++- +..+|+.++|||||||++.||.||++||.... ...++++++..+.-|.+|+.++.+++.||.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            8999999999984 45579999999999999999999999997654 456678888878889999999999999999999


Q ss_pred             hcCCCCCCCHHHHhcCccccch
Q 040472          460 QRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ..||.+||++.++|+.||++..
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCcccCccHHHhccCcccccC
Confidence            9999999999999999999754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-44  Score=383.25  Aligned_cols=257  Identities=30%  Similarity=0.543  Sum_probs=214.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.++||+|+||.||+|.+..++..||+|++....    .......+.+|+++|++++|+||++++++|.+++.++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            468999999999999999999999999999999886432    2234567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||+.|++|.+++.+.+.+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++...... .
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            9999999999999999888899999999999999999999985 7999999999999999999999999999765332 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc----------------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG----------------------  435 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~----------------------  435 (628)
                      ....+||..|+|||++.+. .++.++|||||||++|+|++|+.||...........+.                      
T Consensus       159 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            2345799999999998654 48999999999999999999999997543221111000                      


Q ss_pred             ---------------------CCCCCCCCC-CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          436 ---------------------NSKDIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       436 ---------------------~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                           .....+.++ ..++.++++||.+||++||++||++.||++|+||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                 000001111 1357889999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-45  Score=395.80  Aligned_cols=284  Identities=26%  Similarity=0.446  Sum_probs=239.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      -|..++.||-|+||.|.+++...|...||+|.+++.  +......+.+++.|-.||.....+.||+||..|++++.+|+|
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKa--DVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKA--DVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHH--HHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            588899999999999999999999999999998752  333455567899999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-------
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-------  373 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-------  373 (628)
                      |||++||++..+|-+.+.|.|..+++|+++|.+|+++.|..|+|||||||+|||||.+|+|||+||||+.-+.       
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999985220       


Q ss_pred             --Cc----------------------------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeecc
Q 040472          374 --SC----------------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT  417 (628)
Q Consensus       374 --~~----------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt  417 (628)
                        ..                                  ......+||+.|+|||+|...+ |+..+|||+.||||||||.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhh
Confidence              00                                  0011357999999999998654 9999999999999999999


Q ss_pred             CCCCCCCCchhHHHhhhcCCCCCCCCC--CcCCHHHHHHHHHHhhcCCCCCC---CHHHHhcCccccchHHHhhcCCCcC
Q 040472          418 SKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQRDPSARP---PASKLLDHPFVRDQAVARAGNVNLA  492 (628)
Q Consensus       418 G~~PF~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rp---ta~eiL~Hpwf~~~~~~~~~~~~~~  492 (628)
                      |++||......+..+++.++.....++  .+++.++.+||.++.. +++.|+   .++||..||||+.+++.... .+  
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslR-kq--  942 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLR-KQ--  942 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhh-hc--
Confidence            999998877777777777776554443  5799999999998754 788887   47889999999999987632 11  


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCccccccCc
Q 040472          493 KDSSPYSLDGSRTPPKLDLLPTRKSITLCEG  523 (628)
Q Consensus       493 ~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~  523 (628)
                                  ..+.++.+.-..++++|+.
T Consensus       943 ------------~ApYIP~ItHptDTSNFdp  961 (1034)
T KOG0608|consen  943 ------------RAPYIPRITHPTDTSNFDP  961 (1034)
T ss_pred             ------------cCCcCccccCCCccccCCc
Confidence                        1223455556667777764

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.7e-44  Score=371.02  Aligned_cols=265  Identities=28%  Similarity=0.437  Sum_probs=221.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|+..++||+|+||+||+|.+..+++.||+|++.....  ........+.+|+++|+.++|+||+.+++++.+++.+++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            37788999999999999999999999999999864221  1122345577899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |||+.+++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            9999999999988654  36999999999999999999999999999999999999999999999999999765443334


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC--CCCCCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--SKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~--~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ....|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+..  ......++..++.++.+||.
T Consensus       159 ~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             cCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            456799999999998664 489999999999999999999999986544322222111  11123455678899999999


Q ss_pred             HHhhcCCCCCCC-----HHHHhcCccccchHHHhhcC
Q 040472          457 QCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGN  488 (628)
Q Consensus       457 ~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~  488 (628)
                      +||+.||++||+     +.++++|+||+...+.+...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEA  274 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhc
Confidence            999999999999     88999999999887776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-44  Score=378.54  Aligned_cols=259  Identities=27%  Similarity=0.509  Sum_probs=213.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++.+.||+|+||.||+|+++.+++.||||+++......    ....+.+|++++++++|+||+++++++..++..
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            3578999999999999999999999999999999987533221    123466799999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      ++||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... 
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            999999975 888887654 45899999999999999999999999999999999999999999999999999764332 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---C---------------
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---S---------------  437 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~---------------  437 (628)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+..   .               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            2233456899999999987666689999999999999999999999976543322211110   0               


Q ss_pred             --CCCC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 --KDIP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 --~~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                        ...+        .....++.++.+||++||+.||++|+|+.|+|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence              0000        1113478899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-44  Score=360.51  Aligned_cols=258  Identities=66%  Similarity=1.130  Sum_probs=227.5

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|+..+.||+|+||+||+|.+..+++.|+||++..........+..+.+.+|+.+|+.++|+||+++++++.++..+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            57888999999999999999998999999999876444344456678899999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS  380 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~  380 (628)
                      |||+.+++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999886544333345


Q ss_pred             ccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhh
Q 040472          381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ  460 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  460 (628)
                      ..|+..|++||.+.....++.++|+|||||++|+|++|+.||..........++......+.++..++.++.+||++||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            67899999999986543488999999999999999999999987666555555554445566777889999999999999


Q ss_pred             cCCCCCCCHHHHhcCccc
Q 040472          461 RDPSARPPASKLLDHPFV  478 (628)
Q Consensus       461 ~dP~~Rpta~eiL~Hpwf  478 (628)
                      .+|.+||++.+++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-44  Score=391.21  Aligned_cols=250  Identities=26%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ...+|++++.||+|+||.||+|++..+++.||||+...           ..+.+|+++|++|+|||||+++++|..+...
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            34689999999999999999999999999999996431           3456899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc--
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC--  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~--  375 (628)
                      ++|||++. ++|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....  
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            99999994 689999988888999999999999999999999999999999999999999999999999999754321  


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-------hHHHhhh---c----------
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-------VAAIFKI---G----------  435 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-------~~~~~~i---~----------  435 (628)
                      ......+||+.|+|||++.+. .++.++|||||||+||||++|..||.....       ...+..+   .          
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            223456799999999998664 499999999999999999999987643211       0011000   0          


Q ss_pred             -------------C-CCCCC-CCC-----CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          436 -------------N-SKDIP-EIP-----EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       436 -------------~-~~~~~-~~p-----~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                   . ....+ ..+     ..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                         0 00000 000     124668999999999999999999999999999975

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-45  Score=364.83  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=212.1

Q ss_pred             ccCCeEEe-eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceec--
Q 040472          218 SLSKWKKG-KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELS--  293 (628)
Q Consensus       218 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~--  293 (628)
                      .+++|.+- ++||-|-.|.|..+.++.|++.+|+|++.-          -...++|+++.-..+ |+|||+++++|.+  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            45677775 589999999999999999999999998741          134567888876665 9999999998775  


Q ss_pred             --cccceEEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEecc
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADF  366 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DF  366 (628)
                        ...+.+|||+++||+|+..|+.++.  |+|.++..|++||..|+.|||..+|.||||||||+|...   |-.+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              4568899999999999999998765  999999999999999999999999999999999999965   446999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh----HHHhhhcC--CCCC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV----AAIFKIGN--SKDI  440 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~----~~~~~i~~--~~~~  440 (628)
                      |+|+.-.......+.|-||+|.|||++. ...|+...|+|||||+||-||+|.+||......    ..-.+|..  ....
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            9999877667778899999999999985 445999999999999999999999999764331    11122222  2222


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      .+-|..+|++++++|+.+|+.+|.+|+|++++++|||+.
T Consensus       288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence            244667999999999999999999999999999999985

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.5e-44  Score=362.36  Aligned_cols=258  Identities=45%  Similarity=0.855  Sum_probs=221.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--ccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--ERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~~~  297 (628)
                      .+|+++++||+|+||.||+|++..+++.||||++.............+.+.+|+++|++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999998864333333344567889999999999999999999988763  468


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc--
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC--  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~--  375 (628)
                      ++||||+.|++|.+++.+...+++..+..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988888999999999999999999999999999999999999999999999999998754321  


Q ss_pred             --cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          376 --ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       376 --~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                        .......|+..|+|||++.+. .++.++|||||||++|||++|+.||........+.++......+.++..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence              122345689999999998764 48999999999999999999999998776666665555444445667778899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +|++||. +|++||++++|++|+|++
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=425.06  Aligned_cols=257  Identities=43%  Similarity=0.789  Sum_probs=233.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      -+|+.+.+||.|.||.||-|.+..||...|+|.++.....   ...++.+.+|..+|..|+|||||++||+..+.+.++|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            4899999999999999999999999999999999753322   5567889999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc----
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~----  375 (628)
                      .||||+||+|.++++..+..+|...+.|..|++.||.|||++|||||||||+|||++.+|.+|++|||.|..+...    
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999876443    


Q ss_pred             -cccccccCCCCcCChhhhhccC--CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 -ASMLSFKGSPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 -~~~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                       ......+||+.|||||++.+..  +...++||||||||+.||+||+.||...++..+|+-.+.....|.+|..++.+.+
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence             2345678999999999997643  5778999999999999999999999998877766655566778899999999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +||.+||..||++|.++.|||+|.|-+
T Consensus      1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             HHHHHHHhcCchhhhHHHHHHHhhccc
Confidence            999999999999999999999999965

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-43  Score=367.80  Aligned_cols=261  Identities=32%  Similarity=0.533  Sum_probs=227.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .........+.+|+++|++++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK--IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            47999999999999999999999999999999986421  1123345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      ||||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||+|.||||+.++.+||+|||++......  ..
T Consensus        79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence            9999999999999998889999999999999999999999999999999999999999999999999999876543  33


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ..+|++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+..  ....++..++..++++|++||
T Consensus       157 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         157 TLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCccCCccCCHHHHHHHHHHc
Confidence            45799999999998655 488999999999999999999999987664444444432  223566778999999999999


Q ss_pred             hcCCCCCC-----CHHHHhcCccccchHHHhhc
Q 040472          460 QRDPSARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       460 ~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      +.||.+|+     +++|+++||||+...|....
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  266 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL  266 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCCHHHHh
Confidence            99999999     89999999999988776654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.6e-44  Score=363.67  Aligned_cols=257  Identities=45%  Similarity=0.899  Sum_probs=221.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--cccce
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DERLS  298 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~~~~  298 (628)
                      +|++.++||+|+||.||+|.+..++..||+|++..........+....+.+|+.+|++++|+||+++++++.+  +..++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6899999999999999999999999999999886543333334456778999999999999999999998875  36788


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---  375 (628)
                      ++|||+.+++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999998754321   


Q ss_pred             -cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          376 -ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       376 -~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                       .......++..|+|||++.+. .++.++|||||||++|||++|+.||........+..+......+.++..++..+++|
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             CCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence             112235688999999998654 489999999999999999999999987766666666555455567777789999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      | +||..+|++||+++||++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 57778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=373.56  Aligned_cols=253  Identities=37%  Similarity=0.653  Sum_probs=226.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +-|.++.+||+|+||.||+|+|+++|+.+|||.+.+..       .++.+.+||.|+++++.++||++||.|.....+++
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            35788999999999999999999999999999876532       35678889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          300 YLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      |||||-.|++.++++ ++.+|.|+++..+++..+.||+|||...-||||||+.|||++.+|++||+|||.|.++.+. ..
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            999999999999997 4578999999999999999999999999999999999999999999999999999877553 34


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~dLI~  456 (628)
                      ..+++|||.|||||++..-+ |+.++||||||++..||.-|++||.....+..++.|..... ...-|+.++.++.|||+
T Consensus       186 RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~  264 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR  264 (502)
T ss_pred             hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence            56788999999999997665 99999999999999999999999998888888877755332 11345678899999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||.++|++|-|+.++++|+|+++
T Consensus       265 ~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  265 SCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             HHhcCCHHHHHHHHHHhhhhhhcC
Confidence            999999999999999999999975

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-43  Score=361.37  Aligned_cols=256  Identities=48%  Similarity=0.901  Sum_probs=222.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc----chHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      +|.+++.||+|+||.||+|.+..+++.||+|++.......    ...+..+.+.+|+.++++++|+||+++++++..++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788999999999999999999999999999886532221    123445678999999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      .++||||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||+|+|||++.++.+||+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999988664211


Q ss_pred             -------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          377 -------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       377 -------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                             ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||........+..+.. ...+.++..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISS  238 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccCH
Confidence                   11235688999999998654 488999999999999999999999987766666655544 233456677899


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ++.++|++||+.||.+||++.+|++|+||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.4e-44  Score=382.98  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=209.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~---  294 (628)
                      .+++|++.+.||+|+||.||+|++..+++.||||++.....   .....+.+.+|+.+++.++|+||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            46799999999999999999999999999999998864321   223346677899999999999999999987643   


Q ss_pred             ---ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                         ..+|+||||+.+ +|.+++..  .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence               357999999965 67777753  478999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------------  439 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------------  439 (628)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....+.++.....            
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            6554444556799999999999765 489999999999999999999999987654443332211000            


Q ss_pred             --------C--------------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          440 --------I--------------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       440 --------~--------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                              .                    .......+.++++||.+||+.||.+|||+.|+|+||||.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                    0                    011112356789999999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.4e-44  Score=382.11  Aligned_cols=255  Identities=24%  Similarity=0.428  Sum_probs=208.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~---  294 (628)
                      .+++|++.+.||+|+||.||+|++..+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            4679999999999999999999999999999999886422   1233456778899999999999999999988653   


Q ss_pred             ---ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                         ..+|+||||+.+ +|.+.+..  .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence               357999999965 67666653  588999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--------------  437 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--------------  437 (628)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....+..+...              
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            6554444557799999999998765 4899999999999999999999999765433222111000              


Q ss_pred             ---------CC-----------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          438 ---------KD-----------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       438 ---------~~-----------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                               ..                 ........+.++++||.+||+.||++|||+.|||+||||.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~  315 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN  315 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence                     00                 0011223457889999999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-44  Score=363.19  Aligned_cols=254  Identities=37%  Similarity=0.590  Sum_probs=212.5

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |++++.||+|+||+||+|++..+++.||+|++.....   .........+|+.++++++|+||+++++++.+....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI---EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH---HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc---cccccchhhhhhhccccccccccccccccccccccccccc
Confidence            7899999999999999999999999999999975321   1222234456999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc-cCcccccc
Q 040472          302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCASMLS  380 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~-~~~~~~~~  380 (628)
                      ||+.+++|.++|.....+++..+..++.||++||+|||+++|+|+||||+|||++.++.++|+|||.+... ........
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999999753 22334455


Q ss_pred             ccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc---hhHHHhhhcCCCCCC--CCCCcCCHHHHHHH
Q 040472          381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE---GVAAIFKIGNSKDIP--EIPEHLSDDAKSFI  455 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~---~~~~~~~i~~~~~~~--~~p~~~s~~l~dLI  455 (628)
                      ..+|..|+|||++.....++.++||||||+++|+|++|..||....   ....+.+........  ........++.+||
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            7799999999998634558999999999999999999999998762   222222221111000  11112348999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ++||+.||++||++.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-44  Score=378.92  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=204.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeeccee
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSEL  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~  292 (628)
                      .++|+++++||+|+||.||+|.+     ..+++.||||+++...    .....+.+.+|+.+|..+ +|||||++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            46899999999999999999975     3446789999886321    123346788999999999 8999999999877


Q ss_pred             cc-ccceEEEEecccccHHHHHHhc-------------------------------------------------------
Q 040472          293 SD-ERLSVYLEYVSGGSIHKLLQEY-------------------------------------------------------  316 (628)
Q Consensus       293 ~~-~~~~lVmEy~~GgsL~~~L~~~-------------------------------------------------------  316 (628)
                      .. ..+++||||+.+|+|.++|...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 4689999999999999999752                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc---cccccCCCC
Q 040472          317 -------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPY  386 (628)
Q Consensus       317 -------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~  386 (628)
                             ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   .....++..
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                   2377888899999999999999999999999999999999999999999999986533211   122346788


Q ss_pred             cCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCC
Q 040472          387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA  465 (628)
Q Consensus       387 Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  465 (628)
                      |+|||++.+. .++.++|||||||+||||++ |..||........+............+..++.++.+||.+||+.||++
T Consensus       242 y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         242 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             ccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            9999998754 48999999999999999997 999998754433333332223334456678899999999999999999


Q ss_pred             CCCHHHHhc
Q 040472          466 RPPASKLLD  474 (628)
Q Consensus       466 Rpta~eiL~  474 (628)
                      ||++.||++
T Consensus       321 RPs~~el~~  329 (338)
T cd05102         321 RPTFSALVE  329 (338)
T ss_pred             CcCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.3e-44  Score=396.07  Aligned_cols=254  Identities=28%  Similarity=0.467  Sum_probs=218.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCC-CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSES-GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..|.+.++||+|+||.||+|.+..+ ++.||+|.+...     .......+.+|+.+|+.++|||||++++++..++.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            4599999999999999999998877 788999976431     1233456788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          299 VYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      |||||+.||+|.++|..    ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999988754    35689999999999999999999999999999999999999999999999999987643


Q ss_pred             cc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ..   .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+... ....++..++.++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~  299 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGM  299 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHH
Confidence            22   23456799999999998654 5999999999999999999999999876665555554432 2234566789999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .+||.+||+.||++||++.+++.|+|++.
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999864

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-44  Score=379.75  Aligned_cols=255  Identities=24%  Similarity=0.449  Sum_probs=209.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      .++|++++.||+|+||+||+|++..+++.||||++....   ......+.+.+|+++|++++|+||+++++++...    
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            468999999999999999999999999999999886421   1223345677899999999999999999987643    


Q ss_pred             --ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          295 --ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       295 --~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                        ..+|++||++ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              4578999998 7899888764 57999999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--------------  438 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--------------  438 (628)
                      ..  .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+....              
T Consensus       169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            43  23456799999999999775668999999999999999999999997654433322221100              


Q ss_pred             -------CCCC--------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          439 -------DIPE--------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       439 -------~~~~--------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                             ..+.        .....++.+.+||.+||+.||++||++.|+|+||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                   0011        11235677899999999999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.9e-43  Score=359.72  Aligned_cols=256  Identities=45%  Similarity=0.885  Sum_probs=219.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-cchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +|++++.||+|+||.||+|.+. +++.+|||.++..... ....+...++.+|+++|++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999864 7889999988753221 1223445678999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc----
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~----  375 (628)
                      ||||+.|++|.+++.+.+.+++..+..++.||+.||+|||+.+|+|+||+|+|||++.++.++|+|||++......    
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999998754211    


Q ss_pred             ---cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCCCCCCcCCHHH
Q 040472          376 ---ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDDA  451 (628)
Q Consensus       376 ---~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l  451 (628)
                         .......|+..|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... ...+.++..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence               112235689999999998654 4889999999999999999999999876655554444333 33456677889999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .+||++||+.+|++||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-44  Score=386.42  Aligned_cols=259  Identities=29%  Similarity=0.472  Sum_probs=232.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+..|.+.+.||+|.|+.|.+|++..++..||||+|.+.   .......+.+.+|+++|+.|+|||||+|+.+.+....+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt---~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT---QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc---ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            467899999999999999999999999999999998753   33344455689999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.+|+|+++|.+++++.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+.....
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ..++||++.|.|||++.+..+.+..+|+|+||++||-|+.|.+||++......-.+.....  -.++..++.++++||++
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--ecccceeechhHHHHHH
Confidence            8899999999999999988877899999999999999999999999755433322222211  25667799999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccch
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +|..+|.+|+++++|+.|.|.-..
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchh
Confidence            999999999999999999998543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.1e-43  Score=394.96  Aligned_cols=259  Identities=27%  Similarity=0.433  Sum_probs=219.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      ...+|++.++||+|+||+||+|++..+++.||||++.....   .......+.+|+.+|..++|+||++++..+...+  
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            34699999999999999999999999999999999865322   2344567889999999999999999988775432  


Q ss_pred             ------cceEEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          296 ------RLSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       296 ------~~~lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                            .+++||||+.+|+|.++|...    ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                  378999999999999998643    4689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCc---cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCC
Q 040472          366 FGMAKHMTSC---ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE  442 (628)
Q Consensus       366 FGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~  442 (628)
                      ||+++.+...   ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||........+..+... ....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~-~~~~  264 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG-RYDP  264 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCC
Confidence            9999865432   223456799999999998754 4999999999999999999999999876655444444332 2335


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ++..++.++.+||.+||+.||.+||++.++++|||++..
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            677899999999999999999999999999999998653

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=367.10  Aligned_cols=264  Identities=30%  Similarity=0.463  Sum_probs=222.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+....  .......+.+.+|+++|+.++|+||+++++++.+.+..|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            37999999999999999999999999999999986432  1223356778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          300 YLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      ||||+.|++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.++|+|||++....... 
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999999999754  578999999999999999999999999999999999999999999999999986542211 


Q ss_pred             -----------------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch
Q 040472          377 -----------------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG  427 (628)
Q Consensus       377 -----------------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~  427 (628)
                                                   ......||..|+|||++.+. .++.++|||||||++|+|++|..||...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         11134689999999998755 489999999999999999999999987766


Q ss_pred             hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCC----HHHHhcCccccchHHHhh
Q 040472          428 VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP----ASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       428 ~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt----a~eiL~Hpwf~~~~~~~~  486 (628)
                      ...+.++............++.++.+||++||+.||++||+    ++|+|+|+||+...|...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~  300 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI  300 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence            66555554322211112237899999999999999999999    999999999987666543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-43  Score=368.50  Aligned_cols=259  Identities=27%  Similarity=0.503  Sum_probs=213.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++.+.||+|+||.||+|+++.+++.||||.++......    ....+.+|+.+|+.++|+||+++++++..++.+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            4678999999999999999999999999999999986532221    123566899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      ++||||+. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... 
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            99999997 5888888753 56899999999999999999999999999999999999999999999999999754322 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---C---------------
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---S---------------  437 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~---------------  437 (628)
                      .......+++.|+|||++.+...++.++|||||||++|||++|++||...+....+..+..   .               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            2223346789999999987666688999999999999999999999976554332221110   0               


Q ss_pred             --CCCC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 --KDIP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 --~~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                        ...+        .....++.++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence              0001        1123578899999999999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-43  Score=357.54  Aligned_cols=258  Identities=40%  Similarity=0.817  Sum_probs=219.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc-hHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +|+.++.||+|+||.||+|.+..+++.||||++........ .....+.+.+|+++|++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            48889999999999999999999999999999875332222 22346788999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.|++|.+++.+.+.+++..+..++.||+.||+|||++||+||||+|+||+++.++ .+||+|||++..+..... 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999999888999999999999999999999999999999999999998776 599999999876543211 


Q ss_pred             ----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCCCCCCcCCHH
Q 040472          378 ----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       378 ----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                          .....|+..|+|||++.+. .++.++|||||||++|+|++|..||.....   ...+..+......+.++..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                1234688999999998654 489999999999999999999999965432   22233333333345667778999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +.++|.+||..+|++||++.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=392.09  Aligned_cols=257  Identities=38%  Similarity=0.684  Sum_probs=227.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      -+.|.|+..||.|+||+||+|.++.++-..|.|+|..     .+.+.++.+.-||.||..+.||+||.|++.|..++.++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            3579999999999999999999999998899998863     23556788889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc-ccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~-~~~~~  376 (628)
                      |+.|||.||-...++-+- ..|.|.++..+++|++.||.|||+++|||||||+.|||+.-+|.|+|+|||.+.. .....
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            999999999998887654 5799999999999999999999999999999999999999999999999998754 33445


Q ss_pred             ccccccCCCCcCChhhhh----ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-CCCCCcCCHHH
Q 040472          377 SMLSFKGSPYWMAPEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-PEIPEHLSDDA  451 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~s~~l  451 (628)
                      ...+++|||+|||||+++    ....|+.++||||||++|.||..+.+|....+.+..+.+|...... .--|.+++..+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            667899999999999974    2345999999999999999999999999998888888888654321 12367789999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .|||++||.+||..||++.+||+||||.+
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            99999999999999999999999999974

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-43  Score=359.04  Aligned_cols=255  Identities=38%  Similarity=0.675  Sum_probs=214.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ...+|++++.||+|+||.||+|++..+++.||||++....     ......+.+|+.+|++++|+||+++++++..++.+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            3568999999999999999999999999999999986422     12235678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.+++|.+++...+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998654322 


Q ss_pred             ccccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-CC--CCCcCCHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-PE--IPEHLSDDA  451 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-~~--~p~~~s~~l  451 (628)
                      ......|+..|+|||++..  ...++.++|||||||++|||++|..||...........+...... +.  ....++..+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            2334578999999998742  334788999999999999999999999755443333332222111 11  123468899


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      .+||++||+.+|++||++++||+|+|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-43  Score=362.55  Aligned_cols=254  Identities=33%  Similarity=0.581  Sum_probs=209.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|++..+++.||||+++.....   ....+.+.+|+.++++++|+||+++++++.++..+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            588999999999999999999999999999998643221   22235677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          301 LEYVSGGSIHKLLQEY---GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |||+. ++|.+++...   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99997 5888888643   568999999999999999999999999999999999999999999999999987543221 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC--------------------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--------------------  436 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~--------------------  436 (628)
                      ......+++.|+|||++.+...++.++|||||||++|+|++|++||...........+..                    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            223345789999999987666688999999999999999999999976544332222100                    


Q ss_pred             -------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          437 -------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       437 -------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                             ..........++.++.+||++||+.||++||++.+|++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                   000011223478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-43  Score=369.89  Aligned_cols=246  Identities=28%  Similarity=0.505  Sum_probs=193.5

Q ss_pred             eeeeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--cccceEE
Q 040472          225 GKLLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DERLSVY  300 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~~~~lV  300 (628)
                      +++||+|+||+||+|+++  .+++.||||.++....       ...+.+|+++|++++||||+++++++..  +..+|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            578999999999999975  4678999998853211       1345689999999999999999998854  4568999


Q ss_pred             EEecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe----CCCCCEEEeccC
Q 040472          301 LEYVSGGSIHKLLQEY---------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFG  367 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl----d~~g~vKL~DFG  367 (628)
                      |||+. ++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            99995 5888887532         258999999999999999999999999999999999999    456789999999


Q ss_pred             CcccccCc----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch------------hHHH
Q 040472          368 MAKHMTSC----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG------------VAAI  431 (628)
Q Consensus       368 la~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~------------~~~~  431 (628)
                      +++.....    ......+||+.|+|||++.+...++.++|||||||++|||++|++||.....            ...+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            99865432    1233467899999999997766689999999999999999999999964221            0111


Q ss_pred             hhhcCCC---------CCC------------------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          432 FKIGNSK---------DIP------------------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       432 ~~i~~~~---------~~~------------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+....         ..+                        ......+.++.+||++||+.||++|+|++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1110000         000                        0011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-43  Score=359.46  Aligned_cols=254  Identities=39%  Similarity=0.705  Sum_probs=213.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...     ......+.+|+.+++.++|+||+++++++...+.+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            358999999999999999999999999999999986432     223456778999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      +||||+.+++|.+++...+.+++.+++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...... ..
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999998755332 12


Q ss_pred             cccccCCCCcCChhhhh--ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-CCC--CCcCCHHHH
Q 040472          378 MLSFKGSPYWMAPEVVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-PEI--PEHLSDDAK  452 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-~~~--p~~~s~~l~  452 (628)
                      .....|+..|+|||++.  ....++.++|||||||++|+|++|..||........+......... +..  ...++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23457999999999874  2334888999999999999999999999765443333332221111 111  124678899


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      +||++||+.+|++||++++|++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.3e-43  Score=366.65  Aligned_cols=255  Identities=31%  Similarity=0.565  Sum_probs=213.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.+..++..||+|.++...    ......++.+|+++|++++|+||+++++++.+++.+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            37999999999999999999999999999999886421    23345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||++|++|.+++.+.+.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...... ..
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cc
Confidence            99999999999999988899999999999999999999997 59999999999999999999999999998765332 22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---------------------
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---------------------  437 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---------------------  437 (628)
                      ...+|+..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...                     
T Consensus       156 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            346789999999998654 4899999999999999999999999654322111111000                     


Q ss_pred             --------------CCCCCCC-CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          438 --------------KDIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       438 --------------~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                    ...+.++ ..++.++++||.+||..||++||++.+|++||||.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                          0011111 136788999999999999999999999999999965

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=378.76  Aligned_cols=247  Identities=29%  Similarity=0.480  Sum_probs=213.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .-+.+++++.||+|.||.||+|.+..+ ..||+|.++.....      .+.+.+|++||++|+|+|||+|++++..++.+
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS------PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC------hhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            345667789999999999999998753 47999999754221      24566999999999999999999999998999


Q ss_pred             eEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      |||||||..|+|.++|+.  .+.+...+.+.++.||++|++||+++++|||||-+.||||+.+..|||+|||||+.+.+.
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999999999999986  467899999999999999999999999999999999999999999999999999955443


Q ss_pred             cccccc--cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 ASMLSF--KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~~~~~--~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ......  .-...|.|||.+... .++.|+|||||||+||||+| |+.||.+..+.+.+..+.....++. |..++.++.
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-P~~CP~~vY  434 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-PEGCPDEVY  434 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-CCCCCHHHH
Confidence            322211  123469999999655 59999999999999999998 9999999999888888888777654 667999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHh
Q 040472          453 SFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      ++++.||..+|++|||++.+.
T Consensus       435 ~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  435 ELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHhhCCcccCCCHHHHH
Confidence            999999999999999999664

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.3e-43  Score=360.17  Aligned_cols=256  Identities=33%  Similarity=0.576  Sum_probs=214.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++......   ....+.+.+|++++++++|+||+++++++.....+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            4799999999999999999999999999999988643221   1223457789999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      ||||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            99999999999888777789999999999999999999999999999999999999999999999999998765433 23


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--------------------C
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--------------------K  438 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--------------------~  438 (628)
                      ....++..|+|||++.+...++.++|||||||++|+|++|.+||......+....+...                    .
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            34568899999999876556889999999999999999999999865544333322100                    0


Q ss_pred             CCCC---------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 DIPE---------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ~~~~---------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+.         ....++..+.+||.+||+.+|++||++.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0000         012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.2e-43  Score=355.93  Aligned_cols=253  Identities=30%  Similarity=0.527  Sum_probs=218.9

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||.|+||.||+|++..+++.||||++.....  ......+.+.+|+++++.++|+||+++++++.++..+|+||||+.++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            7999999999999999999999999864321  12234567899999999999999999999999999999999999999


Q ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCc
Q 040472          308 SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYW  387 (628)
Q Consensus       308 sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y  387 (628)
                      +|.+++.+...+++..+..++.||+.||+|||+++++|+||+|+||+|+.++.++|+|||++.............|+..|
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence            99999998888999999999999999999999999999999999999999999999999999876554334456789999


Q ss_pred             CChhhhhccCCCCccccccccccceeeeccCCCCCCCCc--hhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCC
Q 040472          388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE--GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA  465 (628)
Q Consensus       388 ~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  465 (628)
                      ++||++.+. .++.++|+|||||++|+|++|..||....  ......++........++..++.++.+||.+||+.||++
T Consensus       159 ~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  237 (262)
T cd05572         159 VAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE  237 (262)
T ss_pred             cChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence            999998654 48999999999999999999999997665  444444444333445566677899999999999999999


Q ss_pred             CCC-----HHHHhcCccccchHH
Q 040472          466 RPP-----ASKLLDHPFVRDQAV  483 (628)
Q Consensus       466 Rpt-----a~eiL~Hpwf~~~~~  483 (628)
                      |++     +.|+++||||++..|
T Consensus       238 R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         238 RLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             CcCCcccCHHHHhcChhhhCCCC
Confidence            999     999999999987544

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-43  Score=358.26  Aligned_cols=253  Identities=36%  Similarity=0.667  Sum_probs=212.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSD----  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~----  294 (628)
                      ..|++.+.||+|+||.||+|++..+++.||||++.....      ....+.+|+.+++++ +|+||+++++++...    
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            578889999999999999999999999999999864321      124677899999998 699999999998753    


Q ss_pred             --ccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          295 --ERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       295 --~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                        ..+|+||||+.+++|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence              4689999999999999999863  468999999999999999999999999999999999999999999999999998


Q ss_pred             cccCc-cccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC
Q 040472          371 HMTSC-ASMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE  445 (628)
Q Consensus       371 ~~~~~-~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~  445 (628)
                      ..... .......|+..|+|||++..    ...++.++|||||||++|||++|..||...........+...........
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  239 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence            65432 23345679999999999853    22478899999999999999999999976655544444433322223344


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .++.++.+||.+||..||.+||++.+|++||||
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            678899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-43  Score=362.74  Aligned_cols=254  Identities=30%  Similarity=0.540  Sum_probs=207.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|+++.+|+.||+|+++.....   ......+.+|+.++++++|+||+++++++.+...+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            588999999999999999999999999999998653221   12234567899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          301 LEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      |||+.+ +|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            999974 78777764 5679999999999999999999999999999999999999999999999999998654322 22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-hHHHhhhc------------------CCCC
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIG------------------NSKD  439 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i~------------------~~~~  439 (628)
                      ....++..|+|||++.+...++.++|||||||++|+|++|..||..... ...+..+.                  ....
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            3456789999999987766689999999999999999999888643222 11111110                  0000


Q ss_pred             CC---------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          440 IP---------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       440 ~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .+         .....++.++.+||++||+.||.+|||+++|++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            11         1123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-42  Score=350.49  Aligned_cols=253  Identities=30%  Similarity=0.543  Sum_probs=219.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|.+.+.||+|+||.||+|.++.+++.|++|++.....   .......+.+|+++|+.++|+||+++++++.+++..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            58889999999999999999999999999998864221   233456788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      |||+.|++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++...... .
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999999764  578999999999999999999999999999999999999999999999999988664432 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||..........++.. ...+.++..++.++.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHH
Confidence            2345689999999998765 488999999999999999999999987765555554443 23345566788999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccc
Q 040472          458 CLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ||+.+|++||++.++++|||+
T Consensus       236 ~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         236 CLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.8e-43  Score=355.34  Aligned_cols=254  Identities=30%  Similarity=0.490  Sum_probs=221.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+.+|++++++++||||+++++++.....+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            5899999999999999999999999999999986422  12224567889999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS  380 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~  380 (628)
                      |||+.|++|.+++.....+++..+..++.||++||.|||+++|+|+||+|+|||++.++.++|+|||++...........
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            99999999999998878899999999999999999999999999999999999999999999999999987655434445


Q ss_pred             ccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ..|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.....  ...+...... ....++..++.++.++|.+|
T Consensus       159 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         159 TSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             cCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHH
Confidence            67899999999986554 89999999999999999999999986553  2333332221 33456677889999999999


Q ss_pred             hhcCCCCCCCH--HHHhcCccc
Q 040472          459 LQRDPSARPPA--SKLLDHPFV  478 (628)
Q Consensus       459 L~~dP~~Rpta--~eiL~Hpwf  478 (628)
                      |+.||.+|+++  .|+++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.2e-43  Score=356.04  Aligned_cols=258  Identities=47%  Similarity=0.879  Sum_probs=217.8

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-----cchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-----QTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-----~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      +|.+.+.||+|+||.||+|.+..+++.||||.++.....     .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            688999999999999999999999999999988642111     112234567889999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+++||||+.|++|.+++.+.+.+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999754321


Q ss_pred             ---cccccccCCCCcCChhhhhccC-CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC----CCCCcC
Q 040472          376 ---ASMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP----EIPEHL  447 (628)
Q Consensus       376 ---~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~----~~p~~~  447 (628)
                         .......|+..|+|||++.... .++.++||||||+++|+|++|..||...+....+.++.......    .....+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence               1123456899999999986543 47899999999999999999999997666555554433222112    233356


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +.++.+||.+||..+|++||++.+||+||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=382.56  Aligned_cols=254  Identities=38%  Similarity=0.670  Sum_probs=224.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|.-++.||.|+||-||.|++..|.+.||||.+....+.  ..+--.++.+|+.+|++|+|||+|.+.|+|..+...||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ--s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccc--cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence            3577789999999999999999999999999988654332  34445778999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |||||- |+-.++|. ...++.|..+..|+.+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.|..+.+   .
T Consensus       104 VMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---A  179 (948)
T KOG0577|consen  104 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---A  179 (948)
T ss_pred             HHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---h
Confidence            999996 57788776 347899999999999999999999999999999999999999999999999999987655   3


Q ss_pred             ccccCCCCcCChhhhh--ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      .+++|||+|||||||.  ..+.|+-++||||||++..||.-.++|+-..+.+..++.|.......--...++..++.||.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd  259 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  259 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence            4688999999999984  45679999999999999999999999998889999999987654432223568999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCcccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      .||++-|.+|||.+++|.|+|+.
T Consensus       260 ~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  260 SCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             HHHhhCcccCCcHHHHhhcchhc
Confidence            99999999999999999999984

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-42  Score=402.68  Aligned_cols=260  Identities=27%  Similarity=0.514  Sum_probs=217.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--cc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~  295 (628)
                      .+.+|+++++||+|+||+||+|++..+++.||+|++.....   .......+..|+.+|++|+|||||+++++|.+  ..
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            56799999999999999999999999999999999865322   23345678899999999999999999998865  45


Q ss_pred             cceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccccCCCceEeCC-------
Q 040472          296 RLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHAR-------NTVHRDIKGANILVDP-------  357 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~-------gIvHRDIKpeNILld~-------  357 (628)
                      .+||||||+.+++|.++|..    .+.+++..++.|+.||+.||+|||..       +||||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            68999999999999999975    35799999999999999999999984       4999999999999964       


Q ss_pred             ----------CCCEEEeccCCcccccCccccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCc
Q 040472          358 ----------HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYE  426 (628)
Q Consensus       358 ----------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~  426 (628)
                                .+.+||+|||++..+.........+||+.|+|||++.+. ..++.++||||||||||||++|..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      234899999999876544444556799999999998643 348899999999999999999999998766


Q ss_pred             hhHHHhhhcCCCCCCCC-CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          427 GVAAIFKIGNSKDIPEI-PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       427 ~~~~~~~i~~~~~~~~~-p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ....+.......  +.+ ....+.++.+||..||+.+|.+||++.|+|.|+||+...
T Consensus       248 ~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        248 NFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             cHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            555444433222  122 234689999999999999999999999999999997553

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.8e-42  Score=350.17  Aligned_cols=253  Identities=30%  Similarity=0.564  Sum_probs=215.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-cccceE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-DERLSV  299 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-~~~~~l  299 (628)
                      .|++.+.||+|+||.||++.++.+++.||||++....   ......+.+.+|++++++++|+||+++++.+.. +..+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            4899999999999999999999999999999986422   123345668889999999999999999998764 446899


Q ss_pred             EEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          300 YLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      ||||+.+++|.+++...  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999999763  458999999999999999999999999999999999999999999999999998664322 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.. ...+.++..++.++.+||.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHH
Confidence            22345689999999998765 488999999999999999999999987655444444433 2234556678899999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +||+.||++||++.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.3e-43  Score=362.89  Aligned_cols=260  Identities=29%  Similarity=0.505  Sum_probs=215.8

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|.+..+++.||||+++..............+..|++++++++|+||+++++++.+++.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            58899999999999999999999999999999875432211223345677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          301 LEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      |||+ +++|.+++.... .+++..+..++.||++||+|||++||+|+||||+|||++.++.++|+|||+++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 899999998766 89999999999999999999999999999999999999999999999999998664432 22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--------------------
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--------------------  438 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--------------------  438 (628)
                      ....+++.|+|||++.+...++.++|||||||++|||++|.++|........+.++....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            334578899999998765668899999999999999999988887655433332221100                    


Q ss_pred             ------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 ------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                            ....+...++.++.+||.+||+.||++||++.|||+|+||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                  0001123467889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=357.51  Aligned_cols=255  Identities=38%  Similarity=0.714  Sum_probs=220.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||.|+||.||+|++..+++.||||++....    .......+.+|+++++.++|+||+++++++.++..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            37889999999999999999999999999999986422    12334567899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~  378 (628)
                      |+||+.+++|.+++... .+++..+..++.||+.||.|||+++|+||||+|+||+++.++.++|+|||+++..... ...
T Consensus        77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             EEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            99999999999999865 8999999999999999999999999999999999999999999999999999876543 233


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCc-CCHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH-LSDDAKSFIKQ  457 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~s~~l~dLI~~  457 (628)
                      ....++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ..+.++.. ++.++.++|.+
T Consensus       156 ~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  233 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSL  233 (274)
T ss_pred             ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHH
Confidence            4467899999999987654 899999999999999999999999876654444443332 23344444 78999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccch
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||..+|++||+++++++|+||++.
T Consensus       234 ~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         234 CLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HhhCChhhCcCHHHHhhChhhcCC
Confidence            999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-43  Score=358.87  Aligned_cols=257  Identities=39%  Similarity=0.698  Sum_probs=219.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||.|+||.||+|.+..+++.||+|+++..     .....+.+.+|+++|++++|+||+++++++..+..+|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            5799999999999999999999989999999998642     23345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      ||||+.+++|.+++.+. ..+++..++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++...... ..
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            99999999999999764 57999999999999999999999999999999999999999999999999998754332 22


Q ss_pred             cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAK  452 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~  452 (628)
                      .....+++.|+|||++..    ...++.++|||||||++|+|++|+.||...+....+.++..... ....+..++.++.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            334568999999999752    23467899999999999999999999987766555555443221 1123456889999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||.+||+.+|.+||++.+|++|+||.+.
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-42  Score=351.33  Aligned_cols=255  Identities=33%  Similarity=0.635  Sum_probs=217.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||.|+||+||+|.+..++..||+|++.....    ....+.+.+|+++|+.++|+||+++++.+..++.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            479999999999999999999998999999998864221    1245778999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          300 YLEYVSGGSIHKLLQEY---GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ||||+.|++|.+++...   ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++..+....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999999764   458999999999999999999999999999999999999999999999999987654432


Q ss_pred             c-----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCC--CCcC
Q 040472          377 S-----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEI--PEHL  447 (628)
Q Consensus       377 ~-----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~--p~~~  447 (628)
                      .     .....|+..|+|||++.....++.++|||||||++|+|++|..||........+.++.....  ....  ...+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence            2     23456899999999987664689999999999999999999999987665544444333211  1111  1357


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +.++.+||.+||+.||++||++.+|++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            8899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-42  Score=360.52  Aligned_cols=260  Identities=38%  Similarity=0.668  Sum_probs=219.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +.|+++++||.|+||.||+|++..+++.||+|++...     ..+..+.+.+|+.+++.++|+||+++++++..+..+|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            5799999999999999999999999999999998642     23446778889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      ||||+.|++|..++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ..
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999999988764 467899999999999999999999999999999999999999999999999998754322 22


Q ss_pred             cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAK  452 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~  452 (628)
                      .....+++.|+|||++..    ...++.++|||||||++|||++|..||........+.++..... ....+..++.++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            334568999999998742    23468899999999999999999999987665444444432221 1123456788999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      +||++||..||++||+++++++||||....+.
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            99999999999999999999999999765443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=352.05  Aligned_cols=257  Identities=47%  Similarity=0.873  Sum_probs=222.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--ccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--ERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~~~  297 (628)
                      .+|+++++||+|+||.||+|++..+++.||+|++..........+....+.+|++++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            479999999999999999999999999999998754322223345567889999999999999999999998764  468


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc--
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC--  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~--  375 (628)
                      ++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            899999999999999988888999999999999999999999999999999999999999999999999999765321  


Q ss_pred             --cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          376 --ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       376 --~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                        .......|+..|+|||++.+. .++.++|||||||++|+|++|+.||........+.++......+.++..++.++.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence              122345689999999998764 48899999999999999999999998877666666665544456678889999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +|++||+ ++.+||++.+++.|||+
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.1e-43  Score=368.72  Aligned_cols=255  Identities=27%  Similarity=0.446  Sum_probs=205.6

Q ss_pred             EeeeeccC--CcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          224 KGKLLGRG--TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       224 ~~~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      ++++||+|  +|++||+++++.+++.||||+++....   .....+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            56789999  789999999999999999999864321   2344567888999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---
Q 040472          302 EYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---  376 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---  376 (628)
                      ||+.+++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.++|+||+.+.......   
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999999753  458999999999999999999999999999999999999999999999998654332111   


Q ss_pred             -----ccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-----------
Q 040472          377 -----SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-----------  439 (628)
Q Consensus       377 -----~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-----------  439 (628)
                           ......++..|+|||++.+. ..++.++|||||||++|||++|..||.................           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 01123467889999998653 3589999999999999999999999975433222211111000           


Q ss_pred             ---------------------------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          440 ---------------------------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       440 ---------------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                                       .......++.++.+||++||+.||++|||++||++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                             000122356789999999999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-42  Score=358.30  Aligned_cols=252  Identities=28%  Similarity=0.566  Sum_probs=209.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.++||+|+||.||+|++..+++.||||++....    ..+..+.+.+|+++|++++|+||+++++++..++..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            36888999999999999999999999999999886421    23344678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      ||||+.+++|..+    ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus        77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~  151 (279)
T cd06619          77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAK  151 (279)
T ss_pred             EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-ccc
Confidence            9999999998654    45789999999999999999999999999999999999999999999999999765432 233


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh------HHHhhhcCCCCCCCC-CCcCCHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV------AAIFKIGNSKDIPEI-PEHLSDDAK  452 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~------~~~~~i~~~~~~~~~-p~~~s~~l~  452 (628)
                      ..+||..|+|||++.+. .++.++|||||||++|+|++|..||......      ............+.+ ....+.++.
T Consensus       152 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (279)
T cd06619         152 TYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV  230 (279)
T ss_pred             CCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence            46799999999998754 4899999999999999999999999653211      111111111111222 234788999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||.+||+.||++||+++++++|+||+..
T Consensus       231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         231 HFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            99999999999999999999999999743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-42  Score=355.83  Aligned_cols=255  Identities=38%  Similarity=0.676  Sum_probs=216.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+...     .....+.+.+|+++++.++|+||+++++++..++..|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            378889999999999999999999999999988532     233456788899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccc
Q 040472          301 LEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~  378 (628)
                      |||+.+++|..++.+ ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...... ...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999999999998765 467999999999999999999999999999999999999999999999999998754332 223


Q ss_pred             ccccCCCCcCChhhhh----ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHHHHH
Q 040472          379 LSFKGSPYWMAPEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAKS  453 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~d  453 (628)
                      ....++..|+|||++.    ....++.++|||||||++|||++|.+||...........+..... ....+..++.++.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            3456899999999974    223477899999999999999999999987665555544433221 12234568899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||++||+.||.+||++.++++||||+.
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEec
Confidence            999999999999999999999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.9e-42  Score=359.04  Aligned_cols=265  Identities=28%  Similarity=0.430  Sum_probs=221.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||++.+..+++.||||.+....  .........+.+|+++++.++|+||+++++.+..++.+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            37899999999999999999999999999999886432  1123345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc----
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~----  375 (628)
                      ||||+.|++|.+++...+.+++..+..++.|++.||+|||+++|+||||||+||||+.++.+||+|||+++.....    
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999998632100    


Q ss_pred             ------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCC
Q 040472          376 ------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPE  442 (628)
Q Consensus       376 ------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~  442 (628)
                                  .......++..|+|||.+.+. .++.++|||||||++|||++|..||.+....+....+.... ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                        001124578899999998654 48999999999999999999999998655444444333221 2233


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCC---HHHHhcCccccchHHHhhc
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPP---ASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpt---a~eiL~Hpwf~~~~~~~~~  487 (628)
                      ....++.++.+||++||+.||++||+   +.++|+||||....++...
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~  285 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLL  285 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHh
Confidence            33368899999999999999999997   7999999999887776643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-43  Score=375.75  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=201.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+|++++.||+|+||.||+|++..+++.||||+...           .....|+.+|++++|+|||++++++.+....++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            479999999999999999999999999999997532           122458999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||+. ++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++........
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            999995 578887764 467999999999999999999999999999999999999999999999999999764443444


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCC-CCCCchh---------HHHhhhcCC-----CCCC--
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGV---------AAIFKIGNS-----KDIP--  441 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~P-F~~~~~~---------~~~~~i~~~-----~~~~--  441 (628)
                      ....||+.|+|||++.+. .++.++|||||||++|||+++..+ |......         ..+.++...     ...+  
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            556799999999998765 489999999999999999985444 4321110         111111000     0000  


Q ss_pred             ---------------------C----CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          442 ---------------------E----IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       442 ---------------------~----~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                           .    -...++.++.+||++||+.||++|||+.|||+||||++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                 0    00135677888999999999999999999999999974

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3e-42  Score=355.94  Aligned_cols=256  Identities=30%  Similarity=0.458  Sum_probs=208.3

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHH---HHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~---iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      +||+|+||.||+|.+..+++.||||++........  .......+|..   ++....|+||+.+++++..++..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc--hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            48999999999999999999999998864322111  11122333443   34445799999999999999999999999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccC
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG  383 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~G  383 (628)
                      +.|++|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... .....|
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~  157 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVG  157 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCC
Confidence            9999999999988899999999999999999999999999999999999999999999999999987554322 233569


Q ss_pred             CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhc
Q 040472          384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       384 T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      |..|+|||++.+...++.++|||||||++|+|++|..||.....  ...+..... .....++..++.++.+||++||..
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcCCccccCHHHHHHHHHHhcC
Confidence            99999999986545589999999999999999999999965432  222222211 122356677899999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccchHHHhh
Q 040472          462 DPSARP-----PASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       462 dP~~Rp-----ta~eiL~Hpwf~~~~~~~~  486 (628)
                      ||++|+     ++.++++||||++..+...
T Consensus       237 ~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         237 DVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             CHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            999999     6999999999998776553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-42  Score=355.17  Aligned_cols=254  Identities=36%  Similarity=0.651  Sum_probs=212.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceec----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELS----  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~----  293 (628)
                      ...|++.+.||+|+||.||+|++..+++.||+|++...      .....++..|+.+++++ +|+||+++++++..    
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            46899999999999999999999999999999988542      12235678899999998 69999999998853    


Q ss_pred             --cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                        ...+|+||||+.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||+|+.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence              46789999999999999999753  45889999999999999999999999999999999999999999999999998


Q ss_pred             ccccCc-cccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCC
Q 040472          370 KHMTSC-ASMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP  444 (628)
Q Consensus       370 ~~~~~~-~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p  444 (628)
                      ...... .......|++.|+|||++..    ...++.++|||||||++|||++|..||........+..+..........
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  248 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS  248 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence            765422 22344678999999998752    2347889999999999999999999997765555444443322222233


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..++.++.+||++||+.||.+||++.|||+||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            4578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-42  Score=356.70  Aligned_cols=254  Identities=27%  Similarity=0.487  Sum_probs=213.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|.+..+++.||||++......   ......+.+|+.++++++|+||+++++++..+..+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            589999999999999999999999999999998753221   23346788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--c
Q 040472          301 LEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--S  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--~  377 (628)
                      |||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  .
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 9999999865 4679999999999999999999999999999999999999999999999999998664432  2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------------------  439 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------------------  439 (628)
                      .....|+..|+|||++.+...++.++|||||||++|||++|.++|........+..+.....                  
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            33456899999999987666678999999999999999999988876544333222211000                  


Q ss_pred             ----------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          440 ----------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       440 ----------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                +..+...++.++.+||++||+.||++||+++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence                      001123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-42  Score=355.05  Aligned_cols=256  Identities=29%  Similarity=0.475  Sum_probs=215.2

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||+|+||+||+|.+..+++.||||++.....  ........+.+|+++|+.++|+||+++++++...+.+|+||||+.++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            7999999999999999999999999864221  11223455678999999999999999999999999999999999999


Q ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCC
Q 040472          308 SIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP  385 (628)
Q Consensus       308 sL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~  385 (628)
                      +|.+++.+..  .+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++.............++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            9999998765  79999999999999999999999999999999999999999999999999987655433334456888


Q ss_pred             CcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcC
Q 040472          386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD  462 (628)
Q Consensus       386 ~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~d  462 (628)
                      .|+|||++.+.. ++.++|||||||++|+|++|+.||.....   ...+.+... .....++..++.++.++|++||+.|
T Consensus       159 ~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         159 GYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHHccCC
Confidence            999999986654 89999999999999999999999976443   122222111 1223456678999999999999999


Q ss_pred             CCCCC-----CHHHHhcCccccchHHHhhc
Q 040472          463 PSARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       463 P~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      |++||     ++.++++||||++.+|.+..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~  266 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLNWRRLE  266 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence            99999     89999999999988776653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=349.69  Aligned_cols=253  Identities=42%  Similarity=0.725  Sum_probs=216.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....     .+..+.+.+|++++++++|+||+++++++.+...+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            58999999999999999999999999999999987432     2245778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      +|||+.+++|.+++... ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++.+||+|||++....... .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            99999999999999876 789999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             cccccCCCCcCChhhhhcc--CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC---CCCCCCcCCHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD---IPEIPEHLSDDAK  452 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~---~~~~p~~~s~~l~  452 (628)
                      .....++..|+|||++.+.  ..++.++|||||||++|+|++|..||...........+.....   .......++.++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            3446789999999998654  2488899999999999999999999987665444443332211   1122334678899


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      +||++||..+|.+||++.+|+.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-44  Score=359.21  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=213.8

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceEEEEe
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      .++||+|+|+.|--+.+..|+..||||+|.+..     .....++.+|++++.+++ |+||++|+++|+++.++|||||-
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            368999999999999999999999999997532     234567889999999997 99999999999999999999999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---CEEEeccCCcccccC------
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKLADFGMAKHMTS------  374 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~vKL~DFGla~~~~~------  374 (628)
                      |.||.|..+|+++..|+|.++..++++|+.||+|||.+||.||||||+|||...-.   -||||||.|...+..      
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99999999999999999999999999999999999999999999999999996544   389999998764422      


Q ss_pred             --ccccccccCCCCcCChhhhh----ccCCCCccccccccccceeeeccCCCCCCCCch---------------hHHHhh
Q 040472          375 --CASMLSFKGSPYWMAPEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---------------VAAIFK  433 (628)
Q Consensus       375 --~~~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---------------~~~~~~  433 (628)
                        .....+.+|+..|||||++.    ....|+.+.|.||||||||-||+|.+||.+.-.               ...+..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence              12345678999999999963    234589999999999999999999999954211               112223


Q ss_pred             hcCCC-CC-CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          434 IGNSK-DI-PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       434 i~~~~-~~-~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      |.... .. ..-|..+|.+++|||..+|.+|+.+|.++.++++|||++....+
T Consensus       318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            33322 12 23455799999999999999999999999999999999866543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-42  Score=356.94  Aligned_cols=256  Identities=30%  Similarity=0.568  Sum_probs=215.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||.||+|++..+++.||+|.++...    .......+.+|+++|++++|+||+++++++..++.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            36899999999999999999999999999999886421    23335678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          300 YLEYVSGGSIHKLLQEY---GPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~---~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ||||+.|++|..++...   ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999998763   479999999999999999999997 59999999999999999999999999999765332


Q ss_pred             cccccccCCCCcCChhhhhccC-----CCCccccccccccceeeeccCCCCCCCCchhHH---HhhhcCCCCCCCCCCcC
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTN-----GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA---IFKIGNSKDIPEIPEHL  447 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~---~~~i~~~~~~~~~p~~~  447 (628)
                       ......++..|+|||++.+..     .++.++|||||||++|+|++|..||........   +..+. ....+.++..+
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-DGDPPTLPSGY  234 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh-hcCCCCCCccc
Confidence             223356888999999985332     258899999999999999999999975433222   22222 22334566678


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +.++.+||.+||+.+|++||++.++++||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999999643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-42  Score=347.80  Aligned_cols=254  Identities=45%  Similarity=0.863  Sum_probs=216.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|.+..+++.||||+++....   .....+.+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc---chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            58999999999999999999999999999999875322   245678899999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc---
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~---  377 (628)
                      +||+.+++|.+++.....+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++........   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999999999877899999999999999999999999999999999999999999999999999876543222   


Q ss_pred             --cccccCCCCcCChhhhhccC--CCCccccccccccceeeeccCCCCCCCCchhHH-HhhhcCCCCCCCCCCc--CCHH
Q 040472          378 --MLSFKGSPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA-IFKIGNSKDIPEIPEH--LSDD  450 (628)
Q Consensus       378 --~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~-~~~i~~~~~~~~~p~~--~s~~  450 (628)
                        .....++..|+|||++.+..  .++.++|||||||++|+|++|+.||...+.... ...+.. ...+.++..  ++..
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  236 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPE  236 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHH
Confidence              12356889999999986432  378899999999999999999999976543322 222222 333344444  4899


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +.+||++||+.+|++||++.+++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.5e-42  Score=358.47  Aligned_cols=255  Identities=34%  Similarity=0.601  Sum_probs=216.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||+|+||.||+|++..+++.||||.+.....     .....+.+|+.+++.++|+||+++++.+..+...|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            4689999999999999999999999999999998864221     12356788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      +||||+.|++|.+++.+ ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999999999865 568999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  456 (628)
                      .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||........+..+.... .....+..++..+.+||.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             cCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            2345689999999998654 48899999999999999999999997765444333332211 111234568899999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||..||++||++.+|++|+||..
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhc
Confidence            999999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.1e-42  Score=353.81  Aligned_cols=259  Identities=30%  Similarity=0.466  Sum_probs=210.5

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHH-HHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE-CLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      +||+|+||.||+|++..+++.||||++..........+ .......++++++...|+||+.+++++...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999865322211111 11112233445556689999999999999999999999999


Q ss_pred             cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCC
Q 040472          306 GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP  385 (628)
Q Consensus       306 GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~  385 (628)
                      |++|.+++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++....... ....+|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            99999999888889999999999999999999999999999999999999999999999999987654322 23457999


Q ss_pred             CcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCC
Q 040472          386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       386 ~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      .|+|||++.+...++.++|||||||++|||++|+.||.....  ...+...... ....++..++.++.++|++||..+|
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-cCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            999999987554589999999999999999999999976522  1222222211 1235566789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccchHHHhhc
Q 040472          464 SARP-----PASKLLDHPFVRDQAVARAG  487 (628)
Q Consensus       464 ~~Rp-----ta~eiL~Hpwf~~~~~~~~~  487 (628)
                      .+|+     ++.++++||||++..|....
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~~~~~~~  267 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSLDWQMVF  267 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCCCchHhh
Confidence            9999     99999999999987765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-42  Score=356.91  Aligned_cols=243  Identities=20%  Similarity=0.285  Sum_probs=207.1

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----cccceEEE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----DERLSVYL  301 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----~~~~~lVm  301 (628)
                      ..||+|++|.||+|..  +|+.||||+++...  .......+.+.+|+.+|++++|||||++++++.+    ...+++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH--KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccc--cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            6799999999999987  58899999986432  2234456788899999999999999999999876    35789999


Q ss_pred             EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccCcccccc
Q 040472          302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS  380 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~  380 (628)
                      ||+.||+|.+++.+...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......  ..
T Consensus       102 Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~  179 (283)
T PHA02988        102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FK  179 (283)
T ss_pred             EeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cc
Confidence            9999999999999888899999999999999999999984 99999999999999999999999999998654322  23


Q ss_pred             ccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          381 FKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ..||..|+|||++.+. ..++.++|||||||++|||++|..||...........+......+.++..++.++++||.+||
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl  259 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT  259 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence            5689999999998652 458999999999999999999999998776555544443333334556568899999999999


Q ss_pred             hcCCCCCCCHHHHhc
Q 040472          460 QRDPSARPPASKLLD  474 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~  474 (628)
                      +.||++||++.||++
T Consensus       260 ~~dp~~Rps~~ell~  274 (283)
T PHA02988        260 SHDSIKRPNIKEILY  274 (283)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-44  Score=379.70  Aligned_cols=239  Identities=31%  Similarity=0.583  Sum_probs=217.8

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      ...++-||.|+.|-||+|+..  ++.||||+++-            .-..+|+-|++|+|+||+.+.|+|....-++|||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            334567999999999999876  68899997641            1235789999999999999999999999999999


Q ss_pred             EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccc
Q 040472          302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF  381 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~  381 (628)
                      |||..|.|+.+|+....+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++......+..++
T Consensus       192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999988777777889


Q ss_pred             cCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhc
Q 040472          382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       382 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      +||..|||||+|.+.. .+.|+|||||||||||||||..||...+....|..+.....--.+|..++..++-||++||+-
T Consensus       272 aGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence            9999999999998765 999999999999999999999999988888888777766555567888999999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 040472          462 DPSARPPASKLLDH  475 (628)
Q Consensus       462 dP~~Rpta~eiL~H  475 (628)
                      .|..||++.+||.|
T Consensus       351 KpRNRPSFrqil~H  364 (904)
T KOG4721|consen  351 KPRNRPSFRQILLH  364 (904)
T ss_pred             CCCCCccHHHHHHH
Confidence            99999999999988

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.3e-42  Score=347.03  Aligned_cols=253  Identities=33%  Similarity=0.589  Sum_probs=216.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--cccce
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DERLS  298 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~~~~  298 (628)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   ......+++.+|+++++.++|+||+++++++..  ...+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            5889999999999999999999999999999886422   223445678899999999999999999997764  45689


Q ss_pred             EEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          299 VYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLH-----ARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH-----~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                      ++|||+.+++|.+++..    ...+++..++.++.||+.||+|||     +.+|+|+||||+|||++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999999975    367899999999999999999999     899999999999999999999999999999


Q ss_pred             ccccCccc-cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          370 KHMTSCAS-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       370 ~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ........ .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+ .....+.++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-KEGKFRRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-hcCCCCCCccccC
Confidence            87654332 3345789999999998654 4889999999999999999999999876543333333 3334456777889


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .++.+||.+||+.+|++||++.+|++|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-42  Score=375.90  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=206.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+|++++.||+|+||.||+|...  .+++.||||.+...          +...+|+++|++++|+|||++++++..+..+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            57999999999999999999754  45678999977531          2345799999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+|||++. ++|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++....... 
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99999995 6899999877889999999999999999999999999999999999999999999999999997654322 


Q ss_pred             --ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---HHHhhhc---CC-----------
Q 040472          377 --SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIG---NS-----------  437 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---~~~~~i~---~~-----------  437 (628)
                        ......||+.|+|||++.+. .|+.++|||||||+||||++|+.||......   ..+..+.   ..           
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence              12346799999999998654 4899999999999999999999999653211   1111110   00           


Q ss_pred             -----------CCCC--CCC-----CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          438 -----------KDIP--EIP-----EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       438 -----------~~~~--~~p-----~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                                 ...+  .++     ..++.++++||++||+.||++||++.|||.||||+...+.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence                       0000  011     2356789999999999999999999999999999765543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.9e-42  Score=346.99  Aligned_cols=251  Identities=41%  Similarity=0.713  Sum_probs=215.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+...       ...+++.+|++++++++|+||+++++++.++..+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            5799999999999999999999988999999988642       115778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      +|||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++....... .
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999999975 4578999999999999999999999999999999999999999999999999998765433 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  456 (628)
                      .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... .....+..++.++.+||.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            2345588999999998655 58999999999999999999999998655544433332211 111234457889999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +||+.||++||++.|||+|+||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.8e-42  Score=347.45  Aligned_cols=256  Identities=38%  Similarity=0.675  Sum_probs=221.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....    ......+.+|+.++.+++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence            368999999999999999999999999999998864321    1445778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||+.+++|.+++.....+++..+..++.||+.||+|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999999999988889999999999999999999999 99999999999999999999999999999876443322


Q ss_pred             -ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc--h-hHHHhhhcCCCCCCCCCCc-CCHHHHH
Q 040472          379 -LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE--G-VAAIFKIGNSKDIPEIPEH-LSDDAKS  453 (628)
Q Consensus       379 -~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~--~-~~~~~~i~~~~~~~~~p~~-~s~~l~d  453 (628)
                       ....++..|+|||.+.+. .++.++||||||+++|+|++|..||....  . ......+. ....+.++.. ++..+.+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHH
Confidence             245688999999998655 58999999999999999999999997764  2 22233333 3333455555 8899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +|++||..+|++||++.++++||||+..
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            9999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-42  Score=361.27  Aligned_cols=260  Identities=28%  Similarity=0.499  Sum_probs=212.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--E  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~  295 (628)
                      .+++|++.+.||+|+||.||+|++..+++.||+|+++......   .....+.+|+.+|++++|+||+++++++...  +
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            5789999999999999999999999999999999987532211   1123456799999999999999999998765  5


Q ss_pred             cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+++||||+.+ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            68999999965 88888875 36789999999999999999999999999999999999999999999999999987644


Q ss_pred             c-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--------------
Q 040472          375 C-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--------------  439 (628)
Q Consensus       375 ~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--------------  439 (628)
                      . .......+++.|+|||++.+...++.++|||||||++|||++|.+||...+....+..+.....              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            3 2223334688899999987666689999999999999999999999987655444333221100              


Q ss_pred             ------CCC--------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          440 ------IPE--------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       440 ------~~~--------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                            ...        ....+++++.+||++||+.||++||++.+|+.||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                  000        012358899999999999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=354.93  Aligned_cols=256  Identities=30%  Similarity=0.573  Sum_probs=215.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++....   .....+.+.+|+++|++++|+||+++++++..++.+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            379999999999999999999999999999998864322   23345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--c
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--S  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--~  377 (628)
                      ||||+.++.|..++.+...+++..+..++.||+.||+|||+++|+||||+|+||+++.++.+||+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            99999998888777777779999999999999999999999999999999999999999999999999998765433  3


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---------------C----
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---------------K----  438 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---------------~----  438 (628)
                      .....++..|+|||++.+...++.++|||||||++|+|++|++||........+..+...               .    
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            344678999999999976646899999999999999999999999765443332221100               0    


Q ss_pred             -CCC----------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 -DIP----------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 -~~~----------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                       ..+          .++..++.++.+||++||..+|++||++++|++|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             000          1233458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-42  Score=352.31  Aligned_cols=254  Identities=34%  Similarity=0.647  Sum_probs=216.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.....    .+..+++.+|++++++++|+||+++++++..+..+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence            367888999999999999999999999999998865322    2445678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      ||||+.+++|.+++... ..+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999999999876 789999999999999999999999 9999999999999999999999999999876543222


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc----h-hHHHhhhcCCCCCCCCCCc-CCHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE----G-VAAIFKIGNSKDIPEIPEH-LSDDA  451 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~----~-~~~~~~i~~~~~~~~~p~~-~s~~l  451 (628)
                      .. ..++..|+|||++.+. .++.++|||||||++|+|++|..||....    . ...+..+.. ...+.++.. ++.++
T Consensus       157 ~~-~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (265)
T cd06605         157 KT-FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDF  233 (265)
T ss_pred             hc-ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChhhcCHHH
Confidence            22 6789999999998665 58999999999999999999999996542    1 222222222 222334443 88999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .+||.+||..||++||++.+++.||||+.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            99999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-41  Score=344.89  Aligned_cols=253  Identities=32%  Similarity=0.550  Sum_probs=219.0

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||.|+||.||.+++..+++.|++|.+.....   .....+++.+|+++|++++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc---chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            58999999999999999999999999999998864321   233456788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      |||+.+++|.+++.+.  ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++....... .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999999764  568999999999999999999999999999999999999999999999999998664433 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      .....|++.|+|||++.+.. ++.++|||||||++|||++|..||...........+.... ....+..++.++.++|.+
T Consensus       158 ~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHH
Confidence            33466899999999986554 8899999999999999999999998766555555554332 233446688999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccc
Q 040472          458 CLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ||..+|++||++.++|+|+|+
T Consensus       236 ~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8e-42  Score=345.60  Aligned_cols=253  Identities=33%  Similarity=0.580  Sum_probs=217.8

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||++++..+++.||||++.....   .....+.+.+|+.++++++|+||+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC---ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            58999999999999999999999999999999864221   123346788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      |||+.+++|.+++...  ..+++..+..++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++........ 
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999999999764  3588999999999999999999999999999999999999999999999999976544222 


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      .....|++.|+|||++.+. .++.++|||||||++|+|++|..||...+......++.. ...+..+..++.++.++|++
T Consensus       158 ~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         158 ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHHH
Confidence            2234588999999998654 488999999999999999999999987665555555433 23345566789999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccc
Q 040472          458 CLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ||+.+|.+||++.+|++|+||
T Consensus       236 ~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         236 LFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.1e-42  Score=345.56  Aligned_cols=253  Identities=32%  Similarity=0.565  Sum_probs=218.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|.+..+++.||||++.....   ..+..+.+.+|+++|++++|+||+++++.+..++.+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            58999999999999999999999999999999864321   223457788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCcccccCccc
Q 040472          301 LEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~~~~~  377 (628)
                      |||+.|++|.+++...  ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999999764  3589999999999999999999999999999999999998654 589999999987655444


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      .....|+..|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... ....++..++.++.+||.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 AYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-TFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCCCCcCHHHHHHHHH
Confidence            4456789999999998654 4889999999999999999999999876655555444332 2234566789999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccc
Q 040472          458 CLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ||+.||++||++.||++||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.1e-41  Score=342.71  Aligned_cols=249  Identities=33%  Similarity=0.594  Sum_probs=214.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||++.+..+++.||+|.++...    .....+.+.+|+.+++.++|+||+++++++.+++.+|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            5889999999999999999999999999999986432    123456778899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          301 LEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      |||+.+++|.+++..  ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999999998864  3458999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      .....|++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.. .....++..++..+.+||++
T Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-GSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-CCCCCCCcccCHHHHHHHHH
Confidence            2346689999999998654 489999999999999999999999987665544444433 23334566788999999999


Q ss_pred             HhhcCCCCCCCHHHHhcC
Q 040472          458 CLQRDPSARPPASKLLDH  475 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~H  475 (628)
                      ||+.||++||++.+|+.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.3e-42  Score=357.40  Aligned_cols=255  Identities=35%  Similarity=0.625  Sum_probs=218.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||.|+||.||+|++..+++.||||.+....     ....+.+.+|+.+++.++|+||+++++++..++.+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            457999999999999999999999999999999886422     122456788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      +||||+.+++|..++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999999999999875 4689999999999999999999999999999999999999999999999999886544322 


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI~  456 (628)
                      .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...+....+..+... ......+..++..+.+||+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            2345689999999998654 4889999999999999999999999876655444443221 1122345568899999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||..||++||++.+|+.|+||+.
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~  274 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKL  274 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhh
Confidence            999999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-42  Score=355.08  Aligned_cols=256  Identities=33%  Similarity=0.551  Sum_probs=213.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.++||+|+||.||+|+++.+++.||||++......   ....+.+.+|+++|+.++|+||+++++++..++..|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            3789999999999999999999999999999987542221   2334567889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      ||||+.++.|..++.....+++..+..++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++....... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            99999999999888777779999999999999999999999999999999999999999999999999988654322 22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC--------------------CC
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--------------------SK  438 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~--------------------~~  438 (628)
                      ....++..|+|||++.+...++.++|||||||++|||++|++||...........+..                    ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            3456889999999987655678899999999999999999999975443332222110                    00


Q ss_pred             CCC---------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 DIP---------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ~~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+         .....++..+.+||.+||+.+|++||++.+|++|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            001         1123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.4e-42  Score=357.92  Aligned_cols=255  Identities=35%  Similarity=0.616  Sum_probs=216.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||+|+||.||+|++..+++.||||.+.....     ...+.+.+|+.+++.++|+||+++++++..++.+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            4789999999999999999999999999999998864221     12356788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      +||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+|+||||||+||||+.++.++|+|||++........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999999999865 5689999999999999999999999999999999999999999999999999976544322 


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  456 (628)
                      .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+....+..+.... .....+..++..+.+||.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            2345689999999998654 48899999999999999999999997655443333322211 112345568889999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.||++||++.+|++||||+.
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~  274 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKL  274 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhcc
Confidence            999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8e-42  Score=350.70  Aligned_cols=257  Identities=26%  Similarity=0.541  Sum_probs=208.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHH-HHhCCCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL-LSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ++|++.+.||+|+||.||+|+++.+++.||||+++.....   .. ..++..|+.+ ++.++|+||+++++++..+..+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            4799999999999999999999999999999988653221   11 2344455554 67778999999999999999999


Q ss_pred             EEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          299 VYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +||||++ ++|.+++..    ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999996 578777754    34689999999999999999999997 99999999999999999999999999998664


Q ss_pred             CccccccccCCCCcCChhhhhcc---CCCCccccccccccceeeeccCCCCCCCCch-hHHHhhhcCCCCCCCCC-CcCC
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNT---NGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEIP-EHLS  448 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i~~~~~~~~~p-~~~s  448 (628)
                      .........|+..|+|||++.+.   ..++.++|||||||++|+|++|+.||..... ...+..+... ..+.++ ..++
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPAEKFS  234 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCccccC
Confidence            43333345689999999988542   3478899999999999999999999975332 2333333222 122232 3578


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .++.+||.+||+.+|++||++.+|++|+||+...
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            9999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-41  Score=340.75  Aligned_cols=254  Identities=57%  Similarity=1.047  Sum_probs=223.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--ccce
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--ERLS  298 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~~~~  298 (628)
                      +|++.+.||+|+||.||+|.+..+++.|++|++......   ....+.+.+|+.++++++|+||+++++.+.+.  ..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            588899999999999999999999999999998653221   34567889999999999999999999999988  8999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      +||||+.+++|.+++.....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999987655432 


Q ss_pred             --cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          378 --MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       378 --~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                        .....++..|++||.+.... ++.++||||||+++|+|++|..||.... ....+..+......+.++..++.++.+|
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence              34466899999999986544 8999999999999999999999998765 3334444444345567777889999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccc
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      |.+||+.||++||++.++++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.9e-42  Score=373.64  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeeccee
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSEL  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~  292 (628)
                      .++|++++.||+|+||.||+|++..+     ++.||||+++...    .......+.+|+++|+.+ +|+|||++++++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            45899999999999999999986443     4579999886422    123356788999999999 7999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhc--------------------------------------------------------
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEY--------------------------------------------------------  316 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~--------------------------------------------------------  316 (628)
                      ....+|+||||+.+|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999998642                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc---c
Q 040472          317 --------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---L  379 (628)
Q Consensus       317 --------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~---~  379 (628)
                                    .++++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++........   .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                          24778889999999999999999999999999999999999999999999999765332211   1


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...++..|||||++.+. .++.++|||||||++|||++ |..||........+.+..........+..++.++.+||.+|
T Consensus       273 ~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         273 NARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            22356689999998654 49999999999999999997 99999876544444444333333344556789999999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 040472          459 LQRDPSARPPASKLLD  474 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~  474 (628)
                      |+.||++||++.+|++
T Consensus       352 l~~dp~~RPs~~~l~~  367 (374)
T cd05106         352 WNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-42  Score=355.55  Aligned_cols=254  Identities=31%  Similarity=0.576  Sum_probs=210.0

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||.|+||.||+|+++.+++.||||+++.....   ......+.+|+++|++++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            488999999999999999999999999999988643211   22235678899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          301 LEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      |||+. ++|..++..  ...+++..++.++.||+.||+|||+++|+||||+|+|||++.++.+||+|||++....... .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 589888865  3568999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------------------  439 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------------------  439 (628)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.||...+....+.++.....                  
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            23345788999999886655578899999999999999999999976554433332211100                  


Q ss_pred             ---------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          440 ---------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       440 ---------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                               ...+...++.++++||.+||+.||++||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                     001123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-42  Score=347.39  Aligned_cols=254  Identities=36%  Similarity=0.667  Sum_probs=212.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccc--
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDE--  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~--  295 (628)
                      .++|++.+.||+|+||.||+|.++.+++.|++|++....      ....++.+|+.+++++ .|+||+++++++....  
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            478999999999999999999999999999999886421      1235688999999999 6999999999987644  


Q ss_pred             ----cceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          296 ----RLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       296 ----~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                          .+|+||||+.+++|.+++..    ...+++..++.++.||+.||+|||+++|+|+||+|+||+++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence                48999999999999999875    3579999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCc-cccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-C
Q 040472          368 MAKHMTSC-ASMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-P  441 (628)
Q Consensus       368 la~~~~~~-~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-~  441 (628)
                      ++...... .......|+..|+|||++..    ...++.++|||||||+||+|++|..||........+.++...... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            98765332 22334568999999998753    234778999999999999999999999876555555554332211 1


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+..++.++++||++||..||++||++.+|++|||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1223477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.4e-42  Score=359.97  Aligned_cols=246  Identities=28%  Similarity=0.496  Sum_probs=192.3

Q ss_pred             eeeeccCCcEEEEEEEECC--CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--cccceEE
Q 040472          225 GKLLGRGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DERLSVY  300 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~~~~lV  300 (628)
                      +++||+|+||.||+|+++.  ++..||+|.+....       ....+.+|+++|+.++|+||+++++++..  +..+++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            4689999999999998654  56889999875321       12346789999999999999999998854  5678999


Q ss_pred             EEecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe----CCCCCEEEeccC
Q 040472          301 LEYVSGGSIHKLLQEY---------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFG  367 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl----d~~g~vKL~DFG  367 (628)
                      |||+. ++|.+++...         ..+++..++.++.||+.||+|||+++|+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            99986 4787777421         248899999999999999999999999999999999999    456789999999


Q ss_pred             CcccccCcc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---------HH---H
Q 040472          368 MAKHMTSCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---------AA---I  431 (628)
Q Consensus       368 la~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---------~~---~  431 (628)
                      +++......    ......||+.|+|||++.+...++.++|||||||++|||++|.+||......         ..   +
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            998654321    2234578999999999876666899999999999999999999999642211         00   0


Q ss_pred             hhhcC------------CCC---------------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          432 FKIGN------------SKD---------------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       432 ~~i~~------------~~~---------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .....            ...                     ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000            000                     000111245678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-42  Score=351.51  Aligned_cols=256  Identities=38%  Similarity=0.716  Sum_probs=217.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC---CCCeeeeecceeccccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS---HPNIVRYHGSELSDERL  297 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~~~~~~~~~  297 (628)
                      .|++.+.||+|+||.||+|.+..+++.||||+++...    ......++.+|+.++++++   |+||+++++++..+...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            5788899999999999999999999999999886422    1233466788999999997   99999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.|++|.++++. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999999999876 579999999999999999999999999999999999999999999999999998664432 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC-cCCHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE-HLSDDAKSFI  455 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~s~~l~dLI  455 (628)
                      ......|+..|+|||++.+...++.++|||||||++|+|++|..||........+..+... ..+.++. .++.++.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  235 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV  235 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence            2334568999999999876555789999999999999999999999876554444333222 2233333 3788999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .+||+.||++||++.+++.|+||++..
T Consensus       236 ~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         236 AACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999999997543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-41  Score=350.57  Aligned_cols=255  Identities=35%  Similarity=0.668  Sum_probs=210.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeeccee----
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSEL----  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~----  292 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...      .....+.+|+.+++.+ +|+||+++++++.    
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            4579999999999999999999999999999999875321      1124577899999999 6999999999874    


Q ss_pred             -ccccceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          293 -SDERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       293 -~~~~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                       .++.+++||||++|++|.+++..    ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             45679999999999999998753    3568999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCcc-ccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CC
Q 040472          368 MAKHMTSCA-SMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IP  441 (628)
Q Consensus       368 la~~~~~~~-~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~  441 (628)
                      +++...... ......|++.|+|||++..    ...++.++|||||||++|||++|..||........+.++..... ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL  249 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence            997654322 2234569999999998742    23478899999999999999999999987655444444322211 11


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+..++.++.+||.+||+.||++||++.||++|+||
T Consensus       250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2344567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-41  Score=347.49  Aligned_cols=254  Identities=44%  Similarity=0.751  Sum_probs=211.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +.+....+||+|+||.||+|++..++..||+|.+...     .....+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3444456899999999999999999999999987632     23345678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccCCcccccCc
Q 040472          300 YLEYVSGGSIHKLLQEY-GPF--NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l--~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~~~~~  375 (628)
                      ||||+.+++|.+++... ..+  ++..+..++.||+.||+|||++||+||||||+||||+. ++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            99999999999999864 556  88899999999999999999999999999999999976 679999999998765332


Q ss_pred             c-ccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 A-SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~-~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      . ......|+..|+|||++.+. ..++.++|||||||++|+|++|+.||...... ............+.++..++.++.
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence            2 22234589999999998543 34788999999999999999999999764432 222222222334566777899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +||++||+.+|++||++.|++.||||
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.9e-42  Score=352.71  Aligned_cols=251  Identities=26%  Similarity=0.449  Sum_probs=212.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCC-----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESG-----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      +++|++.+.||+|+||.||+|.+...+     ..||+|.++..    ........+.+|+++|.+++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            568999999999999999999876554     67999987632    123445678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP  357 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~  357 (628)
                      .+..+++|||+.+++|.+++...                ..+++..+..++.||+.||+|||+++|+||||||+||||+.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999764                45788899999999999999999999999999999999999


Q ss_pred             CCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhh
Q 040472          358 HGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFK  433 (628)
Q Consensus       358 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~  433 (628)
                      ++.+||+|||+++......   ......+++.|+|||++.+. .++.++|||||||++|||++ |..||......+....
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999997653322   12234568899999998654 48999999999999999998 9999987665554444


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.. ...+..+..++.++.+|+++||+.||.+||++.||+++
T Consensus       239 i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433 33445667889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=354.67  Aligned_cols=255  Identities=29%  Similarity=0.535  Sum_probs=207.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++.+.||+|+||.||+|+++.+++.||||.+.......    ....+.+|++++++++|+||+++++++.+++..|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            578999999999999999999999999999999986432211    1234567999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      +||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999975 899988764 46899999999999999999999999999999999999999999999999998754321 1


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-hHHHhhh---cCCC--------------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKI---GNSK--------------  438 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i---~~~~--------------  438 (628)
                      ......++..|+|||++.+...++.++|||||||++|+|++|+.||..... ...+..+   ....              
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            222345788999999987655689999999999999999999999965442 1111111   0000              


Q ss_pred             ---CC--------CCCCCcCC--HHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 ---DI--------PEIPEHLS--DDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ---~~--------~~~p~~~s--~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                         ..        ......++  .++.++|.+||+.+|++||++.++++|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence               00        00011244  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.1e-41  Score=350.17  Aligned_cols=256  Identities=35%  Similarity=0.647  Sum_probs=212.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSD--  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~--  294 (628)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....      .....+.+|+.+++++ +|+||+++++++...  
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            4578999999999999999999999999999999885321      1234567899999999 799999999988753  


Q ss_pred             ---ccceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                         ..+|+||||+.|++|.++++.    ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence               368999999999999998863    4578999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCcc-ccccccCCCCcCChhhhhccC----CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-C
Q 040472          368 MAKHMTSCA-SMLSFKGSPYWMAPEVVMNTN----GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-P  441 (628)
Q Consensus       368 la~~~~~~~-~~~~~~GT~~Y~APEvl~~~~----~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-~  441 (628)
                      ++....... ......|+..|+|||++....    .++.++|||||||++|||++|+.||........+.++...... .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  253 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL  253 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence            988654322 223456899999999975432    2688999999999999999999999876655555554332211 1


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ..+..++.++.+||.+||+.+|++||++.||++||||+
T Consensus       254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            22445778899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-42  Score=381.01  Aligned_cols=249  Identities=25%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ...|.+.+.||+|+||.||+|++..+++.||||....           ..+.+|+++|++|+|+|||++++++..++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            3579999999999999999999999999999995421           23457999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      ||||++. ++|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++...... 
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999995 6888887653 579999999999999999999999999999999999999999999999999998654321 


Q ss_pred             --ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc-------hhHHHhhhcCCC-----CCCC
Q 040472          377 --SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-------GVAAIFKIGNSK-----DIPE  442 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-------~~~~~~~i~~~~-----~~~~  442 (628)
                        .....+||+.|||||++.+. .++.++||||||||||||++|..++....       ....+.++....     ..+.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence              12346799999999999765 48999999999999999999876542211       011111111100     0000


Q ss_pred             ---------------------C----C---CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          443 ---------------------I----P---EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       443 ---------------------~----p---~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                           .    +   ..++.++.+||.+||+.||.+||++.|||+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                 0    0   135668999999999999999999999999999963

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5e-42  Score=370.45  Aligned_cols=253  Identities=25%  Similarity=0.422  Sum_probs=207.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++++.||+|+||.||+|++     ..++..||||+++....    ....+.+.+|+++|..+ +|||||++++++
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            346899999999999999999964     45677899998863221    22345688899999999 799999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC------------------------------------------------------
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG------------------------------------------------------  317 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~------------------------------------------------------  317 (628)
                      .+....++||||+.||+|.+++.+..                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999999986432                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          318 ---------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       318 ---------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                                           .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 46788899999999999999999999999999999999999999999999998654322


Q ss_pred             cc---ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          377 SM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       377 ~~---~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..   ....++..|+|||++.+. .++.++|||||||++|||++ |..||........+.+..........+...+.+++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  347 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY  347 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence            11   123356679999998655 48999999999999999997 89999776544444444333323344556788999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcC
Q 040472          453 SFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +||.+||+.||++||++.||++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-41  Score=348.34  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=208.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.++...    .......+.+|+.+|++++||||+++++++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            357999999999999999999765   456789999886432    1233467889999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+++||||+.+|+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999999764 5789999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccc--cccCCCCcCChhhhhccCCCCccccccccccceeeec-cCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CASML--SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA-TSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~~~~--~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelL-tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      .....  ...++..|+|||++.+. .++.++|||||||++|||+ +|..||........+..+..... ...+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LPAPRNCPNLL  237 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCCCCCCCHHH
Confidence            21111  23356789999998654 5899999999999999976 49999987665555554443322 34566788999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+++.+||+.+|++||++++|++
T Consensus       238 ~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         238 HQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999965

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-41  Score=354.87  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=201.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC----------------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE----------------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP  282 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp  282 (628)
                      .++|++.++||+|+||.||+|++..                ++..||||+++...    ......++.+|+++|.+++|+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence            3589999999999999999997532                34579999886421    234456788999999999999


Q ss_pred             CeeeeecceeccccceEEEEecccccHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 040472          283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-------------------PFNEPVIQTYTRQILLGLAYLHARNT  343 (628)
Q Consensus       283 nIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~-------------------~l~e~~~~~i~~qIl~aL~yLH~~gI  343 (628)
                      ||+++++++.+.+..++||||+.+++|.+++....                   .+++..+..++.||+.||+|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999986532                   35777889999999999999999999


Q ss_pred             cccccCCCceEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc--C
Q 040472          344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--S  418 (628)
Q Consensus       344 vHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt--G  418 (628)
                      +||||||+||||+.++.+||+|||+++.......   .....++..|||||++.+. .++.++|||||||++|||++  +
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999976533221   1223467889999998654 49999999999999999986  6


Q ss_pred             CCCCCCCchhHHHhhhcC------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHh
Q 040472          419 KPPWSQYEGVAAIFKIGN------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       419 ~~PF~~~~~~~~~~~i~~------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      ..||........+..+..      .......+..++..+.+||.+||+.||++||++.+|.
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            778876544333222111      1111223456788999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8e-42  Score=350.09  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=205.7

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecc--ccce
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSD--ERLS  298 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~--~~~~  298 (628)
                      |++.+.||+|+||.||+|.+..+++.||||+++......   .. ....+|+.++.++. |+||+++++++.++  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            678899999999999999999999999999886432221   11 23346888898886 99999999999987  8999


Q ss_pred             EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||+++. +.+||+|||+++.......
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            99999975 77777765 457899999999999999999999999999999999999999 9999999999987654444


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-------------------C
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-------------------K  438 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-------------------~  438 (628)
                      .....++..|+|||++.....++.++|||||||++|||++|.+||...+..+.+..+...                   .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            445668999999998765555789999999999999999999999765543322222110                   0


Q ss_pred             CCC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 DIP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+        .+...++.++.+||.+||+.+|++||++++|++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000        1123568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.3e-42  Score=354.95  Aligned_cols=257  Identities=28%  Similarity=0.521  Sum_probs=212.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--E  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~  295 (628)
                      .+++|++.+.||.|+||.||+|.+..+++.||||.++.....   ......+.+|+.+|++++|+||+++++++...  .
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   79 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD   79 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence            356899999999999999999999999999999998753222   22334567899999999999999999998877  8


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||+++|+|+||||+||||+.++.+||+|||++.....
T Consensus        80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99999999974 999988764 4589999999999999999999999999999999999999999999999999986644


Q ss_pred             c-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC---------------
Q 040472          375 C-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK---------------  438 (628)
Q Consensus       375 ~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~---------------  438 (628)
                      . .......+++.|+|||++.+...++.++|||||||++|+|++|.+||........+.++....               
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 223345678999999998765557899999999999999999999997655443332221100               


Q ss_pred             --------------CCCCCCCc-CCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 --------------DIPEIPEH-LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 --------------~~~~~p~~-~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                    ....++.. +++.+.+||++||+.||++||++.|+|+|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          00112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.8e-42  Score=345.54  Aligned_cols=251  Identities=34%  Similarity=0.576  Sum_probs=214.1

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||.|+||.||+|++..+++.||||++....  .......+.+.+|++++++++|+||+++++.+..+...|+||||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            689999999999999999999999886422  222355678899999999999999999999999999999999999999


Q ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---------cc
Q 040472          308 SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---------SM  378 (628)
Q Consensus       308 sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---------~~  378 (628)
                      +|.+++.+.+.+++..+..++.||+.||+|||+++|+|+||+|+|||++.++.++|+|||++.......         ..
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            999999988889999999999999999999999999999999999999999999999999987543321         22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCc--CCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~dLI~  456 (628)
                      ....++..|++||++.+.. ++.++||||||+++|+|++|..||...........+....  ...+..  ++..+.+||+
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccCCHHHHHHHH
Confidence            3356888999999986554 8899999999999999999999998766555444443322  122233  4899999999


Q ss_pred             HHhhcCCCCCCCH---HHHhcCccccchHH
Q 040472          457 QCLQRDPSARPPA---SKLLDHPFVRDQAV  483 (628)
Q Consensus       457 ~~L~~dP~~Rpta---~eiL~Hpwf~~~~~  483 (628)
                      +||+.+|.+||++   .++|+||||+++.|
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            9999999999999   99999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-42  Score=352.96  Aligned_cols=255  Identities=27%  Similarity=0.511  Sum_probs=215.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....    .....+++.+|+++++.++|+||+++++++.....++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            468999999999999999999999999999999886422    1334567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||+.+++|.+++.+.+.+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++...... .
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-I  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-c
Confidence            999999999999999988889999999999999999999997 58999999999999999999999999998754322 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh-----------HHHhhhcCCCCCCCCCC-
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-----------AAIFKIGNSKDIPEIPE-  445 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-----------~~~~~i~~~~~~~~~p~-  445 (628)
                      ....+|+..|+|||++.+. .++.++|||||||++|+|++|..||......           ..+..+.. ...+.++. 
T Consensus       159 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSS  236 (284)
T ss_pred             cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCch
Confidence            2345799999999998655 5899999999999999999999999754331           11222221 11222322 


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .++.++.+||.+||+.||++||++.||++|+||..
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            37789999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.7e-42  Score=364.09  Aligned_cols=255  Identities=25%  Similarity=0.445  Sum_probs=208.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~---  294 (628)
                      ...+|++.+.||+|+||.||+|++..+++.||||++.....   .......+.+|+.++++++|+||++++++|...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            35789999999999999999999999999999998853221   223345677899999999999999999988644   


Q ss_pred             ---ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                         ...|+||||+. ++|.+++...  +++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence               35799999996 5888888654  89999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------------  439 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------------  439 (628)
                      ...........++..|+|||++.+. .++.++|||||||++|+|++|+.||...+....+.++.....            
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            6544334456789999999998765 489999999999999999999999976543332222110000            


Q ss_pred             ----------------C----C---------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          440 ----------------I----P---------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       440 ----------------~----~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                                      .    +         ..+...+.++.+||++||+.||++||++.|||+||||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                            0    0         00113466789999999999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.2e-42  Score=352.73  Aligned_cols=256  Identities=30%  Similarity=0.525  Sum_probs=208.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc--
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER--  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~--  296 (628)
                      ++|++.+.||+|+||.||+|++..+++.||||+++.....   ......+.+|+.+++.+. |+||+++++++...+.  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            4799999999999999999999999999999987643221   122356778999999996 6999999999887666  


Q ss_pred             ---ceEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccC
Q 040472          297 ---LSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFG  367 (628)
Q Consensus       297 ---~~lVmEy~~GgsL~~~L~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFG  367 (628)
                         .|+||||+.+ +|.+++...     ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999986 788887642     35799999999999999999999999999999999999998 8899999999


Q ss_pred             CcccccCc-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-------
Q 040472          368 MAKHMTSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-------  439 (628)
Q Consensus       368 la~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-------  439 (628)
                      ++..+... .......+++.|+|||++.+...++.++|||||||++|+|++|..||...+......++.....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98765332 2223345788999999987656689999999999999999999999987655544433211000       


Q ss_pred             -----------CC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          440 -----------IP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       440 -----------~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                                 .+        ...+.++.++.+||.+||..||.+||++.|||.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                       00        11134788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.9e-42  Score=350.48  Aligned_cols=256  Identities=40%  Similarity=0.742  Sum_probs=219.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|+..+.||.|+||.||+|.+..++..||||++....    .......+.+|+.+++++.|+||+++++++.++..+|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            36788899999999999999999999999999886421    12345778899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      ||||+.|++|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+|||++.++.++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            9999999999999875 678999999999999999999999999999999999999999999999999997654322 22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ....++..|+|||++.+. .++.++|+|||||++|||++|..||...........+. ....+.++..++..+.+||.+|
T Consensus       159 ~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHH
Confidence            335688999999998654 48999999999999999999999998765544443332 2233455667888999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccchH
Q 040472          459 LQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      |+.+|++||++.++++|+||....
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhhcc
Confidence            999999999999999999996543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=367.00  Aligned_cols=251  Identities=28%  Similarity=0.469  Sum_probs=213.4

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...+++.++..||+|.||+||+|++-.   .||||++++...   ..+.++.|++|+.+|++-+|.||+-+.|++..+..
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p---t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP---TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC---CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344567788999999999999999864   599999987433   34578889999999999999999999999988777


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc--
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT--  373 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~--  373 (628)
                       .||.-+|+|-+|+.+|+- ...|.....+.|++||++|+.|||.++|||||||..||||.+++.|||+||||+....  
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence             899999999999999974 3578999999999999999999999999999999999999999999999999996532  


Q ss_pred             -CccccccccCCCCcCChhhhhcc--CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCC---CCCcC
Q 040472          374 -SCASMLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---IPEHL  447 (628)
Q Consensus       374 -~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~---~p~~~  447 (628)
                       .........|...|||||+++..  ..|+..+||||||||+|||++|..||........++.+......+.   +-...
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence             22223334578889999999643  3589999999999999999999999996566666777776644443   34557


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++++++|+..||.+++++||.+.+||.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            789999999999999999999999975

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9e-42  Score=352.00  Aligned_cols=259  Identities=29%  Similarity=0.510  Sum_probs=210.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~  297 (628)
                      .++|+..+.||+|+||.||++++..+++.||||.+.....    ......+.+|+.++.++. |+||+++++++..+...
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            3567788999999999999999999999999998864221    134567888999999997 99999999999999999


Q ss_pred             eEEEEecccccHHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          298 SVYLEYVSGGSIHKLL---Q--EYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L---~--~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +++|||+.+ +|.++.   .  ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            999999854 554433   2  236799999999999999999999975 999999999999999999999999999976


Q ss_pred             ccCccccccccCCCCcCChhhhhcc--CCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcCCC---CCCCCCC
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSK---DIPEIPE  445 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~~~---~~~~~p~  445 (628)
                      ...........|+..|+|||++.+.  ..++.++|||||||++|+|++|+.||...... ..+.++....   .....+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            5443333445689999999998655  35899999999999999999999999765432 2222222111   1112223


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .++.++.+||++||+.||++||++++|++||||+...
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            5789999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-41  Score=352.17  Aligned_cols=260  Identities=31%  Similarity=0.536  Sum_probs=211.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++.+.||+|+||.||+|+++.+++.||||.+......   ......+.+|++++++++|+||+++++++.++..+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY   77 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence            36899999999999999999999999999999988643211   123356778999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~~~~~  375 (628)
                      +||||+. ++|.+++....  .+++..+..++.||+.||+|||+++|+||||+|+|||++. ++.+||+|||++......
T Consensus        78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9999995 58888876543  3578889999999999999999999999999999999985 457999999999754322


Q ss_pred             -cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC---------------
Q 040472          376 -ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD---------------  439 (628)
Q Consensus       376 -~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~---------------  439 (628)
                       .......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+.++.....               
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             1223346789999999987655688999999999999999999999976655444443211000               


Q ss_pred             ----CC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          440 ----IP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       440 ----~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                          .+        .....++.++.++|.+||+.+|++||++.++++|+||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                00        01234788999999999999999999999999999998653

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.2e-42  Score=352.16  Aligned_cols=255  Identities=40%  Similarity=0.742  Sum_probs=216.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|++.+.||+|+||.||+|.+..+++.||||+++...    .....+.+.+|++++++++|+||+++++++..+..+|+|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            5777889999999999999999999999999886321    123456788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      |||+.+++|.+++.. +.+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            999999999998865 678999999999999999999999999999999999999999999999999997654322 223


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ...|+..|+|||++.+. .++.++|||||||++|||++|..||...........+.. ...+.+...++.++.+||.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         160 TFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHHHHHHHc
Confidence            35688999999998654 489999999999999999999999976544433333322 2234455668889999999999


Q ss_pred             hcCCCCCCCHHHHhcCccccchH
Q 040472          460 QRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      +.+|++||++.+|++|+||+...
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHh
Confidence            99999999999999999997543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-41  Score=350.99  Aligned_cols=255  Identities=28%  Similarity=0.471  Sum_probs=205.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.......    ....+.+|+.+|+.++|+||+++++++.+++..|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            468999999999999999999999999999999986432211    1234568999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          299 VYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      +||||+. ++|.+++.. ...+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9999996 566666543 456888999999999999999999999999999999999999999999999998754322 2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcC---------------C---
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---------------S---  437 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~---------------~---  437 (628)
                      ......+++.|+|||++.+...++.++|||||||++|||++|..||...... +.+.++..               .   
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            2234567899999999876556888999999999999999999999764432 11111100               0   


Q ss_pred             ----------CCCCCCCC--cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          438 ----------KDIPEIPE--HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       438 ----------~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                .....++.  ..+.++.+||++||+.||.+|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                      00000011  125689999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.1e-41  Score=343.37  Aligned_cols=254  Identities=30%  Similarity=0.549  Sum_probs=211.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++.+.||+|+||.||+|+++.+++.||||.++...  ........++.+|+++|+.++|+||+++++++.+.+..+
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN   78 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence            368999999999999999999999999999999876422  122344567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          299 VYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +||||+.+++|.+++..    ...+++..+..++.||+.||+|||+++|+|+||||+||||+.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999999998853    34589999999999999999999999999999999999999999999999999886543


Q ss_pred             ccc-cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--hHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CAS-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ... .....|++.|+|||++.+. .++.++|||||||++|||++|+.||.....  ......+......+.....++..+
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            221 2235689999999998654 488999999999999999999999965322  222233322222222334577899


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+||.+||+.+|++||++.+|++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-41  Score=349.15  Aligned_cols=253  Identities=30%  Similarity=0.574  Sum_probs=209.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||.|+||.||+|++..+++.||||+++.....    .....+.+|+.++++++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            589999999999999999999999999999998753221    1234566799999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          301 LEYVSGGSIHKLLQEY---GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |||+.+ +|.+++...   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999975 888888654   368999999999999999999999999999999999999999999999999997553321 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-------------------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-------------------  437 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-------------------  437 (628)
                      ......++..|++||++.+...++.++|||||||++|+|++|..||...+..+...++...                   
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            2233567899999999876666789999999999999999999999765544332222110                   


Q ss_pred             CCCC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          438 KDIP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       438 ~~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ...+        .+.+.++.++.++|.+||+.||.+||++.+|++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0000        1113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.5e-41  Score=337.73  Aligned_cols=253  Identities=34%  Similarity=0.655  Sum_probs=220.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||++.+..+++.||+|++.....   ..+..+.+.+|+++++.++|+||+++++.+......++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            58899999999999999999999999999999864322   234456788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          301 LEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |||+++++|.+++.+.    ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999999864    679999999999999999999999999999999999999999999999999997654432


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       ......|++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.. .....++..++.++.++|
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             ceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence             22345689999999988655 488999999999999999999999987665444444433 334566778899999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ++||..+|++||++.++|+||||
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-42  Score=367.44  Aligned_cols=257  Identities=29%  Similarity=0.488  Sum_probs=210.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .-..|+++++||+||.+.||++.... .+.||+|.+..   ...+...+.-+.+||.+|.+|+ |.+||+||+|...++.
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~---~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL---LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH---hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            44689999999999999999998764 45677775542   2334556778899999999997 9999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l-~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +||||||-+ -+|..+|++.... ..-.+++|..|+|.|+.++|++||||.||||.|+|+ -.|.+||+|||.|..+..+
T Consensus       435 lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  435 LYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            999999984 5999999876543 335889999999999999999999999999999998 4789999999999988765


Q ss_pred             cc---cccccCCCCcCChhhhhccC----------CCCccccccccccceeeeccCCCCCCCCch-hHHHhhhcCCCCCC
Q 040472          376 AS---MLSFKGSPYWMAPEVVMNTN----------GYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIP  441 (628)
Q Consensus       376 ~~---~~~~~GT~~Y~APEvl~~~~----------~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i~~~~~~~  441 (628)
                      ..   ..+.+||+.||+||.+....          ..++++||||||||||+|++|++||..+.+ ...+..|....---
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            43   24578999999999985322          256899999999999999999999988764 34455554442212


Q ss_pred             CCCCcCCH-HHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          442 EIPEHLSD-DAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       442 ~~p~~~s~-~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +++..-.. ++.++++.||++||.+|+++.++|+|||+..
T Consensus       593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            33332222 3999999999999999999999999999865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=325.69  Aligned_cols=257  Identities=30%  Similarity=0.564  Sum_probs=217.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+|...++||+|.||+||+|++.++++.||+|.++...++..-   -....+||-+|+.++|.|||+++++...++.+.+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv---pssalreicllkelkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC---cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence            4677788999999999999999999999999999875544322   2345689999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      |+|||. .+|.++... +|.++.+.++.++.|++.||.|||+++++||||||.|+||+.+|++||+|||+++.+...- -
T Consensus        79 vfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   79 VFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             eHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            999995 588888865 5789999999999999999999999999999999999999999999999999999765433 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCC------CCCCC--------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNS------KDIPE--------  442 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~------~~~~~--------  442 (628)
                      ....+-|.+|++|+++.+..-|+...|+||.|||+.|+.. |++.|.+.+-.+++.+|-..      ..+|.        
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            3345689999999999999999999999999999999987 78888887666665554211      11111        


Q ss_pred             ----CC---------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          443 ----IP---------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       443 ----~p---------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                          ++         +.+...-+||++++|..+|.+|++++++|+||||.+
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence                11         235567789999999999999999999999999975

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.7e-41  Score=334.95  Aligned_cols=250  Identities=40%  Similarity=0.754  Sum_probs=216.0

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|.+.+.||+|+||.||++.+..+++.|++|++.....     ...+.+.+|+.+++.++|+||+++++++..+...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            58889999999999999999998999999999864221     3457788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          301 LEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      |||+.|++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            9999999999999876 689999999999999999999999999999999999999999999999999998765543234


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCc--CCHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQ  457 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~dLI~~  457 (628)
                      ...++..|++||++.+.. ++.++||||||+++|+|++|..||...+....+..+.. ...+.++..  ++.++.++|.+
T Consensus       156 ~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence            567899999999986554 88999999999999999999999987654444443332 222233322  38899999999


Q ss_pred             HhhcCCCCCCCHHHHhcCcc
Q 040472          458 CLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      ||+.||++||++.++++|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=343.58  Aligned_cols=252  Identities=29%  Similarity=0.496  Sum_probs=208.1

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHH-HHhCCCCCeeeeecceeccccceEEEEec
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL-LSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      +.||+|+||.||+|.+..+++.||||++.....  ........+..|..+ +..++|+||+++++++..++.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            579999999999999999999999998864211  112223344455544 44568999999999999999999999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCC
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS  384 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT  384 (628)
                      .|++|.++++..+.+++..+..++.||+.||.|||+.+|+||||+|+|||++.++.+||+|||+++....   .....|+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  156 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGT  156 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCC
Confidence            9999999999888899999999999999999999999999999999999999999999999999876433   2335688


Q ss_pred             CCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--CCCCCCCcCCHHHHHHHHHHhhcC
Q 040472          385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--DIPEIPEHLSDDAKSFIKQCLQRD  462 (628)
Q Consensus       385 ~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~dLI~~~L~~d  462 (628)
                      ..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+....  ........++.++.++|.+||+.|
T Consensus       157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            9999999987654 8999999999999999999999998765544433332221  112334467899999999999999


Q ss_pred             CCCCC---CHHHHhcCccccchHH
Q 040472          463 PSARP---PASKLLDHPFVRDQAV  483 (628)
Q Consensus       463 P~~Rp---ta~eiL~Hpwf~~~~~  483 (628)
                      |++||   +++|+|.||||++..|
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCCC
Confidence            99999   5589999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.6e-41  Score=352.08  Aligned_cols=255  Identities=36%  Similarity=0.655  Sum_probs=214.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|++.+.||+|+||.||+|++..+++.||||++....  ....+..+.+.+|+.+++.++|+||+++++++.+++..|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            56899999999999999999999999999999886422  2223445678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||+. |+|.+++.. ...+++..+..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++......   
T Consensus        93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            999997 466666653 567999999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ....++..|+|||++.+  ...++.++|||||||++|||++|..||...+.......+............++.++.+||.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD  248 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence            23568899999998742  3458889999999999999999999998766655555443322211223347889999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.||++||++.+|+.|+||..
T Consensus       249 ~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         249 SCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HHhcCChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-41  Score=359.35  Aligned_cols=257  Identities=27%  Similarity=0.489  Sum_probs=211.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-----  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-----  294 (628)
                      .+|++.+.||+|+||+||+|++..+++.||||.++....   ......++.+|+.+|+.++|+||+++++++...     
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            579999999999999999999999999999998864321   122245667899999999999999999988654     


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            35899999995 68999998888999999999999999999999999999999999999999999999999999986544


Q ss_pred             c-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc------------------
Q 040472          375 C-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG------------------  435 (628)
Q Consensus       375 ~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~------------------  435 (628)
                      . .......++..|+|||++.+...++.++|||||||++|+|++|++||...+....+..+.                  
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3 223445689999999998765558999999999999999999999997643221111100                  


Q ss_pred             ---------CC--CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          436 ---------NS--KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       436 ---------~~--~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                               ..  .........++.++.+||++||+.+|++||++.++++||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                     00  0001122457899999999999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=338.08  Aligned_cols=259  Identities=31%  Similarity=0.557  Sum_probs=221.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .+++.+.+..||.|+.|+||+++.+.+|...|||.+...    ...+..+++...+.++...+ +|+||+++|+|..+..
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            455677788999999999999999999999999999742    23555778888888876665 9999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +++.||.| +-.+..++++ .++++|..+-.+...++.||.||.++ +||||||||.|||+|..|++||||||++..+.+
T Consensus       166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            99999998 5578888875 57899999999999999999999865 899999999999999999999999999988877


Q ss_pred             ccccccccCCCCcCChhhhh--ccCCCCccccccccccceeeeccCCCCCCCCch-hHHHhhhcCCCCCCCCCC--cCCH
Q 040472          375 CASMLSFKGSPYWMAPEVVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEIPE--HLSD  449 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i~~~~~~~~~p~--~~s~  449 (628)
                      ...+....|-+.|||||.+-  ....|+.++||||||++|+||.||+.||...+. .+.+-++.+ ...|.++.  .+|+
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSP  323 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCH
Confidence            77777778999999999873  234689999999999999999999999987544 344445544 33355543  3799


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .+++|+..||++|+.+||...++|+|||++...
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            999999999999999999999999999987543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.8e-41  Score=344.78  Aligned_cols=254  Identities=32%  Similarity=0.554  Sum_probs=218.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~  298 (628)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....  ......+.+.+|+++++++. |+||+++++++.+++.++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            479999999999999999999999999999998864221  12233467888999999999 999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--  376 (628)
                      +||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++|++|+||+|+||+|+.++.++|+|||++.......  
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999999999988899999999999999999999999999999999999999999999999999987553321  


Q ss_pred             -------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC
Q 040472          377 -------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS  437 (628)
Q Consensus       377 -------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~  437 (628)
                                         ......++..|+|||++.+. .++.++|||||||++|+|++|+.||........+..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-  236 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-  236 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-
Confidence                               12235678999999998654 488999999999999999999999987665444444332 


Q ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCH----HHHhcCccc
Q 040472          438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA----SKLLDHPFV  478 (628)
Q Consensus       438 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta----~eiL~Hpwf  478 (628)
                       ....++..+++.+.+||++||+.+|.+||++    +++|+||||
T Consensus       237 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 -LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             1224566789999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=358.94  Aligned_cols=257  Identities=24%  Similarity=0.464  Sum_probs=207.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      .++|++.++||+|+||.||+|++..+++.||||++....    .......+.+|+.+|++++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            368999999999999999999999999999999886321    123345677899999999999999999876543    


Q ss_pred             -ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                       ..+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence             35899999996 588887754 579999999999999999999999999999999999999999999999999997653


Q ss_pred             Ccc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc---CC---------
Q 040472          374 SCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG---NS---------  437 (628)
Q Consensus       374 ~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~---~~---------  437 (628)
                      ...    .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+.   ..         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            322    12235789999999987665568999999999999999999999997543322111110   00         


Q ss_pred             ------------CCCC-----CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 ------------KDIP-----EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 ------------~~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                  ....     .....++.++.+||.+||+.+|++||++.|+++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                        0000     0113467889999999999999999999999999999743

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=352.65  Aligned_cols=255  Identities=26%  Similarity=0.476  Sum_probs=204.6

Q ss_pred             CeEEeeeeccCCcEEEEEEEECC--CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--cc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--ER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~~  296 (628)
                      +|++.++||+|+||.||+|.++.  +++.||||.+.....  ......+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            48899999999999999999988  899999999875321  1122235667899999999999999999999988  88


Q ss_pred             ceEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC----CCCEEEeccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP----HGEIKLADFG  367 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~----~g~vKL~DFG  367 (628)
                      +++||||+.+ +|.+++...     ..+++..++.++.||+.||+|||+++|+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999965 677766432     36899999999999999999999999999999999999999    8999999999


Q ss_pred             CcccccCccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH------------HH
Q 040472          368 MAKHMTSCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA------------AI  431 (628)
Q Consensus       368 la~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~------------~~  431 (628)
                      ++........    ....++|..|+|||++.+...++.++|||||||+||+|++|++||.......            .+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9986533221    2335688999999998776668999999999999999999999997543211            00


Q ss_pred             hhhcC---------------------CCCCCCCC-----------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          432 FKIGN---------------------SKDIPEIP-----------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       432 ~~i~~---------------------~~~~~~~p-----------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .....                     ......++           ...+.++.++|.+||+.||++||++.||++||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00000                     00000111           1467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-41  Score=335.46  Aligned_cols=253  Identities=46%  Similarity=0.862  Sum_probs=222.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||+|++..+++.||||.+.....   .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI---KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc---CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            58899999999999999999999999999999865322   134567889999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-cc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-ML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-~~  379 (628)
                      |||+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999999986654332 23


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ...++..|+|||.+.+.. ++.++|||+||+++|+|++|..||..........++.. ...+.++..++..+.++|.+||
T Consensus       158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHHH
Confidence            456899999999986554 88999999999999999999999987665555555443 3334567778999999999999


Q ss_pred             hcCCCCCCCHHHHhcCccc
Q 040472          460 QRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+|++||++.+++.|+||
T Consensus       236 ~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         236 QKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hCChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-41  Score=353.35  Aligned_cols=255  Identities=31%  Similarity=0.550  Sum_probs=213.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +.|.....||+|+||.||++.+..+++.||||++...     .....+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            3455567899999999999999999999999988532     12345668899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~  378 (628)
                      ||||+.+++|.+++.. +.+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++...... ...
T Consensus        97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            9999999999998864 56899999999999999999999999999999999999999999999999998754322 222


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....|+..|+|||++.+. .++.++|||||||++|||++|..||........+..+.... ........++..+.+||.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            345689999999998654 48999999999999999999999998755544433332211 1111223578899999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccch
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||..||.+||++++|++|+||+..
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhcc
Confidence            999999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=348.85  Aligned_cols=253  Identities=31%  Similarity=0.605  Sum_probs=210.0

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |++.+.||.|++|.||+|.++.+|+.||||++......   ......+.+|+++++.++|+||+++++++.+++..|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            67789999999999999999999999999988643211   222345778999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cc
Q 040472          302 EYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SM  378 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~  378 (628)
                      ||+. ++|.+++....  .+++..+..++.||+.||+|||+++++||||+|+|||++.++.++|+|||++....... ..
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9995 68999998765  78999999999999999999999999999999999999999999999999997653322 22


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---------------------
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---------------------  437 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---------------------  437 (628)
                      ....++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+.++...                     
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            33457889999998866555789999999999999999999999766544333332110                     


Q ss_pred             ------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          438 ------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       438 ------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                            .........++.++.+||.+||+.||++||+++||++|+||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                  00011234577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.5e-41  Score=350.06  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=206.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEE--EEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMC--AIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v--AvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~  294 (628)
                      .+++|++.+.||+|+||.||+|+++.++..+  |+|.++.    ........++.+|+.+|.++ +|+||+++++++.++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            4678999999999999999999998887654  6665542    12234456788999999999 899999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH  358 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~  358 (628)
                      +.+|+||||+.+++|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+||||+.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999997543                47889999999999999999999999999999999999999


Q ss_pred             CCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCC
Q 040472          359 GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNS  437 (628)
Q Consensus       359 g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~  437 (628)
                      +.+||+|||++.............++..|+|||++.+. .++.++|||||||++|||++ |..||......+....+...
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            99999999998643221111122346679999988654 48999999999999999998 99999765554444433322


Q ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       438 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                       .....+..++.++.+||.+||+.+|++||++++++.+
T Consensus       240 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1223455678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-41  Score=346.31  Aligned_cols=250  Identities=26%  Similarity=0.459  Sum_probs=210.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .++|.+.+.||+|+||.||+|.+.     .+++.||||+++..    ...+..+.+.+|+++|+.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            457899999999999999999874     34688999988642    223345788999999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG--------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG  359 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~--------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g  359 (628)
                      ....++||||+.|++|.++|...+              .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            999999999999999999997543              478889999999999999999999999999999999999999


Q ss_pred             CEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhc
Q 040472          360 EIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIG  435 (628)
Q Consensus       360 ~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~  435 (628)
                      .+||+|||+++......   ......+++.|+|||++.+. .++.++|||||||++|||++ |..||........+..+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999997543221   11233467889999998765 48999999999999999998 999998766555554444


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      . ......+..++.++.+||++||+.||++||++.||++
T Consensus       239 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 Q-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             c-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3 2333455678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2e-41  Score=358.79  Aligned_cols=257  Identities=28%  Similarity=0.499  Sum_probs=211.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----cc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----DE  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----~~  295 (628)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.....   .....+.+.+|+.+|++++|+||+++++++..    ..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            689999999999999999999999999999998864322   12335667789999999999999999998763    35


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            6899999995 689999988788999999999999999999999999999999999999999999999999999765332


Q ss_pred             c-----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC--------------
Q 040472          376 A-----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--------------  436 (628)
Q Consensus       376 ~-----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~--------------  436 (628)
                      .     ......|+..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+..              
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            1     112457899999999987655689999999999999999999999976543222111100              


Q ss_pred             ----------CCCC-----CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          437 ----------SKDI-----PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       437 ----------~~~~-----~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                ....     ..+...++.++.+||++||+.+|++||++.+++.||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence                      0000     0112457899999999999999999999999999999964

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-41  Score=347.63  Aligned_cols=264  Identities=30%  Similarity=0.492  Sum_probs=218.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      +|++.+.||+|+||.||+|++.   .+|+.||+|+++.... .......+++.+|+++|+++ +|+||+.+++++..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            4889999999999999999874   4789999999864211 11223346678899999999 49999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|+||||+.+++|.+++.....+++..+..++.||+.||+|||++||+||||+|+|||++.++.+||+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998654322


Q ss_pred             --ccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCCCCCCcCCHH
Q 040472          377 --SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                        ......|+..|+|||++.+. ..++.++|||||||++|+|++|..||.....   ...+.+.... ..+.++..++..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL  238 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHH
Confidence              22346689999999998643 2478899999999999999999999964321   1222222111 223456678899


Q ss_pred             HHHHHHHHhhcCCCCCC-----CHHHHhcCccccchHHHhh
Q 040472          451 AKSFIKQCLQRDPSARP-----PASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~  486 (628)
                      +.+||++||+.||++|+     ++++++.||||....|...
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence            99999999999999997     8999999999998887654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6e-41  Score=338.54  Aligned_cols=253  Identities=33%  Similarity=0.611  Sum_probs=214.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|.+.+.||+|+||.||+|.++.++..||+|.+.....   .....+.+.+|+++++.++|+||+++++.+.++...|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM---PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc---cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            58899999999999999999999999999999865221   112345677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC-EEEeccCCcccccCccc
Q 040472          301 LEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE-IKLADFGMAKHMTSCAS  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~-vKL~DFGla~~~~~~~~  377 (628)
                      |||+.+++|.+++.+..  .+++..+..++.||+.||+|||+++|+|+||||+|||++.++. +||+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999999997643  5799999999999999999999999999999999999988864 69999999976544322


Q ss_pred             -cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          378 -MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                       .....|++.|+|||++.+. .++.++|||||||++|||++|..||........+..+... ....+...++.++.++|.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-YFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-cCCCCCCCCCHHHHHHHH
Confidence             2234589999999988654 4889999999999999999999999876555544444332 233455568899999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +||..+|++||++.+|++||||
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         236 QLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.2e-41  Score=347.37  Aligned_cols=260  Identities=23%  Similarity=0.389  Sum_probs=210.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|++.++||+|+||.||+|.++.     .+..||||.++...    .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34689999999999999999997642     35589999875321    1222345778999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEE
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEYG----------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~~----------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vK  362 (628)
                      +.+..|+||||+.+|+|.+++...+          .+....+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532          245678889999999999999999999999999999999999999


Q ss_pred             EeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCC
Q 040472          363 LADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSK  438 (628)
Q Consensus       363 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~  438 (628)
                      |+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|||++ |..||......+....+.. .
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~  237 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-G  237 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence            999999975433211   1123456789999998654 48999999999999999998 7899987655444333332 2


Q ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc------CccccchHH
Q 040472          439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD------HPFVRDQAV  483 (628)
Q Consensus       439 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~------Hpwf~~~~~  483 (628)
                      .....+..++.++.+||.+||+.||++||++.++++      ||||+++.|
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            233455667899999999999999999999999986      899987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.3e-41  Score=349.32  Aligned_cols=257  Identities=27%  Similarity=0.458  Sum_probs=204.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      .+++|++.++||+|+||.||+|++..+++.||||++......   ......+.+|++++++++||||+++++++....  
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            467899999999999999999999999999999988643211   112234567999999999999999999877654  


Q ss_pred             ------cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          296 ------RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       296 ------~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                            ..++||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                  3599999996 4788877654 3789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcc-----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHH---hhhcCCC--
Q 040472          369 AKHMTSCA-----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSK--  438 (628)
Q Consensus       369 a~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~---~~i~~~~--  438 (628)
                      +..+....     ......++..|+|||++.+...++.++|||||||++|||++|+.||...+.....   ..+....  
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            97653321     1123457889999999876555788999999999999999999999765432221   1111000  


Q ss_pred             ---------------CCCC---------C-CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 ---------------DIPE---------I-PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ---------------~~~~---------~-p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                     ..+.         + +...+..+.+||.+||..||++||+++++|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                           0000         0 11135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.4e-41  Score=345.13  Aligned_cols=252  Identities=25%  Similarity=0.453  Sum_probs=209.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .+++|++.+.||+|+||+||+|.+    ..+++.||+|.++..    ...+....+.+|+.+|++++|+||+++++++..
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   78 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ   78 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence            357899999999999999999985    345678999988632    223445678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY-----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD  356 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~-----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld  356 (628)
                      ....|+||||+.+++|.+++...                 ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~  158 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence            99999999999999999998532                 2478888999999999999999999999999999999999


Q ss_pred             CCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHh
Q 040472          357 PHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIF  432 (628)
Q Consensus       357 ~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~  432 (628)
                      .++.+||+|||+++......   ......++..|+|||++.+. .++.++|||||||++|||++ |..||..........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999997653321   22334467789999998654 48999999999999999998 999997755433333


Q ss_pred             hhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       433 ~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+. .......+..++.++.++|.+||+.||++||++.+|+++
T Consensus       238 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            333 233344567789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-40  Score=344.15  Aligned_cols=255  Identities=34%  Similarity=0.618  Sum_probs=208.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--ccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--ERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~~~  297 (628)
                      ++|+..+.||.|+||.||+|.+..+++.||+|.+.....    .....++.+|+++|++++|+||+++++++.+.  ..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            368999999999999999999999999999998864221    23456788999999999999999999988653  478


Q ss_pred             eEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      |+||||+.|++|.+++..    ...+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999999988753    3568999999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc----h-hHHHhhhcCCCCCCCCC----
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE----G-VAAIFKIGNSKDIPEIP----  444 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~----~-~~~~~~i~~~~~~~~~p----  444 (628)
                      ... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||....    . .+....+... ..+.++    
T Consensus       157 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (287)
T cd06621         157 NSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPG  233 (287)
T ss_pred             ccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCC
Confidence            322 1235688899999998654 48999999999999999999999997641    1 1222222211 111111    


Q ss_pred             --CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          445 --EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       445 --~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                        ..++.++.+||.+||+.+|.+||++.||++|+||+..
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence              2356789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.1e-41  Score=343.70  Aligned_cols=254  Identities=40%  Similarity=0.753  Sum_probs=217.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      -|++.+.||.|+||.||+|.+..+++.||||++....    .....+.+.+|+.++++++|+||+++++++..++.+|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            4778899999999999999999999999999875321    123456788999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      |||+.+++|.+++.. +.+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... ...
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            999999999999875 568999999999999999999999999999999999999999999999999987654322 223


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ...++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.. ...+.+...++.++.++|.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHc
Confidence            35689999999998654 488899999999999999999999987655444443322 2334566678899999999999


Q ss_pred             hcCCCCCCCHHHHhcCccccch
Q 040472          460 QRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +.+|.+||++.++++|+||.+.
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-40  Score=344.91  Aligned_cols=253  Identities=32%  Similarity=0.581  Sum_probs=213.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|...+.||+|+||.||++.+..+++.||||++...     .....+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            455567999999999999999999999999988532     122345678899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      |||+.|++|.+++.. +.+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++....... ...
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            999999999999987 679999999999999999999999999999999999999999999999999887543321 223


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...|+..|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+..... ....+..++..+.+||++|
T Consensus       174 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            35689999999998654 489999999999999999999999977655444444332211 1112234788999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccc
Q 040472          459 LQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |+.+|++||++.++++|+||+.
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             cccChhhCcCHHHHccCccccc
Confidence            9999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=335.69  Aligned_cols=244  Identities=28%  Similarity=0.470  Sum_probs=210.4

Q ss_pred             eeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      +.||+|+||.||+|.+...   +..||||++.....    ....+.+.+|+++++.++|+||+++++++.+...+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS----EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc----hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4699999999999999865   89999999864322    1246778899999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          303 YVSGGSIHKLLQEY---------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       303 y~~GgsL~~~L~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      |+.+++|.+++...         ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999875         789999999999999999999999999999999999999999999999999998765


Q ss_pred             Ccc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          374 SCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       374 ~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...   ......++..|+|||.+... .++.++|||||||++|||++ |..||...........+.. ......+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCh
Confidence            432   22345578899999998655 58999999999999999999 6999988765555555543 233455677899


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++.++|.+||+.+|++||++.|++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.1e-41  Score=359.03  Aligned_cols=252  Identities=26%  Similarity=0.442  Sum_probs=204.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeeccee
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSEL  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~  292 (628)
                      .++|+++++||+|+||.||+|++.     .+++.||||+++...    .....+.+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            358999999999999999999753     345789999886321    123456778899999999 7999999999876


Q ss_pred             c-cccceEEEEecccccHHHHHHhc-------------------------------------------------------
Q 040472          293 S-DERLSVYLEYVSGGSIHKLLQEY-------------------------------------------------------  316 (628)
Q Consensus       293 ~-~~~~~lVmEy~~GgsL~~~L~~~-------------------------------------------------------  316 (628)
                      . +..++++|||+.+++|.++|...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            5 46788999999999999998542                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc---cccccCCCCc
Q 040472          317 ------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYW  387 (628)
Q Consensus       317 ------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y  387 (628)
                            ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....   .....++..|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence                  2578899999999999999999999999999999999999999999999999986533221   2234467789


Q ss_pred             CChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCC
Q 040472          388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR  466 (628)
Q Consensus       388 ~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  466 (628)
                      +|||++.+. .++.++|||||||+||||++ |..||......+.+............+...+.++.+++.+||+.+|++|
T Consensus       242 ~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         242 MAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             cCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            999998765 49999999999999999997 9999976443333333322222334456678999999999999999999


Q ss_pred             CCHHHHhcC
Q 040472          467 PPASKLLDH  475 (628)
Q Consensus       467 pta~eiL~H  475 (628)
                      |++.||++|
T Consensus       321 Ps~~ell~~  329 (337)
T cd05054         321 PTFSELVEI  329 (337)
T ss_pred             cCHHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-41  Score=350.77  Aligned_cols=253  Identities=33%  Similarity=0.575  Sum_probs=213.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|.....||+|+||.||+|.+..+++.||||++.....     ...+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            34455679999999999999999999999999864221     2235678899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      |||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            999999999998765 568999999999999999999999999999999999999999999999999987554322 233


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ..+|+..|+|||++.+. .++.++|||||||++|||++|..||........+..+.... .....+..++.++.++|++|
T Consensus       176 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         176 SLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             ceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            46799999999998654 48999999999999999999999997665555444433221 11223446788999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccc
Q 040472          459 LQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |+.+|++||++.+|++|+||.+
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhcc
Confidence            9999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.5e-41  Score=355.58  Aligned_cols=260  Identities=27%  Similarity=0.470  Sum_probs=211.6

Q ss_pred             CCeE-EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHH---------HHHHHHHHHHHHHhCCCCCeeeeec
Q 040472          220 SKWK-KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE---------CLKQLNQEINLLSQLSHPNIVRYHG  289 (628)
Q Consensus       220 ~~y~-~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~---------~~~~~~~Ei~iL~~l~HpnIV~l~~  289 (628)
                      ++|. +.+.||.|+||+||+|++..+++.||||+++..........         ....+.+|+++|+.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4665 45789999999999999999999999999864322111000         1124678999999999999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                      ++..++.+++||||+. ++|.+++.....+++..+..++.||+.||+|||++||+||||+|+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999996 599999988888999999999999999999999999999999999999999999999999998


Q ss_pred             ccccC---------------ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhh
Q 040472          370 KHMTS---------------CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI  434 (628)
Q Consensus       370 ~~~~~---------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i  434 (628)
                      .....               ........+++.|+|||++.+...++.++|||||||++|||++|.+||...+....+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            75541               111223457889999999876656799999999999999999999999876654433322


Q ss_pred             cCCC--------------------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          435 GNSK--------------------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       435 ~~~~--------------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ....                          .........+.++.+||++||+.+|++||+++|+|.|+||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            1100                          000112345788999999999999999999999999999974

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-40  Score=346.73  Aligned_cols=250  Identities=24%  Similarity=0.432  Sum_probs=206.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCc--EEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQ--MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      ++|++.++||+|+||.||+|+++.++.  .+++|.++...    .....+.+.+|++++.++ +||||+++++++.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            589999999999999999999887765  46888775321    233456788999999999 69999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC
Q 040472          297 LSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE  360 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~  360 (628)
                      +|+||||+.+++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            999999999999999997532                4788999999999999999999999999999999999999999


Q ss_pred             EEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCC
Q 040472          361 IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       361 vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +||+|||++..............+..|+|||++.+. .++.++|||||||++|||++ |..||..........++.... 
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence            999999998643221111222235579999988654 48999999999999999997 999998766555444443322 


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+..++.++.+||.+||+.+|.+||++++|++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            234566789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.4e-41  Score=340.24  Aligned_cols=253  Identities=31%  Similarity=0.585  Sum_probs=209.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++.+.||+|+||.||+|++..+++.||||.+....  ........++.+|+.+++.++|+||+++++++..++..+
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   78 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN   78 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence            357899999999999999999999999999999876422  122334567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          299 VYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +||||+.|++|.+++..    ...+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999999874    34689999999999999999999999999999999999999999999999999876543


Q ss_pred             cc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-hHHH-hhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAI-FKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~-~~i~~~~~~~~~p~~~s~~l  451 (628)
                      .. .....+|+..|+|||++.+. .++.++|||||||++|+|++|..||..... ...+ ..+......+..+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            22 22345789999999998654 488999999999999999999999965332 1122 22222222222334578899


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||.+||+.||++|||+.+|++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-41  Score=355.32  Aligned_cols=257  Identities=28%  Similarity=0.503  Sum_probs=216.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc-----
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE-----  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~-----  295 (628)
                      +|++.+.||+|+||.||+|++..+++.||||++.....   .....+.+.+|+.+|+.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            58999999999999999999999999999998864321   1334567889999999999999999999988875     


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|+||||+. ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            7999999997 589999988789999999999999999999999999999999999999999999999999999876543


Q ss_pred             c----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------------
Q 040472          376 A----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------------  439 (628)
Q Consensus       376 ~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------------  439 (628)
                      .    ......++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+.....            
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            2    233456899999999987664689999999999999999999999977654433332221110            


Q ss_pred             -----------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          440 -----------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       440 -----------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                       ...+...++.++.+||++||+++|++||+++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                             011123468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.4e-41  Score=347.58  Aligned_cols=256  Identities=35%  Similarity=0.618  Sum_probs=215.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||+|+||.||++.+..+++.||+|++....     ....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            478999999999999999999999899999999885321     122456788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      +||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999999999876 458899999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  456 (628)
                      .....|++.|++||.+.+. .++.++|||||||++|+|++|+.||........+..+.... .....+..++..+.+||+
T Consensus       172 ~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             cccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            2345689999999998654 48999999999999999999999998655444333322211 111223457889999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccch
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||+.+|++||++.+++.|+||+..
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcC
Confidence            9999999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-40  Score=344.28  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=209.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ..+|.+.+.||+|+||.||++.+     ..++..||+|.++..     .....+.+.+|+++|++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            35799999999999999999985     335667999987532     23445678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG-------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE  360 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~-------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~  360 (628)
                      .+.+++||||+.+++|.++|...+             .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999997543             4899999999999999999999999999999999999999999


Q ss_pred             EEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcC
Q 040472          361 IKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGN  436 (628)
Q Consensus       361 vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~  436 (628)
                      +||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+..+..
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999976533221   1223457789999998654 58999999999999999998 9999987665555555544


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       437 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .. ....+..++.++.+||.+||+.||.+||++.++++
T Consensus       238 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33 23455668899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=338.61  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .++|++.+.||+|+||.||+|.++..     +..||||.+...    ........+.+|+.+|+.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            46899999999999999999987643     488999987532    112334567889999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEE
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG----------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~----------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL  363 (628)
                      ....++||||+.+++|.+++....          .+.+..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999996532          3677889999999999999999999999999999999999999999


Q ss_pred             eccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCC
Q 040472          364 ADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       364 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +|||+++.+....   ......++..|+|||++.+. .++.++|||||||++|||++ |..||...........+. ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence            9999997653322   12234567899999998654 48999999999999999998 999998765544444443 333


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...++..++.++.+||.+||+.+|++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            44566778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-40  Score=337.10  Aligned_cols=243  Identities=26%  Similarity=0.426  Sum_probs=201.7

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      +.||+|+||.||+|+++.+++.||+|.+...    ...+....+.+|+++|++++|+||+++++++.....+|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            3699999999999999999999999987532    223445678899999999999999999999999999999999999


Q ss_pred             cccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc---ccc
Q 040472          306 GGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSF  381 (628)
Q Consensus       306 GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~---~~~  381 (628)
                      +++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........   ...
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999999764 46899999999999999999999999999999999999999999999999998754322111   011


Q ss_pred             cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhh
Q 040472          382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ  460 (628)
Q Consensus       382 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  460 (628)
                      .++..|+|||.+.+. .++.++|||||||++|||++ |..||...........+... .....+..++..+.+||++||+
T Consensus       157 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         157 QIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcccCCHHHHHHHHHHcC
Confidence            234569999998654 48999999999999999997 99999765544333333222 2234556788999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 040472          461 RDPSARPPASKLLD  474 (628)
Q Consensus       461 ~dP~~Rpta~eiL~  474 (628)
                      .+|++||++.+|++
T Consensus       235 ~~p~~Rps~~~~~~  248 (252)
T cd05084         235 YDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8e-41  Score=347.48  Aligned_cols=256  Identities=29%  Similarity=0.512  Sum_probs=204.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      +++|++.++||+|+||.||+|+++.+++.||||++.......   .....+.+|+++|++++|+||+++++++....   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            679999999999999999999999999999999986532211   11234568999999999999999999875433   


Q ss_pred             -----cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          296 -----RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       296 -----~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                           .+|+||||+.+ +|...+.. ...+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                 46999999965 67666654 457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcc------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC
Q 040472          370 KHMTSCA------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS  437 (628)
Q Consensus       370 ~~~~~~~------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~  437 (628)
                      +......            ......+++.|+|||++.+...++.++|||||||++|||++|.+||...........+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            7543221            1123457889999999876556899999999999999999999999765543322221100


Q ss_pred             C------------CCC---------CC-------CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          438 K------------DIP---------EI-------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       438 ~------------~~~---------~~-------p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .            ..+         ..       ...+..++.+||++||+.||++||++.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            0            000         00       12345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-40  Score=343.19  Aligned_cols=251  Identities=28%  Similarity=0.414  Sum_probs=207.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCC----------------cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESG----------------QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP  282 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg----------------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp  282 (628)
                      .++|++++.||+|+||.||+|.+..++                ..||+|.+....    .....+.+.+|+++|++++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCC
Confidence            468999999999999999999876544                557999876422    234567788999999999999


Q ss_pred             CeeeeecceeccccceEEEEecccccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCC
Q 040472          283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-----------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGA  351 (628)
Q Consensus       283 nIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~-----------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpe  351 (628)
                      ||+++++++..+...++||||+.+++|.+++.+..           .+++..++.++.||+.||+|||+++|+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999998765           6899999999999999999999999999999999


Q ss_pred             ceEeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc--CCCCCCCCc
Q 040472          352 NILVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYE  426 (628)
Q Consensus       352 NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt--G~~PF~~~~  426 (628)
                      |||++.++.++|+|||+++......   ......++..|+|||++.+. .++.++|||||||++|||++  +..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999999999999999987653322   12234567889999998654 48999999999999999988  788887655


Q ss_pred             hhHHHhhhcCC------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          427 GVAAIFKIGNS------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       427 ~~~~~~~i~~~------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ....+..+...      ......+..++.++.+||.+||+.||++||++.||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            44443333221      1112234457789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.2e-41  Score=347.20  Aligned_cols=257  Identities=30%  Similarity=0.514  Sum_probs=209.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      .+++|++.+.||+|+||.||+|.++.+++.||||+++.....   ......+.+|++++++++||||+++++++.+..  
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            467899999999999999999999999999999998753221   112345678999999999999999999887655  


Q ss_pred             --------cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEecc
Q 040472          296 --------RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       296 --------~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DF  366 (628)
                              .+++||||+.+ +|..++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    79999999976 67666664 357899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCcc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---C---
Q 040472          367 GMAKHMTSCA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---K---  438 (628)
Q Consensus       367 Gla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---~---  438 (628)
                      |++.......  ......++..|+|||++.+...++.++|||||||++|||++|++||...+....+..+...   .   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9998654332  1222346788999998865555789999999999999999999999765544333222110   0   


Q ss_pred             CCC----------------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 DIP----------------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 ~~~----------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ..+                      .....++..+.+||.+||+.||.+||++.+|+.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            000                      1123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-40  Score=341.64  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=207.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+....    .......+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4679999999999999999999987     77889999875322    12334567889999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---CEEE
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG-------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKL  363 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~vKL  363 (628)
                      .+..++||||+.|++|.+++.+.+       .+++..+..++.||+.||+|||+++++||||||+|||++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999999997653       488999999999999999999999999999999999998765   5999


Q ss_pred             eccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCC
Q 040472          364 ADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       364 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +|||+++.......   ......+..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.. ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GG  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CC
Confidence            99999986532211   11222356799999987654 9999999999999999997 9999987554443333322 22


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+..++..+.+||.+||+.+|++||++.+|++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            334566788999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-40  Score=336.59  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|.++. +..+|+|.++....      ...++.+|+++|+.++|+||+++++++...+.++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            4579999999999999999998764 56799998753211      1246778999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+|+.++.+||+|||+++.......
T Consensus        76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            99999999999999975 45689999999999999999999999999999999999999999999999999976533221


Q ss_pred             c--ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          378 M--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       378 ~--~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      .  ....++..|+|||++.+. .++.++|||||||++|||++ |+.||........+..+.... ....+...+.++.+|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~l  233 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEV  233 (256)
T ss_pred             eccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHH
Confidence            1  222356689999998654 58999999999999999999 999998776665555554432 233455678899999


Q ss_pred             HHHHhhcCCCCCCCHHHHhc
Q 040472          455 IKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~  474 (628)
                      |.+||+.+|++||++.+|++
T Consensus       234 i~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         234 MYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-40  Score=341.36  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=205.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .++|++.+.||+|+||.||+|++..     ++..||||++....    ......++.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4689999999999999999998642     45679999875321    12234568899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEE
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG----------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~----------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL  363 (628)
                      +...++||||+.+++|.+++....          .+++..+..++.|++.||+|||+++++||||||+||||+.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999997532          3567788999999999999999999999999999999999999999


Q ss_pred             eccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCC
Q 040472          364 ADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       364 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +|||+++.......   .....+++.|+|||++.+. .++.++|||||||++|||++ |..||........+..+. ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG  238 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            99999875432211   1123457789999998654 48999999999999999999 789997765443333332 233


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+..++..+.+||.+||+.||++||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            345566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=337.63  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=205.2

Q ss_pred             eEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc--
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER--  296 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~--  296 (628)
                      |++++.||+|+||.||+|.+..+   +..||||.++...   ........+.+|+.+|+.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            57889999999999999987653   4789999886422   223445678899999999999999999998766544  


Q ss_pred             ----ceEEEEecccccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEecc
Q 040472          297 ----LSVYLEYVSGGSIHKLLQEY------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       297 ----~~lVmEy~~GgsL~~~L~~~------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DF  366 (628)
                          .++||||+.+++|..++...      ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                79999999999999998532      35899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCcccc---ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCC
Q 040472          367 GMAKHMTSCASM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE  442 (628)
Q Consensus       367 Gla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~  442 (628)
                      |+++.+......   ....++..|+|||++.+. .++.++|||||||++|||++ |..||........+..+... ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence            999865432211   112356789999998554 58999999999999999999 99999876655554444433 3345


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+..++.++.++|.+||+.||++||++.|++++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            667789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.4e-41  Score=353.50  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=204.4

Q ss_pred             eeeccC--CcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          226 KLLGRG--TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       226 ~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      ..||+|  +||+||+|++..+++.||||++.....   ..+..+.+.+|+.+++.++|+||++++++|..++.+++||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456776  999999999999999999999864322   234457889999999999999999999999999999999999


Q ss_pred             cccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc----
Q 040472          304 VSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS----  377 (628)
Q Consensus       304 ~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~----  377 (628)
                      +.+++|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+........    
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999999864  3589999999999999999999999999999999999999999999999986543211110    


Q ss_pred             ----cccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC------------
Q 040472          378 ----MLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI------------  440 (628)
Q Consensus       378 ----~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~------------  440 (628)
                          .....++..|+|||++.+. ..++.++|||||||++|||++|..||........+.........            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                0112356679999998653 34789999999999999999999999765443333222111000            


Q ss_pred             ---------------------------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          441 ---------------------------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       441 ---------------------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                                                       ...+..++..+.+||++||+.||++|||+.|+|+|+||+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                             0112235678999999999999999999999999999976644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-40  Score=383.46  Aligned_cols=150  Identities=34%  Similarity=0.586  Sum_probs=138.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|+++++||+|+||+||+|++..+++.||||+++...  ........++.+|+.++..++|+||+++++++.....+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh--ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            678999999999999999999999999999999986432  123445677889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      |||||+.|++|.++|...+.+++..++.|+.||+.||+|||.++||||||||+||||+.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-40  Score=332.95  Aligned_cols=252  Identities=35%  Similarity=0.545  Sum_probs=217.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|++.+.||+|+||.||++.+..+++.||||++.....   .......+.+|+++++.++|+||+++++++.+....|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc---cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            58899999999999999999999999999999864322   123345677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          301 LEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |||+.+++|.+++.+    ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999999876    356899999999999999999999999999999999999999999999999999876544 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+.......+. ....+.++..++.++.++|.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHH
Confidence            23345688999999998654 48889999999999999999999998766544333333 33445566678899999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +||+.+|++||++.++++||++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=379.12  Aligned_cols=247  Identities=27%  Similarity=0.475  Sum_probs=204.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeec-ceec----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHG-SELS----  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~-~~~~----  293 (628)
                      .++++.+.|.+|||+.||+|++...+..||+|.+-..     +++.++.+.+||.+|++|+ |+|||.+++ ....    
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            4678899999999999999999988899999987542     4667888999999999998 999999999 3322    


Q ss_pred             --cccceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCCEEEeccC
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                        .-.++|.||||.||.|-+++..  ...|+|.++++|++|+++|+++||...  |||||||-|||||+.+|+.||||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence              1357889999999999999984  356999999999999999999999998  9999999999999999999999999


Q ss_pred             CcccccCcc-cc---------ccccCCCCcCChhhhh--ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc
Q 040472          368 MAKHMTSCA-SM---------LSFKGSPYWMAPEVVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG  435 (628)
Q Consensus       368 la~~~~~~~-~~---------~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~  435 (628)
                      .|....... ..         ....-|+-|+|||+|-  +...+++|+|||||||+||.||+...||+.......+   .
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl---n  268 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL---N  268 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---e
Confidence            986432211 00         1123689999999973  3445899999999999999999999999875332221   1


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+|.. +.++..+++||+.||+.||++||++.|++.+
T Consensus       269 g~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  269 GNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            22334444 3688999999999999999999999999865

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-40  Score=337.16  Aligned_cols=248  Identities=25%  Similarity=0.414  Sum_probs=209.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|.+.+.||+|+||.||+|.++.+++.||+|+++..      ......+.+|+++|+.++|+||+++++++..+..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            45789999999999999999999999999999987531      122456788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++...  ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999999753  358899999999999999999999999999999999999999999999999998654322


Q ss_pred             cc--ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 SM--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~~--~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      ..  ....++..|+|||++.+. .++.++|||||||++|||++ |..||...+.......+.. ......+..++.++.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  236 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHH
Confidence            11  122346679999988654 48999999999999999998 9999987555444344332 2234556778999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhc
Q 040472          454 FIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ||.+||+.||++||++.++++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-40  Score=363.27  Aligned_cols=252  Identities=24%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~  291 (628)
                      ..++|+++++||+|+||.||+|.+...     +..||||+++...    .....+.+.+|+++|+++. |||||++++++
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            456899999999999999999986433     4579999886422    1233467889999999996 99999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhc-------------------------------------------------------
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEY-------------------------------------------------------  316 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~-------------------------------------------------------  316 (628)
                      .+...+|||||||.+|+|.++|.+.                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999988642                                                       


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe
Q 040472          317 -----------------------------------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV  355 (628)
Q Consensus       317 -----------------------------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl  355 (628)
                                                               ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     236778889999999999999999999999999999999


Q ss_pred             CCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHH
Q 040472          356 DPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAI  431 (628)
Q Consensus       356 d~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~  431 (628)
                      +.++.+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|||++ |..||........+
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            9999999999999986533221   2234567889999998654 48999999999999999997 99999765443333


Q ss_pred             hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       432 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ............+..++.++.+||.+||+.||++||++.+|.+
T Consensus       350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3332222233455678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=341.21  Aligned_cols=253  Identities=32%  Similarity=0.540  Sum_probs=209.5

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--ccceE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--ERLSV  299 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~~~~l  299 (628)
                      |++.+.||.|+||.||+|.+..+++.||||++....   ........+.+|++++++++|+||+++++++.+.  +..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            678899999999999999999999999999997543   1123345677899999999999999999999988  89999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--  376 (628)
                      ||||+.+ +|.+++... ..+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++.......  
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9999975 898888765 579999999999999999999999999999999999999999999999999998664432  


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC------CCC---------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK------DIP---------  441 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~------~~~---------  441 (628)
                      ......++..|+|||.+.+...++.++|||||||++|||++|..||...+....+..+....      .++         
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            22334578899999987665568999999999999999999999998765443332221100      000         


Q ss_pred             --------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          442 --------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       442 --------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                                    .+...++.++.++|++||..+|++||++.++++|+||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          0111138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.4e-40  Score=334.06  Aligned_cols=251  Identities=31%  Similarity=0.611  Sum_probs=209.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++....  ......+++.+|++++++++|+||+++++++..++..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            589999999999999999999999999999998864221  223335678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          300 YLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ||||+.+++|..++..    ...+++..+..++.||+.||+|||+.||+||||+|+|||++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999999864    345899999999999999999999999999999999999999999999999998765432


Q ss_pred             c-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-h-HHHhhhcCCCCCCCCCC-cCCHHH
Q 040472          376 A-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-V-AAIFKIGNSKDIPEIPE-HLSDDA  451 (628)
Q Consensus       376 ~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~-~~~~~i~~~~~~~~~p~-~~s~~l  451 (628)
                      . ......++..|+|||++.+. .++.++|||||||++|+|++|..||..... . .....+.. ...+..+. .++.++
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEEL  237 (267)
T ss_pred             CcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHH
Confidence            2 22345689999999998654 489999999999999999999999965331 1 12222222 22223333 678899


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .++|.+||..+|++||++.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-40  Score=352.90  Aligned_cols=254  Identities=26%  Similarity=0.483  Sum_probs=206.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-----  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-----  294 (628)
                      .+|++.+.||.|+||.||+|+++.+++.||||++.....     ...+.+.+|+++|+.++|+||+++++++...     
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            689999999999999999999999999999998864321     3346788899999999999999999876654     


Q ss_pred             ---------ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEe
Q 040472          295 ---------ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLA  364 (628)
Q Consensus       295 ---------~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~  364 (628)
                               ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                     35789999996 589888864 57899999999999999999999999999999999999975 4578999


Q ss_pred             ccCCcccccCcc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--
Q 040472          365 DFGMAKHMTSCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--  438 (628)
Q Consensus       365 DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--  438 (628)
                      |||++.......    ......++..|+|||++.....++.++|||||||++|+|++|+.||...........+....  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999997653221    11224578899999988665568899999999999999999999997655433332221100  


Q ss_pred             ---------------------CCC-----CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          439 ---------------------DIP-----EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       439 ---------------------~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                           ...     .+...++.++.+||++||+.||++||++.+||.|+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                                 000     112357889999999999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-40  Score=348.51  Aligned_cols=250  Identities=28%  Similarity=0.444  Sum_probs=205.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcE----EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..+|++.+.||+|+||.||+|++..+++.    ||||+++..    ......+++.+|+.+++.++|+||+++++++..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            35899999999999999999998766664    888887532    2234456788999999999999999999998764


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                       ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999999864 468899999999999999999999999999999999999999999999999998765


Q ss_pred             Ccccc---ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          374 SCASM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       374 ~~~~~---~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      .....   ....++..|+|||++.+. .++.++|||||||++|||++ |..||....... +..+.........+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  238 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTI  238 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCH
Confidence            43322   123346789999998654 48999999999999999987 999998754433 2232222222334456788


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++.++|.+||+.||++||++.+|+.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=336.73  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=209.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|++.+.||+|+||+||+|+++.+   ...||||+++...    .......+.+|+.+|++++|+||+++++++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            35799999999999999999988654   4579999876422    2334466888999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..++||||+.+++|.+++... +.+++..+..++.|++.||+|||+++|+||||||+||||+.++.++|+|||+++....
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999999999764 5789999999999999999999999999999999999999999999999999987642


Q ss_pred             -cccc--ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          375 -CASM--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       375 -~~~~--~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                       ....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+.... ....+..++..
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPPPMDCPSA  236 (266)
T ss_pred             cccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence             1111  122356789999998654 58999999999999999998 999997766555554444322 22345568899


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.+||.+||+.+|++||++.+|+++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=338.69  Aligned_cols=252  Identities=29%  Similarity=0.509  Sum_probs=206.0

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeecceecccc--
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSELSDER--  296 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~~~~~--  296 (628)
                      |++.+.||+|+||.||+|+++.+++.||||+++.....   ......+.+|+.+++++   .|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            67899999999999999999989999999998753322   12223455677777666   59999999999988777  


Q ss_pred             ---ceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          297 ---LSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       297 ---~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                         ++++|||+.+ +|.+++....  .+++..++.++.||+.||+|||+++|+|+||+|+|||++.++.+||+|||++..
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               9999999975 8998887643  589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD------------  439 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~------------  439 (628)
                      ...........++..|+|||++.+. .++.++|||||||++|+|++|.+||......+.+.++.....            
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            6554444445688999999998765 489999999999999999999999987655443333321100            


Q ss_pred             -----C--------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          440 -----I--------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       440 -----~--------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                           .        ......++..+.+||.+||+.||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 0        00112356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-40  Score=342.93  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=209.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      +.+|++.+.||+|+||.||+|.+..+     ++.||||+++...    .......+.+|+.++..++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            46788999999999999999987543     5789999886322    23345678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP  357 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~  357 (628)
                      ....++++||+.+++|.+++...                ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999999999998532                34788889999999999999999999999999999999999


Q ss_pred             CCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhh
Q 040472          358 HGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFK  433 (628)
Q Consensus       358 ~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~  433 (628)
                      ++.+||+|||+++.......   .....+++.|+|||++.+. .++.++|||||||++|||++ |..||........+..
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999886533221   1233467899999998654 48999999999999999998 8899987665554444


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.... ...++..++.++.+||.+||+.+|++||++.+|+..
T Consensus       239 i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            44333 334566789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.7e-40  Score=335.76  Aligned_cols=242  Identities=26%  Similarity=0.396  Sum_probs=202.6

Q ss_pred             eeccCCcEEEEEEEE--CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          227 LLGRGTFGHVYLGFN--SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      .||+|+||.||+|.+  ..+++.||||+++...   ......+.+.+|+.+|+.+.|+||+++++++. ++..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            599999999999964  5678899999886432   22345677889999999999999999999875 55779999999


Q ss_pred             ccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc----ccc
Q 040472          305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS----MLS  380 (628)
Q Consensus       305 ~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~----~~~  380 (628)
                      .+++|.+++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++.......    ...
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999999998888899999999999999999999999999999999999999999999999999976543221    112


Q ss_pred             ccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ..++..|+|||++... .++.++|||||||++|||++ |..||...........+.. ...+..+..++.++.+||.+||
T Consensus       158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         158 GKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHh
Confidence            2346789999988544 48899999999999999997 9999987655544444443 3334567789999999999999


Q ss_pred             hcCCCCCCCHHHHhc
Q 040472          460 QRDPSARPPASKLLD  474 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~  474 (628)
                      +.||++||++.+|..
T Consensus       236 ~~~p~~Rp~~~~i~~  250 (257)
T cd05116         236 TYGVDERPGFAVVEL  250 (257)
T ss_pred             ccCchhCcCHHHHHH
Confidence            999999999999854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.2e-40  Score=340.42  Aligned_cols=252  Identities=23%  Similarity=0.437  Sum_probs=208.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++.+.||+|+||.||++.+...     ...||+|.+....    ..+...++.+|+.+++++ +|+||+++++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            346899999999999999999987643     3789999886321    123346688999999999 799999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV  355 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl  355 (628)
                      ..+..+++||||+.+++|..++++.                ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            9999999999999999999999642                458899999999999999999999999999999999999


Q ss_pred             CCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHH
Q 040472          356 DPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAI  431 (628)
Q Consensus       356 d~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~  431 (628)
                      +.++.+||+|||+++.+.....   .....++..|+|||++.+. .++.++|||||||++|||++ |..||.........
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            9999999999999986543221   1222356789999998654 48999999999999999997 99999876554444


Q ss_pred             hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       432 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ..+.. ......+...+.++.+||.+||..||++||++.+++++
T Consensus       245 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33333 22334566788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.9e-40  Score=336.65  Aligned_cols=255  Identities=32%  Similarity=0.602  Sum_probs=213.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      +|.+.+.||+|+||.||++++..++..+++|+++.............++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58899999999999999999988888888888764332222223345577899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          301 LEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |||+.+++|.+++.+    ...+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeecCCCc
Confidence            999999999998864    35689999999999999999999999999999999999997 4679999999987654322


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       ......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.. ...+..+..++.++.++|
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             ccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHHHH
Confidence             23345689999999988654 488899999999999999999999987655555544433 334455667889999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      .+||..+|++||++.+|++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.1e-40  Score=345.85  Aligned_cols=257  Identities=37%  Similarity=0.665  Sum_probs=214.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|...+.||+|+||+||+|++..+++.||||++.....  ......+.+.+|+++++.++|+||+++++++.+....|+|
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            36667889999999999999999999999998864322  2234456788899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          301 LEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      |||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....   ..
T Consensus       100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~  175 (313)
T cd06633         100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---AN  175 (313)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CC
Confidence            99996 577777654 46789999999999999999999999999999999999999999999999999865332   23


Q ss_pred             cccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ...|+..|+|||++..  ...++.++|||||||++|+|++|..||...+....+..+............++..+++||.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY  255 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            4568999999999742  34488899999999999999999999987766665555543332222334577889999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccchHH
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ||+.+|++||++.+++.||||+....
T Consensus       256 ~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         256 CLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             HccCChhhCcCHHHHhcCcccCCCch
Confidence            99999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=340.02  Aligned_cols=252  Identities=35%  Similarity=0.594  Sum_probs=209.5

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~lV  300 (628)
                      |++.+.||+|+||.||+|+...+++.||||++......    .......+|+..+++++ |+||+++++++.+++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            67889999999999999999999999999988643221    11223456899999999 99999999999999999999


Q ss_pred             EEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          301 LEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |||+ +++|.+++....  .+++..+..++.||+.+|.|||++||+|+||+|+||+|+.++.++|+|||++.........
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 789999887754  7899999999999999999999999999999999999999999999999999876554444


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-------------------
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-------------------  439 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-------------------  439 (628)
                      ....++..|+|||++.....++.++||||||+++|||++|++||........+.++.....                   
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            4567899999999886655689999999999999999999999976554443332211000                   


Q ss_pred             ---------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          440 ---------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       440 ---------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                               ...+....+.++.+||++||+.||++||++.||+.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                     001112336789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.8e-40  Score=334.70  Aligned_cols=248  Identities=26%  Similarity=0.456  Sum_probs=207.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.++||+|+||.||+|.+. ++..||+|.+....      ...+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3578999999999999999999865 46779999875321      1246788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ++||||+.+++|.+++...  ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999999999753  56889999999999999999999999999999999999999999999999999865432


Q ss_pred             cc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 AS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..  .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+...... .....++.++.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-PRMENCPDELY  234 (261)
T ss_pred             ceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence            21  1223456789999998654 48899999999999999998 99999876655555554433332 23346889999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||.+||..+|++||+++++++
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         235 DIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=369.64  Aligned_cols=254  Identities=34%  Similarity=0.590  Sum_probs=219.3

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc--ceEE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER--LSVY  300 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~--~~lV  300 (628)
                      +...+||+|+|-+||+|.+..+|..||--.++.... ....+.+++|..|+.+|+.|+|+|||++|+++.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHh-hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            445789999999999999999999988655443221 2234567899999999999999999999999988655  8888


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCC-CCCEEEeccCCcccccCccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~-~g~vKL~DFGla~~~~~~~~  377 (628)
                      .|++..|+|+.|+++.+.++...++.|++||+.||.|||.+.  |||||||.+||+|+. .|.|||+|+|||..+.....
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            999999999999999999999999999999999999999985  999999999999975 58999999999998765443


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCC-CCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE-IPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~-~p~~~s~~l~dLI~  456 (628)
                      . ..+|||.|||||++.  ..|+..+||||||++|+||+|+.+||....+..+|++.......|. +..--.+++++||.
T Consensus       202 k-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe  278 (632)
T KOG0584|consen  202 K-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE  278 (632)
T ss_pred             c-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence            3 378999999999985  3599999999999999999999999999888888888766554442 23334689999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccch
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||.. ..+|+++.|+|+|+||...
T Consensus       279 kCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  279 KCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHhcC-chhccCHHHHhhChhhccc
Confidence            99998 9999999999999999764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-40  Score=340.62  Aligned_cols=257  Identities=39%  Similarity=0.686  Sum_probs=218.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ....|++.+.||+|+||.||+|.+..+++.||+|+++....      ....+.+|+++|+.++|+||+++++++..+...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            34678899999999999999999998999999999874322      346678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |+||||+.|++|.+++.... .+++..+..++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999999999876 89999999999999999999999999999999999999999999999999987543321


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC-CCCCcCCHHHHHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP-EIPEHLSDDAKSF  454 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~s~~l~dL  454 (628)
                       ......++..|++||++.+. .++.++|||||||++|+|++|..||...........+....... ..+..++.++.+|
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             hhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence             22345588999999998654 48999999999999999999999998766554444433221111 1223378899999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      |++||+.+|.+||++.+|++|+||+..
T Consensus       250 i~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-40  Score=339.66  Aligned_cols=245  Identities=23%  Similarity=0.400  Sum_probs=201.7

Q ss_pred             CCeEEeeee--ccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          220 SKWKKGKLL--GRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~L--G~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      ++|++.+.+  |+|+||.||+++++.++..||+|++......        .  .|+.+...+ +|+||+++++.+..++.
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            466666665  9999999999999999999999998642111        0  122222222 69999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~~~  375 (628)
                      +|+||||+.+++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            999999999999999998878999999999999999999999999999999999999999988 9999999998765432


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh----HHHhhhcCCCCCCCCCCcCCHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV----AAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                         ....|+..|+|||++.+. .++.++|||||||++|+|++|..||......    ..+....  ......+..++..+
T Consensus       164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  237 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNA  237 (267)
T ss_pred             ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHH
Confidence               234689999999998654 4899999999999999999999999754321    1122222  12223445789999


Q ss_pred             HHHHHHHhhcCCCCCCC-HHHHhcCccccc
Q 040472          452 KSFIKQCLQRDPSARPP-ASKLLDHPFVRD  480 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpt-a~eiL~Hpwf~~  480 (628)
                      .+||.+||+.+|.+|++ +++||+||||++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 699999999963

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-40  Score=341.56  Aligned_cols=268  Identities=29%  Similarity=0.497  Sum_probs=218.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      +|++.+.||+|+||.||+|++.   .+++.||||+++.... .......+++.+|++++.++ +|+||+.+++.+..+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            4889999999999999999863   4678999999864211 12233456788999999999 59999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|+||||+.+++|.+++.....+++..++.++.|++.||+|||+.+++||||||.|||++.++.++|+|||+++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            99999999999999999887889999999999999999999999999999999999999999999999999987653322


Q ss_pred             --ccccccCCCCcCChhhhhccC-CCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCCCCCCcCCHH
Q 040472          377 --SMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                        ......|+..|+|||.+.+.. .++.++||||||+++|||++|..||.....   ...+.+... ...+..+..++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMSAE  238 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccCHH
Confidence              122356899999999985432 368899999999999999999999954221   112211111 1223456678899


Q ss_pred             HHHHHHHHhhcCCCCCCC---HHHHhcCccccchHHHhhcCCC
Q 040472          451 AKSFIKQCLQRDPSARPP---ASKLLDHPFVRDQAVARAGNVN  490 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpt---a~eiL~Hpwf~~~~~~~~~~~~  490 (628)
                      +.+||.+||+.||++|||   +.++|+|+||+...|....+.+
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~  281 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKR  281 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhc
Confidence            999999999999999998   5678999999998886655443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-40  Score=351.32  Aligned_cols=256  Identities=29%  Similarity=0.497  Sum_probs=211.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   ........+.+|+.+|++++|+||+++++++..+.   
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            468999999999999999999999999999999885321   12333456789999999999999999999987654   


Q ss_pred             ---cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          296 ---RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       296 ---~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                         .+++||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence               358999999 7899988864 67999999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--------------  438 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--------------  438 (628)
                      ..  ......+++.|+|||++.+...++.++|||||||++|+|++|..||...+......++....              
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            43  22345689999999998764558899999999999999999999997655433322221100              


Q ss_pred             ---------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 ---------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ---------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                     ....+...++.++.++|.+||+.||++||++.+++.||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                           0111234578889999999999999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-40  Score=352.75  Aligned_cols=255  Identities=27%  Similarity=0.486  Sum_probs=212.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc--
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER--  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~--  296 (628)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ......+++.+|+.+++.+.|+||+++++++..++.  
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            468999999999999999999999999999999875421   123344667789999999999999999998876654  


Q ss_pred             ----ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          297 ----LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       297 ----~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                          +++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence                89999999 6799998876 57999999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-------------  439 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-------------  439 (628)
                      ...  .....++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+.....             
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            432  33456899999999986654688999999999999999999999976554443332211100             


Q ss_pred             ----------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          440 ----------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       440 ----------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                      .......++.++.+||++||+.||++|||+.+|++||||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence                            00112246889999999999999999999999999999974

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.8e-40  Score=345.04  Aligned_cols=254  Identities=37%  Similarity=0.659  Sum_probs=214.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|+..+.||+|+||.||+|++..++..||||++.....  ...+...++.+|+++|+.++|+||+++++++.+++..|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            347888999999999999999999999999998864322  223455678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||+.| +|.+++.. ...+++..+..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++......   
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9999975 77777653 567899999999999999999999999999999999999999999999999998754332   


Q ss_pred             ccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ....|+..|+|||++..  ...++.++|||||||++|||++|..||...+....+..+............++..+.+||.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  258 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  258 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence            23568999999999742  3448899999999999999999999998766655555554433333334467889999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCcccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +||+.+|.+||++.+|++|+|+.
T Consensus       259 ~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         259 SCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             HHccCCcccCcCHHHHHhChhhh
Confidence            99999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=339.76  Aligned_cols=253  Identities=31%  Similarity=0.583  Sum_probs=211.9

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |++.+.||+|++|.||+|++..+++.+|+|+++.....   ......+.+|+++|++++|+||+++++++.++..+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            56778999999999999999999999999988643222   233467788999999999999999999999999999999


Q ss_pred             EecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          302 EYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       302 Ey~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      ||+.+ +|.+++.. ...+++..+..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||.+....... ...
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99975 88888766 4689999999999999999999999999999999999999999999999999997765433 233


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC---------------------
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK---------------------  438 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~---------------------  438 (628)
                      ...++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+.++....                     
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            35688899999998766468999999999999999999999997766544433321110                     


Q ss_pred             -------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          439 -------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       439 -------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                             ....+...++.++.+||.+||+.||.+||++.+|+.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                   0001223467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.3e-40  Score=341.02  Aligned_cols=249  Identities=27%  Similarity=0.454  Sum_probs=207.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ..+|.+.+.||+|+||.||+|.+.     .++..+++|.++.     ......+.+.+|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            457999999999999999999753     3456788887752     223334678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP  357 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~  357 (628)
                      .+..++||||+.+++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997543                3789999999999999999999999999999999999999


Q ss_pred             CCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhh
Q 040472          358 HGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFK  433 (628)
Q Consensus       358 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~  433 (628)
                      ++.++|+|||++.......   ......++..|+|||++.+. .++.++|||||||++|||++ |..||........+..
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999997653322   12234567889999998654 48999999999999999998 9999977665544444


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +.. ......+..++.++.+||.+||+.||++||++.+|++
T Consensus       238 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            433 3334455667899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.2e-40  Score=371.45  Aligned_cols=255  Identities=27%  Similarity=0.473  Sum_probs=220.5

Q ss_pred             CCccccccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeee
Q 040472          212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR  286 (628)
Q Consensus       212 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~  286 (628)
                      ..+.+....+.+..+.||+|+||+||+|+-.     .+...||||.++.    ..+.+..++|++|+++|..|+|||||+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVr  553 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVR  553 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEE
Confidence            3455566778889999999999999999742     3457899998874    333456788999999999999999999


Q ss_pred             eecceeccccceEEEEecccccHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCc
Q 040472          287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGAN  352 (628)
Q Consensus       287 l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~--------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeN  352 (628)
                      |+|+|..++.+++|+|||..|||.++|....              +|+..+.+.|+.||+.|++||-++.+|||||-..|
T Consensus       554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN  633 (774)
T KOG1026|consen  554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN  633 (774)
T ss_pred             EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence            9999999999999999999999999997432              27888999999999999999999999999999999


Q ss_pred             eEeCCCCCEEEeccCCcccccCcccccc---ccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchh
Q 040472          353 ILVDPHGEIKLADFGMAKHMTSCASMLS---FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGV  428 (628)
Q Consensus       353 ILld~~g~vKL~DFGla~~~~~~~~~~~---~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~  428 (628)
                      +||.++..|||+||||++.+-....+..   ..-...||+||.|+.. +|+.++||||+||+|||+++ |..||.+..+.
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            9999999999999999987644332221   1234689999999855 59999999999999999998 99999999998


Q ss_pred             HHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          429 AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       429 ~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                      +.+..+..... -.-|+.++.++.+|+..||+.+|.+||++.||
T Consensus       713 EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  713 EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            88888876665 56788999999999999999999999999998

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.8e-40  Score=333.86  Aligned_cols=248  Identities=24%  Similarity=0.411  Sum_probs=206.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||+||+|.+.. +..||||.++....      ....+.+|+.++++++||||+++++++.....++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            3579999999999999999998764 45699998763211      1245788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++.......
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999999999999764 4689999999999999999999999999999999999999999999999999876543221


Q ss_pred             c--ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          378 M--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       378 ~--~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      .  ....++..|++||++.+. .++.++|||||||++|+|++ |..||...........+.... ....+...+..+.++
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  233 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRPHLASEKVYAI  233 (256)
T ss_pred             eecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Confidence            1  123356789999998654 48999999999999999998 999998766554444443332 223445578999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcC
Q 040472          455 IKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~H  475 (628)
                      |.+||+.||++||++.+|+++
T Consensus       234 i~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         234 MYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-40  Score=334.23  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=205.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||+|+||.||+|.++ ++..+|||++.....      ....+.+|++++++++|+||+++++++...+..|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            357899999999999999999886 467899998753211      1235677999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999999999999753 5789999999999999999999999999999999999999999999999999976543221


Q ss_pred             cc--cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          378 ML--SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       378 ~~--~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      ..  ...++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... ....+...+.++.+|
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  233 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLYRPKLAPTEVYTI  233 (256)
T ss_pred             cccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHH
Confidence            11  11234579999998654 48999999999999999999 899998766555554444332 234455689999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcC
Q 040472          455 IKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.+||..+|++||++.||++.
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.5e-40  Score=335.79  Aligned_cols=249  Identities=24%  Similarity=0.416  Sum_probs=201.9

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCc--EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-----
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQ--MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-----  294 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-----  294 (628)
                      |.++++||+|+||.||+|++..++.  .||||.++...   ......+.+.+|+++|+.++|+||+++++++...     
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            3567899999999999999887765  58999886432   2234467788999999999999999999876432     


Q ss_pred             -ccceEEEEecccccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQE------YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                       ...++||||+.+|+|.+++..      ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence             257899999999999998742      2347899999999999999999999999999999999999999999999999


Q ss_pred             CcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCC
Q 040472          368 MAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEI  443 (628)
Q Consensus       368 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~  443 (628)
                      +++.+.....   .....+++.|++||++.+. .++.++|||||||++|||++ |..||...........+... .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRLKQ  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence            9987543221   1223467789999998654 48999999999999999999 89999776554444434332 22344


Q ss_pred             CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       444 p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +..++..+.++|.+||+.||++||++.+|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            55788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.4e-40  Score=338.01  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=203.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcE----EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..+|++++.||+|+||+||+|.+..+++.    |++|.+.    ..........+..|+.++.++.|+||+++++++. .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            46899999999999999999999887775    5555543    2223344567888999999999999999999875 4


Q ss_pred             ccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ...++||||+.+|+|.+++.. .+.+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            567899999999999999976 4578999999999999999999999999999999999999999999999999998654


Q ss_pred             Cccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          374 SCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       374 ~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ....   .....++..|+|||++.+. .++.++|||||||++|||++ |..||........ .++......+..+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTI  238 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCH
Confidence            3221   2234577889999998654 48999999999999999998 9999976544332 222223333344555778


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.+++.+||..||++||++.|+++
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.3e-40  Score=337.09  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=205.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcE----EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ...+|++.++||+|+||+||+|++..+++.    ||||+++..    ......+.+.+|+.++..++|+||+++++++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            346899999999999999999998777764    789987532    123345678899999999999999999998875


Q ss_pred             cccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                       ...+++|||+.+|+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             457899999999999999976 457999999999999999999999999999999999999999999999999999876


Q ss_pred             cCcccc---ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          373 TSCASM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       373 ~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ......   ....++..|+|||++.+. .++.++|||||||++|||++ |..||...........+.. ......+...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQPPICT  237 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCCccCC
Confidence            432221   122346789999998655 48999999999999999998 9999976554333322222 22234455688


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .++.++|.+||+.||++||++.++++
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-40  Score=372.31  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=196.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC-CcEEEEEEEeec------------ccccchHHHHHHHHHHHHHHHhCCCCCe
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES-GQMCAIKEVRVV------------CDDQTSKECLKQLNQEINLLSQLSHPNI  284 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~------------~~~~~~~~~~~~~~~Ei~iL~~l~HpnI  284 (628)
                      .+++|++++.||+|+||+||+|..+.. +..+++|.+...            ...........++.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            467999999999999999999876433 222233311100            0001122345678899999999999999


Q ss_pred             eeeecceeccccceEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC
Q 040472          285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG  359 (628)
Q Consensus       285 V~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g  359 (628)
                      |++++++.+.+..|+|||++. ++|..++...     .......++.|+.||+.||+|||++|||||||||+||||+.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999995 5777766432     2344667889999999999999999999999999999999999


Q ss_pred             CEEEeccCCcccccCcc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCC-CCCC--chhHHHhhh
Q 040472          360 EIKLADFGMAKHMTSCA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQY--EGVAAIFKI  434 (628)
Q Consensus       360 ~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~P-F~~~--~~~~~~~~i  434 (628)
                      .+||+|||+++.+....  .....+||..|+|||++.+. .++.++|||||||+||||++|..+ |...  .....+.++
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            99999999998764432  22346799999999998765 499999999999999999998764 4321  111222221


Q ss_pred             cCCC-----CCC----------------CC---------CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          435 GNSK-----DIP----------------EI---------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       435 ~~~~-----~~~----------------~~---------p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ....     .++                ..         ...++.++.++|.+||+.||.+||++.|+|+||||...
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1100     000                00         01256678899999999999999999999999999754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=330.05  Aligned_cols=246  Identities=37%  Similarity=0.625  Sum_probs=213.7

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||+|+||.||++.+..+++.||+|+++....  ........+..|+.++++++|+||+++++.+.++..+|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            7999999999999998999999999865321  22234567889999999999999999999999999999999999999


Q ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cccccccCCCC
Q 040472          308 SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPY  386 (628)
Q Consensus       308 sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~  386 (628)
                      +|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            99999998888999999999999999999999999999999999999999999999999999765443 22344668999


Q ss_pred             cCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCC
Q 040472          387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR  466 (628)
Q Consensus       387 Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  466 (628)
                      |++||.+.+.. ++.++|+||||+++|+|++|..||...+.......+..  ....++..++.++.+||++||..||++|
T Consensus       159 ~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         159 YLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             ccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999986544 78899999999999999999999977665444444433  2345667789999999999999999999


Q ss_pred             CCH---HHHhcCccc
Q 040472          467 PPA---SKLLDHPFV  478 (628)
Q Consensus       467 pta---~eiL~Hpwf  478 (628)
                      |++   +++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.1e-40  Score=343.46  Aligned_cols=252  Identities=25%  Similarity=0.436  Sum_probs=207.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++.+.||+|+||.||+|.+     ..++..||||+++...    .....+.+.+|+++++++ +|+||+++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            346899999999999999999975     3346689999876421    123346788999999999 799999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                      ...+.+|+||||+.+++|.+++....  .+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999997643  3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCC
Q 040472          370 KHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPE  445 (628)
Q Consensus       370 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~  445 (628)
                      +.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||........+.+..........+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            86543221   11234678899999986554 8999999999999999998 9999977655444444333222233455


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..+.++.+||.+||..+|++||++.||++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.6e-40  Score=335.50  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=210.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|+++++||.|+||.||+|++.. +..+|+|++...     ......++.+|+++|+.++|+||+++++++.+.+..+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            4579999999999999999999987 889999988642     1223456888999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999999753  468999999999999999999999999999999999999999999999999997654322


Q ss_pred             c-cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          377 S-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       377 ~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      . .....++..|++||++.+. .++.++|||||||++|+|++ |+.||........+..+.... ....+..++.++.++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  236 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RMPCPAKCPQEIYKI  236 (261)
T ss_pred             ccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cCCCCCCCCHHHHHH
Confidence            1 1223456789999998654 58999999999999999998 899998766555555444332 234456788999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhc
Q 040472          455 IKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~  474 (628)
                      |.+||+.||++||++.+|++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.6e-40  Score=340.45  Aligned_cols=258  Identities=31%  Similarity=0.556  Sum_probs=209.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .+++|++.+.||+|+||.||+|.+..+++.||||.++....    ......+.+|+.++.++. |+||+++++++.++..
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            56789999999999999999999999999999999864321    122345556777666665 9999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +|+||||+. +.|.+++.. .+.+++..+..++.||+.||+|||+ .+|+||||+|+|||++.++.+||+|||++..+..
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 577777765 4678999999999999999999997 5999999999999999999999999999976654


Q ss_pred             ccccccccCCCCcCChhhhhcc---CCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcCCCCCCCCC--CcCC
Q 040472          375 CASMLSFKGSPYWMAPEVVMNT---NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIP--EHLS  448 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~~~~~~~~p--~~~s  448 (628)
                      ........++..|+|||++.+.   ..++.++|||||||++|+|++|+.||...... +.+..+.... .+.++  ..++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCC
Confidence            3333445688899999998543   23788999999999999999999999764332 2222222221 12222  2468


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .++.+||.+||..||++||++++|++|+||+..
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-40  Score=351.12  Aligned_cols=254  Identities=28%  Similarity=0.505  Sum_probs=206.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE----  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~----  295 (628)
                      .+|.+.+.||+|+||.||+|++..+++.||||+++....   .......+.+|+.+++.++|+||+++++++....    
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            589999999999999999999999999999998864221   1223456788999999999999999999887543    


Q ss_pred             --cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          296 --RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       296 --~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                        .+|+||||+. .+|..++.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             CceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence              4699999995 47776653  468999999999999999999999999999999999999999999999999997653


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC---------------
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK---------------  438 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~---------------  438 (628)
                      .  ......++..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+....               
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence            2  22345688999999998765558899999999999999999999998755433322211100               


Q ss_pred             ------CCC--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 ------DIP--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ------~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                            ..+        .....++.++.+||++||+.||++||++.+|+.||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                  000        1112467889999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.2e-40  Score=347.61  Aligned_cols=256  Identities=28%  Similarity=0.513  Sum_probs=206.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCC--CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceec----
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSES--GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELS----  293 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~t--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~----  293 (628)
                      +|++.+.||+|+||.||+|++..+  ++.||||++.....   .....+++.+|+.+++++. |+||+++++++..    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            588999999999999999999888  89999998864221   1223456778999999995 9999999986543    


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ...+|++|||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            246788999985 6899999888889999999999999999999999999999999999999999999999999998654


Q ss_pred             Ccc-----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC------------
Q 040472          374 SCA-----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN------------  436 (628)
Q Consensus       374 ~~~-----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~------------  436 (628)
                      ...     ......||..|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+..            
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            321     123357899999999886655689999999999999999999999976442221111100            


Q ss_pred             -----------------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          437 -----------------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       437 -----------------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                       ..........++..+.+||.+||+.||++||++.+++.||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~  297 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI  297 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence                             00011122346789999999999999999999999999999953

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=337.44  Aligned_cols=253  Identities=32%  Similarity=0.584  Sum_probs=210.7

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |++.+.||+|+||.||+|++..+++.||+|++.....   .....+.+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            5678899999999999999999999999999875331   1223456778999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          302 EYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      ||+. ++|.+++.+. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||+++...... ...
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            9997 5899999876 579999999999999999999999999999999999999999999999999998654432 233


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-------------------CCC
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-------------------KDI  440 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-------------------~~~  440 (628)
                      ...++..|+|||++.+...++.++|||||||++|||++|.+||........+.++...                   ...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            3456788999999876656899999999999999999999999776544333222110                   000


Q ss_pred             C--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          441 P--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       441 ~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +        .....++.++.++|++||+.||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0        1112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.2e-40  Score=342.16  Aligned_cols=255  Identities=36%  Similarity=0.654  Sum_probs=213.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|+..+.||+|+||.||+|+++.+++.||||.+.....  ......+++.+|+++|+.++|+||+++++++......++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            457888999999999999999999999999998864211  123445678889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||++......   
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            999996 577777653 456899999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ....|+..|+|||++.+  ...++.++|||||||++|+|++|..||...+.......+............++..+.+||+
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence            23568999999999753  2347889999999999999999999997766555555444332222233467889999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.+|++||++.++++|+|+..
T Consensus       249 ~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         249 SCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHhhCCcccCCCHHHHhhCccccc
Confidence            999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.8e-40  Score=342.93  Aligned_cols=251  Identities=24%  Similarity=0.434  Sum_probs=206.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC-------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE-------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGS  290 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~  290 (628)
                      .++|.+++.||+|+||.||+|++..       +...||+|.++..    .......++.+|+.+++.+ +|+||++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4689999999999999999998643       2357999988642    1223356788899999999 79999999999


Q ss_pred             eeccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceE
Q 040472          291 ELSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANIL  354 (628)
Q Consensus       291 ~~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNIL  354 (628)
                      +..++.+|+||||+.+++|.++|....                .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                4788899999999999999999999999999999999


Q ss_pred             eCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHH
Q 040472          355 VDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAA  430 (628)
Q Consensus       355 ld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~  430 (628)
                      ++.++.+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|||++ |..||........
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            99999999999999876532211   1112345689999998654 48999999999999999998 8899976554333


Q ss_pred             HhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          431 IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       431 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ...+. .......+..++.++.+||.+||..+|++||++.+|+++
T Consensus       252 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33332 233345666789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-40  Score=350.00  Aligned_cols=259  Identities=28%  Similarity=0.512  Sum_probs=210.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSD--  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~--  294 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.....   .......+.+|+.+++++ +|+||+++++++...  
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC---cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            35789999999999999999999999999999998753211   122235567899999999 999999999988653  


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..+|+||||+. ++|..++... .+.+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            46899999997 5999988765 789999999999999999999999999999999999999999999999999976533


Q ss_pred             cc------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-----------
Q 040472          375 CA------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-----------  437 (628)
Q Consensus       375 ~~------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-----------  437 (628)
                      ..      ....+.||..|+|||++.+...++.++|||||||++|+|++|+.||..........++...           
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21      2234568999999998866566889999999999999999999999764433322211000           


Q ss_pred             ------------------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 ------------------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 ------------------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                        .........++.++.+||.+||+.||++||++.++++|+||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                              00112223478899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.8e-41  Score=341.91  Aligned_cols=260  Identities=28%  Similarity=0.520  Sum_probs=209.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCC----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESG----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .+..|++...||+|.||.||+|..+++.    +.||||.++-..+..   ..-...-+|+.+++.|+|+|||.|..+|..
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t---GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT---GISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC---CcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            4678999999999999999999765543    378999886432211   112335579999999999999999999988


Q ss_pred             -cccceEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC----CCEEE
Q 040472          294 -DERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH----GEIKL  363 (628)
Q Consensus       294 -~~~~~lVmEy~~GgsL~~~L~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~----g~vKL  363 (628)
                       +..++|++||.+. +|..+|+.+     ..++...++.|+.||+.|+.|||++=|+||||||.||||..+    |.|||
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence             8899999999976 888888632     468899999999999999999999999999999999999877    89999


Q ss_pred             eccCCcccccCc----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC------------ch
Q 040472          364 ADFGMAKHMTSC----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY------------EG  427 (628)
Q Consensus       364 ~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~------------~~  427 (628)
                      +|||+++.+...    .....++-|.||+|||.+.+...|+.++|||++|||+.|||+-.+.|.+.            +.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999987542    12334678999999999999999999999999999999999999988542            22


Q ss_pred             hHHHhhhcCCC---CCC---CCCC--------------------------cCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          428 VAAIFKIGNSK---DIP---EIPE--------------------------HLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       428 ~~~~~~i~~~~---~~~---~~p~--------------------------~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ...++++....   .+|   .+|+                          .-++.+.+||.+||+.||.+|.|++++|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            33444442221   111   1111                          124458899999999999999999999999


Q ss_pred             ccccch
Q 040472          476 PFVRDQ  481 (628)
Q Consensus       476 pwf~~~  481 (628)
                      +||+..
T Consensus       338 ~yF~~d  343 (438)
T KOG0666|consen  338 PYFTED  343 (438)
T ss_pred             cccccC
Confidence            999754

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.3e-40  Score=337.44  Aligned_cols=249  Identities=27%  Similarity=0.456  Sum_probs=207.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ..+|++.++||+|+||.||+|..     ..++..+|+|.++..     .......+.+|+++++.++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            35788899999999999999974     335678999987532     23345678999999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG---------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH  358 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~---------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~  358 (628)
                      ....++||||+.+++|.+++....               .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999997643               47899999999999999999999999999999999999999


Q ss_pred             CCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhh
Q 040472          359 GEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKI  434 (628)
Q Consensus       359 g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i  434 (628)
                      +.+||+|||++........   .....+++.|+|||++.+. .++.++|||||||++|||++ |.+||........+..+
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            9999999999875533221   1223357789999998655 48999999999999999998 99999776655555444


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       435 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..... ...+..++..+.+||.+||+.||++||++.+|++
T Consensus       238 ~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33322 2445678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1e-39  Score=333.47  Aligned_cols=250  Identities=25%  Similarity=0.431  Sum_probs=207.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ..+|++++.||+|+||.||+|+++.++.   .||||.++...    .....+.+.+|+.+|++++||||+++++++.+++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3589999999999999999999865543   78999875422    1234567889999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..|+||||+.+++|.+++.+. +.+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999999764 5689999999999999999999999999999999999999999999999999986543


Q ss_pred             cccc----ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 CASM----LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ~~~~----~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ....    ....++..|+|||++.+. .++.++|+|||||++|||++ |..||...........+..... ...+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPAPMDCPA  236 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CCCCCCCCH
Confidence            2211    112235679999998654 48999999999999999886 9999987655444444443322 233456788


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+.+||.+||+.+|.+||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=331.82  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=206.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|.+.. ++.||||.++....      ..+++.+|+.+|++++|+||+++++++...+.+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            34679999999999999999998754 57899998864211      135678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      |+||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999999997644  6899999999999999999999999999999999999999999999999999876432


Q ss_pred             cc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 AS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..  .....++..|+|||++.+. .++.++|||||||++|||++ |+.||........+..+..... ...+..++..+.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MPCPPGCPKELY  234 (261)
T ss_pred             cccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCHHHH
Confidence            11  1112234579999988654 48999999999999999999 9999987665555555443322 234456889999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||.+||+.+|++||++.+|++
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=353.34  Aligned_cols=250  Identities=29%  Similarity=0.471  Sum_probs=199.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc-c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE-R  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~-~  296 (628)
                      ..++|...++||+|+||.||+|.... +..||||.+......    . .++|.+|+.+|.+++|+|||+|+|||.+.+ .
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence            45789889999999999999998775 489999977542221    1 355999999999999999999999999988 4


Q ss_pred             ceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARN---TVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~g---IvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      .+||+||+.+|+|.++|....  .+++....+|+.+++.||+|||..-   |||||||+.|||||.+.++||+|||+|+.
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            999999999999999998654  8999999999999999999999854   99999999999999999999999999976


Q ss_pred             ccC-ccccccc-cCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc---h--hHH----------Hhhh
Q 040472          372 MTS-CASMLSF-KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE---G--VAA----------IFKI  434 (628)
Q Consensus       372 ~~~-~~~~~~~-~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~---~--~~~----------~~~i  434 (628)
                      ... .....+. .||.+|+|||++.. +..+.|+|||||||+|+||++|+.+.+...   .  ...          +..+
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            654 3333333 79999999999865 459999999999999999999998876432   1  111          1111


Q ss_pred             cCCCCC-CCCCC-cCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          435 GNSKDI-PEIPE-HLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       435 ~~~~~~-~~~p~-~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...... ...+. ..-..+..+..+|++.++.+||++.||++
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111110 11111 11223567778999999999999999743

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.9e-40  Score=337.84  Aligned_cols=248  Identities=27%  Similarity=0.438  Sum_probs=203.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      +|++.+.||+|+||.||+|++..     ....+|+|++....    ......++.+|+.+|+.++||||+++++.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            57889999999999999998753     23568888775321    2334567889999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY------------------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGA  351 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~------------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpe  351 (628)
                      ..++||||+.+++|.+++...                        ..+++..+..++.|++.||+|||+++|+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999998642                        24788899999999999999999999999999999


Q ss_pred             ceEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCch
Q 040472          352 NILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEG  427 (628)
Q Consensus       352 NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~  427 (628)
                      ||||+.++.+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999976533221   1223467789999998654 48999999999999999998 9999976554


Q ss_pred             hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          428 VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       428 ~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ......+ ........+..++.++.+||.+||+.+|++||++.+|++
T Consensus       236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            3333222 222223456678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-39  Score=332.57  Aligned_cols=250  Identities=25%  Similarity=0.445  Sum_probs=207.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      +.+|++.+.||+|+||.||+|.++.+++   .||||+++...    .....+++..|+.+++.++||||+++++++.++.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            4579999999999999999999887665   59999886421    2334577899999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+++||||+.+++|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||||+.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999999999976 45689999999999999999999999999999999999999999999999999876533


Q ss_pred             cccc---cccc---CCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcC
Q 040472          375 CASM---LSFK---GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHL  447 (628)
Q Consensus       375 ~~~~---~~~~---GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~  447 (628)
                      ....   ....   .+..|+|||++.+. .++.++|||||||++|||++ |..||...........+...... ..+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~  236 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL-PPPMDC  236 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-CCcccC
Confidence            2211   1111   24579999998654 48999999999999999886 99999876655444444332222 234567


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +..+.+++.+||+.+|.+||++.+|+.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-40  Score=348.51  Aligned_cols=256  Identities=24%  Similarity=0.449  Sum_probs=208.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~---  294 (628)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++....   .....+.+.+|+.++++++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            34789999999999999999999999999999998864211   122345677899999999999999999987643   


Q ss_pred             ---ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                         ..+|++++++ |++|.++++. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence               3478888887 7899888865 4699999999999999999999999999999999999999999999999999876


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-------------  438 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-------------  438 (628)
                      ...  ......++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+....             
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  23345689999999998765568899999999999999999999997544333222111000             


Q ss_pred             -----------CCC-----CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          439 -----------DIP-----EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       439 -----------~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                 ..+     ......+.++.+||.+||+.||.+|+++.++++||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                       000     111235788999999999999999999999999999975

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=355.08  Aligned_cols=253  Identities=28%  Similarity=0.500  Sum_probs=214.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCc---E-EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQ---M-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~-vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      -++-.+.++||+|+||.||+|..+..+.   . ||||..+.  ......+.++.+.+|+++|++++|+|||++||+...+
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            3456667999999999999998765322   3 89998764  2234467788999999999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ..+|||||+|.||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-++|+|++.++.+||+||||++...
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999999999876 59999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccccccc-cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          374 SCASMLSF-KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       374 ~~~~~~~~-~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ........ .-...|+|||.+... -|+.++|||||||++||+++ |..||.+....+...++.........+...+.++
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~  392 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL  392 (474)
T ss_pred             ceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence            22211111 234679999999655 69999999999999999999 8889999888777777744444445666788999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..++.+|+..+|++|+++.++.+
T Consensus       393 ~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  393 AKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHhccCChhhccCHHHHHH
Confidence            99999999999999999999853

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.9e-40  Score=350.07  Aligned_cols=253  Identities=24%  Similarity=0.432  Sum_probs=203.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++++.||+|+||.||+|++     ..+++.||||+++...    .......+.+|+.+|.++ +|+||+++++++
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            346899999999999999999984     3567899999986421    123356788899999999 589999999987


Q ss_pred             ec-cccceEEEEecccccHHHHHHhc------------------------------------------------------
Q 040472          292 LS-DERLSVYLEYVSGGSIHKLLQEY------------------------------------------------------  316 (628)
Q Consensus       292 ~~-~~~~~lVmEy~~GgsL~~~L~~~------------------------------------------------------  316 (628)
                      .. +..+++||||+.+|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            65 45689999999999999998642                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc---ccc
Q 040472          317 -------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---MLS  380 (628)
Q Consensus       317 -------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~---~~~  380 (628)
                                   ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         1357778889999999999999999999999999999999999999999999976532211   112


Q ss_pred             ccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      ..++..|+|||++.+. .++.++|||||||++|+|++ |..||........+............+..++.++.+++.+||
T Consensus       241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence            3356789999998654 48999999999999999996 999997654333333322222233445567889999999999


Q ss_pred             hcCCCCCCCHHHHhcC
Q 040472          460 QRDPSARPPASKLLDH  475 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~H  475 (628)
                      +.||++||++.+|++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=333.51  Aligned_cols=243  Identities=25%  Similarity=0.442  Sum_probs=198.4

Q ss_pred             eeeccCCcEEEEEEEECCCCcE--EEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQM--CAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      ++||+|+||.||+|+++.++..  +|+|.++..    ......+.+.+|++++.++ +|+||+++++++.....+|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3699999999999999888764  577876531    1234456788999999999 79999999999999999999999


Q ss_pred             ecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEecc
Q 040472          303 YVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       303 y~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DF  366 (628)
                      |+.+++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            999999999997543                4788999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPE  445 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~  445 (628)
                      |++..............+..|+|||++... .++.++|||||||++|||++ |..||...........+.... ....+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCCCCC
Confidence            998643221111222346679999998654 48999999999999999997 999997655444444443322 223455


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .++.++.+||.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.9e-40  Score=336.56  Aligned_cols=246  Identities=33%  Similarity=0.553  Sum_probs=202.2

Q ss_pred             EEeeeeccCCcEEEEEEEEC----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          223 KKGKLLGRGTFGHVYLGFNS----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.++.    ....+..+.+.+|+++|++++|+||+++++++...+..+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999999887    4567899998853    222344678889999999999999999999999888899


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+|+|.++|...  ..+++..+..|+.||+.||+|||+++|+|+||++.||||+.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999986  689999999999999999999999999999999999999999999999999998762211


Q ss_pred             ---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          377 ---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       377 ---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                         ......+...|+|||++.... ++.++||||||+++|||++ |+.||..........++.... ....+..++..+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-RLPIPDNCPKDIY  235 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-ETTSBTTSBHHHH
T ss_pred             cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-cceeccchhHHHH
Confidence               122344677899999987654 8999999999999999999 789998876666555553333 3445667899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++|.+||..||++||++.+|++
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-39  Score=340.92  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECC-------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSE-------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~  289 (628)
                      ..++|.+++.||+|+||.||+|++..       ....||+|.++..    ........+.+|+++++++ .|+||+++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            34689999999999999999997632       3457999987632    1233456788999999999 5999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.++..+|+||||+.+|+|.+++...                ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999999753                2478889999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      |++.++.+||+|||+++.......   .....++..|||||++.+. .++.++|||||||++|||++ |..||.......
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999986543211   1122345679999998654 58999999999999999999 899997765444


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+.. ......+..++.++.+||.+||+.||++||++.++++.
T Consensus       245 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         245 LFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4433333 22334566788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-39  Score=334.66  Aligned_cols=248  Identities=28%  Similarity=0.505  Sum_probs=198.2

Q ss_pred             Ce-EEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-
Q 040472          221 KW-KKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-  294 (628)
Q Consensus       221 ~y-~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-  294 (628)
                      +| ++.+.||+|+||+||++.    ...+++.||+|+++....    ......+.+|+++|+.++|+||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            45 889999999999998864    345788999998864321    22345678899999999999999999987653 


Q ss_pred             -ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                       ..+++||||+.+++|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence             468999999999999999976 459999999999999999999999999999999999999999999999999998654


Q ss_pred             Cccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh-HH-------------Hhhhc
Q 040472          374 SCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AA-------------IFKIG  435 (628)
Q Consensus       374 ~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~-------------~~~i~  435 (628)
                      ....    .....++..|+|||++.+. .++.++|||||||++|||++|..||...... ..             +....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            3221    1123456779999998654 4899999999999999999999998543211 00             11111


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ........+..++.++.+|+.+||+.+|++||++.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            111112335567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.7e-40  Score=342.54  Aligned_cols=254  Identities=30%  Similarity=0.446  Sum_probs=200.5

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      .+++.+|.|  |.||++++..+++.||||+++...   ...+..+.+.+|+++|+.++|+||+++++++..++..|++||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            334444444  556666667789999999987531   223456789999999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc----
Q 040472          303 YVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA----  376 (628)
Q Consensus       303 y~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~----  376 (628)
                      |+.+++|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||.+.......    
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999999999863  468999999999999999999999999999999999999999999999999886543211    


Q ss_pred             ----ccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--------CC---
Q 040472          377 ----SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--------DI---  440 (628)
Q Consensus       377 ----~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--------~~---  440 (628)
                          ......++..|+|||++... ..++.++|||||||++|||++|..||........+.......        ..   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                11234578889999998653 348899999999999999999999997654332221111000        00   


Q ss_pred             ---------------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          441 ---------------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       441 ---------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                           ......++.++.+||++||+.||++||++.++|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                                 00112345688999999999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-39  Score=331.73  Aligned_cols=246  Identities=26%  Similarity=0.425  Sum_probs=202.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.++||+|+||.||+|++..+ ..||||+++....      ..+++.+|+++++.++|+||+++++++. +...|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            46799999999999999999988765 4599998864211      1246788999999999999999999874 45689


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++.+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999999763  357899999999999999999999999999999999999999999999999997654322


Q ss_pred             cc--ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 SM--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~~--~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      ..  ....++..|+|||++.+. .++.++|||||||++|||++ |..||........+..+..... ......++..+.+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  234 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECPESLHD  234 (262)
T ss_pred             cccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CCCccccCHHHHH
Confidence            11  123466789999988654 48999999999999999999 8999977655444444433222 2334568899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhc
Q 040472          454 FIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ||.+||+.||++||++.++++
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-39  Score=329.68  Aligned_cols=243  Identities=28%  Similarity=0.479  Sum_probs=202.9

Q ss_pred             eeeccCCcEEEEEEEECC-CCc--EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSE-SGQ--MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~-tg~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      ++||+|+||.||+|.+.. +++  .||||.+.....    .+..+.+.+|+.+|++++|+||+++++++.. ..+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            469999999999998765 333  689998864221    1556788999999999999999999999988 89999999


Q ss_pred             ecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc---
Q 040472          303 YVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS---  377 (628)
Q Consensus       303 y~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~---  377 (628)
                      |+.+++|.+++....  .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.+.....   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999998754  689999999999999999999999999999999999999999999999999987643211   


Q ss_pred             -cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          378 -MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       .....++..|+|||++.+. .++.++|||||||++|||++ |..||......+....+.........+..++..+.++|
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             cccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence             1124577889999988654 48999999999999999998 99999776655544444433333344556789999999


Q ss_pred             HHHhhcCCCCCCCHHHHhc
Q 040472          456 KQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||+.+|++||++.+|++
T Consensus       235 ~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         235 LQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHCCCCcccCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-39  Score=334.56  Aligned_cols=250  Identities=26%  Similarity=0.489  Sum_probs=201.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEE----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--
Q 040472          221 KWKKGKLLGRGTFGHVYLGFN----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--  294 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--  294 (628)
                      -|++.+.||+|+||.||+|+.    ..++..||||.++...    .......+.+|+++|+.+.|+||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            478899999999999999974    5678899999886421    233456789999999999999999999988775  


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ...++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            5789999999999999999764 468999999999999999999999999999999999999999999999999998654


Q ss_pred             Cccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--------------hHHHhhhc
Q 040472          374 SCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--------------VAAIFKIG  435 (628)
Q Consensus       374 ~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--------------~~~~~~i~  435 (628)
                      ....    .....++..|+|||++.+. .++.++|||||||++|||+++..|+.....              ........
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            3221    1234567789999998654 489999999999999999998766432100              01111111


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ........+..++.++.+||.+||+.||++||++.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1111223455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-40  Score=339.05  Aligned_cols=251  Identities=28%  Similarity=0.418  Sum_probs=202.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC--------------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES--------------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI  284 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t--------------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI  284 (628)
                      ..+|++.+.||+|+||.||+|++..+              ...||||.++...    .......+.+|+++|++++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i   79 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNI   79 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCc
Confidence            45899999999999999999987543              2358999886421    23345678899999999999999


Q ss_pred             eeeecceeccccceEEEEecccccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCc
Q 040472          285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGAN  352 (628)
Q Consensus       285 V~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeN  352 (628)
                      +++++++..++.+++||||+.+++|.+++....            .+++..+..++.||+.||+|||+++++||||||+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            999999999999999999999999999986532            36788899999999999999999999999999999


Q ss_pred             eEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc--CCCCCCCCch
Q 040472          353 ILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEG  427 (628)
Q Consensus       353 ILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt--G~~PF~~~~~  427 (628)
                      ||++.++.+||+|||++........   .....++..|+|||++.+. .++.++|||||||++|+|++  +..||.....
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999999976433221   1223456789999998654 48999999999999999987  6788876554


Q ss_pred             hHHHhhhcC------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          428 VAAIFKIGN------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       428 ~~~~~~i~~------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...+..+..      .......+..++..+.+||.+||+.||++||++++|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            333322211      11112334557899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-39  Score=379.17  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=205.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++.++||+|+||.||+|++..+++.||||+++....  ......+++.+|++++++++||||+++++++.+++..|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly   78 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY   78 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence            3689999999999999999999999999999999864321  12344567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          299 VYLEYVSGGSIHKLLQEY-----------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-----------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      +||||++|++|.+++...           ..++...+..++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999999998642           234566788999999999999999999999999999999999999999999


Q ss_pred             CcccccCc-------------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh
Q 040472          368 MAKHMTSC-------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV  428 (628)
Q Consensus       368 la~~~~~~-------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~  428 (628)
                      +++.....                   ......+||+.|||||++.+. .++.++|||||||++|||++|..||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99765210                   001125699999999998765 4899999999999999999999999764433


Q ss_pred             HHHhhhcCCCC-CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          429 AAIFKIGNSKD-IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       429 ~~~~~i~~~~~-~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ........... .......++..+.+++.+||+.||++|++..+.+.+
T Consensus       238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22222111100 001123578899999999999999999887666544

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-39  Score=335.59  Aligned_cols=250  Identities=24%  Similarity=0.452  Sum_probs=207.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .++|++.+.||+|+||.||+|.+.     .++..||||++....    .....+++.+|+.++++++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            468999999999999999999874     367899999886321    23345678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG----------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGA  351 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~----------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpe  351 (628)
                      +..+++||||+.+++|.+++....                      .+++..+..++.||+.||+|||+++++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            999999999999999999997432                      3678889999999999999999999999999999


Q ss_pred             ceEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCch
Q 040472          352 NILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEG  427 (628)
Q Consensus       352 NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~  427 (628)
                      |||++.++.++|+|||++........   ......+..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999875432211   1223356679999998654 48999999999999999997 8889976655


Q ss_pred             hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          428 VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       428 ~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+....+.... ....+..++.++.+||.+||+.+|++||++.||++
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            55444443322 33445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.3e-40  Score=356.29  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=207.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~  291 (628)
                      ..++|.++++||+|+||.||+|++.     .+++.||||+++...    .....+.+.+|+++|.++. |+|||++++++
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            3467899999999999999999864     355789999986421    1223456889999999998 99999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC------------------------------------------------------
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG------------------------------------------------------  317 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~------------------------------------------------------  317 (628)
                      .....+++||||+.+|+|.++|.+.+                                                      
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999999999999996532                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          318 --------------------------------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       318 --------------------------------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                                                                  .+++..+..|+.||+.||+|||+++|+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                        256667888999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      |++.++.+||+|||+++......   ......++..|+|||++.+. .++.++|||||||++|||++ |..||......+
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            99999999999999997643221   12234578899999998654 48999999999999999998 899997655544


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ...........+..+..++.++.+||.+||..+|++||++.+|++.
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4444333232334566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=327.91  Aligned_cols=244  Identities=28%  Similarity=0.466  Sum_probs=207.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ..+|++.+.||.|+||.||+|...  ++.||||.++...      ...+++.+|+.+++.++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            468999999999999999999875  7899999886321      14577889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++....  .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999998765  78999999999999999999999999999999999999999999999999998763322


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      .  ....+..|+|||++... .++.++|||||||++|||++ |..||...........+.. ......+..++.++.+||
T Consensus       157 ~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  232 (256)
T cd05039         157 D--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             c--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHH
Confidence            2  33456679999998654 48899999999999999997 9999987654443333332 222345567889999999


Q ss_pred             HHHhhcCCCCCCCHHHHhc
Q 040472          456 KQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++||..+|++||++.+|++
T Consensus       233 ~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         233 KDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHhccChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3e-39  Score=329.36  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=206.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|+..+.||+|+||.||+|+++.+++   .+|||.++...    .....+.+.+|++++++++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            3578899999999999999999876655   78999875421    1233466889999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..|+||||+.+++|.+++... +.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999999764 6789999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc--cc--cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 CAS--ML--SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ~~~--~~--~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...  ..  ....+..|+|||++.+. .++.++|||||||++|||++ |..||...........+..... ...+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~  237 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LPAPMDCPS  237 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-CCCCCCCCH
Confidence            211  11  12234579999998654 48999999999999999997 9999977655554444443322 233445788


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.+||.+||+.+|++||++.+|++
T Consensus       238 ~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         238 AVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-39  Score=339.52  Aligned_cols=251  Identities=31%  Similarity=0.550  Sum_probs=209.4

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      ...+||+|+||.||++.++.+++.||||++...     .......+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            346799999999999999999999999987531     123346688999999999999999999999999999999999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-cccccc
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SMLSFK  382 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~  382 (628)
                      +.+++|.+++.. +.+++..++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++....... ......
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            999999998754 568999999999999999999999999999999999999999999999999987654322 233456


Q ss_pred             CCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHHHHhhc
Q 040472          383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       383 GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      |++.|+|||++.+. .++.++|+|||||++|+|++|..||........+..+.... ........++.++.++|.+||+.
T Consensus       178 ~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         178 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             cCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            89999999988644 48899999999999999999999998655443333222111 11112235788999999999999


Q ss_pred             CCCCCCCHHHHhcCccccch
Q 040472          462 DPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       462 dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||.+||++.++++|+||...
T Consensus       257 ~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         257 DPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             CcccCcCHHHHhcChHHhcc
Confidence            99999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-39  Score=326.68  Aligned_cols=247  Identities=27%  Similarity=0.499  Sum_probs=208.7

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCC----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESG----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      +++.+.||+|+||.||++++..++    ..||+|+++...    ..+..+.+.+|+.+|+.++|+||+++++++.+.+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            356789999999999999998766    899999986432    122457888999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +++|||+.+++|.+++.....  +++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999999986544  999999999999999999999999999999999999999999999999999866443


Q ss_pred             cccc--cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 ASML--SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~~~--~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ....  ...+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+.... ....+..++.++.
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIY  234 (258)
T ss_pred             cccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHH
Confidence            2211  1236789999999854 458999999999999999998 899998765555444444333 3345556899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++|.+||..||++||++.|+++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=327.97  Aligned_cols=242  Identities=27%  Similarity=0.443  Sum_probs=200.3

Q ss_pred             eeeccCCcEEEEEEEECCCC---cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSESG---QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      ++||+|+||.||+|+...++   ..||+|.+.....    ....+++.+|+++|+.+.|+|||++++++. .+.+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI----AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            46999999999999875554   7899998864221    134567889999999999999999999876 456899999


Q ss_pred             ecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc---
Q 040472          303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML---  379 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~---  379 (628)
                      |+.+++|.++|.....+++..+..++.||+.||+|||.++|+||||||+||||+.++.+||+|||+++.........   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999999999987889999999999999999999999999999999999999999999999999998654322211   


Q ss_pred             -cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          380 -SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       380 -~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                       ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+.......+.... ....+..++..+.+||.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHH
Confidence             11234679999998654 48999999999999999998 999998766544444443322 234556788999999999


Q ss_pred             HhhcCCCCCCCHHHHhc
Q 040472          458 CLQRDPSARPPASKLLD  474 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~  474 (628)
                      ||..+|++||++.+|++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.9e-39  Score=329.03  Aligned_cols=243  Identities=26%  Similarity=0.440  Sum_probs=202.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee-ccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL-SDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~-~~~~~  297 (628)
                      +.+|++.+.||+|+||.||++...  +..||+|.++..       ...+.+.+|+.++++++|+||+++++++. .+...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            568999999999999999999765  778999987531       12356788999999999999999999754 55679


Q ss_pred             eEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      |+||||+.+++|.+++.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999997643  4789999999999999999999999999999999999999999999999998764332


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      .  ....++..|+|||++.+. .++.++|||||||++|||++ |+.||...........+.. ...+..+..++..+.+|
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  231 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV  231 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence            2  233456789999998654 58999999999999999997 9999976554443333322 22334556788999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhc
Q 040472          455 IKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~  474 (628)
                      |.+||+.+|++||++.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2e-39  Score=338.08  Aligned_cols=252  Identities=25%  Similarity=0.451  Sum_probs=207.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-------CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-------ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~  289 (628)
                      ...+|++++.||+|+||.||+|++.       .++..||+|.++..    ......+.+.+|+.+++.+ +|+||+++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            4568999999999999999999752       23457999987532    1233457788999999999 7999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.....+|+||||+.+++|.++|....                .++...+..++.||+.||+|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999997642                467788999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      |++.++.+||+|||+++......   ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.......
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999998654322   12223466789999998654 48999999999999999998 888997765544


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+.... ....+..++.++.+||.+||+.+|++||++.+|++.
T Consensus       248 ~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            444443322 234456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.9e-39  Score=335.63  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=201.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC----------------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE----------------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP  282 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp  282 (628)
                      .++|++.+.||+|+||.||+|.+..                +...||||+++..    .......++.+|+++|+.++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence            3579999999999999999986432                3457899988632    1234456788999999999999


Q ss_pred             CeeeeecceeccccceEEEEecccccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCC
Q 040472          283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-----------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGA  351 (628)
Q Consensus       283 nIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~-----------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpe  351 (628)
                      ||+++++++.+++.+++||||+.+++|.+++....           .+++..+..++.||+.||+|||++||+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~  159 (296)
T cd05095          80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR  159 (296)
T ss_pred             CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence            99999999999999999999999999999997643           3667789999999999999999999999999999


Q ss_pred             ceEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc--CCCCCCCCc
Q 040472          352 NILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYE  426 (628)
Q Consensus       352 NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt--G~~PF~~~~  426 (628)
                      ||||+.++.++|+|||+++.+.....   .....++..|++||++.+. .++.++|||||||++|||++  |..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999999976533221   1123346789999987654 48999999999999999998  788997654


Q ss_pred             hhHHHhhhc------CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          427 GVAAIFKIG------NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       427 ~~~~~~~i~------~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ....+....      ........+..++..+.+||.+||+.||++||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            433322211      111111234457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.4e-39  Score=327.90  Aligned_cols=246  Identities=25%  Similarity=0.430  Sum_probs=203.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.++....   .   .+.+.+|+.+|++++|+||+++++++. ....|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---S---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---C---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            468999999999999999999876 466799998864221   1   245788999999999999999999875 45689


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999999753  458999999999999999999999999999999999999999999999999997654322


Q ss_pred             c--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 S--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      .  .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... ....+...+..+.+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMPCPQDCPISLHE  234 (260)
T ss_pred             cccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHH
Confidence            1  1223356689999988654 48999999999999999999 999998766555555444322 23455678899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhc
Q 040472          454 FIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ||.+||..+|++||++.++++
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.6e-40  Score=333.49  Aligned_cols=239  Identities=23%  Similarity=0.398  Sum_probs=196.4

Q ss_pred             eeeccCCcEEEEEEEECCCCcE-------EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          226 KLLGRGTFGHVYLGFNSESGQM-------CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~-------vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +.||+|+||.||+|.+..++..       ||+|.+..     ......+.+.+|+.+|+.++|+||+++++++..++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            3699999999999998665543       78887642     12344567888999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC--------EEEeccCCc
Q 040472          299 VYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--------IKLADFGMA  369 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~--------vKL~DFGla  369 (628)
                      +||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.        ++|+|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999999997654 5899999999999999999999999999999999999987764        699999998


Q ss_pred             ccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          370 KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       370 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ......   ....++..|+|||++.+...++.++|||||||++|||++| ..||...+..........   ...++...+
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  229 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---RHQLPAPKW  229 (258)
T ss_pred             cccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---cccCCCCCc
Confidence            755332   2356889999999987655689999999999999999998 567665444333222221   224555677


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||.+||+.||++||++++|++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         230 TELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.3e-39  Score=331.44  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=208.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ++|++.+.||+|+||.||+|+.+.     +.+.||+|.+...    ......+.+.+|+++|++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            589999999999999999999754     3567899977431    2233566788999999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG---------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~---------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                      ...++||||+.+++|.+++....         .+++..+..++.||+.||+|||+++|+||||||+||||+.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999998655         689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCcc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCC
Q 040472          366 FGMAKHMTSCA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE  442 (628)
Q Consensus       366 FGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~  442 (628)
                      ||+++......  ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+..+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            99987543211  22234567789999998654 48899999999999999998 8899976555444444433222223


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+..++..+.++|.+||+.+|++||++.|++++
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-39  Score=342.13  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=205.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCC-------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSES-------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      .+|++++.||+|+||.||+|++...       ...||+|+++..    ......+.+.+|+++++++ +|+||+++++++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            5799999999999999999986432       346899987532    2234457788999999999 799999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV  355 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl  355 (628)
                      ..++.+++||||+.+|+|.++|.+..                .++...+..++.||+.||+|||++||+||||||+||||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            99999999999999999999997532                36778889999999999999999999999999999999


Q ss_pred             CCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHH
Q 040472          356 DPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAI  431 (628)
Q Consensus       356 d~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~  431 (628)
                      +.++.+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|||++ |..||.........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999976543221   1222345679999998654 48999999999999999998 89999876554444


Q ss_pred             hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       432 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ..+.. ......+..++.++.+||.+||+.+|++||++.||+++
T Consensus       247 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 KLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44433 22334556788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.3e-39  Score=327.16  Aligned_cols=246  Identities=26%  Similarity=0.441  Sum_probs=204.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      -++|+++++||+|+||.||+|... +++.||+|.+.....      ...++.+|+.++++++|+||+++++++. .+.++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            358999999999999999999865 567899998863221      1346788999999999999999998874 56789


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++...  ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998753  468999999999999999999999999999999999999999999999999997654222


Q ss_pred             c--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 S--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      .  .....++..|+|||++... .++.++|||||||++|||++ |+.||...........+..... ...+..++.++.+
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-MPRPDNCPEELYE  234 (260)
T ss_pred             cccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCHHHHH
Confidence            1  1223466789999998654 48899999999999999998 9999987665544444433222 2455668899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhc
Q 040472          454 FIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ||.+||+.+|++||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-39  Score=327.52  Aligned_cols=241  Identities=27%  Similarity=0.425  Sum_probs=198.2

Q ss_pred             eeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          227 LLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      .||+|+||.||+|.+.  .++..||||++...    ......+.+.+|+.+|++++|+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999765  44567999988542    22344567889999999999999999999875 45789999999


Q ss_pred             ccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc----cc
Q 040472          305 SGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS----ML  379 (628)
Q Consensus       305 ~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~----~~  379 (628)
                      .+++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++........    ..
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999999975 46789999999999999999999999999999999999999999999999999975533221    11


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...++..|+|||++.+. .++.++|||||||++|||++ |..||...........+... .....+...+.++.+||.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         157 AGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             CCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHH
Confidence            12235789999998654 48999999999999999996 99999876655444443332 23455667899999999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 040472          459 LQRDPSARPPASKLLD  474 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~  474 (628)
                      |..+|++||++.+|++
T Consensus       235 ~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         235 WIYKWEDRPNFAKVEE  250 (257)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.6e-39  Score=328.30  Aligned_cols=244  Identities=23%  Similarity=0.352  Sum_probs=193.4

Q ss_pred             eeeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          226 KLLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      +.||+|+||.||+|...  .++..+|+|.++...    .......+.+|+.++++++|+||+++++++.+...+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            46999999999999754  355779999876432    123345688899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          304 VSGGSIHKLLQEYG-----PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       304 ~~GgsL~~~L~~~~-----~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      +.+|+|.++|....     .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999999997532     456778889999999999999999999999999999999999999999999975433221 


Q ss_pred             --cccccCCCCcCChhhhhccC------CCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCC----CCCCCCC
Q 040472          378 --MLSFKGSPYWMAPEVVMNTN------GYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNS----KDIPEIP  444 (628)
Q Consensus       378 --~~~~~GT~~Y~APEvl~~~~------~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~----~~~~~~p  444 (628)
                        .....++..|+|||++.+..      .++.++|||||||++|||++ |..||...............    ...+.+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              12345788899999985321      35789999999999999996 99999765544433222111    1112333


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          445 EHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...+..+.++|++|+ .+|++||+++||+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356788999999999 68999999999973

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=325.02  Aligned_cols=248  Identities=26%  Similarity=0.425  Sum_probs=207.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+.....      ..+++.+|+.++++++|+||+++++++..+...
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            3578999999999999999999976 457899998863211      135678899999999999999999999998999


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ++||||+.+++|.+++...  ..+++..+..++.||+.||+|||++||+|+||||+||||+.++.+||+|||++......
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999999999764  36899999999999999999999999999999999999999999999999998765432


Q ss_pred             cc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 AS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..  .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||........+..+..... ...+...+.++.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-MPRPPNCPEELY  234 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHH
Confidence            11  1122345689999998654 48999999999999999998 9999987665555555543322 233455788999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++|.+||+.+|++||+++++++
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=323.99  Aligned_cols=242  Identities=25%  Similarity=0.448  Sum_probs=201.6

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      ++||+|+||.||+|.+.. ++.||+|+++....    .+....+.+|++++++++|+||+++++++.+....++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            469999999999999887 99999998864221    2345678899999999999999999999999999999999999


Q ss_pred             cccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc---ccc
Q 040472          306 GGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM---LSF  381 (628)
Q Consensus       306 GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~---~~~  381 (628)
                      |++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||||+.++.+||+|||++.........   ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9999999975 356889999999999999999999999999999999999999999999999999765421111   112


Q ss_pred             cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhh
Q 040472          382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ  460 (628)
Q Consensus       382 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  460 (628)
                      .++..|+|||++.+. .++.++|||||||++|||++ |..||...........+.... ....+..++.++.+||.+||+
T Consensus       156 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~  233 (251)
T cd05041         156 QIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMPAPQLCPEEIYRLMLQCWA  233 (251)
T ss_pred             cceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHhc
Confidence            245679999998654 48999999999999999998 899997765444333333222 223456788999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 040472          461 RDPSARPPASKLLD  474 (628)
Q Consensus       461 ~dP~~Rpta~eiL~  474 (628)
                      .+|++||++.||++
T Consensus       234 ~~p~~Rp~~~ell~  247 (251)
T cd05041         234 YDPENRPSFSEIYN  247 (251)
T ss_pred             cChhhCcCHHHHHH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.5e-39  Score=326.17  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=202.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|.+..+ ..+|||.+.....      ..+.+.+|+++|+.++|+||+++++++. .+..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            35799999999999999999988765 4599998753211      1245778999999999999999998875 45689


Q ss_pred             EEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++...  ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999999999764  347899999999999999999999999999999999999999999999999997653322


Q ss_pred             --ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 --SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                        ......++..|+|||++.+. .++.++|||||||++|||++ |..||...........+... .....+..++..+.+
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHE  234 (260)
T ss_pred             ccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHH
Confidence              11223466789999988654 48999999999999999999 99999876555444444332 223445678899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhc
Q 040472          454 FIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ||++||+.||++||++++|++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.5e-39  Score=330.01  Aligned_cols=249  Identities=29%  Similarity=0.501  Sum_probs=199.0

Q ss_pred             CCeEEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--
Q 040472          220 SKWKKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--  293 (628)
                      .+|++.+.||+|+||.||+|.    +..+++.||||++...     .....+.+.+|+++|++++|+||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            479999999999999999997    4567889999987632     23445678899999999999999999997653  


Q ss_pred             cccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ...+++||||+.+++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            45689999999999999999764 56899999999999999999999999999999999999999999999999999865


Q ss_pred             cCcccc----ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---------------HHHhh
Q 040472          373 TSCASM----LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---------------AAIFK  433 (628)
Q Consensus       373 ~~~~~~----~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---------------~~~~~  433 (628)
                      ......    ....++..|+|||++.+. .++.++|||||||++|||++|..++......               ..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            432211    112234569999998654 4899999999999999999987775432111               00111


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +.........+..++.++.+||.+||+.+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11111122334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.3e-39  Score=328.43  Aligned_cols=254  Identities=28%  Similarity=0.507  Sum_probs=210.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECC-CCcEEEEEEEeecccc-----cchHHHHHHHHHHHHHHHh-CCCCCeeeeecceec
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSE-SGQMCAIKEVRVVCDD-----QTSKECLKQLNQEINLLSQ-LSHPNIVRYHGSELS  293 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~-----~~~~~~~~~~~~Ei~iL~~-l~HpnIV~l~~~~~~  293 (628)
                      .|++.+.||+|+||.||+|++.. +++.+|||.+......     ......+.++.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999987 6889999988643221     1223455667789988875 789999999999999


Q ss_pred             cccceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                      ++..++||||+.|++|.+++..    ...+++..++.++.|++.||.|||+ .+|+|+||+|+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998743    3568999999999999999999996 7899999999999999999999999999


Q ss_pred             cccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      +.............|+..|++||++.+. .++.++|||||||++|+|++|..||...........+......+.....++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS  239 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence            9876554444556789999999998754 489999999999999999999999987655544444433332222233578


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||++||+.||++||++.|+..+
T Consensus       240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         240 EDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.8e-39  Score=328.76  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=206.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-  293 (628)
                      .++|++.++||+|+||.||+|.+..    ++..||+|.++.    .......+.+.+|+.+|+.++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4689999999999999999999876    357899998752    1234446778899999999999999999998665 


Q ss_pred             cccceEEEEecccccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY--------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~--------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                      +...++++||+.+++|.+++...        ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            57889999999999999999753        4588999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCcccc---ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCC
Q 040472          366 FGMAKHMTSCASM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIP  441 (628)
Q Consensus       366 FGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~  441 (628)
                      ||+++.+......   ....++..|+|||++.+. .++.++|||||||++|||++ |+.||...+.......+..... .
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~  238 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR-L  238 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-C
Confidence            9999865432211   123456789999998655 48999999999999999998 9999987655444333333222 2


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..+..++.++.++|.+||..||++||++.++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            334567899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.2e-39  Score=341.98  Aligned_cols=255  Identities=30%  Similarity=0.511  Sum_probs=208.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-ccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-DER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-~~~  296 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.....   .....+.+.+|+.+++.++||||++++++|.. ...
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            45689999999999999999999999999999998754221   12234667789999999999999999998876 567


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      .|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+++|+||||+|.|||++.++.+||+|||++.....  
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--  160 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--  160 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence            89999998 6689888864 5688999999999999999999999999999999999999999999999999975433  


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc---------------------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG---------------------  435 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~---------------------  435 (628)
                      ......++..|+|||++.+...++.++|||||||++|+|++|+.||...+.......+.                     
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            22345688999999987654568999999999999999999999997644321111000                     


Q ss_pred             ------CCCC--CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          436 ------NSKD--IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       436 ------~~~~--~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                            ....  .......++.++.++|++||+.+|++||++++++.|+||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~  292 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA  292 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence                  0000  0011234778999999999999999999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-39  Score=322.32  Aligned_cols=242  Identities=26%  Similarity=0.436  Sum_probs=200.7

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecc
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      ++||+|+||.||+|... ++..||+|+++...    ..+....+.+|+++++.++|+||+++++++......++||||+.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            36999999999999865 68899999875322    23334568889999999999999999999999999999999999


Q ss_pred             cccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc--cccc
Q 040472          306 GGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM--LSFK  382 (628)
Q Consensus       306 GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~--~~~~  382 (628)
                      +++|.+++... ..+.+..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  ....
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99999998753 46899999999999999999999999999999999999999999999999998754332111  1123


Q ss_pred             CCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhc
Q 040472          383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       383 GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      ++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... ....+..++.++.+|+.+||+.
T Consensus       156 ~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         156 IPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-RMSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             CcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccc
Confidence            46679999998654 48999999999999999998 999998765554444443322 2345567889999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 040472          462 DPSARPPASKLLD  474 (628)
Q Consensus       462 dP~~Rpta~eiL~  474 (628)
                      +|++||++.++++
T Consensus       234 ~p~~Rp~~~~l~~  246 (250)
T cd05085         234 KPENRPKFSELQK  246 (250)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.2e-39  Score=327.62  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=193.8

Q ss_pred             eeeccCCcEEEEEEEECC--CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          226 KLLGRGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      +.||+|+||.||+|....  ....+|+|.+...    ........+.+|+.+++.++|+||+++++++.+...+|+||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            359999999999996532  3456788866431    1233456678899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          304 VSGGSIHKLLQEYG-----PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       304 ~~GgsL~~~L~~~~-----~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      +.+|+|.++|....     .+.+..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999999997643     246788899999999999999999999999999999999999999999999875432211 


Q ss_pred             --cccccCCCCcCChhhhhc------cCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCC----CCCCCC
Q 040472          378 --MLSFKGSPYWMAPEVVMN------TNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSK----DIPEIP  444 (628)
Q Consensus       378 --~~~~~GT~~Y~APEvl~~------~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~----~~~~~p  444 (628)
                        .....++..|+|||++..      ...++.++|||||||++|||++ |..||........+..+....    ..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              122345678999999743      2346889999999999999999 888997765554444332222    123445


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          445 EHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..++..+.+++..|+ .||++||++++|++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            568889999999999 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=355.74  Aligned_cols=245  Identities=27%  Similarity=0.425  Sum_probs=211.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      ..+.|.+...||.|+|+.|..+.+..+++.+++|++....         .+..+|+.++... +|+||+++++.+.++.+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc---------cccccccchhhhhcCCCcceeecceecCCce
Confidence            4578888899999999999999999999999999986531         2234577666555 59999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe-CCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV-DPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl-d~~g~vKL~DFGla~~~~~~  375 (628)
                      .|+|||++.|+.|.+.|.....+. .++..|++||+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999999999999988766555 7888999999999999999999999999999999 68899999999999877654


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                        ..+.|-|..|.|||++. ..+|+.++||||||++||+||+|+.||........+.....   .+.+...+|.++++||
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~---~~~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ---MPKFSECVSDEAKDLL  543 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc---CCccccccCHHHHHHH
Confidence              44557789999999997 45699999999999999999999999977555434433322   2334478999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ++||+.||.+|+++.+|+.|+||
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-38  Score=322.07  Aligned_cols=247  Identities=26%  Similarity=0.448  Sum_probs=204.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+|++.+.||+|+||.||+|.+. ++..+|||.++.....      ...+.+|+++|++++|+||+++++++......++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            57899999999999999999886 4678999987532111      2457789999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.+++|.+++... +.+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++........ 
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999999999764 5689999999999999999999999999999999999999999999999999875533211 


Q ss_pred             -cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          378 -MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       .....++..|+|||++.+. .++.++|||||||++|||++ |..||........+..+.... ....+...+.++.+|+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  234 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKPRLASQSVYELM  234 (256)
T ss_pred             ccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-CCCCCCCCCHHHHHHH
Confidence             1223356789999998654 48999999999999999998 999998655444444433221 2233445789999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcC
Q 040472          456 KQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+||+.+|++||++.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-38  Score=325.54  Aligned_cols=250  Identities=26%  Similarity=0.439  Sum_probs=206.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ..+|.+.++||+|+||.||+|.+...   ...||||......    ..+..+.+.+|+.+++.++|+||+++++++.+ .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            35789999999999999999987544   3468999775322    13345678899999999999999999998875 5


Q ss_pred             cceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..|+||||+.+++|.+++.+.. .+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            6789999999999999998643 589999999999999999999999999999999999999999999999999976543


Q ss_pred             cccc--ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CASM--LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~~~--~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ....  ....++..|+|||++... .++.++|||||||++|||++ |..||...........+...... ..+..++.++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTL  237 (270)
T ss_pred             ccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHH
Confidence            3221  122345689999988654 58999999999999999886 99999877665555555443332 4556788999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+||.+||..+|.+||++.++++.
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-39  Score=326.97  Aligned_cols=239  Identities=22%  Similarity=0.353  Sum_probs=191.7

Q ss_pred             eeeccCCcEEEEEEEECCC------------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          226 KLLGRGTFGHVYLGFNSES------------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~t------------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      +.||+|+||.||+|+....            ...||+|++...     .......+.+|+.+|+.++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3699999999999975322            235788876431     22334567889999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC-------EEEec
Q 040472          294 DERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE-------IKLAD  365 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~-------vKL~D  365 (628)
                      +...++||||+.+++|..++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.       ++|+|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999999998875 457999999999999999999999999999999999999987664       89999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeec-cCCCCCCCCchhHHHhhhcCCCCCCCCC
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA-TSKPPWSQYEGVAAIFKIGNSKDIPEIP  444 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelL-tG~~PF~~~~~~~~~~~i~~~~~~~~~p  444 (628)
                      ||++......   ....++..|+|||++.+...++.++|||||||++|||+ .|..||......+. ..+....  ....
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~--~~~~  229 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ--CMLV  229 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC--ccCC
Confidence            9998755322   23458889999999865566899999999999999997 58888875432221 2221111  1122


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ...+.++.+||.+||+.||++||++.+|+++
T Consensus       230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            2356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.1e-39  Score=330.46  Aligned_cols=238  Identities=26%  Similarity=0.355  Sum_probs=191.3

Q ss_pred             eeccCCcEEEEEEEECCC------------------------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC
Q 040472          227 LLGRGTFGHVYLGFNSES------------------------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP  282 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~t------------------------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp  282 (628)
                      +||+|+||.||+|....+                        ...||+|++...     .......+.+|+.+++.++|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence            699999999999975321                        235788877531     223345678899999999999


Q ss_pred             CeeeeecceeccccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC--
Q 040472          283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG--  359 (628)
Q Consensus       283 nIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g--  359 (628)
                      ||+++++++..+...++||||+.+|+|..++.+ .+.+++..+..++.||+.||+|||+++|+||||||+||||+.++  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999999975 56789999999999999999999999999999999999997644  


Q ss_pred             -----CEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeee-ccCCCCCCCCchhHHHhh
Q 040472          360 -----EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYEGVAAIFK  433 (628)
Q Consensus       360 -----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyel-LtG~~PF~~~~~~~~~~~  433 (628)
                           .+||+|||++......   ....++..|+|||++.+...++.++|||||||++||| ++|..||...........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                 3899999988644322   2235788899999987655689999999999999998 479999976543322111


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +...   ..++.....++.+||.+||+.+|++||++.+||++
T Consensus       234 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1111   12334456789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.5e-39  Score=325.04  Aligned_cols=229  Identities=25%  Similarity=0.381  Sum_probs=192.6

Q ss_pred             CCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccccHH
Q 040472          231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIH  310 (628)
Q Consensus       231 G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~GgsL~  310 (628)
                      |.||.||+|+++.+++.||+|+++...          ...+|...+....||||+++++++.+.+.+++||||+.|++|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999986421          1223455555667999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCCh
Q 040472          311 KLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP  390 (628)
Q Consensus       311 ~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~AP  390 (628)
                      +++.+...+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++......  .....++..|+||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aP  151 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAP  151 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCC
Confidence            99988888999999999999999999999999999999999999999999999999988655432  2334567889999


Q ss_pred             hhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCH-
Q 040472          391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA-  469 (628)
Q Consensus       391 Evl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta-  469 (628)
                      |.+.+. .++.++|||||||++|||++|+.||......  +.    ......++..++..+++||++||+.||++|+++ 
T Consensus       152 E~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         152 EVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG--IN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh--cc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            987544 4889999999999999999999887643211  10    011123556789999999999999999999985 


Q ss_pred             ----HHHhcCccc
Q 040472          470 ----SKLLDHPFV  478 (628)
Q Consensus       470 ----~eiL~Hpwf  478 (628)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=319.83  Aligned_cols=252  Identities=28%  Similarity=0.420  Sum_probs=205.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER-  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~-  296 (628)
                      +-++|++.+.||+|||+.||++++..+++.||+|.+..     ...+.++...+|++..++++||||++++++...+.. 
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeec-----cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            45799999999999999999999999999999998753     224567888999999999999999999998776544 


Q ss_pred             ----ceEEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCCEEEecc
Q 040472          297 ----LSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       297 ----~~lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~vKL~DF  366 (628)
                          .||++.|...|+|.+.|++.    ..++|.++..|+.+|++||++||+..  ++||||||.|||+...+.++|.||
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence                99999999999999999753    36899999999999999999999998  999999999999999999999999


Q ss_pred             CCcccccCc----------cccccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchh--HHHh
Q 040472          367 GMAKHMTSC----------ASMLSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--AAIF  432 (628)
Q Consensus       367 Gla~~~~~~----------~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--~~~~  432 (628)
                      |.+....-.          +.......|..|+|||.+.-  ....+.++|||||||+||.|+.|..||+..-..  ....
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            998754221          11112346889999998731  223689999999999999999999999642211  1111


Q ss_pred             hhcC-CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          433 KIGN-SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       433 ~i~~-~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+.+ ...+|.- ..+++.+.+||+.||+.||.+||++.+++.+
T Consensus       254 Av~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  254 AVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111 1122322 2389999999999999999999999999864

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3e-38  Score=321.29  Aligned_cols=247  Identities=25%  Similarity=0.441  Sum_probs=203.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|.+. .+..||+|++...      ......+.+|+++++.++|+||+++++++.+ ...
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            3568999999999999999999865 4567999987531      2234678889999999999999999999887 788


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ++||||+.+++|.+++...  ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999999763  45788889999999999999999999999999999999999999999999999765432


Q ss_pred             cc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 AS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..  .....++..|+|||++... .++.++|||||||++|+|++ |+.||...........+..... ...+..++.++.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPRPENCPEELY  233 (260)
T ss_pred             CcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-CCCcccCCHHHH
Confidence            21  1223356779999998654 48999999999999999998 9999987655444444433322 234456889999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +++.+||+.+|++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=325.96  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=206.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCc----EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQ----MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..+|++++.||+|+||.||+|.++.+++    .||+|.+....    .......+.+|+.+|++++|+||+++++++.. 
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            4689999999999999999999877665    58888775322    23445678899999999999999999999887 


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ...++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999999864 568999999999999999999999999999999999999999999999999998664


Q ss_pred             Ccccccc---ccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          374 SCASMLS---FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       374 ~~~~~~~---~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      .......   ..++..|+|||.+... .++.++|||||||++|||++ |..||...........+.. ......+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTI  238 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCH
Confidence            3322111   2235679999988644 48999999999999999998 9999987654443333332 222344556788


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.++|.+||..||.+||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-38  Score=323.01  Aligned_cols=244  Identities=26%  Similarity=0.451  Sum_probs=195.3

Q ss_pred             eeeccCCcEEEEEEEECC---CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee-ccccceEEE
Q 040472          226 KLLGRGTFGHVYLGFNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL-SDERLSVYL  301 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~-~~~~~~lVm  301 (628)
                      +.||+|+||.||+|.+..   +...||||.+...    ......+.+.+|+.+++.++|+||+++++++. .+...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            469999999999998643   3457999987431    12334567888999999999999999999765 466789999


Q ss_pred             EecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc----
Q 040472          302 EYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA----  376 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~----  376 (628)
                      ||+.+++|.+++.+. ..+.+..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999999764 456778888999999999999999999999999999999999999999999997543221    


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                       ......++..|+|||++.+. .++.++|||||||++|||++ |.+||...+.......+... .....+..++..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  234 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEV  234 (262)
T ss_pred             cccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHH
Confidence             11233467789999998654 48999999999999999999 56677665544433333322 2233455678899999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcC
Q 040472          455 IKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.+||+.+|++||++.+|++.
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-38  Score=323.59  Aligned_cols=250  Identities=28%  Similarity=0.484  Sum_probs=202.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEEC----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNS----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--  293 (628)
                      .+|++.+.||+|+||.||+|...    .+++.||||+++.....    ...+.+.+|+++++.+.|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            46888899999999999999864    34889999998643221    345778999999999999999999998877  


Q ss_pred             cccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ....++||||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            568999999999999999997654 6899999999999999999999999999999999999999999999999999876


Q ss_pred             cCcccc----ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh--------------HHHhhh
Q 040472          373 TSCASM----LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--------------AAIFKI  434 (628)
Q Consensus       373 ~~~~~~----~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--------------~~~~~i  434 (628)
                      ......    ....++..|++||.+.+. .++.++|||||||++|||++|..||......              ..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            532211    112345679999998655 4899999999999999999999998643211              111111


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       435 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .........+..++.++.+||.+||+.+|++||++.||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111112234457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.9e-39  Score=326.07  Aligned_cols=243  Identities=26%  Similarity=0.475  Sum_probs=200.1

Q ss_pred             eeeccCCcEEEEEEEECCCC------cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          226 KLLGRGTFGHVYLGFNSESG------QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +.||+|+||.||+|+++...      +.||||.+....    .......+.+|+++|+.++|+||+++++++...+..++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            46999999999999876544      789999875321    12335678889999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-----CEEEeccC
Q 040472          300 YLEYVSGGSIHKLLQEY-------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-----EIKLADFG  367 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-----~vKL~DFG  367 (628)
                      ||||+.+++|.+++...       ..+++..+..++.||+.||+|||+++++|+||||+|||++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999999742       3478899999999999999999999999999999999999877     89999999


Q ss_pred             CcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCC
Q 040472          368 MAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEI  443 (628)
Q Consensus       368 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~  443 (628)
                      +++.......   .....++..|+|||++.+. .++.++|||||||++|||++ |..||...........+... .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCC
Confidence            9976533211   1223457889999998755 48999999999999999998 99999876655544444322 23345


Q ss_pred             CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       444 p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +..++..+.+||.+||+.+|.+||++.+|++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5678899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-38  Score=322.96  Aligned_cols=242  Identities=27%  Similarity=0.475  Sum_probs=200.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++.+.||+|+||.||++.  .+++.||+|.++...       ....+.+|+.+|++++|+||+++++++..+ ..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            5689999999999999999985  468889999875311       124678899999999999999999998764 479


Q ss_pred             EEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          299 VYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +||||+.+++|.+++....  .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999999997643  5789999999999999999999999999999999999999999999999998754322 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       ......+..|+|||++.+. .++.++|||||||++|||++ |+.||...........+... .....+..++.++.+||
T Consensus       154 -~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  230 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLM  230 (254)
T ss_pred             -CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHH
Confidence             1223345679999988654 48999999999999999997 99999876554433333322 22334556889999999


Q ss_pred             HHHhhcCCCCCCCHHHHhc
Q 040472          456 KQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++||+.+|++||++.+|++
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-38  Score=322.39  Aligned_cols=236  Identities=26%  Similarity=0.396  Sum_probs=192.3

Q ss_pred             eeeccCCcEEEEEEEECCCC----------cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          226 KLLGRGTFGHVYLGFNSESG----------QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg----------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      +.||+|+||.||+|.+..++          ..|++|++....     .. ...+.+|+.+|+.++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hh-HHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46999999999999998776          347777664311     11 4678889999999999999999999888 7


Q ss_pred             cceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-------CEEEeccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-------EIKLADFG  367 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-------~vKL~DFG  367 (628)
                      ..++||||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            8899999999999999998765 799999999999999999999999999999999999999887       79999999


Q ss_pred             CcccccCccccccccCCCCcCChhhhhcc-CCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCC
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPE  445 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~  445 (628)
                      ++.....   .....++..|+|||++.+. ..++.++|||||||++|||++ |..||................   ..+.
T Consensus       154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~---~~~~  227 (259)
T cd05037         154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH---RLPM  227 (259)
T ss_pred             ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC---CCCC
Confidence            9986543   2234477889999998654 358999999999999999999 688886654322222221111   1222


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .....+.+||.+||..+|.+||++.+|++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            23478999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-38  Score=329.99  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=202.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcE----EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..+|++.+.||+|+||.||+|.+..++..    ||+|.+...    ........+.+|+.+++.++|+||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            46889999999999999999998877764    677766432    1223344678899999999999999999988754


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                       ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             577999999999999999764 368999999999999999999999999999999999999999999999999998654


Q ss_pred             Cccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          374 SCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       374 ~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ....   .....++..|+|||++.+. .++.++|||||||++|||++ |..||........ ..+.........+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQPPICTI  238 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCH
Confidence            3221   1223457789999998654 48999999999999999997 9999976543222 222222222333455788


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+.++|.+||..+|++||++.++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=353.09  Aligned_cols=259  Identities=36%  Similarity=0.666  Sum_probs=225.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceec-----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELS-----  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~-----  293 (628)
                      +-|++.++||.|.+|+||+++++.+++..|||++....+.+      +.+..|.+||+.+. |||++.+|++|.-     
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE------EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc------HHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            56899999999999999999999999999999987543322      44667899999886 9999999998763     


Q ss_pred             cccceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ++.+|||||||.||+..++++.  ...+.|+.++.|++.++.||.+||.+.+||||||-.|||++.++.|||+|||++.+
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            5789999999999999999985  35799999999999999999999999999999999999999999999999999987


Q ss_pred             ccC-ccccccccCCCCcCChhhhhcc----CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC-CCCC
Q 040472          372 MTS-CASMLSFKGSPYWMAPEVVMNT----NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP-EIPE  445 (628)
Q Consensus       372 ~~~-~~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~-~~p~  445 (628)
                      +.. .....+.+|||.|||||++.-.    ..|+..+|+||||++..||.-|.+|+...-.+..++.|....... .-|+
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence            755 3456778899999999998532    237889999999999999999999999888888888886654322 2367


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      ..++++.+||..||.+|.++||+..++|+|||++++..+
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~~e  291 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQPNE  291 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccccccH
Confidence            789999999999999999999999999999999865533

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=336.26  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=215.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccc--ccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-ccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD--DQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-DER  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-~~~  296 (628)
                      ++|-++.+||+|||+.||+|.+....++||||+-.+...  +.......++..+|..|.+.|.||.||++|++|.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            467788999999999999999999999999998654322  22334567789999999999999999999999864 567


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeC---CCCCEEEeccCCccc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVD---PHGEIKLADFGMAKH  371 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld---~~g~vKL~DFGla~~  371 (628)
                      ++-|+|||+|.+|..+|+.+.-++|.+++.|+.||+.||.||.+..  |||-||||.|||+-   .-|.+||+||||++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            8899999999999999999999999999999999999999999874  99999999999994   347899999999998


Q ss_pred             ccCccc--------cccccCCCCcCChhhhhc---cCCCCccccccccccceeeeccCCCCCCCCchhHHHhh---hcCC
Q 040472          372 MTSCAS--------MLSFKGSPYWMAPEVVMN---TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK---IGNS  437 (628)
Q Consensus       372 ~~~~~~--------~~~~~GT~~Y~APEvl~~---~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~---i~~~  437 (628)
                      +.....        .....||.||++||.+.-   -..++.|+||||+|||+|.+|+|+.||........+..   |...
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            765322        223679999999998743   34578999999999999999999999975433222222   2221


Q ss_pred             CCCC-CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 KDIP-EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 ~~~~-~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ..+. ...+.++.++++||++||++.-++|..+.++..||||...
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            1111 1124589999999999999999999999999999999763

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=361.93  Aligned_cols=250  Identities=25%  Similarity=0.472  Sum_probs=213.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC-C----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES-G----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      -...++++.||+|+||.||.|..... +    ..||||.++...    +.+.+.+|.+|..+|+.++|||||+|+|++.+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~----~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS----SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            45678889999999999999976433 2    348999887533    34557789999999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEecc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY-------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DF  366 (628)
                      ....+|++|||+||+|..+|++.       ..+.....+.++.||+.|+.||+++++|||||.+.|+||+....|||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999875       34888999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCcccc-ccc--cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCC
Q 040472          367 GMAKHMTSCASM-LSF--KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE  442 (628)
Q Consensus       367 Gla~~~~~~~~~-~~~--~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~  442 (628)
                      |||+.+.....+ ...  .--..|||||.++.. .++.|+|||||||+|||+++ |..||....+.+.+....... .-.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~  924 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD  924 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence            999954332211 111  233579999999864 59999999999999999999 999999888877766555544 345


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .|..++..+.+||.+||+.+|++||++..|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            67889999999999999999999999999987

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-38  Score=329.07  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=190.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccc-hHHHH-----HHHHHHHHHHHhCCCCCeeeeec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQT-SKECL-----KQLNQEINLLSQLSHPNIVRYHG  289 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~-~~~~~-----~~~~~Ei~iL~~l~HpnIV~l~~  289 (628)
                      -.+|++.++||+|+||+||+|.+..+   +..+|+|+......... +....     .....++..+..+.|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998877   66778886543222111 01111     11223445566778999999998


Q ss_pred             ceeccc----cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          290 SELSDE----RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       290 ~~~~~~----~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                      ++....    ..+++||++. .++.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            765543    3467788773 47777777666678999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCcc--------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH-------
Q 040472          366 FGMAKHMTSCA--------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA-------  430 (628)
Q Consensus       366 FGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~-------  430 (628)
                      ||+|+.+....        ......||+.|+|||++.+. .++.++|||||||+||||++|..||........       
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            99998653211        12235699999999998654 489999999999999999999999977632211       


Q ss_pred             --HhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          431 --IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       431 --~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                        +.++....   ......+.++.++++.||+.+|++||++++|++
T Consensus       249 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 DFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              11111111   112346789999999999999999999999874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.2e-39  Score=367.68  Aligned_cols=253  Identities=30%  Similarity=0.530  Sum_probs=203.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee------
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL------  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~------  292 (628)
                      +.+|+.+++||+||||.||+++++-+|+.||||+|....    .......+.+|+++|.+|+|||||++|..+.      
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            468899999999999999999999999999999886532    3555678999999999999999999883211      


Q ss_pred             -----------------------------------------------------c--------------------------
Q 040472          293 -----------------------------------------------------S--------------------------  293 (628)
Q Consensus       293 -----------------------------------------------------~--------------------------  293 (628)
                                                                           +                          
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                 0                          


Q ss_pred             --------------------------c--------ccceEEEEecccccHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 040472          294 --------------------------D--------ERLSVYLEYVSGGSIHKLLQEYGPF-NEPVIQTYTRQILLGLAYL  338 (628)
Q Consensus       294 --------------------------~--------~~~~lVmEy~~GgsL~~~L~~~~~l-~e~~~~~i~~qIl~aL~yL  338 (628)
                                                +        ..+||-||||+.-.|.++++++... ....++.+++||++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                      0        1256779999988888888775544 4677899999999999999


Q ss_pred             HhCCccccccCCCceEeCCCCCEEEeccCCccccc-------------------CccccccccCCCCcCChhhhhccC--
Q 040472          339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-------------------SCASMLSFKGSPYWMAPEVVMNTN--  397 (628)
Q Consensus       339 H~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-------------------~~~~~~~~~GT~~Y~APEvl~~~~--  397 (628)
                      |++|||||||||.||+++.++.|||+|||+|+...                   .....+..+||.-|+|||++.+..  
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999999999999999999997611                   112345678999999999997665  


Q ss_pred             CCCccccccccccceeeeccCCCCCCC-CchhHHHhhhcCCCCCCCC---CCcCCHHHHHHHHHHhhcCCCCCCCHHHHh
Q 040472          398 GYSLTVDIWSLGCTVLEMATSKPPWSQ-YEGVAAIFKIGNSKDIPEI---PEHLSDDAKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       398 ~~s~ksDIWSLGvlLyelLtG~~PF~~-~~~~~~~~~i~~~~~~~~~---p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      .|+.|+|||||||||+||+.   ||.. .+....+..+. ...+|..   +..--+.-..+|+.||+.||.+||||.|+|
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            69999999999999999997   4643 33344444443 3333332   333345677899999999999999999999


Q ss_pred             cCcccc
Q 040472          474 DHPFVR  479 (628)
Q Consensus       474 ~Hpwf~  479 (628)
                      ++.||.
T Consensus       870 ~s~llp  875 (1351)
T KOG1035|consen  870 NSELLP  875 (1351)
T ss_pred             hccCCC
Confidence            999997

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.1e-38  Score=320.20  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             eEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          222 WKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      |++.++||+|+||.||+|.+.   .+++.||||++....   ......+++.+|+++|++++||||+++++++...+   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            677889999999999999864   357899999886422   22334567889999999999999999999876532   


Q ss_pred             ---cceEEEEecccccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEecc
Q 040472          296 ---RLSVYLEYVSGGSIHKLLQEY------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       296 ---~~~lVmEy~~GgsL~~~L~~~------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DF  366 (628)
                         ..++++||+.+|+|.+++...      ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               247889999999999887532      24788999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCC
Q 040472          367 GMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE  442 (628)
Q Consensus       367 Gla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~  442 (628)
                      |+++.......   .....+++.|++||.+... .++.++|||||||++|||++ |.+||...+.......+..... ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CC
Confidence            99986533221   1223456789999998654 48899999999999999999 8999977655443333333222 23


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+...+..+.+|+.+||+.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            345678899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.1e-38  Score=320.21  Aligned_cols=243  Identities=20%  Similarity=0.305  Sum_probs=191.1

Q ss_pred             eeccCCcEEEEEEEECCC--CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEec
Q 040472          227 LLGRGTFGHVYLGFNSES--GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYV  304 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~t--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~  304 (628)
                      .||+|+||.||+|....+  ...+++|.++..    ......+.+.+|+.+++.++||||+++++++.+...+|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999975433  234556655431    11234567889999999999999999999999999999999999


Q ss_pred             ccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---cc
Q 040472          305 SGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---AS  377 (628)
Q Consensus       305 ~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---~~  377 (628)
                      .+|+|.+++.+.    ..+.+..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......   ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999999753    34567788899999999999999999999999999999999999999999998643221   11


Q ss_pred             cccccCCCCcCChhhhhcc------CCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCC----CCCCCCCc
Q 040472          378 MLSFKGSPYWMAPEVVMNT------NGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSK----DIPEIPEH  446 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~------~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~----~~~~~p~~  446 (628)
                      ....+++..|+|||++...      ..++.++|||||||++|||++ |..||......+.+.++....    ..+.+...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2345688999999987431      235789999999999999996 577887665544444332221    12344455


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++..+.++|..|| .+|++||++++|++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7889999999999 67999999999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=351.53  Aligned_cols=244  Identities=31%  Similarity=0.532  Sum_probs=199.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE----  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~----  295 (628)
                      .-|...+.||+|+||.||+++++.+|+.||||.++...    ...-.+...+|++||++|+|+|||+++++-.+..    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            46788899999999999999999999999999987532    2233567789999999999999999999876544    


Q ss_pred             --cceEEEEecccccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC--CCCC--EEEecc
Q 040472          296 --RLSVYLEYVSGGSIHKLLQE---YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD--PHGE--IKLADF  366 (628)
Q Consensus       296 --~~~lVmEy~~GgsL~~~L~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld--~~g~--vKL~DF  366 (628)
                        .-.+|||||.||+|+.+|++   ...|+|.+++.++.++..||.|||++|||||||||+||++-  .+|+  .||+||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence              56789999999999999975   35699999999999999999999999999999999999983  3453  799999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH----HHhhhcCCC----
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA----AIFKIGNSK----  438 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~----~~~~i~~~~----  438 (628)
                      |.|+.+.++....+++||+.|++||++.+.+.|+..+|.|||||++|+++||..||.......    .+..+....    
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            999999998888999999999999999766779999999999999999999999996543321    222221111    


Q ss_pred             ---------------CCCCCCCcCCHH----HHHHHHHHhhcCCCCCC
Q 040472          439 ---------------DIPEIPEHLSDD----AKSFIKQCLQRDPSARP  467 (628)
Q Consensus       439 ---------------~~~~~p~~~s~~----l~dLI~~~L~~dP~~Rp  467 (628)
                                     ..-.++.+++..    +..+|..+|..++++|-
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                           000123444444    34567788999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-40  Score=323.65  Aligned_cols=259  Identities=26%  Similarity=0.472  Sum_probs=209.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      .+.|....+||+|.||.||+|+.+++++.||+|++-......   ..-....+|++||+.|+|+|++.++..|...    
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            457888899999999999999999999999998653311111   1123456799999999999999999877642    


Q ss_pred             ----ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          295 ----ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       295 ----~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                          ..+||||.+|+. +|.-+|... .+|+..++..++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence                348999999976 888888765 67999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCc-----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC------CC
Q 040472          370 KHMTSC-----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN------SK  438 (628)
Q Consensus       370 ~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~------~~  438 (628)
                      +.+...     ..++..+.|.+|++||.+.+...|+.+.|||+.||||.||.++.+-|.+..+..++.-|..      ..
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            765322     2234456799999999999999999999999999999999999999987655444433211      01


Q ss_pred             CCCC--------------CCC-------------cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 DIPE--------------IPE-------------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ~~~~--------------~p~-------------~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .+|.              +++             .-.+++.+||.+||..||.+|+.++++|+|.||...
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            1110              110             123588999999999999999999999999999543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=327.42  Aligned_cols=254  Identities=27%  Similarity=0.414  Sum_probs=206.5

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC--CCC----eeeeecc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS--HPN----IVRYHGS  290 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--Hpn----IV~l~~~  290 (628)
                      ....+|++..+||+|.||+|-.+.+..++..||||+++..      ...-+...-|+++|+++.  .|+    +|++.++
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            3457999999999999999999999999999999998742      122334566999999994  233    8899999


Q ss_pred             eeccccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC------------
Q 040472          291 ELSDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD------------  356 (628)
Q Consensus       291 ~~~~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld------------  356 (628)
                      |...++.+||+|.+ |-+++++|.++  .+|+...++.|++||+++++|||+++++|.||||||||+-            
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            99999999999998 77999999875  4789999999999999999999999999999999999983            


Q ss_pred             --------CCCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh
Q 040472          357 --------PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV  428 (628)
Q Consensus       357 --------~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~  428 (628)
                              .+-.|+|+|||.|+....  .+.+++.|..|+|||++++-+ ++..+||||+||||+|+.+|...|...++.
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcH
Confidence                    123599999999986443  346778999999999999875 999999999999999999999999776644


Q ss_pred             HH---HhhhcCCC-------------------CCCCC------------C----------CcCCHHHHHHHHHHhhcCCC
Q 040472          429 AA---IFKIGNSK-------------------DIPEI------------P----------EHLSDDAKSFIKQCLQRDPS  464 (628)
Q Consensus       429 ~~---~~~i~~~~-------------------~~~~~------------p----------~~~s~~l~dLI~~~L~~dP~  464 (628)
                      +.   +.+|....                   ++++-            +          .....++.|||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            42   22221100                   00000            0          01123688999999999999


Q ss_pred             CCCCHHHHhcCccccc
Q 040472          465 ARPPASKLLDHPFVRD  480 (628)
Q Consensus       465 ~Rpta~eiL~Hpwf~~  480 (628)
                      +|+|+.|+|.||||..
T Consensus       396 ~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  396 RRITLREALSHPFFAR  411 (415)
T ss_pred             ccccHHHHhcCHHhhc
Confidence            9999999999999963

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=313.95  Aligned_cols=260  Identities=30%  Similarity=0.473  Sum_probs=212.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHH-hCCCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS-QLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIV~l~~~~~~~~~~  297 (628)
                      -++.+-+..||.|+||+|++-.++.+|+..|||.|+....    ....+++..|.+... .-+.||||++||....++..
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            3456667889999999999999999999999999986433    233567777887654 44699999999999999999


Q ss_pred             eEEEEecccccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          298 SVYLEYVSGGSIHKLLQ-----EYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~-----~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      |+.||+|+ -+|..+.+     +...++|..+-.|....+.||.||.+ ..||||||||+||||+..|.|||||||.+..
T Consensus       139 WiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            99999995 46655443     34679999999999999999999986 4899999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccC-CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCC--C---C
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--P---E  445 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~--p---~  445 (628)
                      +...-..+...|-..|||||.+.... +|+.++||||||++|||+.||..||..++..-.........+.|.+  +   -
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence            65544445567889999999986443 4999999999999999999999999887664333332233333322  1   2


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      +.+..+..||..||.+|-..||.+.++++++|++....
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            47889999999999999999999999999999986543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.8e-39  Score=311.90  Aligned_cols=255  Identities=25%  Similarity=0.476  Sum_probs=215.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSD--  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~--  294 (628)
                      ..++|++.+++|+|.|+.||.|++..+.+.++||+++...        .+.+.+|++||+.|. |+||+.|++...+.  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--------KKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--------HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            5679999999999999999999999999999999997532        356889999999998 99999999998874  


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~~~~  373 (628)
                      ....||+||+++.+...+..   .|+...++.++.||+.||.|||++||+|||+||.|++||.. ..++|+|+|+|.++.
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            56789999999887766654   47788899999999999999999999999999999999875 469999999999999


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCC-CCCchhHHHhhhcCCC------------C-
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVAAIFKIGNSK------------D-  439 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF-~~~~~~~~~~~i~~~~------------~-  439 (628)
                      +.......+.+.+|--||.+.....|+...|+|||||+|..|+..+-|| .+.++.+++.+|....            . 
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            9888888889999999999988888999999999999999999988887 4444444433331110            0 


Q ss_pred             --CCC-------------------CCC-cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          440 --IPE-------------------IPE-HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       440 --~~~-------------------~p~-~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                        .++                   -.. -+++++.|||.++|..|-.+|+|+.|++.||||.....
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence              000                   001 14689999999999999999999999999999976543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.8e-37  Score=302.40  Aligned_cols=242  Identities=38%  Similarity=0.686  Sum_probs=206.3

Q ss_pred             CcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccccHHH
Q 040472          232 TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHK  311 (628)
Q Consensus       232 ~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~GgsL~~  311 (628)
                      +||.||+|.+..+++.||+|++......    ...+.+.+|++++++++|+||+++++++......+++|||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK----KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            5899999999999999999998643221    115778899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCChh
Q 040472          312 LLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE  391 (628)
Q Consensus       312 ~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE  391 (628)
                      ++.....+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++.............++..|++||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            99877669999999999999999999999999999999999999999999999999998766544445567899999999


Q ss_pred             hhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCc--CCHHHHHHHHHHhhcCCCCCCCH
Q 040472          392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPA  469 (628)
Q Consensus       392 vl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~dLI~~~L~~dP~~Rpta  469 (628)
                      .+.+. .++.++|||+||+++|+|++|..||........+.+.............  ++.++.+++.+||..+|++||++
T Consensus       157 ~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  235 (244)
T smart00220      157 VLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA  235 (244)
T ss_pred             HHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence            98644 4888999999999999999999999874444444443332222222222  78899999999999999999999


Q ss_pred             HHHhcCccc
Q 040472          470 SKLLDHPFV  478 (628)
Q Consensus       470 ~eiL~Hpwf  478 (628)
                      .++++||||
T Consensus       236 ~~~~~~~~~  244 (244)
T smart00220      236 EEALQHPFF  244 (244)
T ss_pred             HHHhhCCCC
Confidence            999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=326.59  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=208.8

Q ss_pred             ccccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          214 VTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       214 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      +.+..-+...+.++||+|.||.|.++.-.. +..||||.++...    .....+.|.+||++|.+|+|||||+|+++|..
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a----~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA----TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc----chhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            344455677889999999999999997653 6899999987532    23445789999999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ++.+++||||++.|+|.++|.++.  .+.-.....|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence            999999999999999999998763  234445667999999999999999999999999999999999999999999996


Q ss_pred             ccCccccc---cccCCCCcCChhhhhccCCCCccccccccccceeeec--cCCCCCCCCchhHHHhhhcC------CCCC
Q 040472          372 MTSCASML---SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA--TSKPPWSQYEGVAAIFKIGN------SKDI  440 (628)
Q Consensus       372 ~~~~~~~~---~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelL--tG~~PF~~~~~~~~~~~i~~------~~~~  440 (628)
                      +-....+.   ..+-...|||+|.|...+ ++.++|+|+||++|||++  +...||.+....+.+.....      ....
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            54433221   234567899999987654 999999999999999975  47889987665544443322      1223


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHh
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      ...|.-++.++.+||.+||..|-++||+++++-
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            455677899999999999999999999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7e-37  Score=346.70  Aligned_cols=255  Identities=22%  Similarity=0.296  Sum_probs=180.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS---  290 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~---  290 (628)
                      ..++|++.++||+|+||.||+|++..+    +..||||.+....    ..+   ....|  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e---~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVE---IWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhH---HHHHH--HHHhhchhhHHHHHHhhhc
Confidence            467999999999999999999999988    9999999875311    111   11111  1122222333332222   


Q ss_pred             ---eeccccceEEEEecccccHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 040472          291 ---ELSDERLSVYLEYVSGGSIHKLLQEYGP--------------------FNEPVIQTYTRQILLGLAYLHARNTVHRD  347 (628)
Q Consensus       291 ---~~~~~~~~lVmEy~~GgsL~~~L~~~~~--------------------l~e~~~~~i~~qIl~aL~yLH~~gIvHRD  347 (628)
                         ...+..++|||||+.+++|.+++.....                    ..+..+..++.||+.||+|||+++|||||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456789999999999999999875321                    12345678999999999999999999999


Q ss_pred             cCCCceEeCC-CCCEEEeccCCcccccCcc--ccccccCCCCcCChhhhhccC---------------------CCCccc
Q 040472          348 IKGANILVDP-HGEIKLADFGMAKHMTSCA--SMLSFKGSPYWMAPEVVMNTN---------------------GYSLTV  403 (628)
Q Consensus       348 IKpeNILld~-~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~---------------------~~s~ks  403 (628)
                      |||+||||+. ++.+||+|||+|+.+....  ....+++|+.|||||++....                     .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999998654322  224567999999999764321                     244567


Q ss_pred             cccccccceeeeccCCCCCCCCchhHHHhhhcCC--------------CCCC------CCCCcCCHHHHHHHHHHhhcCC
Q 040472          404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--------------KDIP------EIPEHLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       404 DIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--------------~~~~------~~p~~~s~~l~dLI~~~L~~dP  463 (628)
                      ||||||||||||+++..++...  ...+.++...              ...+      ++.......+.+||++||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            9999999999999987765431  1111111100              0000      0111123456699999999999


Q ss_pred             CCCCCHHHHhcCccccchHH
Q 040472          464 SARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       464 ~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ++|||+.|+|+||||+....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999976543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=318.51  Aligned_cols=252  Identities=27%  Similarity=0.469  Sum_probs=198.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-----C---CCeeeeecce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-----H---PNIVRYHGSE  291 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIV~l~~~~  291 (628)
                      .+|.+.++||+|.|++||+|++..+.+.||+|+.+.      .+...+....||++|++++     |   .+||+|+++|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            699999999999999999999999999999999873      3444566778999999985     2   3699999999


Q ss_pred             ec----cccceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeC--------
Q 040472          292 LS----DERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVD--------  356 (628)
Q Consensus       292 ~~----~~~~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld--------  356 (628)
                      ..    ..+++||+|++ |.+|..+|..  +..++...++.|++|||.||.|||.. ||||.||||+||||.        
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~  230 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAK  230 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhh
Confidence            86    46899999999 8899999985  45799999999999999999999965 999999999999984        


Q ss_pred             --------------------------------------------------------------------------------
Q 040472          357 --------------------------------------------------------------------------------  356 (628)
Q Consensus       357 --------------------------------------------------------------------------------  356 (628)
                                                                                                      
T Consensus       231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n  310 (590)
T KOG1290|consen  231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN  310 (590)
T ss_pred             hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence                                                                                            


Q ss_pred             --------------------------CC----------------------------------------------------
Q 040472          357 --------------------------PH----------------------------------------------------  358 (628)
Q Consensus       357 --------------------------~~----------------------------------------------------  358 (628)
                                                ..                                                    
T Consensus       311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d  390 (590)
T KOG1290|consen  311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD  390 (590)
T ss_pred             ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence                                      00                                                    


Q ss_pred             CCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc---------hhH
Q 040472          359 GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE---------GVA  429 (628)
Q Consensus       359 g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~---------~~~  429 (628)
                      -+|||+|||-|.....  ..+..+.|..|+|||||.+.+ |+..+||||++||+|||+||.+.|+...         ...
T Consensus       391 i~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  391 IRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             eeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            0256666666543321  122345688899999999876 9999999999999999999999995421         122


Q ss_pred             HHhhhcC----------------------------CCCCC---------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          430 AIFKIGN----------------------------SKDIP---------EIPEHLSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       430 ~~~~i~~----------------------------~~~~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                      .+.++..                            .+.++         +++.....++.+||.-||+.+|++|+||.++
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            2222100                            00000         1222334678899999999999999999999


Q ss_pred             hcCccccch
Q 040472          473 LDHPFVRDQ  481 (628)
Q Consensus       473 L~Hpwf~~~  481 (628)
                      |+|||+...
T Consensus       548 l~hPwLn~~  556 (590)
T KOG1290|consen  548 LKHPWLNPV  556 (590)
T ss_pred             hcCccccCC
Confidence            999999654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=333.96  Aligned_cols=252  Identities=26%  Similarity=0.447  Sum_probs=215.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCC-C--cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSES-G--QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ++.+++++||+|.||.|++|.++.. |  -.||||+++....    ......|.+|+.+|.+|+|+|+|+|||+..+ ..
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            4567788999999999999987643 3  3589999975332    2267889999999999999999999999987 78


Q ss_pred             ceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +.||||++.+|+|.+.|++  ...|.......|+.||+.|+.||..+++|||||-..||||-....|||+||||.+.+..
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            8999999999999999986  45788899999999999999999999999999999999999888999999999998776


Q ss_pred             cccccccc----CCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 CASMLSFK----GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ~~~~~~~~----GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...+..+.    -...|+|||.|... .++.++|||++||+||||++ |..||.+......+.+|..... -..|+.+++
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpRPk~cse  342 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPRPKYCSE  342 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCCCCCChH
Confidence            55544332    23469999999655 49999999999999999998 8999999888888877774444 456778999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      ++.++++.||+.+|++||++..|.+.-+.
T Consensus       343 dIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  343 DIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            99999999999999999999998755443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=331.16  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=190.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC----------------CCCcEEEEEEEeecccccchHHH----------HHHHHH
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS----------------ESGQMCAIKEVRVVCDDQTSKEC----------LKQLNQ  271 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~tg~~vAvK~i~~~~~~~~~~~~----------~~~~~~  271 (628)
                      ..++|++.++||+|+||+||+|...                ..++.||||.++...... ..+.          .+....
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~-~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGV-RQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhh-HHHHHhhhhhhhcccchhHH
Confidence            4679999999999999999999752                235679999886432111 0111          122345


Q ss_pred             HHHHHHhCCCCCe-----eeeecceec--------cccceEEEEecccccHHHHHHhcC---------------------
Q 040472          272 EINLLSQLSHPNI-----VRYHGSELS--------DERLSVYLEYVSGGSIHKLLQEYG---------------------  317 (628)
Q Consensus       272 Ei~iL~~l~HpnI-----V~l~~~~~~--------~~~~~lVmEy~~GgsL~~~L~~~~---------------------  317 (628)
                      |+.++.+++|.++     ++++++|..        ....+|||||+.+++|.++|+...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777888876654     667776653        356899999999999999986421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccccc--ccCCCCcCChhh
Q 040472          318 ---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEV  392 (628)
Q Consensus       318 ---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~--~~GT~~Y~APEv  392 (628)
                         .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+........  ..+|+.|+|||+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               234567889999999999999999999999999999999999999999999976543322222  235889999998


Q ss_pred             hhccC---------------------CCCccccccccccceeeeccCCC-CCCCCchhHH-----------HhhhcCCCC
Q 040472          393 VMNTN---------------------GYSLTVDIWSLGCTVLEMATSKP-PWSQYEGVAA-----------IFKIGNSKD  439 (628)
Q Consensus       393 l~~~~---------------------~~s~ksDIWSLGvlLyelLtG~~-PF~~~~~~~~-----------~~~i~~~~~  439 (628)
                      +....                     ....+.||||+|||||+|++|.. ||........           ...+.....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            75321                     11235799999999999999986 7754221111           111111111


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCC---CCCCCHHHHhcCccccc
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDP---SARPPASKLLDHPFVRD  480 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP---~~Rpta~eiL~Hpwf~~  480 (628)
                      .......++..+.|||.+||.+++   .+|+++.|+|+||||..
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            112345678999999999999866   68999999999999953

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=323.60  Aligned_cols=245  Identities=24%  Similarity=0.440  Sum_probs=208.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+.....+||-|.||.||.|.++.-.-.||||.++..      ...++.|..|+.+|+.++|||+|+|+|+|..+..+||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc------chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence            3556668999999999999999998889999988632      2336788999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          300 YLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |.|||..|+|.+||++..+  ++.-.+.+++.||..|++||..+++|||||-..|+||.++..|||+||||++.+..+..
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            9999999999999997653  56667788999999999999999999999999999999999999999999998866432


Q ss_pred             cccccC---CCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          378 MLSFKG---SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       378 ~~~~~G---T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                       +...|   ...|.|||.|.- ..++.|+|||+|||+|||+.| |-.||.+.+.. +++.+......-+-|+.+++.+.+
T Consensus       421 -TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-qVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  421 -TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             -ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHhccccccCCCCCCHHHHH
Confidence             22233   346999999864 458999999999999999987 88899886543 444444444444667889999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHh
Q 040472          454 FIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL  473 (628)
                      |++.||+++|.+||++.||-
T Consensus       498 LMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHH
Confidence            99999999999999999873

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=326.98  Aligned_cols=252  Identities=26%  Similarity=0.470  Sum_probs=219.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCC---cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESG---QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..+..+|.++||.|.||.||+|+.+..+   ..||||.++..    .......+|..|+.||-+++||||++|.|+....
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            3456788999999999999999988766   46999999752    2344457799999999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.+.||.|||++|+|..+|+++ +.|...++.-+++.|+.|++||-++|+|||||.+.||||+.+-.+|++||||++.+.
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999999999864 789999999999999999999999999999999999999999999999999999875


Q ss_pred             Ccc--ccccccC--CCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          374 SCA--SMLSFKG--SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       374 ~~~--~~~~~~G--T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ++.  ...+.-|  ...|-|||.|... +++.++||||+||+|||.++ |..||....+.+.+..|.....+|. |-.++
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-PmDCP  860 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-PMDCP  860 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC-CCCCc
Confidence            543  2222222  2579999999755 49999999999999999765 9999999998888888888777764 44689


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ..+..|+..||++|-.+||.+.||+.+
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999999765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.9e-36  Score=316.56  Aligned_cols=252  Identities=26%  Similarity=0.467  Sum_probs=206.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC------CCeeeeecceec
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH------PNIVRYHGSELS  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIV~l~~~~~~  293 (628)
                      .+|.+....|+|-|++|..|.+..-|..||||+|+.      ..-..+.=..|++||++|..      -|+++|+..|.+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            588999999999999999999999999999999973      12334555679999999963      489999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMA  369 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla  369 (628)
                      .+++|||||-+ ..+|.++|++.|   .|....++.|+.||+.||..|...||+|.||||+||||++.. .+||||||.|
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence            99999999988 579999999876   488889999999999999999999999999999999998754 6899999999


Q ss_pred             ccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-----------
Q 040472          370 KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-----------  438 (628)
Q Consensus       370 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-----------  438 (628)
                      ...... ..+.+..+..|.|||+|++.. |+...|+||+||+||||.||+..|.+..+...+.-.+...           
T Consensus       585 ~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            876553 344455677899999999876 9999999999999999999999997754432221110000           


Q ss_pred             ---------CC-----------------------------------CCCCC---cCCHHHHHHHHHHhhcCCCCCCCHHH
Q 040472          439 ---------DI-----------------------------------PEIPE---HLSDDAKSFIKQCLQRDPSARPPASK  471 (628)
Q Consensus       439 ---------~~-----------------------------------~~~p~---~~s~~l~dLI~~~L~~dP~~Rpta~e  471 (628)
                               ++                                   +.++.   .+-..+++||.+||..||++|.++.+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence                     00                                   00110   12256889999999999999999999


Q ss_pred             HhcCccccc
Q 040472          472 LLDHPFVRD  480 (628)
Q Consensus       472 iL~Hpwf~~  480 (628)
                      +|.||||..
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999963

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=303.94  Aligned_cols=253  Identities=24%  Similarity=0.408  Sum_probs=212.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      ..+|.-++.+|.|.- .|..|.+.-+++.||+|.+.....   .....++..+|..++..+.|+||++++.+|.-.    
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~---n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ---NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc---cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            458888999999999 899999999999999997743321   134457788999999999999999999998754    


Q ss_pred             --ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          295 --ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       295 --~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                        ..+|+||||+. .+|..++.  ..++-..+..++.|++.|++|||+.||+||||||+||+|..++.+||.|||+|+..
T Consensus        92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence              46899999995 58988887  45678899999999999999999999999999999999999999999999999876


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCC----------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE----------  442 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~----------  442 (628)
                      ...-.++.++.|.+|+|||++.+.+ |...+||||+||++.||++|...|.+.+..++..++......+.          
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            6555667788999999999999877 99999999999999999999999987766665555422211100          


Q ss_pred             ------------------------------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          443 ------------------------------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       443 ------------------------------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                                                    -+..-...+++|+.+||..||++|.+++++|+||||+
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                          0011234688999999999999999999999999997

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=326.75  Aligned_cols=259  Identities=39%  Similarity=0.707  Sum_probs=224.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .-++|+++..+|.|+||.||+|+++.+++..|+|+++....+     .+.-+++||-+++.++|+|||.+++.+...+.+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----d~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----cccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            457899999999999999999999999999999999864332     356678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-cc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~  376 (628)
                      +++||||.||+|++..+-.++++|.++..+.++.+.||+|||+.|-+|||||-.|||++..|.|||+|||.+..+.. -.
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence            99999999999999998899999999999999999999999999999999999999999999999999999877654 23


Q ss_pred             ccccccCCCCcCChhhh--hccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCC--CCCcCCHHH
Q 040472          377 SMLSFKGSPYWMAPEVV--MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPE--IPEHLSDDA  451 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl--~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~--~p~~~s~~l  451 (628)
                      ...++.||++|||||+-  ....+|...+|||++|+...|+---++|.-..-....++-..... ..+.  -+...++.+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence            45678999999999985  345569999999999999999988888865555454444433332 2222  234578999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .+|++.+|.++|++||+++.+|.|||+...
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999998643

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=318.55  Aligned_cols=246  Identities=26%  Similarity=0.493  Sum_probs=209.0

Q ss_pred             CeEEeeeeccCCcEEEEEEEECC----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSE----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...+.++||+|.||.||.|....    ..--||||..+..+.    .+..+.|.+|..+|+.++|||||+|+|++. +..
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQP  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeeeee-ccc
Confidence            34456789999999999997532    233588888765443    233567889999999999999999999986 567


Q ss_pred             ceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+||||++.-|.|..+|+.+ ..|+......|+.||+.||+|||+.++|||||-..||||....-|||+|||+++.+...
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            89999999999999999864 57899999999999999999999999999999999999999999999999999988776


Q ss_pred             cccccccC--CCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 ASMLSFKG--SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~~~~~~G--T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..+..-.|  ...|||||.+. ...++.++|||-|||+|||+|. |..||.+..+.+.+..+.+.... ..|+++++.+.
T Consensus       545 ~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl-P~P~nCPp~LY  622 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL-PCPPNCPPALY  622 (974)
T ss_pred             chhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC-CCCCCCChHHH
Confidence            55443333  34699999984 4569999999999999999876 99999998888888888766654 46778999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHh
Q 040472          453 SFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      .|+.+||+.+|.+||.+.+|.
T Consensus       623 slmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHH
Confidence            999999999999999988774

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=301.18  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=209.7

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-----c
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-----E  295 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-----~  295 (628)
                      +.+..+.||-|+||.||.+.+..+|+.||+|++-...   ......+++.+|+++|..++|.|++.+++..+-.     +
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            4455688999999999999999999999999774221   1233457788999999999999999998876643     4


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|+|.|++ ..+|.++|-.-..++.+.++-+++||+.||+|||+.+|+||||||.|+|++.|..+||||||+|+....+
T Consensus       131 EiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            688899998 4699999988889999999999999999999999999999999999999999999999999999976543


Q ss_pred             c--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-------------
Q 040472          376 A--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-------------  440 (628)
Q Consensus       376 ~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-------------  440 (628)
                      .  .++..+-|.+|+|||++++...|+.++||||+|||+.|||-.+..|......+++..|......             
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            3  2344567899999999999999999999999999999999999999765554444333211111             


Q ss_pred             -----------CCC--------CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          441 -----------PEI--------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       441 -----------~~~--------p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                 |.+        +..-..+..+++.++|..||.+|.+.++++.|++..+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                       111        1123357788999999999999999999999999754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=320.21  Aligned_cols=241  Identities=31%  Similarity=0.495  Sum_probs=192.1

Q ss_pred             eeeeccCCcEE-EEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceEEEE
Q 040472          225 GKLLGRGTFGH-VYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       225 ~~~LG~G~fG~-Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      .+++|.|+-|+ ||+|...  ++.||||.+-        .++...+.+||+.|+.-+ |||||++|+...+...+||.+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            36799999886 7999764  7899999653        455677889999999986 9999999999999999999999


Q ss_pred             ecccccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CC--CEEEeccCCccccc
Q 040472          303 YVSGGSIHKLLQEYGP----FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HG--EIKLADFGMAKHMT  373 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~----l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g--~vKL~DFGla~~~~  373 (628)
                      .|. .+|.++++..+.    ......+.++.|++.||++||+.+||||||||.||||+.   ++  .++|+|||+++.+.
T Consensus       584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            995 599999987411    111346789999999999999999999999999999976   34  68999999999875


Q ss_pred             Ccc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHHHhhhcC-CCCCCCCCCcC
Q 040472          374 SCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGN-SKDIPEIPEHL  447 (628)
Q Consensus       374 ~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~~~~i~~-~~~~~~~p~~~  447 (628)
                      ...    ...+..||-+|+|||++.... -+.++||||||||+|+.++| ..||...-..+  ..|.. ......+....
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLP  739 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCc
Confidence            543    234567999999999997655 57799999999999999996 89997532221  11211 12222222222


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ..++.+||.+||..+|..||+|.+||.||||=
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            23899999999999999999999999999993

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=345.10  Aligned_cols=239  Identities=23%  Similarity=0.345  Sum_probs=187.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|+..++||+|+||.||+|+++.++..||||+++....         ....|+++|++++|||||++++++.+++..|+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            456777899999999999999999999999998753211         11246889999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH---ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ||||+++|+|.++++.   +++..+..++.||+.||+|||   +.+|+||||||+|||++.++..++. ||........ 
T Consensus       761 v~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             EEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            9999999999999964   789999999999999999999   6699999999999999998888775 6665443221 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch----hHHHhhh-cCC--------CCC---
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----VAAIFKI-GNS--------KDI---  440 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~----~~~~~~i-~~~--------~~~---  440 (628)
                        ....||+.|||||++.+. .++.++|||||||++|||++|+.||.....    .....+. ...        ...   
T Consensus       836 --~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 --TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence              223689999999998654 599999999999999999999999853211    1111110 000        000   


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .........++.+++.+||+.||++||++.||++.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            01111223357789999999999999999999764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=309.78  Aligned_cols=208  Identities=27%  Similarity=0.396  Sum_probs=181.6

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch---HHHHHHHHHHHHHHHhCC---CCCeeeeec
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS---KECLKQLNQEINLLSQLS---HPNIVRYHG  289 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~---~~~~~~~~~Ei~iL~~l~---HpnIV~l~~  289 (628)
                      .....+|..++.||+|+||.|++|.++.+...|+||.|.+..--...   ...+-.+-.||+||..|+   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            34567899999999999999999999999999999998653211110   111223567999999998   999999999


Q ss_pred             ceeccccceEEEEe-cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          290 SELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       290 ~~~~~~~~~lVmEy-~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                      +|++++++||+||- -+|.+|+++|..+..++|.++..|++|++.|+++||+.||||||||-|||.++.+|-+||+|||.
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999999994 56789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCC
Q 040472          369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQ  424 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~  424 (628)
                      |..... .....++||..|.|||++.+..+.+..-|||+||++||.+++...||..
T Consensus       717 aa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            875443 4566789999999999998888778889999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=269.95  Aligned_cols=212  Identities=26%  Similarity=0.497  Sum_probs=175.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~  298 (628)
                      ++...+..||+|+||.|-+.++..+|...|+|.++....    .+..+++.+|+.+..+. .+|++|.+||.+..+..++
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            345567889999999999999999999999999875332    23456777888886554 5999999999999999999


Q ss_pred             EEEEecccccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          299 VYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       299 lVmEy~~GgsL~~~L----~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.||.|. -+|..+.    ++.+.++|..+-+|+..++.||.|||++ .|||||+||.||||+.+|+||+||||.+..+.
T Consensus       122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            9999995 4776554    4567899999999999999999999976 89999999999999999999999999998765


Q ss_pred             CccccccccCCCCcCChhhhh---ccCCCCccccccccccceeeeccCCCCCCCCch-hHHHhhhcC
Q 040472          374 SCASMLSFKGSPYWMAPEVVM---NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGN  436 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~---~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i~~  436 (628)
                      +.-..+...|...|||||.+.   +..+|+.++||||||++++||.+++.||..... .+++.++..
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            544444456888999999974   334699999999999999999999999987554 344444443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-33  Score=315.80  Aligned_cols=250  Identities=30%  Similarity=0.498  Sum_probs=206.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEEC----C---CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNS----E---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSE  291 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~----~---tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~  291 (628)
                      ++.++.+.||+|.||.|++|.-.    .   ....||||.++....    ....+.+..|+++|+.+. |+||+.+++++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            34566779999999999999632    1   156799998864322    244577899999999996 99999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV  355 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl  355 (628)
                      .....+++|+||+..|+|..+|++..                .+.......++.||+.|++||++..+|||||-+.||||
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI  451 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence            99999999999999999999998755                38888999999999999999999999999999999999


Q ss_pred             CCCCCEEEeccCCcccccCccccc--cccCC--CCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHH
Q 040472          356 DPHGEIKLADFGMAKHMTSCASML--SFKGS--PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAA  430 (628)
Q Consensus       356 d~~g~vKL~DFGla~~~~~~~~~~--~~~GT--~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~  430 (628)
                      ..+..+||+|||+|+.........  .-.|+  ..|||||.+.. ..|+.++||||+||+||||++ |..||.+......
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            999999999999999654433222  11222  34999999976 569999999999999999998 8999987553333


Q ss_pred             HhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          431 IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       431 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +.+........+.|.+++.++.++++.||+.+|++||++.++.+
T Consensus       531 l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            34444444555778889999999999999999999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.5e-33  Score=291.79  Aligned_cols=257  Identities=25%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC---CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~  294 (628)
                      ...|+++++||+|.|++||+|.+..   ..+.||+|.+....       ...++.+|+++|..+. +.||+.+.+++..+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3578999999999999999998877   78899999886422       2356889999999997 99999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~~~~  373 (628)
                      +.+.+||||++..+..+++..   ++..+++.|++.++.||+++|.+|||||||||.|+|.+.. +.-.|+|||+|....
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999888888765   5688999999999999999999999999999999999864 678999999996110


Q ss_pred             -----------------C-c---------------------------cccccccCCCCcCChhhhhccCCCCcccccccc
Q 040472          374 -----------------S-C---------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL  408 (628)
Q Consensus       374 -----------------~-~---------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSL  408 (628)
                                       . .                           .......||++|+|||++.....-+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence                             0 0                           000123599999999999998888999999999


Q ss_pred             ccceeeeccCCCCCCCC-chhHHHhhh---------------------cCCCCCC-------------------------
Q 040472          409 GCTVLEMATSKPPWSQY-EGVAAIFKI---------------------GNSKDIP-------------------------  441 (628)
Q Consensus       409 GvlLyelLtG~~PF~~~-~~~~~~~~i---------------------~~~~~~~-------------------------  441 (628)
                      |||++-+++++.||-.. +....+.++                     .....++                         
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            99999999999998331 111111110                     0000000                         


Q ss_pred             ---CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          442 ---EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       442 ---~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                         ...+..+..+.+|+.+||..||.+|.+++++|+||||.+.....
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~  391 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE  391 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence               00122455889999999999999999999999999998655433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=2.5e-31  Score=255.47  Aligned_cols=212  Identities=42%  Similarity=0.721  Sum_probs=187.1

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG  307 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~Gg  307 (628)
                      ||+|.+|.||++.+..+++.++||++.......    ....+.+|+++++.+.|++|+++++++......+++|||+.|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            689999999999998889999999986432211    3567889999999999999999999999999999999999999


Q ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccCCcccccCcc-ccccccCC
Q 040472          308 SIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCA-SMLSFKGS  384 (628)
Q Consensus       308 sL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~~~~~~-~~~~~~GT  384 (628)
                      +|.+++... ..+++..+..++.+++.+|+|||+.|++|+||++.||+++. +++++|+|||.+....... ......+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999876 57899999999999999999999999999999999999998 8999999999997654432 12335578


Q ss_pred             CCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCC
Q 040472          385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS  464 (628)
Q Consensus       385 ~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  464 (628)
                      ..|++||.+.....++.+.|+|+||+++|+|                                 ..+.++|.+||+.||+
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcc
Confidence            8999999986543588999999999999998                                 6899999999999999


Q ss_pred             CCCCHHHHhcCc
Q 040472          465 ARPPASKLLDHP  476 (628)
Q Consensus       465 ~Rpta~eiL~Hp  476 (628)
                      +||++.++++|+
T Consensus       204 ~R~~~~~l~~~~  215 (215)
T cd00180         204 KRPSAKEILEHL  215 (215)
T ss_pred             cCcCHHHHhhCC
Confidence            999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-32  Score=297.83  Aligned_cols=246  Identities=28%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCc----EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQ----MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+..++||.|+||+||+|.+...++    .||||++..    ....+....+..|+-+|.+|+|||+++|++++.... 
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            45667899999999999998855554    577777653    223344567888999999999999999999998877 


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +.||++|+++|.|.++++. +..+..+..+.|..||++||.|||++++|||||-..||||..-.+|||+|||+++.....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            8899999999999999986 467889999999999999999999999999999999999999999999999999987665


Q ss_pred             cccccc---cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          376 ASMLSF---KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       376 ~~~~~~---~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ......   .-.+.|||-|.+... .|+.++|||||||++||++| |..|+.+.... +|.++....+.-.-|+..+.++
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccCCCCCCccHHH
Confidence            433222   234569999988654 59999999999999999998 89998875443 3333333333334567799999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHh
Q 040472          452 KSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      .-++.+||..|+..||+++++.
T Consensus       930 y~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHH
Confidence            9999999999999999998874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-32  Score=285.03  Aligned_cols=243  Identities=25%  Similarity=0.391  Sum_probs=190.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHH--hCCCCCeeeeecceeccc-
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS--QLSHPNIVRYHGSELSDE-  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~--~l~HpnIV~l~~~~~~~~-  295 (628)
                      +...++.++||+|.||.||+|...  ++.||||++.        .+..+.+++|.+|..  .++|+||++++++..... 
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp--------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP--------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecC--------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            566778889999999999999765  5999999885        233466777877766  457999999999876554 


Q ss_pred             ---cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccccCCCceEeCCCCCEEE
Q 040472          296 ---RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR---------NTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       296 ---~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~---------gIvHRDIKpeNILld~~g~vKL  363 (628)
                         .++||+||.+.|+|.++|.. ..+++.....|+..++.||+|||+.         .|+|||||..||||..|+.+.|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               89999999999999999987 5689999999999999999999963         5999999999999999999999


Q ss_pred             eccCCcccccCcc---ccccccCCCCcCChhhhhccCCCC-----ccccccccccceeeeccCCC------------CCC
Q 040472          364 ADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYS-----LTVDIWSLGCTVLEMATSKP------------PWS  423 (628)
Q Consensus       364 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s-----~ksDIWSLGvlLyelLtG~~------------PF~  423 (628)
                      +|||||..+....   .....+||..|||||+|.+.-.+.     .+.||||+|.|||||++.-.            ||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999998775432   233478999999999997655444     46899999999999988432            232


Q ss_pred             C----CchhHHHhh-hcCCCCCCCCCCc-----CCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          424 Q----YEGVAAIFK-IGNSKDIPEIPEH-----LSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       424 ~----~~~~~~~~~-i~~~~~~~~~p~~-----~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                      .    ....+.+.. +...+..|.++..     -..-+++.|.-||..|++.|+|+.=+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            1    111222222 2223334444432     23468899999999999999998765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1e-30  Score=257.11  Aligned_cols=208  Identities=37%  Similarity=0.641  Sum_probs=180.6

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |.+.+.||.|++|.||++.+..+++.+|||.+......    +..+.+.+|++.++.++|+||+++++++......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            56789999999999999999988999999998753221    24678889999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--cc
Q 040472          302 EYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--SM  378 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~-l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--~~  378 (628)
                      ||+.+++|.+++..... +++..+..++.|++.+|.|||+++++|+||++.||+++.++.++|+|||++.......  ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99999999999988766 8999999999999999999999999999999999999999999999999998765432  33


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCC-CchhHHHhh
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQ-YEGVAAIFK  433 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~-~~~~~~~~~  433 (628)
                      ....++..|++||++.....++.++|||+||+++|+|++|+.||.. .+....+.+
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~  212 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD  212 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence            4466888999999874344578899999999999999999999977 454444444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-31  Score=277.37  Aligned_cols=243  Identities=26%  Similarity=0.390  Sum_probs=189.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHH--hCCCCCeeeeecceecc---
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS--QLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~--~l~HpnIV~l~~~~~~~---  294 (628)
                      .+.++.+.||+|.||.||+|+++  |+.||||++...  +      .+.+.+|.+|.+  .|+|+||+.+++.-..+   
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--d------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--D------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEeccc--c------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            57889999999999999999987  789999998531  1      234556666665  56899999999886654   


Q ss_pred             -ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccCCCceEeCCCCCEEEec
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR--------NTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                       ..+|||.+|.+.|+|+|+|.+ ..++-..+.+++..++.||++||..        .|.|||||..||||..+|.+-|+|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence             369999999999999999998 7789999999999999999999953        499999999999999999999999


Q ss_pred             cCCcccccCcc-----ccccccCCCCcCChhhhhccCCC-----Cccccccccccceeeecc----------CCCCCCC-
Q 040472          366 FGMAKHMTSCA-----SMLSFKGSPYWMAPEVVMNTNGY-----SLTVDIWSLGCTVLEMAT----------SKPPWSQ-  424 (628)
Q Consensus       366 FGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~-----s~ksDIWSLGvlLyelLt----------G~~PF~~-  424 (628)
                      +|||.......     .....+||..|||||+|-..-..     =..+||||||.||||++.          -.+||.+ 
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99997654432     23457899999999998543211     135899999999999875          2467754 


Q ss_pred             ---CchhHHHhhhcCCC-CCCCCCCcCC-----HHHHHHHHHHhhcCCCCCCCHHHHh
Q 040472          425 ---YEGVAAIFKIGNSK-DIPEIPEHLS-----DDAKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       425 ---~~~~~~~~~i~~~~-~~~~~p~~~s-----~~l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                         ....+.+.++.... ..|.+|....     ..+..|++.||..||..|.|+-.|.
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence               23345555554332 2234443322     3566889999999999999987774

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=262.13  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeec-ceeccccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHG-SELSDERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~-~~~~~~~~  297 (628)
                      +.|.+.+.||+|.||.+.+|+|+.+...++||.+..      ....+++|.+|...--.|. |.||+.-|+ .|++.+.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            579999999999999999999999999999998743      2345678889988766665 999998877 48888899


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC-CC-CCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD-PH-GEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld-~~-g~vKL~DFGla~~~~~~  375 (628)
                      +++|||++.|+|..-+.. ..+.|...+.++.|++.||+|||++++||||||.+||||- .| -+|||||||+.+.....
T Consensus        98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            999999999999988876 4478999999999999999999999999999999999993 33 37999999998754332


Q ss_pred             cccccccCCCCcCChhhhhcc----CCCCccccccccccceeeeccCCCCCCCCchh-------HHHhhhcCCCCCCCCC
Q 040472          376 ASMLSFKGSPYWMAPEVVMNT----NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-------AAIFKIGNSKDIPEIP  444 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-------~~~~~i~~~~~~~~~p  444 (628)
                      -..  ..-+..|.+||++...    -...+..|||.||+|+|.+|+|.+||......       .+..+.. ....|..-
T Consensus       177 V~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk-~~~~P~~F  253 (378)
T KOG1345|consen  177 VKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK-NPALPKKF  253 (378)
T ss_pred             ehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-CccCchhh
Confidence            111  2245569999986432    12467899999999999999999999642211       1111111 12334444


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCC---CCHHHHhcCccc
Q 040472          445 EHLSDDAKSFIKQCLQRDPSAR---PPASKLLDHPFV  478 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~R---pta~eiL~Hpwf  478 (628)
                      ..+++.+..+.++-|..++++|   -++.......|.
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            5689999999999999999999   445555555554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=9.3e-31  Score=308.51  Aligned_cols=198  Identities=18%  Similarity=0.243  Sum_probs=147.3

Q ss_pred             hCCC-CCeeeeecce-------eccccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q 040472          278 QLSH-PNIVRYHGSE-------LSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI  348 (628)
Q Consensus       278 ~l~H-pnIV~l~~~~-------~~~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI  348 (628)
                      .++| .||++++++|       .+.+.++++|||+ +++|+++|.. ...+++..++.|++||+.||+|||++|||||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3445 5777888877       3345678889988 6699999975 356999999999999999999999999999999


Q ss_pred             CCCceEeCCC-------------------CCEEEeccCCcccccCc-----------------cccccccCCCCcCChhh
Q 040472          349 KGANILVDPH-------------------GEIKLADFGMAKHMTSC-----------------ASMLSFKGSPYWMAPEV  392 (628)
Q Consensus       349 KpeNILld~~-------------------g~vKL~DFGla~~~~~~-----------------~~~~~~~GT~~Y~APEv  392 (628)
                      ||+||||+..                   +.+||+|||+++.....                 ......+||++|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999643                   45666666666532110                 00112468999999999


Q ss_pred             hhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       393 l~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                      +.+.. |+.++|||||||+||||++|.+||......  +..+.... .+.........+.+++.+||+.||.+||++.||
T Consensus       187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        187 DNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            87654 899999999999999999999987643211  11111111 111111124567799999999999999999999


Q ss_pred             hcCccccc
Q 040472          473 LDHPFVRD  480 (628)
Q Consensus       473 L~Hpwf~~  480 (628)
                      |+||||..
T Consensus       263 l~h~~~~~  270 (793)
T PLN00181        263 LQSEFINE  270 (793)
T ss_pred             hhchhhhh
Confidence            99999964

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-31  Score=289.23  Aligned_cols=274  Identities=25%  Similarity=0.419  Sum_probs=226.9

Q ss_pred             eeccCCcEEEEEEEE---CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceEEEE
Q 040472          227 LLGRGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      .+|+|+||.|++++.   ...++.||+|++++.........   +...|..++..++ |+++|+++..|+.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998753   44588899999876544332222   5566888999998 9999999999999999999999


Q ss_pred             ecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccccccc
Q 040472          303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK  382 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~  382 (628)
                      |..||+|...+.+...+.+..++.+...++.|++++|+.+|+|||+|++||+++.+|++++.|||+.+..-.....   |
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999876443332   8


Q ss_pred             CCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcC
Q 040472          383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD  462 (628)
Q Consensus       383 GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~d  462 (628)
                      ||..|||||++.   ++..++|+||||++++||++|..||..    +.+..|...  ...+|..++..+++++.+++.++
T Consensus       155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLFKRN  225 (612)
T ss_pred             cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhhC
Confidence            999999999985   478899999999999999999999987    333333321  23577889999999999999999


Q ss_pred             CCCCCC-----HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          463 PSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       463 P~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      |..|..     +.||++|+||..+.|......+.             .+++.+.+..+.+...++.+|+..
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~-------------~~~fkp~~~~e~~~~~fd~eft~~  283 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQSIDWNELEARSR-------------PPPFKPGSITERDVAQFDPEFTSQ  283 (612)
T ss_pred             HHHHhccCcchhHHHhccchheeeeHhhHhhcCC-------------CCCCCCcccchhhhhhcCchhccC
Confidence            999975     57999999999999986655443             344445555566666666666543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.6e-29  Score=283.25  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=209.2

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecc-cccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVC-DDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      ...+++|.|+||.|+.+......+.++.|..++.. ....+......+..|+-+-..++|+||+..+..+.+....+.+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45688999999999999888777778877665211 22223333344778888889999999999888888877777779


Q ss_pred             EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-----c
Q 040472          302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-----A  376 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-----~  376 (628)
                      |||++ +|+.++...+.+...++..++.||+.||+|||..||.|||||++|+|+..+|.+||+|||.+......     .
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 99999998889999999999999999999999999999999999999999999999999998765332     2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHH-hhhcC------CCCCCCCCCcCCH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI-FKIGN------SKDIPEIPEHLSD  449 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~-~~i~~------~~~~~~~p~~~s~  449 (628)
                      ....++|+..|+|||++.+.......+||||.|++++.|++|+.||......+.. .....      ......+...++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            2356789999999999977664456799999999999999999999654433221 11111      1111233445788


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      +.+.+|.+||+.||.+|.|+++|++.+||+.+..
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            9999999999999999999999999999987654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2.7e-27  Score=239.00  Aligned_cols=253  Identities=34%  Similarity=0.557  Sum_probs=205.9

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC-CeeeeecceeccccceEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP-NIVRYHGSELSDERLSVY  300 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIV~l~~~~~~~~~~~lV  300 (628)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.......  ......+.+|+.++..+.|+ +|+.+++++......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK--SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc--hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            778899999999999999887   789999886533221  13467788999999999988 799999999777778999


Q ss_pred             EEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCcccccCcc
Q 040472          301 LEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSCA  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~~~~  376 (628)
                      ++|+.+++|.+++....   .+.+..+..++.|++.+|+|+|..+++||||||+|||++..+ .++++|||+++......
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999999998887764   799999999999999999999999999999999999999988 79999999998554432


Q ss_pred             -------ccccccCCCCcCChhhhhcc--CCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCC---
Q 040472          377 -------SMLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIP---  441 (628)
Q Consensus       377 -------~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~---  441 (628)
                             .....+||..|++||.+.+.  ..+....|+|++|++++++++|..||.....   .............+   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                   23567899999999998763  4688999999999999999999999876553   22222222222111   


Q ss_pred             -CCCCcC----CHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          442 -EIPEHL----SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       442 -~~p~~~----s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                       ......    ...+.+++.+|+..+|..|.+..+...+.|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~  279 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA  279 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence             111111    25789999999999999999999998886654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=248.38  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=199.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCC-----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESG-----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      .++++..++-+|.||+||.|++.+..     +.|-+|.++    +..++-.+..+..|..+|..+.|||+..+.++...+
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk----~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK----QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH----hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            46888889999999999999876433     334555443    222334466788899999999999999999987654


Q ss_pred             -ccceEEEEecccccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQEY--------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~~--------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                       ...++++.++.-|+|..+|...        ..++..++..++.||+.|++|||++||||.||...|++||+.-+|||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence             4566678899889999999732        2366778889999999999999999999999999999999999999999


Q ss_pred             cCCcccccCcccccc---ccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCC
Q 040472          366 FGMAKHMTSCASMLS---FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIP  441 (628)
Q Consensus       366 FGla~~~~~~~~~~~---~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~  441 (628)
                      =.+++.+-+...+.-   .--...||++|.+.+.. |+.++|+|||||+||||+| |+.|+...+..+...-+.....+ 
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl-  517 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL-  517 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee-
Confidence            999987654332210   11235699999998765 9999999999999999998 99999887776655555555544 


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .-|.+++.++..++..||+..|++||+++|+..
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            446789999999999999999999999999853

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.5e-28  Score=233.08  Aligned_cols=161  Identities=32%  Similarity=0.413  Sum_probs=128.5

Q ss_pred             ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCC
Q 040472          307 GSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP  385 (628)
Q Consensus       307 gsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~  385 (628)
                      |+|.+++... ..+++.+++.|+.||+.||+|||+++      ||+|||++.++.+|+  ||++.......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            6899999864 56999999999999999999999999      999999999999999  99998654422    26899


Q ss_pred             CcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHh-hhcCC--CCCC---CCCCcCCH--HHHHHHHH
Q 040472          386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNS--KDIP---EIPEHLSD--DAKSFIKQ  457 (628)
Q Consensus       386 ~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~-~i~~~--~~~~---~~p~~~s~--~l~dLI~~  457 (628)
                      .|||||++.+. .++.++|||||||++|||++|+.||.......... .+...  ...+   ..+..++.  ++.+||++
T Consensus        69 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       69 YFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             cccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            99999999765 48999999999999999999999997644322211 11110  1100   11223333  69999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||+.||++||++.|+++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-26  Score=243.84  Aligned_cols=248  Identities=22%  Similarity=0.295  Sum_probs=195.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCC-cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC----CCeeeeecce-ecc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH----PNIVRYHGSE-LSD  294 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIV~l~~~~-~~~  294 (628)
                      +|++.++||+|+||.||+|.+..++ ..+|+|+.........     ..+..|+.+|..+..    .++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999988774 6799998764322111     146678888888863    6899999999 578


Q ss_pred             ccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-----CCEEEeccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-----GEIKLADFG  367 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-----g~vKL~DFG  367 (628)
                      ...|+||+.+ |.+|.++....  +.|+..++..++.|++.+|++||+.|+|||||||+|+++...     ..+.|.|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999998 89999988654  579999999999999999999999999999999999999765     359999999


Q ss_pred             Ccc--cccCcc--------c-cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhh---
Q 040472          368 MAK--HMTSCA--------S-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK---  433 (628)
Q Consensus       368 la~--~~~~~~--------~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~---  433 (628)
                      +++  .+....        . ...+.||..|+++.+..+.. .+.+.|+||+++++.||+.|..||..........+   
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            998  321111        1 22456999999999987654 89999999999999999999999977554322222   


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ..............+.++..++..+-..+..++|....+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            222111111233456788888888888999999999888654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.8e-26  Score=247.49  Aligned_cols=165  Identities=18%  Similarity=0.235  Sum_probs=129.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC-CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeee-eecceecccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE-SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR-YHGSELSDER  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~-l~~~~~~~~~  296 (628)
                      ..+|++++.||+|+||+||+|+++. +++.||||++.............+.+.+|+++|++++|+||+. ++++    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4689999999999999999999876 6788899986422110012334567899999999999999985 5432    46


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccc-CCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI-KGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI-KpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .||||||+.|++|... ..   ..   ...++.|++.||+|||++||+|||| ||+|||++.++++||+|||+|+.+...
T Consensus        93 ~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~  165 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR  165 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence            8999999999999732 11   11   2468899999999999999999999 999999999999999999999865432


Q ss_pred             c---------ccccccCCCCcCChhhhh
Q 040472          376 A---------SMLSFKGSPYWMAPEVVM  394 (628)
Q Consensus       376 ~---------~~~~~~GT~~Y~APEvl~  394 (628)
                      .         .....++++.|+|||++.
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCC
Confidence            2         113466888999999874

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-26  Score=234.36  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=202.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~  298 (628)
                      -+|+++++||+|.||.+++|.+.-+++.||||.-....+       .-++..|.+..+.|. .++|.+.|.+.....+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC-------cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            489999999999999999999999999999997543211       246777888888886 799999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-----CEEEeccCCcccc
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-----EIKLADFGMAKHM  372 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-----~vKL~DFGla~~~  372 (628)
                      ||||++ |-+|+++..-+ ..|+...++.++.|++.-++|+|++.+|+|||||+|+||..-+     .|.|+|||+|+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 89999999865 4699999999999999999999999999999999999996433     5899999999987


Q ss_pred             cCcc--------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC---chhHHHhhhcCCCC--
Q 040472          373 TSCA--------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY---EGVAAIFKIGNSKD--  439 (628)
Q Consensus       373 ~~~~--------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~---~~~~~~~~i~~~~~--  439 (628)
                      .+..        .+.+..||..||+--..++.. -+.+.|+-|||.|++++|-|.+||.+.   ...+...+|...+.  
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            6543        234567999999988877654 788999999999999999999999764   34455666655443  


Q ss_pred             -CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          440 -IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       440 -~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                       +.++...++.++...|+-.=..+-.+-|..+-+
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence             224456688888888888877888888876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-25  Score=218.09  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      ...+|+++++||.|+||.+|+|.+..+|+.||||+-.....       .-++.-|.++.+.|+ ...|..+..++.+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-------CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            45789999999999999999999999999999998653222       235677899999998 4678888888888999


Q ss_pred             ceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccCCcccc
Q 040472          297 LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHM  372 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFGla~~~  372 (628)
                      -.|||+++ |-+|++++.-. ..|+..+++-++-|++.-|+|+|.+++|||||||+|+|+.-+   .++.|+|||+|+.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999998 89999999854 679999999999999999999999999999999999999654   36899999999876


Q ss_pred             cCccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH---HHhhh---cCCC
Q 040472          373 TSCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA---AIFKI---GNSK  438 (628)
Q Consensus       373 ~~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~---~~~~i---~~~~  438 (628)
                      .+...        .....||..|.+--.+.+.. -+...|+-|+|.+|.++.-|..||.+.....   ...+|   ....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST  243 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence            44221        22356999999877665443 5788999999999999999999998754322   22222   2222


Q ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       439 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                      .+..+...++.++.-+|..|=..--++-|...-+
T Consensus       244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl  277 (341)
T KOG1163|consen  244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL  277 (341)
T ss_pred             CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence            3334556788999999999988888888875543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=5.5e-26  Score=259.15  Aligned_cols=225  Identities=29%  Similarity=0.473  Sum_probs=176.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      -.+|..+++|-.|+||.||+++|+.+.+.+|+| +.+..       .+  +++   ||.....|++|             
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------li--lRn---ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LI--LRN---ILTFAGNPFVV-------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hh--hhc---cccccCCccee-------------
Confidence            358999999999999999999999999999995 33211       00  011   44455555555             


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---  375 (628)
                              |+-..+++.-++++...        +.+++|||+.||+|||+||+|+||..-|++||+|||+.+..-..   
T Consensus       136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                    56666677666666433        88999999999999999999999999999999999998642110   


Q ss_pred             -------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCC
Q 040472          376 -------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIP  441 (628)
Q Consensus       376 -------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~  441 (628)
                                   -....+||||.|+||||+...+ |...+|||+||+|+||+|.|..||.+....+.+..+... ..++
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                         0112368999999999998765 999999999999999999999999987666555544332 3344


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCC---CHHHHhcCccccchHHHhh
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARP---PASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rp---ta~eiL~Hpwf~~~~~~~~  486 (628)
                      +-.+.+..+++++|.++|+.+|..|.   .+-+|.+|.||+..+|...
T Consensus       279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~l  326 (1205)
T KOG0606|consen  279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSL  326 (1205)
T ss_pred             ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchh
Confidence            54567889999999999999999995   5778999999999999833

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.9e-23  Score=205.51  Aligned_cols=144  Identities=17%  Similarity=0.182  Sum_probs=113.1

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchH---------------------HHHHHHHHHHHHHHhCCCCC
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSK---------------------ECLKQLNQEINLLSQLSHPN  283 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~---------------------~~~~~~~~Ei~iL~~l~Hpn  283 (628)
                      ...||+|+||.||+|.+. +|+.||||+++.........                     .......+|+++|.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 89999999997642211110                     01123456999999998877


Q ss_pred             eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccccCCCceEeCCCCCEE
Q 040472          284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL-HARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       284 IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yL-H~~gIvHRDIKpeNILld~~g~vK  362 (628)
                      |.....+..  ...+|||||+.|++|...+.+.+.+++..++.++.||+.+|+|| |+.||+||||||+||||+ ++.++
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            644332222  23489999999988776654557899999999999999999999 799999999999999998 57899


Q ss_pred             EeccCCcccc
Q 040472          363 LADFGMAKHM  372 (628)
Q Consensus       363 L~DFGla~~~  372 (628)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=5.6e-23  Score=206.85  Aligned_cols=171  Identities=16%  Similarity=0.186  Sum_probs=132.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHH------HHHHHHHHHhCCCCCeeeeecceec
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ------LNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~------~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      .+|++.++||.|+||.||++..  ++..||||+++.....  .......      +.+|++.+.++.|++|..+.+++..
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~--~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKR--TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCc--hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            6899999999999999999755  4668999998643221  2233333      6799999999999999999888664


Q ss_pred             c--------ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          294 D--------ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       294 ~--------~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                      .        ...+|||||++|.+|.++..    +++    ..+.+|+.+|..||+.||+||||||.|||++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3        35889999999999988742    333    3456999999999999999999999999999988 99999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeee
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM  415 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyel  415 (628)
                      ||............           .+++. ..|..++|+|+|||++..+
T Consensus       178 fg~~~~~~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        178 LSGKRCTAQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CCCcccccchhhHH-----------HHHHH-hHhcccccccceeEeehHH
Confidence            99887653322211           12333 3477899999999998653

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2e-23  Score=217.33  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=182.1

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCC-----------------------------------cEEEEEEEeecccccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESG-----------------------------------QMCAIKEVRVVCDDQT  261 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----------------------------------~~vAvK~i~~~~~~~~  261 (628)
                      ..+++|+++..||+|.-+.||.|....++                                   -..|||.+.....+..
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            35789999999999999999998754311                                   1245665543222233


Q ss_pred             hHHHHHHHHHHHH-------H----------HH-----hCCCCCeeeeecceec--------------------------
Q 040472          262 SKECLKQLNQEIN-------L----------LS-----QLSHPNIVRYHGSELS--------------------------  293 (628)
Q Consensus       262 ~~~~~~~~~~Ei~-------i----------L~-----~l~HpnIV~l~~~~~~--------------------------  293 (628)
                      ....++..-+|.-       .          |.     .-+|||||+++++|.+                          
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            3333333333321       1          11     1259999999988763                          


Q ss_pred             -cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC--CCC--CEEEeccCC
Q 040472          294 -DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD--PHG--EIKLADFGM  368 (628)
Q Consensus       294 -~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld--~~g--~vKL~DFGl  368 (628)
                       ...+|+||.-.. -+|..++.. ...+....+-++.|+++|+.|||++||.|||+|.+||||.  +|+  .+.|+|||+
T Consensus       314 ~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  314 EPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             CCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence             245889998764 488888875 3456777888999999999999999999999999999994  333  589999998


Q ss_pred             cccccCc-------cccccccCCCCcCChhhhhccCCC-----CccccccccccceeeeccCCCCCCCCchhHHHhhhcC
Q 040472          369 AKHMTSC-------ASMLSFKGSPYWMAPEVVMNTNGY-----SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN  436 (628)
Q Consensus       369 a~~~~~~-------~~~~~~~GT~~Y~APEvl~~~~~~-----s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~  436 (628)
                      +-.-...       ......-|...-||||+.....+.     -.|+|.|+.|.+.||++....||........-....+
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq  471 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ  471 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence            7432211       112234477889999997543321     2479999999999999999999987433222222234


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCH---HHHhcC
Q 040472          437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA---SKLLDH  475 (628)
Q Consensus       437 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta---~eiL~H  475 (628)
                      ...+|.+++.+++.+++|+..+|+.||.+|++.   ..+|+.
T Consensus       472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence            456788899999999999999999999999874   345543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=9.3e-23  Score=200.15  Aligned_cols=146  Identities=17%  Similarity=0.180  Sum_probs=115.1

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch---------------------HHHHHHHHHHHHHHHhCCCCC
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS---------------------KECLKQLNQEINLLSQLSHPN  283 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~---------------------~~~~~~~~~Ei~iL~~l~Hpn  283 (628)
                      .+.||+|+||+||+|++. +|+.||||+++........                     ......+..|++.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999987 8999999999764321100                     111233568999999999998


Q ss_pred             eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEE
Q 040472          284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       284 IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vK  362 (628)
                      |.....+...  ..||||||+.|+++...+.....+++..+..++.|++.+|.+||. +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7544433322  348999999988655443344678889999999999999999999 9999999999999998 89999


Q ss_pred             EeccCCcccccC
Q 040472          363 LADFGMAKHMTS  374 (628)
Q Consensus       363 L~DFGla~~~~~  374 (628)
                      |+|||++.....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.1e-22  Score=201.44  Aligned_cols=188  Identities=19%  Similarity=0.125  Sum_probs=141.2

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceEEE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      .+...|++|+||+||++..  .+..++.+.+.....- ...-.-..+.+|+++|++|. |++|++++++    +..|++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~-~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWW-LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhh-hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            3567899999999998855  5677877766432110 01111235789999999996 5889999886    4579999


Q ss_pred             EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccc-CCCceEeCCCCCEEEeccCCcccccCcccc--
Q 040472          302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI-KGANILVDPHGEIKLADFGMAKHMTSCASM--  378 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI-KpeNILld~~g~vKL~DFGla~~~~~~~~~--  378 (628)
                      ||+.|.+|.+.+..      . ...++.|++.+|++||++||+|||| ||+|||++.++.++|+|||+|.........  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999999765432      1 2357889999999999999999999 799999999999999999999855433210  


Q ss_pred             ------------ccccCCCCcCChhhhhccCCCC-ccccccccccceeeeccCCCCCCC
Q 040472          379 ------------LSFKGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQ  424 (628)
Q Consensus       379 ------------~~~~GT~~Y~APEvl~~~~~~s-~ksDIWSLGvlLyelLtG~~PF~~  424 (628)
                                  .-...++.|+.|+...-....+ ...++++.|+.+|.|+|++.++..
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                        0123688999998754332233 567999999999999999988654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=1.8e-22  Score=208.89  Aligned_cols=235  Identities=21%  Similarity=0.297  Sum_probs=153.2

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC----------CC------e
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH----------PN------I  284 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H----------pn------I  284 (628)
                      .+..++.||.|+|+.||.+.+..|++.+|||+.....  ......++++++|.-....+.+          -.      +
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            5678899999999999999999999999999986644  2334456677777655444332          11      2


Q ss_pred             eeeec---ceecc---c-----cceEEEEecccccHHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHhCCcccc
Q 040472          285 VRYHG---SELSD---E-----RLSVYLEYVSGGSIHKLLQ---EYGPF----NEPVIQTYTRQILLGLAYLHARNTVHR  346 (628)
Q Consensus       285 V~l~~---~~~~~---~-----~~~lVmEy~~GgsL~~~L~---~~~~l----~e~~~~~i~~qIl~aL~yLH~~gIvHR  346 (628)
                      +++-+   ++...   .     +.+++|.-+ -++|.+++.   .....    .......+..|++..+++||..||||+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            22221   11111   1     346677777 568888764   22222    122234566899999999999999999


Q ss_pred             ccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCChhhhhcc-------CCCCccccccccccceeeeccCC
Q 040472          347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT-------NGYSLTVDIWSLGCTVLEMATSK  419 (628)
Q Consensus       347 DIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-------~~~s~ksDIWSLGvlLyelLtG~  419 (628)
                      ||||+|+|++.+|.++|+||+...........  ...+..|.+||.....       ..++.+.|.|+||+++|.|.+++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999999877654332221  3356789999986432       23788999999999999999999


Q ss_pred             CCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCC
Q 040472          420 PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR  466 (628)
Q Consensus       420 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  466 (628)
                      .||...........  ...   .-. ++++.+++||+.+|++||++|
T Consensus       248 lPf~~~~~~~~~~~--~f~---~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW--DFS---RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG--GGT---TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc--cch---hcC-CcCHHHHHHHHHHccCCcccC
Confidence            99975433222111  111   112 688999999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=2.7e-23  Score=237.30  Aligned_cols=246  Identities=23%  Similarity=0.274  Sum_probs=185.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      ++...+.||.+.|=+|.+|++.+ |. |+||++-+..+.. .-..+++..+|++ ...++|||++.+.-+...+...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~-sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTI-SLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCC-CchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68888999999999999998875 44 9999986544333 3333444455666 6777899999999998899999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc--cC--cc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM--TS--CA  376 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~--~~--~~  376 (628)
                      -+|+.. +|+|.|..+.-+.+.+-++|+.||+.||.-||..||+|+|||.|||||+.-.-+.|+||.--+-.  ..  ..
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            999955 99999988777888899999999999999999999999999999999999999999999865532  11  11


Q ss_pred             ccccccCC----CCcCChhhhhccC----------CCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCC-CCC
Q 040472          377 SMLSFKGS----PYWMAPEVVMNTN----------GYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNS-KDI  440 (628)
Q Consensus       377 ~~~~~~GT----~~Y~APEvl~~~~----------~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~-~~~  440 (628)
                      ...-+-.|    ..|+|||.+....          ..+++.||||+||+++||++ |+++|.-    .++...... ...
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADD  254 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccC
Confidence            11112222    3499999875422          15788999999999999988 7888852    111111111 000


Q ss_pred             C--CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          441 P--EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       441 ~--~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +  .+..--+..++.||..|++.||.+|.++++.|+.
T Consensus       255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0  0011123478999999999999999999999976

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=5.7e-21  Score=190.65  Aligned_cols=134  Identities=24%  Similarity=0.273  Sum_probs=106.9

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-----CCCCeeeeecceeccc---c
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-----SHPNIVRYHGSELSDE---R  296 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIV~l~~~~~~~~---~  296 (628)
                      .++||+|+||.||.  +..++.. +||++.....     ...+.+.+|+++++.+     .||||++++++++++.   .
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            46799999999995  7777665 6888764211     1346789999999999     5799999999999874   4


Q ss_pred             ce-EEEEe--cccccHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccccCCCceEeCCC----CCEEEeccCC
Q 040472          297 LS-VYLEY--VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL-AYLHARNTVHRDIKGANILVDPH----GEIKLADFGM  368 (628)
Q Consensus       297 ~~-lVmEy--~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL-~yLH~~gIvHRDIKpeNILld~~----g~vKL~DFGl  368 (628)
                      ++ +||||  +.+++|.+++++ +.+++.  ..+++|++.++ +|||+++||||||||+|||++..    ++++|+||+.
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            34 78999  557999999976 457666  36688888888 99999999999999999999743    3799999543


Q ss_pred             c
Q 040472          369 A  369 (628)
Q Consensus       369 a  369 (628)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=9.4e-22  Score=196.30  Aligned_cols=244  Identities=21%  Similarity=0.336  Sum_probs=198.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +.+..+..+|.+...|..|+|++..+  .+++|++++.   +.....-+.|+.|.-.|+-+.||||+.+++.|....++.
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr---~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVR---EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccCc--chhhhhhhhh---hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            34556677899999999999999854  4667877642   222334567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCCEEE--eccCCcccc
Q 040472          299 VYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGEIKL--ADFGMAKHM  372 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~vKL--~DFGla~~~  372 (628)
                      ++..|++.|+|+.+|.+..  ..+..++..++.+|+.|++|||+..  |.---|....++||++...+|  +|--++.+.
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe  343 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE  343 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence            9999999999999998754  3577889999999999999999875  444468888999998876554  443333211


Q ss_pred             cCccccccccCCCCcCChhhhhccCCC--CccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGY--SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~--s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                            ....-.|.||+||.+......  -.++|+|||.++||||.|...||......+--+++........+|+.++..
T Consensus       344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h  417 (448)
T KOG0195|consen  344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH  417 (448)
T ss_pred             ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence                  112347889999999765432  357999999999999999999999999888888888777778999999999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHh
Q 040472          451 AKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      +..|++-||..||.+||.+++|+
T Consensus       418 m~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  418 MNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHhcCCCCcCCCcceeh
Confidence            99999999999999999988764

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=1.5e-20  Score=191.23  Aligned_cols=148  Identities=20%  Similarity=0.180  Sum_probs=116.9

Q ss_pred             CeEEeeeeccCCcEEEEEEE-ECCCCcEEEEEEEeecccccc-------------------hHHHHHHHHHHHHHHHhCC
Q 040472          221 KWKKGKLLGRGTFGHVYLGF-NSESGQMCAIKEVRVVCDDQT-------------------SKECLKQLNQEINLLSQLS  280 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~-~~~tg~~vAvK~i~~~~~~~~-------------------~~~~~~~~~~Ei~iL~~l~  280 (628)
                      .|++.+.||+|+||.||+|+ +..+|+.||||+++.......                   .......+..|+.+|.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57888999999999999999 777899999999875321100                   0112234678999999998


Q ss_pred             CCC--eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccCCCceEeCC
Q 040472          281 HPN--IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN-TVHRDIKGANILVDP  357 (628)
Q Consensus       281 Hpn--IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-IvHRDIKpeNILld~  357 (628)
                      +.+  +.+++++    ...+|||||+.|++|..++.....+.+..+..++.||+.+|+|||.+| |+||||||+|||++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            633  3344432    245899999999888776544456777778899999999999999999 99999999999999 


Q ss_pred             CCCEEEeccCCccccc
Q 040472          358 HGEIKLADFGMAKHMT  373 (628)
Q Consensus       358 ~g~vKL~DFGla~~~~  373 (628)
                      ++.++|+|||++....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999987543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2e-21  Score=221.08  Aligned_cols=258  Identities=27%  Similarity=0.407  Sum_probs=211.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCC-CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSES-GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~  297 (628)
                      ..|.+.+.||+|+|+.|-++.+..+ ...+|+|.+....   .......++..|+.+-..+. |.|++.+++...+.+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            4677788899999999999977443 4456777664332   23445667778999988888 99999999999999999


Q ss_pred             eEEEEecccccHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccccCCCceEeCCCC-CEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLL-QEYG-PFNEPVIQTYTRQILLGLAYLH-ARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L-~~~~-~l~e~~~~~i~~qIl~aL~yLH-~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~  373 (628)
                      ++++||..|+++++-+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999999 5444 6788889999999999999999 99999999999999999999 99999999998765


Q ss_pred             C-cc---ccccccC-CCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHH-hhhcCC--CCCCCCCC
Q 040472          374 S-CA---SMLSFKG-SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI-FKIGNS--KDIPEIPE  445 (628)
Q Consensus       374 ~-~~---~~~~~~G-T~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~-~~i~~~--~~~~~~p~  445 (628)
                      . ..   .....+| ++.|+|||.+.+........|+||+|+++.-|++|..||......... ......  ......+.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            4 22   2345678 999999999877556788999999999999999999999764433222 111111  11234567


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .++..+.+++.++|..+|..|.+.+++..++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78999999999999999999999999999999976

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.3e-19  Score=177.49  Aligned_cols=139  Identities=23%  Similarity=0.327  Sum_probs=115.4

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---chHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      +.||+|++|.||+|++  ++..|+||+........   .......++.+|+.++..+.|++|+....++.+.+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  57789999765322111   111123467889999999999998877777777888999999


Q ss_pred             ecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      |++|++|.+++.....    ....++.+|+.+|.+||+.+++|||++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999876432    7889999999999999999999999999999999 78999999998864

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=6.9e-20  Score=213.29  Aligned_cols=193  Identities=22%  Similarity=0.322  Sum_probs=157.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC---CCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS---HPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~~~~~~  294 (628)
                      ....|.|.+.||+|+||+||+|.+.. |+.||||+-+..+.    .+.+-    -.+++.+|+   -+.|..+..++...
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI----~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYI----CLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeee----hHHHHHhhchhhhcchHHHHHHHccC
Confidence            34689999999999999999999887 99999998764321    22110    122333333   24466666677777


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-------CCCEEEeccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-------HGEIKLADFG  367 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-------~g~vKL~DFG  367 (628)
                      +.-+||+||.+.|+|.++++..+.++|..+..++.|++..|++||..+|||+||||+|+||..       .--++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            888999999999999999998889999999999999999999999999999999999999942       2248999999


Q ss_pred             Ccccc---cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCC
Q 040472          368 MAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP  420 (628)
Q Consensus       368 la~~~---~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~  420 (628)
                      .+..+   .+.......++|-.+-.+|++.|.. ++..+|.|.|+.+++.||.|++
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            98754   3344566788999999999997765 9999999999999999999974

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=4.9e-19  Score=173.74  Aligned_cols=135  Identities=24%  Similarity=0.344  Sum_probs=109.2

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---chHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      +||+|+||.||+|..  ++..|+||+........   .......++.+|++++..+.|.+|....-++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  57889999864321111   1122346788999999999988766555555667778999999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ++|++|.+++.....       .++.||+.+|.+||+.|++|+|++|+|||++ ++.++|+|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998865321       8899999999999999999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=5.1e-19  Score=174.37  Aligned_cols=141  Identities=21%  Similarity=0.225  Sum_probs=110.4

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch-----------------HHHHHHHHHHHHHHHhCCCCC-
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-----------------KECLKQLNQEINLLSQLSHPN-  283 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-----------------~~~~~~~~~Ei~iL~~l~Hpn-  283 (628)
                      |.+.+.||+|+||.||++.+. +|+.||||+++........                 .........|+.++..+.|.+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777899999999999999875 7999999987643211000                 011123678999999998774 


Q ss_pred             -eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEE
Q 040472          284 -IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       284 -IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vK  362 (628)
                       ++.+++    ....++||||+.|++|..++..      .....++.+|+.+|.++|+.||+||||||+||||+.+++++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2456899999999999776431      34668889999999999999999999999999999999999


Q ss_pred             EeccCCccccc
Q 040472          363 LADFGMAKHMT  373 (628)
Q Consensus       363 L~DFGla~~~~  373 (628)
                      |+|||++....
T Consensus       166 liDfg~~~~~~  176 (198)
T cd05144         166 IIDWPQMVSTD  176 (198)
T ss_pred             EEECCccccCC
Confidence            99999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=3.3e-20  Score=200.44  Aligned_cols=175  Identities=23%  Similarity=0.411  Sum_probs=137.1

Q ss_pred             ccceEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ..+||.|++|.-.+|.++|.+..   ..+...++.++.|++.|++|   ++.+|||+||.||+...+.++||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35889999999999999997543   35667789999999999999   9999999999999999999999999999987


Q ss_pred             ccCcc-------ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCC-C
Q 040472          372 MTSCA-------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIP-E  442 (628)
Q Consensus       372 ~~~~~-------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~-~  442 (628)
                      .....       .++...||.+||+||.|.+. .|+.++||||||+||+|++. -...|..   ...+..+ ....+| .
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~-r~g~ip~~  480 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFER---IATLTDI-RDGIIPPE  480 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh-hcCCCChH
Confidence            65544       56677899999999999765 49999999999999999998 3333322   2222222 223333 2


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +.... ++-.+|+.+||...|.+||++.+.--|.|.
T Consensus       481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 FLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             HhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            22222 356689999999999999987777666664

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2e-18  Score=195.48  Aligned_cols=143  Identities=21%  Similarity=0.264  Sum_probs=114.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---chHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ...|...++||+|+||.||++.+..  ..+++|+........   ......+++.+|+++|+.++|++|+..+.++.+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455678999999999999998754  345555432111111   11123456889999999999999998877777777


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ..++||||++|++|.+++.        ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            8899999999999999886        356789999999999999999999999999999 6789999999999753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=2.6e-19  Score=205.07  Aligned_cols=269  Identities=23%  Similarity=0.316  Sum_probs=218.4

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ..+.+.+.+.+-+-+|.|+.++.+.-..++...++|+..+...-  ....++.+..+-.++-...+|.+++....+....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i--~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs  877 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI--RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS  877 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhh--ccccccccCCccCccccCCCCceecccCCCCCCC
Confidence            34667889999999999999999998888988888877542211  1222344555666666667788888877777788


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc--
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT--  373 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~--  373 (628)
                      ..+|||+|+.|++|...|+..+..++.-++.++..+..+++|||...++|||++|.|+|+..+|+.+++|||......  
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            999999999999999999999989999999999999999999999999999999999999999999999998432110  


Q ss_pred             ----------------------------Cc--cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCC
Q 040472          374 ----------------------------SC--ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS  423 (628)
Q Consensus       374 ----------------------------~~--~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~  423 (628)
                                                  ..  .......||+.|++||.+.+.. ....+|||++|++++|.++|.+||.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                        00  1122356899999999998765 7889999999999999999999998


Q ss_pred             CCchhHHHhhhcCC-CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHH---HHhcCccccchHHHhhc
Q 040472          424 QYEGVAAIFKIGNS-KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPAS---KLLDHPFVRDQAVARAG  487 (628)
Q Consensus       424 ~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~---eiL~Hpwf~~~~~~~~~  487 (628)
                      .......+..+... ..++.-+...+.++++++.++|..++.+|.++.   ++..|+||++.+|....
T Consensus      1037 a~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             CcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            76655555444332 344566778999999999999999999999877   99999999999886543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=1.5e-17  Score=161.52  Aligned_cols=142  Identities=23%  Similarity=0.301  Sum_probs=100.9

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHH-HH------------------HHHHHHHHHHHhCCCCC--
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE-CL------------------KQLNQEINLLSQLSHPN--  283 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~-~~------------------~~~~~Ei~iL~~l~Hpn--  283 (628)
                      ++.||+|+||+||+|.+. +++.||||+++.......... ..                  .....|...+.++.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999887 799999999875321111000 00                  01245666666665433  


Q ss_pred             eeeeecceeccccceEEEEecccccHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCE
Q 040472          284 IVRYHGSELSDERLSVYLEYVSGGSIHK-LLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEI  361 (628)
Q Consensus       284 IV~l~~~~~~~~~~~lVmEy~~GgsL~~-~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~v  361 (628)
                      +.+++++    ...++||||+.|+.+.. .+.... . ...++.++.+++.+|.+||. .+|+||||||+|||++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4444433    24689999999854322 122111 1 16688999999999999999 9999999999999999 8999


Q ss_pred             EEeccCCcccccC
Q 040472          362 KLADFGMAKHMTS  374 (628)
Q Consensus       362 KL~DFGla~~~~~  374 (628)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=8.7e-17  Score=163.83  Aligned_cols=141  Identities=23%  Similarity=0.321  Sum_probs=106.6

Q ss_pred             eeeec-cCCcEEEEEEEECCCCcEEEEEEEeecc------ccc--chHHHHHHHHHHHHHHHhCCCCCe--eeeecceec
Q 040472          225 GKLLG-RGTFGHVYLGFNSESGQMCAIKEVRVVC------DDQ--TSKECLKQLNQEINLLSQLSHPNI--VRYHGSELS  293 (628)
Q Consensus       225 ~~~LG-~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~--~~~~~~~~~~~Ei~iL~~l~HpnI--V~l~~~~~~  293 (628)
                      +..|| .|+.|+||.+...  +..++||.+....      ...  .......++.+|++++..|.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35677 7888888888664  7789999885311      100  011233568889999999998875  667766443


Q ss_pred             cc-c---ceEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          294 DE-R---LSVYLEYVSG-GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       294 ~~-~---~~lVmEy~~G-gsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                      .. .   .++||||++| .+|.+++.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            22 2   2599999997 689988865 4566543    57899999999999999999999999999999999999998


Q ss_pred             cccc
Q 040472          369 AKHM  372 (628)
Q Consensus       369 a~~~  372 (628)
                      +...
T Consensus       189 ~~~~  192 (239)
T PRK01723        189 GELR  192 (239)
T ss_pred             cccC
Confidence            8753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.68  E-value=5.2e-17  Score=178.31  Aligned_cols=198  Identities=26%  Similarity=0.441  Sum_probs=155.2

Q ss_pred             HHhCCCCCeeeeecceeccccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccccCCCce
Q 040472          276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNT-VHRDIKGANI  353 (628)
Q Consensus       276 L~~l~HpnIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gI-vHRDIKpeNI  353 (628)
                      |+.+.|.||.+++|.+.+....++|-+||..|+|++.+.. .-.++.--...++++|+.||+|||..-| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678899999999999999999999999999999999986 4567777888999999999999998876 9999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCc---cccccccCCCCcCChhhhhccC--C----CCccccccccccceeeeccCCCCCCC
Q 040472          354 LVDPHGEIKLADFGMAKHMTSC---ASMLSFKGSPYWMAPEVVMNTN--G----YSLTVDIWSLGCTVLEMATSKPPWSQ  424 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~--~----~s~ksDIWSLGvlLyelLtG~~PF~~  424 (628)
                      ++|..-.+||+|||+.......   .......-..-|.|||.+.+..  .    .+.+.||||+|++++|+++..-||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765421   1111122334589999986531  1    36679999999999999999999965


Q ss_pred             C----chhHHHhhhcC---CCCCCCCCC--cCCHHHHHHHHHHhhcCCCCCCCHHHHh
Q 040472          425 Y----EGVAAIFKIGN---SKDIPEIPE--HLSDDAKSFIKQCLQRDPSARPPASKLL  473 (628)
Q Consensus       425 ~----~~~~~~~~i~~---~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rpta~eiL  473 (628)
                      .    +..+.+..+..   ....|.++.  .+.+++..+++.||..+|++||++++|.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            2    22233444333   112233321  3556799999999999999999998874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=1.8e-16  Score=145.38  Aligned_cols=133  Identities=23%  Similarity=0.230  Sum_probs=112.0

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC--CCeeeeecceeccccceEEE
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIV~l~~~~~~~~~~~lVm  301 (628)
                      +.+.||.|.++.||++....  ..++||.+.....       ...+.+|+.+++.+.|  .++++++.++...+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            45789999999999998754  7899998753211       3467789999999986  58999998888888999999


Q ss_pred             EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR---NTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ||+.|+.+..+       +......++.+++.+|++||..   +++|+||+++|||++..+.++|+|||++...
T Consensus        73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            99999887654       4566778899999999999985   6999999999999998899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=9.6e-16  Score=168.67  Aligned_cols=254  Identities=23%  Similarity=0.232  Sum_probs=198.7

Q ss_pred             CCeEEeeeecc--CCcEEEEEEEE--CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecc
Q 040472          220 SKWKKGKLLGR--GTFGHVYLGFN--SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSD  294 (628)
Q Consensus       220 ~~y~~~~~LG~--G~fG~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~  294 (628)
                      ..|.+.+.+|.  |.+|.||.+..  ..+++.+|+|.-+.....   ...-.+-.+|+.....++ |+|+|+.+..+...
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~---p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP---PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC---ccccccccchhhcccccCccccccccCcccccC
Confidence            45677788999  99999999998  889999999974321111   111122345666666776 99999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCccccccCCCceEeCCC-CCEEEeccCC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILL----GLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGM  368 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~-l~e~~~~~i~~qIl~----aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGl  368 (628)
                      +.+|+-+|+| +.+|..+...... +++..++.++.++..    ||.++|..+|+|-|+||+||++..+ ..++++|||+
T Consensus       191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            9999999999 5788888876554 889999999999999    9999999999999999999999999 8899999999


Q ss_pred             cccccCccccc------cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC--chhHHHhhhcCCCCC
Q 040472          369 AKHMTSCASML------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDI  440 (628)
Q Consensus       369 a~~~~~~~~~~------~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~--~~~~~~~~i~~~~~~  440 (628)
                      ...+.......      ...|...|++||++.+  -++.+.||++||.++.+..++...+...  ....   .+......
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---~~r~~~ip  344 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---QLRQGYIP  344 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc---ccccccCc
Confidence            98876554221      1257788999998854  3899999999999999988876655332  2111   22222233


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .++....+.++...+..||+.++-.|++++.+++|++++...
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence            345556777888899999999999999999999999987443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=3.5e-15  Score=167.39  Aligned_cols=146  Identities=18%  Similarity=0.256  Sum_probs=100.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc-----------------------------chHHHHHHH
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-----------------------------TSKECLKQL  269 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~-----------------------------~~~~~~~~~  269 (628)
                      +..|.. +.||.|++|+||+|+.+.+|+.||||+++......                             .-.+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 78999999999999999889999999997532110                             001223334


Q ss_pred             HHHHHHHHhCCCCCeeeeecceec-------------cccceEEEEecccccHHHH--HHhcC----CCCHHHHHHHHHH
Q 040472          270 NQEINLLSQLSHPNIVRYHGSELS-------------DERLSVYLEYVSGGSIHKL--LQEYG----PFNEPVIQTYTRQ  330 (628)
Q Consensus       270 ~~Ei~iL~~l~HpnIV~l~~~~~~-------------~~~~~lVmEy~~GgsL~~~--L~~~~----~l~e~~~~~i~~q  330 (628)
                      .+|+.+++..  .|+.++...|.+             ....+|||||+.|+.|.++  +...+    .+.+..+..++.|
T Consensus       198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            4455444433  233333333332             3445699999999999875  33333    2445555556666


Q ss_pred             HHHHHHHHHhCCccccccCCCceEeCCCC----CEEEeccCCcccccC
Q 040472          331 ILLGLAYLHARNTVHRDIKGANILVDPHG----EIKLADFGMAKHMTS  374 (628)
Q Consensus       331 Il~aL~yLH~~gIvHRDIKpeNILld~~g----~vKL~DFGla~~~~~  374 (628)
                      ++       ..|++|+|+||.||||+.+|    +++++|||++..+..
T Consensus       276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            54       58999999999999999888    999999999976643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=8.2e-14  Score=153.93  Aligned_cols=143  Identities=20%  Similarity=0.239  Sum_probs=99.1

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch-----------------------------HHHHH------HHH
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-----------------------------KECLK------QLN  270 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-----------------------------~~~~~------~~~  270 (628)
                      +.||.|++|+||+|+.+ +|+.||||+.+........                             .+...      ++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999876 6899999998653211110                             00111      244


Q ss_pred             HHHHHHHhCC-----CCCe--eeeecceeccccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 040472          271 QEINLLSQLS-----HPNI--VRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILL-GLAYLHAR  341 (628)
Q Consensus       271 ~Ei~iL~~l~-----HpnI--V~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~-aL~yLH~~  341 (628)
                      +|++.+.++.     +++|  .+++.  ......+|||||++|++|.+++... ..+.   ...++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            4555555542     3332  23332  2234579999999999999876532 1222   3345556655 47889999


Q ss_pred             CccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       342 gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      |++|+|+||.|||++.+++++|+|||++..+..
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999977643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=3.5e-14  Score=156.45  Aligned_cols=251  Identities=25%  Similarity=0.219  Sum_probs=188.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~  295 (628)
                      .+.+|.++..||.|.|+.|+..... .++..|++|.+.......  .. ...-..|+.+...+. |.+++.++..+...+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--AS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hh-hhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3468889999999999999998654 778899999775322111  11 122345666666665 999999999888888


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~~~~~  374 (628)
                      ..|+=.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+...+.-
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            899999999999988777555678899999999999999999999999999999999999876 7889999998864211


Q ss_pred             ccccccccCCCCcC-ChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          375 CASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~-APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                        .......+-+++ ..|++.....+..++|+++||.-+++.+++.+-=.....   ...+. ...++..+. ...++..
T Consensus       420 --~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~-~~~~p~~~~-~~~~~q~  492 (524)
T KOG0601|consen  420 --SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIR-SGDTPNLPG-LKLQLQV  492 (524)
T ss_pred             --ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeee-cccccCCCc-hHHhhhh
Confidence              111222333444 366666666689999999999999999998764222222   11221 223344444 3388899


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +.+.++..++..|+.+.++..|.=|
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchh
Confidence            9999999999999999999887654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=4.3e-13  Score=132.40  Aligned_cols=142  Identities=15%  Similarity=0.200  Sum_probs=103.3

Q ss_pred             eeeeccCCcEEEEEEEECC------CCcEEEEEEEeeccccc--------------------chHHHH-HHHHHHHHHHH
Q 040472          225 GKLLGRGTFGHVYLGFNSE------SGQMCAIKEVRVVCDDQ--------------------TSKECL-KQLNQEINLLS  277 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~------tg~~vAvK~i~~~~~~~--------------------~~~~~~-~~~~~Ei~iL~  277 (628)
                      ...||.|--+.||.|....      .+..+|||+.+......                    .....+ .-.++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3569999999999997653      35789999986422110                    001111 12348999999


Q ss_pred             hCCC--CCeeeeecceeccccceEEEEecccccHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccccCCCce
Q 040472          278 QLSH--PNIVRYHGSELSDERLSVYLEYVSGGSIHK-LLQEYGPFNEPVIQTYTRQILLGLAYL-HARNTVHRDIKGANI  353 (628)
Q Consensus       278 ~l~H--pnIV~l~~~~~~~~~~~lVmEy~~GgsL~~-~L~~~~~l~e~~~~~i~~qIl~aL~yL-H~~gIvHRDIKpeNI  353 (628)
                      ++..  -++.+.+++    ...+|||||+.+..+.. .++ ...+++..+..++.|++.+|.+| |+.||||+||++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            9863  455666654    56789999997654432 232 23456667788899999999999 899999999999999


Q ss_pred             EeCCCCCEEEeccCCcccc
Q 040472          354 LVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~  372 (628)
                      |++ ++.++|+|||.+...
T Consensus       157 L~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EEE-CCcEEEEECCCceeC
Confidence            996 578999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=2.8e-13  Score=128.97  Aligned_cols=128  Identities=17%  Similarity=0.123  Sum_probs=96.4

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccceEEEEe
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~lVmEy  303 (628)
                      .+.|+.|.++.||++...  ++.|+||+......      ....+.+|+.+++.+.+.++ .+++.+.  ....++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            367899999999999865  77899998643211      11245678999998875554 3455443  3346899999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccccCCCceEeCCCCCEEEeccCCccc
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT-----VHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI-----vHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ++|.++...        ......++.+++.+|+.||..++     +|+|+++.|||++ ++.++|+|||.+..
T Consensus        73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999887643        11123567899999999999985     9999999999998 67899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=1.5e-12  Score=145.04  Aligned_cols=168  Identities=23%  Similarity=0.345  Sum_probs=131.3

Q ss_pred             EEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccccHHHHHHhcC
Q 040472          238 LGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG  317 (628)
Q Consensus       238 ~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~  317 (628)
                      .|..+.++..|.|.+++....     +....+.+.++-|+.|+||||+++++.++.++.+|||.|-|.  .|..++++.+
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH
Confidence            456677888999998864322     445567788899999999999999999999999999999984  6888888755


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHH-hCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-cccccCCCCcCChhhhhc
Q 040472          318 PFNEPVIQTYTRQILLGLAYLH-ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMN  395 (628)
Q Consensus       318 ~l~e~~~~~i~~qIl~aL~yLH-~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APEvl~~  395 (628)
                         ...+..-+.||+.||.||| +.+++|++|.-.-|+|+..|++||++|-++........ .....---.|..|+.+..
T Consensus       103 ---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 ---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             ---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence               7778888999999999998 56899999999999999999999999988754432221 111111223666765421


Q ss_pred             cCCCCccccccccccceeeeccC
Q 040472          396 TNGYSLTVDIWSLGCTVLEMATS  418 (628)
Q Consensus       396 ~~~~s~ksDIWSLGvlLyelLtG  418 (628)
                         -.-..|.|-|||+++|++.|
T Consensus       180 ---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 ---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ---cccchhhhhHHHHHHHHhCc
Confidence               12457999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=6.4e-11  Score=114.45  Aligned_cols=136  Identities=20%  Similarity=0.260  Sum_probs=101.1

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeeccc-c-c-chHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD-D-Q-TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~-~-~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmE  302 (628)
                      .+|++|+-+.+|++...  |..+++|.-..+.- . . ...-...+..+|+.+|.++.--.|..-+=++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46889999999999664  44567775322111 1 1 111223457789999999886665554445667788899999


Q ss_pred             ecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       303 y~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      |++|-.|.++|...       ...+++.+-.-+.-||..||||+||.+.||++..+ .+.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99999999898875       24566777777888999999999999999999754 499999999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=3.5e-11  Score=118.97  Aligned_cols=140  Identities=18%  Similarity=0.185  Sum_probs=105.5

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC--Ceeeeecceecc---ccceEE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP--NIVRYHGSELSD---ERLSVY  300 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIV~l~~~~~~~---~~~~lV  300 (628)
                      +.|+.|.++.||++.... |+.|+||+.......    ....++.+|+++++.+.+.  ++.+++.+....   +..++|
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence            579999999999998753 678999986532110    1234678899999999753  456677666553   367899


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA----------------------------------------  340 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~----------------------------------------  340 (628)
                      |||++|.+|.+.+.. ..+++.....++.+++.+|.+||+                                        
T Consensus        79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999999988776532 456677777777788888877773                                        


Q ss_pred             ----------------CCccccccCCCceEeCC--CCCEEEeccCCccc
Q 040472          341 ----------------RNTVHRDIKGANILVDP--HGEIKLADFGMAKH  371 (628)
Q Consensus       341 ----------------~gIvHRDIKpeNILld~--~g~vKL~DFGla~~  371 (628)
                                      ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            23699999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=6.9e-12  Score=129.27  Aligned_cols=197  Identities=26%  Similarity=0.381  Sum_probs=139.8

Q ss_pred             HHHHhCCCCCeeeeecceecc-----ccceEEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 040472          274 NLLSQLSHPNIVRYHGSELSD-----ERLSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARN--  342 (628)
Q Consensus       274 ~iL~~l~HpnIV~l~~~~~~~-----~~~~lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~g--  342 (628)
                      .-|-++-|.|||+++.|+.+.     .+..++.||+.-|+|..+|++.    ..+.+...++|+.||+.||.|||+..  
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            335566799999999887653     3578889999999999999863    35778888999999999999999875  


Q ss_pred             ccccccCCCceEeCCCCCEEEeccCCcccc---c--CccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc
Q 040472          343 TVHRDIKGANILVDPHGEIKLADFGMAKHM---T--SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT  417 (628)
Q Consensus       343 IvHRDIKpeNILld~~g~vKL~DFGla~~~---~--~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt  417 (628)
                      |+|+++..+-|++..+|-+|+.--......   .  .........+-++|.+||.=. ....+.++|||++|.+.+||..
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHH
Confidence            999999999999999998887532211100   0  011111234678899999643 3346778999999999999988


Q ss_pred             CCCCCCCCch----hHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          418 SKPPWSQYEG----VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       418 G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +..--...+.    ...+.....     .+   -...-+++|.+||+-.|..||++.+++-||.+-
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~-----~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVII-----GL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             heeccCCCcceeehhhhhhhhee-----ec---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            7643221111    111111100     00   011235789999999999999999999999753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=2e-10  Score=110.67  Aligned_cols=146  Identities=23%  Similarity=0.269  Sum_probs=109.3

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc--c-chHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD--Q-TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~-~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .+.+|-+|+-++|+++...  |+.+.||.-....-.  . ..+-..++..+|+++|.++.--.|.--.=+|.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999765  788889864322111  1 1122345688999999998755555444457777888999


Q ss_pred             EEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-C--EEEeccCCccc
Q 040472          301 LEYVSG-GSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-E--IKLADFGMAKH  371 (628)
Q Consensus       301 mEy~~G-gsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~--vKL~DFGla~~  371 (628)
                      |||++| -++.+++....  .........++++|-+.|.-||.++|||+||..+||||..++ +  +.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 47788876542  223333478999999999999999999999999999997665 3  58999999853

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=5e-11  Score=133.50  Aligned_cols=155  Identities=23%  Similarity=0.367  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccCccccc----------cccCCCCcCChhhhhccC
Q 040472          329 RQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML----------SFKGSPYWMAPEVVMNTN  397 (628)
Q Consensus       329 ~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~----------~~~GT~~Y~APEvl~~~~  397 (628)
                      .+++.||.|+|.. ++||+.|.|++|.++.++.+||+.|+++..........          ...-...|.|||++.+. 
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-  184 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence            3445999999976 89999999999999999999999999886544321110          11234579999999764 


Q ss_pred             CCCccccccccccceeeec-cCCCCCCCCchhHHH--hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          398 GYSLTVDIWSLGCTVLEMA-TSKPPWSQYEGVAAI--FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       398 ~~s~ksDIWSLGvlLyelL-tG~~PF~~~~~~~~~--~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..+.++|+|||||++|.+. .|+.-+.........  ...........+...++.++++-|.++|..+..-||++.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            4789999999999999999 555555443222111  1111111122345778999999999999999999999999999


Q ss_pred             CccccchHHH
Q 040472          475 HPFVRDQAVA  484 (628)
Q Consensus       475 Hpwf~~~~~~  484 (628)
                      -+||.+....
T Consensus       265 ~~ff~D~~~~  274 (700)
T KOG2137|consen  265 IPFFSDPGLK  274 (700)
T ss_pred             ccccCCchhh
Confidence            9999876543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=2.1e-09  Score=111.52  Aligned_cols=139  Identities=13%  Similarity=0.049  Sum_probs=98.7

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHH----------HHHHHHHHHHhCCCCCee--eeecceec-
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK----------QLNQEINLLSQLSHPNIV--RYHGSELS-  293 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~----------~~~~Ei~iL~~l~HpnIV--~l~~~~~~-  293 (628)
                      .+-.-....|+++..  .|+.|.||......    ..+.++          .+.+|...+.+|...+|.  .+++++.. 
T Consensus        29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~----~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~  102 (268)
T PRK15123         29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTG----WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG  102 (268)
T ss_pred             EEecCCCceEEEEEE--CCEEEEEEEecCCc----HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec
Confidence            344333444666543  47789999663211    111122          367899888888644443  34444432 


Q ss_pred             ----cccceEEEEecccc-cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-------CC
Q 040472          294 ----DERLSVYLEYVSGG-SIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-------HG  359 (628)
Q Consensus       294 ----~~~~~lVmEy~~Gg-sL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-------~g  359 (628)
                          ....+||||++.+- +|.+++..  .....+.....++.+|+..+.-||..||+|+|+++.||||+.       +.
T Consensus       103 ~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        103 SNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             CCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCc
Confidence                23578999999886 79999864  345667788899999999999999999999999999999975       45


Q ss_pred             CEEEeccCCccc
Q 040472          360 EIKLADFGMAKH  371 (628)
Q Consensus       360 ~vKL~DFGla~~  371 (628)
                      .+.|+||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            799999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=1.5e-09  Score=106.70  Aligned_cols=131  Identities=23%  Similarity=0.289  Sum_probs=86.9

Q ss_pred             EEEEEEECCCCcEEEEEEEeecccc---------------------cchHHHHHHHHHHHHHHHhCCCC--Ceeeeecce
Q 040472          235 HVYLGFNSESGQMCAIKEVRVVCDD---------------------QTSKECLKQLNQEINLLSQLSHP--NIVRYHGSE  291 (628)
Q Consensus       235 ~Vy~a~~~~tg~~vAvK~i~~~~~~---------------------~~~~~~~~~~~~Ei~iL~~l~Hp--nIV~l~~~~  291 (628)
                      .||.|... +|..+|||+.+.....                     ..........++|.+.|.++..-  ++.+++++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38999875 5789999997642111                     01112234578899999999865  45666644 


Q ss_pred             eccccceEEEEecc--cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          292 LSDERLSVYLEYVS--GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY-LHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       292 ~~~~~~~lVmEy~~--GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~y-LH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                         ...+|||||+.  |..|..+....  +.......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus        79 ---~~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   79 ---NRNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---ETTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---eCCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               24579999999  76776654432  1245567788888886655 579999999999999999876 999999998


Q ss_pred             ccccc
Q 040472          369 AKHMT  373 (628)
Q Consensus       369 a~~~~  373 (628)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            86543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.91  E-value=1e-08  Score=111.69  Aligned_cols=213  Identities=17%  Similarity=0.205  Sum_probs=151.3

Q ss_pred             CcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----cccceEEEEeccc-
Q 040472          232 TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----DERLSVYLEYVSG-  306 (628)
Q Consensus       232 ~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----~~~~~lVmEy~~G-  306 (628)
                      --.+.|++....+|..|++|.+........     .....-+++++++.|.|||.+.++|..    +..++||++|.++ 
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            346789999999999999998832211111     111234678999999999999999884    5678999999875 


Q ss_pred             ccHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          307 GSIHKLLQE---------------YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       307 gsL~~~L~~---------------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ++|.++--.               ....+|..++.|+.||..||.++|+.|+.-+-|.+.+||++.+.+++|...|....
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence            567665421               12367899999999999999999999999999999999999888888877776654


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCC-CCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~P-F~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      +..+.      +       |-+...    .+-|.=.||.+++.|.||..- |........        ....+-...+.+
T Consensus       443 l~~d~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--------~~~~I~~~yS~D  497 (655)
T KOG3741|consen  443 LQEDP------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS--------HLTRITTTYSTD  497 (655)
T ss_pred             ecCCC------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHH--------HHHHhhhhhhHH
Confidence            43322      0       112221    356888899999999999532 111111111        011233467889


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++++|..+...++++ -++.+++.|
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999999887 666666655

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.86  E-value=8.2e-09  Score=105.35  Aligned_cols=139  Identities=24%  Similarity=0.289  Sum_probs=103.3

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccc---------------ccchHHH--HHHHHHHHHHHHhCCCC--
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD---------------DQTSKEC--LKQLNQEINLLSQLSHP--  282 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---------------~~~~~~~--~~~~~~Ei~iL~~l~Hp--  282 (628)
                      ..++..||-|--+.||.|.+. .|..+|||.-+....               ...+...  ....++|.++|++|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356789999999999999887 588999998643211               1111111  23467899999999754  


Q ss_pred             CeeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEE
Q 040472          283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       283 nIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vK  362 (628)
                      .|.+.+++    ++..+||||++|-.|..+-     +....+..++..|++-+.-+-..||||+|+..-||||+.||.++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            66666643    5678999999997776542     23445556667777777777799999999999999999999999


Q ss_pred             EeccCCcc
Q 040472          363 LADFGMAK  370 (628)
Q Consensus       363 L~DFGla~  370 (628)
                      ++||--+.
T Consensus       243 vIDwPQ~v  250 (304)
T COG0478         243 VIDWPQAV  250 (304)
T ss_pred             EEeCcccc
Confidence            99997554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=1.7e-08  Score=100.59  Aligned_cols=106  Identities=22%  Similarity=0.277  Sum_probs=85.0

Q ss_pred             HHHHHHHHHHHhCCCCC--eeeeecceecc----ccceEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 040472          267 KQLNQEINLLSQLSHPN--IVRYHGSELSD----ERLSVYLEYVSGG-SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH  339 (628)
Q Consensus       267 ~~~~~Ei~iL~~l~Hpn--IV~l~~~~~~~----~~~~lVmEy~~Gg-sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH  339 (628)
                      .+..+|...+..|..-.  +...+++....    ...+||+|+++|. +|.+++.....++......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            35677888877775433  34455554432    3458999999984 79999987656778888999999999999999


Q ss_pred             hCCccccccCCCceEeCCCC---CEEEeccCCcccc
Q 040472          340 ARNTVHRDIKGANILVDPHG---EIKLADFGMAKHM  372 (628)
Q Consensus       340 ~~gIvHRDIKpeNILld~~g---~vKL~DFGla~~~  372 (628)
                      ++||+|+|+++.||||+.++   .+.|+||+-++..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.77  E-value=6.7e-08  Score=103.21  Aligned_cols=236  Identities=18%  Similarity=0.214  Sum_probs=150.0

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeee--------eecceecc
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVR--------YHGSELSD  294 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~--------l~~~~~~~  294 (628)
                      .++.||+|+-+.+|-.-.-.   ..+.|++..-..     ....+.   +..|... .||-+-.        |+|-- ..
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Ppp-----a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPP-----AAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGR-RG   82 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCc-----hHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCC-cc
Confidence            35679999999999763321   234476643111     111111   2223332 3553322        22211 12


Q ss_pred             ccceEEEEecccccH-HHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          295 ERLSVYLEYVSGGSI-HKLLQ------EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL-~~~L~------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      ..+-++|..+.|..= ..++.      ....+.++.+...++.|+.+.+.||+.|.+-+|+.++||||++++.|.|+|-.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence            236778888877532 22221      12346788899999999999999999999999999999999999999999854


Q ss_pred             CcccccCccccccccCCCCcCChhhhh----ccCCCCccccccccccceeeeccC-CCCCCCCch-------hH-HHhh-
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVM----NTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEG-------VA-AIFK-  433 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~-------~~-~~~~-  433 (628)
                      .-.....+..+...+|...|.+||...    -..+-+...|.|.|||+++++|.| +.||.+...       .+ .|.. 
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            333323344455667999999999753    112356789999999999999987 999965321       11 1100 


Q ss_pred             -h-----cCCCCCC---CC-CCcCCHHHHHHHHHHhhc--CCCCCCCHHH
Q 040472          434 -I-----GNSKDIP---EI-PEHLSDDAKSFIKQCLQR--DPSARPPASK  471 (628)
Q Consensus       434 -i-----~~~~~~~---~~-p~~~s~~l~dLI~~~L~~--dP~~Rpta~e  471 (628)
                       .     ......+   .+ ..-++++++.|..+|+..  ++.-||+++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence             0     0000000   11 234788999999999974  4668999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.74  E-value=3.1e-09  Score=118.15  Aligned_cols=239  Identities=23%  Similarity=0.233  Sum_probs=167.8

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC-eeeeecceeccccceEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN-IVRYHGSELSDERLSVY  300 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IV~l~~~~~~~~~~~lV  300 (628)
                      +....-+++|+++++|+.+...+...+ .+++..        .  ....-++++|.+++||| .+..++-++.+...+++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~--------~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ--------T--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeecc--------c--hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            344566899999999999887665544 665531        1  22345789999999999 77778888888899999


Q ss_pred             EEecccc-c-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          301 LEYVSGG-S-IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       301 mEy~~Gg-s-L~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      |+++.++ + ........-.|.+.+...+.+.-+.+|+|||+.--+|||    |||.. ++.+++.||+....+......
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccccc
Confidence            9999887 2 211111222355566677788888999999998888999    88875 478999999998877665556


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC--cCCH-HHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSD-DAKSFI  455 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~s~-~l~dLI  455 (628)
                      .+..+|+.++|||++.+.. +..+.|.|++++--.+|.-|.+|-...  ......+......+.+..  ..+. .-.++.
T Consensus       388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCc
Confidence            6788999999999987654 899999999998777777777775431  111111211111111110  0111 112477


Q ss_pred             HHHhhcCCCCCCCHHHHhcCcccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ..|+...|..|+....++-|.+|.
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfn  488 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFN  488 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhc
Confidence            788888899998888888777664

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=4e-07  Score=90.79  Aligned_cols=141  Identities=16%  Similarity=0.183  Sum_probs=99.6

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeec-ccccchHHHHHHHHHHHHHHHhCCCCC--eeeeecceec----cccceEE
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVV-CDDQTSKECLKQLNQEINLLSQLSHPN--IVRYHGSELS----DERLSVY  300 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IV~l~~~~~~----~~~~~lV  300 (628)
                      -|+||-+-|+.....  |+.|-||.-... ............+.+|+..|++|...+  +.+++.....    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            467888889987554  446888865311 111000112345778998888886333  4454422211    2357899


Q ss_pred             EEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC--EEEeccCCcc
Q 040472          301 LEYVSG-GSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--IKLADFGMAK  370 (628)
Q Consensus       301 mEy~~G-gsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~--vKL~DFGla~  370 (628)
                      +|-+.| -+|.+++.+.  .+.++.....++.+|+..|.-||+.|+.|+|+.+.|||++.+|.  |+++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 5888888653  35677778899999999999999999999999999999987776  9999998665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=5.3e-07  Score=101.27  Aligned_cols=143  Identities=19%  Similarity=0.263  Sum_probs=92.9

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc-------------------------h----HHHHHH------HH
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-------------------------S----KECLKQ------LN  270 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-------------------------~----~~~~~~------~~  270 (628)
                      +.|+.++-|+||+|+.+. |+.||||+.+.......                         -    .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999875 99999999764221110                         0    111122      33


Q ss_pred             HHHHHHHhCC-----CCCe--eeeecceeccccceEEEEecccccHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040472          271 QEINLLSQLS-----HPNI--VRYHGSELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHAR  341 (628)
Q Consensus       271 ~Ei~iL~~l~-----HpnI--V~l~~~~~~~~~~~lVmEy~~GgsL~~~L--~~~~~l~e~~~~~i~~qIl~aL~yLH~~  341 (628)
                      +|..-+.++.     .++|  .++|  ........|+|||++|-.+.+..  +. ..++...+...+.++.  +..+=..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence            4444444442     2332  2332  22245678999999999998884  44 4455333333222221  2223347


Q ss_pred             CccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       342 gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      |++|.|.+|.||+|+.+|++.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999876654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=1.5e-06  Score=87.05  Aligned_cols=139  Identities=18%  Similarity=0.186  Sum_probs=89.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHH------HHHHHHHHHhCC---CCCeeeeecc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ------LNQEINLLSQLS---HPNIVRYHGS  290 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~------~~~Ei~iL~~l~---HpnIV~l~~~  290 (628)
                      .+|++.+++-......|.+..  -+++.+++|+.+.....  .+..+..      ..+++..+..+.   .-.++.++.+
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            477888888887777676663  35788999987542211  1111111      223344343433   2222222222


Q ss_pred             -----eeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          291 -----ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       291 -----~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                           +.--...+|||||++|..|.++..    +.+    .+...|+++|.-||+.|++|+|.+|.|++++. +.++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEE
Confidence                 112345678999999998877643    223    24466778899999999999999999999985 4599999


Q ss_pred             cCCccc
Q 040472          366 FGMAKH  371 (628)
Q Consensus       366 FGla~~  371 (628)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.40  E-value=2.9e-06  Score=83.98  Aligned_cols=138  Identities=25%  Similarity=0.336  Sum_probs=81.9

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC--Ceeeeecceec---cccceE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP--NIVRYHGSELS---DERLSV  299 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIV~l~~~~~~---~~~~~l  299 (628)
                      ++.|+.|..+.||++....  ..++||+...       ......+.+|+.+++.|...  .+.+++.+...   ....++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            4689999999999998765  4899997642       13446677888888887633  24566654322   334689


Q ss_pred             EEEecccccHHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHHH-H
Q 040472          300 YLEYVSGGSIHK----------------LLQ---EY----GPFNEPV---------IQTY------------TRQILL-G  334 (628)
Q Consensus       300 VmEy~~GgsL~~----------------~L~---~~----~~l~e~~---------~~~i------------~~qIl~-a  334 (628)
                      +|+++.|..+..                ++.   ..    ..+....         ....            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999988877                111   11    0001000         0000            011222 3


Q ss_pred             HHHHHh-------CCccccccCCCceEeC-CCCCEEEeccCCccc
Q 040472          335 LAYLHA-------RNTVHRDIKGANILVD-PHGEIKLADFGMAKH  371 (628)
Q Consensus       335 L~yLH~-------~gIvHRDIKpeNILld-~~g~vKL~DFGla~~  371 (628)
                      ++.+++       ..++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            344442       3599999999999999 566678999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.38  E-value=2.1e-06  Score=87.02  Aligned_cols=134  Identities=13%  Similarity=0.141  Sum_probs=83.0

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC--eeeeecceeccccceEEEEe
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN--IVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IV~l~~~~~~~~~~~lVmEy  303 (628)
                      ..||+|..+.||+.    .+..+++|......       ....+.+|.++|+.+..-.  +.+.+++..+.+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence            56899999999984    24467788765311       1234578999998887443  46677777777788999999


Q ss_pred             ccccc-HH--------------HHH----HhcCC-----CCHHH-HHHHHH----------HHHH-HHHHHHh----CCc
Q 040472          304 VSGGS-IH--------------KLL----QEYGP-----FNEPV-IQTYTR----------QILL-GLAYLHA----RNT  343 (628)
Q Consensus       304 ~~Ggs-L~--------------~~L----~~~~~-----l~e~~-~~~i~~----------qIl~-aL~yLH~----~gI  343 (628)
                      ++|.. +.              ..+    .+-..     ..... ...+..          .+.. ...+|..    ..+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            99863 11              111    11011     11110 011100          1111 1222321    247


Q ss_pred             cccccCCCceEeCCCCCEEEeccCCccc
Q 040472          344 VHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       344 vHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +|+|+.|.||+++.++ +.|+||+.+..
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            8999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.36  E-value=1e-05  Score=80.31  Aligned_cols=130  Identities=25%  Similarity=0.325  Sum_probs=90.4

Q ss_pred             CCeEEeeeeccCCc-EEEEEEEECCCCcEEEEEEEee---cccc-----cc--h------HHHHHHHHHHHHHHHhCC--
Q 040472          220 SKWKKGKLLGRGTF-GHVYLGFNSESGQMCAIKEVRV---VCDD-----QT--S------KECLKQLNQEINLLSQLS--  280 (628)
Q Consensus       220 ~~y~~~~~LG~G~f-G~Vy~a~~~~tg~~vAvK~i~~---~~~~-----~~--~------~~~~~~~~~Ei~iL~~l~--  280 (628)
                      .+++.++.||.|.- |.||+++..  |+.||||+++.   ....     ..  .      .....-|..|-+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999764  78999999432   1100     00  0      012335777777755554  


Q ss_pred             -CCCe--eeeecceecc------------------ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 040472          281 -HPNI--VRYHGSELSD------------------ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH  339 (628)
Q Consensus       281 -HpnI--V~l~~~~~~~------------------~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH  339 (628)
                       +.++  |+++|+..-.                  ....||.||+....         .+.    ..-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             5566  8999986322                  12356778776533         222    234567778888999


Q ss_pred             hCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          340 ARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       340 ~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                      ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999988     3589999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.35  E-value=7e-07  Score=105.46  Aligned_cols=206  Identities=24%  Similarity=0.330  Sum_probs=148.8

Q ss_pred             HHHHHHHHHHHHhCCCCCeeeeecceecccc----ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040472          266 LKQLNQEINLLSQLSHPNIVRYHGSELSDER----LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR  341 (628)
Q Consensus       266 ~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~----~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~  341 (628)
                      +....-|+..+..+.|+|++.++.|......    +.+..|+|...++..+++..+..+...++.+..++++||+|+|..
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            3445567777888899999999887665432    334468999999999999999999999999999999999999999


Q ss_pred             CccccccCCC---ceEeCCCCCEEEe--ccCCcccccCccccccccCCCCcCChhhhhccC-CCCccccccccccceeee
Q 040472          342 NTVHRDIKGA---NILVDPHGEIKLA--DFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEM  415 (628)
Q Consensus       342 gIvHRDIKpe---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyel  415 (628)
                      ...|.-|...   +..++.++.+.+.  ||+..+............-+..|.++|...... ......|+|.+|.++..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            7666666555   4445566667766  898887765544444445566677888764322 123346999999999998


Q ss_pred             ccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          416 ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       416 LtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ..|..+-.....   ...+        ++.....+..+++.+|+..+.++|+.+.+++.|+|.+...
T Consensus       386 ~~~~~i~~~~~~---~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  386 SQGEDISEKSAV---PVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hhcCcccccccc---hhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            887654221111   1111        1111112688899999999999999999999999987543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.29  E-value=6.8e-06  Score=83.47  Aligned_cols=140  Identities=18%  Similarity=0.236  Sum_probs=94.3

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch------------------HH-HHHHHHHHHHHHHhCC--CCCe
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS------------------KE-CLKQLNQEINLLSQLS--HPNI  284 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~------------------~~-~~~~~~~Ei~iL~~l~--HpnI  284 (628)
                      ..|..|--+.||+|.. .++..||||+++........                  .. ...-..+|+.-|+++.  +=.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3677888899999975 45889999998753221110                  11 1112456777777775  3334


Q ss_pred             eeeecceeccccceEEEEecccccH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEE
Q 040472          285 VRYHGSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       285 V~l~~~~~~~~~~~lVmEy~~GgsL-~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vK  362 (628)
                      .+-+.+.    .-.|||||+....+ .-.|+.. .+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            4444443    45799999954310 1112221 23333678888899999988877 8999999999999998 88999


Q ss_pred             EeccCCcccc
Q 040472          363 LADFGMAKHM  372 (628)
Q Consensus       363 L~DFGla~~~  372 (628)
                      |+|||-|...
T Consensus       207 iID~~QaV~~  216 (268)
T COG1718         207 IIDVSQAVTI  216 (268)
T ss_pred             EEECcccccc
Confidence            9999987644

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=3.7e-06  Score=94.46  Aligned_cols=143  Identities=20%  Similarity=0.207  Sum_probs=91.8

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc--------------------------chHHHHHHHHH------HH
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ--------------------------TSKECLKQLNQ------EI  273 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~--------------------------~~~~~~~~~~~------Ei  273 (628)
                      +.||.-+.|+||+|+.+. |+.||||+-+......                          .-.+..+.+..      |+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999886 9999999965322111                          01122222222      33


Q ss_pred             H----HHHhCCCCC------eeeeecceeccccceEEEEecccccHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040472          274 N----LLSQLSHPN------IVRYHGSELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHAR  341 (628)
Q Consensus       274 ~----iL~~l~Hpn------IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L--~~~~~l~e~~~~~i~~qIl~aL~yLH~~  341 (628)
                      +    +.+.+.|-+      |.++|..+  .....|+||||+|.-+.++.  .+. .++...+...+.++..-+  |=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~q--If~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQ--IFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHH--HHhc
Confidence            2    233334545      44444332  45678999999999887754  333 355554444444432222  2346


Q ss_pred             CccccccCCCceEeCC----CCCEEEeccCCcccccC
Q 040472          342 NTVHRDIKGANILVDP----HGEIKLADFGMAKHMTS  374 (628)
Q Consensus       342 gIvHRDIKpeNILld~----~g~vKL~DFGla~~~~~  374 (628)
                      |++|.|-+|.||||..    ++++.|.|||+...+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            8999999999999984    56899999999876644

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.27  E-value=4.7e-06  Score=84.66  Aligned_cols=134  Identities=18%  Similarity=0.067  Sum_probs=82.0

Q ss_pred             eccCCc-EEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccceEEEEecc
Q 040472          228 LGRGTF-GHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYLEYVS  305 (628)
Q Consensus       228 LG~G~f-G~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~~lVmEy~~  305 (628)
                      |-.|.+ ..||++...  +..+.||......        ...+.+|+++|+.+. +--+.+++++...++..++|||+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            445555 889999653  3578888654211        234667888888875 4445677877776677899999999


Q ss_pred             cccHHHHH----------------HhcCCC-------CHH------HHHHHH----------------HHHHHHHHHHH-
Q 040472          306 GGSIHKLL----------------QEYGPF-------NEP------VIQTYT----------------RQILLGLAYLH-  339 (628)
Q Consensus       306 GgsL~~~L----------------~~~~~l-------~e~------~~~~i~----------------~qIl~aL~yLH-  339 (628)
                      |..|....                .+-..+       ...      .....+                ..+...++.|- 
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            98776431                110111       100      000000                00111222221 


Q ss_pred             ------hCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          340 ------ARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       340 ------~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                            ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                  12489999999999999877788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.18  E-value=2e-07  Score=111.60  Aligned_cols=212  Identities=13%  Similarity=0.041  Sum_probs=151.9

Q ss_pred             HHHHHHHHHHHHhCCCCCeeeeecceec--cccceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Q 040472          266 LKQLNQEINLLSQLSHPNIVRYHGSELS--DERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLH  339 (628)
Q Consensus       266 ~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH  339 (628)
                      .+.+..|..-++...|++++..+.-...  ....|.+++||.+|.++..|-+    ...+.+..+.....+.+.+..-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            3445556666777789999887765543  4568899999999999999854    334555566666666688888888


Q ss_pred             hCC-----ccccccCCCceEeCCCCCEEEeccCCccccc-CccccccccCCCCcCChhhhhccCCCCcccccccccccee
Q 040472          340 ARN-----TVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVL  413 (628)
Q Consensus       340 ~~g-----IvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLy  413 (628)
                      ...     .+|++||+-|.+|..+-.||+.++|+.+... .........+++.|+.+++.... .++.++|+|..++.+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHH
Confidence            652     7999999999999999999999999999333 23334456788999999976544 4888899999999999


Q ss_pred             eeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          414 EMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       414 elLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +...|..+|....... +..+......-+++...+.++..+...+|-..-.+||.-..++.-+.|.
T Consensus      1432 ~rs~~n~~fi~flq~~-Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQPA-LKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHhcccHHHHHHHHHH-HcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            9999998875432222 2222222323344444445555556666666778899988888877764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.09  E-value=1.5e-05  Score=78.56  Aligned_cols=99  Identities=24%  Similarity=0.137  Sum_probs=80.2

Q ss_pred             HHHHHHHHhCCC-CCeeeeecceeccccceEEEEecccccHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 040472          270 NQEINLLSQLSH-PNIVRYHGSELSDERLSVYLEYVSGGSIHK---LLQEYGPFNEPVIQTYTRQILLGLAYLHA---RN  342 (628)
Q Consensus       270 ~~Ei~iL~~l~H-pnIV~l~~~~~~~~~~~lVmEy~~GgsL~~---~L~~~~~l~e~~~~~i~~qIl~aL~yLH~---~g  342 (628)
                      +.|.-+|+.+.+ +++++++|+|-    .++|.||+..+++..   .+.+.-..++..+..|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999986 69999999983    356889998776642   12223346789999999999999999997   35


Q ss_pred             ccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          343 TVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       343 IvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      +.-.|++++|+-|+.+|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.09  E-value=1.2e-05  Score=77.70  Aligned_cols=130  Identities=23%  Similarity=0.251  Sum_probs=91.3

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCee-eeecceeccccceEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV-RYHGSELSDERLSVY  300 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV-~l~~~~~~~~~~~lV  300 (628)
                      .+..+.|++|.+|.||++.+.  |..+|+|+-+...       ....+..|+++|..+.-.++. ++|.+..    .++.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-------~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~   90 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-------PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIR   90 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-------chhhHHHHHHHHHHhhhcCCCceEEEech----hhhh
Confidence            345678999999999999876  5689999765321       135677899999999876664 4554432    2345


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCC--CceEeCCCCCEEEeccCCcccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG--ANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKp--eNILld~~g~vKL~DFGla~~~  372 (628)
                      |||+.|-.|.++-...   .    +.-+..++++---|-..||-|..|.-  .||++. ++.+.|+||.-|+..
T Consensus        91 me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k  156 (201)
T COG2112          91 MEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhhc
Confidence            9999998888765431   1    22334455554456677999999964  466665 558999999988744

>PLN02876 acyl-CoA dehydrogenase

Probab=98.07  E-value=2.2e-05  Score=93.96  Aligned_cols=143  Identities=15%  Similarity=0.252  Sum_probs=89.0

Q ss_pred             eeeeccCCcEEEEEEEECCCC--cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCe--eeeecceecc---cc
Q 040472          225 GKLLGRGTFGHVYLGFNSESG--QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNI--VRYHGSELSD---ER  296 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--V~l~~~~~~~---~~  296 (628)
                      .+.|+.|.+..+|+......+  ..+++|+......    ......+.+|+++|+.|. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~----~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL----LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc----CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            467899999999998765432  4677775432110    011245778999999996 6665  7777776654   46


Q ss_pred             ceEEEEecccccHHH--------------------HHHhcCC-------C---------CHHHHHHHHHH----------
Q 040472          297 LSVYLEYVSGGSIHK--------------------LLQEYGP-------F---------NEPVIQTYTRQ----------  330 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~--------------------~L~~~~~-------l---------~e~~~~~i~~q----------  330 (628)
                      .|+||||++|..+.+                    .|.+-..       +         -+.++..+..+          
T Consensus       119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~  198 (822)
T PLN02876        119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP  198 (822)
T ss_pred             ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence            889999999864321                    1111000       0         11223222121          


Q ss_pred             -----HHHHHHHHHh-----------CCccccccCCCceEeCCC-CC-EEEeccCCccc
Q 040472          331 -----ILLGLAYLHA-----------RNTVHRDIKGANILVDPH-GE-IKLADFGMAKH  371 (628)
Q Consensus       331 -----Il~aL~yLH~-----------~gIvHRDIKpeNILld~~-g~-vKL~DFGla~~  371 (628)
                           +...+++|..           ..+||+|+++.|||++.+ +. +-|+||.++..
T Consensus       199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence                 2334566643           249999999999999853 34 57999998864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=1.7e-05  Score=80.29  Aligned_cols=72  Identities=13%  Similarity=0.125  Sum_probs=45.0

Q ss_pred             eeeccCCcE-EEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC---Ceeeeecceeccc---cce
Q 040472          226 KLLGRGTFG-HVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP---NIVRYHGSELSDE---RLS  298 (628)
Q Consensus       226 ~~LG~G~fG-~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIV~l~~~~~~~~---~~~  298 (628)
                      +.|+.|+.. .||+.     +..+++|+.+.       ......+.+|+++|..|...   -+.++++.....+   ..+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~   70 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW   70 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence            457777776 49986     23577775432       11234678899999887632   3445554443322   358


Q ss_pred             EEEEecccccH
Q 040472          299 VYLEYVSGGSI  309 (628)
Q Consensus       299 lVmEy~~GgsL  309 (628)
                      ++||+++|.+|
T Consensus        71 ~l~~~i~G~~l   81 (235)
T cd05155          71 SVYRWLEGETA   81 (235)
T ss_pred             EEEEeecCCCC
Confidence            89999998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.91  E-value=0.0001  Score=73.19  Aligned_cols=135  Identities=24%  Similarity=0.323  Sum_probs=93.9

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-----------cchHHHHHHHHHHHHHHHhCC------CCCeeeee
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-----------QTSKECLKQLNQEINLLSQLS------HPNIVRYH  288 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-----------~~~~~~~~~~~~Ei~iL~~l~------HpnIV~l~  288 (628)
                      ..||+|+.=.||.-  .. .....||+++.....           .......++..+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            57999999989874  33 345678988654300           000112455666766665555      78999999


Q ss_pred             cceeccccceEEEEeccc------ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---
Q 040472          289 GSELSDERLSVYLEYVSG------GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---  359 (628)
Q Consensus       289 ~~~~~~~~~~lVmEy~~G------gsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---  359 (628)
                      |+.+++.-.-+|+|.+..      -+|.+++.+ +.+++    .+...+-+-.+||-+++|+.+||+|.||++....   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998764      358888855 44655    3334444556788999999999999999995432   


Q ss_pred             -CEEEec-cCC
Q 040472          360 -EIKLAD-FGM  368 (628)
Q Consensus       360 -~vKL~D-FGl  368 (628)
                       .+.|+| ||.
T Consensus       159 ~~lvlIDG~G~  169 (199)
T PF10707_consen  159 FRLVLIDGLGE  169 (199)
T ss_pred             eEEEEEeCCCC
Confidence             577887 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.83  E-value=0.00015  Score=73.01  Aligned_cols=75  Identities=12%  Similarity=0.122  Sum_probs=47.8

Q ss_pred             eeeeccCCcEEEEEEEECC-CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC-eeeeecceeccccceEEEE
Q 040472          225 GKLLGRGTFGHVYLGFNSE-SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN-IVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IV~l~~~~~~~~~~~lVmE  302 (628)
                      .+.|..|-...||++.... .++.|++|+......      ......+|+.+++.+...+ ++++++.+.    -.+|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence            3568889899999996543 356788997643211      1122346888888886433 344544332    247999


Q ss_pred             ecccccH
Q 040472          303 YVSGGSI  309 (628)
Q Consensus       303 y~~GgsL  309 (628)
                      |++|..|
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.72  E-value=1.6e-05  Score=83.24  Aligned_cols=137  Identities=19%  Similarity=0.222  Sum_probs=98.0

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccc---------------ccchHHHHHH--HHHHHHHHHhCC-CCC
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD---------------DQTSKECLKQ--LNQEINLLSQLS-HPN  283 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---------------~~~~~~~~~~--~~~Ei~iL~~l~-Hpn  283 (628)
                      +.+++.||-|.-+-||.+-+. .|..+++|.-+....               ...++..+.+  ..+|+..|+.|. |-+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456889999999999999776 488899997532111               1112222333  467888898886 332


Q ss_pred             -eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEE
Q 040472          284 -IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       284 -IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vK  362 (628)
                       |.+.++    -++.++|||++.|..|.++-+-      ..+..+...++.-+.-|-.+|+||+|..--||+|+.++.++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence             344443    3567899999999888765321      22345566667777788999999999999999999999999


Q ss_pred             EeccCCc
Q 040472          363 LADFGMA  369 (628)
Q Consensus       363 L~DFGla  369 (628)
                      ++||--+
T Consensus       243 vIDFPQm  249 (465)
T KOG2268|consen  243 VIDFPQM  249 (465)
T ss_pred             EeechHh
Confidence            9999644

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.70  E-value=0.00051  Score=75.27  Aligned_cols=82  Identities=15%  Similarity=0.142  Sum_probs=55.2

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc--cchHHHHHHHHHHHHHHHhCC---CCCeeeeecceeccccceE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD--QTSKECLKQLNQEINLLSQLS---HPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+.||.|.+..||++.....++.|+||.-......  ........+...|.+.|+.+.   ..++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999998654468999974321110  111123456677888888763   3457777766  4566889


Q ss_pred             EEEeccccc
Q 040472          300 YLEYVSGGS  308 (628)
Q Consensus       300 VmEy~~Ggs  308 (628)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>PRK10593 hypothetical protein; Provisional

Probab=97.69  E-value=0.0004  Score=73.24  Aligned_cols=77  Identities=17%  Similarity=0.128  Sum_probs=53.5

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC---CCeeeeecceec---cccc
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH---PNIVRYHGSELS---DERL  297 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIV~l~~~~~~---~~~~  297 (628)
                      -.+.||.|..+.||+..... + .+.+|..+...       ....+..|...|+.|.-   -.+.++++++.+   .+..
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~-------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARSFS-------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecccc-------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            34679999999999985432 3 46777643200       11457789999888853   356777776644   4678


Q ss_pred             eEEEEecccccH
Q 040472          298 SVYLEYVSGGSI  309 (628)
Q Consensus       298 ~lVmEy~~GgsL  309 (628)
                      +||||+++|..+
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.00049  Score=72.58  Aligned_cols=140  Identities=19%  Similarity=0.179  Sum_probs=81.1

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC--Ceeeeecc------eec
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP--NIVRYHGS------ELS  293 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIV~l~~~------~~~  293 (628)
                      ....+.|+.|....||++... ++ .+++|+.....    .   ...+..|++++..|...  .|.+++..      ...
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~----~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~   94 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV----K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL   94 (307)
T ss_pred             ceeccccCCccccceEEEEeC-CC-cEEEEEecCCC----C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence            344677888888899998642 33 57888764311    1   12344566777666422  23444332      122


Q ss_pred             cccceEEEEecccccHH-----------HHH---Hh-cCCCC--------HHH-----HH----------HHHHHHHHHH
Q 040472          294 DERLSVYLEYVSGGSIH-----------KLL---QE-YGPFN--------EPV-----IQ----------TYTRQILLGL  335 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~-----------~~L---~~-~~~l~--------e~~-----~~----------~i~~qIl~aL  335 (628)
                      ++..+++|||++|..+.           ..|   +. ...+.        ...     ..          .....+...+
T Consensus        95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~  174 (307)
T TIGR00938        95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL  174 (307)
T ss_pred             CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence            45678999999985431           111   10 00110        000     00          0011233455


Q ss_pred             HHHHh-------CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          336 AYLHA-------RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       336 ~yLH~-------~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      +++..       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            55643       579999999999999988777899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.46  E-value=0.00033  Score=73.18  Aligned_cols=137  Identities=18%  Similarity=0.174  Sum_probs=82.2

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC--eeeeecc------eeccc
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN--IVRYHGS------ELSDE  295 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IV~l~~~------~~~~~  295 (628)
                      -.+.|..|....+|+....  +..++||+...  .   .   ..++..|+++++.|.+.+  +.+++..      ...++
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--V---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCC--C---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            3567888888999998543  44688997642  1   1   234556777777775322  4444432      12345


Q ss_pred             cceEEEEecccccHHH-----------HH---Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh
Q 040472          296 RLSVYLEYVSGGSIHK-----------LL---QEY-GPFNE--------PVIQ------------TYTRQILLGLAYLHA  340 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~-----------~L---~~~-~~l~e--------~~~~------------~i~~qIl~aL~yLH~  340 (628)
                      ..++||+|++|..+..           .|   +.. ..+..        ....            .....+..++.++.+
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999866421           11   100 00100        0000            011123344555543


Q ss_pred             -------CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          341 -------RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       341 -------~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                             .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                   369999999999999987777899998774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.42  E-value=0.00068  Score=71.10  Aligned_cols=75  Identities=13%  Similarity=0.172  Sum_probs=47.7

Q ss_pred             eeeccCCcEEEEEEEECC------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccce
Q 040472          226 KLLGRGTFGHVYLGFNSE------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLS  298 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~  298 (628)
                      +.|..|--..||++....      +++.|++|+......      ......+|++++..+....+ .++++++..    .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN----G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence            557777778899987543      257899998653211      12345678888888763333 355555432    3


Q ss_pred             EEEEecccccHH
Q 040472          299 VYLEYVSGGSIH  310 (628)
Q Consensus       299 lVmEy~~GgsL~  310 (628)
                      +||||++|..+.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            589999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.31  E-value=0.0017  Score=69.55  Aligned_cols=143  Identities=15%  Similarity=0.156  Sum_probs=94.9

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc--------------------cchHHHHH-HHHHHHHHHHhCCCCC
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD--------------------QTSKECLK-QLNQEINLLSQLSHPN  283 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--------------------~~~~~~~~-~~~~Ei~iL~~l~Hpn  283 (628)
                      ...|..|--+.||.|... +|..+|||+++.....                    .+....++ -...|++-|.+|+.-.
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            356888999999999755 6888999997631100                    01122223 2467888888887555


Q ss_pred             eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCCCceEeCCCCCEE
Q 040472          284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH-ARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       284 IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH-~~gIvHRDIKpeNILld~~g~vK  362 (628)
                      |..---..  -....|||+|+.+...-.=.-+.-.++...+..+-.|++.-+.-|- ..++||.||.--|+|+ .+|.+.
T Consensus       228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly  304 (520)
T KOG2270|consen  228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY  304 (520)
T ss_pred             CCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence            43221111  1234689999953221111112245777788888888888888774 5699999999999999 478999


Q ss_pred             EeccCCccc
Q 040472          363 LADFGMAKH  371 (628)
Q Consensus       363 L~DFGla~~  371 (628)
                      |+|.+-+..
T Consensus       305 iIDVSQSVE  313 (520)
T KOG2270|consen  305 IIDVSQSVE  313 (520)
T ss_pred             EEEcccccc
Confidence            999886643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.30  E-value=0.0012  Score=67.56  Aligned_cols=132  Identities=23%  Similarity=0.285  Sum_probs=75.6

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccceEEEEeccc
Q 040472          228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLSVYLEYVSG  306 (628)
Q Consensus       228 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~lVmEy~~G  306 (628)
                      +..|-.+.+|+..  .+++.+++|.......     ...-...+|..+|+.+..-.+ .+++....    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK-----ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccc-----cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence            5567788899886  3466788886532111     100124678888888864333 34443332    3689999998


Q ss_pred             ccHHH--------------HHHhcC-------CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCccccc
Q 040472          307 GSIHK--------------LLQEYG-------PFNE-PVIQTYTRQI---------LLGLAYLHA--------RNTVHRD  347 (628)
Q Consensus       307 gsL~~--------------~L~~~~-------~l~e-~~~~~i~~qI---------l~aL~yLH~--------~gIvHRD  347 (628)
                      ..+..              .+.+-.       ++.. ..+..+..++         ...++.+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            76532              111111       1111 1122222122         112222222        2489999


Q ss_pred             cCCCceEeCCCCCEEEeccCCccc
Q 040472          348 IKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       348 IKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +.+.|||++.++ +.|+||..|..
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccCc
Confidence            999999998876 88999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.22  E-value=0.0043  Score=65.61  Aligned_cols=30  Identities=27%  Similarity=0.361  Sum_probs=25.6

Q ss_pred             CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          341 RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      .++||+|+.+.|||++.+..+-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999865556899999874

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.17  E-value=0.0018  Score=69.93  Aligned_cols=78  Identities=17%  Similarity=0.202  Sum_probs=50.0

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeecccc--cchHHHHHHHHHHHHHHHhCC--CC-CeeeeecceeccccceEEE
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD--QTSKECLKQLNQEINLLSQLS--HP-NIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~iL~~l~--Hp-nIV~l~~~~~~~~~~~lVm  301 (628)
                      .||.|....||++.+...++.|+||.-......  ....-...+..-|...|+...  .| +++++|  +.+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            589999999999998644468999974321111  111222445567788887664  34 455665  33566677999


Q ss_pred             Eeccc
Q 040472          302 EYVSG  306 (628)
Q Consensus       302 Ey~~G  306 (628)
                      |++..
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.09  E-value=0.0032  Score=65.79  Aligned_cols=30  Identities=33%  Similarity=0.446  Sum_probs=25.3

Q ss_pred             CccccccCCCceEeCCCCC-EEEeccCCccc
Q 040472          342 NTVHRDIKGANILVDPHGE-IKLADFGMAKH  371 (628)
Q Consensus       342 gIvHRDIKpeNILld~~g~-vKL~DFGla~~  371 (628)
                      .++|+|+++.|||++.++. +-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999987565 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.93  E-value=0.00045  Score=76.40  Aligned_cols=162  Identities=21%  Similarity=0.292  Sum_probs=104.5

Q ss_pred             HHHHHHHHHHhCCCCCeeeeecceecc-ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 040472          268 QLNQEINLLSQLSHPNIVRYHGSELSD-ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR  346 (628)
Q Consensus       268 ~~~~Ei~iL~~l~HpnIV~l~~~~~~~-~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHR  346 (628)
                      ++.-..++|+.+.|+|..+++++-... .+..+|||++ +.+|++++..+. +....       ++       .+++.|-
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~~~~~   91 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHGVLHL   91 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------cccccee
Confidence            344557889999999999999887653 4588889999 679999887644 22111       11       2222221


Q ss_pred             ccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc
Q 040472          347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE  426 (628)
Q Consensus       347 DIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~  426 (628)
                           |       .++++| -++..               |  |-.      ..+|+|||++|.++.++..|..-|....
T Consensus        92 -----~-------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l~~~~~  135 (725)
T KOG1093|consen   92 -----N-------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGISLEAELT  135 (725)
T ss_pred             -----h-------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence                 2       233334 11100               0  111      1249999999999999999998776655


Q ss_pred             hhHHHhhhcCCCCCCC----------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          427 GVAAIFKIGNSKDIPE----------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       427 ~~~~~~~i~~~~~~~~----------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ..+....+......+.          +-..++....+++++|+-..|..||...++++++-|.+.
T Consensus       136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            5444443332221111          112356677889999999999999999999999988654

>PLN02236 choline kinase

Probab=96.86  E-value=0.0074  Score=65.04  Aligned_cols=137  Identities=15%  Similarity=0.148  Sum_probs=79.1

Q ss_pred             eeeeccCCcEEEEEEEECC----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccceE
Q 040472          225 GKLLGRGTFGHVYLGFNSE----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLSV  299 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~l  299 (628)
                      .+.|-.|-...+|++....    +++.|++|+......     ..+. ..+|+.+++.+..-+| .++++++...    .
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-----~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-----LFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-----eeec-hHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            3456668888999986432    346788897643221     1122 2568888888874444 3556655332    5


Q ss_pred             EEEecccccHHH--------------HHHhcC--C------C-CHHHHHHHHHHH-----------------HHHHHHH-
Q 040472          300 YLEYVSGGSIHK--------------LLQEYG--P------F-NEPVIQTYTRQI-----------------LLGLAYL-  338 (628)
Q Consensus       300 VmEy~~GgsL~~--------------~L~~~~--~------l-~e~~~~~i~~qI-----------------l~aL~yL-  338 (628)
                      |.||+.|.+|..              .|.+-.  .      + ....+..++.++                 ...+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            789998766531              111100  0      0 112222332211                 1111122 


Q ss_pred             ---H----hCCccccccCCCceEeCC-CCCEEEeccCCccc
Q 040472          339 ---H----ARNTVHRDIKGANILVDP-HGEIKLADFGMAKH  371 (628)
Q Consensus       339 ---H----~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~  371 (628)
                         .    ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               1    225899999999999976 46899999988753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.81  E-value=0.0066  Score=65.03  Aligned_cols=140  Identities=11%  Similarity=0.130  Sum_probs=78.4

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceecccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDER  296 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~  296 (628)
                      ..++ +.|..|=-..+|++.....   +..|++|+.......      .-.-.+|+.+++.+..-+| .++++++. +. 
T Consensus        16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~------~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G-   86 (330)
T PLN02421         16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY------VIDRERELQAIKYLSAAGFGAKLLGVFG-NG-   86 (330)
T ss_pred             ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe------EechHHHHHHHHHHHhcCCCCceeEEeC-Cc-
Confidence            3444 4455588888999865432   337888876432211      1223568888888875444 45665553 22 


Q ss_pred             ceEEEEecccccHHH--------------HHHhcC--C------C-CHHHHHHHHHHH----------------------
Q 040472          297 LSVYLEYVSGGSIHK--------------LLQEYG--P------F-NEPVIQTYTRQI----------------------  331 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~--------------~L~~~~--~------l-~e~~~~~i~~qI----------------------  331 (628)
                        +|.+|++|..|..              .|++-.  .      + -...+..++.++                      
T Consensus        87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l  164 (330)
T PLN02421         87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL  164 (330)
T ss_pred             --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence              5889988765421              111111  1      1 012222222221                      


Q ss_pred             HHHHHH---HH-hCC----ccccccCCCceEeCC-CCCEEEeccCCccc
Q 040472          332 LLGLAY---LH-ARN----TVHRDIKGANILVDP-HGEIKLADFGMAKH  371 (628)
Q Consensus       332 l~aL~y---LH-~~g----IvHRDIKpeNILld~-~g~vKL~DFGla~~  371 (628)
                      ..-+..   +. ..+    ++|.|+.+.|||++. ++.++|+||..|..
T Consensus       165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111222   21 112    799999999999975 57899999998753

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.77  E-value=0.0055  Score=66.99  Aligned_cols=80  Identities=14%  Similarity=0.143  Sum_probs=53.0

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-cchHHHHHHHHHHHHHHHhCC--CC-CeeeeecceeccccceEE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLS--HP-NIVRYHGSELSDERLSVY  300 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~--Hp-nIV~l~~~~~~~~~~~lV  300 (628)
                      .+.||-|.-..||++.+...++.|+||.-...... ....-...+..-|.++|+.+.  .| +++++|  +.+.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence            57799999999999988544567999964321111 111223556677888888764  34 466666  3456777889


Q ss_pred             EEeccc
Q 040472          301 LEYVSG  306 (628)
Q Consensus       301 mEy~~G  306 (628)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.40  E-value=0.049  Score=57.05  Aligned_cols=29  Identities=31%  Similarity=0.470  Sum_probs=25.5

Q ss_pred             CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          341 RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      .+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.37  E-value=0.036  Score=59.08  Aligned_cols=147  Identities=16%  Similarity=0.180  Sum_probs=84.2

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC--eeeeecceeccc--cc
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN--IVRYHGSELSDE--RL  297 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IV~l~~~~~~~~--~~  297 (628)
                      ..+.+.+-.|..-.+|.....  ++.++|. ....   ...........+|..+|+.+.---  +...++.+.++.  ..
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~---~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p  100 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPR---GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP  100 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCCc---cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence            344455544544455655443  6777777 2211   111233456677888888876322  334455555554  67


Q ss_pred             eEEEEecccccH------------------HHHHHhcC--------------CCCHHHHHHHHH--------------HH
Q 040472          298 SVYLEYVSGGSI------------------HKLLQEYG--------------PFNEPVIQTYTR--------------QI  331 (628)
Q Consensus       298 ~lVmEy~~GgsL------------------~~~L~~~~--------------~l~e~~~~~i~~--------------qI  331 (628)
                      |.||+|++|..+                  -+.|..-.              .+...++..+..              .+
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            999999998322                  22221100              011111222221              12


Q ss_pred             HHHHHHHHhC--------CccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          332 LLGLAYLHAR--------NTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       332 l~aL~yLH~~--------gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..-..+|+.+        .++|+|+.+.||+|+.++-+=|+||+++..-.+
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            2344555543        489999999999999988899999999875443

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.95  E-value=0.091  Score=57.87  Aligned_cols=78  Identities=14%  Similarity=0.109  Sum_probs=50.3

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeeccc--ccchHHHHHHHHHHHHHHHhCC---CCCeeeeecceeccccceE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD--DQTSKECLKQLNQEINLLSQLS---HPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~~~~~~~~~~l  299 (628)
                      .+.||.|....||+..+.  ++.|+||.-.....  .........+...|+..|+.+.   ..++.+++.++.  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            577999999999999863  45688996431111  0100012344455666776654   347778887765  55788


Q ss_pred             EEEeccc
Q 040472          300 YLEYVSG  306 (628)
Q Consensus       300 VmEy~~G  306 (628)
                      +|||+++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999977

>PTZ00384 choline kinase; Provisional

Probab=95.89  E-value=0.038  Score=60.51  Aligned_cols=83  Identities=16%  Similarity=0.134  Sum_probs=46.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCC-CcEEEEEE-EeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccc
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSES-GQMCAIKE-VRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERL  297 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~-i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~  297 (628)
                      ++.+ +.|..|--..+|++..... +..+.+|. +.... ... .+..-.-.+|+++++.|...++ .++++.+..    
T Consensus        52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----  124 (383)
T PTZ00384         52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----  124 (383)
T ss_pred             cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence            3444 4566688899999975432 22333332 11110 011 1111223568999999975544 456666642    


Q ss_pred             eEEEEecccccHH
Q 040472          298 SVYLEYVSGGSIH  310 (628)
Q Consensus       298 ~lVmEy~~GgsL~  310 (628)
                      ++|.||++|..|.
T Consensus       125 g~l~efIeGr~l~  137 (383)
T PTZ00384        125 FTIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEEeccccCC
Confidence            6899999987653

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.88  E-value=0.049  Score=57.55  Aligned_cols=30  Identities=20%  Similarity=0.182  Sum_probs=27.4

Q ss_pred             CccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          342 NTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       342 gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +++|+|+.+.|||++.++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.75  E-value=0.053  Score=57.10  Aligned_cols=75  Identities=15%  Similarity=0.087  Sum_probs=46.8

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC---CCCeeeeecceeccccceE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS---HPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~~~~~~~~~~l  299 (628)
                      +..+.|+.|....+|+..  .+++.|.||+-...        ....+..|..-|+.|.   --.+++.+++...++.-||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL   89 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL   89 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence            345679999999999986  66788999976521        1234667777777773   4457788888887777899


Q ss_pred             EEEecccc
Q 040472          300 YLEYVSGG  307 (628)
Q Consensus       300 VmEy~~Gg  307 (628)
                      ||||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99998866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.57  E-value=0.082  Score=52.49  Aligned_cols=30  Identities=40%  Similarity=0.617  Sum_probs=21.2

Q ss_pred             CccccccCCCceEe-CCCCCEEEeccCCccc
Q 040472          342 NTVHRDIKGANILV-DPHGEIKLADFGMAKH  371 (628)
Q Consensus       342 gIvHRDIKpeNILl-d~~g~vKL~DFGla~~  371 (628)
                      -++|.||.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47999999999999 7889999999998853

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=95.36  E-value=0.15  Score=62.61  Aligned_cols=31  Identities=45%  Similarity=0.672  Sum_probs=26.2

Q ss_pred             CCccccccCCCceEeCCCC--CEE-EeccCCccc
Q 040472          341 RNTVHRDIKGANILVDPHG--EIK-LADFGMAKH  371 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~g--~vK-L~DFGla~~  371 (628)
                      .++||.|+.+.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999998875  565 999998753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.04  E-value=0.4  Score=51.18  Aligned_cols=28  Identities=25%  Similarity=0.264  Sum_probs=23.8

Q ss_pred             CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          341 RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      .++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3689999999999995 4 57899999774

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.89  E-value=0.045  Score=58.92  Aligned_cols=72  Identities=21%  Similarity=0.296  Sum_probs=52.3

Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      .+.|++|++- |+.|. .+.   .-...++..++.+.+..|+-+..+ .+=|||+...||||+ +|+|.|+||-+++.-
T Consensus       299 ~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             eEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            3455566654 44443 222   223566778888888777777654 689999999999999 999999999999843

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.55  E-value=0.085  Score=57.62  Aligned_cols=61  Identities=20%  Similarity=0.245  Sum_probs=42.8

Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccccCCCceEeCC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL-HARNTVHRDIKGANILVDP  357 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yL-H~~gIvHRDIKpeNILld~  357 (628)
                      ...||-+|..|-++..+++..+ .+|...+.++.-.+.||--+ --.+++|.|+.|.||+|-.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            3456667999999999887643 34555555555555555443 4568999999999999953

>PTZ00296 choline kinase; Provisional

Probab=94.17  E-value=0.31  Score=54.49  Aligned_cols=76  Identities=12%  Similarity=0.049  Sum_probs=47.0

Q ss_pred             EeeeeccCCcEEEEEEEECC--------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCee-eeecceecc
Q 040472          224 KGKLLGRGTFGHVYLGFNSE--------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV-RYHGSELSD  294 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~--------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV-~l~~~~~~~  294 (628)
                      -.+.|..|---.+|++....        .++.|.+++.-....     ..+ .-.+|..+++.+...+|- ++++.+.  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-----~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-----ELY-NPISEFEVYKTMSKYRIAPQLLNTFS--  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-----cee-CHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence            45678888888899987542        146788887643221     112 234577777777654443 4555442  


Q ss_pred             ccceEEEEecccccH
Q 040472          295 ERLSVYLEYVSGGSI  309 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL  309 (628)
                        -+.|.||++|..|
T Consensus       181 --gg~I~efi~g~~l  193 (442)
T PTZ00296        181 --GGRIEEWLYGDPL  193 (442)
T ss_pred             --CCEEEEeeCCccC
Confidence              3567899988643

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.51  E-value=0.2  Score=50.72  Aligned_cols=85  Identities=19%  Similarity=0.254  Sum_probs=58.3

Q ss_pred             HHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCcc
Q 040472          267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA--RNTV  344 (628)
Q Consensus       267 ~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIv  344 (628)
                      ..+..+.+|+.+++  .|++|..-  +.-.+-+++|+|-.-.            .... .++.-=+.+|.-.|+  .+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~~-N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INFS-NFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cchh-HHHHHhHHHHHHhhccCCCee
Confidence            34567888888775  47887732  3445678899984211            1111 222222567788884  3699


Q ss_pred             ccccCCCceEeCCCCCEEEeccCC
Q 040472          345 HRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       345 HRDIKpeNILld~~g~vKL~DFGl  368 (628)
                      |+|..|+||+-|..|.+||.|=+.
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhh
Confidence            999999999999999999999663

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.79  E-value=0.46  Score=48.48  Aligned_cols=74  Identities=16%  Similarity=0.196  Sum_probs=49.8

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC---CCeeeeecceeccccceEEEE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH---PNIVRYHGSELSDERLSVYLE  302 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIV~l~~~~~~~~~~~lVmE  302 (628)
                      +.+--|..-..|...+-  ...|.||+=        ..+....+..|+.-|+.|.-   -.+.+++.+..+..+.|+|||
T Consensus        22 ~~v~gG~inea~~v~dg--~~~~FvK~n--------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle   91 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--TDPFFVKCN--------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE   91 (286)
T ss_pred             cccCCccccceeEeecC--CcceEEEec--------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence            44555555555555332  356778843        24445677788877777653   456778888889999999999


Q ss_pred             ecccccH
Q 040472          303 YVSGGSI  309 (628)
Q Consensus       303 y~~GgsL  309 (628)
                      |++-+.+
T Consensus        92 ~L~~~~~   98 (286)
T COG3001          92 YLPTGPL   98 (286)
T ss_pred             eccCCCC
Confidence            9987554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	628
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-48
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-48
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-48
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-48
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-47
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-46
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-46
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-46
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-46
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-44
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-44
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-42
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-42
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-42
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-41
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-41
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-40
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-40
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-37
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-37
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-36
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-36
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-35
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-35
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-35
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-35
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-34
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-32
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-32
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-32
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-32
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-32
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-32
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-32
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-32
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-32
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-32
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-32
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-32
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-31
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-31
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-31
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-31
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-31
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-31
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-31
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-31
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-31
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-31
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-31
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-31
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-31
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-31
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-31
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-31
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-31
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-31
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-31
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-31
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-31
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-31
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-31
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-31
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-31
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-31
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-31
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-31
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-31
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-31
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-31
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-31
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-31
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-31
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-31
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-31
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-31
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-31
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-31
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-31
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-31
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-31
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-31
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-31
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-31
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-31
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-31
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-31
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-31
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-31
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-31
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-31
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-31
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-31
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-31
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-31
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-31
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-31
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-31
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-31
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-31
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-31
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-31
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-31
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-31
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-31
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-31
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-31
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-31
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-31
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-31
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-31
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-31
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-31
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-31
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-31
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-31
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-31
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-31
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-31
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-31
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-31
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-31
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-31
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-31
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-31
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-31
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-31
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-31
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-31
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-31
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-31
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-31
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-31
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-31
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-30
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-30
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-30
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-30
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-30
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-30
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-30
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-30
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-30
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-30
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-30
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-30
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-30
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-30
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-30
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-30
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-30
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-30
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-30
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-29
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-29
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-29
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-29
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-29
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-29
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-29
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-29
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-29
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-29
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-29
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-29
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-28
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-28
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-28
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-28
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-28
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-28
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-28
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-28
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-28
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-28
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-28
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-28
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-28
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-28
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-28
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-28
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-28
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-28
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-27
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-27
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-27
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-27
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-27
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-27
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-27
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-27
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-27
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-27
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-27
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-27
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-27
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-27
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-27
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-27
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-27
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-27
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-27
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-26
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-26
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-26
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-26
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-26
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-26
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-26
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-26
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-26
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-26
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-26
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-26
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-26
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-26
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-25
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-25
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-25
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-25
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-25
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-25
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-25
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-25
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-25
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-25
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-25
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-25
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-25
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-25
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-25
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-25
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-25
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-25
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-25
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-25
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-25
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-25
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-25
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-25
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-25
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-25
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-24
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-24
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-24
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-24
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-24
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-24
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-24
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-24
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-24
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-24
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-24
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-24
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-24
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-24
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-24
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-24
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-24
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-24
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-24
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-24
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-24
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-23
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-23
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-23
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-23
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-23
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-23
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-23
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-23
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-23
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-23
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-23
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-23
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-23
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-23
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-23
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-23
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-23
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-23
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-23
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-23
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-23
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-23
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-22
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-22
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-22
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-22
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-22
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-22
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-22
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-22
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-22
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-22
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-22
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-22
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-22
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-22
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-22
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-22
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-22
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-22
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-22
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-22
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-22
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-22
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-22
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-22
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-22
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-22
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-22
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-22
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-22
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-21
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-21
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-21
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-21
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-21
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-21
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-21
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-21
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-21
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-21
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-21
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-21
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-21
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-21
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-21
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-21
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-21
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-21
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-21
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-21
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-21
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-20
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-20
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-20
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-20
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-20
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-20
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-20
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-20
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-20
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-20
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-20
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-20
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-20
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-20
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-20
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-20
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-20
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-20
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-20
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-20
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-20
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-20
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-20
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-20
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-20
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-20
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-20
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-20
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-20
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-20
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-20
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-20
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-20
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-20
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-20
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-20
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-20
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-20
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-20
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-20
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-19
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-19
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-19
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-19
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-19
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-19
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-19
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-19
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-19
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-19
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-18
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-18
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-18
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-18
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-18
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-18
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-18
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-18
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-18
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-18
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-18
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-18
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-18
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-18
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-18
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-18
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-18
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-18
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-18
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-18
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-18
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-18
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-18
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-18
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-18
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-18
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-18
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-18
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-18
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-18
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-17
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
3soa_A	444	Full-Length Human Camkii Length = 444		4e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-16
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-16
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-16
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-16
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-16
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-16
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-15
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-15
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-15
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-15
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-15
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-14
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-13
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-13
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-13
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-13
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-13
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-12

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  191 bits (484), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 102/254 (40%), Positives = 156/254 (61%), Gaps = 8/254 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V+ G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P + +Y+G
Sbjct: 32  KGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L D +L + +EY+ GGS   LL E GP +E  I T  R+IL GL YLH+   +HRDIK
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            AN+L+  HGE+KLADFG+A  +T      + F G+P+WMAPEV+   + Y    DIWSL
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKADIWSL 205
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  +PP S+   +  +F I  + + P +  + S   K F++ CL ++PS RP 
Sbjct: 206 GITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 469 ASKLLDHPFVRDQA 482
           A +LL H F+   A
Sbjct: 265 AKELLKHKFILRNA 278

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  191 bits (484), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 102/254 (40%), Positives = 156/254 (61%), Gaps = 8/254 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V+ G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P + +Y+G
Sbjct: 17  KGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L D +L + +EY+ GGS   LL E GP +E  I T  R+IL GL YLH+   +HRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            AN+L+  HGE+KLADFG+A  +T       +F G+P+WMAPEV+   + Y    DIWSL
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSL 190
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  +PP S+   +  +F I  + + P +  + S   K F++ CL ++PS RP 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 469 ASKLLDHPFVRDQA 482
           A +LL H F+   A
Sbjct: 250 AKELLKHKFILRNA 263

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  191 bits (484), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 102/254 (40%), Positives = 156/254 (61%), Gaps = 8/254 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V+ G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P + +Y+G
Sbjct: 37  KGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L D +L + +EY+ GGS   LL E GP +E  I T  R+IL GL YLH+   +HRDIK
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 350 GANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            AN+L+  HGE+KLADFG+A  +T       +F G+P+WMAPEV+   + Y    DIWSL
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSL 210
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  +PP S+   +  +F I  + + P +  + S   K F++ CL ++PS RP 
Sbjct: 211 GITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPSFRPT 269
Query: 469 ASKLLDHPFVRDQA 482
           A +LL H F+   A
Sbjct: 270 AKELLKHKFILRNA 283

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  190 bits (483), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 102/254 (40%), Positives = 156/254 (61%), Gaps = 8/254 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V+ G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P + +Y+G
Sbjct: 17  KGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L D +L + +EY+ GGS   LL E GP +E  I T  R+IL GL YLH+   +HRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            AN+L+  HGE+KLADFG+A  +T      + F G+P+WMAPEV+   + Y    DIWSL
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKADIWSL 190
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  +PP S+   +  +F I  + + P +  + S   K F++ CL ++PS RP 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 469 ASKLLDHPFVRDQA 482
           A +LL H F+   A
Sbjct: 250 AKELLKHKFILRNA 263

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  185 bits (470), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 105/274 (38%), Positives = 153/274 (55%), Gaps = 16/274 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G++G VY   + E+GQ+ AIK+V V  D       L+++ +EI+++ Q   P++V+Y+GS
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +  L + +EY   GS+  +++       E  I T  +  L GL YLH    +HRDIK
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 350 GANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
             NIL++  G  KLADFG+A  +T   A      G+P+WMAPEV+    GY+   DIWSL
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI-GYNCVADIWSL 211
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKI-GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
           G T +EMA  KPP++    + AIF I  N       PE  SD+   F+KQCL + P  R 
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271
Query: 468 PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLD 501
            A++LL HPFVR      A  V++ +D    ++D
Sbjct: 272 TATQLLQHPFVRS-----AKGVSILRDLINEAMD 300

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/250 (40%), Positives = 147/250 (58%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG VY G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ   P I RY G
Sbjct: 29  KGSFGEVYKGIDNHTKEVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L   +L + +EY+ GGS   LL+  GP  E  I T  R+IL GL YLH+   +HRDIK
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            AN+L+   G++KLADFG+A  +T      + F G+P+WMAPEV+   + Y    DIWSL
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDFKADIWSL 202
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  +PP S    +  +F I  +   P +    S   K F++ CL +DP  RP 
Sbjct: 203 GITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQHSKPFKEFVEACLNKDPRFRPT 261
Query: 469 ASKLLDHPFV 478
           A +LL H F+
Sbjct: 262 AKELLKHKFI 271

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  183 bits (464), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 156/259 (60%), Gaps = 16/259 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +GT+G VY G +  +    AIKE+      +      + L++EI L   L H NIV+Y G
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF--NEPVIQTYTRQILLGLAYLHARNTVHR 346
           S   +  + +++E V GGS+  LL+ ++GP   NE  I  YT+QIL GL YLH    VHR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 347 DIKGANILVDPH-GEIKLADFGMAKHMTS---CASMLSFKGSPYWMAPEVV-MNTNGYSL 401
           DIKG N+L++ + G +K++DFG +K +     C    +F G+  +MAPE++     GY  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEIIDKGPRGYGK 204
Query: 402 TVDIWSLGCTVLEMATSKPPWSQY-EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             DIWSLGCT++EMAT KPP+ +  E  AA+FK+G  K  PEIPE +S +AK+FI +C +
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 461 RDPSARPPASKLLDHPFVR 479
            DP  R  A+ LL   F++
Sbjct: 265 PDPDKRACANDLLVDEFLK 283

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  182 bits (463), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 98/250 (39%), Positives = 150/250 (60%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V+ G ++ + Q+ AIK    + D + +++ ++ + QEI +LSQ     + +Y+G
Sbjct: 33  KGSFGEVFKGIDNRTQQVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L   +L + +EY+ GGS   LL+  GPF+E  I T  ++IL GL YLH+   +HRDIK
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 350 GANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            AN+L+   G++KLADFG+A  +T       +F G+P+WMAPEV+  +  Y    DIWSL
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSL 206
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  +PP S    +  +F I  + + P +    +   K FI  CL +DPS RP 
Sbjct: 207 GITAIELAKGEPPNSDMHPMRVLFLIPKN-NPPTLVGDFTKSFKEFIDACLNKDPSFRPT 265
Query: 469 ASKLLDHPFV 478
           A +LL H F+
Sbjct: 266 AKELLKHKFI 275

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  182 bits (461), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 156/259 (60%), Gaps = 16/259 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +GT+G VY G +  +    AIKE+      +      + L++EI L   L H NIV+Y G
Sbjct: 18  KGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF--NEPVIQTYTRQILLGLAYLHARNTVHR 346
           S   +  + +++E V GGS+  LL+ ++GP   NE  I  YT+QIL GL YLH    VHR
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 347 DIKGANILVDPH-GEIKLADFGMAKHMTS---CASMLSFKGSPYWMAPEVV-MNTNGYSL 401
           DIKG N+L++ + G +K++DFG +K +     C    +F G+  +MAPE++     GY  
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEIIDKGPRGYGK 190
Query: 402 TVDIWSLGCTVLEMATSKPPWSQY-EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             DIWSLGCT++EMAT KPP+ +  E  AA+FK+G  K  PEIPE +S +AK+FI +C +
Sbjct: 191 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 250
Query: 461 RDPSARPPASKLLDHPFVR 479
            DP  R  A+ LL   F++
Sbjct: 251 PDPDKRACANDLLVDEFLK 269

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  176 bits (445), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 98/256 (38%), Positives = 146/256 (57%), Gaps = 14/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY   N E+G + A K +     +  S+E L+    EI +L+   HP IV+  G+
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              D +L + +E+  GG++  ++ E      EP IQ   RQ+L  L +LH++  +HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 350 GANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVV----MNTNGYSLTVD 404
             N+L+   G+I+LADFG+ AK++ +     SF G+PYWMAPEVV    M    Y    D
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 204
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRD 462
           IWSLG T++EMA  +PP  +   +  + KI  S D P +  P   S + + F+K  L ++
Sbjct: 205 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLTPSKWSVEFRDFLKIALDKN 263
Query: 463 PSARPPASKLLDHPFV 478
           P  RP A++LL+HPFV
Sbjct: 264 PETRPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  175 bits (444), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 98/256 (38%), Positives = 146/256 (57%), Gaps = 14/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY   N E+G + A K +     +  S+E L+    EI +L+   HP IV+  G+
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              D +L + +E+  GG++  ++ E      EP IQ   RQ+L  L +LH++  +HRD+K
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 350 GANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVV----MNTNGYSLTVD 404
             N+L+   G+I+LADFG+ AK++ +     SF G+PYWMAPEVV    M    Y    D
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 196
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRD 462
           IWSLG T++EMA  +PP  +   +  + KI  S D P +  P   S + + F+K  L ++
Sbjct: 197 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLTPSKWSVEFRDFLKIALDKN 255
Query: 463 PSARPPASKLLDHPFV 478
           P  RP A++LL+HPFV
Sbjct: 256 PETRPSAAQLLEHPFV 271

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  169 bits (428), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/256 (38%), Positives = 141/256 (55%), Gaps = 14/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY   N E+  + A K +     D  S+E L+    EI++L+   HPNIV+   +
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +  L + +E+ +GG++  ++ E   P  E  IQ   +Q L  L YLH    +HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 350 GANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVVMNTNG----YSLTVD 404
             NIL    G+IKLADFG+ AK+  +     SF G+PYWMAPEVVM        Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRD 462
           +WSLG T++EMA  +PP  +   +  + KI  S+  P +  P   S + K F+K+CL+++
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKN 281
Query: 463 PSARPPASKLLDHPFV 478
             AR   S+LL HPFV
Sbjct: 282 VDARWTTSQLLQHPFV 297

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  169 bits (427), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 149/275 (54%), Gaps = 20/275 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYHG 289
           GT+G VY G + ++GQ+ AIK + V  D++      +++ QEIN+L + SH  NI  Y+G
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNIATYYG 88
Query: 290 SELS------DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHAR 341
           + +       D++L + +E+   GS+  L++        E  I    R+IL GL++LH  
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNG-- 398
             +HRDIKG N+L+  + E+KL DFG++  +  +     +F G+PYWMAPEV+       
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 399 --YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
             Y    D+WSLG T +EMA   PP      + A+F I  +       +  S   +SFI+
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE 268
Query: 457 QCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNL 491
            CL ++ S RP   +L+ HPF+RDQ   R   + L
Sbjct: 269 SCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  169 bits (427), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 98/256 (38%), Positives = 140/256 (54%), Gaps = 14/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY   N E+  + A K +     D  S+E L+    EI++L+   HPNIV+   +
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +  L + +E+ +GG++  ++ E   P  E  IQ   +Q L  L YLH    +HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 350 GANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVVMNTNG----YSLTVD 404
             NIL    G+IKLADFG+ AK+        SF G+PYWMAPEVVM        Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRD 462
           +WSLG T++EMA  +PP  +   +  + KI  S+  P +  P   S + K F+K+CL+++
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKN 281
Query: 463 PSARPPASKLLDHPFV 478
             AR   S+LL HPFV
Sbjct: 282 VDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  167 bits (423), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 139/256 (54%), Gaps = 14/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY   N E+  + A K +     D  S+E L+    EI++L+   HPNIV+   +
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +  L + +E+ +GG++  ++ E   P  E  IQ   +Q L  L YLH    +HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 350 GANILVDPHGEIKLADFGM-AKHMTSCASMLSFKGSPYWMAPEVVMNTNG----YSLTVD 404
             NIL    G+IKLADFG+ AK+         F G+PYWMAPEVVM        Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRD 462
           +WSLG T++EMA  +PP  +   +  + KI  S+  P +  P   S + K F+K+CL+++
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKN 281
Query: 463 PSARPPASKLLDHPFV 478
             AR   S+LL HPFV
Sbjct: 282 VDARWTTSQLLQHPFV 297

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 90/250 (36%), Positives = 132/250 (52%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY   +  + ++ AIK  ++    + S E  + + +E+  L +L HPN ++Y G 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L +    + +EY  G +   L     P  E  I   T   L GLAYLH+ N +HRD+K 
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 351 ANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDIWSL 408
            NIL+   G +KL DFG A  M        F G+PYWMAPEV+  M+   Y   VD+WSL
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  KPP      ++A++ I  ++       H S+  ++F+  CLQ+ P  RP 
Sbjct: 240 GITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 299
Query: 469 ASKLLDHPFV 478
           +  LL H FV
Sbjct: 300 SEVLLKHRFV 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  162 bits (410), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 90/250 (36%), Positives = 132/250 (52%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY   +  + ++ AIK  ++    + S E  + + +E+  L +L HPN ++Y G 
Sbjct: 26  GSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L +    + +EY  G +   L     P  E  I   T   L GLAYLH+ N +HRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 351 ANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV--MNTNGYSLTVDIWSL 408
            NIL+   G +KL DFG A  M        F G+PYWMAPEV+  M+   Y   VD+WSL
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T +E+A  KPP      ++A++ I  ++       H S+  ++F+  CLQ+ P  RP 
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
Query: 469 ASKLLDHPFV 478
           +  LL H FV
Sbjct: 261 SEVLLKHRFV 270

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 135/258 (52%), Gaps = 27/258 (10%)
Query: 248 CAIKEVRVVCDDQTSKEC---LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYV 304
           CA K+ +V       ++C   + +L +EI  +SQ  HPNIV Y+ S +  + L + ++ +
Sbjct: 36  CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95
Query: 305 SGGSIHKLLQEY--------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD 356
           SGGS+  +++          G  +E  I T  R++L GL YLH    +HRD+K  NIL+ 
Sbjct: 96  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG 155
Query: 357 PHGEIKLADFGMAKHMTSCASML------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGC 410
             G +++ADFG++  + +   +       +F G+P WMAPEV+    GY    DIWS G 
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215
Query: 411 TVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP------EHLSDDAKSF---IKQCLQR 461
           T +E+AT   P+ +Y  +  +  +    D P +       E L    KSF   I  CLQ+
Sbjct: 216 TAIELATGAAPYHKYPPMKVLM-LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274
Query: 462 DPSARPPASKLLDHPFVR 479
           DP  RP A++LL H F +
Sbjct: 275 DPEKRPTAAELLRHKFFQ 292

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  152 bits (384), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 135/258 (52%), Gaps = 27/258 (10%)
Query: 248 CAIKEVRVVCDDQTSKEC---LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYV 304
           CA K+ +V       ++C   + +L +EI  +SQ  HPNIV Y+ S +  + L + ++ +
Sbjct: 31  CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 90
Query: 305 SGGSIHKLLQEY--------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD 356
           SGGS+  +++          G  +E  I T  R++L GL YLH    +HRD+K  NIL+ 
Sbjct: 91  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG 150
Query: 357 PHGEIKLADFGMAKHMTSCASML------SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGC 410
             G +++ADFG++  + +   +       +F G+P WMAPEV+    GY    DIWS G 
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 210
Query: 411 TVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP------EHLSDDAKSF---IKQCLQR 461
           T +E+AT   P+ +Y  +  +  +    D P +       E L    KSF   I  CLQ+
Sbjct: 211 TAIELATGAAPYHKYPPM-KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 269
Query: 462 DPSARPPASKLLDHPFVR 479
           DP  RP A++LL H F +
Sbjct: 270 DPEKRPTAAELLRHKFFQ 287

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  149 bits (376), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 135/253 (53%), Gaps = 11/253 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  +PNIV Y  
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENKNPNIVNYLD 84
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+   +HRDIK
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
             NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y   VDIWSL
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRKAYGPKVDIWSL 202
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDPSAR 466
           G   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +CL+ D   R
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
Query: 467 PPASKLLDHPFVR 479
             A +LL H F++
Sbjct: 262 GSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  148 bits (373), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 134/253 (52%), Gaps = 11/253 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  +PNIV Y  
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENKNPNIVNYLD 84
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+   +HRDIK
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
             NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y   VDIWSL
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSL 202
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDPSAR 466
           G   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +CL  D   R
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 467 PPASKLLDHPFVR 479
             A +LL H F++
Sbjct: 262 GSAKELLQHQFLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 134/253 (52%), Gaps = 11/253 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  +PNIV Y  
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENKNPNIVNYLD 84
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+   +HRDIK
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
             NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y   VDIWSL
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV-TRKAYGPKVDIWSL 202
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDPSAR 466
           G   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +CL  D   R
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 467 PPASKLLDHPFVR 479
             A +LL H F++
Sbjct: 262 GSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 135/253 (53%), Gaps = 11/253 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  +PNIV Y  
Sbjct: 31  QGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENKNPNIVNYLD 85
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+   +HRDIK
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 144
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
             NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y   VDIWSL
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRKAYGPKVDIWSL 203
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDPSAR 466
           G   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +CL+ D   R
Sbjct: 204 GIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 262
Query: 467 PPASKLLDHPFVR 479
             A +L+ H F++
Sbjct: 263 GSAKELIQHQFLK 275

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 14/254 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRV--VCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           RG F  VY       G   A+K+V++  + D +   +C+K    EI+LL QL+HPN+++Y
Sbjct: 42  RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPNVIKY 97
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGP----FNEPVIQTYTRQILLGLAYLHARNT 343
           + S + D  L++ LE    G + ++++ +        E  +  Y  Q+   L ++H+R  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           +HRDIK AN+ +   G +KL D G+ +  +S   +  S  G+PY+M+PE + + NGY+  
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-HENGYNFK 216
Query: 403 VDIWSLGCTVLEMATSKPP-WSQYEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQ 460
            DIWSLGC + EMA  + P +     + ++ K     D P +P +H S++ +  +  C+ 
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 276
Query: 461 RDPSARPPASKLLD 474
            DP  RP  + + D
Sbjct: 277 PDPEKRPDVTYVYD 290

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  145 bits (367), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 135/253 (53%), Gaps = 11/253 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  +PNIV Y  
Sbjct: 31  QGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENKNPNIVNYLD 85
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+   +HR+IK
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRNIK 144
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
             NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y   VDIWSL
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSL 203
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIKQCLQRDPSAR 466
           G   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ +CL+ D   R
Sbjct: 204 GIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 262
Query: 467 PPASKLLDHPFVR 479
             A +L+ H F++
Sbjct: 263 GSAKELIQHQFLK 275

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  141 bits (356), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 136/251 (54%), Gaps = 11/251 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V L     SG+  A+K +     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  E L V +E++ GG++  ++ +    NE  I T    +L  LAYLHA+  +HRDIK 
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 351 ANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPEV+ + + Y+  VDIWSLG
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLYATEVDIWSLG 228
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQRDPSARP 467
             V+EM   +PP+     V A+ ++ +S   P++     +S   + F+++ L RDP  R 
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVLRDFLERMLVRDPQERA 287
Query: 468 PASKLLDHPFV 478
            A +LLDHPF+
Sbjct: 288 TAQELLDHPFL 298

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 135/251 (53%), Gaps = 8/251 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG   L  ++E G+   IKE+ +     +SKE  ++  +E+ +L+ + HPNIV+Y  S
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINI--SRMSSKE-REESRREVAVLANMKHPNIVQYRES 91
Query: 291 ELSDERLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +  L + ++Y  GG + K +  Q+   F E  I  +  QI L L ++H R  +HRDI
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           K  NI +   G ++L DFG+A+ + S   +  +  G+PY+++PE+  N   Y+   DIW+
Sbjct: 152 KSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWA 210
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
           LGC + E+ T K  +        + KI  S   P +  H S D +S + Q  +R+P  RP
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 468 PASKLLDHPFV 478
             + +L+  F+
Sbjct: 270 SVNSILEKGFI 280

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   E +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADEPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 73  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC--GTPEYLAPEIIL-SKGYNKAVDWWA 244
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 130/239 (54%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L+  G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G IK+ADFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 39  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 153
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 154 LKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 210
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 211 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 23  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G ++K LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPS-SRRXXLXGTLDYLPPEMI-EGRMHDEKVDLWSL 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 255
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 256 LREVLEHPWI 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  135 bits (339), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 44  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 161 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 218
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 219 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 276
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 277 LREVLEHPWI 286

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 47  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 161
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 162 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 218
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 219 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 73  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 244
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 23  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G ++K LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 255
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 256 LREVLEHPWI 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 19  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 136 KPENLLLGSAGELKIADFGWSCHAPS-SRRTTLSGTLDYLPPEMI-EGRMHDEKVDLWSL 193
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 251
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 252 LREVLEHPWI 261

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 145/284 (51%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 75  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 249
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 250 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 78  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 192
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 252
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 253 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 78  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 192
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 252
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 253 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 145/284 (51%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 145/284 (51%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 72  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY+ GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G IK+ADFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 145/284 (51%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY+ GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G IK+ADFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 70  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 35  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 91
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 92  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 151
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 152 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 209
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 210 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 267
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 268 LREVLEHPWI 277

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIII-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 70  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 129/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + +MA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYQMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 23  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 255
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 256 LREVLEHPWI 265

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 21  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 195
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 196 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 253
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 254 LREVLEHPWI 263

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 75  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 249
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 250 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 74  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 73  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 74  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 73  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 128 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 21  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEMI-EGRMHDEKVDLWSL 195
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 196 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 253
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 254 LREVLEHPWI 263

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 73  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 23  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE +     +   VD+WSL
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEXI-EGRXHDEKVDLWSL 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPX 255
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 256 LREVLEHPWI 265

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 141/280 (50%), Gaps = 34/280 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
             ++ +L +  E++S   + K +          P+I++Y  Q+L GLA+ H+   +HRD+
Sbjct: 74  IHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWS 407
           K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  VDIWS
Sbjct: 133 KPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 192
Query: 408 LGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH------------ 446
           LGC   EM T +   P  S+ + +  IF+   + D      +  +P++            
Sbjct: 193 LGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDF 252
Query: 447 ------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                 L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 253 SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 72  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 144/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+V     H+ L+ +   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 70  IHTENKLYLVFEHV-----HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 72  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 126 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 141/280 (50%), Gaps = 34/280 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
             ++ +L +  E++S   + K +          P+I++Y  Q+L GLA+ H+   +HRD+
Sbjct: 72  IHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWS 407
           K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  VDIWS
Sbjct: 131 KPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 190
Query: 408 LGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH------------ 446
           LGC   EM T +   P  S+ + +  IF+   + D      +  +P++            
Sbjct: 191 LGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDF 250
Query: 447 ------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                 L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 251 SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P  +APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEALAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 70  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 22  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 139 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 196
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 197 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 254
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 255 LREVLEHPWI 264

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 72  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 17  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 73
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 74  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 133
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 134 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 191
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 192 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 249
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 250 LREVLEHPWI 259

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRTELCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 44  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 161 KPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPEMI-EGRMHDEKVDLWSL 218
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 219 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 276
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 277 LREVLEHPWI 286

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 127/235 (54%), Gaps = 13/235 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 70  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 73  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 244
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 141/284 (49%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+ +   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 74  IHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 45  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 160 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 216
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 217 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 23  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSL 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 255
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 256 LREVLEHPWI 265

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 21  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 195
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 196 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 253
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 254 LREVLEHPWI 263

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + ESG   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++AP +++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPAIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 20  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 137 KPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPEMI-EGRMHDEKVDLWSL 194
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 195 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 252
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 253 LREVLEHPWI 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 19  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSL 193
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 251
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 252 LREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 139/287 (48%), Gaps = 48/287 (16%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE---------PVIQTYTRQILLGLAYLHAR 341
             ++ +L +  E+V         Q+   F +         P+I++Y  Q+L GLA+ H+ 
Sbjct: 74  IHTENKLYLVFEHVD--------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYS 400
             +HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH----- 446
             VDIWSLGC   EM T +  +     +  +F+I  +   P+         +P++     
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 447 -------------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                        L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 45  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 160 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 216
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 217 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GL++ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E++S       L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 73  IHTENKLYLVFEFLSMD-----LKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 404 DIWSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKD------IPEIPEH-------- 446
           DIWSLGC   EM T +   P  S+ + +  IF+   + D      +  +P++        
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 19  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPS-SRRDTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 193
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 251
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 252 LREVLEHPWI 261

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 141/284 (49%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E++S       L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 74  IHTENKLYLVFEFLSMD-----LKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+           +    W  APE+++    YS  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +   ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + LEY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G IK+ADFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRTXLCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 21  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPEMI-EGRMHDEKVDLWSL 195
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 196 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 253
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 254 LREVLEHPWI 263

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+ ++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 14  GTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 71  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 142/284 (50%), Gaps = 42/284 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N  +G++ A+ ++R+   D  ++       +EI+LL +L+HPNIV+    
Sbjct: 13  GTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNE------PVIQTYTRQILLGLAYLHARNTV 344
             ++ +L +  E+     +H+ L+++   +       P+I++Y  Q+L GLA+ H+   +
Sbjct: 70  IHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G IKLADFG+A+         + +    W  APE+++    YS  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE---------IPEH-------- 446
           DIWSLGC   EM T +  +     +  +F+I  +   P+         +P++        
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 447 ----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 38  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 152
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 153 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEYLAPEIIL-SKGYNKAVDWWA 209
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 210 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EYV GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+L+D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  132 bits (331), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 20  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+A+FG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 137 KPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 194
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 195 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 252
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 253 LREVLEHPWI 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  132 bits (331), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL     S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 18  KGKFGNVYLAREKNSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 75  GYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEMI-EGRMHDEKVDLWSL 192
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 193 GVLCYEFLVGKPPFEANTYQDTYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 250
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 251 LREVLEHPWI 260

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 17/255 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     +G+  A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 56  GSTGIVCIATEKHTGKQVAVKKM-----DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I T    +L  L+YLH +  +HRDIK 
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G IKL+DFG    ++          G+PYWMAPEV+ +   Y   VDIWSLG
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI-SRLPYGTEVDIWSLG 228
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNS-----KDIPEIPEHLSDDAKSFIKQCLQRDPS 464
             V+EM   +PP+     + A+ +I +S     KD+ ++    S   + F+   L R+PS
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKV----SSVLRGFLDLMLVREPS 284
Query: 465 ARPPASKLLDHPFVR 479
            R  A +LL HPF++
Sbjct: 285 QRATAQELLGHPFLK 299

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 21  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +      G+  ++ PE++     +   VD+WSL
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPEMI-EGRMHDEKVDLWSL 195
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I   +     P+ +++ A+  I + L+ +PS RP 
Sbjct: 196 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPM 253
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 254 LREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 21  KGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+A+FG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 138 KPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 195
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 196 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 253
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 254 LREVLEHPWI 263

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 137/261 (52%), Gaps = 18/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 162 GSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRDIK 
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPE++     Y   VDIWSLG
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLG 334
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDPSAR 466
             V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP+ R
Sbjct: 335 IMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 392
Query: 467 PPASKLLDHPFVRDQAVARAG 487
             A++LL HPF     +A+AG
Sbjct: 393 ATAAELLKHPF-----LAKAG 408

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 126/239 (52%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +   + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 15  KGKFGNVYLAREKQRKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 71
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 72  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 131
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 132 KPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 189
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E    KPP+          +I  S+     P+ +++ A+  I + L+ +PS RP 
Sbjct: 190 GVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 247
Query: 469 ASKLLDHPFV 478
             ++L+HP++
Sbjct: 248 LREVLEHPWI 257

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LK++   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG+AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 127/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G I++ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 137/261 (52%), Gaps = 18/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 85  GSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRDIK 
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 198
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPE++     Y   VDIWSLG
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLG 257
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDPSAR 466
             V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP+ R
Sbjct: 258 IMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 315
Query: 467 PPASKLLDHPFVRDQAVARAG 487
             A++LL HPF     +A+AG
Sbjct: 316 ATAAELLKHPF-----LAKAG 331

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 126/239 (52%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P + + 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 126/239 (52%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P + + 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 128/239 (53%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LK++   +N   +L  ++ P +V+ 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F+EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G I++ DFG+AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 167 LKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 223
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 42  GSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRDIK 
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 155
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPE++ +   Y   VDIWSLG
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGPEVDIWSLG 214
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDPSAR 466
             V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP+ R
Sbjct: 215 IMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 272
Query: 467 PPASKLLDHPFVRDQAVARAG 487
             A++LL HPF     +A+AG
Sbjct: 273 ATAAELLKHPF-----LAKAG 288

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 125/239 (52%), Gaps = 13/239 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN---LLSQLSHPNIVRY 287
           G+FG V L  + E+G   A+K    + D Q   + LKQ+   +N   +L  ++ P + + 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
             S   +  L + +EY  GG +   L+  G F EP  + Y  QI+L   YLH+ + ++RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+++D  G IK+ DFG AK +      L   G+P ++APE+++ + GY+  VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAVDWWA 224
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
           LG  + EMA   PP+   + +    KI + K     P H S D K  ++  LQ D + R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  129 bits (323), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 133/242 (54%), Gaps = 19/242 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC---LKQL---NQEINLLSQLSHPNI 284
           G+FG V+L  +  +G+  A+K ++        KE    LKQ+   N E  +LS ++HP I
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           +R  G+    +++ + ++Y+ GG +  LL++   F  PV + Y  ++ L L YLH+++ +
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           +RD+K  NIL+D +G IK+ DFG AK++      L   G+P ++APEVV +T  Y+ ++D
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC--GTPDYIAPEVV-STKPYNKSID 185
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
            WS G  + EM     P+     +    KI N++     P   ++D K  + + + RD S
Sbjct: 186 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLS 243
Query: 465 AR 466
            R
Sbjct: 244 QR 245

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  129 bits (323), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 40  GSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRDIK 
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 153
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPE++ +   Y   VDIWSLG
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGPEVDIWSLG 212
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDPSAR 466
             V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP+ R
Sbjct: 213 IMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 270
Query: 467 PPASKLLDHPFVRDQAVARAG 487
             A++LL HPF     +A+AG
Sbjct: 271 ATAAELLKHPF-----LAKAG 286

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 137/251 (54%), Gaps = 8/251 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 22  KGKFGNVYLARERQSKFILALK---VLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+  +GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 139 KPENLLLGSNGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 196
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E     PP+  +       +I  S+     P+ +++ A+  I + L+ + S R  
Sbjct: 197 GVLCYEFLVGMPPFEAHTYQETYRRI--SRVEFTFPDFVTEGARDLISRLLKHNASQRLT 254
Query: 469 ASKLLDHPFVR 479
            +++L+HP+++
Sbjct: 255 LAEVLEHPWIK 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  128 bits (322), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 134/217 (61%), Gaps = 7/217 (3%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 128
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 129 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 187
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---SKDIPEI 443
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P     G  AIF++ +   ++  P++
Sbjct: 188 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKL 246
Query: 444 PEHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           P  + S + + F+ +CL ++P+ R    +L+ H F++
Sbjct: 247 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 31  GSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 144
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPE++ +   Y   VDIWSLG
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGPEVDIWSLG 203
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDPSAR 466
             V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP+ R
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 467 PPASKLLDHPFVRDQAVARAG 487
             A++LL HPF     +A+AG
Sbjct: 262 ATAAELLKHPF-----LAKAG 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+ G V +     SG++ A+K++     D   ++  + L  E+ ++    H N+V  + S
Sbjct: 35  GSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L  + L V +E++ GG++  ++  +   NE  I      +L  L+ LHA+  +HRDIK 
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 148
Query: 351 ANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
            +IL+   G +KL+DFG    ++          G+PYWMAPE++ +   Y   VDIWSLG
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGPEVDIWSLG 207
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL---SDDAKSFIKQCLQRDPSAR 466
             V+EM   +PP+     + A+  I +  ++P   ++L   S   K F+ + L RDP+ R
Sbjct: 208 IMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 265
Query: 467 PPASKLLDHPFVRDQAVARAG 487
             A++LL HPF     +A+AG
Sbjct: 266 ATAAELLKHPF-----LAKAG 281

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 137/251 (54%), Gaps = 8/251 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  K  ++ QL +E+ + S L HPNI+R +
Sbjct: 22  KGKFGNVYLARERQSKFILALK---VLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y H++  +HRDI
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+  +GE+K+ADFG + H  S +   +  G+  ++ PE++     +   VD+WSL
Sbjct: 139 KPENLLLGSNGELKIADFGWSVHAPS-SRRDTLCGTLDYLPPEMI-EGRMHDEKVDLWSL 196
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E     PP+  +       +I  S+     P+ +++ A+  I + L+ + S R  
Sbjct: 197 GVLCYEFLVGMPPFEAHTYQETYRRI--SRVEFTFPDFVTEGARDLISRLLKHNASQRLT 254
Query: 469 ASKLLDHPFVR 479
            +++L+HP+++
Sbjct: 255 LAEVLEHPWIK 265

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 130/251 (51%), Gaps = 8/251 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    ++  + A+K   V+   Q  KE ++ QL +EI + S L HPNI+R +
Sbjct: 25  KGKFGNVYLAREKQNKFIMALK---VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                 +R+ + LE+   G ++K LQ++G F+E    T+  ++   L Y H R  +HRDI
Sbjct: 82  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 141
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S        G+  ++ PE++     +   VD+W  
Sbjct: 142 KPENLLMGYKGELKIADFGWSVHAPSLRRR-XMCGTLDYLPPEMI-EGKTHDEKVDLWCA 199
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E     PP+          +I N  D+ + P  LSD +K  I + L+  P  R P
Sbjct: 200 GVLCYEFLVGMPPFDSPSHTETHRRIVNV-DL-KFPPFLSDGSKDLISKLLRYHPPQRLP 257
Query: 469 ASKLLDHPFVR 479
              +++HP+V+
Sbjct: 258 LKGVMEHPWVK 268

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 130/251 (51%), Gaps = 8/251 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    ++  + A+K   V+   Q  KE ++ QL +EI + S L HPNI+R +
Sbjct: 24  KGKFGNVYLAREKQNKFIMALK---VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                 +R+ + LE+   G ++K LQ++G F+E    T+  ++   L Y H R  +HRDI
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S        G+  ++ PE++     +   VD+W  
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRR-XMCGTLDYLPPEMI-EGKTHDEKVDLWCA 198
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G    E     PP+          +I N  D+ + P  LSD +K  I + L+  P  R P
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNV-DL-KFPPFLSDGSKDLISKLLRYHPPQRLP 256
Query: 469 ASKLLDHPFVR 479
              +++HP+V+
Sbjct: 257 LKGVMEHPWVK 267

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 119/212 (56%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI++   L+H ++V +HG    ++ + V LE     S+ +L +      EP  + 
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 121
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           Y RQI+LG  YLH    +HRD+K  N+ ++   E+K+ DFG+A  +        +  G+P
Sbjct: 122 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APE V++  G+S  VD+WS+GC +  +   KPP+          +I   K+   IP+
Sbjct: 182 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPK 238
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A S I++ LQ DP+ARP  ++LL+  F
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLNDEF 270

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 119/212 (56%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI++   L+H ++V +HG    ++ + V LE     S+ +L +      EP  + 
Sbjct: 66  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 125
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           Y RQI+LG  YLH    +HRD+K  N+ ++   E+K+ DFG+A  +        +  G+P
Sbjct: 126 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APE V++  G+S  VD+WS+GC +  +   KPP+          +I   K+   IP+
Sbjct: 186 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPK 242
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A S I++ LQ DP+ARP  ++LL+  F
Sbjct: 243 HINPVAASLIQKMLQTDPTARPTINELLNDEF 274

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYH 288
           +G+FG V L  +  +GQ CA+K   V+   Q  ++  K+ L +E+ LL QL HPNI++ +
Sbjct: 60  KGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 289 GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             E  +++   YL  E  +GG +   +     F+E       RQ+L G+ Y+H    VHR
Sbjct: 117 --EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 174
Query: 347 DIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  N+L++   +   I++ DFG++ H  +   M    G+ Y++APEV+  T  Y    
Sbjct: 175 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKC 232
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQR 461
           D+WS G  +  + +  PP++       + K+   K   E+P+   +S+ AK  I++ L  
Sbjct: 233 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY 292
Query: 462 DPSARPPASKLLDHPFVR 479
            PS R  A   LDH +++
Sbjct: 293 VPSMRISARDALDHEWIQ 310

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYH 288
           +G+FG V L  +  +GQ CA+K   V+   Q  ++  K+ L +E+ LL QL HPNI++ +
Sbjct: 59  KGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 289 GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             E  +++   YL  E  +GG +   +     F+E       RQ+L G+ Y+H    VHR
Sbjct: 116 --EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 173
Query: 347 DIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  N+L++   +   I++ DFG++ H  +   M    G+ Y++APEV+  T  Y    
Sbjct: 174 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKC 231
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQR 461
           D+WS G  +  + +  PP++       + K+   K   E+P+   +S+ AK  I++ L  
Sbjct: 232 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY 291
Query: 462 DPSARPPASKLLDHPFVR 479
            PS R  A   LDH +++
Sbjct: 292 VPSMRISARDALDHEWIQ 309

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 119/212 (56%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI++   L+H ++V +HG    ++ + V LE     S+ +L +      EP  + 
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 121
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           Y RQI+LG  YLH    +HRD+K  N+ ++   E+K+ DFG+A  +        +  G+P
Sbjct: 122 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APE V++  G+S  VD+WS+GC +  +   KPP+          +I   K+   IP+
Sbjct: 182 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPK 238
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A S I++ LQ DP+ARP  ++LL+  F
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLNDEF 270

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 118/212 (55%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI++   L+H ++V +HG    ++ + V LE     S+ +L +      EP  + 
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 145
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSP 385
           Y RQI+LG  YLH    +HRD+K  N+ ++   E+K+ DFG+A  +           G+P
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APE V++  G+S  VD+WS+GC +  +   KPP+          +I   K+   IP+
Sbjct: 206 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPK 262
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A S I++ LQ DP+ARP  ++LL+  F
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLNDEF 294

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYH 288
           +G+FG V L  +  +GQ CA+K   V+   Q  ++  K+ L +E+ LL QL HPNI++ +
Sbjct: 36  KGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 289 GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             E  +++   YL  E  +GG +   +     F+E       RQ+L G+ Y+H    VHR
Sbjct: 93  --EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 150
Query: 347 DIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  N+L++   +   I++ DFG++ H  +   M    G+ Y++APEV+  T  Y    
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKC 208
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQR 461
           D+WS G  +  + +  PP++       + K+   K   E+P+   +S+ AK  I++ L  
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY 268
Query: 462 DPSARPPASKLLDHPFVR 479
            PS R  A   LDH +++
Sbjct: 269 VPSMRISARDALDHEWIQ 286

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 118/212 (55%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI++   L+H ++V +HG    ++ + V LE     S+ +L +      EP  + 
Sbjct: 84  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 143
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSP 385
           Y RQI+LG  YLH    +HRD+K  N+ ++   E+K+ DFG+A  +           G+P
Sbjct: 144 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APE V++  G+S  VD+WS+GC +  +   KPP+          +I   K+   IP+
Sbjct: 204 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPK 260
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A S I++ LQ DP+ARP  ++LL+  F
Sbjct: 261 HINPVAASLIQKMLQTDPTARPTINELLNDEF 292

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYH 288
           +G+FG V L  +  +GQ CA+K   V+   Q  ++  K+ L +E+ LL QL HPNI++ +
Sbjct: 42  KGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 289 GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             E  +++   YL  E  +GG +   +     F+E       RQ+L G+ Y+H    VHR
Sbjct: 99  --EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 156
Query: 347 DIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  N+L++   +   I++ DFG++ H  +   M    G+ Y++APEV+  T  Y    
Sbjct: 157 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKC 214
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQR 461
           D+WS G  +  + +  PP++       + K+   K   E+P+   +S+ AK  I++ L  
Sbjct: 215 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY 274
Query: 462 DPSARPPASKLLDHPFVR 479
            PS R  A   LDH +++
Sbjct: 275 VPSMRISARDALDHEWIQ 292

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 118/212 (55%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI++   L+H ++V +HG    ++ + V LE     S+ +L +      EP  + 
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSP 385
           Y RQI+LG  YLH    +HRD+K  N+ ++   E+K+ DFG+A  +           G+P
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APE V++  G+S  VD+WS+GC +  +   KPP+          +I   K+   IP+
Sbjct: 180 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPK 236
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A S I++ LQ DP+ARP  ++LL+  F
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINELLNDEF 268

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 44/289 (15%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+  VY G N  +G   A+KEV++  ++ T    ++    EI+L+ +L H NIVR +  
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRLYDV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEP------VIQTYTRQILLGLAYLHARNTV 344
             ++ +L++  E++    + K +      N P      +++ +  Q+L GLA+ H    +
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTV 403
           HRD+K  N+L++  G++KL DFG+A+      +  S +    W  AP+V+M +  YS ++
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS----------------------- 437
           DIWS GC + EM T KP +   +  E +  IF I  +                       
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 438 -KDI-----PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
            +D+     P   E L  +   F+   LQ +P  R  A + L HP+  +
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 12/281 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G  G V L F  ++ +  AIK +   +         +    +  EI +L +L+HP I++ 
Sbjct: 27  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 86
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                  E   + LE + GG +   +       E   + Y  Q+LL + YLH    +HRD
Sbjct: 87  KNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 145
Query: 348 IKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGYSLT 402
           +K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY+  
Sbjct: 146 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 205
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K+ L
Sbjct: 206 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 265
Query: 460 QRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSL 500
             DP AR    + L HP+++D+ + R     L++++   +L
Sbjct: 266 VVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTAL 306

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 132/257 (51%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 18  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 72
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APE V+  N Y   VD 
Sbjct: 133 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 191
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 192 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 249
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 250 RLGGGPSDAKEVMEHRF 266

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 12/281 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G  G V L F  ++ +  AIK +   +         +    +  EI +L +L+HP I++ 
Sbjct: 20  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 79
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                  E   + LE + GG +   +       E   + Y  Q+LL + YLH    +HRD
Sbjct: 80  KNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 138
Query: 348 IKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGYSLT 402
           +K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY+  
Sbjct: 139 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 198
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K+ L
Sbjct: 199 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 258
Query: 460 QRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSL 500
             DP AR    + L HP+++D+ + R     L++++   +L
Sbjct: 259 VVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTAL 299

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 12/281 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G  G V L F  ++ +  AIK +   +         +    +  EI +L +L+HP I++ 
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                  E   + LE + GG +   +       E   + Y  Q+LL + YLH    +HRD
Sbjct: 81  KNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 348 IKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGYSLT 402
           +K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY+  
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K+ L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 460 QRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSL 500
             DP AR    + L HP+++D+ + R     L++++   +L
Sbjct: 260 VVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTAL 300

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 132/257 (51%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 69
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APE V+  N Y   VD 
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 188
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 132/257 (51%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 69
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APE V+  N Y   VD 
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 188
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 12/281 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G  G V L F  ++ +  AIK +   +         +    +  EI +L +L+HP I++ 
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                  E   + LE + GG +   +       E   + Y  Q+LL + YLH    +HRD
Sbjct: 81  KNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 348 IKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGYSLT 402
           +K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY+  
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K+ L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 460 QRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSL 500
             DP AR    + L HP+++D+ + R     L++++   +L
Sbjct: 260 VVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTAL 300

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 135/269 (50%), Gaps = 18/269 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLN--QEINLLSQLSHPNI 284
           G  G V L F  ++ +  AI   R++   +    +++E    LN   EI +L +L+HP I
Sbjct: 146 GACGEVKLAFERKTCKKVAI---RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           ++        E   + LE + GG +   +       E   + Y  Q+LL + YLH    +
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 345 HRDIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGY 399
           HRD+K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIK 456
           +  VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 381
Query: 457 QCLQRDPSARPPASKLLDHPFVRDQAVAR 485
           + L  DP AR    + L HP+++D+ + R
Sbjct: 382 KLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 12/266 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G  G V L F  ++ +  AIK +   +         +    +  EI +L +L+HP I++ 
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                  E   + LE + GG +   +       E   + Y  Q+LL + YLH    +HRD
Sbjct: 81  KNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 348 IKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGYSLT 402
           +K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY+  
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K+ L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 460 QRDPSARPPASKLLDHPFVRDQAVAR 485
             DP AR    + L HP+++D+ + R
Sbjct: 260 VVDPKARFTTEEALRHPWLQDEDMKR 285

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYHG 289
           G++G          G++   KE+    D  +  E  KQ L  E+NLL +L HPNIVRY+ 
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 290 SEL--SDERLSVYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTRQILLGLAYLHARN- 342
             +  ++  L + +EY  GG +  ++    +E    +E  +     Q+ L L   H R+ 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 343 ----TVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPYWMAPEVVMN 395
                +HRD+K AN+ +D    +KL DFG+A+   H TS A   +F G+PY+M+PE  MN
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFVGTPYYMSPE-QMN 189
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
              Y+   DIWSLGC + E+    PP++ +       KI   K    IP   SD+    I
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 456 KQCLQRDPSARPPASKLLDHPFV 478
            + L      RP   ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 142/284 (50%), Gaps = 18/284 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLN--QEINLLSQLSHPNI 284
           G  G V L F  ++ +  AI   R++   +    +++E    LN   EI +L +L+HP I
Sbjct: 160 GACGEVKLAFERKTCKKVAI---RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           ++        E   + LE + GG +   +       E   + Y  Q+LL + YLH    +
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 275
Query: 345 HRDIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN--TNGY 399
           HRD+K  N+L+    E   IK+ DFG +K +   + M +  G+P ++APEV+++  T GY
Sbjct: 276 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 335
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIK 456
           +  VD WSLG  +    +  PP+S++    ++      G    IPE+   +S+ A   +K
Sbjct: 336 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 395
Query: 457 QCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSL 500
           + L  DP AR    + L HP+++D+ + R     L++++   +L
Sbjct: 396 KLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTAL 439

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYHG 289
           G++G          G++   KE+    D  +  E  KQ L  E+NLL +L HPNIVRY+ 
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 290 SEL--SDERLSVYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTRQILLGLAYLHARN- 342
             +  ++  L + +EY  GG +  ++    +E    +E  +     Q+ L L   H R+ 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 343 ----TVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPYWMAPEVVMN 395
                +HRD+K AN+ +D    +KL DFG+A+   H TS A   +F G+PY+M+PE  MN
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPE-QMN 189
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
              Y+   DIWSLGC + E+    PP++ +       KI   K    IP   SD+    I
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 456 KQCLQRDPSARPPASKLLDHPFV 478
            + L      RP   ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 69
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M  F G+P ++APE V+  N Y   VD 
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDW 188
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 69
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M  F G+P ++APE V+  N Y   VD 
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDW 188
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 127/241 (52%), Gaps = 11/241 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G+FG V L     + ++ AIK ++   V+ DD    EC     + + LL +   P + +
Sbjct: 29  KGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV--ECTMVEKRVLALLDK--PPFLTQ 84
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +LH R  ++R
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYR 144
Query: 347 DIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+++D  G IK+ADFGM K HM    +   F G+P ++APE++     Y  +VD 
Sbjct: 145 DLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AYQPYGKSVDW 203
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W+ G  + EM   +PP+   E    +F+     ++   P+ LS +A S  K  + + P+ 
Sbjct: 204 WAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLMTKHPAK 261
Query: 466 R 466
           R
Sbjct: 262 R 262

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 20  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 74
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M  F G+P ++APE V+  N Y   VD 
Sbjct: 135 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDW 193
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 251
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 252 RLGGGPSDAKEVMEHRF 268

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K +R   ++  D+ +         E  +L    HP +  
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNTRHPFLTA 69
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+ V+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  N+++D  G IK+ DFG+ K  ++  A+M  F G+P ++APE V+  N Y   VD 
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDW 188
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W LG  + EM   + P+   +    +F++   ++I   P  LS +AKS +   L++DP  
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 466 R-----PPASKLLDHPF 477
           R       A ++++H F
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 134/227 (59%), Gaps = 21/227 (9%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 168
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-------------SKPPWSQYEGVAAIFK 433
           +M+PE +  T+ YS+  DIWS+G +++EMA              S+PP + +E +  I  
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIV- 226
Query: 434 IGNSKDIPEIPEHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
              ++  P++P  + S + + F+ +CL ++P+ R    +L+ H F++
Sbjct: 227 ---NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 132/217 (60%), Gaps = 11/217 (5%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 112
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +   F G+  
Sbjct: 113 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN-EFVGTRS 171
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS---KPPWSQYEGVAAIFKIGNSKDIPEI 443
           +M+PE +  T+ YS+  DIWS+G +++EMA     +PP + +E +  I     ++  P++
Sbjct: 172 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIV----NEPPPKL 226
Query: 444 PEHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           P  + S + + F+ +CL ++P+ R    +L+ H F++
Sbjct: 227 PSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 263

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 132/258 (51%), Gaps = 15/258 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYH 288
           +G+FG V L  +  +GQ CA+K   V+   Q  ++  K+ L +E+ LL QL HPNI + +
Sbjct: 36  KGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 289 GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             E  +++   YL  E  +GG +   +     F+E       RQ+L G+ Y H    VHR
Sbjct: 93  --EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHR 150
Query: 347 DIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  N+L++   +   I++ DFG++ H  +        G+ Y++APEV+  T  Y    
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKC 208
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQR 461
           D+WS G  +  + +  PP++       + K+   K   E+P+   +S+ AK  I++ L  
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTY 268
Query: 462 DPSARPPASKLLDHPFVR 479
            PS R  A   LDH +++
Sbjct: 269 VPSXRISARDALDHEWIQ 286

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A   VR++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 24  KGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F GSP + APE+          VD+WSLG
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 201 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 462 DPSARPPASKLL 473
           +PS R    +++
Sbjct: 251 NPSKRGTLEQIM 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC--LKQLNQEINLLSQLSHPNIVRY 287
           +G+F  VY   +  +G   AIK +    D +   +   ++++  E+ +  QL HP+I+  
Sbjct: 21  KGSFAGVYRAESIHTGLEVAIKMI----DKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +        + + LE    G +++ L+    PF+E   + +  QI+ G+ YLH+   +HR
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 347 DIKGANILVDPHGEIKLADFGMA--------KHMTSCASMLSFKGSPYWMAPEVVMNTNG 398
           D+  +N+L+  +  IK+ADFG+A        KH T C       G+P +++PE+   +  
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-------GTPNYISPEIATRS-A 188
Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           + L  D+WSLGC    +   +PP+        + K+  +    E+P  LS +AK  I Q 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAKDLIHQL 246
Query: 459 LQRDPSARPPASKLLDHPFV 478
           L+R+P+ R   S +LDHPF+
Sbjct: 247 LRRNPADRLSLSSVLDHPFM 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 21/252 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A   VR++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 24  KGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    +  F GSP + APE+          VD+WSLG
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 201 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 462 DPSARPPASKLL 473
           +PS R    +++
Sbjct: 251 NPSKRGTLEQIM 262

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 132/244 (54%), Gaps = 10/244 (4%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL 301
           + +G++ A+K ++     + +K+       E N+L ++ HP IV    +  +  +L + L
Sbjct: 42  ANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100
Query: 302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
           EY+SGG +   L+  G F E     Y  +I + L +LH +  ++RD+K  NI+++  G +
Sbjct: 101 EYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHV 160
Query: 362 KLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP 420
           KL DFG+ K      ++  +F G+  +MAPE++M + G++  VD WSLG  + +M T  P
Sbjct: 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAP 219
Query: 421 PWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP-----PASKLLDH 475
           P++       I KI   K    +P +L+ +A+  +K+ L+R+ ++R       A ++  H
Sbjct: 220 PFTGENRKKTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277
Query: 476 PFVR 479
           PF R
Sbjct: 278 PFFR 281

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           GT+G V+   N E+ ++ A+K VR+  DD+      L+    EI LL +L H NIVR H 
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVRLHD 68
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              SD++L++  E+             G  +  +++++  Q+L GL + H+RN +HRD+K
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA-PEVVMNTNGYSLTVDIWSL 408
             N+L++ +GE+KLADFG+A+         S +    W   P+V+     YS ++D+WS 
Sbjct: 129 PQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 409 GCTVLEMATSKPPW-------SQYEGVAAIF------------KIGNSKDIPEIPE---- 445
           GC   E+A +  P         Q + +  +             K+ + K  P  P     
Sbjct: 189 GCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 446 -----HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                 L+   +  ++  L+ +P  R  A + L HP+  D
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A+K   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 24  KGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F GSP + APE+          VD+WSLG
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 201 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 462 DPSARPPASKLL 473
           +PS R    +++
Sbjct: 251 NPSKRGTLEQIM 262

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 143/279 (51%), Gaps = 34/279 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N+  G+  A+K++R+  +D+       +   EI++L +L H NIV+ +  
Sbjct: 13  GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLYDV 68
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             + +RL +  E++    + KLL    G       +++  Q+L G+AY H R  +HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSL 408
             N+L++  GE+K+ADFG+A+         + +    W  AP+V+M +  YS T+DIWS+
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 409 GCTVLEMATSKPPW---SQYEGVAAIFKIG---NSKDIP---EIPEH------------- 446
           GC   EM    P +   S+ + +  IF+I    NSK+ P   E+P++             
Sbjct: 188 GCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 447 -----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                L +     + + L+ DP+ R  A + L+H + ++
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 143/279 (51%), Gaps = 34/279 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N+  G+  A+K++R+  +D+       +   EI++L +L H NIV+ +  
Sbjct: 13  GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLYDV 68
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             + +RL +  E++    + KLL    G       +++  Q+L G+AY H R  +HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSL 408
             N+L++  GE+K+ADFG+A+         + +    W  AP+V+M +  YS T+DIWS+
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 409 GCTVLEMATSKPPW---SQYEGVAAIFKIG---NSKDIP---EIPEH------------- 446
           GC   EM    P +   S+ + +  IF+I    NSK+ P   E+P++             
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 447 -----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                L +     + + L+ DP+ R  A + L+H + ++
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A+K   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 24  KGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F GSP + APE+          VD+WSLG
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 201 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 462 DPSARPPASKLL 473
           +PS R    +++
Sbjct: 251 NPSKRGTLEQIM 262

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 129/252 (51%), Gaps = 16/252 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG V+       G   A+K   ++ +     E + +  +E+ ++ +L HPNIV + G+
Sbjct: 48  GSFGTVHRA--EWHGSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHARN--TVH 345
                 LS+  EY+S GS+++LL + G     +E    +    +  G+ YLH RN   VH
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMN--TNGYSLT 402
           R++K  N+LVD    +K+ DFG+++   S   S  S  G+P WMAPEV+ +  +N  S  
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-- 220
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
            D++S G  + E+AT + PW        +  +G      EIP +L+    + I+ C   +
Sbjct: 221 -DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 463 PSARPPASKLLD 474
           P  RP  + ++D
Sbjct: 280 PWKRPSFATIMD 291

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 143/279 (51%), Gaps = 34/279 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   N+  G+  A+K++R+  +D+       +   EI++L +L H NIV+ +  
Sbjct: 13  GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLYDV 68
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             + +RL +  E++    + KLL    G       +++  Q+L G+AY H R  +HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSL 408
             N+L++  GE+K+ADFG+A+         + +    W  AP+V+M +  YS T+DIWS+
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 409 GCTVLEMATSKPPW---SQYEGVAAIFKIG---NSKDIP---EIPEH------------- 446
           GC   EM    P +   S+ + +  IF+I    NSK+ P   E+P++             
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 447 -----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                L +     + + L+ DP+ R  A + L+H + ++
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 131/244 (53%), Gaps = 10/244 (4%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL 301
           + +G++ A+K ++     + +K+       E N+L ++ HP IV    +  +  +L + L
Sbjct: 42  ANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100
Query: 302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
           EY+SGG +   L+  G F E     Y  +I + L +LH +  ++RD+K  NI+++  G +
Sbjct: 101 EYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHV 160
Query: 362 KLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP 420
           KL DFG+ K      ++   F G+  +MAPE++M + G++  VD WSLG  + +M T  P
Sbjct: 161 KLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAP 219
Query: 421 PWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR-----PPASKLLDH 475
           P++       I KI   K    +P +L+ +A+  +K+ L+R+ ++R       A ++  H
Sbjct: 220 PFTGENRKKTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277
Query: 476 PFVR 479
           PF R
Sbjct: 278 PFFR 281

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 126/261 (48%), Gaps = 19/261 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQLSHPNIVRYHG 289
           G++G          G++   KE+    D  +  E  KQ L  E+NLL +L HPNIVRY+ 
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 290 SEL--SDERLSVYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTRQILLGLAYLHARN- 342
             +  ++  L + +EY  GG +  ++    +E    +E  +     Q+ L L   H R+ 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 343 ----TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTN 397
                +HRD+K AN+ +D    +KL DFG+A+ +         F G+PY+M+PE  MN  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE-QMNRM 191
Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            Y+   DIWSLGC + E+    PP++ +       KI   K    IP   SD+    I +
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEIITR 250
Query: 458 CLQRDPSARPPASKLLDHPFV 478
            L      RP   ++L++P +
Sbjct: 251 MLNLKDYHRPSVEEILENPLI 271

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G++G V    N ++G++ AIK+     DD+  K   K   +EI LL QL H N+V     
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK---KIAMREIKLLKQLRHENLVNLLEV 92
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPF----NEPVIQTYTRQILLGLAYLHARNTVHR 346
               +R  +  E+V     H +L +   F    +  V+Q Y  QI+ G+ + H+ N +HR
Sbjct: 93  CKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDI 405
           DIK  NILV   G +KL DFG A+ + +   +   + +  W  APE+++    Y   VD+
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDV 208
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKI----GN----------------SKDIPEIPE 445
           W++GC V EM   +P +     +  ++ I    GN                   +PEI E
Sbjct: 209 WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKE 268
Query: 446 H---------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
                     LS+      K+CL  DP  RP  ++LL H F +    A
Sbjct: 269 REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 21/257 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  AIK   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 22  KGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   ++  RQI+  + Y H +  VHRD+K
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 138
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F GSP + APE+          VD+WSLG
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 199 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 248
Query: 462 DPSARPPASKLLDHPFV 478
           +P  R    +++   ++
Sbjct: 249 NPIKRGTLEQIMKDRWI 265

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 128/256 (50%), Gaps = 12/256 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G+FG V+L    ++ Q  AIK ++   V+ DD    EC     + ++L  +  HP +  
Sbjct: 27  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWE--HPFLTH 82
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + E L   +EY++GG +   +Q    F+      Y  +I+LGL +LH++  V+R
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 347 DIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  NIL+D  G IK+ADFGM K +M   A    F G+P ++APE+++    Y+ +VD 
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDW 201
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           WS G  + EM   + P+   +       I    D P  P  L  +AK  + +   R+P  
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 466 RPPA-SKLLDHPFVRD 480
           R      +  HP  R+
Sbjct: 260 RLGVRGDIRQHPLFRE 275

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 133/246 (54%), Gaps = 20/246 (8%)
Query: 230 RGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLK-----QLNQEINLLSQLSH 281
           +G+FG V+L       +SG + A+K ++        K  LK     +   E ++L+ ++H
Sbjct: 38  QGSFGKVFLVRKVTRPDSGHLYAMKVLK--------KATLKVRDRVRTKMERDILADVNH 89
Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P +V+ H +  ++ +L + L+++ GG +   L +   F E  ++ Y  ++ LGL +LH+ 
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSL 149
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  NIL+D  G IKL DFG++K  +       SF G+  +MAPEVV N  G+S
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV-NRQGHS 208
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            + D WS G  + EM T   P+   +    +  I  +K    +P+ LS +A+S ++   +
Sbjct: 209 HSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK--LGMPQFLSTEAQSLLRALFK 266
Query: 461 RDPSAR 466
           R+P+ R
Sbjct: 267 RNPANR 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A+K   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 24  KGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F G+P + APE+          VD+WSLG
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 201 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 462 DPSARPPASKLL 473
           +PS R    +++
Sbjct: 251 NPSKRGTLEQIM 262

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 128/256 (50%), Gaps = 12/256 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G+FG V+L    ++ Q  AIK ++   V+ DD    EC     + ++L  +  HP +  
Sbjct: 28  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWE--HPFLTH 83
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  + E L   +EY++GG +   +Q    F+      Y  +I+LGL +LH++  V+R
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 143
Query: 347 DIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  NIL+D  G IK+ADFGM K +M   A    F G+P ++APE+++    Y+ +VD 
Sbjct: 144 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDW 202
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           WS G  + EM   + P+   +       I    D P  P  L  +AK  + +   R+P  
Sbjct: 203 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 260
Query: 466 RPPA-SKLLDHPFVRD 480
           R      +  HP  R+
Sbjct: 261 RLGVRGDIRQHPLFRE 276

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  118 bits (296), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 129/254 (50%), Gaps = 20/254 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG V+       G   A+K   ++ +     E + +  +E+ ++ +L HPNIV + G+
Sbjct: 48  GSFGTVHRA--EWHGSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHARN--TVH 345
                 LS+  EY+S GS+++LL + G     +E    +    +  G+ YLH RN   VH
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVVMN--TNGYS 400
           RD+K  N+LVD    +K+ DFG+++     +  L  K   G+P WMAPEV+ +  +N  S
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
              D++S G  + E+AT + PW        +  +G      EIP +L+    + I+ C  
Sbjct: 221 ---DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 461 RDPSARPPASKLLD 474
            +P  RP  + ++D
Sbjct: 278 NEPWKRPSFATIMD 291

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A+K   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 17  KGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 133
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F GSP + APE+          VD+WSLG
Sbjct: 134 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 193
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 194 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 243
Query: 462 DPSARPPASKLL 473
           +PS R    +++
Sbjct: 244 NPSKRGTLEQIM 255

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 144/282 (51%), Gaps = 17/282 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT G V+     ++G + A+K++R   + + +K  L  L+    +L     P IV+  G+
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQCFGT 92
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARN-TVHRDI 348
            +++  + + +E + G    KL +   GP  E ++   T  I+  L YL  ++  +HRD+
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM----NTNGYSLTVD 404
           K +NIL+D  G+IKL DFG++  +    +     G   +MAPE +         Y +  D
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL--SDDAKSFIKQCLQRD 462
           +WSLG +++E+AT + P+   +    +      ++ P +P H+  S D +SF+K CL +D
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKD 271
Query: 463 PSARPPASKLLDHPFVR-----DQAVARAGNVNLAKDSSPYS 499
              RP  +KLL+H F++     +  VA      +AK  SP S
Sbjct: 272 HRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRS 313

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 127/257 (49%), Gaps = 21/257 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  AIK   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 25  KGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   ++  RQI+  + Y H +  VHRD+K
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F G+P + APE+          VD+WSLG
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP ++S D ++ +K+ L  
Sbjct: 202 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 462 DPSARPPASKLLDHPFV 478
           +P  R    +++   ++
Sbjct: 252 NPIKRGTLEQIMKDRWI 268

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           GT+G V+   N E+ ++ A+K VR+  DD+      L+    EI LL +L H NIVR H 
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVRLHD 68
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              SD++L++  E+             G  +  +++++  Q+L GL + H+RN +HRD+K
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA-PEVVMNTNGYSLTVDIWSL 408
             N+L++ +GE+KLA+FG+A+         S +    W   P+V+     YS ++D+WS 
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 409 GCTVLEMATSKPPW-------SQYEGVAAIF------------KIGNSKDIPEIPE---- 445
           GC   E+A +  P         Q + +  +             K+ + K  P  P     
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 446 -----HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                 L+   +  ++  L+ +P  R  A + L HP+  D
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 134/249 (53%), Gaps = 20/249 (8%)
Query: 230 RGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLK-----QLNQEINLLSQLSH 281
           +G+FG V+L      S++ Q+ A+K ++        K  LK     +   E ++L +++H
Sbjct: 34  QGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVEVNH 85
Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P IV+ H +  ++ +L + L+++ GG +   L +   F E  ++ Y  ++ L L +LH+ 
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  NIL+D  G IKL DFG++K  +       SF G+  +MAPEVV N  G++
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHT 204
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            + D WS G  + EM T   P+   +    +  I  +K    +P+ LS +A+S ++   +
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRMLFK 262
Query: 461 RDPSARPPA 469
           R+P+ R  A
Sbjct: 263 RNPANRLGA 271

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 127/282 (45%), Gaps = 37/282 (13%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G++G V+   N ++GQ+ AIK+     DD   K   K   +EI +L QL HPN+V     
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK---KIALREIRMLKQLKHPNLVNLLEV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                RL +  EY     +H+L +      E ++++ T Q L  + + H  N +HRD+K 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130
Query: 351 ANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSLG 409
            NIL+  H  IKL DFG A+ +T  +     + +  W  +PE+++    Y   VD+W++G
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIG 190
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEH---------------------- 446
           C   E+ +  P W     V  ++ I  +  D+  IP H                      
Sbjct: 191 CVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL--IPRHQQVFSTNQYFSGVKIPDPEDME 248
Query: 447 --------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                   +S  A   +K CL  DP+ R    +LL HP+  +
Sbjct: 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 112/212 (52%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI +   L +P++V +HG    D+ + V LE     S+ +L +      EP  + 
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           + RQ + G+ YLH    +HRD+K  N+ ++   ++K+ DFG+A  +        +  G+P
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APEV+    G+S  VDIWSLGC +  +   KPP+          +I   K+   +P 
Sbjct: 207 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYSVPR 263
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A + I++ L  DP+ RP  ++LL   F
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAELLTDEF 295

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 134/249 (53%), Gaps = 20/249 (8%)
Query: 230 RGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLK-----QLNQEINLLSQLSH 281
           +G+FG V+L      S++ Q+ A+K ++        K  LK     +   E ++L +++H
Sbjct: 35  QGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVEVNH 86
Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P IV+ H +  ++ +L + L+++ GG +   L +   F E  ++ Y  ++ L L +LH+ 
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  NIL+D  G IKL DFG++K  +       SF G+  +MAPEVV N  G++
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHT 205
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            + D WS G  + EM T   P+   +    +  I  +K    +P+ LS +A+S ++   +
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRMLFK 263
Query: 461 RDPSARPPA 469
           R+P+ R  A
Sbjct: 264 RNPANRLGA 272

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 134/249 (53%), Gaps = 20/249 (8%)
Query: 230 RGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLK-----QLNQEINLLSQLSH 281
           +G+FG V+L      S++ Q+ A+K ++        K  LK     +   E ++L +++H
Sbjct: 34  QGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVEVNH 85
Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P IV+ H +  ++ +L + L+++ GG +   L +   F E  ++ Y  ++ L L +LH+ 
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  NIL+D  G IKL DFG++K  +       SF G+  +MAPEVV N  G++
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHT 204
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            + D WS G  + EM T   P+   +    +  I  +K    +P+ LS +A+S ++   +
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRMLFK 262
Query: 461 RDPSARPPA 469
           R+P+ R  A
Sbjct: 263 RNPANRLGA 271

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI +   L +P++V +HG    D+ + V LE     S+ +L +      EP  + 
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           + RQ + G+ YLH    +HRD+K  N+ ++   ++K+ DFG+A  +           G+P
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APEV+    G+S  VDIWSLGC +  +   KPP+          +I   K+   +P 
Sbjct: 191 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYSVPR 247
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A + I++ L  DP+ RP  ++LL   F
Sbjct: 248 HINPVASALIRRMLHADPTLRPSVAELLTDEF 279

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI +   L +P++V +HG    D+ + V LE     S+ +L +      EP  + 
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           + RQ + G+ YLH    +HRD+K  N+ ++   ++K+ DFG+A  +           G+P
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APEV+    G+S  VDIWSLGC +  +   KPP+          +I   K+   +P 
Sbjct: 207 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYSVPR 263
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A + I++ L  DP+ RP  ++LL   F
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 4/212 (1%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++++ EI +   L +P++V +HG    D+ + V LE     S+ +L +      EP  + 
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCASMLSFKGSP 385
           + RQ + G+ YLH    +HRD+K  N+ ++   ++K+ DFG+A  +           G+P
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            ++APEV+    G+S  VDIWSLGC +  +   KPP+          +I   K+   +P 
Sbjct: 207 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYSVPR 263
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
           H++  A + I++ L  DP+ RP  ++LL   F
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAELLTDEF 295

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 119/240 (49%), Gaps = 9/240 (3%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEV--RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG V L  +       A+K +  + +   +  K  + + N    LL  + HP +V  
Sbjct: 48  KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV---LLKNVKHPFLVGL 104
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           H S  + ++L   L+Y++GG +   LQ    F EP  + Y  +I   L YLH+ N V+RD
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDIW 406
           +K  NIL+D  G I L DFG+ K      S  S F G+P ++APE V++   Y  TVD W
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWW 223
Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
            LG  + EM    PP+           I N     ++  ++++ A+  ++  LQ+D + R
Sbjct: 224 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKR 281

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   +S+ G++ A+K +R+  +D+       +   EI+LL +L HPNIV     
Sbjct: 32  GTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIVSLIDV 87
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
             S+  L++  E++       L +      +  I+ Y  Q+L G+A+ H    +HRD+K 
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147
Query: 351 ANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSLG 409
            N+L++  G +KLADFG+A+         + +    W  AP+V+M +  YS +VDIWS+G
Sbjct: 148 QNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 410 CTVLEMATSKPPW------SQYEGVAAIFKIGNSKDIPEIPEH----------------- 446
           C   EM T KP +       Q   + +I    N ++ P++ E                  
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267
Query: 447 -----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                   +    +   L  DP+ R  A   ++HP+ +D
Sbjct: 268 SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS-HPNIVR 286
           RG++  V L    ++ ++ A+K V+  +V DD    E +  +  E ++  Q S HP +V 
Sbjct: 19  RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHPFLVG 74
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R  ++R
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+L+D  G IKL D+GM K         S F G+P ++APE++   + Y  +VD 
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDW 193
Query: 406 WSLGCTVLEMATSKPPWS--------QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           W+LG  + EM   + P+                +F++   K I  IP  LS  A S +K 
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKS 252
Query: 458 CLQRDPSARP---PASKLLD---HPFVRD 480
            L +DP  R    P +   D   HPF R+
Sbjct: 253 FLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   +S+ G++ A+K +R+  +D+       +   EI+LL +L HPNIV     
Sbjct: 32  GTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIVSLIDV 87
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
             S+  L++  E++       L +      +  I+ Y  Q+L G+A+ H    +HRD+K 
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147
Query: 351 ANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSLG 409
            N+L++  G +KLADFG+A+         + +    W  AP+V+M +  YS +VDIWS+G
Sbjct: 148 QNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 410 CTVLEMATSKPPW------SQYEGVAAIFKIGNSKDIPEIPEH----------------- 446
           C   EM T KP +       Q   + +I    N ++ P++ E                  
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267
Query: 447 -----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                   +    +   L  DP+ R  A   ++HP+ +D
Sbjct: 268 SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 134/269 (49%), Gaps = 24/269 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS-HPNIVR 286
           RG++  V L    ++ ++ A++ V+  +V DD    E +  +  E ++  Q S HP +V 
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R  ++R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+L+D  G IKL D+GM K  +    +  +F G+P ++APE++   + Y  +VD 
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDW 236
Query: 406 WSLGCTVLEMATSKPPWS--------QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           W+LG  + EM   + P+                +F++   K I  IP  LS  A S +K 
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKS 295
Query: 458 CLQRDPSARP---PASKLLD---HPFVRD 480
            L +DP  R    P +   D   HPF R+
Sbjct: 296 FLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS-HPNIVR 286
           RG++  V L    ++ ++ A+K V+  +V DD    E +  +  E ++  Q S HP +V 
Sbjct: 15  RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHPFLVG 70
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R  ++R
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 130
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+L+D  G IKL D+GM K         S F G+P ++APE++   + Y  +VD 
Sbjct: 131 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDW 189
Query: 406 WSLGCTVLEMATSKPPWS--------QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           W+LG  + EM   + P+                +F++   K I  IP  LS  A S +K 
Sbjct: 190 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKS 248
Query: 458 CLQRDPSARP---PASKLLD---HPFVRD 480
            L +DP  R    P +   D   HPF R+
Sbjct: 249 FLNKDPKERLGCHPQTGFADIQGHPFFRN 277

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 135/261 (51%), Gaps = 14/261 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG+F  VY G ++E+    A  E++   D + +K   ++  +E   L  L HPNIVR++ 
Sbjct: 36  RGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 290 SELSDER----LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--T 343
           S  S  +    + +  E  + G++   L+ +      V++++ RQIL GL +LH R    
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 344 VHRDIKGANILVD-PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           +HRD+K  NI +  P G +K+ D G+A  +   +   +  G+P + APE       Y  +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPE--XYEEKYDES 209
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD-DAKSFIKQCLQR 461
           VD+++ G   LE ATS+ P+S+ +  A I++   S   P   + ++  + K  I+ C+++
Sbjct: 210 VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269
Query: 462 DPSARPPASKLLDHPFVRDQA 482
           +   R     LL+H F +++ 
Sbjct: 270 NKDERYSIKDLLNHAFFQEET 290

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS-HPNIVR 286
           RG++  V L    ++ ++ A+K V+  +V DD    E +  +  E ++  Q S HP +V 
Sbjct: 30  RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHPFLVG 85
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R  ++R
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 145
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+L+D  G IKL D+GM K         S F G+P ++APE++   + Y  +VD 
Sbjct: 146 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDW 204
Query: 406 WSLGCTVLEMATSKPPWS--------QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           W+LG  + EM   + P+                +F++   K I  IP  +S  A S +K 
Sbjct: 205 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSMSVKAASVLKS 263
Query: 458 CLQRDPSAR---PPASKLLD---HPFVRD 480
            L +DP  R    P +   D   HPF R+
Sbjct: 264 FLNKDPKERLGCLPQTGFADIQGHPFFRN 292

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A+K   ++   Q +   L++L +E+ +   L+HPNIV+   
Sbjct: 24  KGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L +  EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F G+P + APE+          VD+WSLG
Sbjct: 141 AENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--------IPEHLSDDAKSFIKQCLQR 461
             +  + +   P          F   N K++ E        IP + S D ++ +K+ L  
Sbjct: 201 VILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLIL 250
Query: 462 DPSAR 466
           +PS R
Sbjct: 251 NPSKR 255

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 130/258 (50%), Gaps = 18/258 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K ++   +V  D+ +         E  +L    HP +  
Sbjct: 161 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-----TENRVLQNSRHPFLTA 215
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVH 345
              S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +N V+
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 346 RDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RD+K  N+++D  G IK+ DFG+ K  +   A+M +F G+P ++APE V+  N Y   VD
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 334
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
            W LG  + EM   + P+   +    +F++   ++I   P  L  +AKS +   L++DP 
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 392
Query: 465 AR-----PPASKLLDHPF 477
            R       A +++ H F
Sbjct: 393 QRLGGGSEDAKEIMQHRF 410

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 130/258 (50%), Gaps = 18/258 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K ++   +V  D+ +         E  +L    HP +  
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-----TENRVLQNSRHPFLTA 212
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVH 345
              S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +N V+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 346 RDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RD+K  N+++D  G IK+ DFG+ K  +   A+M +F G+P ++APE V+  N Y   VD
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
            W LG  + EM   + P+   +    +F++   ++I   P  L  +AKS +   L++DP 
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 389
Query: 465 AR-----PPASKLLDHPF 477
            R       A +++ H F
Sbjct: 390 QRLGGGSEDAKEIMQHRF 407

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  +  +    AIK +R      +S     +L +E+ +L  L HPNI++ +  
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN---SKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   + +E   GG +   +     FNE       +Q+L G+ YLH  N VHRD+K 
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164
Query: 351 ANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L++   +   IK+ DFG++    +   M    G+ Y++APEV+     Y    D+WS
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWS 222
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRDPSA 465
           +G  +  +    PP+        + K+   K   + PE  ++S+ AK  IKQ LQ D   
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQR 282
Query: 466 RPPASKLLDHPFVRDQAVARAGNVNL 491
           R  A + L+HP++++    +   + L
Sbjct: 283 RISAQQALEHPWIKEMCSKKESGIEL 308

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 144/264 (54%), Gaps = 22/264 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEI--NLLSQLSHP 282
           RG FG VY    +++G+M A+K     C D+   + +KQ     LN+ I  +L+S    P
Sbjct: 198 RGGFGEVYGCRKADTGKMYAMK-----CLDKKRIK-MKQGETLALNERIMLSLVSTGDCP 251
Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL ++H R 
Sbjct: 252 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 311
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
            V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+     Y  +
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSS 370
Query: 403 VDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            D +SLGC + ++     P+ Q+  +    I ++  +  + E+P+  S + +S ++  LQ
Sbjct: 371 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQ 429
Query: 461 RDPSAR-----PPASKLLDHPFVR 479
           RD + R       A ++ + PF R
Sbjct: 430 RDVNRRLGCLGRGAQEVKESPFFR 453

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 144/264 (54%), Gaps = 22/264 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEI--NLLSQLSHP 282
           RG FG VY    +++G+M A+K     C D+   + +KQ     LN+ I  +L+S    P
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMK-----CLDKKRIK-MKQGETLALNERIMLSLVSTGDCP 252
Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL ++H R 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
            V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+     Y  +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSS 371
Query: 403 VDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            D +SLGC + ++     P+ Q+  +    I ++  +  + E+P+  S + +S ++  LQ
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQ 430
Query: 461 RDPSAR-----PPASKLLDHPFVR 479
           RD + R       A ++ + PF R
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 137/255 (53%), Gaps = 45/255 (17%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 171
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 172 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 230
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-------------SQYEGVA---- 429
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P               Q EG A    
Sbjct: 231 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 289
Query: 430 ---------------------AIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQRDPS 464
                                AIF++ +   ++  P++P  + S + + F+ +CL ++P+
Sbjct: 290 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPA 349
Query: 465 ARPPASKLLDHPFVR 479
            R    +L+ H F++
Sbjct: 350 ERADLKQLMVHAFIK 364

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 144/264 (54%), Gaps = 22/264 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEI--NLLSQLSHP 282
           RG FG VY    +++G+M A+K     C D+   + +KQ     LN+ I  +L+S    P
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMK-----CLDKKRIK-MKQGETLALNERIMLSLVSTGDCP 252
Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL ++H R 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
            V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+     Y  +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSS 371
Query: 403 VDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            D +SLGC + ++     P+ Q+  +    I ++  +  + E+P+  S + +S ++  LQ
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQ 430
Query: 461 RDPSAR-----PPASKLLDHPFVR 479
           RD + R       A ++ + PF R
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 144/264 (54%), Gaps = 22/264 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEI--NLLSQLSHP 282
           RG FG VY    +++G+M A+K     C D+   + +KQ     LN+ I  +L+S    P
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMK-----CLDKKRIK-MKQGETLALNERIMLSLVSTGDCP 252
Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL ++H R 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
            V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+     Y  +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSS 371
Query: 403 VDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            D +SLGC + ++     P+ Q+  +    I ++  +  + E+P+  S + +S ++  LQ
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQ 430
Query: 461 RDPSAR-----PPASKLLDHPFVR 479
           RD + R       A ++ + PF R
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 129/258 (50%), Gaps = 18/258 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K ++   +V  D+ +         E  +L    HP +  
Sbjct: 18  KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-----TENRVLQNSRHPFLTA 72
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVH 345
              S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +N V+
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 346 RDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RD+K  N+++D  G IK+ DFG+ K  +   A+M  F G+P ++APE V+  N Y   VD
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVD 191
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
            W LG  + EM   + P+   +    +F++   ++I   P  L  +AKS +   L++DP 
Sbjct: 192 WWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 249
Query: 465 AR-----PPASKLLDHPF 477
            R       A +++ H F
Sbjct: 250 QRLGGGSEDAKEIMQHRF 267

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 129/258 (50%), Gaps = 18/258 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K ++   +V  D+ +         E  +L    HP +  
Sbjct: 20  KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-----TENRVLQNSRHPFLTA 74
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVH 345
              S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +N V+
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 346 RDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RD+K  N+++D  G IK+ DFG+ K  +   A+M  F G+P ++APE V+  N Y   VD
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVD 193
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
            W LG  + EM   + P+   +    +F++   ++I   P  L  +AKS +   L++DP 
Sbjct: 194 WWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 251
Query: 465 AR-----PPASKLLDHPF 477
            R       A +++ H F
Sbjct: 252 QRLGGGSEDAKEIMQHRF 269

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 129/258 (50%), Gaps = 18/258 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +GTFG V L     +G+  A+K ++   +V  D+ +         E  +L    HP +  
Sbjct: 19  KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-----TENRVLQNSRHPFLTA 73
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVH 345
              S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +N V+
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 346 RDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RD+K  N+++D  G IK+ DFG+ K  +   A+M  F G+P ++APE V+  N Y   VD
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVD 192
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
            W LG  + EM   + P+   +    +F++   ++I   P  L  +AKS +   L++DP 
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 250
Query: 465 AR-----PPASKLLDHPF 477
            R       A +++ H F
Sbjct: 251 QRLGGGSEDAKEIMQHRF 268

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 69  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 119
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 179 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 238
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 239 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 273

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 67  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 117
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 177 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 236
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 237 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 271

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 115
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 137/255 (53%), Gaps = 45/255 (17%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 136
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 195
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-------------SQYEGVA---- 429
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P               Q EG A    
Sbjct: 196 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 430 ---------------------AIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQRDPS 464
                                AIF++ +   ++  P++P  + S + + F+ +CL ++P+
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 314
Query: 465 ARPPASKLLDHPFVR 479
            R    +L+ H F++
Sbjct: 315 ERADLKQLMVHAFIK 329

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 125/257 (48%), Gaps = 19/257 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY  F    G   A+K  R   D+  S + ++ + QE  L + L HPNI+   G 
Sbjct: 18  GGFGKVYRAF--WIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEP-VIQTYTRQILLGLAYLHARNTV---HR 346
            L +  L + +E+  GG ++++L   G    P ++  +  QI  G+ YLH    V   HR
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 347 DIKGANILVDPHGE--------IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNG 398
           D+K +NIL+    E        +K+ DFG+A+       M S  G+  WMAPEV+   + 
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVI-RASM 190
Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           +S   D+WS G  + E+ T + P+   +G+A  + +  +K    IP    +     ++ C
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDC 250
Query: 459 LQRDPSARPPASKLLDH 475
              DP +RP  + +LD 
Sbjct: 251 WNPDPHSRPSFTNILDQ 267

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 110 GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 160
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 220 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 279
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 280 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 314

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 59  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 109
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 228
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 229 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 263

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 137/255 (53%), Gaps = 45/255 (17%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 168
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-------------SQYEGVA---- 429
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P               Q EG A    
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 430 ---------------------AIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQRDPS 464
                                AIF++ +   ++  P++P  + S + + F+ +CL ++P+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 465 ARPPASKLLDHPFVR 479
            R    +L+ H F++
Sbjct: 288 ERADLKQLMVHAFIK 302

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 137/255 (53%), Gaps = 45/255 (17%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 168
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-------------SQYEGVA---- 429
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P               Q EG A    
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 430 ---------------------AIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQRDPS 464
                                AIF++ +   ++  P++P  + S + + F+ +CL ++P+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 465 ARPPASKLLDHPFVR 479
            R    +L+ H F++
Sbjct: 288 ERADLKQLMVHAFIK 302

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 137/255 (53%), Gaps = 45/255 (17%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 168
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-------------SQYEGVA---- 429
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P               Q EG A    
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 430 ---------------------AIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQRDPS 464
                                AIF++ +   ++  P++P  + S + + F+ +CL ++P+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 465 ARPPASKLLDHPFVR 479
            R    +L+ H F++
Sbjct: 288 ERADLKQLMVHAFIK 302

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 137/255 (53%), Gaps = 45/255 (17%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  ++ GL YL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 168
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-------------SQYEGVA---- 429
           +M+PE +  T+ YS+  DIWS+G +++EMA  + P               Q EG A    
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 430 ---------------------AIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQRDPS 464
                                AIF++ +   ++  P++P  + S + + F+ +CL ++P+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 465 ARPPASKLLDHPFVR 479
            R    +L+ H F++
Sbjct: 288 ERADLKQLMVHAFIK 302

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 36  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 86
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 205
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 206 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 240

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 22/285 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG +G V    +  SGQ+ A+K +R   D++  K+ L  L+    ++     P IV+++G
Sbjct: 32  RGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQFYG 88
Query: 290 SELSDERLSVYLEYVSGG------SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-N 342
           +   +    + +E +S         ++ +L +  P  E ++   T   +  L +L     
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP--EEILGKITLATVKALNHLKENLK 146
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTNGY 399
            +HRDIK +NIL+D  G IKL DFG++  +    +     G   +MAPE +    +  GY
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI----PEHLSDDAKSFI 455
            +  D+WSLG T+ E+AT + P+ ++  V          D P++        S    +F+
Sbjct: 207 DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFV 266
Query: 456 KQCLQRDPSARPPASKLLDHPFV---RDQAVARAGNVNLAKDSSP 497
             CL +D S RP   +LL HPF+    ++AV  A  V    D  P
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMP 311

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 131/256 (51%), Gaps = 11/256 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG +G V    +  SGQ+ A+K +R   + Q  K  L  L+     +  +  P  V ++G
Sbjct: 61  RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTFYG 117
Query: 290 SELSDERLSVYLEYV--SGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHAR-NTVH 345
           +   +  + + +E +  S    +K + + G    E ++      I+  L +LH++ + +H
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 177
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTNGYSLT 402
           RD+K +N+L++  G++K+ DFG++ ++    +     G   +MAPE +   +N  GYS+ 
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVK 237
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQR 461
            DIWSLG T++E+A  + P+  +       K    +  P++P +  S +   F  QCL++
Sbjct: 238 SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 297
Query: 462 DPSARPPASKLLDHPF 477
           +   RP   +L+ HPF
Sbjct: 298 NSKERPTYPELMQHPF 313

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 44  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 94
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 213
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 214 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 248

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 122/251 (48%), Gaps = 8/251 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQT--SKECLKQLNQEINLLSQLSHPNIVRYH 288
           GTFG V +G +  +G   A+K    + + Q   S + + ++ +EI  L    HP+I++ +
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVK----ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
               +     + +EYVSGG +   + ++G   E   +   +QIL  + Y H    VHRD+
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+D H   K+ADFG++  M+    + +  GSP + APEV+         VDIWS 
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G  +  +     P+   E V  +FK      +  IPE+L+    + +   LQ DP  R  
Sbjct: 198 GVILYALLCGTLPFDD-EHVPTLFK-KIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRAT 255
Query: 469 ASKLLDHPFVR 479
              + +H + +
Sbjct: 256 IKDIREHEWFK 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 123/251 (49%), Gaps = 8/251 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQT--SKECLKQLNQEINLLSQLSHPNIVRYH 288
           GTFG V +G +  +G   A+K    + + Q   S + + ++ +EI  L    HP+I++ +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVK----ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
               +   + + +EYVSGG +   + + G  +E   +   +QIL G+ Y H    VHRD+
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+D H   K+ADFG++  M+    +    GSP + APEV+         VDIWS 
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G  +  +     P+   + V  +FK      I   P++L+    S +K  LQ DP  R  
Sbjct: 203 GVILYALLCGTLPFDD-DHVPTLFK-KICDGIFYTPQYLNPSVISLLKHMLQVDPMKRAT 260
Query: 469 ASKLLDHPFVR 479
              + +H + +
Sbjct: 261 IKDIREHEWFK 271

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 136/263 (51%), Gaps = 49/263 (18%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           Q+ +E+ +L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L+E     E ++   
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 119
Query: 328 TRQILLGLAYLHARNTV-HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +  +L GLAYL  ++ + HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  
Sbjct: 120 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRS 178
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSK-----PPWSQYEGV------------- 428
           +MAPE +  T+ YS+  DIWS+G +++E+A  +     P   + E +             
Sbjct: 179 YMAPERLQGTH-YSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEP 237
Query: 429 ------------------------AAIFKIGN---SKDIPEIPEHL-SDDAKSFIKQCLQ 460
                                    AIF++ +   ++  P++P  + + D + F+ +CL 
Sbjct: 238 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 297
Query: 461 RDPSARPPASKLLDHPFVRDQAV 483
           ++P+ R     L +H F++   V
Sbjct: 298 KNPAERADLKMLTNHTFIKRSEV 320

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 121/248 (48%), Gaps = 18/248 (7%)
Query: 265 CLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVI 324
           C +++ +E+++L Q+ HPNI+  H    +   + + LE VSGG +   L +    +E   
Sbjct: 58  CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 325 QTYTRQILLGLAYLHARNTVHRDIKGANI-LVD-----PHGEIKLADFGMAKHMTSCASM 378
            ++ +QIL G+ YLH +   H D+K  NI L+D     PH  IKL DFG+A  +      
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH--IKLIDFGLAHEIEDGVEF 175
Query: 379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIG 435
            +  G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A I  + 
Sbjct: 176 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234
Query: 436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV-----RDQAVARAGNVN 490
              D  E     S+ AK FI++ L ++   R    + L HP++     +   V R   VN
Sbjct: 235 YDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVN 293
Query: 491 LAKDSSPY 498
           L      Y
Sbjct: 294 LENFKKQY 301

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 115
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 234
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 101/193 (52%), Gaps = 3/193 (1%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V L  +  +G+  A+K   ++   Q +   L++L +E+ ++  L+HPNIV+   
Sbjct: 25  KGNFAKVKLARHVLTGREVAVK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              +++ L + +EY SGG +   L  +G   E   +   RQI+  + Y H +  VHRD+K
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLK 141
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D    IK+ADFG +   T    + +F GSP + APE+          VD+WSLG
Sbjct: 142 AENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 410 CTVLEMATSKPPW 422
             +  + +   P+
Sbjct: 202 VILYTLVSGSLPF 214

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 132/254 (51%), Gaps = 14/254 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYH 288
           +G FG+VYL    +S  + A+K   V+   Q  KE ++ QL +EI + + L HPNI+R +
Sbjct: 33  KGKFGNVYLAREKKSHFIVALK---VLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLY 89
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                  R+ + LEY   G ++K LQ+   F+E    T   ++   L Y H +  +HRDI
Sbjct: 90  NYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+   GE+K+ADFG + H  S     +  G+  ++ PE++     ++  VD+W +
Sbjct: 150 KPENLLLGLKGELKIADFGWSVHAPSLRRK-TMCGTLDYLPPEMI-EGRMHNEKVDLWCI 207
Query: 409 GCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           G    E+    PP+   S  E    I K+    D+ + P  +   A+  I + L+ +PS 
Sbjct: 208 GVLCYELLVGNPPFESASHNETYRRIVKV----DL-KFPASVPTGAQDLISKLLRHNPSE 262
Query: 466 RPPASKLLDHPFVR 479
           R P +++  HP+VR
Sbjct: 263 RLPLAQVSAHPWVR 276

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 121/251 (48%), Gaps = 8/251 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQT--SKECLKQLNQEINLLSQLSHPNIVRYH 288
           GTFG V +G +  +G   A+K    + + Q   S + + ++ +EI  L    HP+I++ +
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVK----ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
               +     + +EYVSGG +   + ++G   E   +   +QIL  + Y H    VHRD+
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K  N+L+D H   K+ADFG++  M+    +    GSP + APEV+         VDIWS 
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G  +  +     P+   E V  +FK      +  IPE+L+    + +   LQ DP  R  
Sbjct: 198 GVILYALLCGTLPFDD-EHVPTLFK-KIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRAT 255
Query: 469 ASKLLDHPFVR 479
              + +H + +
Sbjct: 256 IKDIREHEWFK 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 130/257 (50%), Gaps = 14/257 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V    +  + Q  A+K   V+       +    + +E+ LL +L HPNI++   
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNIMKLF- 87
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            E+ ++  S Y+  E  +GG +   + +   F+E       +Q+  G+ Y+H  N VHRD
Sbjct: 88  -EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 348 IKGANILVDPHG---EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           +K  NIL++      +IK+ DFG++        M    G+ Y++APEV+  T  Y    D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRD 462
           +WS G  +  + +  PP+        + ++   K   ++P+   +SDDAK  I++ L   
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 463 PSARPPASKLLDHPFVR 479
           PS R  A++ L+HP+++
Sbjct: 265 PSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 130/257 (50%), Gaps = 14/257 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V    +  + Q  A+K   V+       +    + +E+ LL +L HPNI++   
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNIMKLF- 87
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            E+ ++  S Y+  E  +GG +   + +   F+E       +Q+  G+ Y+H  N VHRD
Sbjct: 88  -EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 348 IKGANILVDPHG---EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           +K  NIL++      +IK+ DFG++        M    G+ Y++APEV+  T  Y    D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRD 462
           +WS G  +  + +  PP+        + ++   K   ++P+   +SDDAK  I++ L   
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 463 PSARPPASKLLDHPFVR 479
           PS R  A++ L+HP+++
Sbjct: 265 PSLRITATQCLEHPWIQ 281

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 39  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 89
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 208
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 209 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 243

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 130/257 (50%), Gaps = 14/257 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G+FG V    +  + Q  A+K   V+       +    + +E+ LL +L HPNI++   
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNIMKLF- 87
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            E+ ++  S Y+  E  +GG +   + +   F+E       +Q+  G+ Y+H  N VHRD
Sbjct: 88  -EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 348 IKGANILVDPHG---EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           +K  NIL++      +IK+ DFG++        M    G+ Y++APEV+  T  Y    D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRD 462
           +WS G  +  + +  PP+        + ++   K   ++P+   +SDDAK  I++ L   
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 463 PSARPPASKLLDHPFVR 479
           PS R  A++ L+HP+++
Sbjct: 265 PSLRITATQCLEHPWIQ 281

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 50  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 100
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 219
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 220 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 254

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 43  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 93
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 212
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 213 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 43  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 93
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 212
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 213 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 116/220 (52%), Gaps = 9/220 (4%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+N+L ++ HPNI+  H    +   + + LE VSGG +   L E     E     
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFK 382
           + +QIL G+ YLH++   H D+K  NI L+D   P+  IKL DFG+A  + +     +  
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKD 439
           G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +  I  +    D
Sbjct: 173 GTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             E   + S+ AK FI++ L +DP  R   ++ L+H +++
Sbjct: 232 -EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 126/256 (49%), Gaps = 15/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  +  +G   AIK ++      TS      L  E+ +L QL HPNI++ +  
Sbjct: 32  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNS--GALLDEVAVLKQLDHPNIMKLY-- 87
Query: 291 ELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           E  +++ + YL  E   GG +   +     F+E       +Q+L G  YLH  N VHRD+
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDL 147
Query: 349 KGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  N+L++       IK+ DFG++ H      M    G+ Y++APEV+     Y    D+
Sbjct: 148 KPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDV 205
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS G  +  +    PP+   +  E +  + K   S D P+  + +SD+AK  +K  L  +
Sbjct: 206 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ-VSDEAKQLVKLMLTYE 264
Query: 463 PSARPPASKLLDHPFV 478
           PS R  A + L+HP++
Sbjct: 265 PSKRISAEEALNHPWI 280

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 18/265 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    N E+GQ  A+K V V     +     + L +E ++   L HP+IV    
Sbjct: 34  KGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93
Query: 290 SELSDERLSVYLEYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  SD  L +  E++ G      I K       ++E V   Y RQIL  L Y H  N +H
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153
Query: 346 RDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSL 401
           RD+K  N+L+   +    +KL DFG+A  +     +   + G+P++MAPEVV     Y  
Sbjct: 154 RDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV-KREPYGK 212
Query: 402 TVDIWSLGCTVLEMATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
            VD+W  G  +  + +   P+       +EG+      G  K  P    H+S+ AK  ++
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----GKYKMNPRQWSHISESAKDLVR 268
Query: 457 QCLQRDPSARPPASKLLDHPFVRDQ 481
           + L  DP+ R    + L+HP+++++
Sbjct: 269 RMLMLDPAERITVYEALNHPWLKER 293

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 116/220 (52%), Gaps = 9/220 (4%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+N+L ++ HPNI+  H    +   + + LE VSGG +   L E     E     
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFK 382
           + +QIL G+ YLH++   H D+K  NI L+D   P+  IKL DFG+A  + +     +  
Sbjct: 134 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 193
Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKD 439
           G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +  I  +    D
Sbjct: 194 GTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 252
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             E   + S+ AK FI++ L +DP  R   ++ L+H +++
Sbjct: 253 -EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 127/260 (48%), Gaps = 13/260 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ----EINLLSQLS-HPNI 284
           RG    V    +  +G   A+K + V  + + S E L+++ +    E ++L Q++ HP+I
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAE-RLSPEQLEEVREATRRETHILRQVAGHPHI 162
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           +    S  S   + +  + +  G +   L E    +E   ++  R +L  +++LHA N V
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTN--GY 399
           HRD+K  NIL+D + +I+L+DFG + H+     +    G+P ++APE++   M+    GY
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQ 457
              VD+W+ G  +  +    PP+     +  +  I   +     PE    S   K  I +
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISR 342
Query: 458 CLQRDPSARPPASKLLDHPF 477
            LQ DP AR  A + L HPF
Sbjct: 343 LLQVDPEARLTAEQALQHPF 362

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 32  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 82
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 201
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 202 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 236

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 35  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 85
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 204
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 205 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 116/220 (52%), Gaps = 9/220 (4%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+N+L ++ HPNI+  H    +   + + LE VSGG +   L E     E     
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFK 382
           + +QIL G+ YLH++   H D+K  NI L+D   P+  IKL DFG+A  + +     +  
Sbjct: 120 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 179
Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKD 439
           G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +  I  +    D
Sbjct: 180 GTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 238
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             E   + S+ AK FI++ L +DP  R   ++ L+H +++
Sbjct: 239 -EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 131/261 (50%), Gaps = 17/261 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G+FG V L    E+G + A+K ++   ++ DD    EC     + ++L    +HP + +
Sbjct: 33  KGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV--ECTMTEKRILSLAR--NHPFLTQ 88
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 + +RL   +E+V+GG +   +Q+   F+E   + Y  +I+  L +LH +  ++R
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+L+D  G  KLADFGM K  + +  +  +F G+P ++APE++     Y   VD 
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDW 207
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W++G  + EM     P+           I N + +   P  L +DA   +K  + ++P+ 
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTM 265
Query: 466 RPPA------SKLLDHPFVRD 480
           R  +        +L HPF ++
Sbjct: 266 RLGSLTQGGEHAILRHPFFKE 286

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V          +  K  N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV-------LQGKAFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V          +  K  N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV-------LQGKAFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S+  S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 126/256 (49%), Gaps = 15/256 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  +  +G   AIK ++      TS      L  E+ +L QL HPNI++ +  
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNS--GALLDEVAVLKQLDHPNIMKLY-- 70
Query: 291 ELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           E  +++ + YL  E   GG +   +     F+E       +Q+L G  YLH  N VHRD+
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDL 130
Query: 349 KGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  N+L++       IK+ DFG++ H      M    G+ Y++APEV+     Y    D+
Sbjct: 131 KPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK--YDEKCDV 188
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS G  +  +    PP+   +  E +  + K   S D P+  + +SD+AK  +K  L  +
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ-VSDEAKQLVKLMLTYE 247
Query: 463 PSARPPASKLLDHPFV 478
           PS R  A + L+HP++
Sbjct: 248 PSKRISAEEALNHPWI 263

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 127/244 (52%), Gaps = 7/244 (2%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYHG 289
           G+FG V L +++ +GQ  A+K   ++     +K  ++ ++ +EI+ L  L HP+I++ + 
Sbjct: 24  GSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              S + + + +EY +G  +   + +    +E   + + +QI+  + Y H    VHRD+K
Sbjct: 81  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 139
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D H  +K+ADFG++  MT    + +  GSP + APEV+         VD+WS G
Sbjct: 140 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 199
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
             +  M   + P+   E +  +FK   S  +  +P+ LS  A   IK+ L  +P  R   
Sbjct: 200 VILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISI 257
Query: 470 SKLL 473
            +++
Sbjct: 258 HEIM 261

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 127/244 (52%), Gaps = 7/244 (2%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYHG 289
           G+FG V L +++ +GQ  A+K   ++     +K  ++ ++ +EI+ L  L HP+I++ + 
Sbjct: 15  GSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              S + + + +EY +G  +   + +    +E   + + +QI+  + Y H    VHRD+K
Sbjct: 72  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 130
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D H  +K+ADFG++  MT    + +  GSP + APEV+         VD+WS G
Sbjct: 131 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 190
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
             +  M   + P+   E +  +FK   S  +  +P+ LS  A   IK+ L  +P  R   
Sbjct: 191 VILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISI 248
Query: 470 SKLL 473
            +++
Sbjct: 249 HEIM 252

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 127/244 (52%), Gaps = 7/244 (2%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYHG 289
           G+FG V L +++ +GQ  A+K   ++     +K  ++ ++ +EI+ L  L HP+I++ + 
Sbjct: 19  GSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              S + + + +EY +G  +   + +    +E   + + +QI+  + Y H    VHRD+K
Sbjct: 76  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 134
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D H  +K+ADFG++  MT    + +  GSP + APEV+         VD+WS G
Sbjct: 135 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 194
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
             +  M   + P+   E +  +FK   S  +  +P+ LS  A   IK+ L  +P  R   
Sbjct: 195 VILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISI 252
Query: 470 SKLL 473
            +++
Sbjct: 253 HEIM 256

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 127/244 (52%), Gaps = 7/244 (2%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYHG 289
           G+FG V L +++ +GQ  A+K   ++     +K  ++ ++ +EI+ L  L HP+I++ + 
Sbjct: 25  GSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              S + + + +EY +G  +   + +    +E   + + +QI+  + Y H    VHRD+K
Sbjct: 82  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 140
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG 409
             N+L+D H  +K+ADFG++  MT    + +  GSP + APEV+         VD+WS G
Sbjct: 141 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 200
Query: 410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
             +  M   + P+   E +  +FK   S  +  +P+ LS  A   IK+ L  +P  R   
Sbjct: 201 VILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISI 258
Query: 470 SKLL 473
            +++
Sbjct: 259 HEIM 262

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 113/209 (54%), Gaps = 10/209 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+  VY G +  +  + A+KE+R+  ++      ++    E++LL  L H NIV  H  
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTLHDI 68
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +++ L++  EY+    + + L + G   N   ++ +  Q+L GLAY H +  +HRD+K
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA-PEVVMNTNGYSLTVDIWSL 408
             N+L++  GE+KLADFG+A+  +        +    W   P++++ +  YS  +D+W +
Sbjct: 128 PQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV 187
Query: 409 GCTVLEMATSKPPW---SQYEGVAAIFKI 434
           GC   EMAT +P +   +  E +  IF+I
Sbjct: 188 GCIFYEMATGRPLFPGSTVEEQLHFIFRI 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 26/204 (12%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG      + E+G++  +KE+ +  D++T +  LK    E+ ++  L HPN++++ G
Sbjct: 20  KGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLK----EVKVMRCLEHPNVLKFIG 74
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHR 346
               D+RL+   EY+ GG++  +++      P+++ V  ++ + I  G+AYLH+ N +HR
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV--SFAKDIASGMAYLHSMNIIHR 132
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFK-----------GSPYWMAPE 391
           D+   N LV  +  + +ADFG+A+ M    T    + S K           G+PYWMAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 392 VVMNTNGYSLTVDIWSLGCTVLEM 415
           ++ N   Y   VD++S G  + E+
Sbjct: 193 MI-NGRSYDEKVDVFSFGIVLCEI 215

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V          +  K  N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV-------LQGKAFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  DE  L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 131/256 (51%), Gaps = 11/256 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG +G V    +  SGQ+ A+K +R   + Q  K  L  L+     +  +  P  V ++G
Sbjct: 17  RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTFYG 73
Query: 290 SELSDERLSVYLEYV--SGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHAR-NTVH 345
           +   +  + + +E +  S    +K + + G    E ++      I+  L +LH++ + +H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTNGYSLT 402
           RD+K +N+L++  G++K+ DFG++ ++    +     G   +MAPE +   +N  GYS+ 
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVK 193
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQR 461
            DIWSLG T++E+A  + P+  +       K    +  P++P +  S +   F  QCL++
Sbjct: 194 SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 253
Query: 462 DPSARPPASKLLDHPF 477
           +   RP   +L+ HPF
Sbjct: 254 NSKERPTYPELMQHPF 269

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 135/294 (45%), Gaps = 49/294 (16%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG V+     ES ++ AIK+V     D+  K      N+E+ ++  + HPN+V     
Sbjct: 51  GSFGVVFQAKLVESDEV-AIKKV---LQDKRFK------NRELQIMRIVKHPNVVDLKAF 100
Query: 287 -YHGSELSDER-LSVYLEYVSGGSIHKLLQEYGPFNEP----VIQTYTRQILLGLAYLHA 340
            Y   +  DE  L++ LEYV   ++++  + Y    +     +I+ Y  Q+L  LAY+H+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 341 RNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP  G +KL DFG AK + +    +S   S Y+ APE++     Y
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNY 219
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN------------------SKDIP 441
           +  +DIWS GC + E+   +P +    G+  + +I                        P
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP 279
Query: 442 EIPEH---------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARA 486
           +I  H            DA   I + L+  PSAR  A + L HPF  +     A
Sbjct: 280 QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK----QLNQEINLLSQLSHPNIVR 286
           G F  V L  +  + ++ AIK     C    +KE L+     +  EI +L ++ HPNIV 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIK-----C---IAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 S   L + ++ VSGG +   + E G + E        Q+L  + YLH    VHR
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 347 DIKGANIL---VDPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSLT 402
           D+K  N+L   +D   +I ++DFG++K M    S+LS   G+P ++APE V+    YS  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKA 198
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQ 460
           VD WS+G     +    PP+          +I  ++   + P  + +SD AK FI+  ++
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 258
Query: 461 RDPSARPPASKLLDHPFVRDQAVARAGNVNLAKD 494
           +DP  R    + L HP++       AG+  L K+
Sbjct: 259 KDPEKRFTCEQALQHPWI-------AGDTALDKN 285

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 20/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK----QLNQEINLLSQLSHPNIVR 286
           G F  V L     +G++ A+K     C     K+ LK     +  EI +L ++ H NIV 
Sbjct: 33  GAFSEVVLAEEKATGKLFAVK-----C---IPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 S   L + ++ VSGG +   + E G + E    T  RQ+L  + YLH    VHR
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHR 144
Query: 347 DIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  N+L    D   +I ++DFG++K       M +  G+P ++APE V+    YS  V
Sbjct: 145 DLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAV 203
Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
           D WS+G     +    PP+   +  +    I K     D P   + +SD AK FI+  ++
Sbjct: 204 DCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP-YWDDISDSAKDFIRNLME 262
Query: 461 RDPSARPPASKLLDHPFV 478
           +DP+ R    +   HP++
Sbjct: 263 KDPNKRYTCEQAARHPWI 280

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 126/258 (48%), Gaps = 20/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK----QLNQEINLLSQLSHPNIVR 286
           G F  V L  +  + ++ AIK     C    +KE L+     +  EI +L ++ HPNIV 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIK-----C---IAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 S   L + ++ VSGG +   + E G + E        Q+L  + YLH    VHR
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 347 DIKGANIL---VDPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSLT 402
           D+K  N+L   +D   +I ++DFG++K M    S+LS   G+P ++APE V+    YS  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKA 198
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQ 460
           VD WS+G     +    PP+          +I  ++   + P  + +SD AK FI+  ++
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 258
Query: 461 RDPSARPPASKLLDHPFV 478
           +DP  R    + L HP++
Sbjct: 259 KDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 126/258 (48%), Gaps = 20/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK----QLNQEINLLSQLSHPNIVR 286
           G F  V L  +  + ++ AIK     C    +KE L+     +  EI +L ++ HPNIV 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIK-----C---IAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 S   L + ++ VSGG +   + E G + E        Q+L  + YLH    VHR
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 347 DIKGANIL---VDPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSLT 402
           D+K  N+L   +D   +I ++DFG++K M    S+LS   G+P ++APE V+    YS  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKA 198
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQ 460
           VD WS+G     +    PP+          +I  ++   + P  + +SD AK FI+  ++
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 258
Query: 461 RDPSARPPASKLLDHPFV 478
           +DP  R    + L HP++
Sbjct: 259 KDPEKRFTCEQALQHPWI 276

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 25/268 (9%)
Query: 231 GTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           G +G V+L       ++G++ A+K ++     Q +K   +    E  +L  +   P +V 
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIRQSPFLVT 123
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H +  ++ +L + L+Y++GG +   L +   F E  +Q Y  +I+L L +LH    ++R
Sbjct: 124 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTS--CASMLSFKGSPYWMAPEVVMNTN-GYSLTV 403
           DIK  NIL+D +G + L DFG++K   +        F G+  +MAP++V   + G+   V
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 404 DIWSLGCTVLEMATSKPPW-------SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           D WSLG  + E+ T   P+       SQ E    I      K  P  P+ +S  AK  I+
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-----KSEPPYPQEMSALAKDLIQ 298
Query: 457 QCLQRDPSAR-----PPASKLLDHPFVR 479
           + L +DP  R       A ++ +H F +
Sbjct: 299 RLLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 132/259 (50%), Gaps = 16/259 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G+FG V L     + ++ A+K ++   V+ DD    EC     + + L  +   P + +
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMVEKRVLALPGK--PPFLTQ 406
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +L ++  ++R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 347 DIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+++D  G IK+ADFGM K ++    +   F G+P ++APE++     Y  +VD 
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDW 525
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W+ G  + EM   + P+ + E    +F+     ++   P+ +S +A +  K  + + P  
Sbjct: 526 WAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMTKHPGK 583
Query: 466 R----PPASK-LLDHPFVR 479
           R    P   + + +H F R
Sbjct: 584 RLGCGPEGERDIKEHAFFR 602

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 21/215 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR    
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV---LQDKRFK------NRELQIMRKLDHCNIVRLRYF 81
Query: 287 -YHGSELSDE-RLSVYLEYVSGGSIHKLLQEYGPFNE--PVI--QTYTRQILLGLAYLHA 340
            Y   E  D   L++ L+YV   +++++ + Y    +  PVI  + Y  Q+   LAY+H+
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 341 RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               HRDIK  N+L+DP   + KL DFG AK +      +S   S Y+ APE++     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
           + ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 120/246 (48%), Gaps = 18/246 (7%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+++L Q+ H N++  H    +   + + LE VSGG +   L +    +E    +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD-----PHGEIKLADFGMAKHMTSCASMLS 380
           + +QIL G+ YLH +   H D+K  NI L+D     PH  IKL DFG+A  +       +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH--IKLIDFGLAHEIEDGVEFKN 177
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS 437
             G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A I  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV-----RDQAVARAGNVNLA 492
            D  E   H S+ AK FI++ L ++   R    + L HP++     +   V R   VNL 
Sbjct: 237 FD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
Query: 493 KDSSPY 498
                Y
Sbjct: 296 NFRKQY 301

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 18/246 (7%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+++L Q+ H N++  H    +   + + LE VSGG +   L +    +E    +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILV------DPHGEIKLADFGMAKHMTSCASMLS 380
           + +QIL G+ YLH +   H D+K  NI++       PH  IKL DFG+A  +       +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH--IKLIDFGLAHEIEDGVEFKN 177
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS 437
             G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A I  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV-----RDQAVARAGNVNLA 492
            D  E   H S+ AK FI++ L ++   R    + L HP++     +   V R   VNL 
Sbjct: 237 FD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
Query: 493 KDSSPY 498
                Y
Sbjct: 296 NFRKQY 301

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 98
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A   SF G+  +++PE++   +  S + D+
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-SKSSDL 217
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 272
Query: 463 PSAR 466
            + R
Sbjct: 273 ATKR 276

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK----QLNQEINLLSQLSHPNIVR 286
           G F  V L  +  + ++ AIK +        +K+ L+     +  EI +L ++ HPNIV 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIKCI--------AKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 S   L + ++ VSGG +   + E G + E        Q+L  + YLH    VHR
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 347 DIKGANIL---VDPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSLT 402
           D+K  N+L   +D   +I ++DFG++K M    S+LS   G+P ++APE V+    YS  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKA 198
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQ 460
           VD WS+G     +    PP+          +I  ++   + P  + +SD AK FI+  ++
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 258
Query: 461 RDPSARPPASKLLDHPFVRDQAVARAGNVNLAKD 494
           +DP  R    + L HP++       AG+  L K+
Sbjct: 259 KDPEKRFTCEQALQHPWI-------AGDTALDKN 285

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 126/251 (50%), Gaps = 19/251 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG+FG V+   + ++G  CA+K+VR+        E  +   +E+   + L+ P IV  +G
Sbjct: 103 RGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMACAGLTSPRIVPLYG 152
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           +      +++++E + GGS+ +L++E G   E     Y  Q L GL YLH+R  +H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 350 GANILVDPHG-EIKLADFGMAKHMTS---CASMLS---FKGSPYWMAPEVVMNTNGYSLT 402
             N+L+   G    L DFG A  +       S+L+     G+   MAPEVV+  +     
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAK 271
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDDAKSFIKQCLQR 461
           VD+WS  C +L M     PW+Q+       KI +    + EIP   +      I++ L++
Sbjct: 272 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRK 331
Query: 462 DPSARPPASKL 472
           +P  R  A++L
Sbjct: 332 EPIHRVSAAEL 342

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 125/252 (49%), Gaps = 14/252 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG   L  + ++ ++ A+K +      +  ++  + + +EI     L HPNIVR+   
Sbjct: 30  GNFGVARLMRDKQANELVAVKYI------ERGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L+   L++ +EY SGG + + +   G F+E   + + +Q++ G++Y HA    HRD+K 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKL 143
Query: 351 ANILVD--PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            N L+D  P   +K+ADFG +K     +   S  G+P ++APEV++         D+WS 
Sbjct: 144 ENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 409 GCTVLEMATSKPPWSQYEG----VAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDP 463
           G T+  M     P+   E        I +I N +  IP+   H+S + +  I +    DP
Sbjct: 204 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV-HISPECRHLISRIFVADP 262
Query: 464 SARPPASKLLDH 475
           + R    ++ +H
Sbjct: 263 AKRISIPEIRNH 274

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 8/240 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA-KSFIKQCLQRDPSAR 466
            G  +  M   + PW Q       +     K     P    D A  + + + L  +PSAR
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 8/240 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA-KSFIKQCLQRDPSAR 466
            G  +  M   + PW Q       +     K     P    D A  + + + L  +PSAR
Sbjct: 193 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 19/272 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G F  V+L     +G++ A+K     C  ++       L  EI +L ++ H NIV     
Sbjct: 20  GAFSEVFLVKQRLTGKLFALK-----CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
             S     + ++ VSGG +   + E G + E       +Q+L  + YLH    VHRD+K 
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134
Query: 351 ANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L    + + +I + DFG++K M     M +  G+P ++APE V+    YS  VD WS
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE-VLAQKPYSKAVDCWS 192
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP--EHLSDDAKSFIKQCLQRDPSA 465
           +G     +    PP+ +        KI       E P  + +S+ AK FI   L++DP+ 
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNE 252
Query: 466 RPPASKLLDHPFVRDQAVARAGNVNLAKDSSP 497
           R    K L HP++        GN  L +D  P
Sbjct: 253 RYTCEKALSHPWID-------GNTALHRDIYP 277

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 99
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A   SF G+  +++PE++   +    + D+
Sbjct: 160 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK-SSDL 218
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 219 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 273
Query: 463 PSAR 466
            + R
Sbjct: 274 ATKR 277

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG   L  + +S ++ A+K +      +  ++    + +EI     L HPNIVR+   
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYI------ERGEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L+   L++ +EY SGG + + +   G F+E   + + +Q++ G++Y HA    HRD+K 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 143
Query: 351 ANILVD--PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            N L+D  P   +K+ DFG +K     +   S  G+P ++APEV++         D+WS 
Sbjct: 144 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 409 GCTVLEMATSKPPWSQYEG----VAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDP 463
           G T+  M     P+   E        I +I N +  IP+   H+S + +  I +    DP
Sbjct: 204 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV-HISPECRHLISRIFVADP 262
Query: 464 SARPPASKLLDH 475
           + R    ++ +H
Sbjct: 263 AKRISIPEIRNH 274

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 117/232 (50%), Gaps = 17/232 (7%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+++L Q+ H N++  H    +   + + LE VSGG +   L +    +E    +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD-----PHGEIKLADFGMAKHMTSCASMLS 380
           + +QIL G+ YLH +   H D+K  NI L+D     PH  IKL DFG+A  +       +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH--IKLIDFGLAHEIEDGVEFKN 177
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS 437
             G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A I  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV----RDQAVAR 485
            D  E   H S+ AK FI++ L ++   R    + L HP++      QA+ R
Sbjct: 237 FD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVR 287

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 120/237 (50%), Gaps = 14/237 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR----DQAVAR-AGNVNLAK 493
           E   + S  AK FI++ L +DP  R      L HP+++     QA++R A  VN+ K
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 131
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 192 CGIVLTAMLAGELPWDQ 208

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 131/259 (50%), Gaps = 16/259 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G+FG V L     + ++ A+K ++   V+ DD    EC     + + L  +   P + +
Sbjct: 30  KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMVEKRVLALPGK--PPFLTQ 85
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +L ++  ++R
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 347 DIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           D+K  N+++D  G IK+ADFGM K ++    +   F G+P ++APE++     Y  +VD 
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDW 204
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           W+ G  + EM   + P+   E    +F+     ++   P+ +S +A +  K  + + P  
Sbjct: 205 WAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMTKHPGK 262
Query: 466 R----PPASK-LLDHPFVR 479
           R    P   + + +H F R
Sbjct: 263 RLGCGPEGERDIKEHAFFR 281

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 128/253 (50%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ------LNQEINLLSQLSHPNI 284
           G+FG V L  + ++ Q  A+K +        S++ LK+      + +EI+ L  L HP+I
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFI--------SRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           ++ +    +   + + +EY +GG +   + E     E   + + +QI+  + Y H    V
Sbjct: 72  IKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           HRD+K  N+L+D +  +K+ADFG++  MT    + +  GSP + APEV+         VD
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVD 190
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           +WS G  +  M   + P+   E +  +FK  NS  +  +P+ LS  A+S I++ +  DP 
Sbjct: 191 VWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPM 248
Query: 465 ARPPASKLLDHPF 477
            R    ++   P+
Sbjct: 249 QRITIQEIRRDPW 261

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI + + L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 21  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 76
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 136
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 137 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 195
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 196 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 250
Query: 463 PSAR 466
            + R
Sbjct: 251 ATKR 254

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 124/252 (49%), Gaps = 14/252 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG   L  + +S ++ A+K +      +  ++  + + +EI     L HPNIVR+   
Sbjct: 29  GNFGVARLMRDKQSNELVAVKYI------ERGEKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L+   L++ +EY SGG + + +   G F+E   + + +Q++ G++Y HA    HRD+K 
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 142
Query: 351 ANILVD--PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            N L+D  P   +K+ DFG +K     +   S  G+P ++APEV++         D+WS 
Sbjct: 143 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSC 202
Query: 409 GCTVLEMATSKPPWSQYEG----VAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDP 463
           G T+  M     P+   E        I +I N +  IP+   H+S + +  I +    DP
Sbjct: 203 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV-HISPECRHLISRIFVADP 261
Query: 464 SARPPASKLLDH 475
           + R    ++ +H
Sbjct: 262 AKRISIPEIRNH 273

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 20  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 75
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 136 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 194
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 195 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 249
Query: 463 PSAR 466
            + R
Sbjct: 250 ATKR 253

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 123/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 96
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A   +F G+  +++PE++   +    + D+
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACK-SSDL 215
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 270
Query: 463 PSAR 466
            + R
Sbjct: 271 ATKR 274

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V    +  +G   AIK++        S+   K+  +E+ LL  + H N++     
Sbjct: 36  GAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 291 ELSDERLSVYLEY-----VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
              DE L  + ++       G  + KL++ +    E  IQ    Q+L GL Y+HA   +H
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIH 151
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K  N+ V+   E+K+ DFG+A+   S   M     + ++ APEV++N   Y+ TVDI
Sbjct: 152 RDLKPGNLAVNEDCELKILDFGLARQADS--EMXGXVVTRWYRAPEVILNWMRYTQTVDI 209
Query: 406 WSLGCTVLEMATSKPPWS---QYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK---QCL 459
           WS+GC + EM T K  +      + +  I K+  +     +    SD+AK+++K   +  
Sbjct: 210 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269
Query: 460 QRD-----PSARPPASKLLDHPFVRD 480
           ++D      +A P A  LL+   V D
Sbjct: 270 KKDFASILTNASPLAVNLLEKMLVLD 295

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 125/251 (49%), Gaps = 19/251 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG+FG V+   + ++G  CA+K+VR+        E  +   +E+   + L+ P IV  +G
Sbjct: 84  RGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFR--AEELMACAGLTSPRIVPLYG 133
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           +      +++++E + GGS+ +L++E G   E     Y  Q L GL YLH+R  +H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 350 GANILVDPHG-EIKLADFGMAKHMTS---CASMLS---FKGSPYWMAPEVVMNTNGYSLT 402
             N+L+   G    L DFG A  +        +L+     G+   MAPEVV+  +     
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAK 252
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDDAKSFIKQCLQR 461
           VD+WS  C +L M     PW+Q+       KI +    + EIP   +      I++ L++
Sbjct: 253 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRK 312
Query: 462 DPSARPPASKL 472
           +P  R  A++L
Sbjct: 313 EPIHRVSAAEL 323

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 127/269 (47%), Gaps = 26/269 (9%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+++L Q+ H N++  H    +   + + LE VSGG +   L +    +E    +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD-----PHGEIKLADFGMAKHMTSCASMLS 380
           + +QIL G+ YLH +   H D+K  NI L+D     PH  IKL DFG+A  +       +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH--IKLIDFGLAHEIEDGVEFKN 177
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS 437
             G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A I  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV-----RDQAVARAGNVNLA 492
            D  E     S+ AK FI++ L ++   R    + L HP++     +   V R   VNL 
Sbjct: 237 FD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
Query: 493 KDSSPYSLDGSRTPPKLDLLPTRKSITLC 521
                Y     R   KLD       ++LC
Sbjct: 296 NFRKQY----VRRRWKLDF----SIVSLC 316

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 18  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 73
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 133
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 134 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 192
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 193 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 247
Query: 463 PSAR 466
            + R
Sbjct: 248 ATKR 251

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 95
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A   SF G+  +++PE++   +    + D+
Sbjct: 156 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK-SSDL 214
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 215 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 269
Query: 463 PSAR 466
            + R
Sbjct: 270 ATKR 273

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 98
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXK-SSDL 217
Query: 406 WSLGCTVLEMATSKPPW-SQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+ +  EG+  A I K+       + PE     A+  +++ L  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 272
Query: 463 PSAR 466
            + R
Sbjct: 273 ATKR 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 74
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 134
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 193
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 194 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 248
Query: 463 PSAR 466
            + R
Sbjct: 249 ATKR 252

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 194 CGIVLTAMLAGELPWDQ 210

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 119/235 (50%), Gaps = 14/235 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR----DQAVAR-AGNVNL 491
           E   + S  AK FI++ L +DP  R      L HP+++     QA++R A  VN+
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 119/246 (48%), Gaps = 18/246 (7%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +++ +E+++L Q+ H N++  H    +   + + LE VSGG +   L +    +E    +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD-----PHGEIKLADFGMAKHMTSCASMLS 380
           + +QIL G+ YLH +   H D+K  NI L+D     PH  IKL DFG+A  +       +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH--IKLIDFGLAHEIEDGVEFKN 177
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS 437
             G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A I  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV-----RDQAVARAGNVNLA 492
            D  E     S+ AK FI++ L ++   R    + L HP++     +   V R   VNL 
Sbjct: 237 FD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
Query: 493 KDSSPY 498
                Y
Sbjct: 296 NFRKQY 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 98
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 217
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 272
Query: 463 PSAR 466
            + R
Sbjct: 273 ATKR 276

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V    +  SG+  AIK++        S+   K+  +E+ LL  + H N++     
Sbjct: 53  GAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 291 ELSDERL-SVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                 L + Y  Y+    +   LQ+     F+E  IQ    Q+L GL Y+H+   VHRD
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 169
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+ V+   E+K+ DFG+A+H  + A M  +  + ++ APEV+++   Y+ TVDIWS
Sbjct: 170 LKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWS 227
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDD-AKSFI--------K 456
           +GC + EM T K  +   + +  + +I     +P  E  + L+D  AKS+I        K
Sbjct: 228 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 287
Query: 457 QCLQRDPSARPPASKLLD 474
              Q  P A P A+ LL+
Sbjct: 288 DFTQLFPRASPQAADLLE 305

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 7/222 (3%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           K +  EI +L +LSHPNI++      +   +S+ LE V+GG +   + E G ++E     
Sbjct: 93  KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKG 383
             +QIL  +AYLH    VHRD+K  N+L     P   +K+ADFG++K +     M +  G
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPE 442
           +P + APE ++    Y   VD+WS+G     +     P+    G   +F +I N +    
Sbjct: 213 TPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI 271
Query: 443 IP--EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
            P  + +S +AK  +++ +  DP  R    + L HP+V  +A
Sbjct: 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 119/235 (50%), Gaps = 14/235 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PAFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR----DQAVAR-AGNVNL 491
           E   + S  AK FI++ L +DP  R      L HP+++     QA++R A  VN+
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 96
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 215
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 270
Query: 463 PSAR 466
            + R
Sbjct: 271 ATKR 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 99
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 160 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 218
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 219 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 273
Query: 463 PSAR 466
            + R
Sbjct: 274 ATKR 277

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 119/235 (50%), Gaps = 14/235 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR----DQAVAR-AGNVNL 491
           E   + S  AK FI++ L +DP  R      L HP+++     QA++R A  VN+
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 96
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 215
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 270
Query: 463 PSAR 466
            + R
Sbjct: 271 ATKR 274

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V    +  SG+  AIK++        S+   K+  +E+ LL  + H N++     
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 291 ELSDERL-SVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
                 L + Y  Y+    +   LQ+     F+E  IQ    Q+L GL Y+H+   VHRD
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 151
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  N+ V+   E+K+ DFG+A+H  + A M  +  + ++ APEV+++   Y+ TVDIWS
Sbjct: 152 LKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWS 209
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDD-AKSFI--------K 456
           +GC + EM T K  +   + +  + +I     +P  E  + L+D  AKS+I        K
Sbjct: 210 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 269
Query: 457 QCLQRDPSARPPASKLLD 474
              Q  P A P A+ LL+
Sbjct: 270 DFTQLFPRASPQAADLLE 287

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 98
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 217
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 272
Query: 463 PSAR 466
            + R
Sbjct: 273 ATKR 276

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 98
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 217
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 272
Query: 463 PSAR 466
            + R
Sbjct: 273 ATKR 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 119/235 (50%), Gaps = 14/235 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR----DQAVAR-AGNVNL 491
           E   + S  AK FI++ L +DP  R      L HP+++     QA++R A  VN+
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    N E+GQ  A+K V V     +     + L +E ++   L HP+IV    
Sbjct: 36  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 95
Query: 290 SELSDERLSVYLEYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  SD  L +  E++ G      I K       ++E V   Y RQIL  L Y H  N +H
Sbjct: 96  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 155
Query: 346 RDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSL 401
           RD+K   +L+   +    +KL  FG+A  +     +   + G+P++MAPEVV     Y  
Sbjct: 156 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV-KREPYGK 214
Query: 402 TVDIWSLGCTVLEMATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
            VD+W  G  +  + +   P+       +EG+      G  K  P    H+S+ AK  ++
Sbjct: 215 PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----GKYKMNPRQWSHISESAKDLVR 270
Query: 457 QCLQRDPSARPPASKLLDHPFVRDQ 481
           + L  DP+ R    + L+HP+++++
Sbjct: 271 RMLMLDPAERITVYEALNHPWLKER 295

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 11/238 (4%)
Query: 258 DDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG 317
           D++  ++  +++  EI+LL  L HPNI++        +   +  E+  GG + + +    
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 318 PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKLADFGMAKHMTS 374
            F+E       +QIL G+ YLH  N VHRDIK  NIL++       IK+ DFG++   + 
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
              +    G+ Y++APEV+     Y+   D+WS G  +  +    PP+        I K+
Sbjct: 202 DYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 435 GNSKDIPEIPE--HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVN 490
              K   +  +  ++SD+AK  IK  L  D + R  A + L+  +++      A N+N
Sbjct: 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK----KYANNIN 313

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E +++S+L HP  V+ + +   DE+L   L Y   G + K +++ G F+E   + YT
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSP 385
            +I+  L YLH +  +HRD+K  NIL++    I++ DFG AK +   +  A    F G+ 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPE 442
            +++PE++   +    + D+W+LGC + ++    PP+   ++Y     I K+       +
Sbjct: 197 QYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----D 250
Query: 443 IPEHLSDDAKSFIKQCLQRDPSAR 466
            PE     A+  +++ L  D + R
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKR 274

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 98
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 217
Query: 406 WSLGCTVLEMATSKPPW-SQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+ +  EG+  A I K+       + PE     A+  +++ L  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 272
Query: 463 PSAR 466
            + R
Sbjct: 273 ATKR 276

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 121/244 (49%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 48  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 103
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 163
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 164 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 222
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 223 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 277
Query: 463 PSAR 466
            + R
Sbjct: 278 ATKR 281

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G  G V L  N  + +  A+K    + D + + +C + + +EI +   L+H N+V+++G 
Sbjct: 17  GAAGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
                   ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH     HRDIK 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 351 ANILVDPHGEIKLADFGMA---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
            N+L+D    +K++DFG+A   ++      +    G+  ++APE++     ++  VD+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 408 LGCTVLEMATSKPPWSQ 424
            G  +  M   + PW Q
Sbjct: 193 CGIVLTAMLAGELPWDQ 209

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 25  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 80
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 140
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 141 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 199
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + PE     A+  +++ L  D
Sbjct: 200 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDLVEKLLVLD 254
Query: 463 PSAR 466
            + R
Sbjct: 255 ATKR 258

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 131/260 (50%), Gaps = 16/260 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEV-RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           +G+FG V +   +++ +M A+K + +  C ++     ++ + +E+ ++  L HP +V   
Sbjct: 25  KGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE---VRNVFKELQIMQGLEHPFLVNLW 81
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            S   +E + + ++ + GG +   LQ+   F E  ++ +  ++++ L YL  +  +HRD+
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN--GYSLTVDIW 406
           K  NIL+D HG + + DF +A  +     + +  G+  +MAPE+  +    GYS  VD W
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW 201
Query: 407 SLGCTVLEMATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           SLG T  E+   + P+     +  + +   F+      +   P   S +  S +K+ L+ 
Sbjct: 202 SLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----VVTYPSAWSQEMVSLLKKLLEP 257
Query: 462 DPSAR-PPASKLLDHPFVRD 480
           +P  R    S + + P++ D
Sbjct: 258 NPDQRFSQLSDVQNFPYMND 277

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    N E+GQ  A+K V V     +     + L +E ++   L HP+IV    
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93
Query: 290 SELSDERLSVYLEYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  SD  L +  E++ G      I K       ++E V   Y RQIL  L Y H  N +H
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153
Query: 346 RDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNTNGYSL 401
           RD+K   +L+   +    +KL  FG+A  +     +   + G+P++MAPEVV     Y  
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV-KREPYGK 212
Query: 402 TVDIWSLGCTVLEMATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
            VD+W  G  +  + +   P+       +EG+      G  K  P    H+S+ AK  ++
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----GKYKMNPRQWSHISESAKDLVR 268
Query: 457 QCLQRDPSARPPASKLLDHPFVRDQ 481
           + L  DP+ R    + L+HP+++++
Sbjct: 269 RMLMLDPAERITVYEALNHPWLKER 293

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E +++S+L HP  V+ + +   DE+L   L Y   G + K +++ G F+E   + YT
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 135
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSP 385
            +I+  L YLH +  +HRD+K  NIL++    I++ DFG AK +   +  A    F G+ 
Sbjct: 136 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPE 442
            +++PE++   +    + D+W+LGC + ++    PP+   ++Y     I K+       +
Sbjct: 196 QYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----D 249
Query: 443 IPEHLSDDAKSFIKQCLQRDPSAR 466
            PE     A+  +++ L  D + R
Sbjct: 250 FPEKFFPKARDLVEKLLVLDATKR 273

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG   L  + +S ++ A+K +      +  ++  + + +EI     L HPNIVR+   
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYI------ERGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L+   L++ +EY SGG + + +   G F+E   + + +Q++ G++Y HA    HRD+K 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 143
Query: 351 ANILVD--PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            N L+D  P   +K+  FG +K     +   S  G+P ++APEV++         D+WS 
Sbjct: 144 ENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 409 GCTVLEMATSKPPWSQYEG----VAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDP 463
           G T+  M     P+   E        I +I N +  IP+   H+S + +  I +    DP
Sbjct: 204 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV-HISPECRHLISRIFVADP 262
Query: 464 SARPPASKLLDH 475
           + R    ++ +H
Sbjct: 263 AKRISIPEIRNH 274

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 139/293 (47%), Gaps = 55/293 (18%)
Query: 231 GTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECL-KQLNQEINLLSQLS---HPNIV 285
           G +G V+   + ++G +  A+K VRV    QT +E +     +E+ +L  L    HPN+V
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 286 R-YHGSELS----DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT-----RQILLGL 335
           R +    +S    + +L++  E+V       L        EP + T T      Q+L GL
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
            +LH+   VHRD+K  NILV   G+IKLADFG+A+  +   ++ S   + ++ APEV++ 
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP----------- 444
           ++ Y+  VD+WS+GC   EM   KP    + G + + ++G   D+  +P           
Sbjct: 194 SS-YATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 445 -------------EHLSDD----AKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                        E    D     K  + +CL  +P+ R  A   L HP+ +D
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 180 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 237
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 180 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 237
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 9/218 (4%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
           + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 329 RQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFKGS 384
           +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIP 441
           P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N +   
Sbjct: 181 PEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED 238
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 9/220 (4%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           + + +E+++L ++ HPN++  H    +   + + LE V+GG +   L E     E     
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFK 382
           + +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKD 439
           G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N + 
Sbjct: 179 GTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEF 236
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 139/293 (47%), Gaps = 55/293 (18%)
Query: 231 GTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECL-KQLNQEINLLSQLS---HPNIV 285
           G +G V+   + ++G +  A+K VRV    QT +E +     +E+ +L  L    HPN+V
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 286 R-YHGSELS----DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT-----RQILLGL 335
           R +    +S    + +L++  E+V       L        EP + T T      Q+L GL
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
            +LH+   VHRD+K  NILV   G+IKLADFG+A+  +   ++ S   + ++ APEV++ 
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP----------- 444
           ++ Y+  VD+WS+GC   EM   KP    + G + + ++G   D+  +P           
Sbjct: 194 SS-YATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 445 -------------EHLSDD----AKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                        E    D     K  + +CL  +P+ R  A   L HP+ +D
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 121/244 (49%), Gaps = 18/244 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIK--EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G+F  V L     + +  AIK  E R +  +      +  + +E +++S+L HP  V+ +
Sbjct: 46  GSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFFVKLY 101
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH +  +HRD+
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 161
Query: 349 KGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  NIL++    I++ DFG AK +   +  A    F G+  +++PE++   +    + D+
Sbjct: 162 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK-SSDL 220
Query: 406 WSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           W+LGC + ++    PP+   ++Y     I K+       + P      A+  +++ L  D
Sbjct: 221 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPAAFFPKARDLVEKLLVLD 275
Query: 463 PSAR 466
            + R
Sbjct: 276 ATKR 279

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 119/221 (53%), Gaps = 12/221 (5%)
Query: 266 LKQLNQEINLLSQLSHPNIVRYHGSELSDE----RLSVYLEYVSGGSIHKLLQEYGPFNE 321
           ++Q+ QEI +L +L HPN+V+    E+ D+     L +  E V+ G + ++     P +E
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSE 136
Query: 322 PVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS- 380
              + Y + ++ G+ YLH +  +HRDIK +N+LV   G IK+ADFG++       ++LS 
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 381 FKGSPYWMAPEVVMNTNGY--SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI-GNS 437
             G+P +MAPE +  T        +D+W++G T+      + P+     +    KI   +
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
            + P+ P+ +++D K  I + L ++P +R    ++  HP+V
Sbjct: 257 LEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 15/217 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS---HPNIVRY 287
           G +G VY   +  SG   A+K VRV               +E+ LL +L    HPN+VR 
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79
Query: 288 H---GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHA 340
                +  +D  + V L  E+V    +   L +  P   P   I+   RQ L GL +LHA
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 138
Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
              VHRD+K  NILV   G +KLADFG+A+  +   ++     + ++ APEV++ +  Y+
Sbjct: 139 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YA 197
Query: 401 LTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI 434
             VD+WS+GC   EM   KP +   S+ + +  IF +
Sbjct: 198 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK- 193
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 247

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 122/252 (48%), Gaps = 14/252 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG   L  + +S ++ A+K +      +  ++  + + +EI     L HPNIVR+   
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYI------ERGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L+   L++ +EY SGG + + +   G F+E   + + +Q++ G++Y HA    HRD+K 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 143
Query: 351 ANILVD--PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            N L+D  P   +K+  FG +K     +      G+P ++APEV++         D+WS 
Sbjct: 144 ENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 409 GCTVLEMATSKPPWSQYEG----VAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDP 463
           G T+  M     P+   E        I +I N +  IP+   H+S + +  I +    DP
Sbjct: 204 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV-HISPECRHLISRIFVADP 262
Query: 464 SARPPASKLLDH 475
           + R    ++ +H
Sbjct: 263 AKRISIPEIRNH 274

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 14/251 (5%)
Query: 249 AIKEVRVVCDDQTSKECLKQLNQ----EINLLSQLS-HPNIVRYHGSELSDERLSVYLEY 303
           A+K + V      S E +++L +    E+++L ++S HPNI++   +  ++    +  + 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL 363
           +  G +   L E    +E   +   R +L  +  LH  N VHRD+K  NIL+D    IKL
Sbjct: 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165
Query: 364 ADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTN--GYSLTVDIWSLGCTVLEMATS 418
            DFG +  +     + S  G+P ++APE++   MN N  GY   VD+WS G  +  +   
Sbjct: 166 TDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 419 KPPWSQYEGVAAIFKI--GNSK-DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            PP+   + +  +  I  GN +   PE  ++ SD  K  + + L   P  R  A + L H
Sbjct: 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAH 284
Query: 476 PFVRDQAVARA 486
           PF +   V   
Sbjct: 285 PFFQQYVVEEV 295

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 13/220 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQT 326
           + +E+++L ++ HPN++  H  E+ + +  V L  E V+GG +   L E     E     
Sbjct: 61  IEREVSILKEIQHPNVITLH--EVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANI-LVD---PHGEIKLADFGMAKHMTSCASMLSFK 382
           + +QIL G+ YLH+    H D+K  NI L+D   P   IK+ DFG+A  +       +  
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKD 439
           G+P ++APE+V N     L  D+WS+G     + +   P+   ++ E +A +  + N + 
Sbjct: 179 GTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEF 236
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             E   + S  AK FI++ L +DP  R      L HP+++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 11/256 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG +G V    +  SGQ+ A+K +R   + Q  K  L  L+        +  P  V ++G
Sbjct: 44  RGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXR---TVDCPFTVTFYG 100
Query: 290 SEL--SDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHAR-NTVH 345
           +     D  +   L   S    +K + + G    E ++      I+  L +LH++ + +H
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 160
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTNGYSLT 402
           RD+K +N+L++  G++K  DFG++ ++    +     G   + APE +   +N  GYS+ 
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVK 220
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQR 461
            DIWSLG T +E+A  + P+  +       K    +  P++P +  S +   F  QCL++
Sbjct: 221 SDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 280
Query: 462 DPSARPPASKLLDHPF 477
           +   RP   +L  HPF
Sbjct: 281 NSKERPTYPELXQHPF 296

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 135/280 (48%), Gaps = 35/280 (12%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 51  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 224
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQY--------EGVAAIFK----IGNSKDIPE 442
           +S+  D+WS G  + E+ T    SK P +++        +G   +F     + N+  +P 
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 284
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKL-LDHPFVRDQ 481
            P+   D+    + +C   + + RP    L L    +RDQ
Sbjct: 285 -PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 135/280 (48%), Gaps = 35/280 (12%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 18  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 72
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 132
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 191
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQY--------EGVAAIFK----IGNSKDIPE 442
           +S+  D+WS G  + E+ T    SK P +++        +G   +F     + N+  +P 
Sbjct: 192 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 251
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKL-LDHPFVRDQ 481
            P+   D+    + +C   + + RP    L L    +RDQ
Sbjct: 252 -PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 290

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V       +G+M A K++      +   E +  LN E  +L +++   +V    
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LN-EKQILEKVNSRFVVSLAY 251
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           +  + + L + L  ++GG +   +   G   F E     Y  +I  GL  LH    V+RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  NIL+D HG I+++D G+A H+    ++    G+  +MAPEVV N   Y+ + D W+
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWA 370
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD----DAKSFIKQCLQRDP 463
           LGC + EM   + P+ Q +    I +    + + E+PE  S+     A+S   Q L +DP
Sbjct: 371 LGCLLYEMIAGQSPFQQRK--KKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428
Query: 464 SARP-----PASKLLDHPFVRDQAVARAG 487
           + R       A ++ +HP  +     R G
Sbjct: 429 AERLGCRGGSAREVKEHPLFKKLNFKRLG 457

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 12/214 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH-- 288
           G +G VY   +  SG   A+K VRV   ++       +    +  L    HPN+VR    
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDV 74
Query: 289 -GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNT 343
             +  +D  + V L  E+V    +   L +  P   P   I+   RQ L GL +LHA   
Sbjct: 75  CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 133
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           VHRD+K  NILV   G +KLADFG+A+  +   ++     + ++ APEV++ +  Y+  V
Sbjct: 134 VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST-YATPV 192
Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI 434
           D+WS+GC   EM   KP +   S+ + +  IF +
Sbjct: 193 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 16/260 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYH 288
           RG F  V    +  +GQ  A K ++     +  ++C  ++  EI +L    S P ++  H
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 289 GSELSDERLSVYLEYVSGGSIHKL----LQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
               +   + + LEY +GG I  L    L E    N+ +     +QIL G+ YLH  N V
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI--RLIKQILEGVYYLHQNNIV 153
Query: 345 HRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
           H D+K  NIL+    P G+IK+ DFGM++ +     +    G+P ++APE ++N +  + 
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE-ILNYDPITT 212
Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG--NSKDIPEIPEHLSDDAKSFIKQCL 459
             D+W++G     + T   P+   +       I   N     E    +S  A  FI+  L
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272
Query: 460 QRDPSARPPASKLLDHPFVR 479
            ++P  RP A   L H +++
Sbjct: 273 VKNPEKRPTAEICLSHSWLQ 292

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 27  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 81
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 141
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 200
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++     +  IGN K    I  HL +  K+
Sbjct: 201 FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHLIELLKN 254

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG+FG V+   + ++G  CA+K+VR+        E  +   +E+   + LS P IV  +G
Sbjct: 68  RGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFR--VEELVACAGLSSPRIVPLYG 117
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           +      +++++E + GGS+ +L+++ G   E     Y  Q L GL YLH R  +H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 350 GANILVDPHG-EIKLADFGMAKHMT---SCASMLS---FKGSPYWMAPEVVMNTNGYSLT 402
             N+L+   G    L DFG A  +       S+L+     G+   MAPEVVM        
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAK 236
Query: 403 VDIWSLGCTVLEMATSKPPWSQY 425
           VDIWS  C +L M     PW+QY
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQY 259

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 25  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 79
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 139
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 198
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 199 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 252

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 45/279 (16%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V    N+   +  AIK++R       ++E L  +  E+ LL+ L+H  +VRY+ 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 290 SELSDER-------------LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT--RQILLG 334
           + L                 L + +EY   G+++ L+      N+   + +   RQIL  
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEA 128
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK------------ 382
           L+Y+H++  +HRD+K  NI +D    +K+ DFG+AK++     +L               
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 383 ---GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD 439
              G+  ++A EV+  T  Y+  +D++SLG    EM     P+S       I K   S  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS 245
Query: 440 IPEIPEHLSDD----AKSFIKQCLQRDPSARPPASKLLD 474
           I E P    D+     K  I+  +  DP+ RP A  LL+
Sbjct: 246 I-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 26  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 80
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    +   +  YT QI  G+ YL  + 
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 140
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 199
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 200 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 253

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 23  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 196
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++     +  IGN K    I  HL +  K+
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHLIELLKN 250

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 23  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ +    + + +  YT QI  G+ YL  + 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 196
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 250

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 24  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 78
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    +   +  YT QI  G+ YL  + 
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 138
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 197
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 198 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 251

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V       +G+M A K++      +   E +  LN E  +L +++   +V    
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LN-EKQILEKVNSRFVVSLAY 251
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           +  + + L + L  ++GG +   +   G   F E     Y  +I  GL  LH    V+RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
           +K  NIL+D HG I+++D G+A H+    ++    G+  +MAPEVV N   Y+ + D W+
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWA 370
Query: 408 LGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD----DAKSFIKQCLQRDP 463
           LGC + EM   + P+ Q +    I +    + + E+PE  S+     A+S   Q L +DP
Sbjct: 371 LGCLLYEMIAGQSPFQQRK--KKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428
Query: 464 SARP-----PASKLLDHPFVRDQAVARAG 487
           + R       A ++ +HP  +     R G
Sbjct: 429 AERLGCRGGSAREVKEHPLFKKLNFKRLG 457

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 193
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 247

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 119/251 (47%), Gaps = 14/251 (5%)
Query: 249 AIKEVRVVCDDQTSKECLKQLNQ----EINLLSQLS-HPNIVRYHGSELSDERLSVYLEY 303
           A+K + V      S E +++L +    E+++L ++S HPNI++   +  ++    +  + 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL 363
           +  G +   L E    +E   +   R +L  +  LH  N VHRD+K  NIL+D    IKL
Sbjct: 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165
Query: 364 ADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTN--GYSLTVDIWSLGCTVLEMATS 418
            DFG +  +     +    G+P ++APE++   MN N  GY   VD+WS G  +  +   
Sbjct: 166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 419 KPPWSQYEGVAAIFKI--GNSK-DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            PP+   + +  +  I  GN +   PE  ++ SD  K  + + L   P  R  A + L H
Sbjct: 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAH 284
Query: 476 PFVRDQAVARA 486
           PF +   V   
Sbjct: 285 PFFQQYVVEEV 295

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  F  + ++ APE+++N   Y+ TVDI
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMAGFVATRWYRAPEIMLNWMHYNQTVDI 202
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 261
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 19  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 73
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 133
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 192
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 193 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 246

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  F  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMAGFVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 138/292 (47%), Gaps = 55/292 (18%)
Query: 231 GTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECL-KQLNQEINLLSQLS---HPNIV 285
           G +G V+   + ++G +  A+K VRV    QT +E +     +E+ +L  L    HPN+V
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 286 R-YHGSELS----DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT-----RQILLGL 335
           R +    +S    + +L++  E+V       L        EP + T T      Q+L GL
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
            +LH+   VHRD+K  NILV   G+IKLADFG+A+  +   ++ S   + ++ APEV++ 
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP----------- 444
           ++ Y+  VD+WS+GC   EM   KP    + G + + ++G   D+  +P           
Sbjct: 194 SS-YATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 445 -------------EHLSDD----AKSFIKQCLQRDPSARPPASKLLDHPFVR 479
                        E    D     K  + +CL  +P+ R  A   L HP+ +
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  F  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMAGFVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    +   +  YT QI  G+ YL  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 193
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 247

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 35  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 89  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   ++N YS   D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S       I ++      S D+ ++  +     K  + +CL+
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 268 KKRDERPSFPRIL 280

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG+FG V+   + ++G  CA+K+VR+        E  +   +E+   + LS P IV  +G
Sbjct: 82  RGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFR--VEELVACAGLSSPRIVPLYG 131
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           +      +++++E + GGS+ +L+++ G   E     Y  Q L GL YLH R  +H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 350 GANILVDPHG-EIKLADFGMAKHMT---SCASMLS---FKGSPYWMAPEVVMNTNGYSLT 402
             N+L+   G    L DFG A  +       S+L+     G+   MAPEVVM        
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAK 250
Query: 403 VDIWSLGCTVLEMATSKPPWSQY 425
           VDIWS  C +L M     PW+QY
Sbjct: 251 VDIWSSCCMMLHMLNGCHPWTQY 273

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 38  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 211
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 212 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 265

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 38  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    +   +  YT QI  G+ YL  + 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 211
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++     +  IGN K    I  HL +  K+
Sbjct: 212 FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHLIELLKN 265

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 12/214 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH-- 288
           G +G VY   +  SG   A+K VRV   ++       +    +  L    HPN+VR    
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDV 74
Query: 289 -GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNT 343
             +  +D  + V L  E+V    +   L +  P   P   I+   RQ L GL +LHA   
Sbjct: 75  CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 133
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           VHRD+K  NILV   G +KLADFG+A+  +   ++     + ++ APEV++ +  Y+  V
Sbjct: 134 VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST-YATPV 192
Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI 434
           D+WS+GC   EM   KP +   S+ + +  IF +
Sbjct: 193 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG+FG V+   + ++G  CA+K+VR+        E  +   +E+   + LS P IV  +G
Sbjct: 84  RGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFR--VEELVACAGLSSPRIVPLYG 133
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           +      +++++E + GGS+ +L+++ G   E     Y  Q L GL YLH R  +H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 350 GANILVDPHG-EIKLADFGMAKHMT---SCASMLS---FKGSPYWMAPEVVMNTNGYSLT 402
             N+L+   G    L DFG A  +       S+L+     G+   MAPEVVM        
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAK 252
Query: 403 VDIWSLGCTVLEMATSKPPWSQY 425
           VDIWS  C +L M     PW+QY
Sbjct: 253 VDIWSSCCMMLHMLNGCHPWTQY 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 121/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 23  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +E++  GS+ + LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HRD+   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK- 196
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 250

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 35  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             + + L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 89  STAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   ++N YS   D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S       I ++      S D+ ++  +     K  + +CL+
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 268 KKRDERPSFPRIL 280

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CAKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 202
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 261
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 29/279 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G F  VY   +  + Q+ AIK++++    +      +   +EI LL +LSHPNI+    +
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARNTVHRDIK 349
                 +S+  +++    +  ++++      P  I+ Y    L GL YLH    +HRD+K
Sbjct: 81  FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 139
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM-APEVVMNTNGYSLTVDIWSL 408
             N+L+D +G +KLADFG+AK   S       +    W  APE++     Y + VD+W++
Sbjct: 140 PNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAV 199
Query: 409 GCTVLEMATSKPPW---SQYEGVAAIFKIGNS------------------KDIPEIPEH- 446
           GC + E+    P     S  + +  IF+   +                  K  P IP H 
Sbjct: 200 GCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH 259
Query: 447 ----LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
                 DD    I+     +P AR  A++ L   +  ++
Sbjct: 260 IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 126/256 (49%), Gaps = 13/256 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    +  +G   A K   ++   + S    ++L +E  +  +L HPNIVR H 
Sbjct: 39  KGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S   +    +  + V+GG + + +     ++E       +QIL  +AY H+   VHR++K
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 350 GANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
             N+L+    +   +KLADFG+A  +    +   F G+P +++PE V+  + YS  VDIW
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIW 214
Query: 407 SLGCTVLEMATSKPP-WSQYEG-VAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQCLQRD 462
           + G  +  +    PP W + +  + A  K G + D P  PE   ++ +AKS I   L  +
Sbjct: 215 ACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKSLIDSMLTVN 272
Query: 463 PSARPPASKLLDHPFV 478
           P  R  A + L  P++
Sbjct: 273 PKKRITADQALKVPWI 288

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 113/224 (50%), Gaps = 15/224 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    VYL  ++      AIK + +    +  +E LK+  +E++  SQLSH NIV     
Sbjct: 22  GGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
           +  D+   + +EY+ G ++ + ++ +GP +      +T QIL G+ + H    VHRDIK 
Sbjct: 80  DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKP 139
Query: 351 ANILVDPHGEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
            NIL+D +  +K+ DFG+AK +  TS        G+  + +PE          T DI+S+
Sbjct: 140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSI 198
Query: 409 GCTVLEMATSKPPWSQYEGVA-AIFKIGNS---------KDIPE 442
           G  + EM   +PP++    V+ AI  I +S         KDIP+
Sbjct: 199 GIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ + S ++ A+K ++           ++   +E NL+  L H  +VR +  
Sbjct: 24  GQFGEVWMGYYNNSTKV-AVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +E + +  EY++ GS+   L+  E G    P +  ++ QI  G+AY+  +N +HRD+
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 136
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + AN+LV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAI-NFGCFTIKSDV 194
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  K P+        +  +     +P + E+  D+    +K C +    
Sbjct: 195 WSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCPDELYDIMKMCWKEKAE 253
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 254 ERPTFDYL 261

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 96
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H  +   M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 272
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDXELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 130/253 (51%), Gaps = 24/253 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG V         +  AIK++        S+   K    E+  LS+++HPNIV+ +G
Sbjct: 19  RGAFGVVCKA--KWRAKDVAIKQIE-------SESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHA---RNT 343
           + L+   + + +EY  GGS++ +L    P   +      ++  Q   G+AYLH+   +  
Sbjct: 70  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 344 VHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           +HRD+K  N+L+   G + K+ DFG A  + +   M + KGS  WMAPEV   +N YS  
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSN-YSEK 184
Query: 403 VDIWSLGCTVLEMATSKPPWSQYEGVA--AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            D++S G  + E+ T + P+ +  G A   ++ + N    P I ++L    +S + +C  
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-KNLPKPIESLMTRCWS 243
Query: 461 RDPSARPPASKLL 473
           +DPS RP   +++
Sbjct: 244 KDPSQRPSMEEIV 256

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 52  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 225
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 226 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 284
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 285 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 325

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 96
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H  +   M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 272
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 96
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H  +   M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 272
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 53  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 226
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 227 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 285
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 326

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNAMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 12/214 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH-- 288
           G +G VY   +  SG   A+K VRV   ++       +    +  L    HPN+VR    
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDV 74
Query: 289 -GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNT 343
             +  +D  + V L  E+V    +   L +  P   P   I+   RQ L GL +LHA   
Sbjct: 75  CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 133
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           VHRD+K  NILV   G +KLADFG+A+  +   ++     + ++ APEV++ +  Y+  V
Sbjct: 134 VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST-YATPV 192
Query: 404 DIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI 434
           D+WS+GC   EM   KP +   S+ + +  IF +
Sbjct: 193 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 117/216 (54%), Gaps = 15/216 (6%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPV 323
           K    E+  LS+++HPNIV+ +G+ L+   + + +EY  GGS++ +L    P   +    
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 324 IQTYTRQILLGLAYLHA---RNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASML 379
             ++  Q   G+AYLH+   +  +HRD+K  N+L+   G + K+ DFG A  + +   M 
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMT 161
Query: 380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA--AIFKIGNS 437
           + KGS  WMAPEV   +N YS   D++S G  + E+ T + P+ +  G A   ++ + N 
Sbjct: 162 NNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
              P I ++L    +S + +C  +DPS RP   +++
Sbjct: 221 TRPPLI-KNLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 151 RDLKPSNLAVNEDSELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 208
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 209 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 267
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 268 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G FG   L  +  + ++ A+K +      D+   +E +            L HPNIVR+ 
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH--------RSLRHPNIVRFK 82
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              L+   L++ +EY SGG +++ +   G F+E   + + +Q+L G++Y H+    HRD+
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142
Query: 349 KGANILVD--PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           K  N L+D  P   +K+ DFG +K     +   S  G+P ++APEV++         D+W
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVW 202
Query: 407 SLGCTVLEMATSKPPW 422
           S G T+  M     P+
Sbjct: 203 SCGVTLYVMLVGAYPF 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 43  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 99
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 158
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 159 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 216
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 217 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 275
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 276 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 316

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 23  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 77  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 135
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   ++N YS   D
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S       I ++      S D+ ++  +     K  + +CL+
Sbjct: 196 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 255
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 256 KKRDERPSFPRIL 268

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 202
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 261
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 155 RDLKPSNLAVNEDSELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 212
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 213 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 271
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 272 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 17/256 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+      +G   A K   V+   ++ KE +++   EI  +S L HP +V  H +
Sbjct: 62  GAFGVVHRVTERATGNNFAAK--FVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDA 116
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              D  + +  E++SGG +  K+  E+   +E     Y RQ+  GL ++H  N VH D+K
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 176
Query: 350 GANILVDPH--GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT-NGYSLTVDIW 406
             NI+       E+KL DFG+  H+    S+    G+  + APEV      GY    D+W
Sbjct: 177 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMW 234
Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIG----NSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           S+G     + +   P+        +  +     N  D       +S+D K FI++ L  D
Sbjct: 235 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--SAFSGISEDGKDFIRKLLLAD 292
Query: 463 PSARPPASKLLDHPFV 478
           P+ R    + L+HP++
Sbjct: 293 PNTRMTIHQALEHPWL 308

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKL---SKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 218
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 219 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 277
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 278 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 318

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 14/244 (5%)
Query: 249 AIKEVRVVCDDQTSKECLKQLNQ----EINLLSQLS-HPNIVRYHGSELSDERLSVYLEY 303
           A+K + V      S E +++L +    E+++L ++S HPNI++   +  ++    +  + 
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL 363
           +  G +   L E    +E   +   R +L  +  LH  N VHRD+K  NIL+D    IKL
Sbjct: 93  MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 152
Query: 364 ADFGMAKHMTSCASMLSFKGSPYWMAPEVV---MNTN--GYSLTVDIWSLGCTVLEMATS 418
            DFG +  +     +    G+P ++APE++   MN N  GY   VD+WS G  +  +   
Sbjct: 153 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212
Query: 419 KPPWSQYEGVAAIFKI--GNSK-DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            PP+   + +  +  I  GN +   PE  ++ SD  K  + + L   P  R  A + L H
Sbjct: 213 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAH 271
Query: 476 PFVR 479
           PF +
Sbjct: 272 PFFQ 275

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 230 RGTFGHV----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V    Y      +G++ A+K+++      +++E L+   +EI +L  L H NIV
Sbjct: 21  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIV 75
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARN 342
           +Y G   S  R  L + +EY+  GS+   LQ++    + + +  YT QI  G+ YL  + 
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 135
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            +HR++   NILV+    +K+ DFG+ K +         K    SP +W APE +  +  
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK- 194
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           +S+  D+WS G  + E+ T    SK P +++  +     IGN K    I  HL +  K+
Sbjct: 195 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-----IGNDKQGQMIVFHLIELLKN 248

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 17/256 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+      +G   A K   V+   ++ KE +++   EI  +S L HP +V  H +
Sbjct: 168 GAFGVVHRVTERATGNNFAAK--FVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDA 222
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
              D  + +  E++SGG +  K+  E+   +E     Y RQ+  GL ++H  N VH D+K
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 350 GANILVDPH--GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT-NGYSLTVDIW 406
             NI+       E+KL DFG+  H+    S+    G+  + APEV      GY    D+W
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMW 340
Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIG----NSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           S+G     + +   P+        +  +     N  D       +S+D K FI++ L  D
Sbjct: 341 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--SAFSGISEDGKDFIRKLLLAD 398
Query: 463 PSARPPASKLLDHPFV 478
           P+ R    + L+HP++
Sbjct: 399 PNTRMTIHQALEHPWL 414

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 44  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 160 RDLKPSNLAVNEDXELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 217
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 218 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 276
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 277 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 317

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 39  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 95
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 212
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 213 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 271
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 272 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 52  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 225
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 226 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 284
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 285 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 325

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+L     SG    IK +    +   S+  ++Q+  EI +L  L HPNI++    
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTI----NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 291 ELSDERLSVYLEYVSGGSIHKLL---QEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                 + + +E   GG + + +   Q  G   +E  +    +Q++  LAY H+++ VH+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 347 DIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           D+K  NIL     PH  IK+ DFG+A+   S     +  G+  +MAPEV       +   
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--KRDVTFKC 206
Query: 404 DIWSLGCTVLEMATSKPPW--SQYEGVA--AIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           DIWS G  +  + T   P+  +  E V   A +K  N   +   P  L+  A   +KQ L
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-VECRP--LTPQAVDLLKQML 263
Query: 460 QRDPSARPPASKLLDHPFVR 479
            +DP  RP A+++L H + +
Sbjct: 264 TKDPERRPSAAQVLHHEWFK 283

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 53  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 226
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 227 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 285
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 326

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 211
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 212 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 270
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 271 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 218
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 219 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 277
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 278 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 318

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 218
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 219 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 277
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 278 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 318

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 211
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 212 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 270
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 271 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 91
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 208
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 209 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 267
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 268 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 31  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 146
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 147 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 204
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 205 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 263
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 264 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 304

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 56  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 229
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 230 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 288
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 289 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 329

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 91
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 208
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 209 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 267
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 268 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 141/295 (47%), Gaps = 54/295 (18%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH-- 288
           G  G V+   +++  +  AIK++ V+ D Q+ K  L+    EI ++ +L H NIV+    
Sbjct: 22  GGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKHALR----EIKIIRRLDHDNIVKVFEI 76
Query: 289 ----GSELSD------ERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
               GS+L+D      E  SVY+  EY+     + L  E GP  E   + +  Q+L GL 
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLEEHARLFMYQLLRGLK 134
Query: 337 YLHARNTVHRDIKGANILVDPHGEI-KLADFGMAK----HMTSCASMLSFKGSPYWMAPE 391
           Y+H+ N +HRD+K AN+ ++    + K+ DFG+A+    H +    +     + ++ +P 
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS------QYEGVAAIFKIGNSKDIPE--- 442
           ++++ N Y+  +D+W+ GC   EM T K  ++      Q + +     + + +D  E   
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 443 -IPEHLSDD------------------AKSFIKQCLQRDPSARPPASKLLDHPFV 478
            IP ++ +D                  A  F++Q L   P  R  A + L HP++
Sbjct: 255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 56  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 112
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMXGYVATRWYRAPEIMLNWMHYNQTVDI 229
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 230 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 288
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 289 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 329

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 44  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 100
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 160 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 217
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 218 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 276
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 277 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 317

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 126/256 (49%), Gaps = 13/256 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    +  +G   A K   ++   + S    ++L +E  +  +L HPNIVR H 
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S   +    +  + V+GG + + +     ++E       +QIL  +AY H+   VHR++K
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 350 GANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
             N+L+    +   +KLADFG+A  +    +   F G+P +++PE V+  + YS  VDIW
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIW 191
Query: 407 SLGCTVLEMATSKPP-WSQYEG-VAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRD 462
           + G  +  +    PP W + +  + A  K G + D P  PE   ++ +AKS I   L  +
Sbjct: 192 ACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKSLIDSMLTVN 249
Query: 463 PSARPPASKLLDHPFV 478
           P  R  A + L  P++
Sbjct: 250 PKKRITADQALKVPWI 265

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 91
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 208
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 209 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 267
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 268 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 30  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 203
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 204 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 262
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 263 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 303

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 125/253 (49%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K ++VV     + E  +    E+ +L +  H NI+ + G 
Sbjct: 47  GSFGTVYKG--KWHGDV-AVKILKVV---DPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            ++ + L++  ++  G S++K L  +   F    +    RQ   G+ YLHA+N +HRD+K
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +     +   GS  WMAPEV+   + N +S   D
Sbjct: 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSD 219
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           ++S G  + E+ T + P+S        IF +G    S D+ ++ ++     K  +  C++
Sbjct: 220 VYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVK 279
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 280 KVKEERPLFPQIL 292

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 95
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 212
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 213 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 271
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 272 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 126/256 (49%), Gaps = 13/256 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    +  +G   A K   ++   + S    ++L +E  +  +L HPNIVR H 
Sbjct: 15  KGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S   +    +  + V+GG + + +     ++E       +QIL  +AY H+   VHR++K
Sbjct: 72  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 131
Query: 350 GANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
             N+L+    +   +KLADFG+A  +    +   F G+P +++PE V+  + YS  VDIW
Sbjct: 132 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIW 190
Query: 407 SLGCTVLEMATSKPP-WSQYEG-VAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRD 462
           + G  +  +    PP W + +  + A  K G + D P  PE   ++ +AKS I   L  +
Sbjct: 191 ACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKSLIDSMLTVN 248
Query: 463 PSARPPASKLLDHPFV 478
           P  R  A + L  P++
Sbjct: 249 PKKRITADQALKVPWI 264

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 94
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 211
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 212 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 270
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 271 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 202
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 261
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 32  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 88
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 147
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 148 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 205
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 206 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 264
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 265 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 305

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 30  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 203
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 204 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 262
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 263 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 303

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 272
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+ +H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDSELKILDFGLCRHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 211
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 212 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 270
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 271 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 126/256 (49%), Gaps = 13/256 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V    +  +G   A K   ++   + S    ++L +E  +  +L HPNIVR H 
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S   +    +  + V+GG + + +     ++E       +QIL  +AY H+   VHR++K
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 350 GANILVDPHGE---IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
             N+L+    +   +KLADFG+A  +    +   F G+P +++PE V+  + YS  VDIW
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIW 191
Query: 407 SLGCTVLEMATSKPP-WSQYEG-VAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRD 462
           + G  +  +    PP W + +  + A  K G + D P  PE   ++ +AKS I   L  +
Sbjct: 192 ACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKSLIDSMLTVN 249
Query: 463 PSARPPASKLLDHPFV 478
           P  R  A + L  P++
Sbjct: 250 PKKRITADQALKVPWI 265

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 95
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 212
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 213 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 271
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 272 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL------KQLNQEINLLSQLSHPNI 284
           G++G V  G +SE G   AIK V     D  +   L      K++ +EI LL+   HPNI
Sbjct: 33  GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 285 -----VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
                +  H  E +  +L +  E +       +  +    +   IQ +   ILLGL  LH
Sbjct: 92  LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151
Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               VHRD+   NIL+  + +I + DF +A+  T+ A+   +    ++ APE+VM   G+
Sbjct: 152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGF 211
Query: 400 SLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           +  VD+WS GC + EM   K  +   + Y  +  I ++  +  I ++    S  A+ +++
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLR 271
Query: 457 QCLQRDPS 464
             L   P+
Sbjct: 272 NSLSNVPA 279

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL------KQLNQEINLLSQLSHPNI 284
           G++G V  G +SE G   AIK V     D  +   L      K++ +EI LL+   HPNI
Sbjct: 33  GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 285 -----VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
                +  H  E +  +L +  E +       +  +    +   IQ +   ILLGL  LH
Sbjct: 92  LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151
Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
               VHRD+   NIL+  + +I + DF +A+  T+ A+   +    ++ APE+VM   G+
Sbjct: 152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGF 211
Query: 400 SLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           +  VD+WS GC + EM   K  +   + Y  +  I ++  +  I ++    S  A+ +++
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLR 271
Query: 457 QCLQRDPS 464
             L   P+
Sbjct: 272 NSLSNVPA 279

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 11/252 (4%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G++G V+   + E G++ A+K  R +   +  K+  ++L +  +      HP  VR    
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVK--RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE-- 123
Query: 291 ELSDERLSVYLEY-VSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           +  +E   +YL+  + G S+ +  + +G    E  +  Y R  LL LA+LH++  VH D+
Sbjct: 124 QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           K ANI + P G  KL DFG+   + +  +    +G P +MAPE++  +  Y    D++SL
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAADVFSL 241
Query: 409 GCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           G T+LE+A +       EG     ++      PE    LS + +S +   L+ DP  R  
Sbjct: 242 GLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRAT 298
Query: 469 ASKLLDHPFVRD 480
           A  LL  P +R 
Sbjct: 299 AEALLALPVLRQ 310

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 45/279 (16%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V    N+   +  AIK++R       ++E L  +  E+ LL+ L+H  +VRY+ 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 290 SELSDER-------------LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT--RQILLG 334
           + L                 L + +EY    +++ L+      N+   + +   RQIL  
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN-LNQQRDEYWRLFRQILEA 128
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK------------ 382
           L+Y+H++  +HRD+K  NI +D    +K+ DFG+AK++     +L               
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 383 ---GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD 439
              G+  ++A EV+  T  Y+  +D++SLG    EM     P+S       I K   S  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS 245
Query: 440 IPEIPEHLSDD----AKSFIKQCLQRDPSARPPASKLLD 474
           I E P    D+     K  I+  +  DP+ RP A  LL+
Sbjct: 246 I-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 53  GAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M     + ++ APE+++N   Y+ TVDI
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMXGXVATRWYRAPEIMLNWMHYNQTVDI 226
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 227 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLAQM 285
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 326

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 114/200 (57%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 54  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 109
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VYL  ++ G  ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 168
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 169 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 228
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 229 IDIWSVGCILAEMLSNRPIF 248

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 47  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 220 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 279
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 280 KKRDERPLFPQIL 292

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 39  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 151
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 212 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 271
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 272 KKRDERPLFPQIL 284

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 128/259 (49%), Gaps = 13/259 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+    + +G   A K ++        KE +K    EI++++QL H N+++ + +
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIK--TRGMKDKEEVKN---EISVMNQLDHANLIQLYDA 154
Query: 291 ELSDERLSVYLEYVSGGSIH-KLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             S   + + +EYV GG +  +++ E     E     + +QI  G+ ++H    +H D+K
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 350 GANILV--DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWS 407
             NIL       +IK+ DFG+A+       +    G+P ++APEVV N +  S   D+WS
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWS 273
Query: 408 LGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           +G     + +   P+   +  E +  I       +  E  + +S++AK FI + L ++ S
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKS 332
Query: 465 ARPPASKLLDHPFVRDQAV 483
            R  AS+ L HP++ D  +
Sbjct: 333 WRISASEALKHPWLSDHKL 351

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ D+G+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDYGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 136/312 (43%), Gaps = 54/312 (17%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +GTFG V LG    +G   AIK+V     D   +    Q+ Q+   L+ L HPNIV+   
Sbjct: 33  QGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQD---LAVLHHPNIVQLQS 86
Query: 290 -------SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEP----VIQTYTRQILLGLAYL 338
                   +  D  L+V +EYV   ++H+  + Y          +I+ +  Q++  +  L
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 339 H--ARNTVHRDIKGANILV-DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           H  + N  HRDIK  N+LV +  G +KL DFG AK ++     +++  S Y+ APE++  
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG 205
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPW------SQYEGVAAIF----------------- 432
              Y+  VDIWS+GC   EM   +P +       Q   +  +                  
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD 265
Query: 433 -KIGNSKDIP---EIPEHLSDDAKS---FIKQCLQRDPSARPPASKLLDHPF---VRDQA 482
             + NSK IP      +H   DAK     +   LQ  P  R    + L HP+   + D A
Sbjct: 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325
Query: 483 VARAGNVNLAKD 494
                N +L +D
Sbjct: 326 TKLPNNKDLPED 337

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/354 (22%), Positives = 154/354 (43%), Gaps = 89/354 (25%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG++G+VYL ++  + +  AIK+V  + +D    +C K++ +EI +L++L    I+R + 
Sbjct: 36  RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI--DC-KRILREITILNRLKSDYIIRLYD 92
Query: 290 SELSDE-----RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
             + D+      L + LE ++   + KL +      E  I+T    +LLG  ++H    +
Sbjct: 93  LIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGII 151
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTS-----------------------CASMLSF 381
           HRD+K AN L++    +K+ DFG+A+ + S                          + S 
Sbjct: 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH 211
Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA----------TSKPPW--------- 422
             + ++ APE+++    Y+ ++DIWS GC   E+           T++ P          
Sbjct: 212 VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPL 271
Query: 423 ------------SQYEGVAAIFKI------GNSKDI--PEIPEH---------------- 446
                       S  + +  IF I       + K+I  PE+ ++                
Sbjct: 272 SPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331
Query: 447 --LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPY 498
             +SDD  + ++  L+ +P+ R    + LDHP+++D    +  N +  K   P+
Sbjct: 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPF 385

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M     + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGXVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 231 GTFGHVYLG-FNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L  ++ E   +G+  A+K ++     ++    +  L +EI +L  L H NIV+
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT-----YTRQILLGLAYLH 339
           Y G  +E     + + +E++  GS    L+EY P N+  I       Y  QI  G+ YL 
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMN 395
           +R  VHRD+   N+LV+   ++K+ DFG+ K + +     + K    SP +W APE +M 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 396 TNGYSLTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNS----KDI 440
           +  Y +  D+WS G T+ E+ T       P + +        G   + ++ N+    K +
Sbjct: 204 SKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           P  P +  D+    +++C +  PS R     L++
Sbjct: 263 P-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 47  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 220 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 279
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 280 KKRDERPLFPQIL 292

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 22/265 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V L  +  S ++ A+K +       +  E +K+       +E ++++  + P +
Sbjct: 85  RGAFGEVQLVRHKASQKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFANSPWV 137
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           V+   +   D+ L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+   +
Sbjct: 138 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLI 196
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTNG---Y 399
           HRD+K  N+L+D HG +KLADFG    M  T      +  G+P +++PEV+ +  G   Y
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYY 256
Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSFIKQ 457
               D WS+G  + EM     P+     V    KI + K+    PE   +S  AK+ I  
Sbjct: 257 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICA 316
Query: 458 CL--QRDPSARPPASKLLDHPFVRD 480
            L  +     R    ++  HPF ++
Sbjct: 317 FLTDREVRLGRNGVEEIKQHPFFKN 341

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 19  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 252 KKRDERPLFPQIL 264

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 46  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 100 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 158
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 218
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 219 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 278
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 279 KKRDERPLFPQIL 291

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 42/287 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V       +GQ  AIK++    D  T+    K+  +E+ +L    H NI+     
Sbjct: 66  GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA---KRTLRELKILKHFKHDNIIAIKDI 122
Query: 290 ---SELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
              +    E  SVY+   +    +H+++    P     ++ +  Q+L GL Y+H+   +H
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIH 182
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVVMNTNGYS 400
           RD+K +N+LV+ + E+K+ DFGMA+ + +  +     M  +  + ++ APE++++ + Y+
Sbjct: 183 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 242
Query: 401 LTVDIWSLGCTVLEM-----------------------ATSKPPWSQYEGV----AAIFK 433
             +D+WS+GC   EM                        T  P   Q  G     A I  
Sbjct: 243 QAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS 302
Query: 434 IGNSKDIPEIPEHLSDD--AKSFIKQCLQRDPSARPPASKLLDHPFV 478
           +   + +P    +   D  A S + + L+ +PSAR  A+  L HPF+
Sbjct: 303 LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 133/266 (50%), Gaps = 22/266 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   ++ +SG   A+K++             K+  +E+ LL  + H N++     
Sbjct: 62  GAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 118
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 177
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N   Y++TVDI
Sbjct: 178 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNMTVDI 235
Query: 406 WSLGCTVLEMATSKPPW------SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           WS+GC + E+ T +  +      +Q + +  +     +  I  +P H + +  + + Q  
Sbjct: 236 WSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMP 295
Query: 460 QRDPS-----ARPPASKLLDHPFVRD 480
           +R+ +     A P A  LL+   V D
Sbjct: 296 KRNFADVFIGANPLAVDLLEKMLVLD 321

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 231 GTFGHVYLG-FNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L  ++ E   +G+  A+K ++     ++    +  L +EI +L  L H NIV+
Sbjct: 20  GHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT-----YTRQILLGLAYLH 339
           Y G  +E     + + +E++  GS    L+EY P N+  I       Y  QI  G+ YL 
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMN 395
           +R  VHRD+   N+LV+   ++K+ DFG+ K + +     + K    SP +W APE +M 
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 396 TNGYSLTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNS----KDI 440
           +  Y +  D+WS G T+ E+ T       P + +        G   + ++ N+    K +
Sbjct: 192 SKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 250
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           P  P +  D+    +++C +  PS R     L++
Sbjct: 251 P-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 18/260 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEV-RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           RG++G V +     +    A K++ +   +D      + +  QEI ++  L HPNI+R +
Sbjct: 36  RGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLY 89
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   +  + + +E  +GG + + +     F E       + +L  +AY H  N  HRD+
Sbjct: 90  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 149
Query: 349 KGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  N L     P   +KL DFG+A        M +  G+PY+++P+V+     Y    D 
Sbjct: 150 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDE 207
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE----HLSDDAKSFIKQCLQR 461
           WS G  +  +    PP+S       + KI   +     PE    ++S  A+S I++ L +
Sbjct: 208 WSAGVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPEKDWLNVSPQAESLIRRLLTK 265
Query: 462 DPSARPPASKLLDHPFVRDQ 481
            P  R  + + L+H +   Q
Sbjct: 266 SPKQRITSLQALEHEWFEKQ 285

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 137/281 (48%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++             K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ DF +A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDFYLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 133/287 (46%), Gaps = 42/287 (14%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V       +GQ  AIK++    D  T+    K+  +E+ +L    H NI+     
Sbjct: 65  GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA---KRTLRELKILKHFKHDNIIAIKDI 121
Query: 290 ---SELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
              +    E  SVY+   +    +H+++    P     ++ +  Q+L GL Y+H+   +H
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIH 181
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVVMNTNGYS 400
           RD+K +N+LV+ + E+K+ DFGMA+ + +  +     M  +  + ++ APE++++ + Y+
Sbjct: 182 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 241
Query: 401 LTVDIWSLGCTVLEMATSKPPW------SQYEGV---------AAIFKIGNSKD---IPE 442
             +D+WS+GC   EM   +  +       Q + +         A I  +G  +    I  
Sbjct: 242 QAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS 301
Query: 443 IPEH-----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           +P                 A S + + L+ +PSAR  A+  L HPF+
Sbjct: 302 LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 18/260 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEV-RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           RG++G V +     +    A K++ +   +D      + +  QEI ++  L HPNI+R +
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +   +  + + +E  +GG + + +     F E       + +L  +AY H  N  HRD+
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 132
Query: 349 KGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           K  N L     P   +KL DFG+A        M +  G+PY+++P+V+     Y    D 
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDE 190
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE----HLSDDAKSFIKQCLQR 461
           WS G  +  +    PP+S       + KI   +     PE    ++S  A+S I++ L +
Sbjct: 191 WSAGVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPEKDWLNVSPQAESLIRRLLTK 248
Query: 462 DPSARPPASKLLDHPFVRDQ 481
            P  R  + + L+H +   Q
Sbjct: 249 SPKQRITSLQALEHEWFEKQ 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 24  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 197 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 256
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 257 KKRDERPLFPQIL 269

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 120/243 (49%), Gaps = 16/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ + S ++ A+K ++           ++   +E NL+  L H  +VR +  
Sbjct: 23  GQFGEVWMGYYNNSTKV-AVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +E + +  E+++ GS+   L+  E G    P +  ++ QI  G+AY+  +N +HRD+
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + AN+LV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  ++
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAI-NFGCFTIKSNV 193
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  K P+        +  +     +P + E+  D+    +K C +    
Sbjct: 194 WSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-ENCPDELYDIMKMCWKEKAE 252
Query: 465 ARP 467
            RP
Sbjct: 253 ERP 255

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 24  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 197 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 256
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 257 KKRDERPLFPQIL 269

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 16/254 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+   + E  +   +K ++   V+ D       L ++  EI +LS++ H NI++ 
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94
Query: 288 HGSELSDERLSVYLE-YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                +     + +E + SG  +   +  +   +EP+     RQ++  + YL  ++ +HR
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           DIK  NI++     IKL DFG A ++       +F G+  + APEV+M        +++W
Sbjct: 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMW 214
Query: 407 SLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           SLG T+  +   + P+ + E    AAI            P  +S +  S +   LQ  P 
Sbjct: 215 SLGVTLYTLVFEENPFCELEETVEAAIHP----------PYLVSKELMSLVSGLLQPVPE 264
Query: 465 ARPPASKLLDHPFV 478
            R    KL+  P+V
Sbjct: 265 RRTTLEKLVTDPWV 278

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 21  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 133
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 193
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 194 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 253
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 254 KKRDERPLFPQIL 266

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 46/295 (15%)
Query: 231 GTFGHVYLGFNSESGQMCAIKE---VRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+L   +E   +C  ++   V V      S    K  ++E  LL+ L H +IV++
Sbjct: 24  GAFGKVFL---AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGP-------------FNEPVIQTYTRQILLG 334
           +G  +  + L +  EY+  G ++K L+ +GP               +  +    +QI  G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           + YL +++ VHRD+   N LV  +  +K+ DFGM++ + S         +ML  +    W
Sbjct: 141 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----W 196
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEH 446
           M PE +M    ++   D+WSLG  + E+ T  K PW Q      I  I   + + + P  
Sbjct: 197 MPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPRT 254
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLD 501
              +    +  C QR+P  R     +  H  ++          NLAK +SP  LD
Sbjct: 255 CPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ----------NLAK-ASPVYLD 296

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 19  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +  +L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 252 KKRDERPLFPQIL 264

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+  FG+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILGFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G+FG VY G     G + A+K + V      + + L+    E+ +L +  H NI+ + G 
Sbjct: 19  GSFGTVYKG--KWHGDV-AVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             + + L++  ++  G S+ H L      F    +    RQ   G+ YLHA++ +HRD+K
Sbjct: 73  STAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSPYWMAPEVV--MNTNGYSLTVD 404
             NI +     +K+ DFG+A   +  +    F+   GS  WMAPEV+   + N YS   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 405 IWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGN---SKDIPEIPEHLSDDAKSFIKQCLQ 460
           +++ G  + E+ T + P+S        IF +G    S D+ ++  +     K  + +CL+
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251
Query: 461 RDPSARPPASKLL 473
           +    RP   ++L
Sbjct: 252 KKRDERPLFPQIL 264

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ D G+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDAGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 43/289 (14%)
Query: 231 GTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG V+L         +   + A+K ++     + S+   +   +E  LL+ L H +IV
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIV 106
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV---------------IQTYTRQ 330
           R+ G       L +  EY+  G +++ L+ +GP  + +               +     Q
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKG 383
           +  G+ YL   + VHRD+   N LV     +K+ DFGM++ + S         +ML  + 
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 225
Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE 442
              WM PE ++    ++   D+WS G  + E+ T  K PW Q     AI  I   +++ E
Sbjct: 226 ---WMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL-E 280
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNL 491
            P     +  + ++ C QR+P  R     +      R QA+A+A  V L
Sbjct: 281 RPRACPPEVYAIMRGCWQREPQQRHSIKDV----HARLQALAQAPPVYL 325

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 77  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 191
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK---DLQDVLKCCLKRD 308
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 309 PKQRISIPELLAHPYVQIQT 328

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ D G+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDRGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 77  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 191
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK---DLQDVLKCCLKRD 308
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 309 PKQRISIPELLAHPYVQIQT 328

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 77  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 191
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK---DLQDVLKCCLKRD 308
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 309 PKQRISIPELLAHPYVQIQT 328

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   F++++G   A+K++        S    K+  +E+ LL  + H N++     
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 287 YHGSELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +  +   +E   VYL  ++ G  ++ +++      +  +Q    QIL GL Y+H+ + +H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+K+ D G+A+H      M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 149 RDLKPSNLAVNEDCELKILDGGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 206
Query: 406 WSLGCTVLEMATSK---PPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WS+GC + E+ T +   P     + +  I ++  +     + +  S+ A+++I Q L + 
Sbjct: 207 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-QSLTQM 265
Query: 463 PS---------ARPPASKLLDHPFVRD--------QAVARA 486
           P          A P A  LL+   V D        QA+A A
Sbjct: 266 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 43/289 (14%)
Query: 231 GTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG V+L         +   + A+K ++     + S+   +   +E  LL+ L H +IV
Sbjct: 23  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIV 77
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV---------------IQTYTRQ 330
           R+ G       L +  EY+  G +++ L+ +GP  + +               +     Q
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKG 383
           +  G+ YL   + VHRD+   N LV     +K+ DFGM++ + S         +ML  + 
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 196
Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE 442
              WM PE ++    ++   D+WS G  + E+ T  K PW Q     AI  I   +++ E
Sbjct: 197 ---WMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL-E 251
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNL 491
            P     +  + ++ C QR+P  R     +      R QA+A+A  V L
Sbjct: 252 RPRACPPEVYAIMRGCWQREPQQRHSIKDV----HARLQALAQAPPVYL 296

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 30  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 87  VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 144
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 205 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRD 261
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 262 PKQRISIPELLAHPYVQIQT 281

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 43/289 (14%)
Query: 231 GTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG V+L         +   + A+K ++     + S+   +   +E  LL+ L H +IV
Sbjct: 29  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIV 83
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV---------------IQTYTRQ 330
           R+ G       L +  EY+  G +++ L+ +GP  + +               +     Q
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKG 383
           +  G+ YL   + VHRD+   N LV     +K+ DFGM++ + S         +ML  + 
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 202
Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPE 442
              WM PE ++    ++   D+WS G  + E+ T  K PW Q     AI  I   +++ E
Sbjct: 203 ---WMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL-E 257
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNL 491
            P     +  + ++ C QR+P  R     +      R QA+A+A  V L
Sbjct: 258 RPRACPPEVYAIMRGCWQREPQQRHSIKDV----HARLQALAQAPPVYL 302

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 126/267 (47%), Gaps = 30/267 (11%)
Query: 231 GTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L      N  +G+M A+K ++  C  Q          QEI++L  L H +I++
Sbjct: 25  GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS----GWKQEIDILRTLYHEHIIK 80
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           Y G   +  ++ L + +EYV  GS+   L  +       +  + +QI  G+AYLHA++ +
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYI 139
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNGYS 400
           HR++   N+L+D    +K+ DFG+AK +         +    SP +W APE +     Y 
Sbjct: 140 HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY 199
Query: 401 LTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNSKDIPE---IPEH 446
            + D+WS G T+ E+ T    S+ P +++       +G   + ++    +  E    P+ 
Sbjct: 200 AS-DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 258
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLL 473
              +    +K C + + S RP    L+
Sbjct: 259 CPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   ++       AIK++    + QT   C + L +EI +L +  H N++     
Sbjct: 54  GAYGMVSSAYDHVRKTRVAIKKISPF-EHQTY--CQRTL-REIQILLRFRHENVIGIRDI 109
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              S L   R    ++ +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-FLYQILRGLKYIHSANVLHR 168
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +     + ++ APE+++N+ GY+ +
Sbjct: 169 DLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKS 228
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 229 IDIWSVGCILAEMLSNRPIF 248

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           GT+G VY   ++ + +  AIK +R+   +   +       +E++LL +L H NI+     
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRL---EHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
              + RL +  EY +   + K + +    +  VI+++  Q++ G+ + H+R  +HRD+K 
Sbjct: 102 IHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160
Query: 351 ANILVDPHGE-----IKLADFGMAKHMTSCASMLSFKGSPYWMAP-EVVMNTNGYSLTVD 404
            N+L+          +K+ DFG+A+         + +    W  P E+++ +  YS +VD
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVD 220
Query: 405 IWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE-----HLSDDAKSFIK--- 456
           IWS+ C   EM    P +     +  +FKI     +P+         L D  +SF K   
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRG 280
Query: 457 --------------------QCLQRDPSARPPASKLLDHPF 477
                                 L+ DP  R  A   L+HP+
Sbjct: 281 KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 112/235 (47%), Gaps = 28/235 (11%)
Query: 264 ECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFN-- 320
           EC    ++E+ LL +   HPN++RY  +E   +      +Y++       LQEY      
Sbjct: 59  ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ-----FQYIAIELCAATLQEYVEQKDF 113
Query: 321 -----EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIK--LADFGMAK 370
                EP+  T  +Q   GLA+LH+ N VHRD+K  NIL+   + HG+IK  ++DFG+ K
Sbjct: 114 AHLGLEPI--TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 371 HMTSCASMLSFK----GSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMAT--SKPPW 422
            +       S +    G+  W+APE++        + TVDI+S GC    + +  S P  
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 423 SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
              +  A I     S D     +H    A+  I++ +  DP  RP A  +L HPF
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 34/273 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIV---- 285
           G  G V   F+  +GQ CA+K   ++ D   ++       QE++   Q S  P+IV    
Sbjct: 40  GVNGKVLECFHRRTGQKCALK---LLYDSPKAR-------QEVDHHWQASGGPHIVCILD 89
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y         L + +E + GG +   +QE G   F E       R I   + +LH+ N 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 344 VHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L    +    +KL DFG AK  T  A + +   +PY++APEV +    Y 
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEV-LGPEKYD 207
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI---------PEIPEHLSDDA 451
            + D+WSLG  +  +    PP+  Y         G  + I         PE  E +S+DA
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPF--YSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDA 264
Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           K  I+  L+ DP+ R   ++ ++HP++    V 
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 89  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 148
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 207
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 208 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 267
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 268 DRPTFVALRD 277

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 34/273 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIV---- 285
           G  G V   F+  +GQ CA+K   ++ D   ++       QE++   Q S  P+IV    
Sbjct: 21  GVNGKVLECFHRRTGQKCALK---LLYDSPKAR-------QEVDHHWQASGGPHIVCILD 70
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y         L + +E + GG +   +QE G   F E       R I   + +LH+ N 
Sbjct: 71  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 130
Query: 344 VHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L    +    +KL DFG AK  T  A + +   +PY++APEV +    Y 
Sbjct: 131 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEV-LGPEKYD 188
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI---------PEIPEHLSDDA 451
            + D+WSLG  +  +    PP+  Y         G  + I         PE  E +S+DA
Sbjct: 189 KSCDMWSLGVIMYILLCGFPPF--YSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDA 245
Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           K  I+  L+ DP+ R   ++ ++HP++    V 
Sbjct: 246 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 278

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 122/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 78
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    + +E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 196
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 197 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 254
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 255 SDRPSFAEI 263

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 120/273 (43%), Gaps = 41/273 (15%)
Query: 230 RGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V L         +G + A+K+++    DQ      +   +EI +L  L    IV
Sbjct: 20  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDFIV 74
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARN 342
           +Y G      R  L + +EY+  G +   LQ +    +   +  Y+ QI  G+ YL +R 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            VHRD+   NILV+    +K+ADFG+AK +         +    SP +W APE  ++ N 
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE-SLSDNI 193
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEI----------- 443
           +S   D+WS G  + E+ T    S  P +++     +  +G+ +D+P +           
Sbjct: 194 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGSERDVPALSRLLELLEEGQ 248
Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARPPASKL 472
               P     +    +K C    P  RP  S L
Sbjct: 249 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 122/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    + +E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 200
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 201 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 259 SDRPSFAEI 267

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 22/253 (8%)
Query: 231 GTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+ G            AIK     C + TS    ++  QE   + Q  HP+IV+ 
Sbjct: 21  GQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G  +++  + + +E  + G +   LQ      +   +  Y  Q+   LAYL ++  VHR
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVD 404
           DI   N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI-NFRRFTSASD 194
Query: 405 IWSLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +W  G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C 
Sbjct: 195 VWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCW 249
Query: 460 QRDPSARPPASKL 472
             DPS RP  ++L
Sbjct: 250 AYDPSRRPRFTEL 262

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 33  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 89
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 90  VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 147
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 148 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 207
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 208 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRD 264
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 265 PKQRISIPELLAHPYVQIQT 284

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 49  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 163
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 224 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK---DLQDVLKCCLKRD 280
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 281 PKQRISIPELLAHPYVQIQT 300

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 138
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 197
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 258 DRPTFVALRD 267

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 29  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 85
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 86  VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 143
Query: 360 EIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M   T+     S  G+  +M PE + +      NG S +      D+W
Sbjct: 144 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 203
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 204 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRD 260
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 261 PKQRISIPELLAHPYVQIQT 280

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 19/258 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL---KQLNQEINLLSQLSHPNIVR 286
           +G FG V+ G   +   + AIK + ++ D +   E +   ++  +E+ ++S L+HPNIV+
Sbjct: 29  KGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 287 YHGSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--T 343
            +G   +  R+   +E+V  G + H+LL +  P    V       I LG+ Y+  +N   
Sbjct: 88  LYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 344 VHRDIKGANILVDPHGE-----IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV-MNTN 397
           VHRD++  NI +    E      K+ADFG+++   S  S+    G+  WMAPE +     
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYE--GVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
            Y+   D +S    +  + T + P+ +Y    +  I  I      P IPE      ++ I
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVI 263
Query: 456 KQCLQRDPSARPPASKLL 473
           + C   DP  RP  S ++
Sbjct: 264 ELCWSGDPKKRPHFSYIV 281

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 89  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 148
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 207
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 208 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 267
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 268 DRPTFVALRD 277

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 83  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 142
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 143 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 201
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 202 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 261
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 262 DRPTFVALRD 271

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 57/283 (20%)
Query: 253 VRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL 312
           VR +  +  S E +  L  E+++    +HPNIV Y  + ++D  L V   +++ GS   L
Sbjct: 57  VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL 116
Query: 313 LQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF---- 366
           +  +     NE  I    + +L  L Y+H    VHR +K ++IL+   G++ L+      
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 367 -----GMAKHMTSCASMLSFKGSPYWMAPEVV-MNTNGYSLTVDIWSLGCTVLEMATSKP 420
                G  + +       S K  P W++PEV+  N  GY    DI+S+G T  E+A    
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 421 PWSQYEGVAAIFK---------------------------IGNS---------------K 438
           P+        + +                           + NS                
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
Query: 439 DIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           D P  P H   S     F++QCLQR+P ARP AS LL+H F +
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 52/300 (17%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY-- 287
           +G++G V +   +++  + AIK +      Q + + ++++  E+ L+ +L HPNI R   
Sbjct: 36  QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95
Query: 288 ---------------HGSELSDERLSVYLEYVSG-----------------------GSI 309
                          HG  L D +L+V+++  +G                       GSI
Sbjct: 96  VYEDEQYICLVMELCHGGHLLD-KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 310 HKLLQEYGPFN-EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG--EIKLADF 366
           H   +       E +I    RQI   L YLH +   HRDIK  N L   +   EIKL DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 367 GMAKHMTSCAS-----MLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKP 420
           G++K      +     M +  G+PY++APEV+  TN  Y    D WS G  +  +     
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 421 PWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           P+        I ++ N K   E P +  LS  A+  +   L R+   R  A + L HP++
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 57/283 (20%)
Query: 253 VRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL 312
           VR +  +  S E +  L  E+++    +HPNIV Y  + ++D  L V   +++ GS   L
Sbjct: 41  VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL 100
Query: 313 LQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF---- 366
           +  +     NE  I    + +L  L Y+H    VHR +K ++IL+   G++ L+      
Sbjct: 101 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 160
Query: 367 -----GMAKHMTSCASMLSFKGSPYWMAPEVV-MNTNGYSLTVDIWSLGCTVLEMATSKP 420
                G  + +       S K  P W++PEV+  N  GY    DI+S+G T  E+A    
Sbjct: 161 SMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 219
Query: 421 PWSQYEGVAAIFK---------------------------IGNS---------------K 438
           P+        + +                           + NS                
Sbjct: 220 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 279
Query: 439 DIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           D P  P H   S     F++QCLQR+P ARP AS LL+H F +
Sbjct: 280 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 322

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 138
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 197
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 258 DRPTFVALRD 267

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 89
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 149 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 209 IDIWSVGCILAEMLSNRPIF 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 41/273 (15%)
Query: 230 RGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V L         +G + A+K+++    DQ      +   +EI +L  L    IV
Sbjct: 17  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDFIV 71
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARN 342
           +Y G      R  L + +EY+  G +   LQ +    +   +  Y+ QI  G+ YL +R 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            VHRD+   NILV+    +K+ADFG+AK +         +    SP +W APE  ++ N 
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE-SLSDNI 190
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEI----------- 443
           +S   D+WS G  + E+ T    S  P +++     +  +G  +D+P +           
Sbjct: 191 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGCERDVPALCRLLELLEEGQ 245
Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARPPASKL 472
               P     +    +K C    P  RP  S L
Sbjct: 246 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 231 GTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+ G            AIK     C + TS    ++  QE   + Q  HP+IV+ 
Sbjct: 21  GQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
            G  +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VH
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVH 134
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTV 403
           RDI   N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 193
Query: 404 DIWSLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           D+W  G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C
Sbjct: 194 DVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKC 248
Query: 459 LQRDPSARPPASKL 472
              DPS RP  ++L
Sbjct: 249 WAYDPSRRPRFTEL 262

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 41/273 (15%)
Query: 230 RGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V L         +G + A+K+++    DQ      +   +EI +L  L    IV
Sbjct: 21  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDFIV 75
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARN 342
           +Y G      R  L + +EY+  G +   LQ +    +   +  Y+ QI  G+ YL +R 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            VHRD+   NILV+    +K+ADFG+AK +         +    SP +W APE  ++ N 
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE-SLSDNI 194
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEI----------- 443
           +S   D+WS G  + E+ T    S  P +++     +  +G  +D+P +           
Sbjct: 195 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGCERDVPALCRLLELLEEGQ 249
Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARPPASKL 472
               P     +    +K C    P  RP  S L
Sbjct: 250 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 30/267 (11%)
Query: 231 GTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L      N  +G+M A+K ++  C  Q          QEI++L  L H +I++
Sbjct: 25  GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS----GWKQEIDILRTLYHEHIIK 80
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           Y G   +  ++ L + +EYV  GS+   L  +       +  + +QI  G+AYLH+++ +
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQHYI 139
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNGYS 400
           HR++   N+L+D    +K+ DFG+AK +         +    SP +W APE +     Y 
Sbjct: 140 HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY 199
Query: 401 LTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNSKDIPE---IPEH 446
            + D+WS G T+ E+ T    S+ P +++       +G   + ++    +  E    P+ 
Sbjct: 200 AS-DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 258
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLL 473
              +    +K C + + S RP    L+
Sbjct: 259 CPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G    S +  A+      C + TS    ++  QE   + Q  HP+IV+  G 
Sbjct: 26  GQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 84
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VHRDI
Sbjct: 85  -ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVDIW 406
              N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D+W
Sbjct: 143 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVW 201
Query: 407 SLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C   
Sbjct: 202 MFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAY 256
Query: 462 DPSARPPASKL 472
           DPS RP  ++L
Sbjct: 257 DPSRRPRFTEL 267

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 36  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 91
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 150
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 151 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 211 IDIWSVGCILAEMLSNRPIF 230

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G    S +  A+      C + TS    ++  QE   + Q  HP+IV+  G 
Sbjct: 49  GQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 107
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VHRDI
Sbjct: 108 -ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 165
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVDIW 406
              N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D+W
Sbjct: 166 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVW 224
Query: 407 SLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C   
Sbjct: 225 MFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAY 279
Query: 462 DPSARPPASKL 472
           DPS RP  ++L
Sbjct: 280 DPSRRPRFTEL 290

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 83  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 142
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 143 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 201
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 202 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 261
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 262 DRPTFVALRD 271

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 89
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 149 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 209 IDIWSVGCILAEMLSNRPIF 228

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 200
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 201 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 259 SDRPSFAEI 267

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 89
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 149 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 209 IDIWSVGCILAEMLSNRPIF 228

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G    S +  A+      C + TS    ++  QE   + Q  HP+IV+  G 
Sbjct: 24  GQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VHRDI
Sbjct: 83  -ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 140
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVDIW 406
              N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D+W
Sbjct: 141 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVW 199
Query: 407 SLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C   
Sbjct: 200 MFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAY 254
Query: 462 DPSARPPASKL 472
           DPS RP  ++L
Sbjct: 255 DPSRRPRFTEL 265

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L    H NI+  +  
Sbjct: 36  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLAFRHENIIGINDI 91
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 150
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 151 DLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 211 IDIWSVGCILAEMLSNRPIF 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 42  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 97
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 156
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 157 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 216
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 217 IDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 89
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 149 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 209 IDIWSVGCILAEMLSNRPIF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 93
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 153 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G    S +  A+      C + TS    ++  QE   + Q  HP+IV+  G 
Sbjct: 23  GQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 81
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VHRDI
Sbjct: 82  -ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVDIW 406
              N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D+W
Sbjct: 140 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVW 198
Query: 407 SLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C   
Sbjct: 199 MFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAY 253
Query: 462 DPSARPPASKL 472
           DPS RP  ++L
Sbjct: 254 DPSRRPRFTEL 264

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 13/264 (4%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG V+    + S +    K V+V   DQ        + +EI++L+   H NI+  H 
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARHRNILHLHE 68
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           S  S E L +  E++SG  I + +       NE  I +Y  Q+   L +LH+ N  H DI
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 349 KGANILVDPH--GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           +  NI+        IK+ +FG A+ +    +      +P + APE V   +  S   D+W
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVSTATDMW 187
Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI--PEIPEHLSDDAKSFIKQCLQRDPS 464
           SLG  V  + +   P+        I  I N++     E  + +S +A  F+ + L ++  
Sbjct: 188 SLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247
Query: 465 ARPPASKLLDHPFVRDQAVARAGN 488
           +R  AS+ L HP+++ Q + R   
Sbjct: 248 SRMTASEALQHPWLK-QKIERVST 270

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 89
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 149 DLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 209 IDIWSVGCILAEMLSNRPIF 228

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 114/225 (50%), Gaps = 21/225 (9%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLS-VYLEYVSGGSIHKLLQEYGPFNEPVIQ 325
           ++L +E  +   L HPNIVR H S +S+E    +  + V+GG + + +     ++E    
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDS-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS 133
Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMT-SCASMLSF 381
               QIL  + ++H  + VHRD+K  N+L+        +KLADFG+A  +     +   F
Sbjct: 134 HCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF 193
Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQ-----YEGVAAIFKIG 435
            G+P +++PE V+  + Y   VDIW+ G  +  +    PP W +     Y+ + A     
Sbjct: 194 AGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKA----- 247
Query: 436 NSKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
            + D P  PE   ++ +AK+ I Q L  +P+ R  A + L HP+V
Sbjct: 248 GAYDFPS-PEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 54  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 109
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 168
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 169 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 228
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 229 IDIWSVGCILAEMLSNRPIF 248

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 39  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 94
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 153
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 154 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 213
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 214 IDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 40  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 95
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 154
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 155 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 214
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 215 IDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 31  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 86
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 145
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 146 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 205
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 206 IDIWSVGCILAEMLSNRPIF 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 22/253 (8%)
Query: 231 GTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+ G            AIK     C + TS    ++  QE   + Q  HP+IV+ 
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G  +++  + + +E  + G +   LQ      +   +  Y  Q+   LAYL ++  VHR
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVD 404
           DI   N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASD 574
Query: 405 IWSLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +W  G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C 
Sbjct: 575 VWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCW 629
Query: 460 QRDPSARPPASKL 472
             DPS RP  ++L
Sbjct: 630 AYDPSRRPRFTEL 642

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 93
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 152
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 200
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 201 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 259 SDRPSFAEI 267

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G+FG V  G +++ SG+  ++    +  D  +  E +    +E+N +  L H N++R +G
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             L+     V      G  + +L +  G F    +  Y  Q+  G+ YL ++  +HRD+ 
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 138
Query: 350 GANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDI 405
             N+L+     +K+ DFG+ + +        M   +  P+ W APE  + T  +S   D 
Sbjct: 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDT 197
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W  G T+ EM T  + PW    G   + KI    +    PE    D  + + QC    P 
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257
Query: 465 ARPPASKLLD 474
            RP    L D
Sbjct: 258 DRPTFVALRD 267

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 129/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + + +EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 200
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 201 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 259 SDRPSFAEI 267

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 32  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 87
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 146
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 147 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 206
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 207 IDIWSVGCILAEMLSNRPIF 226

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 41/253 (16%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RGT+GHVY     +          ++     +   C     +EI LL +L HPN++    
Sbjct: 31  RGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHPNVISLQK 85
Query: 290 SELS--DERLSVYLEYVSGGSIH--KLLQEYGPFNEPV------IQTYTRQILLGLAYLH 339
             LS  D ++ +  +Y      H  K  +      +PV      +++   QIL G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 340 ARNTVHRDIKGANILVD----PHGEIKLADFGMAKHMTS----CASMLSFKGSPYWMAPE 391
           A   +HRD+K ANILV       G +K+AD G A+   S     A +     + ++ APE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS------------QYEGVAAIFKI----- 434
           +++    Y+  +DIW++GC   E+ TS+P +              ++ +  IF +     
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265
Query: 435 -GNSKDIPEIPEH 446
             + +DI ++PEH
Sbjct: 266 DKDWEDIKKMPEH 278

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 41/273 (15%)
Query: 230 RGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           +G FG V L         +G + A+K+++    DQ      +   +EI +L  L    IV
Sbjct: 33  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDFIV 87
Query: 286 RYHGSELSDER--LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARN 342
           +Y G      R  L + +EY+  G +   LQ +    +   +  Y+ QI  G+ YL +R 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNG 398
            VHRD+   NILV+    +K+ADFG+AK +         +    SP +W APE  ++ N 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE-SLSDNI 206
Query: 399 YSLTVDIWSLGCTVLEMAT----SKPPWSQYEGVAAIFKIGNSKDIPEI----------- 443
           +S   D+WS G  + E+ T    S  P +++     +  +G  +D+P +           
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGCERDVPALSRLLELLEEGQ 261
Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARPPASKL 472
               P     +    +K C    P  RP  S L
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 81
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 141
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 199
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 200 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 257
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 258 SDRPSFAEI 266

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G    S +  A+      C + TS    ++  QE   + Q  HP+IV+  G 
Sbjct: 21  GQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 79
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VHRDI
Sbjct: 80  -ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVDIW 406
              N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D+W
Sbjct: 138 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVW 196
Query: 407 SLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C   
Sbjct: 197 MFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAY 251
Query: 462 DPSARPPASKL 472
           DPS RP  ++L
Sbjct: 252 DPSRRPRFTEL 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 231 GTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+ G            AIK     C + TS    ++  QE   + Q  HP+IV+ 
Sbjct: 21  GQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G  +++  + + +E  + G +   LQ      +   +  Y  Q+   LAYL ++  VHR
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVD 404
           DI   N+LV     +KL DFG++++M       + KG     WMAPE + N   ++   D
Sbjct: 136 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASD 194
Query: 405 IWSLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +W  G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C 
Sbjct: 195 VWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCW 249
Query: 460 QRDPSARPPASKL 472
             DPS RP  ++L
Sbjct: 250 AYDPSRRPRFTEL 262

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 32  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 87
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 146
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 147 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 206
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 207 IDIWSVGCILAEMLSNRPIF 226

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 323
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HR++
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNL 383
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 441
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 442 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 499
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 500 SDRPSFAEI 508

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 122/258 (47%), Gaps = 19/258 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL---KQLNQEINLLSQLSHPNIVR 286
           +G FG V+ G   +   + AIK + ++ D +   E +   ++  +E+ ++S L+HPNIV+
Sbjct: 29  KGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 287 YHGSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--T 343
            +G   +  R+   +E+V  G + H+LL +  P    V       I LG+ Y+  +N   
Sbjct: 88  LYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 344 VHRDIKGANILVDPHGE-----IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV-MNTN 397
           VHRD++  NI +    E      K+ADFG ++   S  S+    G+  WMAPE +     
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ--SVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYE--GVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
            Y+   D +S    +  + T + P+ +Y    +  I  I      P IPE      ++ I
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVI 263
Query: 456 KQCLQRDPSARPPASKLL 473
           + C   DP  RP  S ++
Sbjct: 264 ELCWSGDPKKRPHFSYIV 281

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 129/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + + +EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 109/200 (54%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++         +  L+    EI +L +  H NI+  +  
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRHENIIGINDI 93
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 152
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 153 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 45/279 (16%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V    N+   +  AIK++R       ++E L  +  E+ LL+ L+H  +VRY+ 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVXLLASLNHQYVVRYYA 69
Query: 290 SELSDER-------------LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT--RQILLG 334
           + L                 L +  EY    +++ L+      N+   + +   RQIL  
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN-LNQQRDEYWRLFRQILEA 128
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK------------ 382
           L+Y+H++  +HR++K  NI +D    +K+ DFG+AK++     +L               
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 383 ---GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD 439
              G+  ++A EV+  T  Y+  +D +SLG    E      P+S       I K   S  
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKKLRSVS 245
Query: 440 IPEIPEHLSDD----AKSFIKQCLQRDPSARPPASKLLD 474
           I E P    D+     K  I+  +  DP+ RP A  LL+
Sbjct: 246 I-EFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G    S +  A+      C + TS    ++  QE   + Q  HP+IV+  G 
Sbjct: 18  GQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +++  + + +E  + G +   LQ  +Y   +   +  Y  Q+   LAYL ++  VHRDI
Sbjct: 77  -ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 134
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVDIW 406
              N+LV  +  +KL DFG++++M       + KG     WMAPE + N   ++   D+W
Sbjct: 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVW 193
Query: 407 SLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
             G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C   
Sbjct: 194 MFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAY 248
Query: 462 DPSARPPASKL 472
           DPS RP  ++L
Sbjct: 249 DPSRRPRFTEL 259

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 79
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 197
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 198 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 255
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 256 SDRPSFAEI 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 195
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 196 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 254 SDRPSFAEI 262

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI----HKLLQEYGPFNEPVIQTY 327
           E  +L+++    IV    +  +   L + +  ++GG I    + + ++   F EP    Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPY 386
           T QI+ GL +LH RN ++RD+K  N+L+D  G ++++D G+A  + +  +    + G+P 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVA-AIFKIGNSKDIPEIP 444
           +MAPE+++    Y  +VD ++LG T+ EM  ++ P+ ++ E V     K    +     P
Sbjct: 355 FMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 445 EHLSDDAKSFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
           +  S  +K F +  LQ+DP  R          L  HP  RD
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L    H NI+  +  
Sbjct: 36  GAYGMVCSAYDNVNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLAFRHENIIGINDI 91
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 150
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 151 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 211 IDIWSVGCILAEMLSNRPIF 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 31  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 89
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 90  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 149
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 150 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 209
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 210 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 266
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 267 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 307

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 79
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 197
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 198 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 255
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 256 SDRPSFAEI 264

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 28  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 86
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 87  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 146
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 147 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 206
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 207 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 263
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 264 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 304

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 78
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 197
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 198 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 256
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 43  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 92
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 93  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 152
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 153 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 211
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 212 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 270
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 271 LIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 231 GTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V+ G            AIK     C + TS    ++  QE   + Q  HP+IV+ 
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G  +++  + + +E  + G +   LQ      +   +  Y  Q+   LAYL ++  VHR
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS--PYWMAPEVVMNTNGYSLTVD 404
           DI   N+LV     +KL DFG++++M       + KG     WMAPE + N   ++   D
Sbjct: 516 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASD 574
Query: 405 IWSLGCTVLE--MATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           +W  G  + E  M   KP    ++GV     I +I N + +P +P +      S + +C 
Sbjct: 575 VWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCW 629
Query: 460 QRDPSARPPASKL 472
             DPS RP  ++L
Sbjct: 630 AYDPSRRPRFTEL 642

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 195
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 196 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 254 SDRPSFAEI 262

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 73  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 122
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 241
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 300
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 79  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 128
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 129 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 188
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 189 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 247
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 248 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 306
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 307 LIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI----HKLLQEYGPFNEPVIQTY 327
           E  +L+++    IV    +  +   L + +  ++GG I    + + ++   F EP    Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPY 386
           T QI+ GL +LH RN ++RD+K  N+L+D  G ++++D G+A  + +  +    + G+P 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVA-AIFKIGNSKDIPEIP 444
           +MAPE+++    Y  +VD ++LG T+ EM  ++ P+ ++ E V     K    +     P
Sbjct: 355 FMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 445 EHLSDDAKSFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
           +  S  +K F +  LQ+DP  R          L  HP  RD
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 82
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQE---------YGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 83  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAY 142
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 203 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 259
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 260 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 300

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI----HKLLQEYGPFNEPVIQTY 327
           E  +L+++    IV    +  +   L + +  ++GG I    + + ++   F EP    Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPY 386
           T QI+ GL +LH RN ++RD+K  N+L+D  G ++++D G+A  + +  +    + G+P 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVA-AIFKIGNSKDIPEIP 444
           +MAPE+++    Y  +VD ++LG T+ EM  ++ P+ ++ E V     K    +     P
Sbjct: 355 FMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 445 EHLSDDAKSFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
           +  S  +K F +  LQ+DP  R          L  HP  RD
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 35  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 84
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 85  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 144
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 145 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 203
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSK-DIPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 204 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 262
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 263 LIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 138
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 198
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 258
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 259 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 315
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 356

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 98  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 157
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 218 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 274
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 275 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 315

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 33/293 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQE---------YGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 98  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAY 157
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 218 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 274
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSP 497
            + +++    ++ C    PS RP   +L++     D+ VA   N      S P
Sbjct: 275 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSNQEYLDLSMP 324

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI----HKLLQEYGPFNEPVIQTY 327
           E  +L+++    IV    +  +   L + +  ++GG I    + + ++   F EP    Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPY 386
           T QI+ GL +LH RN ++RD+K  N+L+D  G ++++D G+A  + +  +    + G+P 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVA-AIFKIGNSKDIPEIP 444
           +MAPE+++    Y  +VD ++LG T+ EM  ++ P+ ++ E V     K    +     P
Sbjct: 355 FMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 445 EHLSDDAKSFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
           +  S  +K F +  LQ+DP  R          L  HP  RD
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 33  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 82
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 83  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 142
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 143 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 201
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 202 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 260
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 261 LIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 90
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 150
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 208
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 209 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 266
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 267 SDRPSFAEI 275

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 32  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 90
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 91  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 150
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 151 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 210
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 211 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 267
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 268 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 308

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 34  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 83
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 84  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 143
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 144 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 202
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 203 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 261
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 262 LIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 22/261 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V       +GQ  A K   ++   + S    ++L +E  +   L HPNIVR H 
Sbjct: 32  KGAFSVVRRCVKVLAGQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S   +    +  + V+GG + + +     ++E       +QIL  + + H    VHRD+K
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLK 148
Query: 350 GANILVDPH---GEIKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
             N+L+        +KLADFG+A  +     +   F G+P +++PE V+  + Y   VD+
Sbjct: 149 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDL 207
Query: 406 WSLGCTVLEMATSKPP-WSQ-----YEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQ 457
           W+ G  +  +    PP W +     Y+ + A      + D P  PE   ++ +AK  I +
Sbjct: 208 WACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPS-PEWDTVTPEAKDLINK 261
Query: 458 CLQRDPSARPPASKLLDHPFV 478
            L  +PS R  A++ L HP++
Sbjct: 262 MLTINPSKRITAAEALKHPWI 282

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 27  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 76
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 77  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 136
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 137 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 195
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 196 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 254
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG++G+VYL ++  + +  AIK+V  + +D    +C K++ +EI +L++L    I+R H 
Sbjct: 38  RGSYGYVYLAYDKNANKNVAIKKVNRMFEDLI--DC-KRILREITILNRLKSDYIIRLHD 94
Query: 290 -----SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
                  L  + L + LE ++   + KL +      E  ++T    +LLG  ++H    +
Sbjct: 95  LIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGII 153
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTS--------------------------CASM 378
           HRD+K AN L++    +K+ DFG+A+ + S                             +
Sbjct: 154 HRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQL 213
Query: 379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM 415
            S   + ++ APE+++    Y+ ++DIWS GC   E+
Sbjct: 214 TSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 28  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 77
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 78  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 137
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 138 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 196
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 197 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 255
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 256 LIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AI+++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIRKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 93
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIHSANVLHR 152
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          Y P + P  Q  ++       
Sbjct: 98  NLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAY 157
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 218 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 274
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
            + +++    ++ C    PS RP   +L++     D+ VA   N
Sbjct: 275 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSN 315

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 277 QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 329
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 330 V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 389 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 446
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 502
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 503 KEPEERPTFEYL--QAFLED 520

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 38/286 (13%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYH 288
            G +  V    + ++G+  A+K +     ++ +     ++ +E+  L Q   + NI+   
Sbjct: 23  EGAYAKVQGAVSLQNGKEYAVKII-----EKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                D R  +  E + GGSI   +Q+   FNE       R +   L +LH +   HRD+
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 349 KGANILVDPHGE---IKLADFGMAKHM---TSCASMLSFK-----GSPYWMAPEVVM--- 394
           K  NIL +   +   +K+ DF +   M    SC  + + +     GS  +MAPEVV    
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 395 -NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV------AAIFKIGNSKDIPEIPE-- 445
                Y    D+WSLG  +  M +  PP+  + G         + ++  +K    I E  
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 446 ---------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
                    H+S +AK  I + L RD   R  A+++L HP+V+ QA
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQA 303

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 75
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 193
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 194 WAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 251
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 252 SDRPSFAEI 260

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 113/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 93
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE+++N+ GY+ +
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 122/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 75
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    + +E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 193
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 194 WAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 251
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 252 SDRPSFAEI 260

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 78
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 197
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 198 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 256
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 27/260 (10%)
Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSV 299
           +E  Q+ AIK V +   ++   + L     EI  L++L      I+R +  E++D+ + +
Sbjct: 49  NEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105
Query: 300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG 359
            +E      ++  L++    +    ++Y + +L  +  +H    VH D+K AN L+   G
Sbjct: 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 163
Query: 360 EIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMNT-----NGYSLTV-----DIW 406
            +KL DFG+A  M      +   S  G+  +M PE + +      NG S +      D+W
Sbjct: 164 MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 407 SLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           SLGC +  M   K P+    +Q   + AI    +  + P+IPE    D +  +K CL+RD
Sbjct: 224 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK---DLQDVLKCCLKRD 280
Query: 463 PSARPPASKLLDHPFVRDQA 482
           P  R    +LL HP+V+ Q 
Sbjct: 281 PKQRISIPELLAHPYVQIQT 300

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 122/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    + +E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 195
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 196 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 254 SDRPSFAEI 262

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 33/293 (11%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V L    G + +         V+++  D T K+ L  L  E+ ++  +  H NI+
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNII 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQ---------EYGPFNEPVIQTYTR------- 329
              G+   D  L V +EY S G++ + LQ          + P + P  Q  ++       
Sbjct: 98  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAY 157
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPY 386
           Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+   H+       + +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK 217
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIP 444
           WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       + P
Sbjct: 218 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGHRMDKP 274
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSP 497
            + +++    ++ C    PS RP   +L++     D+ VA   N      S P
Sbjct: 275 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTSNQEXLDLSMP 324

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 25/280 (8%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G FG VY G   + SG+      ++ +    T K+ +  L  E  ++ Q SH NI+R  G
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQFSHHNIIRLEG 113
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                + + +  EY+  G++ K L+E  G F+   +    R I  G+ YL   N VHRD+
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 173
Query: 349 KGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
              NILV+ +   K++DFG+++ +     +  +    K    W APE + +   ++   D
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASD 232
Query: 405 IWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           +WS G  + E+ T   +P W  S +E + AI   F++    D P     L       + Q
Sbjct: 233 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL-------MMQ 285
Query: 458 CLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSP 497
           C Q++ + RP   K  D   + D+ +    ++    D  P
Sbjct: 286 CWQQERARRP---KFADIVSILDKLIRAPDSLKTLADFDP 322

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 122/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    + +E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 195
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 196 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 254 SDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 78
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPE-SLAYNKFSIKSDV 196
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 197 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 254
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 255 SDRPSFAEI 263

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 19/258 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL---KQLNQEINLLSQLSHPNIVR 286
           +G FG V+ G   +   + AIK + ++ D +   E +   ++  +E+ ++S L+HPNIV+
Sbjct: 29  KGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 287 YHGSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--T 343
            +G   +  R+   +E+V  G + H+LL +  P    V       I LG+ Y+  +N   
Sbjct: 88  LYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 344 VHRDIKGANILVDPHGE-----IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV-MNTN 397
           VHRD++  NI +    E      K+ADF +++   S  S+    G+  WMAPE +     
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ--SVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYE--GVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
            Y+   D +S    +  + T + P+ +Y    +  I  I      P IPE      ++ I
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVI 263
Query: 456 KQCLQRDPSARPPASKLL 473
           + C   DP  RP  S ++
Sbjct: 264 ELCWSGDPKKRPHFSYIV 281

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 119/241 (49%), Gaps = 26/241 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V L  +  + ++ A+K +       +  E +K+       +E ++++  + P +
Sbjct: 79  RGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           V+   +   D  L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+   +
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFI 190
Query: 345 HRDIKGANILVDPHGEIKLADFG----MAKH-MTSCASMLSFKGSPYWMAPEVVMNTNG- 398
           HRD+K  N+L+D  G +KLADFG    M K  M  C + +   G+P +++PEV+ +  G 
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISPEVLKSQGGD 247
Query: 399 --YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSF 454
             Y    D WS+G  + EM     P+     V    KI N K+    P+   +S +AK+ 
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 455 I 455
           I
Sbjct: 308 I 308

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 30/267 (11%)
Query: 231 GTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L      N  +G+M A+K ++     Q          QEI++L  L H +I++
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS----GWKQEIDILRTLYHEHIIK 97
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           Y G   +     L + +EYV  GS+   L  +       +  + +QI  G+AYLHA++ +
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNGYS 400
           HRD+   N+L+D    +K+ DFG+AK +         +    SP +W APE +     Y 
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYY 216
Query: 401 LTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNSKDIPE---IPEH 446
            + D+WS G T+ E+ T    S+ P +++       +G   + ++    +  E    P+ 
Sbjct: 217 AS-DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 275
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLL 473
              +    +K C + + S RP    L+
Sbjct: 276 CPAEVYHLMKNCWETEASFRPTFENLI 302

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 29/265 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 27  GINGKVLQIFNKRTQEKFALKML---------QDCPKA-RREVELHWRASQCPHIVRIVD 76
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L + +E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 77  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 136
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+     +PY++APE V+    Y 
Sbjct: 137 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VLGPEKYD 195
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKD-IPEIPEHLSDDAKS 453
            + D+WSLG  +  +    PP+    G+A         ++G  +   PE  E +S++ K 
Sbjct: 196 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKM 254
Query: 454 FIKQCLQRDPSARPPASKLLDHPFV 478
            I+  L+ +P+ R   ++ ++HP++
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 127/262 (48%), Gaps = 24/262 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V       +GQ  A K   ++   + S    ++L +E  +   L HPNIVR H 
Sbjct: 14  KGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 290 SELSDERLS-VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           S +S+E    +  + V+GG + + +     ++E       +QIL  + + H    VHRD+
Sbjct: 71  S-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDL 129
Query: 349 KGANILVDPHGE---IKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           K  N+L+    +   +KLADFG+A  +     +   F G+P +++PE V+  + Y   VD
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKDPYGKPVD 188
Query: 405 IWSLGCTVLEMATSKPP-WSQ-----YEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIK 456
           +W+ G  +  +    PP W +     Y+ + A      + D P  PE   ++ +AK  I 
Sbjct: 189 MWACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPS-PEWDTVTPEAKDLIN 242
Query: 457 QCLQRDPSARPPASKLLDHPFV 478
           + L  +P+ R  AS+ L HP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 19  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 71
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 72  V-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 131 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 188
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 244
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 245 KDPEERPTFEYL--QAFLED 262

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + + +EY+S G +   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 17  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 69
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 70  V-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 186
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 242
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 243 KDPEERPTFEYL--QAFLED 260

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 93
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +     + ++ APE+++N+ GY+ +
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKS 212
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G +G V   +++ +    AIK++    + QT   C + L +EI +L +  H NI+  +  
Sbjct: 39  GAYGMVCSAYDNLNKVRVAIKKISPF-EHQTY--CQRTL-REIKILLRFRHENIIGINDI 94
Query: 290 --SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             +   ++   VY+ + +    ++KLL+     N+ +   +  QIL GL Y+H+ N +HR
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 153
Query: 347 DIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K +N+L++   ++K+ DFG+A+           +     + ++ APE+++N+ GY+ +
Sbjct: 154 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKS 213
Query: 403 VDIWSLGCTVLEMATSKPPW 422
           +DIWS+GC + EM +++P +
Sbjct: 214 IDIWSVGCILAEMLSNRPIF 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 79
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      N  V+     QI   + YL  +N +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPE-SLAYNKFSIKSDV 197
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 198 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 255
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 256 SDRPSFAEI 264

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 119/241 (49%), Gaps = 26/241 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V L  +  + ++ A+K +       +  E +K+       +E ++++  + P +
Sbjct: 84  RGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFANSPWV 136
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           V+   +   D  L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+   +
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 345 HRDIKGANILVDPHGEIKLADFG----MAKH-MTSCASMLSFKGSPYWMAPEVVMNTNG- 398
           HRD+K  N+L+D  G +KLADFG    M K  M  C + +   G+P +++PEV+ +  G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISPEVLKSQGGD 252
Query: 399 --YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSF 454
             Y    D WS+G  + EM     P+     V    KI N K+    P+   +S +AK+ 
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 455 I 455
           I
Sbjct: 313 I 313

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 200
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 201 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 259 SDRPSFAEI 267

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 195 QGCFGEVWMGTWNGTTRV-AIKTLK---PGNMSPEAFLQ---EAQVMKKLRHEKLVQLYA 247
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 248 V-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+ + +       + +G+ +   W APE  +    +++  D
Sbjct: 307 LRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 364
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 420
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 421 KDPEERPTFEYL--QAFLED 438

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 75
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 193
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 194 WAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 251
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 252 SDRPSFAEI 260

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 119/241 (49%), Gaps = 26/241 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V L  +  + ++ A+K +       +  E +K+       +E ++++  + P +
Sbjct: 84  RGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFANSPWV 136
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           V+   +   D  L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+   +
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 345 HRDIKGANILVDPHGEIKLADFG----MAKH-MTSCASMLSFKGSPYWMAPEVVMNTNG- 398
           HRD+K  N+L+D  G +KLADFG    M K  M  C + +   G+P +++PEV+ +  G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISPEVLKSQGGD 252
Query: 399 --YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLSDDAKSF 454
             Y    D WS+G  + EM     P+     V    KI N K+    P+   +S +AK+ 
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 455 I 455
           I
Sbjct: 313 I 313

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 22/261 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G F  V       +GQ  A K   ++   + S    ++L +E  +   L HPNIVR H 
Sbjct: 14  KGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
           S   +    +  + V+GG + + +     ++E       +QIL  + + H    VHRD+K
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLK 130
Query: 350 GANILVDPHGE---IKLADFGMAKHMT-SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
             N+L+    +   +KLADFG+A  +     +   F G+P +++PE V+  + Y   VD+
Sbjct: 131 PENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDM 189
Query: 406 WSLGCTVLEMATSKPP-WSQ-----YEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQ 457
           W+ G  +  +    PP W +     Y+ + A      + D P  PE   ++ +AK  I +
Sbjct: 190 WACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPS-PEWDTVTPEAKDLINK 243
Query: 458 CLQRDPSARPPASKLLDHPFV 478
            L  +P+ R  AS+ L HP++
Sbjct: 244 MLTINPAKRITASEALKHPWI 264

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +     +  + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 150
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP------------------FNEPVIQTY 327
              G+   D  L V +EY S G++ + L+   P                  F + V  TY
Sbjct: 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 211 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 269 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 325
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 326 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ ++ H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKIRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +             
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 195
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 196 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 254 SDRPSFAEI 262

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 284
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      +  V+     QI   + YL  +N +HR++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 402
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 403 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 460
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 461 SDRPSFAEI 469

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +             
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 HLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 127/260 (48%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           +  ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 21/257 (8%)
Query: 230 RGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +G FG VY G   +  Q    CAIK +  + + Q  +  L+    E  L+  L+HPN++ 
Sbjct: 31  KGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR----EGLLMRGLNHPNVLA 86
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLLQEYGPFNEPVIQ---TYTRQILLGLAYLHARN 342
             G  L  E L  V L Y+  G + + ++   P   P ++   ++  Q+  G+ YL  + 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMT-----SCASMLSFKGSPYWMAPEVVMNTN 397
            VHRD+   N ++D    +K+ADFG+A+ +      S       +    W A E  + T 
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE-SLQTY 203
Query: 398 GYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
            ++   D+WS G  + E+ T   PP+   +       +   + +P+ PE+  D     ++
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQ 262
Query: 457 QCLQRDPSARPPASKLL 473
           QC + DP+ RP    L+
Sbjct: 263 QCWEADPAVRPTFRVLV 279

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 35  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 93
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 94  NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 153
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 154 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 212 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 268
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 269 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 194 QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 246
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 247 V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 306 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 363
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 419
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 420 KEPEERPTFEYL--QAFLED 437

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 33  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 91
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 92  NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 151
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 152 --QLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 210 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 266
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 267 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 TLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 38  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 96
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 97  NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 156
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 157 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 215 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 271
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 272 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 194 QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 246
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 247 V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 306 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 363
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 419
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 420 KEPEERPTFEYL--QAFLED 437

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  E+++ G++   L+E      +  V+     QI   + YL  +N +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDV 195
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++++       E PE   +     ++ C Q +P
Sbjct: 196 WAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 464 SARPPASKL 472
           S RP  +++
Sbjct: 254 SDRPSFAEI 262

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/319 (22%), Positives = 140/319 (43%), Gaps = 75/319 (23%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYH 288
           +G +G V+   +  +G++ A+K++     + T  +   +  +EI +L++LS H NIV   
Sbjct: 19  KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELSGHENIVNLL 75
Query: 289 GSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYT-RQILLGLAYLHARNTVHR 346
               +D    VYL +      +H +++      EPV + Y   Q++  + YLH+   +HR
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLHSGGLLHR 133
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCAS----------------------MLSFKGS 384
           D+K +NIL++    +K+ADFG+++   +                         +  +  +
Sbjct: 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW------SQYEGVAAIFKIGNSK 438
            ++ APE+++ +  Y+  +D+WSLGC + E+   KP +      +Q E +  +    +++
Sbjct: 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNE 253
Query: 439 DIPEIP--------EHL-------------------------------SDDAKSFIKQCL 459
           D+  I         E L                               +++A   + + L
Sbjct: 254 DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313
Query: 460 QRDPSARPPASKLLDHPFV 478
           Q +P+ R  A+  L HPFV
Sbjct: 314 QFNPNKRISANDALKHPFV 332

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 18  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 70
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 71  V-VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTAPEAALYGR-FTIKSD 187
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 188 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 243
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 244 KEPEERPTFEYL--QAFLED 261

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG+V    + ++G+  AIK+    C  + S +  ++   EI ++ +L+HPN+V     
Sbjct: 26  GGFGYVLRWIHQDTGEQVAIKQ----CRQELSPKNRERWCLEIQIMKKLNHPNVV--SAR 79
Query: 291 ELSD--ERLS------VYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLH 339
           E+ D  ++L+      + +EY  GG + K L ++       E  I+T    I   L YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 340 ARNTVHRDIKGANILVDPHGEI---KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT 396
               +HRD+K  NI++ P  +    K+ D G AK +        F G+  ++APE ++  
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE-LLEQ 198
Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPW 422
             Y++TVD WS G    E  T   P+
Sbjct: 199 KKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG+V    + ++G+  AIK+    C  + S +  ++   EI ++ +L+HPN+V     
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQ----CRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 291 ELSDERLS------VYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHAR 341
               ++L+      + +EY  GG + K L ++       E  I+T    I   L YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 342 NTVHRDIKGANILVDPHGEI---KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNG 398
             +HRD+K  NI++ P  +    K+ D G AK +        F G+  ++APE ++    
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE-LLEQKK 199
Query: 399 YSLTVDIWSLGCTVLEMATSKPPW 422
           Y++TVD WS G    E  T   P+
Sbjct: 200 YTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 105/251 (41%), Gaps = 17/251 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG V+ G       + A+K     C +    +   +  QE  +L Q SHPNIVR  G
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKS----CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                + + + +E V GG     L+  G       +         G+ YL ++  +HRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPY-WMAPEVVMNTNGYSLTVDI 405
              N LV     +K++DFGM++         S   +  P  W APE  +N   YS   D+
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE-ALNYGRYSSESDV 298
Query: 406 WSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           WS G  + E     A+  P  S  +    + K G    +P  PE   D     ++QC   
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LP-CPELCPDAVFRLMEQCWAY 354
Query: 462 DPSARPPASKL 472
           +P  RP  S +
Sbjct: 355 EPGQRPSFSTI 365

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 28  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 80
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S G +   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 81  V-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 197
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 253
Query: 461 RDPSARPPASKLLDHPFVRD 480
           +DP  RP    L    F+ D
Sbjct: 254 KDPEERPTFEYL--QAFLED 271

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 49/247 (19%)
Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEY-------------VSGGSIHKLLQEY 316
            EI LL++   HPN++RY+ SE +D  L + LE              VS  ++ KL +EY
Sbjct: 75  MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENL-KLQKEY 133
Query: 317 GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-------------EIKL 363
            P       +  RQI  G+A+LH+   +HRD+K  NILV                  I +
Sbjct: 134 NPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 187
Query: 364 ADFGMAKHMTSCASMLSFK-----GSPYWMAPEVVMNTNGYSLT--VDIWSLGCTVLE-M 415
           +DFG+ K + S             G+  W APE++  +    LT  +DI+S+GC     +
Sbjct: 188 SDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247
Query: 416 ATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPAS 470
           +  K P+      +   +  IF +   K + +    L  +A   I Q +  DP  RP A 
Sbjct: 248 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 471 KLLDHPF 477
           K+L HP 
Sbjct: 306 KVLRHPL 312

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 121/243 (49%), Gaps = 17/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++   ++  ++ A+K ++           ++    E N++  L H  +V+ H  
Sbjct: 199 GQFGEVWMATYNKHTKV-AVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  E+++ GS+   L+      +P+  +  ++ QI  G+A++  RN +HRD+
Sbjct: 252 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 311 RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDV 368
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  ++E+ T  + P+        I  +     +P  PE+  ++  + + +C +  P 
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPE 427
Query: 465 ARP 467
            RP
Sbjct: 428 ERP 430

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 49/247 (19%)
Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEY-------------VSGGSIHKLLQEY 316
            EI LL++   HPN++RY+ SE +D  L + LE              VS  ++ KL +EY
Sbjct: 75  MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENL-KLQKEY 133
Query: 317 GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-------------EIKL 363
            P       +  RQI  G+A+LH+   +HRD+K  NILV                  I +
Sbjct: 134 NPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 187
Query: 364 ADFGMAKHMTSCASMLSFK-----GSPYWMAPEVVMNTNGYSLT--VDIWSLGCTVLE-M 415
           +DFG+ K + S             G+  W APE++  +    LT  +DI+S+GC     +
Sbjct: 188 SDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247
Query: 416 ATSKPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPAS 470
           +  K P+      +   +  IF +   K + +    L  +A   I Q +  DP  RP A 
Sbjct: 248 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 471 KLLDHPF 477
           K+L HP 
Sbjct: 306 KVLRHPL 312

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLS-VYLEYVSGGSIHKLLQEYGPFNEPVIQ 325
           ++L +E  +   L H NIVR H S +S+E    +  + V+GG + + +     ++E    
Sbjct: 48  QKLEREARICRLLKHSNIVRLHDS-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS 106
Query: 326 TYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMT-SCASMLSF 381
              +QIL  + + H    VHRD+K  N+L+        +KLADFG+A  +     +   F
Sbjct: 107 HCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGF 166
Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQ-----YEGVAAIFKIG 435
            G+P +++PE V+    Y   VDIW+ G  +  +    PP W +     Y+ + A     
Sbjct: 167 AGTPGYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKA----- 220
Query: 436 NSKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
            + D P  PE   ++ +AK+ I Q L  +P+ R  A + L HP+V
Sbjct: 221 GAYDFPS-PEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +++ADFG+A+ + +        + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 116/253 (45%), Gaps = 57/253 (22%)
Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEY-------------VSGGSIHKLLQEY 316
            EI LL++   HPN++RY+ SE +D  L + LE              VS  ++ KL +EY
Sbjct: 57  MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENL-KLQKEY 115
Query: 317 GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-------------EIKL 363
            P       +  RQI  G+A+LH+   +HRD+K  NILV                  I +
Sbjct: 116 NPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 364 ADFGMAKHMTSCASMLSFK-------GSPYWMAPEVVMNTNG------YSLTVDIWSLGC 410
           +DFG+ K + S  S  SF+       G+  W APE++  +N        + ++DI+S+GC
Sbjct: 170 SDFGLCKKLDSGQS--SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 411 TVLEMATS-KPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
               + +  K P+      +   +  IF +   K + +    L  +A   I Q +  DP 
Sbjct: 228 VFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPL 285
Query: 465 ARPPASKLLDHPF 477
            RP A K+L HP 
Sbjct: 286 KRPTAMKVLRHPL 298

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 105/251 (41%), Gaps = 17/251 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG V+ G       + A+K     C +    +   +  QE  +L Q SHPNIVR  G
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKS----CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
                + + + +E V GG     L+  G       +         G+ YL ++  +HRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPY-WMAPEVVMNTNGYSLTVDI 405
              N LV     +K++DFGM++         S   +  P  W APE  +N   YS   D+
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSESDV 298
Query: 406 WSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
           WS G  + E     A+  P  S  +    + K G    +P  PE   D     ++QC   
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LP-CPELCPDAVFRLMEQCWAY 354
Query: 462 DPSARPPASKL 472
           +P  RP  S +
Sbjct: 355 EPGQRPSFSTI 365

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 21  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 73
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 74  V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 190
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 191 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 246
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 247 KEPEERPTFEYL--QAFLED 264

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 34/262 (12%)
Query: 231 GTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G FG V+L   +N    +   +  V+ + D   +    K   +E  LL+ L H +IV+++
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIVKFY 83
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ----------------IL 332
           G     + L +  EY+  G ++K L+ +GP    ++    RQ                I 
Sbjct: 84  GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSP 385
            G+ YL +++ VHRD+   N LV  +  +K+ DFGM++ + S         +ML  +   
Sbjct: 144 SGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR--- 200
Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIP 444
            WM PE +M    ++   D+WS G  + E+ T  K PW Q      I  I   + + E P
Sbjct: 201 -WMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERP 257
Query: 445 EHLSDDAKSFIKQCLQRDPSAR 466
                +    +  C QR+P  R
Sbjct: 258 RVCPKEVYDVMLGCWQREPQQR 279

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 26/268 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH-- 288
           G +G V   +++   Q  A+K++             ++  +E+ LL  L H N++     
Sbjct: 39  GAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHLKHENVIGLLDV 95
Query: 289 ---GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
               + + D      +  + G  ++ +++     +E V Q    Q+L GL Y+H+   +H
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHV-QFLVYQLLRGLKYIHSAGIIH 154
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +N+ V+   E+++ DFG+A+   +   M  +  + ++ APE+++N   Y+ TVDI
Sbjct: 155 RDLKPSNVAVNEDSELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHYNQTVDI 212
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL----SDDAKSFIKQCL-- 459
           WS+GC + E+   K  +   + +  + +I      P  PE L    S+ A+++I Q L  
Sbjct: 213 WSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHARTYI-QSLPP 270
Query: 460 --QRDPS-----ARPPASKLLDHPFVRD 480
             Q+D S     A P A  LL    V D
Sbjct: 271 MPQKDLSSIFRGANPLAIDLLGRMLVLD 298

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 115/248 (46%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V LG     GQ      V+++ +   S++   +  QE   + +LSHP +V+++G 
Sbjct: 19  GQFGVVKLG--KWKGQYDV--AVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV-IQTYTRQILLGLAYLHARNTVHRDIK 349
              +  + +  EY+S G +   L+ +G   EP  +      +  G+A+L +   +HRD+ 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N LVD    +K++DFGM +++      +S  G+ +   W APE V +   YS   D+W
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPE-VFHYFKYSSKSDVW 189
Query: 407 SLGCTVLEM-ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           + G  + E+ +  K P+  Y     + K+     +   P   SD     +  C    P  
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQIMYSCWHELPEK 248
Query: 466 RPPASKLL 473
           RP   +LL
Sbjct: 249 RPTFQQLL 256

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 119/243 (48%), Gaps = 17/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++   ++  ++     V+ +     S E       E N++  L H  +V+ H  
Sbjct: 26  GQFGEVWMATYNKHTKVA----VKTMKPGSMSVEAFLA---EANVMKTLQHDKLVKLHAV 78
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  E+++ GS+   L+      +P+  +  ++ QI  G+A++  RN +HRD+
Sbjct: 79  -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDV 195
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  ++E+ T  + P+        I  +     +P  PE+  ++  + + +C +  P 
Sbjct: 196 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPE 254
Query: 465 ARP 467
            RP
Sbjct: 255 ERP 257

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 117/240 (48%), Gaps = 21/240 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++   ++  ++ A+K ++           ++    E N++  L H  +V+ H  
Sbjct: 193 GQFGEVWMATYNKHTKV-AVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  E+++ GS+   L+      +P+  +  ++ QI  G+A++  RN +HRD+
Sbjct: 246 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           + ANILV      K+ADFG+A+        +  K    W APE + N   +++  D+WS 
Sbjct: 305 RAANILVSASLVCKIADFGLAR--------VGAKFPIKWTAPEAI-NFGSFTIKSDVWSF 355
Query: 409 GCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
           G  ++E+ T  + P+        I  +     +P  PE+  ++  + + +C +  P  RP
Sbjct: 356 GILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEERP 414

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 33/267 (12%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR--- 286
           G  G V   FN  + +  A+K +         ++C K   +E+ L  + S  P+IVR   
Sbjct: 73  GINGKVLQIFNKRTQEKFALKXL---------QDCPKA-RREVELHWRASQCPHIVRIVD 122
Query: 287 -YHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNT 343
            Y       + L +  E + GG +   +Q+ G   F E       + I   + YLH+ N 
Sbjct: 123 VYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINI 182
Query: 344 VHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
            HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APE V+    Y 
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYD 241
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI---------PEIPEHLSDDA 451
            + D WSLG     +    PP+    G+A     G    I         PE  E +S++ 
Sbjct: 242 KSCDXWSLGVIXYILLCGYPPFYSNHGLA--ISPGXKTRIRXGQYEFPNPEWSE-VSEEV 298
Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFV 478
           K  I+  L+ +P+ R   ++  +HP++
Sbjct: 299 KXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 194 QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 246
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY+S GS+   L+ E G +   P +     QI  G+AY+   N VHRD
Sbjct: 247 V-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 306 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 363
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 419
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 420 KEPEERPTFEYL--QAFLED 437

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 133/319 (41%), Gaps = 84/319 (26%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G+FG V   F+ ESG+  A+K+V     D   K      N+E++++  L H NI++    
Sbjct: 18  GSFGIVCEVFDIESGKRFALKKV---LQDPRYK------NRELDIMKVLDHVNIIKLVDY 68
Query: 287 ------------------------------YHGSEL----SDERLSVYLEYVSGGSIHKL 312
                                         +H S +     ++ L+V +EYV   ++HK+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 313 LQEYG------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLAD 365
           L+ +       P N  +I  Y  Q+   + ++H+    HRDIK  N+LV+     +KL D
Sbjct: 128 LKSFIRSGRSIPMN--LISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY 425
           FG AK +      ++   S ++ APE+++    Y+ ++D+WS+GC   E+   KP +S  
Sbjct: 186 FGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245
Query: 426 EGVAAIFKIGNSKDIPE---------------------------IPEHLSDDAKSFIKQC 458
             +  + +I      P                            +PE     A   ++Q 
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305
Query: 459 LQRDPSARPPASKLLDHPF 477
           L+ +P  R    + + HPF
Sbjct: 306 LRYEPDLRINPYEAMAHPF 324

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 19/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVV--CDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G FG V+      +G++   K +      D  T K        EI++++QL HP ++  H
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-------NEISIMNQLHHPKLINLH 114
Query: 289 GSELSDERLSVYLEYVSGGSIH-KLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
            +      + + LE++SGG +  ++  E    +E  +  Y RQ   GL ++H  + VH D
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 348 IKGANILVDPH--GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           IK  NI+ +      +K+ DFG+A  +     +     +  + APE+V +        D+
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDM 233
Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH----LSDDAKSFIKQCLQR 461
           W++G     + +   P++  + +  +  +       E  E     +S +AK FIK  LQ+
Sbjct: 234 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--WEFDEDAFSSVSPEAKDFIKNLLQK 291
Query: 462 DPSARPPASKLLDHPFVR 479
           +P  R      L+HP+++
Sbjct: 292 EPRKRLTVHDALEHPWLK 309

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T +E L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EEDLSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V +EY S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++L +E  +   L HPNIVR H S   +    +  + V+GG + + +     ++E     
Sbjct: 55  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 114
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMT-SCASMLSFK 382
             +QIL  + + H    VHR++K  N+L+        +KLADFG+A  +     +   F 
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQ-----YEGVAAIFKIGN 436
           G+P +++PE V+  + Y   VD+W+ G  +  +    PP W +     Y+ + A      
Sbjct: 175 GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-----G 228
Query: 437 SKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           + D P  PE   ++ +AK  I + L  +PS R  A++ L HP++
Sbjct: 229 AYDFPS-PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 25  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 77
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY++ GS+   L+ E G +   P +   + QI  G+AY+   N VHRD
Sbjct: 78  V-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED-NEWTARQGAKFPIKWTAPEAALYGR-FTIKSD 194
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 250
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 251 KEPEERPTFEYL--QAFLED 268

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 25/260 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V++G  + + ++ AIK ++       S E   Q   E  ++ +L H  +V+ + 
Sbjct: 25  QGCFGEVWMGTWNGTTRV-AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 77
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQ-EYGPF-NEPVIQTYTRQILLGLAYLHARNTVHRD 347
             +S+E + +  EY++ GS+   L+ E G +   P +   + QI  G+AY+   N VHRD
Sbjct: 78  V-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           ++ ANILV  +   K+ADFG+A+ +       + +G+ +   W APE  +    +++  D
Sbjct: 137 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 194
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKSFIKQCLQ 460
           +WS G  + E+ T  + P+        + ++     +   PE PE L D     + QC +
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----LMCQCWR 250
Query: 461 RDPSARPPASKLLDHPFVRD 480
           ++P  RP    L    F+ D
Sbjct: 251 KEPEERPTFEYL--QAFLED 268

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 133/294 (45%), Gaps = 50/294 (17%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V    +  +G++ AIK++        +   L+    EI +L    H NI+     
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITIFNI 77
Query: 291 ELSD--ERLS-VYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +  D  E  + VY+ + +    +H+++      ++  IQ +  Q L  +  LH  N +HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCAS-----------MLSFKGSPYWMAPEVVMN 395
           D+K +N+L++ + ++K+ DFG+A+ +   A+           M+ F  + ++ APEV++ 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKP--PWSQYE-GVAAIFKIGNS--------------- 437
           +  YS  +D+WS GC + E+   +P  P   Y   +  IF I  +               
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 438 ----KDIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               K +P  P          ++      +++ L  DP+ R  A + L+HP+++
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 30/267 (11%)
Query: 231 GTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L      N  +G+M A+K ++  C  Q          +EI +L  L H +IV+
Sbjct: 20  GHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRS----GWQREIEILRTLYHEHIVK 75
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           Y G   +  ++ + + +EYV  GS+   L  +       +  + +QI  G+AYLHA++ +
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHYI 134
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTNGYS 400
           HR +   N+L+D    +K+ DFG+AK +         +    SP +W APE +     Y 
Sbjct: 135 HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYY 194
Query: 401 LTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNSKDIPE---IPEH 446
            + D+WS G T+ E+ T    ++ P +++       +G   + ++    +  E    P+ 
Sbjct: 195 AS-DVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDR 253
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLL 473
              +    +K C + + S RP    L+
Sbjct: 254 CPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 36/270 (13%)
Query: 231 GTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG V L      N  +G+M A+K ++  C  Q          +EI +L  L H +IV+
Sbjct: 19  GHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRS----GWQREIEILRTLYHEHIVK 74
Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHAR 341
           Y G   +  ++ + + +EYV  GS    L++Y P        +  + +QI  G+AYLHA+
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGS----LRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK---GSP-YWMAPEVVMNTN 397
           + +HR +   N+L+D    +K+ DFG+AK +         +    SP +W APE +    
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 398 GYSLTVDIWSLGCTVLEMAT----SKPPWSQY-------EGVAAIFKIGNSKDIPE---I 443
            Y  + D+WS G T+ E+ T    ++ P +++       +G   + ++    +  E    
Sbjct: 191 FYYAS-DVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPR 249
Query: 444 PEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           P+    +    +K C + + S RP    L+
Sbjct: 250 PDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 24/267 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   +++   Q  A+K++             ++  +E+ LL  L H N++     
Sbjct: 39  GAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHLKHENVIGLLDV 95
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +  +   ++   VYL     G+    + +    ++  +Q    Q+L GL Y+H+   +HR
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 155
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           D+K +N+ V+   E+++ DFG+A+   +   M  +  + ++ APE+++N   Y+ TVDIW
Sbjct: 156 DLKPSNVAVNEDSELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL----SDDAKSFIKQCL--- 459
           S+GC + E+   K  +   + +  + +I      P  PE L    S+ A+++I Q L   
Sbjct: 214 SVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHARTYI-QSLPPM 271
Query: 460 -QRDPS-----ARPPASKLLDHPFVRD 480
            Q+D S     A P A  LL    V D
Sbjct: 272 PQKDLSSIFRGANPLAIDLLGRMLVLD 298

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V + Y S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 127/267 (47%), Gaps = 24/267 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G +G V   +++   Q  A+K++             ++  +E+ LL  L H N++     
Sbjct: 31  GAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHLKHENVIGLLDV 87
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +  +   ++   VYL     G+    + +    ++  +Q    Q+L GL Y+H+   +HR
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 147
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIW 406
           D+K +N+ V+   E+++ DFG+A+       M  +  + ++ APE+++N   Y+ TVDIW
Sbjct: 148 DLKPSNVAVNEDCELRILDFGLARQADE--EMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205
Query: 407 SLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL----SDDAKSFIKQCL--- 459
           S+GC + E+   K  +   + +  + +I      P  PE L    S+ A+++I Q L   
Sbjct: 206 SVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHARTYI-QSLPPM 263
Query: 460 -QRDPS-----ARPPASKLLDHPFVRD 480
            Q+D S     A P A  LL    V D
Sbjct: 264 PQKDLSSIFRGANPLAIDLLGRMLVLD 290

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 34/272 (12%)
Query: 231 GTFGHVYL----GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIV 285
           G FG V +    G + +  +      V+++ DD T K+ L  L  E+ ++  +  H NI+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNII 104
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL------------------QEYGPFNEPVIQTY 327
              G+   D  L V + Y S G++ + L                  +E   F + V  TY
Sbjct: 105 NLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---ASMLSFKGS 384
             Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +        + +  
Sbjct: 165 --QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPE 442
             WMAPE + +   Y+   D+WS G  + E+ T     S Y G  V  +FK+       +
Sbjct: 223 VKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLKEGHRMD 279
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            P + +++    ++ C    PS RP   +L++
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 112/251 (44%), Gaps = 53/251 (21%)
Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEY-------------VSGGSIHKLLQEY 316
            EI LL++   HPN++RY+ SE +D  L + LE              VS  ++ KL +EY
Sbjct: 57  MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENL-KLQKEY 115
Query: 317 GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-------------EIKL 363
            P       +  RQI  G+A+LH+   +HRD+K  NILV                  I +
Sbjct: 116 NPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 364 ADFGMAKHMTSCASMLSFK-----GSPYWMAPEVVMNTNG------YSLTVDIWSLGCTV 412
           +DFG+ K + S             G+  W APE++  +N        + ++DI+S+GC  
Sbjct: 170 SDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 413 LEMATS-KPPW-----SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR 466
             + +  K P+      +   +  IF +   K + +    L  +A   I Q +  DP  R
Sbjct: 230 YYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKR 287
Query: 467 PPASKLLDHPF 477
           P A K+L HP 
Sbjct: 288 PTAMKVLRHPL 298

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 20/262 (7%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLS----HP 282
           +G FG V+ G         AIK +   RV+     S      L  E+ LL ++     HP
Sbjct: 41  KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL--EVALLWKVGAGGGHP 98
Query: 283 NIVRYHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
            ++R      + E   + LE  +    +   + E GP  E   + +  Q++  + + H+R
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 342 NTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             VHRDIK  NIL+D   G  KL DFG    +        F G+  +  PE +     ++
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
           L   +WSLG  + +M     P+ + + +         +     P H+S D  + I++CL 
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERDQEIL--------EAELHFPAHVSPDCCALIRRCLA 269
Query: 461 RDPSARPPASKLLDHPFVRDQA 482
             PS+RP   ++L  P+++  A
Sbjct: 270 PKPSSRPSLEEILLDPWMQTPA 291

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV---- 285
           +GTFG V+   + ++GQ  A+K  +V+ +++     +  L +EI +L  L H N+V    
Sbjct: 28  QGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITAL-REIKILQLLKHENVVNLIE 84
Query: 286 --RYHGSELSDERLSVYL-----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
             R   S  +  + S+YL     E+   G +  +L +   F    I+   + +L GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVV 393
           H    +HRD+K AN+L+   G +KLADFG+A+  +   +       +   + ++  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKP 420
           +    Y   +D+W  GC + EM T  P
Sbjct: 202 LGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV---- 285
           +GTFG V+   + ++GQ  A+K  +V+ +++     +  L +EI +L  L H N+V    
Sbjct: 28  QGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITAL-REIKILQLLKHENVVNLIE 84
Query: 286 --RYHGSELSDERLSVYL-----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
             R   S  +  + S+YL     E+   G +  +L +   F    I+   + +L GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVV 393
           H    +HRD+K AN+L+   G +KLADFG+A+  +   +       +   + ++  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKP 420
           +    Y   +D+W  GC + EM T  P
Sbjct: 202 LGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 39/219 (17%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY--- 287
           G++GHV   ++    ++ AIK++  V +D    +C K++ +EI +L++L+H ++V+    
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVFEDLI--DC-KRILREIAILNRLNHDHVVKVLDI 120
Query: 288 ---HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
                 E  DE L V LE ++     KL +      E  I+T    +L+G+ Y+H+   +
Sbjct: 121 VIPKDVEKFDE-LYVVLE-IADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGIL 178
Query: 345 HRDIKGANILVDPHGEIKLADFGMAK---------------------------HMTSCAS 377
           HRD+K AN LV+    +K+ DFG+A+                           H  +   
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
Query: 378 MLSFKGSPYWM-APEVVMNTNGYSLTVDIWSLGCTVLEM 415
            L+      W  APE+++    Y+  +D+WS+GC   E+
Sbjct: 239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 33/261 (12%)
Query: 233 FGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           FG VY G        E  Q  AIK ++    D+      ++   E  L ++L HPN+V  
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE----------------PVIQTYTRQI 331
            G    D+ LS+   Y S G +H+ L    P ++                P       QI
Sbjct: 78  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----W 387
             G+ YL + + VH+D+   N+LV     +K++D G+ + + + A      G+      W
Sbjct: 138 AAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADYYKLLGNSLLPIRW 196
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEH 446
           MAPE +M    +S+  DIWS G  + E+ +    P+  Y     +  I N + +P  P+ 
Sbjct: 197 MAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP-CPDD 254
Query: 447 LSDDAKSFIKQCLQRDPSARP 467
                 + + +C    PS RP
Sbjct: 255 CPAWVYALMIECWNEFPSRRP 275

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 132/294 (44%), Gaps = 50/294 (17%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V    +  +G++ AIK++        +   L+    EI +L    H NI+     
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITIFNI 77
Query: 291 ELSD--ERLS-VYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +  D  E  + VY+ + +    +H+++      ++  IQ +  Q L  +  LH  N +HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCAS-----------MLSFKGSPYWMAPEVVMN 395
           D+K +N+L++ + ++K+ DFG+A+ +   A+           M  +  + ++ APEV++ 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKP--PWSQYE-GVAAIFKIGNS--------------- 437
           +  YS  +D+WS GC + E+   +P  P   Y   +  IF I  +               
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 438 ----KDIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               K +P  P          ++      +++ L  DP+ R  A + L+HP+++
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV---- 285
           +GTFG V+   + ++GQ  A+K  +V+ +++     +  L +EI +L  L H N+V    
Sbjct: 27  QGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITAL-REIKILQLLKHENVVNLIE 83
Query: 286 --RYHGSELSDERLSVYL-----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
             R   S  +  + S+YL     E+   G +  +L +   F    I+   + +L GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 140
Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVV 393
           H    +HRD+K AN+L+   G +KLADFG+A+  +   +       +   + ++  PE++
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 200
Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKP 420
           +    Y   +D+W  GC + EM T  P
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV---- 285
           +GTFG V+   + ++GQ  A+K  +V+ +++     +  L +EI +L  L H N+V    
Sbjct: 28  QGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITAL-REIKILQLLKHENVVNLIE 84
Query: 286 --RYHGSELSDERLSVYL-----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
             R   S  +  + S+YL     E+   G +  +L +   F    I+   + +L GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVV 393
           H    +HRD+K AN+L+   G +KLADFG+A+  +   +       +   + ++  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKP 420
           +    Y   +D+W  GC + EM T  P
Sbjct: 202 LGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 33/261 (12%)
Query: 233 FGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           FG VY G        E  Q  AIK ++    D+      ++   E  L ++L HPN+V  
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLREEFRHEAMLRARLQHPNVVCL 94
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE----------------PVIQTYTRQI 331
            G    D+ LS+   Y S G +H+ L    P ++                P       QI
Sbjct: 95  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 154
Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----W 387
             G+ YL + + VH+D+   N+LV     +K++D G+ + + + A      G+      W
Sbjct: 155 AAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADYYKLLGNSLLPIRW 213
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEH 446
           MAPE +M    +S+  DIWS G  + E+ +    P+  Y     +  I N + +P  P+ 
Sbjct: 214 MAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP-CPDD 271
Query: 447 LSDDAKSFIKQCLQRDPSARP 467
                 + + +C    PS RP
Sbjct: 272 CPAWVYALMIECWNEFPSRRP 292

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+LG+     ++ AIK +R   +   S+E      +E  ++ +LSHP +V+ +G 
Sbjct: 18  GQFGLVHLGYWLNKDKV-AIKTIR---EGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            L    + +  E++  G +   L+ + G F    +      +  G+AYL   + +HRD+ 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLA 130
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N LV  +  IK++DFGM + +       S  G+ +   W +PE V + + YS   D+W
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVW 188
Query: 407 SLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           S G  + E+ +  K P+        +  I     + + P   S      +  C +  P  
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 247
Query: 466 RPPASKLL 473
           RP  S+LL
Sbjct: 248 RPAFSRLL 255

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V +     + ++ A+K +          E LK+       +E ++L       I
Sbjct: 84  RGAFGEVAVVKLKNADKVFAMKIL-------NKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNT 343
              H +   D  L + ++Y  GG +  LL ++     E + + Y  ++++ +  +H  + 
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNTNG--- 398
           VHRDIK  NIL+D +G I+LADFG    +    ++ S    G+P +++PE++    G   
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 399 -YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD---DAKSF 454
            Y    D WSLG  + EM   + P+     V    KI N K+  + P  ++D   +AK  
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316
Query: 455 IKQ--CLQRDPSARPPASKLLDHPF 477
           I++  C +     +        HPF
Sbjct: 317 IRRLICSREHRLGQNGIEDFKKHPF 341

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 114/222 (51%), Gaps = 32/222 (14%)
Query: 281 HPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           HPNIV+ H  E+  ++L  +L  E ++GG + + +++   F+E       R+++  ++++
Sbjct: 65  HPNIVKLH--EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 339 HARNTVHRDIKGANILV---DPHGEIKLADFGMAK--------HMTSCASMLSFKGSPYW 387
           H    VHRD+K  N+L    + + EIK+ DFG A+          T C ++       ++
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL-------HY 175
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-------GVAAIFKI--GNSK 438
            APE ++N NGY  + D+WSLG  +  M + + P+  ++        V  + KI  G+  
Sbjct: 176 AAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
              E  +++S +AK  I+  L  DP+ R   S L  + +++D
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 114/244 (46%), Gaps = 17/244 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G VY+G   +     A+K ++   D    +E LK    E  ++ ++ HPN+V+  G 
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKE--DTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 96
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
              +    +  EY+  G++   L+E         V+     QI   + YL  +N +HRD+
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDL 156
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
              N LV  +  +K+ADFG+++ MT   +  +  G+ +   W APE  +  N +S+  D+
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNTFSIKSDV 214
Query: 406 WSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           W+ G  + E+AT     S Y G+  + ++ +       E PE         ++ C +  P
Sbjct: 215 WAFGVLLWEIATYGM--SPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSP 272
Query: 464 SARP 467
           + RP
Sbjct: 273 ADRP 276

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 12/220 (5%)
Query: 270 NQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
            +EI +L +   HPNI+         + + V  E + GG +   +     F+E       
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL 122
Query: 329 RQILLGLAYLHARNTVHRDIKGANIL-VDPHGE---IKLADFGMAKHMTSCASMLSFKG- 383
             I   + YLHA+  VHRD+K +NIL VD  G    I++ DFG AK + +   +L     
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY-----EGVAAIFKIGNSK 438
           +  ++APE V+   GY    DIWSLG  +  M T   P++       E + A    G   
Sbjct: 183 TANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                   +SD AK  + + L  DP  R  A+ +L HP++
Sbjct: 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 32/219 (14%)
Query: 294 DERLSVYLEYVSGGSIHKLLQEYGPFNE--------PVIQTYTRQILLGLAYLH-ARNTV 344
           DE   +Y EY+   SI K  + +   ++         VI+   + +L   +Y+H  +N  
Sbjct: 116 DEVYIIY-EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS-LTV 403
           HRD+K +NIL+D +G +KL+DFG +++M     +   +G+  +M PE   N + Y+   V
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVD-KKIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 404 DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP------------------- 444
           DIWSLG  +  M  +  P+S    +  +F    +K+I E P                   
Sbjct: 234 DIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSN 292
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV 483
             LS++   F+K  L+++P+ R  +   L H ++ D  +
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+LG+     ++ AIK +R   +   S+E      +E  ++ +LSHP +V+ +G 
Sbjct: 18  GQFGLVHLGYWLNKDKV-AIKTIR---EGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            L    + +  E++  G +   L+ + G F    +      +  G+AYL     +HRD+ 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 130
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N LV  +  IK++DFGM + +       S  G+ +   W +PE V + + YS   D+W
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVW 188
Query: 407 SLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           S G  + E+ +  K P+        +  I     + + P   S      +  C +  P  
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 247
Query: 466 RPPASKLL 473
           RP  S+LL
Sbjct: 248 RPAFSRLL 255

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+LG+     ++ AIK +R   +   S+E      +E  ++ +LSHP +V+ +G 
Sbjct: 21  GQFGLVHLGYWLNKDKV-AIKTIR---EGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 73
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            L    + +  E++  G +   L+ + G F    +      +  G+AYL     +HRD+ 
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 133
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N LV  +  IK++DFGM + +       S  G+ +   W +PE V + + YS   D+W
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVW 191
Query: 407 SLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           S G  + E+ +  K P+        +  I     + + P   S      +  C +  P  
Sbjct: 192 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPED 250
Query: 466 RPPASKLL 473
           RP  S+LL
Sbjct: 251 RPAFSRLL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+LG+     ++ AIK +R   +   S+E      +E  ++ +LSHP +V+ +G 
Sbjct: 16  GQFGLVHLGYWLNKDKV-AIKTIR---EGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 68
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            L    + +  E++  G +   L+ + G F    +      +  G+AYL     +HRD+ 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N LV  +  IK++DFGM + +       S  G+ +   W +PE V + + YS   D+W
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVW 186
Query: 407 SLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           S G  + E+ +  K P+        +  I     + + P   S      +  C +  P  
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 245
Query: 466 RPPASKLL 473
           RP  S+LL
Sbjct: 246 RPAFSRLL 253

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 131/294 (44%), Gaps = 50/294 (17%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G +G V    +  +G++ AIK++        +   L+    EI +L    H NI+     
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITIFNI 77
Query: 291 ELSD--ERLS-VYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
           +  D  E  + VY+ + +    +H+++      ++  IQ +  Q L  +  LH  N +HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCAS-----------MLSFKGSPYWMAPEVVMN 395
           D+K +N+L++ + ++K+ DFG+A+ +   A+           M     + ++ APEV++ 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 396 TNGYSLTVDIWSLGCTVLEMATSKP--PWSQYE-GVAAIFKIGNS--------------- 437
           +  YS  +D+WS GC + E+   +P  P   Y   +  IF I  +               
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 438 ----KDIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               K +P  P          ++      +++ L  DP+ R  A + L+HP+++
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 8/151 (5%)
Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTR 329
           E NL+ QL H  +VR +   ++ E + +  EY+  GS+   L+        +  +     
Sbjct: 58  EANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY--- 386
           QI  G+A++  RN +HRD++ ANILV      K+ADFG+A+ +   A   + +G+ +   
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIK 175
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
           W APE + N   +++  D+WS G  + E+ T
Sbjct: 176 WTAPEAI-NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 17/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 32  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 84
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 85  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 143
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 144 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 201
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 202 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 260
Query: 465 ARP 467
            RP
Sbjct: 261 DRP 263

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 17/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 34  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 86
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 87  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 145
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 146 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 203
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 204 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 262
Query: 465 ARP 467
            RP
Sbjct: 263 DRP 265

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 111/250 (44%), Gaps = 19/250 (7%)
Query: 231 GTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G FG V+LG+  N +   +  IKE  +  DD           +E  ++ +LSHP +V+ +
Sbjct: 38  GQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD---------FIEEAEVMMKLSHPKLVQLY 88
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           G  L    + +  E++  G +   L+ + G F    +      +  G+AYL     +HRD
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 348 IKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVD 404
           +   N LV  +  IK++DFGM + +       S  G+ +   W +PE V + + YS   D
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSD 206
Query: 405 IWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           +WS G  + E+ +  K P+        +  I     + + P   S      +  C +  P
Sbjct: 207 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERP 265
Query: 464 SARPPASKLL 473
             RP  S+LL
Sbjct: 266 EDRPAFSRLL 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 17/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 30  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 83  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 141
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 199
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 258
Query: 465 ARP 467
            RP
Sbjct: 259 DRP 261

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 118/262 (45%), Gaps = 16/262 (6%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG F  V +    ++GQ+ A+K +     D   +  +    +E ++L       I + H 
Sbjct: 71  RGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 290 SELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
           +   +  L + +EY  GG +  LL ++G      + + Y  +I++ +  +H    VHRDI
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSF--KGSPYWMAPEVVMNTNGYSLT---- 402
           K  NIL+D  G I+LADFG    + +  ++ S    G+P +++PE++    G   T    
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248
Query: 403 --VDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
              D W+LG    EM   + P+   S  E    I        +P + E + ++A+ FI++
Sbjct: 249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308
Query: 458 --CLQRDPSARPPASKLLDHPF 477
             C       R  A     HPF
Sbjct: 309 LLCPPETRLGRGGAGDFRTHPF 330

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 17/243 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 33  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 85
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 86  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 144
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 145 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 202
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 203 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 261
Query: 465 ARP 467
            RP
Sbjct: 262 DRP 264

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 15/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+LG+     ++ AIK +R   +   S+E      +E  ++ +LSHP +V+ +G 
Sbjct: 19  GQFGLVHLGYWLNKDKV-AIKTIR---EGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            L    + +  E++  G +   L+ + G F    +      +  G+AYL     +HRD+ 
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N LV  +  IK++DFGM + +       S  G+ +   W +PE V + + YS   D+W
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVW 189
Query: 407 SLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
           S G  + E+ +  K P+        +  I     + + P   S      +  C +  P  
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPED 248
Query: 466 RPPASKLL 473
           RP  S+LL
Sbjct: 249 RPAFSRLL 256

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 114/248 (45%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 24  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 193
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 252
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 253 DRPTFDYL 260

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 36/268 (13%)
Query: 230 RGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           +G FG V       E G    +  V+++  D  +   +++  +E   + +  HP++ +  
Sbjct: 33  KGEFGSVREAQLKQEDGSFVKVA-VKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 289 GSELSDE---RL---SVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTR---QILLGL 335
           G  L      RL    V L ++  G +H  L        PFN P +QT  R    I  G+
Sbjct: 92  GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP-LQTLVRFMVDIACGM 150
Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-------CASMLSFKGSPYWM 388
            YL +RN +HRD+   N ++     + +ADFG+++ + S       CAS L  K    W+
Sbjct: 151 EYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK----WL 206
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAI-FKIGNS--KDIPEIP 444
           A E + + N Y++  D+W+ G T+ E+ T  + P++  E      + IG +  K  PE  
Sbjct: 207 ALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECM 265
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKL 472
           E + D     + QC   DP  RP  + L
Sbjct: 266 EEVYD----LMYQCWSADPKQRPSFTCL 289

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 15/192 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 30  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 82
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 83  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 141
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 199
Query: 406 WSLGCTVLEMAT 417
           WS G  + E+ T
Sbjct: 200 WSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 15/192 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++     V+ +     S +       E NL+ QL H  +VR +  
Sbjct: 29  GQFGEVWMGYYNGHTKVA----VKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 81
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 82  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 140
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 141 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 198
Query: 406 WSLGCTVLEMAT 417
           WS G  + E+ T
Sbjct: 199 WSFGILLTEIVT 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 116/248 (46%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++ A+K ++       S +       E NL+ QL H  +VR +  
Sbjct: 26  GQFGEVWMGYYNGHTKV-AVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 78
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 79  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 137
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 138 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 195
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 254
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 255 DRPTFDYL 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 116/248 (46%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++ A+K ++       S +       E NL+ QL H  +VR +  
Sbjct: 24  GQFGEVWMGYYNGHTKV-AVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 193
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 252
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 253 DRPTFDYL 260

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 112/222 (50%), Gaps = 13/222 (5%)
Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQT 326
           + +EI LL +L H N+++      ++E+  +Y+  EY   G + ++L        PV Q 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQA 111
Query: 327 --YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---SMLSF 381
             Y  Q++ GL YLH++  VH+DIK  N+L+   G +K++  G+A+ +   A   +  + 
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 382 KGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IGNSKD 439
           +GSP +  PE+    + +S   VDIWS G T+  + T   P+ + + +  +F+ IG  K 
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIG--KG 228
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
              IP          +K  L+ +P+ R    ++  H + R +
Sbjct: 229 SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++ A+K ++       S +       E NL+ QL H  +VR +  
Sbjct: 25  GQFGEVWMGYYNGHTKV-AVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 77
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 78  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 136
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 137 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 194
Query: 406 WSLGCTVLEMAT 417
           WS G  + E+ T
Sbjct: 195 WSFGILLTEIVT 206

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 116/248 (46%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++ A+K ++       S +       E NL+ QL H  +VR +  
Sbjct: 24  GQFGEVWMGYYNGHTKV-AVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 193
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 252
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 253 DRPTFDYL 260

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 116/248 (46%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++ A+K ++       S +       E NL+ QL H  +VR +  
Sbjct: 19  GQFGEVWMGYYNGHTKV-AVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 71
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HRD+
Sbjct: 72  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 130
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 131 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 188
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 247
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 248 DRPTFDYL 255

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG VY G  ++ G + A+K ++    ++  +    Q   E+ ++S   H N++R  G
Sbjct: 48  RGGFGKVYKGRLAD-GTLVAVKRLK----EERXQGGELQFQTEVEMISMAVHRNLLRLRG 102
Query: 290 SELS-DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL-----GLAYLHAR-- 341
             ++  ERL VY  Y++ GS+   L+E  P ++P +    RQ +      GLAYLH    
Sbjct: 103 FCMTPTERLLVY-PYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLHDHCD 160
Query: 342 -NTVHRDIKGANILVDPHGEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTNG 398
              +HRD+K ANIL+D   E  + DFG+AK M         + +G+   +APE  ++T  
Sbjct: 161 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE-YLSTGK 219
Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            S   D++  G  +LE+ T +  +        + ++ N  D+      L D  K  +K+
Sbjct: 220 SSEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDV-----MLLDWVKGLLKE 266

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 84  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG AK + +       +G      WMA E +++   Y+  
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 201
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 202 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 254
Query: 456 KQCLQRDPSARPPASKLL 473
           ++C   D  +RP   +L+
Sbjct: 255 RKCWMIDADSRPKFRELI 272

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 86  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 203
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 204 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 256
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 257 VKCWMIDADSRPKFRELI 274

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG VY G  ++ G + A+K ++    ++ ++    Q   E+ ++S   H N++R  G
Sbjct: 40  RGGFGKVYKGRLAD-GXLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 290 SELS-DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL-----GLAYLHAR-- 341
             ++  ERL VY  Y++ GS+   L+E  P ++P +    RQ +      GLAYLH    
Sbjct: 95  FCMTPTERLLVY-PYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 342 -NTVHRDIKGANILVDPHGEIKLADFGMAKHM--TSCASMLSFKGSPYWMAPEVVMNTNG 398
              +HRD+K ANIL+D   E  + DFG+AK M         + +G    +APE  ++T  
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE-YLSTGK 211
Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            S   D++  G  +LE+ T +  +        + ++ N  D+      L D  K  +K+
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDV-----MLLDWVKGLLKE 258

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 36  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 92  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 209
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 210 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 262
Query: 456 KQCLQRDPSARPPASKLL 473
           ++C   D  +RP   +L+
Sbjct: 263 RKCWMIDADSRPKFRELI 280

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 85  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 202
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 203 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 255
Query: 456 KQCLQRDPSARPPASKLL 473
           ++C   D  +RP   +L+
Sbjct: 256 RKCWMIDADSRPKFRELI 273

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 84  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 201
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 202 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 254
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 255 VKCWMIDADSRPKFRELI 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 89  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 206
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 207 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 259
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 260 VKCWMIDADSRPKFRELI 277

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 83  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 200
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 201 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 253
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 254 VKCWMIDADSRPKFRELI 271

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 83  LLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 200
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 201 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 253
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 254 VKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 85  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 202
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 203 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 255
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 256 VKCWMIDADSRPKFRELI 273

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 17/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    V+L  +    +  A+K +R   D         +  +E    + L+HP IV  + +
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 291 ELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             ++        + +EYV G ++  ++   GP                L + H    +HR
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 140
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K ANIL+     +K+ DFG+A+ +     S     +  G+  +++PE      G S+ 
Sbjct: 141 DVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE---QARGDSVD 197
Query: 403 V--DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQC 458
              D++SLGC + E+ T +PP++    V+  ++      IP    H  LS D  + + + 
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L ++P  R   +  +    VR
Sbjct: 258 LAKNPENRYQTAAEMRADLVR 278

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 82  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 199
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 200 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 252
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 253 VKCWMIDADSRPKFRELI 270

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 82  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 199
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 200 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 252
Query: 456 KQCLQRDPSARPPASKLL 473
           ++C   D  +RP   +L+
Sbjct: 253 RKCWMIDADSRPKFRELI 270

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 115/245 (46%), Gaps = 22/245 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V +     + ++ A+K +          E LK+       +E ++L       I
Sbjct: 100 RGAFGEVAVVKMKNTERIYAMKIL-------NKWEMLKRAETACFREERDVLVNGDCQWI 152
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNT 343
              H +   +  L + ++Y  GG +  LL ++     E + + Y  +++L +  +H  + 
Sbjct: 153 TALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY 212
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNTNG--- 398
           VHRDIK  N+L+D +G I+LADFG    M    ++ S    G+P +++PE++        
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 399 -YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD---DAKSF 454
            Y    D WSLG  + EM   + P+     V    KI N ++  + P H++D   +AK  
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 332
Query: 455 IKQCL 459
           I++ +
Sbjct: 333 IQRLI 337

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+L+D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 111/230 (48%), Gaps = 21/230 (9%)
Query: 231 GTFGHVYLG-FNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G FG V  G +     Q+  AIK    V    T K   +++ +E  ++ QL +P IVR  
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-PV--IQTYTRQILLGLAYLHARNTVH 345
           G     E L + +E   GG +HK L   G   E PV  +     Q+ +G+ YL  +N VH
Sbjct: 77  GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS----PYWMAPEVVMNTNGYSL 401
           RD+   N+L+      K++DFG++K + +  S  + + +      W APE + N   +S 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSS 192
Query: 402 TVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSKDI-PEIPEHL 447
             D+WS G T+ E ++  + P+ + +G  V A  + G   +  PE P  L
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 37/247 (14%)
Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR 329
           +E+ +L Q   H N++        ++R  +  E + GGSI   + +   FNE       +
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ 118
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHM--------TSCASM 378
            +   L +LH +   HRD+K  NIL +   +   +K+ DFG+   +         S   +
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPEL 178
Query: 379 LSFKGSPYWMAPEVV----MNTNGYSLTVDIWSLGCTVLEMATSKPP----------WSQ 424
           L+  GS  +MAPEVV       + Y    D+WSLG  +  + +  PP          W +
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 425 YEGVAA----IFK-IGNSKDIPEIPE----HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            E   A    +F+ I   K   E P+    H+S  AK  I + L RD   R  A+++L H
Sbjct: 239 GEACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 476 PFVRDQA 482
           P+V+  A
Sbjct: 297 PWVQGCA 303

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 115/245 (46%), Gaps = 22/245 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-----LNQEINLLSQLSHPNI 284
           RG FG V +     + ++ A+K +          E LK+       +E ++L       I
Sbjct: 84  RGAFGEVAVVKMKNTERIYAMKIL-------NKWEMLKRAETACFREERDVLVNGDCQWI 136
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNT 343
              H +   +  L + ++Y  GG +  LL ++     E + + Y  +++L +  +H  + 
Sbjct: 137 TALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY 196
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNTNG--- 398
           VHRDIK  N+L+D +G I+LADFG    M    ++ S    G+P +++PE++        
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 399 -YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD---DAKSF 454
            Y    D WSLG  + EM   + P+     V    KI N ++  + P H++D   +AK  
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 316
Query: 455 IKQCL 459
           I++ +
Sbjct: 317 IQRLI 321

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 21/230 (9%)
Query: 231 GTFGHVYLG-FNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G FG V  G +     Q+  AIK    V    T K   +++ +E  ++ QL +P IVR  
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 289 GSELSDERLSVYLEYVSGGSIHKLL---QEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           G     E L + +E   GG +HK L   +E  P +   +     Q+ +G+ YL  +N VH
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN--VAELLHQVSMGMKYLEEKNFVH 459
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS----PYWMAPEVVMNTNGYSL 401
           R++   N+L+      K++DFG++K + +  S  + + +      W APE + N   +S 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSS 518
Query: 402 TVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSKDI-PEIPEHL 447
             D+WS G T+ E ++  + P+ + +G  V A  + G   +  PE P  L
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 266 LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE---YGP---- 318
           L+ L  E N+L Q++HP++++ +G+   D  L + +EY   GS+   L+E    GP    
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 319 ---------FNEP--------VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
                     + P         + ++  QI  G+ YL   + VHRD+   NILV    ++
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKM 189
Query: 362 KLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS 418
           K++DFG+++ +    S +          WMA E + + + Y+   D+WS G  + E+ T 
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTL 248
Query: 419 KPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               + Y G+    +F +  +    E P++ S++    + QC +++P  RP
Sbjct: 249 GG--NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 12/220 (5%)
Query: 270 NQEINLLSQL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
            +EI +L +   HPNI+         + + V  E   GG +   +     F+E       
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL 122
Query: 329 RQILLGLAYLHARNTVHRDIKGANIL-VDPHGE---IKLADFGMAKHMTSCASMLSFKG- 383
             I   + YLHA+  VHRD+K +NIL VD  G    I++ DFG AK + +   +L     
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY-----EGVAAIFKIGNSK 438
           +  ++APE V+   GY    DIWSLG  +    T   P++       E + A    G   
Sbjct: 183 TANFVAPE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                   +SD AK  + + L  DP  R  A+ +L HP++
Sbjct: 242 LSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 130/290 (44%), Gaps = 55/290 (18%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYH 288
           RG +  V+   N  + +   +K ++ V  ++        + +EI +L  L   PNI+   
Sbjct: 47  RGKYSEVFEAINITNNEKVVVKILKPVKKNK--------IKREIKILENLRGGPNIITL- 97
Query: 289 GSELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
            +++  + +S    +  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +
Sbjct: 98  -ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIM 153
Query: 345 HRDIKGANILVD-PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           HRD+K  N+++D  H +++L D+G+A+             S Y+  PE++++   Y  ++
Sbjct: 154 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 213
Query: 404 DIWSLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIP--------------- 444
           D+WSLGC +  M   K P+      Y+ +  I K+  ++D+ +                 
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 273
Query: 445 ----------------EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                           +HL S +A  F+ + L+ D  +R  A + ++HP+
Sbjct: 274 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY G     G+   I     + ++ T  +   +   E  +++ + HP++VR  G 
Sbjct: 49  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 108
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            LS   + +  + +  G + + + E+       ++  +  QI  G+ YL  R  VHRD+ 
Sbjct: 109 CLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA 167
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N+LV     +K+ DFG+A+ +       +  G      WMA E + +   ++   D+W
Sbjct: 168 ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVW 226
Query: 407 SLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEIPEH---------LSDDAKSFI 455
           S G T+ E+ T   KP    Y+G+        +++IP++ E           + D    +
Sbjct: 227 SYGVTIWELMTFGGKP----YDGIP-------TREIPDLLEKGERLPQPPICTIDVYMVM 275
Query: 456 KQCLQRDPSARPPASKL 472
            +C   D  +RP   +L
Sbjct: 276 VKCWMIDADSRPKFKEL 292

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 116/248 (46%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G+ +   ++ A+K ++       S +       E NL+ QL H  +VR +  
Sbjct: 20  GQFGEVWMGYYNGHTKV-AVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLVRLYAV 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPV--IQTYTRQILLGLAYLHARNTVHRDI 348
            ++ E + +  EY+  GS+   L+        +  +     QI  G+A++  RN +HR++
Sbjct: 73  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNL 131
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE + N   +++  D+
Sbjct: 132 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDV 189
Query: 406 WSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        I  +     +   P++  ++    ++ C +  P 
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPE 248
Query: 465 ARPPASKL 472
            RP    L
Sbjct: 249 DRPTFDYL 256

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 266 LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE---YGP---- 318
           L+ L  E N+L Q++HP++++ +G+   D  L + +EY   GS+   L+E    GP    
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 319 ---------FNEP--------VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
                     + P         + ++  QI  G+ YL     VHRD+   NILV    ++
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 362 KLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS 418
           K++DFG+++ +    S +          WMA E + + + Y+   D+WS G  + E+ T 
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTL 248
Query: 419 KPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               + Y G+    +F +  +    E P++ S++    + QC +++P  RP
Sbjct: 249 GG--NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 84  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG AK + +       +G      WMA E +++   Y+  
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 201
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 202 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 254
Query: 456 KQCLQRDPSARPPASKLL 473
           ++C   D  +RP   +L+
Sbjct: 255 RKCWMIDADSRPKFRELI 272

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 112/261 (42%), Gaps = 17/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    V+L  +    +  A+K +R   D         +  +E    + L+HP IV  + +
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 291 ELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             ++        + +EYV G ++  ++   GP                L + H    +HR
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 140
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K ANI++     +K+ DFG+A+ +     S     +  G+  +++PE      G S+ 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---QARGDSVD 197
Query: 403 V--DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQC 458
              D++SLGC + E+ T +PP++    V+  ++      IP    H  LS D  + + + 
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L ++P  R   +  +    VR
Sbjct: 258 LAKNPENRYQTAAEMRADLVR 278

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 266 LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE---YGP---- 318
           L+ L  E N+L Q++HP++++ +G+   D  L + +EY   GS+   L+E    GP    
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 319 ---------FNEP--------VIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
                     + P         + ++  QI  G+ YL     VHRD+   NILV    ++
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 362 KLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS 418
           K++DFG+++ +    S +          WMA E + + + Y+   D+WS G  + E+ T 
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTL 248
Query: 419 KPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               + Y G+    +F +  +    E P++ S++    + QC +++P  RP
Sbjct: 249 GG--NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G  G V   +++   +  AIK++     +QT     K+  +E+ L+  ++H NI+     
Sbjct: 35  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKXVNHKNIISLLNV 91
Query: 287 YHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   +  +E   VYL   +   ++ +++Q     +   +     Q+L G+ +LH+   +H
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIH 149
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV++   GY   VDI
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDI 208
Query: 406 WSLGCTVLEMATSK 419
           WS+GC + EM   K
Sbjct: 209 WSVGCIMGEMVRHK 222

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY G     G+   I     + ++ T  +   +   E  +++ + HP++VR  G 
Sbjct: 26  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 85
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            LS   + +  + +  G + + + E+       ++  +  QI  G+ YL  R  VHRD+ 
Sbjct: 86  CLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA 144
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N+LV     +K+ DFG+A+ +       +  G      WMA E + +   ++   D+W
Sbjct: 145 ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVW 203
Query: 407 SLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEIPEH---------LSDDAKSFI 455
           S G T+ E+ T   KP    Y+G+        +++IP++ E           + D    +
Sbjct: 204 SYGVTIWELMTFGGKP----YDGIP-------TREIPDLLEKGERLPQPPICTIDVYMVM 252
Query: 456 KQCLQRDPSARPPASKL 472
            +C   D  +RP   +L
Sbjct: 253 VKCWMIDADSRPKFKEL 269

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 51  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 107 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 165
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 224
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 225 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 277
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 278 VKCWMIDADSRPKFRELI 295

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 117/260 (45%), Gaps = 19/260 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V++G         AIK ++       S E   +   E  ++ +L H  +V+ +  
Sbjct: 20  GQFGEVWMG-TWNGNTKVAIKTLK---PGTMSPESFLE---EAQIMKKLKHDKLVQLYAV 72
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +S+E + +  EY++ GS+   L+  E      P +     Q+  G+AY+   N +HRD+
Sbjct: 73  -VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 131
Query: 349 KGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDI 405
           + ANILV      K+ADFG+A+ +       + +G+ +   W APE  +    +++  D+
Sbjct: 132 RSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGR-FTIKSDV 189
Query: 406 WSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
           WS G  + E+ T  + P+        + ++     +P  P+         +  C ++DP 
Sbjct: 190 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-CPQDCPISLHELMIHCWKKDPE 248
Query: 465 ARPPASKLLDHPFVRDQAVA 484
            RP    L    F+ D   A
Sbjct: 249 ERPTFEYL--QSFLEDYFTA 266

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 84  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 201
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 202 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 254
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 255 VKCWMIDADSRPKFRELI 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 112/261 (42%), Gaps = 17/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    V+L  +    +  A+K +R   D         +  +E    + L+HP IV  + +
Sbjct: 23  GGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAIVAVYAT 80
Query: 291 ELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             ++        + +EYV G ++  ++   GP                L + H    +HR
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 140
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K ANI++     +K+ DFG+A+ +     S     +  G+  +++PE      G S+ 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---QARGDSVD 197
Query: 403 V--DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQC 458
              D++SLGC + E+ T +PP++    V+  ++      IP    H  LS D  + + + 
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L ++P  R   +  +    VR
Sbjct: 258 LAKNPENRYQTAAEMRADLVR 278

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 115 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 171
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 172 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 231
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 232 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 291
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 292 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 337

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 89  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 206
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 207 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 259
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 260 VKCWMIDADSRPKFRELI 277

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 226 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 285
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 331

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 85  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 202
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 203 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 255
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 256 VKCWMIDADSRPKFRELI 273

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 84  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG AK + +       +G      WMA E +++   Y+  
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 201
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 202 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 254
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 255 VKCWMIDADSRPKFRELI 272

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 82  LLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 199
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 200 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 252
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 253 VKCWMIDADSRPKFRELI 270

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 89  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 206
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 207 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 259
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 260 VKCWMIDADSRPKFRELI 277

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 85  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 202
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 203 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 255
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 256 VKCWMIDADSRPKFRELI 273

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 32  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 88  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 146
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 205
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 206 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 258
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 259 VKCWMIDADSRPKFRELI 276

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 104 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 136
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M+ F  + Y+ AP
Sbjct: 137 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAP 196
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 197 EVILGM-GYKENVDIWSVGCIMGEM 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 82  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 199
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 200 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 252
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 253 VKCWMIDADSRPKFRELI 270

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 82  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 199
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 200 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 252
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 253 VKCWMIDADSRPKFRELI 270

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 23/258 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V  G     G+      ++ +    T K+  +    E +++ Q  HPN++   G 
Sbjct: 44  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNVIHLEGV 102
Query: 291 ELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
                 + +  E++  GS+   L Q  G F    +    R I  G+ YL   N VHRD+ 
Sbjct: 103 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA 162
Query: 350 GANILVDPHGEIKLADFGMAKHMT------SCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
             NILV+ +   K++DFG+++ +       +  S L  K    W APE +     ++   
Sbjct: 163 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSAS 221
Query: 404 DIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIK 456
           D+WS G  + E+ +   +P W  +  + + AI   +++    D P     L  D      
Sbjct: 222 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD------ 275
Query: 457 QCLQRDPSARPPASKLLD 474
            C Q+D + RP   ++++
Sbjct: 276 -CWQKDRNHRPKFGQIVN 292

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + + ++ +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 86  LLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG AK + +       +G      WMA E +++   Y+  
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 203
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 204 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 256
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 257 VKCWMIDADSRPKFRELI 274

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
            G FG VY G+ + +    A+K++  + D  T++E  +Q +QEI ++++  H N+V   G
Sbjct: 41  EGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 290 -SELSDERLSVYLEYVSGGSIHKL--LQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            S   D+   VY+   +G  + +L  L    P +  +     +    G+ +LH  + +HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTV 403
           DIK ANIL+D     K++DFG+A+     A  +      G+  +MAPE +      +   
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE--ITPKS 215
Query: 404 DIWSLGCTVLEMATSKPPWSQY 425
           DI+S G  +LE+ T  P   ++
Sbjct: 216 DIYSFGVVLLEIITGLPAVDEH 237

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 76  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 193
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 194 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 246
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 247 VKCWMIDADSRPKFRELI 264

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 140 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 172
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHK 260

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
            G FG VY G+ + +    A+K++  + D  T++E  +Q +QEI ++++  H N+V   G
Sbjct: 35  EGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 290 -SELSDERLSVYLEYVSGGSIHKL--LQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            S   D+   VY+   +G  + +L  L    P +  +     +    G+ +LH  + +HR
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTV 403
           DIK ANIL+D     K++DFG+A+     A  +      G+  +MAPE +      +   
Sbjct: 152 DIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE--ITPKS 209
Query: 404 DIWSLGCTVLEMATSKPPWSQY 425
           DI+S G  +LE+ T  P   ++
Sbjct: 210 DIYSFGVVLLEIITGLPAVDEH 231

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G  G V   +++   +  AIK++     +QT     K+  +E+ L+  ++H NI+     
Sbjct: 35  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKXVNHKNIISLLNV 91
Query: 287 YHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   +  +E   VYL   +   ++ +++Q     +   +     Q+L G+ +LH+   +H
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV++   GY   VDI
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDI 208
Query: 406 WSLGCTVLEMATSK 419
           WS+GC + EM   K
Sbjct: 209 WSVGCIMGEMVRHK 222

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLRQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQA 482
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQA
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 23  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 79  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+  
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 196
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 197 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 249
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 250 VKCWMIDADSRPKFRELI 267

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
            G FG VY G+ + +    A+K++  + D  T++E  +Q +QEI ++++  H N+V   G
Sbjct: 41  EGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 290 -SELSDERLSVYLEYVSGGSIHKL--LQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            S   D+   VY+   +G  + +L  L    P +  +     +    G+ +LH  + +HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTV 403
           DIK ANIL+D     K++DFG+A+     A  +      G+  +MAPE +      +   
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE--ITPKS 215
Query: 404 DIWSLGCTVLEMATSKPPWSQY 425
           DI+S G  +LE+ T  P   ++
Sbjct: 216 DIYSFGVVLLEIITGLPAVDEH 237

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 112/261 (42%), Gaps = 17/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    V+L  +    +  A+K +R   D         +  +E    + L+HP IV  + +
Sbjct: 23  GGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 291 ELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             ++        + +EYV G ++  ++   GP                L + H    +HR
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 140
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K ANI++     +K+ DFG+A+ +     S     +  G+  +++PE      G S+ 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---QARGDSVD 197
Query: 403 V--DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQC 458
              D++SLGC + E+ T +PP++    V+  ++      IP    H  LS D  + + + 
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L ++P  R   +  +    VR
Sbjct: 258 LAKNPENRYQTAAEMRADLVR 278

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G  G V   +++   +  AIK++     +QT     K+  +E+ L+  ++H NI+     
Sbjct: 35  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIISLLNV 91
Query: 287 YHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   +  +E   VYL   +   ++ +++Q     +   +     Q+L G+ +LH+   +H
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIH 149
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV++   GY   VDI
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDI 208
Query: 406 WSLGCTVLEMATSK 419
           WS+GC + EM   K
Sbjct: 209 WSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G  G V   +++   +  AIK++     +QT     K+  +E+ L+  ++H NI+     
Sbjct: 28  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIISLLNV 84
Query: 287 YHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   +  +E   VYL   +   ++ +++Q     +   +     Q+L G+ +LH+   +H
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIH 142
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV++   GY   VDI
Sbjct: 143 RDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDI 201
Query: 406 WSLGCTVLEMATSK 419
           WS+GC + EM   K
Sbjct: 202 WSVGCIMGEMVRHK 215

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 140 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 172
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 101 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 133
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 194 EVILGM-GYKENVDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 103 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 135
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 103 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 135
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 96  QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 128
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 189 EVILGM-GYKENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 96  QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 128
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 189 EVILGM-GYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 89  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG AK + +       +G      WMA E +++   Y+  
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 206
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 207 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 259
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 260 VKCWMIDADSRPKFRELI 277

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY G     G+   I    +   + TS +  K++  E  +++ + +P++ R  G 
Sbjct: 60  GAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 119
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
            L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VHRD+ 
Sbjct: 120 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 178
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIW 406
             N+LV     +K+ DFG+AK + +       +G      WMA E +++   Y+   D+W
Sbjct: 179 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVW 237
Query: 407 SLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           S G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    + +C 
Sbjct: 238 SYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIMVKCW 290
Query: 460 QRDPSARPPASKLL 473
             D  +RP   +L+
Sbjct: 291 MIDADSRPKFRELI 304

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ L+ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 95  QDVYLVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 127
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHK 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 111/270 (41%), Gaps = 37/270 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+L+H NIV
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKLNHQNIV 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 213
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 214 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 269
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +        + QC Q  P  RP  + +L+ 
Sbjct: 270 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 299

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 28/258 (10%)
Query: 231 GTFGHVYLGFNSESGQMC----AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           G FG VY G     G+      AIKE+R    + TS +  K++  E  +++ + +P++ R
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVH 345
             G  L+   + +  + +  G +   ++E+        +  +  QI  G+ YL  R  VH
Sbjct: 82  LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLT 402
           RD+   N+LV     +K+ DFG AK + +       +G      WMA E +++   Y+  
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ 199
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQYEGVAA-----IFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G TV E+ T  SKP    Y+G+ A     I + G    +P+ P   + D    +
Sbjct: 200 SDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER--LPQ-PPICTIDVYMIM 252
Query: 456 KQCLQRDPSARPPASKLL 473
            +C   D  +RP   +L+
Sbjct: 253 VKCWMIDADSRPKFRELI 270

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G  G V   F++  G   A+K++     +QT     K+  +E+ LL  ++H NI+     
Sbjct: 35  GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVNHKNIISLLNV 91
Query: 287 YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           +   +  +E   VYL  E +       +  E    +   +     Q+L G+ +LH+   +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGII 148
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV++   GY+  VD
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYAANVD 207
Query: 405 IWSLGCTVLEMA 416
           IWS+GC + E+ 
Sbjct: 208 IWSVGCIMGELV 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L+G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 112/261 (42%), Gaps = 17/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    V+L  +    +  A+K +R   D         +  +E    + L+HP IV  + +
Sbjct: 40  GGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 97
Query: 291 ELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             ++        + +EYV G ++  ++   GP                L + H    +HR
Sbjct: 98  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 157
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K ANI++     +K+ DFG+A+ +     S     +  G+  +++PE      G S+ 
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---QARGDSVD 214
Query: 403 V--DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQC 458
              D++SLGC + E+ T +PP++    V+  ++      IP    H  LS D  + + + 
Sbjct: 215 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 274
Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L ++P  R   +  +    VR
Sbjct: 275 LAKNPENRYQTAAEMRADLVR 295

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 111/269 (41%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+L+H NIV
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKLNHQNIV 111
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 227
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 228 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 283
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 284 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 44/236 (18%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQAVARAGNVNLA 492
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V++Q+   A N  L+
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCADNAVLS 342

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 18/252 (7%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G FG VY G + +  G+   I      C    + +  ++   E  ++  L HP+IV+  G
Sbjct: 35  GFFGEVYEGVYTNHKGE--KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 92
Query: 290 SELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
             + +E   + +E    G + H L +         +  Y+ QI   +AYL + N VHRDI
Sbjct: 93  I-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 151
Query: 349 KGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
              NILV     +KL DFG+++++       +  + L  K    WM+PE + N   ++  
Sbjct: 152 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESI-NFRRFTTA 206
Query: 403 VDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
            D+W     + E ++  K P+   E    I  +     +P+ P+       + + +C   
Sbjct: 207 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWDY 265
Query: 462 DPSARPPASKLL 473
           DPS RP  ++L+
Sbjct: 266 DPSDRPRFTELV 277

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 44/225 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 226 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 285
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQ 481
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQ
Sbjct: 286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 44/225 (19%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 227 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 286
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQ 481
              +HL S +A  F+ + L+ D  +R  A + ++HP+    V+DQ
Sbjct: 287 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 230 RGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
            G FG VY G + +  G+   I      C    + +  ++   E  ++  L HP+IV+  
Sbjct: 22  EGFFGEVYEGVYTNHKGE--KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 289 GSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRD 347
           G  + +E   + +E    G + H L +         +  Y+ QI   +AYL + N VHRD
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 138
Query: 348 IKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
           I   NILV     +KL DFG+++++       +  + L  K    WM+PE + N   ++ 
Sbjct: 139 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESI-NFRRFTT 193
Query: 402 TVDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             D+W     + E ++  K P+   E    I  +     +P+ P+       + + +C  
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWD 252
Query: 461 RDPSARPPASKLL 473
            DPS RP  ++L+
Sbjct: 253 YDPSDRPRFTELV 265

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 109/247 (44%), Gaps = 37/247 (14%)
Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR 329
           +E+ +L Q   H N++        ++R  +  E + GGSI   + +   FNE       +
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ 118
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHM--------TSCASM 378
            +   L +LH +   HRD+K  NIL +   +   +K+ DF +   +         S   +
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 379 LSFKGSPYWMAPEVV----MNTNGYSLTVDIWSLGCTVLEMATSKPP----------WSQ 424
           L+  GS  +MAPEVV       + Y    D+WSLG  +  + +  PP          W +
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 425 YEGVAA----IFK-IGNSKDIPEIPE----HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            E   A    +F+ I   K   E P+    H+S  AK  I + L RD   R  A+++L H
Sbjct: 239 GEACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 476 PFVRDQA 482
           P+V+  A
Sbjct: 297 PWVQGCA 303

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 45/273 (16%)
Query: 231 GTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG V+          E   M A+K ++    ++ S +      +E  L+++  +PNIV
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASADMQADFQREAALMAEFDNPNIV 113
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ-------------------- 325
           +  G     + + +  EY++ G +++ L+   P     +                     
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 326 ----TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF 381
                  RQ+  G+AYL  R  VHRD+   N LV  +  +K+ADFG+++++ S A     
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS-ADYYKA 232
Query: 382 KGSPY----WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS--KPPWSQ-YEGVAAIFKI 434
            G+      WM PE +   N Y+   D+W+ G  + E+ +   +P +   +E V    + 
Sbjct: 233 DGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291
Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
           GN   I   PE+   +  + ++ C  + P+ RP
Sbjct: 292 GN---ILACPENCPLELYNLMRLCWSKLPADRP 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---- 286
           G  G V   F++  G   A+K++     +QT     K+  +E+ LL  ++H NI+     
Sbjct: 33  GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVNHKNIISLLNV 89
Query: 287 YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           +   +  +E   VYL  E +       +  E    +   +     Q+L G+ +LH+   +
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGII 146
Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           HRD+K +NI+V     +K+ DFG+A+  ++   M  +  + Y+ APEV++   GY   VD
Sbjct: 147 HRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM-GYKENVD 205
Query: 405 IWSLGCTVLEMA 416
           IWS+GC + E+ 
Sbjct: 206 IWSVGCIMGELV 217

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 18/252 (7%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G FG VY G + +  G+   I      C    + +  ++   E  ++  L HP+IV+  G
Sbjct: 19  GFFGEVYEGVYTNHKGE--KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 76
Query: 290 SELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
             + +E   + +E    G + H L +         +  Y+ QI   +AYL + N VHRDI
Sbjct: 77  I-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 135
Query: 349 KGANILVDPHGEIKLADFGMAKHMT------SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
              NILV     +KL DFG+++++       +  + L  K    WM+PE + N   ++  
Sbjct: 136 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESI-NFRRFTTA 190
Query: 403 VDIWSLGCTVLE-MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR 461
            D+W     + E ++  K P+   E    I  +     +P+ P+       + + +C   
Sbjct: 191 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWDY 249
Query: 462 DPSARPPASKLL 473
           DPS RP  ++L+
Sbjct: 250 DPSDRPRFTELV 261

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/274 (21%), Positives = 119/274 (43%), Gaps = 47/274 (17%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+   +   G+   I+ V+   +         +  +E+  L++L H NIV Y+G 
Sbjct: 23  GGFGQVFKAKHRIDGKTYVIRRVKYNNE---------KAEREVKALAKLDHVNIVHYNGC 73
Query: 291 --------ELSDERLS---------------------VYLEYVSGGSIHKLLQEY--GPF 319
                   E SD+ L                      + +E+   G++ + +++      
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 320 NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML 379
           ++ +      QI  G+ Y+H++  +HRD+K +NI +    ++K+ DFG+   + +     
Sbjct: 134 DKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD 439
             KG+  +M+PE + ++  Y   VD+++LG  + E+        +        + G   D
Sbjct: 194 RSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD 252
Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           I +  E      K+ +++ L + P  RP  S++L
Sbjct: 253 IFDKKE------KTLLQKLLSKKPEDRPNTSEIL 280

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V  G     G+  +   ++ +    T ++  ++   E +++ Q  HPNI+R  G 
Sbjct: 25  GEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRLEGV 83
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +   + +  E++  G++   L+   G F    +    R I  G+ YL   + VHRD+ 
Sbjct: 84  VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLA 143
Query: 350 GANILVDPHGEIKLADFGMAKHMT------SCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
             NILV+ +   K++DFG+++ +       +  S L  K    W APE +     ++   
Sbjct: 144 ARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI-AFRKFTSAS 202
Query: 404 DIWSLGCTVLEMAT--SKPPW--SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           D WS G  + E+ +   +P W  S  + + AI +       P+ P  L       +  C 
Sbjct: 203 DAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSL----HQLMLDCW 258
Query: 460 QRDPSARP 467
           Q+D +ARP
Sbjct: 259 QKDRNARP 266

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 17/248 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V  G     G+  +   ++ +    T ++  ++   E +++ Q  HPNI+R  G 
Sbjct: 27  GEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRLEGV 85
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
             +   + +  E++  G++   L+   G F    +    R I  G+ YL   + VHRD+ 
Sbjct: 86  VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLA 145
Query: 350 GANILVDPHGEIKLADFGMAKHMT------SCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
             NILV+ +   K++DFG+++ +       +  S L  K    W APE +     ++   
Sbjct: 146 ARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA-FRKFTSAS 204
Query: 404 DIWSLGCTVLEMAT--SKPPW--SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
           D WS G  + E+ +   +P W  S  + + AI +       P+ P  L       +  C 
Sbjct: 205 DAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSL----HQLMLDCW 260
Query: 460 QRDPSARP 467
           Q+D +ARP
Sbjct: 261 QKDRNARP 268

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 111/261 (42%), Gaps = 17/261 (6%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G    V+L  +    +  A+K +R   D         +  +E    + L+HP IV  + +
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 291 ELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
             ++        + +EYV G ++  ++   GP                L + H    +HR
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 140
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+K ANI++     +K+ DFG+A+ +     S     +  G+  +++PE      G S+ 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---QARGDSVD 197
Query: 403 V--DIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH--LSDDAKSFIKQC 458
              D++SLGC + E+ T +PP++     +  ++      IP    H  LS D  + + + 
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L ++P  R   +  +    VR
Sbjct: 258 LAKNPENRYQTAAEMRADLVR 278

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 110/270 (40%), Gaps = 37/270 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 213
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 214 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 269
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +        + QC Q  P  RP  + +L+ 
Sbjct: 270 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 299

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  E+V+     +L Q    ++   I+ Y  +IL  L Y H+   +HRD+K  N+++D 
Sbjct: 108 ALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 164
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
            H +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 165 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDIPEIP---------------------------- 444
             K P+      Y+ +  I K+  ++D+ +                              
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284
Query: 445 ---EHL-SDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
              +HL S +A  F+ + L+ D  +R  A + ++HP+
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 107 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 139
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 140 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 199
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VD+WS+GC + EM   K
Sbjct: 200 EVILGM-GYKENVDLWSVGCIMGEMVCHK 227

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 33  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 88
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 149 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 204
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 205 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 260
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 261 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 109/270 (40%), Gaps = 37/270 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 59  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 114
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +           +ML  K    WM
Sbjct: 175 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK----WM 230
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 231 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 286
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +        + QC Q  P  RP  + +L+ 
Sbjct: 287 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 316

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 68  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 123
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 184 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 239
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 240 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 295
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 296 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 110/270 (40%), Gaps = 37/270 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 48  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 103
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 164 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 219
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 220 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 275
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +        + QC Q  P  RP  + +L+ 
Sbjct: 276 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 305

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 109/270 (40%), Gaps = 37/270 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 137
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +           +ML  K    WM
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK----WM 253
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 254 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 309
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +        + QC Q  P  RP  + +L+ 
Sbjct: 310 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 96
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 212
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 213 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 268
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 269 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 38  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 96
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFNEPV-----------IQTYTRQ 330
             G+       L V +E+   G++   L+    E+ P+  P            +  Y+ Q
Sbjct: 97  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQ 156
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---- 386
           +  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG       
Sbjct: 157 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDARLPLK 215
Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDIPE 442
           WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G       
Sbjct: 216 WMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---R 271
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            P++ + +    +  C   +PS RP  S+L++H
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 110/270 (40%), Gaps = 37/270 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 58  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 113
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 174 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 229
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 230 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 285
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +        + QC Q  P  RP  + +L+ 
Sbjct: 286 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 315

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/261 (21%), Positives = 117/261 (44%), Gaps = 34/261 (13%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG- 289
           G FG V+   +   G+   IK V+   +         +  +E+  L++L H NIV Y+G 
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIVHYNGC 72
Query: 290 ---------------SELSDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQIL 332
                          S    + L + +E+   G++ + +++      ++ +      QI 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            G+ Y+H++  ++RD+K +NI +    ++K+ DFG+   + +       KG+  +M+PE 
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQ 192
Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           + ++  Y   VD+++LG  + E+        +        + G   DI +  E      K
Sbjct: 193 I-SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKE------K 245
Query: 453 SFIKQCLQRDPSARPPASKLL 473
           + +++ L + P  RP  S++L
Sbjct: 246 TLLQKLLSKKPEDRPNTSEIL 266

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 96  QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 128
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VD+WS+GC + EM   K
Sbjct: 189 EVILGM-GYKENVDLWSVGCIMGEMVCHK 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 12/232 (5%)
Query: 248 CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG 307
            AIK ++    ++  ++ L     E +++ Q  HPNI+R  G         +  EY+  G
Sbjct: 80  VAIKALKAGYTERQRRDFLS----EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 308 SIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF 366
           S+   L+ + G F    +    R +  G+ YL     VHRD+   N+LVD +   K++DF
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 367 GMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPP 421
           G+++ +     +  +    K    W APE +     +S   D+WS G  + E +A  + P
Sbjct: 196 GLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERP 254
Query: 422 WSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           +        I  +     +P  P          +  C  +D + RP  S+++
Sbjct: 255 YWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 20/258 (7%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEV-RVVCDDQTSKECLKQLNQEINLLSQLS--HPNIVRY 287
           G FG VY G         AIK V +    D        ++  E+ LL ++S     ++R 
Sbjct: 19  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 78
Query: 288 HGSELSDERLSVYLEYVS-GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
                  +   + LE +     +   + E G   E + +++  Q+L  + + H    +HR
Sbjct: 79  LDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 138
Query: 347 DIKGANILVDPH-GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           DIK  NIL+D + GE+KL DFG    +        F G+  +  PE +     +  +  +
Sbjct: 139 DIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAV 197
Query: 406 WSLGCTVLEMATSKPPWSQYEGVA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
           WSLG  + +M     P+   E +      F+           + +S + +  I+ CL   
Sbjct: 198 WSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSECQHLIRWCLALR 246
Query: 463 PSARPPASKLLDHPFVRD 480
           PS RP   ++ +HP+++D
Sbjct: 247 PSDRPTFEEIQNHPWMQD 264

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 97
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK----WM 213
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 214 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 269
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 270 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 103 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 135
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEM 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+A+ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 270 NQEINLLSQL-SHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++EI +L +   HPNI+     ++ D+   VYL  E + GG +   +     F+E     
Sbjct: 68  SEEIEILLRYGQHPNIITL--KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF 125
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANIL-VDPHGE---IKLADFGMAKHMTSCASMLSFK 382
               I   + YLH++  VHRD+K +NIL VD  G    +++ DFG AK + +   +L   
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 383 G-SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSK 438
             +  ++APE V+   GY    DIWSLG  +  M     P++          + +IG+ K
Sbjct: 186 CYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 439 DIPEIP--EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                     +S+ AK  + + L  DP  R  A ++L HP+V
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 270 NQEINLLSQL-SHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQT 326
           ++EI +L +   HPNI+     ++ D+   VYL  E + GG +   +     F+E     
Sbjct: 68  SEEIEILLRYGQHPNIITL--KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF 125
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANIL-VDPHGE---IKLADFGMAKHMTSCASMLSFK 382
               I   + YLH++  VHRD+K +NIL VD  G    +++ DFG AK + +   +L   
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 383 G-SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSK 438
             +  ++APE V+   GY    DIWSLG  +  M     P++          + +IG+ K
Sbjct: 186 CYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 439 DIPEIP--EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                     +S+ AK  + + L  DP  R  A ++L HP+V
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 12/232 (5%)
Query: 248 CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG 307
            AIK ++    ++  ++ L     E +++ Q  HPNI+R  G         +  EY+  G
Sbjct: 80  VAIKALKAGYTERQRRDFLS----EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 308 SIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF 366
           S+   L+ + G F    +    R +  G+ YL     VHRD+   N+LVD +   K++DF
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 367 GMAKHMT----SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPP 421
           G+++ +     +  +    K    W APE +     +S   D+WS G  + E +A  + P
Sbjct: 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERP 254
Query: 422 WSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           +        I  +     +P  P          +  C  +D + RP  S+++
Sbjct: 255 YWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 231 GTFGHVYLGFNSESG--QMC-AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V  G     G  ++C AIK ++    D+  ++ L     E +++ Q  HPNI+  
Sbjct: 40  GEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL----SEASIMGQFDHPNIIHL 95
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L++  G F    +    R I  G+ YL   + VHR
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHR 155
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NILV+ +   K++DFGM++ +     +  +    K    W APE +     ++  
Sbjct: 156 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSA 214
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + AI   +++    D P     L  D     
Sbjct: 215 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD----- 269
Query: 456 KQCLQRDPSARPPASKLLD 474
             C Q++ S RP   ++++
Sbjct: 270 --CWQKERSDRPKFGQIVN 286

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 111/258 (43%), Gaps = 23/258 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V  G     G+      ++ +    T K+  +    E +++ Q  HPN++   G 
Sbjct: 18  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNVIHLEGV 76
Query: 291 ELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
                 + +  E++  GS+   L Q  G F    +    R I  G+ YL   N VHR + 
Sbjct: 77  VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALA 136
Query: 350 GANILVDPHGEIKLADFGMAKHMT------SCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
             NILV+ +   K++DFG+++ +       +  S L  K    W APE +     ++   
Sbjct: 137 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSAS 195
Query: 404 DIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFIK 456
           D+WS G  + E+ +   +P W  +  + + AI   +++    D P     L  D      
Sbjct: 196 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD------ 249
Query: 457 QCLQRDPSARPPASKLLD 474
            C Q+D + RP   ++++
Sbjct: 250 -CWQKDRNHRPKFGQIVN 266

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 39  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 94
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 153
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE-SLQTQK 212
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 271
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 272 CWHPKAEMRPSFSELV 287

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 111
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + +E ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 227
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 228 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 283
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 284 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 161
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 162 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 220
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 221 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ +H NIV
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKFNHQNIV 96
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + +E ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 212
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMAT---SKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            PE  M    ++   D WS G  + E+ +      P    + V      G   D    P+
Sbjct: 213 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPK 268
Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
           +        + QC Q  P  RP  + +L+
Sbjct: 269 NCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 157 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 216 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 58  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 113
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 172
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 231
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 290
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 291 CWHPKAEMRPSFSELV 306

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 176
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 177 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 235
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 236 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 175
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 176 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 234
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 235 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 24/216 (11%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G   +V+ G + ++G + AIK    V ++ +    +    +E  +L +L+H NIV+   
Sbjct: 19  QGATANVFRGRHKKTGDLFAIK----VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 290 --SELSDERLSVYLEYVSGGSIHKLLQE----YG-PFNEPVIQTYTRQILLGLAYLHARN 342
              E +     + +E+   GS++ +L+E    YG P +E +I    R ++ G+ +L    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI--VLRDVVGGMNHLRENG 132
Query: 343 TVHRDIKGANIL----VDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM---- 394
            VHR+IK  NI+     D     KL DFG A+ +      +S  G+  ++ P++      
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 395 ---NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
              +   Y  TVD+WS+G T    AT   P+  +EG
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 136 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 196 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 255 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 32  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 87
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 146
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 205
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 206 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 264
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 265 CWHPKAEMRPSFSELV 280

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 176
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 177 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 235
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 236 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP------N 283
           +G+FG V   ++ +  Q  A+K VR        K   +Q  +EI +L  L         N
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHAR 341
           ++    +      + +  E +S  ++++L+++  +  F+ P+++ +   IL  L  LH  
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 342 NTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSC---ASMLSFKGSPYWMAPEVVMNT 396
             +H D+K  NIL+   G   IK+ DFG     +SC     + +   S ++ APEV++  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 397 NGYSLTVDIWSLGCTVLEMATSKP 420
             Y + +D+WSLGC + E+ T  P
Sbjct: 275 R-YGMPIDMWSLGCILAELLTGYP 297

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 101 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 160
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 161 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 219
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 220 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 189 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 247
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 248 IIGGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 190 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 248
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 249 IIGGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 190 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 248
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 249 IIGGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 189 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 247
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 248 IIGGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 203
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 204 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 262
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 263 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 161
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 162 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 220
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 221 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 38  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 93
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 152
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 211
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 270
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 271 CWHPKAEMRPSFSELV 286

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 175
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 176 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 234
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 235 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 40  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 95
Query: 287 YHGSELSDE-RLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 154
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 213
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 272
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 273 CWHPKAEMRPSFSELV 288

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 190 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 248
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 249 IIGGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 189 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 247
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 248 IIGGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 35  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 90
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 149
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 208
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 267
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 268 CWHPKAEMRPSFSELV 283

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 188
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 189 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 247
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 248 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 161
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 162 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 220
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 221 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 189
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE- 426
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 190 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 248
Query: 427 --GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             G    F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 249 IIGGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 149 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 208
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 209 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 267
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 268 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 312

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 37  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 92
Query: 287 YHGSELSDE-RLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 151
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 210
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 269
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 270 CWHPKAEMRPSFSELV 285

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 100 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 159
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 160 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 218
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 219 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
            G FG VY G+ + +    A+K++  + D  T++E  +Q +QEI + ++  H N+V   G
Sbjct: 32  EGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 290 -SELSDERLSVYLEYVSGGSIHKL--LQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            S   D+   VY+   +G  + +L  L    P +        +    G+ +LH  + +HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLS---FKGSPYWMAPEVVMNTNGYSLTV 403
           DIK ANIL+D     K++DFG+A+     A  +      G+  + APE +      +   
Sbjct: 149 DIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE--ITPKS 206
Query: 404 DIWSLGCTVLEMATSKPPWSQY 425
           DI+S G  +LE+ T  P   ++
Sbjct: 207 DIYSFGVVLLEIITGLPAVDEH 228

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 59  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 114
Query: 287 YHGSELSDE-RLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 173
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 232
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 291
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 292 CWHPKAEMRPSFSELV 307

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 157 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
Query: 428 VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +     IG         + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 216 I-----IGGQV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP------N 283
           +G+FG V   ++ +  Q  A+K VR        K   +Q  +EI +L  L         N
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHAR 341
           ++    +      + +  E +S  ++++L+++  +  F+ P+++ +   IL  L  LH  
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 342 NTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNT 396
             +H D+K  NIL+   G   IK+ DFG     +SC     + +   S ++ APEV++  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 397 NGYSLTVDIWSLGCTVLEMATSKP 420
             Y + +D+WSLGC + E+ T  P
Sbjct: 275 R-YGMPIDMWSLGCILAELLTGYP 297

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 124 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 183
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 184 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 242
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 243 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 39  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 94
Query: 287 YHGSELSDE-RLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 153
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 212
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 271
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 272 CWHPKAEMRPSFSELV 287

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 203
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 204 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 262
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 263 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 231 GTFGHVYLGFNSESG--QMC-AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V  G     G  ++C AIK ++    D+  ++ L     E +++ Q  HPNI+  
Sbjct: 19  GEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL----SEASIMGQFDHPNIIHL 74
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L++  G F    +    R I  G+ YL   + VHR
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 134
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NILV+ +   K++DFGM++ +     +  +    K    W APE +     ++  
Sbjct: 135 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSA 193
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + AI   +++    D P     L  D     
Sbjct: 194 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD----- 248
Query: 456 KQCLQRDPSARPPASKLLD 474
             C Q++ S RP   ++++
Sbjct: 249 --CWQKERSDRPKFGQIVN 265

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 231 GTFGHVYLGFNSESG--QMC-AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V  G     G  ++C AIK ++    D+  ++ L     E +++ Q  HPNI+  
Sbjct: 25  GEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL----SEASIMGQFDHPNIIHL 80
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L++  G F    +    R I  G+ YL   + VHR
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 140
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NILV+ +   K++DFGM++ +     +  +    K    W APE +     ++  
Sbjct: 141 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSA 199
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + AI   +++    D P     L  D     
Sbjct: 200 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD----- 254
Query: 456 KQCLQRDPSARPPASKLLD 474
             C Q++ S RP   ++++
Sbjct: 255 --CWQKERSDRPKFGQIVN 271

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 157 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 216 IIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 39  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 97
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFNEP------------VIQTYTR 329
             G+       L V +E+   G++   L+    E+ P+ E              +  Y+ 
Sbjct: 98  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSF 157
Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY--- 386
           Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG      
Sbjct: 158 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPL 216
Query: 387 -WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDIP 441
            WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G      
Sbjct: 217 KWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 272
Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
             P++ + +    +  C   +PS RP  S+L++H
Sbjct: 273 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 25/251 (9%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V LG     G   A+K ++   +D T++  L     E ++++QL H N+V+  G
Sbjct: 203 KGEFGDVMLG--DYRGNKVAVKCIK---NDATAQAFL----AEASVMTQLRHSNLVQLLG 253
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVH 345
             + +E+  +Y+  EY++ GS+   L+  G        +  ++  +   + YL   N VH
Sbjct: 254 V-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+   N+LV      K++DFG+ K  +S     + K    W APE  +    +S   D+
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE-ALREKKFSTKSDV 369
Query: 406 WSLGCTVLEMAT-SKPPWSQ--YEGVAAIFKIGNSKDIPE-IPEHLSDDAKSFIKQCLQR 461
           WS G  + E+ +  + P+ +   + V    + G   D P+  P  + D     +K C   
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD----VMKNCWHL 425
Query: 462 DPSARPPASKL 472
           D + RP   +L
Sbjct: 426 DAATRPTFLQL 436

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 203
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 204 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 262
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   PS RP   ++ +HP+++D
Sbjct: 263 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 22/254 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G     G+   I     V +D++ ++  + +   +  +  L H +IVR  G 
Sbjct: 42  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 101
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
                 L +  +Y+  GS+   + Q  G     ++  +  QI  G+ YL     VHR++ 
Sbjct: 102 -CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 160
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSF---KGSPYWMAPEVVMNTNGYSLTVDIW 406
             N+L+    ++++ADFG+A  +      L +   K    WMA E + +   Y+   D+W
Sbjct: 161 ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-HFGKYTHQSDVW 219
Query: 407 SLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD------DAKSFIKQC 458
           S G TV E+ T  ++P    Y G     ++    D+ E  E L+       D    + +C
Sbjct: 220 SYGVTVWELMTFGAEP----YAG----LRLAEVPDLLEKGERLAQPQICTIDVYMVMVKC 271
Query: 459 LQRDPSARPPASKL 472
              D + RP   +L
Sbjct: 272 WMIDENIRPTFKEL 285

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 40  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 95
Query: 287 YHGSELSDE-RLSVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ YL ++  
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKF 154
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 213
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 272
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 273 CWHPKAEMRPSFSELV 288

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 29/266 (10%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 27  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 85
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 86  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 145
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----YWMAPEV 392
           L+A+  VHRD+   N +V     +K+ DFGM + +   A     KG        WMAPE 
Sbjct: 146 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYR--KGGKGLLPVRWMAPE- 202
Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEHLS 448
            +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE ++
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 449 DDAKSFIKQCLQRDPSARPPASKLLD 474
           D     ++ C Q +P  RP   ++++
Sbjct: 263 D----LMRMCWQFNPKMRPTFLEIVN 284

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 11/190 (5%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV----R 286
           G  G V   +++   +  AIK++     +QT     K+  +E+ L+  ++H NI+     
Sbjct: 35  GAQGIVVAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKVVNHKNIIGLLNV 91
Query: 287 YHGSELSDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
           +   +  +E   VY+   +   ++ +++Q     +   +     Q+L+G+ +LH+   +H
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIH 149
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV++   GY   VDI
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDI 208
Query: 406 WSLGCTVLEM 415
           WS+G  + EM
Sbjct: 209 WSVGVIMGEM 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 54  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 109
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 169
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 170 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 228
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 229 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 283
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 284 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 319

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G   +V+ G + ++G + AIK    V ++ +    +    +E  +L +L+H NIV+   
Sbjct: 19  QGATANVFRGRHKKTGDLFAIK----VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 290 --SELSDERLSVYLEYVSGGSIHKLLQE----YG-PFNEPVIQTYTRQILLGLAYLHARN 342
              E +     + +E+   GS++ +L+E    YG P +E +I    R ++ G+ +L    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI--VLRDVVGGMNHLRENG 132
Query: 343 TVHRDIKGANIL----VDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM---- 394
            VHR+IK  NI+     D     KL DFG A+ +      +   G+  ++ P++      
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVL 192
Query: 395 ---NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
              +   Y  TVD+WS+G T    AT   P+  +EG
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 125/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+ + +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 99  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 154
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 213
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 272
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 331
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 332 CWHPKAEMRPSFSELV 347

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/236 (21%), Positives = 106/236 (44%), Gaps = 44/236 (18%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  EY++     +L Q    F+   I+ Y  ++L  L Y H++  +HRD+K  N+++D 
Sbjct: 111 ALVFEYINNTDFKQLYQILTDFD---IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 167
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
              +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 168 QQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 227
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDI--------PEIPEHLSD--------------- 449
             + P+      Y+ +  I K+  ++++         ++  H +D               
Sbjct: 228 FRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIH 287
Query: 450 ---------DAKSFIKQCLQRDPSARPPASKLLDHPF----VRDQAVARAGNVNLA 492
                    +A   + + L+ D   R  A + ++HP+    V++Q+   A N  L+
Sbjct: 288 SENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLS 343

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L+G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ AP
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+G  + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEM 218

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M     + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VDIWS+GC + EM   K
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVCHK 222

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 22/254 (8%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG V+ G     G+   I     V +D++ ++  + +   +  +  L H +IVR  G 
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83
Query: 291 ELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIK 349
                 L +  +Y+  GS+   + Q  G     ++  +  QI  G+ YL     VHR++ 
Sbjct: 84  -CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 350 GANILVDPHGEIKLADFGMAKHMTSCASMLSF---KGSPYWMAPEVVMNTNGYSLTVDIW 406
             N+L+    ++++ADFG+A  +      L +   K    WMA E + +   Y+   D+W
Sbjct: 143 ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-HFGKYTHQSDVW 201
Query: 407 SLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD------DAKSFIKQC 458
           S G TV E+ T  ++P    Y G     ++    D+ E  E L+       D    + +C
Sbjct: 202 SYGVTVWELMTFGAEP----YAG----LRLAEVPDLLEKGERLAQPQICTIDVYMVMVKC 253
Query: 459 LQRDPSARPPASKL 472
              D + RP   +L
Sbjct: 254 WMIDENIRPTFKEL 267

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 40  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 95
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 154
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 213
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 272
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 273 CWHPKAEMRPSFSELV 288

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP------N 283
           +G FG V   ++ +  Q  A+K VR        K   +Q  +EI +L  L         N
Sbjct: 107 KGXFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHAR 341
           ++    +      + +  E +S  ++++L+++  +  F+ P+++ +   IL  L  LH  
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 342 NTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSC---ASMLSFKGSPYWMAPEVVMNT 396
             +H D+K  NIL+   G   IK+ DFG     +SC     +     S ++ APEV++  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYXXIQSRFYRAPEVILGA 274
Query: 397 NGYSLTVDIWSLGCTVLEMATSKP 420
             Y + +D+WSLGC + E+ T  P
Sbjct: 275 R-YGMPIDMWSLGCILAELLTGYP 297

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 44  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 99
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 159
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 160 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 218
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 219 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 273
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 274 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 309

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 45  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 100
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 159
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 218
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 277
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 278 CWHPKAEMRPSFSELV 293

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 123/266 (46%), Gaps = 29/266 (10%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 27  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 85
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 86  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 145
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----YWMAPEV 392
           L+A+  VHRD+   N +V     +K+ DFGM + +         KG        WMAPE 
Sbjct: 146 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX--XRKGGKGLLPVRWMAPE- 202
Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEHLS 448
            +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE ++
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 449 DDAKSFIKQCLQRDPSARPPASKLLD 474
           D     ++ C Q +P+ RP   ++++
Sbjct: 263 D----LMRMCWQFNPNMRPTFLEIVN 284

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 41  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 96
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 155
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMT-----SCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 214
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 273
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 274 CWHPKAEMRPSFSELV 289

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 117/258 (45%), Gaps = 27/258 (10%)
Query: 231 GTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V  G     G+     AIK ++V   ++  ++ L     E +++ Q  HPN+V  
Sbjct: 54  GEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL----CEASIMGQFDHPNVVHL 109
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + + +E++  G++   L+++ G F    +    R I  G+ YL     VHR
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHR 169
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NILV+ +   K++DFG+++ +     +  +    K    W APE +     ++  
Sbjct: 170 DLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI-QYRKFTSA 228
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + AI   +++    D P     L  D     
Sbjct: 229 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLD----- 283
Query: 456 KQCLQRDPSARPPASKLL 473
             C Q++ + RP   +++
Sbjct: 284 --CWQKERAERPKFEQIV 299

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 115/261 (44%), Gaps = 25/261 (9%)
Query: 231 GTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           G FG V  G    E G    +  V+ +  D +S+  +++   E   +   SHPN++R  G
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVA-VKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103
Query: 290 S--ELSDERL---SVYLEYVSGGSIHKLLQ----EYGPFNEPV--IQTYTRQILLGLAYL 338
              E+S + +    V L ++  G +H  L     E GP + P+  +  +   I LG+ YL
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMN 395
             RN +HRD+   N ++     + +ADFG++K + S       + +     W+A E + +
Sbjct: 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223
Query: 396 TNGYSLTVDIWSLGCTVLEMATS----KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
              Y+   D+W+ G T+ E+AT      P    +E    +      K     PE   D+ 
Sbjct: 224 -RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ----PEDCLDEL 278
Query: 452 KSFIKQCLQRDPSARPPASKL 472
              +  C + DP  RP  S L
Sbjct: 279 YEIMYSCWRTDPLDRPTFSVL 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 40  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 95
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 154
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 213
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 272
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 273 CWHPKAEMRPSFSELV 288

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 27  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 82
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 143 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 201
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 202 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 256
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 257 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 292

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 28/145 (19%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M     + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEM 415
           EV++   GY   VDIWS+GC + EM
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEM 218

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 26/257 (10%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS 290
           G FG VY G     G+   I     V  + TS +  K++  E  +++ +  P + R  G 
Sbjct: 28  GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGI 87
Query: 291 ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKG 350
            L+     V      G  +  + +  G      +  +  QI  G++YL     VHRD+  
Sbjct: 88  CLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAA 147
Query: 351 ANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEVVMNTNGYSLTVDIWS 407
            N+LV     +K+ DFG+A+ +    +     G      WMA E ++    ++   D+WS
Sbjct: 148 RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR-FTHQSDVWS 206
Query: 408 LGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEIPEH---------LSDDAKSFIK 456
            G TV E+ T  +KP    Y+G+ A       ++IP++ E           + D    + 
Sbjct: 207 YGVTVWELMTFGAKP----YDGIPA-------REIPDLLEKGERLPQPPICTIDVYMIMV 255
Query: 457 QCLQRDPSARPPASKLL 473
           +C   D   RP   +L+
Sbjct: 256 KCWMIDSECRPRFRELV 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 115/259 (44%), Gaps = 27/259 (10%)
Query: 231 GTFGHVYLGFNSESGQM---CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V  G     G+     AIK ++V   ++  ++ L     E +++ Q  HPNI+  
Sbjct: 33  GEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIHL 88
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  EY+  GS+   L++  G F    +    R I  G+ YL     VHR
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHR 148
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W APE +     ++  
Sbjct: 149 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI-AFRKFTSA 207
Query: 403 VDIWSLGCTVLEMAT--SKPPWSQ-----YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W        + V   +++ +  D P     L  D     
Sbjct: 208 SDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLD----- 262
Query: 456 KQCLQRDPSARPPASKLLD 474
             C Q++ ++RP   ++++
Sbjct: 263 --CWQKERNSRPKFDEIVN 279

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 41  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 96
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 155
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 214
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 273
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 274 CWHPKAEMRPSFSELV 289

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 24  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 82
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 83  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 142
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----YWMAPEV 392
           L+A+  VHRD+   N +V     +K+ DFGM + +         KG        WMAPE 
Sbjct: 143 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX--XRKGGKGLLPVRWMAPE- 199
Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEHLS 448
            +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE ++
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 259
Query: 449 DDAKSFIKQCLQRDPSARPPASKLLD 474
           D     ++ C Q +P  RP   ++++
Sbjct: 260 D----LMRMCWQFNPKMRPTFLEIVN 281

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG 367
           +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D + GE+KL DFG
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 176
Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
               +        F G+  +  PE +     +  +  +WSLG  + +M     P+   E 
Sbjct: 177 SGALLKDTVYT-DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 235
Query: 428 VA---AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +      F+           + +S + +  I+ CL   P  RP   ++ +HP+++D
Sbjct: 236 IIRGQVFFR-----------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQD 280

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V LG     G   A+K ++   +D T++  L     E ++++QL H N+V+  G
Sbjct: 22  KGEFGDVMLG--DYRGNKVAVKCIK---NDATAQAFL----AEASVMTQLRHSNLVQLLG 72
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVH 345
             + +E+  +Y+  EY++ GS+   L+  G        +  ++  +   + YL   N VH
Sbjct: 73  V-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 131
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+   N+LV      K++DFG+ K  +S     + K    W APE  +    +S   D+
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE-ALREAAFSTKSDV 188
Query: 406 WSLGCTVLEM 415
           WS G  + E+
Sbjct: 189 WSFGILLWEI 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 27  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 85
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 86  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 145
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----YWMAPEV 392
           L+A+  VHRD+   N +V     +K+ DFGM + +         KG        WMAPE 
Sbjct: 146 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX--XRKGGKGLLPVRWMAPE- 202
Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEHLS 448
            +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE ++
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 449 DDAKSFIKQCLQRDPSARPPASKLLD 474
           D     ++ C Q +P  RP   ++++
Sbjct: 263 D----LMRMCWQFNPKMRPTFLEIVN 284

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 230 RGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           RG FG VY G    N      CA+K +  + D       + Q   E  ++   SHPN++ 
Sbjct: 38  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLS 93
Query: 287 YHGSELSDERL-SVYLEYVSGGSIHKLL--QEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
             G  L  E    V L Y+  G +   +  + + P  + +I  +  Q+  G+ +L ++  
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 152
Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYWMAPEVVMNTNG 398
           VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E  + T  
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 211
Query: 399 YSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           ++   D+WS G  + E+ T   PP+           +   + + + PE+  D     + +
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 270
Query: 458 CLQRDPSARPPASKLL 473
           C       RP  S+L+
Sbjct: 271 CWHPKAEMRPSFSELV 286

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 95
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V +E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 154
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDARLP 213
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 214 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 270
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 271 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V LG     G   A+K ++   +D T++  L     E ++++QL H N+V+  G
Sbjct: 31  KGEFGDVMLG--DYRGNKVAVKCIK---NDATAQAFL----AEASVMTQLRHSNLVQLLG 81
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVH 345
             + +E+  +Y+  EY++ GS+   L+  G        +  ++  +   + YL   N VH
Sbjct: 82  V-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+   N+LV      K++DFG+ K  +S     + K    W APE  +    +S   D+
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE-ALREKKFSTKSDV 197
Query: 406 WSLGCTVLEM 415
           WS G  + E+
Sbjct: 198 WSFGILLWEI 207

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 28/149 (18%)
Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           Q++ ++ +L   N+ +    EL  ER+S YL Y                          Q
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMS-YLLY--------------------------Q 134
Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M     + Y+ AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSK 419
           EV++   GY   VD+WS+GC + EM   K
Sbjct: 195 EVILGM-GYKENVDLWSVGCIMGEMVCHK 222

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 475
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 476 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHG 533
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 534 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 592
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 593 GCPAGCPREMYD----LMNLCWTYDVENRP 618

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 474
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 475 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHG 532
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 533 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 591
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 592 GCPAGCPREMYD----LMNLCWTYDVENRP 617

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 33/268 (12%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 26  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 84
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 85  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 144
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWMAP 390
           L+A+  VHRD+   N +V     +K+ DFGM + +            +L  +    WMAP
Sbjct: 145 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WMAP 200
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEH 446
           E  +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE 
Sbjct: 201 E-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 259
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLD 474
           ++D     ++ C Q +P  RP   ++++
Sbjct: 260 VTD----LMRMCWQFNPKMRPTFLEIVN 283

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVN 86
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V +E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 87  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 145
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDARLP 204
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 205 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 261
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 262 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD- 356
           ++  EY++     +L Q    F+   I+ Y  ++L  L Y H++  +HRD+K  N+++D 
Sbjct: 116 ALVFEYINNTDFKQLYQILTDFD---IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 172
Query: 357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
              +++L D+G+A+             S Y+  PE++++   Y  ++D+WSLGC +  M 
Sbjct: 173 QQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 232
Query: 417 TSKPPW----SQYEGVAAIFKIGNSKDI 440
             + P+      Y+ +  I K+  ++++
Sbjct: 233 FRREPFFHGQDNYDQLVRIAKVLGTEEL 260

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           +G FG V LG     G   A+K ++   +D T++  L     E ++++QL H N+V+  G
Sbjct: 16  KGEFGDVMLG--DYRGNKVAVKCIK---NDATAQAFL----AEASVMTQLRHSNLVQLLG 66
Query: 290 SELSDERLSVYL--EYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVH 345
             + +E+  +Y+  EY++ GS+   L+  G        +  ++  +   + YL   N VH
Sbjct: 67  V-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 125
Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDI 405
           RD+   N+LV      K++DFG+ K  +S     + K    W APE  +    +S   D+
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE-ALREKKFSTKSDV 182
Query: 406 WSLGCTVLEM 415
           WS G  + E+
Sbjct: 183 WSFGILLWEI 192

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 95
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V +E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 154
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLP 213
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 214 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 270
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 271 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 95
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V +E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 154
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR-KGDARLP 213
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 214 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 270
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 271 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 74  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVN 132
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V +E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 191
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLP 250
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 251 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 307
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 308 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 58/284 (20%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-------SHPN 283
           G FG V+       G + AIK          SK+ L     E N L ++        H +
Sbjct: 18  GEFGSVFKCVKRLDGCIYAIKR---------SKKPLAGSVDEQNALREVYAHAVLGQHSH 68
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLH 339
           +VRY  +   D+ + +  EY +GGS+   + E       F E  ++    Q+  GL Y+H
Sbjct: 69  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 128
Query: 340 ARNTVHRDIKGANILVD----PHGE---------------IKLADFGMAKHMTSCASMLS 380
           + + VH DIK +NI +     P+                  K+ D G   H+T  +S   
Sbjct: 129 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQV 185
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGVAAIFKI 434
            +G   ++A EV+     +    DI++L  TV+  A ++P       W +          
Sbjct: 186 EEGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEI--------- 236
Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                +P IP+ LS +    +K  +  DP  RP A  L+ H  +
Sbjct: 237 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 33/268 (12%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 27  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 85
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 86  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 145
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWMAP 390
           L+A+  VHRD+   N +V     +K+ DFGM + +            +L  +    WMAP
Sbjct: 146 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WMAP 201
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEH 446
           E  +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE 
Sbjct: 202 E-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLD 474
           ++D     ++ C Q +P  RP   ++++
Sbjct: 261 VTD----LMRMCWQFNPKMRPTFLEIVN 284

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 41/275 (14%)
Query: 231 GTFGHV-----YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNI 284
           G FG V     Y    S++    A+K ++      T +E L     E+ +LS L +H NI
Sbjct: 57  GAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMS---ELKVLSYLGNHMNI 112
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQE-----YGPFNEPVIQ-------------T 326
           V   G+        V  EY   G +   L+            P I              +
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI-KLADFGMAKHMTSCASMLSFKGSP 385
           ++ Q+  G+A+L ++N +HRD+   NIL+  HG I K+ DFG+A+H+ + ++ +  KG+ 
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYV-VKGNA 230
Query: 386 Y----WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSK 438
                WMAPE + N   Y+   D+WS G  + E+ +     S Y G+   +  +K+    
Sbjct: 231 RLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGS--SPYPGMPVDSKFYKMIKEG 287
Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
                PEH   +    +K C   DP  RP   +++
Sbjct: 288 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 86
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V  E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 145
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDARLP 204
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 205 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 261
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 262 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 231 GTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           G FG VY G      N  S    A+K +  V  +Q   + L     E  ++S+ +H NIV
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFL----MEALIISKFNHQNIV 111
Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF-NEPV------IQTYTRQILLGLAYL 338
           R  G  L      + LE ++GG +   L+E  P  ++P       +    R I  G  YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 339 HARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCA-------SMLSFKGSPYWM 388
              + +HRDI   N L+    P    K+ DFGMA+ +   +       +ML  K    WM
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 227
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS 448
            PE  M    ++   D WS G  + E+ +        +    + +   S    + P++  
Sbjct: 228 PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 449 DDAKSFIKQCLQRDPSARPPASKLLD 474
                 + QC Q  P  RP  + +L+
Sbjct: 287 GPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 125/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  E +  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 20  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 75
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 76  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----YWMA 389
           +AYL+A   VHRD+   N +V     +K+ DFGM + +         KG        WM+
Sbjct: 136 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX--XRKGGKGLLPVRWMS 193
Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIPEH 446
           PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P++
Sbjct: 194 PE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKPDN 249
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLL 473
             D     ++ C Q +P  RP   +++
Sbjct: 250 CPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--XYKAQTHG 174
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 175 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 233
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 234 GCPAGCPREMYD----LMNLCWTYDVENRP 259

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 130
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 188
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 189 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 247
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 248 GCPAGCPREMYD----LMNLCWTYDVENRP 273

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVN 86
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V  E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 145
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLP 204
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 205 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 261
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 262 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 29  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 84
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSP-----YWMA 389
           +AYL+A   VHRD+   N +V     +K+ DFGM + +         KG        WM+
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX--XRKGGKGLLPVRWMS 202
Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIPEH 446
           PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P++
Sbjct: 203 PE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKPDN 258
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLL 473
             D     ++ C Q +P  RP   +++
Sbjct: 259 CPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 36/275 (13%)
Query: 230 RGTFGHVYLG--FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVR 286
           RG FG V     F  +    C    V+++ +  T  E  + L  E+ +L  + H  N+V 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVN 86
Query: 287 YHGSELS-DERLSVYLEYVSGGSIHKLLQ----EYGPFN-------------EPVIQTYT 328
             G+       L V  E+   G++   L+    E+ P+              E +I  Y+
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYS 145
Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-- 386
            Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +  KG     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLP 204
Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEM----ATSKPPWSQYEGVAAIFKIGNSKDI 440
             WMAPE + +   Y++  D+WS G  + E+    A+  P     E      K G     
Sbjct: 205 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 261
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              P++ + +    +  C   +PS RP  S+L++H
Sbjct: 262 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 190
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 191 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 249
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 250 GCPAGCPREMYD----LMNLCWTYDVENRP 275

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 190
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 191 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 249
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 250 GCPAGCPREMYD----LMNLCWTYDVENRP 275

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 35  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 90
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           +AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +    W
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 206
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIP 444
           M+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P
Sbjct: 207 MSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 262
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           ++  D     ++ C Q +P  RP   +++
Sbjct: 263 DNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 58/284 (20%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-------SHPN 283
           G FG V+       G + AIK          SK+ L     E N L ++        H +
Sbjct: 20  GEFGSVFKCVKRLDGCIYAIKR---------SKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLH 339
           +VRY  +   D+ + +  EY +GGS+   + E       F E  ++    Q+  GL Y+H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 340 ARNTVHRDIKGANILVD----PHGE---------------IKLADFGMAKHMTSCASMLS 380
           + + VH DIK +NI +     P+                  K+ D G   H+T  +S   
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQV 187
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGVAAIFKI 434
            +G   ++A EV+     +    DI++L  TV+  A ++P       W +          
Sbjct: 188 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI--------- 238
Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                +P IP+ LS +    +K  +  DP  RP A  L+ H  +
Sbjct: 239 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 58/284 (20%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-------SHPN 283
           G FG V+       G + AIK          SK+ L     E N L ++        H +
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKR---------SKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLH 339
           +VRY  +   D+ + +  EY +GGS+   + E       F E  ++    Q+  GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 340 ARNTVHRDIKGANILVD----PHGE---------------IKLADFGMAKHMTSCASMLS 380
           + + VH DIK +NI +     P+                  K+ D G   H+T  +S   
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQV 189
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGVAAIFKI 434
            +G   ++A EV+     +    DI++L  TV+  A ++P       W +          
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI--------- 240
Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                +P IP+ LS +    +K  +  DP  RP A  L+ H  +
Sbjct: 241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 174
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 175 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 233
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 234 GCPAGCPREMYD----LMNLCWTYDVENRP 259

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 58/284 (20%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-------SHPN 283
           G FG V+       G + AIK          SK+ L     E N L ++        H +
Sbjct: 20  GEFGSVFKCVKRLDGCIYAIKR---------SKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLH 339
           +VRY  +   D+ + +  EY +GGS+   + E       F E  ++    Q+  GL Y+H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 340 ARNTVHRDIKGANILVD----PHGE---------------IKLADFGMAKHMTSCASMLS 380
           + + VH DIK +NI +     P+                  K+ D G   H+T  +S   
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQV 187
Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGVAAIFKI 434
            +G   ++A EV+     +    DI++L  TV+  A ++P       W +          
Sbjct: 188 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI--------- 238
Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                +P IP+ LS +    +K  +  DP  RP A  L+ H  +
Sbjct: 239 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 110
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 111 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 168
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 169 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 227
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 228 GCPAGCPREMYD----LMNLCWTYDVENRP 253

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 122
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 180
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 181 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 240 GCPAGCPREMYD----LMNLCWTYDVENRP 265

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 125/281 (44%), Gaps = 30/281 (10%)
Query: 231 GTFGHV---YLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           G FG V    L   S+     AIK ++V   ++  ++ L     E +++ Q  HPNI+R 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHPNIIRL 111
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
            G     + + +  E +  GS+   L+++   F    +    R I  G+ YL     VHR
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 347 DIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEVVMNTNGYSLT 402
           D+   NIL++ +   K++DFG+++ +     +  +    K    W +PE +     ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSA 230
Query: 403 VDIWSLGCTVLEMAT--SKPPW--SQYEGVAAI---FKIGNSKDIPEIPEHLSDDAKSFI 455
            D+WS G  + E+ +   +P W  S  + + A+   +++    D P     L  D     
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD----- 285
Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
             C Q+D + RP   +++    + D+ +   G++ +   ++
Sbjct: 286 --CWQKDRNNRPKFEQIVS---ILDKLIRNPGSLKIITSAA 321

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 38/280 (13%)
Query: 230 RGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG 289
           RG FG V+   N       AIK +R+   +   ++ ++    E+  L++L HP IVRY  
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR----EVKALAKLEHPGIVRYFN 70
Query: 290 SEL---SDERLS-----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL-------- 333
           + L   + E+L      VYL Y+      K   +        I+   R + L        
Sbjct: 71  AWLEKNTTEKLQPSSPKVYL-YIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFK---- 382
            + +LH++  +HRD+K +NI       +K+ DFG+   M       T    M ++     
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 383 --GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI 440
             G+  +M+PE + + N YS  VDI+SLG  + E+    P  +Q E V  +  + N K  
Sbjct: 190 QVGTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKFP 246
Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           P   +    +    ++  L   P  RP A  ++++    D
Sbjct: 247 PLFTQKYPCEY-VMVQDMLSPSPMERPEAINIIENAVFED 285

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 25  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 80
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 81  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           +AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +    W
Sbjct: 141 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 196
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIP 444
           M+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P
Sbjct: 197 MSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 252
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           ++  D     ++ C Q +P  RP   +++
Sbjct: 253 DNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY 327
           +L  E N++ QL +P IVR  G     E   + +E    G ++K LQ+     +  I   
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 112
Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
             Q+ +G+ YL   N VHRD+   N+L+      K++DFG++K + +  +   +K   + 
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 170
Query: 387 -----WMAPEVVMNTNGYSLTVDIWSLGCTVLE-MATSKPPWSQYEG--VAAIFKIGNSK 438
                W APE + N   +S   D+WS G  + E  +  + P+   +G  V A+ + G   
Sbjct: 171 KWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229
Query: 439 DIPE-IPEHLSDDAKSFIKQCLQRDPSARP 467
             P   P  + D     +  C   D   RP
Sbjct: 230 GCPAGCPREMYD----LMNLCWTYDVENRP 255

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 33/268 (12%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 28  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 86
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 87  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 146
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWMAP 390
           L+A+  VHR++   N +V     +K+ DFGM + +            +L  +    WMAP
Sbjct: 147 LNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WMAP 202
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEH 446
           E  +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE 
Sbjct: 203 E-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 261
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLD 474
           ++D     ++ C Q +P+ RP   ++++
Sbjct: 262 VTD----LMRMCWQFNPNMRPTFLEIVN 285

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 22  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 77
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           +AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +    W
Sbjct: 138 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 193
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIP 444
           M+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P
Sbjct: 194 MSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 249
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           ++  D     ++ C Q +P  RP   +++
Sbjct: 250 DNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 27/275 (9%)
Query: 231 GTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ-LNQEINLLSQL-SHPNIVRYH 288
           G FG V        G+  A+ +V V     T+    K+ L  E+ ++S L  H NIV   
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQE---------YGPFNEPVIQTYTR-------QIL 332
           G+      + V  EY   G +   L+          Y P + P  Q  +R       Q+ 
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVA 176
Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----WM 388
            G+A+L ++N +HRD+   N+L+      K+ DFG+A+ + + ++ +  KG+      WM
Sbjct: 177 QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWM 235
Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHL 447
           APE + +   Y++  D+WS G  + E+ +    P+      +  +K+         P   
Sbjct: 236 APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA 294
Query: 448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
             +  S ++ C   +P+ RP   ++    F+++QA
Sbjct: 295 PKNIYSIMQACWALEPTHRPTFQQICS--FLQEQA 327

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 33/268 (12%)
Query: 230 RGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRY 287
           +G+FG VY G   +   G+      V+ V +  + +E ++ LN E +++   +  ++VR 
Sbjct: 27  QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRL 85
Query: 288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTR---QILLGLAY 337
            G     +   V +E ++ G +   L+   P  E       P +Q   +   +I  G+AY
Sbjct: 86  LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 145
Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWMAP 390
           L+A+  VHR++   N +V     +K+ DFGM + +            +L  +    WMAP
Sbjct: 146 LNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WMAP 201
Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKDIPE-IPEH 446
           E  +    ++ + D+WS G  + E+ + ++ P+     E V      G   D P+  PE 
Sbjct: 202 E-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLD 474
           ++D     ++ C Q +P+ RP   ++++
Sbjct: 261 VTD----LMRMCWQFNPNMRPTFLEIVN 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 29  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 84
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           +AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +    W
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 200
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIP 444
           M+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P
Sbjct: 201 MSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 256
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           ++  D     ++ C Q +P  RP   +++
Sbjct: 257 DNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 35  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 90
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           +AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +    W
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 206
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIP 444
           M+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P
Sbjct: 207 MSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 262
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           ++  D     ++ C Q +P  RP   +++
Sbjct: 263 DNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 8/211 (3%)
Query: 268 QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQT 326
           +  +E  ++  LSH  +V+ +G       + +  EY++ G +   L+E    F    +  
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 109
Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
             + +   + YL ++  +HRD+   N LV+  G +K++DFG+++++       S +GS +
Sbjct: 110 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSRGSKF 168
Query: 387 ---WMAPEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYEGVAAIFKIGNSKDIPE 442
              W  PEV+M +  +S   DIW+ G  + E+ +  K P+ ++        I     +  
Sbjct: 169 PVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227
Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
            P   S+   + +  C       RP    LL
Sbjct: 228 -PHLASEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 230 RGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           +G+FG VY G        E     AIK V    +  + +E ++ LN E +++ + +  ++
Sbjct: 26  QGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN-EASVMKEFNCHHV 81
Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPF--NEPVIQ--TYTRQILL------G 334
           VR  G     +   V +E ++ G +   L+   P   N PV+   + ++ I +      G
Sbjct: 82  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYW 387
           +AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +    W
Sbjct: 142 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 197
Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA--AIFKIGNSKDIPEIP 444
           M+PE  +    ++   D+WS G  + E+AT ++ P   Y+G++   + +      + + P
Sbjct: 198 MSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 253
Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           ++  D     ++ C Q +P  RP   +++
Sbjct: 254 DNCPDMLFELMRMCWQYNPKMRPSFLEII 282
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	628
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-156
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-141
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-137
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-117
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-117
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-116
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-109
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-108
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-107
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-98
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-93
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-92
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-90
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-90
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-89
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-87
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-86
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-85
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-84
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-83
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-82
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-82
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-81
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-79
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-78
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-78
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-77
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-75
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-75
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-75
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-74
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-70
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-70
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-67
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-64
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-64
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-64
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-63
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-63
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-62
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-62
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-62
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-61
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-61
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-61
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-61
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-61
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-60
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-60
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-59
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-59
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-58
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-58
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-58
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-58
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-58
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-58
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-58
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-58
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-57
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-57
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-57
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-57
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-57
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-57
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-57
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-57
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-57
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-57
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-57
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-56
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-56
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-56
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-56
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-56
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-56
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-56
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-56
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-56
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-55
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-55
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-55
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-55
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-55
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-54
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-54
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-54
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-54
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-54
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-54
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-54
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-54
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-53
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-53
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-53
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-53
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-53
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-53
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-53
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-53
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-52
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-52
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-52
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-51
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-51
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-51
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-51
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-51
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-51
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-51
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-51
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-51
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-50
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-50
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-50
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-49
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-49
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-49
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-49
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-49
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-49
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-49
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-48
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-48
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-45
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-44
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-43
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-41
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-39
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-38
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-38
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-37
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-37
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-35
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-35
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-34
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-30
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-30
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-28
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-28
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-27
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-26
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  449 bits (1156), Expect = e-156
 Identities = 112/291 (38%), Positives = 163/291 (56%), Gaps = 12/291 (4%)

Query: 199 SPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD 258
           S  S     C       +    +     +LG+GT+G VY G +  +    AIKE+     
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--- 57

Query: 259 DQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ-EYG 317
                   + L++EI L   L H NIV+Y GS   +  + +++E V GGS+  LL+ ++G
Sbjct: 58  --RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 318 PF--NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTS 374
           P   NE  I  YT+QIL GL YLH    VHRDIKG N+L++ + G +K++DFG +K +  
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 375 CASML-SFKGSPYWMAPEVV-MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY-EGVAAI 431
                 +F G+  +MAPE++     GY    DIWSLGCT++EMAT KPP+ +  E  AA+
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

Query: 432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
           FK+G  K  PEIPE +S +AK+FI +C + DP  R  A+ LL   F++  +
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  413 bits (1064), Expect = e-141
 Identities = 82/298 (27%), Positives = 126/298 (42%), Gaps = 19/298 (6%)

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
           P    +                   +        +GRG+FG V+   + ++G  CA+K+V
Sbjct: 32  PETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV 91

Query: 254 RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL 313
           R+               +E+   + LS P IV  +G+      +++++E + GGS+ +L+
Sbjct: 92  RLEVFRV----------EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141

Query: 314 QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHM 372
           ++ G   E     Y  Q L GL YLH R  +H D+K  N+L+   G    L DFG A  +
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 373 T------SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE 426
                  S  +     G+   MAPEVVM        VDIWS  C +L M     PW+QY 
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260

Query: 427 GVAAIFKIGNS-KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV 483
                 KI +    I EIP   +      I++ L+++P  R  A +L        Q V
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  400 bits (1029), Expect = e-137
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 14/268 (5%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
            K    +GRG+F  VY G ++E+    A  E++   D + +K   ++  +E  +L  L H
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFKEEAEMLKGLQH 84

Query: 282 PNIVRYHGSEL----SDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
           PNIVR++ S        + + +  E ++ G++   L+ +      V++++ RQIL GL +
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144

Query: 338 LHARNT--VHRDIKGANILVD-PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM 394
           LH R    +HRD+K  NI +  P G +K+ D G+A    + +   +  G+P +MAPE+  
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY- 202

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE-IPEHLSDDAKS 453
               Y  +VD+++ G  +LEMATS+ P+S+ +  A I++   S   P    +    + K 
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261

Query: 454 FIKQCLQRDPSARPPASKLLDHPFVRDQ 481
            I+ C++++   R     LL+H F +++
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  350 bits (900), Expect = e-117
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 9/283 (3%)

Query: 198 GSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVC 257
           G  +     P    S         +++   LG G++G V+   + E G++ A+K      
Sbjct: 35  GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-- 92

Query: 258 DDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG 317
             +  K+  ++L +  +      HP  VR   +      L +  E   G S+ +  + +G
Sbjct: 93  PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWG 151

Query: 318 -PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA 376
               E  +  Y R  LL LA+LH++  VH D+K ANI + P G  KL DFG+   + +  
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211

Query: 377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN 436
           +    +G P +MAPE++     Y    D++SLG T+LE+A +       EG     ++  
Sbjct: 212 AGEVQEGDPRYMAPELLQ--GSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ 266

Query: 437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               PE    LS + +S +   L+ DP  R  A  LL  P +R
Sbjct: 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  349 bits (897), Expect = e-117
 Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 32/291 (10%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
            G+     +++ + + +G G FG V+       G + AIK  +       S +    L +
Sbjct: 3   MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK--PLAGSVDEQNALRE 60

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTY 327
                    H ++VRY  +   D+ + +  EY +GGS+   + E       F E  ++  
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEI-------------------KLADFGM 368
             Q+  GL Y+H+ + VH DIK +NI +                         K+ D G 
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV 428
              ++S       +G   ++A EV+     +    DI++L  TV+  A ++P     +  
Sbjct: 181 VTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237

Query: 429 AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             I +      +P IP+ LS +    +K  +  DP  RP A  L+ H  + 
Sbjct: 238 HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  348 bits (894), Expect = e-116
 Identities = 85/304 (27%), Positives = 148/304 (48%), Gaps = 16/304 (5%)

Query: 183 IEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNS 242
           +++        P+P   P                N+L+ ++  K +GRG F  VY     
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMGY------NTLANFRIEKKIGRGQFSEVYRAACL 54

Query: 243 ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE 302
             G   A+K+V++   D    +      +EI+LL QL+HPN+++Y+ S + D  L++ LE
Sbjct: 55  LDGVPVALKKVQI--FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112

Query: 303 YVSGGSIHKLLQEYG----PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH 358
               G + ++++ +        E  +  Y  Q+   L ++H+R  +HRDIK AN+ +   
Sbjct: 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 172

Query: 359 GEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
           G +KL D G+ +  +S  +   S  G+PY+M+PE +   NGY+   DIWSLGC + EMA 
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAA 231

Query: 418 SKPPW-SQYEGVAAIFKIGNSKDIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            + P+      + ++ K     D P +P +H S++ +  +  C+  DP  RP  + + D 
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 476 PFVR 479
               
Sbjct: 292 AKRM 295

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  332 bits (852), Expect = e-109
 Identities = 84/351 (23%), Positives = 145/351 (41%), Gaps = 23/351 (6%)

Query: 168 HARLSGMSVDSPTGKIEDGKSQCHKLPLP-PGSPTSPSALPCSRTSGVTENSLSKWKKGK 226
           H   S   V   +G  E   ++  +  +  P   T       S  +         +   K
Sbjct: 3   HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK 62

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN--I 284
            +G G    V+   N E  Q+ AIK V +   ++   + L     EI  L++L   +  I
Sbjct: 63  QIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           +R +  E++D+ + + +E      ++  L++    +    ++Y + +L  +  +H    V
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTNG--- 398
           H D+K AN L+   G +KL DFG+A  M   T+     S  G+  +M PE + + +    
Sbjct: 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236

Query: 399 -------YSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEIPEHLSDD 450
                   S   D+WSLGC +  M   K P+ Q    ++ +  I +     E P+    D
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLD 501
            +  +K CL+RDP  R    +LL HP+V+ Q            +   Y L 
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 347

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  329 bits (846), Expect = e-108
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 22/297 (7%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +   K +G G    V+   N E  Q+ AIK V +   ++   + L     EI  L++L 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQ 65

Query: 281 HPN--IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
             +  I+R +  E++D+ + + +E      ++  L++    +    ++Y + +L  +  +
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML---SFKGSPYWMAPEVVMN 395
           H    VH D+K AN L+   G +KL DFG+A  M    + +   S  G+  +M PE + +
Sbjct: 125 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 396 TNG----------YSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEIP 444
            +            S   D+WSLGC +  M   K P+ Q    ++ +  I +     E P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243

Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLD 501
           +    D +  +K CL+RDP  R    +LL HP+V+ Q            +   Y L 
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  324 bits (833), Expect = e-107
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 22/277 (7%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +   K +G G    V+   N E  Q+ AIK V +   ++   + L     EI  L++L 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQ 84

Query: 281 HPN--IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
             +  I+R +  E++D+ + + +E      ++  L++    +    ++Y + +L  +  +
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMN 395
           H    VH D+K AN L+   G +KL DFG+A  M   T+     S  G+  +M PE + +
Sbjct: 144 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 396 TN----------GYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEIP 444
            +            S   D+WSLGC +  M   K P+ Q    ++ +  I +     E P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262

Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
           +    D +  +K CL+RDP  R    +LL HP+V+ Q
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  302 bits (775), Expect = 7e-98
 Identities = 89/349 (25%), Positives = 162/349 (46%), Gaps = 11/349 (3%)

Query: 202 SPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT 261
             S +     +     S+ K+ + + +G G+FG   L  ++E G+   IKE+ +    + 
Sbjct: 7   HSSGVDLGTENL-YFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRM 62

Query: 262 SKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY--GPF 319
           S +  ++  +E+ +L+ + HPNIV+Y  S   +  L + ++Y  GG + K +       F
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122

Query: 320 NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML 379
            E  I  +  QI L L ++H R  +HRDIK  NI +   G ++L DFG+A+ + S   + 
Sbjct: 123 QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182

Query: 380 -SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK 438
            +  G+PY+++PE+  N   Y+   DIW+LGC + E+ T K  +        + KI  S 
Sbjct: 183 RACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISG 240

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPY 498
             P +  H S D +S + Q  +R+P  RP  + +L+  F+  +         +A++    
Sbjct: 241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLK 300

Query: 499 SLDGSRTPPKLDLLP--TRKSITLCEGDYLANPLVPTSRALNNPRENAR 545
           +     + P     P   + SI++     +  P       L   +   +
Sbjct: 301 TFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  297 bits (763), Expect = 1e-96
 Identities = 103/264 (39%), Positives = 161/264 (60%), Gaps = 8/264 (3%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             + K + +G+G+FG V+ G ++ + ++ AIK    + D + +++ ++ + QEI +LSQ 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQC 77

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
             P + +Y+GS L D +L + +EY+ GGS   LL+  GP +E  I T  R+IL GL YLH
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH 136

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMNTNG 398
           +   +HRDIK AN+L+  HGE+KLADFG+A  +T       +F G+P+WMAPEV+   + 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SA 195

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           Y    DIWSLG T +E+A  +PP S+   +  +F I  + + P +  + S   K F++ C
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEAC 254

Query: 459 LQRDPSARPPASKLLDHPFVRDQA 482
           L ++PS RP A +LL H F+   A
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNA 278

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  289 bits (743), Expect = 1e-93
 Identities = 82/285 (28%), Positives = 140/285 (49%), Gaps = 26/285 (9%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
            +   ++  +++G G    V   + +   +  AIK      + +  +  + +L +EI  +
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIK----RINLEKCQTSMDELLKEIQAM 67

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY--------GPFNEPVIQTYT 328
           SQ  HPNIV Y+ S +  + L + ++ +SGGS+  +++          G  +E  I T  
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML------SFK 382
           R++L GL YLH    +HRD+K  NIL+   G +++ADFG++  + +   +       +F 
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK---- 438
           G+P WMAPEV+    GY    DIWS G T +E+AT   P+ +Y  +  +     +     
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247

Query: 439 ----DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
                  E+ +      +  I  CLQ+DP  RP A++LL H F +
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  290 bits (744), Expect = 3e-93
 Identities = 97/299 (32%), Positives = 148/299 (49%), Gaps = 9/299 (3%)

Query: 184 EDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSE 243
           E+   Q    P+P G        P        ++    +   + +G G+FG VY   +  
Sbjct: 18  ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77

Query: 244 SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY 303
           + ++ AIK++      + S E  + + +E+  L +L HPN ++Y G  L +    + +EY
Sbjct: 78  NSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135

Query: 304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL 363
             G +   L     P  E  I   T   L GLAYLH+ N +HRD+K  NIL+   G +KL
Sbjct: 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195

Query: 364 ADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPP 421
            DFG A  M    S +   G+PYWMAPEV++      Y   VD+WSLG T +E+A  KPP
Sbjct: 196 GDFGSASIMAPANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

Query: 422 WSQYEGVAAIFKIGNSKDIPEI-PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
                 ++A++ I  + + P +   H S+  ++F+  CLQ+ P  RP +  LL H FV 
Sbjct: 253 LFNMNAMSALYHIAQN-ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  288 bits (738), Expect = 4e-93
 Identities = 97/269 (36%), Positives = 145/269 (53%), Gaps = 14/269 (5%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            W+    LG G FG VY   N E+G + A K +    +++     L+    EI +L+   
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILATCD 74

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
           HP IV+  G+   D +L + +E+  GG++  ++ E      EP IQ   RQ+L  L +LH
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMNT-- 396
           ++  +HRD+K  N+L+   G+I+LADFG++           SF G+PYWMAPEVVM    
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 397 --NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAK 452
               Y    DIWSLG T++EMA  +PP  +   +  + KI  S D P +  P   S + +
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLTPSKWSVEFR 253

Query: 453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
            F+K  L ++P  RP A++LL+HPFV   
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  285 bits (731), Expect = 9e-92
 Identities = 106/294 (36%), Positives = 159/294 (54%), Gaps = 21/294 (7%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +   + LG G++G VY   + E+GQ+ AIK+V V  +       L+++ +EI+++ Q  
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESD-----LQEIIKEISIMQQCD 82

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLH 339
            P++V+Y+GS   +  L + +EY   GS+  +++       E  I T  +  L GL YLH
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMNTNG 398
               +HRDIK  NIL++  G  KLADFG+A  +T   +   +  G+P+WMAPEV+    G
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 201

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIK 456
           Y+   DIWSLG T +EMA  KPP++    + AIF I  +   P    PE  SD+   F+K
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVK 260

Query: 457 QCLQRDPSARPPASKLLDHPFVRDQA--------VARAGNVNLAKDSSPYSLDG 502
           QCL + P  R  A++LL HPFVR           +  A +V L +  S    +G
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREEG 314

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  282 bits (723), Expect = 2e-90
 Identities = 97/277 (35%), Positives = 153/277 (55%), Gaps = 22/277 (7%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             ++  +L+G GT+G VY G + ++GQ+ AIK + V  D++      +++ QEIN+L + 
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKY 77

Query: 280 S-HPNIVRYHGS------ELSDERLSVYLEYVSGGSIHKLLQ--EYGPFNEPVIQTYTRQ 330
           S H NI  Y+G+         D++L + +E+   GS+  L++  +     E  I    R+
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMA 389
           IL GL++LH    +HRDIKG N+L+  + E+KL DFG++  +        +F G+PYWMA
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 390 PEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI-P 444
           PEV+         Y    D+WSLG T +EMA   PP      + A+F I  +   P +  
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PAPRLKS 256

Query: 445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
           +  S   +SFI+ CL ++ S RP   +L+ HPF+RDQ
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  281 bits (720), Expect = 2e-90
 Identities = 93/263 (35%), Positives = 141/263 (53%), Gaps = 11/263 (4%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            K+ + + +G+G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ + 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMREN 74

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            +PNIV Y  S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH 133

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMNTNG 398
           +   +HRDIK  NIL+   G +KL DFG    +T   S   +  G+PYWMAPEVV     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-A 192

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIK 456
           Y   VDIWSLG   +EM   +PP+     + A++ I  +   PE+  PE LS   + F+ 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLN 251

Query: 457 QCLQRDPSARPPASKLLDHPFVR 479
           +CL+ D   R  A +LL H F++
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLK 274

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  279 bits (715), Expect = 3e-89
 Identities = 89/263 (33%), Positives = 138/263 (52%), Gaps = 11/263 (4%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
                   +G G+ G V L     SG+  A+K + +    Q  +E L     E+ ++   
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL--RKQQRRELLFN---EVVIMRDY 99

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            H N+V  + S L  E L V +E++ GG++  ++ +    NE  I T    +L  LAYLH
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLH 158

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-MLSFKGSPYWMAPEVVMNTNG 398
           A+  +HRDIK  +IL+   G +KL+DFG    ++       S  G+PYWMAPEV+  +  
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS-L 217

Query: 399 YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAKSFIK 456
           Y+  VDIWSLG  V+EM   +PP+     V A+ ++ +S   P++     +S   + F++
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLE 276

Query: 457 QCLQRDPSARPPASKLLDHPFVR 479
           + L RDP  R  A +LLDHPF+ 
Sbjct: 277 RMLVRDPQERATAQELLDHPFLL 299

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  273 bits (699), Expect = 2e-87
 Identities = 59/287 (20%), Positives = 129/287 (44%), Gaps = 34/287 (11%)

Query: 214 VTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEI 273
           V +     +K+ +L+G G FG V+   +   G+   IK V+   +++ ++       +E+
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--YNNEKAE-------REV 55

Query: 274 NLLSQLSHPNIVRYHGS----------------ELSDERLSVYLEYVSGGSIHKLLQEY- 316
             L++L H NIV Y+G                     + L + +E+   G++ + +++  
Sbjct: 56  KALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115

Query: 317 -GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC 375
               ++ +      QI  G+ Y+H++  ++RD+K +NI +    ++K+ DFG+   + + 
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG 435
                 KG+  +M+PE + +   Y   VD+++LG  + E+         +E       + 
Sbjct: 176 GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLR 232

Query: 436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
           +      I +      K+ +++ L + P  RP  S++L    V  ++
Sbjct: 233 D----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  270 bits (693), Expect = 1e-86
 Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 17/279 (6%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
            +    ++    +G G++G          G++   KE+        ++   + L  E+NL
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNL 58

Query: 276 LSQLSHPNIVRYHGS--ELSDERLSVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTR 329
           L +L HPNIVRY+    + ++  L + +EY  GG +  ++ +        +E  +     
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118

Query: 330 QILLGLAYLHARNT-----VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKG 383
           Q+ L L   H R+      +HRD+K AN+ +D    +KL DFG+A+ +    S   +F G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI 443
           +PY+M+PE +     Y+   DIWSLGC + E+    PP++ +       KI   K    I
Sbjct: 179 TPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRI 236

Query: 444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
           P   SD+    I + L      RP   ++L++P + +  
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  271 bits (695), Expect = 1e-85
 Identities = 68/317 (21%), Positives = 118/317 (37%), Gaps = 60/317 (18%)

Query: 220 SKWKKGKLLGRG--TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
             ++   ++G+G      V L     +G+   ++ + +   +  S E +  L  E+++  
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQGELHVSK 81

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGL 335
             +HPNIV Y  + ++D  L V   +++ GS   L+  +     NE  I    + +L  L
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFG--------MAKHMTSCASMLSFKGSPYW 387
            Y+H    VHR +K ++IL+   G++ L+             +                W
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 388 MAPEVVM-NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI------------ 434
           ++PEV+  N  GY    DI+S+G T  E+A    P+        + +             
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 435 --------------------------------GNSKDIPEIPEHLSDDAKSFIKQCLQRD 462
                                                        S     F++QCLQR+
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 463 PSARPPASKLLDHPFVR 479
           P ARP AS LL+H F +
Sbjct: 322 PDARPSASTLLNHSFFK 338

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  264 bits (678), Expect = 4e-84
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 39/294 (13%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
            S +++  +LG+G FG V    N+   +  AIK++R       ++E L  +  E+ LL+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58

Query: 279 LSHPNIVRYHGSELSDERLS-----------VYL--EYVSGGSIHKLLQEYG-PFNEPVI 324
           L+H  +VRY+ + L                 +++  EY   G+++ L+            
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 325 QTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS------- 377
               RQIL  L+Y+H++  +HRD+K  NI +D    +K+ DFG+AK++            
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 378 --------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA 429
                   + S  G+  ++A EV+  T  Y+  +D++SLG    EM    P  +  E V 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN 236

Query: 430 AIFKI--GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
            + K+   + +  P+  ++     K  I+  +  DP+ RP A  LL+  ++  +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  262 bits (673), Expect = 2e-83
 Identities = 70/287 (24%), Positives = 138/287 (48%), Gaps = 20/287 (6%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-LL 276
                +    LGRG +G V    +  SGQ+ A+K +R   + Q      K+L  +++  +
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISM 60

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQIL 332
             +  P  V ++G+   +  + + +E +   S+ K  ++         E ++      I+
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 333 LGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
             L +LH+  + +HRD+K +N+L++  G++K+ DFG++ ++    +     G   +MAPE
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

Query: 392 VVM---NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIP-EH 446
            +    N  GYS+  DIWSLG T++E+A  + P+  +      + ++      P++P + 
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLPADK 238

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAK 493
            S +   F  QCL+++   RP   +L+ HPF        +   ++A 
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL---HESKGTDVAS 282

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  261 bits (668), Expect = 2e-82
 Identities = 75/275 (27%), Positives = 140/275 (50%), Gaps = 17/275 (6%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-LLSQLSHPNIVR 286
           +G GT G V+     ++G + A+K++R   + +      K++  +++ +L     P IV+
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQ 88

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVH 345
             G+ +++  + + +E +   +     +  GP  E ++   T  I+  L YL      +H
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN----GYSL 401
           RD+K +NIL+D  G+IKL DFG++  +    +     G   +MAPE +   +     Y +
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIPEHL--SDDAKSFIKQC 458
             D+WSLG +++E+AT + P+   +     + K+    + P +P H+  S D +SF+K C
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDC 267

Query: 459 LQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAK 493
           L +D   RP  +KLL+H F++         V++A 
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKR---YETLEVDVAS 299

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  260 bits (666), Expect = 5e-82
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 24/281 (8%)

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-LLSQLSHPNIVR 286
           +GRG +G V    +  SGQ+ A+K +R   D++      KQL  +++ ++     P IV+
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQ 85

Query: 287 YHGSELSDERLSVYLEYVSGGSIHKLLQEY-----GPFNEPVIQTYTRQILLGLAYLHA- 340
           ++G+   +    + +E +   S  K  +           E ++   T   +  L +L   
Sbjct: 86  FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM---NTN 397
              +HRDIK +NIL+D  G IKL DFG++  +    +     G   +MAPE +    +  
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIP----EHLSDDAK 452
           GY +  D+WSLG T+ E+AT + P+ ++  V   + ++    D P++        S    
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFI 263

Query: 453 SFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAK 493
           +F+  CL +D S RP   +LL HPF+          V +A 
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFILM---YEERAVEVAC 301

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  253 bits (647), Expect = 1e-79
 Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 36/290 (12%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L+ ++  + LGRG FG V+   N       AIK +R+       +   +++ +E+  L++
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAK 59

Query: 279 LSHPNIVRYHGS----------ELSDERLSVY--LEYVSGGSIHKLLQE---YGPFNEPV 323
           L HP IVRY  +          + S  ++ +Y  ++     ++   +            V
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS--------- 374
                 QI   + +LH++  +HRD+K +NI       +K+ DFG+   M           
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 375 ----CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA 430
                A      G+  +M+PE +   N YS  VDI+SLG  + E+    P  +Q E V  
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRT 236

Query: 431 IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           +  + N K  P +           ++  L   P  RP A  ++++    D
Sbjct: 237 LTDVRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  255 bits (652), Expect = 1e-78
 Identities = 74/306 (24%), Positives = 121/306 (39%), Gaps = 27/306 (8%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +    +LG G  G +         +  A+K +          EC    ++E+ LL +  
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI--------LPECFSFADREVQLLRESD 75

Query: 281 -HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            HPN++RY  +E   +   + +E  +      + Q+          T  +Q   GLA+LH
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 340 ARNTVHRDIKGANILVDPHGE-----IKLADFGMAKHMT----SCASMLSFKGSPYWMAP 390
           + N VHRD+K  NIL+            ++DFG+ K +     S +      G+  W+AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 391 EVVMNTN--GYSLTVDIWSLGCTVLEMATS-KPP-WSQYEGVAAIFKIGNSKDIPEIPEH 446
           E++        + TVDI+S GC    + +    P     +  A I     S D     +H
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTP 506
               A+  I++ +  DP  RP A  +L HPF           +   +D S      S   
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK----QLQFFQDVSDRIEKESLDG 311

Query: 507 PKLDLL 512
           P +  L
Sbjct: 312 PIVKQL 317

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  252 bits (644), Expect = 2e-78
 Identities = 84/322 (26%), Positives = 147/322 (45%), Gaps = 54/322 (16%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E     ++K   LG G  G V+   +  SG + A K + +            Q+ +E+ +
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQV 84

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           L + + P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   +  ++ GL
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144

Query: 336 AYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVV 393
            YL      +HRD+K +NILV+  GEIKL DFG++  +    SM  SF G+  +M+PE +
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERL 202

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA------------------------ 429
                YS+  DIWS+G +++EMA  + P    +                           
Sbjct: 203 QG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 430 --------------AIFK----IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASK 471
                         AIF+    I N           S + + F+ +CL ++P+ R    +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 472 LLDHPFVRDQAVARAGNVNLAK 493
           L+ H F++    + A  V+ A 
Sbjct: 322 LMVHAFIKR---SDAEEVDFAG 340

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  246 bits (631), Expect = 2e-77
 Identities = 82/270 (30%), Positives = 142/270 (52%), Gaps = 22/270 (8%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL-KQLNQEINLL 276
           +L  ++ G+ LG+G FG+VYL    +S  + A+K   V+   Q  K  +  QL +E+ + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQ 63

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           S L HPNI+R +G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH------MTSCASMLSFKGSPYWMAP 390
           Y H++  +HRDIK  N+L+   GE+K+ADFG + H         C       G+  ++ P
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------GTLDYLPP 176

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSD 449
           E++     +   VD+WSLG    E    KPP+ +       + +I   +     P+ +++
Sbjct: 177 EMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVE--FTFPDFVTE 232

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
            A+  I + L+ +PS RP   ++L+HP++ 
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  242 bits (619), Expect = 1e-75
 Identities = 82/279 (29%), Positives = 141/279 (50%), Gaps = 25/279 (8%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL-KQLN 270
           +      +  +K G LLG+G+F  VY   +  +G   AIK   ++      K  + +++ 
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQ 59

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTR 329
            E+ +  QL HP+I+  +        + + LE    G +++ L+    PF+E   + +  
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA--------KHMTSCASMLSF 381
           QI+ G+ YLH+   +HRD+  +N+L+  +  IK+ADFG+A        KH T C      
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC------ 173

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDI 440
            G+P +++PE+    + + L  D+WSLGC    +   +PP+   + V     K+  +   
Sbjct: 174 -GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLAD-- 228

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
            E+P  LS +AK  I Q L+R+P+ R   S +LDHPF+ 
Sbjct: 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  244 bits (624), Expect = 1e-75
 Identities = 90/348 (25%), Positives = 161/348 (46%), Gaps = 39/348 (11%)

Query: 184 EDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSE 243
            D           PG+P +           V   S  ++ +G+ LG+G F   +   +++
Sbjct: 5   ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDAD 64

Query: 244 SGQMCAIKEVRVVCDDQTSKECLK-QLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE 302
           + ++ A K   +V      K   + +++ EI++   L+H ++V +HG    ++ + V LE
Sbjct: 65  TKEVFAGK---IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121

Query: 303 YVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK 362
                S+ +L +      EP  + Y RQI+LG  YLH    +HRD+K  N+ ++   E+K
Sbjct: 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 181

Query: 363 LADFGMA--------KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE 414
           + DFG+A        +    C       G+P ++APEV+    G+S  VD+WS+GC +  
Sbjct: 182 IGDFGLATKVEYDGERKKVLC-------GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYT 233

Query: 415 MATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
           +   KPP+ +   +   + +I   K+   IP+H++  A S I++ LQ DP+ARP  ++LL
Sbjct: 234 LLVGKPPF-ETSCLKETYLRI--KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

Query: 474 DHPFVRDQAVARAGNVNLAKDSSPYSLDGS--RTPPKLDLLPTRKSIT 519
           +  F                   P  L  +    PP+  + P+    +
Sbjct: 291 NDEFFT-------------SGYIPARLPITCLTIPPRFSIAPSSLDPS 325

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  241 bits (617), Expect = 3e-75
 Identities = 85/310 (27%), Positives = 153/310 (49%), Gaps = 39/310 (12%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEINL 275
            S  ++ +G+ LG+G F   +   ++++ ++ A K   +V      K   + +++ EI++
Sbjct: 12  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQREKMSMEISI 68

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
              L+H ++V +HG    ++ + V LE     S+ +L +      EP  + Y RQI+LG 
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMA--------KHMTSCASMLSFKGSPYW 387
            YLH    +HRD+K  N+ ++   E+K+ DFG+A        +    C       G+P +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNY 181

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEH 446
           +APEV+    G+S  VD+WS+GC +  +   KPP+ +   +   + +I   K+   IP+H
Sbjct: 182 IAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRI--KKNEYSIPKH 237

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGS--R 504
           ++  A S I++ LQ DP+ARP  ++LL+  F                   P  L  +   
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFT-------------SGYIPARLPITCLT 284

Query: 505 TPPKLDLLPT 514
            PP+  + P+
Sbjct: 285 IPPRFSIAPS 294

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  237 bits (608), Expect = 5e-74
 Identities = 83/270 (30%), Positives = 135/270 (50%), Gaps = 22/270 (8%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL-KQLNQEINLL 276
           ++  +  G+ LG+G FG+VYL    ++  + A+K   V+   Q  KE +  QL +EI + 
Sbjct: 12  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALK---VLFKSQLEKEGVEHQLRREIEIQ 68

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           S L HPNI+R +      +R+ + LE+   G ++K LQ++G F+E    T+  ++   L 
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH------MTSCASMLSFKGSPYWMAP 390
           Y H R  +HRDIK  N+L+   GE+K+ADFG + H       T C       G+  ++ P
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-------GTLDYLPP 181

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSD 449
           E++     +   VD+W  G    E     PP+           +I N     + P  LSD
Sbjct: 182 EMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVD--LKFPPFLSD 237

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
            +K  I + L+  P  R P   +++HP+V+
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  233 bits (597), Expect = 1e-70
 Identities = 76/310 (24%), Positives = 137/310 (44%), Gaps = 46/310 (14%)

Query: 209 SRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQ 268
           +      ++  +     K+LG G+ G V     S  G+  A+K +          +    
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRM--------LIDFCDI 54

Query: 269 LNQEINLLSQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ-- 325
              EI LL++   HPN++RY+ SE +D  L + LE     ++  L++     +E +    
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQK 113

Query: 326 -----TYTRQILLGLAYLHARNTVHRDIKGANILVD-------------PHGEIKLADFG 367
                +  RQI  G+A+LH+   +HRD+K  NILV               +  I ++DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 368 MAKHM-----TSCASMLSFKGSPYWMAPEVVMNTN------GYSLTVDIWSLGCTVLEMA 416
           + K +     +   ++ +  G+  W APE++  +N        + ++DI+S+GC    + 
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 417 TS-KPP-WSQYEGVAAIFK-IGNSKDIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKL 472
           +  K P   +Y   + I + I +  ++  +    L  +A   I Q +  DP  RP A K+
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

Query: 473 LDHPFVRDQA 482
           L HP    ++
Sbjct: 294 LRHPLFWPKS 303

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  228 bits (583), Expect = 6e-70
 Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 28/278 (10%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +   + LG G F +V L      G   A+K +         ++  ++  +E ++    +
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFN 84

Query: 281 HPNIVRYHGS--ELSDERLSVYL--EYVSGGSIHKLLQEY----GPFNEPVIQTYTRQIL 332
           HPNI+R           +   +L   +   G++   ++          E  I      I 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG----------MAKHMTSCASMLSFK 382
            GL  +HA+   HRD+K  NIL+   G+  L D G           ++   +     + +
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 383 GSPYWMAPEVVMNTNGYSLT--VDIWSLGCTVLEMATSKPP--WSQYEGVAAIFKIGNSK 438
            +  + APE+    +   +    D+WSLGC +  M   + P      +G +    + N  
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
            IP      S      +   +  DP  RP    LL   
Sbjct: 265 SIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  221 bits (566), Expect = 2e-67
 Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 47/298 (15%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W    +LG+G   +V+ G + ++G + AIK    V ++ +    +    +E  +L +L+H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK----VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 282 PNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLA 336
            NIV+    E         L  E+   GS++ +L+E        E       R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 337 YLHARNTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
           +L     VHR+IK  NI+     D     KL DFG A+ +      +S  G+  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 393 V-------MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----VAAIFKIGNSK--- 438
                    +   Y  TVD+WS+G T    AT   P+  +EG       ++KI   K   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 439 -----------------DIP---EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
                            D+P    +   L       +   L+ D        +     
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  213 bits (544), Expect = 2e-64
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 22/268 (8%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
            + LG G FG V+L     SG    IK +    +   S+  ++Q+  EI +L  L HPNI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTI----NKDRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 285 VRYHGSELSDERLSVYL--EYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           ++    E+ ++  ++Y+  E   GG     I          +E  +    +Q++  LAY 
Sbjct: 83  IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 339 HARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           H+++ VH+D+K  NIL     PH  IK+ DFG+A+   S     +  G+  +MAPEV   
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-- 198

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIPEHLSDDAK 452
               +   DIWS G  +  + T   P          +  K    + +       L+  A 
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVECRPLTPQAV 256

Query: 453 SFIKQCLQRDPSARPPASKLLDHPFVRD 480
             +KQ L +DP  RP A+++L H + + 
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  216 bits (551), Expect = 2e-64
 Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 47/297 (15%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W    +LG+G   +V+ G + ++G + AIK    V ++ +    +    +E  +L +L+H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK----VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 282 PNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLA 336
            NIV+    E         L  E+   GS++ +L+E        E       R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 337 YLHARNTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
           +L     VHR+IK  NI+     D     KL DFG A+ +      +S  G+  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 393 V-------MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----VAAIFKIGNSK--- 438
                    +   Y  TVD+WS+G T    AT   P+  +EG       ++KI   K   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 439 -----------------DIP---EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
                            D+P    +   L       +   L+ D        +    
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  213 bits (545), Expect = 5e-64
 Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 55/311 (17%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIK------------EVRVVCDDQTSK 263
           +  ++ ++  + L +G F  + L    +  +  A+K              +   D  + K
Sbjct: 27  DKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIK 84

Query: 264 ECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG------ 317
                   E+ +++ + +   +   G   + + + +  EY+   SI K  + +       
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 318 --PFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHM-- 372
                  VI+   + +L   +Y+H  +N  HRD+K +NIL+D +G +KL+DFG +++M  
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 373 ----TSCASMLSFKGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEG 427
                S        G+  +M PE   N + Y+   VDIWSLG  +  M  +  P+S    
Sbjct: 205 KKIKGSR-------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257

Query: 428 VAAIF-KIGNSK-----------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
           +  +F  I                             LS++   F+K  L+++P+ R  +
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 470 SKLLDHPFVRD 480
              L H ++ D
Sbjct: 318 EDALKHEWLAD 328

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  214 bits (547), Expect = 2e-63
 Identities = 76/290 (26%), Positives = 136/290 (46%), Gaps = 16/290 (5%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQ 268
           S   +    ++   K LG G  G V L F  ++ +  AI+ +   +         +    
Sbjct: 127 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN 186

Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQT 326
           +  EI +L +L+HP I++       D     Y+  E + GG +   +       E   + 
Sbjct: 187 VETEIEILKKLNHPCIIKIK--NFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL 243

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKG 383
           Y  Q+LL + YLH    +HRD+K  N+L+   +    IK+ DFG +K +   + M +  G
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303

Query: 384 SPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSK-D 439
           +P ++APEV+++    GY+  VD WSLG  +    +  PP+S++    ++  +I + K +
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363

Query: 440 IPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGN 488
                   +S+ A   +K+ L  DP AR    + L HP+++D+ + R   
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 413

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  216 bits (552), Expect = 2e-63
 Identities = 80/290 (27%), Positives = 140/290 (48%), Gaps = 16/290 (5%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
             +    +++ K LG G +G V L  +  +    AIK   ++     S     +L +E+ 
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK---IIRKTSVSTSSNSKLLEEVA 88

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           +L  L HPNI++ +  +  +++ + YL  E   GG +   +     FNE       +Q+L
Sbjct: 89  VLKLLDHPNIMKLY--DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146

Query: 333 LGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA 389
            G+ YLH  N VHRD+K  N+L+   +    IK+ DFG++    +   M    G+ Y++A
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEH 446
           PEV+     Y    D+WS+G  +  +    PP+   +  E +  + K   + D PE   +
Sbjct: 207 PEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK-N 263

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
           +S+ AK  IKQ LQ D   R  A + L+HP++++    +   + L   ++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  213 bits (544), Expect = 3e-62
 Identities = 80/276 (28%), Positives = 138/276 (50%), Gaps = 15/276 (5%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
           T     ++K  ++LG+G+FG V L  +  +GQ CA+K +         K   + L +E+ 
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK--RQVKQKTDKESLLREVQ 78

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           LL QL HPNI++ +  E  +++   YL  E  +GG +   +     F+E       RQ+L
Sbjct: 79  LLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136

Query: 333 LGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA 389
            G+ Y+H    VHRD+K  N+L+        I++ DFG++ H  +   M    G+ Y++A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-W--SQYEGVAAIFKIGNSKDIPEIPEH 446
           PEV+     Y    D+WS G  +  + +  PP    ++Y+ +  + K   + ++P+    
Sbjct: 197 PEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-K 253

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
           +S+ AK  I++ L   PS R  A   LDH +++   
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  212 bits (542), Expect = 5e-62
 Identities = 78/280 (27%), Positives = 140/280 (50%), Gaps = 16/280 (5%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
             +LG+G+FG V    +  + Q  A+K   V+       +    + +E+ LL +L HPNI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 285 VRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
           ++    E+ ++  S Y+  E  +GG +   + +   F+E       +Q+  G+ Y+H  N
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 343 TVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
            VHRD+K  NIL+   +   +IK+ DFG++        M    G+ Y++APEV+  T  Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--Y 199

Query: 400 SLTVDIWSLGCTVLEMATSKPP-W--SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
               D+WS G  +  + +  PP +  ++Y+ +  +     + D+P+    +SDDAK  I+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIR 258

Query: 457 QCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSS 496
           + L   PS R  A++ L+HP+++  +       +L    S
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLES 298

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  212 bits (541), Expect = 9e-62
 Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 23/285 (8%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIK--------EVRVVCDDQTSKECL 266
                  + K + LG G +G V L          AIK        + R   D++  ++  
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVI 324
           +++  EI+LL  L HPNI++    ++ +++   YL  E+  GG + + +     F+E   
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148

Query: 325 QTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSF 381
               +QIL G+ YLH  N VHRDIK  NIL+   +    IK+ DFG++   +    +   
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK- 438
            G+ Y++APEV+     Y+   D+WS G  +  +    PP     +    I  K+   K 
Sbjct: 209 LGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGG--QNDQDIIKKVEKGKY 264

Query: 439 DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
                  +++SD+AK  IK  L  D + R  A + L+  +++  A
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  206 bits (527), Expect = 1e-61
 Identities = 76/300 (25%), Positives = 137/300 (45%), Gaps = 22/300 (7%)

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
                 P + S           +     +K GK+LG G+F  V L     + +  AIK +
Sbjct: 4   TAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL 63

Query: 254 R---VVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIH 310
               ++ +++        + +E +++S+L HP  V+ + +   DE+L   L Y   G + 
Sbjct: 64  EKRHIIKENKV-----PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118

Query: 311 KLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK 370
           K +++ G F+E   + YT +I+  L YLH +  +HRD+K  NIL++    I++ DFG AK
Sbjct: 119 KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 178

Query: 371 HMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG 427
            ++  +      SF G+  +++PE++        + D+W+LGC + ++    PP+     
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRA-GN 236

Query: 428 VAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP------PASKLLDHPFVRD 480
              IF KI   +   + PE     A+  +++ L  D + R           L  HPF   
Sbjct: 237 EYLIFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  205 bits (525), Expect = 2e-61
 Identities = 81/311 (26%), Positives = 144/311 (46%), Gaps = 16/311 (5%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQ 268
           S   +    ++   K LG G  G V L F  ++ +  AIK +   +         +    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61

Query: 269 LNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQT 326
           +  EI +L +L+HP I++       D     Y+  E + GG +   +       E   + 
Sbjct: 62  VETEIEILKKLNHPCIIKIK--NFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSCASMLSFKG 383
           Y  Q+LL + YLH    +HRD+K  N+L+    E   IK+ DFG +K +   + M +  G
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178

Query: 384 SPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSK-D 439
           +P ++APEV+++    GY+  VD WSLG  +    +  PP+S++    ++  +I + K +
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

Query: 440 IPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPY 498
                   +S+ A   +K+ L  DP AR    + L HP+++D+ + R     L++++   
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298

Query: 499 SLDGSRTPPKL 509
           +L      P  
Sbjct: 299 ALPQVLAQPST 309

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  205 bits (524), Expect = 2e-61
 Identities = 76/251 (30%), Positives = 127/251 (50%), Gaps = 16/251 (6%)

Query: 225 GKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
            + +G G+FG V+   ++   G   A+K +    +     E + +  +E+ ++ +L HPN
Sbjct: 42  KEKIGAGSFGTVHRAEWH---GSDVAVKILM---EQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHA 340
           IV + G+      LS+  EY+S GS+++LL + G     +E    +    +  G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 341 RNT--VHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMNTN 397
           RN   VHR++K  N+LVD    +K+ DFG+++   S   S  S  G+P WMAPEV +   
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV-LRDE 214

Query: 398 GYSLTVDIWSLGCTVL-EMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
             +   D++S G  +L E+AT + PW        +  +G      EIP +L+    + I+
Sbjct: 215 PSNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273

Query: 457 QCLQRDPSARP 467
            C   +P  RP
Sbjct: 274 GCWTNEPWKRP 284

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  204 bits (521), Expect = 2e-61
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 20/279 (7%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
             +    +     +GRG++G V +     +    A K++      +   E + +  QEI 
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-----PKYFVEDVDRFKQEIE 58

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           ++  L HPNI+R +  E  ++   +YL  E  +GG + + +     F E       + +L
Sbjct: 59  IMKSLDHPNIIRLY--ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 333 LGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA 389
             +AY H  N  HRD+K  N L     P   +KL DFG+A        M +  G+PY+++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-E 445
           P+V+     Y    D WS G  +  +    PP  +  +  + +  KI       PE    
Sbjct: 177 PQVL--EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWL 232

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           ++S  A+S I++ L + P  R  + + L+H +   Q  +
Sbjct: 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  214 bits (545), Expect = 6e-61
 Identities = 72/302 (23%), Positives = 117/302 (38%), Gaps = 39/302 (12%)

Query: 210 RTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQL 269
           R+  +   +   W+  + LG G FG+V    + ++G+  AIK     C  + S +  ++ 
Sbjct: 4   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERW 59

Query: 270 NQEINLLSQLSHPNIVR----YHGSELSDERLSVYL--EYVSGGSIHKLLQEYG---PFN 320
             EI ++ +L+HPN+V       G +         L  EY  GG + K L ++       
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119

Query: 321 EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSCAS 377
           E  I+T    I   L YLH    +HRD+K  NI++ P  +    K+ D G AK +     
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179

Query: 378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS 437
              F G+  ++APE++     Y++TVD WS G    E  T   P+               
Sbjct: 180 CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 438 KDIPEI------------------PEHLS----DDAKSFIKQCLQRDPSARPPASKLLDH 475
           K    I                  P HLS       + +++  L      R    +  + 
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298

Query: 476 PF 477
             
Sbjct: 299 GC 300

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  206 bits (527), Expect = 7e-61
 Identities = 67/267 (25%), Positives = 127/267 (47%), Gaps = 22/267 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           + +G+G+FG V +   +++ +M A+K +         K+   + N+      E+ ++  L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGL 72

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            HP +V    S   +E + + ++ + GG +   LQ+   F E  ++ +  ++++ L YL 
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN-- 397
            +  +HRD+K  NIL+D HG + + DF +A  +     + +  G+  +MAPE+  +    
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPW--SQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSF 454
           GYS  VD WSLG T  E+   + P+          I         +   P   S +  S 
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWSQEMVSL 250

Query: 455 IKQCLQRDPSAR-PPASKLLDHPFVRD 480
           +K+ L+ +P  R    S + + P++ D
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMND 277

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  202 bits (517), Expect = 1e-60
 Identities = 75/280 (26%), Positives = 133/280 (47%), Gaps = 18/280 (6%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
                    ++    +LG+G+FG V    +  + Q  A+K   V+       +    + +
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILR 70

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTR 329
           E+ LL +L HPNI++    E+ ++  S Y+  E  +GG +   + +   F+E       +
Sbjct: 71  EVELLKKLDHPNIMKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128

Query: 330 QILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           Q+  G+ Y+H  N VHRD+K  NIL+   +   +IK+ DFG++        M    G+ Y
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEI 443
           ++APEV+     Y    D+WS G  +  + +  PP + + E    I  ++   K      
Sbjct: 189 YIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLP 244

Query: 444 P-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
               +SDDAK  I++ L   PS R  A++ L+HP+++  +
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (516), Expect = 2e-60
 Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 17/270 (6%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVC--DDQTSKECLKQLNQEINLL 276
            ++ +  K +G+G FG V+ G   +   + AIK + +     +    E  ++  +E+ ++
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGL 335
           S L+HPNIV+ +G         + +E+V  G ++  L +   P    V       I LG+
Sbjct: 78  SNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 336 AYLHARNT--VHRDIKGANILVDPHGE-----IKLADFGMAKHMTSCASMLSFKGSPYWM 388
            Y+  +N   VHRD++  NI +    E      K+ADFG+++      S+    G+  WM
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWM 193

Query: 389 APEVVMNTNG-YSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPE 445
           APE +      Y+   D +S    +  + T + P+ +Y    +  I  I      P IPE
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
                 ++ I+ C   DP  RP  S ++  
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  204 bits (521), Expect = 2e-60
 Identities = 45/333 (13%), Positives = 97/333 (29%), Gaps = 68/333 (20%)

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
               G P    +    R             +G +LG+          + E+G+   +   
Sbjct: 55  LWNTGQPFRVESELGERPR--------TLVRGTVLGQEDPYAYLEATDQETGESFEVHVP 106

Query: 254 RVVCDDQTSKECLKQLNQEI-------------------------NLLSQLSHPNIVRYH 288
                ++     +KQ+ +E+                         +L+       ++R  
Sbjct: 107 YF--TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164

Query: 289 GSELSDERLSVYLEY--------VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
             E     LS +  Y          G  +      +           T Q++  LA LH 
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNG-- 398
              VH  ++  +I++D  G + L  F          + +    S  +  PE+        
Sbjct: 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATIS 281

Query: 399 --------YSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHL 447
                    + + D W+LG  +  +  +  P    +   G   IF+           +++
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR---------SCKNI 332

Query: 448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
               ++ ++  L+     R    + ++ P    
Sbjct: 333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (511), Expect = 6e-60
 Identities = 74/263 (28%), Positives = 127/263 (48%), Gaps = 19/263 (7%)

Query: 225 GKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
            +++G G FG VY   +    G   A+K  R   D+  S+  ++ + QE  L + L HPN
Sbjct: 12  EEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQT-IENVRQEAKLFAMLKHPN 67

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           I+   G  L +  L + +E+  GG ++++L         ++  +  QI  G+ YLH    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 344 ---VHRDIKGANILVD--------PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
              +HRD+K +NIL+          +  +K+ DFG+A+       M S  G+  WMAPEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEV 185

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
            +  + +S   D+WS G  + E+ T + P+   +G+A  + +  +K    IP    +   
Sbjct: 186 -IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244

Query: 453 SFIKQCLQRDPSARPPASKLLDH 475
             ++ C   DP +RP  + +LD 
Sbjct: 245 KLMEDCWNPDPHSRPSFTNILDQ 267

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  201 bits (514), Expect = 1e-59
 Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 58/312 (18%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
              +G+G++G V +   +++  + AIK +      Q + + ++++  E+ L+ +L HPNI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 285 VRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYG------------------------- 317
            R +  E+ ++   + L  E   GG +   L  +                          
Sbjct: 91  ARLY--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 318 ---------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV--DPHGE 360
                             E +I    RQI   L YLH +   HRDIK  N L   +   E
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208

Query: 361 IKLADFGMAKHMTSCASMLSFK-----GSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLE 414
           IKL DFG++K      +   +      G+PY++APEV+  TN  Y    D WS G  +  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 415 MATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPAS 470
           +     P     +  A    ++ N K          LS  A+  +   L R+   R  A 
Sbjct: 269 LLMGAVPFPGVND--ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326

Query: 471 KLLDHPFVRDQA 482
           + L HP++   +
Sbjct: 327 RALQHPWISQFS 338

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  200 bits (510), Expect = 3e-59
 Identities = 62/331 (18%), Positives = 111/331 (33%), Gaps = 73/331 (22%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIK----------------EVRV------- 255
           L+ ++  + +GRG FG V+   N       AIK                EV+        
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 256 ------------------------------VCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
                                              +S   +   + +I  +   S  N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEP---VIQTYTRQILLGLAYLHARN 342
                      L + ++     ++   +       +    V      QI   + +LH++ 
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTS-------------CASMLSFKGSPYWMA 389
            +HRD+K +NI       +K+ DFG+   M                A+     G+  +M+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD 449
           PE +   N YS  VDI+SLG  + E+       +Q E V  I  + N K  P +      
Sbjct: 245 PEQIHGNN-YSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLK-FPLLFTQKYP 300

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                ++  L   P+ RP A+ ++++    +
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  197 bits (503), Expect = 1e-58
 Identities = 75/293 (25%), Positives = 132/293 (45%), Gaps = 32/293 (10%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
           +      +   + LG+G F  V    +  +G   A K   ++   + S    ++L +E  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREAR 57

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           +  +L HPNIVR H  +   E    YL  + V+GG + + +     ++E       +QIL
Sbjct: 58  ICRKLQHPNIVRLH--DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 115

Query: 333 LGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA 389
             +AY H+   VHR++K  N+L+        +KLADFG+A  +    +   F G+P +++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175

Query: 390 PEVVMNTNGYSLTVDIWSLG-------CTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-D 439
           PEV+   + YS  VDIW+ G                 PP W + +    ++ +I     D
Sbjct: 176 PEVL-KKDPYSKPVDIWACGVILYILLVGY-------PPFWDEDQ--HRLYAQIKAGAYD 225

Query: 440 IPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNL 491
            P    + ++ +AKS I   L  +P  R  A + L  P++ ++    A  ++ 
Sbjct: 226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE-RVASAIHR 277

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  198 bits (506), Expect = 1e-58
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 16/269 (5%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV-CDDQTSKECLKQLNQEINLLSQLSHPN 283
           G+ LG G F  V       +G   A K ++             +++ +E+++L Q+ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 284 IVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           ++  H  ++ + R  V L  E VSGG +   L +    +E    ++ +QIL G+ YLH +
Sbjct: 77  VITLH--DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 342 NTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
              H D+K  NI++     P   IKL DFG+A  +       +  G+P ++APE+V N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYE 193

Query: 398 GYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKS 453
              L  D+WS+G     + +   P     +        I +   D  E    H S+ AK 
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANITSVSYDFDEEFFSHTSELAKD 251

Query: 454 FIKQCLQRDPSARPPASKLLDHPFVRDQA 482
           FI++ L ++   R    + L HP++    
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVD 280

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  197 bits (504), Expect = 1e-58
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 23/300 (7%)

Query: 201 TSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ 260
           T  +ALP S +   T      ++  ++LGRG    V    +  + +  A+K + V     
Sbjct: 1   TRDAALPGSHS---THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS 57

Query: 261 TSKECLK----QLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLL 313
            S E ++       +E+++L ++S HPNI++    +  +     +L  + +  G +   L
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYL 115

Query: 314 QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT 373
            E    +E   +   R +L  +  LH  N VHRD+K  NIL+D    IKL DFG +  + 
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 374 SCASMLSFKGSPYWMAPEVVMNTN-----GYSLTVDIWSLGCTVLEMATSKPP-WSQYEG 427
               +    G+P ++APE++  +      GY   VD+WS G  +  +    PP W + + 
Sbjct: 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ- 234

Query: 428 VAAIF-KIGNSK-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
              +   I +          +  SD  K  + + L   P  R  A + L HPF +   V 
Sbjct: 235 -MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  196 bits (501), Expect = 2e-58
 Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 16/271 (5%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV-CDDQTSKECLKQLNQEINLLSQLSHPN 283
           G+ LG G F  V       +G+  A K ++             +++ +E+N+L ++ HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 284 IVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           I+  H  ++ + +  V L  E VSGG +   L E     E     + +QIL G+ YLH++
Sbjct: 70  IITLH--DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127

Query: 342 NTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
              H D+K  NI++     P+  IKL DFG+A  + +     +  G+P ++APE+V N  
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-NYE 186

Query: 398 GYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKS 453
              L  D+WS+G     + +   P   + +        I     D  E    + S+ AK 
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETK--QETLTNISAVNYDFDEEYFSNTSELAKD 244

Query: 454 FIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           FI++ L +DP  R   ++ L+H +++     
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  199 bits (506), Expect = 3e-58
 Identities = 46/321 (14%), Positives = 99/321 (30%), Gaps = 45/321 (14%)

Query: 199 SPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD 258
           +   P     +  S +++    K K  + L  G    V+L  + E  +  A+K   +   
Sbjct: 42  ATVWPQNAETTVDSLLSQGE-RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM--G 98

Query: 259 DQTSKECLKQLNQEINLLSQLSHPN------------------------IVRYHGSELSD 294
            + S+  L++L++     ++L   +                          +    +   
Sbjct: 99  AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDY 158

Query: 295 ERLSVYL--EYVSG------GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHR 346
              +  L     S        ++  +    G      +   T Q++   A L ++  VH 
Sbjct: 159 AVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218

Query: 347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM-NTNGYSLTVDI 405
                N+ + P G + L D      + +     S      +   E +  +T  ++  ++ 
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNA 276

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE-------HLSDDAKSFIKQC 458
           W LG ++  +     P+              S  +P            L D  K+ I + 
Sbjct: 277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336

Query: 459 LQRDPSARPPASKLLDHPFVR 479
           L  D   R    + ++ P   
Sbjct: 337 LNFDRRRRLLPLEAMETPEFL 357

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  197 bits (502), Expect = 3e-58
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 20/277 (7%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
           T N    +   ++LG G F  V+L     +G++ A+K     C  ++       L  EI 
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK-----CIKKSPAFRDSSLENEIA 58

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           +L ++ H NIV     ++ +     YL  + VSGG +   + E G + E       +Q+L
Sbjct: 59  VLKKIKHENIVTLE--DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL 116

Query: 333 LGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMA 389
             + YLH    VHRD+K  N+L    + + +I + DFG++K   +   M +  G+P ++A
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVA 175

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-E 445
           PEV +    YS  VD WS+G     +    PP +   E  + +F KI     +      +
Sbjct: 176 PEV-LAQKPYSKAVDCWSIGVITYILLCGYPPFYE--ETESKLFEKIKEGYYEFESPFWD 232

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
            +S+ AK FI   L++DP+ R    K L HP++    
Sbjct: 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  197 bits (503), Expect = 4e-58
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 16/281 (5%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV-CDDQTSKECLKQLNQEI 273
            EN    +  G+ LG G F  V       +G   A K ++             + + +E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 274 NLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
           ++L ++ HPN++  H  E+ + +  V L  E V+GG +   L E     E     + +QI
Sbjct: 66  SILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 332 LLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYW 387
           L G+ YLH+    H D+K  NI++     P   IK+ DFG+A  +       +  G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP 444
           +APE+V N     L  D+WS+G     + +   P     +        +     +  +  
Sbjct: 184 VAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEY 240

Query: 445 -EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
             + S  AK FI++ L +DP  R      L HP+++ +   
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (500), Expect = 4e-58
 Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 28/286 (9%)

Query: 209 SRTSGVTENSLSKW-------KKGKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQ 260
                 + ++   W         G+ +G G+FG VY G ++ +     A+K + V     
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNV---TA 58

Query: 261 TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-F 319
            + + L+    E+ +L +  H NI+ + G   +  +L++  ++  G S++  L      F
Sbjct: 59  PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKF 117

Query: 320 NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---A 376
               +    RQ   G+ YLHA++ +HRD+K  NI +     +K+ DFG+A   +      
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177

Query: 377 SMLSFKGSPYWMAPEVVMNTNG--YSLTVDIWSLGCTVL-EMATSKPPWSQYEGV-AAIF 432
                 GS  WMAPEV+   +   YS   D+++ G  VL E+ T + P+S        I 
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIE 236

Query: 433 KIGNSK---DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            +G      D+ ++  +     K  + +CL++    RP   ++L  
Sbjct: 237 MVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  198 bits (505), Expect = 5e-58
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 35/308 (11%)

Query: 197 PGSPTSPSALPCSRTSGVTENSLSKWKK----GKLLGRGTFGHVYLGFNSESGQMCAIKE 252
           P   +        R S    N+ +K+       + LG+G F  V    +  +G   A K 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 253 VRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIH 310
           +      + S    ++L +E  +  +L HPNIVR H  +   E    YL  + V+GG + 
Sbjct: 62  INT---KKLSARDFQKLEREARICRKLQHPNIVRLH--DSIQEESFHYLVFDLVTGGELF 116

Query: 311 KLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFG 367
           + +     ++E       +QIL  +AY H+   VHR++K  N+L+        +KLADFG
Sbjct: 117 EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176

Query: 368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLG-------CTVLEMATSKP 420
           +A  +    +   F G+P +++PEV+   + YS  VDIW+ G                 P
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGY-------P 228

Query: 421 P-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
           P W + +    ++ +I     D P    + ++ +AKS I   L  +P  R  A + L  P
Sbjct: 229 PFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286

Query: 477 FVRDQAVA 484
           ++ ++   
Sbjct: 287 WICNRERV 294

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  196 bits (500), Expect = 7e-58
 Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 30/281 (10%)

Query: 218 SLSKW-------KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN 270
           S+            G++LG+G FG      + E+G++  +KE+      +  +E  +   
Sbjct: 1   SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-----RFDEETQRTFL 55

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTR 329
           +E+ ++  L HPN++++ G    D+RL+   EY+ GG++  +++     +      ++ +
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA------------- 376
            I  G+AYLH+ N +HRD+   N LV  +  + +ADFG+A+ M                 
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 377 --SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI 434
                +  G+PYWMAPE++     Y   VD++S G  + E+         Y      F +
Sbjct: 176 RKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234

Query: 435 GNSKDI-PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                +    P +          +C   DP  RP   KL  
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  195 bits (499), Expect = 1e-57
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 27/277 (9%)

Query: 224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HP 282
           K K LG G+F       + +S Q  A+K +        SK       +EI  L     HP
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKII--------SKRMEANTQKEITALKLCEGHP 66

Query: 283 NIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           NIV+ H  E+  ++L  +L  E ++GG + + +++   F+E       R+++  ++++H 
Sbjct: 67  NIVKLH--EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 341 RNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPEVVMNT 396
              VHRD+K  N+L    + + EIK+ DFG A+        L     + ++ APE++ N 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQ 183

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAA-----IF-KIGNSK-DIPEIP-EHL 447
           NGY  + D+WSLG  +  M + + P  S    +       I  KI            +++
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243

Query: 448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           S +AK  I+  L  DP+ R   S L  + +++D +  
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  197 bits (502), Expect = 1e-57
 Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 16/273 (5%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV-CDDQTSKECLKQLNQEINLLSQLSHPN 283
           G+ LG G F  V       +G   A K ++           C +++ +E+++L Q+ HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 284 IVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           I+  H  ++ + R  V L  E VSGG +   L +    +E    ++ +QIL G+ YLH +
Sbjct: 77  IITLH--DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 342 NTVHRDIKGANILV----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
              H D+K  NI++     P   IKL DFG+A  +       +  G+P ++APE+V N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYE 193

Query: 398 GYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKS 453
              L  D+WS+G     + +   P     +        I     D  E      S+ AK 
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 454 FIKQCLQRDPSARPPASKLLDHPFVRDQAVARA 486
           FI++ L ++   R    + L HP++      +A
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  195 bits (499), Expect = 1e-57
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 24/275 (8%)

Query: 224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-P 282
             K LGRG F  V    +  +GQ  A K ++     +  ++C  ++  EI +L      P
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCP 89

Query: 283 NIVRYHGSELSDERLSVYL--EYVSGGSI-HKLLQE-YGPFNEPVIQTYTRQILLGLAYL 338
            ++  H  E+ +    + L  EY +GG I    L E     +E  +    +QIL G+ YL
Sbjct: 90  RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 339 HARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           H  N VH D+K  NIL+    P G+IK+ DFGM++ +     +    G+P ++APE++ N
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL-N 206

Query: 396 TNGYSLTVDIWSLGCTVLE--MATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSD 449
            +  +   D+W++G  ++   + T   P   +       +  I     D  E     +S 
Sbjct: 207 YDPITTATDMWNIG--IIAYMLLTHTSPFVGEDN--QETYLNISQVNVDYSEETFSSVSQ 262

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
            A  FI+  L ++P  RP A   L H +++     
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  194 bits (495), Expect = 3e-57
 Identities = 75/258 (29%), Positives = 129/258 (50%), Gaps = 24/258 (9%)

Query: 219 LSKWKKGKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
             + +  +++GRG FG V    +     +  AIK++        S+   K    E+  LS
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIE-------SESERKAFIVELRQLS 56

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLG 334
           +++HPNIV+ +G+      + + +EY  GGS++ +L    P   +      ++  Q   G
Sbjct: 57  RVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 335 LAYLHARNT---VHRDIKGANILVDPHGE-IKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +AYLH+      +HRD+K  N+L+   G  +K+ DFG A  + +   M + KGS  WMAP
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAP 172

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-AIFKIGNSKDIPEIPEHLSD 449
           EV    + YS   D++S G  + E+ T + P+ +  G A  I    ++   P + ++L  
Sbjct: 173 EVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231

Query: 450 DAKSFIKQCLQRDPSARP 467
             +S + +C  +DPS RP
Sbjct: 232 PIESLMTRCWSKDPSQRP 249

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  194 bits (494), Expect = 3e-57
 Identities = 76/300 (25%), Positives = 142/300 (47%), Gaps = 33/300 (11%)

Query: 209 SRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV--------------- 253
           S  S      L+++     +G+G++G V L +N       A+K +               
Sbjct: 2   SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61

Query: 254 ------RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG--SELSDERLSVYLEYVS 305
                          +  ++Q+ QEI +L +L HPN+V+      + +++ L +  E V+
Sbjct: 62  PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121

Query: 306 GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD 365
            G + ++     P +E   + Y + ++ G+ YLH +  +HRDIK +N+LV   G IK+AD
Sbjct: 122 QGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 366 FGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTN-GYS-LTVDIWSLGCTVLEMATSKPPW 422
           FG++       ++LS   G+P +MAPE +  T   +S   +D+W++G T+      + P+
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 423 SQYEGVAAIF-KIGNSKDIPEIPEH--LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
              E +  +  KI       E P+   +++D K  I + L ++P +R    ++  HP+V 
Sbjct: 241 MD-ERIMCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  194 bits (495), Expect = 6e-57
 Identities = 92/321 (28%), Positives = 138/321 (42%), Gaps = 59/321 (18%)

Query: 196 PPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV 255
             G       L           S+ K++   L+G G++G V    N ++G++ AIK+   
Sbjct: 9   SSGVDLGTENLYF--------QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60

Query: 256 VCDDQ-TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ 314
             DD+   K  ++    EI LL QL H N+V         +R  +  E+V   +I   L+
Sbjct: 61  SDDDKMVKKIAMR----EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115

Query: 315 EY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT 373
            +    +  V+Q Y  QI+ G+ + H+ N +HRDIK  NILV   G +KL DFG A+   
Sbjct: 116 LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--- 172

Query: 374 SCASMLSFKGSPY-------WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW--- 422
                L+  G  Y       W  APE+++    Y   VD+W++GC V EM   +P +   
Sbjct: 173 ----TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228

Query: 423 SQYEGVAAIFKI-G----------------NSKDIPEIPE---------HLSDDAKSFIK 456
           S  + +  I    G                    +PEI E          LS+      K
Sbjct: 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK 288

Query: 457 QCLQRDPSARPPASKLLDHPF 477
           +CL  DP  RP  ++LL H F
Sbjct: 289 KCLHIDPDKRPFCAELLHHDF 309

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  194 bits (495), Expect = 6e-57
 Identities = 67/313 (21%), Positives = 121/313 (38%), Gaps = 43/313 (13%)

Query: 198 GSPTSPSALPCSRTSGVTENSLS----KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
             P S         S     ++     + +  ++L  G F  VY   +  SG+  A+K +
Sbjct: 2   AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL 61

Query: 254 RVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVY-------LEYVS 305
                    +E  + + QE+  + +LS HPNIV++  +    +  S         L  + 
Sbjct: 62  LS-----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116

Query: 306 GGSIHKLLQEY---GPFNEPVIQTYTRQILLGLAYLHARNT--VHRDIKGANILVDPHGE 360
            G + + L++    GP +   +     Q    + ++H +    +HRD+K  N+L+   G 
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176

Query: 361 IKLADFGMAKHMTSCASMLSFK-------------GSPYWMAPEVVMNTNG--YSLTVDI 405
           IKL DFG A  ++                       +P +  PE++   +        DI
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQCLQRDPS 464
           W+LGC +  +   + P   +E   A  +I N K  IP           S I+  LQ +P 
Sbjct: 237 WALGCILYLLCFRQHP---FED-GAKLRIVNGKYSIPPHDTQ-YTVFHSLIRAMLQVNPE 291

Query: 465 ARPPASKLLDHPF 477
            R   ++++    
Sbjct: 292 ERLSIAEVVHQLQ 304

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  194 bits (496), Expect = 7e-57
 Identities = 79/324 (24%), Positives = 136/324 (41%), Gaps = 36/324 (11%)

Query: 178 SPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKK----GKLLGRGTF 233
             +G     ++   +      +  +P          +  ++             LGRG  
Sbjct: 7   HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66

Query: 234 GHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS 293
             VY      + +  A+K ++            K +  EI +L +LSHPNI++    E+ 
Sbjct: 67  SIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLK--EIF 117

Query: 294 DERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGA 351
           +    + L  E V+GG +   + E G ++E       +QIL  +AYLH    VHRD+K  
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177

Query: 352 NILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSL 408
           N+L     P   +K+ADFG++K +     M +  G+P + APE++     Y   VD+WS+
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSV 236

Query: 409 G-------CTVLEMATSKPPWSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKSFIKQC 458
           G       C          P+    G   +F +I N +        + +S +AK  +++ 
Sbjct: 237 GIITYILLCGF-------EPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL 289

Query: 459 LQRDPSARPPASKLLDHPFVRDQA 482
           +  DP  R    + L HP+V  +A
Sbjct: 290 IVLDPKKRLTTFQALQHPWVTGKA 313

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  196 bits (499), Expect = 7e-57
 Identities = 73/347 (21%), Positives = 138/347 (39%), Gaps = 35/347 (10%)

Query: 156 GSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVT 215
           GS       S +  +  G  ++      ED   +    P+              +   V 
Sbjct: 3   GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVE------------VKQGSVY 50

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           +     +   + LG G FG V+      +G++   K +         K  +K    EI++
Sbjct: 51  D----YYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKN---EISI 101

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIH-KLLQEYGPFNEPVIQTYTRQIL 332
           ++QL HP ++  H  +  +++  + L  E++SGG +  ++  E    +E  +  Y RQ  
Sbjct: 102 MNQLHHPKLINLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159

Query: 333 LGLAYLHARNTVHRDIKGANILV--DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
            GL ++H  + VH DIK  NI+        +K+ DFG+A  +     +     +  + AP
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EH 446
           E+V +        D+W++G     + +   P     E        +     +  E     
Sbjct: 220 EIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDEDAFSS 276

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAK 493
           +S +AK FIK  LQ++P  R      L+HP+++         +  ++
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  194 bits (495), Expect = 8e-57
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 19/265 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KLLG+GTFG V L     +G+  A+K +R   ++  D+           E  +L    HP
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV--AHTVT---ESRVLQNTRHP 65

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +     +  + +RL   +EY +GG +   L     F E   + Y  +I+  L YLH+R+
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSL 401
            V+RDIK  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APEV+ + N Y  
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGR 184

Query: 402 TVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
            VD W LG  + EM   + P+   +    +F  I   +     P  LS +AKS +   L+
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 241

Query: 461 RDPSAR-----PPASKLLDHPFVRD 480
           +DP  R       A ++++H F   
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLS 266

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  197 bits (503), Expect = 9e-57
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 32/287 (11%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
                 +++  + LG+G F  V       +GQ  A   +          + L++   E  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EAR 62

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           +   L HPNIVR H  +   E    YL  + V+GG + + +     ++E       +QIL
Sbjct: 63  ICRLLKHPNIVRLH--DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120

Query: 333 LGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWM 388
             + + H    VHR++K  N+L+        +KLADFG+A  +         F G+P ++
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 389 APEVVMNTNGYSLTVDIWSLG-------CTVLEMATSKPP-WSQYEGVAAIF-KIGNSK- 438
           +PE V+  + Y   VD+W+ G                 PP W   E    ++ +I     
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVILYILLVGY-------PPFWD--EDQHRLYQQIKAGAY 230

Query: 439 DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           D P    + ++ +AK  I + L  +PS R  A++ L HP++  ++  
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV 277

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  194 bits (495), Expect = 9e-57
 Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 42/285 (14%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKECLKQLNQEINLLSQLSH 281
            +++G+G F  V    N E+GQ  A+K V   +       S E LK+   E ++   L H
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR---EASICHMLKH 85

Query: 282 PNIVRYHGSELSDERLSVYL--EYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           P+IV     E       +Y+  E++ G      I K       ++E V   Y RQIL  L
Sbjct: 86  PHIVELL--ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 336 AYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFK-GSPYWMAPE 391
            Y H  N +HRD+K   +L+   +    +KL  FG+A  +     +   + G+P++MAPE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203

Query: 392 VVMNTNGYSLTVDIWSLG-------CTVLEMATSKPP-WSQYEGVAAIFKIGN----SKD 439
           VV     Y   VD+W  G                  P +   E +      G      + 
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSGC-------LPFYGTKERLFEGIIKGKYKMNPRQ 255

Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
              I    S+ AK  +++ L  DP+ R    + L+HP+++++   
Sbjct: 256 WSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  194 bits (495), Expect = 1e-56
 Identities = 82/248 (33%), Positives = 130/248 (52%), Gaps = 21/248 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           K LG G+FG V L  + ESG   A+K +         K+ + +L Q      E  +L  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAV 98

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
           + P +V+   S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           + + ++RD+K  N+L+D  G I++ DFG AK +       +  G+P  +APE++++  GY
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILS-KGY 215

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQC 458
           +  VD W+LG  + EMA   PP+   +    I+ KI + K     P H S D K  ++  
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNL 272

Query: 459 LQRDPSAR 466
           LQ D + R
Sbjct: 273 LQVDLTKR 280

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  193 bits (493), Expect = 1e-56
 Identities = 78/267 (29%), Positives = 140/267 (52%), Gaps = 26/267 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           + LG G+FG V+L  +  +G+  A+K ++        KE + +L Q      E  +LS +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIV 63

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
           +HP I+R  G+    +++ + ++Y+ GG +  LL++   F  PV + Y  ++ L L YLH
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           +++ ++RD+K  NIL+D +G IK+ DFG AK++       +  G+P ++APEVV     Y
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVST-KPY 180

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQC 458
           + ++D WS G  + EM     P+         + KI N++     P   ++D K  + + 
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRL 237

Query: 459 LQRDPSAR-----PPASKLLDHPFVRD 480
           + RD S R          + +HP+ ++
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  193 bits (492), Expect = 1e-56
 Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 20/274 (7%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
            + LGRG FG V+    + S +    K V+              + +EI++L+   H NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVKKEISILNIARHRNI 63

Query: 285 VRYHGSELSDERLSVYL--EYVSGGSIH-KLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           +  H  E  +    + +  E++SG  I  ++       NE  I +Y  Q+   L +LH+ 
Sbjct: 64  LHLH--ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 342 NTVHRDIKGANILV--DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           N  H DI+  NI+        IK+ +FG A+ +    +      +P + APEV    +  
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-QHDVV 180

Query: 400 SLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-EHLSDDAKSFI 455
           S   D+WSLG  V  + +   P  ++      I   I N++    E   + +S +A  F+
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQAVARAGNV 489
            + L ++  +R  AS+ L HP+++ +    +  V
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  194 bits (496), Expect = 1e-56
 Identities = 78/361 (21%), Positives = 156/361 (43%), Gaps = 25/361 (6%)

Query: 147 NLMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSAL 206
           NL  +S        +         +   +  +    ++  ++    + +P         +
Sbjct: 18  NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI 77

Query: 207 PCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL 266
             ++   V         K ++LG G FG V+    + +G   A K ++         +  
Sbjct: 78  VTAKQGAVNS--FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-----RGMKDK 130

Query: 267 KQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIH-KLLQEYGPFNEPV 323
           +++  EI++++QL H N+++ +  +  + +  + L  EYV GG +  +++ E     E  
Sbjct: 131 EEVKNEISVMNQLDHANLIQLY--DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD 188

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSCASMLSF 381
              + +QI  G+ ++H    +H D+K  NIL        IK+ DFG+A+       +   
Sbjct: 189 TILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE--MATSKPP-WSQYEGVAAIF-KIGNS 437
            G+P ++APEVV N +  S   D+WS+G  V+   + +   P     +  A     I   
Sbjct: 249 FGTPEFLAPEVV-NYDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDND--AETLNNILAC 303

Query: 438 K-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDS 495
           + D+ +   + +S++AK FI + L ++ S R  AS+ L HP++ D  +    +    K+ 
Sbjct: 304 RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNR 363

Query: 496 S 496
            
Sbjct: 364 G 364

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  200 bits (509), Expect = 2e-56
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 24/270 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           ++LG+G FG V       +G+M A K++         K+ +K+         E  +L ++
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKV 241

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAY 337
           +   +V    +  + + L + L  ++GG +   +   G   F E     Y  +I  GL  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
           LH    V+RD+K  NIL+D HG I+++D G+A H+    ++    G+  +MAPEVV N  
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE- 360

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--KDIPEIPEHLSDDAKSFI 455
            Y+ + D W+LGC + EM   + P+ Q +      ++     +   E  E  S  A+S  
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

Query: 456 KQCLQRDPSAR-----PPASKLLDHPFVRD 480
            Q L +DP+ R       A ++ +HP  + 
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  199 bits (507), Expect = 2e-56
 Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 27/273 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           ++LGRG FG V+      +G++ A K++         K+ LK+         E  +L+++
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKV 242

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGS----IHKLLQEYGPFNEPVIQTYTRQILLGL 335
               IV    +  +   L + +  ++GG     I+ + ++   F EP    YT QI+ GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVM 394
            +LH RN ++RD+K  N+L+D  G ++++D G+A            + G+P +MAPE+++
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--KDIPEIPEHLSDDAK 452
               Y  +VD ++LG T+ EM  ++ P+          ++     +     P+  S  +K
Sbjct: 363 GE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421

Query: 453 SFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
            F +  LQ+DP  R          L  HP  RD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  193 bits (492), Expect = 2e-56
 Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 18/287 (6%)

Query: 200 PTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV---RVV 256
              P A+     +        K+     LG G FG V+   + E  +   +K +   +V+
Sbjct: 4   EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63

Query: 257 CDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLE---YVSGGSIHKLL 313
            D       L ++  EI +LS++ H NI++    ++ + +    L    + SG  +   +
Sbjct: 64  EDCWIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFI 121

Query: 314 QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT 373
             +   +EP+     RQ++  + YL  ++ +HRDIK  NI++     IKL DFG A ++ 
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181

Query: 374 SCASMLSFKGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF 432
                 +F G+  + APEV+M  N Y    +++WSLG T+  +   + P+ + E      
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPFCELE------ 234

Query: 433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           +   +      P  +S +  S +   LQ  P  R    KL+  P+V 
Sbjct: 235 ETVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  190 bits (486), Expect = 3e-56
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 24/271 (8%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            W   + LG G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLN 63

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           H N+V+++G         ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHM----------TSCASMLSFKGSPYWMAP 390
               HRDIK  N+L+D    +K++DFG+A               C       G+  ++AP
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-------GTLPYVAP 176

Query: 391 EVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EHLS 448
           E++     +    VD+WS G  +  M   + PW Q       +     K     P + + 
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               + + + L  +PSAR     +    +  
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  191 bits (488), Expect = 4e-56
 Identities = 64/303 (21%), Positives = 133/303 (43%), Gaps = 31/303 (10%)

Query: 196 PPGSPTSPSALPCSRTSGVTENSLSKW-------KKGKLLGRGTFGHVYLGF-NSESGQM 247
           P  + +  SA    R +  T   L +W       + G+L+G+G FG VY G  + E    
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---- 57

Query: 248 CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGG 307
            AI+ + +   ++ +++ LK   +E+    Q  H N+V + G+ +S   L++      G 
Sbjct: 58  VAIRLIDI---ERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114

Query: 308 SIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF 366
           +++ ++++     +    +   ++I+ G+ YLHA+  +H+D+K  N+  D +G++ + DF
Sbjct: 115 TLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDF 173

Query: 367 GMAKHMTSCAS------MLSFKGSPYWMAPEVVMNT--------NGYSLTVDIWSLGCTV 412
           G+        +      +    G    +APE++             +S   D+++LG   
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233

Query: 413 LEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
            E+   + P+      A I+++G           +  +    +  C   +   RP  +KL
Sbjct: 234 YELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293

Query: 473 LDH 475
           +D 
Sbjct: 294 MDM 296

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (484), Expect = 4e-56
 Identities = 48/253 (18%), Positives = 97/253 (38%), Gaps = 21/253 (8%)

Query: 225 GKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
              L     G ++ G +    G    +K ++       S    +  N+E   L   SHPN
Sbjct: 15  LTKLNENHSGELWKGRWQ---GNDIVVKVLK---VRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 284 IVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLH 339
           ++   G          ++   ++  GS++ +L E      ++     +   +  G+A+LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 340 ARNT--VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN-- 395
                     +   ++++D     +++   +     S   M     +P W+APE +    
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAWVAPEALQKKP 184

Query: 396 TNGYSLTVDIWSLGCTVL-EMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
            +    + D+WS    +L E+ T + P++    +    K+      P IP  +S      
Sbjct: 185 EDTNRRSADMWSFA-VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243

Query: 455 IKQCLQRDPSARP 467
           +K C+  DP+ RP
Sbjct: 244 MKICMNEDPAKRP 256

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  191 bits (488), Expect = 6e-56
 Identities = 79/270 (29%), Positives = 140/270 (51%), Gaps = 27/270 (10%)

Query: 226 KLLGRGTFGHVYL---GFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ-----EINLLS 277
           K+LG+G+FG V+L      S++ Q+ A+K ++        K  LK  ++     E ++L 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILV 81

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
           +++HP IV+ H +  ++ +L + L+++ GG +   L +   F E  ++ Y  ++ L L +
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNT 396
           LH+   ++RD+K  NIL+D  G IKL DFG++K  +       SF G+  +MAPEVV   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR- 200

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFI 455
            G++ + D WS G  + EM T   P+   +        I  +K    +P+ LS +A+S +
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAK--LGMPQFLSPEAQSLL 257

Query: 456 KQCLQRDPSAR-----PPASKLLDHPFVRD 480
           +   +R+P+ R         ++  H F   
Sbjct: 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  190 bits (486), Expect = 1e-55
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 24/281 (8%)

Query: 209 SRTSGVTENS-LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK 267
           S  S   E   +  ++  K +G+G F  V L  +  +G+  AIK   ++   Q +   L+
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQ 59

Query: 268 QLNQEINLLSQLSHPNIVR-YHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT 326
           +L +E+ ++  L+HPNIV+ +   E +++ L + +EY SGG +   L  +G   E   ++
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIE-TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118

Query: 327 YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASML 379
             RQI+  + Y H +  VHRD+K  N+L+D    IK+ADFG +            C    
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---- 174

Query: 380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSK 438
              G+P + APE+          VD+WSLG  +  + +   P+   + +  +  ++   K
Sbjct: 175 ---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGK 230

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               IP ++S D ++ +K+ L  +P  R    +++   ++ 
Sbjct: 231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  190 bits (485), Expect = 2e-55
 Identities = 78/267 (29%), Positives = 141/267 (52%), Gaps = 19/267 (7%)

Query: 226 KLLGRGTFGHVYL---GFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS 280
           ++LG+G +G V+       + +G++ A+K ++  ++  +       K    E N+L ++ 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVK 79

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HP IV    +  +  +L + LEY+SGG +   L+  G F E     Y  +I + L +LH 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           +  ++RD+K  NI+++  G +KL DFG+ K  +       +F G+  +MAPE++M  +G+
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGH 198

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQC 458
           +  VD WSLG  + +M T  PP++  E       KI   K    +P +L+ +A+  +K+ 
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCK--LNLPPYLTQEARDLLKKL 255

Query: 459 LQRDPSAR-----PPASKLLDHPFVRD 480
           L+R+ ++R       A ++  HPF R 
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRH 282

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  189 bits (483), Expect = 2e-55
 Identities = 84/301 (27%), Positives = 134/301 (44%), Gaps = 51/301 (16%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLS 277
           + K++K   +G G++G V+   N ++GQ+ AIK+     DD    K  L+    EI +L 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLK 57

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLA 336
           QL HPN+V          RL +  EY    ++   L  Y     E ++++ T Q L  + 
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-------WM- 388
           + H  N +HRD+K  NIL+  H  IKL DFG A+       +L+     Y       W  
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-------LLTGPSDYYDDEVATRWYR 169

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKI-G--------- 435
           +PE+++    Y   VD+W++GC   E+ +  P W   S  + +  I K  G         
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229

Query: 436 -------NSKDIPEIPE---------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
                  +   IP+  +         ++S  A   +K CL  DP+ R    +LL HP+  
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

Query: 480 D 480
           +
Sbjct: 290 N 290

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  198 bits (505), Expect = 3e-55
 Identities = 81/280 (28%), Positives = 140/280 (50%), Gaps = 44/280 (15%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ------EINLLSQL 279
           +++GRG FG VY    +++G+M A+K +         K+ +K          E  +LS +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLD--------KKRIKMKQGETLALNERIMLSLV 246

Query: 280 S---HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           S    P IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT 396
           ++H R  V+RD+K ANIL+D HG ++++D G+A   +      +  G+  +MAPEV+   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKG 365

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI-----------PE 445
             Y  + D +SLGC + ++     P          F+   +KD  EI           P+
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP----------FRQHKTKDKHEIDRMTLTMAVELPD 415

Query: 446 HLSDDAKSFIKQCLQRDPSAR-----PPASKLLDHPFVRD 480
             S + +S ++  LQRD + R       A ++ + PF R 
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  189 bits (483), Expect = 7e-55
 Identities = 75/353 (21%), Positives = 135/353 (38%), Gaps = 35/353 (9%)

Query: 150 PKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCS 209
            +                  R            + + K      P    +    S  P  
Sbjct: 22  ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81

Query: 210 R--TSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV---RVVCDDQTSKE 264
                   +    K+    ++GRG    V    +  +G   A+K +         +  +E
Sbjct: 82  ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141

Query: 265 CLKQLNQEINLLSQLS-HPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNE 321
             +   +E ++L Q++ HP+I+     +  +    ++L  + +  G +   L E    +E
Sbjct: 142 VREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199

Query: 322 PVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF 381
              ++  R +L  +++LHA N VHRD+K  NIL+D + +I+L+DFG + H+     +   
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL 259

Query: 382 KGSPYWMAPEVVMNTN-----GYSLTVDIWSLG-------CTVLEMATSKPP-WSQYEGV 428
            G+P ++APE++  +      GY   VD+W+ G                 PP W + +  
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-------PPFWHRRQ-- 310

Query: 429 AAIF-KIGNSK-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
             +   I   +        +  S   K  I + LQ DP AR  A + L HPF 
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  187 bits (477), Expect = 2e-54
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 24/271 (8%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            W   + LG G +G V L  N  + +  A+K    + D + + +C + + +EI +   L+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLN 63

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           H N+V+++G         ++LEY SGG +   ++      EP  Q +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHM----------TSCASMLSFKGSPYWMAP 390
               HRDIK  N+L+D    +K++DFG+A               C       G+  ++AP
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-------GTLPYVAP 176

Query: 391 EVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIP-EHLS 448
           E++     +    VD+WS G  +  M   + PW Q       +     K     P + + 
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               + + + L  +PSAR     +    +  
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  187 bits (478), Expect = 2e-54
 Identities = 76/338 (22%), Positives = 136/338 (40%), Gaps = 68/338 (20%)

Query: 191 HKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAI 250
           H +         P ++  S     T  S+ ++++   LG GT+G VY   ++ + +  AI
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSAT--SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 251 KEVRVVCDDQ----TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSG 306
           K +R+  +++    T+        +E++LL +L H NI+        + RL +  EY   
Sbjct: 65  KRIRLEHEEEGVPGTAI-------REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 307 GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-----HGEI 361
             + K + +    +  VI+++  Q++ G+ + H+R  +HRD+K  N+L+          +
Sbjct: 118 -DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 362 KLADFGMAKHMTSCASMLSFKGSPY----------WM-APEVVMNTNGYSLTVDIWSLGC 410
           K+ DFG+A+            G P           W   PE+++ +  YS +VDIWS+ C
Sbjct: 177 KIGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226

Query: 411 TVLEMATSKP--------------------P----W---SQYEGVAAIFKIGNSKDIPEI 443
              EM    P                    P    W   +        F     K +  +
Sbjct: 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286

Query: 444 -PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
               L D+    +   L+ DP  R  A   L+HP+   
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  187 bits (478), Expect = 2e-54
 Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 25/273 (9%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPN 283
            + +G G++       +  +    A+K +        SK    +   EI +L +   HPN
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPTE---EIEILLRYGQHPN 77

Query: 284 IVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           I+     ++ D+   VY+  E + GG +   +     F+E         I   + YLHA+
Sbjct: 78  IITLK--DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135

Query: 342 NTVHRDIKGANILVDPHGE----IKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNT 396
             VHRD+K +NIL          I++ DFG AK + +   +L     +  ++APEV+   
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER- 194

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPP-WSQY-EGVAAIF-KIGNSK-DIPEIP-EHLSDDA 451
            GY    DIWSLG  +  M T   P  +   +    I  +IG+ K  +       +SD A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           K  + + L  DP  R  A+ +L HP++      
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  188 bits (479), Expect = 2e-54
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 16/262 (6%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQ-LSH 281
           K+LG+G+FG V+L    ++ Q  AIK ++   V+ DD    EC      E  +LS    H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMV---EKRVLSLAWEH 77

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P +     +  + E L   +EY++GG +   +Q    F+      Y  +I+LGL +LH++
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             V+RD+K  NIL+D  G IK+ADFGM K +M   A   +F G+P ++APE+++    Y+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYN 196

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCL 459
            +VD WS G  + EM   + P+   +    +F  I      P  P  L  +AK  + +  
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLF 253

Query: 460 QRDPSARPPASK-LLDHPFVRD 480
            R+P  R      +  HP  R+
Sbjct: 254 VREPEKRLGVRGDIRQHPLFRE 275

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  193 bits (493), Expect = 3e-54
 Identities = 79/340 (23%), Positives = 132/340 (38%), Gaps = 18/340 (5%)

Query: 153 PCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTS 212
           PC  +     P      R          GKI  GK                   P     
Sbjct: 93  PCEPTAPVLIPGDERKRRRG--YDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYP-QPVE 149

Query: 213 GVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQE 272
              ++ L  +   + LG G FG V+      +G   A K V         +   + + +E
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKE 204

Query: 273 INLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI-HKLLQEYGPFNEPVIQTYTRQI 331
           I  +S L HP +V  H +   D  + +  E++SGG +  K+  E+   +E     Y RQ+
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 264

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSCASMLSFKGSPYWMA 389
             GL ++H  N VH D+K  NI+        +KL DFG+  H+    S+    G+  + A
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGVAAIF-KIGNSK-DIPEIP-E 445
           PEV           D+WS+G     + +   P   + +        + +   ++ +    
Sbjct: 325 PEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDWNMDDSAFS 381

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR 485
            +S+D K FI++ L  DP+ R    + L+HP++       
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  187 bits (478), Expect = 3e-54
 Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 28/275 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQ-LSH 281
           +++GRG++  V L    ++ ++ A+K V+   V  D+    + ++    E ++  Q  +H
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI--DWVQT---EKHVFEQASNH 69

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P +V  H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  N+L+D  G IKL D+GM K  +    +  +F G+P ++APE++     Y 
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYG 188

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF---------KIGNSKDIPEIPEHLSDDA 451
            +VD W+LG  + EM   + P+                    I   +    IP  LS  A
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 246

Query: 452 KSFIKQCLQRDPSAR------PPASKLLDHPFVRD 480
            S +K  L +DP  R         + +  HPF R+
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  185 bits (473), Expect = 4e-54
 Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 34/278 (12%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSK--ECLKQLNQEINLLSQ 278
           K+  G LLG G++G V    +SE+    A+K   ++   +  +       + +EI LL +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 279 LSHPNIVRYHGSELSDERLSVYL--EYVSGGSI---HKLLQEYGPFNEPVIQTYTRQILL 333
           L H N+++      ++E+  +Y+  EY   G       + +    F       Y  Q++ 
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLID 120

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM----------TSCASMLSFKG 383
           GL YLH++  VH+DIK  N+L+   G +K++  G+A+ +          TS        G
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-------G 173

Query: 384 SPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIP 441
           SP +  PE+    + +S   VDIWS G T+  + T   P+ + + +  +F  IG      
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGS--Y 230

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
            IP          +K  L+ +P+ R    ++  H + R
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  186 bits (475), Expect = 9e-54
 Identities = 78/267 (29%), Positives = 136/267 (50%), Gaps = 21/267 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQ-LSH 281
           ++LG+G+FG V L    E+G + A+K ++   ++ DD    EC      E  +LS   +H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV--ECTMT---EKRILSLARNH 83

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P + +      + +RL   +E+V+GG +   +Q+   F+E   + Y  +I+  L +LH +
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  N+L+D  G  KLADFGM K  + +  +  +F G+P ++APE++     Y 
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYG 202

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCL 459
             VD W++G  + EM     P+   E    +F  I N +     P  L +DA   +K  +
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDE--VVYPTWLHEDATGILKSFM 259

Query: 460 QRDPSAR------PPASKLLDHPFVRD 480
            ++P+ R           +L HPF ++
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKE 286

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  189 bits (481), Expect = 1e-53
 Identities = 82/266 (30%), Positives = 131/266 (49%), Gaps = 20/266 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           KLLG+GTFG V L     +G+  A+K ++   +V  D+           E  +L    HP
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV--AHTLT---ENRVLQNSRHP 208

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-R 341
            +     S  + +RL   +EY +GG +   L     F+E   + Y  +I+  L YLH+ +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
           N V+RD+K  N+++D  G IK+ DFG+ K  +   A+M +F G+P ++APEV+ + N Y 
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYG 327

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCL 459
             VD W LG  + EM   + P+   +    +F  I   +     P  L  +AKS +   L
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLL 384

Query: 460 QRDPSAR-----PPASKLLDHPFVRD 480
           ++DP  R       A +++ H F   
Sbjct: 385 KKDPKQRLGGGSEDAKEIMQHRFFAG 410

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  186 bits (475), Expect = 1e-53
 Identities = 84/297 (28%), Positives = 144/297 (48%), Gaps = 22/297 (7%)

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
           P PP +P+    L  S          S +   K++G+G+FG V L  +       A+K +
Sbjct: 15  PAPPPAPSQQINLGPSSNPHAK---PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL 71

Query: 254 R---VVCDDQTSKECLKQLNQEINLLSQ-LSHPNIVRYHGSELSDERLSVYLEYVSGGSI 309
           +   ++   +   + +     E N+L + + HP +V  H S  + ++L   L+Y++GG +
Sbjct: 72  QKKAILKKKEE--KHIMS---ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 310 HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA 369
              LQ    F EP  + Y  +I   L YLH+ N V+RD+K  NIL+D  G I L DFG+ 
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

Query: 370 K-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV 428
           K ++   ++  +F G+P ++APEV+     Y  TVD W LG  + EM    PP+      
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNT 244

Query: 429 AAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR----PPASKLLDHPFVRD 480
           A ++  I N     ++  ++++ A+  ++  LQ+D + R        ++  H F   
Sbjct: 245 AEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  186 bits (473), Expect = 4e-53
 Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 28/275 (10%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQ-LSH 281
           +++GRG++  V L    ++ ++ A++ V+   V  D+    + ++    E ++  Q  +H
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDI--DWVQT---EKHVFEQASNH 112

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P +V  H    ++ RL   +EYV+GG +   +Q      E   + Y+ +I L L YLH R
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  N+L+D  G IKL D+GM K  +    +  +F G+P ++APE++     Y 
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYG 231

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF---------KIGNSKDIPEIPEHLSDDA 451
            +VD W+LG  + EM   + P+                    I   +    IP  LS  A
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 289

Query: 452 KSFIKQCLQRDPSAR------PPASKLLDHPFVRD 480
            S +K  L +DP  R         + +  HPF R+
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  184 bits (470), Expect = 5e-53
 Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 20/266 (7%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQ-LSH 281
            +LG+G+FG V L     + ++ A+K ++   V+ DD    EC      E  +L+     
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMV---EKRVLALPGKP 80

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P + + H    + +RL   +EYV+GG +   +Q+ G F EP    Y  +I +GL +L ++
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
             ++RD+K  N+++D  G IK+ADFGM K ++    +  +F G+P ++APE++     Y 
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYG 199

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCL 459
            +VD W+ G  + EM   + P+   E    +F  I         P+ +S +A +  K  +
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLM 256

Query: 460 QRDPSAR-----PPASKLLDHPFVRD 480
            + P  R          + +H F R 
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRY 282

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  184 bits (470), Expect = 5e-53
 Identities = 85/322 (26%), Positives = 141/322 (43%), Gaps = 30/322 (9%)

Query: 184 EDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKG-------KLLGRGTFGHV 236
           E G S         G       L           +    K G       K+LG G +G V
Sbjct: 11  EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70

Query: 237 YL---GFNSESGQMCAI----KEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYH 288
           +L       ++G++ A+    K   V     T  E  +    E  +L  +   P +V  H
Sbjct: 71  FLVRKISGHDTGKLYAMKVLKKATIVQKAKTT--EHTRT---ERQVLEHIRQSPFLVTLH 125

Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDI 348
            +  ++ +L + L+Y++GG +   L +   F E  +Q Y  +I+L L +LH    ++RDI
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185

Query: 349 KGANILVDPHGEIKLADFGMAK-HMTSCASM-LSFKGSPYWMAPEVVM-NTNGYSLTVDI 405
           K  NIL+D +G + L DFG++K  +         F G+  +MAP++V    +G+   VD 
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245

Query: 406 WSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--KDIPEIPEHLSDDAKSFIKQCLQRDP 463
           WSLG  + E+ T   P++      +  +I     K  P  P+ +S  AK  I++ L +DP
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDP 305

Query: 464 SAR-----PPASKLLDHPFVRD 480
             R       A ++ +H F + 
Sbjct: 306 KKRLGCGPRDADEIKEHLFFQK 327

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  182 bits (465), Expect = 5e-53
 Identities = 82/306 (26%), Positives = 144/306 (47%), Gaps = 62/306 (20%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEIN 274
           + K++K + +G GT+G V+   N E+ ++ A+K VR+  DD+    ++        +EI 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------REIC 53

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILL 333
           LL +L H NIVR H    SD++L++  E+     + K         +  +++++  Q+L 
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY------- 386
           GL + H+RN +HRD+K  N+L++ +GE+KLA+FG+A+            G P        
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEV 162

Query: 387 ---WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW----SQYEGVAAIFKI-G-- 435
              W   P+V+     YS ++D+WS GC   E+A +  P        + +  IF++ G  
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222

Query: 436 ------------NSKDIPEIPE---------HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                       + K  P  P           L+   +  ++  L+ +P  R  A + L 
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

Query: 475 HPFVRD 480
           HP+  D
Sbjct: 283 HPYFSD 288

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  182 bits (464), Expect = 9e-53
 Identities = 83/332 (25%), Positives = 137/332 (41%), Gaps = 43/332 (12%)

Query: 196 PPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV-R 254
           PP  P +P+  P  +     E   ++++ G LLG+G FG V+ G         AIK + R
Sbjct: 10  PPAPPGTPTPPPGGKDR---EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR 66

Query: 255 VVCDDQTSKECLKQLNQEINLLSQLS----HPNIVRYHGSELSDERLSVYLEY-VSGGSI 309
                 +          E+ LL ++     HP ++R      + E   + LE  +    +
Sbjct: 67  NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126

Query: 310 HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGM 368
              + E GP  E   + +  Q++  + + H+R  VHRDIK  NIL+D   G  KL DFG 
Sbjct: 127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186

Query: 369 AKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPP 421
              +                G+  +  PE +   + Y  L   +WSLG  + +M     P
Sbjct: 187 GALLHDEPYTDFD-------GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIP 238

Query: 422 WSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
           + + +      +I  ++     P H+S D  + I++CL   PS+RP   ++L  P+++  
Sbjct: 239 FERDQ------EILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290

Query: 482 AVARAGNVNLAKDSSPYSLDGSRTPPKLDLLP 513
                     A+D       G   P    LLP
Sbjct: 291 ----------AEDVPLNPSKGGPAPLAWSLLP 312

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  180 bits (460), Expect = 1e-52
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 28/271 (10%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECL-KQLNQEINLLSQL 279
            +  G  LG GTFG V +G +  +G   A+K   ++   +     +  ++ +EI  L   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 280 SHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            HP+I++ +  ++       ++  EYVSGG +   + ++G   E   +   +QIL  + Y
Sbjct: 69  RHPHIIKLY--QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFKGSPYWMAP 390
            H    VHRD+K  N+L+D H   K+ADFG++  M       TSC       GSP + AP
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-------GSPNYAAP 179

Query: 391 EVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLS 448
           EV+     Y+   VDIWS G  +  +     P+   E V  +F KI     +  IPE+L+
Sbjct: 180 EVISG-RLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKI--RGGVFYIPEYLN 235

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               + +   LQ DP  R     + +H + +
Sbjct: 236 RSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  181 bits (461), Expect = 5e-52
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 37/297 (12%)

Query: 207 PCSRTSGVTEN-SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC 265
           P  +   VT++  LSK    ++LG G  G V   F+  +GQ CA+K +            
Sbjct: 19  PEPKKYAVTDDYQLSK----QVLGLGVNGKVLECFHRRTGQKCALKLL--------YDS- 65

Query: 266 LKQLNQEINLLSQLS-HPNIVRYHGS--ELSDERLSVYL--EYVSGGS----IHKLLQEY 316
             +  QE++   Q S  P+IV        +   +  + +  E + GG     I +  +  
Sbjct: 66  -PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGD 122

Query: 317 GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMT 373
             F E       R I   + +LH+ N  HRD+K  N+L    +    +KL DFG AK  T
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182

Query: 374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAA 430
              ++ +   +PY++APEV+     Y  + D+WSLG  +  +    PP+   +       
Sbjct: 183 Q-NALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240

Query: 431 IF-KIGNSK-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           +  +I   +   P      +S+DAK  I+  L+ DP+ R   ++ ++HP++    V 
Sbjct: 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  180 bits (459), Expect = 6e-52
 Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 31/302 (10%)

Query: 194 PLPPGSPTSPSALPCSRTSGVT---ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAI 250
            +P GS  +P     +         E   S+++ G LLG G FG VY G         AI
Sbjct: 14  LVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73

Query: 251 KEV-RVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSVYLEYVSG- 306
           K V +    D        ++  E+ LL ++S     ++R        +   + LE     
Sbjct: 74  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133

Query: 307 GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLAD 365
             +   + E G   E + +++  Q+L  + + H    +HRDIK  NIL+D   GE+KL D
Sbjct: 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193

Query: 366 FGMAKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATS 418
           FG    +                G+  +  PE +   + Y   +  +WSLG  + +M   
Sbjct: 194 FGSGALLKDTVYTDFD-------GTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCG 245

Query: 419 KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
             P+   E      +I   +      + +S + +  I+ CL   PS RP   ++ +HP++
Sbjct: 246 DIPFEHDE------EI--IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

Query: 479 RD 480
           +D
Sbjct: 298 QD 299

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  182 bits (463), Expect = 1e-51
 Identities = 78/335 (23%), Positives = 135/335 (40%), Gaps = 35/335 (10%)

Query: 172 SGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKK----GKL 227
             +   +P    +         P  P  P           SG+     +         ++
Sbjct: 10  PPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV 69

Query: 228 LGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVR 286
           LG G  G V   FN  + +  A+K   ++ D        ++   E+ L  + S  P+IVR
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARR---EVELHWRASQCPHIVR 119

Query: 287 YHGS--ELSDERLSVYL--EYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
                  L   R  + +  E + GG     I    +    F E       + I   + YL
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL 177

Query: 339 HARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           H+ N  HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APEV+  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGV--AAIF-KIGNSK-DIPEIP-EHLSD 449
              Y  + D+WSLG  +  +    PP +S +       +  +I   + + P      +S+
Sbjct: 238 E-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           + K  I+  L+ +P+ R   ++ ++HP++      
Sbjct: 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  178 bits (454), Expect = 1e-51
 Identities = 80/305 (26%), Positives = 138/305 (45%), Gaps = 62/305 (20%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEIN 274
           + K+   + +G GT+G VY   N   G+  A+K++R+  +D+    T+        +EI+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-------REIS 52

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILL 333
           +L +L H NIV+ +    + +RL +  E++    + KLL    G       +++  Q+L 
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY------- 386
           G+AY H R  +HRD+K  N+L++  GE+K+ADFG+A+            G P        
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEI 161

Query: 387 ---WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP--------------------P- 421
              W  AP+V+M +  YS T+DIWS+GC   EM    P                    P 
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221

Query: 422 ---W---SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
              W   ++       F +          + L +     + + L+ DP+ R  A + L+H
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281

Query: 476 PFVRD 480
            + ++
Sbjct: 282 AYFKE 286

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  179 bits (457), Expect = 2e-51
 Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 55/302 (18%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           +  + K   LG GT+  VY G +  +  + A+KE+R+  ++      ++    E++LL  
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKD 56

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAY 337
           L H NIV  H    +++ L++  EY+    + + L + G   N   ++ +  Q+L GLAY
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----------W 387
            H +  +HRD+K  N+L++  GE+KLADFG+A+           K  P           W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLW 165

Query: 388 M-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP--------------------P----W 422
              P++++ +  YS  +D+W +GC   EMAT +P                    P    W
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

Query: 423 ---SQYEGVAAI-FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
                 E      +    ++ +      L  D    + + LQ +   R  A   + HPF 
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

Query: 479 RD 480
             
Sbjct: 286 LS 287

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  179 bits (456), Expect = 2e-51
 Identities = 73/294 (24%), Positives = 117/294 (39%), Gaps = 42/294 (14%)

Query: 224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HP 282
           +  +LG G    V    N  + Q  A+K +     ++       ++ +E+ +L Q   H 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKII-----EKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 283 NIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           N++     E  +E    YL  E + GGSI   + +   FNE       + +   L +LH 
Sbjct: 72  NVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 341 RNTVHRDIKGANILV---DPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMA 389
           +   HRD+K  NIL    +    +K+ DF +   +         S   +L+  GS  +MA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 390 PEVVM----NTNGYSLTVDIWSLG-------C-------TVLEMATSKPPWSQYEGVAAI 431
           PEVV       + Y    D+WSLG                           +       +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 432 F-KIGNSK-DIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA 482
           F  I   K + P+    H+S  AK  I + L RD   R  A+++L HP+V+  A
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  181 bits (461), Expect = 2e-51
 Identities = 49/355 (13%), Positives = 103/355 (29%), Gaps = 61/355 (17%)

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
               G P    +    R   +         +G +LG+          + E+G+   +   
Sbjct: 60  LWNTGQPFRVESELGERPRTL--------VRGTVLGQEDPYAYLEATDQETGESFEVHVP 111

Query: 254 RVVCDDQTSKECLKQLNQEINLLSQLS----------------------HPNIVRYHGSE 291
                ++     +KQ+ +E+  L  L                        P   +     
Sbjct: 112 YF--TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169

Query: 292 LSDERLSVYLEYVS-----------GGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           L +  + V   +             G  +      +           T Q++  LA LH 
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML--SFKGSPYWMAPEVVM---- 394
              VH  ++  +I++D  G + L  F       + A          P   A  ++     
Sbjct: 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQH 289

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
           +    +   D W+LG  +  +  +  P    +   G   IF     +    IP+      
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF-----RSCKNIPQ----PV 340

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTP 506
           ++ ++  L+     R    + ++ P         +  + L +     + +G   P
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPP 395

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  181 bits (462), Expect = 3e-51
 Identities = 84/352 (23%), Positives = 150/352 (42%), Gaps = 48/352 (13%)

Query: 167 LHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGK 226
           +  R    S       ++   +            +  + +  +   G        +   K
Sbjct: 1   MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           ++G G+FG VY     +SG++ AIK+V     D+  K      N+E+ ++ +L H NIVR
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDHCNIVR 111

Query: 287 -----YHGSELSDER-LSVYLEYVSGGSIHKLLQEYGPFNEPV----IQTYTRQILLGLA 336
                Y   E  DE  L++ L+YV   +++++ + Y    + +    ++ Y  Q+   LA
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 337 YLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           Y+H+    HRDIK  N+L+DP    +KL DFG AK +      +S+  S Y+ APE++  
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI----G--NSKDIPEI------ 443
              Y+ ++D+WS GC + E+   +P +    GV  + +I    G    + I E+      
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290

Query: 444 ---------------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                                +A +   + L+  P+AR    +   H F  +
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  177 bits (452), Expect = 6e-51
 Identities = 81/312 (25%), Positives = 141/312 (45%), Gaps = 62/312 (19%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
           +S S++K+ + LG GT+  VY G N  +G   A+KEV++  ++ T    ++    EI+L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLM 57

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGG-----SIHKLLQEYGPFNEPVIQTYTRQI 331
            +L H NIVR +    ++ +L++  E++            +          +++ +  Q+
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY----- 386
           L GLA+ H    +HRD+K  N+L++  G++KL DFG+A+            G P      
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPVNTFSS 167

Query: 387 -----WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP-------------------- 420
                W  AP+V+M +  YS ++DIWS GC + EM T KP                    
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

Query: 421 P----W---SQYEGVAAIFKIGNSKDIPEI-----PEHLSDDAKSFIKQCLQRDPSARPP 468
           P    W   ++        +    +D+ ++      E L  +   F+   LQ +P  R  
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287

Query: 469 ASKLLDHPFVRD 480
           A + L HP+  +
Sbjct: 288 AKQALHHPWFAE 299

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  178 bits (453), Expect = 6e-51
 Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 29/277 (10%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLK-QLNQEI 273
           ++  +  +   + LG G+FG V L  + ++ Q  A+K    +      K  +  ++ +EI
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREI 60

Query: 274 NLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
           + L  L HP+I++ +  ++      + +  EY  GG +   + E     E   + + +QI
Sbjct: 61  SYLKLLRHPHIIKLY--DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFKGS 384
           +  + Y H    VHRD+K  N+L+D +  +K+ADFG++  M       TSC       GS
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-------GS 170

Query: 385 PYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPE 442
           P + APEV+     Y+   VD+WS G  +  M   + P+   E +  +F K+  +  +  
Sbjct: 171 PNYAAPEVING-KLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKV--NSCVYV 226

Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           +P+ LS  A+S I++ +  DP  R    ++   P+  
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  178 bits (453), Expect = 1e-50
 Identities = 76/310 (24%), Positives = 129/310 (41%), Gaps = 65/310 (20%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKE-----CLKQLNQ 271
           +   +++K   LG G F  VY   +  + Q+ AIK++++    + +K+      L+    
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE-AKDGINRTALR---- 61

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIH---KLLQEYG-PFNEPVIQTY 327
           EI LL +LSHPNI+    +      +S+  +++          ++++         I+ Y
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAY 117

Query: 328 TRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY- 386
               L GL YLH    +HRD+K  N+L+D +G +KLADFG+AK            GSP  
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK----------SFGSPNR 167

Query: 387 ---------WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFK 433
                    W  APE++     Y + VD+W++GC + E+    P     S  + +  IF+
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227

Query: 434 I-G--------------NSKDIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPAS 470
             G              +       P            DD    I+     +P AR  A+
Sbjct: 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287

Query: 471 KLLDHPFVRD 480
           + L   +  +
Sbjct: 288 QALKMKYFSN 297

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  178 bits (453), Expect = 4e-50
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 22/266 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K++GRG FG V L  +  + ++ A+K +    ++    +         +E ++++  + P
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS-----AFFWEERDIMAFANSP 129

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN 342
            +V+   +   D  L + +EY+ GG +  L+  Y    E   + YT +++L L  +H+  
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 188

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNTNG-- 398
            +HRD+K  N+L+D  G +KLADFG    M     +      G+P +++PEV+ +  G  
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248

Query: 399 -YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEH--LSDDAKSF 454
            Y    D WS+G  + EM     P+   + +   + KI N K+    P+   +S +AK+ 
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307

Query: 455 IKQCLQRDPSAR---PPASKLLDHPF 477
           I      D   R       ++  H F
Sbjct: 308 ICA-FLTDREVRLGRNGVEEIKRHLF 332

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  175 bits (445), Expect = 5e-50
 Identities = 87/316 (27%), Positives = 142/316 (44%), Gaps = 63/316 (19%)

Query: 209 SRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKE 264
            R +   +  + K++K + +G GT+G VY   +S  G++ A+K +R+  +D+    T+  
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI- 67

Query: 265 CLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPV 323
                 +EI+LL +L HPNIV       S+  L++  E++    + K+L E      +  
Sbjct: 68  ------REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQ 120

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG 383
           I+ Y  Q+L G+A+ H    +HRD+K  N+L++  G +KLADFG+A+            G
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR----------AFG 170

Query: 384 SPY----------WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------------ 420
            P           W  AP+V+M +  YS +VDIWS+GC   EM T KP            
Sbjct: 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP 230

Query: 421 --------P----W---SQYEGVAAI-FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPS 464
                   P    W    +        F++   K    I      +    +   L  DP+
Sbjct: 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290

Query: 465 ARPPASKLLDHPFVRD 480
            R  A   ++HP+ +D
Sbjct: 291 KRISARDAMNHPYFKD 306

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  172 bits (439), Expect = 3e-49
 Identities = 81/316 (25%), Positives = 124/316 (39%), Gaps = 73/316 (23%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ----EI 273
           + S+++    +G G +G VY   +  SG   A+K VRV             L      E+
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGGGGGGGLPISTVREV 62

Query: 274 NLLSQLS---HPNIVR----YHGSELSDERLSVYL--EYVSGGSIH---KLLQEYGP--F 319
            LL +L    HPN+VR       S   D  + V L  E+V           L +  P   
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRT-DREIKVTLVFEHVD----QDLRTYLDKAPPPGL 117

Query: 320 NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML 379
               I+   RQ L GL +LHA   VHRD+K  NILV   G +KLADFG+A+         
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR--------- 168

Query: 380 SFKGSPYWM----------APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYE 426
                   +          APEV++ +  Y+  VD+WS+GC   EM   KP +   S+ +
Sbjct: 169 -IYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226

Query: 427 GVAAIFKI----------GNSK------------DIPEIPEHLSDDAKSFIKQCLQRDPS 464
            +  IF +           +               +  +   + +     + + L  +P 
Sbjct: 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286

Query: 465 ARPPASKLLDHPFVRD 480
            R  A + L H ++  
Sbjct: 287 KRISAFRALQHSYLHK 302

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  177 bits (450), Expect = 4e-49
 Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 28/271 (10%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQL 279
            +  G  LG GTFG V +G +  +G   A+K   ++   +  S + + ++ +EI  L   
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLDVVGKIRREIQNLKLF 73

Query: 280 SHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            HP+I++ +  ++      +++  EYVSGG +   + + G  +E   +   +QIL G+ Y
Sbjct: 74  RHPHIIKLY--QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFKGSPYWMAP 390
            H    VHRD+K  N+L+D H   K+ADFG++  M       TSC       GSP + AP
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-------GSPNYAAP 184

Query: 391 EVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKDIPEIPEHLS 448
           EV+     Y+   VDIWS G  +  +     P+   + V  +F KI     I   P++L+
Sbjct: 185 EVISG-RLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKI--CDGIFYTPQYLN 240

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
               S +K  LQ DP  R     + +H + +
Sbjct: 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFK 271

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  173 bits (441), Expect = 6e-49
 Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 39/299 (13%)

Query: 197 PGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV 256
               T P  +P    S        ++   K +G G FG   L  +  + ++ A+K    +
Sbjct: 4   APVTTGPLDMPIMHDSD-------RYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YI 53

Query: 257 CDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY 316
                  E    + +EI     L HPNIVR+    L+   L++ +EY SGG +++ +   
Sbjct: 54  ERGAAIDE---NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110

Query: 317 GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD--PHGEIKLADFGMAKHM-- 372
           G F+E   + + +Q+L G++Y H+    HRD+K  N L+D  P   +K+ DFG +K    
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170

Query: 373 -----TSCASMLSFKGSPYWMAPEVVMNTNGYS-LTVDIWSLGCTVLEMATSKPPWSQYE 426
                ++        G+P ++APEV++    Y     D+WS G T+  M     P+ +  
Sbjct: 171 HSQPKSTV-------GTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPF-EDP 221

Query: 427 GVAAIFKIGNSK------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
                ++    +       IP+    +S +    I +    DP+ R    ++  H +  
Sbjct: 222 EEPRDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  180 bits (458), Expect = 6e-49
 Identities = 83/363 (22%), Positives = 155/363 (42%), Gaps = 27/363 (7%)

Query: 134 SYGDPRVNGDIKFNLMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKL 193
           S  D   +     + + K+   G     S         +       +   E+ + +  + 
Sbjct: 252 SRNDFMGSLSFGISELQKAGVDGWFKLLSQEE--GEYFNVPVPPEGSEGNEELRQKFERA 309

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKG-----KLLGRGTFGHVYLGFNSESGQMC 248
            +  G+         + +      +  + K        +LG+G+FG V L     + ++ 
Sbjct: 310 KIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELY 369

Query: 249 AIKEVR---VVCDDQTSKECLKQLNQEINLLSQ-LSHPNIVRYHGSELSDERLSVYLEYV 304
           A+K ++   V+ DD    EC      E  +L+     P + + H    + +RL   +EYV
Sbjct: 370 AVKILKKDVVIQDDDV--ECTMV---EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424

Query: 305 SGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLA 364
           +GG +   +Q+ G F EP    Y  +I +GL +L ++  ++RD+K  N+++D  G IK+A
Sbjct: 425 NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 484

Query: 365 DFGMAK-HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWS 423
           DFGM K ++    +  +F G+P ++APE++     Y  +VD W+ G  + EM   + P+ 
Sbjct: 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE 543

Query: 424 QYEGVAAIF-KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSAR-----PPASKLLDHPF 477
             E    +F  I         P+ +S +A +  K  + + P  R          + +H F
Sbjct: 544 G-EDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

Query: 478 VRD 480
            R 
Sbjct: 601 FRY 603

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  175 bits (445), Expect = 6e-49
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 26/274 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K++GRG F  V +    ++GQ+ A+K +    ++   +    C ++   E ++L      
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV--SCFRE---ERDVLVNGDRR 121

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHAR 341
            I + H +   +  L + +EY  GG +  LL ++G      + + Y  +I++ +  +H  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMN---- 395
             VHRDIK  NIL+D  G I+LADFG    + +  ++ S    G+P +++PE++      
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241

Query: 396 --TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKD---IPEIPEHLSD 449
             T  Y    D W+LG    EM   + P+   +  A  + KI + K+   +P + E + +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPE 300

Query: 450 DAKSFIKQCLQRDPSAR---PPASKLLDHPFVRD 480
           +A+ FI++ L   P  R     A     HPF   
Sbjct: 301 EARDFIQR-LLCPPETRLGRGGAGDFRTHPFFFG 333

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  174 bits (443), Expect = 7e-49
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 51/300 (17%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             +   K++G G+FG V+     ES ++ AIK+V     D+  K      N+E+ ++  +
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQ---DKRFK------NRELQIMRIV 89

Query: 280 SHPNIVR-----YHGSELSDERLSVYL--EYVSGGSIHKLLQEYG----PFNEPVIQTYT 328
            HPN+V      Y   +  DE + + L  EYV   ++++  + Y          +I+ Y 
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDE-VFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTSCASMLSFKGSPYW 387
            Q+L  LAY+H+    HRDIK  N+L+DP  G +KL DFG AK + +    +S+  S Y+
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYY 207

Query: 388 MAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI----G--NSKDIP 441
            APE++     Y+  +DIWS GC + E+   +P +    G+  + +I    G  + + I 
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267

Query: 442 EI---------------------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
            +                           DA   I + L+  PSAR  A + L HPF  +
Sbjct: 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  175 bits (445), Expect = 9e-49
 Identities = 69/268 (25%), Positives = 125/268 (46%), Gaps = 22/268 (8%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVR---VVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K++GRG FG V +     + ++ A+K +    ++   +T   C ++   E ++L      
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET--ACFRE---ERDVLVNGDSK 134

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHAR 341
            I   H +   D  L + ++Y  GG +  LL ++     E + + Y  ++++ +  +H  
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVM----N 395
           + VHRDIK  NIL+D +G I+LADFG    +    ++ S    G+P +++PE++      
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF-KIGNSKD---IPEIPEHLSDDA 451
              Y    D WSLG  + EM   + P+   E +   + KI N K+    P     +S++A
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENA 313

Query: 452 KSFIKQCLQRDPS--ARPPASKLLDHPF 477
           K  I++ +        +        HPF
Sbjct: 314 KDLIRRLICSREHRLGQNGIEDFKKHPF 341

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  172 bits (437), Expect = 2e-48
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 51/313 (16%)

Query: 212 SGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ 271
              +   + +++  ++ G+GTFG V LG    +G   AIK+V      Q  +   ++L Q
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNREL-Q 68

Query: 272 EINLLSQLSHPNIVR---YHGSELSDERLSVYL----EYVSGGSIHKLLQEYGPFNEPV- 323
            +  L+ L HPNIV+   Y  +    +R  +YL    EYV   ++H+  + Y        
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127

Query: 324 ---IQTYTRQILLGLAYLHAR--NTVHRDIKGANILVDPH-GEIKLADFGMAKHMTSCAS 377
              I+ +  Q++  +  LH    N  HRDIK  N+LV+   G +KL DFG AK ++    
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP----------------- 420
            +++  S Y+ APE++     Y+  VDIWS+GC   EM   +P                 
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

Query: 421 ---P----WSQYEGVAAIFKIGN------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
              P      +         + N      S    +     + +A   +   LQ  P  R 
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307

Query: 468 PASKLLDHPFVRD 480
              + L HP+  +
Sbjct: 308 KPYEALCHPYFDE 320

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  170 bits (434), Expect = 6e-48
 Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 68/314 (21%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEI 273
            +SK++K   +G+GTFG V+   + ++GQ  A+K+V +  + +    T+        +EI
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-------REI 67

Query: 274 NLLSQLSHPNIVR------YHGSELSDERLSVYL--EYVSGGSIH---KLLQEYG-PFNE 321
            +L  L H N+V          S  +  + S+YL  ++      H    LL      F  
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTL 123

Query: 322 PVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF 381
             I+   + +L GL Y+H    +HRD+K AN+L+   G +KLADFG+A+  +   +    
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS--- 180

Query: 382 KGSPY-------WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------------- 420
           + + Y       W   PE+++    Y   +D+W  GC + EM T  P             
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240

Query: 421 -------P-------WSQYEGVAAI-FKIGNSKDIPEIPEHL--SDDAKSFIKQCLQRDP 463
                             YE    +    G  + + +  +       A   I + L  DP
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300

Query: 464 SARPPASKLLDHPF 477
           + R  +   L+H F
Sbjct: 301 AQRIDSDDALNHDF 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  170 bits (432), Expect = 1e-47
 Identities = 48/307 (15%), Positives = 95/307 (30%), Gaps = 36/307 (11%)

Query: 197 PGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLG-----FNSESGQMCAIK 251
           P +      LP  +     +          LLG G F  VY        ++++ Q   +K
Sbjct: 42  PNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK 101

Query: 252 EVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHK 311
               V       E      Q +  L        ++++ + L      +  E  S G++  
Sbjct: 102 ----VQKPANPWE-FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLN 156

Query: 312 LLQEYG-----PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV----------- 355
            +  Y         + ++ ++  ++L  +  +H    +H DIK  N ++           
Sbjct: 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216

Query: 356 DPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTV 412
           D    + L D G +  M          +   +  +   E++ N   ++  +D + +  TV
Sbjct: 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATV 275

Query: 413 LEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
             M        + EG     +         +P    D    F    L        P+  L
Sbjct: 276 YCMLFGTYMKVKNEGGECKPE----GLFRRLPH--LDMWNEFFHVMLNIPDCHHLPSLDL 329

Query: 473 LDHPFVR 479
           L     +
Sbjct: 330 LRQKLKK 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (424), Expect = 3e-47
 Identities = 72/296 (24%), Positives = 115/296 (38%), Gaps = 55/296 (18%)

Query: 223 KKGKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
              + +G+G +G V+ G +    G+  A+K      +    +E       E+     L H
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ---GENVAVKIFSSRDEKSWFRE------TELYNTVMLRH 61

Query: 282 PNIVRYHGSELSDERLSVYL----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            NI+ +  S+++    S  L     Y   GS++  LQ     +          I  GLA+
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAH 120

Query: 338 LHARNT--------VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFK-----GS 384
           LH             HRD+K  NILV  +G+  +AD G+A   +   + L        G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 385 PYWMAPEV-----VMNTNGYSLTVDIWSLGCTVL-EMATS----------KPPWSQYEGV 428
             +MAPEV      ++       VDIW+ G  VL E+A            KPP+      
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 429 AAIFK-----IGNSKDIPEIPEHLSDDA-----KSFIKQCLQRDPSARPPASKLLD 474
              F+     +   +  P IP     D         +K+C  ++PSAR  A ++  
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  163 bits (415), Expect = 2e-45
 Identities = 68/330 (20%), Positives = 120/330 (36%), Gaps = 60/330 (18%)

Query: 195 LPPGSPTSPSALP-CSRTSGVTENSLSKW------KKGKLLGRGTFGHVYLGFNSESGQM 247
           +PPG           S  SG     L +       +  K +G+G +G V++G     G+ 
Sbjct: 5   IPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEK 62

Query: 248 CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL----SDERLSVYLEY 303
            A+K      +    +E       EI     + H NI+ +  +++    S  +L +  +Y
Sbjct: 63  VAVKVFFTTEEASWFRE------TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116

Query: 304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT--------VHRDIKGANILV 355
              GS++  L+     +   +       + GL +LH             HRD+K  NILV
Sbjct: 117 HENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175

Query: 356 DPHGEIKLADFGMAKHMTSC-----ASMLSFKGSPYWMAPEV-----VMNTNGYSLTVDI 405
             +G   +AD G+A    S          +  G+  +M PEV       N     +  D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235

Query: 406 WSLGCTVL-EMAT----------SKPPWSQYEGVAAIFK-----IGNSKDIPEIPEHLSD 449
           +S G  +L E+A            + P+         ++     +   K  P  P   S 
Sbjct: 236 YSFGL-ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSS 294

Query: 450 DA-----KSFIKQCLQRDPSARPPASKLLD 474
           D         + +C   +P++R  A ++  
Sbjct: 295 DECLRQMGKLMTECWAHNPASRLTALRVKK 324

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  163 bits (414), Expect = 2e-45
 Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 77/317 (24%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNS-ESGQMCAIKEVRVVCDDQ----TSKECLKQLNQE 272
           +  +++    +G G +G V+   +    G+  A+K VRV   ++    ++        +E
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-------RE 61

Query: 273 INLLSQLS---HPNIVR----YHGSELSDERLSVYL--EYVSGGSIH---KLLQEYGP-- 318
           + +L  L    HPN+VR       S    E   + L  E+V           L +     
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVD----QDLTTYLDKVPEPG 116

Query: 319 FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM 378
                I+    Q+L GL +LH+   VHRD+K  NILV   G+IKLADFG+A+        
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------- 168

Query: 379 LSFKGSPYWM----------APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQY 425
                    +          APEV++ ++ Y+  VD+WS+GC   EM   KP +   S  
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225

Query: 426 EGVAAIFKI----------GNSK------------DIPEIPEHLSDDAKSFIKQCLQRDP 463
           + +  I  +           +               I +    + +  K  + +CL  +P
Sbjct: 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285

Query: 464 SARPPASKLLDHPFVRD 480
           + R  A   L HP+ +D
Sbjct: 286 AKRISAYSALSHPYFQD 302

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  158 bits (403), Expect = 3e-44
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 52/278 (18%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPN 283
            ++LG G  G V   FN  + +  A+K   ++ D        ++   E+ L  + S  P+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARR---EVELHWRASQCPH 72

Query: 284 IVRYHGS--ELSDERLSVYL--EYVSGG----SIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           IVR       L   R  + +  E + GG     I    +    F E       + I   +
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAI 130

Query: 336 AYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            YLH+ N  HRD+K  N+L     P+  +KL DFG A                     E 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KET 170

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPP-WSQYEGV--AAIF-KIGNSK-DIPEIP-EH 446
                 Y  + D+WSLG  +  +    PP +S +       +  +I   + + P      
Sbjct: 171 T--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228

Query: 447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA 484
           +S++ K  I+  L+ +P+ R   ++ ++HP++      
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  160 bits (406), Expect = 9e-44
 Identities = 77/335 (22%), Positives = 135/335 (40%), Gaps = 80/335 (23%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E S  K+  GK LG G+FG V   F+ ESG+  A+K+V    D +         N+E+++
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ--DPRYK-------NRELDI 53

Query: 276 LSQLSHPNIVR------------------------------------YHGSELSDERLSV 299
           +  L H NI++                                            +   +
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 300 YL--EYVSGGSIHKLLQEYGPFNEPV----IQTYTRQILLGLAYLHARNTVHRDIKGANI 353
            +  EYV   ++HK+L+ +      +    I  Y  Q+   + ++H+    HRDIK  N+
Sbjct: 114 NVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172

Query: 354 LVDPH-GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTV 412
           LV+     +KL DFG AK +      +++  S ++ APE+++    Y+ ++D+WS+GC  
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 413 LEMATSKPPWSQYEGV---AAIFKI-G--NSKDIPEI---------------------PE 445
            E+   KP +S    +     I +I G    + +  +                     PE
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                A   ++Q L+ +P  R    + + HPF   
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  157 bits (399), Expect = 3e-43
 Identities = 68/331 (20%), Positives = 110/331 (33%), Gaps = 59/331 (17%)

Query: 194 PLPPGSPTSPSALPCSRTSG--------VTENSLSKWKKGKLLGRGTFGHVYLGFNSESG 245
           P      T    +    TSG        V           + +G+G FG V+ G     G
Sbjct: 8   PFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRG--KWRG 65

Query: 246 QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL---- 301
           +  A+K      +    +E       EI     L H NI+ +  ++  D      L    
Sbjct: 66  EEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119

Query: 302 EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT--------VHRDIKGANI 353
           +Y   GS+   L  Y       +         GLA+LH             HRD+K  NI
Sbjct: 120 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 354 LVDPHGEIKLADFGMAKHMTSCASMLSFK-----GSPYWMAPEVVMNTNG-----YSLTV 403
           LV  +G   +AD G+A    S    +        G+  +MAPEV+ ++            
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

Query: 404 DIWSLGCTVLEMAT----------SKPPWSQYEGVAAIFK-----IGNSKDIPEIPEHLS 448
           DI+++G    E+A            + P+          +     +   K  P IP    
Sbjct: 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298

Query: 449 DDA-----KSFIKQCLQRDPSARPPASKLLD 474
                      +++C   + +AR  A ++  
Sbjct: 299 SCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  156 bits (397), Expect = 4e-43
 Identities = 69/310 (22%), Positives = 126/310 (40%), Gaps = 64/310 (20%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             ++  + LGRG +  V+   N  + +   +K ++ V   +          +EI +L  L
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--------KREIKILENL 87

Query: 280 S-HPNIVRYHGSELSD------ERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
              PNI+      L+D       R    + E+V+     +L Q      +  I+ Y  +I
Sbjct: 88  RGGPNIIT-----LADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEI 139

Query: 332 LLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           L  L Y H+   +HRD+K  N+++D  H +++L D+G+A+             S Y+  P
Sbjct: 140 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW----SQYEGVAAIF-------------K 433
           E++++   Y  ++D+WSLGC +  M   K P+      Y+ +  I              K
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259

Query: 434 IGNSKD---IPEIPEH----------------LSDDAKSFIKQCLQRDPSARPPASKLLD 474
                D      +  H                +S +A  F+ + L+ D  +R  A + ++
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319

Query: 475 HPF---VRDQ 481
           HP+   V   
Sbjct: 320 HPYFYTVVKD 329

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  152 bits (385), Expect = 2e-41
 Identities = 62/310 (20%), Positives = 110/310 (35%), Gaps = 57/310 (18%)

Query: 209 SRTSGVT------ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS 262
             +SGV              +  ++  RG FG V+        +  A+K   +       
Sbjct: 7   HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQ 64

Query: 263 KECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL----EYVSGGSIHKLLQEYGP 318
            E       E+  L  + H NI+++ G+E     + V L     +   GS+   L+    
Sbjct: 65  NE------YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-V 117

Query: 319 FNEPVIQTYTRQILLGLAYLHARNT----------VHRDIKGANILVDPHGEIKLADFGM 368
            +   +      +  GLAYLH               HRDIK  N+L+  +    +ADFG+
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 369 AK---HMTSCASMLSFKGSPYWMAPEVVMNT----NGYSLTVDIWSLGCTVLEMATSKPP 421
           A       S        G+  +MAPEV+           L +D++++G  + E+A+    
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 422 WSQ---------YEGVAAIFKIGNSKDI-------PEIPEHLSDDA-----KSFIKQCLQ 460
                        E +     + + +++       P + ++    A        I++C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 461 RDPSARPPAS 470
            D  AR  A 
Sbjct: 298 HDAEARLSAG 307

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  153 bits (389), Expect = 3e-41
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 72/323 (22%)

Query: 223 KKGKLLGRGTFGHVYLGFN--SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +G  +GRGT+GHVY       +  +  A+K++        S    +    EI LL +L 
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACR----EIALLRELK 76

Query: 281 HPNIVRYHGSELSDERLSVYL--EYVS--------GGSIHKLLQEYGPFNEPVIQTYTRQ 330
           HPN++      LS     V+L  +Y               K  ++       ++++   Q
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDP----HGEIKLADFGMAKHMTSCASMLSFKGSP- 385
           IL G+ YLHA   +HRD+K ANILV       G +K+AD G A+   S    L+      
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 386 --YWM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------------PWSQYEGVAA 430
             +W  APE+++    Y+  +DIW++GC   E+ TS+P                ++ +  
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256

Query: 431 IFKI-G--NSKDIPEI---PEH---------------------------LSDDAKSFIKQ 457
           IF + G    KD  +I   PEH                               A   +++
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

Query: 458 CLQRDPSARPPASKLLDHPFVRD 480
            L  DP  R  + + +  P+  +
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLE 339

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (380), Expect = 1e-40
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 34/302 (11%)

Query: 193 LPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLG----FNSESGQMC 248
           +P         +          T+      K  + LG+G FG V +         +G++ 
Sbjct: 14  IPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV 73

Query: 249 AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSG 306
           A+K+++   ++      L+   +EI +L  L H NIV+Y G   S  R ++ L  EY+  
Sbjct: 74  AVKKLQHSTEEH-----LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128

Query: 307 GSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD 365
           GS+   LQ++    +   +  YT QI  G+ YL  +  +HRD+   NILV+    +K+ D
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188

Query: 366 FGMAKHM---TSCASMLSFKGSP-YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT---- 417
           FG+ K +        +     SP +W APE  +  + +S+  D+WS G  + E+ T    
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELFTYIEK 247

Query: 418 ------------SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA 465
                             Q      I  + N+  +P  P+   D+    + +C   + + 
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQ 306

Query: 466 RP 467
           RP
Sbjct: 307 RP 308

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  147 bits (373), Expect = 4e-40
 Identities = 71/272 (26%), Positives = 122/272 (44%), Gaps = 34/272 (12%)

Query: 223 KKGKLLGRGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           K  + LG+G FG V +         +G++ A+K+++   ++      L+   +EI +L  
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-----LRDFEREIEILKS 67

Query: 279 LSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGL 335
           L H NIV+Y G   S  R ++ L  EY+  GS+   LQ++    +   +  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSP-YWMAPE 391
            YL  +  +HRD+   NILV+    +K+ DFG+ K +        +     SP +W APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMAT----------------SKPPWSQYEGVAAIFKIG 435
             +  + +S+  D+WS G  + E+ T                      Q      I  + 
Sbjct: 188 -SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246

Query: 436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
           N+  +P  P+   D+    + +C   + + RP
Sbjct: 247 NNGRLPR-PDGCPDEIYMIMTECWNNNVNQRP 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  146 bits (371), Expect = 1e-39
 Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 32/297 (10%)

Query: 188 SQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQM 247
              H             +                ++  +L+GRG  G VY   ++   ++
Sbjct: 2   GSSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERI 61

Query: 248 CAIKEVRV-VCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSG 306
            A+K +   +  D   +    ++ +E     +L  P++V  H     D +L V +  ++G
Sbjct: 62  VALKLMSETLSSDPVFRT---RMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118

Query: 307 GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF 366
             +  +L+  GP   P      RQI   L   HA    HRD+K  NILV       L DF
Sbjct: 119 VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178

Query: 367 GMAK-----HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLT--VDIWSLGCTVLEMATSK 419
           G+A       +T   + +   G+ Y+MAPE          T   DI++L C + E  T  
Sbjct: 179 GIASATTDEKLTQLGNTV---GTLYYMAPERFS---ESHATYRADIYALTCVLYECLTGS 232

Query: 420 PPWSQYEG--VAAIFKIGN------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP 468
           PP   Y+G  ++ +    N      S   P IP     DA   I + + ++P  R  
Sbjct: 233 PP---YQGDQLSVMGAHINQAIPRPSTVRPGIPVAF--DA--VIARGMAKNPEDRYV 282

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  146 bits (371), Expect = 2e-39
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 31/270 (11%)

Query: 223 KKGKLLGRGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           K    LG+G FG V L         +G + A+K+++        ++  +   +EI +L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQ--RDFQREIQILKA 80

Query: 279 LSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGL 335
           L    IV+Y G      R S+ L  EY+  G +   LQ +    +   +  Y+ QI  G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPY-WMAPE 391
            YL +R  VHRD+   NILV+    +K+ADFG+AK +        +     SP  W APE
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI------ 443
             ++ N +S   D+WS G  + E+ T   K      E +  +    +   +  +      
Sbjct: 201 -SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 444 ------PEHLSDDAKSFIKQCLQRDPSARP 467
                 P     +    +K C    P  RP
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRP 289

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  145 bits (369), Expect = 2e-39
 Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 30/269 (11%)

Query: 223 KKGKLLGRGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           KK + LG G FG V L      N  +G+M A+K ++     Q      +    EI++L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ----EIDILRT 89

Query: 279 LSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           L H +I++Y G        S+ L  EYV  GS+   L  +       +  + +QI  G+A
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS---CASMLSFKGSP-YWMAPEV 392
           YLHA++ +HRD+   N+L+D    +K+ DFG+AK +        +     SP +W APE 
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE- 207

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-----SKPPWSQYEGVAAIFKIGNSKDIPEI---- 443
            +    +    D+WS G T+ E+ T       PP    E +           + E+    
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

Query: 444 -----PEHLSDDAKSFIKQCLQRDPSARP 467
                P+    +    +K C + + S RP
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRP 296

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  145 bits (367), Expect = 4e-39
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 32/271 (11%)

Query: 223 KKGKLLGRGTFGHVYLG----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           K+ + LG G FG V L         +G+  A+K ++         +  K    EI +L  
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK----EIEILRN 79

Query: 279 LSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGL 335
           L H NIV+Y G    D    + L  E++  GS+ + L +     N      Y  QI  G+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG---SP-YWMAPE 391
            YL +R  VHRD+   N+LV+   ++K+ DFG+ K + +     + K    SP +W APE
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMAT---------------SKPPWSQYEGVAAIFKIGN 436
            +   + + +  D+WS G T+ E+ T                 P   Q      +  +  
Sbjct: 200 CL-MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258

Query: 437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
            K +P  P +  D+    +++C +  PS R 
Sbjct: 259 GKRLPC-PPNCPDEVYQLMRKCWEFQPSNRT 288

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  145 bits (368), Expect = 5e-39
 Identities = 67/311 (21%), Positives = 108/311 (34%), Gaps = 62/311 (19%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
              L   K  +L+GRG +G VY G  S   +  A+K            E      + I  
Sbjct: 9   SLDLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINE------KNIYR 60

Query: 276 LSQLSHPNIVRYHGSEL-----SDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
           +  + H NI R+   +            + +EY   GS+ K L  +   +          
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHS 119

Query: 331 ILLGLAYLHARNT---------VHRDIKGANILVDPHGEIKLADFGMAKHMTSC------ 375
           +  GLAYLH              HRD+   N+LV   G   ++DFG++  +T        
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 376 ---ASMLSFKGSPYWMAPEVVMNT------NGYSLTVDIWSLGCTVLEMA---TSKPPWS 423
               + +S  G+  +MAPEV+               VD+++LG    E+    T   P  
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 424 QYEGVAAIFK---------------IGNSKDIPEIPEHLSDDAKSF------IKQCLQRD 462
                   F+               +   K  P+ PE   +++ +       I+ C  +D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 463 PSARPPASKLL 473
             AR  A    
Sbjct: 300 AEARLTAQXAE 310

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  146 bits (370), Expect = 8e-39
 Identities = 68/264 (25%), Positives = 106/264 (40%), Gaps = 29/264 (10%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
           G+ +GRG FG V+ G       + A+K  R         + L+    E  +L Q SHPNI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ----EARILKQYSHPNI 174

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNT 343
           VR  G     + + + +E V GG     L+  G       +         G+ YL ++  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--SMLSFKGSPY-WMAPEVVMNTNGYS 400
           +HRD+   N LV     +K++DFGM++        +    +  P  W APE  +N   YS
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYGRYS 293

Query: 401 LTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI--------PEHLSDD 450
              D+WS G  + E  +  + P    Y        + N +    +        PE   D 
Sbjct: 294 SESDVWSFGILLWETFSLGASP----YPN------LSNQQTREFVEKGGRLPCPELCPDA 343

Query: 451 AKSFIKQCLQRDPSARPPASKLLD 474
               ++QC   +P  RP  S +  
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  145 bits (368), Expect = 9e-39
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 43/296 (14%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
             +     +G G +G V    +  SG+  AIK++      +      K+  +E+ LL  +
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF---AKRAYRELLLLKHM 80

Query: 280 SHPNIVRYHGSELSDERLS----VYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
            H N++           L      YL   ++    + K++     F+E  IQ    Q+L 
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL--KFSEEKIQYLVYQMLK 137

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV 393
           GL Y+H+   VHRD+K  N+ V+   E+K+ DFG+A+H  +   M  +  + ++ APEV+
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVI 195

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGV---------AAIFKIGNSK 438
           ++   Y+ TVDIWS+GC + EM T K          Q   +           + K+ +  
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 439 ------DIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                  +P+ P           S  A   +++ L+ D   R  A++ L HPF   
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (362), Expect = 1e-38
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 21/255 (8%)

Query: 224 KGKLLGRGTFGHVYLG-FNSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           + K LG G FG V  G +  +      A+K ++   ++        +L  E N++ QL +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDN 77

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           P IVR  G     E   + +E    G ++K LQ+     +  I     Q+ +G+ YL   
Sbjct: 78  PYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMAPEVV 393
           N VHRD+   N+L+      K++DFG++K +                 K    W APE  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPE-C 191

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           +N   +S   D+WS G  + E  +  + P+   +G      +   + +   P     +  
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMY 250

Query: 453 SFIKQCLQRDPSARP 467
             +  C   D   RP
Sbjct: 251 DLMNLCWTYDVENRP 265

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (362), Expect = 2e-38
 Identities = 79/304 (25%), Positives = 136/304 (44%), Gaps = 47/304 (15%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEINLLSQLSHPN 283
              LG G    VYL  ++      AIK + +   + + +   LK+  +E++  SQLSH N
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEET---LKRFEREVHNSSQLSHQN 72

Query: 284 IVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR 341
           IV     ++ +E    YL  EY+ G ++ + ++ +GP +      +T QIL G+ + H  
Sbjct: 73  IVSMI--DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 342 NTVHRDIKGANILVDPHGEIKLADFGMAK-----HMTSCASMLSFKGSPYWMAPEVVMNT 396
             VHRDIK  NIL+D +  +K+ DFG+AK      +T    +L   G+  + +PE     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL---GTVQYFSPEQAK-- 185

Query: 397 NGYSLTV--DIWSLGCTVLEMATSKPPWSQYEG---VAAIFK-------IGNSKDIPEIP 444
            G +     DI+S+G  + EM   +PP   + G   V+   K          +    +IP
Sbjct: 186 -GEATDECTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241

Query: 445 EHLSDDAKSFIKQCLQRDPSARPP-ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGS 503
           + LS+     I +  ++D + R     ++ D        ++   +     +   Y LD  
Sbjct: 242 QSLSN----VILRATEKDKANRYKTIQEMKD-------DLSSVLH-ENRANEDVYELDKM 289

Query: 504 RTPP 507
           +T  
Sbjct: 290 KTIA 293

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  146 bits (371), Expect = 2e-38
 Identities = 75/383 (19%), Positives = 139/383 (36%), Gaps = 103/383 (26%)

Query: 194 PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEV 253
                   S                  +++   L+G G++GHV   ++    ++ AIK++
Sbjct: 27  GQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86

Query: 254 RVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR-----YHGSELSDERLSVYLEYVSGGS 308
             V +D       K++ +EI +L++L+H ++V+             + L V LE      
Sbjct: 87  LRVFEDLID---CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSD 142

Query: 309 IHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM 368
             KL +      E  I+T    +L+G+ Y+H+   +HRD+K AN LV+    +K+ DFG+
Sbjct: 143 FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202

Query: 369 AKHMTSCASMLSFKGSPYWM----------------------------APEVVMNTNGYS 400
           A+ +    +  S                                    APE+++    Y+
Sbjct: 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262

Query: 401 LTVDIWSLGCTVLEMATS-----------KP--PWSQYEGVAA----------------- 430
             +D+WS+GC   E+               P  P S    ++                  
Sbjct: 263 EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322

Query: 431 ----IFK-IG--NSKDIPEIPEHLSDDAKSFIK--------------------------Q 457
               IF  +G  + +DI  +     +DAK +I+                          +
Sbjct: 323 QLNVIFNILGTPSEEDIEALE---KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKR 379

Query: 458 CLQRDPSARPPASKLLDHPFVRD 480
            L  +P+ R   ++ L HPF ++
Sbjct: 380 MLVFNPNKRITINECLAHPFFKE 402

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  142 bits (361), Expect = 4e-38
 Identities = 63/274 (22%), Positives = 118/274 (43%), Gaps = 40/274 (14%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEINLLSQLSHPN 283
           G++LG G    V+L  +    +  A+K +R  +  D +      +  +E    + L+HP 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF---YLRFRREAQNAAALNHPA 73

Query: 284 IVRYH--GSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
           IV  +  G   +      Y+  EYV G ++  ++   GP                L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAK-------HMTSCASMLSFKGSPYWMAPEV 392
               +HRD+K ANI++     +K+ DFG+A+        +T  A+++   G+  +++PE 
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI---GTAQYLSPEQ 190

Query: 393 VMNTNGYSLTV--DIWSLGCTVLEMATSKPPWSQYEG---VAAIFK------IGNSKDIP 441
                G S+    D++SLGC + E+ T +PP   + G   V+  ++      I  S    
Sbjct: 191 AR---GDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSARHE 244

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPP-ASKLLD 474
            +   L       + + L ++P  R   A+++  
Sbjct: 245 GLSADLDA----VVLKALAKNPENRYQTAAEMRA 274

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  142 bits (360), Expect = 1e-37
 Identities = 69/324 (21%), Positives = 134/324 (41%), Gaps = 68/324 (20%)

Query: 211 TSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLN 270
              +  N  S ++   LLG G +G V    +  +G++ AIK++        +   L+   
Sbjct: 2   PKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR--- 58

Query: 271 QEINLLSQLSHPNIVR-------YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNE 321
            EI +L    H NI+              ++    VY+  E +    +H+++      ++
Sbjct: 59  -EIKILKHFKHENIITIFNIQRPDSFENFNE----VYIIQELM-QTDLHRVIST-QMLSD 111

Query: 322 PVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSF 381
             IQ +  Q L  +  LH  N +HRD+K +N+L++ + ++K+ DFG+A+ +   A+  S 
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 382 KGSP-----------YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP---------- 420
                          ++ APEV++ +  YS  +D+WS GC + E+   +P          
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

Query: 421 ----------PWSQYEGVAAIFKIGNSK------DIPEIPE--------HLSDDAKSFIK 456
                     P S       +  I + +       +P  P          ++      ++
Sbjct: 232 LLLIFGIIGTPHSD----NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287

Query: 457 QCLQRDPSARPPASKLLDHPFVRD 480
           + L  DP+ R  A + L+HP+++ 
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQT 311

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (357), Expect = 2e-37
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 44/268 (16%)

Query: 223 KKGKLLGRGTFGHVYLGF---NSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           KK K+LG G FG VY G      E  ++  AIKE+R     + +KE L     E  +++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL----DEAYVMAS 73

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAY 337
           + +P++ R  G       + +  + +  G +   ++E+        +  +  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFKGSPYWMAP 390
           L  R  VHRD+   N+LV     +K+ DFG+AK +        +    +  K    WMA 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMAL 188

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI----- 443
           E +     Y+   D+WS G TV E+ T  SKP    Y+G+        + +I  I     
Sbjct: 189 ESI-LHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGI-------PASEISSILEKGE 236

Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARP 467
               P   + D    +++C   D  +RP
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRP 264

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  139 bits (353), Expect = 2e-37
 Identities = 66/256 (25%), Positives = 114/256 (44%), Gaps = 22/256 (8%)

Query: 223 KKGKLLGRGTFGHVYLG-FNSESGQ--MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
              ++LG G FG VY G + +  G+    A+K  +  C     ++ +     E  ++  L
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM----SEAVIMKNL 70

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYL 338
            HP+IV+  G  + +E   + +E    G +   L+          +  Y+ QI   +AYL
Sbjct: 71  DHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSPYWMAPEV 392
            + N VHRDI   NILV     +KL DFG+++++       +  + L  K    WM+PE 
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPE- 184

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
            +N   ++   D+W     + E+ +  K P+   E    I  +     +P+ P+      
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVL 243

Query: 452 KSFIKQCLQRDPSARP 467
            + + +C   DPS RP
Sbjct: 244 YTLMTRCWDYDPSDRP 259

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  141 bits (357), Expect = 4e-37
 Identities = 67/297 (22%), Positives = 133/297 (44%), Gaps = 44/297 (14%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQ 278
            +++    +G G +G V   F++++G   A+K++         +K   +    E+ LL  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKH 84

Query: 279 LSHPNIVRYHGSELSDERLS----VYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           + H N++           L     VYL    + G  ++ +++      +  +Q    QIL
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQIL 142

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            GL Y+H+ + +HRD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEI 200

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGV---------AAIFKIGNS 437
           ++N   Y+ TVDIWS+GC + E+ T +          Q + +           + KI + 
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260

Query: 438 ------KDIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                 + + ++P+          +  A   +++ L  D   R  A++ L H +   
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (350), Expect = 6e-37
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 23/252 (9%)

Query: 228 LGRGTFGHVYLG-FNSESGQMC-AIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG G FG V  G +     Q+  AIK ++   +   ++E +    +E  ++ QL +P IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM----REAQIMHQLDNPYIV 73

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTV 344
           R  G     E L + +E   GG +HK L           +     Q+ +G+ YL  +N V
Sbjct: 74  RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMAPEVVMNT 396
           HRD+   N+L+      K++DFG++K +           A     K    W APE  +N 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPE-CINF 187

Query: 397 NGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI 455
             +S   D+WS G T+ E  +  + P+ + +G   +  I   K +   P     +  + +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALM 246

Query: 456 KQCLQRDPSARP 467
             C       RP
Sbjct: 247 SDCWIYKWEDRP 258

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (350), Expect = 6e-37
 Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 32/279 (11%)

Query: 211 TSGVTENSLSKW-------KKGKLLGRGTFGHVYLG-FNSESGQM--CAIKEVRVVCDDQ 260
           ++G                +  + LG G+FG V  G +++ SG+    A+K ++   D  
Sbjct: 2   SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP--DVL 59

Query: 261 TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP 318
           +  E +    +E+N +  L H N++R +G  L+     + +  E    GS+   L+++  
Sbjct: 60  SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQG 116

Query: 319 -FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM----- 372
            F    +  Y  Q+  G+ YL ++  +HRD+   N+L+     +K+ DFG+ + +     
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

Query: 373 ---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGV 428
                    + F     W APE  + T  +S   D W  G T+ EM T  + PW    G 
Sbjct: 177 HYVMQEHRKVPFA----WCAPE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231

Query: 429 AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
             + KI    +    PE    D  + + QC    P  RP
Sbjct: 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 270

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  139 bits (352), Expect = 7e-37
 Identities = 78/309 (25%), Positives = 136/309 (44%), Gaps = 58/309 (18%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLS 277
            S++   K LG G  G V+   +++  +  AIK  ++V  D  S K  L+    EI ++ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALR----EIKIIR 63

Query: 278 QLSHPNIVR------------YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPV 323
           +L H NIV+                    E  SVY+  EY+    +  +L++ GP  E  
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEH 121

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSCASMLSFK 382
            + +  Q+L GL Y+H+ N +HRD+K AN+ ++     +K+ DFG+A+ M    S     
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 383 GSPY----WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGV--- 428
            S      W  +P ++++ N Y+  +D+W+ GC   EM T K          Q + +   
Sbjct: 182 -SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 429 ------AAIFKIGNS-------------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPA 469
                     ++ +              K + ++   +S +A  F++Q L   P  R  A
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 470 SKLLDHPFV 478
            + L HP++
Sbjct: 301 EEALSHPYM 309

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  140 bits (354), Expect = 1e-36
 Identities = 66/307 (21%), Positives = 123/307 (40%), Gaps = 55/307 (17%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLS 277
           L +++  K +G G  G V   +++   +  AIK++     +QT +K   +    E+ L+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79

Query: 278 QLSHPNIVRYHGSELSDERLS----VYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
            ++H NI+         + L     VY+  E +   ++ +++Q     +   +     Q+
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQM 136

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
           L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APE
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKP------------------------------- 420
           V++    Y   VDIWS+GC + EM                                    
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 421 ---------PWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASK 471
                    P         +F         E  +  +  A+  + + L  D S R    +
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 472 LLDHPFV 478
            L HP++
Sbjct: 316 ALQHPYI 322

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  144 bits (365), Expect = 1e-36
 Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 28/301 (9%)

Query: 227 LLGRGTFGHVYLGFNSE-SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
            +  G  G +YL  +   +G+   +K +    D +           E   L+++ HP+IV
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA----QAMAMAERQFLAEVVHPSIV 142

Query: 286 RYH--GSELSDERLSV-YL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           +              V Y+  EYV G S+ +   +  P  E +   Y  +IL  L+YLH+
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI--AYLLEILPALSYLHS 200

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYS 400
              V+ D+K  NI++     +KL D G    + S   +    G+P + APE+V    G +
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY---GTPGFQAPEIV--RTGPT 254

Query: 401 LTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
           +  DI+++G T+  +    P      G       G  +D P +  + S      +++ + 
Sbjct: 255 VATDIYTVGRTLAALTLDLPT---RNGRYV---DGLPEDDPVLKTYDSYGR--LLRRAID 306

Query: 461 RDPSARPP-ASKLLDH-PFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSI 518
            DP  R   A ++      V  + VA+   V     S+ +S   S     L +  T   +
Sbjct: 307 PDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYL 366

Query: 519 T 519
            
Sbjct: 367 D 367

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (350), Expect = 1e-36
 Identities = 67/304 (22%), Positives = 115/304 (37%), Gaps = 26/304 (8%)

Query: 177 DSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHV 236
                    GK    +    P +   P        S   E   S+    K++G G  G V
Sbjct: 9   SGRENLYFQGKLPEPQFYAEPHTYEEPGRAG---RSFTREIEASRIHIEKIIGSGDSGEV 65

Query: 237 YLG---FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS 293
             G      +     AIK ++    ++  ++ L     E +++ Q  HPNI+R  G    
Sbjct: 66  CYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL----SEASIMGQFDHPNIIRLEGVVTR 121

Query: 294 DERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGAN 352
                +  EY+  GS+   L+ + G F    +    R +  G+ YL     VHRD+   N
Sbjct: 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN 181

Query: 353 ILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           +LVD +   K++DFG+++ +        T+    +  +    W APE  +    +S   D
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR----WTAPE-AIAFRTFSSASD 236

Query: 405 IWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDP 463
           +WS G  + E+    + P+        I  +     +P  P          +  C  +D 
Sbjct: 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDR 295

Query: 464 SARP 467
           + RP
Sbjct: 296 AQRP 299

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  138 bits (350), Expect = 3e-36
 Identities = 76/296 (25%), Positives = 134/296 (45%), Gaps = 42/296 (14%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           + ++  + +G G +G V    +  +G   AIK++      +      K+  +E+ LL  +
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF---AKRAYRELRLLKHM 81

Query: 280 SHPNIVRYHGSELSDERLS----VYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
            H N++        DE L      YL   ++ G  + KL++      E  IQ    Q+L 
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV 393
           GL Y+HA   +HRD+K  N+ V+   E+K+ DFG+A+   S   M  +  + ++ APEV+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVI 197

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGV---------AAIFKIGNSK 438
           +N   Y+ TVDIWS+GC + EM T K          Q + +           + ++ + +
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257

Query: 439 ------DIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                  +PE+ +        + S  A + +++ L  D   R  A + L HP+   
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (356), Expect = 4e-36
 Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 37/301 (12%)

Query: 184 EDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSE 243
                    L  P      P+    S      E   +       LG G +G VY G   +
Sbjct: 184 TVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK 243

Query: 244 SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY 303
                A+K ++   +D    E   +  +E  ++ ++ HPN+V+  G    +    +  E+
Sbjct: 244 YSLTVAVKTLK---EDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297

Query: 304 VSGGSIHKLLQEYGPFNEPVIQ--TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI 361
           ++ G++   L+E        +       QI   + YL  +N +HR++   N LV  +  +
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357

Query: 362 KLADFGMAKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEM 415
           K+ADFG+++ M          +    K    W APE  +  N +S+  D+W+ G  + E+
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPE-SLAYNKFSIKSDVWAFGVLLWEI 412

Query: 416 AT-SKPPWSQYEGVAAIFKIGNSKDIP--------EIPEHLSDDAKSFIKQCLQRDPSAR 466
           AT    P   Y G+        S+           E PE   +     ++ C Q +PS R
Sbjct: 413 ATYGMSP---YPGID------LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463

Query: 467 P 467
           P
Sbjct: 464 P 464

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  137 bits (347), Expect = 8e-36
 Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 52/307 (16%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC------LKQLNQEI 273
           S +   + +  G++G V  G +SE G   AIK V     D  +          K++ +EI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 274 NLLSQLSHPNIVR-------YHGSELSDERLSVYL--EYVSGGSIHKLLQ-EYGPFNEPV 323
            LL+   HPNI+        +    +      +YL  E +    + +++  +    +   
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHK----LYLVTELM-RTDLAQVIHDQRIVISPQH 135

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG 383
           IQ +   ILLGL  LH    VHRD+   NIL+  + +I + DF +A+  T+ A+   +  
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGV--------- 428
             ++ APE+VM   G++  VD+WS GC + EM   K        ++Q   +         
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255

Query: 429 AAIFKIGNSK-------DIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLL 473
             +    +          +  +P              A   I + L+ +P  R    + L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315

Query: 474 DHPFVRD 480
            HP+   
Sbjct: 316 RHPYFES 322

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (341), Expect = 8e-36
 Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 22/256 (8%)

Query: 223 KKGKLLGRGTFGHVYLG---FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           + G+ +G G FG V+ G            AIK  +    D   ++ L    QE   + Q 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQF 73

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYL 338
            HP+IV+  G  +++  + + +E  + G +   LQ      +   +  Y  Q+   LAYL
Sbjct: 74  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSPYWMAPEV 392
            ++  VHRDI   N+LV  +  +KL DFG++++M       +    L  K    WMAPE 
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPE- 187

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
            +N   ++   D+W  G  + E+      P+   +    I +I N + +P  P +     
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCPPTL 246

Query: 452 KSFIKQCLQRDPSARP 467
            S + +C   DPS RP
Sbjct: 247 YSLMTKCWAYDPSRRP 262

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (350), Expect = 1e-35
 Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 18/283 (6%)

Query: 190 CHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCA 249
           CH+L     +                E      +    LG+G FG V++G  + + +  A
Sbjct: 157 CHRLTTVCPTSKPQ---TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VA 212

Query: 250 IKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI 309
           IK ++       S E      QE  ++ +L H  +V+ +   +S+E + +  EY+S GS+
Sbjct: 213 IKTLK---PGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 265

Query: 310 HKLLQEYGPFNEPVIQ--TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG 367
              L+        + Q      QI  G+AY+   N VHRD++ ANILV  +   K+ADFG
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325

Query: 368 MAKHMTSCASMLSFKGS-PY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ 424
           +A+ +             P  W APE       +++  D+WS G  + E+ T  + P+  
Sbjct: 326 LARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384

Query: 425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
                 + ++     +P  P    +     + QC +++P  RP
Sbjct: 385 MVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERP 426

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  136 bits (345), Expect = 2e-35
 Identities = 70/304 (23%), Positives = 132/304 (43%), Gaps = 54/304 (17%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            ++     +G G +G V   +++ +    AIK++         +  L+    EI +L + 
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRF 82

Query: 280 SHPNIVR-------YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQ 330
            H NI+            ++ D    VY+  + +    ++KLL+     +   I  +  Q
Sbjct: 83  RHENIIGINDIIRAPTIEQMKD----VYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQ 136

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---- 386
           IL GL Y+H+ N +HRD+K +N+L++   ++K+ DFG+A+          F  + Y    
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-TEYVATR 195

Query: 387 WM-APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------PWSQYEGV---------AA 430
           W  APE+++N+ GY+ ++DIWS+GC + EM +++P         Q   +           
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

Query: 431 IFKIGNSK------DIPEIPE--------HLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
           +  I N K       +P   +        +    A   + + L  +P  R    + L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315

Query: 477 FVRD 480
           ++  
Sbjct: 316 YLEQ 319

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (342), Expect = 2e-35
 Identities = 64/268 (23%), Positives = 115/268 (42%), Gaps = 44/268 (16%)

Query: 223 KKGKLLGRGTFGHVYLGF---NSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           +K K+LG G FG V+ G      ES ++   IK +      Q+ +         +  +  
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT----DHMLAIGS 71

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAY 337
           L H +IVR  G       L +  +Y+  GS+   ++++ G     ++  +  QI  G+ Y
Sbjct: 72  LDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFKGSPYWMAP 390
           L     VHR++   N+L+    ++++ADFG+A  +           +    K    WMA 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMAL 186

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI----- 443
           E  ++   Y+   D+WS G TV E+ T  ++P    Y G+          ++P++     
Sbjct: 187 E-SIHFGKYTHQSDVWSYGVTVWELMTFGAEP----YAGL-------RLAEVPDLLEKGE 234

Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARP 467
               P+  + D    + +C   D + RP
Sbjct: 235 RLAQPQICTIDVYMVMVKCWMIDENIRP 262

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  133 bits (338), Expect = 2e-35
 Identities = 55/267 (20%), Positives = 101/267 (37%), Gaps = 38/267 (14%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV---VCDDQTSKECLKQLNQEINLLSQL 279
              + LG+GTF  ++ G   E G    + E  V   V D            +  +++S+L
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EAASMMSKL 69

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYL 338
           SH ++V  +G  +  +   +  E+V  GS+   L++     N        +Q+   + +L
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 339 HARNTVHRDIKGANILVDPHGE--------IKLADFGMAKHMTSCASMLSFKGSPY---- 386
                +H ++   NIL+    +        IKL+D G++  +                  
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---------KDILQER 180

Query: 387 --WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKI--GNSKDIP 441
             W+ PE + N    +L  D WS G T+ E+ +    P S  +    +      +    P
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP 240

Query: 442 EIPE-HLSDDAKSFIKQCLQRDPSARP 467
           +  E        + I  C+  +P  RP
Sbjct: 241 KAAELA------NLINNCMDYEPDHRP 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 4e-35
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 23/259 (8%)

Query: 223 KKGKLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
              +++G+G FG VY G     +++   CAIK +  + + Q  +  L    +E  L+  L
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL----REGLLMRGL 79

Query: 280 SHPNIVRYHG-SELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAY 337
           +HPN++   G     +    V L Y+  G + + ++          + ++  Q+  G+ Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS----PY-WMAPEV 392
           L  +  VHRD+   N ++D    +K+ADFG+A+ +         +      P  W A E 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE- 198

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKIGNSKDIPEIPEHLS 448
            + T  ++   D+WS G  + E+ T  + P    Y  +    +            PE+  
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YRHIDPFDLTHFLAQGRRLPQPEYCP 254

Query: 449 DDAKSFIKQCLQRDPSARP 467
           D     ++QC + DP+ RP
Sbjct: 255 DSLYQVMQQCWEADPAVRP 273

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  135 bits (343), Expect = 4e-35
 Identities = 72/335 (21%), Positives = 135/335 (40%), Gaps = 81/335 (24%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLS 277
           L K++  K LG+G +G V+   +  +G++ A+K++     + T ++   +    EI +L+
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63

Query: 278 QLS-HPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLG 334
           +LS H NIV       +D    VYL  +Y+    +H +++          Q    Q++  
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKV 121

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM------ 388
           + YLH+   +HRD+K +NIL++    +K+ADFG+++   +   + +              
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 389 ----------------APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------------ 420
                           APE+++ +  Y+  +D+WSLGC + E+   KP            
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241

Query: 421 -----------------------------------PWSQYEGVAAIFKIGNSKDIPEIPE 445
                                                S    +   +K    K  P+   
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK--A 299

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
             +++A   + + LQ +P+ R  A+  L HPFV  
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  136 bits (345), Expect = 4e-35
 Identities = 61/268 (22%), Positives = 110/268 (41%), Gaps = 33/268 (12%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
              +    L+GRG++G+VYL ++  + +  AIK+V  + +D       K++ +EI +L++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID---CKRILREITILNR 81

Query: 279 LSHPNIVRYH-----GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
           L    I+R +        L  + L + LE      + KL +      E  I+T    +LL
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLL 140

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWM----- 388
           G  ++H    +HRD+K AN L++    +K+ DFG+A+ + S                   
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 389 ------------------APEVVMNTNGYSLTVDIWSLGCTVLEM-ATSKPPWSQYEGVA 429
                             APE+++    Y+ ++DIWS GC   E+    +   +      
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            +F   +   +           KS   Q
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  137 bits (347), Expect = 4e-35
 Identities = 68/307 (22%), Positives = 126/307 (41%), Gaps = 55/307 (17%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLS 277
           L +++  K +G G  G V   +++   +  AIK++     +QT +K   +    E+ L+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 278 QLSHPNIVR----YHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
            ++H NI+     +   +  +E   VYL  E +   ++ +++Q     +   +     Q+
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQM 173

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
           L G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APE
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKP------------------------------- 420
           V++    Y   VDIWS+GC + EM   K                                
Sbjct: 234 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 421 ---------PWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASK 471
                    P         +F         E  +  +  A+  + + L  DP+ R     
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352

Query: 472 LLDHPFV 478
            L HP++
Sbjct: 353 ALQHPYI 359

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (341), Expect = 6e-35
 Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 23/258 (8%)

Query: 223 KKGKLLGRGTFGHVYLG---FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
              K++G G FG V  G     S+     AIK ++V   ++  ++ L     E +++ Q 
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL----GEASIMGQF 103

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYL 338
            HPNI+R  G     + + +  EY+  GS+   L+++   F    +    R I  G+ YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMAP 390
                VHRD+   NIL++ +   K++DFG+ + +        T+    +  +    W +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR----WTSP 219

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD 449
           E  +    ++   D+WS G  + E+ +  + P+ +      I  +     +P  P     
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPA 277

Query: 450 DAKSFIKQCLQRDPSARP 467
                +  C Q+D + RP
Sbjct: 278 ALYQLMLDCWQKDRNNRP 295

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  139 bits (351), Expect = 7e-35
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 31/295 (10%)

Query: 187 KSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGF---NSE 243
                              +P +R   +    +   + G+ +G G FG V+ G       
Sbjct: 360 SVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI---ELGRCIGEGQFGDVHQGIYMSPEN 416

Query: 244 SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY 303
                AIK  +    D   ++ L    QE   + Q  HP+IV+  G  +++  + + +E 
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDHPHIVKLIGV-ITENPVWIIMEL 471

Query: 304 VSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK 362
            + G +   LQ      +   +  Y  Q+   LAYL ++  VHRDI   N+LV  +  +K
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531

Query: 363 LADFGMAKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
           L DFG++++M       +    L  K    WMAPE  +N   ++   D+W  G  + E+ 
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIK----WMAPE-SINFRRFTSASDVWMFGVCMWEIL 586

Query: 417 T--SKPPWSQYEGVAA--IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               KP    ++GV    +     + +   +P +      S + +C   DPS RP
Sbjct: 587 MHGVKP----FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 637

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (337), Expect = 8e-35
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 37/276 (13%)

Query: 225 GKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            + LG+G+FG VY G        E     AIK V      +   E L     E +++ + 
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL----NEASVMKEF 85

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYT--------R 329
           +  ++VR  G     +   V +E ++ G +   L+   P   N PV+   +         
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFK 382
           +I  G+AYL+A   VHRD+   N +V     +K+ DFGM + +            +L  +
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKD 439
               WM+PE + +   ++   D+WS G  + E+AT ++ P+     E V      G    
Sbjct: 206 ----WMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG--- 257

Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           + + P++  D     ++ C Q +P  RP   +++  
Sbjct: 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  135 bits (343), Expect = 1e-34
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 56/301 (18%)

Query: 190 CHKLPLPPGSPTSPSALPCSRTSGVTENSLSKW-------KKGKLLGRGTFGHVYLG-FN 241
           C +L  P     + +A          E   S W       K  + +G+G FG V LG + 
Sbjct: 164 CTRLIKPKVMEGTVAAQ--------DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215

Query: 242 SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL 301
              G   A+K ++   +D T++  L     E ++++QL H N+V+  G  + +E+  +Y+
Sbjct: 216 ---GNKVAVKCIK---NDATAQAFL----AEASVMTQLRHSNLVQLLGV-IVEEKGGLYI 264

Query: 302 --EYVSGGSIHKLLQEYGPFNEPVIQ--TYTRQILLGLAYLHARNTVHRDIKGANILVDP 357
             EY++ GS+   L+  G           ++  +   + YL   N VHRD+   N+LV  
Sbjct: 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324

Query: 358 HGEIKLADFGMAKHMTSCASMLSFKGSPY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEMA 416
               K++DFG+ K  +S          P  W APE  +    +S   D+WS G  + E+ 
Sbjct: 325 DNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPE-ALREKKFSTKSDVWSFGILLWEIY 380

Query: 417 T--SKPPWSQYEGVAAIFKIGNSKDIP--------EIPEHLSDDAKSFIKQCLQRDPSAR 466
           +    P    Y        I     +P        + P+         +K C   D + R
Sbjct: 381 SFGRVP----YPR------IPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430

Query: 467 P 467
           P
Sbjct: 431 P 431

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (335), Expect = 2e-34
 Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 44/268 (16%)

Query: 223 KKGKLLGRGTFGHVYLGF---NSESGQM-CAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           KK K+LG G FG VY G      E  ++  AIKE+R     + +KE L     E  +++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL----DEAYVMAS 73

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAY 337
           + +P++ R  G       + +  + +  G +   ++E+        +  +  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------TSCASMLSFKGSPYWMAP 390
           L  R  VHRD+   N+LV     +K+ DFG+AK +        +    +  K    WMA 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMAL 188

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI----- 443
           E +     Y+   D+WS G TV E+ T  SKP    Y+G+        + +I  I     
Sbjct: 189 ESI-LHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGI-------PASEISSILEKGE 236

Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARP 467
               P   + D    + +C   D  +RP
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRP 264

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  131 bits (331), Expect = 2e-34
 Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 48/272 (17%)

Query: 221 KW-------KKGKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQE 272
                       K LG G FG V LG +  +     A+K ++   +   S++   +  QE
Sbjct: 2   HMELKREEITLLKELGSGQFGVVKLGKWKGQ--YDVAVKMIK---EGSMSED---EFFQE 53

Query: 273 INLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQI 331
              + +LSHP +V+++G    +  + +  EY+S G +   L+ +G       +      +
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSP 385
             G+A+L +   +HRD+   N LVD    +K++DFGM +++      +S  +    K   
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--- 170

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI 443
            W APE V +   YS   D+W+ G  + E+ +    P    Y+         NS+ + ++
Sbjct: 171 -WSAPE-VFHYFKYSSKSDVWAFGILMWEVFSLGKMP----YDL------YTNSEVVLKV 218

Query: 444 --------PEHLSDDAKSFIKQCLQRDPSARP 467
                   P   SD     +  C    P  RP
Sbjct: 219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRP 250

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 2e-34
 Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 38/277 (13%)

Query: 225 GKLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           G++LG+G FG V          S    A+K ++    D  +   +++  +E   + +  H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEEFLREAACMKEFDH 84

Query: 282 PNIVRYHG------SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT------YTR 329
           P++ +  G      ++       V L ++  G +H  L        P          +  
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFK 382
            I  G+ YL +RN +HRD+   N ++     + +ADFG+++ + S        AS L  K
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKIGNSK 438
               W+A E + + N Y++  D+W+ G T+ E+ T    P    Y G+    I+      
Sbjct: 205 ----WLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP----YAGIENAEIYNYLIGG 255

Query: 439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +  + P    ++    + QC   DP  RP  + L   
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  132 bits (334), Expect = 2e-34
 Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 66/294 (22%)

Query: 215 TEN--SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQE 272
           T N         G  +G G FG VY G+   +    A+K++  +  D T++E  +Q +QE
Sbjct: 24  TNNFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAM-VDITTEELKQQFDQE 80

Query: 273 INLLSQLSHPNIVRYHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR- 329
           I ++++  H N+V   G  S+  D+   VY  Y+  GS+   L        P +  + R 
Sbjct: 81  IKVMAKCQHENLVELLGFSSD-GDDLCLVY-VYMPNGSLLDRL--SCLDGTPPLSWHMRC 136

Query: 330 QILL----GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK--------HMTSCAS 377
           +I      G+ +LH  + +HRDIK ANIL+D     K++DFG+A+         MTS   
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS--- 193

Query: 378 MLSFKGSPYWMAPEVVMNTNGYS--------LTV--DIWSLGCTVLEMATSKPPWSQYEG 427
                          ++ T  Y         +T   DI+S G  +LE+ T  P   ++  
Sbjct: 194 --------------RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 428 ----VA-AIFKIGNSKDIPEI--PEHLSD-DAKSFIK------QCLQRDPSARP 467
               +          K I +    + ++D D+ S         QCL    + RP
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRP 292

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (333), Expect = 2e-34
 Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 44/300 (14%)

Query: 208 CSRTSGVTENSLSKW-------KKGKLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVC 257
             R S   +N L            GK+LG G FG V  G       +    A+K ++   
Sbjct: 15  VPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK--- 71

Query: 258 DDQTSKECLKQLNQEINLLSQLSHPNIVRYHG-----SELSDERLSVYLEYVSGGSIHKL 312
            D +S+  +++   E   +   SHPN++R  G     S     +  V L ++  G +H  
Sbjct: 72  LDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY 131

Query: 313 LQEYGPFNEPVIQT------YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF 366
           L        P          +   I LG+ YL  RN +HRD+   N ++     + +ADF
Sbjct: 132 LLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191

Query: 367 GMAKHMTSC-------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-- 417
           G++K + S         + +  K    W+A E  +    Y+   D+W+ G T+ E+AT  
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVK----WIAIE-SLADRVYTSKSDVWAFGVTMWEIATRG 246

Query: 418 SKPPWSQYEGVAA--IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
             P    Y GV    ++         + PE   D+    +  C + DP  RP  S L   
Sbjct: 247 MTP----YPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (330), Expect = 2e-34
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 39/266 (14%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
            + +G+G FG V LG     G   A+K ++   +D T++  L     E ++++QL H N+
Sbjct: 26  LQTIGKGEFGDVMLG--DYRGNKVAVKCIK---NDATAQAFL----AEASVMTQLRHSNL 76

Query: 285 VRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHA 340
           V+  G  + +E+  +Y+  EY++ GS+   L+  G        +  ++  +   + YL  
Sbjct: 77  VQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-WMAPEVVMNTNGY 399
            N VHRD+   N+LV      K++DFG+ K  +S          P  W APE  +    +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPE-ALREKKF 191

Query: 400 SLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI--------PEHLSD 449
           S   D+WS G  + E+ +    P    Y  +           +P +        P+    
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP----YPRIP------LKDVVPRVEKGYKMDAPDGCPP 241

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDH 475
                +K C   D + RP   +L + 
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQ 267

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 3e-34
 Identities = 76/349 (21%), Positives = 123/349 (35%), Gaps = 24/349 (6%)

Query: 134 SYGDPRVNGDIKFNLMPKSPCAGSRGPT-SPTSPLHARLSGMSVDSPTGKIEDGKSQCHK 192
           S  DP  +          S  AG   P  SP       +  +S         +       
Sbjct: 2   SPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGA 61

Query: 193 LPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGF---NSESGQMCA 249
             +          L  +    V   S       +++GRG FG VY G    N      CA
Sbjct: 62  NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 121

Query: 250 IKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG-SELSDERLSVYLEYVSGGS 308
           +K +  + D     + L     E  ++   SHPN++   G    S+    V L Y+  G 
Sbjct: 122 VKSLNRITDIGEVSQFL----TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 177

Query: 309 IHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG 367
           +   ++          +  +  Q+  G+ +L ++  VHRD+   N ++D    +K+ADFG
Sbjct: 178 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 368 MAKHMTSCASMLSFKGS----PY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKP 420
           +A+ M           +    P  WMA E  + T  ++   D+WS G  + E+ T  + P
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

Query: 421 PWSQYEGVAA--IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
               Y  V    I            PE+  D     + +C       RP
Sbjct: 297 ----YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP 341

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  132 bits (333), Expect = 3e-34
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 42/268 (15%)

Query: 223 KKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
            + K++G G FG VY G     + +     AIK ++    ++   + L     E  ++ Q
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL----GEAGIMGQ 102

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAY 337
            SH NI+R  G     + + +  EY+  G++ K L+E    F+   +    R I  G+ Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMA 389
           L   N VHRD+   NILV+ +   K++DFG+++ +        T+    +  +    W A
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR----WTA 218

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI---- 443
           PE  ++   ++   D+WS G  + E+ T   +P    Y  +       N + +  I    
Sbjct: 219 PE-AISYRKFTSASDVWSFGIVMWEVMTYGERP----YWEL------SNHEVMKAINDGF 267

Query: 444 ----PEHLSDDAKSFIKQCLQRDPSARP 467
               P          + QC Q++ + RP
Sbjct: 268 RLPTPMDCPSAIYQLMMQCWQQERARRP 295

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (343), Expect = 5e-34
 Identities = 77/340 (22%), Positives = 130/340 (38%), Gaps = 31/340 (9%)

Query: 148 LMPKSPCAGSRGPTSPTSPLHARLSGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALP 207
               S  +G+  PT P  P         +D+        +      P  P      +++ 
Sbjct: 256 NSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVF 315

Query: 208 CSRTSGVTENSLSKWK--------KGKLLGRGTFGHVYLG-FNSESGQM-CAIKEVRVVC 257
            S  S   E    K              LG G FG V  G +     Q+  AIK ++   
Sbjct: 316 ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375

Query: 258 DDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG 317
           +   ++E ++    E  ++ QL +P IVR  G   ++  + V +E   GG +HK L    
Sbjct: 376 EKADTEEMMR----EAQIMHQLDNPYIVRLIGVCQAEALMLV-MEMAGGGPLHKFLVGKR 430

Query: 318 P-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---- 372
                  +     Q+ +G+ YL  +N VHR++   N+L+      K++DFG++K +    
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

Query: 373 ----TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEG 427
                  A     K    W APE  +N   +S   D+WS G T+ E  +  + P+ + +G
Sbjct: 491 SYYTARSAGKWPLK----WYAPE-CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

Query: 428 VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
              +  I   K +   P     +  + +  C       RP
Sbjct: 546 PEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRP 584

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  129 bits (327), Expect = 8e-34
 Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 31/257 (12%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
              LG G +G VY G   +     A+K ++   +D    E   +  +E  ++ ++ HPN+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVE---EFLKEAAVMKEIKHPNL 71

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARN 342
           V+  G    +    +  E+++ G++   L+E      +  V+     QI   + YL  +N
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 343 TVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS-PY-WMAPEVVMNTNGYS 400
            +HRD+   N LV  +  +K+ADFG+++ MT            P  W APE  +  N +S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFS 190

Query: 401 LTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI--------PEHLSDD 450
           +  D+W+ G  + E+AT    P    Y G+        S+    +        PE   + 
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP----YPGID------LSQVYELLEKDYRMERPEGCPEK 240

Query: 451 AKSFIKQCLQRDPSARP 467
               ++ C Q +PS RP
Sbjct: 241 VYELMRACWQWNPSDRP 257

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  129 bits (327), Expect = 1e-33
 Identities = 63/257 (24%), Positives = 103/257 (40%), Gaps = 23/257 (8%)

Query: 225 GKLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
            +++GRG FG VY G    N      CA+K +  + D     + L     E  ++   SH
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL----TEGIIMKDFSH 85

Query: 282 PNIVRYHG-SELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLH 339
           PN++   G    S+    V L Y+  G +   ++          +  +  Q+  G+ YL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY-----WMAPEVVM 394
           ++  VHRD+   N ++D    +K+ADFG+A+ M           +       WMA E + 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 204

Query: 395 NTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKIGNSKDIPEIPEHLSDD 450
            T  ++   D+WS G  + E+ T  + P    Y  V    I            PE+  D 
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRRLLQPEYCPDP 260

Query: 451 AKSFIKQCLQRDPSARP 467
               + +C       RP
Sbjct: 261 LYEVMLKCWHPKAEMRP 277

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 2e-33
 Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 47/298 (15%)

Query: 213 GVTENSLSKW-------KKGKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQ 260
           G   + +             + LG G FG V+L        ++   + A+K ++    D 
Sbjct: 1   GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DP 56

Query: 261 TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFN 320
           T     K   +E  LL+ L H +IV+++G     + L +  EY+  G ++K L+ +GP  
Sbjct: 57  TLAA-RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115

Query: 321 EPVIQTYTR----------------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLA 364
             ++    R                QI  G+ YL +++ VHRD+   N LV  +  +K+ 
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 175

Query: 365 DFGMAKHMTSC-------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
           DFGM++ + S         +ML  +    WM PE +M    ++   D+WS G  + E+ T
Sbjct: 176 DFGMSRDVYSTDYYRVGGHTMLPIR----WMPPESIMY-RKFTTESDVWSFGVILWEIFT 230

Query: 418 -SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
             K PW Q      I  I   + + E P     +    +  C QR+P  R    ++  
Sbjct: 231 YGKQPWFQLSNTEVIECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (324), Expect = 2e-33
 Identities = 60/279 (21%), Positives = 115/279 (41%), Gaps = 32/279 (11%)

Query: 207 PCSRTSGVTENSLS--KW-------KKGKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVV 256
           P    +  +   L    W          K LG G FG V  G +  +     AIK ++  
Sbjct: 2   PLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ--YDVAIKMIK-- 57

Query: 257 CDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY 316
            +   S++   +  +E  ++  LSH  +V+ +G       + +  EY++ G +   L+E 
Sbjct: 58  -EGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113

Query: 317 GP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM--- 372
              F    +    + +   + YL ++  +HRD+   N LV+  G +K++DFG+++++   
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

Query: 373 ---TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGV 428
              +S  S    +    W  PE V+  + +S   DIW+ G  + E+ +  K P+ ++   
Sbjct: 174 EYTSSVGSKFPVR----WSPPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228

Query: 429 AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
                I     +   P   S+   + +  C       RP
Sbjct: 229 ETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERP 266

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  130 bits (328), Expect = 3e-33
 Identities = 71/337 (21%), Positives = 126/337 (37%), Gaps = 102/337 (30%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS----- 280
           + LG G F  V+L  +  +    A+K VR            +    EI LL +++     
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT------EAAEDEIKLLQRVNDADNT 78

Query: 281 ------HPNIVR------YHGSE-----LSDERLSVYLEYVSGGSIHKLLQ--EYGPFNE 321
                   +I++      + G       +  E L        G ++  L++  E+     
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL--------GENLLALIKKYEHRGIPL 130

Query: 322 PVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDP------HGEIKLADFGMA----K 370
             ++  ++Q+LLGL Y+H R   +H DIK  N+L++         +IK+AD G A    +
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190

Query: 371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP---------P 421
           H T+         +  + +PEV++    +    DIWS  C + E+ T             
Sbjct: 191 HYTNSIQ------TREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243

Query: 422 WSQYEGVAAIFKI----------------------GNSKDI------------PEIPEHL 447
               + +A I ++                      G  ++I             E  +  
Sbjct: 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 303

Query: 448 SDDAKSF---IKQCLQRDPSARPPASKLLDHPFVRDQ 481
            D+AK     +   LQ DP  R  A  L++HP+++D 
Sbjct: 304 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (320), Expect = 4e-33
 Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 30/263 (11%)

Query: 221 KW-------KKGKLLGRGTFGHVYLG-FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQE 272
           KW          + +G G FG V+LG + ++     AIK +R   +   S+E      +E
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTIR---EGAMSEE---DFIEE 53

Query: 273 INLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQI 331
             ++ +LSHP +V+ +G  L    + +  E++  G +   L+   G F    +      +
Sbjct: 54  AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSP 385
             G+AYL     +HRD+   N LV  +  IK++DFGM + +      +S  +    K   
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 170

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIP 444
            W +PE V + + YS   D+WS G  + E+ +  K P+        +  I     + + P
Sbjct: 171 -WASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-P 227

Query: 445 EHLSDDAKSFIKQCLQRDPSARP 467
              S      +  C +  P  RP
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRP 250

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  132 bits (333), Expect = 5e-33
 Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 18/283 (6%)

Query: 190 CHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCA 249
           CH+L     +                E      +    LG+G FG V++G  + + +  A
Sbjct: 240 CHRLTTVCPTSKPQ---TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VA 295

Query: 250 IKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI 309
           IK ++       S E      QE  ++ +L H  +V+ +   +S+E + +  EY+S GS+
Sbjct: 296 IKTLK---PGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 348

Query: 310 HKLLQEYGPFNEPVIQ--TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG 367
              L+        + Q      QI  G+AY+   N VHRD++ ANILV  +   K+ADFG
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408

Query: 368 MAKHMTSCASMLSFKGS-PY-WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ 424
           +A+ +             P  W APE       +++  D+WS G  + E+ T  + P+  
Sbjct: 409 LARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467

Query: 425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
                 + ++     +P  P    +     + QC +++P  RP
Sbjct: 468 MVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERP 509

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (323), Expect = 6e-33
 Identities = 77/305 (25%), Positives = 113/305 (37%), Gaps = 52/305 (17%)

Query: 207 PCSRTSGVTENSLSKW-------KKGKLLGRGTFGHVYLGF-----NSESGQMCAIKEVR 254
           P    +G T +               + LG G FG VY G      N  S    A+K + 
Sbjct: 10  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69

Query: 255 VVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQ 314
            VC +Q   + L     E  ++S+ +H NIVR  G  L      + +E ++GG +   L+
Sbjct: 70  EVCSEQDELDFL----MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125

Query: 315 EYGPFNEPVIQ-------TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLA 364
           E  P                 R I  G  YL   + +HRDI   N L+   G     K+ 
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185

Query: 365 DFGMAKHMTSC-------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT 417
           DFGMA+ +           +ML  K    WM PE  M    ++   D WS G  + E+ +
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLPVK----WMPPEAFME-GIFTSKTDTWSFGVLLWEIFS 240

Query: 418 --SKPPWSQYEG-----VAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPAS 470
               P    Y       V      G      + P++        + QC Q  P  RP  +
Sbjct: 241 LGYMP----YPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293

Query: 471 KLLDH 475
            +L+ 
Sbjct: 294 IILER 298

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (318), Expect = 1e-32
 Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 41/263 (15%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K  + LG G FG V++G+ +   +  A+K ++       S +       E NL+ QL H 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK---QGSMSPD---AFLAEANLMKQLQHQ 68

Query: 283 NIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ--TYTRQILLGLAYLHA 340
            +VR +   ++ E + +  EY+  GS+   L+        + +      QI  G+A++  
Sbjct: 69  RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHM------TSCASMLSFKGSPYWMAPEVVM 394
           RN +HRD++ ANILV      K+ADFG+A+ +          +    K    W APE  +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPE-AI 182

Query: 395 NTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI--------P 444
           N   +++  D+WS G  + E+ T    P    Y G      + N + I  +        P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP----YPG------MTNPEVIQNLERGYRMVRP 232

Query: 445 EHLSDDAKSFIKQCLQRDPSARP 467
           ++  ++    ++ C +  P  RP
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRP 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (319), Expect = 1e-32
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 43/274 (15%)

Query: 225 GKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            + LG   FG VY G        E  Q  AIK ++   +    +E       E  L ++L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR----HEAMLRARL 69

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT----------- 328
            HPN+V   G    D+ LS+   Y S G +H+ L    P ++                  
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 329 -----RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------A 376
                 QI  G+ YL + + VH+D+   N+LV     +K++D G+ + + +         
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFK 433
           S+L  +    WMAPE +M    +S+  DIWS G  + E+ +    P+  Y  + V  + +
Sbjct: 190 SLLPIR----WMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

Query: 434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARP 467
                 +   P+       + + +C    PS RP
Sbjct: 245 NRQ---VLPCPDDCPAWVYALMIECWNEFPSRRP 275

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (322), Expect = 1e-32
 Identities = 69/341 (20%), Positives = 125/341 (36%), Gaps = 58/341 (17%)

Query: 181 GKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKW-------KKGKLLGRGTF 233
           G +E        LP               R   +    L          +  + +G G F
Sbjct: 1   GAMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 60

Query: 234 GHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYH 288
           G V+          E   M A+K ++         +      +E  L+++  +PNIV+  
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD----FQREAALMAEFDNPNIVKLL 116

Query: 289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT-------------------- 328
           G     + + +  EY++ G +++ L+   P     +                        
Sbjct: 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176

Query: 329 ----RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------AS 377
               RQ+  G+AYL  R  VHRD+   N LV  +  +K+ADFG+++++ S          
Sbjct: 177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 236

Query: 378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKI 434
            +  +    WM PE +   N Y+   D+W+ G  + E+ +    P+     E V    + 
Sbjct: 237 AIPIR----WMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291

Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           GN   I   PE+   +  + ++ C  + P+ RP    +   
Sbjct: 292 GN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  129 bits (325), Expect = 3e-32
 Identities = 73/296 (24%), Positives = 130/296 (43%), Gaps = 45/296 (15%)

Query: 190 CHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCA 249
           C KL +P  S                E      K  K LG G FG V++   ++  +  A
Sbjct: 162 CQKLSVPCMSSKPQKPW----EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VA 216

Query: 250 IKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI 309
           +K ++       S E       E N++  L H  +V+ H   ++ E + +  E+++ GS+
Sbjct: 217 VKTMK---PGSMSVE---AFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSL 269

Query: 310 HKLLQEYGPFNEPVIQ--TYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG 367
              L+      +P+ +   ++ QI  G+A++  RN +HRD++ ANILV      K+ADFG
Sbjct: 270 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329

Query: 368 MAKHM------TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SK 419
           +A+ +          +    K    W APE  +N   +++  D+WS G  ++E+ T    
Sbjct: 330 LARVIEDNEYTAREGAKFPIK----WTAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRI 384

Query: 420 PPWSQYEGVAAIFKIGNSKDIPEI--------PEHLSDDAKSFIKQCLQRDPSARP 467
           P    Y G++      N + I  +        PE+  ++  + + +C +  P  RP
Sbjct: 385 P----YPGMS------NPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERP 430

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  126 bits (318), Expect = 6e-32
 Identities = 74/276 (26%), Positives = 109/276 (39%), Gaps = 37/276 (13%)

Query: 225 GKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            + LG G FG VY G      N  S    A+K +  VC +Q   + L     E  ++S+ 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----MEALIISKF 131

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ-------TYTRQIL 332
           +H NIVR  G  L      + LE ++GG +   L+E  P                 R I 
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSC-------ASMLSFK 382
            G  YL   + +HRDI   N L+   G     K+ DFGMA+ +           +ML  K
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKIGNSKD 439
               WM PE  M    ++   D WS G  + E+ +    P+     + V      G    
Sbjct: 252 ----WMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 303

Query: 440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
             + P++        + QC Q  P  RP  + +L+ 
Sbjct: 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (315), Expect = 8e-32
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 43/281 (15%)

Query: 225 GKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
              LG G FG V+L         +   + A+K ++   +        +   +E  LL+ L
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-----RQDFQREAELLTML 100

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT----------- 328
            H +IVR+ G       L +  EY+  G +++ L+ +GP  + +                
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 329 ----RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------AS 377
                Q+  G+ YL   + VHRD+   N LV     +K+ DFGM++ + S         +
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQY--EGVAAIFKI 434
           ML  +    WM PE ++    ++   D+WS G  + E+ T  K PW Q            
Sbjct: 221 MLPIR----WMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

Query: 435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           G      E P     +  + ++ C QR+P  R     +   
Sbjct: 276 GR---ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 1e-31
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 53/291 (18%)

Query: 225 GKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           GK LG G FG V                 A+K ++   ++ +  E L+ L  E N+L Q+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSE-LRDLLSEFNVLKQV 83

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQT------------- 326
           +HP++++ +G+   D  L + +EY   GS+   L+E        + +             
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 327 -----------YTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS- 374
                      +  QI  G+ YL     VHRD+   NILV    ++K++DFG+++ +   
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 375 ------CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYE 426
                     +  K    WMA E + + + Y+   D+WS G  + E+ T    P    Y 
Sbjct: 204 DSYVKRSQGRIPVK----WMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNP----YP 254

Query: 427 GVAA--IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           G+    +F +  +    E P++ S++    + QC +++P  RP  + +   
Sbjct: 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  123 bits (310), Expect = 3e-31
 Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 41/269 (15%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           L+G G FG VY G     G   A+K          S + +++   EI  LS   HP++V 
Sbjct: 46  LIGHGVFGKVYKGV-LRDGAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVS 99

Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTY-TR-QILL----GLAYL 338
             G   E  +E + +Y +Y+  G++ + L  YG     +  ++  R +I +    GL YL
Sbjct: 100 LIGFCDE-RNEMILIY-KYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYL 155

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLS--FKGSPYWMAPEVVMN 395
           H R  +HRD+K  NIL+D +   K+ DFG++K  T    + LS   KG+  ++ PE  + 
Sbjct: 156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI- 214

Query: 396 TNGYSLTV--DIWSLGCTVLEMATSKPP---------WSQYEGVAAIFKIGNSKDI--PE 442
             G  LT   D++S G  + E+  ++            +  E        G  + I  P 
Sbjct: 215 -KGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272

Query: 443 IPEHLS-DDAKSFIK---QCLQRDPSARP 467
           + + +  +  + F     +CL      RP
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRP 301

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  122 bits (308), Expect = 5e-31
 Identities = 75/317 (23%), Positives = 122/317 (38%), Gaps = 57/317 (17%)

Query: 202 SPSALPCSRTSGVTENSLSKW-------KKGKLLGRGTFGHVYLGF-----NSESGQMCA 249
            P  LP            SKW       K GK LGRG FG V          + + +  A
Sbjct: 2   DPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 61

Query: 250 IKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG-SELSDERLSVYLEYVSGG 307
           +K ++   +  T  E  + L  E+ +L  +  H N+V   G        L V +E+   G
Sbjct: 62  VKMLK---EGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117

Query: 308 SIHKLLQEYGPFNEPVIQTYTR----------------QILLGLAYLHARNTVHRDIKGA 351
           ++   L+       P                       Q+  G+ +L +R  +HRD+   
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177

Query: 352 NILVDPHGEIKLADFGMAKHM--------TSCASMLSFKGSPYWMAPEVVMNTNGYSLTV 403
           NIL+     +K+ DFG+A+ +           A  L  K    WMAPE  +    Y++  
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLPLK----WMAPE-TIFDRVYTIQS 231

Query: 404 DIWSLGCTVLEMAT--SKPPWSQYEGVAA---IFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           D+WS G  + E+ +  + P    Y GV       +          P++ + +    +  C
Sbjct: 232 DVWSFGVLLWEIFSLGASP----YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287

Query: 459 LQRDPSARPPASKLLDH 475
              +PS RP  S+L++H
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  123 bits (311), Expect = 6e-31
 Identities = 83/346 (23%), Positives = 137/346 (39%), Gaps = 65/346 (18%)

Query: 172 SGMSVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKW-------KK 224
           S  S++S T  +            P  +  S   LP             KW         
Sbjct: 36  SSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELP----------EDPKWEFPRDKLTL 85

Query: 225 GKLLGRGTFGHVYLG-------FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           GK LG G FG V +           +     A+K ++   DD T K+ L  L  E+ ++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKD-LSDLVSEMEMMK 141

Query: 278 QL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR------- 329
            +  H NI+   G+   D  L V +EY S G++ + L+   P          R       
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 330 ---------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----- 375
                    Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +      
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 376 --ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA- 430
                L  K    WMAPE + +   Y+   D+WS G  + E+ T    P    Y G+   
Sbjct: 262 TTNGRLPVK----WMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP----YPGIPVE 312

Query: 431 -IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            +FK+       + P + +++    ++ C    PS RP   +L++ 
Sbjct: 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (303), Expect = 3e-30
 Identities = 72/288 (25%), Positives = 111/288 (38%), Gaps = 51/288 (17%)

Query: 225 GKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           GK LG G FG V          S++    A+K ++         E  + L  E+ +LS L
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTE-REALMSELKVLSYL 83

Query: 280 -SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT---------- 328
            +H NIV   G+        V  EY   G +   L+           +            
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 329 --------RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-------- 372
                    Q+  G+A+L ++N +HRD+   NIL+      K+ DFG+A+ +        
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA 430
              A  L  K    WMAPE + N   Y+   D+WS G  + E+ +  S P    Y G+  
Sbjct: 204 KGNA-RLPVK----WMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP----YPGMPV 253

Query: 431 ---IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
               +K+         PEH   +    +K C   DP  RP   +++  
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (303), Expect = 3e-30
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 48/286 (16%)

Query: 225 GKLLGRGTFGHVYLG-------FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           GK LG G FG V +           +     A+K ++   DD T K+ L  L  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKD-LSDLVSEMEMMK 95

Query: 278 QL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR------- 329
            +  H NI+   G+   D  L V +EY S G++ + L+   P          R       
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 330 ---------QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC----- 375
                    Q+  G+ YL ++  +HRD+   N+LV  +  +K+ADFG+A+ + +      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 376 --ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA- 430
                L  K    WMAPE  +    Y+   D+WS G  + E+ T    P    Y G+   
Sbjct: 216 TTNGRLPVK----WMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPGIPVE 266

Query: 431 -IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            +FK+       + P + +++    ++ C    PS RP   +L++ 
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  121 bits (305), Expect = 4e-30
 Identities = 81/321 (25%), Positives = 131/321 (40%), Gaps = 58/321 (18%)

Query: 200 PTSPSALPCSRTSGVTENSLS---KW-------KKGKLLGRGTFGHVYLG-------FNS 242
           PT+ +       +GV+E  L    +W         GK LG G FG V L           
Sbjct: 39  PTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKP 98

Query: 243 ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVYL 301
                 A+K ++    D T K+ L  L  E+ ++  +  H NI+   G+   D  L V +
Sbjct: 99  NRVTKVAVKMLK---SDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154

Query: 302 EYVSGGSIHKLLQEYGPFNEPVIQTYT----------------RQILLGLAYLHARNTVH 345
           EY S G++ + LQ   P         +                 Q+  G+ YL ++  +H
Sbjct: 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTSC-------ASMLSFKGSPYWMAPEVVMNTNG 398
           RD+   N+LV     +K+ADFG+A+ +             L  K    WMAPE + +   
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFD-RI 269

Query: 399 YSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKIGNSKDIPEIPEHLSDDAKSF 454
           Y+   D+WS G  + E+ T    P    Y GV    +FK+       + P + +++    
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMM 325

Query: 455 IKQCLQRDPSARPPASKLLDH 475
           ++ C    PS RP   +L++ 
Sbjct: 326 MRDCWHAVPSQRPTFKQLVED 346

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  119 bits (300), Expect = 9e-30
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 42/276 (15%)

Query: 227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR 286
           +LGRG FG VY G     G + A+K       ++ ++    Q   E+ ++S   H N++R
Sbjct: 37  ILGRGGFGKVYKG-RLADGTLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 91

Query: 287 YHG--SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTR-QILLG----LAYLH 339
             G       ERL VY  Y++ GS+   L+E    ++P +    R +I LG    LAYLH
Sbjct: 92  LRGFCMT-PTERLLVY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLH 148

Query: 340 ---ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVM 394
                  +HRD+K ANIL+D   E  + DFG+AK M    + ++   +G+   +APE + 
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208

Query: 395 NTNGYSLTV--DIWSLGCTVLEMAT-------SKPPWSQYEG----VAAIFKIGNSKDI- 440
              G   +   D++  G  +LE+ T       ++            V  + K    + + 
Sbjct: 209 --TGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265

Query: 441 -PEIPEHLSDD-AKSFIK---QCLQRDPSARPPASK 471
             ++  +  D+  +  I+    C Q  P  RP  S+
Sbjct: 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  119 bits (301), Expect = 1e-29
 Identities = 67/338 (19%), Positives = 115/338 (34%), Gaps = 98/338 (28%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP--- 282
            L+G+G+FG V   ++    +  AIK ++        K  L Q   E+ LL  ++     
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTE 113

Query: 283 ---NIVRYHGSE-------LSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQ 330
               IV             L  E LS         +++ LL+       +  + + + +Q
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY--------NLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 331 ILLGLAYLHAR--NTVHRDIKGANILV--DPHGEIKLADFGMAKHMTSCASMLSFKGSPY 386
           +   L +L     + +H D+K  NIL+       IK+ DFG +  +     +  +  S +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRF 223

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT---------------------SKPPWS-- 423
           + +PEV++    Y L +D+WSLGC ++EM T                       PP    
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 424 ---------------------QYEGVAAIFKIGNSKDIPEI---------------PEHL 447
                                + +     +K   ++ +  I                 H 
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 448 SDDAKSFI---KQCLQRDPSARPPASKLLDHPFVRDQA 482
             D   F     + L  DP  R      L H F +  A
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  116 bits (294), Expect = 6e-29
 Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 59/290 (20%)

Query: 225 GKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           GK LG G FG V           ++    A+K ++       + E  + L  E+ ++S L
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADE-KEALMSELKIMSHL 106

Query: 280 -SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT---------- 328
             H NIV   G+      + V  EY   G +   L+      E                 
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 329 ----RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-------AS 377
                Q+  G+A+L ++N +HRD+   N+L+      K+ DFG+A+ + +         +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVL--EMAT--SKPPWSQYEGVAAIFK 433
            L  K    WMAPE + +   Y++  D+WS G  +L  E+ +    P    Y G+     
Sbjct: 227 RLPVK----WMAPESIFD-CVYTVQSDVWSYG--ILLWEIFSLGLNP----YPGILV--- 272

Query: 434 IGNSKDIPEI--------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
             NSK    +        P     +  S ++ C   +P+ RP   ++   
Sbjct: 273 --NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (289), Expect = 2e-28
 Identities = 64/309 (20%), Positives = 120/309 (38%), Gaps = 46/309 (14%)

Query: 225 GKLLGRGTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SH 281
             ++G G FG V              AIK ++   +  +  +  +    E+ +L +L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDD-HRDFAGELEVLCKLGHH 85

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT------------- 328
           PNI+   G+      L + +EY   G++   L++                          
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 329 ---RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK----HMTSCASMLSF 381
                +  G+ YL  +  +HRD+   NILV  +   K+ADFG+++    ++      L  
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAA--IFKIGNS 437
           +    WMA E  +N + Y+   D+WS G  + E+ +    P    Y G+    +++    
Sbjct: 206 R----WMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----YCGMTCAELYEKLPQ 256

Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL---LDHPFVRDQAVARAGNVNLAKD 494
               E P +  D+    ++QC +  P  RP  +++   L+      +      N  L + 
Sbjct: 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML---EERKTYVNTTLYEK 313

Query: 495 SSPYSLDGS 503
            +   +D S
Sbjct: 314 FTYAGIDCS 322

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  115 bits (290), Expect = 3e-28
 Identities = 71/342 (20%), Positives = 123/342 (35%), Gaps = 112/342 (32%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           + +G GTFG V L  + ++ +  A+K VR +      K+  +    E ++L ++ + +I 
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDIN 94

Query: 286 RYHGSELSD------------ERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQI 331
             +  +               E L          S+++++       F+   I+ Y  +I
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGP--------SLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 332 LLGLAYLHARNTVHRDIKGANIL-VDPHG------------------------EIKLADF 366
           L  L YL   +  H D+K  NIL  DP+                          IKL DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 367 GMA----KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSK--- 419
           G A     +  S  +      +  + APEV++N  G+ ++ D+WS GC + E+ T     
Sbjct: 207 GCATFKSDYHGSIIN------TRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF 259

Query: 420 PPWSQYEGVAAIFKI-------------------------------------------GN 436
                 E +A +  I                                             
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319

Query: 437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
              + +I +H  +    F+   LQ DP+ RP  ++LL H F+
Sbjct: 320 CLPLYKIIKH--ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (289), Expect = 3e-28
 Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 56/293 (19%)

Query: 225 GKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           GK+LG G FG V          +      A+K ++   +   S E  + L  E+ +++QL
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSE-REALMSELKMMTQL 105

Query: 280 -SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT---------- 328
            SH NIV   G+      + +  EY   G +   L+            Y           
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 329 -------------RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM--- 372
                         Q+  G+ +L  ++ VHRD+   N+LV     +K+ DFG+A+ +   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 373 -----TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQY 425
                   A  L  K    WMAPE +     Y++  D+WS G  + E+ +    P    Y
Sbjct: 226 SNYVVRGNA-RLPVK----WMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP----Y 275

Query: 426 EGVAA---IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            G+      +K+  +    + P + +++    ++ C   D   RP    L   
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  112 bits (282), Expect = 3e-27
 Identities = 60/340 (17%), Positives = 104/340 (30%), Gaps = 106/340 (31%)

Query: 226 KLLGRGTFGHVYLGF-NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP-- 282
             LG GTFG V     ++      A+K +R V       +  +    EIN+L ++     
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDK 78

Query: 283 ----NIVRYHGSE-------LSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTR 329
                 V             ++ E L          +  + L+E    P+  P ++    
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGK--------NTFEFLKENNFQPYPLPHVRHMAY 130

Query: 330 QILLGLAYLHARNTVHRDIKGANILV-------------------DPHGEIKLADFGMAK 370
           Q+   L +LH     H D+K  NIL                      +  I++ADFG   
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--- 187

Query: 371 HMTSCASMLSFKGSPY-----WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP----- 420
                A+      +       +  PEV++   G++   D+WS+GC + E           
Sbjct: 188 ----SATFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTH 242

Query: 421 -----------------------------------PWSQYEGVAAIFKIGNSKDIPEIPE 445
                                               W +       +   N K +     
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS-SDGRYVKENCKPLKSYML 301

Query: 446 HLSDDAKS---FIKQCLQRDPSARPPASKLLDHPFVRDQA 482
             S +       +++ L+ DP+ R   ++ L HPF     
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  111 bits (280), Expect = 4e-27
 Identities = 66/336 (19%), Positives = 112/336 (33%), Gaps = 104/336 (30%)

Query: 226 KLLGRGTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP-- 282
             LG G FG V    + ++G +  A+K V+ V          +    EI +L  L+    
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDP 73

Query: 283 ----NIVRYHGSE-------LSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTR 329
                 V+            +  E L +        S +  ++E G  PF    I+    
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGL--------STYDFIKENGFLPFRLDHIRKMAY 125

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHG-------------------EIKLADFGMA- 369
           QI   + +LH+    H D+K  NIL                        +IK+ DFG A 
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185

Query: 370 ---KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKP------ 420
              +H ++  S      + ++ APEV++   G+S   D+WS+GC ++E            
Sbjct: 186 YDDEHHSTLVS------TRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 421 ----------------------------------PWSQYEGVAAIFKIGNSKDIPEI--P 444
                                              W ++            K + E    
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVS-RACKPLKEFMLS 297

Query: 445 EHLSDDA-KSFIKQCLQRDPSARPPASKLLDHPFVR 479
           + +  +     I++ L+ DP+ R    + L HPF  
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  112 bits (281), Expect = 1e-26
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 34/212 (16%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH---- 281
           K++G+G+FG V   ++ +  Q  A+K VR        K   +Q  +EI +L  L      
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKD 156

Query: 282 --PNIVRYHGSE-------LSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQ 330
              N++    +        ++ E LS+        ++++L+++  +  F+ P+++ +   
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM--------NLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHG--EIKLADFGMAKHMTSCASMLSFKGSPYWM 388
           IL  L  LH    +H D+K  NIL+   G   IK+ DFG + +        ++  S ++ 
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSRFYR 266

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKP 420
           APEV++    Y + +D+WSLGC + E+ T  P
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAELLTGYP 297

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (270), Expect = 3e-26
 Identities = 41/307 (13%), Positives = 86/307 (28%), Gaps = 62/307 (20%)

Query: 194 PLPPGSPTSPSALPCSRTSG----VTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCA 249
                 P     +P +R +     +              G       +   ++   +  A
Sbjct: 11  RESSAPPDDVQLVPGARIANGRYRLLI----------FHGGVPPLQFWQALDTALDRQVA 60

Query: 250 IKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI 309
           +  V          + L++       LS++  P + R      +     V  E++ GGS+
Sbjct: 61  LTFVDP--QGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118

Query: 310 HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA 369
            ++     P     I+   + +       H           + + V   G++ LA     
Sbjct: 119 QEVADT-SPSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT- 175

Query: 370 KHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYE 426
                             M           +   DI  +G ++  +  ++ P        
Sbjct: 176 ------------------MPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209

Query: 427 GVAAIFKIGN------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           G+A   +         +    +IP  +S        + +Q D   R  ++ L     +  
Sbjct: 210 GLAPAERDTAGQPIEPADIDRDIPFQISA----VAARSVQGDGGIRSASTLL----NLMQ 261

Query: 481 QAVARAG 487
           QA A A 
Sbjct: 262 QATAVAD 268

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 96.5 bits (240), Expect = 1e-21
 Identities = 75/374 (20%), Positives = 123/374 (32%), Gaps = 140/374 (37%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-----S 280
           + LG G F  V+L ++ +  +  A+K   VV   +   E       EI LL  +     +
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTE---TALDEIRLLKSVRNSDPN 96

Query: 281 HPNIVRYHGSELSDERLSVYLEY-------------VSGGSIHKLLQ--EYGPFNEPVIQ 325
            PN  R    +L D       +              V G  + K +    Y     P ++
Sbjct: 97  DPN--REMVVQLLD-----DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149

Query: 326 TYTRQILLGLAYLHAR-NTVHRDIKGANILV----------------------------- 355
              +Q+L GL YLH +   +H DIK  NIL+                             
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 356 --------------------DPHGEIKLADFGMA----KHMTSCASMLSFKGSPYWMAPE 391
                                   ++K+AD G A    KH T          +  + + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ------TRQYRSLE 263

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---------VAAIFKI-------- 434
           V++  +GY+   DIWS  C   E+AT    +  + G         +A I ++        
Sbjct: 264 VLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 435 --------------GNSKDIPEIP------------EHLSDDAK---SFIKQCLQRDPSA 465
                         G+ K I ++             E   ++A     F+   L+  P  
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 466 RPPASKLLDHPFVR 479
           R  A++ L HP++ 
Sbjct: 383 RATAAECLRHPWLN 396

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 58/305 (19%), Positives = 114/305 (37%), Gaps = 58/305 (19%)

Query: 178 SPTGKIEDGKSQCHKL--PLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGH 235
             +  ++ G    +    P P G               + +   ++W  GK +G G FG 
Sbjct: 6   HHSSGVDLGTENLYFQSMPFPEGKV-------------LDDMEGNQWVLGKKIGSGGFGL 52

Query: 236 VYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS--------------- 280
           +YL F +   +  A   V+V   +         L  E+    +++               
Sbjct: 53  IYLAFPTNKPEKDARHVVKVEYQEN------GPLFSELKFYQRVAKKDCIKKWIERKQLD 106

Query: 281 HPNIVRYHGSELSDERLSVY----LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           +  I  ++GS L++ +   Y    +E + G  + K+  + G F +  +     ++L  L 
Sbjct: 107 YLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLE 165

Query: 337 YLHARNTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSCASML--------SFKGSPY 386
           Y+H    VH DIK AN+L+       + LAD+G++       +             G+  
Sbjct: 166 YIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIE 225

Query: 387 WMAPEVVMNT-NGYSLT--VDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI 443
           + +    ++   G +L+   D+  LG  +L     K PW Q        +   +  + E+
Sbjct: 226 FTS----LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL 281

Query: 444 PEHLS 448
           P+ + 
Sbjct: 282 PQSVL 286

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 63/333 (18%), Positives = 113/333 (33%), Gaps = 92/333 (27%)

Query: 225 GKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKEC------LKQLNQEI 273
           GK LGRG FG V          + + +  A+K ++        +        L  +   +
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 274 N--------------------------LLSQL---------------SHPNIVRYHGSEL 292
           N                          L + L                      Y G+  
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 293 SD--ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQ---------------TYTRQILLGL 335
            D   RL       S  S   + ++     E                    Y+ Q+  G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPY---WMAPEV 392
            +L +R  +HRD+   NIL+     +K+ DFG+A+ +      +    +     WMAPE 
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMAT--SKPPWSQYEGVAAIFKIGNSKDIPEI------- 443
           + +   Y++  D+WS G  + E+ +  + P    Y GV       + +    +       
Sbjct: 267 IFD-RVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKI-----DEEFCRRLKEGTRMR 316

Query: 444 -PEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            P++ + +    +  C   +PS RP  S+L++H
Sbjct: 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 37/241 (15%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +K G+ +G G+FG ++ G N  + Q  AIK      D         QL  E      L+
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLA 63

Query: 281 H-PNI--VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLA 336
               I  V Y G E     + V ++ + G S+  LL   G  F+   +    +Q+L  + 
Sbjct: 64  GCTGIPNVYYFGQE-GLHNVLV-IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 337 YLHARNTVHRDIKGANILVDPHG-----EIKLADFGMAKHMTSCASML--------SFKG 383
            +H ++ V+RDIK  N L+          I + DFGM K      +          +  G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 384 SPYWMAPEVVMNT-NGYSLTV--DIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNS 437
           +  +M+    +NT  G   +   D+ +LG   +       PW   +         +IG  
Sbjct: 181 TARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236

Query: 438 K 438
           K
Sbjct: 237 K 237

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 59/276 (21%), Positives = 113/276 (40%), Gaps = 38/276 (13%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +++ G+ +G G+FG +YLG +  +G+  AIK   V            QL+ E  +   + 
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQ 62

Query: 281 H-PNI--VRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLA 336
               I  +R+ G+E  D  + V +E + G S+  L       F+   +     Q++  + 
Sbjct: 63  GGVGIPTIRWCGAE-GDYNVMV-MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119

Query: 337 YLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSCASML--------SFKGSP 385
           Y+H++N +HRD+K  N L+    +   + + DFG+AK      +          +  G+ 
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 386 YWMAPEVVMNT-NGYSLTV--DIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSK- 438
            + +    +NT  G   +   D+ SLG  ++       PW   +         +I   K 
Sbjct: 180 RYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235

Query: 439 --DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
              I  + +    +  +++  C       +P  S L
Sbjct: 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 53/270 (19%), Positives = 98/270 (36%), Gaps = 46/270 (17%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            WK G  +G+G FG +YL  +  S +        VV  + +       L  E+    + +
Sbjct: 36  AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAA 91

Query: 281 HPN---------------IVRYHGSELSDERLSVY----LEYVSGGSIHKLLQE-YGPFN 320
            P                + +Y GS L D+    Y    ++   G  + K+ +     F+
Sbjct: 92  KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFS 150

Query: 321 EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSCASM 378
              +   + +IL  L Y+H    VH DIK +N+L++      + L D+G+A         
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

Query: 379 L--------SFKGSPYWMAPEVVMNT-NGYSLT--VDIWSLGCTVLEMATSKPPWSQYEG 427
                       G+  + +    ++  NG + +   D+  LG  +++  T   PW     
Sbjct: 211 KAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266

Query: 428 V---AAIFKIGNSKDIPEIPEHLSDDAKSF 454
                   KI   ++I  +       A + 
Sbjct: 267 DPKYVRDSKIRYRENIASL-MDKCFPAANA 295

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 38/215 (17%), Positives = 66/215 (30%), Gaps = 32/215 (14%)

Query: 175 SVDSPTGKIEDGKSQCHKLPLPPGSPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFG 234
            VD  T  +           LP G+              +T+ S  +WK      R   G
Sbjct: 10  GVDLGTENLYFQSMTTSLEALPTGTV-------------LTDKSGRQWKLKSFQTRDNQG 56

Query: 235 HVYLGFNSESGQMCAIKEVRVV------CDDQTSKE-------CLKQLNQEINLLSQLSH 281
            +Y    + +    +  + +         D +   E              +   L     
Sbjct: 57  ILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116

Query: 282 PNIVRYHGSELSDERLSVY-LEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYL 338
             I    G  +  ++     L  + G S+   L        +E  +     ++L  L +L
Sbjct: 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175

Query: 339 HARNTVHRDIKGANILVDP--HGEIKLADFGMAKH 371
           H    VH ++   NI VDP    ++ LA +G A  
Sbjct: 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 75.3 bits (184), Expect = 7e-15
 Identities = 35/246 (14%), Positives = 72/246 (29%), Gaps = 59/246 (23%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC---LKQLNQEIN 274
              K ++ + +G G FG V+           AIK + +   D  +       +++  EI 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 275 LLSQL---------SHPNIVRYHG------------------------------SELSDE 295
           +  +L              +  +                                   D+
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANIL 354
           +L + LE+  GG   + ++     +    ++   Q+   LA   A     HRD+   N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 355 VDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE 414
           +      KL      K  T                 +V +    Y+L+           +
Sbjct: 195 LKKTSLKKLHYTLNGKSST-------IPSCGL----QVSIID--YTLSRLERDGIVVFCD 241

Query: 415 MATSKP 420
           ++  + 
Sbjct: 242 VSMDED 247

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 49/247 (19%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIK-EVRVVCDDQTSKECLKQLNQEINLLSQL 279
            ++ GK +G G FG + LG N  + +  AIK E         S+    QL+ E     QL
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM------KSRAP--QLHLEYRFYKQL 61

Query: 280 SH-PNI--VRYHGSE-----LSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQ 330
                I  V Y G       +  E L        G S+  L       F+   +     Q
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELL--------GPSLEDLFDLCDRTFSLKTVLMIAIQ 113

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGE-----IKLADFGMAKHMTSCASML------ 379
           ++  + Y+H++N ++RD+K  N L+   G      I + DF +AK      +        
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 380 --SFKGSPYWMAPEVVMNT-NGYSLT--VDIWSLGCTVLEMATSKPPWSQYEGV---AAI 431
             S  G+  +M+    +NT  G   +   D+ +LG   +       PW   +        
Sbjct: 174 HKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229

Query: 432 FKIGNSK 438
            KIG++K
Sbjct: 230 QKIGDTK 236

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 73.9 bits (181), Expect = 5e-14
 Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 35/239 (14%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K++ G+ +G G+FG +YLG N ++ +  AIK   V            QL  E  +   L 
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQ 60

Query: 281 -HPNI--VRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLA 336
               I  VR+ G E      +V +  + G S+  L        +   +     Q++  + 
Sbjct: 61  GGTGIPNVRWFGVE---GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 337 YLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSCASML--------SFKGSP 385
           ++H+++ +HRDIK  N L+        + + DFG+AK     ++          +  G+ 
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 386 YWMAPEVVMNT-NGYSLTV--DIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIGNSK 438
            + +    +NT  G   +   D+ SLG  ++       PW   +         KI   K
Sbjct: 178 RYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 8e-09
 Identities = 77/549 (14%), Positives = 155/549 (28%), Gaps = 191/549 (34%)

Query: 235 HVYLGFNSESGQMCAIKEVRVVCDD-------QTSKECLKQL--NQEINLLSQLSHP-NI 284
           H ++ F +   Q      + V  D        +  ++  K +   +EI+ +       + 
Sbjct: 4   HHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQ-ILLGLAYLHARNT 343
                  L  ++  +  ++V       L   Y     P I+T  RQ  ++   Y+  R+ 
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEV----LRINYKFLMSP-IKTEQRQPSMMTRMYIEQRDR 118

Query: 344 VHRD-----------------IKGANILVDPHGEIKLADFGMA---KHMTSC--ASMLS- 380
           ++ D                 ++ A + + P   + +   G+    K   +     +   
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI--DGVLGSGK---TWVALDVCLS 173

Query: 381 ------FKGSPYWM------APEVVM--------------------------NTN----- 397
                      +W+      +PE V+                            +     
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233

Query: 398 --------GY--SLTV--DIWS--------LGCTVLEMATSKPPWSQYEGVAAIFKIGNS 437
                    Y   L V  ++ +        L C +L   T++     ++ V        +
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL--LTTR-----FKQVTDFLSAATT 286

Query: 438 KDIPEIPEHLS---DDAKSFIKQCLQRDPSARPPASKLLDHPFV--------RDQAVARA 486
             I      ++   D+ KS + + L   P   P       +P          RD  +A  
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NPRRLSIIAESIRDG-LATW 344

Query: 487 GN---VNLAK-----DSSPYSLDGSRTPP-------KLDLLPTRKSI---TLC----EGD 524
            N   VN  K     +SS   L+    P        +L + P    I    L     +  
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLE----PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 525 Y-----LANPLVPTSRALNNPRENARTITSLPVSPCSSP----------LRQYGPSHKSC 569
                 + N L   S     P+E+  +I S+ +                +  Y       
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460

Query: 570 F--LSPPHP-----SYAVMGQSSGYNL------GDYSGYPTRSNPRYINDPWLETSLLKA 616
              L PP+      S+       G++L         + +       +++  +LE  +   
Sbjct: 461 SDDLIPPYLDQYFYSHI------GHHLKNIEHPERMTLFRMV----FLDFRFLEQKIRHD 510

Query: 617 QTPGTSPRS 625
            T   +  S
Sbjct: 511 STAWNASGS 519

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	628
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.91
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.74
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.49
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.82
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.82
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.54
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.49
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.46
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.42
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.34
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.28
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.25
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.2
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.07
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.89
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.71
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.19
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	89.17
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	88.44
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	87.31
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.88

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.4e-64  Score=528.29  Aligned_cols=264  Identities=28%  Similarity=0.475  Sum_probs=235.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|+++++||+|+||+||+|+++.+++.||||++.+...  ......+++.+|+++|++|+|||||+++++|++++.+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            4689999999999999999999999999999999974211  11223567899999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---  375 (628)
                      ||||||.||+|.++|++.+.++|.+++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...   
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999976432   


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ....++|||+.|||||++.+. .|+.++|||||||+||||++|++||...+....+.++....  ..+|..+++++++||
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARDLV  265 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHHHH
Confidence            234578999999999999765 49999999999999999999999998877666666665433  357788999999999


Q ss_pred             HHHhhcCCCCCCCHHH------HhcCccccchHHHhhc
Q 040472          456 KQCLQRDPSARPPASK------LLDHPFVRDQAVARAG  487 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~e------iL~Hpwf~~~~~~~~~  487 (628)
                      ++||++||++|+|++|      |++||||++.+|....
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence            9999999999999987      6899999998887653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.7e-62  Score=506.06  Aligned_cols=258  Identities=27%  Similarity=0.458  Sum_probs=212.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|+++.+++.||||++++...  ...+..+++.+|+++|++++|||||++++++.+++.+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            36799999999999999999999999999999999975322  1233456789999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      ||||||| +|+|.++|.+.+.+++.+++.|++||+.||+|||++|||||||||+||||+.++++||+|||+|+.......
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            9999999 789999999999999999999999999999999999999999999999999999999999999988776666


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ..+.+||+.|||||++.+...++.++|||||||+||||++|+.||...+....+..+....  ..++..+++++++||++
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  245 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLSPGAAGLIKR  245 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            6778999999999999877656789999999999999999999998766555555554322  35678899999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||++||++|||++|||+||||+.
T Consensus       246 ~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          246 MLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999963

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-62  Score=521.72  Aligned_cols=260  Identities=31%  Similarity=0.567  Sum_probs=226.3

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++++...   .....+++.+|+++|++|+|||||+++++|.+++.
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            357899999999999999999999999999999999975432   23446788999999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +|||||||+||+|.++|...  ..++|.+++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999999999754  4579999999999999999999999999999999999999999999999999987754


Q ss_pred             cc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          375 CA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       375 ~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      .. ...+.+||+.|||||++.+. .|+.++||||||||||||++|++||...+..+.+.++.... .+.++..++.++++
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~  255 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHH
T ss_pred             CcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHH
Confidence            33 33467899999999999765 49999999999999999999999999877777776665543 45677889999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||++||++||++|||++|||+||||+..
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-61  Score=515.91  Aligned_cols=255  Identities=31%  Similarity=0.538  Sum_probs=226.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++.....     .+.+.+|+++|++++|||||+++++|.+++.+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            357999999999999999999999999999999997543221     245788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      ||||||+||+|.+++.+ +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ..
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999999999976 67999999999999999999999999999999999999999999999999999877543 34


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  456 (628)
                      ..+.+||+.|||||++.+. .|+.++||||||||||||++|++||...+....+..+.... .....+..+++++++||+
T Consensus       227 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            5678999999999998655 59999999999999999999999998877766666554332 122345679999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||++||++|||++|||+||||+.
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcC
Confidence            999999999999999999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-62  Score=513.54  Aligned_cols=267  Identities=28%  Similarity=0.467  Sum_probs=228.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|++++.||+|+||+||+|++.   .+++.||||++++.......   ..++.+|+++|++++|||||+++++|.+++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            368999999999999999999884   46889999999753221111   235778999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-  374 (628)
                      .+|||||||+||+|.++|.+.+.+++.+++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.... 
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999986543 


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      .....+.+||+.|||||++.+. .|+.++|||||||+||||++|++||.+.+..+.+.++....  ..+|..+++++++|
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSL  256 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred             CccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCcCCHHHHHH
Confidence            3345678999999999999765 59999999999999999999999999877776666665433  35678899999999


Q ss_pred             HHHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCc
Q 040472          455 IKQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       455 I~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      |++||++||++|||     ++||++||||++.+|......++
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~  298 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI  298 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCC
Confidence            99999999999998     58999999999999987765443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-60  Score=518.55  Aligned_cols=255  Identities=31%  Similarity=0.538  Sum_probs=226.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....     .+.+.+|+.+|+.|+|||||+++++|.+++.+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            467999999999999999999999999999999997543221     245789999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      ||||||+||+|.++++. +.++|.+++.|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+... ..
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999999999999975 67999999999999999999999999999999999999999999999999999877543 34


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  456 (628)
                      ..+++||++|||||++.+. .|+.++||||||||||||++|++||.+......+..+.... .....+..+++++++||+
T Consensus       304 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            5678999999999998765 59999999999999999999999998877766666654332 122345679999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||++||++|+|+.|||+||||+.
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcC
Confidence            999999999999999999999974

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-60  Score=494.08  Aligned_cols=256  Identities=30%  Similarity=0.542  Sum_probs=221.0

Q ss_pred             CCe-EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----c
Q 040472          220 SKW-KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----D  294 (628)
Q Consensus       220 ~~y-~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----~  294 (628)
                      .+| ++.++||+|+||+||+|+++.++..||||++....   ......+++.+|+++|++|+|||||+++++|.+    +
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            344 77889999999999999999999999999987432   223446789999999999999999999999875    4


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeC-CCCCEEEeccCCccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVD-PHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld-~~g~vKL~DFGla~~  371 (628)
                      +.+|||||||.||+|.++|++.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+ .+|.+||+|||+|+.
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            568999999999999999999999999999999999999999999998  99999999999997 479999999999986


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCCCCCCcCCHH
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDD  450 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~s~~  450 (628)
                      ... ....+.+||+.|||||++.+  .|+.++|||||||+||||+||++||........+.+.... .....++..++++
T Consensus       182 ~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          182 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             CCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence            433 34456899999999998853  4999999999999999999999999876665555544333 3333456678899


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +++||.+||++||++|||++|||+||||++.
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.9e-60  Score=499.59  Aligned_cols=246  Identities=32%  Similarity=0.494  Sum_probs=214.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .++.|++.++||+|+||+||+|+++.+|+.||||++++...          ..+|+.+|++|+|||||+++++|.+++.+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45689999999999999999999999999999999975221          23699999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~~~~  376 (628)
                      |||||||+||+|.++|++.+.|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+....
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999988 69999999998765432


Q ss_pred             ------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCH
Q 040472          377 ------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSD  449 (628)
Q Consensus       377 ------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~  449 (628)
                            ....++||+.|||||++.+. .|+.++||||||||||||++|++||........+.++.... ....++..+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence                  12346899999999999765 49999999999999999999999998766555555554332 22357788999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++++||++||++||++|||+.||++
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~  309 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRR  309 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHH
Confidence            9999999999999999999999853

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.3e-58  Score=522.91  Aligned_cols=274  Identities=27%  Similarity=0.429  Sum_probs=233.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-cchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ++++|+++++||+|+||+||+|+++.+|+.||||++++.... ............++.+++.++|||||+|+++|++++.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            578999999999999999999999999999999999753211 1112233344556777888899999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|||||||.||+|.++|.+.+.|+|..++.|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+... 
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-  345 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  345 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--hHHHh-hhcCCCCCCCCCCcCCHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIF-KIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~-~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      ...+.|||+.|||||++.+...|+.++|||||||||||||+|++||.....  ...+. .+..  ....+|..+++++++
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRS  423 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCccCCHHHHH
Confidence            345689999999999997555699999999999999999999999975432  22222 2222  223567889999999


Q ss_pred             HHHHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCC
Q 040472          454 FIKQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKD  494 (628)
Q Consensus       454 LI~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~  494 (628)
                      ||++||++||.+|++     ++||++||||++++|..........+
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP  469 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP  469 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCS
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcC
Confidence            999999999999998     79999999999999998876555433

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-58  Score=497.26  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=221.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec------
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS------  293 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~------  293 (628)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....   .....+++.+|+++|+.|+|||||++++++..      
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            589999999999999999999999999999999864322   23445678899999999999999999998654      


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      .+.+|||||||. |+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            467999999995 6899999998999999999999999999999999999999999999999999999999999998753


Q ss_pred             C-----ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC--------
Q 040472          374 S-----CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI--------  440 (628)
Q Consensus       374 ~-----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~--------  440 (628)
                      .     .....+++||++|||||++.+...|+.++||||||||||||++|++||.+.+....+..|......        
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            3     223456899999999999988777899999999999999999999999887666555444211100        


Q ss_pred             -------------C--------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          441 -------------P--------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       441 -------------~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                   +        .+...++.++.+||++||++||++|+|++|+|+||||++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                         0        0123578999999999999999999999999999999753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-58  Score=484.11  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=205.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      +++|++++.||+|+||+||+|+++.+++.||||+++...    .....+++.+|+++|++|+|||||+++++|.+.+   
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            457999999999999999999999999999999997532    2334567889999999999999999999987654   


Q ss_pred             ---------cceEEEEecccccHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEE
Q 040472          296 ---------RLSVYLEYVSGGSIHKLLQEYGPF---NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       296 ---------~~~lVmEy~~GgsL~~~L~~~~~l---~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL  363 (628)
                               .+|||||||.||+|.+++...+.+   .+..++.|+.||+.||+|||++|||||||||+||||+.+|++||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                     379999999999999999876654   44668899999999999999999999999999999999999999


Q ss_pred             eccCCcccccCcc-------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-hH
Q 040472          364 ADFGMAKHMTSCA-------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VA  429 (628)
Q Consensus       364 ~DFGla~~~~~~~-------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~  429 (628)
                      +|||+|+.+....             ...+.+||+.|||||++.+. .|+.++|||||||+||||++   ||..... ..
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            9999998764321             23456899999999999765 59999999999999999996   7865432 23


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      .+..+.. ...+..+...++++.+||++||+.||++|||+.|||+||||++.++
T Consensus       236 ~~~~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          236 TLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            3333332 2233334456678899999999999999999999999999988765

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-56  Score=478.19  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=208.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDE  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~  295 (628)
                      ++|+++++||+|+||+||+|+++   .+++.||||++....       ...++.+|+++|+.+ +|||||+++++|.+++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            57999999999999999999875   467899999885321       124577899999998 5999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~~~~~  374 (628)
                      ++|||||||+||+|.++++   .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +++||+|||+|+....
T Consensus        94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            9999999999999999984   59999999999999999999999999999999999999876 7999999999975432


Q ss_pred             c-----------------------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC
Q 040472          375 C-----------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY  425 (628)
Q Consensus       375 ~-----------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~  425 (628)
                      .                             ....+.+||++|||||++.+...|+.++||||||||+|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            1                             12335689999999999987777999999999999999999999999543


Q ss_pred             c-hhHHHhhhcC----------------------------------------------------CCCCCCCCCcCCHHHH
Q 040472          426 E-GVAAIFKIGN----------------------------------------------------SKDIPEIPEHLSDDAK  452 (628)
Q Consensus       426 ~-~~~~~~~i~~----------------------------------------------------~~~~~~~p~~~s~~l~  452 (628)
                      . ....+..+..                                                    .....+.+..++++++
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            2 2222221100                                                    0000122456899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      |||++||+.||++|+|++|+|+||||++..
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-56  Score=465.58  Aligned_cols=255  Identities=27%  Similarity=0.486  Sum_probs=219.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|.+++.||+|+||+||+|++.     .++..||||+++..     ..+..+++.+|+++|++|+|||||++++++.
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3468999999999999999999875     46889999998632     2345678999999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEYG-------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG  359 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~~-------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g  359 (628)
                      +++.+|||||||+||+|.++|++.+             .+++.+++.|+.||+.||+|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            9999999999999999999997643             699999999999999999999999999999999999999999


Q ss_pred             CEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhc
Q 040472          360 EIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIG  435 (628)
Q Consensus       360 ~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~  435 (628)
                      ++||+|||+|+.......   ....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||......+.+..+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999986544322   2235699999999999765 49999999999999999998 999999877766666665


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ... .+..|..+++++.+||.+||+.||++||++.||  |.|+++.
T Consensus       245 ~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          245 QGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             cCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            433 356778899999999999999999999999999  4577654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-55  Score=499.36  Aligned_cols=260  Identities=26%  Similarity=0.419  Sum_probs=231.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++....     ....+.+.+|+++|+.|+|||||+|+++|.+++.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            35689999999999999999999999999999999986422     2234678899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC--CCEEEeccCCccccc
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH--GEIKLADFGMAKHMT  373 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~--g~vKL~DFGla~~~~  373 (628)
                      +|||||||.||+|.++|.+ .+.|++.+++.|++||+.||+|||++||+||||||+||||+.+  +++||+|||+|+.+.
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999999964 5789999999999999999999999999999999999999854  899999999999887


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDA  451 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l  451 (628)
                      ........+||+.|||||++.+. .|+.++|||||||+|||||+|.+||.+....+.+..+.....  ....+..++.++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             CCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            77777778999999999999765 499999999999999999999999998877777776654432  123446799999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ++||++||++||++||++.|||+||||+...
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            9999999999999999999999999998543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-55  Score=464.54  Aligned_cols=251  Identities=27%  Similarity=0.461  Sum_probs=211.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|.+.++||+|+||+||+|+++     .+++.||||+++..     .....++|.+|+++|++|+|||||++++++.
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3468999999999999999999865     46889999998632     2345678999999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEY---------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP  357 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~---------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~  357 (628)
                      +++.+|||||||+||+|.++|++.               +++++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999753               35899999999999999999999999999999999999999


Q ss_pred             CCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhh
Q 040472          358 HGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFK  433 (628)
Q Consensus       358 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~  433 (628)
                      ++.+||+|||+|+......   .....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||......+.+..
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999998764332   22346799999999999765 49999999999999999998 9999998777766666


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.... .+..|..+++++.+||.+||+.||++|||+.||+++
T Consensus       273 i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            65443 346778899999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-55  Score=460.78  Aligned_cols=253  Identities=27%  Similarity=0.460  Sum_probs=210.5

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      +...++++++++||+|+||+||+|++..   .||||+++...   ...+..+.|.+|+++|++++|||||++++++. ++
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~  104 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD  104 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence            3456789999999999999999998653   59999987532   23455678999999999999999999999875 46


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+|||||||+||+|.++|... +.+++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            789999999999999999754 6799999999999999999999999999999999999999999999999999987543


Q ss_pred             c---cccccccCCCCcCChhhhhcc--CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc-CC---CCCCCCCC
Q 040472          375 C---ASMLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG-NS---KDIPEIPE  445 (628)
Q Consensus       375 ~---~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~-~~---~~~~~~p~  445 (628)
                      .   ......+||+.|||||++.+.  ..|+.++|||||||+||||+||+.||........+..+. ..   ...+.++.
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence            2   234457899999999999643  348999999999999999999999998766554444332 22   22345667


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.++.+||.+||+.||++|||+.||+++
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            899999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.9e-55  Score=458.93  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=219.2

Q ss_pred             cccccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeec
Q 040472          215 TENSLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG  289 (628)
Q Consensus       215 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~  289 (628)
                      .+..++++++.+.||+|+||+||+|+..     .+++.||||+++....    ....++|.+|+.+|++|+|||||++++
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g   96 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLG   96 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence            3445678999999999999999999863     4678999999864322    223467889999999999999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.+++.+|||||||++|+|.++|...                ..+++..+..|+.||+.||+|||+++||||||||+||
T Consensus        97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI  176 (308)
T 4gt4_A           97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV  176 (308)
T ss_dssp             EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence            999999999999999999999999643                3589999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++++||+|||+|+......   .....+||+.|||||++.+. .|+.++|||||||+||||+| |..||.+....+
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998764332   23456899999999999765 49999999999999999998 899999887766


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+..+.... .+..|..++.++.+||.+||+.||++||++.||+++
T Consensus       256 ~~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          256 VVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            666665443 345678899999999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=462.19  Aligned_cols=294  Identities=26%  Similarity=0.477  Sum_probs=247.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|+++++||+|+||+||+|+++.+++.||||++++..  .......+.+.+|+.+|+.+ +|||||++++++.+.+.
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH--hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            5689999999999999999999999999999999997421  11223356678899999988 69999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Cc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~  375 (628)
                      +||||||+.||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998643 23


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...+....+.++....  ..++..++.++.+||
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  255 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLHEDATGIL  255 (353)
T ss_dssp             -------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence            3455678999999999997654 9999999999999999999999998877766666665433  356677999999999


Q ss_pred             HHHhhcCCCCCCCH------HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCC
Q 040472          456 KQCLQRDPSARPPA------SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANP  529 (628)
Q Consensus       456 ~~~L~~dP~~Rpta------~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~  529 (628)
                      ++||++||++|+++      +||++||||++.+|........             .||+.+.+....++++|+.+|+.++
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~-------------~~p~~p~~~~~~~~~~f~~~~~~~~  322 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQI-------------EPPFRPRIKSREDVSNFDPDFIKEE  322 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCS-------------CCSCCCCCCSTTCCTTSCHHHHTSC
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcC-------------CCCccCCCCCcccccccCcccccCC
Confidence            99999999999998      8999999999999987654433             4556666677778888887776643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9e-54  Score=453.95  Aligned_cols=293  Identities=29%  Similarity=0.461  Sum_probs=250.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|+++.+++.||||++++...  .......++.+|+.+|+.++||||+++++++.+.+.+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            46799999999999999999999999999999999974211  1122346688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Ccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~~  376 (628)
                      |+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ...
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999998643 333


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||...+.......+....  ..++..++.++.+||+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~  237 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence            45568899999999998654 59999999999999999999999998766555554443322  3567789999999999


Q ss_pred             HHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          457 QCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       457 ~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      +||+.||++||     +++||++||||++.+|.......             ..||+.+.+....+..+|+.+|+..
T Consensus       238 ~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~-------------~~pp~~p~~~~~~d~~~f~~~~~~~  301 (337)
T 1o6l_A          238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK-------------LLPPFKPQVTSEVDTRYFDDEFTAQ  301 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC-------------SCCSCCCCCSSTTCCTTSCHHHHTS
T ss_pred             HHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCC-------------CCCCCCCCCCCcchhhcccchhccC
Confidence            99999999999     89999999999999888765433             2455556666667777887666654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-53  Score=463.39  Aligned_cols=296  Identities=27%  Similarity=0.475  Sum_probs=249.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|+++++||+|+||+||+|+++.+++.||||++++...  ...+..+.+.+|+.+|.++ +|||||+++++|.+.+.
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            46799999999999999999999999999999999975322  2233455678899999887 79999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc-cCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~-~~~  375 (628)
                      +||||||+.||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.. ...
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999999999899999999999999999999999999999999999999999999999999999863 334


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc--------hhHHHhhhcCCCCCCCCCCcC
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE--------GVAAIFKIGNSKDIPEIPEHL  447 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~--------~~~~~~~i~~~~~~~~~p~~~  447 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||+||||++|+.||....        ....+.+.... ....++..+
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~  285 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSL  285 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCCCCTTS
T ss_pred             CccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccCCCCcC
Confidence            455678999999999999765 49999999999999999999999996321        11222222111 123567789


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCH------HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPA------SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLC  521 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta------~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~  521 (628)
                      +.++++||++||++||++|+++      +||++||||++.+|......+             ..||+.+.+....++.+|
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~-------------~~pp~~p~~~~~~d~~~f  352 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ-------------VVPPFKPNISGEFGLDNF  352 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTC-------------SCCSCCCCCCSSTTGGGS
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCC-------------CCCCCcCCCCCccchhhc
Confidence            9999999999999999999984      899999999999998765433             346667777788889999


Q ss_pred             CccccCCCC
Q 040472          522 EGDYLANPL  530 (628)
Q Consensus       522 ~~~~~~~~~  530 (628)
                      +.+|+.++.
T Consensus       353 d~~~~~~~~  361 (396)
T 4dc2_A          353 DSQFTNEPV  361 (396)
T ss_dssp             CHHHHTSCC
T ss_pred             ChhhccCCC
Confidence            988877654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.1e-54  Score=460.05  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=216.6

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC-CCeeeeecc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYHGS  290 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV~l~~~  290 (628)
                      ...++|++++.||+|+||+||+|++..+     ++.||||+++..    ......+.+.+|+++|.++.| ||||+++++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~----~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc----cChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3457899999999999999999997654     467999988632    223345778999999999975 899999999


Q ss_pred             eec-cccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          291 ELS-DERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       291 ~~~-~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      |.+ ++.+|||||||++|+|.++|+..                ..+++..+..|+.||+.||+|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            866 46799999999999999999753                3489999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++.+||+|||+|+.+....   .....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.....
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998764432   23456799999999999765 49999999999999999998 999998866555


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+.++......+..|..+++++.+||.+||+.||++|||+.||++|
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5544443344456778899999999999999999999999999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4e-53  Score=455.29  Aligned_cols=294  Identities=29%  Similarity=0.437  Sum_probs=232.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHH-HHhCCCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL-LSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||++++....  ......++.+|..+ ++.++|||||++++++.+.+.
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            467999999999999999999999999999999999753221  22334566777777 577899999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Cc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~  375 (628)
                      +||||||+.||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998643 33


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||++|||++|..||...+.......+....  ..++..++.++++||
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Confidence            345668899999999999765 49999999999999999999999998877666665554432  346678999999999


Q ss_pred             HHHhhcCCCCCCCH----HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCC
Q 040472          456 KQCLQRDPSARPPA----SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANP  529 (628)
Q Consensus       456 ~~~L~~dP~~Rpta----~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~  529 (628)
                      ++||+.||++|+++    .+|++|+||++.+|.......             ..||+.+.+....++.+|+.+|+.++
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~-------------~~pp~~p~~~~~~d~~~f~~~~~~~~  335 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKK-------------ITPPFNPNVSGPNDLRHFDPEFTEEP  335 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTC-------------SCCSCCCSCCC---------------
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCC-------------CCCCCCCCCCCcchhhhcCccccccc
Confidence            99999999999986    699999999999998765433             34556666666777888887776653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.9e-52  Score=444.83  Aligned_cols=294  Identities=28%  Similarity=0.483  Sum_probs=246.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|++++.||+|+||+||+|+++.+++.||||++++...  ...+..+.+.+|+.+|+++ +|||||++++++.+++.
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            46799999999999999999999999999999999975322  2345567788999999988 79999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Cc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~  375 (628)
                      +|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999998643 33


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC--------chhHHHh-hhcCCCCCCCCCCc
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY--------EGVAAIF-KIGNSKDIPEIPEH  446 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~--------~~~~~~~-~i~~~~~~~~~p~~  446 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...        .....+. .+...  ...++..
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~  241 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRS  241 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTT
T ss_pred             CcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCC
Confidence            345567899999999999765 4999999999999999999999999642        1111222 22221  2356778


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCH------HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPA------SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITL  520 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta------~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~  520 (628)
                      ++.++++||++||+.||++||++      +||++||||++.+|......+.             .||+.+.+....++.+
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~-------------~~p~~p~~~~~~~~~~  308 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV-------------VPPFKPNISGEFGLDN  308 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCS-------------CCSCCCCCCTTTCGGG
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCC-------------CCCcCCCCCCcchhhh
Confidence            99999999999999999999985      8999999999998877654332             3445555556667777


Q ss_pred             cCccccCCC
Q 040472          521 CEGDYLANP  529 (628)
Q Consensus       521 ~~~~~~~~~  529 (628)
                      |+..++.++
T Consensus       309 ~~~~~~~~~  317 (345)
T 3a8x_A          309 FDSQFTNEP  317 (345)
T ss_dssp             SCHHHHTSC
T ss_pred             cCcccccCc
Confidence            776665543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.8e-53  Score=450.75  Aligned_cols=293  Identities=27%  Similarity=0.468  Sum_probs=234.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|+++++||+|+||+||+|+++.+++.||||+++....  ......+.+..|+.+|..+ +||||+++++++.+.+.
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            56899999999999999999999999999999999974211  0112245677899999876 89999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-c
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-C  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~  375 (628)
                      +|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.... .
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999999999999989999999999999999999999999999999999999999999999999999986432 3


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...+....+..+....  +.++..++.++.+||
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLL  249 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCCCcccCHHHHHHH
Confidence            345568899999999999765 49999999999999999999999998876665555554332  356778999999999


Q ss_pred             HHHhhcCCCCCCCHH-HHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          456 KQCLQRDPSARPPAS-KLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~-eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      ++||+.||++||++. +|++||||++.+|........             .||+.+.+....+.++|+.+|+..
T Consensus       250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~-------------~~p~~p~~~~~~d~~~f~~~~~~~  310 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI-------------DPPFRPKVKSPFDCSNFDKEFLNE  310 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS-------------CC----------------------
T ss_pred             HHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCC-------------CCCcCCCCCCcchhhhcchhhccc
Confidence            999999999999998 999999999999887654332             345555566666777887666554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-52  Score=440.02  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=232.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++....   ......+++.+|+++|+.++||||+++++++.+.+.+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            4679999999999999999999999999999999987532   2344567788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999988776666


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+.......+....  ..++..++.++.+||++
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence            6778999999999999876645689999999999999999999998876655555554332  35667799999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||+.||.+|||++|||+||||+.
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             HCCCChhHCcCHHHHhcCHhhcC
Confidence            99999999999999999999964

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.5e-53  Score=449.80  Aligned_cols=292  Identities=25%  Similarity=0.430  Sum_probs=245.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|+++++||+|+||+||+|+++.+++.||||+++....  ......+.+.+|+.+|..+ +||||+++++++.+.+.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            56899999999999999999999999999999999975211  1112345678899999988 79999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Cc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~  375 (628)
                      +||||||+.||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998643 23


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC  252 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence            345567899999999999765 49999999999999999999999998876666555554432  356778999999999


Q ss_pred             HHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          456 KQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       456 ~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      ++||+.||++||+     +++|++||||++.+|........             .||+.+.+... ++.+|+..++..
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~-------------~~p~~p~~~~~-~~~~f~~~~~~~  316 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI-------------QPPYKPKACGR-NAENFDRFFTRH  316 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCS-------------CCSCCCCCCCC---CHHHHHHHHS
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCC-------------CCCcCCCCCCc-chhhccchhccC
Confidence            9999999999994     79999999999999987754433             34555555555 777777655543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-52  Score=444.76  Aligned_cols=290  Identities=29%  Similarity=0.477  Sum_probs=248.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|+++.+++.||||+++....  ......+++.+|+++|+.++||||+++++++.+.+.+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            46899999999999999999999999999999999864211  1112346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      ||||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....  
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999999999999899999999999999999999999999999999999999999999999999999876442  


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+....  ..++..++.++.+||++
T Consensus       195 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  271 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHH
T ss_pred             cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            3457899999999999765 49999999999999999999999998876666555554432  35677899999999999


Q ss_pred             HhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          458 CLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       458 ~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      ||+.||++||+     ++||++||||++.+|........             .+|+.+.+....+.++|+ +|..+
T Consensus       272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~-------------~~p~~p~~~~~~~~~~f~-~~~~~  333 (350)
T 1rdq_E          272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV-------------EAPFIPKFKGPGDTSNFD-DYEEE  333 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCS-------------CCSCCCCCCSTTCCTTSC-CCCCC
T ss_pred             HhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccC-------------CCCCCCCCCCcccccccc-ccccc
Confidence            99999999998     99999999999998877654333             344555555666677776 45443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-52  Score=436.90  Aligned_cols=266  Identities=29%  Similarity=0.530  Sum_probs=234.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|+++.+++.||||+++....  ......+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            46899999999999999999999999999999999974211  1112345678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++....  .
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--V  159 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--C
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--c
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999987543  2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+. .++.++|||||||++|||++|..||...+......++....  ..++..++.++.+||++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence            3457899999999998765 49999999999999999999999998877666665554432  35667899999999999


Q ss_pred             HhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCC
Q 040472          458 CLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVN  490 (628)
Q Consensus       458 ~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~  490 (628)
                      ||+.||++|+     ++++|++||||++..|.......
T Consensus       237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~  274 (318)
T 1fot_A          237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN  274 (318)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTC
T ss_pred             HhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCC
Confidence            9999999999     89999999999999988776544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-52  Score=455.41  Aligned_cols=293  Identities=28%  Similarity=0.463  Sum_probs=237.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|+++++||+|+||.||+|+++.+++.||||+++...  ........++.+|+.+|+.++||||+++++++.+.+.+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV--IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhh--hhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            4578999999999999999999999999999999987421  11233456678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccC-c
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-C  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~  375 (628)
                      ||||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+ +|||||||||+||||+.++++||+|||+++.... .
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999999998999999999999999999999998 9999999999999999999999999999986433 3


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||+||||++|+.||...+.......+....  ..++..++.++.+||
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence            345567899999999998765 59999999999999999999999998776655555544322  346678999999999


Q ss_pred             HHHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCC
Q 040472          456 KQCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLAN  528 (628)
Q Consensus       456 ~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~  528 (628)
                      .+||+.||++||     +++|||+||||++..|.......             ..||+.+.+....+..+|+.+|+.+
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~-------------~~pp~~p~~~~~~~~~~~~~~~~~~  445 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK-------------LSPPFKPQVTSETDTRYFDEEFTAQ  445 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC-------------SCCSCCCSCSSTTCCTTC-------
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCc-------------CCCCccCCCCCccchhhcchhhhcC
Confidence            999999999999     99999999999998887765433             3456667777788888888888764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.7e-52  Score=453.40  Aligned_cols=292  Identities=24%  Similarity=0.358  Sum_probs=242.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||++++....  .....+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            457999999999999999999999999999999998642100  011123477899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      ||||||+.||+|.+++++ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++...... 
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999999999999976 579999999999999999999999999999999999999999999999999998765433 


Q ss_pred             -ccccccCCCCcCChhhhhccCC---CCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCC--CCcCCHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNG---YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDD  450 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~---~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~--p~~~s~~  450 (628)
                       ...+.+||+.|+|||++.+...   |+.++|||||||+||||++|+.||...+....+.++........+  ...++.+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence             2346789999999999975432   789999999999999999999999887766666665443211122  2468999


Q ss_pred             HHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccc
Q 040472          451 AKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDY  525 (628)
Q Consensus       451 l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~  525 (628)
                      +++||++||+.+|.+  |++++||++||||++..|......             ...||+.+.+....++++|+...
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~-------------~~~~p~~p~~~~~~d~~~fd~~~  367 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLR-------------DTVAPVVPDLSSDIDTSNFDDLE  367 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGG-------------GSCCSCCCCCSSTTCCTTSCCCC
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhc-------------ccCCCCCCcCCCccchhhcCCcc
Confidence            999999999999988  999999999999998877544322             23456667777777788887533

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.1e-52  Score=455.90  Aligned_cols=291  Identities=23%  Similarity=0.345  Sum_probs=243.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||++++...  ........+.+|+.+|..++|+|||+++++|.+++.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh--hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            45799999999999999999999999999999999864211  0011123478899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ||||||+.||+|.++|.+ .+.+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999987 5789999999999999999999999999999999999999999999999999998664433


Q ss_pred             c--cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---CCCCCCCCcC
Q 040472          377 S--MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---KDIPEIPEHL  447 (628)
Q Consensus       377 ~--~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---~~~~~~p~~~  447 (628)
                      .  ....+||+.|||||++..    ...|+.++|||||||+||||++|+.||...+..+.+.++...   ...+.....+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence            2  334789999999999862    345899999999999999999999999887766666555432   2334444569


Q ss_pred             CHHHHHHHHHHhhcCCCC--CCCHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccc
Q 040472          448 SDDAKSFIKQCLQRDPSA--RPPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDY  525 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~--Rpta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~  525 (628)
                      +.++++||++||..+|++  |++++||++||||++.+|.....               ..+|+.+.+....+.++|+.++
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~---------------~~~p~~P~~~~~~d~~~fd~~~  374 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRN---------------CEAPYIPEVSSPTDTSNFDVDD  374 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGG---------------SCCSCCCCCSSTTCCTTSCCC-
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhh---------------CCCCCCCcCCCccchhhcCCcc
Confidence            999999999999988888  99999999999999988876521               2355566666667777776544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.5e-51  Score=429.67  Aligned_cols=292  Identities=28%  Similarity=0.467  Sum_probs=225.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|+++++||+|+||.||+|++.   .+++.||||+++..... ........+.+|+.+|+.++||||+++++++.++
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            4578999999999999999999985   68999999998753211 1123345678899999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +.+|+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999976433


Q ss_pred             -ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          375 -CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       375 -~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                       .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+.++....  ..++..++.++.+
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~  250 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEARD  250 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTSCHHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHH
Confidence             2234457899999999998765 48999999999999999999999998876665555554322  3566789999999


Q ss_pred             HHHHHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCcccc
Q 040472          454 FIKQCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYL  526 (628)
Q Consensus       454 LI~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~  526 (628)
                      ||++||+.||++||     ++.||++||||++..|........             .+|+.+.+....++..++..++
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~-------------~~p~~p~~~~~~~~~~~~~~~~  315 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV-------------EPPFKPLLQSEEDVSQFDSKFT  315 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCS-------------CCSCCCC---------------
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccC-------------CCCCCCCcCChhhhhhcchhhh
Confidence            99999999999999     899999999999988877654332             2344444445555556654443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.7e-51  Score=472.92  Aligned_cols=293  Identities=25%  Similarity=0.439  Sum_probs=252.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .+++|+++++||+|+||+||+|+++.+++.||||++++...  ......+.+..|+.+|..+ +|+||+++++++++.+.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            57899999999999999999999999999999999974211  1112345677899999988 69999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc-Cc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-SC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~-~~  375 (628)
                      +||||||+.||+|.++|++.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++... ..
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998643 33


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|||||++.+. .|+.++||||||||||||++|++||...+..+.+..+....  ..++..++.++.+||
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC  573 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence            445668899999999999655 59999999999999999999999999877777766665533  357778999999999


Q ss_pred             HHHhhcCCCCCCCH-----HHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccCCC
Q 040472          456 KQCLQRDPSARPPA-----SKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLANP  529 (628)
Q Consensus       456 ~~~L~~dP~~Rpta-----~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~~~  529 (628)
                      ++||++||++|+++     +||++||||++++|.......+             .||+.+.+.. .++.+|+..|+..+
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~-------------~pp~~p~~~~-~~~~~f~~~~~~~~  638 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI-------------QPPYKPKASG-RNAENFDRFFTRHP  638 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCS-------------CCSCCCBCCG-GGHHHHTTTTTSSC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCC-------------CCCCCCcCCC-CchhhcCchhccCC
Confidence            99999999999997     9999999999999988765433             4555555555 67788887777654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=441.39  Aligned_cols=271  Identities=24%  Similarity=0.465  Sum_probs=235.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++.....  ......+.+.+|+++|+.++|||||+++++|.+.+.+
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            56899999999999999999999999999999999864211  1122346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.+.....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999998766666


Q ss_pred             cccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ....+||+.|+|||++.+  ...|+.++|||||||+||||++|+.||.....   ...+..+..  ....++..++.++.
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~~~  248 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQEMV  248 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHHHH
Confidence            677899999999999864  23489999999999999999999999974322   222222221  22356678999999


Q ss_pred             HHHHHHhhcCCCCCCC-HHHHhcCccccchHHHhhcCCCcC
Q 040472          453 SFIKQCLQRDPSARPP-ASKLLDHPFVRDQAVARAGNVNLA  492 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpt-a~eiL~Hpwf~~~~~~~~~~~~~~  492 (628)
                      +||++||+.||++||+ +++|++||||++.+|.......+.
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~  289 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLI  289 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCC
Confidence            9999999999999998 999999999999999887665543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-51  Score=449.30  Aligned_cols=288  Identities=25%  Similarity=0.385  Sum_probs=235.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||++++..  .......+.+.+|+.+|..++|+||++++++|++++.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~--~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            4579999999999999999999999999999999996421  11112234578899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ||||||+.||+|.++|.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998764 79999999999999999999999999999999999999999999999999998765433


Q ss_pred             c--cccccCCCCcCChhhhhc------cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---CCCCCCCC
Q 040472          377 S--MLSFKGSPYWMAPEVVMN------TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---KDIPEIPE  445 (628)
Q Consensus       377 ~--~~~~~GT~~Y~APEvl~~------~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---~~~~~~p~  445 (628)
                      .  ....+||+.|+|||++..      ...|+.++|||||||++|||++|+.||...+......++...   ...+.++.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            2  335689999999999873      235899999999999999999999999887766655555432   23344456


Q ss_pred             cCCHHHHHHHHHHhhcCCCCC---CCHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 040472          446 HLSDDAKSFIKQCLQRDPSAR---PPASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCE  522 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~R---pta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~  522 (628)
                      .++.++++||++||+ +|++|   ++++||++||||++.+|....               ...||+.+.+....++.+|+
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~---------------~~~~p~~p~~~~~~d~~~f~  360 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR---------------DSVPPFTPDFEGATDTCNFD  360 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST---------------TSCCSCCCC-----CCSSCC
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh---------------hcCCCCCCcCCCcccccccC
Confidence            799999999999999 99998   589999999999988876542               12456666666666777776


Q ss_pred             c
Q 040472          523 G  523 (628)
Q Consensus       523 ~  523 (628)
                      .
T Consensus       361 ~  361 (412)
T 2vd5_A          361 L  361 (412)
T ss_dssp             -
T ss_pred             c
Confidence            4

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.9e-51  Score=437.01  Aligned_cols=265  Identities=26%  Similarity=0.432  Sum_probs=230.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch-HHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++++.||+|+||+||+|+++.+++.||||+++........ ....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46899999999999999999999999999999999764322111 11245688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC----CEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG----EIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g----~vKL~DFGla~~~~  373 (628)
                      |+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++    .+||+|||+++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999999888999999999999999999999999999999999999998877    79999999998876


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDA  451 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l  451 (628)
                      ........+||+.|+|||++.+. .|+.++|||||||++|+|++|..||........+..+.....  ....+..++.++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  249 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA  249 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence            66556678899999999998654 499999999999999999999999988776666655544322  112335689999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      ++||++||..||++||++.|+|+||||+...+.
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  282 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ  282 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence            999999999999999999999999999865543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.6e-50  Score=415.01  Aligned_cols=260  Identities=28%  Similarity=0.512  Sum_probs=216.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|+++.+++.||||+++.....   ....+.+.+|+.+|++++||||+++++++.+++.++
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            46899999999999999999999999999999999754322   233466789999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      +||||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus        78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            99999987544444455688999999999999999999999999999999999999999999999999999876432 23


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCC-CCCchhHHHhhhcC---C----------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVAAIFKIGN---S----------------  437 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF-~~~~~~~~~~~i~~---~----------------  437 (628)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|..|| ...+....+..+..   .                
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            345679999999999977666899999999999999999988775 43333332222211   0                


Q ss_pred             --------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 --------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 --------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                              .........++.++++||++||+.||++|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                    01112234588999999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-50  Score=416.10  Aligned_cols=256  Identities=34%  Similarity=0.606  Sum_probs=223.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ...+|++.+.||+|+||+||+|++..+++.||||++.......     .+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            4578999999999999999999999999999999987533221     35578899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.|++|.+++.+. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999999999864 69999999999999999999999999999999999999999999999999998765433 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCCCCCCcCCHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI  455 (628)
                      .....+||+.|+|||++.+. .++.++|||||||++|||++|..||........+..+... ......+..++..+.+||
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            34457899999999998765 4999999999999999999999999877665554443222 112244667999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .+||+.||++||++.|+|+||||+.
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHccCChhHCcCHHHHhhChhhcc
Confidence            9999999999999999999999974

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.1e-51  Score=425.57  Aligned_cols=247  Identities=25%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE----  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~----  295 (628)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++..    ...  ......|+.++.+++|||||++++++.+++    
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~----~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG----GHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            4689999999999999999987  5899999998632    111  122345777778899999999999998754    


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccCCCceEeCCCCCEEEeccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR--------NTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      .+|||||||+||+|.++|++ ..+++..+..++.|++.||+|||++        +||||||||+||||+.++++||+|||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            58999999999999999976 5689999999999999999999987        99999999999999999999999999


Q ss_pred             CcccccCccc-----cccccCCCCcCChhhhhccC-----CCCccccccccccceeeeccCCCCCCCCc-----------
Q 040472          368 MAKHMTSCAS-----MLSFKGSPYWMAPEVVMNTN-----GYSLTVDIWSLGCTVLEMATSKPPWSQYE-----------  426 (628)
Q Consensus       368 la~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvlLyelLtG~~PF~~~~-----------  426 (628)
                      +|+.......     ....+||+.|||||++.+..     .|+.++|||||||+||||+||.+||....           
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            9987644322     23468999999999986532     36789999999999999999987763211           


Q ss_pred             ---hhHHHhh-hcCCCCCCCCCCc-----CCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          427 ---GVAAIFK-IGNSKDIPEIPEH-----LSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       427 ---~~~~~~~-i~~~~~~~~~p~~-----~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                         ....+.+ +......+.+|..     ....+.+||.+||+.||++|||+.||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               1122222 2222333444433     33578899999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.4e-51  Score=431.54  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=225.9

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||+|+||+||+|++..+++.||||++.....  ...+....+.+|+.+|+.++||||+++++++.+.+.
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            356899999999999999999999999999999999864211  111123568899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 78999999988999999999999999999999999999999999999999999999999999998877666


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||..........++..  ....++..++.++.+||+
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS--SCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCcccCCHHHHHHHH
Confidence            667788999999999997665447899999999999999999999986544333333222  223567789999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.||.+|||++||++||||+.
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHcCCChhHCcCHHHHHhChhhcc
Confidence            999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.3e-50  Score=428.40  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=226.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||.||+|+++.+++.||||++.....   .....+.+.+|+.+|+.++|||||++++++.+++..|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3589999999999999999999999999999999875322   2344577899999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---CEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~vKL~DFGla~~~~~~  375 (628)
                      +||||+.||+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++   .+||+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999999999888999999999999999999999999999999999999998654   5999999999877665


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~d  453 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...+....+..+.....  ....+..++.++.+
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             cccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            555667899999999998754 499999999999999999999999987666555544433221  11233568999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||.+||+.||++||++.|+|+||||+..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.8e-50  Score=423.30  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=220.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|++..+++.||||++.....    ....+.+.+|+.+++.++|+|||++++++.+++..
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            35799999999999999999999999999999999864321    22335678999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc--
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC--  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~--  375 (628)
                      |+||||+.|++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            999999999999999998888999999999999999999999999999999999999999999999999999865322  


Q ss_pred             -cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          376 -ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       376 -~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                       ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||...... ...............+..++.++.+
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence             22345789999999999977654588999999999999999999999765443 2222222223223334678999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||++||+.||++||++.||++||||+.
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhcc
Confidence            999999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-50  Score=421.66  Aligned_cols=264  Identities=25%  Similarity=0.425  Sum_probs=227.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch-HHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++++.||+|+||.||+|+++.+++.||||+++........ ....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35799999999999999999999999999999999754322111 11245688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC----CEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG----EIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g----~vKL~DFGla~~~~  373 (628)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++    .+||+|||+++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999999888999999999999999999999999999999999999999887    89999999998776


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDA  451 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l  451 (628)
                      ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+.....  ....+..++.++
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  248 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence            55555667899999999998654 489999999999999999999999987665555444432211  112234688999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      .+||++||+.||++||++.|+|+||||+...+
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            99999999999999999999999999986554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-49  Score=437.26  Aligned_cols=263  Identities=27%  Similarity=0.470  Sum_probs=203.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-----  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-----  293 (628)
                      .++|+++++||+|+||+||+|+++.+++.||||++....   ......+++.+|+++|+.++|+|||++++++..     
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            368999999999999999999999999999999986432   234456788999999999999999999999854     


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ...+|+||||+ +++|.+++.....+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++...
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            35799999998 67999999988899999999999999999999999999999999999999999999999999998654


Q ss_pred             Cc----------------------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeecc--------
Q 040472          374 SC----------------------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT--------  417 (628)
Q Consensus       374 ~~----------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt--------  417 (628)
                      ..                            ......+||++|+|||++.....|+.++||||||||||||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            21                            123456899999999988666679999999999999999999        


Q ss_pred             ---CCCCCCCCch--------------------hH---HHhhhcC--------------------------CCCCCCCCC
Q 040472          418 ---SKPPWSQYEG--------------------VA---AIFKIGN--------------------------SKDIPEIPE  445 (628)
Q Consensus       418 ---G~~PF~~~~~--------------------~~---~~~~i~~--------------------------~~~~~~~p~  445 (628)
                         |+++|.+...                    ..   .+..+..                          ...+.....
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               6677754321                    11   1111100                          001112234


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      .++.++.+||++||+.||++|||++|||+||||++..+..
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            5789999999999999999999999999999998765543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.6e-50  Score=411.12  Aligned_cols=258  Identities=29%  Similarity=0.529  Sum_probs=213.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|++ .+++.||||+++.....   ....+.+.+|+++|++++||||+++++++.+.+.+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV   76 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEE
Confidence            46899999999999999999998 67899999998653322   112356778999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      +||||+.+ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            99999975 999988764 67999999999999999999999999999999999999999999999999999865432 2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---CC---C-----------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---SK---D-----------  439 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~~---~-----------  439 (628)
                      .....+||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+..   ..   .           
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            334467999999999997666689999999999999999999999987665444333211   00   0           


Q ss_pred             ----------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          440 ----------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       440 ----------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                +..+...++.++.+||++||+.||++||++.|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                      001224588999999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-49  Score=416.20  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=213.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+|++. +++.||||+++....   .....+.+.+|+++|++++||||+++++++.+++.+
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            4679999999999999999999986 589999999864322   223346778999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      ++||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... 
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999999975 777777654 56999999999999999999999999999999999999999999999999999876432 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc---CCCCC------------
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG---NSKDI------------  440 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~---~~~~~------------  440 (628)
                      ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+.   .....            
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            233456799999999999776668999999999999999999999997655443333221   11100            


Q ss_pred             -------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          441 -------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       441 -------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                   ..+...+++++.+||++||+.||++|||+.|||+||||++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                         01123478899999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-50  Score=421.36  Aligned_cols=256  Identities=29%  Similarity=0.397  Sum_probs=224.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||+||+|++..+++.||+|+++..      ......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            57899999999999999999999999999999998632      122356789999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC--CCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP--HGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~--~g~vKL~DFGla~~~~~~  375 (628)
                      +||||+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++.....
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999999999865 47999999999999999999999999999999999999987  789999999999887665


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~d  453 (628)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+.......  ..+..++.++.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            555667899999999998754 48999999999999999999999998876665555554332211  123468999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||++||+.||++|||+.|+|+||||++.
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            9999999999999999999999999753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-49  Score=424.86  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=207.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||+||+|+++.+++.||||++......      .+.+.+|+.+++.++|||||++++++.+.+.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            357899999999999999999999999999999998643221      24577899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC--EEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~--vKL~DFGla~~~~~~  375 (628)
                      |+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++.....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999999998899999999999999999999999999999999999999987765  999999999865444


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch----hHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----VAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.....    ...+..+............++.++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  251 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC  251 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence            4455678999999999997765344559999999999999999999976433    222233332222222233689999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .+||++||+.||++|||+.||++||||..
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          252 CHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            99999999999999999999999999954

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-50  Score=414.26  Aligned_cols=261  Identities=30%  Similarity=0.504  Sum_probs=213.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~~~~  295 (628)
                      .++|+++++||+|+||+||+|++..+++.||||+++..............+.+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            4699999999999999999999999999999999975432211111123455677776665   4999999999988755


Q ss_pred             -----cceEEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          296 -----RLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       296 -----~~~lVmEy~~GgsL~~~L~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                           .+++||||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence                 5899999996 599999987654  99999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---C---CCC-
Q 040472          369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---K---DIP-  441 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---~---~~~-  441 (628)
                      ++...........+||+.|+|||++.+.. ++.++|||||||++|||++|++||........+.++...   .   .++ 
T Consensus       167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (308)
T 3g33_A          167 ARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  245 (308)
T ss_dssp             TTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred             ccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            98776655566778999999999997654 999999999999999999999999876665544443211   0   000 


Q ss_pred             ------------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          442 ------------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       442 ------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                        .+...++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                              0123578999999999999999999999999999999754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=435.25  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=224.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....   ......+.+.+|+++|+.++|||||++++++.+++.+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            468999999999999999999999999999999987532   22344567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC---CCCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld---~~g~vKL~DFGla~~~~~~  375 (628)
                      +||||+.||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+   .++.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999999999999999989999999999999999999999999999999999999998   4678999999999876543


Q ss_pred             c-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHH
Q 040472          376 A-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~  452 (628)
                      . .....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...+....+..+.....  ....+..+++++.
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            3 34567899999999998654 599999999999999999999999988766555555443321  1233457899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||++||+.||++||++.|+|+||||++.
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999999754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.2e-50  Score=422.85  Aligned_cols=262  Identities=26%  Similarity=0.504  Sum_probs=213.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|+++++||+|+||+||+|++..+++.||||+++...   ......+.+.+|+++|++++||||+++++++.+++.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            5679999999999999999999999999999999986432   2233455677899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC-----CCCCEEEeccCCcccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD-----PHGEIKLADFGMAKHM  372 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld-----~~g~vKL~DFGla~~~  372 (628)
                      ||||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+     .++.+||+|||+++..
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999997 59999999988999999999999999999999999999999999999994     4556999999999865


Q ss_pred             cCc-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-----------
Q 040472          373 TSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-----------  440 (628)
Q Consensus       373 ~~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-----------  440 (628)
                      ... ......+||+.|+|||++.+...++.++|||||||++|||++|..||........+..+......           
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            432 23345678999999999977666899999999999999999999999877665554443211000           


Q ss_pred             --------CC---------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          441 --------PE---------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       441 --------~~---------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                              +.         ++..++.++.+||++||+.||++|||+.|||+||||++..|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                    00         01127899999999999999999999999999999987644

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.9e-50  Score=412.53  Aligned_cols=261  Identities=26%  Similarity=0.464  Sum_probs=214.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---------------------chHHHHHHHHHHHHHH
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---------------------TSKECLKQLNQEINLL  276 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---------------------~~~~~~~~~~~Ei~iL  276 (628)
                      .+++|++.+.||+|+||.||+|++..+++.||||++.......                     ......+.+.+|+++|
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            4679999999999999999999999999999999986532111                     0112245688999999


Q ss_pred             HhCCCCCeeeeecceec--cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceE
Q 040472          277 SQLSHPNIVRYHGSELS--DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANIL  354 (628)
Q Consensus       277 ~~l~HpnIV~l~~~~~~--~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNIL  354 (628)
                      ++++||||+++++++.+  .+.+|+||||+.+++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            99999999999999987  568999999999999988664 367999999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeccCCcccccCcc-ccccccCCCCcCChhhhhccCC--CCccccccccccceeeeccCCCCCCCCchhHHH
Q 040472          355 VDPHGEIKLADFGMAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNG--YSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI  431 (628)
Q Consensus       355 ld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~--~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~  431 (628)
                      |+.++.+||+|||+++...... .....+||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  249 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH  249 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence            9999999999999998765432 3345679999999999865432  478899999999999999999999876554444


Q ss_pred             hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       432 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ..+............++.++.+||++||+.||++||++.|||+||||+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            444332221222346899999999999999999999999999999995

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.3e-50  Score=425.32  Aligned_cols=262  Identities=28%  Similarity=0.437  Sum_probs=218.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||+||+|+++.+++.||||++.............+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            57999999999999999999999999999999986422111111124568899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC---EEEeccCCcccc
Q 040472          300 YLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHM  372 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~---vKL~DFGla~~~  372 (628)
                      |||||.|++|.+++.+.    ..+++..++.++.||+.||+|||++||+||||||+||||+.++.   +||+|||+++..
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999999888643    35899999999999999999999999999999999999987654   999999999876


Q ss_pred             cCccc-cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCH
Q 040472          373 TSCAS-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSD  449 (628)
Q Consensus       373 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~  449 (628)
                      ..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+..+.....  .+..+..++.
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCCH
Confidence            54332 3456899999999998765 489999999999999999999999987432 22222222111  1122346899


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ++++||++||+.||++||++.|+|+||||++...
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERDR  295 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence            9999999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-49  Score=425.00  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=219.9

Q ss_pred             ccCCeEEeeeeccC--CcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          218 SLSKWKKGKLLGRG--TFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ..++|+++++||+|  +||+||+|+++.+++.||||+++...   ...+..+.+.+|+.+|+.++|||||++++++.+++
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            45799999999999  99999999999999999999997532   23456678899999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      .+|+||||+.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999999875  679999999999999999999999999999999999999999999999999986542


Q ss_pred             Cc--------cccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-----
Q 040472          374 SC--------ASMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-----  439 (628)
Q Consensus       374 ~~--------~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-----  439 (628)
                      ..        ......+||+.|+|||++.+. ..++.++|||||||++|||++|+.||........+..+.....     
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            21        112234799999999999763 4589999999999999999999999987655444433321110     


Q ss_pred             ---------------------------------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          440 ---------------------------------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       440 ---------------------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                                             ...++..++.++.+||++||+.||++|||+.|||+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                   01134567899999999999999999999999999999986


Q ss_pred             hHH
Q 040472          481 QAV  483 (628)
Q Consensus       481 ~~~  483 (628)
                      ..+
T Consensus       340 ~~~  342 (389)
T 3gni_B          340 IKR  342 (389)
T ss_dssp             C--
T ss_pred             Hhh
Confidence            543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-49  Score=449.81  Aligned_cols=271  Identities=28%  Similarity=0.448  Sum_probs=232.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||.||+|+++.+++.||||++.+...  ........+.+|+++|+.++|||||++++++.+.+.+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            45789999999999999999999999999999999964211  1112245678899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ||||||+.||+|.+++...+  .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.+...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999998754  4999999999999999999999999999999999999999999999999999887665


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ......+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.....   ...+...... ....++..++.+++
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~~  417 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQAR  417 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHHH
T ss_pred             ccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHHH
Confidence            555667899999999999765 499999999999999999999999976432   2222222111 12355678999999


Q ss_pred             HHHHHHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCcC
Q 040472          453 SFIKQCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNLA  492 (628)
Q Consensus       453 dLI~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~~  492 (628)
                      +||++||+.||++||     +++||++||||++.+|.........
T Consensus       418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~  462 (576)
T 2acx_A          418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLE  462 (576)
T ss_dssp             HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCC
Confidence            999999999999999     7999999999999999877655443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-49  Score=426.25  Aligned_cols=259  Identities=26%  Similarity=0.488  Sum_probs=209.5

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE  295 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~  295 (628)
                      ..+++|++++.||+|+||+||+|++..+++.||||++....   ......+++.+|+.+|+.+. |+|||++++++..++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            35689999999999999999999999999999999885422   22344567889999999998 999999999997544


Q ss_pred             --cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          296 --RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       296 --~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                        .+|+||||+. ++|..++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence              7899999997 589999876 679999999999999999999999999999999999999999999999999998653


Q ss_pred             C----------------------ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHH
Q 040472          374 S----------------------CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI  431 (628)
Q Consensus       374 ~----------------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~  431 (628)
                      .                      .......+||++|+|||++.+...|+.++|||||||+||||++|++||.+.+....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2                      112344689999999999987667999999999999999999999999887665554


Q ss_pred             hhhcCCCCCCC---------------------------------------------CCCcCCHHHHHHHHHHhhcCCCCC
Q 040472          432 FKIGNSKDIPE---------------------------------------------IPEHLSDDAKSFIKQCLQRDPSAR  466 (628)
Q Consensus       432 ~~i~~~~~~~~---------------------------------------------~p~~~s~~l~dLI~~~L~~dP~~R  466 (628)
                      ..+......+.                                             .+..++.++.+||++||+.||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            44321111100                                             112578999999999999999999


Q ss_pred             CCHHHHhcCccccc
Q 040472          467 PPASKLLDHPFVRD  480 (628)
Q Consensus       467 pta~eiL~Hpwf~~  480 (628)
                      ||++|+|+||||+.
T Consensus       321 ~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          321 ISANDALKHPFVSI  334 (388)
T ss_dssp             CCHHHHTTSTTTTT
T ss_pred             CCHHHHhCCHHHHH
Confidence            99999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.2e-49  Score=400.39  Aligned_cols=260  Identities=27%  Similarity=0.428  Sum_probs=227.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.....   .....+.+.+|+.++++++|+||+++++++.++...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence            4689999999999999999999999999999999875322   3444677889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC---EEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~---vKL~DFGla~~~~~~  375 (628)
                      +||||+.|++|.+++.....+++..+..++.||+.||+|||++||+||||||+||||+.++.   +||+|||++......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999999998899999999999999999999999999999999999999987665   999999999877666


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--CCCCCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--DIPEIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~d  453 (628)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....  ........++.++.+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            666667899999999998765 48999999999999999999999998766555444433222  112233568999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ||++||+.||++||++.|+|+||||++..
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            99999999999999999999999997643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-49  Score=439.74  Aligned_cols=259  Identities=29%  Similarity=0.451  Sum_probs=230.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|++..+|+.||||++.....  ...+....+.+|+.+|+.++||||+++++++.+.+.+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999999999999999999864211  1112346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999988766555


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|..||..........++....  ...+..++.++.+||++
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccCCHHHHHHHHH
Confidence            6678899999999999776545789999999999999999999998766655555554432  34567789999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||+.||++|||+.||++||||+.
T Consensus       250 ~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          250 MLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             HcCCCchhCcCHHHHHhCHHhhh
Confidence            99999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-49  Score=408.71  Aligned_cols=262  Identities=29%  Similarity=0.507  Sum_probs=217.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|++..+++.||||++....   ......+.+.+|+++|++++|+||+++++++.+.+.++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            468999999999999999999999999999999885432   23444567889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      +||||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999999876532 23


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC--------------------C
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--------------------S  437 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~--------------------~  437 (628)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|..||........+..+..                    .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            34567999999999998766689999999999999999999999987655443332211                    0


Q ss_pred             CCCCCC---------CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          438 KDIPEI---------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       438 ~~~~~~---------p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ...+..         ...++.++.+||++||+.||++|||++|||+||||++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            011110         1357889999999999999999999999999999987543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.3e-49  Score=413.04  Aligned_cols=260  Identities=30%  Similarity=0.544  Sum_probs=204.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|+++.+++.||||+++......    ..+.+.+|+++|++++|||||++++++.+++.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   78 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKL   78 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence            3568999999999999999999999999999999997543221    234567899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEY------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      |+||||+. ++|.+++...      ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99999997 5999998754      3589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCc-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---CC---------
Q 040472          372 MTSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---SK---------  438 (628)
Q Consensus       372 ~~~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~~---------  438 (628)
                      .... ......+||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+..   ..         
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6432 2334567999999999997665689999999999999999999999987665444333211   00         


Q ss_pred             -------CC-------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          439 -------DI-------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       439 -------~~-------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                             ..             +.....++.++.+||++||+.||++|||+.|||+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                   00             011235788999999999999999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=422.81  Aligned_cols=259  Identities=26%  Similarity=0.399  Sum_probs=218.6

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |...++||+|+||.||+|++..+++.||||+++...     ....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            344678999999999999999999999999987421     233567889999999999999999999999999999999


Q ss_pred             EecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe--CCCCCEEEeccCCcccccCcccc
Q 040472          302 EYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV--DPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       302 Ey~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl--d~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||  +.++.+||+|||+++.+......
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999999999988654 579999999999999999999999999999999999999  56789999999999987666556


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~dLI~  456 (628)
                      ...+||+.|+|||++.+. .++.++|||||||+||||++|..||........+..+.....  .......++.++.+||+
T Consensus       246 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            667899999999998654 489999999999999999999999988776665555543321  11223468999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      +||+.||++||++.|+|+||||++..+...
T Consensus       325 ~~L~~dp~~Rps~~e~l~hp~~~~~~~~~~  354 (373)
T 2x4f_A          325 KLLIKEKSWRISASEALKHPWLSDHKLHSR  354 (373)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHCHHHHHH
T ss_pred             HHcCCChhhCCCHHHHhcCcCcCCCchhhh
Confidence            999999999999999999999998766443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.6e-49  Score=399.67  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=225.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.++||+|+||.||+|++..++..||+|++......     ..+.+.+|+++|++++||||+++++++.+.+.++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            45899999999999999999999999999999998653221     2456889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe---CCCCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl---d~~g~vKL~DFGla~~~~~~  375 (628)
                      +||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||++......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999999999988999999999999999999999999999999999999999   78889999999999887666


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~d  453 (628)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||...........+.......  .....++.++.+
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          163 KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            66667789999999999854  38999999999999999999999998876665555554332211  111258899999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ||++||+.||++||++.++|+||||++..
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999997653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-49  Score=427.03  Aligned_cols=252  Identities=28%  Similarity=0.475  Sum_probs=204.3

Q ss_pred             ccCCeEEe-eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHH-HhCCCCCeeeeecceec--
Q 040472          218 SLSKWKKG-KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL-SQLSHPNIVRYHGSELS--  293 (628)
Q Consensus       218 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIV~l~~~~~~--  293 (628)
                      .+++|++. ++||+|+||+||+|+++.+++.||||+++..          ..+.+|+.++ +.++||||++++++|..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            56788887 7999999999999999999999999998621          2456788887 45579999999998875  


Q ss_pred             --cccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEecc
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADF  366 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DF  366 (628)
                        ...+|||||||.||+|.++|...+  .+++..++.|+.||+.||+|||++|||||||||+||||+.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              678999999999999999998754  5999999999999999999999999999999999999987   789999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH------HHhhhcCCCCC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA------AIFKIGNSKDI  440 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~------~~~~i~~~~~~  440 (628)
                      |+++...........+||+.|+|||++.+. .|+.++||||||||||||++|+.||.......      ...........
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            999877655556678899999999998654 59999999999999999999999997643221      11111111111


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ...+..++.++.+||++||+.||++||++.|||+||||..
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            1233568999999999999999999999999999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-48  Score=424.16  Aligned_cols=262  Identities=27%  Similarity=0.467  Sum_probs=213.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      .++|+++++||+|+||+||+|+++.+++.||||+++...   ......+++.+|+++|+.++|+|||++++++...    
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            468999999999999999999999999999999986432   2344567889999999999999999999998876    


Q ss_pred             -ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                       ..+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence             57999999985 6999999988889999999999999999999999999999999999999999999999999998764


Q ss_pred             Ccc-----------------------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCC---------
Q 040472          374 SCA-----------------------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP---------  421 (628)
Q Consensus       374 ~~~-----------------------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~P---------  421 (628)
                      ...                       .....+||++|+|||++.....|+.++||||||||||||++|..|         
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            321                       235678999999999986666799999999999999999985444         


Q ss_pred             --CCCCch-----------------hHH---Hhhhc---------------------CCCCCC-----CCCCcCCHHHHH
Q 040472          422 --WSQYEG-----------------VAA---IFKIG---------------------NSKDIP-----EIPEHLSDDAKS  453 (628)
Q Consensus       422 --F~~~~~-----------------~~~---~~~i~---------------------~~~~~~-----~~p~~~s~~l~d  453 (628)
                        |.+...                 ..+   +..+.                     ......     .....+++++.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence              332210                 011   11100                     000000     011458999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      ||++||+.||++|||++|+|+||||++..+.
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            9999999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.8e-49  Score=401.31  Aligned_cols=258  Identities=31%  Similarity=0.547  Sum_probs=222.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++....  .........+.+|+.++++++||||+++++++.+.+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            5689999999999999999999999999999999986421  11122346688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      ++||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence            999999999999999999899999999999999999999999999999999999999999999999999998654332 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....  ..++..++.++.+||++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  240 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISR  240 (279)
T ss_dssp             ----CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCCcCCHHHHHHHHH
Confidence            3456799999999998654 48999999999999999999999998766555554443322  24566789999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccch
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||+.||++||++.|||+||||++.
T Consensus       241 ~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HhccChhhCCCHHHHhhCccccCC
Confidence            999999999999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.2e-49  Score=442.05  Aligned_cols=269  Identities=26%  Similarity=0.433  Sum_probs=229.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.++||+|+||+||+|+++.+++.||||++.+...  ......+.+.+|+++|++++|||||++++++.+...+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            45789999999999999999999999999999999864211  1112245788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ||||||+.||+|.++|...    ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999999764    369999999999999999999999999999999999999999999999999998765


Q ss_pred             Cccc-cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch----hHHHhhhcCCCCCCCCCCcCC
Q 040472          374 SCAS-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----VAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       374 ~~~~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      .... ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.....    ......+..  ....++..++
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s  417 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKFS  417 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSC
T ss_pred             CCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCcccC
Confidence            4433 3456899999999999764 599999999999999999999999976421    222222222  1235667899


Q ss_pred             HHHHHHHHHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCc
Q 040472          449 DDAKSFIKQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      .++++||++||+.||++||+     +++|++||||++..|........
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~  465 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML  465 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCC
Confidence            99999999999999999996     58999999999999987765443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-49  Score=423.17  Aligned_cols=258  Identities=23%  Similarity=0.406  Sum_probs=224.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++....     ......+.+|+.+|+.++|||||++++++.+...+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            3578999999999999999999999999999999986421     22245688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC--CCCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP--HGEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~--~g~vKL~DFGla~~~~~  374 (628)
                      |+||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.  ++.+||+|||+++....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999999999765 47999999999999999999999999999999999999974  46799999999988766


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--CCCCCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--DIPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~  452 (628)
                      .......+||+.|+|||++.+. .++.++|||||||++|||++|..||........+..+....  .....+..++.++.
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          204 DEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            5555566899999999998754 48999999999999999999999998876655555443322  22234457899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||++||+.||++||++.|||+||||++.
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            99999999999999999999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.5e-49  Score=417.46  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=206.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...       ..+.+.+|+++|++++||||+++++++.+.+.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence            3468999999999999999999999999999999987421       235577899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DFGla~~~~~  374 (628)
                      ++||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.   ++.+||+|||+++....
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            999999999999999998888999999999999999999999999999999999999975   88999999999987665


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH-HHhhhcCCC--CCCCCCCcCCHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-AIFKIGNSK--DIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~-~~~~i~~~~--~~~~~p~~~s~~l  451 (628)
                      .......+||+.|+|||++.+. .++.++|||||||++|||++|..||....... .+..+....  .....+..++.++
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          204 QVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ---------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             ccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            5445567899999999998765 48999999999999999999999997655443 222332221  1223446789999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .+||++||+.||++||++.|+|+||||.+.
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-48  Score=416.72  Aligned_cols=257  Identities=29%  Similarity=0.486  Sum_probs=214.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      ..++|++++.||+|+||.||+|++..+|+.||||++....   ......+++.+|+++|+.++||||+++++++....  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            3478999999999999999999999999999999885422   23445677889999999999999999999988763  


Q ss_pred             ----cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          296 ----RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       296 ----~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                          .+|+||||+ +++|.++++. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                469999999 8899999986 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---------------  436 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---------------  436 (628)
                      ...  .....+||++|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+..               
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            543  244568999999999998756699999999999999999999999987665544433211               


Q ss_pred             --------------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 --------------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 --------------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                    ...+..+...+++++.+||++||+.||++|||++|+|+||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                          011123345678999999999999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-48  Score=430.90  Aligned_cols=256  Identities=25%  Similarity=0.446  Sum_probs=209.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      ..++|++++.||+|+||+||+|++..+++.||||++...   .......+++.+|+.+|+.++|||||++++++....  
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence            467999999999999999999999999999999998743   223455678889999999999999999999987654  


Q ss_pred             ----cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          296 ----RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       296 ----~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                          .+||||||+.+ +|.+++..  .+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence                56999999976 56666653  589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC-----------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-----------  440 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~-----------  440 (628)
                      ..........+||++|+|||++.+. .|+.++|||||||+||||++|++||.+.+....+.++......           
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             cCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            7665556678899999999999775 5999999999999999999999999887655544443211000           


Q ss_pred             ---------CC---------CCCc-----------CCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          441 ---------PE---------IPEH-----------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       441 ---------~~---------~p~~-----------~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                               +.         ++..           .+.++.+||++||+.||++|||++|+|+||||+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                     00         0000           1568999999999999999999999999999974

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-48  Score=409.20  Aligned_cols=265  Identities=25%  Similarity=0.410  Sum_probs=228.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch-HHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++++.||+|+||.||+|+++.+++.||||+++........ ....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46799999999999999999999999999999999754322111 11245688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC----CEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG----EIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g----~vKL~DFGla~~~~  373 (628)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999888    79999999998776


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDA  451 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l  451 (628)
                      .........||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+.....  .+.++..++.++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA  249 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             ccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence            65555667899999999998654 489999999999999999999999987666555555443221  112235688999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      .+||++||+.||++||++.|+|+||||+...+.
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            999999999999999999999999999865443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-48  Score=398.68  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=212.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|++..+++.||||++......    ...+.+.+|+++|++++||||+++++++.+...+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            46899999999999999999999999999999998753321    12466889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe---CCCCCEEEeccCCccc
Q 040472          299 VYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKH  371 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl---d~~g~vKL~DFGla~~  371 (628)
                      +||||+.|++|.+++...    ..+++..++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||++..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999999998643    679999999999999999999999999999999999999   4567899999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-CCCCCCCCcCCHH
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-KDIPEIPEHLSDD  450 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~s~~  450 (628)
                      ..........+||+.|+|||++.  ..++.++|||||||++|||++|+.||...........+... .........++++
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             ----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             cCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            76655556678999999999985  34899999999999999999999999876554443333221 1122222347899


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +.+||++||+.||++||++.|||+||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.1e-48  Score=398.30  Aligned_cols=266  Identities=25%  Similarity=0.415  Sum_probs=228.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc----chHHHHHHHHHHHHHHHhCC-CCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ----TSKECLKQLNQEINLLSQLS-HPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~  292 (628)
                      ..++|++.+.||+|+||.||+|+++.+++.||||+++......    ......+.+.+|+++|+++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4679999999999999999999999999999999997543211    11234567889999999996 999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ++..+++||||+.+++|.+++.....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999877


Q ss_pred             cCccccccccCCCCcCChhhhhc-----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC--CCCCC
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMN-----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI--PEIPE  445 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~-----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~--~~~p~  445 (628)
                      .........+||+.|+|||++.+     ...++.++|||||||++|+|++|..||...........+......  .....
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            66555566789999999999852     345889999999999999999999999876655444443322211  12234


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      .++.++.+||.+||+.||++||++.|||+||||++..+
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            68999999999999999999999999999999986654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-48  Score=408.79  Aligned_cols=259  Identities=30%  Similarity=0.527  Sum_probs=227.1

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ....+|++++.||+|+||.||+|++..+++.||+|++.....  ......+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            345789999999999999999999999999999999864321  223456778899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      +|+||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... 
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999876432 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+....  ..++..++.++.+||
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li  272 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLI  272 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHH
T ss_pred             ccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHHHH
Confidence            233456799999999998754 48999999999999999999999998766555444443322  245667899999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccccc
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ++||+.||++||++.|||+|+||+.
T Consensus       273 ~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999964

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.4e-49  Score=428.04  Aligned_cols=268  Identities=29%  Similarity=0.481  Sum_probs=213.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---chHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.......   ........+.+|+.+|++++|||||++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3478999999999999999999999999999999997532111   112223457899999999999999999999754 


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---CEEEeccCCccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKLADFGMAKH  371 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~vKL~DFGla~~  371 (628)
                      +.+|+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++   .+||+|||+++.
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            45899999999999999999888999999999999999999999999999999999999997654   599999999998


Q ss_pred             ccCccccccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---CCCCCCCCc
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---KDIPEIPEH  446 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---~~~~~~p~~  446 (628)
                      ..........+||+.|+|||++.+  ...|+.++|||||||++|+|++|..||........+......   ...+..+..
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            766555567889999999999853  345889999999999999999999999765433222222111   122233356


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ++.++.+||++||+.||++||++.|+|+||||++..+.+.
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~  411 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK  411 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHH
Confidence            8999999999999999999999999999999998776543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-49  Score=414.03  Aligned_cols=264  Identities=28%  Similarity=0.438  Sum_probs=218.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++.............+.+.+|+++|++++|||||++++++.+.+.+
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            34689999999999999999999999999999999875322112234457789999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 040472          298 SVYLEYVSGGSIHKLLQEY----------------------------------------GPFNEPVIQTYTRQILLGLAY  337 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~----------------------------------------~~l~e~~~~~i~~qIl~aL~y  337 (628)
                      ++||||+.||+|.+++...                                        ..+++..++.++.||+.||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            9999999999999998521                                        123677889999999999999


Q ss_pred             HHhCCccccccCCCceEeCCCC--CEEEeccCCcccccCcc-----ccccccCCCCcCChhhhhcc-CCCCccccccccc
Q 040472          338 LHARNTVHRDIKGANILVDPHG--EIKLADFGMAKHMTSCA-----SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLG  409 (628)
Q Consensus       338 LH~~gIvHRDIKpeNILld~~g--~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLG  409 (628)
                      ||++||+||||||+||||+.++  .+||+|||+++.+....     ......||+.|+|||++.+. ..++.++||||||
T Consensus       184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            9999999999999999998776  89999999998653321     23456799999999998642 4589999999999


Q ss_pred             cceeeeccCCCCCCCCchhHHHhhhcCCCCCCC--CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          410 CTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       410 vlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      |++|||++|+.||........+..+........  ....++.++.+||++||+.||.+||++.|+|+||||++.
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            999999999999988776666655544332222  223488999999999999999999999999999999754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-48  Score=413.20  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=214.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++++.||+|+||+||+|+++.+++.||||+++....         ...+|+++|.++ +||||+++++++.+++.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            4689999999999999999999999999999999975322         134588888887 699999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-C---CEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-G---EIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g---~vKL~DFGla~~~~  373 (628)
                      |+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||..+ +   .+||+|||+++...
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999999999988899999999999999999999999999999999999998543 3   59999999998765


Q ss_pred             Cc-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC---chhHHHhhhcCC--CCCCCCCCcC
Q 040472          374 SC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY---EGVAAIFKIGNS--KDIPEIPEHL  447 (628)
Q Consensus       374 ~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~---~~~~~~~~i~~~--~~~~~~p~~~  447 (628)
                      .. ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||...   .....+..+...  ......+..+
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            43 3345678999999999997654 899999999999999999999999753   222223333222  1222345679


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +.++++||++||+.||++||++.+||+||||.+
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999999999964

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-48  Score=413.18  Aligned_cols=263  Identities=26%  Similarity=0.461  Sum_probs=213.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||+++............+.+.+|+++|+.++||||+++++++.+.+.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            35789999999999999999999999999999999865332222222335678999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      ++||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... 
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999976 888888764 46999999999999999999999999999999999999999999999999999876433 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC------CCCC--------
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS------KDIP--------  441 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~------~~~~--------  441 (628)
                      ......+||+.|+|||++.+...++.++|||||||++|||++|.+||........+.++...      ..++        
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            23445789999999999976666899999999999999999999999876655544433211      0000        


Q ss_pred             -------C-----CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          442 -------E-----IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       442 -------~-----~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                             .     +...++.++.+||++||+.||++|||+.|+|+||||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                   0     114567899999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.4e-48  Score=393.66  Aligned_cols=253  Identities=26%  Similarity=0.392  Sum_probs=216.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++++.||+|+||.||+|++..+++.||||+++.....   .....++.+|+.++..+ +||||+++++++.+++.+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            46899999999999999999999999999999998753222   22346678899999999 899999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---------------
Q 040472          298 SVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---------------  358 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---------------  358 (628)
                      ++||||+.|++|.+++.+.    ..+++..++.++.||+.||+|||++||+||||||+||||+.+               
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999865    679999999999999999999999999999999999999844               


Q ss_pred             ----CCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhh
Q 040472          359 ----GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI  434 (628)
Q Consensus       359 ----g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i  434 (628)
                          ..+||+|||++.......   ...||+.|+|||++.+...++.++|||||||++|+|++|.+++........+.. 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-  242 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ-  242 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT-
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc-
Confidence                479999999998765432   345999999999997665677899999999999999999988765544333322 


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          435 GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       435 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                         ...+.++..++.++.+||++||+.||++||++.|+++||||++.
T Consensus       243 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 ---GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             ---TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence               23456777899999999999999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-48  Score=397.06  Aligned_cols=259  Identities=28%  Similarity=0.450  Sum_probs=216.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++....  ....+..+.+.+|+.+|+.++|+||+++++++.+.+.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            4579999999999999999999999999999999986421  11122346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999987765544


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||...........+...  ...++..++.++.+||.+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHHH
Confidence            556679999999999876554578999999999999999999999876554444444322  234566789999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||+.||++||++.||++||||++
T Consensus       245 ~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HccCChhhCCCHHHHHhChhhcc
Confidence            99999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-49  Score=410.26  Aligned_cols=254  Identities=24%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      +++|++++.||+|+||.||+|+++.+++.||||+++....    ....+.+.+|+++|++++|||||++++++.+..   
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            4689999999999999999999999999999999975332    223467889999999999999999999886543   


Q ss_pred             ------------------------------------------------------cceEEEEecccccHHHHHHhcCC---
Q 040472          296 ------------------------------------------------------RLSVYLEYVSGGSIHKLLQEYGP---  318 (628)
Q Consensus       296 ------------------------------------------------------~~~lVmEy~~GgsL~~~L~~~~~---  318 (628)
                                                                            .+++|||||.|++|.+++.+...   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  28999999999999999987654   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-------------ccccccCCC
Q 040472          319 FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-------------SMLSFKGSP  385 (628)
Q Consensus       319 l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-------------~~~~~~GT~  385 (628)
                      ..+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......             .....+||+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            4556789999999999999999999999999999999999999999999998765431             234467999


Q ss_pred             CcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCC
Q 040472          386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSA  465 (628)
Q Consensus       386 ~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  465 (628)
                      .|+|||++.+. .++.++|||||||++|||++|..|+....  ..+..+. ....+......++++.+||++||+.||++
T Consensus       241 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             GGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             CccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCc
Confidence            99999998765 48999999999999999999987754321  1222222 22233333456788999999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 040472          466 RPPASKLLDHPFVRD  480 (628)
Q Consensus       466 Rpta~eiL~Hpwf~~  480 (628)
                      ||++.|||+||||++
T Consensus       317 Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          317 RPEATDIIENAIFEN  331 (332)
T ss_dssp             SCCHHHHHHSTTCCC
T ss_pred             CCCHHHHhhchhhhc
Confidence            999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-48  Score=409.52  Aligned_cols=269  Identities=30%  Similarity=0.489  Sum_probs=223.5

Q ss_pred             ccccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          214 VTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       214 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      +....+++|+++++||+|+||.||+|++..+++.||||++....   ......+.+.+|+.+|++++|+||+++++++.+
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            34456789999999999999999999999999999999986432   234445678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      .+.+|+||||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            99999999999999999998888889999999999999999999999999999999999999999999999999998654


Q ss_pred             Cc-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC----------------
Q 040472          374 SC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----------------  436 (628)
Q Consensus       374 ~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~----------------  436 (628)
                      .. ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+..                
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            32 2334567999999999997765689999999999999999999999987665444333211                


Q ss_pred             ----CCCCCCC---------CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          437 ----SKDIPEI---------PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       437 ----~~~~~~~---------p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                          ....+.+         ...++.++.+||++||+.||++||++.|||+||||+...+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE  317 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhh
Confidence                0111111         135789999999999999999999999999999998765443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.4e-48  Score=397.10  Aligned_cols=258  Identities=30%  Similarity=0.518  Sum_probs=225.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++.....  ......+.+.+|+++++.++|+||+++++++.+.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            46799999999999999999999999999999999864211  1111245688999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765432 2


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....  ..++..++.++.+||++
T Consensus       169 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--cCCCCcCCHHHHHHHHH
Confidence            3456799999999998764 48999999999999999999999998766655555544322  24667789999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccch
Q 040472          458 CLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||+.||.+||++.+|++||||+..
T Consensus       246 ~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-48  Score=429.82  Aligned_cols=261  Identities=28%  Similarity=0.461  Sum_probs=222.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||+||+|+++.++..||||+++......   .....+.+|+.+|+.++|||||++++++.+...+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc---hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            357999999999999999999999999999999997532211   12356788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFGla~~~~~~  375 (628)
                      +|||||.||+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+..   +.+||+|||++......
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999999999988999999999999999999999999999999999999999764   45999999999887766


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC--CCCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI--PEIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~d  453 (628)
                      ......+||+.|+|||++.  ..|+.++|||||||++|+|++|.+||........+..+......  ...+..++.++++
T Consensus       193 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence            6666788999999999985  34999999999999999999999999887766555555433221  1223568999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                      ||++||+.||.+|||+.|+|+||||+.....
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  301 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSK  301 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCcccccCccc
Confidence            9999999999999999999999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-49  Score=417.02  Aligned_cols=270  Identities=29%  Similarity=0.485  Sum_probs=223.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~  293 (628)
                      .+++|+++++||+|+||+||+|++.   .+++.||||+++...... .....+.+.+|+++|+++ +|+||+++++++.+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            4579999999999999999999984   589999999986432111 011224566799999999 69999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ++.+||||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999998654


Q ss_pred             Cc--cccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCch---hHHHh-hhcCCCCCCCCCCc
Q 040472          374 SC--ASMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIF-KIGNSKDIPEIPEH  446 (628)
Q Consensus       374 ~~--~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~-~i~~~~~~~~~p~~  446 (628)
                      ..  ......+||+.|+|||++.+. ..++.++|||||||+||||++|+.||.....   ...+. .+..  ..+.++..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  288 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQE  288 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCTT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCcc
Confidence            32  223456899999999998752 3478999999999999999999999964321   12222 2211  22456678


Q ss_pred             CCHHHHHHHHHHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCC
Q 040472          447 LSDDAKSFIKQCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVN  490 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~  490 (628)
                      ++..+.+||++||+.||++||     +++||++|+||++..|.......
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~  337 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK  337 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhcc
Confidence            999999999999999999999     99999999999988887665433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=396.85  Aligned_cols=259  Identities=29%  Similarity=0.548  Sum_probs=200.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++.....  ...+..+.+.+|+.++++++||||+++++++.+.+.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            46789999999999999999999999999999999864211  1112246788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      |+||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999875 67999999999999999999999999999999999999999999999999999876432 


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+.++....  ..++..++.++.+||
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li  243 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAKDLI  243 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTSCHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCccccCHHHHHHH
Confidence            233456799999999998654 48999999999999999999999998655444443332221  245667899999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcCccccch
Q 040472          456 KQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ++||+.||++||++.+|++||||.+.
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-48  Score=396.24  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=205.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||+||+|++..+++.||||+++...   ......+.+.++..+++.++||||+++++++.+++..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            4578999999999999999999999999999999986432   2233344555666678889999999999999999999


Q ss_pred             eEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          298 SVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ++||||+.| +|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999974 88777653    46899999999999999999999998 9999999999999999999999999999877


Q ss_pred             cCccccccccCCCCcCChhhh---hccCCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcCCCCCCCCCCcCC
Q 040472          373 TSCASMLSFKGSPYWMAPEVV---MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl---~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ..........||+.|+|||++   .....++.++|||||||++|+|++|+.||.... ....+...............++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            655555556799999999997   344558999999999999999999999997633 3333333333332233345689


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .++.+||.+||+.||++||++.||++||||+...
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            9999999999999999999999999999997653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.7e-48  Score=394.78  Aligned_cols=259  Identities=25%  Similarity=0.446  Sum_probs=221.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||.||+|++..+++.||||++.....    ....+.+.+|+.+++.++|+||+++++++.+++..|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            4689999999999999999999999999999999864322    223467889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---  375 (628)
                      +||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......   
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999999999988888999999999999999999999999999999999999999999999999999865432   


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH-HHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-AIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      ......+||+.|+|||++.+...++.++|||||||++|+|++|..||....... .+..+.........+..++.++.+|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            123456799999999998765545789999999999999999999997654332 2222222222223345689999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      |++||+.||++||++.||++||||++.
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccCh
Confidence            999999999999999999999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-48  Score=431.97  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=227.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|+++++||+|+||.||+|+++.+++.||||++.......  ....+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468999999999999999999999999999999986432211  122467889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe---CCCCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl---d~~g~vKL~DFGla~~~~~~  375 (628)
                      +||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||+++.+...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999988999999999999999999999999999999999999999   46789999999999887666


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCC--CCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPE--IPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l~d  453 (628)
                      ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||........+..+........  .+..++.++++
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            55566789999999999864  489999999999999999999999988776666665544332222  23568999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ||++||+.||++|||+.|+|+||||+..
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            9999999999999999999999999754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-48  Score=403.66  Aligned_cols=253  Identities=29%  Similarity=0.426  Sum_probs=208.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHH-hCCCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS-QLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++.++||+|+||+||+|++..+++.||||++.....  .... ..+...|+..+. .++|+|||++++++.+++.+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            3689999999999999999999999999999998754322  2222 333444555554 44899999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ||||||+ +++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999999 67898888765 469999999999999999999999999999999999999999999999999998776555


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      .....+||+.|+|||++.+  .++.++|||||||++|||++|..+|........+   ......+.++..++.++.+||+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hccCCCcccccCCCHHHHHHHH
Confidence            5556779999999999864  4899999999999999999997776654433332   2222223445678999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.||++||++.|||+||||++
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8e-49  Score=414.51  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=221.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc---hHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT---SKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++++.||+|+||+||+|+++.+++.||||+++.......   .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            34689999999999999999999999999999999975321110   111234567799999999999999999999999


Q ss_pred             ccceEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGG-SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~Gg-sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.+++||||+.+| +|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999998766 999999998899999999999999999999999999999999999999999999999999998876


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      ........+||+.|+|||++.+...++.++|||||||++|+|++|..||......      .  ......+..++.++.+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~--~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V--EAAIHPPYLVSKELMS  253 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T--TTCCCCSSCCCHHHHH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H--hhccCCCcccCHHHHH
Confidence            6666667789999999999977654488999999999999999999999764321      1  1112345568999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||++||+.||++||++.+|++||||++
T Consensus       254 li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             HHHHHccCChhhCcCHHHHhcCccccC
Confidence            999999999999999999999999964

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-48  Score=430.02  Aligned_cols=258  Identities=27%  Similarity=0.466  Sum_probs=223.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||++.......   .....+.+|+++|++++|||||++++++.+...+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            3468999999999999999999999999999999986432211   1235678999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC---CCCCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld---~~g~vKL~DFGla~~~~~  374 (628)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+   .++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999999889999999999999999999999999999999999999995   456799999999987766


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~  452 (628)
                      .......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||........+..+.......  ..+..++.+++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence            655666789999999999864  49999999999999999999999998877666655554433222  22356899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||++||+.||++|||+.|+|+||||+.
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            9999999999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-48  Score=415.22  Aligned_cols=255  Identities=30%  Similarity=0.523  Sum_probs=214.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----  293 (628)
                      ...+|++++.||+|+||+||+|++..+++.||||++.....         ...+|+++|+.++|+|||+++++|..    
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34689999999999999999999999999999998864321         12369999999999999999999844    


Q ss_pred             ----------------------------------cccceEEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 040472          294 ----------------------------------DERLSVYLEYVSGGSIHKLLQ----EYGPFNEPVIQTYTRQILLGL  335 (628)
Q Consensus       294 ----------------------------------~~~~~lVmEy~~GgsL~~~L~----~~~~l~e~~~~~i~~qIl~aL  335 (628)
                                                        +..+++||||+.| +|.+++.    ....+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              3348899999974 7776665    457899999999999999999


Q ss_pred             HHHHhCCccccccCCCceEeC-CCCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceee
Q 040472          336 AYLHARNTVHRDIKGANILVD-PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLE  414 (628)
Q Consensus       336 ~yLH~~gIvHRDIKpeNILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLye  414 (628)
                      +|||++||+||||||+||||+ .++.+||+|||+++...........+||+.|+|||++.+...++.++|||||||++||
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            999999999999999999997 6889999999999987666666677899999999999876669999999999999999


Q ss_pred             eccCCCCCCCCchhHHHhhhcCC------------------CCCC---------CCCCcCCHHHHHHHHHHhhcCCCCCC
Q 040472          415 MATSKPPWSQYEGVAAIFKIGNS------------------KDIP---------EIPEHLSDDAKSFIKQCLQRDPSARP  467 (628)
Q Consensus       415 lLtG~~PF~~~~~~~~~~~i~~~------------------~~~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rp  467 (628)
                      |++|+.||......+.+..+...                  ...+         .++..++.++.+||++||+.||++||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999887665554443210                  0011         13456889999999999999999999


Q ss_pred             CHHHHhcCccccchH
Q 040472          468 PASKLLDHPFVRDQA  482 (628)
Q Consensus       468 ta~eiL~Hpwf~~~~  482 (628)
                      |+.|+|+||||++..
T Consensus       315 t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          315 NPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CHHHHHTSGGGHHHH
T ss_pred             CHHHHhcCHHHHHHH
Confidence            999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.7e-48  Score=411.65  Aligned_cols=261  Identities=27%  Similarity=0.462  Sum_probs=225.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc---hHHHHHHHHHHHHHHHhC-CCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT---SKECLKQLNQEINLLSQL-SHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~  294 (628)
                      .++|++.+.||+|+||.||+|+++.+|+.||||+++.......   ..+..+.+.+|+.+|+++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            3679999999999999999999999999999999975432211   123456788999999999 799999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..+|+||||+.|++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999988766


Q ss_pred             ccccccccCCCCcCChhhhhcc-----CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCCCcC
Q 040472          375 CASMLSFKGSPYWMAPEVVMNT-----NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHL  447 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~-----~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p~~~  447 (628)
                      .......+||+.|+|||++.+.     ..++.++|||||||++|+|++|..||........+..+.......  ..+..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            6556678899999999998642     248899999999999999999999998766555544443322111  112467


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      +.++.+||++||+.||++||++.|||+||||+
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            89999999999999999999999999999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-47  Score=395.48  Aligned_cols=258  Identities=30%  Similarity=0.528  Sum_probs=226.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||+|++.....  ......+.+.+|+.+++.++|+||+++++++.+++.+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            45789999999999999999999999999999999864322  2234557788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      ++||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999876432 2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....  ..++..++.++.+||+
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCccccCHHHHHHHH
Confidence            33456799999999998654 48999999999999999999999998766555555444322  3456788999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.||++||++.|+++|+||+.
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHcccChhhCcCHHHHhhChheec
Confidence            999999999999999999999964

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=412.20  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=209.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|++..+++.||||+++....    ......+.+|+++|+.++|+||+++++++.+++.++
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   76 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence            4689999999999999999999999999999999864221    111223457999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      +||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            9999997 5888888765 45999999999999999999999999999999999999999999999999999865432 2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---CCC---CC---------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---SKD---IP---------  441 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~~~---~~---------  441 (628)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+..   ...   ++         
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            334467899999999998766789999999999999999999999987665444333211   100   00         


Q ss_pred             -------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          442 -------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       442 -------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                   .....++.++.+||++||+.||++|||++|||+||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                         0123578899999999999999999999999999999764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-48  Score=405.99  Aligned_cols=266  Identities=30%  Similarity=0.518  Sum_probs=218.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc---cchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD---QTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|++++.||+|+||.||+|++..+++.||||++......   .........+.+|+++|++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46899999999999999999999999999999998643211   111223446789999999999999999999987654


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC---EEEeccCCcccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHM  372 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~---vKL~DFGla~~~  372 (628)
                       +|+||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.   +||+|||+++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999998889999999999999999999999999999999999999987664   999999999877


Q ss_pred             cCccccccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhh-h--cCCCCCCCCCCcC
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-I--GNSKDIPEIPEHL  447 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~-i--~~~~~~~~~p~~~  447 (628)
                      .........+||+.|+|||++..  ...++.++|||||||++|+|++|..||........+.. +  ......+..+..+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  247 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence            65444455679999999999842  44589999999999999999999999976443222211 1  1112222334568


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      +.++.+||++||+.||++||++.++|+||||++..+.+
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~  285 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  285 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHH
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHH
Confidence            99999999999999999999999999999998876644

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-48  Score=401.21  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=209.0

Q ss_pred             cCCeEEe-eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecccc
Q 040472          219 LSKWKKG-KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDER  296 (628)
Q Consensus       219 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~  296 (628)
                      .++|++. ++||+|+||+||+|++..+++.||||++.....     .....+.+|+++|.++ +||||+++++++.+++.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            4689885 789999999999999999999999999875322     1235678899999985 69999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC---EEEeccCCccccc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLADFGMAKHMT  373 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~---vKL~DFGla~~~~  373 (628)
                      +|+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.   +||+|||++....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999999999998889999999999999999999999999999999999999998776   9999999997653


Q ss_pred             Cc--------cccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchh-------------
Q 040472          374 SC--------ASMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-------------  428 (628)
Q Consensus       374 ~~--------~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-------------  428 (628)
                      ..        ......+||+.|+|||++.+    ...++.++|||||||++|||++|+.||......             
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            21        12234569999999999864    134789999999999999999999999764321             


Q ss_pred             --HHHhhhcCCCCCCCCC----CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          429 --AAIFKIGNSKDIPEIP----EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       429 --~~~~~i~~~~~~~~~p----~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                        .....+....  ..++    ..++.++++||++||+.||++||++.|||+||||++..
T Consensus       246 ~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          246 QNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence              1112221111  1222    35889999999999999999999999999999998654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.9e-48  Score=429.09  Aligned_cols=261  Identities=28%  Similarity=0.444  Sum_probs=224.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc--------hHHHHHHHHHHHHHHHhCCCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT--------SKECLKQLNQEINLLSQLSHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~--------~~~~~~~~~~Ei~iL~~l~HpnIV~l~~  289 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||++........        .....+.+.+|+.+|++++|||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999999999999999975321110        0123467889999999999999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---CEEEecc
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKLADF  366 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~vKL~DF  366 (628)
                      ++.+...+|||||||.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999999889999999999999999999999999999999999999998776   6999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIP  444 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p  444 (628)
                      |++............+||+.|+|||++.+  .|+.++|||||||++|+|++|..||........+..+.......  ..+
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW  271 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            99988766656667789999999999853  49999999999999999999999998877666665554433211  122


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ..++.++++||++||+.||.+|||+.|+|+||||+.
T Consensus       272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            568999999999999999999999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-48  Score=405.46  Aligned_cols=260  Identities=23%  Similarity=0.411  Sum_probs=217.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||+++...  .........+.+|++++++++||||+++++++......
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            3578999999999999999999999999999999986532  22345567889999999999999999999998876654


Q ss_pred             ----eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          298 ----SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ----~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                          |+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence                9999999999999999988999999999999999999999999999999999999999999999999999998654


Q ss_pred             Ccc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCCCcC
Q 040472          374 SCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHL  447 (628)
Q Consensus       374 ~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p~~~  447 (628)
                      ...    .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......+  .....+
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             --------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             ccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            322    22346799999999999765 49999999999999999999999998876655554443332222  123458


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +.++.+||.+||+.||++||++.++|.|+|++.
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            999999999999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-48  Score=406.23  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=215.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC--CCeeeeecceecccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDER  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIV~l~~~~~~~~~  296 (628)
                      -.+|++++.||+|+||.||+|.+. +++.||||++....   ......+.+.+|+.+|++++|  +||+++++++.++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            457999999999999999999885 68999999987532   234556788999999999986  999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|||||+ .+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+ ++.+||+|||+++......
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9999995 5889999999989999999999999999999999999999999999999997 6889999999998764432


Q ss_pred             c---cccccCCCCcCChhhhhc----------cCCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcCCCCCCC
Q 040472          377 S---MLSFKGSPYWMAPEVVMN----------TNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPE  442 (628)
Q Consensus       377 ~---~~~~~GT~~Y~APEvl~~----------~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~~~~~~~  442 (628)
                      .   ....+||+.|+|||++.+          ...++.++|||||||+||||++|+.||.... ....+..+........
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            2   235679999999999864          2458999999999999999999999997643 3344444444444456


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ++...+.++.+||.+||+.||++||++.|||+||||+.
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            67778899999999999999999999999999999963

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5e-48  Score=394.73  Aligned_cols=263  Identities=27%  Similarity=0.441  Sum_probs=221.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch-HHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS-KECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ++|++++.||+|+||.||+|++..+++.||||+++........ ....+.+.+|+.+|++++||||+++++++.+...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            4799999999999999999999999999999999754322111 112466889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC----CEEEeccCCcccccC
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG----EIKLADFGMAKHMTS  374 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g----~vKL~DFGla~~~~~  374 (628)
                      +||||+.+++|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999999888999999999999999999999999999999999999998877    899999999987765


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~  452 (628)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+.....  .......++..+.
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             -------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            5555567799999999998654 489999999999999999999999987666555554433221  1122346789999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      +||++||+.||++||++.|+|+||||+....
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            9999999999999999999999999987644

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-47  Score=400.92  Aligned_cols=253  Identities=34%  Similarity=0.566  Sum_probs=218.8

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|+..+.||+|+||.||+|++..+|+.||||++......     ..+.+.+|+.+|++++|+||+++++++...+.+|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            478889999999999999999999999999998743221     235677899999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-ccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-SML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~~~  379 (628)
                      |||+.|++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  199 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence            999999999999875 579999999999999999999999999999999999999999999999999998765432 334


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~dLI~~~  458 (628)
                      ..+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+..... .......++.++.+||.+|
T Consensus       200 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             cccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            56899999999998654 589999999999999999999999987666555544433221 1123346889999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccc
Q 040472          459 LQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |+.||++||++.||++||||..
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGG
T ss_pred             ccCChhhCcCHHHHhcChhhcc
Confidence            9999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.8e-48  Score=408.96  Aligned_cols=261  Identities=29%  Similarity=0.496  Sum_probs=220.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....    .....+.+.+|+.+|++++|+||+++++++.+++.+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            4568999999999999999999999999999999987532    244567789999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |+||||+.|++|.+++.+.+.+++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||++...... 
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999999988999999999999999999999996 9999999999999999999999999999765332 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhh-----------------------
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-----------------------  433 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~-----------------------  433 (628)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........                       
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence            23346799999999998765 499999999999999999999999976443221111                       


Q ss_pred             -------------------hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHH
Q 040472          434 -------------------IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVA  484 (628)
Q Consensus       434 -------------------i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~  484 (628)
                                         +............++.++.+||++||+.||++|||+.|+|+||||+...+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence                               111111111223478999999999999999999999999999999876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-47  Score=392.22  Aligned_cols=257  Identities=30%  Similarity=0.524  Sum_probs=219.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----c
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----D  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----~  294 (628)
                      ...|++.+.||+|+||.||+|++..++..||+|++.....   .....+.+.+|+.+|++++||||+++++++..    .
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            3568999999999999999999999999999999874322   23446778899999999999999999998875    4


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeC-CCCCEEEeccCCccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVD-PHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld-~~g~vKL~DFGla~~  371 (628)
                      ..+++||||+.+++|.+++...+.+++..++.++.||+.||+|||+++  |+||||||+||||+ .++.+||+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            568999999999999999999899999999999999999999999999  99999999999997 789999999999975


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhh-hcCCCCCCCCCCcCCHH
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~-i~~~~~~~~~p~~~s~~  450 (628)
                      .... .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||........+.. +........++...+.+
T Consensus       182 ~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          182 KRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             CCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             cccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            4432 3345679999999998753  489999999999999999999999987555444443 33333333455667899


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +.+||++||+.||++||++.|||+||||++.
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            9999999999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-47  Score=413.88  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=216.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC--CCCeeeeecceeccccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS--HPNIVRYHGSELSDERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIV~l~~~~~~~~~~  297 (628)
                      .+|++++.||+|+||+||+|++.. ++.||||++.....   .....+.+.+|+.+|+++.  |+|||++++++..++.+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            569999999999999999999875 89999999875322   3455678899999999997  59999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      ||||| +.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||||+ ++.+||+|||+++.+.... 
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99999 56889999999988999999999999999999999999999999999999995 6899999999998765432 


Q ss_pred             --ccccccCCCCcCChhhhhcc----------CCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcCCCCCCCC
Q 040472          377 --SMLSFKGSPYWMAPEVVMNT----------NGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPEI  443 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~----------~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~~~~~~~~  443 (628)
                        .....+||+.|+|||++.+.          ..++.++||||||||||||++|+.||.... ....+..+........+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  289 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  289 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence              23456899999999998641          358999999999999999999999997643 33444444444444456


Q ss_pred             CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       444 p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +...+.++.+||++||+.||++||++.|||+||||+.
T Consensus       290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence            6677899999999999999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-47  Score=406.71  Aligned_cols=255  Identities=36%  Similarity=0.659  Sum_probs=221.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ..|++++.||+|+||+||+|++..+++.||||++.....  ...+..+.+.+|+++|++++|||||++++++.+++..||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            569999999999999999999999999999999865322  234456788999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccc
Q 040472          300 YLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~  378 (628)
                      ||||+. |+|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......   
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            999997 57877775 4578999999999999999999999999999999999999999999999999999866432   


Q ss_pred             ccccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ...+||+.|+|||++.+  ...++.++|||||||++|||++|+.||........+..+.........+..++..+.+||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  287 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  287 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            34679999999999853  3458999999999999999999999998877666665554443333345678999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccc
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||+.||++||++++||+||||..
T Consensus       288 ~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          288 SCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHcccChhhCcCHHHHhhChhhhc
Confidence            999999999999999999999953

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-48  Score=409.83  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=196.3

Q ss_pred             CCeEEe---eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccc
Q 040472          220 SKWKKG---KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDE  295 (628)
Q Consensus       220 ~~y~~~---~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~  295 (628)
                      ++|++.   ++||+|+||+||+|+++.+++.||||++...        ....+.+|+.+|+.+. ||||+++++++.++.
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            456664   7899999999999999999999999998631        2345678999999998 999999999999999


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---CEEEeccCCcccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---EIKLADFGMAKHM  372 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~vKL~DFGla~~~  372 (628)
                      .+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++   .+||+|||+++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            9999999999999999999989999999999999999999999999999999999999997766   7999999999865


Q ss_pred             cCc-cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-------hHHHhhhcCCCCC--CC
Q 040472          373 TSC-ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-------VAAIFKIGNSKDI--PE  442 (628)
Q Consensus       373 ~~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-------~~~~~~i~~~~~~--~~  442 (628)
                      ... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....       ...+..+......  ..
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            443 234556799999999998655 499999999999999999999999975432       2233333332211  11


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .+..+++++++||++||+.||++||++.||++||||++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            22458999999999999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.8e-48  Score=419.17  Aligned_cols=253  Identities=29%  Similarity=0.497  Sum_probs=210.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      ..+|+++++||+|+||+||+|++..+++.||||++.....         ...+|+++|+.++|+|||+++++|...    
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            3479999999999999999999999999999998864221         234699999999999999999988542    


Q ss_pred             --ccceEEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccC
Q 040472          295 --ERLSVYLEYVSGGSIHKLLQ----EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFG  367 (628)
Q Consensus       295 --~~~~lVmEy~~GgsL~~~L~----~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFG  367 (628)
                        ..+++||||+.+ +|.+++.    ....+++..++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence              347799999976 6666554    34679999999999999999999999999999999999999965 568999999


Q ss_pred             CcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC----------
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS----------  437 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~----------  437 (628)
                      +++.+.........+||+.|+|||++.+...|+.++||||||||||||++|++||........+.++...          
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9997765555566789999999999977656999999999999999999999999876655444333210          


Q ss_pred             --------CCCCC---------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 --------KDIPE---------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 --------~~~~~---------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                              ...+.         ++..++.++.+||++||+.||++||++.|+|+||||++.
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence                    01111         234578999999999999999999999999999999754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1e-47  Score=407.18  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=211.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-----CCCeeeeecceec
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-----HPNIVRYHGSELS  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIV~l~~~~~~  293 (628)
                      .++|+++++||+|+||+||+|++..+++.||||+++.      .....+.+..|+.+|+.+.     |+|||++++++..
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            4689999999999999999999999999999999863      1334466778999999997     9999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC--------------
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP--------------  357 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~--------------  357 (628)
                      .+.+++||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+||||+.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 999999998654  5999999999999999999999999999999999999975              


Q ss_pred             -----------CCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc
Q 040472          358 -----------HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE  426 (628)
Q Consensus       358 -----------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~  426 (628)
                                 ++.+||+|||+++....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                       78999999999986543  23456799999999999765 49999999999999999999999998765


Q ss_pred             hhHHHhhhcCCCC---------------------------CCC-----------------CCCcCCHHHHHHHHHHhhcC
Q 040472          427 GVAAIFKIGNSKD---------------------------IPE-----------------IPEHLSDDAKSFIKQCLQRD  462 (628)
Q Consensus       427 ~~~~~~~i~~~~~---------------------------~~~-----------------~p~~~s~~l~dLI~~~L~~d  462 (628)
                      ....+..+.....                           ++.                 +....++.+.+||++||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            4443322211000                           000                 01112477889999999999


Q ss_pred             CCCCCCHHHHhcCcccc
Q 040472          463 PSARPPASKLLDHPFVR  479 (628)
Q Consensus       463 P~~Rpta~eiL~Hpwf~  479 (628)
                      |++|||+.|||+||||+
T Consensus       344 P~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          344 PTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGGSCCHHHHTTSGGGC
T ss_pred             hhhCCCHHHHhcCcccC
Confidence            99999999999999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-47  Score=406.24  Aligned_cols=259  Identities=26%  Similarity=0.427  Sum_probs=212.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----  293 (628)
                      .+++|++++.||+|+||+||+|++..+++.||||++.......   .....+.+|+++|+.++|+||+++++++.+    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            4679999999999999999999999999999999886433221   123456789999999999999999999887    


Q ss_pred             ----cccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          294 ----DERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       294 ----~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                          .+.+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4468999999976 66666654 46799999999999999999999999999999999999999999999999999


Q ss_pred             cccccC-----ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--CCCC
Q 040472          369 AKHMTS-----CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--KDIP  441 (628)
Q Consensus       369 a~~~~~-----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--~~~~  441 (628)
                      ++.+..     .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..+...  ...+
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            986542     223345679999999999977666899999999999999999999999876654443332110  0111


Q ss_pred             CCCCc----------------------------CCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          442 EIPEH----------------------------LSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       442 ~~p~~----------------------------~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      .....                            .++++.+||++||+.||++||+++|+|+||||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            11111                            2678999999999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.4e-48  Score=403.74  Aligned_cols=262  Identities=27%  Similarity=0.451  Sum_probs=219.4

Q ss_pred             CCeEEe-eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccc
Q 040472          220 SKWKKG-KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERL  297 (628)
Q Consensus       220 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~  297 (628)
                      ++|.+. +.||+|+||.||+|+++.+++.||||+++......   .....+.+|+.+|+.+. ||||+++++++.+.+.+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            467777 89999999999999999999999999987543222   22356788999999995 69999999999999999


Q ss_pred             eEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEeccCCcccc
Q 040472          298 SVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADFGMAKHM  372 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DFGla~~~  372 (628)
                      |+||||+.||+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+||||+.   ++.+||+|||+++..
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            999999999999999865  367999999999999999999999999999999999999987   789999999999877


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--CCCCCCCCcCCHH
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--KDIPEIPEHLSDD  450 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~s~~  450 (628)
                      .........+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...  .........++..
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL  263 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             CCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence            665555667899999999998655 4899999999999999999999999877665554443322  2223444578999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      +.+||++||+.||++||++++||+||||++..+..
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence            99999999999999999999999999998766543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.7e-47  Score=406.09  Aligned_cols=256  Identities=23%  Similarity=0.464  Sum_probs=216.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc-----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD-----  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~-----  294 (628)
                      .+|+++++||+|+||.||+|++..+++.||||++...    ......+.+.+|+++|++++||||+++++++...     
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            5899999999999999999999999999999998642    2244457788999999999999999999998764     


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..+|+||||+. ++|.++++. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       103 ~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          103 KDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             CCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            47899999996 599999876 5699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-------------
Q 040472          375 CAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-------------  437 (628)
Q Consensus       375 ~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-------------  437 (628)
                      ...    ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+...             
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            322    244689999999999877666899999999999999999999999876554443332110             


Q ss_pred             --------------C--CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 --------------K--DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 --------------~--~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                    .  .+..+...++.++.+||++||+.||++|||+.|||+||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                          0  0011224578999999999999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.9e-48  Score=402.37  Aligned_cols=254  Identities=24%  Similarity=0.445  Sum_probs=214.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceec--c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELS--D  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~--~  294 (628)
                      ..++|+++++||+|+||.||+|++..+++.||||+++...        .+.+.+|+.+|++++ |+||+++++++.+  .
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            4578999999999999999999999999999999986311        256788999999997 9999999999987  6


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~  373 (628)
                      ...++||||+.+++|.++++.   +++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            778999999999999999864   88999999999999999999999999999999999999777 89999999998776


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcC---------------C
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGN---------------S  437 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~---------------~  437 (628)
                      ........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.... ....+..+..               .
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            66666667899999999999775669999999999999999999999994322 1111111000               0


Q ss_pred             C--------------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          438 K--------------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       438 ~--------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      .                    .....+..++.++.+||++||+.||++|||++|||+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            0                    00112233789999999999999999999999999999998654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-47  Score=395.35  Aligned_cols=255  Identities=29%  Similarity=0.449  Sum_probs=219.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|++..+++.||||+++....     ...+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            4689999999999999999999999999999999874221     12356789999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe---CCCCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl---d~~g~vKL~DFGla~~~~~~  375 (628)
                      +||||+.|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||   +.++.+||+|||++......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999999999988899999999999999999999999999999999999999   77889999999999764432


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--CCCCCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--DIPEIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~d  453 (628)
                       .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....  .....+..++.++.+
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          163 -IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             -TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             -ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence             33445799999999998654 48999999999999999999999998766555444443322  122344678999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||.+||+.||++||++.|+|+||||++
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHcCCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-47  Score=393.18  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=215.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++++.||+|+||.||+|++..+++.||||++.....  ...+..+++.+|+.++++++||||+++++++.+++.+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            4689999999999999999999999999999999865322  23556788999999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--  376 (628)
                      +||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++......  
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            999999999999999998999999999999999999999999999999999999999999999999999998764432  


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC---CCCCCcCCHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI---PEIPEHLSDDAKS  453 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~---~~~p~~~s~~l~d  453 (628)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........+.......   ..++..+++.+.+
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             -------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             ccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence            23346799999999998765 4899999999999999999999999887665554444332221   1245668999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      +|.+||+.||++||+..+.+.+.|
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHhcCCHhHccccHHHHHHHH
Confidence            999999999999995555555554

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-47  Score=411.52  Aligned_cols=257  Identities=24%  Similarity=0.447  Sum_probs=199.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~---  294 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++....   ......+++.+|+++|+.++|+||+++++++...   
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence            3479999999999999999999999999999999885422   2234557788999999999999999999998754   


Q ss_pred             ---ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                         ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence               5689999999 7899999876 6799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--------------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--------------  437 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--------------  437 (628)
                      ...  .....+||++|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+...              
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            543  2345679999999999987566999999999999999999999999876655443332110              


Q ss_pred             ----------CCCC-----CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 ----------KDIP-----EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 ----------~~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                ...+     .+...++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                      0001     1123468899999999999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=399.37  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=212.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--c
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--R  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--~  296 (628)
                      -++|+++++||+|+||+||+|++..+++.||||+++.....    ...+.+.+|+++|++++||||+++++++....  .
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            36899999999999999999999999999999998643211    12456678999999999999999999988755  7


Q ss_pred             ceEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe----CCCCCEEEeccCCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFGMA  369 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl----d~~g~vKL~DFGla  369 (628)
                      +++||||+.|++|.+++....   .+++..++.++.||+.||+|||++||+||||||+||||    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            899999999999999998653   39999999999999999999999999999999999999    77788999999999


Q ss_pred             ccccCccccccccCCCCcCChhhhhc-------cCCCCccccccccccceeeeccCCCCCCCCch----hHHHhhhcCCC
Q 040472          370 KHMTSCASMLSFKGSPYWMAPEVVMN-------TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----VAAIFKIGNSK  438 (628)
Q Consensus       370 ~~~~~~~~~~~~~GT~~Y~APEvl~~-------~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~----~~~~~~i~~~~  438 (628)
                      +...........+||+.|+|||++..       ...++.++|||||||++|||++|+.||.....    ...+.++....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            88776666667789999999999863       34589999999999999999999999964332    22222221110


Q ss_pred             -----------------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          439 -----------------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       439 -----------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                                             ....+...++..+.+||++||+.||++||+++|+|+||-
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                                   011233456678999999999999999999999999964

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9e-47  Score=403.71  Aligned_cols=256  Identities=24%  Similarity=0.430  Sum_probs=205.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--  295 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++....   ......+.+.+|+.+|+.++||||+++++++...+  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            4579999999999999999999999999999999987432   22445677889999999999999999999987765  


Q ss_pred             ----cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          296 ----RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       296 ----~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                          .+|+||||+.+ +|.+++.  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence                68999999975 7888886  4689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC----------
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP----------  441 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~----------  441 (628)
                      ..........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....+.++......+          
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            6554445567899999999999765 49999999999999999999999998876655554443321110          


Q ss_pred             ----------CC--------------C------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          442 ----------EI--------------P------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       442 ----------~~--------------p------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                                .+              +      ...+.++++||++||+.||++|||++|||+||||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                      00              0      012578999999999999999999999999999964

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.3e-47  Score=411.04  Aligned_cols=254  Identities=31%  Similarity=0.507  Sum_probs=210.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      ..+|+++++||+|+||+||+|++..+++ ||+|++.....         ...+|+++|+.++|+|||++++++....   
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3579999999999999999999987766 88887753221         1236999999999999999999986543   


Q ss_pred             ---cceEEEEecccccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC-CCCCEEEeccCC
Q 040472          296 ---RLSVYLEYVSGGSIHKLLQ---EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD-PHGEIKLADFGM  368 (628)
Q Consensus       296 ---~~~lVmEy~~GgsL~~~L~---~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld-~~g~vKL~DFGl  368 (628)
                         .+++||||+.++.+..+..   ....+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence               3889999998754443332   356799999999999999999999999999999999999998 789999999999


Q ss_pred             cccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC-----------
Q 040472          369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS-----------  437 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~-----------  437 (628)
                      ++...........+||+.|+|||++.+...|+.++|||||||+||||++|++||........+..+...           
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            988766666667889999999999977667999999999999999999999999887655444433211           


Q ss_pred             -------CCCCC---------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          438 -------KDIPE---------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       438 -------~~~~~---------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                             ...+.         ++..+++++.+||++||+.||++||++.|+|+||||++..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                   01111         2345889999999999999999999999999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-48  Score=416.02  Aligned_cols=252  Identities=14%  Similarity=0.179  Sum_probs=204.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHH---HHHHhCCCCCeeeee-------
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEI---NLLSQLSHPNIVRYH-------  288 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIV~l~-------  288 (628)
                      .++|++++.||+|+||+||+|++..+++.||||++......  .....+.+.+|+   ++|++++|||||+++       
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C--CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc--chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            46899999999999999999999999999999999753221  123457788999   455566799999998       


Q ss_pred             cceeccc-----------------cceEEEEecccccHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcc
Q 040472          289 GSELSDE-----------------RLSVYLEYVSGGSIHKLLQEYGPFNE-------PVIQTYTRQILLGLAYLHARNTV  344 (628)
Q Consensus       289 ~~~~~~~-----------------~~~lVmEy~~GgsL~~~L~~~~~l~e-------~~~~~i~~qIl~aL~yLH~~gIv  344 (628)
                      +++.+.+                 ..||||||+ +|+|.+++...+.+++       ..+..|+.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4444432                 388999999 6899999987666666       77888999999999999999999


Q ss_pred             ccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCChhhhhcc----------CCCCccccccccccceee
Q 040472          345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT----------NGYSLTVDIWSLGCTVLE  414 (628)
Q Consensus       345 HRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~----------~~~s~ksDIWSLGvlLye  414 (628)
                      ||||||+||||+.++.+||+|||+++....  .....+| +.|+|||++.+.          ..++.++|||||||+|||
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999999999999999999986433  3445678 999999999765          248999999999999999


Q ss_pred             eccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          415 MATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       415 lLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      |++|+.||...........+..      .+..++.++.+||.+||+.||++||++.|+|+||||++..
T Consensus       306 lltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            9999999976554333333321      2346889999999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=395.67  Aligned_cols=260  Identities=37%  Similarity=0.674  Sum_probs=215.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceec---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELS---  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~---  293 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++......      ...+.+|+.+|+++ +|+||+++++++..   
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            357899999999999999999999999999999998743221      25677899999999 79999999999887   


Q ss_pred             ---cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          294 ---DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       294 ---~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                         .+.+|+||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence               56899999999999999999864  5799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCc-cccccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCC
Q 040472          369 AKHMTSC-ASMLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI  443 (628)
Q Consensus       369 a~~~~~~-~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~  443 (628)
                      +...... ......+||+.|+|||++..    ...++.++|||||||++|+|++|..||........+..+.........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  255 (326)
T 2x7f_A          176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK  255 (326)
T ss_dssp             TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred             ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCC
Confidence            9865432 22345679999999999862    334889999999999999999999999877666555554433332334


Q ss_pred             CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       444 p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ...++.++.+||++||+.||++||++.+|++||||++...
T Consensus       256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            5568999999999999999999999999999999986543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-47  Score=406.03  Aligned_cols=259  Identities=28%  Similarity=0.449  Sum_probs=204.5

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||+|+||+||+|++..+++.||||++......      ..+..+|++.|..++||||+++++++.....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            4678999999999999999999999999999999988542221      1244567888899999999999999876443


Q ss_pred             -------ceEEEEecccccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCCCceEeCC-CCCEE
Q 040472          297 -------LSVYLEYVSGGSIHKLL----QEYGPFNEPVIQTYTRQILLGLAYLH--ARNTVHRDIKGANILVDP-HGEIK  362 (628)
Q Consensus       297 -------~~lVmEy~~GgsL~~~L----~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHRDIKpeNILld~-~g~vK  362 (628)
                             +++||||+.++ |...+    .....+++..++.++.||+.||.|||  ++||+||||||+||||+. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                   88999999875 43333    35677999999999999999999999  999999999999999996 89999


Q ss_pred             EeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC----
Q 040472          363 LADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK----  438 (628)
Q Consensus       363 L~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~----  438 (628)
                      |+|||+++...........+||+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+....    
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            9999999987766666677899999999999776668999999999999999999999998766554443332100    


Q ss_pred             --------------------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          439 --------------------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       439 --------------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                                                ..+......+.++.+||.+||+.||++||++.|||+||||++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                                      01122233678999999999999999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.6e-47  Score=394.72  Aligned_cols=251  Identities=30%  Similarity=0.521  Sum_probs=210.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ...+|++.+.||+|+||+||+|++  +++.||||++....   ...+..+.+.+|+++|++++||||+++++++.+.+.+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD---FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC---CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            457999999999999999999987  47899999986432   2345567889999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGP---FNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~---l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ++||||+.|++|.+++.+.+.   +++..++.++.||+.||+|||++|  |+||||||+||||+.++.+||+|||+++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999987553   999999999999999999999999  999999999999999999999999999765


Q ss_pred             cCcc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          373 TSCA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       373 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      .... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+........++..++.++
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             ------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             cccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            4322 23456799999999999765 489999999999999999999999988776666555543444456778899999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||++||+.||++||++.+|++
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-46  Score=401.86  Aligned_cols=255  Identities=28%  Similarity=0.475  Sum_probs=212.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc-
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL-  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~-  297 (628)
                      .++|++++.||+|+||.||+|+++.+++.||||++....   ......+++.+|+.+|+.++||||+++++++...+.. 
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            368999999999999999999999999999999986432   2344567788999999999999999999999887665 


Q ss_pred             -----eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          298 -----SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       298 -----~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                           |+||||+. ++|.+++.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             cceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                 99999996 68888875  35999999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--------------  438 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--------------  438 (628)
                      ..  .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+....              
T Consensus       195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            43  23456799999999999775669999999999999999999999998766544443331100              


Q ss_pred             ---------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 ---------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ---------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                     ....+...++.++.+||++||+.||++||++.|+|+||||+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                           0011234578999999999999999999999999999999754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-46  Score=397.17  Aligned_cols=258  Identities=24%  Similarity=0.472  Sum_probs=214.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD---  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~---  294 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||+++..    .......++.+|+++|++++|+||+++++++..+   
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            457999999999999999999999999999999998632    2234456788999999999999999999987654   


Q ss_pred             --ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          295 --ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       295 --~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                        ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence              68999999996 699999876 67999999999999999999999999999999999999999999999999999865


Q ss_pred             cCcc-----------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---CC
Q 040472          373 TSCA-----------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---SK  438 (628)
Q Consensus       373 ~~~~-----------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~~  438 (628)
                      ....           .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+..   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            4321           123457999999999987656699999999999999999999999987654433322110   00


Q ss_pred             ----------------------CC-----CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          439 ----------------------DI-----PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       439 ----------------------~~-----~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                            ..     ......++.++.+||++||+.||++||++.|||+||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                  00     01124688999999999999999999999999999999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-47  Score=393.43  Aligned_cols=261  Identities=31%  Similarity=0.606  Sum_probs=198.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++....    .....+.+.+|+.+|++++||||+++++++...+..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3579999999999999999999999899999999875421    123356788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          298 SVYLEYVSGGSIHKLLQE--------YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~--------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                      ++||||+.|++|.+++..        .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999999974        456999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCcc------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-----
Q 040472          370 KHMTSCA------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-----  438 (628)
Q Consensus       370 ~~~~~~~------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-----  438 (628)
                      .......      ......||+.|+|||++.+...++.++|||||||++|+|++|+.||................     
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            7654321      12345799999999998764558999999999999999999999998765544433322111     


Q ss_pred             ---CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          439 ---DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       439 ---~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                         ........++.++.+||.+||+.||.+||++.+|++||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence               11233456889999999999999999999999999999997643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-46  Score=411.79  Aligned_cols=254  Identities=27%  Similarity=0.490  Sum_probs=211.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC------CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL------SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIV~l~~~~  291 (628)
                      ...+|+++++||+|+||+||+|++..+++.||||+++.      .....+++.+|+++|+.+      .|+||+++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            34689999999999999999999999999999999863      133446677888888877      577999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC--EEEeccC
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--IKLADFG  367 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~--vKL~DFG  367 (628)
                      ...+.+++||||+. ++|.+++....  .+++..++.|+.||+.||+|||++|||||||||+||||+.++.  +||+|||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999999995 68999987653  5999999999999999999999999999999999999999887  9999999


Q ss_pred             CcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC----------
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS----------  437 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~----------  437 (628)
                      ++.....  .....+||+.|+|||++.+.. |+.++|||||||+||||++|.+||...+....+..+...          
T Consensus       248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            9976433  334568999999999997654 999999999999999999999999876654433322110          


Q ss_pred             -----------CCCC------------------------------------CCCCcCCHHHHHHHHHHhhcCCCCCCCHH
Q 040472          438 -----------KDIP------------------------------------EIPEHLSDDAKSFIKQCLQRDPSARPPAS  470 (628)
Q Consensus       438 -----------~~~~------------------------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~  470 (628)
                                 ...+                                    .++...++++.+||++||+.||++|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                       0000                                    01123478899999999999999999999


Q ss_pred             HHhcCccccch
Q 040472          471 KLLDHPFVRDQ  481 (628)
Q Consensus       471 eiL~Hpwf~~~  481 (628)
                      |||+||||++.
T Consensus       405 e~L~Hpw~~~~  415 (429)
T 3kvw_A          405 QALRHPWLRRR  415 (429)
T ss_dssp             HHHTSTTTC--
T ss_pred             HHhCChhhccC
Confidence            99999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-46  Score=389.06  Aligned_cols=257  Identities=39%  Similarity=0.745  Sum_probs=224.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..+.|++++.||+|+||.||+|++..+++.||||++......    ...+.+.+|+.+|+.++|+||+++++++.++..+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            346899999999999999999999999999999998753221    2356788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.|++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999999999999975 679999999999999999999999999999999999999999999999999998765432 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.. ...+.++..++.++.+||.
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHHHH
Confidence            33456799999999998754 489999999999999999999999987665554444432 2234566788999999999


Q ss_pred             HHhhcCCCCCCCHHHHhcCccccch
Q 040472          457 QCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       457 ~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||+.||++||++.+|++|+||...
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcC
Confidence            9999999999999999999999643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=394.13  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=215.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ...+|++.++||+|+||.||+|++..+++   .||||+++...    .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            45789999999999999999999986655   49999986421    234457788999999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.+||||||+.|++|.++++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999754 689999999999999999999999999999999999999999999999999998764


Q ss_pred             Ccc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          374 SCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       374 ~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ...    ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||........+..+..... ...+..++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  280 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR-LPAPMGCP  280 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-CCCCCCcC
Confidence            322    12234567889999999755 48999999999999999999 9999988777666665554433 34566799


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||.+||+.||++||++.+|++.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999853

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=388.11  Aligned_cols=258  Identities=39%  Similarity=0.693  Sum_probs=216.1

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ....++|++.+.||+|+||.||+|++..+++.||||++....       ..+.+.+|+.+|+.++|+||+++++++.+++
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            334578999999999999999999999999999999986422       1356788999999999999999999999999


Q ss_pred             cceEEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+|+||||+.+++|.+++. ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999999999999997 456899999999999999999999999999999999999999999999999999986644


Q ss_pred             cc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHH
Q 040472          375 CA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~  452 (628)
                      .. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+.... .....+..++.++.
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence            32 23456799999999998655 48999999999999999999999998766555444432221 11233556889999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||++||+.||++||++.+||+||||+..
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            99999999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.4e-47  Score=384.89  Aligned_cols=259  Identities=29%  Similarity=0.528  Sum_probs=220.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee--ccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL--SDE  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~--~~~  295 (628)
                      ..++|++++.||+|+||.||+|+++.+++.||||++.....   .....+.+.+|+++|++++||||+++++++.  .+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            35799999999999999999999999999999999875322   2344677899999999999999999999875  467


Q ss_pred             cceEEEEecccccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCCCceEeCCCCCEEEecc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY----GPFNEPVIQTYTRQILLGLAYLHARN-----TVHRDIKGANILVDPHGEIKLADF  366 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~----~~l~e~~~~~i~~qIl~aL~yLH~~g-----IvHRDIKpeNILld~~g~vKL~DF  366 (628)
                      .+|+||||+.|++|.+++...    ..+++..++.++.||+.||+|||+++     |+||||||+||||+.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            899999999999999999753    34999999999999999999999999     999999999999999999999999


Q ss_pred             CCcccccCccc-cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC
Q 040472          367 GMAKHMTSCAS-MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE  445 (628)
Q Consensus       367 Gla~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~  445 (628)
                      |+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... ..+.++.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~  238 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPY  238 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCCT
T ss_pred             chheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-ccccCCc
Confidence            99986644322 2345799999999998765 4899999999999999999999999877655444444332 2345667


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .++.++.+||++||+.||++||++.||++|+|+.+.
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            899999999999999999999999999999999653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-46  Score=388.07  Aligned_cols=260  Identities=37%  Similarity=0.667  Sum_probs=217.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||+|++....     ....+.+.+|+++|+.++||||+++++++.+++.+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            4578999999999999999999999999999999986432     12246788899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-c
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-C  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~  375 (628)
                      ++||||+.+++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999999999876 46799999999999999999999999999999999999999999999999999764322 1


Q ss_pred             cccccccCCCCcCChhhhh----ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC-CCCCCCcCCHH
Q 040472          376 ASMLSFKGSPYWMAPEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD-IPEIPEHLSDD  450 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~s~~  450 (628)
                      .......||+.|+|||++.    ....++.++|||||||++|+|++|..||........+..+..... ....+..++.+
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence            2233467999999999984    244588999999999999999999999988766555544433221 11335678999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      +.+||++||+.||++||++.+|++||||+...
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            99999999999999999999999999997543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=392.21  Aligned_cols=257  Identities=26%  Similarity=0.462  Sum_probs=209.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee------
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL------  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~------  292 (628)
                      .++|++++.||+|+||.||+|++..+++.||||++...     .....+++.+|+++|++++||||+++++++.      
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            46899999999999999999999999999999988642     2345677889999999999999999998863      


Q ss_pred             --------ccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC-CCCCEEE
Q 040472          293 --------SDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD-PHGEIKL  363 (628)
Q Consensus       293 --------~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld-~~g~vKL  363 (628)
                              +...+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence                    4467899999997 699999875 6799999999999999999999999999999999999997 5679999


Q ss_pred             eccCCcccccCc----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC
Q 040472          364 ADFGMAKHMTSC----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       364 ~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +|||+++.....    .......+|..|+|||++.+...++.++|||||||++|||++|+.||........+..+.....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999865432    2233456899999999987656699999999999999999999999987665444333321100


Q ss_pred             ----------------------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          440 ----------------------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       440 ----------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                                                  ...+...++.++.+||++||+.||++||++.|||+||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                                        0112345889999999999999999999999999999997543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.3e-47  Score=389.97  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=222.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++.......   ...+.+.+|+++|++++||||+++++++.+.+.+
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            4568999999999999999999999999999999987533221   2245678999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFGla~~~~~  374 (628)
                      |+||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.+   +.+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999999999888899999999999999999999999999999999999999764   4699999999987655


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCC--CCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEI--PEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~--p~~~s~~l~  452 (628)
                      ........||+.|+|||++.+  .++.++|||||||++|+|++|..||...........+.........  ...++.++.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          177 NTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            544455678999999999864  3899999999999999999999999876665554444333221122  246899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||++||+.||++||++.|+|+||||++.
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.4e-47  Score=404.76  Aligned_cols=262  Identities=16%  Similarity=0.143  Sum_probs=196.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC--CCCCeeeeecc-------
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL--SHPNIVRYHGS-------  290 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIV~l~~~-------  290 (628)
                      .+|++++.||+|+||+||+|++..+++.||||+++....  ......+.+.+|+.+++.|  +||||++++..       
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            469999999999999999999999999999999976332  2344556777885544444  69998886533       


Q ss_pred             eecc-----------------ccceEEEEecccccHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCcccc
Q 040472          291 ELSD-----------------ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVI------QTYTRQILLGLAYLHARNTVHR  346 (628)
Q Consensus       291 ~~~~-----------------~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~------~~i~~qIl~aL~yLH~~gIvHR  346 (628)
                      +...                 ..+||||||+. |+|.+++... ..+.+..+      ..++.||+.||+|||++|||||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            3222                 34899999998 8999999864 34455555      5777999999999999999999


Q ss_pred             ccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCChhhhhc-cCCCCccccccccccceeeeccCCCCCCCC
Q 040472          347 DIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN-TNGYSLTVDIWSLGCTVLEMATSKPPWSQY  425 (628)
Q Consensus       347 DIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvlLyelLtG~~PF~~~  425 (628)
                      ||||+||||+.++.+||+|||+++......  ....+|+.|+|||++.+ ...++.++|||||||+||||++|+.||...
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999998664322  14457799999999965 134899999999999999999999999765


Q ss_pred             chhH--HHhh-----hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          426 EGVA--AIFK-----IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       426 ~~~~--~~~~-----i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      ....  ....     ..........+..++.++.+||.+||+.||++||++.++|+||||++..+...
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence            3211  0100     00111111223478999999999999999999999999999999998776543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=395.75  Aligned_cols=255  Identities=28%  Similarity=0.474  Sum_probs=213.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc--
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER--  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~--  296 (628)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++....   ......+++.+|+.+|+.++||||+++++++.....  
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            368999999999999999999999999999999986422   234456778899999999999999999999987654  


Q ss_pred             ----ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          297 ----LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       297 ----~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                          +|+||||+. ++|.+++..  .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                499999997 688888753  5999999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC----------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----------------  436 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~----------------  436 (628)
                      ...  ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+..                
T Consensus       177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            432  34467999999999997756689999999999999999999999987654433322211                


Q ss_pred             -------------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 -------------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 -------------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                   ......+...++.++.+||++||+.||++||++.|+|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         112233445789999999999999999999999999999999753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.3e-47  Score=400.11  Aligned_cols=253  Identities=24%  Similarity=0.432  Sum_probs=214.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEE-----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++++.||+|+||.||+|+     +..+++.||||+++..    ......+.+.+|+++|.++ +|||||++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            45799999999999999999998     5567799999998632    2234457789999999999 799999999998


Q ss_pred             eccc-cceEEEEecccccHHHHHHhcCC----------------------------------------------------
Q 040472          292 LSDE-RLSVYLEYVSGGSIHKLLQEYGP----------------------------------------------------  318 (628)
Q Consensus       292 ~~~~-~~~lVmEy~~GgsL~~~L~~~~~----------------------------------------------------  318 (628)
                      .+.+ .+++||||+.||+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 59999999999999999986543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc---ccccc
Q 040472          319 --------------FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA---SMLSF  381 (628)
Q Consensus       319 --------------l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~---~~~~~  381 (628)
                                    +++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......   .....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                          8999999999999999999999999999999999999999999999999998653322   23345


Q ss_pred             cCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhh
Q 040472          382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ  460 (628)
Q Consensus       382 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  460 (628)
                      .||+.|+|||++.+. .++.++|||||||++|||++ |..||........+............+..++.++.+||.+||+
T Consensus       256 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          256 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             EECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            689999999998765 49999999999999999998 9999987655444444333333456677899999999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q 040472          461 RDPSARPPASKLLDH  475 (628)
Q Consensus       461 ~dP~~Rpta~eiL~H  475 (628)
                      .||++||++.||++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.2e-46  Score=401.29  Aligned_cols=252  Identities=25%  Similarity=0.450  Sum_probs=215.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-------CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-------ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~  289 (628)
                      ..++|++++.||+|+||+||+|++.       .++..||||+++..    ......+.+.+|+.+|+++ +|||||++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            4578999999999999999999874       34567999988642    2344567899999999999 8999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.+++.+|+||||+.||+|.++|....                .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998653                478999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.......
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999998654432   22335678899999998765 49999999999999999999 999998766554


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+..+.. ...+..+..++.++.+||++||+.||++||++.||+++
T Consensus       314 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444433 23345677899999999999999999999999999865

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.3e-46  Score=388.96  Aligned_cols=258  Identities=30%  Similarity=0.516  Sum_probs=213.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEEC-CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeeccee--
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNS-ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSEL--  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~--  292 (628)
                      .++|++++.||+|+||.||+|++. .+++.||||+++........   ...+.+|+.+++.+   .||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            468999999999999999999995 67899999998754322111   12344566666655   8999999999987  


Q ss_pred             ---ccccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          293 ---SDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       293 ---~~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                         ....+++||||+. |+|.+++....  .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence               5678999999997 59999998753  49999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC----------
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS----------  437 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~----------  437 (628)
                      +++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+...          
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            99876655555567899999999998765 4899999999999999999999999876655444333210          


Q ss_pred             ---------------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 ---------------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 ---------------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                     .....+...++.++.+||++||+.||++||++.|+|+||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                           01112345688999999999999999999999999999999754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=389.13  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=215.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee--cccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL--SDER  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~--~~~~  296 (628)
                      +++|++++.||+|+||.||+|++..+++.||||+++...... .....+.+.+|+++|++++|+||+++++++.  +...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            578999999999999999999999999999999986422111 1123567889999999999999999999984  4568


Q ss_pred             ceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +|+||||+.++ |.+++..  ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999999876 7777765  45799999999999999999999999999999999999999999999999999986543


Q ss_pred             ---ccccccccCCCCcCChhhhhccC-CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          375 ---CASMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       375 ---~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                         ........||+.|+|||++.+.. .++.++|||||||++|||++|..||...........+....  ..++..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~  239 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIPGDCGPP  239 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCCSSSCHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--CCCCCccCHH
Confidence               22234567999999999986533 24779999999999999999999998766555444443322  2456778999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +.+||++||+.||++||++.||++||||+..
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            9999999999999999999999999999753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.4e-47  Score=400.09  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=207.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc------cchHHHHHHHHHHHHHHHhCCCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD------QTSKECLKQLNQEINLLSQLSHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~------~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~  291 (628)
                      ..++|+++++||+|+||.||+|++.. ++.||||++......      .......+++.+|+++|++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34789999999999999999999865 899999998643221      12344567899999999999999999999998


Q ss_pred             ec-----cccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEec
Q 040472          292 LS-----DERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLAD  365 (628)
Q Consensus       292 ~~-----~~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~D  365 (628)
                      ..     ...+|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            54     346899999997 5777777654 4799999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC--------
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS--------  437 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~--------  437 (628)
                      ||+++...........+||+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+...        
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999987655555566789999999999977566999999999999999999999999876544433332110        


Q ss_pred             -----------------CCC-----CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          438 -----------------KDI-----PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       438 -----------------~~~-----~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                       ...     ......++..+.+||++||+.||++|||+.|||+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                             000     01224568899999999999999999999999999999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-46  Score=384.67  Aligned_cols=256  Identities=29%  Similarity=0.480  Sum_probs=208.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-----  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-----  293 (628)
                      .++|++++.||+|+||.||+|++..+++.||||++..      .....+.+.+|+.+|++++||||+++++++.+     
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            3589999999999999999999999999999999863      23445778899999999999999999998754     


Q ss_pred             --------cccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEe
Q 040472          294 --------DERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLA  364 (628)
Q Consensus       294 --------~~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~  364 (628)
                              ...+|+||||+.|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                    467899999999999999998643 57889999999999999999999999999999999999999999999


Q ss_pred             ccCCcccccCc---------------cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch-h
Q 040472          365 DFGMAKHMTSC---------------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-V  428 (628)
Q Consensus       365 DFGla~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~  428 (628)
                      |||++......               ......+||+.|+|||++.+...++.++|||||||++|+|++   ||..... .
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            99999765421               123346799999999999766568999999999999999998   5654322 2


Q ss_pred             HHHhhhcC--CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          429 AAIFKIGN--SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       429 ~~~~~i~~--~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      .....+..  ....+.++...+..+.+||++||+.||.+||++.+|++||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            22222222  12223455667889999999999999999999999999999975443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=384.63  Aligned_cols=259  Identities=41%  Similarity=0.673  Sum_probs=215.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|....+||+|+||.||+|++..+++.||||++....     ....+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus        20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            3455666679999999999999999999999999986432     22346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-CCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEY---GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-~g~vKL~DFGla~~~~  373 (628)
                      ++||||+.+++|.+++...   ..+++..+..++.||+.||+|||++||+||||||+||||+. ++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            9999999999999999865   24678999999999999999999999999999999999987 8999999999998764


Q ss_pred             Ccc-ccccccCCCCcCChhhhhcc-CCCCccccccccccceeeeccCCCCCCCCchhH-HHhhhcCCCCCCCCCCcCCHH
Q 040472          374 SCA-SMLSFKGSPYWMAPEVVMNT-NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-AIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       374 ~~~-~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||....... ...........+.++..++.+
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE  254 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence            422 23456799999999998653 237899999999999999999999997543322 222222223345667789999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +.+||.+||+.||++||++.++|+|+||+..
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-47  Score=391.60  Aligned_cols=256  Identities=27%  Similarity=0.489  Sum_probs=212.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|+++++||+|+||+||+|++..+++.||||++..     ...+..+.+.+|+++|++++||||+++++++.+++..
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            35799999999999999999999999999999998743     2345567889999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ++||||+.|++|.++++. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999999987 5679999999999999999999999999999999999999999999999999998654322


Q ss_pred             c---------------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc-CCCCC
Q 040472          377 S---------------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG-NSKDI  440 (628)
Q Consensus       377 ~---------------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~-~~~~~  440 (628)
                      .               ....+||+.|+|||++.+. .++.++|||||||++|||++|..||............. .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            1               1256799999999999764 58999999999999999999999986532211100000 00000


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ...+..++.++.+||.+||+.||++||++.+|++  |++..
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            1234567889999999999999999999999986  55443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.3e-47  Score=403.56  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=205.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC--------CCCeeeeecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS--------HPNIVRYHGS  290 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIV~l~~~  290 (628)
                      .++|+++++||+|+||+||+|++..+++.||||+++..      ....+.+.+|+.+|+.++        |+||++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            47899999999999999999999999999999998631      334567889999999886        7889999999


Q ss_pred             ee----ccccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCC----
Q 040472          291 EL----SDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHG----  359 (628)
Q Consensus       291 ~~----~~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g----  359 (628)
                      +.    +...+||||||+ +++|.+++.+.  ..+++..++.|+.||+.||+|||++ ||+||||||+||||+.++    
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            88    567899999999 55666665543  5799999999999999999999998 999999999999999775    


Q ss_pred             ---------------------------------------------CEEEeccCCcccccCccccccccCCCCcCChhhhh
Q 040472          360 ---------------------------------------------EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM  394 (628)
Q Consensus       360 ---------------------------------------------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~  394 (628)
                                                                   .+||+|||++......  ....+||+.|+|||++.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence                                                         7999999999876432  34567999999999997


Q ss_pred             ccCCCCccccccccccceeeeccCCCCCCCCch------hHH---HhhhcCCC----------------------CC---
Q 040472          395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG------VAA---IFKIGNSK----------------------DI---  440 (628)
Q Consensus       395 ~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~------~~~---~~~i~~~~----------------------~~---  440 (628)
                      +.. ++.++|||||||+||||++|+.||.....      ...   +..+....                      ..   
T Consensus       267 ~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          267 GSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             TSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             CCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            654 99999999999999999999999975331      111   11110000                      00   


Q ss_pred             ------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          441 ------------PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       441 ------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                                  ..++...+.++.+||++||+.||++|||+.|||+||||+
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                        012334567889999999999999999999999999996

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=407.38  Aligned_cols=254  Identities=27%  Similarity=0.473  Sum_probs=191.6

Q ss_pred             CCeEE-eeeeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee--cc
Q 040472          220 SKWKK-GKLLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL--SD  294 (628)
Q Consensus       220 ~~y~~-~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~--~~  294 (628)
                      +.|++ +++||+|+||+||+|+++  .+++.||||++.....       ...+.+|+.+|++++|||||++++++.  .+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            35666 568999999999999976  5789999998863211       135678999999999999999999995  47


Q ss_pred             ccceEEEEecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe----CCCCCE
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY---------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV----DPHGEI  361 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl----d~~g~v  361 (628)
                      ..+||||||+. ++|.+++...         ..+++..++.|+.||+.||+|||++||+||||||+||||    +.++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            78999999996 5888877532         249999999999999999999999999999999999999    677899


Q ss_pred             EEeccCCcccccCc----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch----------
Q 040472          362 KLADFGMAKHMTSC----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG----------  427 (628)
Q Consensus       362 KL~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~----------  427 (628)
                      ||+|||+++.+...    ......+||+.|+|||++.+...++.++||||||||||||++|++||.....          
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999876432    2334578999999999998766699999999999999999999999964322          


Q ss_pred             --hHHHhhhcCCCCCCC---------------------------------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 040472          428 --VAAIFKIGNSKDIPE---------------------------------IPEHLSDDAKSFIKQCLQRDPSARPPASKL  472 (628)
Q Consensus       428 --~~~~~~i~~~~~~~~---------------------------------~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei  472 (628)
                        ...+...........                                 .....+.++.+||++||+.||++|||++||
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence              111111111100000                                 011236789999999999999999999999


Q ss_pred             hcCccccch
Q 040472          473 LDHPFVRDQ  481 (628)
Q Consensus       473 L~Hpwf~~~  481 (628)
                      |+||||++.
T Consensus       332 L~hp~f~~~  340 (405)
T 3rgf_A          332 MQDPYFLED  340 (405)
T ss_dssp             HTSGGGTSS
T ss_pred             hcChhhccC
Confidence            999999753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=400.40  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=218.0

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEE-----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecc
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS  290 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~  290 (628)
                      +...++|++++.||+|+||+||+|+     +..+++.||||+++..    .......++.+|+.+|++++|||||+++++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3456789999999999999999999     4567889999988532    223445678889999999999999999999


Q ss_pred             eeccccceEEEEecccccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC---C
Q 040472          291 ELSDERLSVYLEYVSGGSIHKLLQEYG-------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG---E  360 (628)
Q Consensus       291 ~~~~~~~~lVmEy~~GgsL~~~L~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g---~  360 (628)
                      +.+....|+||||+.||+|.+++....       .+++..++.++.||+.||+|||++||+||||||+||||+.++   .
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999998653       489999999999999999999999999999999999999655   4


Q ss_pred             EEEeccCCcccccCc---cccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcC
Q 040472          361 IKLADFGMAKHMTSC---ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGN  436 (628)
Q Consensus       361 vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~  436 (628)
                      +||+|||+++.+...   .......||+.|+|||++.+. .++.++|||||||+||||++ |..||........+..+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999754321   223345689999999998765 49999999999999999998 9999988766655555544


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       437 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      .. ....+..++.++.+||++||+.||++||++.+|++|.|+-
T Consensus       302 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          302 GG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            33 3455677899999999999999999999999999998764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=390.81  Aligned_cols=256  Identities=27%  Similarity=0.456  Sum_probs=208.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc-hHHHHHHHHHHHHHHHhC----CCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQL----SHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l----~HpnIV~l~~~~~  292 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++........ .......+.+|+.++.++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            35689999999999999999999999999999999864322111 112233466799999998    8999999999999


Q ss_pred             ccccceEEEEe-cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC-CCCCEEEeccCCcc
Q 040472          293 SDERLSVYLEY-VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD-PHGEIKLADFGMAK  370 (628)
Q Consensus       293 ~~~~~~lVmEy-~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld-~~g~vKL~DFGla~  370 (628)
                      +.+..++|||| +.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++.
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            99999999999 78999999999988999999999999999999999999999999999999998 78999999999998


Q ss_pred             cccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||......   ...     ...++..++.+
T Consensus       189 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~-----~~~~~~~~~~~  259 (312)
T 2iwi_A          189 LLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---LEA-----ELHFPAHVSPD  259 (312)
T ss_dssp             ECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHT-----CCCCCTTSCHH
T ss_pred             hcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---hhh-----ccCCcccCCHH
Confidence            76543 3345679999999999876654456899999999999999999999764321   111     12455678999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      +.+||++||+.||++||++.||++||||+...
T Consensus       260 ~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            99999999999999999999999999997643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-46  Score=394.18  Aligned_cols=263  Identities=25%  Similarity=0.440  Sum_probs=221.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc------------hHHHHHHHHHHHHHHHhCCCCCee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT------------SKECLKQLNQEINLLSQLSHPNIV  285 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~------------~~~~~~~~~~Ei~iL~~l~HpnIV  285 (628)
                      .+++|++++.||+|+||.||+|++  +++.||||++........            .....+.+.+|+.+|++++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            467999999999999999999998  899999999864221110            001126788999999999999999


Q ss_pred             eeecceeccccceEEEEecccccHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeC
Q 040472          286 RYHGSELSDERLSVYLEYVSGGSIHKL------LQE--YGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVD  356 (628)
Q Consensus       286 ~l~~~~~~~~~~~lVmEy~~GgsL~~~------L~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld  356 (628)
                      ++++++.+.+.+|+||||+.+++|.++      +..  ...+++..++.++.||+.||+|||+ +||+||||||+||||+
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            999999999999999999999999998      665  5789999999999999999999999 9999999999999999


Q ss_pred             CCCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCc-cccccccccceeeeccCCCCCCCCch-hHHHhhh
Q 040472          357 PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSL-TVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKI  434 (628)
Q Consensus       357 ~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~-ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i  434 (628)
                      .++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|||++|..||..... ......+
T Consensus       187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9999999999999876443 3445679999999999876544666 99999999999999999999987655 3333333


Q ss_pred             cCCCCCCCCC-------------------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHHHh
Q 040472          435 GNSKDIPEIP-------------------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAVAR  485 (628)
Q Consensus       435 ~~~~~~~~~p-------------------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~  485 (628)
                      ....  ..++                   ..++.++.+||++||+.||++||++.|+++||||++..+..
T Consensus       266 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~  333 (348)
T 2pml_X          266 RTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED  333 (348)
T ss_dssp             TSCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred             hccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence            3221  1222                   56899999999999999999999999999999998766544

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.1e-46  Score=387.58  Aligned_cols=253  Identities=24%  Similarity=0.382  Sum_probs=210.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEE-CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC------Ceeeeecce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFN-SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP------NIVRYHGSE  291 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~-~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp------nIV~l~~~~  291 (628)
                      .++|++++.||+|+||.||+|++ ..+++.||||+++..      ....+.+.+|+++|+.++|+      +|+++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            46999999999999999999998 568899999998631      23456788899999988765      499999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC------------
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP------------  357 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~------------  357 (628)
                      .+.+.+++||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+||||+.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 889999998765  6899999999999999999999999999999999999987            


Q ss_pred             -------CCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH
Q 040472          358 -------HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA  430 (628)
Q Consensus       358 -------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~  430 (628)
                             ++.+||+|||+++....  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...+....
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   66899999999986543  23456799999999999765 489999999999999999999999987554432


Q ss_pred             HhhhcCCC-C-----------------------------------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCC
Q 040472          431 IFKIGNSK-D-----------------------------------------IPEIPEHLSDDAKSFIKQCLQRDPSARPP  468 (628)
Q Consensus       431 ~~~i~~~~-~-----------------------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt  468 (628)
                      +..+.... .                                         ........+.++.+||++||+.||++||+
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            22111000 0                                         00112234578999999999999999999


Q ss_pred             HHHHhcCccccch
Q 040472          469 ASKLLDHPFVRDQ  481 (628)
Q Consensus       469 a~eiL~Hpwf~~~  481 (628)
                      +.|||+||||+..
T Consensus       323 ~~ell~hp~f~~~  335 (339)
T 1z57_A          323 LREALKHPFFDLL  335 (339)
T ss_dssp             HHHHTTSGGGGGG
T ss_pred             HHHHhcCHHHHHH
Confidence            9999999999754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.4e-46  Score=388.41  Aligned_cols=258  Identities=22%  Similarity=0.410  Sum_probs=198.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|++++.||+|+||.||+|++..++.   .||||+++....   .....+.+.+|+++|++++||||+++++++....
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            4689999999999999999999887765   899998864321   2234577889999999999999999999998876


Q ss_pred             cc------eEEEEecccccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEE
Q 040472          296 RL------SVYLEYVSGGSIHKLLQEYG------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       296 ~~------~lVmEy~~GgsL~~~L~~~~------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL  363 (628)
                      ..      ++||||+.+++|.+++....      .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            65      99999999999999996543      5999999999999999999999999999999999999999999999


Q ss_pred             eccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCC
Q 040472          364 ADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       364 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||...........+.... 
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-  256 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-  256 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-
Confidence            99999986544322   2234577899999998765 49999999999999999999 999998876665555554433 


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCC-------HHHHhcCccccch
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPP-------ASKLLDHPFVRDQ  481 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt-------a~eiL~Hpwf~~~  481 (628)
                      ....+..++.++.+||++||+.||++||+       ++++++|+|+...
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            33556678999999999999999999999       7788899998654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8e-46  Score=384.23  Aligned_cols=261  Identities=29%  Similarity=0.501  Sum_probs=199.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+++|++++.||+|+||.||+|+++.+++.||||++....   ......+.+.++..+++.++|+||+++++++.+++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            35789999999999999999999999999999999987432   222333445566677889999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +|+||||+ ++.+..++.. .+.+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||++.....
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99999999 6677766654 57899999999999999999999995 999999999999999999999999999987655


Q ss_pred             ccccccccCCCCcCChhhhh----ccCCCCccccccccccceeeeccCCCCCCCCch-hHHHhhhcCCCCCCCC--CCcC
Q 040472          375 CASMLSFKGSPYWMAPEVVM----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG-VAAIFKIGNSKDIPEI--PEHL  447 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~-~~~~~~i~~~~~~~~~--p~~~  447 (628)
                      ........||+.|+|||++.    ....++.++|||||||++|+|++|+.||..... ...+..+.... .+.+  ...+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  256 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPGHMGF  256 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCSSSCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCccCCC
Confidence            44455567999999999985    234588999999999999999999999986433 23333322211 1222  2358


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      +.++.+||.+||+.||.+||++.+|++||||++..
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            89999999999999999999999999999997643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.4e-46  Score=375.90  Aligned_cols=253  Identities=29%  Similarity=0.565  Sum_probs=207.0

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++.+.||+|+||.||+|++.  ++.||||+++..... ......+.+.+|+++++.++||||+++++++.+++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            35679999999999999999999875  789999988643221 112335678899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCCCceEeCC--------CCCEEEec
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN---TVHRDIKGANILVDP--------HGEIKLAD  365 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHRDIKpeNILld~--------~g~vKL~D  365 (628)
                      +++||||+.|++|.+++.. ..+++..++.++.||+.||+|||++|   |+||||||+||||+.        ++.+||+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999999864 67999999999999999999999999   899999999999986        67899999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCC
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE  445 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~  445 (628)
                      ||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+........++.
T Consensus       160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3dtc_A          160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS  237 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred             CCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence            99998654432 2345799999999998765 489999999999999999999999998777666666555555556777


Q ss_pred             cCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       446 ~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.++.+||++||+.||++||++.|++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            899999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=389.34  Aligned_cols=252  Identities=24%  Similarity=0.442  Sum_probs=216.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|++++.||+|+||.||+|++.     .+++.||||+++..    ......+.+.+|+.+|++++||||+++++++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4578999999999999999999987     45689999998642    22445678899999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEY------------------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDI  348 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~------------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI  348 (628)
                      +++.+|+||||+.+++|.+++...                        ..+++..++.++.||+.||+|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999864                        56899999999999999999999999999999


Q ss_pred             CCCceEeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCC
Q 040472          349 KGANILVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ  424 (628)
Q Consensus       349 KpeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~  424 (628)
                      ||+||||+.++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999997654322   22345689999999998765 49999999999999999999 9999988


Q ss_pred             CchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       425 ~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .........+... ....++..++.++.+||++||+.||++||++.+|+++
T Consensus       280 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          280 MAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             SCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CChHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            7665555555433 3345677899999999999999999999999999754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.1e-46  Score=388.45  Aligned_cols=259  Identities=30%  Similarity=0.514  Sum_probs=193.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHH-HHHhCCCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN-LLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..++|++++.||+|+||.||+|+++.+++.||||+++....    .....++..|+. +++.++||||+++++++.+++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            45799999999999999999999999999999999975321    223344555555 7788899999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQE-----YGPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      .|+||||+.+ +|.+++..     ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999975 88887763     56799999999999999999999999 99999999999999999999999999998


Q ss_pred             cccCccccccccCCCCcCChhhhh---ccCCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcCCCCCCCC---
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVM---NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEI---  443 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~---~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~~~~~~~~---  443 (628)
                      ............||+.|+|||++.   ....++.++|||||||++|+|++|+.||...... ..+..+.. ...+.+   
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  253 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK-GDPPQLSNS  253 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC-SCCCCCCCC
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc-CCCCCCCCc
Confidence            765544444557999999999983   2344899999999999999999999999865432 22222222 111222   


Q ss_pred             -CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          444 -PEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       444 -p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                       ...++.++.+||++||+.||++||++.+|++||||....
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence             246889999999999999999999999999999997654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-45  Score=382.38  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=215.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|++++.||+|+||.||+|++     ..+++.||||+++..    ......+.+.+|+++|++++||||+++++++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            457899999999999999999988     345689999988632    22445678899999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEYGP------------------------FNEPVIQTYTRQILLGLAYLHARNTVHRDI  348 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~~~------------------------l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI  348 (628)
                      +++.+++||||+.|++|.+++.....                        +++..++.++.||+.||+|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            99999999999999999999987543                        899999999999999999999999999999


Q ss_pred             CCCceEeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCC
Q 040472          349 KGANILVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ  424 (628)
Q Consensus       349 KpeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~  424 (628)
                      ||+||||+.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998664332   12334578899999998765 48999999999999999999 9999987


Q ss_pred             CchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       425 ~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .........+.. ......+..++.++.+||.+||+.||++||++.+|+++
T Consensus       256 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            655444444333 23345667899999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-45  Score=375.53  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=213.1

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++++.||+|+||.||+|.+. ++..||||+++.....      .+++.+|+++|++++|+||+++++++.+++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            34679999999999999999999887 5778999998643211      2457889999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +++||||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999999999986 567999999999999999999999999999999999999999999999999999865432


Q ss_pred             c--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 A--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      .  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.... ....+..+++++.
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  251 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVY  251 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred             ccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-CCCCCCcCCHHHH
Confidence            2  22334578889999998765 49999999999999999998 999998877666665554432 2345567889999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcC
Q 040472          453 SFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +||++||+.||++||++.+|++|
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-45  Score=373.38  Aligned_cols=249  Identities=27%  Similarity=0.432  Sum_probs=214.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|++. +++.||||++......      .+++.+|+++|++++||||+++++++.++..+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            3568999999999999999999987 4778999998643211      24578899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ++||||+.+++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999999999975 4568999999999999999999999999999999999999999999999999998654332


Q ss_pred             --ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 --SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                        ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... ....+..++.++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQ  238 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHH
T ss_pred             cccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCCCcCCHHHHH
Confidence              22335578889999998655 49999999999999999999 999998877666555554432 33456678999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcC
Q 040472          454 FIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ||++||+.||++||++.++++|
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-46  Score=389.36  Aligned_cols=255  Identities=24%  Similarity=0.375  Sum_probs=214.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++++.||+|+||.||+|++     ..+++.||||+++...    .....+.+.+|+.+|+++ +||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            457999999999999999999997     3467789999986422    223346788999999999 899999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG-----------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDI  348 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~-----------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI  348 (628)
                      .+.+.+|+||||+.+|+|.+++....                       .+++..++.++.||+.||+|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999998643                       3789999999999999999999999999999


Q ss_pred             CCCceEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCC
Q 040472          349 KGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ  424 (628)
Q Consensus       349 KpeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~  424 (628)
                      ||+||||+.++.+||+|||++........   .....||+.|+|||++.+. .++.++|||||||+||+|++ |..||..
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999986543322   2334578899999998765 49999999999999999998 9999987


Q ss_pred             CchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       425 ~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      ......+..+.........+..++.++.+||.+||+.||.+||++.+|++|-.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            66555544444444444566778999999999999999999999999998643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.8e-45  Score=371.87  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=214.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|.+. ++..||||+++.....      .+++.+|+++|++++||||+++++++.++..+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            4578999999999999999999877 5678999998643221      24578899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ++||||+.+++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998754 59999999999999999999999999999999999999999999999999998664432


Q ss_pred             --ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          377 --SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       377 --~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                        ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+.... ....+..++.++.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQ  236 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHH
Confidence              223345677899999987654 8999999999999999999 999998877666665554433 23445668999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcC
Q 040472          454 FIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ||++||+.||++||++.+|+++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-45  Score=381.72  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=215.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++++.||+|+||.||+|++     ..+++.||||+++...    .....+.+.+|+.+|+++ +||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            457899999999999999999985     4578899999986422    233456788999999999 899999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      .+++..++||||+.+|+|.+++....                  .+++..++.++.||+.||+|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998654                  489999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++.+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.......
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            999999999999999987654332   2234578899999998765 49999999999999999999 999998765544


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+............+..++.++.+||++||+.||.+||++.||+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4444333233334556789999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-45  Score=388.31  Aligned_cols=258  Identities=23%  Similarity=0.376  Sum_probs=210.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCC-cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC------eeeeecce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESG-QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN------IVRYHGSE  291 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------IV~l~~~~  291 (628)
                      .++|++++.||+|+||+||+|++..++ +.||||+++..      ....+.+.+|+.+|+.++|++      |+.+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            479999999999999999999998777 78999998631      233466788999999987665      89999999


Q ss_pred             eccccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe--------------
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV--------------  355 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl--------------  355 (628)
                      ...+.++|||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||              
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999999 66777776654  479999999999999999999999999999999999999              


Q ss_pred             -----CCCCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH
Q 040472          356 -----DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA  430 (628)
Q Consensus       356 -----d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~  430 (628)
                           +.++.+||+|||+++....  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                 5678999999999986543  23456799999999999765 499999999999999999999999987654433


Q ss_pred             HhhhcCCC-CCC-----------------------------------------CCCCcCCHHHHHHHHHHhhcCCCCCCC
Q 040472          431 IFKIGNSK-DIP-----------------------------------------EIPEHLSDDAKSFIKQCLQRDPSARPP  468 (628)
Q Consensus       431 ~~~i~~~~-~~~-----------------------------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt  468 (628)
                      +..+.... ..+                                         ......+.++.+||++||+.||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            22211100 000                                         001123458899999999999999999


Q ss_pred             HHHHhcCccccchHHHhh
Q 040472          469 ASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       469 a~eiL~Hpwf~~~~~~~~  486 (628)
                      +.|||+||||++..+...
T Consensus       328 ~~e~l~hp~f~~~~~~~~  345 (355)
T 2eu9_A          328 LAEALLHPFFAGLTPEER  345 (355)
T ss_dssp             HHHHTTSGGGGGCCHHHH
T ss_pred             HHHHhcChhhcCCChhhc
Confidence            999999999987665443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-45  Score=396.48  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=209.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CC-----Ceeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HP-----NIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIV~l~~~~  291 (628)
                      ..++|+++++||+|+||+||+|++..+++.||||+++.      ......++.+|+.+|+.+. |+     +|+++++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            46799999999999999999999999999999999863      1334567788999988886 55     499999999


Q ss_pred             eccccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCCCceEeC--CCCCEEEec
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLH--ARNTVHRDIKGANILVD--PHGEIKLAD  365 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHRDIKpeNILld--~~g~vKL~D  365 (628)
                      ...+.+||||||+. ++|.+++...  ..+++..++.++.||+.||+|||  +.|||||||||+||||+  .++.+||+|
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999996 5999999865  46999999999999999999999  57999999999999995  477899999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC----
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP----  441 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~----  441 (628)
                      ||+++....  .....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||........+..+......+    
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987643  234567999999999997654 9999999999999999999999998766554443322100000    


Q ss_pred             ------------CCC------------------C----------------------------cCCHHHHHHHHHHhhcCC
Q 040472          442 ------------EIP------------------E----------------------------HLSDDAKSFIKQCLQRDP  463 (628)
Q Consensus       442 ------------~~p------------------~----------------------------~~s~~l~dLI~~~L~~dP  463 (628)
                                  .++                  .                            ....++.+||++||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                        000                  0                            011478999999999999


Q ss_pred             CCCCCHHHHhcCccccchH
Q 040472          464 SARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       464 ~~Rpta~eiL~Hpwf~~~~  482 (628)
                      ++|||+.|||+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.6e-46  Score=389.74  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=217.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc-hHHHHHHHHHHHHHHHhCC--CCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQLS--HPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~--HpnIV~l~~~~~~~  294 (628)
                      ..++|+++++||+|+||.||+|++..+++.||||+++....... .....+.+.+|+.+|++++  |+||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            34689999999999999999999999999999999975322110 0011234667999999996  59999999999999


Q ss_pred             ccceEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC-CCCCEEEeccCCcccc
Q 040472          295 ERLSVYLEYVSG-GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD-PHGEIKLADFGMAKHM  372 (628)
Q Consensus       295 ~~~~lVmEy~~G-gsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld-~~g~vKL~DFGla~~~  372 (628)
                      +.+++||||+.+ ++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++..
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            999999999986 89999999989999999999999999999999999999999999999998 6789999999999876


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ... ......||+.|+|||++.+...++.++|||||||++|||++|+.||......   ...     ...++..++.++.
T Consensus       201 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~-----~~~~~~~~~~~~~  271 (320)
T 3a99_A          201 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IRG-----QVFFRQRVSSECQ  271 (320)
T ss_dssp             CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHC-----CCCCSSCCCHHHH
T ss_pred             ccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---hcc-----cccccccCCHHHH
Confidence            543 3345679999999999876654578999999999999999999999764321   111     1234567899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccchH
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQA  482 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~  482 (628)
                      +||++||+.||++||+++||++||||++..
T Consensus       272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            999999999999999999999999998653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-45  Score=380.94  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=213.3

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC--CCCeeeeecceecccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS--HPNIVRYHGSELSDER  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIV~l~~~~~~~~~  296 (628)
                      ..+|++++.||+|+||.||+|++. +++.||||++....   ......+.+.+|+++|+++.  |+||+++++++.+++.
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc---ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            457999999999999999999886 48899999987532   22445678899999999997  5999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|+||| +.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+ ++.+||+|||+++......
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            999999 55889999999988999999999999999999999999999999999999996 5899999999998764432


Q ss_pred             c---cccccCCCCcCChhhhhcc----------CCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhcCCCCCCC
Q 040472          377 S---MLSFKGSPYWMAPEVVMNT----------NGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIGNSKDIPE  442 (628)
Q Consensus       377 ~---~~~~~GT~~Y~APEvl~~~----------~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~~~~~~~~  442 (628)
                      .   ....+||+.|+|||++.+.          ..++.++|||||||++|+|++|..||.... ....+..+........
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  260 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  260 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence            2   2345799999999998641          358889999999999999999999997643 3333444444333345


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ++...+.++.+||++||+.||++||++.|||+||||+..
T Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            666778999999999999999999999999999999754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.7e-45  Score=370.71  Aligned_cols=248  Identities=19%  Similarity=0.333  Sum_probs=214.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--E  295 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--~  295 (628)
                      ..++|++.+.||+|+||.||+|++.  ++.||||+++...   ......+.+.+|+.+|++++||||+++++++.+.  .
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD---WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT---CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            5679999999999999999999985  8899999987532   2244457789999999999999999999999887  7


Q ss_pred             cceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      .+++||||+.||+|.+++....  .+++..++.++.||+.||+|||+++  |+||||||+|||++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            8999999999999999998765  4899999999999999999999999  99999999999999999999999988764


Q ss_pred             ccCccccccccCCCCcCChhhhhccC--CCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          372 MTSCASMLSFKGSPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       372 ~~~~~~~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...    ....||+.|+|||++.+..  .++.++|||||||++|||++|+.||...........+......+.++..++.
T Consensus       163 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          163 FQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             TSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             ecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            322    2356899999999987543  2334899999999999999999999887776666655555555677788999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.+||++||+.||++||++.+|++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=391.06  Aligned_cols=252  Identities=25%  Similarity=0.443  Sum_probs=216.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC-------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES-------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~  289 (628)
                      ..++|++++.||+|+||.||+|++..+       +..||||+++..    ......+++.+|+++|+++ +|||||++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            346899999999999999999997543       357999998642    2344567889999999999 8999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.+++.+++||||+.+|+|.+++....                .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                499999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.......
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998664322   23345678899999999764 49999999999999999999 999998766555


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+.. ......+..++.++.+||++||+.||++||++.||+++
T Consensus       302 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 LFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444433 33345667899999999999999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-45  Score=378.82  Aligned_cols=251  Identities=26%  Similarity=0.468  Sum_probs=205.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ..++|++++.||+|+||+||+|+    +..+++.||||++...     .....+.+.+|+++|++++||||+++++++..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45799999999999999999998    5678999999988632     24456778999999999999999999998865


Q ss_pred             --cccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                        ...+++||||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              356899999999999999998754 59999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH---------------HH
Q 040472          371 HMTSCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA---------------AI  431 (628)
Q Consensus       371 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~---------------~~  431 (628)
                      .......    .....+|..|+|||++.+. .++.++|||||||++|||++|..||.......               .+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            7644321    2234577889999998765 49999999999999999999999986532110               11


Q ss_pred             hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       432 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ............+..++.++.+||++||+.||++||++.||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1111122233456788999999999999999999999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-45  Score=374.67  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++++.||+|+||.||+|++..+   +..||||+++..    ......+.+.+|+.+|++++||||+++++++. +
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            457999999999999999999998654   457999987532    22445677899999999999999999999984 5


Q ss_pred             ccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +..|+||||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999998654 79999999999999999999999999999999999999999999999999998764


Q ss_pred             Cccc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          374 SCAS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       374 ~~~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ....  .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||........+..+.... ...++..++.+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  245 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPT  245 (281)
T ss_dssp             -----------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHH
T ss_pred             cccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence            4322  2234577899999998654 48999999999999999996 999998776655555554433 23566789999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.+||++||+.||++||++.+|+++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9e-46  Score=379.17  Aligned_cols=247  Identities=21%  Similarity=0.368  Sum_probs=208.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCC-------cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESG-------QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS  290 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~  290 (628)
                      ..++|++.+.||+|+||+||+|++..++       ..||+|++....     ....+.+.+|+.+|++++||||++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            4578999999999999999999998877       469999885422     2234678899999999999999999999


Q ss_pred             eeccccceEEEEecccccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC--------E
Q 040472          291 ELSDERLSVYLEYVSGGSIHKLLQEYGP-FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE--------I  361 (628)
Q Consensus       291 ~~~~~~~~lVmEy~~GgsL~~~L~~~~~-l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~--------v  361 (628)
                      +.+++..++||||+.|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+||||+.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999998887        9


Q ss_pred             EEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHHHhhhcCCCCC
Q 040472          362 KLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDI  440 (628)
Q Consensus       362 KL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~~~~i~~~~~~  440 (628)
                      ||+|||++......   ....||+.|+|||++.+...++.++|||||||++|||++| .+||..............   .
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---~  234 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---R  234 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---T
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc---c
Confidence            99999999765432   2345899999999997645699999999999999999995 555555444333332222   2


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ..++...+.++.+||++||+.||++||++.+|++|
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            34455678889999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-45  Score=386.69  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=204.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.++||+|+||+||+|++..+++.+++|+..+...........+++.+|+.+|++++||||+++++++.+.. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            346899999999999999999999888877644433221111222334567889999999999999999999998754 7


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ++||||+.+|+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            899999999999999987 4679999999999999999999999999999999999999999999999999998664332


Q ss_pred             c---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          377 S---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       377 ~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      .   .....||+.|+|||++.+. .++.++|||||||++|||++ |+.||...........+... .....+..++.++.
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  249 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVY  249 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCHHHH
T ss_pred             ccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-CCCCCCccCCHHHH
Confidence            2   2234578899999999765 49999999999999999999 99999876554443333332 23345667899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcC
Q 040472          453 SFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +||.+||+.||++||++.+|+++
T Consensus       250 ~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          250 MIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-45  Score=384.29  Aligned_cols=253  Identities=24%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEE--EEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceec
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMC--AIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELS  293 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v--AvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~  293 (628)
                      ..+++|++.+.||+|+||.||+|++..++..+  |||.++..    ......+++.+|+++|+++ +||||+++++++.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            45689999999999999999999999888866  88988632    1233456788999999999 89999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP  357 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~  357 (628)
                      .+.+|+||||+.+++|.+++....                .+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            999999999999999999998654                7999999999999999999999999999999999999999


Q ss_pred             CCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcC
Q 040472          358 HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGN  436 (628)
Q Consensus       358 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~  436 (628)
                      ++.+||+|||+++............+++.|+|||++.+. .++.++|||||||++|||++ |..||...........+..
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            999999999999755433333445678999999998654 48999999999999999998 9999988766555555443


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       437 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .. ....+..++.++.+||++||+.||++||++.+++++
T Consensus       257 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 GY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32 334566789999999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.9e-45  Score=394.51  Aligned_cols=251  Identities=25%  Similarity=0.430  Sum_probs=214.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|+++.+++.||||+++..    ...+..+.+.+|+++|++++|||||++++++.+++.+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            456899999999999999999999999999999988632    2234456788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      |+||||+.||+|.++++..+ .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999999998654 69999999999999999999999999999999999999999999999999998654322


Q ss_pred             cc---ccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          377 SM---LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       377 ~~---~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..   ....+++.|+|||++.+. .++.++|||||||+||||++ |..||...........+.... ....+..++.++.
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  345 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPCPELCPDAVF  345 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred             eeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHH
Confidence            11   112356789999998755 48999999999999999998 999998876655444443332 3345677899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||++||+.||++||++.+|++
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.3e-46  Score=389.73  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=207.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcE----EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ..++|+++++||+|+||+||+|++..+++.    ||+|++....    .....+.+.+|+.++++++|+||+++++++. 
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            346899999999999999999999988887    5555543221    1122345678999999999999999999886 


Q ss_pred             cccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ++..++||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.+
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            56789999999999999999864 67999999999999999999999999999999999999999999999999999876


Q ss_pred             cCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          373 TSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       373 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ....   ......||..|+|||++.+. .++.++|||||||++|+|++ |..||...........+... .....+..++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQICT  243 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCTTBC
T ss_pred             CcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCCcCc
Confidence            4432   22345688899999999765 49999999999999999999 99999876554444433332 2334556688


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||.+||+.||++||++.+|++|
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.2e-45  Score=388.61  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=206.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-----------CCCeee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-----------HPNIVR  286 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIV~  286 (628)
                      ...+|++++.||+|+||+||+|++..+++.||||++..      .....+.+.+|+.+|+++.           |+||++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            34689999999999999999999999999999999863      1233456788999998886           899999


Q ss_pred             eecceeccc----cceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCCCceEeC---
Q 040472          287 YHGSELSDE----RLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHAR-NTVHRDIKGANILVD---  356 (628)
Q Consensus       287 l~~~~~~~~----~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHRDIKpeNILld---  356 (628)
                      +++++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+||||+   
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999988654    799999999 99999999863  4599999999999999999999998 999999999999994   


Q ss_pred             ---CCCCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch------
Q 040472          357 ---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG------  427 (628)
Q Consensus       357 ---~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~------  427 (628)
                         ..+.+||+|||++......  ....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.....      
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               3447999999999866432  33457999999999997654 89999999999999999999999975431      


Q ss_pred             hHHHhhhc---CC----------------------C---------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCC
Q 040472          428 VAAIFKIG---NS----------------------K---------------DIPEIPEHLSDDAKSFIKQCLQRDPSARP  467 (628)
Q Consensus       428 ~~~~~~i~---~~----------------------~---------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp  467 (628)
                      ...+..+.   ..                      .               ....++..++.++.+||++||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            11111110   00                      0               00123345678899999999999999999


Q ss_pred             CHHHHhcCccccch
Q 040472          468 PASKLLDHPFVRDQ  481 (628)
Q Consensus       468 ta~eiL~Hpwf~~~  481 (628)
                      ++.|||+||||++.
T Consensus       327 t~~ell~hp~f~~~  340 (373)
T 1q8y_A          327 DAGGLVNHPWLKDT  340 (373)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhhChhhhcc
Confidence            99999999999754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.3e-45  Score=372.50  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=211.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHH---HHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC---LKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....... ....   .+.+.+|+.+|++++|+||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            3578999999999999999999999999999999986533222 1222   26788999999999999999999998765


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCC-----EEEecc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGE-----IKLADF  366 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~-----vKL~DF  366 (628)
                      .  ++||||+.+++|.+++.+. ..+++..++.++.||+.||+|||++|  |+||||||+||||+.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            4  7999999999998888654 57999999999999999999999999  999999999999988776     999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhc-cCCCCccccccccccceeeeccCCCCCCCCchhH--HHhhhcCCCCCCCC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMN-TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA--AIFKIGNSKDIPEI  443 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~--~~~~i~~~~~~~~~  443 (628)
                      |+++....  ......||+.|+|||++.. ...++.++|||||||++|||++|+.||.......  ....+......+.+
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI  251 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence            99975443  3345679999999999842 3347889999999999999999999997654322  23333333444567


Q ss_pred             CCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          444 PEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       444 p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +..++.++.+||++||+.||++||++.||++
T Consensus       252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            7789999999999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-45  Score=380.51  Aligned_cols=253  Identities=24%  Similarity=0.431  Sum_probs=212.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|++++.||+|+||.||+|++     ..+++.||||+++..    ......+.+.+|+.+|.++ +||||+++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            457999999999999999999985     457789999998642    2234456788999999999 699999999998


Q ss_pred             eccc-cceEEEEecccccHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceE
Q 040472          292 LSDE-RLSVYLEYVSGGSIHKLLQEYGP----------------FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANIL  354 (628)
Q Consensus       292 ~~~~-~~~lVmEy~~GgsL~~~L~~~~~----------------l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNIL  354 (628)
                      ...+ .+++||||+.|++|.+++.....                +++..++.++.||+.||+|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7754 59999999999999999987543                899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHH
Q 040472          355 VDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAA  430 (628)
Q Consensus       355 ld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~  430 (628)
                      |+.++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||........
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            9999999999999998654332   22345688999999998765 49999999999999999998 9999987654443


Q ss_pred             HhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          431 IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       431 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +............+..++.++.+||.+||+.||.+||++.||++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333322223345566789999999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-44  Score=374.99  Aligned_cols=256  Identities=31%  Similarity=0.576  Sum_probs=203.3

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ..+.+|++.+.||+|+||.||+|++..+++.||||+++...  .........+.+|+.+|++++|+||+++++++.+++.
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS--SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh--ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            35679999999999999999999999999999999986422  2234556778899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          297 LSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      +++||||+.+++|.+++..    ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999999974    456899999999999999999999999999999999999999999999999999865


Q ss_pred             cCcc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch--hHHHhhhcCCCCCCCCCCcCCH
Q 040472          373 TSCA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--VAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       373 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....  ......+......+.....++.
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             cCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            4432 23346799999999998754 489999999999999999999999965321  2222233322222223356899


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++.+||.+||+.||++||++.+|+++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.7e-45  Score=378.27  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||++....  .......+.+.+|+.++++++||||+++++++.+++.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            4689999999999999999999999999999999886432  22345567889999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999997654432 


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSF  454 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dL  454 (628)
                       ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... ....++..++.++.+|
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  268 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV  268 (309)
T ss_dssp             -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred             ccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence             22346799999999998654 48999999999999999999999998765443222222221 1224556788999999


Q ss_pred             HHHHhhcCCCCCC-CHHHHhc
Q 040472          455 IKQCLQRDPSARP-PASKLLD  474 (628)
Q Consensus       455 I~~~L~~dP~~Rp-ta~eiL~  474 (628)
                      |.+||+.||++|| +++++++
T Consensus       269 i~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          269 IARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999 8888764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.2e-45  Score=379.71  Aligned_cols=252  Identities=24%  Similarity=0.404  Sum_probs=215.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++...    ........+.+|+.+|+.++|+||+++++++.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            3468999999999999999999876     46788999988632    22344567889999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEE
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEY----------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIK  362 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~----------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vK  362 (628)
                      +.+..++||||+.+++|.+++...          ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999999753          4578999999999999999999999999999999999999999999


Q ss_pred             EeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCC
Q 040472          363 LADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSK  438 (628)
Q Consensus       363 L~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~  438 (628)
                      |+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+... 
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-  256 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-  256 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC-
Confidence            99999998654322   12234578999999998765 48999999999999999999 89999887665555444433 


Q ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       439 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .....+..++.++.+||++||+.||++||++.||++|
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3345667899999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.9e-45  Score=373.77  Aligned_cols=248  Identities=22%  Similarity=0.302  Sum_probs=208.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~  297 (628)
                      .++|++++.||+|+||+||+|++..+++.||||++.....       .+.+.+|+.+++.+ +|+||+++++++.+....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            4689999999999999999999999999999998864321       13467899999999 699999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC-----EEEeccCCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE-----IKLADFGMAKH  371 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~-----vKL~DFGla~~  371 (628)
                      ++||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 999999998754 6999999999999999999999999999999999999987776     99999999987


Q ss_pred             ccCcc--------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcC---C
Q 040472          372 MTSCA--------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGN---S  437 (628)
Q Consensus       372 ~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~---~  437 (628)
                      .....        .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   ...+..+..   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            64432        13456799999999998765 489999999999999999999999976432   222222211   1


Q ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       438 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ...+.+...++.++.+||.+||+.||++||++.+|++.
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11223344688999999999999999999999999754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.2e-45  Score=381.34  Aligned_cols=254  Identities=23%  Similarity=0.410  Sum_probs=214.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCc-----EEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQ-----MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGS  290 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~  290 (628)
                      ...++|++++.||+|+||.||+|.+..+++     .||||+++...    .....+.+.+|+.+|+++ +||||++++++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345799999999999999999999977665     79999886422    234457788999999999 89999999999


Q ss_pred             eeccccceEEEEecccccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC
Q 040472          291 ELSDERLSVYLEYVSGGSIHKLLQEY--------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD  356 (628)
Q Consensus       291 ~~~~~~~~lVmEy~~GgsL~~~L~~~--------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld  356 (628)
                      +.+.+.+|+||||+.+|+|.+++...              ..+++..++.++.||+.||+|||++||+||||||+||||+
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999999753              3579999999999999999999999999999999999999


Q ss_pred             CCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHh
Q 040472          357 PHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIF  432 (628)
Q Consensus       357 ~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~  432 (628)
                      .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++ |..||........+.
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            999999999999986543221   2234578899999998765 49999999999999999998 999998765544444


Q ss_pred             hhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       433 ~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+.........+..++.++.+||.+||+.||.+||++.||+++
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            4333333334566788999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-45  Score=384.96  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=204.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~  298 (628)
                      .+|++++.||+|+||+||+|++..+++.||||++.....       .+++.+|+.+|+++ +|+||+++++++.+++..+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            689999999999999999999999999999999864322       13477899999999 8999999999999999999


Q ss_pred             EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC-----EEEeccCCcccc
Q 040472          299 VYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE-----IKLADFGMAKHM  372 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~-----vKL~DFGla~~~  372 (628)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.     +||+|||+++.+
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 9999999986 468999999999999999999999999999999999999998887     999999999875


Q ss_pred             cCccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcCC---C
Q 040472          373 TSCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGNS---K  438 (628)
Q Consensus       373 ~~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~~---~  438 (628)
                      .....        ....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.....   ...+..+...   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            43221        2457899999999999765 489999999999999999999999976432   2222222111   0


Q ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       439 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ....+...++ ++.+||++||+.||.+||++.+|++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            0011122344 9999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-44  Score=371.01  Aligned_cols=250  Identities=24%  Similarity=0.415  Sum_probs=215.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....      ...+.+.+|+++|++++|+||+++++++.+++.+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            4578999999999999999999999999999999986321      1246788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      |+||||+.|++|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999864  45999999999999999999999999999999999999999999999999999876543


Q ss_pred             c--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 A--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      .  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+.......+... .....+..++.++.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVY  242 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHH
T ss_pred             ccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCHHHH
Confidence            2  22334578899999998765 49999999999999999999 99999876554444433332 23455677899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcC
Q 040472          453 SFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +||++||+.||++||++.+|++.
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHHH
Confidence            99999999999999999999764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-45  Score=385.55  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=184.7

Q ss_pred             ccCCeEEee-eeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec---
Q 040472          218 SLSKWKKGK-LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS---  293 (628)
Q Consensus       218 ~~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~---  293 (628)
                      ..++|++.+ +||+|+||+||+|+++.+++.||||++...      ...   ..+....++.+.|+||+++++++..   
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKA---RQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHH---HHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            346899955 699999999999999999999999998631      111   1223344677899999999999876   


Q ss_pred             -cccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---CCEEEeccC
Q 040472          294 -DERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---GEIKLADFG  367 (628)
Q Consensus       294 -~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g~vKL~DFG  367 (628)
                       ...+++||||+.||+|.+++.+.+  .+++..++.++.||+.||+|||++||+||||||+||||+.+   +.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             456899999999999999998754  69999999999999999999999999999999999999764   459999999


Q ss_pred             CcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHH----hhh--cCCCCCC
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI----FKI--GNSKDIP  441 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~----~~i--~~~~~~~  441 (628)
                      +++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........    ..+  .......
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TCEEC-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             cceecccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            99865432 33456789999999998654 4899999999999999999999999764432211    111  1111111


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ..+..++.++.+||++||+.||++||++.|||+||||++.
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            2335689999999999999999999999999999999754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-44  Score=372.59  Aligned_cols=251  Identities=27%  Similarity=0.478  Sum_probs=207.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..+|++++.||+|+||.||+|+    +..+++.||||+++....    ....+.+.+|+++|+.++|+||+++++++.+.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            4579999999999999999998    577899999999864321    22346788999999999999999999999876


Q ss_pred             --ccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          295 --ERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       295 --~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                        ..+++||||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              678999999999999999954 46799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCC--------------chhHHHhh
Q 040472          372 MTSCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQY--------------EGVAAIFK  433 (628)
Q Consensus       372 ~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~--------------~~~~~~~~  433 (628)
                      .....    ......||..|+|||++.+.. ++.++|||||||++|+|++|..||...              .....+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            65432    223456888999999987654 889999999999999999999986432              11122222


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          434 IGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       434 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ..........+..++.++.+||++||+.||++||++.+|++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            22223334566789999999999999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=382.44  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ...+|+++++||+|+||+||+|++..+++.||+|+..+...........+.+.+|+.+|++++||||+++++++.++. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            347899999999999999999999988887755543222111112223467889999999999999999999998754 8


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      ++||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            899999999999999986 4679999999999999999999999999999999999999999999999999998764322


Q ss_pred             c---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          377 S---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       377 ~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      .   .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||...........+... .....+..++.++.
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  249 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVY  249 (327)
T ss_dssp             --------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCHHHH
T ss_pred             ccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHH
Confidence            2   2234578899999999765 49999999999999999999 99999876655444444332 23345667899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcC
Q 040472          453 SFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +||++||+.||++||++.||++.
T Consensus       250 ~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.4e-45  Score=371.49  Aligned_cols=245  Identities=23%  Similarity=0.426  Sum_probs=211.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-----  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-----  293 (628)
                      ..+|++++.||+|+||.||+|++..+++.||||+++...         ..+.+|+++|++++||||+++++++..     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            468999999999999999999999999999999987432         245689999999999999999998764     


Q ss_pred             -----------cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC
Q 040472          294 -----------DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE  360 (628)
Q Consensus       294 -----------~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~  360 (628)
                                 ...+|+||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence                       45689999999999999999754  67999999999999999999999999999999999999999999


Q ss_pred             EEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC
Q 040472          361 IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI  440 (628)
Q Consensus       361 vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~  440 (628)
                      +||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.....  ....+..    
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~----  233 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRD----  233 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHT----
T ss_pred             EEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhc----
Confidence            999999999877665555567799999999998754 489999999999999999999998754222  1122221    


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ..++..++.++.+||++||+.||++||++.|+++|.|.-
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            124456889999999999999999999999999998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.2e-44  Score=400.64  Aligned_cols=250  Identities=24%  Similarity=0.409  Sum_probs=215.1

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ....+|++.+.||+|+||.||+|+++.++..||||+++....      ..+.+.+|+.+|++++|||||++++++.+.+.
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            345789999999999999999999999999999999864221      13568899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +||||||+.+|+|.++|...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999999864  4589999999999999999999999999999999999999999999999999987643


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ..  ......+++.|+|||++.+. .++.++|||||||+||||++ |..||...+.......+... .....+..++.++
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  448 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKV  448 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence            32  12234567889999998755 49999999999999999999 99999876655444444332 2335667899999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||++||+.||++||++.+|++
T Consensus       449 ~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.9e-44  Score=378.92  Aligned_cols=252  Identities=25%  Similarity=0.454  Sum_probs=213.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-------CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-------ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~  289 (628)
                      ..++|++++.||+|+||.||+|++.       .++..||||+++..    ......+.+.+|+++|+++ +||||+++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            3579999999999999999999985       45778999988632    2244567789999999999 8999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.+++.+|+||||+.+++|.+++....                .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999998654                389999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99999999999999998664432   22334578899999998765 48999999999999999999 999998765544


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+... .....+..++.++.+||++||+.||.+||++.||+++
T Consensus       268 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            44333322 2345567789999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-45  Score=389.46  Aligned_cols=256  Identities=20%  Similarity=0.303  Sum_probs=201.6

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCC-----CcEEEEEEEeeccccc-chHHHHH-----HHHHHHHHHHhCCCCCee
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSES-----GQMCAIKEVRVVCDDQ-TSKECLK-----QLNQEINLLSQLSHPNIV  285 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~-~~~~~~~-----~~~~Ei~iL~~l~HpnIV  285 (628)
                      ...++|+++++||+|+||.||+|++..+     ++.||||++....... .+.+.++     .+.+|+.++..++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456999999999999999999998765     5889999986432111 0111111     244567778889999999


Q ss_pred             eeecceecc----ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC--CC
Q 040472          286 RYHGSELSD----ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD--PH  358 (628)
Q Consensus       286 ~l~~~~~~~----~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld--~~  358 (628)
                      ++++++.+.    ..+||||||+ |++|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998875    4589999999 99999999876 6899999999999999999999999999999999999998  88


Q ss_pred             CCEEEeccCCcccccCccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH
Q 040472          359 GEIKLADFGMAKHMTSCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA  430 (628)
Q Consensus       359 g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~  430 (628)
                      +.+||+|||+++.+.....        ....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||........
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            9999999999986643321        13456999999999997654 99999999999999999999999975322111


Q ss_pred             HhhhcC---CCCCC------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          431 IFKIGN---SKDIP------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       431 ~~~i~~---~~~~~------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ......   ...+.      -....++.++.+||..||+.||++||++.+|++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111000   00000      012457899999999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-45  Score=380.00  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=213.5

Q ss_pred             cccccCCeEEeeeeccCCcEEEEEEE-----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeec
Q 040472          215 TENSLSKWKKGKLLGRGTFGHVYLGF-----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHG  289 (628)
Q Consensus       215 ~~~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~  289 (628)
                      .+...++|++++.||+|+||.||+|+     +..+++.||||++...    .......++.+|+.+|++++||||+++++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  100 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIG  100 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----cchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence            33456799999999999999999998     5677889999988532    22344567889999999999999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC---C
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYG-------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH---G  359 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~---g  359 (628)
                      ++.+....|+||||+.|++|.+++....       .+++..++.++.||+.||+|||++||+||||||+||||+.+   .
T Consensus       101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence            9999999999999999999999998753       48999999999999999999999999999999999999854   4


Q ss_pred             CEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhc
Q 040472          360 EIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIG  435 (628)
Q Consensus       360 ~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~  435 (628)
                      .+||+|||++.......   ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            69999999997543221   22345689999999998765 48999999999999999998 999998766555444443


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      .. .....+..++.++.+||.+||+.||.+||++.+|++|.|+-
T Consensus       260 ~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          260 SG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            33 23455677899999999999999999999999999998864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=385.70  Aligned_cols=256  Identities=21%  Similarity=0.289  Sum_probs=200.5

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECC---CCcEEEEEEEeecccccc-hHHHH-----HHHHHHHHHHHhCCCCCeeee
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSE---SGQMCAIKEVRVVCDDQT-SKECL-----KQLNQEINLLSQLSHPNIVRY  287 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~-~~~~~-----~~~~~Ei~iL~~l~HpnIV~l  287 (628)
                      ...++|++++.||+|+||.||+|++..   ++..||||++........ +...+     ..+.+|+.+++.++|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            345789999999999999999999987   788999999875322111 11111     236688999999999999999


Q ss_pred             ecceec----cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC--CE
Q 040472          288 HGSELS----DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG--EI  361 (628)
Q Consensus       288 ~~~~~~----~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g--~v  361 (628)
                      ++++.+    ...+|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999887    78899999999 999999999888999999999999999999999999999999999999998877  99


Q ss_pred             EEeccCCcccccCcc--------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc-hhHHHh
Q 040472          362 KLADFGMAKHMTSCA--------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIF  432 (628)
Q Consensus       362 KL~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~  432 (628)
                      ||+|||+++.+....        .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+.
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999998664322        12446799999999998765 48999999999999999999999995421 111111


Q ss_pred             hhcC--CCCCCC------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          433 KIGN--SKDIPE------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       433 ~i~~--~~~~~~------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ....  ....+.      ....++.++.+||.+||+.||++||++.+|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1100  001110      01268899999999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-44  Score=362.94  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=213.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|++.+.||+|+||.||+|++. +++.||||+++.....      .+.+.+|++++++++||||+++++++.+++.++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            468999999999999999999987 5788999998643211      246788999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-  376 (628)
                      +||||+.+++|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999999865 568999999999999999999999999999999999999999999999999998654322 


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                       ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.... ....+..++.++.+|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQI  237 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHH
T ss_pred             cccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHHHH
Confidence             22334578899999998755 48999999999999999999 999998776655555554432 234556789999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcC
Q 040472          455 IKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~H  475 (628)
                      |++||+.||++||++.+++++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-44  Score=369.55  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=211.5

Q ss_pred             ccCCeEEee-eeccCCcEEEEEEE--ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGK-LLGRGTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~-~LG~G~fG~Vy~a~--~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ...+|++.+ .||+|+||.||+|.  +..+++.||||+++...   ......+.+.+|+++|+.++||||+++++++ ..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            346899998 99999999999995  46678999999986432   1233456789999999999999999999998 66


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +.+++||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            78899999999999999999888899999999999999999999999999999999999999999999999999987644


Q ss_pred             ccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 CAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...........+.. ...+.++..++.
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  247 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPR  247 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCH
T ss_pred             CCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCH
Confidence            322    12244678999999987554 8999999999999999999 9999987665554444433 233456778999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.+||++||+.||++||++.+|++
T Consensus       248 ~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          248 EMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-44  Score=388.58  Aligned_cols=251  Identities=23%  Similarity=0.412  Sum_probs=202.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC---CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS---ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ...+|++.++||+|+||.||+|+++   .++..||||+++...    .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            4568999999999999999999886   567789999886422    234457789999999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.+|+||||+.|++|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998754 79999999999999999999999999999999999999999999999999998764


Q ss_pred             Cccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          374 SCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       374 ~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ....    .....+|+.|+|||++.+. .++.++|||||||+||||++ |+.||........+..+..... ...+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~-~~~~~~~~  276 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-LPPPMDCP  276 (373)
T ss_dssp             ---------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE-CCCCTTCB
T ss_pred             cCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCcccc
Confidence            3321    1123457889999998765 49999999999999999997 9999987766555554443322 23455788


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .++.+||.+||+.||++||++.+|++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-45  Score=382.68  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=207.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||.||+|++. +++.||||++....     ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            4579999999999999999999965 68999999875422     12356788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~----~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      |+||||+.+|+|.+++....    .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999999999997543    58999999999999999999999999999999999999999999999999998643


Q ss_pred             Cc---cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHH------hh---------hc
Q 040472          374 SC---ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAI------FK---------IG  435 (628)
Q Consensus       374 ~~---~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~------~~---------i~  435 (628)
                      ..   .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.........      ..         +.
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          191 ELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             cccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            32   1223456899999999987654 899999999999999999999999653221100      00         00


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCc
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHP  476 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hp  476 (628)
                      .......+....+.++.+||.+||+.||++||++.||+++-
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            11111223344567899999999999999999999999763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-44  Score=378.99  Aligned_cols=252  Identities=26%  Similarity=0.457  Sum_probs=211.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL-  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~-  292 (628)
                      ..++|++++.||+|+||.||+|+    +..+++.||||++...     .....+.+.+|+++|++++|+||+++++++. 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            34699999999999999999998    5678999999998642     2344567899999999999999999999876 


Q ss_pred             -ccccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          293 -SDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       293 -~~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                       +...+|+||||+.|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence             45668999999999999999986 4569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCcc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh--------------HHHh
Q 040472          371 HMTSCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--------------AAIF  432 (628)
Q Consensus       371 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--------------~~~~  432 (628)
                      ......    ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......              ..+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            764332    22335688899999998765 4899999999999999999999998653221              1222


Q ss_pred             hhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       433 ~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ...........+..++.++.+||++||+.||++||++.||+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222233345567899999999999999999999999999755

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=394.16  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=209.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc--c
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE--R  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~--~  296 (628)
                      -++|+++++||+|+||+||+|++..+++.||||+++....    ....+.+.+|+++|++++||||+++++++.+..  .
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            3589999999999999999999999999999999864221    112456678999999999999999999988755  7


Q ss_pred             ceEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe----CCCCCEEEeccCCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV----DPHGEIKLADFGMA  369 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl----d~~g~vKL~DFGla  369 (628)
                      .|+||||+.||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+||||    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999999999999998643   39999999999999999999999999999999999999    77778999999999


Q ss_pred             ccccCccccccccCCCCcCChhhhhcc-------CCCCccccccccccceeeeccCCCCCCCCc----hhHHHhhhcCCC
Q 040472          370 KHMTSCASMLSFKGSPYWMAPEVVMNT-------NGYSLTVDIWSLGCTVLEMATSKPPWSQYE----GVAAIFKIGNSK  438 (628)
Q Consensus       370 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-------~~~s~ksDIWSLGvlLyelLtG~~PF~~~~----~~~~~~~i~~~~  438 (628)
                      +...........+||+.|+|||++.+.       ..++.++|||||||++|||++|+.||....    ....+.++....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            887766666677899999999998642       347889999999999999999999996432    222333322211


Q ss_pred             C-----------------------CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          439 D-----------------------IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       439 ~-----------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .                       ...+...++..+.+||++||+.||++|+++.|++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            0                       112234466788999999999999999999998654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.6e-45  Score=380.37  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=201.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER-  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~-  296 (628)
                      ...+|+++++||+|+||+||+|++.  ++.||||++...      ........+|+.+|++++|||||++++++.+... 
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            4579999999999999999999876  789999998632      1223445669999999999999999999987543 


Q ss_pred             ---ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccccCCCceEeCCCCCEEE
Q 040472          297 ---LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR----------NTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       297 ---~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~----------gIvHRDIKpeNILld~~g~vKL  363 (628)
                         +++||||+.+|+|.++++. ..+++..++.++.||+.||+|||++          ||+||||||+||||+.++.+||
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence               6999999999999999976 5699999999999999999999999          9999999999999999999999


Q ss_pred             eccCCcccccCcc---ccccccCCCCcCChhhhhcc----CCCCccccccccccceeeeccCCCCCCCCch---------
Q 040472          364 ADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNT----NGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---------  427 (628)
Q Consensus       364 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---------  427 (628)
                      +|||+++......   .....+||+.|+|||++.+.    ..++.++|||||||++|||++|+.||.....         
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            9999998654432   23346799999999998753    2366789999999999999999999965321         


Q ss_pred             ------hHHHhh-hcCCCCCCCCCC-----cCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          428 ------VAAIFK-IGNSKDIPEIPE-----HLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       428 ------~~~~~~-i~~~~~~~~~p~-----~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                            ...+.. +......+.++.     ..+.++.+||++||+.||++||++.||++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  111111 122222222222     234569999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-44  Score=366.48  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=207.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      -.|+++++||+|+||+||+|++..+++   .||||++..    .......+.+.+|+.+|++++||||+++++++.+.+.
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   96 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG   96 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence            367888999999999999999765544   799998853    2234456788899999999999999999999987666


Q ss_pred             c-eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 L-SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~-~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      . ++||||+.+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            5 999999999999999986 46789999999999999999999999999999999999999999999999999986543


Q ss_pred             cc-----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          375 CA-----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       375 ~~-----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ..     ......+|+.|+|||++.+. .++.++|||||||++|+|++| .+||...+.......+... .....+..++
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  254 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLPQPEYCP  254 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-CCCCCCTTCC
T ss_pred             CcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-CCCCCCccch
Confidence            22     22345688999999998654 489999999999999999995 5555554444433333332 2344566789


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||++||+.||.+||++.++++.
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.6e-44  Score=367.51  Aligned_cols=250  Identities=27%  Similarity=0.527  Sum_probs=198.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .-++|+++++||+|+||+||+|++..   .||||+++....   .....+.+.+|+.+|++++|+||+++++++ ....+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            45689999999999999999997653   599999875332   344567789999999999999999999954 56678


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC--
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS--  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~--  374 (628)
                      ++||||+.|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....  
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999999964 45799999999999999999999999999999999999999999999999999976543  


Q ss_pred             -ccccccccCCCCcCChhhhh--ccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC----CCCCCCCCCcC
Q 040472          375 -CASMLSFKGSPYWMAPEVVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----SKDIPEIPEHL  447 (628)
Q Consensus       375 -~~~~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~----~~~~~~~p~~~  447 (628)
                       ........||+.|+|||++.  ....++.++|||||||++|+|++|+.||........+.....    ......+...+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence             22234467999999999985  234588899999999999999999999987655444433321    22233455678


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +.++.+||.+||+.||++||++.+|++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-44  Score=367.34  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=213.5

Q ss_pred             cCCeEEee-eeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGK-LLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||||+++..    ......+.+.+|+++|++++||||+++++++ ..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            45777776 9999999999999854  56888999998642    2345567889999999999999999999999 566


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            799999999999999999754 5699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 CAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...    .....||+.|+|||++.+. .++.++|||||||++|||++ |+.||...........+... ..+.++..++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~  240 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPP  240 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCH
T ss_pred             CcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCCCCcCH
Confidence            322    2234578999999998654 48999999999999999998 99999876665555444432 23456778999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      ++.+||++||+.||++||++.+|++|.+
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-44  Score=374.42  Aligned_cols=252  Identities=26%  Similarity=0.430  Sum_probs=207.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCC----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESG----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ...+|++.++||+|+||.||+|++..++    ..||||+++...    .......+.+|+++|++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            4578999999999999999999887553    459999886422    23345678899999999999999999999999


Q ss_pred             cccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      .+.++|||||+.+++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999864 67999999999999999999999999999999999999999999999999999876


Q ss_pred             cCccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcC
Q 040472          373 TSCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHL  447 (628)
Q Consensus       373 ~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~  447 (628)
                      .....    .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||........+..+..... ...+..+
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  275 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LPTPMDC  275 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTC
T ss_pred             ccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-CCCcccC
Confidence            43221    1223467899999998654 48999999999999999998 9999987766555555544332 3445678


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.++.+||++||+.||++||++.+|+++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.8e-44  Score=390.99  Aligned_cols=245  Identities=24%  Similarity=0.442  Sum_probs=209.1

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc-
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE-  295 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~-  295 (628)
                      ...++|++++.||+|+||.||+|.+.  ++.||||+++...       ..+.+.+|+++|++++|||||++++++...+ 
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            35678999999999999999999875  7799999986421       2356889999999999999999999977654 


Q ss_pred             cceEEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      .+||||||+.+|+|.++++..+.  +++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            79999999999999999987654  7999999999999999999999999999999999999999999999999998653


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ...  ....+++.|+|||++.+. .++.++|||||||+||||++ |+.||......+.+..+.... ....+..++.++.
T Consensus       341 ~~~--~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~  416 (450)
T 1k9a_A          341 STQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVY  416 (450)
T ss_dssp             --------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred             ccc--cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHH
Confidence            322  233678999999999754 59999999999999999998 999998766555555544332 3456778999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||++||+.||++||++.+|++
T Consensus       417 ~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          417 DVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=374.72  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=205.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee----c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL----S  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~----~  293 (628)
                      ..++|++++.||+|+||.||+|++..+++.||||++...     .....+.+.+|+++++.++||||+++++++.    .
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            346899999999999999999999999999999998642     2344567889999999999999999999987    3


Q ss_pred             cccceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                      ....|+||||+.+++|.+++..    ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            4578999999999999999976    467999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCcc----------ccccccCCCCcCChhhhhccC--CCCccccccccccceeeeccCCCCCCCCchh--HHHhhhc
Q 040472          370 KHMTSCA----------SMLSFKGSPYWMAPEVVMNTN--GYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--AAIFKIG  435 (628)
Q Consensus       370 ~~~~~~~----------~~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--~~~~~i~  435 (628)
                      .......          ......||+.|+|||++.+..  .++.++|||||||++|+|++|+.||......  .....+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            7643211          112345899999999986432  2688999999999999999999999542110  1111111


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          436 NSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       436 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .... ......++.++.+||++||+.||.+||++.+|+++
T Consensus       262 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 NQLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            1111 22345688999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-44  Score=366.16  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=207.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECC---CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++.+.||+|+||+||+|++..   ++..||||+++...    .....+++.+|+.+|+.++||||+++++++.+ 
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            45799999999999999999998654   34569999886421    23445778999999999999999999999864 


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +..|+||||+.+++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            5678999999999999999865 469999999999999999999999999999999999999999999999999998664


Q ss_pred             Ccc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          374 SCA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       374 ~~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ...  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.... ....+..+++.
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  242 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPV  242 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCCHH
T ss_pred             cccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCCHH
Confidence            432  12334578899999998654 48999999999999999998 999997655544443333222 23455678999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.+||++||+.||++||++.||+++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.4e-44  Score=371.02  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=204.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECC---CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSE---SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++++.||+|+||.||+|++..   +++.||||+++...   ......+.+.+|+.+|++++||||+++++++.+.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34689999999999999999998765   56689999986432   2244567789999999999999999999998875


Q ss_pred             c-----cceEEEEecccccHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEE
Q 040472          295 E-----RLSVYLEYVSGGSIHKLLQ------EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       295 ~-----~~~lVmEy~~GgsL~~~L~------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL  363 (628)
                      .     ..++||||+.+++|.+++.      ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            5     3599999999999999984      2356999999999999999999999999999999999999999999999


Q ss_pred             eccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCC
Q 040472          364 ADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKD  439 (628)
Q Consensus       364 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~  439 (628)
                      +|||+++......   ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence            9999998654332   12234578899999998654 59999999999999999999 999998766555544443332 


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ....+..++.++.+||.+||+.||++||++.+|+++
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            345667789999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-45  Score=380.39  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=205.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.++||+|+||.||+|++. +++.||||++......    ....++.+|+++|+.++|+||+++++++.+.+..
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            4578999999999999999999854 6899999998643211    1123578899999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG----PFNEPVIQTYTRQILLGLAYLHAR---NTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~----~l~e~~~~~i~~qIl~aL~yLH~~---gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      ++||||+.+|+|.+++....    .+++..+..++.||+.||+|||++   ||+||||||+||||+.++.+||+|||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999998643    499999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCcc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc-----h---hHHHhhhcCC---
Q 040472          371 HMTSCA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-----G---VAAIFKIGNS---  437 (628)
Q Consensus       371 ~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-----~---~~~~~~i~~~---  437 (628)
                      ......  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....     .   ...+......   
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             ccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            764322  234456999999999987654 8999999999999999999999995211     0   0111111111   


Q ss_pred             ------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          438 ------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       438 ------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                            .....++...+.++.+||.+||+.||++||++.||++|-+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                  1111223344578999999999999999999999998744

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-44  Score=369.02  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=196.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHh--CCCCCeeeeecceec--
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ--LSHPNIVRYHGSELS--  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIV~l~~~~~~--  293 (628)
                      ..++|++++.||+|+||+||+|++  +++.||||++...        ....+.+|.+++..  ++||||+++++++.+  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            346899999999999999999987  5899999988531        12344556666666  789999999998654  


Q ss_pred             --cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccccCCCceEeCCCCCEEE
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH--------ARNTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH--------~~gIvHRDIKpeNILld~~g~vKL  363 (628)
                        ...+++||||+.+|+|.++++. ..+++..+..++.||+.||+|||        +++|+||||||+||||+.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999965 57999999999999999999999        999999999999999999999999


Q ss_pred             eccCCcccccCccc-----cccccCCCCcCChhhhhccC-----CCCccccccccccceeeeccC----------CCCCC
Q 040472          364 ADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVVMNTN-----GYSLTVDIWSLGCTVLEMATS----------KPPWS  423 (628)
Q Consensus       364 ~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvlLyelLtG----------~~PF~  423 (628)
                      +|||+++.......     ....+||+.|+|||++.+..     .++.++|||||||++|||++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999976543322     23357999999999987543     245789999999999999999          88885


Q ss_pred             CCc----hhHHHhhh-cCCCCCCCCC-----CcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          424 QYE----GVAAIFKI-GNSKDIPEIP-----EHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       424 ~~~----~~~~~~~i-~~~~~~~~~p-----~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...    ....+... ......+.++     ..++.++.+||++||+.||++||++.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            432    11222222 1222223333     235678999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-43  Score=388.25  Aligned_cols=248  Identities=25%  Similarity=0.440  Sum_probs=211.5

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++.+.||+|+||.||+|.+.. +..||||+++....      ..+.+.+|+++|++++|||||++++++. .+.
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            345789999999999999999999864 67899999864221      1467889999999999999999999986 678


Q ss_pred             ceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +||||||+.+|+|.++|+..  ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999999999854  3689999999999999999999999999999999999999999999999999987643


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ..  ......+|+.|+|||++... .++.++|||||||+||||++ |+.||......+.+..+..... ...+..++.++
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l  414 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPRPENCPEEL  414 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CCCCTTSCHHH
T ss_pred             CceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence            22  12234567889999998654 49999999999999999999 9999988776665555544333 34466789999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||.+||+.||++||++.+|++
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHH
Confidence            99999999999999999999964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-44  Score=368.02  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=205.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECC-CCc--EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSE-SGQ--MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++++.||+|+||+||+|++.. +++  .||||+++....  ...+..+.+.+|+++|++++|+||+++++++.++
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            34689999999999999999998643 333  689998864321  1234567889999999999999999999999876


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      . .++||||+.+++|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 89999999999999999764 679999999999999999999999999999999999999999999999999998764


Q ss_pred             Cccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          374 SCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       374 ~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ....    .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||........+..+.........+..++
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            4321    2234578899999998765 48999999999999999999 9999988777666666655444445567799


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .++.+||.+||+.||++||++.+|++
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=372.52  Aligned_cols=249  Identities=22%  Similarity=0.382  Sum_probs=189.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeeccee-----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSEL-----  292 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~-----  292 (628)
                      -.+|++.++||+|+||.||+|++..+++.||||++...     .....+.+.+|+.+|+++. ||||+++++++.     
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            35899999999999999999999999999999988542     2344567889999999996 999999999883     


Q ss_pred             ---ccccceEEEEecccccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeCCCCCEEEe
Q 040472          293 ---SDERLSVYLEYVSGGSIHKLLQE---YGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVDPHGEIKLA  364 (628)
Q Consensus       293 ---~~~~~~lVmEy~~GgsL~~~L~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld~~g~vKL~  364 (628)
                         ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||+|||++|  |+||||||+||||+.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence               3456899999995 699988865   467999999999999999999999999  9999999999999999999999


Q ss_pred             ccCCcccccCccc-------------cccccCCCCcCChhhhh--ccCCCCccccccccccceeeeccCCCCCCCCchhH
Q 040472          365 DFGMAKHMTSCAS-------------MLSFKGSPYWMAPEVVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA  429 (628)
Q Consensus       365 DFGla~~~~~~~~-------------~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~  429 (628)
                      |||+++.......             ....+||+.|+|||++.  ....++.++|||||||++|+|++|..||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            9999987643221             12456999999999983  23458899999999999999999999997644433


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      .+....    ........+..+.+||++||+.||++||++.|+++|-+
T Consensus       261 ~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 IVNGKY----SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----C----CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhcCcc----cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222211    12233456778999999999999999999999998743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-43  Score=364.78  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecce-ec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSE-LS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~-~~  293 (628)
                      ...+|++.++||+|+||+||+|++..+   ...||||.++..    ......+++.+|+.+|++++||||+++++++ ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS   98 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence            345799999999999999999987543   345889987532    2344567788999999999999999999985 45


Q ss_pred             cccceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ++..++||||+.+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            6789999999999999999976 456899999999999999999999999999999999999999999999999999865


Q ss_pred             cCcc-----ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCc
Q 040472          373 TSCA-----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEH  446 (628)
Q Consensus       373 ~~~~-----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~  446 (628)
                      ....     ......||+.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+.... ....+..
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  256 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEY  256 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCCCTT
T ss_pred             cccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCCCcc
Confidence            4322     22335678899999998765 49999999999999999999 677777655544444443332 2344667


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++.++.+||++||+.||++||++.||++.
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-43  Score=360.84  Aligned_cols=247  Identities=26%  Similarity=0.433  Sum_probs=209.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||.||+|++. ++..||||+++....      ..+.+.+|+++|++++|+||+++++++. ++..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   82 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI   82 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence            3468999999999999999999976 567899998864221      1356788999999999999999999886 5568


Q ss_pred             eEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ++||||+.|++|.+++....  .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999999997543  7999999999999999999999999999999999999999999999999999876543


Q ss_pred             cc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 AS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..  .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||........+..+.... ....+..++.++.
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  240 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RMVRPDNCPEELY  240 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred             ccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-CCCCcccccHHHH
Confidence            22  2334578899999998654 48999999999999999999 999998776655555544332 2345667899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||++||+.||++||++.+|++
T Consensus       241 ~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          241 QLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.1e-44  Score=363.12  Aligned_cols=244  Identities=25%  Similarity=0.439  Sum_probs=201.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-ccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-DER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-~~~  296 (628)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||+++...       ..+.+.+|+++|++++|+||+++++++.+ ++.
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            4679999999999999999999875  7899999886321       24568899999999999999999998655 458


Q ss_pred             ceEEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGP--FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +|+||||+.+++|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999999999986543  89999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  453 (628)
                      ..  ....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+... .....+..++.++.+
T Consensus       170 ~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  245 (278)
T 1byg_A          170 TQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYE  245 (278)
T ss_dssp             --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHH
T ss_pred             cc--cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHH
Confidence            22  234588999999998754 48999999999999999998 99999876655544444332 334566789999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhc
Q 040472          454 FIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ||++||+.||++||++.|+++
T Consensus       246 li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          246 VMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=367.96  Aligned_cols=243  Identities=30%  Similarity=0.533  Sum_probs=198.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++.+.||+|+||+||+|++.  ++.||||++...       ...+.+.+|+++|++++||||+++++++.  +..
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   74 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACL--NPV   74 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence            4578999999999999999999875  788999987521       22467889999999999999999999887  458


Q ss_pred             eEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCCCceEeCCCCC-EEEeccCCcc
Q 040472          298 SVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHA---RNTVHRDIKGANILVDPHGE-IKLADFGMAK  370 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~---~gIvHRDIKpeNILld~~g~-vKL~DFGla~  370 (628)
                      ++||||+.|++|.+++....   .+++..+..++.||+.||+|||+   +||+||||||+||||+.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            99999999999999998655   47889999999999999999999   89999999999999998886 7999999997


Q ss_pred             cccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh--HHHhhhcCCCCCCCCCCcCC
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~s  448 (628)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......  .....+. ....+.++..++
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  230 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLP  230 (307)
T ss_dssp             ------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCC
T ss_pred             ccccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccC
Confidence            65432  2335699999999998754 5899999999999999999999999754322  2222222 223345567789


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||.+||+.||++||++.+|+++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.6e-44  Score=365.15  Aligned_cols=247  Identities=21%  Similarity=0.331  Sum_probs=199.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecce-eccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSE-LSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~-~~~~~~  297 (628)
                      .++|++++.||+|+||+||+|++..+++.||||++.....       ..++.+|+.+++.++|++++..+.++ ...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            4689999999999999999999999999999998754221       23467899999999988877665554 667788


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe---CCCCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl---d~~g~vKL~DFGla~~~~  373 (628)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||+++...
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 9999999985 4679999999999999999999999999999999999999   788999999999998764


Q ss_pred             Cccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---HHHhhhc---CCCC
Q 040472          374 SCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---AAIFKIG---NSKD  439 (628)
Q Consensus       374 ~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---~~~~~i~---~~~~  439 (628)
                      ....        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......   ..+..+.   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4321        23467999999999987654 899999999999999999999999764321   1111111   1111


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...+...++.++.+||++||+.||++||++.+|++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11223567899999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-43  Score=362.97  Aligned_cols=247  Identities=21%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecce-eccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSE-LSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~-~~~~~~  297 (628)
                      .++|++++.||+|+||.||+|++..+++.||||++......       .++.+|+.+++.++|++++..+.++ ......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            46899999999999999999999999999999998643221       3477899999999988866655544 567788


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC---CCCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld---~~g~vKL~DFGla~~~~  373 (628)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+   .++.+||+|||+++...
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            9999999 9999999974 46799999999999999999999999999999999999994   78899999999998765


Q ss_pred             Cccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcC---CCC
Q 040472          374 SCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGN---SKD  439 (628)
Q Consensus       374 ~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~---~~~  439 (628)
                      ....        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....   ...+..+..   ...
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4322        24567999999999987654 89999999999999999999999976322   111111111   111


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...+...++.++.+||++||+.||++||++.+|++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            11233568899999999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=392.16  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=198.8

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~  298 (628)
                      .+|++.++||+|+||+||. ....+++.||||++.....        ..+.+|+++|+.+ +|||||++++++.+...+|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            4699999999999999764 3455789999998854221        2245799999999 7999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---C--CCEEEeccCCcccc
Q 040472          299 VYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---H--GEIKLADFGMAKHM  372 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~--g~vKL~DFGla~~~  372 (628)
                      ||||||. |+|.+++.... .+.+..+..++.||+.||+|||++||+||||||+||||+.   +  ..+||+|||+++..
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9999996 59999997653 4666678899999999999999999999999999999953   2  35889999999876


Q ss_pred             cCc----cccccccCCCCcCChhhhhc--cCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCC-CCCCCC
Q 040472          373 TSC----ASMLSFKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSK-DIPEIP  444 (628)
Q Consensus       373 ~~~----~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~-~~~~~p  444 (628)
                      ...    ......+||+.|+|||++.+  ...++.++|||||||++|||++ |..||...........+.... ......
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  253 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE  253 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence            533    22345779999999999864  3447889999999999999999 999996543332222221111 111222


Q ss_pred             CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          445 EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       445 ~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ...+..+.+||++||+.||++||++.||++||||....+
T Consensus       254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            345677899999999999999999999999999987665

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.2e-43  Score=363.96  Aligned_cols=232  Identities=27%  Similarity=0.475  Sum_probs=192.5

Q ss_pred             ccCCeEEe-eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHH-HhCCCCCeeeeecceec--
Q 040472          218 SLSKWKKG-KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL-SQLSHPNIVRYHGSELS--  293 (628)
Q Consensus       218 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIV~l~~~~~~--  293 (628)
                      .+++|.+. ++||+|+||.||+|++..+++.||||+++.          ...+.+|+.++ +.++||||+++++++.+  
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            56789888 889999999999999999999999999863          13456788887 66689999999999887  


Q ss_pred             --cccceEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEecc
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADF  366 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DF  366 (628)
                        ...+|+||||+.|++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||||+.   ++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence              778999999999999999998754  6999999999999999999999999999999999999998   788999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIP  444 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p  444 (628)
                      |++.....                      ..++.++|||||||++|||++|+.||...........+.....  ...++
T Consensus       165 g~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          165 GFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             TTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            99865321                      2378899999999999999999999976544332221111111  11222


Q ss_pred             ----CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          445 ----EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       445 ----~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                          ..++.++.+||++||+.||++||++.|+|+||||++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence                4689999999999999999999999999999999754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=379.51  Aligned_cols=244  Identities=17%  Similarity=0.201  Sum_probs=198.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEE-----EECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC---CCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS---HPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a-----~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~  289 (628)
                      ..++|++.++||+|+||+||+|     .+..+++.||||+++...        ...+.+|+++++.++   |+||+++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3468999999999999999999     467789999999986321        235667888888887   999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-------
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQE-----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-------  357 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-------  357 (628)
                      ++..++..||||||+.||+|.+++..     ...+++..++.|+.||+.||+|||++|||||||||+||||+.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     457999999999999999999999999999999999999988       


Q ss_pred             ----CCCEEEeccCCccccc---CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHH
Q 040472          358 ----HGEIKLADFGMAKHMT---SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA  430 (628)
Q Consensus       358 ----~g~vKL~DFGla~~~~---~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~  430 (628)
                          ++.+||+|||+|+.+.   ........+||+.|||||++.+.. |+.++|||||||+||||++|+.||....... 
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                8999999999997543   333455678999999999997654 9999999999999999999999996533211 


Q ss_pred             HhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCc
Q 040472          431 IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHP  476 (628)
Q Consensus       431 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hp  476 (628)
                       ..+.  .....+  ..++.+.+++..||+.+|.+|++..+.+.+.
T Consensus       293 -~~~~--~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          293 -CKPE--GLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             -EEEC--SCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             -eeec--hhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence             1111  111122  2467899999999999999997655544443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-44  Score=376.98  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=201.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC--------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeee---
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES--------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVR---  286 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t--------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~---  286 (628)
                      ..++|++++.||+|+||.||+|++..+        ++.||||++...          +.+.+|+++|++++|+||++   
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhh
Confidence            357999999999999999999999874        889999998632          35678999999999999988   


Q ss_pred             ------------eecceec-cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCC
Q 040472          287 ------------YHGSELS-DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGA  351 (628)
Q Consensus       287 ------------l~~~~~~-~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpe  351 (628)
                                  +++++.. +..+|+||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                        4555554 67899999999 99999999875  78999999999999999999999999999999999


Q ss_pred             ceEeCCCC--CEEEeccCCcccccCccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCC
Q 040472          352 NILVDPHG--EIKLADFGMAKHMTSCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPP  421 (628)
Q Consensus       352 NILld~~g--~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~P  421 (628)
                      ||||+.++  .+||+|||+++.+.....        .....||+.|+|||++.+. .++.++|||||||+||||++|+.|
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999988  899999999986643221        2345799999999998765 499999999999999999999999


Q ss_pred             CCCCc-hhHHHhhhc-----CCCCC---CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          422 WSQYE-GVAAIFKIG-----NSKDI---PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       422 F~~~~-~~~~~~~i~-----~~~~~---~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      |.... ....+....     .....   ...+..++.++.+||++||+.||++||++.+|++.
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            97653 222222211     11110   01123578999999999999999999999999763

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-43  Score=369.89  Aligned_cols=248  Identities=27%  Similarity=0.467  Sum_probs=205.7

Q ss_pred             CeEEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc--
Q 040472          221 KWKKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD--  294 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~--  294 (628)
                      .|++++.||+|+||+||++.    +..+++.||||+++..    ......+.+.+|+++|++++||||+++++++.+.  
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            35999999999999998875    3457899999998642    2234567789999999999999999999999874  


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..+++||||+.+++|.+++.+. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            6789999999999999999864 499999999999999999999999999999999999999999999999999987654


Q ss_pred             ccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh--------------HHHhhhcC
Q 040472          375 CAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--------------AAIFKIGN  436 (628)
Q Consensus       375 ~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--------------~~~~~i~~  436 (628)
                      ...    .....||..|+|||++.+.. ++.++|||||||++|+|++|..||......              ..+.....
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            321    23456888999999997654 889999999999999999999999653211              11222222


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       437 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .......+..++.++.+||++||+.||++||++.||++
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            23334566789999999999999999999999999984

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.2e-43  Score=401.24  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=206.7

Q ss_pred             CeEE-eeeeccCCcEEEEEEEE--CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          221 KWKK-GKLLGRGTFGHVYLGFN--SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       221 ~y~~-~~~LG~G~fG~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+.+ .+.||+|+||.||+|.+  +.+++.||||+++.....   ....+++.+|+++|++++|||||++++++. .+.+
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  444 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND---PALKDELLAEANVMQQLDNPYIVRMIGICE-AESW  444 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC---GGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCE
Confidence            3444 35899999999999954  566789999998753222   233567889999999999999999999986 4568


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      +|||||+.+|+|.++|.....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus       445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999987644321


Q ss_pred             ----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          378 ----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       378 ----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                          .....+|+.|+|||++.+. .++.++|||||||+||||++ |+.||...........+.... ....+..++.++.
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~  602 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMY  602 (635)
T ss_dssp             ----------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred             ccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHH
Confidence                2234578899999999654 49999999999999999998 999998877665555554433 3456778999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||++||+.||++||++.+|++
T Consensus       603 ~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          603 DLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-43  Score=387.12  Aligned_cols=252  Identities=30%  Similarity=0.450  Sum_probs=194.0

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~  298 (628)
                      +.|.+.++||+|+||+||.+ ...+|+.||||++...        ..+.+.+|+++|+++ +|||||++++++.+++.+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence            45667899999999999876 4557999999988631        124567899999876 8999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-------------
Q 040472          299 VYLEYVSGGSIHKLLQEYGPF-------NEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-------------  358 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l-------~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-------------  358 (628)
                      ||||||. |+|.+++......       .+..++.++.||+.||+|||++||+||||||+||||+.+             
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9999995 6999999875433       233457899999999999999999999999999999654             


Q ss_pred             CCEEEeccCCcccccCccc-----cccccCCCCcCChhhhhc------cCCCCccccccccccceeeecc-CCCCCCCCc
Q 040472          359 GEIKLADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVVMN------TNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYE  426 (628)
Q Consensus       359 g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~------~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~  426 (628)
                      +++||+|||+++.......     ....+||+.|+|||++.+      ...++.++|||||||++|||++ |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            4899999999987654321     234679999999999865      2458999999999999999999 999997543


Q ss_pred             hhH-HHhh-hcCCCCCCC-CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          427 GVA-AIFK-IGNSKDIPE-IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       427 ~~~-~~~~-i~~~~~~~~-~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ... .+.. ......... ....++.++.+||++||+.||++||++.+|++||||...
T Consensus       245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             THHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             hhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            222 1111 111111111 122456899999999999999999999999999999754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=379.58  Aligned_cols=250  Identities=24%  Similarity=0.410  Sum_probs=199.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCC---cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee-ccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESG---QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL-SDE  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~-~~~  295 (628)
                      ..|++.++||+|+||+||+|++..++   ..||||.++...    .....+++.+|+.+|++++||||+++++++. .++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            46889999999999999999875432   468999875422    2344677899999999999999999999865 456


Q ss_pred             cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..|+||||+.+|+|.++++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            889999999999999999864 4689999999999999999999999999999999999999999999999999986533


Q ss_pred             cc-----ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCC
Q 040472          375 CA-----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS  448 (628)
Q Consensus       375 ~~-----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s  448 (628)
                      ..     ......+|+.|+|||++.+. .++.++|||||||++|||++ |.+||...........+.... ....+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCC
Confidence            22     12334578899999998765 49999999999999999999 788887655544444443332 234566789


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          449 DDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       449 ~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .++.+||.+||+.||++||++.||+++
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999865

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.9e-43  Score=383.59  Aligned_cols=248  Identities=26%  Similarity=0.415  Sum_probs=206.5

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++.+.||+|+||.||+|.+.. +..||||+++....   .   .+.+.+|+++|++++||||+++++++.+ +.
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            345789999999999999999999875 46799999864321   1   2467899999999999999999999876 77


Q ss_pred             ceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +||||||+.+|+|.++|..  ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            9999999999999999974  35699999999999999999999999999999999999999999999999999987643


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ..  ......++..|+|||++.+. .++.++|||||||+||||++ |+.||......+.+..+..... ...+..++.++
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l  410 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECPESL  410 (452)
T ss_dssp             ----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTSCHHH
T ss_pred             CceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence            22  12234577899999998765 49999999999999999999 9999988766665555544332 34567799999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||.+||+.||++||++++|++
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=368.91  Aligned_cols=248  Identities=26%  Similarity=0.375  Sum_probs=190.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee-----
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL-----  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~-----  292 (628)
                      .+++|+++++||+|+||.||+|++  +++.||||++....    ...  .....|+..+..++|+||+++++++.     
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQN--FINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhh--HHHHHHHHHHHhccCcchhhheecccccccC
Confidence            568999999999999999999976  58999999986421    111  11223444455689999999997443     


Q ss_pred             ccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccccCCCceEeCCCCCEEE
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR---------NTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~---------gIvHRDIKpeNILld~~g~vKL  363 (628)
                      ....+||||||+.+|+|.+++... .+++..+..++.||+.||+|||++         ||+||||||+||||+.++.+||
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            234678999999999999999764 458999999999999999999999         9999999999999999999999


Q ss_pred             eccCCcccccCc---------cccccccCCCCcCChhhhhcc------CCCCccccccccccceeeeccCCCCCCCCchh
Q 040472          364 ADFGMAKHMTSC---------ASMLSFKGSPYWMAPEVVMNT------NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV  428 (628)
Q Consensus       364 ~DFGla~~~~~~---------~~~~~~~GT~~Y~APEvl~~~------~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~  428 (628)
                      +|||+++.+...         ......+||+.|+|||++.+.      ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            999999865432         122346799999999998652      23677899999999999999997776332110


Q ss_pred             -----------------HHHh-hhcCCCCCCCCCCc------CCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          429 -----------------AAIF-KIGNSKDIPEIPEH------LSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       429 -----------------~~~~-~i~~~~~~~~~p~~------~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                                       ..+. .+......+.++..      ++.++.+||.+||+.||++||++.||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                             0111 11112222233322      4558999999999999999999999954

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-43  Score=363.58  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=203.9

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEE
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYL  301 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVm  301 (628)
                      |..++.||+|+||.||+|++  +++.||||++..... ....+..+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            44558999999999999976  578999999864322 122344577889999999999999999999999999999999


Q ss_pred             EecccccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--
Q 040472          302 EYVSGGSIHKLLQE---YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--  376 (628)
Q Consensus       302 Ey~~GgsL~~~L~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--  376 (628)
                      ||+.+++|.+++..   ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......  
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            99999999999974   3469999999999999999999999999999999999999999999999999998654322  


Q ss_pred             -ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhh----cC---------CCCCCC
Q 040472          377 -SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI----GN---------SKDIPE  442 (628)
Q Consensus       377 -~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i----~~---------~~~~~~  442 (628)
                       ......||+.|+|||++.+  .++.++|||||||++|+|++|..||........+..+    ..         ......
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence             2234579999999999864  3889999999999999999999999764432211111    00         011223


Q ss_pred             CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          443 IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       443 ~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+...+..+.+||.+||+.||.+||++.+|+++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            344566789999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.1e-43  Score=390.76  Aligned_cols=262  Identities=20%  Similarity=0.302  Sum_probs=212.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC-CCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV~l~~~~~~~~~~  297 (628)
                      .++|+++++||+|+||.||+|++..+++.||||++......       .++.+|+++++.|.| ++|+.+..++...+..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            46899999999999999999999999999999988653322       246789999999986 5566666677778889


Q ss_pred             eEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEe---CCCCCEEEeccCCccccc
Q 040472          298 SVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILl---d~~g~vKL~DFGla~~~~  373 (628)
                      +|||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+++.+.
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999985 5679999999999999999999999999999999999999   578899999999998765


Q ss_pred             Cccc--------cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcC---CCC
Q 040472          374 SCAS--------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGN---SKD  439 (628)
Q Consensus       374 ~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~---~~~  439 (628)
                      ....        ....+||+.|+|||++.+. .++.++||||||||||||++|+.||.....   ...+.++..   ...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            4322        1256799999999999765 499999999999999999999999976432   122222111   111


Q ss_pred             CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHh----------cCccccchHHHhhcCC
Q 040472          440 IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL----------DHPFVRDQAVARAGNV  489 (628)
Q Consensus       440 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL----------~Hpwf~~~~~~~~~~~  489 (628)
                      +..+...++.++.+||.+||+.||++||++.+|+          .++|+...+|......
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~  296 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence            1223356789999999999999999999998875          3567767777655443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=368.79  Aligned_cols=251  Identities=23%  Similarity=0.427  Sum_probs=207.0

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++++.||+|+||.||+|++..   .||||+++......   ...+.+.+|+.++++++|+||+++++++.+.+.
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            356899999999999999999998864   49999986543221   122456789999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-
Q 040472          297 LSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-  374 (628)
                      +++||||+.|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+ ++.+||+|||++..... 
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999999998754 799999999999999999999999999999999999998 78999999999875421 


Q ss_pred             -----ccccccccCCCCcCChhhhhc--------cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC
Q 040472          375 -----CASMLSFKGSPYWMAPEVVMN--------TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP  441 (628)
Q Consensus       375 -----~~~~~~~~GT~~Y~APEvl~~--------~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~  441 (628)
                           ........||+.|+|||++.+        ...++.++|||||||++|||++|+.||...........+.......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 122234568999999999864        2347899999999999999999999998876665555554443333


Q ss_pred             CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       442 ~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .....++.++.+||.+||+.||++||++.+|++
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            333468889999999999999999999999976

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.9e-43  Score=392.34  Aligned_cols=248  Identities=26%  Similarity=0.417  Sum_probs=211.4

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++.++||+|+||.||+|++.. +..||||+++....   .   .+.+.+|+++|++++|+|||++++++.+ +.
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---C---HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            345789999999999999999999875 46799999864321   1   2467899999999999999999999876 78


Q ss_pred             ceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +||||||+.+|+|.++|+..  ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+..
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999999999753  5699999999999999999999999999999999999999999999999999987643


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ..  ......++..|+|||++.+. .++.++|||||||+||||++ |+.||......+.+..+..... ...+..++.++
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l  493 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECPESL  493 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHH
T ss_pred             CceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence            22  12234577899999998765 49999999999999999999 9999988766665555544332 34566789999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhc
Q 040472          452 KSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+||.+||+.||++||++++|++
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-43  Score=365.69  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=194.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHh--CCCCCeeeeecceecc-
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ--LSHPNIVRYHGSELSD-  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIV~l~~~~~~~-  294 (628)
                      ..++|++++.||+|+||.||+|++.  ++.||||++....        .....+|.+++..  ++|+||+++++++... 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3468999999999999999999875  8999999985311        1233445555554  4899999999998876 


Q ss_pred             ---ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccCCCceEeCCCCCEEE
Q 040472          295 ---ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR--------NTVHRDIKGANILVDPHGEIKL  363 (628)
Q Consensus       295 ---~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIvHRDIKpeNILld~~g~vKL  363 (628)
                         ..+|+||||+.+|+|.++++. ..+++..++.++.||+.||+|||++        ||+||||||+||||+.++.+||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence               789999999999999999976 4799999999999999999999999        9999999999999999999999


Q ss_pred             eccCCcccccCccc-----cccccCCCCcCChhhhhccCCCCc------cccccccccceeeeccC----------CCCC
Q 040472          364 ADFGMAKHMTSCAS-----MLSFKGSPYWMAPEVVMNTNGYSL------TVDIWSLGCTVLEMATS----------KPPW  422 (628)
Q Consensus       364 ~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~s~------ksDIWSLGvlLyelLtG----------~~PF  422 (628)
                      +|||+++.+.....     ....+||+.|+|||++.+.. +..      ++|||||||++|||++|          ..||
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999976543322     12457999999999987554 444      39999999999999999          7777


Q ss_pred             CCCch----hHHHhhh-cCCCCCCCCCC-----cCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          423 SQYEG----VAAIFKI-GNSKDIPEIPE-----HLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       423 ~~~~~----~~~~~~i-~~~~~~~~~p~-----~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .....    ...+... ......+.++.     .++.++.+||++||+.||++||++.+|++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            54211    1122221 11122233332     456789999999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=367.00  Aligned_cols=251  Identities=26%  Similarity=0.470  Sum_probs=207.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEE----ECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGF----NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~  293 (628)
                      ...+|++++.||+|+||.||+|+    +..+++.||||++...     ..+..+.+.+|+++|++++|+||+++++++..
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            34689999999999999999998    4678999999998642     23345678899999999999999999998876


Q ss_pred             cc--cceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          294 DE--RLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       294 ~~--~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      .+  .+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            44  789999999999999999875 469999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh---------------HHH
Q 040472          371 HMTSCAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV---------------AAI  431 (628)
Q Consensus       371 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~---------------~~~  431 (628)
                      .......    .....++..|+|||++.+.. ++.++|||||||++|||++|..||......               ..+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            7654322    22345778899999987654 899999999999999999999998642110               011


Q ss_pred             hhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          432 FKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       432 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ............+..++.++.+||++||+.||++||++.||++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1111122223456678999999999999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=395.91  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=205.8

Q ss_pred             CCeEEee-eeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          220 SKWKKGK-LLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      .++.+.+ .||+|+||.||+|.++  .++..||||+++....    ....+.+.+|+++|++++|||||++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            4566666 8999999999999875  4567799999875322    2234678899999999999999999999876 56


Q ss_pred             ceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +||||||+.+|+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999999999754 56999999999999999999999999999999999999999999999999999876433


Q ss_pred             cc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          376 AS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       376 ~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ..    .....+|+.|+|||++.+. .++.++|||||||+||||++ |+.||......+.+..+.... ....+..++.+
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~  567 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPE  567 (613)
T ss_dssp             ------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHH
Confidence            21    1223467899999998754 59999999999999999998 999998877666555554433 34566789999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +.+||.+||+.||++||++.+|++
T Consensus       568 l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          568 LYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-44  Score=380.98  Aligned_cols=248  Identities=18%  Similarity=0.231  Sum_probs=195.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---chHHHHHHHHHHHHHHHhCC--------------
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---TSKECLKQLNQEINLLSQLS--------------  280 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~--------------  280 (628)
                      ..++|++++.||+|+||+||+|++  +++.||||+++......   ......+.+.+|+.+|+.++              
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999988  68999999997643210   11223466788999988886              


Q ss_pred             ------------CCCeeeeecceec-------------cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 040472          281 ------------HPNIVRYHGSELS-------------DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL  335 (628)
Q Consensus       281 ------------HpnIV~l~~~~~~-------------~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL  335 (628)
                                  |||||+++++|.+             .+.+||||||+.+|+|.+.+.+ +.+++..++.|+.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence                        5555666666654             7899999999999987776654 6789999999999999999


Q ss_pred             HHHH-hCCccccccCCCceEeCCCC--------------------CEEEeccCCcccccCccccccccCCCCcCChhhhh
Q 040472          336 AYLH-ARNTVHRDIKGANILVDPHG--------------------EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM  394 (628)
Q Consensus       336 ~yLH-~~gIvHRDIKpeNILld~~g--------------------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~  394 (628)
                      +||| ++|||||||||+||||+.++                    .+||+|||+|+.....    ..+||+.|||||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999887                    8999999999876542    347999999999987


Q ss_pred             ccCCCCccccccccccc-eeeeccCCCCCCCCch----hHHHhhhcCCC--CCCCCCCcCCHHHHHHHHHHhhcCCCCCC
Q 040472          395 NTNGYSLTVDIWSLGCT-VLEMATSKPPWSQYEG----VAAIFKIGNSK--DIPEIPEHLSDDAKSFIKQCLQRDPSARP  467 (628)
Q Consensus       395 ~~~~~s~ksDIWSLGvl-LyelLtG~~PF~~~~~----~~~~~~i~~~~--~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp  467 (628)
                      +.  .+.++|||||+++ .++++.|..||.....    ...+.......  ....++..+++++++||++||++|     
T Consensus       251 g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----  323 (336)
T 2vuw_A          251 GD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----  323 (336)
T ss_dssp             CC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred             CC--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence            54  3889999998776 8889999999965321    11222111111  111223457899999999999987     


Q ss_pred             CHHHHh-cCcccc
Q 040472          468 PASKLL-DHPFVR  479 (628)
Q Consensus       468 ta~eiL-~Hpwf~  479 (628)
                      |++|+| +||||+
T Consensus       324 sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 SATDLLCQHSLFK  336 (336)
T ss_dssp             SHHHHHHHCGGGC
T ss_pred             CHHHHHhcCCCcC
Confidence            999999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-42  Score=362.79  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=201.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHh--CCCCCeeeeecceeccc-
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ--LSHPNIVRYHGSELSDE-  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIV~l~~~~~~~~-  295 (628)
                      .++|++++.||+|+||.||+|++  +++.||||++...        ....+.+|++++..  ++||||+++++++.... 
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            46899999999999999999988  4899999998531        12456778888887  78999999999998876 


Q ss_pred             ---cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccccCCCceEeCCCCCEEEe
Q 040472          296 ---RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH--------ARNTVHRDIKGANILVDPHGEIKLA  364 (628)
Q Consensus       296 ---~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH--------~~gIvHRDIKpeNILld~~g~vKL~  364 (628)
                         .+|+||||+.+|+|.+++.+ ..+++..++.++.||+.||+|||        +++|+||||||+||||+.++.+||+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence               89999999999999999976 56999999999999999999999        8999999999999999999999999


Q ss_pred             ccCCcccccCcc-----ccccccCCCCcCChhhhhccCC-----CCccccccccccceeeeccC----------CCCCCC
Q 040472          365 DFGMAKHMTSCA-----SMLSFKGSPYWMAPEVVMNTNG-----YSLTVDIWSLGCTVLEMATS----------KPPWSQ  424 (628)
Q Consensus       365 DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~-----~s~ksDIWSLGvlLyelLtG----------~~PF~~  424 (628)
                      |||++.......     .....+||+.|+|||++.+...     ++.++|||||||++|||++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            999998665433     2244579999999999865422     33689999999999999999          788865


Q ss_pred             Cc----hhHHHhh-hcCCCCCCCCCC-----cCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          425 YE----GVAAIFK-IGNSKDIPEIPE-----HLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       425 ~~----~~~~~~~-i~~~~~~~~~p~-----~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ..    ....+.. +......+.++.     .++..+.+||++||+.||++||++.+|++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            32    1222222 222222233333     344689999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-43  Score=404.10  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=212.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----  293 (628)
                      .+++|++++.||+|+||.||+|++..+++.||||+++..    ......+.+.+|+++|++++||||+++++++..    
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            457999999999999999999999999999999988642    224456778899999999999999999998765    


Q ss_pred             --cccceEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC---EEEec
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEYG---PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---IKLAD  365 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~---vKL~D  365 (628)
                        ++..|+||||+.||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+||||+.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              778899999999999999998754   6999999999999999999999999999999999999997765   99999


Q ss_pred             cCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhc----------
Q 040472          366 FGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIG----------  435 (628)
Q Consensus       366 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~----------  435 (628)
                      ||++............+||+.|+|||++.+. .++.++|||||||++|+|++|..||........+....          
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             cccccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            9999887666556667899999999998654 59999999999999999999999996542221110000          


Q ss_pred             ----CC--------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          436 ----NS--------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       436 ----~~--------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                          ..        .....+...++.++.+||++||+.||++||++.++++||||+....
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence                00        0011233457789999999999999999999999999999987543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-43  Score=379.96  Aligned_cols=253  Identities=15%  Similarity=0.162  Sum_probs=197.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC-CCeeeee---------
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYH---------  288 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV~l~---------  288 (628)
                      ..+|+++++||+|+||+||+|++..+++.||||+++....  ......+.+.+|+.+++.+.| .|+..+.         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            3468999999999999999999999999999998863222  222335678899999999987 3221111         


Q ss_pred             ------------cceec-----cccceEEEEecccccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 040472          289 ------------GSELS-----DERLSVYLEYVSGGSIHKLLQE-------YGPFNEPVIQTYTRQILLGLAYLHARNTV  344 (628)
Q Consensus       289 ------------~~~~~-----~~~~~lVmEy~~GgsL~~~L~~-------~~~l~e~~~~~i~~qIl~aL~yLH~~gIv  344 (628)
                                  .++..     ...++++|+++ +++|.++++.       ...+++..+..++.||+.||+|||++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                        11111     22456777766 6899999852       23477888999999999999999999999


Q ss_pred             ccccCCCceEeCCCCCEEEeccCCcccccCccccccccCCCCcCChhhhh---------ccCCCCccccccccccceeee
Q 040472          345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM---------NTNGYSLTVDIWSLGCTVLEM  415 (628)
Q Consensus       345 HRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~---------~~~~~s~ksDIWSLGvlLyel  415 (628)
                      ||||||+||||+.++.+||+|||+++.....  ....+| +.|+|||++.         ....++.++|||||||+||||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999999865433  455678 9999999984         233478899999999999999


Q ss_pred             ccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          416 ATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       416 LtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      ++|+.||...........+..      ....++.++.+||.+||+.||++||++.++++||||++...
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            999999987554433333221      12357899999999999999999999999999999987643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.1e-41  Score=389.21  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=210.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCC---CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSES---GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++++.||+|+||.||+|++..+   +..||||+++..    ......+.+.+|+.+|++++|||||++++++. +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            456899999999999999999998654   467899987532    22345577889999999999999999999985 5


Q ss_pred             ccceEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.+|+||||+.+|+|.++++..+ .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            67999999999999999998654 68999999999999999999999999999999999999999999999999998764


Q ss_pred             Cccc--cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          374 SCAS--MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       374 ~~~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ....  .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||........+..+.... ...++..++.+
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  620 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPT  620 (656)
T ss_dssp             C----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHH
Confidence            4322  2234577899999998755 59999999999999999997 999998877666555554433 23466789999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +.+||.+||+.||++||++.+|++.
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.1e-41  Score=348.90  Aligned_cols=224  Identities=14%  Similarity=0.142  Sum_probs=188.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||.||+|++..+++.||||++.....  ...+..+.+.+|+.++.+++|+||+++++++.+++..|+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV--LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc--cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            689999999999999999999999999999999864322  224556788999999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML  379 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~  379 (628)
                      ||||+.|++|.+++++ + ..+.++..|+.||+.||+|||++||+||||||+||||+.+|.+||+++|            
T Consensus       109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence            9999999999999965 3 4566788999999999999999999999999999999999999998553            


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHh---hhcCCCCC--CCCCCcCCHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF---KIGNSKDI--PEIPEHLSDDAKSF  454 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~---~i~~~~~~--~~~p~~~s~~l~dL  454 (628)
                             |++        .++.++|||||||+||||++|+.||........+.   +.......  ..+...++.++.+|
T Consensus       175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  239 (286)
T 3uqc_A          175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV  239 (286)
T ss_dssp             -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred             -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence                   333        27889999999999999999999998755433221   11111111  12345689999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcC
Q 040472          455 IKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~H  475 (628)
                      |.+||+.||++| ++.|+++.
T Consensus       240 i~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          240 AARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHcccCCccC-CHHHHHHH
Confidence            999999999999 99999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-41  Score=388.66  Aligned_cols=242  Identities=21%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC-CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc-
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE-SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER-  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~-  296 (628)
                      .++|+++++||+|+||+||+|++.. +++.||||++...    ...+....+.+|+++|++++|||||++++++.+.+. 
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3799999999999999999999976 7899999987532    223455678899999999999999999999988766 


Q ss_pred             ----ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          297 ----LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       297 ----~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                          .||||||+.|++|.+++..  .+++..++.|+.||+.||+|||++|||||||||+||||+.+ .+||+|||+++..
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence                7999999999999998765  79999999999999999999999999999999999999875 9999999999876


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ...   ...+||+.|+|||++.+.  ++.++|||||||+||+|++|.+||.......    +   . .......++..+.
T Consensus       232 ~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----~---~-~~~~~~~~~~~l~  298 (681)
T 2pzi_A          232 NSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----L---P-EDDPVLKTYDSYG  298 (681)
T ss_dssp             TCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----C---C-TTCHHHHHCHHHH
T ss_pred             ccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----c---c-ccccccccCHHHH
Confidence            543   456799999999998653  5899999999999999999999887521100    0   0 0001112467899


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||.+||+.||++||+..+++.|+|+.-
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            9999999999999999999999999753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.8e-35  Score=330.50  Aligned_cols=234  Identities=14%  Similarity=0.080  Sum_probs=165.5

Q ss_pred             eeccCCcEEEEEEEECCCCcEEEEEEEeeccc-----ccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceeccccceEE
Q 040472          227 LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD-----DQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       227 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .++.|++|.++.++....|+.||||++.+...     ........+++.+|+++|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            47788888888888888899999999975321     112234456799999999999 599999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASML  379 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~~  379 (628)
                      ||||+|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+..... ....
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            9999999999999999998875   57899999999999999999999999999999999999999999876543 3445


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHh
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL  459 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  459 (628)
                      +.+||+.|||||++.+  .+..++|+|++|+++|+|+++..+|..     .+...      +  +..  ..+..++..++
T Consensus       398 t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~~~-----~l~~~------~--~~~--~~~~~l~~~l~  460 (569)
T 4azs_A          398 NLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNWLY-----AVWQE------P--VER--WNFVLLLALFE  460 (569)
T ss_dssp             HHHHHHHHHHHHHC-------------------CCCCTTHHHHHH-----HHHTS------C--GGG--CSHHHHHHHHH
T ss_pred             CceechhhccHHHhCC--CCCCcccccccccchhhhccccchhHH-----HhhcC------C--CCC--CcHHHHHHHHh
Confidence            6789999999999865  367789999999999999887655421     11111      0  001  12456777778


Q ss_pred             hcCCCCCCCHHHHhcCccccc
Q 040472          460 QRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       460 ~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ..++..|+.......++|...
T Consensus       461 ~~~~~~~~~~~~~~~~~~~~~  481 (569)
T 4azs_A          461 KKAKLPSAEQQRGATEQWIIA  481 (569)
T ss_dssp             TGGGSCCGGGSSCCHHHHHHH
T ss_pred             CCCCCCCCChhhhccchhHHH
Confidence            888888887777777777643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.9e-29  Score=283.65  Aligned_cols=188  Identities=14%  Similarity=0.171  Sum_probs=145.6

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc---chHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ---TSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ...++||+|+||+||+|.  ..++.+|+|++.......   ......+++.+|+++|++++|+||+++..++...+..||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            456799999999999993  457889999875422111   122235678999999999999999977666667888999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc--
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~--  377 (628)
                      ||||++|++|.+++.+        +..++.||+.||+|||++||+||||||+||||+.  ++||+|||+++.......  
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999999986        6689999999999999999999999999999998  999999999998755322  


Q ss_pred             ------cccccCCCCcCChhhhhc-cCCCCccccccccccceeeeccCCCCC
Q 040472          378 ------MLSFKGSPYWMAPEVVMN-TNGYSLTVDIWSLGCTVLEMATSKPPW  422 (628)
Q Consensus       378 ------~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvlLyelLtG~~PF  422 (628)
                            ...++||+.|||||++.. ...|+..+|+|+..+-.++.+.++.+|
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                  235789999999999865 134888899999887776666655544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.3e-26  Score=235.71  Aligned_cols=149  Identities=20%  Similarity=0.198  Sum_probs=120.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc----hH---------HHHHHHHHHHHHHHhCCCCCeeee
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT----SK---------ECLKQLNQEINLLSQLSHPNIVRY  287 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~----~~---------~~~~~~~~Ei~iL~~l~HpnIV~l  287 (628)
                      .|.+++.||+|+||.||+|++ .+|+.||||+++.......    ..         .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            455669999999999999999 8899999999864221100    00         23567889999999999  5 777


Q ss_pred             ecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccC
Q 040472          288 HGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       288 ~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      ++++. .+..|+||||++|++|.+ +.      ...+..++.||+.||+|||++||+||||||+||||+ ++.+||+|||
T Consensus       167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          167 PKVYA-WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CCEEE-EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             CeEEe-ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            77553 467899999999999988 42      233567999999999999999999999999999999 9999999999


Q ss_pred             CcccccCccccccccCCCCcCChhhhh
Q 040472          368 MAKHMTSCASMLSFKGSPYWMAPEVVM  394 (628)
Q Consensus       368 la~~~~~~~~~~~~~GT~~Y~APEvl~  394 (628)
                      +|+.            +..|+|||++.
T Consensus       238 ~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          238 QSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TCEE------------TTSTTHHHHHH
T ss_pred             CCeE------------CCCCCHHHHHH
Confidence            9963            44588999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=5.6e-22  Score=201.81  Aligned_cols=143  Identities=15%  Similarity=0.211  Sum_probs=111.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcE--EEEEEEeecccccc-------------------hHHHHHHHHHHHHHHHhC
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQM--CAIKEVRVVCDDQT-------------------SKECLKQLNQEINLLSQL  279 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~~~~~-------------------~~~~~~~~~~Ei~iL~~l  279 (628)
                      -|++++.||+|+||.||+|.+..+|+.  ||||+++.......                   .......+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367899999999999999999778999  99999754211100                   112234678999999999


Q ss_pred             CCCCe--eeeecceeccccceEEEEeccc-c----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCCC
Q 040472          280 SHPNI--VRYHGSELSDERLSVYLEYVSG-G----SIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH-ARNTVHRDIKGA  351 (628)
Q Consensus       280 ~HpnI--V~l~~~~~~~~~~~lVmEy~~G-g----sL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH-~~gIvHRDIKpe  351 (628)
                      .|++|  +.++++    ...+|||||+.+ |    .|.+++..   +++..+..++.||+.||.||| +.|||||||||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            88764  333332    467999999942 3    67766543   235678899999999999999 999999999999


Q ss_pred             ceEeCCCCCEEEeccCCcccc
Q 040472          352 NILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       352 NILld~~g~vKL~DFGla~~~  372 (628)
                      ||||+.  .++|+|||+|...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999987  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=3.7e-19  Score=191.42  Aligned_cols=142  Identities=13%  Similarity=0.172  Sum_probs=102.1

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-------------cchHHHH----HHHHHHHHHHHhCCCCC
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-------------QTSKECL----KQLNQEINLLSQLSHPN  283 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-------------~~~~~~~----~~~~~Ei~iL~~l~Hpn  283 (628)
                      -|++++.||+|+||.||+|.+. +|+.||||+++.....             .......    ....+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3899999999999999999885 6999999998632110             0001111    11245677777775444


Q ss_pred             eeeeecceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCC---
Q 040472          284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGE---  360 (628)
Q Consensus       284 IV~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~---  360 (628)
                      |.-.. .+ .....+|||||+.|+.|.++..      ...+..++.||+.+|.|||++|||||||||.||||+.+|.   
T Consensus       175 v~vp~-p~-~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          175 FPVPE-PI-AQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CSCCC-EE-EEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCCe-ee-eccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            32111 11 1234579999999999876532      2345678899999999999999999999999999987763   


Q ss_pred             -------EEEeccCCccc
Q 040472          361 -------IKLADFGMAKH  371 (628)
Q Consensus       361 -------vKL~DFGla~~  371 (628)
                             +.|+||+-+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                   89999997653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=6.1e-13  Score=134.02  Aligned_cols=142  Identities=13%  Similarity=0.092  Sum_probs=112.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .+..|++...++.|+++.||++...  ++.|+||+........     ...+.+|+.+|+.+. +..+.++++++.+.+.
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            4568999999999999999999643  6789999875321111     134778999999885 6778889999888889


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA------------------------------------  340 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~------------------------------------  340 (628)
                      .|+||||++|.+|.+.+.     +......++.+++.+|..||+                                    
T Consensus        85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999999987632     223345788999999999998                                    


Q ss_pred             -----------------------CCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          341 -----------------------RNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       341 -----------------------~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                                             ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                   3489999999999998655567999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=7e-12  Score=124.90  Aligned_cols=136  Identities=16%  Similarity=0.054  Sum_probs=99.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC--eeeeecceecccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN--IVRYHGSELSDER  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IV~l~~~~~~~~~  296 (628)
                      +..|.+..+.+.|..+.||++.. .+|..|+||+....        ....+.+|+.+|+.+.+.+  +.++++++..++.
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~   89 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   89 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence            45666655555677799999954 45778999986532        1134678999998886544  5668888888888


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN----------------------------------  342 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g----------------------------------  342 (628)
                      .++||||++|.+|.  ..   ...   ...++.+++..|..||...                                  
T Consensus        90 ~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             CEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            99999999999884  21   111   2356667777777777643                                  


Q ss_pred             ------------------------ccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          343 ------------------------TVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       343 ------------------------IvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                                              ++|+|+++.|||++.++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                    99999999999998766667999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=4.1e-11  Score=126.62  Aligned_cols=140  Identities=13%  Similarity=0.170  Sum_probs=104.9

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEe--ecccccchHHHHHHHHHHHHHHHhCC--CCCeeeeecceecc---cc
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVR--VVCDDQTSKECLKQLNQEINLLSQLS--HPNIVRYHGSELSD---ER  296 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~--~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIV~l~~~~~~~---~~  296 (628)
                      ..+.|+.|.++.||++...  +..++||+..  ....    ......+.+|+.+|+.|.  +..+++++.++.+.   +.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            4578999999999998754  4678888653  2110    112346778999999997  45578888887765   45


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA------------------------------------  340 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~------------------------------------  340 (628)
                      .|+||||++|..|.+..  ...+++.....++.+++..|..||.                                    
T Consensus       116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            89999999998875421  2346788888999999999999997                                    


Q ss_pred             ----------------------CCccccccCCCceEeCCCCC--EEEeccCCccc
Q 040472          341 ----------------------RNTVHRDIKGANILVDPHGE--IKLADFGMAKH  371 (628)
Q Consensus       341 ----------------------~gIvHRDIKpeNILld~~g~--vKL~DFGla~~  371 (628)
                                            ..++|+|+++.|||++.++.  +.|+||+++..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  35899999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=7.9e-11  Score=121.68  Aligned_cols=184  Identities=17%  Similarity=0.181  Sum_probs=122.3

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCC--eeeeecceeccc---cceE
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPN--IVRYHGSELSDE---RLSV  299 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn--IV~l~~~~~~~~---~~~l  299 (628)
                      +.|+.|.+..||++.     ..++||+...       ......+.+|+.+|+.+. +..  +.+++.+....+   ..|+
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            569999999999972     5688897532       134567889999998884 332  345554443333   4588


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA---------------------------------------  340 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~---------------------------------------  340 (628)
                      ||||++|..|.....  ..++..+...++.|++..|+.||.                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999999999875433  346777788888888888888886                                       


Q ss_pred             -------------------CCccccccCCCceEeCC--CCCEEEeccCCcccccCccccccccCCCCcCChhhhh----c
Q 040472          341 -------------------RNTVHRDIKGANILVDP--HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM----N  395 (628)
Q Consensus       341 -------------------~gIvHRDIKpeNILld~--~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~----~  395 (628)
                                         ..++|+|+++.|||++.  .+.+.|+||+.+.................-..++.+.    .
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                               13699999999999987  4567899999986533211111000000002232211    1


Q ss_pred             cCC---------CCccccccccccceeeeccCCCCCC
Q 040472          396 TNG---------YSLTVDIWSLGCTVLEMATSKPPWS  423 (628)
Q Consensus       396 ~~~---------~s~ksDIWSLGvlLyelLtG~~PF~  423 (628)
                      ...         .....++|++++++|.+.+|..+|.
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            110         1123589999999999999997763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.74  E-value=7.9e-08  Score=96.75  Aligned_cols=139  Identities=15%  Similarity=0.147  Sum_probs=96.9

Q ss_pred             CCeEEeeeeccCCcE-EEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccc
Q 040472          220 SKWKKGKLLGRGTFG-HVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERL  297 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG-~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~  297 (628)
                      ..|+. +.+..|..| .||+......+..++||+-..        .....+.+|+.+|+.|. +--|.+++.++.+++..
T Consensus        25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~   95 (272)
T 4gkh_A           25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA   95 (272)
T ss_dssp             TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence            34443 234555555 699988777788899997642        12356778999998886 33367788888888999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-------------------------------------  340 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-------------------------------------  340 (628)
                      |+|||+++|.++.+.....    ......+..++...|.-||.                                     
T Consensus        96 ~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (272)
T 4gkh_A           96 WLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER  171 (272)
T ss_dssp             EEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred             EEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence            9999999998887665431    11223344445555555552                                     


Q ss_pred             --------------C-------CccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          341 --------------R-------NTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       341 --------------~-------gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                                    .       .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          1       178999999999998777677999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.70  E-value=1.4e-07  Score=97.75  Aligned_cols=133  Identities=22%  Similarity=0.168  Sum_probs=93.3

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC---Ceeeeeccee-ccccceEE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP---NIVRYHGSEL-SDERLSVY  300 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIV~l~~~~~-~~~~~~lV  300 (628)
                      .+.|+.|....||+.     +..++||+-..       ......+.+|+++|+.|.+.   .|.+++.+.. ..+..|+|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            356899999999998     56788887421       23456788999999999752   2556666653 45667899


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHAR---------------------------------------  341 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~---------------------------------------  341 (628)
                      |||++|..|....-  ..++......++.++...|+.||+.                                       
T Consensus        92 ~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           92 YRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             EECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             EeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            99999988876321  2234444455555555555555532                                       


Q ss_pred             ---------------------CccccccCCCceEeCC---CCCE-EEeccCCccc
Q 040472          342 ---------------------NTVHRDIKGANILVDP---HGEI-KLADFGMAKH  371 (628)
Q Consensus       342 ---------------------gIvHRDIKpeNILld~---~g~v-KL~DFGla~~  371 (628)
                                           .++|+|+++.|||++.   ++.+ .|+||+.+..
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 3599999999999987   4554 8999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.41  E-value=4.4e-07  Score=96.98  Aligned_cols=81  Identities=17%  Similarity=0.148  Sum_probs=49.8

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccch--HHHHHHHHHHHHHHHhCCC--C-CeeeeecceeccccceE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTS--KECLKQLNQEINLLSQLSH--P-NIVRYHGSELSDERLSV  299 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~--~~~~~~~~~Ei~iL~~l~H--p-nIV~l~~~~~~~~~~~l  299 (628)
                      .+.||.|.++.||++....+++.|+||...........  .....++..|+++|+.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            46899999999999976656788999976432110000  0012345678888887742  3 34455543  4556789


Q ss_pred             EEEecccc
Q 040472          300 YLEYVSGG  307 (628)
Q Consensus       300 VmEy~~Gg  307 (628)
                      ||||+.|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.22  E-value=1.4e-06  Score=91.43  Aligned_cols=85  Identities=11%  Similarity=0.053  Sum_probs=53.9

Q ss_pred             EEeeee-ccCCcEEEEEEEEC--C----CCcEEEEEEEeeccc-ccchHHHHHHHHHHHHHHHhCC-C--CCeeeeecce
Q 040472          223 KKGKLL-GRGTFGHVYLGFNS--E----SGQMCAIKEVRVVCD-DQTSKECLKQLNQEINLLSQLS-H--PNIVRYHGSE  291 (628)
Q Consensus       223 ~~~~~L-G~G~fG~Vy~a~~~--~----tg~~vAvK~i~~~~~-~~~~~~~~~~~~~Ei~iL~~l~-H--pnIV~l~~~~  291 (628)
                      ...+.| +.|....+|++...  .    +++.+++|+...... ....   ...+.+|+.+|+.|. +  -.+.+++.++
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            345678 89999999998653  1    156788886542110 0000   124567888887775 2  2466777766


Q ss_pred             ecc---ccceEEEEecccccHH
Q 040472          292 LSD---ERLSVYLEYVSGGSIH  310 (628)
Q Consensus       292 ~~~---~~~~lVmEy~~GgsL~  310 (628)
                      .+.   +..|+||||++|..|.
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCCC
T ss_pred             cCCCccCCceEEEEecCCCChh
Confidence            554   3568999999986653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=1.1e-05  Score=83.24  Aligned_cols=135  Identities=16%  Similarity=0.134  Sum_probs=76.9

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC--CCCeeeeec------ceecccc
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS--HPNIVRYHG------SELSDER  296 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIV~l~~------~~~~~~~  296 (628)
                      .+.|+.|..+.||++...  +..++||+...   .   .   .++..|+.+++.|.  .-.|.+++.      +....+.
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~---~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~  105 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHR---P---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF  105 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECS---C---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCC---C---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE
Confidence            356777788999999754  34589998753   1   1   22334455554443  112334433      1234567


Q ss_pred             ceEEEEecccccHH-----------HHH---Hh-cCCC--C-----------HH--------H-----------------
Q 040472          297 LSVYLEYVSGGSIH-----------KLL---QE-YGPF--N-----------EP--------V-----------------  323 (628)
Q Consensus       297 ~~lVmEy~~GgsL~-----------~~L---~~-~~~l--~-----------e~--------~-----------------  323 (628)
                      .++||||++|..+.           ..|   +. ...+  +           ..        .                 
T Consensus       106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  185 (346)
T 2q83_A          106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS  185 (346)
T ss_dssp             EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred             EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence            89999999986432           111   11 0111  0           00        0                 


Q ss_pred             ------HHHHHHHHHHHHHHHHh-------------CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          324 ------IQTYTRQILLGLAYLHA-------------RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       324 ------~~~i~~qIl~aL~yLH~-------------~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                            +..+..++..++++|+.             ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                  11122234446666653             579999999999999888899999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.92  E-value=4.4e-05  Score=82.27  Aligned_cols=32  Identities=16%  Similarity=0.256  Sum_probs=27.9

Q ss_pred             hCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       340 ~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      ...++|+|+++.|||++.++ ++|+||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45799999999999998776 999999988653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.82  E-value=5.6e-05  Score=77.49  Aligned_cols=132  Identities=11%  Similarity=0.098  Sum_probs=74.5

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccceEEEEe
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~lVmEy  303 (628)
                      .+.|+.|....+|++      ..|+||+.......      .....+|+.+++.+...+| .+++++  +.+.-++|+||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEee
Confidence            678999999999999      45888876532111      1122457777776652222 455544  34456789999


Q ss_pred             c-ccccHHH---------------HHHh---cC-CCC-----HHHHHHHHH--------------HHHHHHHHHH----h
Q 040472          304 V-SGGSIHK---------------LLQE---YG-PFN-----EPVIQTYTR--------------QILLGLAYLH----A  340 (628)
Q Consensus       304 ~-~GgsL~~---------------~L~~---~~-~l~-----e~~~~~i~~--------------qIl~aL~yLH----~  340 (628)
                      + .|..|..               .|.+   .. .+.     ...+..+..              .+...+..|.    .
T Consensus        89 i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~  168 (301)
T 3dxq_A           89 IAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA  168 (301)
T ss_dssp             CTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence            9 7655431               1111   11 011     111111111              1111122221    1


Q ss_pred             ----CCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          341 ----RNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       341 ----~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                          ..++|+|+.+.||| ..++.+.|+||..+..
T Consensus       169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             cCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                13899999999999 5567899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.82  E-value=5e-05  Score=79.13  Aligned_cols=76  Identities=17%  Similarity=0.096  Sum_probs=58.5

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC---CCCeeeeecceeccccceEE
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS---HPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIV~l~~~~~~~~~~~lV  300 (628)
                      -.+.|+.|.+..||+...  ++..|+||+....        ....+..|+.+|+.|.   ...+++++.+....+..|+|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            346799999999999864  4678889976421        1355778988888874   35678888888777889999


Q ss_pred             EEecccccH
Q 040472          301 LEYVSGGSI  309 (628)
Q Consensus       301 mEy~~GgsL  309 (628)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.54  E-value=0.00029  Score=72.67  Aligned_cols=76  Identities=14%  Similarity=-0.001  Sum_probs=46.4

Q ss_pred             eeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCC--Ceeeeecc-----eeccccce
Q 040472          226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP--NIVRYHGS-----ELSDERLS  298 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIV~l~~~-----~~~~~~~~  298 (628)
                      +.|+ |....||++... +|+.++||+......   .   ...+..|+.+++.|...  .+++++..     ...++..+
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~---~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~  103 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF  103 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC---C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence            4566 888899987543 466799998752211   1   23455677777766421  24444443     12245567


Q ss_pred             EEEEecccccH
Q 040472          299 VYLEYVSGGSI  309 (628)
Q Consensus       299 lVmEy~~GgsL  309 (628)
                      +||||++|..+
T Consensus       104 ~l~~~i~G~~~  114 (328)
T 1zyl_A          104 AVFPSVGGRQF  114 (328)
T ss_dssp             EEEECCCCEEC
T ss_pred             EEEEecCCCCC
Confidence            89999988543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.49  E-value=0.00018  Score=74.60  Aligned_cols=31  Identities=35%  Similarity=0.452  Sum_probs=27.1

Q ss_pred             CCccccccCCCceEeCCC----CCEEEeccCCccc
Q 040472          341 RNTVHRDIKGANILVDPH----GEIKLADFGMAKH  371 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~----g~vKL~DFGla~~  371 (628)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999875    6799999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.46  E-value=0.00024  Score=73.02  Aligned_cols=139  Identities=15%  Similarity=0.099  Sum_probs=77.5

Q ss_pred             EEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC--eeeeecc------eecc
Q 040472          223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN--IVRYHGS------ELSD  294 (628)
Q Consensus       223 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IV~l~~~------~~~~  294 (628)
                      ...+.|+.|....||++... ++ .+++|+.....       ....+..|+.+++.|....  +.+++..      ...+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            34567888999999999754 23 68899875310       1123455777776664212  3333321      1224


Q ss_pred             ccceEEEEecccccHH-----------HH---HHhc-CCC--------CHHHHHH----H-----------HHHHHHHHH
Q 040472          295 ERLSVYLEYVSGGSIH-----------KL---LQEY-GPF--------NEPVIQT----Y-----------TRQILLGLA  336 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~-----------~~---L~~~-~~l--------~e~~~~~----i-----------~~qIl~aL~  336 (628)
                      +..++||+|++|..+.           ..   ++.. ..+        ....-..    .           ...+...++
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            5678999999986431           11   1111 011        1000000    0           011344566


Q ss_pred             HHHh-------CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          337 YLHA-------RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       337 yLH~-------~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      +|+.       .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            6653       369999999999999876556899999775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.42  E-value=0.00029  Score=75.33  Aligned_cols=136  Identities=15%  Similarity=0.163  Sum_probs=80.5

Q ss_pred             eeeccCCcEEEEEEEECC-------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceeccccc
Q 040472          226 KLLGRGTFGHVYLGFNSE-------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDERL  297 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~~  297 (628)
                      +.|..|-...+|++....       +++.|.||+.....      .....+.+|.++|+.|. +.-..++++++.+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~------~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL------QGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc------chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            567788889999987642       35788898752211      11234558888888775 3223566766543    


Q ss_pred             eEEEEecccccHHH--------------HHHh---cC-C----C--CHHHHHHHHHHHH-------------------HH
Q 040472          298 SVYLEYVSGGSIHK--------------LLQE---YG-P----F--NEPVIQTYTRQIL-------------------LG  334 (628)
Q Consensus       298 ~lVmEy~~GgsL~~--------------~L~~---~~-~----l--~e~~~~~i~~qIl-------------------~a  334 (628)
                      .+||||++|..|..              .|.+   .. .    .  -..++..++.++.                   ..
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            28999999866531              1111   10 1    1  1344555554432                   22


Q ss_pred             HHHHH----hC----CccccccCCCceEeCCC----CCEEEeccCCccc
Q 040472          335 LAYLH----AR----NTVHRDIKGANILVDPH----GEIKLADFGMAKH  371 (628)
Q Consensus       335 L~yLH----~~----gIvHRDIKpeNILld~~----g~vKL~DFGla~~  371 (628)
                      ++.|.    ..    .++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33333    22    48999999999999876    6899999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.34  E-value=0.00071  Score=73.37  Aligned_cols=74  Identities=15%  Similarity=0.116  Sum_probs=49.0

Q ss_pred             eeeeccCCcEEEEEEEECC-------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceecccc
Q 040472          225 GKLLGRGTFGHVYLGFNSE-------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDER  296 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~  296 (628)
                      .+.|+.|....||++....       +++.|+||+....   . .   ...+.+|+.+++.|...+| .++++.+.+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---C-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence            4678999999999997653       2578999977321   1 1   1233468888888763333 567766542   


Q ss_pred             ceEEEEecccccH
Q 040472          297 LSVYLEYVSGGSI  309 (628)
Q Consensus       297 ~~lVmEy~~GgsL  309 (628)
                       .+||||++|..|
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999987544

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.28  E-value=0.0018  Score=65.71  Aligned_cols=79  Identities=14%  Similarity=0.041  Sum_probs=53.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC---CCeeeeecceecccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH---PNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIV~l~~~~~~~~~  296 (628)
                      .+..-.+.+|.|..+.||++... +|+.|.||+-......     ....+..|+..|+.|.-   --+++++++    +.
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~   84 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA-----LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DD   84 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC-----CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ET
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc-----hhhHHHHHHHHHHHHHhhCCCCcceEEec----cC
Confidence            35566788999999999999754 6889999965321111     11346789999888852   124445543    23


Q ss_pred             ceEEEEeccccc
Q 040472          297 LSVYLEYVSGGS  308 (628)
Q Consensus       297 ~~lVmEy~~Ggs  308 (628)
                      -++||||+.++.
T Consensus        85 ~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 RTLAMEWVDERP   96 (288)
T ss_dssp             TEEEEECCCCCC
T ss_pred             ceEEEEeecccC
Confidence            578999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.25  E-value=0.0017  Score=71.20  Aligned_cols=75  Identities=12%  Similarity=0.042  Sum_probs=48.9

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccceEEEEe
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~lVmEy  303 (628)
                      .+.|+.|-...+|++.....+..|+||+.........      ...+|+.+|+.|...+| .++++++. +   .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEe
Confidence            4678999999999998764457889997643211111      11478888988875444 56777663 2   359999


Q ss_pred             cccccH
Q 040472          304 VSGGSI  309 (628)
Q Consensus       304 ~~GgsL  309 (628)
                      ++|..|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.21  E-value=0.00065  Score=67.01  Aligned_cols=122  Identities=23%  Similarity=0.174  Sum_probs=82.9

Q ss_pred             ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH-HhCCccccccCCCceEeCCCCCEEEeccCCcccccCccccccccCC
Q 040472          307 GSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYL-HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGS  384 (628)
Q Consensus       307 gsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yL-H~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT  384 (628)
                      -+|.++|+.. .+++|++++.++.|.+.+|.-+ +.+.-..+=+.+..|+|..+|.|-+.+ ..+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            4899999854 6899999999999999998776 222223444567999999999998764 2111           112


Q ss_pred             CCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhc
Q 040472          385 PYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQR  461 (628)
Q Consensus       385 ~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  461 (628)
                      ..+.+||...  ...+.+.=|||||++||.-|--..|                   +..+..+|+.+..||..|...
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhc
Confidence            2456888653  2357788999999999987653322                   133456999999999999765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.20  E-value=0.0007  Score=71.33  Aligned_cols=75  Identities=12%  Similarity=0.034  Sum_probs=43.6

Q ss_pred             eeeeccCCcEEEEEEEECC--------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCC-eeeeecceeccc
Q 040472          225 GKLLGRGTFGHVYLGFNSE--------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN-IVRYHGSELSDE  295 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~--------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IV~l~~~~~~~~  295 (628)
                      .+.|+.|....||++....        .+..|++|+.......      +.....|+.+|+.|...+ +.++++.+    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~~~~E~~~l~~L~~~g~~P~~~~~~----  107 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE------LYNTISEFEVYKTMSKYKIAPQLLNTF----  107 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG------TSCHHHHHHHHHHHHHTTSSCCEEEEE----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc------eecHHHHHHHHHHHHhcCCCCceEEec----
Confidence            4678889899999997653        1367888876431111      112356777877775323 44666544    


Q ss_pred             cceEEEEecccccH
Q 040472          296 RLSVYLEYVSGGSI  309 (628)
Q Consensus       296 ~~~lVmEy~~GgsL  309 (628)
                      .-++||||++|..|
T Consensus       108 ~~~~v~e~i~G~~l  121 (369)
T 3c5i_A          108 NGGRIEEWLYGDPL  121 (369)
T ss_dssp             TTEEEEECCCSEEC
T ss_pred             CCcEEEEEecCCcC
Confidence            23789999998643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.07  E-value=0.002  Score=67.41  Aligned_cols=31  Identities=26%  Similarity=0.339  Sum_probs=27.3

Q ss_pred             CCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          341 RNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3589999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.71  E-value=0.054  Score=58.55  Aligned_cols=75  Identities=9%  Similarity=0.013  Sum_probs=47.4

Q ss_pred             eeeeccCCcEEEEEEEECCC-------CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          225 GKLLGRGTFGHVYLGFNSES-------GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~t-------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .+.|..|-...+|++.....       ++.|+||+.......      .-...+|..+++.|. +.-..++++.+.    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~------~idR~~E~~~l~~L~~~gi~P~l~~~~~----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK------FYDSKVELDVFRYLSNINIAPNIIADFP----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C------CCCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch------hcCHHHHHHHHHHHHhcCCCCCEEEEcC----
Confidence            46788888999999976521       577888875332111      112346788887775 222345555332    


Q ss_pred             ceEEEEecccccH
Q 040472          297 LSVYLEYVSGGSI  309 (628)
Q Consensus       297 ~~lVmEy~~GgsL  309 (628)
                      -++||||++|..|
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            3789999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.19  E-value=0.068  Score=56.99  Aligned_cols=29  Identities=28%  Similarity=0.433  Sum_probs=24.7

Q ss_pred             ccccccCCCceEe------CCCCCEEEeccCCccc
Q 040472          343 TVHRDIKGANILV------DPHGEIKLADFGMAKH  371 (628)
Q Consensus       343 IvHRDIKpeNILl------d~~g~vKL~DFGla~~  371 (628)
                      ++|+|+.+.|||+      +.++.++|+||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4456799999998853

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=89.17  E-value=6.1  Score=45.07  Aligned_cols=80  Identities=21%  Similarity=0.346  Sum_probs=48.9

Q ss_pred             eecceeccccceEEEEecccccHHHHHHhcCC---------------C--CHHHHHHHHHHHH--HHHHHHHhCCccccc
Q 040472          287 YHGSELSDERLSVYLEYVSGGSIHKLLQEYGP---------------F--NEPVIQTYTRQIL--LGLAYLHARNTVHRD  347 (628)
Q Consensus       287 l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~---------------l--~e~~~~~i~~qIl--~aL~yLH~~gIvHRD  347 (628)
                      .|.+.-.....-| +|+++..+|.+++.+.+.               +  .......+++.++  ..+.|+=  ||  +|
T Consensus       478 ~Y~Vipls~~~GL-IE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YIL--Gl--GD  552 (696)
T 2x6h_A          478 PYKVLATSSKHGF-LQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLL--GV--GD  552 (696)
T ss_dssp             CCCEEESSTTCEE-EECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHH--TC--CC
T ss_pred             ccEEEeccCCCCe-eeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHc--cC--CC
Confidence            3444444444333 477777777776654331               1  1123344555543  3444443  33  58


Q ss_pred             cCCCceEeCCCCCEEEeccCCccc
Q 040472          348 IKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       348 IKpeNILld~~g~vKL~DFGla~~  371 (628)
                      =.++||||+.+|++.=+|||++..
T Consensus       553 RH~~NILid~tG~v~HIDFG~~f~  576 (696)
T 2x6h_A          553 RHLDNLLLTTNGKLFHIDFGYILG  576 (696)
T ss_dssp             CCTTTEEECTTSCEEECCCCSCTT
T ss_pred             CCCcceEEeCCCCEEEEeehhhhc
Confidence            889999999999999999998853

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=88.44  E-value=5.2  Score=41.62  Aligned_cols=140  Identities=15%  Similarity=0.191  Sum_probs=76.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecc--------
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGS--------  290 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~--------  290 (628)
                      +.+++.++.+-.|..|.++.+.   ++..|+||-..     ..   ..+.+-.++...-.+.-|+..-+...        
T Consensus        68 l~~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s~-----~l---~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~  136 (342)
T 1cja_A           68 LQQFKGIERSEKGTEGLFFVET---ESGVFIVKRST-----NI---ESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNML  136 (342)
T ss_dssp             GGGEEEEEECCSTTSCEEEEEE---SSCEEEEECCT-----TH---HHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHH
T ss_pred             ccCeeEEEeccCCCCCeEEEEe---CCCEEEEeCcH-----HH---HHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHH
Confidence            4457788888888766555554   46788888431     11   12223334433344555552211100        


Q ss_pred             --------------eeccccceEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----ccc-cccC
Q 040472          291 --------------ELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARN----TVH-RDIK  349 (628)
Q Consensus       291 --------------~~~~~~~~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g----IvH-RDIK  349 (628)
                                    ...+...+++|||+.|..|.+.-..  ...+.+.....+.  -+.+++++..+.    .+. .--.
T Consensus       137 ~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN  214 (342)
T 1cja_A          137 ECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGN  214 (342)
T ss_dssp             HHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCC
T ss_pred             HHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCC
Confidence                          0012356699999998776643111  1113333332221  145677777663    221 2257


Q ss_pred             CCceEeCCCCC-EEEeccCCccc
Q 040472          350 GANILVDPHGE-IKLADFGMAKH  371 (628)
Q Consensus       350 peNILld~~g~-vKL~DFGla~~  371 (628)
                      ++|||++.++. +.++|-+++..
T Consensus       215 ~~NIL~~~~n~~~~~IDhn~af~  237 (342)
T 1cja_A          215 LDNIMLSERGATVVPIDSKIIPL  237 (342)
T ss_dssp             GGGEEEESBTTCEEECSCCCCCC
T ss_pred             hhheEEeCCCCeEEEEcCCcccc
Confidence            89999977554 99999998864

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=87.31  E-value=9.1  Score=43.01  Aligned_cols=82  Identities=16%  Similarity=0.295  Sum_probs=49.6

Q ss_pred             eeeecceeccccceEEEEecccccHHHHHHhcCC-----------------CCHHHHHHHHHHHH--HHHHHHHhCCccc
Q 040472          285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP-----------------FNEPVIQTYTRQIL--LGLAYLHARNTVH  345 (628)
Q Consensus       285 V~l~~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~-----------------l~e~~~~~i~~qIl--~aL~yLH~~gIvH  345 (628)
                      ++.|.+.-.....-| +|++++-++.+++.+.+.                 ........+++.++  ..+-|+=  ||  
T Consensus       402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YIL--Gi--  476 (614)
T 3ls8_A          402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYIL--GV--  476 (614)
T ss_dssp             CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHH--TC--
T ss_pred             eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheee--ec--
Confidence            344444444444433 578777666665543221                 11233445555554  3445554  33  


Q ss_pred             cccCCCceEeCCCCCEEEeccCCccc
Q 040472          346 RDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       346 RDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +|=.++||||+.+|++.=+|||.+..
T Consensus       477 gDRH~~NILld~tG~v~HIDFG~~f~  502 (614)
T 3ls8_A          477 GDRHLDNLLLTKTGKLFHIDFGYILG  502 (614)
T ss_dssp             CCCCTTSEEECTTSCEEECCCSSCTT
T ss_pred             cCCCCcceeEcCCCCEeeeehHHhhc
Confidence            47789999999999999999998853

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.88  E-value=0.093  Score=57.31  Aligned_cols=63  Identities=13%  Similarity=0.078  Sum_probs=17.3

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEE------EEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAI------KEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAv------K~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      +.+.||   ||.||++........||+      |.++.   .....+....+.+|..+++.++|+||++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~---~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQ---DGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccc---ccccccccccccccccccccccccccCCCcceEE
Confidence            345576   999999988765567888      55432   1222344456778999999999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	628
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-86
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-85
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-84
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-83
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-80
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-79
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-78
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-78
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-78
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-77
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-76
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-75
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-75
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-74
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-72
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-72
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-72
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-70
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-70
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-70
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-68
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-68
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-66
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-66
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-65
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-65
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-65
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-64
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-64
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-64
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-63
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-63
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-63
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-62
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-61
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-60
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-58
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-57
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-56
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-51
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-40
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-27

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  269 bits (688), Expect = 1e-86
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 6/262 (2%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           +L  ++ G+ LG+G FG+VYL    +S  + A+K +              QL +E+ + S
Sbjct: 4   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRREVEIQS 61

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            L HPNI+R +G      R+ + LEY   G++++ LQ+   F+E    TY  ++   L+Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
            H++  +HRDIK  N+L+   GE+K+ADFG + H  S     +  G+  ++ PE++    
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEG-R 179

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            +   VD+WSLG    E    KPP+          +I   +     P+ +++ A+  I +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISR 237

Query: 458 CLQRDPSARPPASKLLDHPFVR 479
            L+ +PS RP   ++L+HP++ 
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  266 bits (682), Expect = 4e-85
 Identities = 92/266 (34%), Positives = 139/266 (52%), Gaps = 7/266 (2%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           ++    +   + +G G+FG VY   +  + ++ AIK++      + S E  + + +E+  
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRF 68

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
           L +L HPN ++Y G  L +    + +EY  G +   L     P  E  I   T   L GL
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV-- 393
           AYLH+ N +HRD+K  NIL+   G +KL DFG A  M       SF G+PYWMAPEV+  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILA 185

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
           M+   Y   VD+WSLG T +E+A  KPP      ++A++ I  ++       H S+  ++
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245

Query: 454 FIKQCLQRDPSARPPASKLLDHPFVR 479
           F+  CLQ+ P  RP +  LL H FV 
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVL 271

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (674), Expect = 3e-84
 Identities = 99/265 (37%), Positives = 141/265 (53%), Gaps = 12/265 (4%)

Query: 222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
           W+    LG G FG VY   N E+  + A K +     D  S+E L+    EI++L+   H
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMVEIDILASCDH 68

Query: 282 PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHA 340
           PNIV+   +   +  L + +E+ +GG++  ++ E   P  E  IQ   +Q L  L YLH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVM----N 395
              +HRD+K  NIL    G+IKLADFG++   T       SF G+PYWMAPEVVM     
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSF 454
              Y    D+WSLG T++EMA  +PP  +   +  + KI  S+      P   S + K F
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 455 IKQCLQRDPSARPPASKLLDHPFVR 479
           +K+CL+++  AR   S+LL HPFV 
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVT 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 8e-83
 Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 8/265 (3%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           +  W   + LG G +G V L  N  + +  A+K V +    + + +C + + +EI +   
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKM 59

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           L+H N+V+++G         ++LEY SGG +   ++      EP  Q +  Q++ G+ YL
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMN 395
           H     HRDIK  N+L+D    +K++DFG+A           +    G+  ++APE++  
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IGNSKDIPEIPEHLSDDAKSF 454
              ++  VD+WS G  +  M   + PW Q       +      K      + +     + 
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 455 IKQCLQRDPSARPPASKLLDHPFVR 479
           + + L  +PSAR     +    +  
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYN 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (646), Expect = 2e-80
 Identities = 81/270 (30%), Positives = 128/270 (47%), Gaps = 17/270 (6%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            ++    +G G++G          G++   KE+      +  K+ L     E+NLL +L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLLRELK 61

Query: 281 HPNIVRYHGSELSDERLSVYL--EYVSGGS----IHKLLQEYGPFNEPVIQTYTRQILLG 334
           HPNIVRY+   +     ++Y+  EY  GG     I K  +E    +E  +     Q+ L 
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 335 LAYLHARNT-----VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWM 388
           L   H R+      +HRD+K AN+ +D    +KL DFG+A+ +    S   +F G+PY+M
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLS 448
           +PE  MN   Y+   DIWSLGC + E+    PP++ +       KI   K    IP   S
Sbjct: 182 SPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYS 239

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFV 478
           D+    I + L      RP   ++L++P +
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  250 bits (640), Expect = 2e-79
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 12/271 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQ----EINLL 276
            ++  ++LGRG    V    +  + +  A+K + V      S E +++L +    E+++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 277 SQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
            ++S HPNI++   +  ++    +  + +  G +   L E    +E   +   R +L  +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM- 394
             LH  N VHRD+K  NIL+D    IKL DFG +  +     +    G+P ++APE++  
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183

Query: 395 ----NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE--HLS 448
               N  GY   VD+WS G  +  +    PP+   + +  +  I +       PE    S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVR 479
           D  K  + + L   P  R  A + L HPF +
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (636), Expect = 7e-79
 Identities = 76/265 (28%), Positives = 139/265 (52%), Gaps = 14/265 (5%)

Query: 223 KKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHP 282
           K    +GRG+F  VY G ++E+    A  E++   D + +K   ++  +E  +L  L HP
Sbjct: 12  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 283 NIVRYHGS----ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           NIVR++ S        + + +  E ++ G++   L+ +      V++++ RQIL GL +L
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 339 HARNT--VHRDIKGANILV-DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
           H R    +HRD+K  NI +  P G +K+ D G+A    + +   +  G+P +MAPE+   
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY-- 185

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IGNSKDIPEIPEHLSDDAKSF 454
              Y  +VD+++ G  +LEMATS+ P+S+ +  A I++ + +        +    + K  
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245

Query: 455 IKQCLQRDPSARPPASKLLDHPFVR 479
           I+ C++++   R     LL+H F +
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (632), Expect = 5e-78
 Identities = 92/262 (35%), Positives = 138/262 (52%), Gaps = 9/262 (3%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+ + + +G+G  G VY   +  +GQ  AI+++ +    Q  KE +     EI ++ +  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN---EILVMRENK 75

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           +PNIV Y  S L  + L V +EY++GGS+  ++ E    +E  I    R+ L  L +LH+
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS 134

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS-FKGSPYWMAPEVVMNTNGY 399
              +HRDIK  NIL+   G +KL DFG    +T   S  S   G+PYWMAPEVV     Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAY 193

Query: 400 SLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP-EIPEHLSDDAKSFIKQC 458
              VDIWSLG   +EM   +PP+     + A++ I  +     + PE LS   + F+ +C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 459 LQRDPSARPPASKLLDHPFVRD 480
           L  D   R  A +LL H F++ 
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKI 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (632), Expect = 5e-78
 Identities = 73/269 (27%), Positives = 129/269 (47%), Gaps = 14/269 (5%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +K GK+LG G+F  V L     + +  AIK +         +  +  + +E +++S+L 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLD 66

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           HP  V+ + +   DE+L   L Y   G + K +++ G F+E   + YT +I+  L YLH 
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 341 RNTVHRDIKGANILVDPHGEIKLADFGMAKHM---TSCASMLSFKGSPYWMAPEVVMNTN 397
           +  +HRD+K  NIL++    I++ DFG AK +   +  A   SF G+  +++PE ++   
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEK 185

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
               + D+W+LGC + ++    PP+          KI   +   + PE     A+  +++
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVEK 243

Query: 458 CLQRDPSARPPASK------LLDHPFVRD 480
            L  D + R    +      L  HPF   
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  249 bits (637), Expect = 6e-78
 Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 11/270 (4%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           ++ L  +   + LG G FG V+      +G   A K V    +        + + +EI  
Sbjct: 22  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-----KETVRKEIQT 76

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLG 334
           +S L HP +V  H +   D  + +  E++SGG + + +  E+   +E     Y RQ+  G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 335 LAYLHARNTVHRDIKGANILVDPH--GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
           L ++H  N VH D+K  NI+       E+KL DFG+  H+    S+    G+  + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI--GNSKDIPEIPEHLSDD 450
                      D+WS+G     + +   P+        +  +   +          +S+D
Sbjct: 197 AEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
            K FI++ L  DP+ R    + L+HP++  
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 5e-77
 Identities = 80/316 (25%), Positives = 148/316 (46%), Gaps = 52/316 (16%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            ++K   LG G  G V+   +  SG + A K + +    +       Q+ +E+ +L + +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECN 62

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
            P IV ++G+  SD  +S+ +E++ GGS+ ++L++ G   E ++   +  ++ GL YL  
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 341 RNT-VHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGY 399
           ++  +HRD+K +NILV+  GEIKL DFG++  +    +  SF G+  +M+PE +     Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQ-GTHY 180

Query: 400 SLTVDIWSLGCTVLEMATSKPPW--SQYEGVAAIFKIGNSKDIPEIPE------------ 445
           S+  DIWS+G +++EMA  + P      + +  +F      D  E P             
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 446 ----------------------------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPF 477
                                         S + + F+ +CL ++P+ R    +L+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

Query: 478 VRDQAVARAGNVNLAK 493
           ++    + A  V+ A 
Sbjct: 301 IKR---SDAEEVDFAG 313

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 3e-76
 Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 17/270 (6%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E    +   G+ +G G+FG VY G   +     A+K + V      + + L+    E+ +
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNV---TAPTPQQLQAFKNEVGV 57

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLG 334
           L +  H NI+ + G   +  +L++  ++  G S++  L      F    +    RQ   G
Sbjct: 58  LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK---HMTSCASMLSFKGSPYWMAPE 391
           + YLHA++ +HRD+K  NI +     +K+ DFG+A      +         GS  WMAPE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 392 VVM--NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK----DIPEIPE 445
           V+   + N YS   D+++ G  + E+ T + P+S       I  +        D+ ++  
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +     K  + +CL++    RP   ++L  
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  241 bits (616), Expect = 2e-75
 Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 10/272 (3%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
            E+    +    +LG G F  V L  +  + ++ AIK +      +  +     +  EI 
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA----KKALEGKEGSMENEIA 59

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLG 334
           +L ++ HPNIV       S   L + ++ VSGG +   + E G + E        Q+L  
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 335 LAYLHARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
           + YLH    VHRD+K  N+L    D   +I ++DFG++K     + + +  G+P ++APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI--GNSKDIPEIPEHLSD 449
           V+     YS  VD WS+G     +    PP+          +I     +      + +SD
Sbjct: 180 VLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238

Query: 450 DAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
            AK FI+  +++DP  R    + L HP++   
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  241 bits (617), Expect = 5e-75
 Identities = 60/269 (22%), Positives = 121/269 (44%), Gaps = 11/269 (4%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
           +    +   + LG G FG V+      +G++   K +               +  EI+++
Sbjct: 26  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIM 80

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLGL 335
           +QL HP ++  H +      + + LE++SGG +   +  E    +E  +  Y RQ   GL
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 336 AYLHARNTVHRDIKGANILVDPH--GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVV 393
            ++H  + VH DIK  NI+ +      +K+ DFG+A  +     +     +  + APE +
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 199

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI--GNSKDIPEIPEHLSDDA 451
           ++        D+W++G     + +   P++  + +  +  +   + +   +    +S +A
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259

Query: 452 KSFIKQCLQRDPSARPPASKLLDHPFVRD 480
           K FIK  LQ++P  R      L+HP+++ 
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 288

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 1e-74
 Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 12/266 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           K+   + LGRG FG V+    + S +    K V+V   DQ        + +EI++L+   
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ------VLVKKEISILNIAR 59

Query: 281 HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLH 339
           H NI+  H S  S E L +  E++SG  I + +       NE  I +Y  Q+   L +LH
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 340 ARNTVHRDIKGANILVDPHGE--IKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
           + N  H DI+  NI+        IK+ +FG A+ +    +      +P + APEV  + +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-D 178

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDDAKSFI 455
             S   D+WSLG  V  + +   P+        I  I N++     E  + +S +A  F+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 456 KQCLQRDPSARPPASKLLDHPFVRDQ 481
            + L ++  +R  AS+ L HP+++ +
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQK 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  234 bits (597), Expect = 1e-72
 Identities = 77/268 (28%), Positives = 145/268 (54%), Gaps = 12/268 (4%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           SL  ++  + LG G+FG V+L  +  +G+  A+K ++   +     + ++  N E  +LS
Sbjct: 2   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLS 59

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            ++HP I+R  G+    +++ + ++Y+ GG +  LL++   F  PV + Y  ++ L L Y
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
           LH+++ ++RD+K  NIL+D +G IK+ DFG AK++       +  G+P ++APE V++T 
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPE-VVSTK 176

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
            Y+ ++D WS G  + EM     P+     +    KI N++     P   ++D K  + +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSR 234

Query: 458 CLQRDPSARPP-----ASKLLDHPFVRD 480
            + RD S R          + +HP+ ++
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 2e-72
 Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 8/265 (3%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS- 277
           +  +   K+LG+G+FG V+L    ++ Q  AIK ++   D     + ++    E  +LS 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSL 58

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
              HP +     +  + E L   +EY++GG +   +Q    F+      Y  +I+LGL +
Sbjct: 59  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFKGSPYWMAPEVVMNT 396
           LH++  V+RD+K  NIL+D  G IK+ADFGM K      A   +F G+P ++APE ++  
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE-ILLG 177

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
             Y+ +VD WS G  + EM   + P+   +       I    D P  P  L  +AK  + 
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLV 235

Query: 457 QCLQRDPSARPPA-SKLLDHPFVRD 480
           +   R+P  R      +  HP  R+
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFRE 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  235 bits (600), Expect = 2e-72
 Identities = 76/271 (28%), Positives = 144/271 (53%), Gaps = 10/271 (3%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVV-CDDQTSKECLKQLNQEINLL 276
           +++ +   +++GRG FG VY    +++G+M A+K +       +  +         ++L+
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           S    P IV    +  + ++LS  L+ ++GG +H  L ++G F+E  ++ Y  +I+LGL 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT 396
           ++H R  V+RD+K ANIL+D HG ++++D G+A   +      S  G+  +MAPEV+   
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 180

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQY--EGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
             Y  + D +SLGC + ++     P+ Q+  +    I ++  +    E+P+  S + +S 
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRSL 239

Query: 455 IKQCLQRDPSARP-----PASKLLDHPFVRD 480
           ++  LQRD + R       A ++ + PF R 
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 8e-72
 Identities = 67/266 (25%), Positives = 115/266 (43%), Gaps = 14/266 (5%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEINLLSQ 278
           S+++ G LLG G FG VY G         AIK V      D        ++  E+ LL +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 279 LS--HPNIVRYHGSELSDERLSVYLEYVSGGS-IHKLLQEYGPFNEPVIQTYTRQILLGL 335
           +S     ++R        +   + LE       +   + E G   E + +++  Q+L  +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 336 AYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM 394
            + H    +HRDIK  NIL+D + GE+KL DFG    +        F G+  +  PE + 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF 454
               +  +  +WSLG  + +M     P+   E +         +      + +S + +  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFRQRVSSECQHL 234

Query: 455 IKQCLQRDPSARPPASKLLDHPFVRD 480
           I+ CL   PS RP   ++ +HP+++D
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 1e-70
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 8/273 (2%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVR-VVCDDQTSKECLKQLNQEIN 274
           EN    +  G+ LG G F  V       +G   A K ++             + + +E++
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLG 334
           +L ++ HPN++  H    +   + + LE V+GG +   L E     E     + +QIL G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 335 LAYLHARNTVHRDIKGANILVDPHGE----IKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           + YLH+    H D+K  NI++         IK+ DFG+A  +       +  G+P ++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI--GNSKDIPEIPEHLS 448
           E ++N     L  D+WS+G     + +   P+        +  +   N +   E   + S
Sbjct: 186 E-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
             AK FI++ L +DP  R      L HP+++ +
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 4e-70
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 27/282 (9%)

Query: 226 KLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
             LG G F  VY   +  + Q+ AIK++++    +      +   +EI LL +LSHPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVH 345
               +      +S+  +++       +           I+ Y    L GL YLH    +H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 346 RDIKGANILVDPHGEIKLADFGMAKHMTS-CASMLSFKGSPYWMAPEVVMNTNGYSLTVD 404
           RD+K  N+L+D +G +KLADFG+AK   S   +      + ++ APE++     Y + VD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 405 IWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPE---------------- 445
           +W++GC + E+    P     S  + +  IF+   +    + P+                
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 446 -------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     DD    I+     +P AR  A++ L   +  +
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 4e-70
 Identities = 60/264 (22%), Positives = 116/264 (43%), Gaps = 17/264 (6%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
             ++ + K  + +G+G FG V LG     G   A+K ++       +    +    E ++
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-------NDATAQAFLAEASV 53

Query: 276 LSQLSHPNIVRYHGSELSDE-RLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQIL 332
           ++QL H N+V+  G  + ++  L +  EY++ GS+   L+  G        +  ++  + 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
             + YL   N VHRD+   N+LV      K++DFG+ K  +S  +  + K    W APE 
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEA 171

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
            +    +S   D+WS G  + E+ +  + P+ +      + ++       + P+      
Sbjct: 172 -LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAPDGCPPAV 229

Query: 452 KSFIKQCLQRDPSARPPASKLLDH 475
              +K C   D + RP   +L + 
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 6e-70
 Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 27/273 (9%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPN 283
            ++LG G  G V   FN  + +  A+K ++             +  +E+ L  + S  P+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPH 66

Query: 284 IVRYHG----SELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILLGLAY 337
           IVR            + L + +E + GG +   +Q+ G   F E       + I   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 338 LHARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVM 394
           LH+ N  HRD+K  N+L     P+  +KL DFG AK  TS  S+ +   +PY++APEV +
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-L 185

Query: 395 NTNGYSLTVDIWSLGCTVLEMATSKPPW------SQYEGVAAIFKIGNSKDIPEIPEHLS 448
               Y  + D+WSLG  +  +    PP+      +   G+    ++G  +        +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ 481
           ++ K  I+  L+ +P+ R   ++ ++HP++   
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 2e-69
 Identities = 82/269 (30%), Positives = 136/269 (50%), Gaps = 11/269 (4%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
           +++ +   KLLG+GTFG V L     +G+  A+K +R   +   +K+ +     E  +L 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQ 60

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
              HP +     +  + +RL   +EY +GG +   L     F E   + Y  +I+  L Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKH-MTSCASMLSFKGSPYWMAPEVVMNT 396
           LH+R+ V+RDIK  N+++D  G IK+ DFG+ K  ++  A+M +F G+P ++APEV+ + 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED- 179

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           N Y   VD W LG  + EM   + P+   +       I   +     P  LS +AKS + 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLA 237

Query: 457 QCLQRDPSARPP-----ASKLLDHPFVRD 480
             L++DP  R       A ++++H F   
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  222 bits (566), Expect = 2e-68
 Identities = 61/269 (22%), Positives = 116/269 (43%), Gaps = 13/269 (4%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +++ G++LG G    V+L  +    +  A+K +R   D         +  +E    + L+
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALN 65

Query: 281 HPNIVRYHGSELSDERLSVYL----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           HP IV  + +  ++           EYV G ++  ++   GP                L 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSPYWMAPEV 392
           + H    +HRD+K ANI++     +K+ DFG+A+ +     S     +  G+  +++PE 
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE- 184

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSDD 450
               +      D++SLGC + E+ T +PP++    V+  ++      IP     E LS D
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHPFVR 479
             + + + L ++P  R   +  +    VR
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 2e-68
 Identities = 63/262 (24%), Positives = 111/262 (42%), Gaps = 16/262 (6%)

Query: 226 KLLGRGTFGHVYLGF--NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPN 283
           K LG G FG V  G+    +  +  A+K ++   ++        +L  E N++ QL +P 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDNPY 69

Query: 284 IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           IVR  G   ++  + V  E    G ++K LQ+     +  I     Q+ +G+ YL   N 
Sbjct: 70  IVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTS----CASMLSFKGSPYWMAPEVVMNTNGY 399
           VHRD+   N+L+      K++DFG++K + +      +    K    W APE  +N   +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYYKF 187

Query: 400 SLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC 458
           S   D+WS G  + E  +  + P+   +G      +   +     P     +    +  C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLC 246

Query: 459 LQRDPSARPPASKL---LDHPF 477
              D   RP  + +   L + +
Sbjct: 247 WTYDVENRPGFAAVELRLRNYY 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  215 bits (549), Expect = 5e-66
 Identities = 75/290 (25%), Positives = 139/290 (47%), Gaps = 32/290 (11%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           + K+   + +G GT+G VY   N+  G+  A+K++R+   ++  +       +EI++L +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL---EKEDEGIPSTTIREISILKE 56

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           L H NIV+ +    + +RL +  E++       L    G       +++  Q+L G+AY 
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-TSCASMLSFKGSPYWMAPEVVMNTN 397
           H R  +HRD+K  N+L++  GE+K+ADFG+A+              + ++ AP+V+M + 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDIPEIPE--------- 445
            YS T+DIWS+GC   EM    P +   S+ + +  IF+I  + +    P          
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 446 ---------------HLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                           L +     + + L+ DP+ R  A + L+H + ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 8e-66
 Identities = 68/267 (25%), Positives = 107/267 (40%), Gaps = 13/267 (4%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEIN 274
                +  + LG G+FG V  G     S      A+K ++   D  +  E +    +E+N
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP--DVLSQPEAMDDFIREVN 63

Query: 275 LLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL-LQEYGPFNEPVIQTYTRQILL 333
            +  L H N++R +G  L+     V  E    GS+     +  G F    +  Y  Q+  
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML----SFKGSPYWMA 389
           G+ YL ++  +HRD+   N+L+     +K+ DFG+ + +             K    W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 390 PEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLS 448
           PE +     +S   D W  G T+ EM T  + PW    G   + KI    +    PE   
Sbjct: 183 PESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 449 DDAKSFIKQCLQRDPSARPPASKLLDH 475
            D  + + QC    P  RP    L D 
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (551), Expect = 2e-65
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 12/268 (4%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
            L ++ + K LG G+FG V L  + ESG   A+K +          + ++    E  +L 
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQ 96

Query: 278 QLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAY 337
            ++ P +V+   S   +  L + +EYV+GG +   L+  G F+EP  + Y  QI+L   Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTN 397
           LH+ + ++RD+K  N+L+D  G I++ DFG AK +       +  G+P  +APE++++  
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS-K 213

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ 457
           GY+  VD W+LG  + EMA   PP+   + +    KI + K     P H S D K  ++ 
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRN 271

Query: 458 CLQRDPSARPP-----ASKLLDHPFVRD 480
            LQ D + R        + + +H +   
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 4e-65
 Identities = 61/289 (21%), Positives = 115/289 (39%), Gaps = 30/289 (10%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-VCDDQTSKECLKQLNQEIN 274
           E      + GK+LG G FG V         +     +V V +  ++      + L  E+ 
Sbjct: 33  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92

Query: 275 LLSQL-SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE------------------ 315
           +++QL SH NIV   G+      + +  EY   G +   L+                   
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 316 -----YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAK 370
                        +  +  Q+  G+ +L  ++ VHRD+   N+LV     +K+ DFG+A+
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 371 HMTSCASML---SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYE 426
            + S ++ +   + +    WMAPE +     Y++  D+WS G  + E+ +    P+    
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 427 GVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
             A  +K+  +    + P + +++    ++ C   D   RP    L   
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 5e-65
 Identities = 58/255 (22%), Positives = 105/255 (41%), Gaps = 13/255 (5%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
            K LG G FG V  G         AIK ++             +  +E  ++  LSH  +
Sbjct: 9   LKELGTGQFGVVKYGKW-RGQYDVAIKMIKE------GSMSEDEFIEEAKVMMNLSHEKL 61

Query: 285 VRYHGSELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNT 343
           V+ +G       + +  EY++ G +   L+     F    +    + +   + YL ++  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121

Query: 344 VHRDIKGANILVDPHGEIKLADFGMAKHMTS--CASMLSFKGSPYWMAPEVVMNTNGYSL 401
           +HRD+   N LV+  G +K++DFG+++++      S +  K    W  PEV+M  + +S 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-YSKFSS 180

Query: 402 TVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQ 460
             DIW+ G  + E+ +  K P+ ++        I         P   S+   + +  C  
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYRPHLASEKVYTIMYSCWH 239

Query: 461 RDPSARPPASKLLDH 475
                RP    LL +
Sbjct: 240 EKADERPTFKILLSN 254

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 7e-65
 Identities = 82/291 (28%), Positives = 141/291 (48%), Gaps = 32/291 (10%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           +  ++K + +G GT+G VY   N  +G++ A+K++R+   D  ++       +EI+LL +
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKE 57

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL-LQEYGPFNEPVIQTYTRQILLGLAY 337
           L+HPNIV+      ++ +L +  E++       +          P+I++Y  Q+L GLA+
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 338 LHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML-SFKGSPYWMAPEVVMNT 396
            H+   +HRD+K  N+L++  G IKLADFG+A+              + ++ APE+++  
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN-------------------- 436
             YS  VDIWSLGC   EM T +  +     +  +F+I                      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 437 -------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                   +D  ++   L +D +S + Q L  DP+ R  A   L HPF +D
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 7e-65
 Identities = 69/263 (26%), Positives = 119/263 (45%), Gaps = 14/263 (5%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
            + + G+ +G G FG V+ G            AIK  +    + TS    ++  QE   +
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK----NCTSDSVREKFLQEALTM 62

Query: 277 SQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGL 335
            Q  HP+IV+  G  +++  + + +E  + G +   LQ      +   +  Y  Q+   L
Sbjct: 63  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVV 393
           AYL ++  VHRDI   N+LV  +  +KL DFG++++M       +   K    WMAPE  
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-S 180

Query: 394 MNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK 452
           +N   ++   D+W  G  + E+      P+   +    I +I N + +P +P +      
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLY 239

Query: 453 SFIKQCLQRDPSARPPASKLLDH 475
           S + +C   DPS RP  ++L   
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (541), Expect = 1e-64
 Identities = 61/275 (22%), Positives = 123/275 (44%), Gaps = 13/275 (4%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E   +       LG G +G VY G   +     A+K ++           +++  +E  +
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAV 66

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILL 333
           + ++ HPN+V+  G    +    +  E+++ G++   L+E      +  V+     QI  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS--CASMLSFKGSPYWMAPE 391
            + YL  +N +HRD+   N LV  +  +K+ADFG+++ MT     +    K    W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
             +  N +S+  D+W+ G  + E+AT          ++ ++++       E PE   +  
Sbjct: 187 S-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245

Query: 452 KSFIKQCLQRDPSARPPASKLLD--HPFVRDQAVA 484
              ++ C Q +PS RP  +++        ++ +++
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 2e-64
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 4/259 (1%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           +++KK K+LG G FG VY G     G+   I        + TS +  K++  E  +++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
            +P++ R  G  L+     +      G  +  + +         +  +  QI  G+ YL 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS---CASMLSFKGSPYWMAPEVVMNT 396
            R  VHRD+   N+LV     +K+ DFG+AK + +          K    WMA E +++ 
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH- 187

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
             Y+   D+WS G TV E+ T           + I  I    +    P   + D    + 
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247

Query: 457 QCLQRDPSARPPASKLLDH 475
           +C   D  +RP   +L+  
Sbjct: 248 KCWMIDADSRPKFRELIIE 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-64
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 18/262 (6%)

Query: 228 LGRGTFGHVYLGFN--SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIV 285
           LG G FG V  G     +     AIK ++      T K   +++ +E  ++ QL +P IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 286 RYHGSELSDERLSVYLEYVSGGSIHKLL-QEYGPFNEPVIQTYTRQILLGLAYLHARNTV 344
           R  G   ++  + V  E   GG +HK L  +        +     Q+ +G+ YL  +N V
Sbjct: 73  RLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 345 HRDIKGANILVDPHGEIKLADFGMAKHMTSCASML----SFKGSPYWMAPEVVMNTNGYS 400
           HRD+   N+L+      K++DFG++K + +  S      + K    W APE  +N   +S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFS 190

Query: 401 LTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCL 459
              D+WS G T+ E  +  + P+ + +G   +  I   K   E P     +  + +  C 
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPPELYALMSDCW 249

Query: 460 QRDPSARPPASKL---LDHPFV 478
                 RP    +   +   + 
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYY 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 5e-64
 Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 16/269 (5%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E      K  + LG G FG V++G+        A+K ++                 E NL
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQ------GSMSPDAFLAEANL 61

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG--PFNEPVIQTYTRQILL 333
           + QL H  +VR +     +    +  EY+  GS+   L+           +     QI  
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 334 GLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML--SFKGSPYWMAPE 391
           G+A++  RN +HRD++ ANILV      K+ADFG+A+ +           K    W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA 451
             +N   +++  D+WS G  + E+ T             + +          P++  ++ 
Sbjct: 181 A-INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239

Query: 452 KSFIKQCLQRDPSARPPASKL---LDHPF 477
              ++ C +  P  RP    L   L+  F
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-63
 Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 38/294 (12%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           + ++  + +G G +G V    +  +G   AIK++        S+   K+  +E+ LL  +
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY---RPFQSELFAKRAYRELRLLKHM 74

Query: 280 SHPNIVRYHGSELSDERLS----VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
            H N++        DE L      YL     G+    L ++    E  IQ    Q+L GL
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMN 395
            Y+HA   +HRD+K  N+ V+   E+K+ DFG+A+   S   M  +  + ++ APEV++N
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILN 192

Query: 396 TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN------------------- 436
              Y+ TVDIWS+GC + EM T K  +   + +  + +I                     
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 437 ----------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                      KD   I  + S  A + +++ L  D   R  A + L HP+   
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-63
 Identities = 65/298 (21%), Positives = 132/298 (44%), Gaps = 42/298 (14%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
            ++     +G G +G V   +++ +    AIK++         +  L+    EI +L + 
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRF 63

Query: 280 SHPNIVRYHG---SELSDERLSVYL-EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL 335
            H NI+  +    +   ++   VYL  ++ G  ++KLL+     +   I  +  QIL GL
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGL 122

Query: 336 AYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS----CASMLSFKGSPYWMAPE 391
            Y+H+ N +HRD+K +N+L++   ++K+ DFG+A+           +  +  + ++ APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 392 VVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP---------- 441
           +++N+ GY+ ++DIWS+GC + EM +++P +     +  +  I      P          
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 442 -------------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                               +  +    A   + + L  +P  R    + L HP++  
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 1e-63
 Identities = 75/291 (25%), Positives = 140/291 (48%), Gaps = 32/291 (10%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           + K++K + +G GT+G V+   N E+ ++ A+K VR+   D   +       +EI LL +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKE 57

Query: 279 LSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYL 338
           L H NIVR H    SD++L++  E+             G  +  +++++  Q+L GL + 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKG-SPYWMAPEVVMNTN 397
           H+RN +HRD+K  N+L++ +GE+KLA+FG+A+         S +  + ++  P+V+    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 398 GYSLTVDIWSLGCTVLEMATSKPPW----SQYEGVAAIFKI------------------- 434
            YS ++D+WS GC   E+A +  P        + +  IF++                   
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 435 -----GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                  +  +  +   L+   +  ++  L+ +P  R  A + L HP+  D
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (533), Expect = 2e-63
 Identities = 64/268 (23%), Positives = 112/268 (41%), Gaps = 11/268 (4%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINL 275
           E  +S  K  +++G G FG V  G     G+      ++ +    T K+  +    E ++
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASI 80

Query: 276 LSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL-LQEYGPFNEPVIQTYTRQILLG 334
           + Q  HPN++   G       + +  E++  GS+     Q  G F    +    R I  G
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 335 LAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASM------LSFKGSPYWM 388
           + YL   N VHRD+   NILV+ +   K++DFG+++ +    S       L  K    W 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHL 447
           APE  +    ++   D+WS G  + E+ +  + P+        I  I     +P  P   
Sbjct: 201 APE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-PPMDC 258

Query: 448 SDDAKSFIKQCLQRDPSARPPASKLLDH 475
                  +  C Q+D + RP   ++++ 
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-63
 Identities = 80/289 (27%), Positives = 145/289 (50%), Gaps = 19/289 (6%)

Query: 210 RTSGVTEN----SLSKWKKGKLLGRGTFGHVYLG---FNSESGQMCAIKEVRVVCDDQTS 262
           RT+ +T +     +  ++  K+LG G +G V+L       ++G++ A+K ++     Q +
Sbjct: 10  RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69

Query: 263 KECLKQLNQEINLLSQLSH-PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNE 321
           K   +    E  +L  +   P +V  H +  ++ +L + L+Y++GG +   L +   F E
Sbjct: 70  KT-TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 128

Query: 322 PVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS--ML 379
             +Q Y  +I+L L +LH    ++RDIK  NIL+D +G + L DFG++K   +  +    
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188

Query: 380 SFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI--GN 436
            F G+  +MAP++V   + G+   VD WSLG  + E+ T   P++      +  +I    
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248

Query: 437 SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPP-----ASKLLDHPFVRD 480
            K  P  P+ +S  AK  I++ L +DP  R       A ++ +H F + 
Sbjct: 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-63
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 11/259 (4%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           S+    + +G G FG V+LG+   +    AIK +R            +   +E  ++ +L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57

Query: 280 SHPNIVRYHGSELSDERLSVYLEYVSGGSIHKL-LQEYGPFNEPVIQTYTRQILLGLAYL 338
           SHP +V+ +G  L    + +  E++  G +      + G F    +      +  G+AYL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 339 HARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS--FKGSPYWMAPEVVMNT 396
                +HRD+   N LV  +  IK++DFGM + +       S   K    W +PEV  + 
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV-FSF 176

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK 456
           + YS   D+WS G  + E+ +      +    + + +  ++      P   S      + 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236

Query: 457 QCLQRDPSARPPASKLLDH 475
            C +  P  RP  S+LL  
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  205 bits (522), Expect = 6e-62
 Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 29/281 (10%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +++ G+ +G G+FG +YLG +  +G+  AIK   V       K    QL+ E  +   + 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIYKMMQ 60

Query: 281 HPN-IVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
               I          +   + +E +              F+   +     Q++  + Y+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 340 ARNTVHRDIKGANILV---DPHGEIKLADFGMAKHMTSCASML--------SFKGSPYWM 388
           ++N +HRD+K  N L+        + + DFG+AK      +          +  G+  + 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 389 APEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN------SKDIPE 442
           +    +     S   D+ SLG  ++       PW   +      K         S  I  
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 443 IPEHLSDDAKSFIKQCLQRDPSARPPAS---KLLDHPFVRD 480
           + +    +  +++  C       +P  S   +L  + F R 
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  205 bits (522), Expect = 8e-62
 Identities = 62/291 (21%), Positives = 122/291 (41%), Gaps = 39/291 (13%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLN 270
           E   +  +  + +G G FG V+          E   M A+K ++    ++ S +      
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASADMQADFQ 64

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG------------- 317
           +E  L+++  +PNIV+  G     + + +  EY++ G +++ L+                
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 318 -----------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADF 366
                      P +        RQ+  G+AYL  R  VHRD+   N LV  +  +K+ADF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184

Query: 367 GMAKHMTS---CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPW 422
           G+++++ S     +  +      WM PE +   N Y+   D+W+ G  + E+ +    P+
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 423 SQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
                   I+ + +  +I   PE+   +  + ++ C  + P+ RP    + 
Sbjct: 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-61
 Identities = 80/319 (25%), Positives = 134/319 (42%), Gaps = 49/319 (15%)

Query: 199 SPTSPSALPCSRTSGVTENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCD 258
             T+  A P        E S   +   K++G G+FG VY     +SG++ AIK+V     
Sbjct: 2   KVTTVVATPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----- 53

Query: 259 DQTSKECLKQLNQEINLLSQLSHPNIVRYH------GSELSDERLSVYLEYVSGG---SI 309
                +  +  N+E+ ++ +L H NIVR        G +  +  L++ L+YV        
Sbjct: 54  ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 310 HKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI-KLADFGM 368
               +         ++ Y  Q+   LAY+H+    HRDIK  N+L+DP   + KL DFG 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169

Query: 369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV 428
           AK +      +S+  S Y+ APE++     Y+ ++D+WS GC + E+   +P +    GV
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

Query: 429 AAIFKIGN------------------SKDIPEIPEH---------LSDDAKSFIKQCLQR 461
             + +I                        P+I  H            +A +   + L+ 
Sbjct: 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289

Query: 462 DPSARPPASKLLDHPFVRD 480
            P+AR    +   H F  +
Sbjct: 290 TPTARLTPLEACAHSFFDE 308

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 1e-61
 Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 20/275 (7%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS 277
             +  K   ++G G FG V      + G        R+   +  SK+  +    E+ +L 
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLC 65

Query: 278 QLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEY----------------GPFN 320
           +L  HPNI+   G+      L + +EY   G++   L++                    +
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 321 EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS 380
              +  +   +  G+ YL  +  +HRD+   NILV  +   K+ADFG+++          
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

Query: 381 FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI 440
            +    WMA E  +N + Y+   D+WS G  + E+ +           A +++       
Sbjct: 186 GRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
            E P +  D+    ++QC +  P  RP  +++L  
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-61
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 33/295 (11%)

Query: 218 SLSKWKKGKLLGRGTFGHVYLGFNSES-GQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
           +  +++    +G G +G V+   + ++ G+  A+K VRV   ++       +    +  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 277 SQLSHPNIVRYHG-----SELSDERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQ 330
               HPN+VR            + +L++  E+V       L +          I+    Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 331 ILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAP 390
           +L GL +LH+   VHRD+K  NILV   G+IKLADFG+A+  +   ++ S   + ++ AP
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 391 EVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI---------------- 434
           E V+  + Y+  VD+WS+GC   EM   KP +     V  + KI                
Sbjct: 185 E-VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 435 ---------GNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                     +++ I +    + +  K  + +CL  +P+ R  A   L HP+ +D
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 5e-61
 Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 46/307 (14%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
           + +SK++K   +G+GTFG V+   + ++GQ  A+K+V +   +   +       +EI +L
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKIL 63

Query: 277 SQLSHPNIVRYHGS--------ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYT 328
             L H N+V                   + +  ++        L      F    I+   
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 329 RQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKG 383
           + +L GL Y+H    +HRD+K AN+L+   G +KLADFG+A+       +      +   
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 384 SPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNSKDI 440
           + ++  PE+++    Y   +D+W  GC + EM T  P     ++   +A I ++  S   
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 441 PEIPE---------------------------HLSDDAKSFIKQCLQRDPSARPPASKLL 473
              P                                 A   I + L  DP+ R  +   L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 474 DHPFVRD 480
           +H F   
Sbjct: 304 NHDFFWS 310

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-60
 Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 20/280 (7%)

Query: 210 RTSGVT----ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKEC 265
           +T G+     E      +    LG+G FG V++G         AIK ++           
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK------PGTMS 55

Query: 266 LKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSI--HKLLQEYGPFNEPV 323
            +   QE  ++ +L H  +V+ +     +    V  EY+S GS+      +       P 
Sbjct: 56  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQ 114

Query: 324 IQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS--CASMLSF 381
           +     QI  G+AY+   N VHRD++ ANILV  +   K+ADFG+A+ +      +    
Sbjct: 115 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174

Query: 382 KGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP 441
           K    W APE  +    +++  D+WS G  + E+ T             +          
Sbjct: 175 KFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233

Query: 442 EIPEHLSDDAKSFIKQCLQRDPSARPPASKL---LDHPFV 478
             P    +     + QC +++P  RP    L   L+  F 
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-60
 Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 14/269 (5%)

Query: 215 TENSLSKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLN 270
           TE   S   + K++G G FG VY G    S        AIK ++    ++   + L    
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL---- 57

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTR 329
            E  ++ Q SH NI+R  G     + + +  EY+  G++ K L+E  G F+   +    R
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117

Query: 330 QILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM----TSCASMLSFKGSP 385
            I  G+ YL   N VHRD+   NILV+ +   K++DFG+++ +     +  +    K   
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 386 YWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPE 445
            W APE +     ++   D+WS G  + E+ T             + K  N       P 
Sbjct: 178 RWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 236

Query: 446 HLSDDAKSFIKQCLQRDPSARPPASKLLD 474
                    + QC Q++ + RP  + ++ 
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  200 bits (510), Expect = 9e-60
 Identities = 65/304 (21%), Positives = 128/304 (42%), Gaps = 51/304 (16%)

Query: 217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLL 276
            +   ++  + LGRG +  V+   N  + +   +K ++            K++ +EI +L
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKIL 83

Query: 277 SQLS-HPNIVRYHGSELSDERLSVYL--EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILL 333
             L   PNI+            +  L  E+V+     +L Q      +  I+ Y  +IL 
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILK 140

Query: 334 GLAYLHARNTVHRDIKGANILVDP-HGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            L Y H+   +HRD+K  N+++D  H +++L D+G+A+             S Y+  PE+
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPW----SQYEGVAAIFKIGNSKDIPEIPE--- 445
           +++   Y  ++D+WSLGC +  M   K P+      Y+ +  I K+  ++D+ +  +   
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 446 -----------------------------HLSDDAKSFIKQCLQRDPSARPPASKLLDHP 476
                                         +S +A  F+ + L+ D  +R  A + ++HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320

Query: 477 FVRD 480
           +   
Sbjct: 321 YFYT 324

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-58
 Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 17/262 (6%)

Query: 225 GKLLGRGTFGHVYLGF---NSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH 281
            +++GRG FG VY G    N      CA+K +    +  T    + Q   E  ++   SH
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL----NRITDIGEVSQFLTEGIIMKDFSH 87

Query: 282 PNIVRYHGSELSDE-RLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLH 339
           PN++   G  L  E    V L Y+  G +   ++ E        +  +  Q+  G+ +L 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 340 ARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-----SCASMLSFKGSPYWMAPEVVM 394
           ++  VHRD+   N ++D    +K+ADFG+A+ M      S  +    K    WMA E + 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 395 NTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKS 453
            T  ++   D+WS G  + E+ T   PP+           +   +     PE+  D    
Sbjct: 208 -TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDPLYE 265

Query: 454 FIKQCLQRDPSARPPASKLLDH 475
            + +C       RP  S+L+  
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-57
 Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 24/283 (8%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV---VCDDQTSKECLKQLNQE 272
           E    +   GK LG G FG V L       +    +  +V   +     +++ L  L  E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68

Query: 273 INLLSQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGP------------- 318
           + ++  +  H NI+   G+   D  L V +EY S G++ + LQ   P             
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 319 ---FNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT-- 373
               +   + +   Q+  G+ YL ++  +HRD+   N+LV     +K+ADFG+A+ +   
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 374 -SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIF 432
                  + +    WMAPE  +    Y+   D+WS G  + E+ T          V  +F
Sbjct: 189 DYYKKTTNGRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           K+       + P + +++    ++ C    PS RP   +L++ 
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 4e-57
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 33/286 (11%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLG-----FNSESGQMCAIKEVRVVCDDQTSKECLKQLN 270
           E   ++   GK LG G FG V          S++    A+K ++            + L 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK----PSAHLTEREALM 74

Query: 271 QEINLLSQLS-HPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG------------ 317
            E+ +LS L  H NIV   G+        V  EY   G +   L+               
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 318 ------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH 371
                   +   + +++ Q+  G+A+L ++N +HRD+   NIL+      K+ DFG+A+ 
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 372 MTSCASMLS---FKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV 428
           + + ++ +     +    WMAPE + N   Y+   D+WS G  + E+ +          V
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 429 -AAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLL 473
            +  +K+         PEH   +    +K C   DP  RP   +++
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 3e-56
 Identities = 65/293 (22%), Positives = 128/293 (43%), Gaps = 38/293 (12%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
           +++    +G G +G V   F++++G   A+K++        S    K+  +E+ LL  + 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMK 75

Query: 281 HPNIVRYHGS----ELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLA 336
           H N++            +E   VYL     G+    + +     +  +Q    QIL GL 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 337 YLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNT 396
           Y+H+ + +HRD+K +N+ V+   E+K+ DFG+A+H      M  +  + ++ APE+++N 
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 193

Query: 397 NGYSLTVDIWSLGCTVLEMATSKPPW---SQYEGVAAIFKIGNS---------------- 437
             Y+ TVDIWS+GC + E+ T +  +      + +  I ++  +                
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 438 ----------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
                      +   +    +  A   +++ L  D   R  A++ L H +   
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 5e-56
 Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 24/283 (8%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRV--VCDDQTSKECLKQLNQEI 273
           E    + K GK LGRG FG V         +    + V V  + +  T  E    +++  
Sbjct: 9   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68

Query: 274 NLLSQLSHPNIVRYHGSELSD-ERLSVYLEYVSGGSIHKLLQEYG--------------- 317
            L+    H N+V   G+       L V +E+   G++   L+                  
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 318 -PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA 376
                  +  Y+ Q+  G+ +L +R  +HRD+   NIL+     +K+ DFG+A+ +    
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 377 SML---SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIF 432
             +     +    WMAPE +     Y++  D+WS G  + E+ +    P+   +      
Sbjct: 189 DYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 433 KIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH 475
           +          P++ + +    +  C   +PS RP  S+L++H
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 8e-56
 Identities = 63/289 (21%), Positives = 113/289 (39%), Gaps = 29/289 (10%)

Query: 216 ENSLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLN 270
           E +  K    + LG+G+FG VY G        E     AIK V     +  S     +  
Sbjct: 16  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----EAASMRERIEFL 71

Query: 271 QEINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYG----------PFN 320
            E +++ + +  ++VR  G     +   V +E ++ G +   L+             P +
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 321 EPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASML- 379
              +     +I  G+AYL+A   VHRD+   N +V     +K+ DFGM + +        
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 380 --SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS 437
                    WM+PE  +    ++   D+WS G  + E+AT      Q      + +    
Sbjct: 192 GGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

Query: 438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD------HPFVRD 480
             + + P++  D     ++ C Q +P  RP   +++        P  R+
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  188 bits (478), Expect = 1e-55
 Identities = 51/274 (18%), Positives = 92/274 (33%), Gaps = 28/274 (10%)

Query: 221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS 280
            +K G+ +G G+FG ++ G N  + Q  AIK      D         QL  E      L+
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLA 58

Query: 281 H-PNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLH 339
               I   +          + ++ +       L      F+   +    +Q+L  +  +H
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 340 ARNTVHRDIKGANILVD-----PHGEIKLADFGMAKHMTSCAS--------MLSFKGSPY 386
            ++ V+RDIK  N L+          I + DFGM K      +          +  G+  
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 387 WMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA---AIFKIGNSKD---I 440
           +M+    +     S   D+ +LG   +       PW   +         +IG  K    +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD 474
            E+     ++   ++         A P    L  
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-53
 Identities = 63/308 (20%), Positives = 122/308 (39%), Gaps = 53/308 (17%)

Query: 219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ 278
           L +++  K +G G  G V   +++   +  AIK++        ++   K+  +E+ L+  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKC 72

Query: 279 LSHPNIVRYHGSELSD------ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQIL 332
           ++H NI+               + + + +E +       +  E    +   +     Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 129

Query: 333 LGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEV 392
            G+ +LH+   +HRD+K +NI+V     +K+ DFG+A+   +   M  +  + Y+ APEV
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 393 VMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP----------- 441
           ++   GY   VDIWS+GC + EM   K  +   + +    K+      P           
Sbjct: 190 ILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 442 -----------------------------EIPEHLSDDAKSFIKQCLQRDPSARPPASKL 472
                                        E  +  +  A+  + + L  DP+ R      
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 473 LDHPFVRD 480
           L HP++  
Sbjct: 309 LQHPYINV 316

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-51
 Identities = 65/292 (22%), Positives = 103/292 (35%), Gaps = 51/292 (17%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI 284
            + +G+G FG V+ G     G+  A+K      +    +E       EI     L H NI
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA------EIYQTVMLRHENI 59

Query: 285 VRYHGSELSDERLSVYL----EYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA 340
           + +  ++  D      L    +Y   GS+   L  Y    E +I+        GLA+LH 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 118

Query: 341 --------RNTVHRDIKGANILVDPHGEIKLADFGMAKHM-----TSCASMLSFKGSPYW 387
                       HRD+K  NILV  +G   +AD G+A        T   +     G+  +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 388 MAPEVV-----MNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI-- 440
           MAPEV+     M         DI+++G    E+A        +E     +      D   
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 441 -------------PEIPEHLS-----DDAKSFIKQCLQRDPSARPPASKLLD 474
                        P IP               +++C   + +AR  A ++  
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (374), Expect = 3e-40
 Identities = 63/330 (19%), Positives = 117/330 (35%), Gaps = 78/330 (23%)

Query: 220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL 279
           +++   + LG G F  V+L  +  +    A+K VR        K   +    EI LL ++
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRV 66

Query: 280 SHPNIVR-------------YHGSELSDERLSVYLEYVSGGSIHKLL---QEYGPFNEPV 323
           +  +  +              H +      + V + +   G     L    E+       
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 324 IQTYTRQILLGLAYL-HARNTVHRDIKGANILVDPHG------EIKLADFGMAKHMTSCA 376
           ++  ++Q+LLGL Y+      +H DIK  N+L++         +IK+AD G A       
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDE 184

Query: 377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG--------- 427
              +   +  + +PE V+    +    DIWS  C + E+ T    +   EG         
Sbjct: 185 HYTNSIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

Query: 428 VAAIFKIGNS-------------------------------------KDIPEIPEHLSDD 450
           +A I ++                                         +  +  +  + +
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

Query: 451 AKSFIKQCLQRDPSARPPASKLLDHPFVRD 480
              F+   LQ DP  R  A  L++HP+++D
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 39/207 (18%), Positives = 68/207 (32%), Gaps = 37/207 (17%)

Query: 225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRV-------------VCDDQTSKECLKQLNQ 271
           GKL+G G    V+  ++ E    C +K  +V               D   S   ++    
Sbjct: 5   GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 272 EINLLSQLSHPNIVRYHGSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQI 331
           E   L +L    + + +  E      +V +E +    ++                    I
Sbjct: 64  EFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLDMI 112

Query: 332 LLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLSFKGSPYWMAPE 391
           L  +A  + R  VH D+   N+LV   G I + DF  +         +  +G    +  +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVE-------VGEEGWREILERD 164

Query: 392 VVMNTN----GYSLTVDIWSLGCTVLE 414
           V          Y    DI S    +L+
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	628
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.53
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.41
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.12
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.73
d1e7ua4	369	Phoshoinositide 3-kinase (PI3K), catalytic domain	80.9

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-60  Score=502.68  Aligned_cols=292  Identities=29%  Similarity=0.470  Sum_probs=248.6

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ++++|+++++||+|+||+||+|+++.+++.||||++++...  ......+++.+|+.+|++++|||||+++++|++++.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            57899999999999999999999999999999999974211  1122356788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-cc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CA  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~  376 (628)
                      |+|||||.||+|.+++.+.+.++|..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.... ..
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987644 34


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      .....+||+.|||||++.+. .|+.++|||||||+||||++|++||...+....+..+....  ..+|..+++++++||+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHH
Confidence            55668999999999999765 49999999999999999999999998877666555554432  4678889999999999


Q ss_pred             HHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCcCCCCCCCCCCCCCCCCCCCCCCCCccccccCccccC
Q 040472          457 QCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNLAKDSSPYSLDGSRTPPKLDLLPTRKSITLCEGDYLA  527 (628)
Q Consensus       457 ~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~~~~~~p~~~~~s~~pp~~~~~~~~~~~~~~~~~~~~  527 (628)
                      +||++||++|+     +++||++||||++.+|........             .||..+.+....+..+++.+++.
T Consensus       238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~-------------~~p~~P~~~~~~~~~~f~~~~~~  300 (337)
T d1o6la_         238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-------------LPPFKPQVTSEVDTRYFDDEFTA  300 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS-------------CCSCCCCCSSTTCCTTSCHHHHT
T ss_pred             hhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCC-------------CCCCCCCCCChhhhhhcCchhhh
Confidence            99999999999     499999999999988876544332             23344444445555566554443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=489.96  Aligned_cols=258  Identities=25%  Similarity=0.450  Sum_probs=222.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|+++.+++.||||++....    ..+..+++.+|+++|++++|||||++++++.+++.+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            568999999999999999999999999999999987532    1233456889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---  375 (628)
                      ||||||.||+|.++|+..+.+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....   
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999876432   


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH-HHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-AIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      ......+||+.|||||++.+...++.++|||||||+||||++|++||....... ....+.........+..+++++.+|
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            234567899999999999776645788999999999999999999997654432 3333333333334456789999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |++||+.||++|||++|||+||||+.
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            99999999999999999999999964

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-60  Score=485.93  Aligned_cols=257  Identities=31%  Similarity=0.546  Sum_probs=228.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ++++|++++.||+|+||+||+|+++.+++.||||++.+...  ......+++.+|+++|++++|||||++++++.+++.+
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            46899999999999999999999999999999999864211  1122346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |||||||.||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+..... .
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-C
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999876543 3


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|||||++.+. .|+.++|||||||+||||++|+.||........+.++....  ..++..+++++++||++
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  237 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISR  237 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHH
Confidence            4457899999999999765 48999999999999999999999998876666666554433  35677899999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||+.||++|||++|||+||||+.
T Consensus       238 ~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         238 LLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-60  Score=488.52  Aligned_cols=263  Identities=28%  Similarity=0.482  Sum_probs=229.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|+++++||+|+||+||+|+++.+++.||||++++...  ......+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            579999999999999999999999999999999874211  112234678899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc---c
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC---A  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~---~  376 (628)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+...   .
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876432   2


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      ...+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||...+....+.++....  ..++..+++++++||+
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCCTTCCHHHHHHHH
T ss_pred             ccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCCCccCCHHHHHHHH
Confidence            33457899999999999765 49999999999999999999999999877666666665433  3567789999999999


Q ss_pred             HHhhcCCCCCCCHHH------HhcCccccchHHHhhc
Q 040472          457 QCLQRDPSARPPASK------LLDHPFVRDQAVARAG  487 (628)
Q Consensus       457 ~~L~~dP~~Rpta~e------iL~Hpwf~~~~~~~~~  487 (628)
                      +||+.||++|||++|      |++||||++.+|.+..
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence            999999999999987      6899999988776554

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.3e-59  Score=486.23  Aligned_cols=267  Identities=29%  Similarity=0.532  Sum_probs=236.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++++...  ......+++.+|+.+|++++|||||++++++.+++.+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   79 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   79 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence            46899999999999999999999999999999999974211  1122356788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+|||||.||+|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....  
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999876543  


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ..+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||...+....+.++....  ..++..+++++++||++
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            3467899999999999765 49999999999999999999999999877766666665433  35677899999999999


Q ss_pred             HhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCc
Q 040472          458 CLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       458 ~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      ||++||.+|+     ++++||+||||++..|........
T Consensus       235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~  273 (316)
T d1fota_         235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI  273 (316)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred             HhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCC
Confidence            9999999996     899999999999999887655443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-59  Score=482.20  Aligned_cols=254  Identities=34%  Similarity=0.608  Sum_probs=224.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.....     ..+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            5799999999999999999999999999999998753222     13568899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccc
Q 040472          300 YLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASM  378 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~  378 (628)
                      |||||.||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ...
T Consensus        95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence            9999999999998875 57999999999999999999999999999999999999999999999999999876543 344


Q ss_pred             ccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHHHHHHH
Q 040472          379 LSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       379 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~  457 (628)
                      ...+||+.|||||++.+. .|+.++|||||||+||+|++|+.||........+..+.... .....+..++.++++||++
T Consensus       174 ~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             cccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            567899999999999764 59999999999999999999999998877666655543322 2234567899999999999


Q ss_pred             HhhcCCCCCCCHHHHhcCccccc
Q 040472          458 CLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       458 ~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||+.||++|||++|||+||||+.
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999963

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=486.21  Aligned_cols=259  Identities=29%  Similarity=0.515  Sum_probs=218.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      -++|+++++||+|+||+||+|+++.+|+.||||+++....    ....+++.+|+.+|++++|||||+++++|.+++.+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3689999999999999999999999999999999975322    233467889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      ||||||.||+|.+++.+.+.+++..++.++.||+.||+|||+ +|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-T
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-c
Confidence            999999999999999999999999999999999999999997 59999999999999999999999999999876432 3


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhh-hc---------------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IG---------------------  435 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~-i~---------------------  435 (628)
                      ..+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||...+....... +.                     
T Consensus       160 ~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             C---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             cccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            3467899999999999875 499999999999999999999999976432211000 00                     


Q ss_pred             -------------------CCCCCCCCC-CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          436 -------------------NSKDIPEIP-EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       436 -------------------~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                                         .....+.++ ..++.++++||++||+.||++|||++|+|+||||+...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                               000111122 236889999999999999999999999999999986654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-58  Score=482.46  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=209.6

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      .++|+++++||+|+||+||+|+++.+++.||||++......    ...+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            35699999999999999999999999999999999753221    22356789999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC---CCCCEEEeccCCcccccCc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD---PHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld---~~g~vKL~DFGla~~~~~~  375 (628)
                      ||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||+.   .++.+||+|||+|+.....
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999999999989999999999999999999999999999999999999994   5789999999999887666


Q ss_pred             cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHHH
Q 040472          376 ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAKS  453 (628)
Q Consensus       376 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~d  453 (628)
                      ....+.+||+.|||||++.+. .|+.++|||||||+||||++|++||...........+.....  ....+..+++++++
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ---------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             CeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence            666678899999999999765 499999999999999999999999988766666555544332  22345679999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      ||++||++||++|||++|||+||||++
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-58  Score=477.65  Aligned_cols=266  Identities=25%  Similarity=0.432  Sum_probs=230.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc-hHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT-SKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++...... .....+.+.+|+++|++++|||||+++++|.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999975432211 1123467889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC----CEEEeccCCcccccC
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG----EIKLADFGMAKHMTS  374 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g----~vKL~DFGla~~~~~  374 (628)
                      ||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.++    .+||+|||+|+....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999989999999999999999999999999999999999999998776    599999999998876


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~  452 (628)
                      .......+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+..+.....  ...++..++.+++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  248 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence            6666778899999999999764 599999999999999999999999998777666666544332  1223457899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccchHHHhh
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQAVARA  486 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~~~~  486 (628)
                      +||++||+.||++|||++|||+||||++.++...
T Consensus       249 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence            9999999999999999999999999998766443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-58  Score=475.61  Aligned_cols=256  Identities=38%  Similarity=0.651  Sum_probs=224.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      +.|++++.||+|+||+||+|+++.+++.||||+++.....     ..+.+.+|+++|++++|||||++++++.+++.+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            4799999999999999999999999999999998753222     24567899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      |||||.||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+..... ..
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            9999999999999875 467999999999999999999999999999999999999999999999999999765432 23


Q ss_pred             cccccCCCCcCChhhhhc----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC-CCCCCCCcCCHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMN----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK-DIPEIPEHLSDDAK  452 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~  452 (628)
                      ....+||+.|||||++..    ...|+.++|||||||+||||++|++||......+.+.++.... .....+..++++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            446789999999999852    3448999999999999999999999998877766666654432 22244567999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||++||+.||++|||++|||+||||+.
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999963

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-57  Score=484.78  Aligned_cols=265  Identities=30%  Similarity=0.503  Sum_probs=235.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+++.+|+++|+.++|||||++++++.+...+
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            3679999999999999999999999999999999986421  11122346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS  377 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~  377 (628)
                      |+||||+.||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999877543  


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHH
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQ  457 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  457 (628)
                      ....+||+.|||||++.+. .|+.++|||||||+||||++|++||...+....+.++....  ..++..+++++.+||++
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHH
Confidence            3457899999999999765 49999999999999999999999998877666666665433  35677899999999999


Q ss_pred             HhhcCCCCCC-----CHHHHhcCccccchHHHhhcCC
Q 040472          458 CLQRDPSARP-----PASKLLDHPFVRDQAVARAGNV  489 (628)
Q Consensus       458 ~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~  489 (628)
                      ||+.||.+|+     ++++||+||||++.+|......
T Consensus       272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~  308 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR  308 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred             HhhhCHHhccccccccHHHHHcCccccCCCHHHHHhc
Confidence            9999999995     8999999999999988776543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-58  Score=478.56  Aligned_cols=255  Identities=36%  Similarity=0.641  Sum_probs=227.9

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEE
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVY  300 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lV  300 (628)
                      .|++++.||+|+||+||+|+++.+++.||||+++....  ...+..+.+.+|+++|++++|||||++++++.+++.+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            59999999999999999999999999999999875322  2345567899999999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcccccc
Q 040472          301 LEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCASMLS  380 (628)
Q Consensus       301 mEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~~~~  380 (628)
                      ||||.||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....   ..
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~  170 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  170 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cc
Confidence            999999999988888889999999999999999999999999999999999999999999999999999875442   35


Q ss_pred             ccCCCCcCChhhhhc--cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          381 FKGSPYWMAPEVVMN--TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       381 ~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      .+||+.|||||++.+  ...|+.++|||||||++|||++|..||........+.++.........+..+++++++||++|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            679999999999864  235899999999999999999999999887777777766555444444567899999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccc
Q 040472          459 LQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       459 L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |+.||++|||++|||+||||+.
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999963

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-57  Score=486.91  Aligned_cols=272  Identities=28%  Similarity=0.442  Sum_probs=231.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-cchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-QTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ++++|+++++||+|+||+||+|+++.+|+.||||++.+.... ........+..+|+++|+.++|||||+++++|.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            478999999999999999999999999999999998642211 1112223334456788888899999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA  376 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~  376 (628)
                      +|||||||.||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh--HHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--AAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                      .....+||+.|||||++.+...|+.++|||||||+||||++|+.||......  ..+.+... .....++..+++++++|
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSL  239 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SCCCCCCSSSCHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCCCCHHHHHH
Confidence            3445789999999999976666999999999999999999999999764332  22333222 23346677899999999


Q ss_pred             HHHHhhcCCCCCCC-----HHHHhcCccccchHHHhhcCCCc
Q 040472          455 IKQCLQRDPSARPP-----ASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       455 I~~~L~~dP~~Rpt-----a~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      |.+||+.||++||+     ++||++||||++.+|......+.
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~  281 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY  281 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCC
Confidence            99999999999999     79999999999998877655443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=466.34  Aligned_cols=252  Identities=30%  Similarity=0.540  Sum_probs=218.5

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----cccc
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----DERL  297 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----~~~~  297 (628)
                      |++.++||+|+||+||+|+++.+++.||||++.....   .....+++.+|+++|++++|||||++++++.+    +..+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            4778899999999999999999999999999875322   23445678999999999999999999999865    4568


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCCCceEeC-CCCCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARN--TVHRDIKGANILVD-PHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHRDIKpeNILld-~~g~vKL~DFGla~~~~~  374 (628)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++  ||||||||+||||+ .++.+||+|||+|+....
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999999999999999999999999999999999998  99999999999996 578999999999986443


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhh-hcCCCCCCCCCCcCCHHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFK-IGNSKDIPEIPEHLSDDAKS  453 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~-i~~~~~~~~~p~~~s~~l~d  453 (628)
                       ......+||+.|||||++.+  .|+.++|||||||+||||++|+.||........+.+ +........++..+++++++
T Consensus       168 -~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         168 -SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  244 (270)
T ss_dssp             -TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             -CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence             23446789999999998853  499999999999999999999999987665555544 33333333556678999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          454 FIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       454 LI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ||++||+.||++|||++|||+||||+
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-58  Score=469.49  Aligned_cols=255  Identities=29%  Similarity=0.529  Sum_probs=212.4

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec--ccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS--DER  296 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~--~~~  296 (628)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++....   .....+.+.+|+++|++++|||||++++++.+  ++.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence            3689999999999999999999999999999999875332   23445778999999999999999999999865  567


Q ss_pred             ceEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCCCceEeCCCCCEEEeccC
Q 040472          297 LSVYLEYVSGGSIHKLLQE----YGPFNEPVIQTYTRQILLGLAYLHARN-----TVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~----~~~l~e~~~~~i~~qIl~aL~yLH~~g-----IvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      +|||||||+||+|.+++.+    ...+++..++.++.||+.||+|||+++     ||||||||+||||+.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            8999999999999999864    467999999999999999999999876     9999999999999999999999999


Q ss_pred             CcccccCcc-ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCc
Q 040472          368 MAKHMTSCA-SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEH  446 (628)
Q Consensus       368 la~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~  446 (628)
                      +|+.+.... .....+||+.|||||++.+. .|+.++|||||||+||||++|+.||......+...++... ..+.++..
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~  237 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYR  237 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTT
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcc
Confidence            998765433 33467899999999999654 4999999999999999999999999887666655555433 34567788


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhcCccc
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLDHPFV  478 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf  478 (628)
                      +++++.+||++||+.||++|||++|||+|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999999995

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-58  Score=480.62  Aligned_cols=266  Identities=29%  Similarity=0.489  Sum_probs=230.8

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHH-hCCCCCeeeeecceeccccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLS-QLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIV~l~~~~~~~~~~  297 (628)
                      +++|++++.||+|+||+||+|+++.+++.||||++++...  ...+..+.+..|+.++. .++|||||++++++.+++.+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            4689999999999999999999999999999999974211  11122345566777664 78999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-c
Q 040472          298 SVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-A  376 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~  376 (628)
                      |||||||.||+|.++|...+.+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+++..... .
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999866443 3


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHH
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIK  456 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  456 (628)
                      .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+......+.++...  .+.++..+++++++||+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~  235 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLV  235 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHH
Confidence            34457899999999999765 4999999999999999999999999887766666555433  34677889999999999


Q ss_pred             HHhhcCCCCCCCHH-HHhcCccccchHHHhhcCC
Q 040472          457 QCLQRDPSARPPAS-KLLDHPFVRDQAVARAGNV  489 (628)
Q Consensus       457 ~~L~~dP~~Rpta~-eiL~Hpwf~~~~~~~~~~~  489 (628)
                      +||++||++||++. ||++||||++..|......
T Consensus       236 ~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~  269 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDIRQHPLFREINWEELERK  269 (320)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTT
T ss_pred             HhcccCCCCCcCHHHHHHhCchhccCCHHHHHhc
Confidence            99999999999996 8999999998877765443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-57  Score=484.92  Aligned_cols=258  Identities=27%  Similarity=0.421  Sum_probs=228.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++....     ....+.+.+|+++|++|+|||||++++++.+++.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4679999999999999999999999999999999986421     23346788999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC--CCCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP--HGEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~--~g~vKL~DFGla~~~~~  374 (628)
                      |||||||.||+|.++|. +.+.+++..++.|+.||+.||+|||++|||||||||+||||+.  ++.+||+|||+|+.+..
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999999999995 4568999999999999999999999999999999999999964  57899999999998877


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~  452 (628)
                      .......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+....+.+..+.....  .......++++++
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             ccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            6666778999999999999765 489999999999999999999999988766666665543322  1233457899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      +||++||+.||++|||++|||+||||++.
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-57  Score=482.52  Aligned_cols=257  Identities=23%  Similarity=0.406  Sum_probs=227.9

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++...     ....+.+.+|+.+|++|+|||||+++++|.+++.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3568999999999999999999999999999999987421     22245678999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeC--CCCCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVD--PHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld--~~g~vKL~DFGla~~~~~  374 (628)
                      |||||||+||+|.+++... ..|++.+++.|+.||+.||+|||++|||||||||+||||+  .++.+||+|||+|+.+..
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999999999999987654 4799999999999999999999999999999999999997  578999999999998877


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCC--CCCCCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSK--DIPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~  452 (628)
                      .......+||+.|||||++.+. .|+.++|||||||+||||++|++||.+......+..+....  .....+..+++++.
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            6666778899999999999765 49999999999999999999999999877766666654432  22345567999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||++||+.||.+|||+.|||+||||++
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.9e-57  Score=462.38  Aligned_cols=261  Identities=25%  Similarity=0.418  Sum_probs=230.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccc----hHHHHHHHHHHHHHHHhCC-CCCeeeeecceecc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQT----SKECLKQLNQEINLLSQLS-HPNIVRYHGSELSD  294 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~----~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~  294 (628)
                      ++|++++.||+|+||+||+|+++.+++.||||++++......    .+...+++.+|+.+|++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            689999999999999999999999999999999976433222    2334557889999999997 99999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +.+|||||||+||+|.++|+..+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998776


Q ss_pred             ccccccccCCCCcCChhhhhc-----cCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCC--CCCCCCcC
Q 040472          375 CASMLSFKGSPYWMAPEVVMN-----TNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKD--IPEIPEHL  447 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~-----~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~--~~~~p~~~  447 (628)
                      .......+||+.|+|||++.+     ...++.++|||||||+||||++|+.||...+.......+.....  .......+
T Consensus       163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (277)
T d1phka_         163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY  242 (277)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred             CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            655666889999999999863     23478899999999999999999999998776666555544322  22334579


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      |+++++||++||+.||++||+++|||+||||+.
T Consensus       243 s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            999999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-57  Score=468.09  Aligned_cols=258  Identities=27%  Similarity=0.440  Sum_probs=216.0

Q ss_pred             EeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          224 KGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      .+++||+|+||+||+|+++.+|+.||||+++............+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46899999999999999999999999999875433333333446788999999999999999999999999999999999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-ccccccc
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-ASMLSFK  382 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~~~~~~  382 (628)
                      +.|+++..++.....+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ......+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999988888887788999999999999999999999999999999999999999999999999999876543 3345578


Q ss_pred             CCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC------C---------------CCC
Q 040472          383 GSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS------K---------------DIP  441 (628)
Q Consensus       383 GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~------~---------------~~~  441 (628)
                      ||+.|||||++.....|+.++|||||||++|||++|.+||......+.+.++...      .               ..+
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999977767899999999999999999999999877666554443210      0               000


Q ss_pred             C-----CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          442 E-----IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       442 ~-----~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      .     +...+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            1     113578999999999999999999999999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=468.46  Aligned_cols=256  Identities=29%  Similarity=0.404  Sum_probs=225.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      -+++|++++.||+|+||+||+|+++.+++.||||+++...      .....+.+|+++|++++|||||+++++|.+++.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            3578999999999999999999999999999999997532      1124578999999999999999999999999999


Q ss_pred             eEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC--CCEEEeccCCcccccC
Q 040472          298 SVYLEYVSGGSIHKLLQEYG-PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH--GEIKLADFGMAKHMTS  374 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~--g~vKL~DFGla~~~~~  374 (628)
                      |||||||.||+|.++|.+.+ .+++.+++.|+.||+.||+|||++||+||||||+||||+.+  ..+||+|||+++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999999999998765 79999999999999999999999999999999999999854  4799999999998766


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCC--CCCCCcCCHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDI--PEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~  452 (628)
                      .......+||+.|+|||++.+. .|+.++|||||||+||+|++|..||........+..+......  ...+..++.+++
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            6666677899999999998765 4999999999999999999999999887776666665443321  122346899999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                      +||++||+.||++|||++|||+||||+.
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            9999999999999999999999999964

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=454.41  Aligned_cols=260  Identities=31%  Similarity=0.555  Sum_probs=216.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|+++.+++.||||+++....   .....+++.+|+++|++++|||||++++++.++..+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence            4799999999999999999999999999999999964321   1233467889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC-cc
Q 040472          299 VYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS-CA  376 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~-~~  376 (628)
                      +||||+.++.+..+... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.... ..
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99999976544444333 46799999999999999999999999999999999999999999999999999987644 33


Q ss_pred             ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC----C------------CC
Q 040472          377 SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS----K------------DI  440 (628)
Q Consensus       377 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~----~------------~~  440 (628)
                      .....+||+.|+|||++.....++.++|||||||++|+|++|+.||...+....+.++...    .            ..
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            4455689999999999887776789999999999999999999999876655544433110    0            00


Q ss_pred             CC-----------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          441 PE-----------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       441 ~~-----------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      ..           ....++.++++||++||+.||++|||++|||+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00           113578999999999999999999999999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=452.89  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=217.2

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeeccccc-chHHHHHHHHHHHHHHHhCC--CCCeeeeecceecccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQ-TSKECLKQLNQEINLLSQLS--HPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~iL~~l~--HpnIV~l~~~~~~~~~  296 (628)
                      ++|+++++||+|+||+||+|+++.+++.||||++++..... .......++.+|+.+|++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            58999999999999999999999999999999987532211 11112234668999999997  8999999999999999


Q ss_pred             ceEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC-CCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSG-GSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH-GEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~G-gsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~-g~vKL~DFGla~~~~~  374 (628)
                      +|+||||+.+ ++|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999976 6889999988999999999999999999999999999999999999999854 7999999999986543


Q ss_pred             ccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHH
Q 040472          375 CASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSF  454 (628)
Q Consensus       375 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  454 (628)
                       ....+.+||+.|||||++.+...++.++|||||||+||||++|+.||...+.   +.+.     ...++..+|+++++|
T Consensus       164 -~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i~~~-----~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         164 -TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---IIRG-----QVFFRQRVSSECQHL  234 (273)
T ss_dssp             -SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HHHC-----CCCCSSCCCHHHHHH
T ss_pred             -ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---Hhhc-----ccCCCCCCCHHHHHH
Confidence             3345678999999999998766567889999999999999999999986432   2111     124566799999999


Q ss_pred             HHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          455 IKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       455 I~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                      |++||+.||++|||++|||+||||++.
T Consensus       235 i~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=462.47  Aligned_cols=252  Identities=27%  Similarity=0.455  Sum_probs=211.6

Q ss_pred             ccCCeEEee-eeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHh-CCCCCeeeeecceec--
Q 040472          218 SLSKWKKGK-LLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQ-LSHPNIVRYHGSELS--  293 (628)
Q Consensus       218 ~~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIV~l~~~~~~--  293 (628)
                      .+++|++.. +||+|+||+||+|+++.+++.||||+++.          ...+.+|+.++.+ ++|||||+++++|.+  
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            467999874 69999999999999999999999999863          1346679988654 579999999999876  


Q ss_pred             --cccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEecc
Q 040472          294 --DERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADF  366 (628)
Q Consensus       294 --~~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DF  366 (628)
                        +..+|||||||+||+|.++|.+.  ..|+|.+++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              56799999999999999999875  36999999999999999999999999999999999999985   457999999


Q ss_pred             CCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhh---cCCCC--CC
Q 040472          367 GMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI---GNSKD--IP  441 (628)
Q Consensus       367 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i---~~~~~--~~  441 (628)
                      |+|+...........+||+.|||||++.+.. |+.++|||||||+||+|++|++||.+.........+   .....  .+
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            9999877766677789999999999987654 999999999999999999999999765433322221   11111  11


Q ss_pred             -CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          442 -EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       442 -~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                       ..+..+++++++||++||+.||++||++.|||+||||++
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             112368999999999999999999999999999999964

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-54  Score=446.66  Aligned_cols=258  Identities=28%  Similarity=0.488  Sum_probs=217.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|+++ +++.||||+++.....   ....+++.+|+.+|++++|||||++++++.+++.+|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   76 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV   76 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCcee
Confidence            479999999999999999999986 7899999999653221   223467889999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-cc
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-AS  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-~~  377 (628)
                      ++|||+.++.+..+.+..+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++...... ..
T Consensus        77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99999998888888888889999999999999999999999999999999999999999999999999999876443 23


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---C-----------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---S-----------------  437 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~-----------------  437 (628)
                      .....|++.|+|||++.+...++.++|||||||++|||++|+.||......+.+.++..   .                 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            34567999999999998777789999999999999999999999987655544433211   0                 


Q ss_pred             -------CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          438 -------KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       438 -------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                             .........+++++.+||++||+.||++|||++|||+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                   0001233567899999999999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=445.41  Aligned_cols=259  Identities=30%  Similarity=0.498  Sum_probs=213.9

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCC-CcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC---CCCCeeeeecceec-
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSES-GQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL---SHPNIVRYHGSELS-  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIV~l~~~~~~-  293 (628)
                      -++|++++.||+|+||+||+|++..+ ++.||||+++........   ...+.+|+.+|+.|   +|||||+++++|.. 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            36999999999999999999999765 678999999764322211   12344567666655   79999999998853 


Q ss_pred             ----cccceEEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          294 ----DERLSVYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       294 ----~~~~~lVmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                          +..+|++|||+.++.+..... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence                457899999999888765544 346799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC------------
Q 040472          369 AKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN------------  436 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~------------  436 (628)
                      ++...........+||+.|||||++.+. .|+.++|||||||++|||++|++||...+..+.+.++..            
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            9877666666778899999999999765 499999999999999999999999987665554433311            


Q ss_pred             -------------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 -------------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 -------------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                   ......+...+++++++||++||+.||++|||+.|||+||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                         001112445689999999999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-54  Score=443.82  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=217.2

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ...++|++++.||+|+||+||+|+++.+++.||||+++....      ..+++.+|+++|++++|||||++++++.+++.
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            345789999999999999999999999999999998864221      13568899999999999999999999999999


Q ss_pred             ceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          297 LSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      +|||||||.+|+|.++|.+.  ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999999999764  5789999999999999999999999999999999999999999999999999987654


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      ..  ......||+.|||||++.+. .|+.++|||||||++|||++|..||........+.++......+.++..++.++.
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  246 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  246 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHH
Confidence            32  22334589999999998765 4999999999999999999977766554445555554444445677888999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      +||++||+.||++|||+.||++
T Consensus       247 ~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         247 ELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-53  Score=438.44  Aligned_cols=257  Identities=23%  Similarity=0.418  Sum_probs=212.9

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE----  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~----  295 (628)
                      ++|++++.||+|+||+||+|+++.+++.||||+++....  ...+..+++.+|+++|+.++|||||++++++.+++    
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            579999999999999999999999999999999975322  23455678999999999999999999999988754    


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      .+|||||||+|++|.+++...+.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||+++.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            38999999999999999999999999999999999999999999999999999999999999999999999998765332


Q ss_pred             ----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCCCCCC--CCCCcCCH
Q 040472          376 ----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNSKDIP--EIPEHLSD  449 (628)
Q Consensus       376 ----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~~~~~--~~p~~~s~  449 (628)
                          ......+||+.|||||++.+. .|+.++|||||||+||||++|++||......+.+.++......+  .....+++
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  243 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA  243 (277)
T ss_dssp             --------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred             cccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence                234457899999999998765 49999999999999999999999999877766665554433222  34567999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhcCcccc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLDHPFVR  479 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~  479 (628)
                      ++.+||++||++||++||+..+.|.|+|++
T Consensus       244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         244 DLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            999999999999999999444444566653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=449.07  Aligned_cols=253  Identities=24%  Similarity=0.388  Sum_probs=216.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCc-----EEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQ-----MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|+++++||+|+||+||+|++..+++     .||||.+....    .......+.+|+.+|.++ +|||||++++++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            34689999999999999999999876554     68999875322    123345688999999998 899999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEY-----------------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDI  348 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~-----------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI  348 (628)
                      .+.+.+|||||||+||+|.++|+..                       ..+++..++.|+.||+.||+|||+++||||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            9999999999999999999999754                       24889999999999999999999999999999


Q ss_pred             CCCceEeCCCCCEEEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCC
Q 040472          349 KGANILVDPHGEIKLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQ  424 (628)
Q Consensus       349 KpeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~  424 (628)
                      ||+|||++.++++||+|||+|+.......   ..+.+||+.|||||++.+. .|+.++|||||||+||||++ |++||.+
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987654332   2346689999999998765 49999999999999999997 8999988


Q ss_pred             CchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       425 ~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ......+.++......+..+..+++++++||.+||+.||++|||++||++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            766666666655555567788899999999999999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-53  Score=432.60  Aligned_cols=259  Identities=28%  Similarity=0.505  Sum_probs=222.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccce
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLS  298 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~  298 (628)
                      +++|++++.||+|+||+||+|+++.+++.||||+++....   ......++.+|+.+|+.++|+|||++++++.+...++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   77 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence            4789999999999999999999999999999999975432   2345678899999999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc-c
Q 040472          299 VYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA-S  377 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~-~  377 (628)
                      +|||++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++++||+|||+++...... .
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            999999999999999988999999999999999999999999999999999999999999999999999998765433 3


Q ss_pred             cccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCc-hhHHHhhhc---C-----------------
Q 040472          378 MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYE-GVAAIFKIG---N-----------------  436 (628)
Q Consensus       378 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~-~~~~~~~i~---~-----------------  436 (628)
                      .....+++.|+|||++.....++.++|||||||++|||++|+.||.... ..+.+.++.   .                 
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            3345678899999999877768999999999999999999999874332 222222210   0                 


Q ss_pred             -------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          437 -------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       437 -------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                             ..........+++++.+||++||+.||.+|||++|||+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                   01112334567899999999999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-53  Score=439.48  Aligned_cols=252  Identities=25%  Similarity=0.449  Sum_probs=205.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCc---EEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQ---MCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~  294 (628)
                      ..++|++.++||+|+||+||+|+++.+++   .||||.+...    ......+++.+|+++|++++|||||++++++.++
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            45789999999999999999999987765   4777766432    2234457789999999999999999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      +.+|+|||||+||+|.+++... +.+++.+++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.+.
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999999988764 579999999999999999999999999999999999999999999999999998764


Q ss_pred             Cccc------cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCc
Q 040472          374 SCAS------MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEH  446 (628)
Q Consensus       374 ~~~~------~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~  446 (628)
                      ....      .....||+.|||||++.+. .|+.++|||||||+||||+| |++||........+..+..... +..+..
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~  257 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-LPPPMD  257 (299)
T ss_dssp             ----------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTT
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCcc
Confidence            4322      1224579999999998754 59999999999999999998 8999988777666666654433 346678


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++.++.+||.+||+.||++||++.||+++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999999865

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=446.26  Aligned_cols=252  Identities=29%  Similarity=0.484  Sum_probs=212.3

Q ss_pred             CeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec------c
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS------D  294 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~------~  294 (628)
                      +|+.+++||+|+||+||+|+++.+++.||||+++....         .+.+|+++|++++|+|||+++++|..      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            69999999999999999999999999999999875321         12469999999999999999998854      2


Q ss_pred             ccceEEEEecccccHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCcc
Q 040472          295 ERLSVYLEYVSGGSIHKLL---QEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAK  370 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L---~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~  370 (628)
                      .++|||||||.++.+..+.   .....+++..++.|++||+.||+|||++|||||||||+||||+.++ .+||+|||+++
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            3578999999876544433   3456799999999999999999999999999999999999999875 89999999999


Q ss_pred             cccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC--------------
Q 040472          371 HMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN--------------  436 (628)
Q Consensus       371 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~--------------  436 (628)
                      .........+.+||+.|+|||++.+...|+.++|||||||++|||++|++||........+.++..              
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            877666677788999999999988777799999999999999999999999987665554443311              


Q ss_pred             ----CCCCC---------CCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 ----SKDIP---------EIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 ----~~~~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                          ....+         .....+++++.+||++||+.||++|||+.|||+||||++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                00111         1123578999999999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=437.59  Aligned_cols=251  Identities=26%  Similarity=0.483  Sum_probs=208.2

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||+||+|+.+   ..||||+++.....   .+..+.+.+|+++|++++|||||++++++. ++.+
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~   78 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL   78 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence            3468999999999999999999754   35999998754322   234577899999999999999999999865 5678


Q ss_pred             eEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc-
Q 040472          298 SVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC-  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~-  375 (628)
                      +||||||+||+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+..... 
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999999754 67999999999999999999999999999999999999999999999999999876432 


Q ss_pred             --cccccccCCCCcCChhhhhcc--CCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC-C---CCCCCCCCcC
Q 040472          376 --ASMLSFKGSPYWMAPEVVMNT--NGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN-S---KDIPEIPEHL  447 (628)
Q Consensus       376 --~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~-~---~~~~~~p~~~  447 (628)
                        ......+||+.|||||++.+.  ..|+.++|||||||+||||+||+.||........+..+.. .   .....++..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              233457899999999998643  3489999999999999999999999987665544433322 1   2233566778


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          448 SDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++++.+||.+||+.||++|||+.||+++
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=443.79  Aligned_cols=256  Identities=29%  Similarity=0.486  Sum_probs=213.1

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc---
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE---  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~---  295 (628)
                      -++|+++++||+|+||+||+|+++.+|+.||||+++...   ......+++.+|+++|++++|||||+++++|...+   
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence            468999999999999999999999999999999986432   23455678899999999999999999999988654   


Q ss_pred             ---cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          296 ---RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       296 ---~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                         .+||||||+ |.+|..+++ .+.|++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence               579999999 678877765 468999999999999999999999999999999999999999999999999999876


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC----------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN----------------  436 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~----------------  436 (628)
                      ..  .....+||+.|+|||++.+...++.++|||||||++|||++|++||...+....+..+..                
T Consensus       172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            44  345578999999999998777789999999999999999999999987654443322111                


Q ss_pred             -------------CCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 -------------SKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 -------------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                   ......+...+++++.+||++||+.||++|||+.|||+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                         111123345689999999999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-53  Score=432.75  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=212.7

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||+||+|+++ +++.||||+++.....      .+.+.+|+++|++++|||||++++++. ++.+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~   82 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI   82 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC------HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCe
Confidence            4478999999999999999999986 5788999998642211      256889999999999999999999875 4678


Q ss_pred             eEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ||||||+++|+|.+++...  ..+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999999987643  36999999999999999999999999999999999999999999999999999877543


Q ss_pred             c--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 A--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      .  ......||+.|||||++.+. .|+.++|||||||+||||+|| .+||........+..+... ..+..+..+++++.
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~  240 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELY  240 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHH
T ss_pred             ccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCcccChHHHH
Confidence            2  23446799999999998765 499999999999999999995 5555555444444444433 33456778999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc--Ccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD--HPFVR  479 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~--Hpwf~  479 (628)
                      +||++||+.||++|||++||++  |+||.
T Consensus       241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999988  77874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=429.69  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=202.4

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|++++.||+|+||+||+|+++ +++.||||+++.....      .+++.+|+++|++++|||||++++++.+++.+|+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc------HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            58999999999999999999987 5678999998642211      2467899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....... 
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999998754 5689999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          378 -MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       .....||+.|||||++.+. .|+.++|||||||+||||+| |.+||........+..+... ..+..|..+++++.+||
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             -------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHH
T ss_pred             eecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHH
Confidence             2346799999999999765 49999999999999999999 56666655554444444333 33456677899999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcC
Q 040472          456 KQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+||+.||++||+++||++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=433.22  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=208.6

Q ss_pred             eeeccCCcEEEEEEEEC--CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceEEEEe
Q 040472          226 KLLGRGTFGHVYLGFNS--ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       226 ~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      ++||+|+||+||+|.+.  .+++.||||+++...   ......+++.+|+++|++++|||||++++++.+ +..||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence            57999999999999764  456789999986432   223345678999999999999999999999864 567899999


Q ss_pred             cccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc----cc
Q 040472          304 VSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS----ML  379 (628)
Q Consensus       304 ~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~----~~  379 (628)
                      |++|+|.+++++...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+.....    ..
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999999999989999999999999999999999999999999999999999999999999999987644322    23


Q ss_pred             cccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHH
Q 040472          380 SFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQC  458 (628)
Q Consensus       380 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  458 (628)
                      ...||+.|||||++.+. .++.++|||||||++|||++ |+.||......+....+.. ...+.++..++.++.+||.+|
T Consensus       169 ~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         169 HGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             --CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHH
Confidence            35699999999999765 49999999999999999997 8999988766555554543 334567788999999999999


Q ss_pred             hhcCCCCCCCHHHH---hcCcccc
Q 040472          459 LQRDPSARPPASKL---LDHPFVR  479 (628)
Q Consensus       459 L~~dP~~Rpta~ei---L~Hpwf~  479 (628)
                      |+.||++||++++|   |+|+|+.
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999998   4565553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=437.99  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=213.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec----
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS----  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~----  293 (628)
                      .+++|+++++||+|+||+||+|+++.+|+.||||++......   ....+++.+|+++|++++|+||+++++++..    
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            468999999999999999999999999999999998653222   2234567889999999999999999998755    


Q ss_pred             ----cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCc
Q 040472          294 ----DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMA  369 (628)
Q Consensus       294 ----~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla  369 (628)
                          +..+|+||||+.++.+..+......+++..++.+++||+.||+|||++|||||||||+||||+.++.+||+|||++
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence                4568999999998888777777788999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCc-----cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---CCCC-
Q 040472          370 KHMTSC-----ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---SKDI-  440 (628)
Q Consensus       370 ~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---~~~~-  440 (628)
                      +.+...     ......+||+.|+|||++.+...|+.++|||||||++|||++|++||...+....+..+..   .... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            765432     2334567999999999998776799999999999999999999999987655443332211   0000 


Q ss_pred             --CC---------------CC---------CcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          441 --PE---------------IP---------EHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       441 --~~---------------~p---------~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                        ..               ..         ...++++.+||++||+.||++|+|++|||+||||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence              00               00         013678899999999999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.9e-53  Score=440.98  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=214.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceec--c
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELS--D  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~--~  294 (628)
                      ..++|+++++||+|+||+||+|+++.+++.||||+++...        .+++.+|+++|++++ ||||++++++|..  .
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            4578999999999999999999999999999999986421        256788999999996 9999999999874  4


Q ss_pred             ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCC-CEEEeccCCccccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHG-EIKLADFGMAKHMT  373 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g-~vKL~DFGla~~~~  373 (628)
                      ..+++|||||.+++|..+.   +.+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus       105 ~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             CceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            5799999999999998764   4699999999999999999999999999999999999998765 69999999999877


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhH-H---Hhhhc------------CC
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVA-A---IFKIG------------NS  437 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~-~---~~~i~------------~~  437 (628)
                      ........+||+.|+|||++.+...++.++|||||||++|||++|+.||....... .   +.++.            ..
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            76667778899999999999877778999999999999999999999996543211 1   10000            00


Q ss_pred             C--------------------CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccchHH
Q 040472          438 K--------------------DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQAV  483 (628)
Q Consensus       438 ~--------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~~~  483 (628)
                      .                    ........+++++.+||++||+.||++|||++|||+||||++..|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0                    001122357899999999999999999999999999999987543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=443.85  Aligned_cols=272  Identities=28%  Similarity=0.477  Sum_probs=227.3

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE---CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC-CCeeeeecceec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN---SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYHGSELS  293 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV~l~~~~~~  293 (628)
                      .+++|++++.||+|+||+||+|++   +.+|+.||||++++...... ....+++.+|+++|++++| |||+++++++.+
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            578999999999999999999987   45789999999864321111 1123567789999999976 899999999999


Q ss_pred             cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          294 DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       294 ~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                      ...+++||||+.||+|.+++...+.+.+..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998764


Q ss_pred             Cc--cccccccCCCCcCChhhhhccC-CCCccccccccccceeeeccCCCCCCCCchhHH---HhhhcCCCCCCCCCCcC
Q 040472          374 SC--ASMLSFKGSPYWMAPEVVMNTN-GYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAA---IFKIGNSKDIPEIPEHL  447 (628)
Q Consensus       374 ~~--~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~---~~~i~~~~~~~~~p~~~  447 (628)
                      ..  ....+..||+.|+|||++.+.. .++.++|||||||+||||++|+.||........   +.+... ...+.++..+
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~~  259 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEM  259 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCTTS
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-cCCCCCcccC
Confidence            32  2345678999999999986543 478899999999999999999999976443222   222111 2234567789


Q ss_pred             CHHHHHHHHHHhhcCCCCCC-----CHHHHhcCccccchHHHhhcCCCc
Q 040472          448 SDDAKSFIKQCLQRDPSARP-----PASKLLDHPFVRDQAVARAGNVNL  491 (628)
Q Consensus       448 s~~l~dLI~~~L~~dP~~Rp-----ta~eiL~Hpwf~~~~~~~~~~~~~  491 (628)
                      ++++.+||++||+.||++|+     |++|||+||||+++.|.......+
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~  308 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV  308 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCC
Confidence            99999999999999999999     589999999999988877655443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=432.49  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=214.4

Q ss_pred             CCeEEeee-eccCCcEEEEEEEECC--CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecccc
Q 040472          220 SKWKKGKL-LGRGTFGHVYLGFNSE--SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDER  296 (628)
Q Consensus       220 ~~y~~~~~-LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~  296 (628)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||+++..    ......+++.+|+++|++++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            57888885 9999999999998754  4557999998642    234456788999999999999999999999865 56


Q ss_pred             ceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          297 LSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      +|||||||+||+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999999999999865 467999999999999999999999999999999999999999999999999999876543


Q ss_pred             c----ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          376 A----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       376 ~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      .    .....+||+.|||||++.+. .++.++|||||||+||||+| |+.||......+.+..+... ..+.++..++.+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~  240 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPE  240 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred             ccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHH
Confidence            2    22345789999999998765 49999999999999999998 99999887666555555443 345677889999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHH---hcCccc
Q 040472          451 AKSFIKQCLQRDPSARPPASKL---LDHPFV  478 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~ei---L~Hpwf  478 (628)
                      +.+||.+||+.||++||++.+|   |+|.|+
T Consensus       241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999888   566765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=440.18  Aligned_cols=257  Identities=23%  Similarity=0.458  Sum_probs=211.0

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE----  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~----  295 (628)
                      ++|+++++||+|+||+||+|+++.+|+.||||++++..    .....+++.+|+.+|++++|||||++++++..+.    
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            57999999999999999999999999999999986422    2445677889999999999999999999987653    


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      ..+++|+|+.||+|.++++. +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             ceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            23455566779999999975 57999999999999999999999999999999999999999999999999999865443


Q ss_pred             c----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcC---------------
Q 040472          376 A----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGN---------------  436 (628)
Q Consensus       376 ~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~---------------  436 (628)
                      .    .....+||+.|+|||++.....++.++||||+||++|||++|+.||..............               
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            2    234567999999999987777789999999999999999999999976544322221100               


Q ss_pred             ------------CCC--CCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccch
Q 040472          437 ------------SKD--IPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRDQ  481 (628)
Q Consensus       437 ------------~~~--~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~~  481 (628)
                                  ...  ...+...++.++++||.+||+.||++|||++|||+||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                        000  011234678999999999999999999999999999999743

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=422.09  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=217.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccceE
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERLSV  299 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~~l  299 (628)
                      ++|+++++||+|+||+||+|+++ +++.||||+++.....      .+.+.+|++++++++|||||++++++.+++.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            68999999999999999999985 6889999999753221      2467899999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCccc-
Q 040472          300 YLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCAS-  377 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~~-  377 (628)
                      ||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..... 
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999999999764 56799999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHHHHHH
Q 040472          378 -MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDAKSFI  455 (628)
Q Consensus       378 -~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  455 (628)
                       .....||+.|+|||++.+.. |+.++|||||||++|||+| |+.||......+...++.... ....|..++.++.+||
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIM  234 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccccHHHHHHH
Confidence             33467999999999997654 9999999999999999998 899999887776666665543 3457788999999999


Q ss_pred             HHHhhcCCCCCCCHHHHhcC
Q 040472          456 KQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       456 ~~~L~~dP~~Rpta~eiL~H  475 (628)
                      ++||+.||++|||+++|++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=423.88  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=204.7

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECCCC----cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSESG----QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ...+.|++.++||+|+||.||+|+++.++    ..||||+++...    ......++.+|+++|++++|||||++++++.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            34568999999999999999999987654    469999886422    2334567889999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +.+.+++||||+.+++|.+++... ..+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999999988754 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcc----ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCC-CCCchhHHHhhhcCCCCCCCCCCc
Q 040472          372 MTSCA----SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVAAIFKIGNSKDIPEIPEH  446 (628)
Q Consensus       372 ~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF-~~~~~~~~~~~i~~~~~~~~~p~~  446 (628)
                      +....    ......||+.|||||++.+. .++.++|||||||+||||++|..|| ......+.+..+. ....+..+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~  237 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD  237 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchh
Confidence            64432    22335689999999998765 5999999999999999999965554 4444433333333 3344566778


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          447 LSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       447 ~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.++.+||.+||+.||++||++.||++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=435.29  Aligned_cols=256  Identities=24%  Similarity=0.437  Sum_probs=212.0

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceecc----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSD----  294 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~----  294 (628)
                      -++|+++++||+|+||+||+|+++.+|+.||||+++...   ......+++.+|+++|++++|+|||++++++...    
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            368999999999999999999999999999999987432   2334456788999999999999999999998643    


Q ss_pred             -ccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCccccc
Q 040472          295 -ERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMT  373 (628)
Q Consensus       295 -~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~  373 (628)
                       ...++||||+.||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++....
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence             345677788889999999965 579999999999999999999999999999999999999999999999999997653


Q ss_pred             CccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC----------------
Q 040472          374 SCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS----------------  437 (628)
Q Consensus       374 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~----------------  437 (628)
                      .  ...+.+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...                
T Consensus       173 ~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             G--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             c--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence            3  3445679999999999887777899999999999999999999999876544333322110                


Q ss_pred             --------CCCCC-----CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          438 --------KDIPE-----IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       438 --------~~~~~-----~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                              ...+.     ....+++++++||++||+.||++|||+.|||+||||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                    00111     12357899999999999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=420.40  Aligned_cols=250  Identities=27%  Similarity=0.434  Sum_probs=204.2

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCC---cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESG---QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|++++.||+|+||+||+|++..++   ..||||+++..    ......+.+.+|+++|++++|||||++++++. ++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            468999999999999999999987553   45788876432    23444577899999999999999999999985 57


Q ss_pred             cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+|+||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            89999999999999998765 46799999999999999999999999999999999999999999999999999987654


Q ss_pred             cc--ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          375 CA--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       375 ~~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ..  ......||+.|+|||++.+. .|+.++|||||||+||||++ |.+||......+.+.++.... .+.++..+++++
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  238 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL  238 (273)
T ss_dssp             ----------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHH
T ss_pred             CcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHH
Confidence            32  23345689999999999765 49999999999999999998 899998877766666665443 346778899999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+||.+||+.||++|||+.||++|
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=422.51  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=206.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDERL  297 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~~~  297 (628)
                      ..++|++++.||+|+||+||+|+++.+ +.||||+++.....      .+.+.+|+.+|++++|+|||++++++. ++.+
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~------~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~   86 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   86 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC------HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence            457999999999999999999999765 57999998643221      256889999999999999999999985 4668


Q ss_pred             eEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCc
Q 040472          298 SVYLEYVSGGSIHKLLQE--YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSC  375 (628)
Q Consensus       298 ~lVmEy~~GgsL~~~L~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~  375 (628)
                      |+||||+.+|+|..++..  ...+++.+++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999999998864  467999999999999999999999999999999999999999999999999999876433


Q ss_pred             c--ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCC-CCCchhHHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          376 A--SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPW-SQYEGVAAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       376 ~--~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF-~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                      .  ......||+.|+|||++.+. .++.++|||||||+||||++|..|| ......+.+..+.. .....++..++++++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~  244 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLH  244 (285)
T ss_dssp             ---------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHH
T ss_pred             CceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHH
Confidence            2  23346799999999999765 4999999999999999999965555 44444444444443 333457788999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhc--Ccccc
Q 040472          453 SFIKQCLQRDPSARPPASKLLD--HPFVR  479 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~--Hpwf~  479 (628)
                      +||.+||+.||++||++++|++  ++||.
T Consensus       245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         245 DLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            9999999999999999999987  77774

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=433.25  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=200.7

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-----
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-----  293 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-----  293 (628)
                      +++|+++++||+|+||+||+|+++.+|+.||||+++...   ......+++.+|+.+|++++|||||+++++|..     
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh---cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            478999999999999999999999999999999997533   234456788999999999999999999999864     


Q ss_pred             -cccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          294 -DERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       294 -~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                       ...+|+|||||.|+.+. .+.  ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~~~~~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             TCCEEEEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cCceeEEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence             36789999999765554 443  56899999999999999999999999999999999999999999999999999877


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhhcCC---------------
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKIGNS---------------  437 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i~~~---------------  437 (628)
                      .........+||+.|+|||++.+. .++.++|||||||++|+|++|++||...+......++...               
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             -----------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             ccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            666666677899999999999775 5999999999999999999999999765543332222100               


Q ss_pred             --------CCCCC-----------------CCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcCccccc
Q 040472          438 --------KDIPE-----------------IPEHLSDDAKSFIKQCLQRDPSARPPASKLLDHPFVRD  480 (628)
Q Consensus       438 --------~~~~~-----------------~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~Hpwf~~  480 (628)
                              .....                 ....++.++.+||++||+.||++|||++|||+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                    00000                 01124678999999999999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=423.59  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|+++++||+|+||+||+|++..     +++.||||+++...    .....+.+.+|+.++.++ +|+|||.+++++
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            34689999999999999999999754     45789999886422    233346677788877776 589999999987


Q ss_pred             ec-cccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceE
Q 040472          292 LS-DERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANIL  354 (628)
Q Consensus       292 ~~-~~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNIL  354 (628)
                      .. +..+++|||||++|+|.++|+..                ..+++..++.|+.||+.||+|||+++||||||||+|||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence            65 45789999999999999999753                24889999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHH
Q 040472          355 VDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAA  430 (628)
Q Consensus       355 ld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~  430 (628)
                      |+.++++||+|||+|+......   .....+||+.|||||++.+. .++.++|||||||++|||++| .+||........
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998654332   23456799999999999765 499999999999999999986 568877665555


Q ss_pred             HhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          431 IFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       431 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +..+......+.++..+++++.+||.+||+.||++|||++||++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            554444444557778899999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-51  Score=425.96  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=205.6

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcE----EEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQM----CAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      ++|+++++||+|+||+||+|++..+|+.    ||||.++..    ...+..+++.+|+++|++++|||||++++++.+ +
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            5799999999999999999999888874    666666432    222345678999999999999999999999976 4


Q ss_pred             cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      ..+++|||+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            67788999999999998875 46799999999999999999999999999999999999999999999999999987644


Q ss_pred             ccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHH
Q 040472          375 CAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDD  450 (628)
Q Consensus       375 ~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~  450 (628)
                      ...   .....||+.|||||++.+. .|+.++|||||||+||||+| |.+||......+....+.. ...+..+..++.+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-TCCCCCCTTBCHH
T ss_pred             ccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHH
Confidence            322   2335689999999999765 49999999999999999998 8999987655444333332 3334567789999


Q ss_pred             HHHHHHHHhhcCCCCCCCHHHHhcCcc
Q 040472          451 AKSFIKQCLQRDPSARPPASKLLDHPF  477 (628)
Q Consensus       451 l~dLI~~~L~~dP~~Rpta~eiL~Hpw  477 (628)
                      +.+||.+||+.||++|||+.||++|-.
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999998843

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=422.74  Aligned_cols=252  Identities=24%  Similarity=0.422  Sum_probs=213.5

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcE--EEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecceecc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQM--CAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSELSD  294 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~~~~  294 (628)
                      ..++|+++++||+|+||+||+|+++.++..  ||||.++...    ..+..+.+.+|+++|.++ +|||||++++++.++
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            457999999999999999999999988875  5666654321    223456789999999999 699999999999999


Q ss_pred             ccceEEEEecccccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCC
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY----------------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPH  358 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~  358 (628)
                      +.+|+||||++||+|.++|++.                ..+++..+..++.||+.||.|||+++||||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999999754                568999999999999999999999999999999999999999


Q ss_pred             CCEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCC-CCCCCCchhHHHhhhcCC
Q 040472          359 GEIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSK-PPWSQYEGVAAIFKIGNS  437 (628)
Q Consensus       359 g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~-~PF~~~~~~~~~~~i~~~  437 (628)
                      +.+||+|||+++............||..|+|||++.+. .|+.++|||||||++|||++|. +||...+..+.+..+...
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            99999999999876655555566799999999999765 4999999999999999999965 578776665555555443


Q ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       438 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                       ..+.++..+++++++||.+||+.||++||++.||++|
T Consensus       243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             3456778899999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-50  Score=418.05  Aligned_cols=251  Identities=24%  Similarity=0.448  Sum_probs=215.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEEC-----CCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeeccee
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNS-----ESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSEL  292 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~  292 (628)
                      ..++|++++.||+|+||+||+|+++     .+++.||||+++..    ...+..+++.+|+++|++++||||+++++++.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh----cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            4568999999999999999999875     35688999988632    22445678899999999999999999999999


Q ss_pred             ccccceEEEEecccccHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q 040472          293 SDERLSVYLEYVSGGSIHKLLQEYG------------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDI  348 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL~~~L~~~~------------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDI  348 (628)
                      +.+.+++||||+.+|+|.++|....                        .+++..+..|+.||+.||+|||+++||||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            9999999999999999999997532                        3889999999999999999999999999999


Q ss_pred             CCCceEeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCC-CCCCC
Q 040472          349 KGANILVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSK-PPWSQ  424 (628)
Q Consensus       349 KpeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~-~PF~~  424 (628)
                      ||+||||+.++++||+|||+|+.+....   ...+.+||+.|+|||++.+. .|+.++|||||||+||||++|. +||..
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999999999999999998654432   23356799999999999765 4999999999999999999985 67887


Q ss_pred             CchhHHHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          425 YEGVAAIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       425 ~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ....+.+..+... ..+.++..++.++.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7766666665544 356778889999999999999999999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=410.50  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=205.9

Q ss_pred             ccccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-c
Q 040472          216 ENSLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-D  294 (628)
Q Consensus       216 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-~  294 (628)
                      +..+++|++++.||+|+||.||+|+++  |..||||+++...       ..+.+.+|+++|++++|||||++++++.+ +
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            345779999999999999999999985  7789999986321       23568899999999999999999998865 5


Q ss_pred             ccceEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccc
Q 040472          295 ERLSVYLEYVSGGSIHKLLQEY--GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHM  372 (628)
Q Consensus       295 ~~~~lVmEy~~GgsL~~~L~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~  372 (628)
                      +.+||||||+++|+|.++|...  ..+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++..
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence            6789999999999999999754  35899999999999999999999999999999999999999999999999999875


Q ss_pred             cCccccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCHHH
Q 040472          373 TSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSDDA  451 (628)
Q Consensus       373 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  451 (628)
                      ...  .....+|..|+|||++.+. .++.++|||||||++|||++ |++||......+.+..+... ..+.++..+++++
T Consensus       154 ~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  229 (262)
T d1byga_         154 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAV  229 (262)
T ss_dssp             ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHH
T ss_pred             CCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHH
Confidence            443  3345689999999999765 49999999999999999998 79999877666666665443 4456788899999


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          452 KSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       452 ~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      .+||++||+.||++|||+.+|+++
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=413.29  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=206.5

Q ss_pred             cCCeEEeeeeccCCcEEEEEEEECC-CC--cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc
Q 040472          219 LSKWKKGKLLGRGTFGHVYLGFNSE-SG--QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE  295 (628)
Q Consensus       219 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~  295 (628)
                      .++|++.+.||+|+||.||+|++.. ++  ..||||+++....  ...+..+++.+|+++|++++|||||++++++.+ +
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            3689999999999999999998643 33  3689998864322  223456789999999999999999999999965 5


Q ss_pred             cceEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQE-YGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTS  374 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~  374 (628)
                      .+++||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            78999999999999988764 46799999999999999999999999999999999999999999999999999997644


Q ss_pred             ccc----cccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhHHHhhhcCCCCCCCCCCcCCH
Q 040472          375 CAS----MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVAAIFKIGNSKDIPEIPEHLSD  449 (628)
Q Consensus       375 ~~~----~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~s~  449 (628)
                      ...    .....|+..|+|||++.+. .++.++|||||||++|||++ |..||......+.+.++......+..+..++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            322    2235688899999999765 49999999999999999998 89999988877777777666555667788999


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          450 DAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       450 ~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ++.+||.+||+.||++|||+.||++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999963

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=413.12  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=210.1

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCC-------cEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESG-------QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHG  289 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~  289 (628)
                      ..++|++++.||+|+||.||+|++..++       ..||||+++..    ........+.+|+.++.++ +|||||++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc----cChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            3579999999999999999999876554       47999988642    2234456788899898888 7999999999


Q ss_pred             ceeccccceEEEEecccccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          290 SELSDERLSVYLEYVSGGSIHKLLQEYG----------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       290 ~~~~~~~~~lVmEy~~GgsL~~~L~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      ++.+++.+++||||+.+|+|.++|....                .+++..++.++.||+.||+|||+++||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            9999999999999999999999997543                489999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      |++.++.+||+|||+++......   .....+||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.......
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            99999999999999998765432   23346799999999999765 59999999999999999998 799998766554


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ....+.. ...+..+..+++++.+||++||+.||++|||+.||++
T Consensus       246 ~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            4444443 4455778889999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=413.42  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=216.4

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEE-----CCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhC-CCCCeeeeecce
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFN-----SESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQL-SHPNIVRYHGSE  291 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIV~l~~~~  291 (628)
                      ..++|+++++||+|+||.||+|++     ..+++.||||+++...    .......+.+|+.++.++ +|||||++++++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            347999999999999999999986     3567899999986432    233456788999999999 599999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCce
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEYG------------------PFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANI  353 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~~------------------~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNI  353 (628)
                      .+.+.+|||||||.+|+|.++|++..                  .+++..++.|+.||+.||+|||+++||||||||+||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI  176 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence            99999999999999999999997543                  589999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEeccCCcccccCcc---ccccccCCCCcCChhhhhccCCCCccccccccccceeeecc-CCCCCCCCchhH
Q 040472          354 LVDPHGEIKLADFGMAKHMTSCA---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMAT-SKPPWSQYEGVA  429 (628)
Q Consensus       354 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLt-G~~PF~~~~~~~  429 (628)
                      ||+.++.+||+|||+++......   .....+||+.|+|||++.+. .++.++|||||||+||||+| |.+||.......
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765432   22346799999999999765 59999999999999999998 666676666655


Q ss_pred             HHhhhcCCCCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          430 AIFKIGNSKDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       430 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      .+.++......+..+..++.++.+||.+||+.||++||+++||++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            565555445556677789999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=408.74  Aligned_cols=257  Identities=24%  Similarity=0.389  Sum_probs=218.6

Q ss_pred             cccCCeEEeeeeccCCcEEEEEEEECC-----CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecce
Q 040472          217 NSLSKWKKGKLLGRGTFGHVYLGFNSE-----SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSE  291 (628)
Q Consensus       217 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~  291 (628)
                      ...++|++++.||+|+||.||+|.++.     +++.||||+++..    ...+....+.+|+++|++++|||||++++++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            345799999999999999999998752     4578999988632    2234456788999999999999999999999


Q ss_pred             eccccceEEEEecccccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCE
Q 040472          292 LSDERLSVYLEYVSGGSIHKLLQEY----------GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEI  361 (628)
Q Consensus       292 ~~~~~~~lVmEy~~GgsL~~~L~~~----------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~v  361 (628)
                      ..++.+++||||+.+|+|.+++...          ..+++..+..++.||+.||.|||+++||||||||+||||+.++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999998642          246889999999999999999999999999999999999999999


Q ss_pred             EEeccCCcccccCccc---cccccCCCCcCChhhhhccCCCCccccccccccceeeeccC-CCCCCCCchhHHHhhhcCC
Q 040472          362 KLADFGMAKHMTSCAS---MLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATS-KPPWSQYEGVAAIFKIGNS  437 (628)
Q Consensus       362 KL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG-~~PF~~~~~~~~~~~i~~~  437 (628)
                      ||+|||+|+.......   ....+||+.|+|||.+.+. .++.++|||||||+||||++| .+||......+.+..+...
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999986644322   2335689999999999765 489999999999999999998 5788877666666555543


Q ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc------Ccccc
Q 040472          438 KDIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD------HPFVR  479 (628)
Q Consensus       438 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~------Hpwf~  479 (628)
                      . .+.++..++..+.+||.+||+.||++||++.+|++      +|+|+
T Consensus       252 ~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         252 G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             C-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence            3 45677889999999999999999999999999987      56654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=402.17  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=202.1

Q ss_pred             EeeeeccCCcEEEEEEEECCCC---cEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceec-cccceE
Q 040472          224 KGKLLGRGTFGHVYLGFNSESG---QMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELS-DERLSV  299 (628)
Q Consensus       224 ~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~-~~~~~l  299 (628)
                      ..++||+|+||+||+|++..++   ..||||+++..    ......+++.+|+++|++++|||||++++++.. +..+++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            3678999999999999986543   36899988632    234456789999999999999999999999765 568999


Q ss_pred             EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCCcccccCcc--
Q 040472          300 YLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGMAKHMTSCA--  376 (628)
Q Consensus       300 VmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGla~~~~~~~--  376 (628)
                      |||||++|+|.+++... ..+.+..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++......  
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999998854 467788899999999999999999999999999999999999999999999998754332  


Q ss_pred             ---ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh-HHHhhhcCCCCCCCCCCcCCHHHH
Q 040472          377 ---SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV-AAIFKIGNSKDIPEIPEHLSDDAK  452 (628)
Q Consensus       377 ---~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~  452 (628)
                         ......||+.|+|||++.+. .++.++|||||||+||||++|..||...... .....+... ..+..+..+++++.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHH
T ss_pred             cceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHH
Confidence               12235689999999998765 4999999999999999999977777543332 222333322 33456778999999


Q ss_pred             HHHHHHhhcCCCCCCCHHHHhcC
Q 040472          453 SFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       453 dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                      +||.+||+.||++||++.||++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-47  Score=396.79  Aligned_cols=250  Identities=20%  Similarity=0.330  Sum_probs=198.1

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-eeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-VRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-V~l~~~~~~~~~~~  298 (628)
                      ++|++++.||+|+||+||+|++..+++.||||++......       .++.+|+++++.++|+|+ +.+.+++.+++..+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            4799999999999999999999999999999998753221       246789999999987665 55566677788899


Q ss_pred             EEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC---CCCEEEeccCCcccccC
Q 040472          299 VYLEYVSGGSIHKLLQ-EYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP---HGEIKLADFGMAKHMTS  374 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~---~g~vKL~DFGla~~~~~  374 (628)
                      +||||+. ++|.+.+. ..+.+++..+..++.||+.||+|||++|||||||||+|||++.   +..+||+|||+|+.+..
T Consensus        80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999995 55555554 4568999999999999999999999999999999999999864   44799999999987643


Q ss_pred             cc--------ccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchhHHHhhh------cCCCCC
Q 040472          375 CA--------SMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGVAAIFKI------GNSKDI  440 (628)
Q Consensus       375 ~~--------~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~~~~~~i------~~~~~~  440 (628)
                      ..        .....+||+.|||||++.+.. ++.++|||||||++|||++|..||...........+      ......
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            22        234567999999999997654 999999999999999999999999764432221111      101112


Q ss_pred             CCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHH---hcCccc
Q 040472          441 PEIPEHLSDDAKSFIKQCLQRDPSARPPASKL---LDHPFV  478 (628)
Q Consensus       441 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~ei---L~Hpwf  478 (628)
                      +.+...+++++.+||.+||+.||++||++.+|   |+|.|.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            23445788999999999999999999998755   556554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-46  Score=389.23  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=204.3

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC-CCeeeeecceeccccce
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH-PNIVRYHGSELSDERLS  298 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV~l~~~~~~~~~~~  298 (628)
                      ++|+++++||+|+||+||+|++..+++.||||++......       ..+.+|+++++.|.| +||+.+++++.++...|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            5899999999999999999999999999999988643221       245678999999975 89999999999999999


Q ss_pred             EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCC-----CCCEEEeccCCcccc
Q 040472          299 VYLEYVSGGSIHKLLQEY-GPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDP-----HGEIKLADFGMAKHM  372 (628)
Q Consensus       299 lVmEy~~GgsL~~~L~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~-----~g~vKL~DFGla~~~  372 (628)
                      +||||+ |++|.++++.. ..+++..+..++.|++.||+|||++|||||||||+||||+.     ++.+||+|||+|+.+
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 78999998765 47999999999999999999999999999999999999964     578999999999875


Q ss_pred             cCc--------cccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCch---hHHHhhhcC---CC
Q 040472          373 TSC--------ASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEG---VAAIFKIGN---SK  438 (628)
Q Consensus       373 ~~~--------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~---~~~~~~i~~---~~  438 (628)
                      ...        ......+||+.|||||++.+. .++.++|||||||++|||++|..||.....   .....++..   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            432        123456899999999999765 499999999999999999999999975432   122222211   11


Q ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCCCCCCCHHHHhc
Q 040472          439 DIPEIPEHLSDDAKSFIKQCLQRDPSARPPASKLLD  474 (628)
Q Consensus       439 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~eiL~  474 (628)
                      ...++...+++++.+||..|++.+|++||+++.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            122344568899999999999999999999887754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=389.62  Aligned_cols=247  Identities=25%  Similarity=0.320  Sum_probs=192.5

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCeeeeecceeccc----
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNIVRYHGSELSDE----  295 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~~~~~~~~----  295 (628)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++..    ...  ....+.|+..+.+++|||||++++++.+++    
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~----~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG----GHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            4788999999999999999986  5899999988531    111  122234666667889999999999988754    


Q ss_pred             cceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccccCCCceEeCCCCCEEEeccC
Q 040472          296 RLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHA--------RNTVHRDIKGANILVDPHGEIKLADFG  367 (628)
Q Consensus       296 ~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~--------~gIvHRDIKpeNILld~~g~vKL~DFG  367 (628)
                      .+|||||||.+|+|.++|++ ..+++..+..++.|++.||+|||.        +|||||||||+||||+.++++||+|||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            58999999999999999987 468999999999999999999996        599999999999999999999999999


Q ss_pred             CcccccCcc-----ccccccCCCCcCChhhhhccC-----CCCccccccccccceeeeccCCCCCCCCc-----------
Q 040472          368 MAKHMTSCA-----SMLSFKGSPYWMAPEVVMNTN-----GYSLTVDIWSLGCTVLEMATSKPPWSQYE-----------  426 (628)
Q Consensus       368 la~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvlLyelLtG~~PF~~~~-----------  426 (628)
                      +++......     .....+||+.|||||++.+..     .++.++|||||||+||||+||..||....           
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            998764432     223467999999999986432     25778999999999999999998874311           


Q ss_pred             ---hhHHHhhh-cCCCCCCCCCCc-----CCHHHHHHHHHHhhcCCCCCCCHHHHhcC
Q 040472          427 ---GVAAIFKI-GNSKDIPEIPEH-----LSDDAKSFIKQCLQRDPSARPPASKLLDH  475 (628)
Q Consensus       427 ---~~~~~~~i-~~~~~~~~~p~~-----~s~~l~dLI~~~L~~dP~~Rpta~eiL~H  475 (628)
                         ....+... ......+.++..     ....+.+||++||+.||++|||+.||+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               11112221 111222333332     23468999999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-45  Score=384.56  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=194.7

Q ss_pred             CCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-----------CCCeeeee
Q 040472          220 SKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-----------HPNIVRYH  288 (628)
Q Consensus       220 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIV~l~  288 (628)
                      .+|+++++||+|+||+||+|+++.+|+.||||+++..      ....+.+.+|+++|+.++           |+|||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            4699999999999999999999999999999998642      222356678888888775           57899999


Q ss_pred             cceecc--ccceEEEEecccccHHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCCCceEeCCCC---
Q 040472          289 GSELSD--ERLSVYLEYVSGGSIHKL-L--QEYGPFNEPVIQTYTRQILLGLAYLHA-RNTVHRDIKGANILVDPHG---  359 (628)
Q Consensus       289 ~~~~~~--~~~~lVmEy~~GgsL~~~-L--~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHRDIKpeNILld~~g---  359 (628)
                      +++...  ...+++|+++..+..... .  .....+.+..++.++.||+.||+|||+ .||+||||||+||||+.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            887653  456666666654443322 2  234678999999999999999999998 8999999999999998765   


Q ss_pred             ---CEEEeccCCcccccCccccccccCCCCcCChhhhhccCCCCccccccccccceeeeccCCCCCCCCchh--------
Q 040472          360 ---EIKLADFGMAKHMTSCASMLSFKGSPYWMAPEVVMNTNGYSLTVDIWSLGCTVLEMATSKPPWSQYEGV--------  428 (628)
Q Consensus       360 ---~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvlLyelLtG~~PF~~~~~~--------  428 (628)
                         .+||+|||.+.....  .....+||+.|+|||++... .|+.++|||||||++++|++|+.||...+..        
T Consensus       167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               399999999976543  33456799999999998765 4899999999999999999999999643221        


Q ss_pred             -HHHhhh-cC---------------------CCCC---------------CCCCCcCCHHHHHHHHHHhhcCCCCCCCHH
Q 040472          429 -AAIFKI-GN---------------------SKDI---------------PEIPEHLSDDAKSFIKQCLQRDPSARPPAS  470 (628)
Q Consensus       429 -~~~~~i-~~---------------------~~~~---------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpta~  470 (628)
                       .....+ ..                     ...+               .......++++.+||.+||+.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence             000000 00                     0000               112234568899999999999999999999


Q ss_pred             HHhcCccccch
Q 040472          471 KLLDHPFVRDQ  481 (628)
Q Consensus       471 eiL~Hpwf~~~  481 (628)
                      |||+||||++.
T Consensus       324 e~L~Hp~f~~~  334 (362)
T d1q8ya_         324 GLVNHPWLKDT  334 (362)
T ss_dssp             HHHTCGGGTTC
T ss_pred             HHhcCcccCCC
Confidence            99999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.2e-26  Score=218.85  Aligned_cols=167  Identities=20%  Similarity=0.186  Sum_probs=123.6

Q ss_pred             eEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc-------------cchHHHHHHHHHHHHHHHhCCCCCeeeee
Q 040472          222 WKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD-------------QTSKECLKQLNQEINLLSQLSHPNIVRYH  288 (628)
Q Consensus       222 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-------------~~~~~~~~~~~~Ei~iL~~l~HpnIV~l~  288 (628)
                      +.++++||+|+||+||+|++. +|+.||||+++.....             .........+.+|+.+|.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            357899999999999999985 6899999987532110             01122234466789999999999999887


Q ss_pred             cceeccccceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCCCceEeCCCCCEEEeccCC
Q 040472          289 GSELSDERLSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGLAYLHARNTVHRDIKGANILVDPHGEIKLADFGM  368 (628)
Q Consensus       289 ~~~~~~~~~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHRDIKpeNILld~~g~vKL~DFGl  368 (628)
                      ++.    ..++||||+.+..+.+       +.+..+..++.||+.+|+|||++||+||||||+||||+.+ .++|+|||+
T Consensus        81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            653    3479999999876543       4566678899999999999999999999999999999854 599999999


Q ss_pred             cccccCccccccccCCCCcCCh------hhhhccCCCCcccccccccc
Q 040472          369 AKHMTSCASMLSFKGSPYWMAP------EVVMNTNGYSLTVDIWSLGC  410 (628)
Q Consensus       369 a~~~~~~~~~~~~~GT~~Y~AP------Evl~~~~~~s~ksDIWSLGv  410 (628)
                      |.........       .|...      |.+ . ..|+.++|+||+.-
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~  187 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAID  187 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHH
Confidence            9765432111       12111      222 2 24889999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.53  E-value=8.6e-08  Score=93.57  Aligned_cols=142  Identities=13%  Similarity=0.084  Sum_probs=91.8

Q ss_pred             ccCCeEEeeeeccCCcEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeecceecccc
Q 040472          218 SLSKWKKGKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSELSDER  296 (628)
Q Consensus       218 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~~~~~  296 (628)
                      .++.|+..+..+.++.+.||+..  .+++.++||........     ....+.+|..+|+.+. +--+.+++.++.+++.
T Consensus        12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-----chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            45678887776666667999884  34667888876432111     1234567888887775 3336677888888888


Q ss_pred             ceEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHH-----------------------------------------
Q 040472          297 LSVYLEYVSGGSIHKLLQEYGPFNEPVIQTYTRQILLGL-----------------------------------------  335 (628)
Q Consensus       297 ~~lVmEy~~GgsL~~~L~~~~~l~e~~~~~i~~qIl~aL-----------------------------------------  335 (628)
                      .|+||++++|..+.......     .....++.++...|                                         
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999998875543210     00111222222222                                         


Q ss_pred             ------------HHHHhC------CccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          336 ------------AYLHAR------NTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       336 ------------~yLH~~------gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                                  ..+.+.      .++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                        223222      278999999999998766667999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.12  E-value=2.1e-06  Score=89.65  Aligned_cols=82  Identities=17%  Similarity=0.143  Sum_probs=50.1

Q ss_pred             eeeeccCCcEEEEEEEECCCCcEEEEEEEeecccc--cchHHHHHHHHHHHHHHHhCC-C--CCeeeeecceeccccceE
Q 040472          225 GKLLGRGTFGHVYLGFNSESGQMCAIKEVRVVCDD--QTSKECLKQLNQEINLLSQLS-H--PNIVRYHGSELSDERLSV  299 (628)
Q Consensus       225 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~iL~~l~-H--pnIV~l~~~~~~~~~~~l  299 (628)
                      .+.||.|....||++.+..+++.|+||.-......  ........+...|+.+|+.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45689999999999988777889999964321110  000111234556888877663 2  345566543  4567789


Q ss_pred             EEEeccccc
Q 040472          300 YLEYVSGGS  308 (628)
Q Consensus       300 VmEy~~Ggs  308 (628)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=6.4e-06  Score=79.42  Aligned_cols=136  Identities=18%  Similarity=0.068  Sum_probs=83.1

Q ss_pred             eeccCCc-EEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCC--CCeeeeecceeccccceEEEEe
Q 040472          227 LLGRGTF-GHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSH--PNIVRYHGSELSDERLSVYLEY  303 (628)
Q Consensus       227 ~LG~G~f-G~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIV~l~~~~~~~~~~~lVmEy  303 (628)
                      .+..|.. +.||+.... ++..++||......        ...+..|+.+|+.|..  -.+.+++.+..+++..++||||
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            3445543 689998653 46678889764321        1235667777776653  2356778888888899999999


Q ss_pred             cccccHHH--------------HHHhcCC-------CCH--HH-----HHHH---------------HHHHHHHHHHHHh
Q 040472          304 VSGGSIHK--------------LLQEYGP-------FNE--PV-----IQTY---------------TRQILLGLAYLHA  340 (628)
Q Consensus       304 ~~GgsL~~--------------~L~~~~~-------l~e--~~-----~~~i---------------~~qIl~aL~yLH~  340 (628)
                      ++|.++.+              +|.+-..       +..  ..     ...+               ...+...+..+..
T Consensus        88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (255)
T d1nd4a_          88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  167 (255)
T ss_dssp             CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            99876532              1111111       100  00     0000               0012334455544


Q ss_pred             C-------CccccccCCCceEeCCCCCEEEeccCCccc
Q 040472          341 R-------NTVHRDIKGANILVDPHGEIKLADFGMAKH  371 (628)
Q Consensus       341 ~-------gIvHRDIKpeNILld~~g~vKL~DFGla~~  371 (628)
                      +       .+||+|+.+.|||++.++.+-|+||+.+..
T Consensus       168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            3       279999999999998776678999998753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.41  E-value=0.00018  Score=72.34  Aligned_cols=69  Identities=17%  Similarity=0.074  Sum_probs=43.1

Q ss_pred             cEEEEEEEECCCCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCCCCCe-----eeee--cceeccccceEEEEecc
Q 040472          233 FGHVYLGFNSESGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLSHPNI-----VRYH--GSELSDERLSVYLEYVS  305 (628)
Q Consensus       233 fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-----V~l~--~~~~~~~~~~lVmEy~~  305 (628)
                      --.||++.. .+|..|++|+.+.....      .+++..|+.+|..|....|     +..-  ..+..++..+.+++++.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWT------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSC------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCC------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            357999965 46888999988642211      2456678888877753222     1111  12344667888899988


Q ss_pred             ccc
Q 040472          306 GGS  308 (628)
Q Consensus       306 Ggs  308 (628)
                      |..
T Consensus       108 G~~  110 (325)
T d1zyla1         108 GRQ  110 (325)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            744

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.12  E-value=0.00051  Score=70.82  Aligned_cols=77  Identities=16%  Similarity=0.082  Sum_probs=50.5

Q ss_pred             CeEEeeeeccCCcEEEEEEEECC-------CCcEEEEEEEeecccccchHHHHHHHHHHHHHHHhCC-CCCeeeeeccee
Q 040472          221 KWKKGKLLGRGTFGHVYLGFNSE-------SGQMCAIKEVRVVCDDQTSKECLKQLNQEINLLSQLS-HPNIVRYHGSEL  292 (628)
Q Consensus       221 ~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIV~l~~~~~  292 (628)
                      ++++ +.|+.|---.+|++....       ..+.|.+++.- ..  ..    .....+|..+++.+. +.-..++++++.
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ET----ESHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CC----HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--ch----hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            3444 679999999999998653       24567666653 11  11    123457888888886 433457777764


Q ss_pred             ccccceEEEEecccccH
Q 040472          293 SDERLSVYLEYVSGGSI  309 (628)
Q Consensus       293 ~~~~~~lVmEy~~GgsL  309 (628)
                      +    .+||||++|..|
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            3    689999988654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.73  E-value=0.0011  Score=65.50  Aligned_cols=30  Identities=23%  Similarity=0.231  Sum_probs=26.6

Q ss_pred             CCccccccCCCceEeCCCCCEEEeccCCcc
Q 040472          341 RNTVHRDIKGANILVDPHGEIKLADFGMAK  370 (628)
Q Consensus       341 ~gIvHRDIKpeNILld~~g~vKL~DFGla~  370 (628)
                      .|+||+|+.++|||++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999988777899999874